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IN THE SUPREME COURT OF THE STATE OF IDAHO 
BILLIE JO MAJOR, an individual, 
Plaintiff-Appellant -Cross Respondent, 
vs. 
SECURITY EQUIPMENT CORPORATION, a 
Missouri corporation, 
Defendant-Respondent-Cross Appellant. 
Supreme Court Docket No. 39414-2011 
CLERK'S RECORD ON APPEAL 
Appeal from the District Court of the Fourth Judicial District, in and for the County of Ada. 
HONORABLE CHERI C. COPSEY 
DARWIN OVERSON CHRISTOPHER C. BURKE 
ATTORNEY FOR APPELLANT ATTORNEY FOR RESPONDENT 
BOISE, IDAHO BOISE, IDAHO 
000002
Date: 4/2/2012 Fourth Judicial District Court - Ada County User: CCLUNDMJ 
Time: 11 :02 AM ROA Report 
Page 1 of 8 Case: CV-PI-2010-03515 Current Judge: Cheri C. Copsey 
Billie Jo Major vs. Security Equipment Corporation 
Billie Jo Major vs. Security Equipment Corporation 
Date Code User Judge 
2/24/2010 NCPI CCHOLMEE New Case Filed - Personal Injury Cheri C. Copsey 
COMP CCHOLMEE Complaint Filed Cheri C. Copsey 
SMFI CCHOLMEE Summons Filed Cheri C. Copsey 
4/5/2010 ANSW CCHOLMEE Answer to Complaint and Demand for Jury Trial Cheri C. Copsey 
(Burke for Security Equipment Corpoartion) 
4/8/2010 AFOS CCMASTLW Affidavit Of Service (03/16/10) Cheri C. Copsey 
4/21/2010 NOTS CCNELSRF Notice Of Service Cheri C. Copsey 
4/26/2010 HRSC TCWEATJB Hearing Scheduled (Status by Phone Cheri C. Copsey 
OS/21/201008:30 AM) 
5/7/2010 STIP CCGARDAL Stipulation for Scheduling and Planning Cheri C. Copsey 
5/21/2010 CONV CCCHILER Hearing result for Status by Phone held on Cheri C. Copsey 
OS/21/201008:30 AM: Conference Vacated ; 
submitted stipulation 
5/28/2010 ORDR CCCHILER Order Governing Proceedings and Setting Trial Cheri C. Copsey 
HRSC CCCHILER Hearing Scheduled (Jury Trial 07/25/2011 09:00 Cheri C. Copsey 
AM) 11 days 
HRSC CCCHILER Hearing Scheduled (Pretrial Conference Cheri C. Copsey 
07/14/2011 04:30 PM) 
6/8/2010 AFOS CCWRIGRM Affidavit Of Service (06/07/10) Cheri C. Copsey 
6/10/2010 AFOS CCMASTLW Affidavit Of Service (06/09/10) Cheri C. Copsey 
6/25/2010 NOTC CCCHILER Notice of Compliance Cheri C. Copsey 
8/5/2010 NOTC CCNELSRF Notice of Compliance Cheri C. Copsey 
12/20/2010 NOTS CCJOYCCN Notice Of Service Cheri C. Copsey 
1/11/2011 NOTS CCJOYCCN Notice Of Service Cheri C. Copsey 
1/21/2011 NOTS CCNELSRF Notice Of Service Cheri C. Copsey 
1/26/2011 ORDR TCWEATJB Confidentiality Order Cheri C. Copsey 
NOTS CCSULLJA Notice Of Service Cheri C. Copsey 
2/4/2011 AFOS CCCHILER Affidavit Of Service (1/31/11) Cheri C. Copsey 
AMEN CCCHILER Amended Notice of Taking Deposition of Karin A Cheri C. Copsey 
Pacheco, M.D., MSPH 
NOTD CCCHILER Notice Of Taking Deposition of Karin A Pacheco, Cheri C. Copsey 
MD., MSPH 
2/8/2011 STIP CCNELSRF Stipulation to Enlarge Time for Expert Disclosures Cheri C. Copsey 
by 30 Days 
2/9/2011 NOTS CCNELSRF Notice Of Service Cheri C. Copsey 
·2/10/2011 OR DR TCWEATJB Order For Enlargement Of Time To Disclose Cheri C. Copsey 
Expert Witnesses 
2/14/2011 ACCP CCNELSRF (2) Acceptance Of Service 02/14/11 Cheri C. Copsey 
2/16/2011 NOTS CCDWONCP Notice Of Service of Defendant's Responses to Cheri C. Copsey 
Plaintiffs Third Set of Discovery Requests 
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Notice of Taking Rule 30(b)(6) Deposition Duces Cheri C. Copsey 
Tecum of Defendant Security Equipment 
Corporation 
Amended Notice of Taking Deposition Duces 
Tecum of Security Equipment Corporation 
Notice Of Service 
Notice Of Service 
Notice of Compliance 
Notice Of Service of Defendant's Responses to 
Plaintiffs Fourth Set of Discovery Requests 
Notice of Compliance 
Security Equipment Corp's Motion For Summary 
Judgment 
Affidavit of Christopher Reilly PhD 
Document sealed 
Affidavit of Robert Nance 
Document sealed 
Affidavit of Counsel 
Document sealed 
Memorandum in Support 
Defendants Expert Disclosures 
Hearing Scheduled (Status by Phone 
05/13/2011 09:00 AM) 
Hearing result for Status by Phone held on 
05/13/2011 09:00 AM: Hearing Held 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Continued (Jury Trial 10/17/2011 09:00 AM) 
days 
11 Cheri C. Copsey 
Continued (Pretrial Conference 09/22/2011 
04:30 PM) 
Hearing Scheduled (Motion for Summary 
Judgment 07/14/2011 03:00 PM) 
Cheri C. Copsey 
Cheri C. Copsey 
Order Governing Proceedings and Setting Trial Cheri C. Copsey 
Supplemental Affidavit of Counsel in Support of Cheri C. Copsey 
Motion for Summary Judgment 
Stipulation to Enlarge the Time for Plaintiffs Cheri C. Copsey 
Rebuttal Expert Disclosures 
Notice of Compliance Cheri C. Copsey 
Order For Enlargement Of Time To Disclose Cheri C. Copsey 
Plaintiffs Rebuttal Expert Witnesses 
Plaintiffs Disclosure of Rebuttal Expert Witness Cheri C. Copsey 
Testimony 
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Plaintiffs Opposition to Motion for Summary 
Judgment and Memorandum in Support of 
Cross-Motion 
Affidavit of Counsel 
Document sealed 
Affidavit of Garold S. Yost, Ph .D. 
Affidavit of J.P. Purswell , Ph.D., P.E., CPE 
Notice Of Hearing (7/14/2011 @3:00 PM) 
Judge 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Notice Of Hearing (07/14/2011 at 3:00 p.m.) RE: Cheri C. Copsey 
Plaintiffs Cross-Motion for Partial Summary 
Judgment 
Sec's Motion to Strike 
Affidavit of Thomas J. Lloyd 
Memorandum in Support 
Reply Memorandum in Support of Defendant's 
Motion for Summary Judgment 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Memorandum In Opposition To Cross Motion For Cheri C. Copsey 
Partial Summary Judgment 
Affidavit Of Christopher Burke In Support Of Cheri C. Copsey 
Opposition To Cross Motion For Summary 
Judgment 
Affidavit Of Nicholas Roberts In Support Of Cheri C. Copsey 
Opposition To Cross Motion For Summary 
Judgment 
Second Affidavit Of Robert Nance In Support Of Cheri C. Copsey 
Opposition To Cross Motion For Summary 
Judgment 
Affidavit of Thomas J Lloyd III In Support of Cheri C. Copsey 
Opposition to Cross Motion for Summary 
Judgment 
Opposition to Motion to Strike Portions of the 
Affidavit of Garold Yost 
Reply to Opposition to Cross Motion for Partial 
Summary Judgment 
Cheri C. Copsey 
Cheri C. Copsey 
Amended Affidavit of J P Purswell Cheri C. Copsey 
Ex Parte Motion to Strike Amended Affidavit of JP Cheri C. Copsey 
Purswell Filed in Opposition to Motion for 
Summary Judgment 
Motion for Order Shortening Time for Filing the Cheri C. Copsey 
Amended Affidavit of Dr Purswell 
Affidavit of Counsel in Opposition to Defendants Cheri C. Copsey 
Ex Parte Motion to Strike Dr Purswells Amended 
Affidavit and in Support of Plaintiffs Motion to 
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Billie Jo Major vs. Security Equipment Corporation 
Date Code User 
7/12/2011 OBJC CCVIDASL 
7/13/2011 CO NT TCWEATJB 
7/14/2011 CO NT TCWEATJB 
DCHH TCWEATJB 
7/19/2011 ORDR TCWEATJB 
7/22/2011 MOSJ CCMASTLW 
AFFD CCMASTLW 
MEMO CCMASTLW 
7/25/2011 SCHE TCWEATJB 
HRSC TCWEATJB 







7/29/2011 NOHG CCSWEECE 




Plaintiffs Objection and Opposition to Secs Ex Cheri C. Copsey 
Parte Moiton to Strike Amended Affidavit of J P 
Purswell Filed in Opposition to Defendants Motion 
for Summary Judgment 
Continued (Motion for Summary Judgment Cheri C. Copsey 
09/15/2011 03:00 PM) Plaintiffs Cross-Motion for 
Partial Summary Judgment 
Continued (Motion for Summary Judgment Cheri C. Copsey 
07/14/2011 03:00 PM) Plaintiffs Cross-Motion for 
Partial Summary Judgment 
Hearing result for Motion for Summary Judgment Cheri C. Copsey 
scheduled on 07/14/2011 03:00 PM: District 
Court Hearing Held 
Court Reporter: Kim Madsen 
Number of Transcript Pages for this hearing 
estimated: Under 100 Pages 
Order Re Pending Motions For Summary Cheri C. Copsey 
Judgment And To Strike Affidavit Of Gerald Yost 
Defendants' 2nd Motion For Summary Judgment Cheri C. Copsey 
2nd Affidavit of Christopher Burke 
Memorandum in Support 
Scheduling Order 
Hearing Scheduled (Motion for Summary 
Judgment 09/15/2011 02:30 PM) 
(2) Notice of Compliance 
Motion for Reconsideration 
Affidavit of Counsel 
Affidavit of Billie Jo Major 
Affidavit of Garold Yost Ph.D 
Memorandum in Support 
Plaintiffs 2nd Supplemental Expert Witness 
Disclosure 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Notice Of Hearing On Plaintiffs Motion For Cheri C. Copsey 
Reconsideration (09-15-11 @2:30 pm) 
SEC's Motion to Strike Portions of Second Cheri C. Copsey 
Affidavit of Gerold S. Yost, Ph.d Filed in Support 
of Plaintiffs Motion for Reconsideration 
Affidavit of Thomas J. Lloyd III in Support of Cheri C. Copsey 
SEC's Motion to Strike Portions of Second 
Affidavit of Gerold S. Yost, Ph.d 
Memorandum in Support of SEC's Motion to Cheri C. Copsey 
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Billie Jo Major vs. Security Equipment Corporation 
Date Code User Judge 
8/26/2011 MEMO CCDWONCP Reply Memorandum in Support of Defendant's Cheri C. Copsey 
Second Motion for Summary Judgment and in 
Opposition to Plaintiffs Motion for 
Reconsideration 
9/1/2011 NOHG CCRANDJD Notice Of Hearing re Motion to Strike Portions of Cheri C. Copsey 
Second Affidavit of Gerold Yost 
(09.15.11@2:30pm) 
9/8/2011 NOTC TCWEGEKE Notice of Compliance Cheri C. Copsey 
OPPO TCWEGEKE Plaintiffs Opposition to SEC's Motion to Strike Cheri C. Copsey 
Portions of the Second Affidavit of Garold S. Yost 
AFFD TCWEGEKE Affidavit of Counsel in Opposition to SEC's Motion Cheri C. Copsey 
to Strike 
REPL TCWEGEKE Reply Memorandum in Support of Plaintiffs Cheri C. Copsey 
Motion for Reconsideration 
9/15/2011 BREF CCDWONCP Plaintiffs Trial Brief Cheri C. Copsey 
PLWI CCDWONCP Plaintiffs Witness List Cheri C. Copsey 
PLEX CCDWONCP Plaintiffs Exhibit List for Trial Cheri C. Copsey 
MISC CCDWONCP Plaintiffs' Proposed Jury Instructions Cheri C. Copsey 
HRHD CCCHILER Hearing result for Motion for Summary Judgment Cheri C. Copsey 
scheduled on 09/15/2011 02:30 PM: Hearing 
Held and Motion for Reconsideration and Motion 
to Strike Portions of Second Affidavit of Gerald 
Yost 
9/16/2011 MOTN CCRANDJD Motion in Limine Cheri C. Copsey 
AFSM CCRANDJD Affidavit In Support Of Motion Cheri C. Copsey 
MEMO CCRANDJD Memorandum in Support of Motion in Limine Cheri C. Copsey 
9/20/2011 MOTN CCWRIGRM Defendants Motion for Clarification Cheri C. Copsey 
AFFD CCWRIGRM Affidavit of Counsel in Support of Motion Cheri C. Copsey 
MEMO CCWRIGRM Memorandum in Support of Defenadnts Motion Cheri C. Copsey 
for Clarification 
MOTN CCNELSRF Defs Motion In Limine No. 1 to Exclude Evidence Cheri C. Copsey 
of Damages Outside of Three Day Period 
Following 3/3/2008 Exposure 
MEMO CCNELSRF Memorandum in Support of Defs Motion In Cheri C. Copsey 
Limine No. 1 to Exclude Evidence of Damages 
Outside of Three Day Period Following 3/3/2008 
Exposure 
9/21/2011 MOTN CCSWEECE Motion To Vacate Trial (Overson for Plaintiff) Cheri C. Copsey 
OPPO CCWRIGRM Defendants Opposition to Plaintiffs Motion to Cheri C. Copsey 
Vacate Trial 
9/22/2011 OBJE MCBIEHKJ Objection to Defendants Proposed Order Cheri C. Copsey 
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Billie Jo Major vs. Security Equipment Corporation 
Billie Jo Major vs. Security Equipment Corporation 
Date Code User 
9/22/2011 AFFD CCNELSRF Affidavit of Counsel in Support of Plfs Motion to 
Vacate the Trial and In Response to Defs 
Objection to the Motion to Vacate 
DCHH TCWEATJB Hearing result for Pretrial Conference scheduled 
on 09/22/2011 04:30 PM: District Court Hearing 
Held 
Court Reporter: Kim Madsen 
Number of Transcript Pages for this hearing 
estimated: Under 100 Pages 
HRVC TCWEATJB Hearing result for Jury Trial scheduled on 
10/17/2011 09:00 AM: Hearing Vacated 11 days 
HRSC TCWEATJB Hearing Scheduled (Motion for Summary 
Judgment 10/17/2011 09:00 AM) 
9/29/2011 STIP CCMASTLW Stipulation for Briefing Schedule 
10/4/2011 MOTN CCMASTLW Pltfs Motion for Reconsideration of Court's Order 
Granting Defendant's Motions for Summary 
Judgment 
AFFD CCMASTLW Affidavit of Billie Jo Major 
AFFD CCMASTLW Affidavit of Counsel 
MEMO CCMASTLW Memorandum in Opposition to Defs Motion for 
Clarification and in Support of Pltfs Motion for 
Reconsideration 
10/11/2011 MEMO CCWRIGRM Defendants Memorandum in Opposition to 
Plaintiffs Second Motion for Reconsideration and 
in Reply to Plaintiffs Opposition to Defendants 
Motion for Clarification 
10/12/2011 CONT TCWEATJB Continued (Motion for Summary Judgment 
10/17/201103:00 PM) 
10/14/2011 NOTH TCWEGEKE Notice Of Hearing 
10/17/2011 DCHH TCWEATJB Hearing result for Motion for Summary Judgment 
scheduled on 10/17/2011 03:00 PM: District 
Court Hearing Held 
Court Reporter: Kim Madsen 
Number of Transcript Pages for this hearing 
estimated: Under 100 Pages 
10/20/2011 ORDR TCWEATJB Order Granting Defendant's Motions For 
Summary Judgment, Striking Affidavit Of Gerold 
Yost And Denying Plaintiffs Motions For 
Reconsideration 
JDMT TCWEATJB Judgment 
CDIS TCWEATJB Civil Disposition entered for: Security Equipment 
Corporation, Defendant; Major, Billie Jo, Plaintiff. 
Filing date: 10/20/2011 
STAT TCWEATJB STATUS CHANGED: Closed 
User: CCLUNDMJ 
Judge 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
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ROA Report 
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Billie Jo Major vs. Security Equipment Corporation 
Billie Jo Major vs. Security Equipment Corporation 
Date Code User 
10/24/2011 MOTN CCBOYIDR Plaintiffs Motion for Reconsideration of the 
Court's Orders Granting Defendant's Motion to 
Strike the Affidavit of DR. Yost, and Motions for 
Summary Judgment 
AFFD CCBOYIDR Affidavit of Garold S. Yost, PH. D., in Support of 
Plaintiffs Motion for Reconsideration of this 
Court's Order Striking the Second Affidavit of DR. 
Yost 
MEMO CCBOYIDR Memorandum in Support of Plaintiffs Motion for 
Reconsideration of the Court's Orders Granting 
Defendant's Motion to Strike the Affidavit of DR. 
Yost, and Motions for Summary Judgment 
10/25/2011 MISC CCNELSRF Errata RE: Affidavit of Garold S. Yost PHD, In 
Support of Plfs Motion for Reconsideration of this 
Court's Order Striking the Second Affidavit of Dr. 
Yost 
11/3/2011 MECO CCNELSRF Security Equipment Corp's Memorandum of Cost 
11/10/2011 NOHG CCRANDJD Notice Of Hearing re Motion for Reconsideration 
of the Courts Orders Granting Motion to Strike 
(12.15.11@4pm) 
HRSC CCRANDJD Hearing Scheduled (Motion 12/15/2011 04 :00 
PM) Motion for Reconsideration of the Courts 
Order Granting Motion to Strike Affidavit 
STAT CCRANDJD STATUS CHANGED: Closed pending clerk 
action 
11/23/2011 APSC CCTHIEBJ Appealed To The Supreme Court 
12/1/2011 MOTN CCVIDASL Motion to Strike Third Affidavit of Garold Yost 
PHD Filed in Support of Plaintiffs Motion for 
Reconsideration 
MOTN CCVIDASL Motion for Award of Attorney Fees and Costs 
AFFD CCVIDASL Affidavit of Counsel in Support of Security 
Equipment Corporations Motion for Award of 
Attorney Fees and Costs 
MEMO CCVIDASL Memorandum in Opposition to Plaintiffs Third 
Motion for Reconsideration and in Support of 
Security Equipment Corporations Motion to Strike 
Third Affidavit of Garold Yost and for Award of 
Attorney Fees and Costs 
NOHG CCVIDASL Notice Of Hearing Re Motions to Strike Third 
Affidavit of Garold Yost and for Attorney Fees and 
Costs (12.15.11 @ 4:00 pm) 
12/5/2011 RQST CCSWEECE Security Equipment Corporations Request For 
Additional Record 
12/8/2011 MOTN CCDEREDL Motion to Shorten Time for Consideration of 
Plaintiffs Motion for Reconsideration for a 
Continuance of the Hearing 
User: CCLUNDMJ 
Judge 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
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Billie Jo Major vs. Security Equipment Corporation 
Date Code User 
12/8/2011 MOTN CCDEREDL Motion to Enlarge Time for Submitting Affidavit 
Showing Mistake Inadvertence or Excusable 
Neglect Under IRCP 60(b) 
AFFD CCDEREDL Affidavit of Counsel in Support of Plaintiffs Reply 
MISC CCDEREDL Plaintiffs Reply re: Third Motion for 
Reconsideration 
12/9/2011 CONT TCWEATJB Continued (Motion 01/26/201203:00 PM) 
Motion for Reconsideration of the Courts Order 
Granting Motion to Strike Affidavit and Motions to 
Strike Third Affidavit of Garold Yost and for 
Attorney Fees and Costs 
NOTH TCWEGEKE Notice Of Hearing 
12/13/2011 REPL CCNELSRF Reply Memorandum in Support of Security 
Equipment Corp's Motion to Srike Third Affidavit 
of Garold Yost 
1/26/2012 DCHH TCWEATJB Hearing result for Motion scheduled on 
01/26/201203:00 PM: District Court Hearing Hel( 
Court Reporter: Kim Madsen 
Number of Transcript Pages for this hearing 
estimated: Under 100 Pages 
2/3/2012 ORDR TCWEATJB Order Denying Plaintiffs Third Motion For 
Reconsideration , Denying Defendant's Motion To 
Strike Third Affidavit Of Garald Yost, Denying 
Defendant's Motion For Rule 56(c) Attorney Fees, 
And Awarding Defendant Costs 
AMJD TCWEATJB Amended Judgment 
2/21/2012 AMEN CCLUNDMJ Amended Notice of Appeal 
(file stamped 02/17/2012) 
2/27/2012 APSC CCLUNDMJ Notice of Cross-Appeal (Security Equipment 
Corp) 
REQU CCLUNDMJ Request for Additional Record Following 
Appellant's Amended Notice of Appeal (Security 
Equipment Corp) 
3/6/2012 NOCA CCWRIGRM Notice Of Change Of Address 




Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
Cheri C. Copsey 
r
W
Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220








FEB 2 4 2010
J DAVID N VARRO Clerk
By E HOWES
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA







CV P 1 0351
COMPLAINT AND
DEMAND FORJURY TRIAL
COMES NOW the above captioned Plaintiff by and through her attorneys of record
Jones Swartz PLLC and for her claims against the Defendant captioned above complains and
alleges as follows
GENERAL ALLEGATIONS
1 At all times mentioned herein Plaintiff Plaintiff or Ms Major was a
resident of Ada county state of Idaho and is a citizen of the state of Idaho for jurisdictional
purposes





Z -CJ --c: 
o 
Darwin Overso , ISB #5 87 
Eric B. S artz, ISB #6396 
JONES & S , PLLC 
1673 W. Shoreline Drive, Suite 220 
Post Office Box 7808 
Boise, ID 83707 
Telephone: (208) 489-8989 
Facsimile: (208) 489-8988 
Attorneys for Plaintiff, Billie Jo Major 
NO' ___ ~=~FE::;:-__ _ 
FILED 0 A.M ____ -tP.M ___ _ 
FE  242010 
J. AVI  AV , Clerk 
By E. HOlJJlES 
DEPUTY 
IN HE IS I  RT F E  J I I  IS I   
E TE F I , I    E    
BILLIE JO AJOR, and individual, 
Plaintiff, 
vs. 
SECURITY EQUIPMENT CORPORATION, 
a Missouri corporation, 
f ndant. 
CV  I 100 351' , 
ase . ------------------
  
    
S  the above-captioned Plaintiff, by and through her attorneys of record, 
Jones & Swartz PLLC, and for her clai s against the Defendant captioned above, co plains and 
alleges as follows: 
  
1. At all ti s enti d herein, Plaintiff ("Pl intiff' or " s. j r") was a 
resident of Ada county, state of Idaho, and is a citizen of the state of Idaho for jurisdictional 
purposes. 
COMPLAINT AND DEMAND FOR mRY TRIAL - 1 
2 At all times mentioned herein the Defendant Security Equipment Corporation
was a Missouri corporation conducting business in Idaho and therefore subject to the long arm
jurisdiction of this Court pursuant to Idaho Code 5514 and the Due Process Clause of the
United States Constitution
3 Venue is proper in Ada County pursuant to Idaho Code 5404
4 The amount in controversy exceeds 10000 the jurisdictional minimum of this
Court
5 In July 2004 Ms Major was hired by the Idaho Department of Corrections
IDC as a prison guard While employed with the IDC Ms Major was trained in the use of
5 oleoresin capsicum pepper spray OC Spray Part of the training consisted ofMs Major
entering a room that had been sprayed with 5 OC Spray where she would spend 10 to 12
seconds inducing her to cough After training with 5 OC Spray for a total of four hours
Ms Major was provided 10 OC Spray as a less than lethal tool for protection and prisoner
control During her normal work day Ms Major was exposed to OC Spray through the process
ofbreaking up fights between prisoners and decontaminating prisoners who had been exposed to
OC Spray In the course ofher job performance Ms Major would commonly get OC Spray on
her clothes and be required to perform an eighthour work shift without being able to change out
of the clothes that had been contaminated with OC Spray
6 Predating her employment at IDC Ms Major had a history of one to two episodes
ofbronchitis per year characterized by symptoms of earache yellow nasal drainage sore throat
and cough A seven to tenday course of antibiotics normally resolved the condition but on
several occasions she also required the use of an inhaler Between these episodes of bronchitis
she did not experience residual symptoms After approximately one year of employment at IDC
COMPLAINT ANDDEMAND FOR JURYTRIAL 2
000011
2. At a l times mentioned here , the Defen , Security Equipment or , 
was a Missouri corporation, conducting business in Idaho, and therefore subject to the long arm 
jurisdiction of this Court pursuant to Idaho Code § 5-514 a  the ue Proce s Clause of the 
United States Co stit ti . 
3. Venue is proper in Ada County pursuant to Idaho Code § 5-40 . 
4. The a ount in controversy e ceeds $1 ,0 0, the jurisdictional inimu   this 
rt. 
. In July 2004, s. ajor as hired by the Idaho epart ent f orrections 
("IDC") as a prison guard. hile e ployed ith the I , s. ajor as trained in the use of 
5% oleoresin capsicum pepper spray ("OC Spray"). Part of the training consisted of Ms. Major 
entering a room that had been sprayed with 5% OC Spray, where she would spend 10 to 12 
seconds, inducing her to cough. fter   %        , 
Ms. Major was provided 10% DC Spray as a less than lethal tool for protection and prisoner 
control. uring her nor al ork day, s. ajor as exposed to  Spray through the process 
of breaking up fights between prisoners and decontaminating prisoners who had been exposed to 
DC Spray. In the course of her job performance, Ms. Major would commonly get OC Spray on 
her clothes and be required to perform an eight-hour work shift without being able to change out 
f t e cl t es t at a  ee  c ta i ate  it   pray. 
. Predating her employment at IDC, s. ajor had a history of one to two episodes 
of bronchitis per year, characterized by symptoms of earache, yellow nasal drainage, sore throat, 
and cough. A seven to ten-day course of antibiotics nor ally resolved the condition, but on 
several occasions she also required the use of an inhaler. Bet een these episodes of bronchitis 
she did not experience residual symptoms. After approximately one year of employment at IDC, 
COMPLAINT AND DEM  FOR JURy TRIAL - 2 
Ms Major began to experience more frequent episodes of bronchitis with an cough that would
continue during the periods between episodes ofbronchitis
7 In February 2008 Ms Major was placed on light duty for three weeks due to an
episode of bronchitis and sinusitis with cough Light duty consisted of opening and closing
security doors electronically for other guards and did not include direct exposure to OC Spray
8 On March 3 2008 Ms Major completed a mandatory training involving cell
extraction and OC Spray Prior OC Spray training had always been conducted with 5 OC
Spray However the March 3 2008 training was performed with Defendantsproduct sold under
the name ofSabre Red which is a 10 OC Spray Defendant advertises its Sabre Red OC Spray
to be 8 to 88 stronger than the competition Defendant advertises in its marketing
literature that its Sabre Red OC Spray is the most potent defense spray on the market and that it
is from twenty 20 all the way up to ninetyfive 95 percent hotter than other USA brands
Scoville Heat Units is one method of measuring the potency of an OC Spray product and
Defendant advertises its Sabre Red OC Spray product to be2000Scoville Heat Units which
is significantly higher than other OC Spray products on the market and 400 times as hot as an
average jalapeno pepper On another measure Defendant advertises its Sabre Red OC Spray
product as containing 133Major Capsaicinoids which are the pharmacologically active and
pain producing components of the hot pepper and the active ingredients in Oleoresin Capsicum
that make it effective as a law enforcement tool Defendant advertises that its Sabre Red OC
Spray has the highest content ofMajor Capsaicinoids ofany OC Spray on the market
9 The only warnings included with DefendantsSabre Red OC Spray product are as
follows
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Ms. Major began to experience more frequent episodes of bronchitis with an cough that would 
continue during the periods between episodes of bronchitis. 
7. In February 200S, s. ajor as placed on light duty for three eeks due to an 
episode of bronchitis and sinusitis with cough. Light duty consiste  f ope ing and closing 
security doors electronically for other guards and did not include direct exposure to OC Spray. 
S. n arch , 2 S, . ajor c lete  a a t r  training i lving cell 
e traction a   ra . rior  ra  training a  al a s ee  conducted ith %  
Spray. However, the arch 3, 200S training was perfor ed with Defendant's product sold under 
the na e of Sabre ed, hich is a 10%  Spray. efendant advertises its Sabre ed  Spray 
to be "S% to SS% stronger than the co petition." e  s   ts  
literature that its abre ed  pray is the ost potent defense spray on the arket and that it 
is "from twenty (20) all the way up to ninety-five (95) percent hotter than other USA brands." 
c ille eat its is e et  f eas ri  t e te c  f a   ra  r ct, a  
efe a t a ertises its a re e   ra  r ct t  e ,0 0,000 c ville eat its, ic  
is significantly higher than other OC Spray products on the market and 400 times as hot as an 
average jalapeno pepper.   sure,       pr y 
product as containing 1.33% "Major Capsaicinoids" which are the pharmacologically active and 
pain-producing components of the hot pepper and the active ingredients in Oleoresin Capsicum 
t at a e it effecti e as a la  enf rce e t tool. efe a t a ertises t at its Sabre e   
Spray has the highest content of Major Capsaicinoids of any OC Spray on the market. 
9. The only arnings included ith efendant's Sabre Red C Spray product are as 
follows: 
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Warning keep out of reach of children The use of this
substance or device for any purpose other than self defense is a
crime under the law The contents are dangeroususe with care
First Aid Begin decontamination process immediately after
restraining subject Remove subject from contaminated area to
area of fresh air Verbally reassure subject If available rinse
effected areas with clean cool running water and soap Repeat if
necessary Do not rub or use creams lotions oils or salves For
eye contact flush with cold water for 15 minutes or longer Only
qualified medical personnel should remove contacts Periodically
monitor subject until they are fully recovered Get medical
attention if symptoms persist
The product does not identify what the symptoms are that may occur from use of the Sabre Red
OC Spray product
10 OC Spray acts directly on the peripheral sensory nerves and exposure elicits an
intense physiological response that includes nociception temporary blindness lacrimation
disorientation shortness of breath choking and coughing OC Spray enters the body through the
skin through the respiratory system through the eyes and by way of being ingested Acute
respiratory and cardiovascular responses to OC Spray include burning gagging gasping
inability to breathe inability to speak cyanosis apnea respiratory arrest airway edema
constriction systemic vasodilation hypertension bradycardia atrioventricular blockade and
asystole Capsaicin sensitive nerves play an important role in cough airway reactivity and
inflammation Chronic exposure to Capsaicincontaining products such as OC Spray can lead to
chronic respiratory symptoms and illness such as chronic cough chronic bronchitis pulmonary
fibrosis bronchiectasis and hemoptysis
11 After the approximately twoandahalf hour Sabre Red OC Spray training on
March 3 2008 Ms Major experienced a worsening of her cough that did not resolve She was
taken off work by her doctor on March 4 2008 and has been unable to return ever since Over
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arning keep out of reach of childre . The use of this 
substance or device for any purpose other than self defense is a 
crime under the la . The contents are dangerous-use ith ca . 
First Aid: Begin deconta ination process immediately after 
restraining subject. Re ove subject fro  conta inated area to 
area of fresh ai . erbally reass re s j t. If a , rinse 
effected areas with cle , cool running water a d s . epeat if 
necessary. o not rub or use crea s, lotions, oils, or salves. For 
eye contact, flush ith cold ater for 15 inutes or longer. nly 
qualified edical personnel should re ove contacts. Periodically 
onitor subject until they are fully recovered. et e ical 
attention if sy pto s persist. 
The product does not identify what the symptoms are that may occur from use of the Sabre Red 
OC Spray product. 
. C Spray acts directly on the peripheral sensory nerves and exposure elicits an 
intense physiological response that includes nociception, temporary blindness, lacrimation, 
disorientation, shortness of breath, choking and COUghing.  Spray enters the body through the 
skin, through the respiratory system, through the eyes and by way of being ingested. cute 
respiratory and cardiovascular responses to OC Spray include burning, gagging, gasping, 
inability to breathe, inability to speak, cyanosis, apnea, respiratory arrest, airway edema, 
constriction, systemic vasodilation, hypertension, bradycardia, atrioventricular blockade, and 
asystole. Capsaicin-sensitive nerves play an important role in cough, airway reactivity and 
infla ation. hronic exposure to apsaicin-containing products such as  Spray can lead to 
chronic respiratory symptoms and illness such as chronic cough, chronic bronchitis, pulmonary 
fibrosis, bronchiectasis, and he optysis. 
11. fter the approxi ately t o-and-a-half hour Sabre Red C Spray training on 
arch 3, 2008, s. ajor experienced a worsening of her cough that did not resolve. She was 
taken off work by her doctor on arch 4, 2008, and has been unable to return ever since. Over 
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time her cough became even more continuous and debilitating She is unable to sleep her lungs
continuously feel as though they are on fire she has coughing spells so intense that she damaged
her ribs and has become permanently disabled and unable to work Ms Major cannot exercise or
exert herself in any way and has suffered severe weight gain as a result Severe coughing is
triggered merely by talking The excessive coughing causes Ms Major nausea leading to
vomiting headaches and dizziness and great anxiety and depression At times the coughing is
so violent that Ms Major passes out
12 In addition to the physical manifestations ofher condition Ms Major has suffered
the loss of the companionship of her many friends who are employed in law enforcement She
has become hyper sensitive to the presence of OC Spray and anyone who has been slightly
exposed becomes a physical irritant to her condition Holding a can ofOC Spray that has never
been deployed causes her mouth and lips to burn
13 On March 12 2008 Ms Major was referred by her primary physician to
Dr Hendrickson a pulmonary physician to evaluate her chronic severe cough Over the
following year a litany of tests were performed followed by a number of diagnoses that were
later ruled out by further testing In November 2008 Dr Hendrickson reported that he suspected
Ms Major had Reactive Airway Dysfunction Syndrome RADS which is a work related
asthma caused by various toxic irritants in the workplace Dr Hendrickson concluded that
Ms Major RADS was secondary to her exposure to OC Spray during her employment with
IDC
14 Dr Hendrickson referred Ms Major to the National Jewish Health Hospital for
further evaluation ofher chronic cough After additional testing Dr Hendrickson was diagnosed
in April 2009 by Dr Karen Pacheco as suffering from irritant triggered vocal cord dysfunction
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time her cough became even more continuous and debilitating. She is unable to sleep, her lungs 
continuously feel as though they are on fire, she has coughing spells so intense that she damaged 
her ribs and has become per anently disabled and unable to ork. s. ajor cannot exercise or 
exert herself in any way, and has suffered severe weight gain as a result. Severe coughing is 
triggered merely by talking. he e cessive coughing causes . ajor ausea lea ing to 
vomiting, headaches and dizziness, and great anxiety and depression. At times, the coughing is 
so violent that s. ajor passes out. 
. In addition to the physical anifestations of her condition, s. ajor has suffered 
the loss of the companionship of her many friends who are employed in law enforcement. She 
has become hyper sensitive to the presence of OC Spray and anyone who has been slightly 
exposed becomes a physical irritant to her condition. Holding a can of OC Spray that has never 
been deployed causes her mouth and lips to burn. 
.  arch , 8, s. aj r as referre   er n ar  sicia  t  
Dr. Hendrickson, a pulmonary physician, to evaluate her chronic severe cough. Over the 
following year, a litany of tests were performed followed by a number of diagnoses that were 
later ruled out by further testing. In November 2008, Dr. Hendrickson reported that he suspected 
Ms. Major had Reactive Airway Dysfunction Syndrome ("RADS"), i  is  r -r l t  
asth a caused by various toxic irritants in the orkplace. r. ri s  l  t t 
Ms. Major's RADS was secondary to her exposure to OC Spray during her employment with 
I C. 
14. r. endrickson referred s. ajor to the ational Jewish ealth ospital for 
further evaluation of her chronic cough. fter additional testing, r. endrickson was diagnosed 
in April 2009 by Dr. Karen Pacheco as suffering from irritant-triggered vocal cord dysfunction 
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and secondary cough attributable to OC Spray exposure at the IDC and esophageal dysmotility
and reflux aggravated by OC Spray exposure at the IDC
FIRST CAUSE OFACTION
STRICT PRODUCT LIABILITY
15 Plaintiff hereby incorporates and realleges each and every preceding paragraph as
if set forth in full herein
16 The Sabre Red OC Spray manufactured by Defendant was unreasonably
dangerous and defective in that it utilized a concentration of major capsaicinoids in its product
that was far in excess of what is reasonably safe for either acute or chronic human exposure
Defendant knew or should have known that the excessively high potency of Sabre Red OC Spray
was grossly in excess of what is reasonably safe for use within closed environments such as
within the IDC Such a potent concentration of capsaicinoids posed an acute threat to prison
guards such as Ms Major Defendant knew or should have known that its product posed an
acute threat to prison guards like Ms Major because it expressly marketed its product to prison
facilities such as IDC
17 Defendants failure to provide a safe OC Spray was a proximate cause of the
subject injuries and damages suffered byMs Major
SECOND CAUSE OFACTION
FAILURE TO PROVIDE ADEOUATE WARNING
18 Plaintiff hereby incorporates and realleges each and every preceding paragraph as
ifset forth in full herein
19 At all times mentioned herein Defendant was negligent in failing to provide
adequate warnings and instructions to the consumer including Ms Major such that Sabre Red
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and secondary cough attributable to OC Spray exposure at the IDC, and esophageal dysmotility 
and reflux aggravated by OC Spray exposure at the IDe. 
IRS  USE F CTION 
S   IABILITY 
1 . Plaintiff hereby incorporates and realleges each and every preceding paragraph as 
if set rt  in full i . 
. he abre ed  pray anufactured by efendant as unreasonably 
dangerous and defective in that it utilized a concentration of major capsaicinoids in its product 
t at as far in e cess f at is reas a l  safe f r either ac te r c r ic a  e s re. 
efe a t e  r l    t t t  i l  i  t   r    r  
was grossly in excess of what is reasonably safe for use within closed environments such as 
ithin t e I . Such a potent concentration of capsaicinoids posed an acute threat to prison 
guards such as Ms. Major.            
acute threat to prison guards like s. ajor because it expressly arketed its product to prison 
f ilities s  s I . 
7. efendant's fail re t  r i e a safe  ra  as a r i ate ca se f t e 
subject injuries and damages suffered by Ms. Major. 
    
   Q  I  
18. laintiff r b  i r r t s  r ll s   ev r  r cedi  r gr  as 
if s t f rt  i  f ll erein. 
19. t l  ti  ti  erein, f nt  egli t i  f ili  t  provi  
adequate warnings and instructions to the consumer, including Ms. Major, such that Sabre Red 
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OC Spray was unreasonably dangerous and hazardous with respect to its foreseeable and
intended use within prison facilities such as IDC Said warnings should have consisted of a
warning that Sabre Red OC Spray should only be used for training officers who do not have a
history of respiratory illness such as chronic asthma or bronchitis or other health problems that
may make the officer more susceptible to injury by Sabre Red OC Spray Said warnings should
have consisted of a warning expressing what types of symptoms officers should be cognizant of
as requiring medical attention Said warnings should have consisted of a warning that the use of
a strong irritant such as Sabre Red OC Spray may cause respiratory illness such as BADS
chronic cough syndrome vocal cord dysfunction esophageal dysmotility and reflux and that it
may act as an aggravating factor for those who may already have one or more of those medical
conditions Instructions should have been included clearly defining the safe use of the product
and further warning against use within confined areas chronic exposure and prolonged periods
of exposure
20 Defendants failure to provide adequate warnings and instructions for safe usage
was the proximate cause of the subject accident injuries and damages suffered byMs Major
THIRD CAUSE OFACTION
BREACH OF EXPRESS WARRANTY
21 Plaintiff hereby incorporates and realleges each and every preceding paragraph as
if set forth in full herein
22 At all times mentioned herein Defendant actually designed manufactured
distributed andor was responsible for the design manufacture or distribution of the subject
Sabre Red OC Spray Defendant was therefore a merchant with respect to the sale manufacture
andordistribution of Sabre Red OC Spray ultimately utilized by Ms Major
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OC Spray was unreasonably dangerous and hazardous with respect to its foreseeable and 
intended use within prison facilities such as IDC. Said arnings s ld have consisted of a 
warning that Sabre Red OC Spray should only be used for training officers who do not have a 
history of respiratory illness, such as chronic asthma or bronchitis, or other health problems that 
may make the officer more susceptible to injury by Sabre Red OC Spray. Said warnings should 
have c nsisted f a ar ing e pressing hat t pes f s pto s fficers s ld e c iza t f 
as requiring medical attention. Said warnings should have consisted of a warning that the use of 
a strong irritant such as Sabre Red OC Spray may cause respiratory illness such as RADS, 
chronic cough syndrome, vocal cord dysfunction, esophageal dysmotility and reflux, and that it 
may act as an aggravating factor for those who may already have one or more of those medical 
c iti s. I str ctions s l  a e ee  i clude  clearl  efi i  t e safe se f t e r ct, 
and further warning against use within confined areas, chronic exposure, and prolonged periods 
of exposure. 
. dant's il  t  i  t  i s  i t ti     
was the proximate cause ofthe subject accident, injuries and damages suffered by Ms. Major. 
    
    
21. laintiff hereby incorporates and realleges each and every preceding paragraph as 
    l  erein. 
2. t ll ti  ti  erein, f t ctually signed, anufactured, 
distributed and/or as responsible for the design, anufacture, or distribution of the subject 
Sabre Red OC Spray. Defendant was therefore a erchant with respect to the sale, anufacture 
and/or distribution of Sabre ed C Spray ulti ately utilized by s. ajor. 
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23 In marketing andor selling the Sabre Red OC Spray Defendant expressly
warranted to the consumer including Ms Major that it was fit for the ordinary purpose for
which it was sold was reasonably safe was ofmerchantable quality and was reasonably fit for
the purpose of officer training officer safety and prison population control within a prison
facility such as IDC
24 Defendant knew or should have known that the consumer including Ms Major
would utilize Sabre Red for such purpose and would rely upon the skill and judgment of the
Defendant in furnishing goods suitable for that purpose
25 The subject Sabre Red OC Spray designed manufactured andor sold by the
Defendant and used by Ms Major was neither safe merchantable nor fit for its intended
purpose
26 Defendant breached the express warranties made that the subject Sabre Red OC
Spray was fit for the ordinary purpose for which it was sold was reasonably safe was of
merchantable quality and was reasonably fit for the purpose of officer training officer safety
and prison population control within aprison facility such as IDC
27 Defendants breach of its express warranties to the consumer including
Ms Major was a proximate cause of the subject accident and injuries suffered byMs Major
FOURTH CAUSE OF ACTION
BREACH OF IMPLIED WARRANTY
28 Plaintiff hereby incorporates and realleges each and every preceding paragraph as
if set forth in full herein
29 At all times mentioned herein Defendant actually designed manufactured
distributed andor was responsible for the design manufacture or distribution of the subject
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2 . In arketing and/or selling the a re Red C S ra , efendant e pressl  
arranted to the consu er, including s. ajor, that it as fit for the ordinary purpose for 
hich it as sold, as reasonably safe, as f erchantable quality, and as reasonably fit for 
the purpose of officer training, officer safety, and prison population control within a prison 
facility such as IDC. 
2 . efendant ne  r  e  that  r, inclu ing . r, 
ould tilize re ed for  rpose  o ld r l   t  ill  judg ent  t  
efendant in furnishing goods suitable for that purpose. 
. The subject Sabre Red C Spray designed, anufactured and/or sold by the 
efendant and used by s. ajor as neither safe, erchantable, nor fit for its intended 
purpose. 
. f t r  t  ress rr tie   t t t  j t r    
Spray was fit for the ordinary purpose for which it was sold, was reasonably safe, was of 
erchantable quality, and as reasonably fit for the purpose of officer training, officer safety, 
and prison popUlation control within a prison facility such as IDC. 
. efendant's breach of its express arranties to the consu er, including 
Ms. Major, was a proximate cause of the subject accident and injuries suffered by Ms. Major. 
    
    
8. Plaintiff hereby incorporates and realleges each and every preceding paragraph as 
i  s t f t  i  f ll erein. 
29. t all ti  nti  erein, f nt actually esigned, nufactured, 
distributed and/or was responsible for the design, manufacture, or distribution of the subject 
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Sabre Red OC Spray Defendant was therefore a merchant with respect to the sale manufacture
andordistribution of the Sabre Red OC Spray ultimately utilized byMs Major
30 In marketing andor selling the Sabre Red OC Spray Defendant impliedly
warranted to the consumer including Ms Major that it was fit for the ordinary purpose for
which it was sold was reasonably safe was ofmerchantable quality and was reasonably fit for
the purpose of officer training officer safety and prison population control within a prison
facility such as IDC
31 Defendant knew or should have known that the consumer including Ms Major
would utilize the subject Sabre Red OC Spray for such purpose and would rely upon the skill and
judgment of the Defendant in furnishing goods suitable for that purpose
32 The subject Sabre Red OC Spray designed manufactured andor sold by the
Defendant and used by Ms Major was neither safe merchantable nor fit for its intended
purpose
33 Defendant breached the implied warranties made that the subject Sabre Red OC
Spray was fit for the ordinary purpose for which it was sold was reasonably safe was of
merchantable quality and was reasonably fit for the purpose of officer training officer safety
and prison population control within aprison facility such as IDC
34 Defendants breach of its implied warranties to the consumer including
Ms Major was a proximate cause of the subject accident injuries and damages suffered by
Ms Major
DAMAGES
35 Plaintiff hereby incorporates and realleges each and every preceding paragraph as
ifset forth in full herein
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Sabre Red  Spray. efendant as therefore a erchant ith respect to the sale, anufacture 
and/or istribution of the Sabre ed  ra  ultimately utilized  s. aj r. 
3 . In ar eting and/or s lling t e re ed  r , efenda t i pliedly 
arrante  to the c s r, including s. j r, that it as fit f r t  r i r  rpose f r 
hich it as s l , as reas a l  safe, as f ercha ta le alit , a  as reas a l  fit f r 
the purpose of officer training, officer safety, and prison population control within a prison 
facility such as I C. 
. efe t      t at  r, i luding . j r, 
ould utilize the subject Sabre Red C Spray for such purpose and ould rely upon the skill and 
judg ent ofthe efendant in furnishing goods suitable for that purpose. 
. he subject abre ed  pray designed, anufactured and/or sold by the 
Defendant and used by s. ajor was neither safe, merchantable, nor fit for its intended 
purpose. 
. e e a t  t  i lie  tie   t t t  j t    
Spray was fit for the ordinary purpose for which it was sold, was reasonably safe, was of 
merchantable quality, and was reasonably fit for the purpose of officer training, officer safety, 
and prison population control within a prison facility such as IDC. 
. efendant's breach of its i plied arranties to the consu er, including 
s. ajor, was a proximate cause of the subject accident, injuries and damages suffered by 
s. ajor. 
S 
5. Plaintiff hereby incorporates and realleges each and every preceding paragraph as 
i  t f t  i  ll rein. 
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36 As a direct and proximate result of the actions of Defendant as pled above
Ms Major has suffered severe physical and emotional injuries to her mind and body
Ms Major injuries have caused and may continue to cause her great mental and physical pain
suffering anguish impairment permanent disfigurement loss of enjoyment of life lost wages
and loss of future earnings
37 As a direct and proximate result of the bodily injuries suffered byMs Major she
has incurred expenses for medical care as well as other expenses related to her injuries and it is
reasonably anticipated that expenses for medical care will continue into the future The exact
amount of these expenses is unknown to Ms Major at the present time and will be proven at the
time and place set for trial
DEMAND FORJURY TRIAL
38 Plaintiff hereby demands a jury trial on all issues properly tried to a jury
DEMAND FOR ATTORNEY FEES
39 As a result of the Defendantsconduct complained of herein Plaintiff has been
required to retain the services of legal counsel to represent her interests in this matter Pursuant
to Idaho Code 12120 and 12121 Rules 54d1and 54e1of the Idaho Rules of Civil
Procedure and all other applicable laws Plaintiff is entitled to an award of reasonable attorney
fees and costs incurred herein
PRAYER FOR RELIEF
WHEREFORE Plaintiff prays for judgment against the Defendant as follows
1 A sum adequate to compensate her for general damages including but not limited
to past present and future physical and mental pain and suffering anguish permanent
disfigurement and loss of enjoyment oflife
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3 . s a direct a  proximate res lt of the actions f efendant as pled a e, 
s. ajor has suffered severe physical and emotional injuries to her mind and body. 
s. ajor's injuries have caused and ay continue to cause her great ental and physical pain, 
suffering, anguish, impairment, permanent disfigurement, loss of enjoyment of life, lost wages, 
and loss of future earnings. 
. s a direct and proximate result f the bodily injuries suffered  s. ajor, she 
has incurred expenses for edical care as ell as other expenses related to her injuries and it is 
reasonably anticipated that expenses for medical care will continue into the future. The exact 
a ount f these expenses is unkno n to s. ajor at the present ti e and ill be proven at the 
time and place set for trial. 
    
. Plaintiff hereby de ands a jury trial on all issues properly tried to a jury. 
    
. s  r s lt f t  f ndant's t l i  f rein, l i tiff s  
required to retain the services of legal counsel to represent her interests in this atter. Pursuant 
t    §§ 12-120 and 12-121, ules 54(d)(1) and 54(e)(1) f the Idaho ules f ivil 
rocedure, and all other applicable la s, laintiff is entitled to an a ard f reasonable attorney 
    r i . 
   
RE, l intiff r  f r j t i t t  f t  f ll s: 
.  s  t  t  s t  r f r r l ges, i l i  t t li it  
to past, present and future physical and mental pain and suffering, anguish, permanent 
disfigurement, and loss of enjoyment of life; 
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2 A sum adequate to compensate her for her special damages consisting of past and
future medical and related expenses in an amount unknown to Plaintiff at this time but which
sum shall be more readily ascertained at the trial of this matter
3 A sum adequate to compensate her for her special damages consisting of past and
future lost income in an amount unknown to Plaintiff at this time but which sum shall be more
readily ascertained at the trial ofthis matter
4 Prejudgment interest to Plaintiff
5 Plaintiffs reasonable attorney fees and costs incurred in the prosecution of this
action or10000 should this matter proceed by default and
6 Such other and further reliefas this Court deems just and equitable
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2.  su  adequate to co pensate her for her special da ages consisting of past and 
future e ical a d related e penses in a  a nt no n to lai tiff at t is ti e t hich 
s  s ll be ore re il  as rtaine  at t e trial f t is tt r; 
.  s  a e uate t  c pensate er for er s ecial a ages c sisting f past a  
future lost inco e   t  t  f  t is ti e t ich  s   ore 
rea il  ascertai e  at t e trial ft is atter; 
. rejudg ent interest to laintiff; 
. laintiffs reasonable attorney fees and costs incurred in the prosecution f this 
action, or $10,000 should this atter proceed by default; and 
. c  t er a  f rt er relief as t is rt ee s j st a  e ita le. 
E  this 24th day of February, 2010. 
J  &   
y~~~~==~~~ ________ __ 
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Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220




Attorneys for Plaintiff Billie Jo Major
BILLIE JO MAJOR and individual
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NOTICE YOU HAVE BEEN SUED BY THE ABOVENAMED PLAINTIFF THE
COURT MAY ENTER JUDGMENT AGAINST YOU WITHOUT FURTHER NOTICE
UNLESS YOU RESPOND WITHIN TWENTY 20 DAYS READ THE INFORMATION
BELOW
TO SECURITY EQUIPMENT CORPORATION
You are hereby notified that in order to defend this lawsuit an appropriate written
response must be filed with the above designated Court within twenty 20 days after service of
this Summons on you If you fail to so respond the Court may enter judgment against you as
demanded by the Plaintiff in the Complaint
A copy ofthe Complaint is served with this Summons If you wish to seek the advice or
representation by an attorney in this matter you should do so promptly so that your written
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Eric B. S artz, ISB #6396 
J ES & S , PLLC 
1673 . Shoreline rive, Suite 220 
Post ffice ox 7808 
Boise, I  83707 
Telephone: (208) 489-8989 
Facsi ile: (208) 489-8988 
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  ~ 2010 
J. VI  VA RO, lerl( 
By . H L  
DEPUTY 
       J    
   I , I        
I IE J  J , a  i i i al, 
l i tiff, 
vs. 
SECURITY EQUIP ENT CORPORATION, 
a Missouri corporation, 
nt. 
cv  I  0 5 f 5 
as  . ________ _ 
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: SECURITY EQUIP ENT CORPORATION 
ou are hereby notified that in order to defend this lawsuit, an appropriate ritten 
response must be filed with the above designated Court within twenty (20) days after service of 
this Su ons on you. If you fail to so respond, the Court ay enter judg ent against you as 
demanded by the Plaintiff in the Complaint. 
A copy of the Co plaint is served with this Su ons. If you wish to seek the advice or 
representation by an attorney in this matter, you should do so promptly so that your written 
response, if any, may be filed in time and other legal rights protected. 
S ONS-l 
An appropriate written response requires compliance with Rule 10aand other Idaho
Rules of Civil Procedure and shall also include
The title and number of this case
2 If your response is an Answer to the Complaint it must contain admissions or
denials of the separate allegations of the Complaint and other defenses you may
claim
3 Your signature mailing address and telephone number or the signature mailing
address and telephone number of your attorney
4 Proof of mailing or delivery of a copy of your response to Plaintiffs attorney as
designated above
To determine whether you must pay a filing fee with your response contact the Clerk of
the abovenamed Court
DATED this day of February 2010
J DAVID NAVARRO





An appropriate written response requires co pliance ith Rule lO(a)(I) and other Idaho 
Rules of i il Procedure and s l also inclu : 
1. The title and number of this cas . 
2. If your response is an ns er to the o plaint, it ust contain ad issions or 
denials of the separate allegations of the o plaint and other defenses you ay 
c . 
3. Your signature, mailing address and telephone number, or the signature, mailing 
address and telephone nu ber of your attorney. 
. Proof of ailing or delivery of a copy of your response to Plaintiffs attorney, as 
designated above. 
o eter ine hether  ust a  a filin  fee it  r res se, c tact t e ler  f 
the e-named . 
TE  is M- day f ebruary, 2010. 
.   








APR 0 5 2010
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA





J DAVID NAVARRO Clerk
By E HOLMES
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA










Defendant Security Equipment Corporation SEC or Defendant by and through its
counsel of record Greener Burke ShoemakerPA by way of answer to PlaintiffsComplaint and
Demand for Jury Trial Complaint admits denies and alleges as follows
ANSWER
1 SEC denies each and every allegation contained PlaintiffsComplaint not
specifically admitted herein
2 SEC is without sufficient information to form a beliefas to the truth of the
allegations contained in Paragraphs 1 47 and 1014 and therefore denies the allegations of
those Paragraphs
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hristopher . urke, IS  #2098 
GREENER R E S AKER P  
95  . annock tr t, ite 900 
oise, Idaho 83702 
J. I  . l r  
y . L  
D:!;>UTY 
Tel: (208) 319-2600 
Fa : (20 ) -2601 
Attorneys for Defendant 
  IS ICT   E   IS I    
  I ,        
I LIE J  J , an individual, 
Plaintiff, 
. 
SE IT  E IP E T 
P RATI , a issouri corporation, 
nt. 
as  o.: -PI-I  
ENDANT'S S   
I TIFF'S   
   I  
efendant Security quip ent orporation ("S " or "Defendant"),   t r  it  
c sel f record, ree er r e e a er P.A.,  a  f a s er t  laintiffs lai t a  
De and for Jury Trial ("Co plaint"), a its, e ies a  alle es as f ll s: 
 
.  i    v r  ll ti  t i  laintiff s pl i t t 
specifically admitted herein. 
.   t uff  i t  t    eli f  t  t  t  f  
allegations contained in Paragraphs 1, 4-7, and 10-14, and therefore denies the allegations of 
those Paragraphs. 
EFENDANT'S S E  T  PLAINTIFF'S PL I T  E  F  JUR  T I L - Page 1 
(14542-0 II #325069) 
With respect to Paragraph 2 of PlaintiffsComplaint SEC admits that it is a
Missouri corporation and that it has in the past conducted business in the state of Idaho SEC is
without sufficient information to form a belief as to the truth of the remaining allegations of
Paragraph 2 and therefore denies them
4 SEC admits the allegations of Paragraph 3 of PlaintiffsComplaint
With respect to Paragraph 8 of PlaintiffsComplaint SEC alleges that its
advertising speaks for itself and denies the allegations of that Paragraph with respect to
advertising to the extent inconsistent therewith SEC is without sufficient information to form a
belief as to the truth of the remaining allegations of Paragraph 8 and therefore denies them
6 SEC denies the allegations of Paragraphs 9 16 17 19 20 23 24 26 27 30 31
33 34 36 37 and 39 of Plaintiff s Complaint
7 With respect to Paragraphs 15 18 21 28 and 35 SEC realleges its answers to the
other Paragraphs of Plaintiff s Complaint as if set forth in full herein
8 With respect to Paragraph 22 of Plaintiffs Complaint SEC admits that it designs
manufactures and sells Sabre Red OC spray but alleges that it is without sufficient information
to form a belief as to the truth of the remaining allegations of Paragraph 22 and therefore denies
them
9 With respect to Paragraphs 25 and 32 of Plaintiff s Complaint SEC is without
sufficient information to form a belief as to the truth of the allegations concerning whether
Plaintiff was exposed to Sabre Red OC spray designed manufactured andor sold by SEC and
therefore denies those allegations SEC denies the remaining allegations of Paragraphs 25 and
32
DEFENDANTSANSWER TO PLAINTIFFSCOMPLAINT AND DEMAND FOR JURY TRIAL Page 2
14542011 325069
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3. ith respect to Paragraph 2 of Plaintiff s o plaint, SE  ad its that it is a 
issouri corporation and that it has, in the past, conducted business in the state of Idaho. SEC is 
ithout s fficient infor ation t  f r  a belief as t  the truth f the re ai i  alle atio s f 
Paragraph 2 and therefore denies the . 
.  its t e lle tions f r raph  f l i tiffs l i t. 
5. ith respect to Paragraph 8 of Plaintiff s o plaint, SE  alleges that its 
advertising speaks for itself, and denies the allegations of that Paragraph ith respect to 
advertising to the extent inconsistent there ith. S  is ithout sufficient infor ation to for  a 
belief as to the truth of the re aining allegations of Paragraph 8, and therefore denies the . 
. SEC denies the allegations of Paragraphs 9, 16, 17, 19, 20, 23, 24, 26, 27, 30, 31, 
33,34,36,37, and 39 of Plaintiffs Complaint. 
. ith respect to Paragraphs 15, 18,21,28 and 35, S  realleges its ans ers to the 
other Paragraphs of Plaintiff s Co plaint as if set forth in full herein. 
. ith respect to aragraph 22 f laintiffs o plaint,  ad its that it designs, 
anufactures and sells Sabre ed  spray, but alleges that it is ithout sufficient infor ation 
to for  a belief as to the truth of the re aining allegations of Paragraph 22, and therefore denies 
t e . 
. ith respect to Paragraphs 25 and 32 of Plaintiffs o plaint, SE  is ithout 
s fficie t i f r ati  t  f r  a elief as t  t e tr t  f t e alle ati s c cer i  et er 
Plaintiff as exposed to Sabre ed  spray designed, anufactured and/or sold by SEC, and 
therefore denies those allegations. SEC denies the re aining allegations of Paragraphs 25 and 
32. 
EFENDANT'S   LAINTIF 'S OMPLAI   E   JU  TRI  -   
(14542-0 II #325(69) 
10 With respect to Paragraph 29 of Plaintiff s Complaint SEC admits that it has
designed manufactured and distributed Sabre Red OC spray but is without sufficient
information to form a belief as to the truth of the remaining allegations of Paragraph 29 and
therefore denies them
AFFIRMATIVE DEFENSES
Plaintiff s Complaint and each and every allegation contained therein fails to
state a claim against SEC upon which relief may be granted
2 Any damage injury or condition alleged in Plaintiff s Complaint was caused or
substantially contributed to by the negligence comparative fault causation andor responsibility
ofPlaintiff
Any damage injury or condition alleged in Plaintiff s Complaint was caused or
substantially contributed to by the negligence comparative fault andor responsibility of third
parties other than SEC including but not limited to Plaintiff s employer for whom or which
SEC had no responsibility
4 At all times denying any responsibility on its part SEC alleges that if liability is
asserted against it then the comparative fault causation andor responsibility of all parties
joined and nonjoined including that of Plaintiff andor her employer must be evaluated and
liability apportioned among all persons and entities in proportion to respective fault or
responsibility andor pursuant to Idaho law
If Plaintiff sustained any injuries or incurred any damages the same were caused
in whole or in part by the acts or omissions of persons other than SEC over whom or which SEC
DEFENDANTSANSWER TO PLAINTIFFSCOMPLAINT AND DEMAND FOR JURY TRIAL Page 3
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1 . ith respect to Paragraph 29 of Plaintiffs o plaint, S  ad its that it has 
designed, manufactured and distributed Sabre Red OC spray, but is without sufficient 
infor ation to for   ief  to the truth f the re ing le a ions   ,  
therefore e ies th . 
III 
I E S S 
1. lai tiff s lai t, a  each a  e er  alle ati  c tained t erei , fails t  
state a claim against SEC upon which relief may be granted. 
. n  , i j r  r ition ll  i  l i tiffs laint as s  r 
substantially contributed to by the negligence, co parative fault, causation andlor responsibility 
 l i tiff. 
3. ny da age, injury or condition alleged in Plaintiffs Co plaint as caused or 
substantially contributed to by the negligence, comparative fault andlor responsibility of third 
parties other than SEC, including, but not limited to, Plaintiffs employer, for whom or which 
SEC had no responsibility. 
. t all ti es denying any responsibility on its part, SEC alleges that if liability is 
asserted against it, then the co parative fault, causation andlor responsibility of all parties, 
joined and non-joined, including that of Plaintiff andlor her employer, must be evaluated, and 
liability apportioned a ong all persons and entities in proportion to respective fault or 
responsibility andlor pursuant to Idaho law. 
5. If Plaintiff sustained any injuries or incurred any da ages, the sa e ere caused 
in hole or in part by the acts or o issions of persons other than SEC, over ho  or hich SE  
EFENDANT'S   LAINTIF 'S PL I  A   F  J  I  - Page 3 
(11\51\2-0 II #325069) 
had no control or by the intervening superseding negligence or wrongful conduct of third parties
over which SEC had no control
6 Without admitting that Plaintiff suffered any injury or damages as a result of any
defect in the product at issue in this action Plaintiff s damages are barred or must be reduced due
to Plaintiff s failure to take reasonable steps to mitigate such damages
7 Without admitting that Plaintiff suffered any injury or damage as a result of any
defect in the product at issue in this action and without admitting that the product in this action
was sold or distributed by SEC SEC alleges upon information and belief that the product in
question was altered or modified after it left SECscontrol and that the alterations or
modifications of said product proximately caused Plaintiff s alleged harm
8 Without admitting that Plaintiff suffered any injury or damage as a result of any
defect in the product at issue in this action SEC alleges that Plaintiff failed to observe a
condition of the product which would have been obvious to an ordinary reasonably prudent
person and therefore Plaintiff s damages are subject to reduction
9 Any injuries or damages sustained by Plaintiff for the result of the misuse or
abuse of the product in this action by Plaintiff Plaintiffs employer andor other persons or
entities for whom or which SEC is not responsible
10 Without admitting that Plaintiff suffered any injury or damage as a result of any
defect in the product at issue in this action SEC alleges that Plaintiffandor other product users
including but not limited to Plaintiff s employer knew or should have known ofthe products
condition and voluntarily used the product andor voluntarily assumed the risk of harm from the
productsuse thereby proximately causing Plaintiff s damage
DEFENDANTSANSWER TO PLAINTIFFSCOMPLAINT AND DEMAND FOR JURY TRIAL Page 4
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had no control, or by the intervening superseding negligence or rongful conduct of third parties 
over hich  had o c . 
6. ithout ad itting that Plaintiff suffered any injury or da ages as a result of any 
defect in the product at issue in this action, Plaintiff s da ages are barred or ust be reduced due 
to laintiffs failure to take reasonable steps to itigate such da ages. 
. ithout itting t at l i tiff ffere   inj r  r a e   r lt f  
defect in the product at issue in this action, and ithout ad itting that the product in this action 
as sold or distributed by ,  alleges, upon infor ation and belief, that the product in 
question was altered or modified after it left SEC's control, and that the alterations or 
odifications of said product proxi ately caused Plaintiffs alleged har . 
. ithout ad itting that laintiff suffered any injury or da age as a result f any 
defect in the product at issue in this action, SEC alleges that Plaintiff failed to observe a 
condition of the product which would have been obvious to an ordinary, reasonably prudent 
person, and therefore Plaintiffs da ages are subject to reduction. 
. Any injuries or da ages sustained by Plaintiff for the result of the isuse or 
abuse of the product in this action by Plaintiff, Plaintiffs employer, and/or other persons or 
entities for ho  or hich SE  is not responsible. 
0. ithout ad itting that Plaintiff suffered any injury or da age as a result of any 
defect in the product at issue in this action, SEC alleges that Plaintiff and/or other product users, 
including, but not limited to, Plaintiffs employer, knew or should have known ofthe product's 
condition and voluntarily used the product and/or voluntarily assu ed the risk of har  fro  the 
product's use, thereby proximately causing Plaintiffs damage. 
DEFENDANT'S ANS ER TO PLAINTIFF'S CO PLAINT AND DE AND FOR JURY TRIAL - Page 4 
(14542-011 #325069) 
11 Plaintiff s recovery if any must be offset by any compensation or benefits
including workers compensation benefits paid to or on account of Plaintiff Plaintiffs health
care providers or insurance carriers Plaintiffs employer or any other collateral source as a
result of the accident andor Plaintiffs injuries
12 Plaintiffsnon economic loss damages are limited by the statutory cap on non
economic damages under Idaho Code 61603
13 Plaintiff s injuries conditions and damages were caused by preexisting injuries
14 Plaintiff s warranty claims are barred by lack of privity
15 Plaintiff s warranty claims are barred by lack of timely and reasonable notice
16 Without admitting the existence of any warranties SEC alleges that if such
warranties existed the warranties and any remedies were limited and excluded
17 The products designed manufactured and distributed by SEC were at all relevant
times in conformity with the state oftheart for design and manufacture of similar products
18 SEC reserves the right to assert additional affirmative defenses which may
become apparent through discovery
DEMAND FORJURY TRIAL
SEC hereby respectfully demands a trial by jury as to all issues raised by the pleadings in
this matter pursuant toIRCPRule 38b
ATTORNEYS FEES
SEC has been forced to retain attorneys and has incurred and will continue to incur
attorneys fees and costs in defending this action SEC is entitledto recover from Plaintiff its
DEFENDANTSANSWER TO PLAINTIFFSCOMPLAINT AND DEMAND FOR JURY TRIAL Page 5
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. laintiffs recovery, if any, ust be offset by any co pensation or benefits, 
including orker's co pensation benefits, paid to or on account of laintiff, laintiff s health 
care providers or insurance carriers, Plaintiff s e ployer or any other collateral source, as a 
result of the accident and/or Plaintiffs injuries. 
. lai tiffs on-ec ic loss a ages are li ite   the stat t r  ca   -
econo ic da ages under Idaho ode § -16 . 
. laintiffs injuries, conditions and da ages ere caused by pre-existing injuries. 
. lai tiffs arra t  clai s are arre   lac  f ri it . 
. laintiffs arranty clai s are barred by lack f ti ely and reasonable notice. 
. ithout ad itting the existence of any arranties, S  alleges that if such 
arra ties i t , t e ties   ies  li ite   l . 
. The products designed, anufactured and distributed by SEC ere, at all relevant 
ti es, in confor ity with the state-of-the-art for design and anufacture of si ilar products. 
.  reserves the right to assert additional affir ative defenses hich ay 
become apparent through discovery. 
   I  
SEC hereby respectfully de ands a trial by jury as to all issues raised by the pleadings in 
this matter pursuant to I.R.C.P. Rule 38(b). 
S'  
S  has been forced to retain attorneys, and has incurred and ill continue to incur, 
attorneys' fees and costs in defending this action. SE  is entitled to recover fro  Plaintiff its 
FENDANT'S  T  LAINTIF 'S PL I    F   I  - Page 5 
(14542-011 #325069) 
costs and reasonable attorneys fees pursuant to Idaho Code 12121 andor 12120IRCP
Rule 54 andor any other applicable Idaho statute
PRAYER
WHEREFORE SEC prays that
Plaintiff take nothing by way of her Complaint against SEC
2 The Court award judgment in favor of SEC
The Court dismiss Plaintiff Complaint with prejudice and award SEC its costs
and attorneysfees and
4 For such other and further relief as may be deemed just and proper
DATED thisI day of April 2010
GR NE URKE SHOE A R P A
Christopher C Burke
Attorneys for Defendant
DEFENDANTSANSWER TO PLAINTIFFSCOMPLAINT AND DEMAND FOR JURY TRIAL Page E
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costs a d reas a le att r e s' fees rs a t t  Ida o e §§ -121 /or -12 , I.R.C.P. 
Rule 54, and/or any other applicable Idaho statute. 
 
F , S  prays that: 
1. Plaintiff take nothing by ay of her o plaint against SE ; 
.  rt r  jud t i  f r f ; 
3. he ourt dis iss laintiffs o plaint ith prejudice and a ard  its costs 
and attorney's fees; and 
. r s c  t er a  f rt er relief as a  e ee e  just a  r er. 
E   ~ day of April, 2010. 
st e  .  
ttorneys for efendant 
FENDANT'S   LAINTIF 'S PLAI     J  I  - age 6 
(14542-0 II #325069) 
1 41
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing DefendantsAnswer to
Plaintiffs Complaint and Demand for Jury Trial on the following named personson the
date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
TONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED this4 day of April 2010
0
Christopher C Burke




  E 
I hereby certify that I caused to be served the foregoing efendant's s er to 
l i tiff's l i t  e  f   ial  the follo in   rson(s)  t e 
ate indicated l , in t e  dicated l : 
ar in verson, Esq. 
ric . rt , s . 
J S & S , P C 
 . reline ri e, ite  
. .   
/' 
[ /) ia .S.  
[ ] ia a  e  
[ ]  le (20 /489-89 ) 
[ ] i  r i t li r  
oise, Idaho 83707 
------.-~----------------------------~--------------------------------~ 
TE  s ~ day of April, 2010. 
CbfrJl~L 
rist er . r e 
EFENDANT'S   LAINTIF 'S PL I     J  I  -   
(14542-0 II #325069) 
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IN THE
DISTRICT COURT OF THE 4TH JUDICIAL DISTRICT COUNTY OF ADA IDAHO
Op












SUMMONS COMPLAINT AND DEMAND FORJURY
TRIAL
The undersigned being first duty sworn on oath deposes and says Thatshe is now and at all times
herein mentioned was a citizen of the United States over the age of eighteen not an officer of a
plaintiff corporation not a party to nor interested in the above entitled action has the authority to
serve pleadings in the State named below and is competent to be a witness therein
On the 16th day of March 2010 at358 PM at the address of SECURITY EQUIPMENT
CORPORATION 747 SUN PARK Drive FENTON St Louis County MO 63026 this affiant served
the above described documents upon SECURITY EQUIPMENTCORPORATION A MISSOURI
CORPORATION by then and there personalty delivering 1 true and correct copyies thereof by then
presenting to and leaving the same with BOB NANCE VICE PRESIDENT A white male approx
3540 years of age 510 60 in heightweighing 240260 Ibs with black hair a mustache and a
beard
No Information was provided or discovered that indicates that the subjects served are members of the
US military
DATED this 17th day of March 2010
PUB ANGELA J ALLTOP
NOTARV My Commission Expires
Michael H Bailey Reg UL 920 St Louis O SEAL r May 23 2011
Jefferson County
Commission 07062321
SUBSCRIB AND SWORN to before me this 17th day of March 2010
lpatblr
NOTARY PUB n d f r the State ofMissouri
Residing at
My Commission Expires
FOR Beth Luchini ORIGINAL PROOF OF Trackin 8158278 SEA
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Defendant
Case No CVPI 1003515
NOTICE OF SERVICE OF DISCOVERY
REQUESTS TO PLAINTIFF
PLEASE TAKE NOTICE that on the 5 day of April 2010 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke ShoemakerPA
served the following documents viaUS Mail
a DefendantsFirst Set ofInterrogatories and RequestsforProduction of
Documents to Plaintiff and
b This Notice ofService ofDiscovery Requests to Plaintiff









.M_---P.  ..... -'"~--
    
s  . ,  #2098 
  E   
 .  t,   
i ,   
.1: eA'\1I~y ~.\$~; elAfk 
l: (2 ) -2600 
x: (20 ) -2601 
ttorne s f r f t 
       I I     
  ,        
I IE 10 J , a  i i i al, 
laintiff,  o.: - I-I0  
OEPUTY 
v.      
  I I  
I  I  
CORPORATION, a issouri corporation, 
ant. 
  I  t t,  t  th   ril, , f t curit  
Equip ent Corporation, by and through its counsel of record, Greener Burke Shoe aker P.A., 
served the follo ing docu ents via .S. ail: 
. efendant's irst Set f Interrogatories and equests for roduction f 
ts t  l i t(ff;  
. his otice f Service f iscovery equests to laintiff. 
  ~lJ_Aiay  ril, . 
Christopher C. Burke 
tt rne s f r f t 
" 42-011 (329 35_doc) J I   I   I  S S  I IFF - a e  
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice of Service of Discovery
Requests to Plaintiff on the following named personson the date indicated below in the
manner indicated below
Darwin Overson Esq
Eric 13 Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED thisVday of April 2010
Christopher C Burke
NOTICE OF SERVICE OF DISCOVERY REQUESTS TO PLAINTIFF Page 2
14542011 329735doe
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I   I  
I r  rtif  t t I s  t   s r  t  f r i  ti  f er i  f is  
e ests to lai tiff on the follo ing na ed person(s) on the date indicated belo , in the 
a er i icate  elow: 
i  rson, . 
i  B. rtz, q. 
J S & ,  
 . li  i , it   
. .   
ois ,   
 t isM day  ril, . 
[  ] i  .S. il 
[ ] ia and elivery 
[ ] ia acsi ile (208/489-8988) 
[ ] ia vernight elivery 
ICE F S ICE F IS ERY ESTS  P INTIFF - Page 2 
14542-011 (3 9735.doc) 
N0
M
APR 2 6 2010
J DAVID NAVARRO Clerk
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT pEPATHERBv






Case No CV PI 1003515
NOTICE OF TELEPHONIC STATUS
CONFERENCE UNDERICP16a
16b
Upon review the Court has determined that this matter is appropriate for a
scheduling order underIRCP16b
A telephonic status conference is hereby set for May 21 2010 at830am
before the Honorable Cheri C Copsey Ada County Courthouse Boise Idaho A
scheduling order underIRCP16b may be issued following this conference
All parties must appear telephonically at this time in person or by counsel
Counsel must be the handling attorney or be fully familiar with the case and have
authority to bind their client and lawfirm on all matters set forth inIRCP16aand
16b The Court will initiate the conference call unless otherwise specified
In lieu of this status conference if all parties agree on all matters set forth on the
attached stipulation for scheduling and planning the stipulation may be completed
signed and filed before the date set for the status conference
Dated this 9 L day of April 2010
CHERI C COPSEY
DISTRICT JUDGE
NOTICE OF STATUS CONFERENCE UNDERICP16a 16b Page 1
It
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FILED --P.M ____ _ 
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J. DAVI  NAVARRO CI 
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT80'f=~~~~~ERBY erk 
   I HO, I   F  T     
  JOR, 
laintif ,  o.  I 1 -0  
vs. 
  RP., I   I   
C NFERENCE UNDER I,R.C.P. 16(a) 
& 6(b) 
f dant. 
pon revie , the ourt has deter ined that this atter is appropriate for a 
li    ,R.C.P 6(b). 
 t l i  st t s c f r c  is r y s t f r  ,2010, t :30 .m. 
f r  t  r l  ri . ,  ty rt , i , I o.  
sc ling r r r I,R.C.P 6(b) y  iss  f ll i  t is c f r ce. 
All parties ust appear telephonically at this ti e in person or by counsel. 
l st  t  li  tt r , r  f ll  f ili r it  t  ,   
authority to bind their client and lawfir  on all atters set forth in I,R.C.P 16(a) and 
16(b). The Court will initiate the conference call unless otherwise specified. 
I  li  f t i  t t s f r , if ll rti s r   ll tt rs t f rt   t  
attached stipulation for scheduling and planning, the stipulation may be completed, 
signed nd filed efore t  ate t f r t  t tus c f . 
ted this ~ L. day f pril . 
1, ..... t.~ 
E I . ~ 
I I T E 
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Case No CV PI 10 03515
STIPULATION FOR SCHEDULING
AND PLANNING
1 The parties hereby stipulate to the following preferences for trial dates Please
confer and complete Do not attach unavailable dates
a Week of Monday 20
b Week of Monday 20
c Week of Monday 20
The Courtsclerk will confirm dates with counsel if preferences cannot be met A
pretrial conference will be scheduled 10 to 21 days prior to trial
2 Parties estimate the case will take days to try
Case to be tried as a
OCourt Trial
12 Person Jury Trial
6 Person Jury Trial
3 Parties further stipulate to the following scheduling deadlines
a The last day to file amendments to any pleading including amendments
to add claims for punitive damages or to join any additional parties shall be
b The advancing party shall disclose all expert witnesses to be used at trial
by
NOTICE OF STATUS CONFERENCE UNDERICP16a 16b Page 2
000034
I   I     F T  I I  I   
   I HO, I        
  J , 
l intif , 
vs.  o.   -03  
  RP.,    
  
f nt. 
1.  rti s r y sti l t  t  t  f ll i  r f r c s f r tri l t s: (Pleas  
  l te.    "unavail  ".) 
(a)  f , ,  __ 
(b)  f , ,  __ 
(c)   , ,  __ 
The ourt's clerk ill confir  dates ith counsel if preferences cannot be et.  
r tri l f r  ill  l   t    ri r t  tri l. 
2. rti  ti t  t   ill t  days to try. 
se t   tri   : 
( ) rt ri l 
( )  r  r  ri l 
( )  r  r  ri l 
3. rti  f rt r ti l t  t  t  f ll i  li g li : 
. The last day to file a end ents to any pleading (including a end ents 
to add clai s for punitive da ages), or to join any additional parties, shall be 
b.  cing rty ll i l  ll xpert itnesses t    t tri l 
by ________________________________ _ 
TICE F STATUS CONFERENCE E  LR.C.P. 16(a) & 16(b) --Page 2--
C The responding party shall disclose all rebuttal expert witnesses to be
used at trial by
d The last day for the initiation of any discovery serving an interrogatory
requesting a document or noticing a deposition shall be
e The last day motions for summary judgment can be scheduled for oral
argument is must be at least 60 days prior to tria this date
cannot be changed without Court approval Summary judgment must be heard by the
Court no later than 60 days before trial
4 With the respect to settlement procedure the parties request that
Court schedule a further Rule 16 Status Conference approximately
90 days prior to trial on or about to review and facilitate
settlement possibilities with Counsel
No action by the Court is necessary at this time The parties agree to
pursue settlement if and as appropriate on their own
5 The parties reserve the right to amend this stipulation by agreement of all parties
with exception of 3 e and each party reserves the right to seek amendment hereof








Counsel for Other Parties
Date
Date
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c.  r i  rt  ll i l  ll r tt l rt it  t   
used at trial by _______________ _ 
.  l t  f  t  i iti ti  f  i  (ser i   i t r tory, 
r sti   c t r tici   siti ) s ll  __________ _ 
.  l t  ti  f r r  j t   l  f r r l 
r t i  , (mu t  t l t   ri r t  tri l -   
t   it t rt roval.) r  j t t  r   t  
rt  l t r t    f r  tri l. 
. it  t  t t  ttl t re, t  ti  t t t: 
(~The t l   f t  l   t t  f  i t l  
  ri r t  tri l (on r t _________ -J)     
ttl t i iliti  it  l. 
( __ ) No ti   t  rt is r  t t i  ti e.  rti  r  t  
r  ttl nt, if   r ri t ,  t ir . 
.  rti s r s rv  t  ri t t   t is sti l ti  y r t f ll rti s 
(with exception of 3 (e)), and each party reserves the right to seek a end ent hereof 
 t r.  t   t  f t  t t  f  f    t 
y ti e. 
l f r laintiff(s): 
__________________ Date: ________ _ 
__________________ ate: ________ _ 
l f r efendant(s): 
te: ------------------ ---------
__________________ te: ________ _ 
   ti s: 
__________________ ate: ________ _ 
__________________ te: ________ _ 
I      LR.C.P. 6(a) & 6(b) --Pag  --
AVAILABLE CIVIL TRIAL WEEKS ASSIGNED
TO JUDGE COPSEYFOR 20102011
November 8 2010 May 2 2011
November 15 2010 May 9 2011
December 6 2010 May 16 2011
December 13 2010 May 23 2011
December 27 2010 June 6 2011
January 3 2011 June 13 2011
January 10 2011 June 20 2011
January 18 2011 July 11 2011
January 31 2011 July 18 2011
February 7 2011 July 25 2011
February 14 2011 August 1 2011
February 22 2011 August 8 2011
February 28 2011 August 15 2011
March 7 2011 August 22 2011
March 14 2011 September 6 2011
March 21 2011 September 12 2011
April 4 2011 September 19 2011
April 11 2011 October 3 2011
April 18 2011 October 11 2011
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CERTIFICATE OF MAILING
I hereby certify that on this aL day of April 2010 1 mailed served a true
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I I  F I  
I h r  certif  t t o  t i  J., b day of April 2010, I ailed (served) a true 
 c rr t  f t  it i  instr  to: 
I   
E I  B. S A TZ 
 &  
  7808 
I ,   
I  .  
   
 .  ,   
I ,I   
. DAV D N RRO 
l rk of the District 






MAY 0 7 21
DAVIE NAVARRO Cierk
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT 0 BA GARDEN
bW AV






Case No CV PI 1003595
STIPULATION FOR SCHEDULING
AND PLANNING
1 The parties hereby stipulate to the following preferences for trial dates Please
confer and complete Do not attach unavailable dates
a Week of Monday July 25 20
b Week of Monday August 1 s or 15 20 11
c Week of Monday 20
The Courts clerk will confirm dates with counsel if preferences cannot be met A
pretrial conference will be scheduled 10 to 21 days prior to trial
2 Parties estimate the case will take 11 days to try
Case to be tried as a
Court Trial
x 12 Person Jury Trial
6 Person Jury Trial
3 Parties further stipulate to the following scheduling deadlines
a The last day to file amendments to any pleading including amendments
to add claims for punitive damages or to join any additional parties shall be
150d Prior to Trial
b The advancing party shall disclose all expert witnesses to be used at trial
by 150d Prior to Trial
NOTICE OF STATUS CONFERENCE UNDERICP16a 16b Page 2
M
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MAY 07 2mn 
, DAVID NAVARRO, Clerk 
IN THE DISTRICT C  OF THE FOURTH JUDICIAL DISTRICT 01= By A. GARDEN 
THE ST T  OF IDAHO, IN AN  FOR T  T  OF ADA 
I I   AJOR, 
laintiff, 
vs,  o.  I 1 · 1  
I   ORP., I   I  
 I  
Defendant. 
1. The parties hereby stipulate to the following preferences for trial dates: (Please 
f   l te.    "unav il l  ".) 
(a) k f ay, __ _ _l Y"'-- _  __________ • 20.l.L.-. 
(b) eek f onday.  , 8 or 15 .  11 . 
(c) eek of onday. _____________ , 20 ___ . 
he ourt's clerk ill confir  dates ith counsel if preferences cannot be et.  
r tri l f r  ill  l   t    ri r t  tri l. 
2. rti s i t  t     11 days to try. 
 t   t i   : 
( __ ) rt rial 
(~_) 12 r  r  ri l 
( __ ) 6 erson Jury Trial 
3. arties f rther tipulate to t  f ll i  sc eduling de li : 
a. The last day to file amendments to any pleading (including amendments 
to add claims for punitive damages), or to join any additional parties, shall be 
150d Prior to rial 
b. The advancing party shall disclose all expert witnesses to be used at trial 
b 150d Prior to Trial y--------------------------------
NOTICE OF STATUS CONFERENCE UNDER LR.C.P. 1 (a) & 16(b) --Page 2·· 
o!::l=>tnv 
C The responding party shall disclose all rebuttal expert witnesses to be
used at trial by 120d Prior to Trial
d The last day for the initiation of any discovery serving an interrogatory
requesting a document or noticing a deposition shall be 45d Prior to Trial
e The last day motions for summary judgment can be scheduled for oral
argument is 60d Pri toTriabust be at least 60 days prior to tria this date
cannot be changed without Court approval Summary judgment must be heard by the
Court no later than 60 days before trial
4 With the respect to settlement procedure the parties request that
The Court schedule a further Rule 16 Status Conference approximately
90 days prior to trial on or about to review and facilitate
settlement possibilities with Counsel
x No action by the Court is necessary at this time The parties agree to
pursue settlement if and as appropriate on their own
5 The parties reserve the right to amend this stipulation by agreement of all parties
with exception of 3 e and each party reserves the right to seek amendment hereof











Counsel for Other Parties
Date
Date
NOTICE OF STATUS CONFERENCE UNDERICP16a 16b Page 3
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\ ~ 
c. The responding party shall disclose all rebuttal expert witnesses to be 
used at trial by __ 1_2_od_p_r_i_o_r_t_o_Tr_l_' a_l ____ _ 
d. The last day for the initiation of any discovery (serving an interrogatory, 
45d Prior to Trial 
requesti  a docu e t or noticing a deposition) shall be _________ _ 
e. Th  last day otio  for su r  judg ent can be scheduled for oral 
arg t is 60d Prior to Tri~hnust be at least 60 days prior to tri l- this date 
cannot be changed without Court approval.) Su ary judg ent ust be heard by the 
t  l t  t  6   f r  trial. 
4. it  t  r t t  ttl t r cedure, t  rti  requ st t at: 
(-> The Court schedule a further Rule 16 Status Conference approximately 
  i   i l (o    _________ ) t  r vi   f cilit t  
  i  nsel. 
(_X_)No action by the Court is necessary at this time. The parties agree to 
 tl ent,    riate,  i  . 
5. The parties reserve the right to amend this stipulation by agreement of all parties 
(wit  ti  f  (e»,   rt  r r  t  ri t t   t r f 
by Court order. Any party may request a further status conference for any purpose at 
any time.------:>-<-
9~~ns_~1 f  pr n'~l/-}_// 
\--'-. -- -o-~-~_l---::7 :-~~--~---~---:~:-"'-~---~~:-::' ... ~--~~~~-~.~'-,~({~-:-:lu~~h~~~~~~~~= :::: 1; 2~;: v/o 
l f r fendant(s): 
______________________________________ Date: ________________ __ 
_____________________________________ Date: ________________ __ 
ounsel for ther rti s: 
_____________________________________ Date: ________________ __ 
_____________________________________ Date: ________________ __ 
NOTICE OF STATUS CONFERENCE UNDER I.R.C.P. 1 (a) & 16(b) --Page 3·-
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
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Case No CVPI 1003515
ORDER GOVERNING PROCEEDINGS
AND SETTING TRIAL
1 The stipulation for scheduling and planning signed by all parties is hereby
approved and adopted as the Order of this Court pursuant toIRCP16b No party
may vary from the stipulation of this order without approval of the Court
2 Trial is set for a Jury Trial to commence on July 25 2011 at 900am
for 11 days The Jury will be drawn the Friday before trial in chambers You may
observe if you wish
NOTICE OF INTENT TO RELY ON PANEL OF JUDGES AS ALTERNATES
Notice is hereby given pursuant toICRP40g that an alternate judge May be
assigned to preside over the trial of this case The following is a list of potential
alternate judges
Hon Phillip M Becker
Hon GDCarey
Hon Dennis Goff
Hon George R Reinhart III
Hon Ronald Schilling
Hon W H Woodland




Hon Daniel C Hurlbutt Jr
Hon Nathan Higer
Hon Linda Copple Trout
All Sitting Fourth District Judges




I   I I      J I I L I TRI TJ?~i)~~",;.. v,_"t;;~. 
   I AHO, I        
IlIyEQIIU) 
  J R, 
l intif , 
vs. 
 o.  -0351  
  I  
   
  RP., 
f t. 
1. The stipulation for scheduling and planning signed by all parties is hereby 
approved and adopted as the rder of this Court pursuant to I.RC.P 16(b). No party 
 r  fr  t  ti l ti  f t is r r it t r v l f t  rt. 
2. ri l i  t f r  r  ri l t    l  ,  t : 0 .m. 
f   .  r  ill  r  t  ri y f r  tri l i  rs. ou ay 
   . 
I   I     L     
otice is hereby given, pursuant to I.C.RP. 40(g) that an alternate judge may be 
i  t  r i e r t  tri l f t i  . The following is a list of potential 
lt t  j : 
a . i lip . r 
a . .D. rey 
a . nis ff 
a . r   i t, I I 
a . ld illi  
a . . . l d 
a . t r  . ti l  
a .  d 
a . ff ee 
a . i l l 
a . i l . rl tt, r. 
a . t  i r 
an. Linda opple rout 
ll Sitting Fourth istrict Judges 
ORDER VERNING PROCEEDINGS  TTING TRIAL --- Page 1 
Unless a party has previously exercised their right to disqualification without
cause under Rule 40d1each party shall have the right to file one 1 motion for
disqualification without cause as to any alternate judge not later than ten 10 days after
service of this written notice listing the alternate judge
3 A pretrial conference will be held on July 14 2011 at 430 pm IF A
PARTY FAILS TO APPEAR AT THE PRETRIAL CONFERENCE WITHOUT GOOD
CAUSE SUCH FAILURE SHALL BE SUFFICIENT GROUND FOR ENTRY OF
JUDGMENT AGAINST SUCH PARTY OR DISMISSAL OF THE ACTION OF SUCH
PARTY WITH PREJUDICE WITHOUT FURTHER NOTICE
4 Any party who does not intend to oppose a motion shall immediately notify
opposing counsel and the court by filing a pleading titled NonOpposition to Motion
The moving party shall serve and file with affidavits or other documentary evidence
upon which the moving party intends to rely with the motion Each motion other than
routine or uncontested matters shall be accompanied by a separate brief containing all
the reasons and points and authorities relied upon by the moving party Before
scheduling a hearing for a motion for summary judgment file the motion and the
memorandum in support The Court will schedule the hearing and issue a scheduling
order after reviewing the motion and supporting memorandum All parties shall supply
two 2 additional courtesy copies of all motions and supporting memoranda to
chambers Unless otherwise stated any deadlines for filing Motions and Motions to
Amend stipulated to by the parties apply to Motions to Amend to add a Claim for
Punitive Damages All memoranda must comply with the local rules See Local Rule
8 In no event may the parties agree to schedule dispositive motions to be heard
within 2 months of trial
5 All parties must be represented at the pretrial conference Counsel must
be the handling attorney or be fully familiar with the case and have authority to bind the
client and law firm to all matters withinIRCP16 In addition to the requirements of
IRCP16c d and e at the pretrial conference each party shall be required to
serve on all other parties and lodge with the Court a complete list of exhibits and
ORDERGOVERNING PROCEEDINGS AND SETTING TRIAL Page 2 000041
l   t   i l  i  t i  i t t  i lifi ti  it t 
 r l  0(d)(1),  rt  ll  t  ri t t  fil   (1) ti  f r 
i lifi ti  it t   t   lt r t  j  t l t r t  t  (1 )  ft r 
r i  f t i  ritt  ti  li ti  t  lt r t  j ge. 
.  r tri l f r  ill  l   l  ,  t :30 .m. I   
      -TRI     
E,          
           
,  I ,   I E. 
.  rt    t i t  t    ti  ll i i t l  tif  
opposing counsel and the court by filing a pleading titled "Non- pposition to otion." 
 i  rt  ll r   fil  it  ffi it  r t r t r  i ce, 
 i  t  i  rt  i t  t  r l  it  t  ti n.  ti , t r t  
routine or uncontested atters, shall be acco panied by a separate brief containing all 
t  r   i t   t riti  r li    t  i  rt . f r  
li   ri  f r  ti  f r r  j t. fil  t  ti   t  
r  i  s rt.  rt ill sc l  t  ri   iss   sc li  
r r ft r r i i  t  ti   rti  r . ll rti  ll l  
t  (2) iti l rt  i  f ll ti   rti  r  t  
rs. l ss t r is  st t d, y li s f r fili  ti s  ti s to 
 i l t     i  l   i       l i   
iti  s. ll r  t l  it  t  l l r l s.  l l  
8. In no event ay the parties agree to schedule dispositive otions to be heard 
i     l. 
. ll i  t     i l . l  
be t  li  tt r y, r be f lly f ili r it  t  c s   v  t rity t  i  t  
li    fi   ll  i  ,R.C.P. . I  iti  t  t  r ir ts f 
I,R.C.P. 6(c), (d)  (e), t t  r tri l f r ,  rt  ll  r ir  t  
serve on all other parties and lodge ith the ourt a co plete list of exhibits and 
 I  I S  I   --- Page 2 
witnesses in accordance withIRCP16h Parties shall submit to the Court no later
than five 5 days before the final pretrial conference a PreTrial Memoranda which will
include the following
a Elements of Plaintiffscase Plaintiff
b Defenses of Defendant case Defendant
C Contested facts
d Contested issues of law
e Evidentiary issues
f Agreed or stipulated facts and
g Memorandum of Points and Authorities on issues of law
6 Exhibits should be premarked prior to opening of court All approved
videotape or audiotape presentations must be cued in advance and all equipment
tested for sound picture etc prior to presenting evidence contained therein The
parties are responsible for reviewing proposed exhibits for redactions to ensure that
objectionable material is not seen by the jury Dry runs are encouraged before
coming to court and before court begins All exhibits are to be handed to the court
officer instead of the witness
7 Counsel should be familiar with the local rules including the page
limitations and argument limitations
8 In the case of a jury trial Proposed jury instructions must be submitted by
the pretrail conference with copies to opposing counsel However contrary toIRCP
51 if counsel requests standard Idaho Civil Jury Instructions IDJI counsel should only
submit a captioned document listing the requested instructions by number Counsel
need not comply with the requirements of IRCP 51 a1 and submit the actual
instructions with duplicates If counsel requests modified instructions counsel should
submit only one copy of those requested instructions as modified clearly identifying the
source upon which counsel relies for the instruction
8 In the case of a Court trial each party shall submit proposed findings of
facts and conclusions of law to the Court at the pretrial conference unless otherwise
permitted by the Court
ORDER GOVERNING PROCEEDINGS AND SETTING TRIAL Page 3 000042
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i  i   i  .R.C.P. 6(h). i  ll i    urt,  l  
t  fiv  (5) ys f r  t  fi l r -trial c f r ce,  r -Tri l r  ic  ill 
i l   ll i : 
. l t  f l intiffs  (Pl i tiff); 
. f  f fendant's  (Def t) 
c.  ts; 
.    ; 
. i ti r  i  
. r  r ti l t  f t ;  
.         . 
. i it  l   re- r  ri r t  i  f rt. ll r  
videotape or audiotape presentations ust be cued in advance, and all equip ent 
t t  f r d, i t re, tc. ri r t  r ti  i  t i  t r in.  
rti  r  r i l  f r r i i  r  i it  f r r ti  t  r  t t 
j ti l  t ri l i  t   t  j ry. "Dr  r s" r  r  f r  
i  t  rt,  f r  rt i s. l         
i r,    . 
. ounsel should be fa iliar ith the local rules, including the page 
li it ti   r t li it ti ns. 
. I  t   f  j  t i l,  j  i t ti  t  itt   
t  r -tr il f r  it  i  t  i  sel. r tr r  t  I.R.C.P 
51, if counsel requests standard Idaho Civil Jury Instructions (IDJI), counsel should only 
s it  c ti  c t listi  t  r st  i str cti s y r.  
 t c ly it  t  r ir ts f I.R.C.P 51 (a)(1)  s it t  ct l 
i tr ti  it  li t s.  l  i i  i tr tions, l l  
sub it only one copy of those requested instructions, as odified, clearly identifying the 
r   i  l li  f  t  i t ti n. 
. In the case of a ourt trial, each party shall sub it proposed findings of 
f t   l i  f l  t  t  rt t t  r tri l f r nce, l  t r i  
per itted by the ourt. 
  I S    --- Page 3 
IF A PARTY FAILS TO APPEAR AT TRIAL WITHOUT GOOD CAUSE SUCH
FAILURE SHALL BE SUFFICIENT GROUND FOR ENTRY OF JUDGMENT AGAINST
SUCH PARTY OR DISMISSAL OF THE ACTION OF SUCH PARTY WITH
PREJUDICE WITHOUT FURTHER NOTICE
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IF A PARTY FAILS TO APPEAR AT TRIAL WITHOUT GOOD CAUSE, SUCH 
FAIL  SHALL BE SUFFICIENT GROU  FOR ENTRY OF JUDG ENT AGAINST 
SUCH PARTY OR DISMISSAL OF THE ACTION OF SUCH PARTY, WITH 
PREJUDICE, IT  F T  NOTICE. 
Dated this 1st day of June, 2010. &W to '!J![\fil\l~"~ 
I . C PSEY 
istrict J  
ORDER GOVERNING PROC EDINGS AND SE TING TRIAL --- Page 4 
CERTIFICATE OF MAILING
I hereby certify that on this 1 st day of June 2010 1 mailed served a true and








950 W BANNOCK ST STE 900
BOISE ID 83702
J DAVID NAVARRO
Clerk of the District Court
By
Emily Child Deputy Court Clerk
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CERTIFICAT  OF MAILI  
I hereby certify that on this 1 st day of June, 2010, I mailed (served) a true and 
correct copy of the within instru ent to: 
DAR IN OVERSON 
ERIC B. S ARTZ 
JONES & TZ 
PO BOX 7808 
ISE, I  83707 
I  .  
   
 .  ,   
B ISE, I  83702 
.   
     
y: ~. CJAJiJ 
E ily hild, eputy ourt lerk 
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF





Greener Burke Shoemaker PA









Received by TRI COUNTY PROCESS SERVING LLC on June 4 2010 to be served on IDAHO
DEPARTMENT OF CORRECTIONS
I Zach D Heesch who being duly sworn depose and say that on Monday June 7 2010 at230 PM I
SERVED the within named Idaho Department of Corrections by delivering two true copies of the
Subpoena Duces Tecum and Notice of Taking Deposition to John McKinney Deputy Attorney
General a person authorized to accept service on behalf of Idaho Department of Corrections Said
service was effected at 7001 Jefferson Street Boise ID 83702
I hereby acknowledge that I am a Process Server in the county in which service was effected I am over
the age of Eighteen years and not a party to the action
Our Reference Number 96160
Client Reference Christopher C Burke
Subscribed and sworn before me today
Monday June 7 2010




Notary Public r the State of Idaho
Residing at Wise Idaho
My Commission Expires on February 12th 2015000045
I i  EIVED 
J, QAVID NAv/\HHQ. C:I4;ri< 
;.;t~(' I\r\.~~'t~ 
IN THE DISTRICT T  E T  JUDICIAL ISTRICT F .... ·"" 
THE TATE OF I , I  AND F R THE T  F A 
Billie Jo ajor 
vs. 
Security Equipment Corporation 
or: 
r r urke r  
 . ck t., t . 900 
Boise, 1083702 
 F I  
   
Pl intiff(s): 
I I  F SERVICE 
O ndant(s): 
ase r: -PI- 15 
:ss 
) 
Received by TRI-COUNTY PROCESS SERVING LLC on June 4, 2010 to be served on IDAHO 
  I . 
I, Zach D. Heesch, who being duly sworn, depose and say that on onday, June 7,2010, at 2:30 P , I: 
 t  it i   I  rt t f rr ti   li ri  t  tr  i  f t  
Subpoena Duces Tecum and Notice of Taking Deposition to John McKinney, Deputy Attorney 
eneral, a person authorized to accept service on behalf of Idaho Depart ent of Corrections. Said 
r i   ff t  t 00 W. ff r  tr et, ise, 1083702. 
I hereby acknowledge that I am a Process Server in the county in which service was effected. I am over 
the age of Eighteen years and not a party to the action. 
r f r  ber:  
Client Reference: Christopher C. Burke 
TRI-COUNTY PROCESS SERVING LLC 
P.O. Box 1224 
Boise, 10, 83701 
(208) 344-4132 
i   s r  bef r   to  
onday, Ju  7,201  
Notary Public 
Residing at Ise, Idaho 
My Commission Expires on February 12th, 2015 
ORIGINAL
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA





IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR an individual





SUBPOENA DUCES TECUM AND
NOTICE OF TAKING DEPOSITION OF
IDAHO DEPARTMENT OF
CORRECTIONS
THE STATE OF IDAHO SENDS GREETINGSTO
Attn Records Custodian
Copy also served upon
co Deputy Attorney General assigned for BrentReinke Director
IDAHO DEPARTMENT OF CORRECTIONS IDAHO DEPARTMENT OF CORRECTIONS
700W Jefferson Street 1299 N Orchard Street Suite 110
Boise ID 837200010 Boise ID 83706
YOU ARE HEREBY COMMANDED to appear and attend a deposition before a
certified court reporter at the offices of Greener Burke Shoemaker PA950 West Bannock
Suite 900 Boise Idaho on July 13 2010 at930amto testify in the above entitled action
now pending before the abovenamed Court
SUBPOENA DUCES TECUM AND NOTICE OF TAKING DEPOSITION OF IDAHO
DEPARTMENT OF CORRECTIONS Page 1
14542 011 335191doc
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Christopher C. Burke, ISB #2098 
GREENER BURKE S E AKER PA 
950 . Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
\ \  
IN E IS ICT      IS IC    
  I , I        
ILLIE J  J , an individual, 
Plaintiff, 
v. 
SE IT  E IP E T 
CORPORATION, a Missouri corporation, 
ant. 
se o.: - I-  
    
  I  I   
   
 
 S  F I  S S I S : 
tt : ec r s st ia  
c/o Deputy Attorney General assigned for 
I  P  F I S 
700 . Jefferson treet 
Boise, ID 83720-0010 
 l  ser  on: 
t i ke,  
I  A   TI  
 . r r  treet, Suit  1  
oi e, I   
    to appear and attend a deposition before a 
certified court reporter, at the offices of Greener Burke Shoemaker P .A., 950 est Bannock, 
Suite 900, Boise, Idaho, on July 13,2010, at 9:30 a.m., to testify in the above-entitled action, 
now pending before the above-named Court. 
SUBPOENA D  TECU  A D NOTI  OF TA I  DEPOSITION OF I  
DEPARTMENT OF CORRECTI S Page 1 
14542-011 ( 35191.doc) 
YOU ARE COMMANDED to bring with you all of the documents andor other materials
described in Exhibit Aattached hereto
If you fail to appear at the appointed location on the date and time specified above you
may be held in contempt of court and the aggrieved parties may recover from you the sum of
1000 as well as any damages which they may sustain by your failure to attend as a witness
You may satisfy this subpoena without appearing for your deposition if copies of
those documents and other materials described in Exhibit A hereto are delivered to the
offices of Greener Burke Shoemaker PA 950 West Bannock Suite 900 Boise Idaho
83702 on or before500pmon July 12 2010
BY ORDER OF THE COURT
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DEPARTMENT OF CORRECTIONS Page 2
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OU RE C ANDED to bring ith you all of the docu ents and/or other aterials 
described in Exhibit "A" attached heret . 
If you fail to appear at the appointed location on the date and time specified above, you 
may be held in contempt of court, and the aggrieved parties may recover from you the sum of 
$1 0.00 as ell as a  a ages ic  t e  a  s stai   r failure to atte d as a itness. 
You ay satisfy this subpoena without appearing for your deposition if copies of 
those e ts   t i ls ibed i  ibit" A" t   livere  t  t  
ice    e er .A.,   ck, te , , , 
83702, on or before 5:00 p.m. on July 12,2010. 
    T. 
TE  t is£day of ay, 2010. 
hristopher . urke 
tt   t 
SUBPOEN  S TECUM AN  NOTI  OF TAKI  DEPOSITION OF ID  
DEPART E T F CORRECTI S Page 2 
14542-011 ( 35191.doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Subpoena Duces Tecum on the
following named persons on the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O Box 7808
BoiseIdaho 83707
ViaUSMail
X Via Hand Delivery
Via Facsimile 2084898988
ViaOvernight Delivery
DATED this day ofMay 2010
CLWL
Christopher C Burke
SUBPOENA DUCES TECUM AND NOTICE OF TAKING DEPOSITION OF IDAHO
DEPARTMENT OF CORRECTIONS Page 3
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FICATE F E 
I hereby certify that I caused to be served the foregoing Subpoena Duces Tecu  on the 
following named person(s) on the date indicated below, in the manner indicated below: 
ar in verson, Esq. 
Eric B. Swartz, Esq. 
J  & TZ, P LC 
1673 . Shoreline rive, Suite 220 
. .   
oise, Idaho 83707 
 s ~y of ay, 2010. 
[ ] ia .S. il 
[X] ia a d e  
[ ] ia i ile (208/489-89 ) 
[ ] ia e ig t li e  
hristopher . urke 
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EXHIBIT A
REQUESTED DOCUMENTS
Security Equipment Corporation requests that you produce the following documents
Definitions
1 The term Document means and includes any kind of written typewritten or
printed recorded or graphic matters however produced or reproduced ofwhich You have any
knowledge or information whether in Your possession or under Your control or not relating or
pertaining in any way to the subject matter of this action This definition includes but is not
limited to any and all originals all file copies and all other copies no matter how or by whom
prepared and all drafts prepared in connection with such writings whether used or not of the
following papers agreements contracts notices memoranda correspondence letters
telegrams telexes cables statements books invoices purchase orders reports studies treatises
articles transcripts minutes records telephone logs accounting books maps photographs
films transcriptions and recordings settlements notes summaries schedules drawings
sketches acknowledgments diaries tapes pictures computer programsemail electronic data
and metadata hard copies of electronic data or other graphic symbolic recorded or retaken
materials of any nature whatsoever Any Document which contains any comments notations
addition insertion or marking of any kind which is not part of another Document is to be
considered as a separate Document
2 The terms You and Your refer to said shall mean the Idaho Department of
Corrections and shall include its agents representatives consultants and attorneys
3 The term Major shall mean Plaintiff Billie Jo Major DOB Social
Security No allegedly employed by IDC between July 2004 and May 2008
4 The term SEC shall mean Defendant Security Equipment Corporation and shall
include its agents employees and representatives
5 The term Lawsuit shall mean that Lawsuit entitled Billie Jo Major v Security
Equipment Corporation filed in and for the Fourth Judicial District Ada County Idaho Case
No CV PI 1003515 and shall include all claims asserted or which may have been asserted
therein
6 The term WC Carrier shall mean any insurance carrier agency or entity which
insured Majors employer for workers compensation liability andor which paid workers
compensation benefits to or on behalf ofMajor as a result of the Incident




S  S 
Security Equipment orporation requests that you produce the follo ing docu ents: 
itions 
. he ter  "Docu t" eans  includes  ind  t , i te   
printed, recorded, or graphic matters, however produced or reproduced, of which You have any 
knowledge or information, whether in Your possession or under Your control or not, relating or 
pertaining in any way to the subject matter of this action. This definition includes, but is not 
li ited to, any and all originals, all file copies and all other copies, no atter ho  or by ho  
prepared, and all drafts prepared in connection with such writings, whether used or not, of the 
following: papers, agree ents, , , , , r , 
telegrams, telexes, cables, statements, books, invoices, purchase orders, reports, studies, treatises, 
articles, transcripts, minutes, records, telephone logs, accounting books, maps, photographs, 
films, transcriptions and recordings, settlements, notes, summaries, schedules, drawings, 
sketches, acknowledgments, diaries, tapes, pictures, computer programs, e-mail, electronic data 
and metadata, hard copies of electronic data, or other graphic, symbolic, recorded or retaken 
materials of any nature whatsoever. Any Document which contains any comments, notations, 
addition, insertion, or arking of any kind hich is not part of another ocu ent is to be 
considered as a separate ocu ent. 
.   "Y "  "Yo r"   i  al     r t  
Corrections, and shall include its agents, representatives, consultants and attorneys. 
3. The ter  "Major" shall ean Plaintiff Billie Jo ajor, DOB Social 
Security No. allegedly e ployed by IDC between July 2004 and ay  
.  t  "S " hall  t rit  i t orporation,  all 
include its agents, employees and representatives. 
5.  t r  "La uit" hal    it ntitl  ill   j r v. ecurit  
Equipment Corporation, filed in and for the Fourth Judicial District, Ada County, Idaho, Case 
o.  I 1003515, and shall include all clai s asserted or hich ay have been asserted 
t erein. 
6.  t r  "  arrier" shall  any i s r  carrier, agency r entity hich 
insured Major's employer for worker's compensation liability, and/or which paid worker's 
compensation benefits to or on behalf of ajor as a result of the Incident. 
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7 The term IDC shall mean Idaho Department of Corrections andorany other
person or entity who or which employed Major at the time of the Incident alleged in the
Complaint in the Lawsuit
8 The term Incident shall mean any and all exposures by Major to oleoresin
capsicum pepper spray OC Spray products including but not limited to OC Spray from the
Product during the course of her employment with IDC or otherwise which exposure is alleged
in Plaintiff s Complaint in the Lawsuit
9 The term Product shall mean that Sabre Red OC Spray product that is the
subject of the Incident and Plaintiffs Complaint in the Lawsuit
10 The term OC Spray shall mean any aerosol or water based spray containing
concentrations of oleoresin capsicum pepper
11 The Employment shall mean Majors employment by IDC allegedly between
July 2004 and May 2008
Documents to Be Produced
Security Equipment Corporation requests that you produce the following documents
I Majorsentire personnel and employment file relating to her employment by IDC
2 All documents relating to IDCs purchase or acquisition of any and all OC Spray
products purchased or acquired by IDC and used by IDC at any facility at which
Major was employed at any time during Majorsemployment with IDC
3 All documents relating to IDCsoperation and use of OC Spray products at any
IDC facility at any time during Majors employment with IDC
4 All installation instruction operation maintenance care andor servicing
manuals brochures procedures or related documents pertaining to OC Spray
products in the possession of IDC for the time period of Majors employment with
IDC
5 All instructions warnings or cautions affixed to or provided with the Product at
the time of its purchase by IDC
6 All instructions warnings and cautions affixed to or provided with any OC Spray
products purchased by IDC at any time during Majors employment with IDC
7 All IDC employee handbooks handouts brochures andorIDC rules regulations
policies procedures guidelines or memos or other related documents relating to
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. he ter  "ID " ll  Ida  e art e t f rr ti , nd/or  t r 
rs  r tit   r i  loyed aj r t t e ti e f t  I ide t lle  i  t  
o plaint in the La suit. 
. e  "Incid t"  e          
capsicum pepper spray ("OC Spray") products, including, but not li ited to  pray fro  the 
Product, during the course of her e ploy ent with IDC, or otherwise, which exposure is alleged 
in Plaintiff s o plaint in the a suit. 
. he t r  "Pro ct" ll e  t t r    r  r t t t i  t  
s j t f t  I i t  l i tiffs l i t i  t  suit. 
. he ter  "~C Spray" shall ean any aerosol or ater based spray containing 
concentrations of oleoresin capsicu  pepper. 
. The "Employ ent" shall ean ajors e ploy ent by I C, allegedly bet een 
July 2004 and ay 2008. 
   c  
Security quip ent orporation requests that you produce the follo ing docu ents: 
1. ajor's entire personnel and e ploy ent file relating to her e ploy ent by I e. 
. ll docu ents relating to I C's purchase or acquisition of any and all C Spray 
products purchased or acquired by IDC and used by IDC at any facility at which 
aj r as e l e  at a  ti e ri  ajor's e l e t it  I . 
. ll docu ents relating to I C's operation and use of  Spray products at any 
I  facility at any ti e during ajors e ploy ent ith I . 
. ll installation, instruction, operation, aintenance, care and/or servlcmg 
anuals, brochures, procedures or related docu ents pertaining to  pray 
products in the possession of I  for the ti e period of ajors e ploy ent ith 
. 
. ll i str ti s, r i s r ti s ffi  t  r r i  it  t  r t t 
the ti e of its purchase by I . 
. ll i str cti s, ar i s a  cauti s affi e  t  r r i e  it  a   ra  
products purchased by IDC at any ti e during ajors e ploy ent with IDC. 
. ll I  e ployee handbooks, handouts, brochures and/or I  rules, regulations, 
policies, procedures, guidelines or e os or other related docu ents relating to 
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OC Spray or OC Spray safety in IDCs possession andor in effect at IDC at the
time of the Incident andorduring Major employment with IDC
8 All documents relating to the salaries wages and benefits paid Major by IDC
during and after IDCsemployment of Major
9 All notes memos correspondence reports and other documents prepared kept or
maintained by or on behalf of IDC or any of its representatives in connection
with or as part of any investigation or review of the Incident andorMajors use of
the or exposure to OC Spray while employed by IDC
10 The Product andor any component parts or attachments thereto and any
warnings labels and instructions provided therewith or affixed thereto
11 All documents relating to Majors exposure to OC Spray products at any time
during her employment with IDC
12 All brochures manuals handbooks policies procedures guidelines
PowerPoints DVDs and videos used by IDC andor provided to Major in
connection with any OC Spray training received by Major at or at the request of
IDC during Majors employment with IDC
13 All documents relating to any OC Spray Training received by Major while
employed by IDC
14 All documents received by IDC from any OC Spray product manufacturer
relating to OC Spray products at any time during and after Majors employment
with IDC
15 All documents pertaining to the sale shipment distribution andor use of any OC
Spray product to or at any site at which Major allegedly sustained exposure to OC
Spray during her employment at IDC
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 Spray or  Spray safety in I C's possession and/or in effect at I  at the 
ti e f the Incide t nd/or ri  jor's l t ith I . 
. ll c e ts relating t  t e salaries, ages a  e efits ai  aj r  I  
ri  a  after I C's e l e t f aj r. 
. l , , , ts    ,   
aintained by or on behalf of I , or any of its representatives, in connection 
it  r  rt f  investigation r r i  f t  I ide t nd/or ajors s  f 
the or exposure to  Spray hile e ployed by I . 
. The Product, and/or any t rts r tt ts t r t ,   
warnings, labels and instructions provided therewith or affixed thereto. 
. ll docu ents relating to ajors exposure to  Spray products at any ti e 
during her e ploy ent ith I e. 
.  r c res, a als, oks, licies, r ce res, i eli es, 
o erPoint's, D's and videos used by I  and/or provided to ajor in 
connection ith any  pray training received by ajor at or at the request of 
I  during ajors e ploy ent ith I . 
. ll docu ents relating to any  pray raining received by ajor hile 
employed by IDC. 
. ll ts i        t t  
relating to C Spray products at any ti e during and after ajors e ploy ent 
 . 
. All documents pertaining to the sale, shipment, distribution and/or use of any OC 
Spray product to or at any site at hich ajor allegedly sustained exposure to  
Spray during her e ploy ent at I . 
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF




Greener Burke Shoemaker PA






Plaintiffs AFFIDAVIT OF SERVICE
Defendants
Case Number CVPI1003515
Received by TRICOUNTY PROCESS SERVING LLC on June 4 2010 to be served on IDAHO
DEPARTMENT OF CORRECTIONS
I Zach D Heesch who being duly sworn depose and say that on Wednesday June 9 2010 at 328
PM I
SERVED the within named Idaho Department of Corrections by delivering a true copy of the
Subpoena Duces Tecum and Notice of Taking Deposition to Bill Loomis Deputy Attorney General a
person authorized to accept service on behalf of Idaho Department of Corrections Said service was
effected at 1299 N Orchard St Suite 110 Boise ID 83706
I hereby acknowledge that I am a Process Server in the county in which service was effected I am over
the age of Eighteen years and not a party to the action
Our Reference Number 96161
Client Reference Christopher C Burke
Subscribed and sworn before me today
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IN THE DISTRICT COURT OF THE FOURTH JUDICIALDISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Defendant
Case No CVPI1003515
SUBPOENA DUCES TECUM AND
NOTICE OF TAKING DEPOSITION OF
IDAHO DEPARTMENT OF
CORRECTIONS
THE STATE OF IDAHO SENDS GREETINGS TO
Attn Records Custodian
Copy also served upon
co Deputy Attorney General assigned for Brent Reinke Director
IDAHO DEPARTMENT OF CORRECTIONS IDAHO DEPARTMENT OF CORRECTIONS
700 W Jefferson Street 1299 N Orchard Street Suite 110
Boise ID 837200010 Boise ID 83706
YOU ARE HEREBY COMMANDED to appear and attend a deposition before a
certified court reporter at the offices ofGreener Burke Shoemaker PA950 West Bannock
Suite 900 Boise Idaho on July 13 2010 at930amto testify in the above entitled action
now pending before the abovenamed Court
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hristopher . urke, IS  #2098 
GREENER BURKE S KER P  
950 . annock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
ttorneys for efendant 
\ \ Al 
  IS       IS    
E  I , I    E    
I IE J  J ,  i i i l, 
Plaintiff, 
v. 
SECURITY EQUIP ENT 
CORPORATION, a issouri corporation, 
ant. 
as  o.: - I-I  
    
  I  I   
   
S 
   I   I  :' 
t : r   
c/o Deputy Attorney General assigned for 
I    I  
700 . Jefferson Street 
Boise, ID 83720-0010 
 l   on: 
r t einke, irect r 
I    TI  
 .  treet, uit   
ise,   
    t  a ear a  atte  a epositi  ef re a 
certified court reporter, at the offices of Greener Burke Shoemaker P.A., 950 est Bannock, 
Suite 900, Boise, Idaho, on July 13,2010, at 9:30 a.m., to testify in the above-entitled action, 
now pending before the above-named Court. 
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DEPART   CORRECTI  Page 1 
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YOU ARE COMMANDED to bring with you all of the documents andorother materials
described in ExhibitA attached hereto
If you fail to appear at the appointed location on the date and time specified above you
may be held in contempt of court and the aggrieved parties may recover from you the sum of
1000 as well as any damages which they may sustain by your failure to attend as a witness
You may satisfy this subpoena without appearing for your deposition if copies of
those documents and other materials described in Exhibit A hereto are delivered to the
offices of Greener Burke Shoemaker PA950 West Bannock Suite 900 Boise Idaho
83702 on or before 500pmon July 12 2010
BYORDER OF THE COURT
DATED this day of May 2010
G E
KER
URKE HOE KER PA
Christopher C Burke
Attorneys for Defendant
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  DE  to bring ith you all ofthe docu ents and/or other aterials 
 n t "A" ta  t . 
If  f il t  r t t e i te  l ti   t  t   ti  s ified ve,  
ay be held in conte pt f court, and the aggrieved parties ay recover fro  you the su  f 
$1 0. 0 s ll s  a es i  t   s st i   r f il r  t  tt  s  it ss. 
 a  satisf  t is s e a it t a eari  f r r e siti  if c ies f 
    als e   ibit" A"   e    
ffice  f r r r e er .A.,  e t ck, it  , i , I o, 
83702, on or before 5:00 p.m. on July 12,2010. 
    . 
 is£da  of ay, 2010. 
rist r . r  
tt r e s f r efe a t 
    I   I  I I   I  
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CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Subpoena Duces Tecum on the
following named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O Box 7808
Boise Idaho 83707
ViaUS Mail
X Via Hand Delivery
Via Facsimile 2084898988
Via Overnight Delivery
DATED this day ofMay 2010
CtWL
Christopher C Burke
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FICATE   
I hereby certify that I caused to be served the foregoing oe a ces ec  on the 
following named person(s) on the date indicated below, in the manner indicated below: 
ar in rs , s . 
Eric B. S artz, Esq. 
J ES & TZ, P  
1673 . horeline rive, uite 220 
. . ox 8 
Boise, Idaho 83707 
TE  t s ~y of ay, 2010. 
[ ] ia .S. il 
[X] ia a  li r  
[ ] ia le (208/489-89 ) 
[ ] ia t e  
hristopher . urke 
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EXHIBITA
REQUESTED DOCUMENTS
Security Equipment Corporation requests that you produce the following documents
Definitions
1 The term Document means and includes any kind of written typewritten or
printed recorded or graphic matters however produced or reproduced of which You have any
knowledge or information whether in Your possession or under Your control or not relating or
pertaining in any way to the subject matter of this action This definition includes but is not
limited to any and all originals all file copies and all other copies no matter how or by whom
prepared and all drafts prepared in connection with such writings whether used or not of the
following papers agreements contracts notices memoranda correspondence letters
telegrams telexes cables statements books invoices purchase orders reports studies treatises
articles transcripts minutes records telephone logs accounting books maps photographs
films transcriptions and recordings settlements notes summaries schedules drawings
sketches acknowledgments diaries tapes pictures computer programsemail electronic data
and metadata hard copies of electronic data or other graphic symbolic recorded or retaken
materials of any nature whatsoever Any Document which contains any comments notations
addition insertion or marking of any kind which is not part of another Document is to be
considered as a separate Document
2 The terms You and Your refer to said shall mean the Idaho Department of
Corrections and shall include its agents representatives consultants and attorneys
3 The term Major shall mean Plaintiff Billie Jo Major DOB Social
Security No 5 allegedly employed by IDC between July 2004 and May 2008
4 The term SEC shall mean Defendant Security Equipment Corporation and shall
include its agents employees and representatives
5 The term Lawsuit shall mean that Lawsuit entitled Billie Jo Major v Security
Equipment Corporation filed in and for the Fourth Judicial District Ada County Idaho Case
No CV PI 1003515 and shall include all claims asserted or which may have been asserted
therein
6 The term WC Carrier shall mean any insurance carrier agency or entity which
insured Majors employer for workers compensation liability andor which paid workers
compensation benefits to or on behalf ofMajor as a result of the Incident




S  S 
Security Equip ent Corporation requests that you produce the following docu ents: 
itions 
. he ter  "Docu t" eans  cludes  in   t , t i ten  
printed, recorded, or graphic matters, however produced or reproduced, of which You have any 
kno ledge or infor ation, hether in our possession or under our control or not, relating or 
pertaining in any way to the subject matter of this action. This definition includes, but is not 
limited to, any and all originals, all file copies and all other copies, no matter how or by whom 
prepared, and all drafts prepared in connection with such writings, whether used or not, of the 
follo ing: papers, agree ents, tr ts, ti s, , rr s , l tt r , 
telegrams, telexes, cables, statements, books, invoices, purchase orders, reports, studies, treatises, 
articles, transcripts, inutes, records, telephone logs, accounting books, aps, photographs, 
fil s, transcriptions and recordings, settle ents, notes, su aries, schedules, drawings, 
sketches, acknowledgments, diaries, tapes, pictures, computer programs, e-mail, electronic data 
and etadata, hard copies of electronic data, or other graphic, sy bolic, recorded or retaken 
aterials of any nature hatsoever. ny ocu ent hich contains any co ents, notations, 
addition, insertion, or marking of any kind which is not part of another Document is to be 
considered as a separate Document. 
.   "Yo "  "Yo r"    l     r  f 
orrections, and shall include its agents, representatives, consultants and attorneys. 
. The ter  "Major" shall ean Plaintiff Billie Jo ajor, DOB Social 
Security No. ; allegedly employed by IDC between July 2004 and ay
.  t r  "S C" hall  f t ecurit  i t r oration,  shall 
include its agents, e ployees and representatives. 
.  t  "La uit" shall  t t uit titl  illi   j r . ecurity 
Equipment Corporation, filed in and for the Fourth Judicial District, Ada County, Idaho, Case 
o.  I 1003515, and shall include all clai s asserted or hich ay have been asserted 
t rein. 
6. he ter  "  arrier" shall ean any insurance carrier, agency or entity hich 
insured ajor's employer for worker's compensation liability, and/or which paid worker's 
compensation benefits to or on behalf of Major as a result of the Incident. 
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7 The term IDC shall mean Idaho Department of Corrections andor any other
person or entity who or which employed Major at the time of the Incident alleged in the
Complaint in the Lawsuit
8 The term Incident shall mean any and all exposures by Major to oleoresin
capsicum pepper spray OC Spray products including but not limited to OC Spray from the
Product during the course of her employment with IDC or otherwise which exposure is alleged
in PlaintiffsComplaint in the Lawsuit
9 The term Product shall mean that Sabre Red OC Spray product that is the
subject ofthe Incident and Plaintiff s Complaint in the Lawsuit
10 The term OC Spray shall mean any aerosol or water based spray containing
concentrations of oleoresin capsicum pepper
11 The Employment shall mean Majors employment by IDC allegedly between
July 2004 and May 2008
Documents to Be Produced
Security Equipment Corporation requests that you produce the following documents
1 Majorsentire personnel and employment file relating to her employment by IDC
2 All documents relating to IDCs purchase or acquisition of any and all OC Spray
products purchased or acquired by IDC and used by IDC at any facility at which
Major was employed at any time during Majorsemployment with IDC
3 All documents relating to IDCs operation and use of OC Spray products at any
IDC facility at any time during Majors employment with IDC
4 All installation instruction operation maintenance care andor servicing
manuals brochures procedures or related documents pertaining to OC Spray
products in the possession of IDC for the time period of Majors employment with
IDC
5 All instructions warnings or cautions affixed to or provided with the Product at
the time of its purchase by IDC
6 All instructions warnings and cautions affixed to or provided with any OC Spray
products purchased by IDC at any time during Majors employment with IDC
7 All IDC employee handbooks handouts brochures andor IDC rules regulations
policies procedures guidelines or memos or other related documents relating to
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. The ter  "IDC" shall ean Idaho epart ent of Corrections, and/or any other 
person or entity ho or hich e ployed ajor at the ti e of the Incident alleged in the 
o plaint in the La suit. 
. e  "Incid t"        aj r   
capsicu  pepper spray ("OC Spray") r cts, i cl i , t t li ite  t   ra  fr  t e 
r ct, ri  t e c rse f er e l ent it  I , r t er ise, ic  e s re is alle e  
in Plaintiff s Co plaint in the Lawsuit. 
.  t  "Pro ct" ll  t t     t t t i  t  
subject of the Incident and Plaintiffs o plaint in the a suit. 
. he ter  "~C pray" shall ean any aerosol or ater based spray containing 
concentrations of oleoresin capsicu  pepper. 
. The "Employ ent" shall ean ajors e ploy ent by I C, allegedly bet een 
J l   a  a  . 
ts    
Security Equip ent orporation requests that you produce the follo ing docu ents: 
. ajor's entire personnel and e ploy ent file relating to her e ploy ent by I C. 
. ll docu ents relating to I C's purchase or acquisition of any and all  Spray 
products purchased or acquired by I  and used by I  at any facility at hich 
ajor was e ployed at any ti e during ajor's e ploy ent with IDC. 
. All documents relating to IDC's operation and use of OC Spray products at any 
I  facility at any ti e during ajors e ploy ent ith I . 
. ll installation, instruction, operation, aintenance, care and/or servicing 
anuals, brochures, procedures or related docu ents pertaining to C Spray 
products in the possession of IDC for the time period of ajors employment with 
. 
. ll instructions, arnings or cautions affixed to or provided ith the roduct at 
the time of its purchase by IDC. 
. ll instructions, arnings and cautions affixed to or provided ith any  pray 
products purchased by IDC at any time during ajors employment with IDC. 
. All IDC employee handbooks, handouts, brochures and/or IDC rules, regulations, 
policies, procedures, guidelines or e os or other related docu ents relating to 
I I    S P E  S  - Page  
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OC Spray or OC Spray safety in IDCs possession andor in effect at IDC at the
time of the Incident andorduring Majorsemployment with IDC
8 All documents relating to the salaries wages and benefits paid Major by IDC
during and after IDCsemployment of Major
9 All notes memos correspondence reports and other documents prepared kept or
maintained by or on behalf of IDC or any of its representatives in connection
with or as part of any investigation or review of the Incident andorMajors use of
the or exposure to OC Spray while employed by IDC
10 The Product andor any component parts or attachments thereto and any
warnings labels and instructions provided therewith or affixed thereto
11 All documents relating to Majors exposure to OC Spray products at any time
during her employment with IDC
12 All brochures manuals handbooks policies procedures guidelines
PowerPointsDVDsand videos used by IDC andor provided to Major in
connection with any OC Spray training received by Major at or at the request of
IDC during Majors employment with IDC
13 All documents relating to any OC Spray Training received by Major while
employed by IDC
14 All documents received by IDC from any OC Spray product manufacturer
relating to OC Spray products at any time during and after Majors employment
with IDC
15 All documents pertaining to the sale shipment distribution andor use of any OC
Spray product to or at any site at which Major allegedly sustained exposure to OC
Spray during her employment at IDC
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Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220




Attorneys for Plaintiff Billie Jo Major
JUN 2 5 2010
J DAVID NAVARRO Clerk
ByCARLY LATIMORE
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA






Case No CV PI 1003515
NOTICE OF COMPLIANCE
TO THE CLERK OF THE ABOVEENTITLED COURT
PLEASE TAKE NOTICE that on the 25th day of June 2010 Plaintiff by and
through her counsel of record Jones Swartz PLLC served PLAINTIFFS
SUPPLEMENTAL ANSWERS AND RESPONSES TO DEFENDANTS FIRST SET OF
INTERROGATORIES AND REQUESTS FOR PRODUCTION together with a copy of
this NOTICE OF COMPLIANCE upon counsel for the Defendants
JC
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J ES & S , PLLC 
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ttorneys for laintiff, illie Jo ajor 
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CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 25th day of June 2010 a true and correct copy of the
foregoing document was served on the following individualsby the method indicated
Christopher C Burke
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise ID 83702
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Case No CV PI 1003515
Plaintiff




TO THE CLERK OF THE ABOVEENTITLED COURT
PLEASE TAKE NOTICE that on the 5th day of August 2010 Plaintiff by and through
her counsel of record Jones Swartz PLLC served Plaintiffs Second Supplemental Answers
and Responses to DefendantsFirst Set of Interrogatories and Requests for Production
together with a copy of this Notice of Compliance upon counsel for the Defendant as follows
J
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Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 200 83702
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IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Case No CV PI 1003515
Plaintiff




TO THE CLERK OF THE ABOVE ENTITLED COURT
PLEASE TAKE NOTICE that on the 16th day of December 2010 Plaintiff by and
through her counsel of record Jones Swartz PLLC served Plaintiffs First Set of
Interrogatories Requests for Production and Requests for Admission to Defendant
together with a copy of this Notice of Service upon counsel for the Defendant as follows
Christopher C Burke
GREENERBURKE SHOEMAKER PA
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Attorneys for Plaintiff Billie Jo Major
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CHRISTOPHER D RICH Clerk
By ELYSHIA HOLMES
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Case No CV PI 1003515
Plaintiff




TO THE CLERK OF THE ABOVE ENTITLED COURT
PLEASE TAKE NOTICE that on the 10th day of January 2011 Plaintiff by and
through her counsel of record Jones Swartz PLLC served Plaintiffs Second Set of
Interrogatories Requests for Production and Requests for Admission to Defendant
together with a copy of this Notice of Service upon counsel for the Defendant as follows
Christopher C Burke
GREENER BURKE SHOEMAKER PA
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JAN 2 1 2011
Attorneys for Plaintiff Billie Jo Major
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CHRISTOPHER D RICH Clerk
By LARAAMES
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA






Case No CV PI 1003515
NOTICE OF SERVICE
TO THE CLERK OF THE ABOVEENTITLED COURT
PLEASE TAKE NOTICE that on the 19th day of January 2011 Plaintiff by and through
her counsel of record Jones Swartz PLLC served Plaintiffs Third Set of Interrogatories
and Requests for Production together with a copy of this Notice of Service upon counsel for
the Defendant as follows
Christopher C Burke
GREENER BURKE SHOEMAKER PA
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Ada County Clerk
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CHRISTOPHER D RICH Clerk
BY JOHN WEATHERBY
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA








Plaintiff Billie Jo Major Major and Defendant Security Equipment Corporation
SEC by and through their undersigned counsel ofrecord having entered a Confidentiality
Agreement Agreement in the form attached hereto as Exhibit A and good cause appearing
for the approval and adoption of that Agreement
NOWTHEREFORE IT IS HEREBY ORDERED THAT
1 The Agreement attached is hereby approved and adopted by this Court
2 All documents and materials properly designated by the Parties as Confidential
Documents as the term is defined in the Agreement shall be governed by and subject to the
terms of the parties Agreement
3 The terms and conditions of the Agreement shall be binding upon all persons who
have access to and review any documents or materials designated confidential and
ORIGINAL NO I
PM




JAN 2 ~ 2011 
Ada ounty lerk 
\ \  
NO 
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JAN 2 6 2011 
CHRISTOPHER D. I , Clerk 
By JOHN WEATHERBY 
DEPUTY 
IN THE ISTRICT   E F  J I I  ISTRICT F E 
TE F I , IN   E    
ILLIE J  J , an individual, 
l i tiff, ase .: - I-lO 5 
v.   
SECURITY EQUIP ENT 
I , a issouri corporation, 
t. 
Plaintiff Billie Jo ajor ("Major")      
("SE "), by and through their undersigned counsel of record, having entered a Confidentiality 
Agreement ("Agreement")        "A,"    ri  
for the approval and adoption of that Agreement, 
 T EREF RE, IT IS EREB  R ERE  T T: 
1. The Agree ent attached is hereby approved and adopted by this Court; 
. ll docu ents and aterials properly designated by the arties as onfidential 
Documents (as the term is defined in the Agreement) shall be governed by and subject to the 
terms of the parties' Agreement; 
3. e ter s an  conditi s of the ree ent shall e bindi g  all pers s w  
have access to and revie  any docu ents or aterials designated confidential; and 
III 
III 
CONFIDENTIALITY ORDER - PAGE 1 14542-011 ( 68281) 
4 All Confidential Documents and materials shall survive the termination of this
action and shall retain their confidential designation and remain subject to this Order until such
time if ever as the Court may order otherwise
JL
DATED THIS k day of January 2011
B
Judge Cheri C Copsey
Fourth Judicial District Court Ada County
CONFIDENTIALITY ORDER PAGE 2 14542 011 368281000070
4. l fide tial ocuments a d ate ials s l s ive the ter ination f this 
action and shall retain their c fide tial d si ti , and re ain s ject to this rder u til s  
ti e, if ever, as the ourt ay order other ise. 
J.,-, 
DATED THIS ~t) day of January, 2011. 
y &.wv-.~ 
J e eri . se  
t   t t,   
CONFIDENTIALIT  R ER - PA E 2 14542- 11 ( 8281) 
CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this a L day ofJanuary 2011 a true and correct copy ofthe
above and foregoing document was forwarded addressed as follows in the manner indicated
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O BOX 7808
V ViaUS Mail





Christopher C Burke Esq
GREENER BURKE SHOEMAKER PA








CONFIDENTIALITY ORDER PAGE 3 14542 011 368281000071
IC TE F  
I  IF  that n this ~   r , ,  true a d re t  f the 
above and foregoing docu ent as for arded addressed as follo s in the anner indicated: 
ar in ers , s . 
Eric B. Swartz, Esq. 
J ES & S , P C 
 . line , te  
. . ox 8 
oise, Idaho 83707 
ttorneys for laintiff 
Christopher C. Burke, Esq. 
E  E ER .A. 
950 est annock treet, uite 900 
oise, Idaho 83702 
Attorneys for Defendant 
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CONFIDENTIALITY AGREEMENT
This Confidentiality Agreement the Agreement is made and entered into by and
between Plaintiff Billie Jo Major Major and Defendant Security Equipment Corporation
SEC Major and SEC are individually referred to as Party and collectively referred to as
Parties
RECITALS
Major and SEC are Parties to litigation currently pending in the District Court of the
Fourth Judicial District of the State of Idaho in and for the County ofAda which case has been
designated as Billie Jo Major vs Security Equipment Corporation Case No CVPI1003515
the Litigation
Each Party has requested or will request copies of documents and other things
Documents in the possession of or under the control of another Parry The Parties believe
that it is appropriate for them to memorialize their understanding and agreement as to the
production use and disclosure of Documents in this case
The Parties desire that the terms of this Agreement be approved and adopted by order of
the Court in the Litigation
THEREFORE the Parties agree as follows
1 The Parties acknowledge that Documents exchanged in this litigation may contain
confidential andorproprietary information and trade secrets Confidential Documents
2 The Parties agree to produce Confidential Documents only upon the condition that
they remain confidential
3 The Parties agree that any Party may designate any Documentsasconfidential
by placing or affixing thereon in such manner as will not interfere with the reasonable legibility
of the materials the word CONFIDENTIAL or an otherwise similar appropriate notice
4 The Parties agree that during the pendency of this Litigation including any
subsequent appeals each Party including its authorized agents consultants experts attorneys
attorneys staff and authorized court reporters and court staff may review copy and use the
Confidential Documents only for purposes of the Litigation and for no other purposes and that
the Parties agree to take the following steps to preserve and protect the confidential nature of the
Confidential Documents
a Non Disclosure During the life of this Agreement and after this Litigation
including any subsequent appeals the Parties including their authorized agents consultants
experts attorneys attorneys staff and authorized court reporters and court staff will not use




his fi ti lity gree t (the "'Agr ement") is a e  tere  i t    
bet een Plaintiff illie Jo ajor ("'Major")  efe a t rit  ip e t r r ti  
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designated as illie Jo ajor vs. Security quip ent orporation, ase o. -PI-1003515 
(the "Litigation"). 
Each Party has requested or will request copies of documents and other things 
("Documents") in the possession of or under the control of another Party. The Parties believe 
that it is appropriate for the  to e orialize their understanding and agree ent as to the 
production, use and disclosure of Documents in this case. 
 ties i  t t t  t   t i  gre t    t     
the Court in the Litigation. 
T E EF E, the Parties agree as follo s: 
.  tie  le ge t t t   i  t i  litig ti   t i  
confidential and/or proprietary information and trade secrets ("Confidential Documents"). 
.  rties r  t  r  fi ti l t  l   t  iti  t t 
they remain confidential. 
. he arties agree that any arty ay designate any ocument(s) as confidential 
by placing or affixing thereon, in such anner as will not interfere with the reasonable legibility 
f t  t ri ls, t  r  "CO I NTIAL" r  t r is  si il r r ri t  ti . 
. he Parties agree that during the pendency of this itigation, including any 
subsequent appeals, each Party, including its authorized agents, consultants, experts, attorneys, 
attorneys' staff, and authorized court reporters and court staff, ay review, copy and use the 
onfidential ocu ents only for purposes of the Litigation, and for no other purposes, and that 
the Parties agree to take the following steps to preserve and protect the confidential nature of the 
fi ti l ts. 
. on- isclosure: uring the life f this gree ent and after this itigation, 
including any subsequent appeals, the Parties, including their authorized agents, consultants, 
experts, attorneys, attorneys' staff, and authorized court reporters and court staff, will not use, 
NFIDENTIALIT  EE E T - Page 1 
14542-011 (368282) 
disclose or otherwise permit any person or entity access to any of the Confidential Documents
other than as required for the purpose of the Litigation including any subsequent appeals and as
provided in this Agreement
b Authorized Disclosures The Parties and their attorneys will ensure that those
persons to whom the Confidential Documents are disclosed are advised ofthis Agreement and
Confidentiality Order and the confidential nature of the Documents and that they are precluded
from disclosing the information in any manner or to any person not required in the pursuit of the
Litigation including any subsequent appeals
C Prevent Disclosure The Parties and their attorneys shall properly secure and
control all Confidential Documents and take all reasonable precautions to prevent unauthorized
access to or reproduction or disclosure of the Confidential Documents to unauthorized persons
or entities
d Return or Destroy the documents Upon termination of the pendency of the
Litigation including any subsequent appeals the Parties and their attorneys will deliver to the
other Party or Parties or destroy all tangible copies of the Confidential Documents and
documents that refer or otherwise disclose the confidential information contained in the
Confidential Documents The Parties will also take all reasonable steps necessary to retrieve and
return to the other Parties or to confirm destruction of all Confidential Documents and
documents that refer to or otherwise disclose the confidential information in the Confidential
Documents previously produced or provided to their agents consultants attorney staff experts
and other authorized court reporters and court staff
5 If aParty disagrees with a designation of confidentiality the Party shall notify the
other Parties in writing If the Parties cannot otherwise agree the Party who disagrees with the
confidential designation may file a motion with the Court contesting the designation
6 Any Party may designate any transcript or portions of any transcript of any
deposition or any deposition exhibits as confidential either by notifying all Parties on the record
of the deposition or by written notice within thirty 30 days after receipt of the deposition
transcript ofany confidential designation The transcript or portions oftranscript and exhibits so
designated shall be bound separately under seal and prominently marked Confidential Material
Subject to Confidential Order or such other similar designation Any and all computer readable
versions ofthe deposition transcript andorexhibits shall also be so marked
7 Confidential Documents may be referred to or incorporated into briefs affidavits
pleadings or other documents filed with the Court provided such Confidential Documents or
information are filed with the clerk of the Court under seal and prominently marked
Confidential Material Subject to Confidential Order Any reasonable similar designation shall
also suffice
8 Confidential Documents offered into evidence at any trial or hearing in the
CONFIDENTIALITY AGREEMENT Page 2
14542011368282000073
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ocu ents, previously produced or provided to their agents, consultants, attorney staff, experts 
and other authorized court reporters and court staff 
. If a Party disagrees ith a designation of confidentiality, the Party shall notify the 
other arties in riting. If the arties cannot other ise agree, the arty ho disagrees ith the 
confidential designation ay file a otion with the Court contesting the designation. 
. Any Party ay designate any transcript or portions of any transcript of any 
deposition, or any deposition exhibits, as confidential, either by notifying all Parties on the record 
of the deposition or by written notice within thirty (30) days after receipt of the deposition 
transcript of any confidential designation. The transcript or portions of transcript and exhibits so 
designated shall be bound separately under seal and pro inently arked "Confidential aterial 
Subject to Confidential Order," or such other similar designation. Any and all computer readable 
versions of the deposition transcript and/or exhibits shall also be so marked. 
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pleadings or other documents filed with the Court, provided such Confidential Documents or 
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0124011 1133 FAX 208 489 8988 Jones Swartz
opportunity to seek protection from disclosure of the Confidential Documents or other
confidential information
9 The Parties agree that this Agreement shall survive the termination ofthe
Litigation The Parties further agree that this Agreement shall be submitted to the Court for
approval and adoption in the form of the Confidentiality Order attached to this Agreement as
Exhibit A
WHEREFORE by the signature of their counsel below the Parties acknowledge that they
have reviewed carefully what has been expressed in this Agreement and understand that its terms






Dated el24 If GR SH P
Christopher C Burke
Attorney for Defendant
CONFIDENTIALITY AGREEMENT page 3
14542 011368282
000074
~lr24/2011 11:33 FAX 208 489 89 8 Jones Swartz 
opportunity to seek protection from disclosure of the Confidential Documents or other 
confidential infor ation. 
9. The Parties agree that this Agreement shall survive the tennination of the 
itigati . The Parties further agree that this gree ent shall be sub itted t  the o rt for 
approval and adoption in the form of the Confidentiality Order attached to this Agreement as 
xhibit "A." 
E , b  t e signature f t eir c sel el , t e arties ac ledge that t e  
have revie ed carefully hat has been e presse  in this gree ent, and dersta  t at its ter s 
are legally binding on them. 
ated 12!- ?4 -  r 
CONFIDENTIALITY AGREEMENT - Page 3 
 ers  
 .  
ttorneys for laintiff 
hristopher C. urke 
  t 




JAN 2 6 2011
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA





CHRISTOPHER D RICH Clerk
By ABBY GARDEN
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA








NOTICE OF SERVICE OF DEFENDANTS
RESPONSES TO PLAINTIFF FIRST SET
OF DISCOVERY REQUESTS
Defendant
PLEASE TAKE NOTICE that on the 26 day of January 2011 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke Shoemaker PA
served the following documents in the manner indicated on the service list
a DefendantsResponses to PlaintiffsFirst Set oflnterrogatories Requests for
Production ofDocuments and Requests for Admission and
b This Notice ofService ofDefendantsResponses to PlaintiffsFirst Set of
Discovery Requests








Christopher C. Burke, ISB #2098 
GREENER BURKE S KER P  
950 . Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
RiGiNAL NO.----~;::__..".J7A~"...-­
FILED ~'L7l A.M. _____ ,P.M . ....:::;.._-'-'-__ _ 
JA    20 1 
ISTOPHER D. I , l rk 
By BBY ARDEN 
DEPUTY 
I  E IS I  T  E  J I I  IS I   E 
  , I    E    
BILLIE JO AJOR, an individual, 
Plaintiff, 
v. 
SECURITY EQUIP ENT 
CORPORATION, a issouri corporation, 
ant. 
 .: - I-I  
    FENDANT'S 
  LAINTIF 'S   
   
  I  that, on the 26th day of January, 2011, efendant ecurity 
Equipment Corporation, by and through its counsel of record, Greener Burke Shoemaker P.A., 
served the following documents in the manner indicated on the service list: 
. Defendant's Responses to Plaintiff's First Set of interrogatories, Requests for 
Production of Documents, and Requests for Admission; and 
b. This Notice of Service of Defendant'S Responses to Plaintiff's First Set of 
Discovery Requests. 
DATED this 26th day of January, 2011. 
P.A. 
ristopher . urke 
ttorneys for efendant 
TICE F SERVICE F DEFENDANT'S RESP SES T  PLAINTIFF'S FIRST SET OF DISCOVERY 
REQUESTS - Page I 
14542-011 (365857.doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice of Service of
DefendantsResponses to Plaintiffs First Set of Discovery Requests on the following named
persons on the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O Box 7808
Boise Idaho 83707
ViaUSMail
x Via Hand Delivery
Via Facsimile 2084898988
Via Overnight Delivery
DATED this 26 day of January 2011
Aristoppherurke




IFICA TE F  
I hereby certify that I caused to be served the foregoing otice of Service of 
Defendant's Responses to Plaintiff's First Set of Discovery Requests on the following named 
person(s) on the date indicated below, in the manner indicated below: 
Darwin Overson, Esq. 
Eric . S artz, Esq. 
 & ,  
 . reline ri e, ite  
. .   
oise, Idaho 83707 
E  this 26th day f January, 2011. 
[ ] ia .S. a  
[ ] ia and eliver  
[ ] ia le (208/489-89 ) 
[ ] ia er ig t eli er  
  ER I   FENDANT'S  T  LAINTIF 'S FI  SET O  I  






IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF













Case Number CV PI 1003515
Defendants
Received by TRI COUNTY PROCESS SERVING LLC on January 26 2011 to be served on WILLIAM
M LOOMIS
I Zach D Heesch who being duly sworn depose and say that on Monday January 31 2011 at 119
AM I
SERVED the within named persons by delivering to and leaving with WILLIAM M LOOMIS a true copy
of the Subpoena Said service was effected at Department of Corrections 1299 N Orchard Street
Ste 110 Boise ID 83706
1hereby acknowledge that I am a Process Server in the county in which service was effected I am over
the age of Eighteen years and not a party to the action
Our Reference Number 104276
Client Reference Darwin Overson
Subscribed and sworn before me today
Monday January 31 2011
0YARZ
Q
O V ARy 16
TRI COUNTY PROCESS tEEkINGLLZ G
POBox 1224 PUali OBoise ID 83701 s0
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   I , I        
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laintiff(s): 
I I   I  
fendant(s): 
 r:  I 3515 
:ss 
) 
c iv  y I-   I    J ry ,  t   s rv   I I  
. I . 
I,  . sch,  i  ly rn,    t t  y, r  ,2 , t 1 :19 
, I: 
SERVED the within na ed person(s) by delivering to and leaving with ILLIA  . L IS a true copy 
of the ubpoena. aid service as effected at epart ent of orrections, 1299 . rchard treet, 
Ste. 110, Boise, 10 83706. 
I r  l  t t I   r  r r i  t  t  i  i  r i   ff cted. I  r 
the age of Eighteen years and not a party to the action. 
  ber: 6 
 f r nce:   
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...... <;;.,1'> •••••••• -1¢' ' .... 
"5l;- •••• ..., .. ,: ~ *. e. (' ~ .... :<: '\ARY·.-: : ~ : *-0 ~: 
ri   r  f r   t  
nday,  1,  
TRI-COUNTY PROCESS !>E~ING"t.t~ G j ~ 
. O.   ~ ... U~ \..,\ l : '===-"""""":::--:--::--~-:--~-:-""7"'7~-:----'<----
Boise, 10, 83701 -:'" S'.... • •• ·X:-0 .... ~ 
(208) 344-4132 "'" l'-1;;;o··;~\)I'>\\\ .... . 
t", l' ", 
I" ...... ", 
JJ Darwin L Overson ISB 45887
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 200 83702






BILLIE JO MAJOR and individual
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF










TO DEFENDANT SECURITY EQUIPMENT CORPORATION AND ITS
ATTORNEYS OF RECORD
PLEASE TAKE NOTICE that Defendant will take testimony on oral examination of
Plaintiffs expert witness KARINA PACHECOMDMSPH before a court reporter and notary
public with the firm Hunter Geist at National Jewish Hospital 1400 Jackson St Denver CO
80206 on Thursday April 21 2011 commencing at830amand concluding at 1230pmThe
deposition will continue thereafter on Friday April 22 2011 commencing at 830am and
concluding at 1230pm




z -(!J -a: o 
ar in . vers , ISB #5887 
J ES & S RTZ P LC 
=--!l~ 
1673 . S reline ri , ite 200 [837 ] 
Post ffice ox 7808 
oise, Idaho 83707-7808 
Telephone: (208) 489-8989 
Facsi ile: (208) 489-8988 
E-mail: dar in jonesandswartzlaw.com 
Attorneys for Plaintiff 
FEB ~ ~ 1011 
IN E IS IC         
E   ,    E    
I IE J  J , and individual, 
Plaintiff, 
vs. 
I  I  RATI , 
a Missouri corporation, 
ant. 
s  .  I 15 
   
 I   
 . , .D.,  
  I   PORATI N,   
S  RD: 
  I  t t f t ill t  t sti   r l i ti  f 
Plaintiffs expert itness, ARIN . P C ECO, .D., SPH, before a court reporter and notary 
public with the firm Hunter & ist, t ti l i  spital,  c  t., nver,  
80206, on Thursday, pril 21, 2011, co encing at 8:30 a.m. and concluding at 12:30 p.m. The 
deposition will continue thereafter on Friday, April 22, 2011, commencing at 8:30 a.m. and 
concluding at 12:30 p.m. 
 I   I  ITI   I  . ACHECO, .D.,  - 1 
This deposition will be taken for purposes of discovery for use at trial and for all other
permissible purposes under the Idaho Rules ofCivil Procedure




I HEREBY CERTIFY that on this 2nd day ofFebruary 2011 a true and correct copy of the
foregoing document was served by the method indicated addressed as follows
Christopher C Burke
GREENER BURKE SHOEMAKER PA
950W Bannock Street Suite 900
Boise ID 83702
HUNTER GEIST









AMENDED NOTICE OF TAKING DEPOSITION OF KARIN A PACHECOMDMSPH 2
US Mail
X Fax 303 8329525
000079
is e siti  ill e ta e  f r r oses f isc very, f r se at trial, a  f r all t er 
r i i l  r s  r t  I a  les f i il r r . 
 this 2nd day of February, 2011. 
 & LC~~-"'" 
((~-\ 
   
I E E  E TIF  that on this 2nd day of February, 2011, a true and correct copy ofthe 
f r i  t  r   t  t  i i t , r   f ll s: 
Christopher C. Burke 
     
 .  t t, it   
i ,   
TER&  
 r t tr et, ite  
r,   
l : (8 ) -849  
[ ] .S. i  
[X] x: -2601 
[ ] vernight elivery 
[ ] essenger elivery 
[ ] ail: c r e greenerlaw.com 
[ ] .S. il 
[X] Fax: (303) 832-9525 
[ ] Ove· elivery 
[] essenger Delivery 
Emai : uling@huntergeist.com 
E E    I  I    . , .D.,  -  
Darwin L Overson ISB 5887
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 200 83702







FEB 0 4 2011
CHRISTOPHER D Rat CWk
ByKATHYWEM
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Case No CV PI 1003515
Plaintiff





TO DEFENDANT SECURITY EQUIPMENT CORPORATION AND ITS
ATTORNEYS OF RECORD
PLEASE TAKE NOTICE that Plaintiff will take testimony on oral examination of her
expert witness KARIN A PACHECOMDMSPH in lieu of trial testimony before a court reporter
and notary public with the firm Hunter Geist at National Jewish Hospital 1400 Jackson St
Denver CO 80206 on Thursday April 21 2011 commencing at 103 amand concluding at
1230pm The deposition will continue thereafter on Friday April 22 2011 commencing at
830am and concluding at 1230pm
NOTICE OF TAKING DEPOSITION OF KARIN A PACHECOMDMSPH 1
0V
000080
....I « :z -C!l -a: o 
ar in . verson, IS  #5887 
J  &  LC 
1673 . horeline rive, uite 200 [83702] 
st fice   
ois , Idaho -7808 
Telephone: (208) 489-8989 
Facsi ile: (208) 489-8988 
E-mail: dar in jonesandswartzlaw.com 
ttorneys f r lai tiff 
NO~-~FiLEO~ .... -;;:z,~ ~,-,':""':":. Y::2~:: 
A .. M_---..PJL~ 
  ZOll 
I  . AIOH, IaI  
 Y iiJIH. 
Deputy 
 E IS      I I    
 S  F I , I   F    F  
I IE J  J ,  i i i l, 
laintiff, 
vs. 
I  I  ORATI , 
a issouri corporation, 
nt. 
 .    
   I  
  . , .D.,  
  I  I  ORATI N,  I  
  RD: 
   t t l i ti  ill t  t ti   l i ti    
expert itness, KARIN A. PACHECO, .D., SP , in lieu of trial testi ony, before a court reporter 
and notary public with the firm Hunter & eist, at ational Je ish ospital, 1400 Jackson t., 
enver,  80206, on Thursday, pril 21, 2011, co encing at 10:30 a.m. and concluding at 
12:30 p.m. The deposition will continue thereafter on Friday, April 22, 2011, commencing at 
8:30 a.m. and concluding at 12:30 p.m. 
I   I  I I   I  . A HECO, .D.,  - 1 
This deposition will be taken for purposes of discovery for use at trial and for all other
permissible purposes under the Idaho Rules ofCivil Procedure





I HEREBY CERTIFY that on this 31 st day ofJanuary 2011 a true and correct copy ofthe
foregoing document was served by the method indicated addressed as follows
Christopher C Burke
GREENER BURKE SHOEMAKER PA

















NOTICE OF TAKING DEPOSITION OF KARIN A PACHECOMDMSPH 2
000081
is iti  ill e t   rposes  i r ,  s  t t i l,   ll t  
pennissible purposes under the Idaho ules f ivil rocedure. 
E  this 31st day of January, 2011. 
 &  =--_____ 
~-=== __ ~~~------------
 .  
   
I E E  E TIF  that on this 31st day of January, 2011, a true and correct copy ofthe 
foregoing docu ent as served by the ethod indicated, addressed as follo s: 
Christopher C. Burke 
  E    
 .  t t, it   
oise, I  83702 
TER&  
 r t tr t, it   
enver,  80203 
Telephone: (800) 525-8490 
[/[Y.S. il 
V1 x: -26  
[ ] vernight elivery 
[ ] es   
[ ] E ail: cburke greenerlaw.com 
I  F I  P SI I  F I  . P O, .D., SP  -  
2011 0207 1643 Grp 1r Burke
Darwin Overson ISB 5887
Eric B Swarth ISIS 96396
JONES SWART PLLC
1673 W Shoreline Drive Suite 200 83702






Attorneys for Plaintiff BillieloMajor
12083781224 208 489 8488 P 1
NO FILED
AM
FEB 0 8 2011
CHRISTOPHER D RICH Clerk
ByCARLY LATIMORE
DEPUTY
IN TIFDISTRICTCOURTOFriFOURTH JUDICIAL DISTRICT OF
flI STATE OF IDAHO IN AND FOR TICOUNTYOFADA






Case No CV P1 1003515
STIPULATION TO ENLARGE
THE TIME FOR EXPERT
DISCLOSURES BY 30 DAYS
The parties to the aboveentitled action by and tIZrOLIgh their respective counsel of record
hereby stipulate and agree to enlarge the time Ior disclosing their respective expert witnesses b
thirty 30 days Specifically Plaintiff shall have until March 28 2011 to disclose herLNpCrt
witnesses and the Defendant shall have until April 27 2011 to disclose its expert witnesses
DATED this 7th day of February 2011








20 1-02-07 16:43 Grl ~r Burke 
ar in ers , IS  #5 87 
ric . S tl., ISH #6396 
J S & TZ P LC 
1673 . Shoreline rive, uite 200 [83702] 
Post 1ce ox 7808 
oise,]O 07 
Telephone: (208) 489-8989 
P i il : (20 ) -8988 
Email: darwin@joncsandswartzlaw.com 
eric@jonesandswartzlaw.c()J11 
ttorneys for 1)lnintiff, Billie ,)0 M~ljor 
1224 > 208 89 988  /1 
:: "fM t4 : 
  2011 
I T PHER . , l r  
 e  L TI  
DEPUTY 
 HE l TR]CT COURT OF THE  I I    
THE   . r    HE OUNTY   
IE  .  l. 
l i tiff, 
vs. 
SECURITY EQUIP ENT CORPORATrON. 
a issouri corporation. 
nt. 
-------..;;;...==:.;..;.;,....-"-~---.-.. ,., 
c .  I  
I   RGI~ 
    
I>I     
The parties to the above-entitled aClio!'l~ by and through theil' respective counsel 01' l'ccol'd~ 
hereby stipulate and agree to enlarge the time for disclosing their respective expert witnesses by 
thirty (30) days. Spcci fically ~ Plail1ti rr shall haw 1I11ti I March 28, 20 11 ~ to disclose her cxpcrt 
it esses. a  t e efe a t s all a e til ril . 1. to iscl se its ex el1 it csses. 
I  .  
Counsellor P/ail1f[{f 
:~EE?i;L~: L 
HR STOI>I-IER . BU  
/o  / m/ nI 








Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 3192600
Fax 208 319 2601
Attorneys for Defendant
FcB 0 9 2011
CHRISTOPHER D RICH Clerl
By ABBY GARDEN
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Defendant
Case No CVPI 1003515
NOTICE OF SERVICE OF DEFENDANTS
RESPONSES TO PLAINTIFF SECOND
SET OF DISCOVERY REQUESTS
PLEASE TAKE NOTICE that on the 9 day ofFebruary 2011 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke Shoemaker PA
served the following documents in the manner indicated on the service list
a DefendantsResponses to PlaintiffsSecond Set ofInterrogatories Requests
Production ofDocuments andRequests for Admission and
b This Notice ofService ofDefendantsResponses to PlaintiffsSecond Set of
Discovery Requests









J~Il') \1'( A11.\ '" 'P-II'I 
O G\~~AL 
NO.= __ J:ii'j;;n--,i~_ 
FILED + A.M,--___ P.M._=t _ _ 
Christopher C. Burke, ISB #2098 
GREENER BURKE SHOEMAKER PA 
950 W. Bannock Street, Suite 900 
Boise, Idaho 83702 
F!:B 0 9 2011 
CHRISTOPHER D. RIC , Cieri 
By ABBY GARDEN 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
IN HE ISTRICT C RT F HE  J I I L ISTRICT F THE 
ST TE F ID , I  ND F R T E C T  F  




CORPORATION, a Missouri corporation, 
ant. 
ase o.: - I- 5 
    NDANT'S 
S S  I TIFF'S  
    
PLE SE T E TICE that, on the 9th day of February, 2011, efendant Security 
Equipment Corporation, by and through its counsel of record, Greener Burke Shoemaker P.A., 
served the following documents in the manner indicated on the service list: 
a. Defendant's Responses to Plaintiff's Second Set of Interrogatories, Requestsfor 
Production of Documents, and Requests for Admission; and 
b. This Notice of Service of Defendant's Responses to Plaintiff's Second Set of 
Discovery Requests. 
DATED this 9th day of February, 2011. 
Christopher C. Burke 
At orneys for Defendant 
110TICE OF SERVICE OF DEFENDANT'S RESPONSES TO PLAINTIFF'S SECOND SET OF DISCOVERY 
REQUESTS ~ Page I 
14542-011 (367929 doc) 
DEPUTY 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice ofService of
DefendantsResponses to Plaintiffs Second Set of Discovery Requests on the following
named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O Box 7808
Boise Idaho 83707
ViaUS Mail
x Via Hand Delivery
Via Facsimile 2084898988
ViaOvernight Delivery
DATED this 91h day of February 2011
Christopher C Burke
NOTICE OF SERVICE OF DEFENDANTSRESPONSES TO PLAINTIFFSSECOND SET OF DISCOVERY
REQUESTS Page 2
14542011 367929doc 000084
CERTIFICATE OF SERVICE 
I hereby certify that I caused to be served the foregoing Notice of Service of 
Defendant's Responses to Plaintiff's Second Set of Discovery Requests on the following 
named person(s) on the date indicated below, in the manner indicated below: 
r---------------------------------~-------------------------------------
Darwin Overson, Esq. [ ] ia U.S. ail 
Eric B. Swartz, Esq. [ x ] Via and elivery 
JONES & SWARTZ, PLLC [ ] ia Fa ile (208/489-898 ) 
1673 . Shoreline rive, Suite 220 [ ] ia vernight e iver  
P. O. Box 7808 
Boise, Idaho 83707 
DATED this 9th day of February, 2011. 
NOTICE OF SERVICE OF DEFENDANT'S RESPONSES TO PLAINTIFF'S SECOND SET OF DISCOVERY 





Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZPLLC











CHRISTOPHER D RICH Clerk
By JOHN WEATHERBY
0614M
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA






The Stipulation of the parties having come before this Court and good cause appearing
therefor IT IS HEREBY ORDERED that the time for disclosure of the parties respective expert
witnesses is hereby enlarged by thirty 30 days Specifically Plaintiff shall have until March 28
2011 to disclose her expert witnesses and Defendant shall have until April 27 2011 to disclose
its expert witnesses
All
Case No CV PI 1003515
ORDER FOR ENLARGEMENT
OFTIME TO DISCLOSE EXPERT
WITNESSES
DATED this tj day of February 2011
CHERI C COPSEY 61STRQT JUDGE
ORDER FOR ENLARGEMENT OF TIME TO DISCLOSE EXPERT WITNESSES 1
J
000085
 E'~I E 0 
  _' 
.Ada ounty G.ar  
a in ve , ISB #5 87 
ric . S artz, ISB #6396 
J NES &  P LC 
1673 . Shoreline rive, Suite 200 [83702] 
Post ffice Box 7  
oise, ID 07 
Telephone: (208) 489-8989 
Facsimile: (208) 489-8988 
ail: dar in jonesandswartzlaw.com 
eric jonesandswartzlaw.com 
Attorneys for Plaintiff, Billie Jo ajor 
~--------~~~~---_M~ _____ ~_RM J~~~ 
  0  
I  . I , l  
   
DEPUTY 
I   IS         
   ,        
I IE J  J , and individual, 
laintiff, 
vs. 
S I  IP  P RATI , 
a issouri corporation, 
ant. 
 .   5 
   
   S   
NESS  
The Stipulation of the parties having come before this Court, and good cause appearing 
therefor, IT IS E E  E E  that the ti e for disclosure of the parties' respective expert 
itnesses is hereby enlarged by thirty (30) days. Specifically, Plaintiff shall have until arch 28, 
2011, to disclose her expert witnesses, and Defendant shall have until April 27, 2011, to disclose 
its expert witnesses. 
~ 
 t  q  f bruary, 1. 
~ 
I . PSEY~ JU  
    I  T  I   I  - 1 
CLERKSCERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 11 day of February 2011 a true and correct















GREENER BURKE SHOEMAKER PA










ORDER FOR ENLARGEMENT OF TIME TO DISCLOSE EXPERT WITNESSES 2
000086
LERK.S I   I  
  I  t t  t i  " a  f ebruary, 011, a tr e a  c rrect 
copy of the foregoing docu ent as served on the follo ing individual(s) by the ethod 
i icated: 
i  .  
ric . S artz 
 &  
 . r l  i , i   
.O. ox  
,  -780  
  ff 
ri t r . r  
     
 .  t, i   
i ,   
l f  f t 
[,f] .S. il 
[') x: -8  
[ ] essenger Delivery 
[ ] ail: darwin@jonesandswartzlaw.com 
eric@jonesandswartzlaw.com 
hlf .S. il r ]Fax: -2  
[ ] essenger elivery 
[ ] ail: cburke greenerlaw.com 
,CL  
By __ ~~~ ________ ~ ________ __ 
 






CHRIS10 L D 1 iICH Clerk
By LARAsVZS
DEPUTY
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 319 2600
Fax 208 3192601
Attorneys for Defendant
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Defendant
Case No CVPI 1003515
ACCEPTANCE OF SERVICE
The undersigned William M Loomis Deputy Attorney General for the Idaho
Department of Corrections IDOC hereby accepts service of the attached First Amended
Subpoenas to Appear and Attend and Notices of Deposition of IDOC Witnesses Sergeant Nick
Doan Sergeant Joshua Overgaard Sergeant Link and Sergeant Dan Schaffer in this matter on
behalf of the IDOC
A
DATED this day of February 2011 IDAHO DEPAR ENT OF C ECTIONSj
William M Loomis
Deputy Attorney General
ACCEPTANCE OF SERVICE Page I
V1 14542011 369194doc 000087
Christopher C. Burke, ISB #2098 
GREENER BURKE SHOEMAKER PA 
950 W. Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
NO._~ ---;::;;-;'ir~m .. --Hffi""'tn.~-­
AM.---__ P.!VI.----t'::ti~l,lI~_. 
FEB 1 4 2011 
CHRISTOP}·;:.:.FI iJ. nICH, Clerk 
By LAF~,t.\ ':W;E.S 
DEPUTY 
IN THE IS ICT RT F E F  J I I  IS IC  F E 
E F I , I  D R E    




CORPORATION, a Missouri corporation, 
nt. 
ase o.: - I-  
   
The undersigned, illiam M. Loomis, Deputy Attorney General for the Idaho 
Department of Corrections ("IDOC"), hereby accepts service f the attached irst ended 
Subpoenas to Appear and Attend and Notices of Deposition oflDOC Witnesses (Sergeant Nick 
Doan, Sergeant Joshua Overgaard, Sergeant Link, and Sergeant Dan Schaffer) in this matter on 
behalf of the IDOC. 
 this if day of February, 2011. 
ACCEPTANCE OF SERVICE - Page 1 
14542-011 (369194.doc) 
illi  M. Loomis 
Deputy At orney General 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Acceptance of Service on the
following named personson the date indicated below in the manner indicated below
Darwin Overson Esq ViaUS Mail
Eric B Swartz Esq Via Hand Delivery
TONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 Via Overnight Delivery
P O Box 7808
Boise Idaho 83707
DATED this Cday of February 2011
Christopher C Burke
ACCEPTANCE OF SERVICE Page 2
14542011 369194doe
000088
CERTIFICATE OF S ICE 
I hereby certify that I caused to be served the foregoing Acceptance of Service on the 
following named person(s) on the date indicated below, in the manner indicated below: 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
JONES & S ARTZ, PLLC 
1673 . Shoreline rive, Suite 220 
P. O. Box 7808 
Boise, Idaho 83707 
/ 
[ /j ia U.S. ail 
[ ] Via Hand Delivery 
[ ] ia Facs ile (208/489-89 ) 
[ ] ia vernight e ive  
DATED(hiS~daYOfFebruarY'20~~~ l 
ristopher . r  
ACCEPTANCE OF SERVICE - Page 2 
14542-011 (369194.doc) 
Christopher C Burke ISB 42098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 319 2600
Fax 208 3192601
Attorneys for Defendant
IN THE DISTRICT COURT OF THE FOURTII JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THFI COUNTY OF ADA




CORPORATION a Missouri corporation
Case No CVPI 1003515
FIRST AMENDED SUBPEONA TO
APPEAR AND ATTEND AND NOTICE
OF DEPOSITION OF IDOC WITNESSES
Defendant
THE STATE OF IDAHO TO
Sgt Dan Schaffer Sgt Joshua Overgaard Sgt Nick Doan Sgt Link
co Deputy Attorney General assigned for
IDAHO DEPARTMENT OF CORRECTIONS
700 W Jefferson Street
Boise ID 837200010
Copy also served upon
Brent Reinke Director
IDAHO DEPARTMENT OF CORRECTIONS
1299 N Orchard Street Suite 110
Boise ID 83706
YOU ARE COMMANDED to appear at the place date and time specified below to
testify at the taking of a deposition in the above case YOU ARE FURTHER NOTIFIED that
if you fail to appear at the place and time specified below you may be held in contempt of court





Christopher C. Burke, ISB #2098 
GREENER BURKE SHOEMAKER PA 
950 . Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
TN THE ISTRICT T F THE F H J I I L IS IC   E 
  E F I , I   F R THE    




CORPORATION, a issouri corporation, 
nt. 
   I  : 
ase o.: - -I 5 
 E E    
     
 I    ES  
Sgt. Dan Schaffer, Sgt. .Joshua Overgaard, Sgt. Nick Doan, Sgt. Link 
c/o Deputy Attorney General assigned for 
IDAHO DEPARTMENT OF CORRECTIONS 
100  . .Jefferson Street 
Boise, ID 83720-0010 
Copy also served upon: 
Brent Reinke, Director 
I  DEPART E T F CORRECTI S 
1299 N. rchard Street, Suite 110 
Boise, ID 83106 
 E COM E  to appear at the place, date and ti e specified belo  to 
testify at the taking of a deposition in the above case. YOU ARE FURTHER NOTIFIED that 
if you fail to appear at the place and time specified below, you may be held in contempt of court, 
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF DEPOSITION OF IDOC 
WIT ESSES- Page I 
(369190 doc) 
145~2-0 II 
and Defendant may recover from you the sum of 100 and all damages which Defendant may
sustain by your failure to appear and attend
PLEASE TAKE NOTICE that Defendant Security Equipment Corporation SEC
will take the depositions of the following deponents as indicated below
February 14 2011 at 200 pm
February 15 2011 at 830 am
February 15 2011 at 1200 pm





The depositions will be held at the law offices of Greener Burke Shoemaker PA located
at 950 W Bannock Suite 900 Boise ID 83702 Such examination shall continue from dayto
day until concluded or as agreed by the parties and will be before a notary public and court
reporter or other officer authorized to administer an oath
This deposition shall be taken pursuant to the Idaho Rules of Civil Procedure
DATED this 2nd day of February 2011
GR NER BURKE SHOT MAKE P
v
Chistopher C Bur e
Attorneys for Defendant
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF DEPOSITION OF DOC
WITNESSES Page 2 14542011
369190doc
000090
and Defendant may recover from you the sum of $1 00 and all damages which Defendant may 
sustain by your failure to appear and attend. 
EASE TAKE N ICE that efendant Sec rity Equipment Corporation ("SEC") 
will take the depositions of the following deponents as indicated belo : 
February 14, 2011 at 2:00 p.m. S . Dan Sc affer 
February 15,2011 at 8:30 a.m. gt. Joshua vergaard 
February 15,2011 at 12:00 p.m. t. ink 
February 15,2011 at 2:00 p.m. t. icholas a  
The depositions will be held at the law offices of Greener Burke Shoemaker P.A. located 
at 950 . annock, Suite 900, oise, 1083702. Such exa ination shaII continue fro  day-to-
day until concluded, or as agreed by the parties, and will be before a notary public and court 
reporter, or other officer authorized to administer an oath. 
This deposition shall be taken pursuant to the Idaho Rules of Civil Procedure. 
DATED this 2nd day of February, 2011. 
GR. NER BURKE SHO[K~~~ 
-~[) I~ ___ ~_-----
ChI' stopher (?~ 
tt  f r f t 
FIRST A ENDED SUBPOENA TO APPEAR AND A TrEND AND NOTICE OF DEPOSITION OF !DOC 
WIT SES ~ Page 2 14542-011 
(369190.doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing First Amended Subpoena to
Appear and Attend and Notice of Deposition of IDOC Witnesses on the following named
personson the date indicated below in the manner indicated below
Darwin Overson Esq 4 ViaUSMail
Eric B Swartz Esq Via hand Delivery
TONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 Via Overnight Delivery
P O Box 7808
Boise Idaho 83707
DATED this 2 day of February 2011
Christopher C Burke
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF DEPOSITION OF IDOC
WITNESSES Page 3 14542011
369190doc
000091
FICATE  ICE 
I hereby certify that I caused to be served the foregoing irst ended Subpoena to 
Appear and Attend and Notice of Deposition of 100C itnesses on the following named 
person(s) on the date indicated below, in the manner indicated below: 
ar in verson, sq. 
Eric B. Swartz, Esq. 
J ES & S RTZ, PLLC 
673 . eline i , ite 0 
. .   
is , Idaho 7 
.'-- - .. --L------.. --~ ------------
I/] ia .S. a l 
[ ] ia Hand e ivery 
[ ] ia i ile (208/489-89 ) 
[ ] ia i t liver  
I   SU OEN   E     I  F DEPOSITI   I  
I  - Page 3 
(369190.doc) 








CHRISTJPIER D F11CsI Clerk
By LAPA XVIES
DEPUTY
Christopher C Burke ISB 42098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 3192600
Fax 208 319 2601
Attorneys for Defendant
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAIIO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR an individual
Plaintiff
SECURITY EQUIPMENT
CORPORATION a Missouri corporation
Defendant
Case No CVPI 1003515
ACCEPTANCE OF SERVICE
The undersigned William M Loomis Deputy Attorney General for the Idaho
Department of Corrections IDOC hereby accepts service of the attached First Amended
Subpoena to Appear and Attend and Notice of Rule 30b6Deposition of Idaho Department of
Corrections in this matter on behalf of the IDOC









.M. _____ ,P.M._-=~':lL'___ 
Christopher C. Burke, ISB #2098 
GREENER BURKE SHOEMAKER PA 
950 W. Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
FEB 1 4 2011 
C ISTOPHER 0, Ri H, Clerk 
By L/J,T-lA f\f,'iES 
DEPUTY 
I  THE IS I  C URT F E  J I I  IS I  F THE 
 TE F ID HO, I   F R E    
ILLIE J  J , a  i i i l, 
Plaintiff, 
v. 
SECURITY EQUIP ENT 
CORPORATION, a issouri corporation, 
f ant. 
s  .:  - I-l  
    
The undersigned, illiam . Loomis, Deputy Attorney General for the Idaho 
Department of Corrections ("IDOC"), r  c ts ser i  f t  tt  irst  
Subpoena to Appear and Attend and Notice of Rule 30(b)(6) Deposition ofIdaho Department of 
Corrections in this matter on behalf of the IDOe. 
 this 1'/ day of February, 2011. 
/ ACCEPTANCE OF SERVICE ~ Page I V 14542-011 (368238.doc) 
il i  . L o is 
eputy tt rney General 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Acceptance of Service on the
following named personson the date indicated below in the manner indicated below
Darwin Overson Esq ViaUSMail
Eric B Swartz Esq Via Hand Delivery
JONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 Via Overnight Delivery
P O Box 7808
Boise Idaho 83707
DATED this X day of January 2011
Christopher C Burke
ACCEPTANCE OF SERVICE Page 2
14542011 368238doc 000093
CERTIFICATE OF SERVICE 
I hereby certify that I caused to be served the foregoing Acceptance of Service on the 
following named person(s) on the date indicated below, in the manner indicated below: 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
JONES & SWARTZ, PLLC 
1673 . Shoreline rive, Suite 220 
P. . ox 08 
Boise, Idaho 83707 
J 
[/] Via .S. ail 
[ ] ia Hand elivery . 
[ ] ia Facs ile (2 8/489-898 ) 
[ ] ia er ig t elivery 
. TE  t is A  nuar , 011.~ 
 .  
ACCEPTANCE OF SERVICE - Page 2 
14542-011 (368238.doc) 
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 319 2600
Fax 208 3192601
Attorneys for Defendant
IN THE DISTRICT COURT OF THE FOURTHJUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR an individual
Plaintiff Case No CVPI 1003515
V
SECURITY EQUIPMENT
CORPORATION a Missouri corporation
Defendant
THE STATE OF IDAHO TO
FIRST AMENDED SUBPEONA TO




Deputy Attorney General assigned for Copy also served upon
IDAHO DEPARTMENTOF CORRECTIONS Brent Reinke Director
700 W Jefferson Street IDAHO DFPARTMENT OF CORRECTIONS
Boise ID 837200010 1299 N Orchard Street Suite 110
Boise 11 83706
YOU ARE COMMANDED to appear at the place date and time specified below to
testify at the taking of a deposition in the above case YOU ARE FURTHER NOTIFIED that
if you fail to appear at the place and time specified below you may be held in contempt of court
and Defendant may recover from you the sum of 100 and all damages which Defendant may
sustain by your failure to appear and attend
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE 30b6DEPOSITION
OF IDAHO DEPARTMENT OF CORRECTIONS Page I 14542011 372252doc
000094
Christopher C. Burke, ISB #2098 
GREENER BURKE SHOEMAKER PA 
950 W. Bannock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE 
ST TE F I , IN  F R T E C T  F  




CORPORATION, a Missouri corporation, 
f ant. 
 ST TE F I  T : 
Deputy Attorney General assigned for 
IDAHO DEPARTMENT OF CORRECTIONS 
700 . Jefferson Street 
Boise, ID 83720-00tO 
se o.: - I-I  
    
     
01<'  0(b)(6) I   
   
 
 al  r  pon: 
r t einke, i t r 
I  EPA T  O  I  
129  . r r  treet, Suit  11  
oise, ID 83706 
   to appear at the place, date and ti e specified belo  to 
testify at the taking of a deposition in the above casco YOU ARE FURTHER NOTIFIED that 
if you fail to appear at the plaee and time specified below, you may be held in contempt of court, 
and Defendant may recover from you the sum of $1 00 and all damages which Defendant may 
sustain by your failure to appear and attend. 
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE 30(b)(6) DEPOSITION 
OF IDAHO DEPARTMENT OF CORRECTIONS ~ Page I 14542·()11 (372252 doc) 
PLEASE FAKE NOTICE that pursuant to Rules 30b6and 45a of the Idaho Rules
of Civil Procedure Rule Defendant Security Equipment Corporation SEC will take the
deposition of the Idaho Department of Corrections IDOC
through one or more of its officers
directors managing agents or other personsto give testimony on the topics designated in
Exhibit A attached hereto The deposition will begin at 830am on February 14 2011 and
will be held at the law offices of Greener Burke Shoemaker PA located at 950 W Bannock
Suite 900 Boise ID 83702 Such examination shall continue from day today until concluded
or as agreed by the parties and will be before a notary public and court reporter or other officer
authorized to administer an oath
Pursuant to Idaho Rule of Civil Procedure Rule30b6Idaho Department of
Corrections shall designate one or more of its officers directors or other persons who consent to
testify on its behalf and who have knowledge of matters pertaining or otherwise related to the
areas of inquiry andor topics which are described in detail in Exhibit A hereto
This deposition shall be taken pursuant to the Idaho Rules of Civil Procedure
DATED this 2 day of February 2011
GR NF U KESrlo M E A
1
Chn opher C Burke
Attorneys for Defendant
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE450zbi16DEPOSITION
OF IDAHO DEPARTMENT OF CORRECTIONS Page 2
000095
PLEASE TAKE NOTICE that, pursuant to Rules 30(b)(6) and 45(a) of the Idaho Rules 
of Civil Procedure Rule Defendant, Security Equipment Corporation ("SEC"), will take the 
deposition of the Idaho Department of Corrections ("lDOC"), through one or more of its onicers, 
directors, managing agents, or other person(s) to give testimony on the topics designated in 
Exhibit "A" attached hereto. The deposition will begin at 8:30 a.m. on February 14,2011 and 
will be held at the law offices of Greener Burke Shoemaker P.A. located at 950 W. Bannock, 
Suite 900, Boise, ID 83702. Such examination shall continue from day-to-day until concluded, 
or as agreed by the parties, and wil I be before a notary public and court reporter, or other officer 
authorized to administer an oath. 
Pursuant to Idaho Rule of Civil Procedure Rule 30(b)(6), Idaho Department of 
Corrections, shall designate one or more of its officers, directors or other persons who consent to 
testify on its behalf and who have knowledge of matters pertaining or otherwise related to the 
areas of inquiry and/or topics which are described in detail in Exhibit "A" hereto. 
This deposition shall be taken pursuant to the Idaho Rules of Civil Procedure. 
DATED this 2nd day of February, 2011. 
Chn opher C. Burke 
Attorneys for Defendant 
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE 30(b)(6) DEPOSITION 
OF IDAHO DEPARTMENT OF CORRECTIONS - Page 2 14542-011 (3722S2.doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing First Amended Subpoena to
Appear and Attend and Notice of Rule 30b6Deposition of Idaho Department of
Corrections on the following named personson the date indicated below in the manner
indicated below
Darwin Overson Esq J ViaUS Mail
Eric B Swartz Esq Via hand Delivery
JONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 J Via Overnight Delivery
P O Box 7808
Boise Idaho 83707
DATED this 2
d day of February 2011 4L
Chri opher C Burke
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE 30b6DEPOSITION
OF IDAHO DEPARTMENT OF CORRECTIONS Page 3
1454201 I 372252doc
000096
CERTIFICATE OF SERVICE 
I hereby certify that 1 caused to be served the foregoing First Amended Subpoena to 
Appear and Attend and Notice of Rule 30(b)(6) Deposition of Idaho Department of 
Corrections on the following named person(s) on the date indicated below, in the manner 
indicated below: 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
JONES & SWARTZ, PLLC 
1673 W. Shoreline Drive, Suite 220 
P. O. Box 7808 
Boise, Idaho 83707 
-~~- ['Via U.S. a·j-}--------- l 
[ 1 Via Hand elivery I 
[ 1 Via Facsi ile (208/489-898 ) 
I 1 Via r i t livery 
~~-.---~.-
 T  t is "d   r , . . ~ L 
_(lQ .. ~._ 
ch~~urke 
FIRST AMENDED SUBPOENA TO APPEAR AND ATTEND AND NOTICE OF RULE 30(b)(6) DEPOSITION 




1 The term Document means and includes any kind of written typewritten or
printed recorded or graphic matters however produced or reproduced of which You have any
knowledge or information whether in Your possession or under Your control or not relating or
pertaining in any way to the subject matter of this action This definition includes but is not
limited to any and all originals all file copies and all other copies no matter how or by whom
prepared and all drafts prepared in connection with such writings whether used or not of the
following papers agreements contracts notices memoranda correspondence
letters
telegrams telexes cables statements books invoices purchase orders reports studies treatises
articles transcripts minutes records telephone logs accounting books maps photographs
films transcriptions and recordings settlements notes summaries schedules drawings
sketches acknowledgments diaries tapes pictures computer programs email electronic data
and metadata hard copies of electronic data or other graphic symbolic recorded or retaken
materials of any nature whatsoever Any Document which contains any comments notations
addition insertion or marking of any kind which is not part of another Document is to be
considered as a separate Document
2 The terms You Your and IDOL refer to and shall mean the Idaho
Department of Corrections and shall include its agents representatives consultants and
attorneys andor any other person or entity who or which employed Major at the time of the
Incident alleged in the Complaint in the Lawsuit For purposes of this deposition IDOC shall be
limited to mean the Idaho Maximum Security Institution located at 13400 S Pleasant Valley
Road in Kuna Idaho the South Boise Women Correctional Center located in Boise Idaho and
any other facility in which Plaintiff Billie Joe Major worked during her employment with IDOL
3 Major shall mean Plaintiff Billie Jo Major DOB Social
Security No allegedly employed by IDOL between July 2004 and M 8
4 The term SEC shall mean Defendant Security Equipment Corporation and shall
include its agents employees and representatives
5 The term Lawsuit shall mean that Lawsuit entitled Billie Jo Major v Security
Equipment Corporation filed in and for the Fourth Judicial District Ada County Idaho Case
No CV PI 1003515 and shall include all claims asserted or which may have been asserted
therein
6 The term WC Carrier shall mean any insurance carrier agency or entity which
insured Majors employer for workers compensation liability andor which paid workers






AREAS OF I QUIRYITOPICSFOR 30(b)(6) DEPOSITION 
DEFINITIONS 
1. The term "Document" means and includes any kind of written, typewritten or 
printed, recorded, or graphic matters, however produced or reproduced, of which You have any 
knowledge or information, whether in Your possession or under Your control or not, rc lating or 
pertaining in any way to the subject matter of this action. This definition includes, but is not 
limited to, any and all originals, all file copies and all other copies, no matter how or by whom 
prepared, and all drafts prepared in connection with such writings, whether used or not, of the 
following: papers, agreements, co tra , notice , e oranda, corres , letters, 
telegrams, telexes, cables, statements, books, invoices, purchase orders, reports, studies, treatises, 
articles, transcripts, minutes, records, telephone logs, accounting books, maps, photographs, 
films, transcriptions and recordings, settlements, notes, summaries, schedules, drawings, 
sketches, acknowledgments, diaries, tapes, pictures, computer programs, e-mail, electronic data 
and mctadata, hard copies of electronic data, or other graphic, symbolic, recorded or retaken 
materials of any nature whatsoever. Any Document which contains any comments, notations, 
addition, insertion, or marking of any kind which is not part of another Document is to be 
considered as a separate Document. 
2. The ter s "You," "Your" and "lO C" refer to and shall ean the Idaho 
Department of Corrections, and shall include its agents, representatives, consultants and 
attorneys and/or any other person or entity who or which employed Major at the time of thc 
Incident alleged in the Complaint in the Lawsuit. For purposes of this deposition, lOOC shall be 
limited to mean the Idaho Maximum Security Institution located at 13400 S. Pleasant Valley 
Road in Kuna, Idaho, the South Boise Women's Correctional Center located in Boise, Idaho and 
any other facility in which Plaintiff Billie Joe Major worked during her cmployment with lOOC. 
3. The term "Major" shall mean Plaintiff Billie Jo Major, DOB Social 
Security No. allegedly employed by moe between July 2004 and M 8. 
4. The ter  "S C" shall ean Defendant Security qui nt Corporation, and shall 
include its agents, employees and representatives. 
5. The ter  " a suit" shall mean that Lawsuit entitled Billie Jo Major v. Security 
EqUipment Corporation, filed in and for the Fourth Judicial District, Ada County, Idaho, Case 
No. CV PI 1003515, and shall include all claims asserted or which may have been asserted 
therein. 
6. The term "  Carrier" shall mean any insurance carrier, agency or entity which 
insured Major's employer for worker's compensation liability, and/or which paid worker's 
compensation benefits to or on behalf of Major as a result of the Incident. 
EXHIBIT A 
Page 1 (14542-0 II J60S(9) 
7 The term Incident shall mean any and all exposures by Major to oleoresin
capsicum pepper spray OC Spray products including but not limited to OC Spray from the
Product during the course of her employment with IDOC or otherwise which exposure is
alleged in PlaintiffsComplaint in the Lawsuit
S The term Product shall mean that Sabre Red OC Spray product that is the
subject of the Incident and PlaintiffsComplaint in the Lawsuit
9 The term OC Spray shall mean any aerosol or water based spray containing
concentrations of oleoresin capsicum pepper
10 The Employment shall mean Majors employment by IDOC allegedly between
July 2004 and May 2008
DESIGNATED TOPICS
Pursuant to Rules 30b6and 45a of the Idaho Rules of Civil Procedure IDOC is
required to give testimony on the following topics
1 The use of OC Spray by IDOC during the timeframe of 2004 through 2008
2 Any IDOC policies or procedures in place during the timeframe of 2004 through
2008 regarding the purchase of OC Spray
3 The purchase by IDOC of OC Spray products 20022008 and purchase orders and
invoices regarding such purchases
4 Training andor certifications relating to or regarding OC Spray required for or given
to any Correction Officer of IDOL during the timeframe of 2004 through 2008
5 Training andor certifications relating to or regarding OC Spray required or attended
by Major at any time during her Employment
6 Any and all use of OC Spray by Major at any time during her Employment
7 Any and all exposure to OC Spray by Major at any time during her Employment
EXHIBIT A
Page 2 14542011 360909
000098
.. ' \ ... 
7. The term "Incident" shall ean any and all exposures by ajor to oleoresin 
capsicum pepper spray ("OC Spray") products, including, but not limited to OC Spray from the 
Product, during the course of her employment with IDOC, or otherwise, which exposure is 
alleged in Plaintiffs Complaint in the Lawsuit. 
8. he term "Prod t" s all ean that Sabre Red OC ra  roduct that is the 
subject of the Incident and Plaintiffs Complaint in the Lawsuit. 
9. he tenn "OC Spray" shall ean any aerosol or ater based spray containing 
concentrations of oleoresin capsicum pepper. 
J O. The "Employment" shall mean Majors employment by lDOe, allegedly bctwecn 
July 2004 and May 2008. 
 CS 
Pursuant to Rules 30(b)(6) and 45(a) of the Idaho Rules of Civil Procedure, IDOC is 
required to give testimony on the following topics: 
I. The use of C Spray by I C during the ti efra e of 2004 through 2008. 
2. Any IDOC policies or procedures in place during the timeframe of 2004 through 
2008 regarding the purchase ofOC Spray. 
3. The purchase by l oe of oe Spray products 2002-2008 and purchase orders, and 
invoices regarding such purchases. 
4. Training and/or certifications relating to or regarding OC Spray required for or given 
to any Correction Officer of moc during the timeframe of 2004 through 2008. 
5. Training and/or certifications relating to or regarding OC Spray required or attended 
by Major at any time during her Employment. 
6. Any and all use of OC Spray by Major at any time during her Employment. 
7. Any and all exposure to OC Spray by ajor at any time during her Employment. 
EXHIBIT A 
Page 2 (14542-01  360809) 
Tr
8 All positions job responsibilities and work locations held by Major during the entire
duration of her Employment
9 All policies procedures andor protocols regarding exposure to OC Spray or
decontamination after exposure to OC Spray in effect at IDOC during the timeframe of 2004
through 2008
10 IDOC policy 307
11 Any and all disciplinary actions taken against Major at any time during her
Employment including any and all disciplinary actions leading up to or resulting in Plaintiff s
termination from IDOC





... I ' '''' 
8. All positions, job responsibilities and work locations held by Major during the entire 
duration of her Employment. 
9. All policies, procedures and/or protocols regarding exposure to OC Spray or 
deconta ination after exposure to OC Spray in effect at moc during the timeframe of 2004 
through 2008. 
10. !DOC policy 307. 
11. Any and all disciplinary actions taken against Major at any time during hcr 
Employment, including any and all disciplinary actions leading up to or resulting in Plaintiffs 
te ination ro  moc. 
12. Major's physical and mental condition during her employment by moe. 
EXHIBIT A 
Page 3 (14542-0 II 360R(9) 
Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA
950W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 3192600
Fax 208 319 2601
Attorneys for Defendant
0 R I G I N N0
FILED
AM P
FEB 1 6 2011
CHRISTOPHER D RICH Clerk
By PAT7HCIAA DWONCH
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Case No CVPI 1003515
NOTICE OF SERVICE OF DEFENDANTS
RESPONSES TO PLAINTIFF THIRD
SET OF DISCOVERY REQUESTS
Defendant
PLEASE TAKE NOTICE that on the 16 day of February 2011 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke ShoemakerPA
served the following documents in the manner indicated on the service list
DefendantsResponses to Plaintiffs Third Set ofInterrogatories and Requests for
Production ofDocuments and
b This Notice ofService ofDefendantsResponses to PlaintiffsThird e of
Discovery Requests
DATED this 16 day of February 2011




NOTICE OF SERVICE OF DEFENDANTSRESPONSES TO PLAINTIFFSTHIRD SET OF DISCOVERY
REQUESTS Page 1 14542011 369923doc
000100
Christopher C. Burke, ISB #2098 
ER RKE S KER P  
9  . annock treet, ite 900 
oise, Idaho 02 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
~~.----F-"~flJl< 
FE    2011 
I  . I , i ri< 
y T:lI  A. NCH 
DEPUTY 
I  E IS IC    E   IS    
  I , I    E    
I IE J  J , an individual, 
Plaintiff, 
v. 
S I  IP  
CORPORATION, a Missouri corporation, 
nt. 
s  o.: - I-I  
    ENDANT'S 
  LAINTIF 'S  
   S 
  I  t t,  t  6th  f r ary, , f t curit  
Equipment Corporation, by and through its counsel of record, Greener Burke Shoemaker P.A., 
served the following documents in the manner indicated on the service list: 
a. efendant's Responses to Plaint(ff's Third Set of Interrogatories and Requestsfhr 
roduction f ocu ents; and 
. This otice (~fService of efendant 's Responses to Plaintiff's Third Set of 
Discovery Requests. 
DATED this 16th day of February, 2011. 
hristopher . urke 
ttorneys for efendant 
  ER I   EFENDANT'S  T  PLAINTIF 'S T I  SE   DI V  
REQUESTS-Page I 14542-0 II ( h9 2Jdoc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice of Service of
DefendantsResponses to Plaintiffs Third Set of Discovery Requests on the following
named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
TONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED this 16 day of February 2011
U
Christopher C Burke
NOTICE OF SERVICE OF DEFENDANTSRESPONSES TO PLAINTIFFSTHIRD SET OF DISCOVERY
REQUESTS Page 2 14542011 369923doc
000101
   
I hereby certify that I caused to be served the foregoing otice of Service of 
f ndant's es onses t  l i tiff's i d t f is  ests  t e f llo in  
a e  erson(s)  the ate i icated el , i  t e a er indicated el : 
~--------------------------------~------------------------------------
ar in rs , s . [ ] a .S.  
ric . artz, sq. [ ] ia  e  
J S & ,  [ ]  i  (20 /4 9-8 ) 
 . r line ri , ite  [ ] i  r i t li r  
. .   
oise, Idaho 83707 
TE  this 16th day f ebruary, 2011. 
~Hl _____ _ 
--  
rist er . r e 
    FENDANT'S   LAINTIF 'S     




FEB 2 8 2011
CHRISTOPHER D
BY CARLY RICH ClDEPYUT ORE
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Plaintiff
Case No CV PI 1003515
VS
SECURITY EQUIPMENT
CORPORATION a Missouri corporation
Defendant
NOTICE OF TAKING RULE30b6
DEPOSITION DUCES TECUM OF
DEFENDANT SECURITY EQUIPMENT
CORPORATION
TO DEFENDANT SECURITY EQUIPMENT CORPORATION AND ITS ATTORNEYS
OF RECORD
Pursuant to Rule 30b6of the Idaho Rules of Civil Procedure Defendant is directed to
designate a person or persons most knowledgeable about the categories of topics identified below to
appear and give testimony on oral examination in the above entitled action before a certified court
reporter and notary public commencing at 900 am on March 17 2011 at the offices of Greener
Burke Shoemaker PA 950W Bannock St Suite 900 Boise Idaho and continuing thereafter from
day to day until such time as the taking of the deposition may be adjourned
NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUMOF DEFENDANT SECURITY
EQUIPMENT CORPOATION 1
Eric B Swartz ISB 6396
Darwin L Overson ISB 5887
JONES SWARTZ PLLC
0 1673 W Shoreline Drive Suite 200 83702
ir
Post Office Box 7808
Boise Idaho 837077808







<:r= z -(!J -c : o 
ri  . rt , I  #639  
in . r on,  #588  
 &   
 . r li e ri , ite  [8 2] 
 ice   
,  -7808 
Telephone: (208) 489-8989 
si il : (2 ) -8988 
ail: eric j nesandswartzlaw.com 
ar in jonesandswartzlaw.com 
torneys  i ti  
NO.: 
A.M.=_:::,:,:.:~:;mI~ijj.~~"':};~ ,'~/;J_IL~L 
EB 8201  
CHRIST PHER 0 R 
y  LATlMO/CH, lerk 
eP TY Rt: 
       I I    
   I , I        
IE  ,  i i i l, 
l intif , 
vs. 
  
RATI , a issouri corporation, 
nt. 
 .    
I   I   30(b)(6) 
    
 I   
 
 F  S I  IP  P RATI ,  I S S 
 : 
Pursuant to Rule 30(b)(6) of the Idaho Rules of Civil Procedure, Defendant is directed to 
designate a person or persons ost kno ledgeable about the categories of topics identified belo  to 
appear and give testi ony on oral exa ination in the above-entitled action before a certified court 
reporter and notary public, co encing at 9:00 a.m. on arch 17, 2011, at the offices of reener 
r  r ,  .  t., it  , is , I o,  ti i  t r ft r fr  
day to day until such ti e as the taking of the deposition ay be adjourned. 
I  F I   30(b)( 6) P SI I  S  F F  S I  
I  I  -  
Categories for Testimony
1 All documents correspondence witnesses and anything else that supports or
tends to support SECsAnswer and Affirmative Defenses to Ms Major Complaint
2 SECsanswers and responses to discovery
3 SECs design testing manufacturing packaging marketing and selling of its
Sabre Red OC spray products
4 Studies of its Sabre Red OC spray products
5 SECs selection ofwhich studies to do
6 SECs research for and drafting and distribution of safety information related to
its Sabre Red OC spray products and
7 Any training and training materials that SEC offers in regard to the use of its
Sabre Red OC spray products
The designee is requested to bring with them and be prepared to produce at that time all
ofthe following documents Any and all materials responsive to written discovery not previously
produced
This deposition will be taken pursuant to the Idaho Rules of Civil Procedure You are
notified to appear and take such part in the examination as you may deem proper




NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUM OF DEFENDANT SECURITY
EQUIPMENT CORPOATION 2
000103
ate ries f r esti ny: 
. ll ts, , it s,  t i  l  t t t   
tends to support SEC's ns er and ffirmative efenses to s. ajor's o plaint; 
. C's a s ers a  res ses t  isc ery; 
. C's esi n, testi g, a facturi g, ackaging, ar eti , a  selli  f its 
abre ed  spray products; 
. Studies of its Sabre ed  spray products; 
. C's l ti  f i  t ie  t  ; 
. C's research for, and drafting and distribution f safety infor ation related to 
its Sabre ed  spray products; and 
. ny training and training aterials that SEC offers in regard to the use of its 
Sabre ed  spray products. 
 signee( s) is r st  t  ri  it  t    r r  t  r  t t t ti  ll 
ofthe following docu ents: Any and all aterials responsive to written discovery not previously 
produced. 
This deposition ill be taken pursuant to the Idaho Rules of Civil Procedure.   
notified to appear and take such part in the exa ination as you ay dee  proper. 
DATED this 25th day of February, 2011. 
 .  
 .  
I   I   0(b)( 6) I I  ES    I  
I  I  -  
CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 25th day of February 2011 a true and correct copy of
the foregoing document was served on the following individualsbythe method indicated
Christopher C Burke USMail
GREENER BURKE SHOEMAKER PA X Fax 3192601
950 W Bannock Street Suite 900 Overnight Delivery
Boise ID 83702 Messenger Delivery
Email cburke@greenerlawcom
MMCourt Reporting USMail
421 W Franklin St X Fax 3458800





NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUM OF DEFENDANT SECURITY
EQUIPMENT CORPOATION 3
000104
I    
I  I  t t  t i  t    ruary, 1,  tr   rr t   
t  f r i  t s s r   t  f ll i  i dividual(s)  t  t  i i t : 
ri t r . r  
  E   
 .  t t,   
,   
&M  r  
421 . ranklin t. 
i ,   
[ ] .S. il 
[X] ax: -26  
[ ] r i t li r  
[ ] esse er eli er  
[ ] ail: r e gre nerlaw.com 
[ ] .S. il 
[X] x: -88  
[ ] vernight elivery 




 . W Z 
 .  
ICE  I   0(b)(6) I I      I  





CHRISTOPHER D RICH Clerk
By ABBY GARDEN
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual










TO DEFENDANT SECURITY EQUIPMENT CORPORATION AND ITS
ATTORNEYS OF RECORD
Pursuant to Idaho Rule of Civil Procedure 30b6 Defendant Security Equipment
Corporation SEC is hereby directed to designate aperson or persons most knowledgeable about
the categories of topics identified below to appear and give testimony on oral examination in the
above entitled action before a certified court reporter and notary public commencing at 900am
on March 17 2011 at the offices of Greener Burke Shoemaker PA 950 W Bannock St Suite 900
AMENDED NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUM OF DEFENDANT
SECURITY EQUIPMENT CORPORATION 1
Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZPLLC
1673 W Shoreline Drive Suite 200 83702






Attorneys for Plaintiff Billie Jo Major
000105
Darwin ers , ISB #5 87 
Eric B. S artz, ISB #6396 
J ES & S Z PLLC 
1673 . Shoreline rive, Suite 200 [837 ] 
ost ffice ox 7808 
Boise, ID 83707 
Telephone: (208) 489-8989 
Facsimile: (208) 489-8988 
E ail: dar in jonesandswartzlaw.com 
eric jonesandswartzlaw.com 
Attorneys for Plaintiff, Billie Jo ajor 
~~. ____ F_IL~.~_~+-__ 
MA~ 0 1 2011 
RIST PHER . I , lerk 
By ABBY  
DEPUTY 
I   IS I       IS I   
   I , I        
I IE J  J , and individual, 
Plaintiff, 
vs. 
SECURITY EQUIP ENT CORPORATION, 
a issouri corporation, 
nt. 
ase .    
E E     
 0(b)(6) I   
  , I  
  
: EFE T, SE IT  E IP E T PORATI N,  ITS 
S  CORD: 
t t   l  f i il r r  0(b)( 6), f t ecurit  qui nt 
Corporation ("SEC") is r  ir t  t  si t  a rs  r rs s st l l  about 
the categories of topics identified below to appear and give testimony on oral examination in the 
above-entitled action before a certified court reporter and notary public, co encing at 9:00 a.m. 
on arch 17, 2011, at the offices of Greener Burke Shoemaker PA, 950 W. Bannock St., Suite 900, 
A ENDED NOTICE OF TAKING RULE 30(b)(6) DEPOSITION DUCES TECUM OF DEFENDANT 
SECURITY EQUIPMENT CORPORATION - 1 
Boise Idaho and continuing thereafter from day to day until such time as the taking of the
deposition maybe adjourned
Categories for Testimony
I All documents correspondence witnesses and anything else that supports or
tends to support SECsAnswer and Affirmative Defenses to PlaintiffsComplaint
2 SECsanswers and responses to discovery
3 SECs design testing manufacturing packaging marketing and selling of its
Sabre Red OC spray products
4 Studies of SECs Sabre Red OC spray products
5 SECsselection of which studies to do
6 SECsresearch for and drafting and distribution of safety information related to
its Sabre Red OC spray products and
7 Any training and training materials that SEC offers in regard to the use of its
Sabre Red OC spray products
The designee is requested to bring with himer and be prepared to produce at that time
all of the following documents
1 Any and all materials responsive to written discovery not previously produced
and
2 One of each of SECsSabre Red OC products that it sold to the Idaho Department
of Correction IDOC from 2003 to the present along with all literature that was delivered to
the IDOC in conjunction with the delivery of each such product
This deposition will be taken pursuant to the Idaho Rules ofCivil Procedure
AMENDED NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUM OF DEFENDANT
SECURITY EQUIPMENT CORPORATION 2
000106
oise, Idaho, and continuing thereafter fro  day to day until such ti e as the taking of the 
deposition may be adjourned. 
Categories for Testi ony: 
1. ll d ts, c rres , itness s, a d t ing lse that s rts r 
tends to support SEC's ns er and ffirmative efenses to Plaintiffs Co plaint; 
. 's ans ers and responses to discovery; 
. 's d si , t sti , f t ri , i , r ti ,  s lling f its 
Sabre Red OC spray products; 
. t ies f C's a re e   s ra  r cts; 
. C's    e   ; 
. C's r s r  f r  r fti   istri tion f s f t  i for atio  r l t  t  
its Sabre Red OC spray products; and 
. ny training and training aterials that SE  offers in regard to the use of its 
Sabre Red C spray products. 
he designee(s) is requested to bring ith him/her and be prepared to produce at that ti e 
all of the following docu ents: 
. ny and all aterials responsive to ritten discovery not previously produced; 
 
. ne f each f EC's abre ed  products that it sold to the Idaho epart ent 
f rr ti  ("IDO ") fr   t  t  r sent, l  it  ll lit r t r  t t s eli r  t  
the IDOC in conjunction with the delivery of each such product. 
This deposition ill be taken pursuant to the Idaho Rules of Civil Procedure. 
A ENDED NOTICE OF TAKING RULE 30(b)(6) DEPOSITION DUCES TECU  OF DEFENDANT 
SECURITY EQUIPMENT CORPORATION - 2 






I HEREBY CERTIFY that on this 3rd day ofMarch 2011 a true and correct copy of the
foregoing document was served on the following individualsbythe method indicated
Christopher C Burke
GREENER BURKE SHOEMAKER PA














AMENDED NOTICE OF TAKING RULE 30b6DEPOSITION DUCES TECUMOF DEFENDANT
SECURITY EQUIPMENT CORPORATION 3
ERIC B SWARTZ
000107
TED this 3rd day of arch, 2011. 
 .  
IC TE   
I  I  t t  t is r   f r , ,  tr   rre t  f t  
foregoing document was served on the following individual(s) by the method indicated: 
Christopher C. Burke 
 E    
 .  tr t, it   
Boise, ID 83702 
&M  p I  
 . r li  tr t 
Boise, I  83702 
[ ] .S. i  
[X] x: -2601 
[ ] esse er eli er  
[ ] ail: cburke greenerlaw.com 
[ ] .S. i  
[X] x: -88  
[ ] esse er eli er  
[ ] ~' ~~1Ynl-imser 
DARWIN L.  
 .  
 I   I   30(b)(6) POSITI   T CU   DEFENDANT 




Christopher C Burke ISB 42098
Thomas J Lloyd III ISB 47772
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 319 2600
Fax 208 3192601
Attorneys for Defendant
MAR 2 1 2011
CHRISTOPHER D RICH Clerk
By ELYSHIA HOLMES
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR an individual
Plaintiff Case No CVPI 1003515
SECURITY EQUIPMENT
CORPORATION a Missouri corporation
Defendant
NOTICE OF SERVICE OF DEFENDANTS
DISCOVERY TO PLAINTIFF
PLEASE TAKE NOTICE that on the 18 day ofMarch 2011 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke ShoemakerPA
served the following documents in the manner indicated on the service list
a DefendantsFirst Set ofRequests for Admission and Second Set of
Interrogatories and Requests for Production ofDocumews to Plaintiff and
b This Notice o Service ofDefendantsDiscovery to Plaintiff
NOTICE OF SERVICE OF DEFENDANTSDISCOVERY TO PLAINTIFF Page 1 14542011 381318doc
000108
I I L 
NO. FILED bf 
.M._----P.M. ~ = 
Christopher C. Burke, ISB #2098 
Thomas 1. Lloyd III, ISB #7772 
GREENER BURKE SHOEMAKER PA 
950 . Bannock Street, Suite 900 
Boise, Idaho 83702 
MAR 2 1 20 1 
CHRISTOPHER D. RI , Clerk 
By ELYSHIA HOLMES 
DEPUTY 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
I  HE IS IC  RT F E  J I I  IS I  F E 
 F I , I    E    
ILLIE J  J , an individual, 
Plaintiff, 
v. 
ase .: - I-  
    ENDANT'S 
   
SEC RIT  E IP E T 
CORPORA nON, a Missouri corporation, 
f dant. 
  I  that, on the 18th day f arch, 2011, efendant ecurity 
Equipment Corporation, by and through its counsel of record, Greener Burke Shoemaker P.A., 
served the following documents in the manner indicated on the service list: 
III 
III 
/ / / 
a. Defendant's First Set of Requestsfor Admission, and Second Set of 
Interrogatories and Requests/or Production of Documents to Plaintiff, and 
b. is otice f ervice of efendant's isc very to PlaintifF 
NOTICE OF SERVICE OF DEFENDANT'S DISCOVERY TO PLAINTIFF -- Page I 14542-011 (3RI318d()c) 
DATED this 18 day of March 2011
GREENER BURKE SHOEMAKER PA
I
Christopher C Burke
Thomas J Lloyd III
Attorneys for Defendant
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice of Service of
DefendantsDiscovery to Plaintiff on the following named persons on the date indicated
below in the manner indicated below
Darwin Overson Esq x Via US Mail
Eric B Swartz Esq Via Hand Delivery
JONES SWARTZ PLLC x Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 ViaOvernight Delivery
P O Box 7808
BoiseIdaho 83707
DATED this l 8 day of March 2011
Christopher C Burke
Thomas J Lloyd III
NOTICE OF SERVICE OF DEFENDANTSDISCOVERY TO PLAINTIFF Page 2 14542 011 381318dc
000109
DATED this 18th day of arch, 2011. 
GREENER BURKE S OE AKER P.A. 
--L J.?LrL ;0= 
Christopher C. Burke 
Thomas J. loyd I I 
A torneys for efendant 
IC TE   
I hereby certify that I caused to be served the foregoing Notice of Service of 
Defendant's Discovery to Plaintiff on the following named person(s) on the date indicated 
below, in the manner indicated below: 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
JONES & S RTZ, PLLC 
1673 . Shoreline rive, Suite 220 
P. . Box 7808 
Boise, Idaho 83707 
DATED this 18th day of March, 2011. 
[  ] ia .S.  - ---l 
[ ] i   li  
[  ] i  i il  (20 /489-8 8) 
[ ] i  r i t li r  
-----I--- ~ ~i:Z::::-=-~. -~~ -
rist er . r e 
ho as J. loyd III 




MAR 2 3 2011
CHRISTOPHER D RICH Clerk
By ELYSHIA HOLMES
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIALDISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
BILLIE JO MAJOR and individual
Case No CV PI 1003515
Plaintiff




TO THE CLERK OF THE ABOVEENTITLED COURT
PLEASE TAKE NOTICE that on the 18th day of March 2011 Plaintiff by and through
her counsel of record Jones Swartz PLLC served Plaintiffs Fourth Set of Interrogatories
and Requests for Production together with a copy of this Notice of Service upon counsel for
the Defendant as follows
Christopher C Burke
GREENER BURKE SHOEMAKER PA






NOTICE OF SERVICE 1
Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZPLLC
1673 W Shoreline Drive Suite 220









ar in vers , ISB #5 87 
Eric . S artz, ISB #6396 
J ES & , PLLC 
73 . S reline ri , ite 220 
Post ffice o  7808 
Boise, ID 83707 
Telephone: (208) 489-8989 
Facsimile: (208) 489-8988 
ttorneys for Plaintiff, illie Jo ajor 
~~. ____ F_IL~~. '1.6aTJ 
  2011 
I  . , l r  
y ELYSHIA  
OEPUTY 
I  E IS I       IS I   
E   ,    E    
I IE J  J , and individual, 
l intiff, 
vs. 
I  I  RATI , 
a Missouri corporation, 
ant. 
 .   5 
   
:     -  T: 
  I  t t  t  t   f rch, 11, laintiff,   t r  
her counsel of record, Jones & rt  LL , s r  l i tiff's rt  t f I t rr t ri s 
and equests for Production, together ith a copy of this otice of Service, upon counsel for 
t  f t s f ll s: 
Christopher C. Burke 
     
950 . Bannock Street, Suite 900 
Boise, ID 83702 
I   SERVI  -  
[ ] .S. il 
[ ] ax: -26  
[ ] ss r li r  
[ ] ail: cb r green rlaw.com 




NOTICE OF SERVICE 2
000111
TED this 18th day of arch, 2011. 
I  F SERVICE - 2 
J ES & S RTZ P LC 
~
r7 1, 
ARWINL i  ~ 
I  . S A TZ 
Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZPLLC
1673 W Shoreline Drive Suite 200 83702






Attorneys forPlaintiff Billie Jo Major
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA









APR 0 5 2011
CHRISTOPHER D RICH Clerk
By STEPHANIE VIDAK
DEPUTY
Case No CV PI 1003515
NOTICE OF COMPLIANCE
TO THE CLERK OFTHE ABOVE ENTITLED COURT
PLEASE TAKE NOTICE that on the 5th dayofApril 2011 Plaintiff by and through her
counsel of record Jones Swartz PLLC served Plaintiffs Third Supplemental Answers and
Responses to DefendantsFirst Set of Interrogatories and Requests for Production together
with a copy of this Notice of Compliance upon counsel for the Defendant as follows




z -(!J -0: 
o 
Darwin verson, ISB #5887 
Eric . S artz, ISB #6396 
J ES & Z PLLC 
1673 . Shoreline Drive, Suite 200 [83702] 
Post ffice ox 7808 
Boise, ID 83707 
Telephone: (208) 489-8989 
Facsimile: (208) 489-8988 
E ail: dar in jonesandswartzlaw.com 
eric jonesandswartzlaw.com 
Attorneys for Plaintiff, Billie Jo ajor 
P    2011 
I  D. I , lerk 
y STEPHANIE I K 
DEPUTY 
 E IS I    E     
T E ST TE F I , I   F  T E T  F  
ILLIE J  J , and individual, 
Plaintiff, 
vs. 
SECURITY EQUIP ENT CORPORATION, 
a Missouri corporation, 
ant. 
ase .  I  
   
:     - I  RT: 
  I  that on the 5th day f pril, 2011, laintiff, by and through her 
counsel of record, Jones & rt  LLC, s r  laintiff's ir  uppl t l s rs an  
Responses to Defendant's First Set of Interrogatories and Requests for Production, together 
with a copy of this Notice of Compliance, upon counsel for the Defendant as follows: 
TI  F COMPLIA E - 1 
Christopher C Burke
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise ID 83702








NOTICE OF COMPLIANCE 2
000113
Christopher C. Burke 
EE ER BURKE S ER   
950 . a c  treet, ite  
oise, I  83702 
DATED this 5th day of April, 2011. 
I  F O PLI  -  
[ --Y6.S. ail 
f] F : 319-2601 
[ ] essenger eliver  
[ ] il: cburke gre nerlaw.com 
y~~~~~==~ ______ _ 
I  . ERS  





Christopher C Burke ISB 2098
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Tel 208 319 2600
Fax 208 3192601
Attorneys for Defendant
CHRISTOPHER D RICH Clerk
By LARAAMES
DEPUTY
IN THE DISTRICTCOURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Case No CVPI 1003515
NOTICE OF SERVICE OF DEPENDANTS
RESPONSES TO PLAINTIFFSFOURTfI
SET OF DISCOVERY REQUESTS
Defendant
PLEASE TAKENOTICE that on the 14 day of April 2011 Defendant Security
Equipment Corporation by and through its counsel of record Greener Burke Shoemaker PA
served the following documents in the manner indicated on the service list
a DefendantsResponses to Plaintiffs Fourth Set of Interrogatories and Requests
far Production and
b This Notice ofService ofDefendantsResponses to PlaintiffsFourth Set of
Discovery Requests
DATED this 14 day of April 2011




NOTICE OF SERVICE OF DEFENDANTSRESPONSES TO PLAINTIFFSFOURTH SET OF DISCOVERY
REQUESTS Page 1 14542011 382008doc
A
000114
Christopher C. Burke, ISB #2098 
GREENER BURKE S E KER P  
950 . annock Street, Suite 900 
Boise, Idaho 83702 
Tel: (208) 319-2600 
Fax: (208) 319-2601 
Attorneys for Defendant 
~~~ ----~~.~. 9) '3 va 
P   4 2011 
HRISTOPHER . RI , lerk 
By LARA AMES 
DEPUTY 
 E  RT F E  J  IS   E 
 F I ,        
I LIE .10 J , an individual, 
Plaintiff, 
v. 
SE IT  E IP E T 
C RP RATI , a issouri corporation, 
ant. 
 o.:  - I-l  
ICE    FENDANTS 
  LAINTIF 'S H 
    
PLE SE T E TICE that, on the 14th day of April, 2011, Defendant Security 
Equipment Corporation, by and through its counsel of record, Greener Burke Shoemaker P.A., 
served the follo ing docu ents in the anner indicated on the service list: 
a. efendant '.'I Responses to Plainttlrs Fourth Set o.flnterrogatories and Requests 
for Production; and 
. This otice of Service of efendant's Responses to Plaintiff's Fourth Set of 
Discovery Requests. 
DATED this 14th day of April, 2011. 
Christopher C. Burke 
Attorneys for Defendant 
 
TI  OF SERVI   DEFENDANT'S RESP  TO PLAINTIF 'S FOURT  SET OF DI  
REQUESTS ~ Page I 14542-  ( 82008 doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Notice of Service of
DefendantsResponses to Plaintiffs Fourth Set of Discovery Requests on the following
named personson the date indicated below in the manner indicated below
Darwin Overson Esq x ViaUS Mail
Eric B Swartz Esq Via Hand Delivery
JONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 Via Overnight Delivery
P O Box 7808
Boise Idaho 83707
DATED this 14 day of April 2011
C stopher C Burke
NOTICE OF SERVICE OF DEFENDANTSRESPONSES TO PLAINTIFFSFOURTH SET OF DISCOVERY
REQUESTS Page 2 14542011 382008doc
000115
C IFICATE F S E 
I hereby certify that I caused to be served the foregoing Notice of Service of 
efendant's esponses to Plaintiffs Fourth Set of iscovery equests on the following 
named person(s) on the date indicated below, in the manner indicated below: 
r---------------------,-------------------
ar in verson, Esq. 
Eric B. Swartz, Esq. 
J ES & S , P  
1673 . Shoreline rive, Suite 220 
. . o   
ise, Idaho 7 
DATED this 14th day of April, 2011. 
[ ] ia .S.  
[ 1 ia and eliver  
[ ] ia a si ile (208/489-89 ) 
[ J ia g t ivery 
I  OF SERVI   DEFENDANT'S RESPON  TO PLAINTIF 'S FOURT  SET OF DI  
REQUESTS - Page 2 14542-  ( 82008 doc) 
1
r
Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 200 83702






Attorneys for Plaintiff Billie Jo Major
AM ILE
PM
APR 2 0 2011
CHRISTOPHER 0 RICH ClerkBy STEPHANIE VIDAK
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA






Case No CV PI 1003515
NOTICE OF COMPLIANCE
TO THE CLERK OF THE ABOVE ENTITLED COURT
PLEASE TAKE NOTICE that on the 5th day ofApril 2011 Plaintiff by and through her
counsel of record Jones Swartz PLLC served Plaintiffs Answers and Responses to
DefendantsFirst Set of Requests for Admission and Second Set of Interrogatories and
Requests for Production of Ddocuments together with a copy of this Notice of Compliance
upon counsel for the Defendant as follows




Z -(!J -a:: 
o 
ar in rs , IS  #5 87 
ric . artz, IS  #6396 
J ES &  LC 
1673 . Shoreline Drive, Suite 200 [83702] 
 fice   
oise,I  83707 
Telephone: (208) 489-8989 
acsi ile: (20 ) -8988 
E ail: dar in jonesandswartzlaw.com 
eric jonesandswartzlaw.com 
ttorneys for Plaintiff, illie Jo ajor 
NO,: 
A.M.~=---7=i!=llLEEBo-"""':2~''''''_,~""" 
--~-PM. 4d . Ol::r 
AP   2011 
I T  D 
By STEPHANIE ~/g~K Clerk 
TY 
          
   I , I        
I IE J  J , a  i i i al, 
l intiff, 
vs. 
I  I  RATI , 
a issouri corporation, 
ant. 
 .    
   
:     -  URT: 
  I  t t  t  t   f ril, 1, l intiff,   t r  r 
counsel of record, Jones & rt  , r  l i tiff's r    t  
efendant's irst et of equests for d ission, and econd et of Interrogatories and 
Requests for Production of Ddocu ents, together with a copy of this Notice of Co pliance, 
upon counsel for the Defendant as follows: 
   - 1 
Christopher C Burke
GREENER BURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise ID 83702







NOTICE OF COMPLIANCE 2
000117
Christopher C. Burke 
GREE ER URKE S KER P  
950 . annock Street, ite 900 
Boise, ID 83702 
DATED this 18th day of April, 2011. 
TI  F COMPLI  - 2 
[ ] .S. ail 
[ ] Fa : 319-2601 
~e seng  elivery 





Christopher C Burke ISB 2098
Thomas J Lloyd III ISB 7772
GREENER BURKE SHOEMAKER PA





AiR 2 2 20
CHRISTOPHER D RICH Clerk
By STEPHANIE ViDAK
DEPUTY
IN THE DISTRICTCOURT OF THE FOURTH JUDICIAL DISTRICT OF TI1F
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA
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Defendant Security Equipment Corporation SEC by and through its counsel of
record Greener Burke Shoemaker PA pursuant to Rule 56 of the Idaho Rules of Civil
Procedure and hereby respectfully moves this Court for an order granting summary judgn
against Plaintiff Billie Jo Major Plaintiff on all claims asserted in PlaintiffsComplaint
The basis for this Motion is that as to Plaintiffswarranty claims she has already agreed
to dismiss those claims and further she cannot present any evidence that SEC ever created an
express warranty whatsoever Plaintiffs causes of action in strict liability and failure to provlic
adequate warning similarly fail as Plaintiff will be unable to present evidence of a fundamcrtal
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Defendant Security Equip ent Corporation ("S C"),  a  t r  its c sel f 
record, reener urke Shoe aker P.A., pursuant to ule 56 of the Idaho ules of ivil 
Procedure, and hereby respectfully oves this ourt for an order granting su ary judgm,~nt 
against Plaintiff Billie .10 ajor ("Plaintiff') on all clai s asserted in Plaintiff s Co plaint. 
he basis for this otion is that, as to Plaintiff's arranty clai s, she has already agreed 
t  is iss t s  l i s , f rt r, s  t res t  i e ce t t  r r t   
express arranty hatsoever. Plaintiff's causes of action in strict liability and failure to prcWlc!C 
adequate arning si ilarly fail, as Plaintiff ill be unable to present evidence of a funda erlal 
F  S I  IP  PORATION'S I  F  S  J ENT- Page I 
-011 (3 742I.doc) 
element of her claims that Plaintiff knew or should have known of the danger of the harms that
Plaintiff complains of in this litigation
This Motion is supported by the pleadings previously filed with the Court as well as the
Memorandum in Support of this Motion the Affidavit of Robert Nancc the Affidavit of
Christopher A Reilly PhD and the Affidavit of Counsel all in Support of this Motion and
each filed concurrently herewith
Oral argument is requested
DATED this 22 day of April 2011
GREENER BURKE SHOEMAKER PA
Christopher C Burke
Thomas J Lloyd III
Attorneys for Defendant
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element of her clai s: that Plaintiff knew or should have known of the danger of the harms tt1at 
Plaintiff complains of in this litigation. 
This Motion is supported by the pleadings previously filed with the Court, as well as lhe 
emorandum in Support of this otion, the Affidavit of Robert Nance, the Affidavit of 
Christopher A. Reilly, Ph.D., and the Affidavit of Counsel, all in Support of this Motion and 
each filed concurrently herewith. 
Oral argument is requested. 
DATED this 22nd day of April, 2011. 
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CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing DEFENDANT SECURITY
EQUIPMENT CORPORATIONSMOTION FOR PARTIAL SUMMARY JUDGMENT on the
following named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
P O Box 7808
Boise Idaho 83707
DATED this 22 day of April 2011
Via USMail
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CE IFICATE F S E 
I hereby certify that I caused to be served the foregoing DEFENDANT SECURITY 
EQUIPMENT CORPORATION'S MOTION FOR PARTIAL SUMMARY JUDGMENT on the 
following named person(s) on the date indicated below, in the manner indicated below: 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
J ES & S ARTZ, PLLC 
1673 . horeline rive, uite 220 
. . o   
Boise, Idaho 83707 
DATED this nnd day of April, 2011. 
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Case No CVPI1003515




Defendant Security Equipment Corporation SEC or Defendant by and through its
counsel of record Greener Burke Shoemaker PA pursuant toIRCP56 and in support of its
Motion for Summary Judgment Motion filed herewith submits this memorandum
I INTRODUCTION
This action arises out of Plaintiffs limited exposure to law enforcementgrade pepper
spray products during her employment with the Idaho Department of Corrections IDOC In
the course of her employment and training with IDOC Plaintiff was exposed to irritant pep1 r
spray products made from oleoresin capsicum OC Throughout the years of her
employment Plaintiff used andor trained with a variety of OC spray products sold by different
MEMORANDUM IN SUPPORT OF DEFENDANTSMOTION FOR SUMMARY JUDGMENT Page 1
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  F , I   R     
I IE .10 J , an individual, 
laintiff, 
v. 
SECURITY EQUIP ENT 
CORPORATION, a Missouri corporation, 
nt. 
s  o.: -P -I  
    
FENDANT'S OTION  
Y.J DGMI<:  
efendant Security Equip ent Corporation ("SEC" or "Defendant"),     
counsel of record, Greener Burke Shoe aker P.A., pursuant to I.R.C.P. 56, and in support of its 
otion for Su ary Judg ent ("Motion")  rewith, i   orandum. 
.  
his action arises out f laintiff's li ited exposure to la  enforce ent-grade pepper 
spray products during her employment with the Idaho Department of Corrections ("ID C"), 1n 
the course of her employment and training with IDOC, Plaintiff was exposed to irritant pep;ler 
spray products, made fro  l r si  capsicum (" "). Throughout the years of her 
employment, PlaintifT used and/or trained with a variety of OC spray products sold by different 
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14542-011 (387048 doc) 
manufacturers The Defendant in this litigation Security Equipment Corporation SEC is
only one of those manufacturers
Following disciplinary action by IDOC which resulted in her termination Plaintiff
instituted the present action against SEC In her Complaint Plaintiff has asserted causes of
action for Strict Liability Failure to Provide Adequate Warning Breach of Express Warranties
and Breach of Implied Warranties SEC brings the present Motion for Summary Judgment on
the basis that Plaintiff will be unable to prove a fundamental element of her claims both in Strict
Liability for defective design and in Failure to Provide Adequate Warning Because Plaintiff
cannot demonstrate that SEC should have known or foreseen a risk of the particular chronic or
longterm adverse health effects of which she complains in this litigation SEC cannot be held
liable under either of the theories advanced in PlaintiffsFirst or Second Causes of Action As
the only known and proven risks of exposure to OC spray are acute temporary reversible
recoverable and transient SEC is entitled to judgment as a matter of law on Plaintiffs First and
Second Causes of Action
Further Plaintiff has been unable to produce any evidence of an applicable express
warranty and has even conceded in discovery that she intends to dismiss the warrantybased
causes of action Because no voluntary dismissal has been sought by Plaintiff since she claimed
intent to dismiss the warranty claims over ten 10 months ago and because the warranty claims
1 Idaho law recognizes three 3 categories of strict liability manufacturing defect design
defect or failure to warn Mortensen v Chevron Chemical Company 107 Idaho 836 839 693 P2d
1038 1041 1984 From the allegations in the Complaint it appears as though Plaintiffs First Cause of
Action seeks to impose liability on SEC for the second of these categories design defect Complaint I
16
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manufacturers. The efendant in this litigatio , Sec rity Equipment orporation ("SEC"). IS 
only one of those anufacturers. 
Following disciplinary action by IDOC which resulted in her termination, Plaintiff 
instituted the present action against SE . In er l i t, Pl i tiff as ss rted auses f 
action for Strict Liabil ity l, Failure to Provide Adequate arning, Breach of Express arranties 
and Breach of Implied arranties. SEC brings the present otion for Summary Judgment on 
t  is that l i ti f ill e a le t  rove  unda e t l le t   lai s t  i  t ict 
Liability (for defective design) and in Failure to Provide Adequate Warning. Because Plaintiff 
t strate that  l  e   res   is   t e ti la  i   
long-term adverse health effects of which she complains in this litigation, SEC cannot be held 
ia e er t e   e ies   laintif s      .  
the only known and proven risks of exposure to OC spray are acute, temporary, reversihlc, 
recoverable and transient, SE  is entitled to judg ent as a atter of la  on Plaintiff s First and 
ec  a ses f cti . 
Further, Plaintiff has been unable to produce any evidence of an applicable express 
warranty, and has even conceded in discovery that she intends to dismiss the warranty-based 
causes f action. ecause no voluntary dis issal has been sought by laintiff since she clai ed 
intent to dis iss the arranty clai s over ten (10) onths ago, and because the arranty clai s 
I Idaho law recognizes three (3) categories of strict liability: "manufacturing defect, design 
defect, or failure to arn." ortensen v. Chevron Chemical Company, 107 Idaho 836, 839, 693 P.2d 
1038, 1041 (1984). From the allegations in the Complaint, it appears as though Plaintiff's First Cause or 
Action seeks to impose liability on SEC for the second of these categories - desi  defect. ( plaint.'1 
16.) 
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themselves are without merit or factual basis SEC is entitled to judgment as a matter of law on
PlaintiffsThird and Fourth Causes of Action
IL STATEMENT OF UNDISPUTED FACTS
The Parties
1 Plaintiff Billie Jo Major Ms Major or Plaintiff was at the time of the filing
of this action a resident of Ada County Idaho Complaint and Demand for Jury Trial
Complaint 1 Ms Major claims that she suffered injuries following exposure to oleoresin
capsicum OC spray also referred to as pepper spray during a training session she was
attending as an employee of the Idaho Department of Corrections IDOC Plaintiffs
Complaint Complaint 8 She specifically claims that she suffers from a longterm or
chronic respiratory illness such as RADS chronic cough syndrome vocal cord dysfunction
esophageal dysmotility and or gastrointestinal reflux andor a long term chronic aggravation or
exacerbation of an existing health condition as a result of her exposure to OC spray Complaint
T 11 and 19 Affidavit of Counsel in Support of DefendantsMotion for Summary Judgment
Aff Counsel 9 and Exhibit H p 14
2 SEC is a Missouri corporation that has in the past conducted business in the state
of Idaho DefendantsAnswer to Plaintiffs Complaint and Demand for Jury Trial Answer
113
3 SEC is a manufacturer and retailer of self defense products including a line of
pepper sprays or OC sprays SEC sells its products to law enforcement agencies as well as
civilians Affidavit of Robert Nance in Support of DefendantsMotion for Summary Judgment
filed concurrently herewith Nance Aff If 2
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themselves are ithout it or factual ,  is e titled to judgment as a atter f la   
Pl i tif s hird d ourth auses  cti . 
I.   ISP TEn S 
he ties 
. Plaintiff illie Jo ajor ("Ms. ajor" or "Plaintiff') as, at the ti e of the fil ing 
f this acti , a resi e t f da t , Ida . (Complaint a  e and f r J r  rial 
("Complaint"), '1 .) s. ajor lai s t at s e s ffered injuries f llo in  s re t  l r si  
capsIcum ("OC") spray, also referred to as pepper spray, during a training session she as 
attending as an employee of the Idaho Department of Corrections ("IDOC"). (Pl intifj~<;' 
Complaint ("Complaint"), ~ 8.)  ifi ll  lai s t t  ffers fr   l -term r 
chronic respiratory illness, such as RADS, chronic cough syndro e, vocal cord dysfunction, 
esophageal dys otility and/or gastrointestinal reflux, and/or a long ter  chronic aggravation or 
exacerbation of an existing health condition, as a result of her exposure to  spray. (Co plaint, 
~~ 11 and 19; ffidavit of ounsel in Support of efendant's otion for Su ary Judg ent 
("Aff. l"), ~ 9 and Exhibit , p. 14.) 
. S  is a issouri corporation that has, in the past, conducted business in the state 
ofIdaho. (Defendant's Answer to Plaintiffs Complaint and Demand for Jury Trial ("Answer'"), 
.  i   f t r r  r t il r f self f  r ucts, i l i   li  f 
pepper sprays or OC sprays. S  sells its products to la  enforce ent agencies as ell as 
ci ilia s. (Affida it f ert a ce i  u rt f efendant's ti  f r u ar  Judg e t 
filed concurrently here ith ("Nance ff. "), ,r 2.) 
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4 The SEC product line which Plaintiff bases her allegations in her Complaint upon
is SECs SABRE Red law enforcement 10 OC spray Complaint 8
Plaintiffs Employment with IDOC
5 Ms Major was employed as a correctional officer for the IDOC from July 2004
through May 2008 Aff Counsel 2 and Exhibit A 35216
6 During her employment for the IDOC Ms Major worked at two different
correctional facilities the Idaho Maximum Security Institution IMSI and the South Boise
WomensCorrectional Facility Aff Counsel 2 and Exhibit A 351725 Ms Major worked
at IMSI from July 2004 to July 2006 and there again from August or September 2007 to May
2008 Id at 351725 361012 and 46612 Ms Major worked at the South Boise Womens
Correctional Facility from roughly July 2006 through August or September 2007 the timeframe
between her different stints at IMSI Id 351725 and 4120427
7 While employed with IDOC Ms Major was required to attend different training
courses which were taught by other IDOC personnel Aff Counsel 2 3 and 5 Exhibit A
9210 9317 Exhibit B 9059213 and Exhibit D The training courses included among other
training courses annual training regarding the use of OC spray 1d
8 IDOC personnel recognize three different levels of OC spray exposure
specifically level 1 level 2 or level 3 Aff Counsel 3 Exhibit B 98149911 A Level 1
exposure when an individual has direct contact with an OC product such as when someone is
sprayed directly Id A Level 2 exposure when an individual handles a contaminated
subject so the individual is getting OC on their skin and getting vapor coming off the
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. he S  product line hich Plaintiff bases her allegations in her o plaint upon 
is C's  e  la  f r t 0%  r . (Co l i t, ~ .) 
's loy e t t   
. s. ajor as e ployed as a correctional officer for the I  fro  July, 2004 
through ay, 2008. (Aff. Counsel, ~   ibit , 5:2-1 .) 
. During her e ploy ent for the IDOC s. ajor worked at two diffcrent 
ti l iliti ; t e da  a i u  it  tit tion ("IMS ")    ise 
o en's Correctional Facility. (Aff. Counsel, '1    , 5: 17-2 .) . a r  
at I SI fro  July, 2004 to July, 2006 and there again fro  ugust or Septe ber, 2007 to ay, 
2008. (Id., at 35:17-25,36:10-12 and 46:6-12.) s. ajor worked at the South Boise omen's 
rr ti l ility fr  r l  J ly,  t r  st r t ber, , t  ti fra  
t e  r iffere t sti ts t I I. (I ., 5:17-25  1 :20- 2:7.) 
. hile e ployed ith I  s. ajor as required to attend different training 
courses hich ere taught by othcr I  personnel. (AfT. ounsel, ~'I ,   , i it /\, 
92:10-93:17, Exhibit B, 90:5-92:13 and Exhibit D.) The training courses included, a ong othcr 
training courses, annual training regarding the use of OC spray. (ld.) 
. I  personnel recognize three different levels of  spray expOSll1'e, 
specifically level 1, level 2 or level 3. (AfT. Counsel, ,r , i it , 8: 14- 9: 1.)  "Levell" 
exposure hen an individual has direct contact ith an  product, such as hen so eone is 
sprayed directly. (Id.) A "Level 2" exposure when an individual handles a conta inated 
subject, so the individual is getting  on their skin and getting vapor co ing off the 
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contaminated subject Id A Level 3 exposure when an individual is generally in an area that
has been contaminated typically by walking through a contaminated area Id
9 All IDOC correctional officers attending OC spray training through IDOC
training courses would at most get a Level 3 exposure to OC if they were exposed at all Aff
Counsel 3 Exhibit B 10020
10 The correctional officers employed by the IDOC typically carried with them a
stream based OC spray Aff Counsel 3 Exhibit B 331820 3413517 and 3518 3612
Streambased OC products do not have as great an impact of cross contamination ie higher
likelihood of containing people outside of the individual you are trying to spray as fog OC
products Id OC stream products because of the nature of the larger particulates primarily
effect the eyes and only secondarily the respiratory tract Id
11 As part of her employment at IDOL Ms Major like all other employees was
required to sign post orders which included governing document specific to the work area
assigned which detailed job duties and reporting requirements The post orders required
correction officers to carry OC spray Aff Counsel 3 and Exhibit B 108321
12 Ms Major has not been employed nor has she applied for any jobs since she was
terminated from IDOC in May 2008 Aff Counsel 112 and Exhibit A 9149
Plaintiffs Use of and Exposure to Product
13 IDOC purchased law enforcement pepper spray products from SEC during the
timeframe of December 2005 to January 2008 while Plaintiff was employed at IDOL Aff
Nance 4 and Exhibit A
MEMORANDUM IN SUPPORT OF DEFENDANTSMOTION FOR SUMMARY JUDGMENT Page 5
14542011 387048doc
000125
conta inated subject. (ld.)  "Level 3" exposure hen an individual is generally in an area that 
has been conta inated, typically by alking through a conta inated area. (ld.) 
. ll I  c rrecti al fficers atte ing  s ra  trai i  t r  I  
training courses ould at ost get a evel 3 exposure to , if they ere exposed at all. (Aff. 
ounsel, ~ 3, xhibit , 100:1-20.) 
.  rr tio al fficers l   t e I  t i ll  rri  it  t   
str  s   s r . (Aff. sel, ~ , i it , 3:18-2 , 4:1-35:17  5:18- 6:12.) 
Stream-based OC products do not have as great an impact of cross-contamination (i.e. higher 
likelihoo  f t i i  le t i  f t  i i i l  r  tr i  t  ray)  f   
products. (ld) OC stream products, because of the nature or the larger particulates, primari Iy 
effect the eyes and only secondarily the respiratory tract. (ld.) 
. s part f her e ploy ent at I C, s. ajor, like all other e ployees. 'v\,as 
required to sign post orders which included governing document specific to the work area 
assigned hich detailed job duties and reporting require ents. he post orders required 
correction officers to carry OC spray. (Aff. Counsel, ~  a  i it , 08:3-21.) 
2. s. ajor has not been e ployed, nor has she applied for any jobs since she as 
ter inated fro  l  in ay, 2008. (Aff. ounsel, ~12 and Exhibit , 91 :4-9.) 
l i tifrs sc f  s re t  r ct 
3. I  purchased la  enforce ent pepper spray products fro  S  during lhe 
ti efra e of Dece ber, 2005 to January, 2008 while Plaintiff was e ployed at IDOe. (/\ iT. 
a ce, ~ 4 and Exhibit A.) 
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14 IDOC did not actually issue any of SECs products to its employees for use until
sometime in the late spring or early summer of 2007 Aff Counsel 7 Exhibit F 5624 5721
Prior to that time IDOC employees were issued and were using pepper spray products from a
competitor manufacturer Defense Technologies Id
15 Ms Major attended IDOC training sessions wherein she received minor acute
level 3 exposures to OC spray on only four occasions in almost five years namely on August 20
2004 February 14 2006 February 21 2007 and March 3 2008 Aff Counsel 11113 4 and 6
Exhibit B 1824 195 Exhibit C and Exhibit E 6312 6513 These exposures generally
lasted only seconds a minute at most Id Ms Major was only exposed to SECs products at
two of these four trainings on February 14 2006 and March 3 2008 Aff Counsel 3 4 6 7
and 8 Exhibit B 134 1385Exhibit C Exhibit E 63126513Exhibit F 56245721 and
Exhibit G 37 23 and Nance Aff 4 and Exhibit A In the other two trainings she vas
exposed to OC spray products manufactured by Defense Technologies Id
OC Spray Generally
16 There are various types of OC spray products manufactured for sale in the United
States including OC sprays which are foams or fogs aerosols streams bombs and powdered
Aff Counsel 3 and Exhibit B 2973083321 349 The different types of OC sprays have
different functions and are used for different purposes Id 3122324
17 The manufacture and sale of OC spray is regulated by the United States
Consumer Product Safety Commission under the Federal Hazardous Substances Act as a sell
pressurized irritant Nance Aff 116
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. IDOC did not actually issue any of S C's products to its e ployees for use until 
so etime in the late spring or early su er of2007. CAff. ounsel, ~ , t F 6:24- 7:21.) 
rior to that ti e, I OC e loyees ere iss e  a  ere si  e er s ray roducts fro  a 
competitor manufacturer, Defense Technologies. (Id.) 
. s. ajor attended I OC training sessions herein she received inor acute 
level 3 exposures to  spray on only four occasions in al ost five years; na ely on ugust 20, 
2004, February 14, 2006, February 21, 2007 and arch 3, 2008. (Aff. Counsel, '1'1 3, 4 and 6, 
Exhibit B, 18:24-19:15, Exhibit C and Exhibit E, 63:12-65:13.) es  s res r l  
lasted only seconds, a minute at most. (ld.) s. ajor was only exposed to SEC's products at 
t o f these four trainings, on ebruary 14,2006 and arch 3, 2008. (Aff. ounsel, ~~ , . (),  
and 8, Exhibit , 134:14-138:5, Exhibit , Exhibit E, 63:12-65:13, Exhibit r, 56:24-57:21 ,md 
i it , 7:3-2  ;  ff., ~   i it .) I  t  t r t  tr i i s s  \Vas 
exposed to OC spray products manufactured by Defense Technologies. (Id.) 
  ll  
6. here are various types of  spray products anufactured for sale in the nited 
States including  sprays hich are foa s or fogs, aerosols, strea s, bo bs and po dered. 
(Aff. Counsel, ~   i it , 9:7-30:8, 3:21- 4:9.)  iff r t t s f  s r s  
iffer t f ti s  r   f r iff r t r s. (l . 1 : 2- 2:4.) 
7. e a fact re a  sale f  spra  is re late   t e ite  tates 
Consumer Product Safety Commission under the Federal Hazardous Substances Act as a "sci f-
pressurized irritant." (Nance Aff. '16.) 
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18 The effects of OC sprays exposure to individuals are acute transient reversible
and recoverable within a short period of time typically wearing off within minutes Aff
Counsel 3 6 7 8 and 10 Exhibit B 36133725 Exhibit E 35376Exhibit F 5113
5322Exhibit G 2517266and 165 17 and Exhibit I 958965Affidavit of Christopher A
Reilly PhD in Support of DefendantsMotion for Summary Judgment Reilly Aff T and
Nance Aff 2 These effects include mucus production redness of the eyes watery eyes or
crying involuntary closing of the eyes burning sensation of the skin such as a sunburn
inflammation of the skin sneezing and coughing and can slightly restrict airways Id OC
sprays are designed and intended to have these acute effects as they are made for self defense
and protection and are used by law enforcement officers to subdue criminal suspects and
inmates without the need to use more lethal forms of force Id
19 There is no published literature that definitively states or otherwise establishes
within a reasonable degree of scientific probability a conclusive or casual association between
exposure to OC spray and chronic or long term health conditions or disease Reilly Aff 37
Nance Aff 817 Aff Counsel 10 and 11 Exhibit I 9411 953 and Exhibit J 1289
1314
20 Based upon available scientific and medical literature published prior to 2008 a
manufacturer of OC spray products such as SEC could not know or have been put on notice that
exposure to OC spray was a foreseeable cause of any of the chronic medical conditions
complained of by Plaintiff Reilly Aff 1110 Aff Counsel 1I 10 Exhibit 1 1442 1467
MEMORANDUM IN SUPPORT OF DEFENDANTSMOTION FOR SUMMARY JUDGMENT Page 7
14542011 387048doc
000127
1 . he effects of  sprays exposure to individuals are acute, transient, reversible 
and recoverable ithin a short period of ti e, typically earing off ithin inutes. (Af . 
Counsel, ~ , , ,  a d 1 , ibit , 6:13- 7:25, ibit , 5:3-37:6, i it , 1: 13-
3: 2, ibit , 5:17-26:6, a  5:1-17 and E hibit I, 5:8-96:5; ffida it f ristopher . 
Reilly, Ph.D. in Support of Defendant's otion for Summary Judgment ("Reilly Aff."), ~ 7: and 
ance f. ~ .) hese ffects in lu  cus r ti , re ness f t e s, t r  es r 
crying, involuntary closing of the eyes, burning sensation of the skin (such as a sunburn), 
inflammation  the i , s ing  i ,   li tl  r tri t ir . (I .) OC 
sprays are designed and intended to have these acute effects as they arc made for self defCllsc 
and protection, and are used by law enforcement officers to subdue criminal suspects cmd 
i ates it t t e  t  s  r  l t l for s f f r . (J .) 
. There is no published literature that definitively states or otherwise establishes 
ithin a reasonable degree f scientific probability a conclusive or casual association bet een 
exposure to  spray and chronic or long ter  health conditions or disease. (Reilly ff. ~~ -7; 
 f . ~~ 8-17; ff. Counsel ~~   , i it I, 4:11-95:3  i it J, 28:9-
131 :4.) 
0. ased upon available scientific and edical literature published prior to 2008. a 
anufacturer of C spray products, such as SEC, could not kno  or have been put on notice that 
exposure to OC spray was a foreseeable cause of any of the chronic medical conditions 
complained of by Plaintiff. (Reilly AfT '110; All. Counsel '110, Exhihit 1, 144:2-146:7.) 
III 
III 
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III LEGAL STANDARD
Summary judgment is appropriate if the pleadings depositions and admissions on file
together with the affidavits if any show that there is no genuine issue as to any material fact and
that the moving party is entitled to a judgment as a matter of law IRCP56c When a
motion for summary judgment has been supported by depositions affidavits or other evidence
the adverse party may not rest upon the mere allegations or denials of that partyspleadings but
the partys response by affidavits or as otherwise provided in this rule must set forth specific
facts showing that there is a genuine issue for trial LRCP56e see also Gardner v Evans
110 Idaho 925 929 719 P2d 1185 1189 1986 A mere scintilla of evidence or only a slight
doubt as to the facts is insufficient to withstand summary judgment there must be sufficient
evidence upon which a jury could reasonably return a verdict for the party opposing the motion
Corbridge v Clark Equil Co 112 Idaho 85 87 7301 1005 1007 1986
The party seeking summary judgment bears the initial burden to show that there is no
genuine issue of material fact and that he or she is entitled to judgment as a matter of law
McCorkle v Northwestern Mut Life Ins Co 141 Idaho 550 554 112 P3d 838 842 CtApp
2005 The movant may meet this burden by establishing the absence of evidence on an element
that the nonmoving party will be required to prove at trial Dunnick v Elder 126 Idaho 308
311 882 P2d 475 478 CtApp 1994 This may be accomplished either by an affirmative
showing with the moving partysown evidence or by a review ofthe non movantsevidence and
the contention that the required proof of an element is lacking Heath v Honkers MiniMcrrl
Inc 134 Idaho 711 712 8 11254 1255 CtApp 2000 Once such an absence of evidence
has been demonstrated the burden shifts to the party opposing the motion to show through
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I . LEG  RD 
Summary judgment is appropriate "if the pleadings, depositions, and admissions on file, 
together with the affidavits, if any, show that there is no genuine issue as to any material fact and 
that the moving party is entitled to a judgment as a matter of law." I.R.C.P. 56(c). hen a 
otion for su ary judgment has been supported by depositions, affidavits or other evidence, 
the adverse party "may not rest upon the mere allegations or denials of that party's pleadings, but 
the party's response, by affidavits or as otherwise provided in this rule, must set forth speci fic 
facts showing that there is a genuine issue for trial." I.R.C.P. 56(e); see also Gardner v. Evans, 
110 Idaho 925, 929, 719 P.2d 1185, 1189 (1986). A mere scintilla of evidence or only a slight 
doubt as to the facts is insufficient to ithstand su ary judg ent; there ust be sufficient 
evidence upon hich a jury could reasonably return a verdict for the party opposing the otion. 
CorhridRe v. Clark Equip. Co., 112 Idaho 85, 87, 730 P.2d 1005, 1007 (1986). 
The party seeking summary judgment bears the initial burden to show that there is no 
genuine issue of material fact, and that he or she is entitled to judgment as a matter of lmv. 
c orkle v. orth estern ut. (fe Ins. o., 141 Idaho 550, 554, 112 .3d 838, 842 ( LApp. 
2005). The movant may meet this burden by establishing the absence of evidence on an element 
that the non oving party ill be required to prove at trial. unnick v. Elder, 126 Idaho 308, 
311, 882 P.2d 475, 478 (CLApp. 1994). his ay be acco plished either by an affir ative 
showing with the moving party's own evidence or by a review of the non-movant's evidence (ll1d 
the contention that the required proof of an cle ent is lacking. Heath v. Honker's ini- ort. 
Inc., 134 Idaho 711, 712, 8 P.3d 1254, 1255 (CLApp. 2(00). nce such an absence ofevidcllcc 
has been de onstrated, the burden shifts to thc party opposing the otion to sho  through 
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further depositions discovery responses or affidavits that there is indeed a genuine issue for
trial Id
Because Plaintiff 1 has already conceded her warranty claims 2 cannot demonstrate
any factual basis to justify an expectation that SEC should have warned against Plaintiff
alleged chronic or longterm adverse health effects and 3 will be unable to identify any known
or foreseeable risk of the adverse health effects alleged by Plaintiff from use of SECsproduct
Plaintiff is unable to meet her burden on Summary Judgment and SEC is entitled to judgment as
a matter of law on each of Plaintiff s four causes ofaction
IV ARGUMENT
1 SEC Is Entitled To Judgment As A Matter Of Law On Plaintiffs Warranty Claims
In Plaintiffs Third Cause of Action she alleges that SEC expressly warranted to the
consumer that the Sabre Red OC Spray was fit for the ordinary purpose for which it was
sold was reasonably safe was of merchantable quality and was reasonably fit for the intended
purposes Complaint J1 23 In her Fourth Cause of Action Plaintiff alleges that SI C
impliedly warranted all of the same things Id 1130 Notwithstanding these allegations
Plaintiff has not been able to identify any information or produce any documents establishing
any express warranty provided by SEC which would be relevant to this action
In fact SEC is entitled to judgment as a matter of law on both the Third and Fourth
Causes of Action in Plaintiffs Complaint primarily because Plaintiff has conceded in discovery
that these claims have no merit Aff Counsel Exhibit 14 p 27 In her First Supplemental
Responses to Requests for Production of Documents served on counsel for SEC on Tune 24
2010 Plaintiff provided the following discovery response
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further depositions, discovery responses, or affidavits that there is indeed a genuine issue ror 
tri l. I . 
ecause l i tif : 1) has already conceded her arranty clai s; 2) cannot de onstrate 
any factual basis to justify an expectation that SEC should have warned against Plaintiff's 
alleged chronic or long-term adverse health effects; and 3) will be unable to identify any known 
 oresee le is   the erse t  ects lege    ro    C's ct: 
l i ti f is nable to eet he  burden   e t   i  titlc  t  judg cnt  
 te   n   l i tiff'  fo  ses  . 
.  
.  Is ntitled o Judg ent s  atter f a  n laintifrs arranty lai s. 
I  l i tiff's ir  sc f ti , s  lle s t t  "expressl  rra t  t  t c 
r ... that [the abre ed  pray 1 as fit for the ordinary purpose for hich it as 
sold, as reasonably safe, as of erchantable quality, and as reasonably fit for the [intendedJ 
purpose[s]." (Complaint,'1 23.) I  r rt  s  f ti , l i tiff ll s t t I:  
"impliedly warranted" all of the same things. (I .,'1 30.) ot ithstanding these allegations, 
l i tiff s t  l  t  i ntif   i f r ti  r r   ts stablis i  
any express warranty provided by SEC which would be relevant to this action. 
In fact, SEC is entitled to judg ent as a atter of la  on both the Third and Fourth 
Causes of Action in Plaintiff's Complaint primarily because Plaintiff has conceded in discovery 
that these clai s have no erit. ( ff. ounsel, xhibit H, p. 27.) In her [Firstl Supple ental 
Responses to Requests for Production of Documents. served on counsel for SEC on June 24, 
2010, Plainti ff provided the following discovery response: 
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Request No 21 Please produce all Documents evidencing any
written notice provided You andor Major to SEC regarding any
alleged breach of express or implied warranties
Supplemental Response to Request For Production No 21
Plaintiff supplements her Response to Request for Production No
21 by stating that she will be dismissing the warranty claim and
therefore no further response to this request is necessary
Id emphasis added
To date now some ten 10 months after the foregoing discovery response and 11er
apparent decision to not further litigate these causes of action SEC has not seen any such
voluntary dismissal by Plaintiff Nonetheless SEC has relied upon this representation and has
not dedicated any additional time to litigating Plaintiffs Third and Fourth Causes of Action As
a result SEC is entitled to Summary Judgment on Plaintiffs Third and Fourth Causes of Action
In the event that Plaintiff attempts to resurrect her warranty claims summary judgment
will nevertheless be proper on Plaintiffs express warranty claim Idahoscodification of the
Uniform Commercial Code UCC establishes when and how an express warranty arises in the
sale of a product
1 Express warranties by the seller are created as follows
a Any affirmation of fact or promise made by the seller to the
buyer which relates to the goods and becomes part of the basis
of the bargain creates an express warranty that the goods shall
conform to the affirmation or promise
b Any description of the goods which is made part of the
basis of the bargain creates an express warranty that the goods
shall conform to the description
c Any sample or model which is made part of the basis of the
bargain creates an express warranty that the whole of the goods
shall conform to the sample or model
IC 282313
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Request No. 21: Please produce all Documents evidencing any 
written notice provided You and/or ajor to SEC regarding any 
alleged breach of express or implied warranties. 
S pple ental Response to equest For roduction o. 21: 
Plaintiff supplements her Response to Request for Production No. 
21 by stating that she ill be dis issing the arranty claim and 
therefore no further response to this request is ecessary. 
(ld. (emphasis added).) 
To date, no  so e ten (10) onths after the foregoing discovery response and her 
apparent decision to not further litigate these causes of action, SEC has not seen any such 
voluntary dismissal by Plaintifr. Nonetheless, SEC has relied upon this representation and has 
not dedicated any additional ti e to litigating Plaintiffs Third and Fourth Causes of Action. As 
a result, SEC is entitled to Summary Judgment on Plaintiffs Third and Fourth Causes of Acticn. 
In the event that Plaintiff atte pts to resurrect her arranty clai s, su ary judg ent 
ill nevertheless be proper on Plaintiffs express arranty clai . I aho's ifi ti   t  
if r  ercial e (,'UC ") ishes          
sale of a product: 
(1) Express warranties by the seller are created as follows: 
I.C. § 28-2-313. 
(a) ny affir ation f fact or pro ise ade by the seller to the 
buyer hich relates to the goods and beco es part of the basis 
of the bargain creates an express arranty that the goods shall 
c f r  t  t e affir ati  r r ise. 
(b) Any description of the goods which is ade part of the 
basis of the bargain creates an express warranty that the goods 
shall conform to the description. 
(c) ny sample or odel hich is ade part of the basis of the 
bargain creates an express arranty that the hole of the goods 
shall confor  to the sample or odel. 
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PlaintiffsThird Cause of Action can be maintained only if defendant SEC breached an
express warranty as created in accordance with the foregoing provision the UCC As noted
above the allegations set forth in Plaintiffs Complaint fail to identify any express warranty
which would forms abasis for her claim Complaint 2127
The issue before the Court is straightforward Plaintiff has failed to provide any
competent evidence through discovery or otherwise that any express warranty was created by
SEC upon which Plaintiff relied so as to provide a foundation for her Third Cause of Action
The Idaho Supreme Court has previously addressed the same question that is now before this
Court Can a cause of action for breach of an express warranty exist when the plaintiff fail Is to
produce evidence of an express warranty Puckett v Oakfabco Inc 132 Idaho 816 824 979
P2d 1174 1182 1998 emphasis added Affirming the dismissal of the plaintiffsexpress
warranty claim the Court concluded Pucketts warranty claim is therefore limited to the
implied warranty of merchantability Id citing IC 282314 Similarly Plaintiffsfalkire
to produce any evidence of an express warranty made or breached by SEC on which her claim
could possibly be maintained is grounds for summary judgment
As Plaintiff has made the representation that she will be dismissing her warranty claims
and has otherwise failed to present any evidence that any express warranty was ever created she
ought to be estopped from now reviving those warranty claims at this late stage of the litigation
2 SEC Is Entitled To Judgment As A Matter Of Law On Plaintiffs Remaining Causes
of Action As Plaintiff Cannot Prove That SEC Knew Or Should Have Known Of
The Chronic or LongTerm Adverse Health Effects That Plaintiff Claims
Plaintiffs remaining causes of action which allege Strict Liability and Failure to Provide
Adequate Warning are also ripe for surnmary adjudication As noted above in order to
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P i tif 's Third Cause of Action can be aintained only if defendant S C breached al1 
express warranty as created in accordance with the foregoing provision the Cc. As noted 
above, the allegations set forth in Plaintiff's Complaint fail to identify any express warranty 
hich ould for s  basis for her cl i . (Complai t, '1'Il21-2 .) 
he issue before the ourt is straightfor ard: Plaintiff has failed to provide any 
competent evidence through discovery or otherwise that any express warranty was created by 
SEC, upon which Plaintiff relied, so as to provide a foundation for her Third Cause of Action. 
The Idaho Supreme Court has previously addressed the same question that is now before this 
rt: a   s  f ti   e    ress a ra t  i t e  t e l i ti  "fail[ : t  
produce evidence Q[ an express warranty"? tt v. j' , I c.,  I  , ,  
P.2d 1174, 1182 (1998) (emphasis added). firming  s iss   e l intif s ress 
warranty claim, the Court concluded: "Puckett's warranty claim is rtherefore 1 limited to the 
implied warranty of merchantability." Id. (citing I.C. § -2-3 4). i ilarly, l intif s ilu  
to produce any evidence of an express warranty made or breached by SEC on which her claim 
could possibly be maintained, is grounds for summary judgment. 
As Plaintiff has ade the representation that she will be dis issing her warranty clai s 
and has otherwise failed to present any evidence that any express warranty was ever created. she 
ought to be estopped from now reviving those warranty claims at this late stage of the litigation. 
. SE  Is Entitled To Judg ent s  atter f La  n Plaintiffs e aining amcs 
of ction, s Plaintiff annot Prove That SE  ne  r Should ave no n f 
The Chronic or Long-Ter  Adverse Health Effects That Plaintiff Clai s. 
Plaintiff's re aining causes of action, which allege Strict Liability and Failure to Provide 
Adequate arning, are also ripe for summary adjudication. s not d above, i  or r to 
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withstand Summary Judgment when challenged Plaintiff must be able to present evidence to
create a genuine issue of material fact on each element of each of her causes of action heath 1
Honkers MiniMart Inc 134 Idaho at 712 Because Plaintiff will be unable to present any
evidence that gives rise to any duty by SEC or to otherwise impose liability on either theory
advanced in her First or Second Causes of Action SEC is entitled to judgment as a matter of law
A Legal Standards
i Failure to Provide Adequate Warning
The specific legal basis for a manufacturers duty to warn as set forth in Puckett i
Oakfabco Inc supra is as follows
Failure to warn can be a basis for recovery in a products liability
action whether alleged under a theory of strict liability in tort or
negligence See Watson v Navistar IntlTrans Corp 121 Idaho
643 660 827 P2d 656 673 1992 A product is defective if the
defendant has reason to anticipate that danger may result from a
particular use of his product and fails to give adequate warnings
of such danger
132 Idaho at 823 quoting Rindlisbaker v Wilson 95 Idaho 752 519 P2d 421 1974 and
Restatement Second of Torts 402A cmt h emphasis added The limitation outlined in
Puckett that a manufacturer has a duty to warn of a danger only if it has reason to anticipate
that danger is repeated throughout Idaho case law The duty to warn has been held generally to
apply only to a supplier who knows or has reason to know the unsafe condition of the product
when used for the purpose for which it was supplied Robinson v Williamsen Idaho Equipment
Company Inc 94 Idaho 819 826 498 P2d 1292 1299 1972 Hornbook law is consistent
with this principle
One who supplies a chattel for another to use is subject to
liability to those whom the supplier should expect to use the chattel
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ithstand Su ary Judg ent hen challenged, Plaintiff ust be able to present evidencc to 
create a genuine issue of material fact on each element of each of her causes of action. I leal Ii v. 
onker's ini-Mart, Inc., 134 Idaho at 712. eca se f   le  res  ,m  
evidence that gives rise to any duty by SE , or to other ise i pose liability on either theory 
a ce  i  r irst r d auses f ti , f:  is title  t  judg e t s  tt r f l . 
. Legal Standards. 
i. ail re to rovide e ate ar ing 
The specific legal basis for a manufacturer's duty to warn, as set forth in Puckett v. 
Oalifabco, Inc., supra, is as follows: 
Failure to arn can be a basis for recovery in a products liability 
action, hether alleged under a theory of strict liability in tort or 
li .  t  . i t  I t'! ns., orp.,  I  
643, 660, 827 P.2d 656, 673 (1992) A product is defective if "the 
efe dant' has re s  t  ticipate t t er y res lt fr  a 
particular use' f his product and fails to give adequate arnings 
of such danger." 
132 Idaho at 823 (quoting Rindlisbaker v. ilson, 95 Idaho 752, 519 P.2d 421 (1974), ,md 
estate ent (Second) of orts § 402A, cmt. h) (emphasis added).  ta  t   
uckett, that a anufacturer has a duty to arn of a danger only it it has "reason to anticipatc" 
that danger, is repeated throughout Idaho case la : "The duty to arn has bcen held generally to 
apply only to a supplier who knows or has reason 10 knmv the unsafe condition of thc prod uct 
hen used for the purpose for hich it as supplied." Robinson v. illia sen Idaho Equip ent 
Company, Inc., 94 Idaho 819, 826,498 P.2d 1292, 1299 (1972). Hornbook law is consistent 
with this principle: 
One who supplies ... a chattel for another to usc is subject to 
liability to those ho  the supplier should expect to use the chattel 
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for physical harm caused by the use of the chattel in the
manner for which and by a person for whose use it is supplied if
the supplier
a knows or has reason to know that the chattel is or is
likely to be dangerous for the use for which it is supplied and
b has no reason to believe that those for whose use the
chattel is supplied will realize its dangerous condition and
c fails to exercise reasonable care to inform them of its
dangerous condition or of the facts which make it likely to be
dangerous
Restatement Second of Torts 388 emphasis added The supplier is under a duty to
exercise reasonable care to disclose its condition in so far as it is known to him to those who are
to use it or to inform them that it is fit only for these limited uses or if used with the particular
precautions Id emt H emphasis added
Further a manufacturer will not be held liable for failure to warn of a risk of a product
that is otherwise dangerous if the specific danger or harm alleged by the plaintiff is unknown or
unforeseeable See Sidwell v William Prym Inc 112 Idaho 76 730 P2d 996 1986 In
Sidwell which involved a manufacturer of sewing pins the Idaho Supreme Court determined
that even though the manufacturer could anticipate the danger of a pin pricking puncturing or
piercing dressmaking or other materials or the bodily surface of a user no reasonable Juror
could find that the manufacturer could foresee the danger that the pins would be thrust into the
body with sufficient force to strike a bone and shatter Id at 7879 The Court based its
decision in part on the fact that even plaintiffs own expert witness admitted that while
billions of such pins have been sold that he had no knowledge of any other similar accident or
complaint of injury caused by such pins Id at 79
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· . . for sical ar  se   t e s  f t e tt l i  t e 
a er f r ich a   a erson for hose se it is s lie , if 
the supplier 
(a) kno s or has reason to kno  that the chattel is or is 
likely to be dangerous for the use for which it is supplied, and 
(b) has no reason to believe that those for whose use the 
ttel is s lied ill e lize its  iti ,  
(c) fails t  r is  re le re t  i for  t   its 
dangerous condition or of the facts hich ake it likely to be 
r s. 
Restatement (Second) of Torts § 388 (emphasis added). 'Tflhe supplier is under a duty 10 
r ise r le r  t  is lose its iti , i  f   it is  t  i , t  t s   r  
to se it, r t  i f r  t e  t at it is fit l  f r t ese li ite  ses, r if se  it  t e artic lar 
precautions." Id., cmt. H (emphasis added). 
rt r,  f t r r ill t  l  lia le f r f il r  t  r  f  ri  f  r t 
that is other ise dangerous if the specific danger or har  alleged by the plaintiff is unkno n or 
able. See Sid ell v. illia  ry , Inc., 112 Idaho 76, 730 P .2d 996 (1986). I  
i ell, i  i lve   f t r r f i  i , t  I  r  rt t r i  
that even though "the anufacturer could anticipate the danger of a pin pricking, puncturing, or 
piercing dressmaking or other materials or the bodily surface of a user," no reasonable juror 
could find that the anufacturer could "foresee the danger that the pins ould bc thrust into the 
body with sufficient force to strike a bone and shatter." [d. t -7 .    i  
decision, in part, on the fact that "[ eJven plaintiff so n cxpcrt itness ad itted that hile 
billions of such pins have been sold, that he had no knowledge of any other Isi ilarl accident or 
complaint of injury caused by such pins." Jd. at 79. 
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The theory behind requiring a manufacturer to warn only against known or foreseeable
risks has been reemphasized in the Restatement Third of Torts Products Liability 2 The
Restatement notes on required warnings articulate well the rationale behind not mandating
warnings for risks that are merely speculative or far fetched Such warnings would tend to
debase warnings and detract the user attention from warnings about risks of greater
significance Restatement Third of Torts Products Liability 2 Reporters Note to curt i
As such an overwhelming majority of jurisdictions supports the proposition that a
manufacturer has a duty to warn only of risks that were known or should have been known to a
reasonable person Id Reporters Note to cmt m citing Shell Oil Co v Gutierrez 581 P2d
271 Ariz Ct App 1978 Anderson v Owens Corning Fiberglass Corp 810 P2d 549 Cal
1991 Fibreboard Corp v Fenton 845 P2d 1168 Colo 1993 A manufacturer cannot warn
of dangers that were not known to it or knowable in light of the generally recognized and
prevailing scientific and technical knowledge available at the time of manufacture and
distribution
Because per the facts of this case as discussed below Plaintiff will be unable to set forth
any evidence to create a genuine issue of material fact that the available scientific knowledge of
the effects of OC exposure would have given SEC reason to warn against the harm complained
of in this lawsuit Plaintiff cannot satisfy a most fundamental element of her claim of inadequate
warnings SEC is therefore entitled to judgment as a matter of law
ii Strict Liability Defective Design
2 Defendant recognizes that Idaho has not yet adopted the Restatement Third of Torts
However those cases cited and discussed in the notes of the Restatement Third of Torts in this section
were all issued prior to the Restatement Third of Torts and demonstrate a trend in the case law
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he the ry e ind re iring a a fact rer to arn ly a ai st  r foreseea le 
risks has been reemphasized in the Restatement (Third) of Torts: Products Liability, § 2. e 
estate ent's notes on required arnings articulate ell the rationale behind not andating 
arnings for risks that arc erely speculative or far-fetched: "Such ings    
debase arnings and detract the user's attention fro  arnings about risks of greater 
significance." Restatement (Third) of Torts: Products Liability, § , r r '   m!. . 
s such, "[a]n over hel ing ajority of jurisdictions supports the proposition that a 
anufacturer has a duty to arn only of risks that ere kno n or should have been kno n to a 
reasonable person." [d., Reporters' Note to cmt. m (citing Shell Oil Co. v. Gutierrez, 581 P.2d 
271 (Ariz. Ct. App. 1978); Anderson v. Owens-Corning Fiberglass Corp., 810 P.2d 549 (Cal. 
1991); Fibreboard Corp. v. Fenton, 845 P.2d 1168 (Colo. 1993) ("A manufacturer cannot warn 
of dangers that ere not kno n to it or kno able in light of the generally recognized cllld 
prevailing scientific and technical knowledge available at the time of manufacture Clnd 
i tri ti n. ")). 
Because, per the facts of this case as discussed below, Plaintiff will be unable to set forth 
any evidence to create a genuine issue of material fact that the available scientific knowledge of 
the effects of C exposure ould have given SEC reason to arn against the har  co plained 
of in this la suit, laintiff cannot satisfy a ost funda ental ele ent f her clai  of inadequate 
arn1l1gs. SE  is therefore entitled to judg ent as a atter of la . 
ii. Strict Liability (Defective esign) 
2 efendant recognizes that Idaho has not yet adopted the Restate ent (Third) of Torts. 
o ever, those cases cited and discussed in the notes of the estate ent (Third) ofT0l1s in this sectiol1 
were all issued prior to the Restatement (Third) of Torts and demonstrate a trend in the case law. 
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The same principles that are discussed in the foregoing section imposing liability only
when risks are known or foreseeable apply to a cause of action based on an alleged design
defect According to well settled Idaho law a manufacturer has a duty to design its product so
as to eliminate unreasonable risks of foreseeable injuries Puckett 132 Idaho at 821 citing
Zimmerman v Volkswagen ofAm Inc 128 Idaho 851 854 920 P2d 67 70 1996 emphasis
added see also Pate v Columbia Mach Inc 930 F Supp 451 460 D Idaho 1996 finding
strict liability only for design defect that was found to be foreseeable and in fact well known
Farmer v IntlHarvester Co 97 Idaho 742 751 553 1 1306 1315 1976 it is thus the
manufacturersduty to design and manufacture its products so as to eliminate unreasonable risks
offoreseeable injury citing Larsen v General Motors Corp 391 F2d 495 8th Cir 1968
Dyson v General Motors Corp 298FSupp 1064FDPa1969Baumgardner v American
Motors Corp 83 Wash2d751 522P2d 829 1974
Especially when dealing with products that provide a benefit to society as does OC
Spray in providing an effective non lethal tool for law enforcement personnel strict liability will
not be found for unforeseeable dangers It follows that when the balance appears at the time of
distribution to tip toward the benefit of a product strict liability will not attach when an
unexpected and unknown risk injures a user Toner v Lederle Laboratories a Division o
American Cyanamid Co 112 Idaho 328 338 732 1 297 307 1987 Thus the balancing
between benefits and risks is based on the best available information at the time of distribution
Id see also Restatement Second of Torts 402A cmt k The seller of such products
is not to be held to strict liability for unfortunate consequences attending their use merely
because he has undertaken to supply the public with an apparently useful and desirable product
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The sa e principles that are discussed in the foregoing section, imposing liability only 
hen risks are known r fores l , a l  to  cause f tion ase    lleged design 
defect. ccording to ell-settled Idaho la , "a anufacturer has a duty to design its product 'so 
as to eliminate unreasonable risks offoreseeable injuries. '" tt, 2 Idaho   (citing 
Zimmerman v. Volkswagen of Am., Inc., 128 Idaho 851, 854,920 P.2d 67, 70 (1996)) (emphasis 
added); see also Pate v. Columbia ach., Inc., 930 F. Supp. 451,460 (D. Idaho 1996) (finding 
strict liability only for design defect that as found to be '·foreseeable. and in fact ell-knowl:"): 
ar er v. I t'f rvester o.,  Ida  , ,  P.2d ,  (19 ) C .. . it is thus the 
anufacturer's duty to design and anufacture its products so as to eli inate unreasonable ri:;ks 
offoreseeable injury.") (citing Larsen v. eneral otors Corp., 391 F.2d 495 (8th Cir. 1968); 
Dyson v. General otors Corp., 298 F.Supp. 1064 (E.D.Pa.1969); Baumgardner v. American 
Motors Corp., 83 ash.2d 751, 522 P.2d 829 (1974)). 
Especially hen dealing ith products that provide a benefit to society, as docs  
Spray in providing an effective, non-lethal tool for law enforcement personnel, strict liability 'vvill 
not be found for unforeseeable dangers: "It follo s that hen the balance appears at the ti e of 
distribution to tip to ard the benefit of a product, strict liability ill not attach hen an 
unexpected and unkno n risk injures a user." r .  r t ri s.   f 
American Cyanamid Co., 112 Idaho 328, 338, 732 P.2d 297. 307 (1987). "Thus, the balancing 
 f s      t   i    t   f i t l' 
.. " Id; see also Restatement (Second) of Torts, § 402A, c t. k ("The seller of such products 
is t t  e el  t  strict liabilit  f r f rt ate c se e ces atten i  t eir sc, el\:!  
because he has undertaken to supply the public with an apparently useful and desirable product, 
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attended with a known but apparently reasonable risk While the law is generous to Plaintiff
in this regard holding the manufacturer to the knowledge and experience of experts in tlcir
fields the law does not require the manufacturer to be clairvoyant but instead guard ls
against strict liability resulting from unknown risks Toner 112 Idaho at 338
The Restatement Third of Torts Products Liability 2 elaborates on the concept of
foreseeability in strict liability cases A product b is defective in design when the
foreseeable risks of harm posed by the product could have been reduced or avoided
Thus in connection with a claim of inadequate design instruction or warning plaintiff should
bear the burden of establishing that the risk in question was known or should have been known
to the relevant manufacturing community Id cmt in emphasis added
Again based on the known information on OC Spray discussed in the following
section Plaintiff will be unable to set forth any evidence to create a genuine issue of material
fact that exposure to OC Spray put SEC on sufficient notice of the dangers alleged by Plaintiff so
as to establish a basis for strict liability Thus Plaintiff cannot meet the burden of proving this
fundamental element of her claim and SEC is therefore entitled to judgment as a matter of law
B Application
According to the foregoing standards SEC can only be held liable and can only be said
to have had a duty to warn Plaintiff of the adverse health effects to which she attributes her
exposure to SECs product if those chronic or longterm adverse health effects were or shoizld
have been known or foreseeable to SEC at the time it sold its product to the IDOL Restatement
Secondof Torts 402A cmts h i k Sidwell 112 Idaho at 78 79
The indisputable evidence in this case reveals that the last order that IDOC placed NAith
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attended ith a kno n but apparently reasonable risk."). hile the la  is e erous to i li f 
in this regard, holding the manufacturer "to the knowledge and experience of experts in their 
fields," the la  does not require the anufacturer to "be clairvoyant," but instead "guardls] 
against strict liability resulting from unknown risks." Toner, 112 Idaho at 338. 
he estate ent (Third) of orts: Products iability, § , rates  t e ce t  
foreseeability in strict liability cases: "A product ... (b) is f tive i  i n e  t  
foreseeable risks of harm posed by the product could have been reduced or avoided .... " 
"Thus, in connection ith a clai  of inadequate design, instruction, or arning, plaintiff should 
bear the burden f establishing that the risk in question as kno n or should have been knovm 
t  t e r le t f t ring unity." I ., c t. m (emphasis a ded). 
Again, based on the known information on OC Spray (discussed 111 the follow:ng 
section), Plaintiff ill be unable to set forth any evidence to create a genuine issue of aterial 
fact that exposure to  Spray put SE  on sufficient notice of the dangers alleged by Plaintiil so 
as to establish a basis for strict liability. Thus, Plaintiff cannot eet the burden of proving this 
f t l l t f r l i ,   i  t r f r  titl  t  j t   tt r f l v\ 
B. pplication. 
ccording to the foregoing standards,  can only be held liable, and can only be said 
to have had a duty to arn Plaintiff of the adverse health effects to hich she attributes her 
exposure to SEC's product, if those chronic or long-ter  adverse health effects were or should 
   r f r l  t   t t  ti  it l  it  r t t  t  I C. state ent 
(Second) of Torts, § 402A, c ts. h, i, k; Sidwell, 112 Idaho at 78-79. 
The indisputable evidence in this case reveals that the last order that l e placed \"ilh 
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SEC occurred in January 2008 Nance Aff 114 Exhibit A Accordingly any literature or
other information published or created after that time cannot be imputed to SEC for purposes of
this litigation rather SEC will only be liable under either of the theories advanced in Plaintiffs
First and Second Causes of Action if the literature or information available before January 2008
was sufficient to give rise to a conclusion that SEC knew or should have known that Plaintiffs
particular chronic or long term conditions were a likely probable or even possible risk from
exposure to OC spray products Plaintiff will not be able to meet her burden in this regard
Both Plaintiff and SEC have retained expert witnesses in this case and testimony has
been taken from these experts in affidavit or deposition testimony Neither Plaintiffs experts
nor SECsexperts have been able to identify any scientific study or published literature that has
concluded or even tested for the chronic or long term effects alleged by Plaintiff from her
exposure to OC spray products Reilly Aff 37 and 10 Nance Aff 817 Aff Counsel l
10 and 11 Exhibit I 9411953 14421467 and Exhibit J 1289 1314 According to fir
Chris Reilly one of SECsretained experts despite his twelve years as a research toxicologist
with an emphasis on the effects of OC sprays he has not discovered any article study report
manuscript journal or other literature that definitively states or otherwise establishes within a
reasonable degree of scientific probability a conclusive or casual association between exposure
to OC spray or even more generally capsaicinoids and chronic or long term health conditions or
disease Reilly Aff If 7
Dr Gary Yost retained by Plaintiff was similarly unable to point to any literature or
information available at the time that SEC sold its OC spray products to IDOC which would
have given rise to a need for SEC to warn against the chronic or longterm health conditions
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SEC occurred in January, 2008. (Nance Aff., '1 4, Exhibit .) ccordingly, any literature or 
other information published or created after that time cannot be imputed to SEC for purposes of 
this litigation; rather, SEC will only be liable under either of the theories advanced in Plaintifrs 
First a d e ond auses f ction if the literature  information lable before J r , 08 
as sufficient to give risc to a conclusion that SEC kne  or should have kno n that Plainti tT's 
particular chronic or long-term conditions were a likely, probable, or even possible risk li·()m 
exposure to OC spray products. Plaintiff will not be able to meet her burden in this regard. 
th lai tiff a   a e retaine  e ert itnesses i  t is case, a  testi  bas 
been taken from these experts in affidavit or deposition testimony. Neither Plaintiffs experts 
nor SEC's experts have bcen able to identify any scientific study or published literature that has 
c cl ed, r e e  tcste  f r, t e c r ic r l -ter  c!Tects alle e   lai tiff fr  er 
exposure to OC spray products. (Reilly Aff. ~'l -7  ; e  fT '1'1 -1 ; fT l ~:'l 
10 and 11, Exhibit I, 94:11-95:3,144:2-146:7 and Exhibit J, 128:9-131:4.)   I) . 
Chris Reilly, one of SEC's retained experts, despite his twelve years as a research toxicologist 
with an emphasis on the effects of OC sprays, he has "not discovered any article, study, report, 
manuscript, journal or other literature that definitively states or otherwise establishes within a 
reasonable degree of scientific probability a conclusive or casual association between exposure 
to OC spray (or even more generally capsaicinoids) and chronic or long term health conditions Of 
disease." (Reilly Af1'., '17.) 
r. ary ost, retained by Plaintiff, as si ilarly unable to point to any literature or 
infor ation available at the ti e that SE  sold its  spray products to I  hich \Vould 
have given rise to a need for SEC to warn against the chronic or long-term health conditions 
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complained of by Plaintiff
Q But you cantcite me to one specific paper out there that
existed prior to March of 2008 that specifically would have put
layperson without your background on notice that exposure to
their product could have caused these long term health conditions
A No
Aff Counsel 10 Exhibit I 14627 SEC admits that Dr Yoststestimony would likely be
sufficient to create a genuine issue of material fact to withstand summary judgment as to the
question of whether Plaintiffshealth conditions were actually caused by exposure to SECsOC
Spray products However SEC contents that there is no dispute or issue of fact as to the on the
threshold issue addressed by this motion which is that Plaintiff cannot establish that SEC had or
should have had knowledge of or foreseen the risks of the chronic or longterm adverse hellth
effects which Plaintiff complains of here As Plaintiff cannot establish this requisite fact the
inquiry need not proceed to Yoststestimony as to whether or not Plaintiffshealth conditions
were actually caused by her exposure to OC spray products
Further during discovery SEC asked Plaintiff to identify any known literature that she
contends ought to have put SEC on notice of any risks relevant to her alleged chronic or long
term health conditions In response Plaintiff identified eleven publications
Hamyman Mark Kam Peter CAPSAICIN A REVIEW OF ITS
PHARMACOLOGY AND CLINICAL APPLICATION Vol 19 Journal
Current Anesthesia and Critical Care pp 338 343 2008
2 Alawi Khadija Keeble Julie THE PARADOXICAL ROLE OF TRPVI
RECEPTOR IN INFLAMMATION Vol 125 Pharmacology and
Therapeutics pp 189195 2010
3 CA Reilly DJ Crouch GS Yost and A Fatah DETERMINATION
OF CAPSAICIN NONIVAMIDE AND DIHYDROCAPSAICIN IN BLOOD AND
TISSUE BY LIQUID CtiROMATOGRAPI IYTANDIMMASSSPICTIwMFTRY
J Ana Toxicol 26 313 319 2002
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complained of by Plaintiff: 
Q. But you can't cite me to one specific paper out there that 
existed prior to arch of 2008 that specifically would have put 
layperson's without your background on notice that exposure to 
their product could have caused these long-term health conditions? 
. . 
(Aff. Counsel, ~ 10, Exhibit 1,146:2-7.)  ad its that r. ost's testi ony ould likely bc 
sufficient to create a genuine issue of material fact to withstand summary judgment as to the 
question of whether Plaintiff's health conditions werc actually caused by exposure to SEC's OC 
Spray products. However, SEC contents that there is no dispute or issue of fact as to the on the 
threshold issue addressed by this otion, which is that Plaintiff cannot establish that SEC had or 
should have had knowledge of or foreseen the risks of the chronic or long-term adverse hc,J\th 
effects which Plaintiff complains of here. As Plaintiff cannot establish this requisite fact. the 
inquiry need not proceed to Yost's testimony as to whether or not Plaintiff's health conditions 
ere actually caused by her exposure to C spray products. 
Further, during discovery, SE  asked Plaintiff to identify any kno n literature that she 
contends ought to have put SEC on notice of any risks relevant to her alleged chronic or long-
ter  health conditions. In response, Plaintiff identified cleven publications: 
1. Hamyman, ark & , eter, APSAICIN:  EVI   I  
  LI I  pPLICATION, ol. 19 Journal 
rre t est esi   ritic l are, p. -  (2 8) 
2. Alawi, Khadija & eble, Julie,  PARADOXI AL L  F PVI 
T  I  I FLA TI N, ol. 125, Phar acology and 
Therapeutics, pp. 189-195 (2010) 
3. c.A. Reilly, D.1. Crouch, .S. Yost, and .A. Fatah, DETERMINATION 
OF CAPSAICIN, ONIVAMIDE, AND I R C PSAICIN IN BL D AND 
TISSUE BY LIQUID CHRO ATOGRAPIIy-TANDEM ASS SPECTROMETRY, 
.J na. Toxicol., 26, 313-319 (2002). 
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4 CA Reilly JLTaylor DLLanza BA Carr DJ Crouch and GS
Yost CAPSAICINOIDS CAUSE INFLAMMATION AND EPITHELIAL CELL
DEATH THROUGH ACTIVATION OF VANILLOID RECEPTORS Tox Sci
73 170181 2003
5 CA Reilly and GS Yost STRUCTURAL AND ENZYMATIC
PARAMETERS THAT DETERMINE ALKYL
DEHYDROGENATIONHYDROXYLATION OF CAPSAICINOIDS BY P450
ENZYMES Drug Metab Dispos 33 530536 2005
6 CA Reilly ME Johansen DL Lanza 1 Lee JO Lim and GS
Yost CALCIUM DEPENDENT AND INDEPENDENT MECHANISMS OF
CAPSAICIN RECEPTOR TRPVIMEDIAFED CYIOKINE PRODUCTION
AND CELL DEATH IN HUMAN BRONCHIAL EPITHELIAL CELLS J
Biochem Molec Toxicol 19 266275 2005
7 ME Johansen CA Reilly and GS Yost TRPVI ANTAGONISTS
ELEVATE CELL SURFACE POPULATIONS AND RECEPTOR FUNCTION TO
EXACERBATE TRPVIMEDIATED TOXICIIF IN HUMAN LUNG
EPITHELIAL CELLS Toxicol Sci 89 278 86 2006
8 CA Reilly and GS Yost METABOLISM OF CAPSAICINOIDS BY P450
ENZYMES A REVIEW OF RECENT FINDINGS ON REACTION
MECHANISMS BIOACTIVATION AND DETOXIFICATION PROCESSES
Drug Metab Rev 38 685706 2006
9 KC Thomas AS Sabnis ME Johansen DL Lanza PJ Moos
GS Yost and CAReilly TRPVI AGONISTS CAUSE ENDOPLASMIc
RETICULUM STRESS AND CELL DEATH IN HUMAN LUNG CELLS J
Pharmacol Exp Ther 321 830838 2007
10 BF Bessac and SE Jordt BREATHTAKING TRP CHANNELS TRPAI
AND TRPVI IN AIRWAY CHEMOSENSATION AND REFLEX CONTROL
Physiology 23 360370 2008
11 DA Groneberg A Niimi Q Thai Dinh B Cosio Mark Hew A
Fischer and KF Chung INCREASED EXPRESSION OF TRANSIENT
RECEPTOR POTENTIAL VANILLOID1 IN AIRWAY NERVES OF CHRONIC
COUGH American Journal ofRespiratory and Critical Care Medicine
Vol 170 1276 1280 2004
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. .A. eilly, J.L. Taylor, .L. Lanza, .A. arr, J. rouch, and .S. 
Yost, CAPSAICINOIDS CAUSE INFLA ATI N AND EPITHELIAL CELL 
ATH  cnv ATION   ANILLOID , . ci., 
,1 -181 (20 3). 
. .A. Reilly  .S. t,   E ZY ATI  
ETERS  I  L L 
ENATION/HYDROXYLATION  I I IDS   
ENZY ES, rug etab. ispos., 33, 530-536 (2005). 
. c.A. illy, .E. Johansen, .L. za, J. Lee, J.-O. i , and .S. 
t, -   I  I   
I I   (T PVJ)- I T  TOKIN  I  
    I-Iu   I  , .J 
i . l . xico!., , -275 (2 5). 
. M.E. Johansen, c.A. Reilly, and G.S. Yost, TRPVI ANTAGONISTS 
      I   
 PVI-ME I  OXICITIES    
I I L , ico!. ci., , -86 (2 6). 
. c.A. Reilly and G.S. Yost, METABOLISM OF CAPSAICINOIDS BY P450 
S:     I I   I  
I , I - c I  I ,  I I I  ES, 
rug etab. ev., 38, 685-706 (2006). 
. .C. , .S. nis, .E. , .L. za, .J. s, 
G.S. Yost, and c.A. Reilly, T PVI AGONISTS CAUSE ENDOPLASMIC 
    EATH I    LS, .  
har acol. xp. her., 321, 830-838 (2007). 
0. B.F. Bessac and S.E. Jordt, BREATHTAKING T P CHANNELS: T I 
  I        , 
Physiology, 23, 360-370 (2008). 
1. .A. roneberg, . ii i, . hai inh, . osio, rk e , . 
Fischer, and .F. hung, INCREASED EXPRESSI N OF TRANSIENT 
  I I -1 I  I     
H, ri  r l f espir t r   riti l r  dici e, 
ol. 170, 1276-1280 (2004). 
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Aff Counsel 1112 Exhibit K pp 67 The foregoing publications fail to create a genuine issuc
of material fact on the preliminary question of whether Plaintiffs alleged health conditions
were known or foreseeable risks of exposure to OC spray sufficient to give rise to liability un1cr
the standards articulated above
First seven of the identified publications were authored or coauthored by Dr Reilly
According to him none of those articles definitively state or otherwise establish within a
reasonable degree of scientific probability a conclusive or casual association between exposure
to OC spray or even more generally capsaicinoids and chronic or long term health conditions or
disease or chronicirreversible exacerbation of preexisting health conditions Reilly Aff 11
8 Notably many of those seven articles were coauthored by Dr Yost as well who when
asked the question quoted above did not himself point to these articles as concluding tilat
Plaintiffs alleged health problems were or should have been known or foreseeable Aff
Counsel 10 Exhibit 1 14421467
Of the remaining four articles three must be automatically disregarded for purposes of
the present inquiry Articles 1 2 and 10 were all published after the last instance in which S1C
sold OC spray to IDOL during the timeframe that Plaintiff was employed with the IDOC
Applicable law affirmatively establishes that sellers need not be clairvoyant and SEC can only
be held to the best available information at the time of distribution Toner 112 Idaho at 3 8
The final article published in 2004 fails to provide notice of the risk of Ilaintiis
alleged health conditions sufficient to give rise to liability under either Strict Liability or
Failure to Provide Adequate Warning
Nothing in that article definitively states or otherwise establishes
within a reasonable degree of scientific probability a conclusive or
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(Aff. Counsel, '112, Exhibit K, pp. 6-7.) The foregoing publications fail to create a genuine issue 
of aterial fact on the preli inary question of hether Plaintiff's alleged health condition(s) 
ere no n r foreseea le risks f e s re t   s ra . s fficient to ive rise t  lia ilit  nder 
the standards ticulated a . 
irst, s en f the ide tified lications ere t red r - t red  r. ill . 
ccording to hi , "none of those articles definitively state or other ise establish ithin a 
reasonable degree of scientific probability a conclusive or casual association between exposure 
to  spray (or even ore generally capsaicinoids) and chronic or long ter  health conditions or 
disease, or chronic/irreversible exacerbation of pre-existing health conditions." (Reilly fT, " 
8.) Notably, any of those seven articles were co-authored by Dr. Yost as well, who, when 
asked the question quoted above, did not himself point to these articles as concluding that 
Plaintiff's alleged health proble s ere or should have been kno n or foreseeable. ( fT. 
Counsel,~' , i it ,14 :2- 46:7.) 
f the re aining four articles, three ust be auto atically disregarded for purposes of 
the present inquiry. Articles 1, 2 and 10 were all published afier the last instance in which S I:C 
sold OC spray to IDOC during the timeframe that Plaintiff was employed with the IDOC. 
Applicable law affirmatively establishes that "sellers need not be clairvoyant," and SEC can only 
 l    "bes  i    t    istribution." ner,    38. 
The final article, published in 2004, fails to provide notice of the risk of Plaintilrs 
alleged health condition(s) sufficient to give rise to liability under either Strict Liability or 
Failure to Provide dequate arning: 
Nothing in that article definiti vcly states or otherwise establishes 
ithin a reasonable degree of scientific prohahility a conclusive or 
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casual association between exposure to OC spray or even more
generally capsaicinoids and chronic or long term health conditions
or disease or chronic exacerbation of preexisting health
conditions In addition the article does not conclude that there is a
definitive danger of longterm or chronic adverse health effects for
either healthy individuals or individuals with preexisting health
conditions Any attempt to read such a conclusion out of that
article whether individually or in conjunction with any other
article is speculative as there is no scientific study to date linking
a single shortterm exposure to OC Spray at any plausible dose
with any longterm or chronic adverse health effects or
chronicirreversible exacerbation of pre existing health conditions
Reilly Aff 9 Dr Yost agreed that any conclusion drawn from the 2004 article regard ng
longterm or chronic conditions would be speculative at best and in all events less credible
Q Is there a citation to that
A Yes KROEPB Berg 2004
Q And have you reviewed that publication
A I dontthinkso
Q Do you know what its based on You
A Well maybe I have seen it Increased of airways nerve every
nerves of chronic cough 2004 From the title I would say its
probably relevant but Im not sure ifIve seen it I would have
to find it
Q Okay So can you get inflammation with TRPV 1 exposures
that result only in acute adverse health reactions
A Only in acute
Q Yes
A Probably
Q And just because somebody has inflammation doesnt
necessarily mean youre going to have a chronic reaction
correct
A Thats correct
Q As you said most people who have exposure to OC will
resolve their symptoms within a matter of hoursl or a day
A Yeah
Q And just because somebody has inflammation or even if
somebody is in advertised and has inflammation they arent
necessarily going to have a chronic reaction are they
A No they arentBut thats not my point My point is it is
specifically associated with the disease process youre talking
about chronic cough and TRPV 1 and Capsaicins and if the
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casual ass iation between exposure to OC spray (or e en ore 
generally capsaicinoids) and chronic or long term health conditions 
or disease, or chronic exacerbation of pr -existing health 
con itions. In a iti , the article does not conclude that there is a 
definitive danger of long-term or chronic adverse health effects for 
either healthy individuals or individuals ith pre-existing health 
c tions. ny atte pt to read such a conclusion out of that 
article, whether individually or in co junction ith  ther 
article, is speCUlative, as there is no scientific study to date linking 
a single, short-term exposure to OC Spray, at any plausible dose, 
ith any long-term  c erse ealt  e , r 
iclirreversible  f re- sting he th . 
(Reilly Aff., ~ 9.) Dr. Yost agreed that any conclusion drawn from the 2004 article regard'ng 





Is t r   it ti  t  t t? 
Yes. IKROEPB Berg 2004. 
nd have you revie ed that publication? 
 n't  . 
Q. Do you know what it's based on? You? 
A. ell, aybe I have seen it. Increased of air ays, nerve every 
nerves of chronic cough, 2004.       t's 
probably relevant, but I'm not sure if I've seen it. I would have 
  . 
Q. Okay. So can you get infla ation ith P l exposures 
t t r lt l  i  t  r  lt  r ctions? 
A. Only in acute? 
Q. Yes. 
A. Probably. 
Q. And just  so  s i n ation, oesn't 
necessarily ean you're going to have a chronic reaction, 
or ect? 
. hat's correct. 
Q. As you said, most people who have exposure to OC will 
resolve their sy pto s ithin a attcr of hours 1 or a day? 
. ah. 
Q. And just because somebody has inflammation or even if 
so ebody is in advertised and has infla ation, they aren't 
necessarily going to have a chronic reaction, are they? 
. No, they aren't, But that's not my point. y point is it is 
specifically associated with the disease proccss you're talking 
about, chronic cough, and TRPV 1 and Capsaicins and if the 
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hammer keeps hitting you over the head enough times you
ought to believe them Whether results in a chronic situation or
acute is certainly chronic is less credible than acute yes
Aff Counsel 10 Exhibit I 1325 133 Following the foregoing exchange and despite his
own hypothesis as to any causal link between exposure to OC spray and Plaintiffs allcrcd
medical condition Dr Yost confirmed that even the 2004 article would not have sufficiently
advised SEC of the alleged health risks associated with Plaintiff s present complaints
Q Well do you think people that weren trained in toxicology
such as yourself would have been able to review the medical
literature and the scientific literature that existed on or prior to
March of 2008 and been able to determine that there would
have been a life altering condition that resulted from pepper
spray exposure
A I dont see evidence that the normal ways for industrial hygiene
officers and personnel to evaluate such kinds of exposures may
or may not have existed at that time I haventseen it
Aff Counsel 1110 Exhibit I 144211456
Based on the testimony of Plaintiffsown witnesses there can be no genuine dispute that
SEC had no knowledge based on the thenavailable scientific information that the harms
complained of in this litigation would produce from the use of its products even if the
allegations in Plaintiffs Complaint are otherwise true which SEC does not concede As such
Plaintiff cannot meet a fundamental element of her claims for Strict Liability and Inadequate
Warnings Entry of Summary Judgment in favor of SEC is therefore warranted
3 While the deposition testimony of Dr Yost has been provided with this filing Defendant has
also taken the deposition of Plaintiff diagnosing physician Dr Karen Pacheco As that deposition was
concluded as of the date of this filing the transcript was not immediately available Nonetheless Dr
Pacheco was similarly unable to identify a basis for Plaintiff to claim that SEC should have known of the
harms alleged by Plaintiff
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ha mer keeps hitting you over the head enough ti es, you 
ought to believe them. hether results in a chronic situation or 
acute is certainly -- chronic is less credible than a t , ye . 
(Aff. Counsel, ~ 10, Exhibit 1,132:5-133:13.) Follo ing the foregoing exchange, and despite his 
own hypothesis as to any causal link between exposure to OC spray and Plaintiffs alleged 
e ical iti , r. ost c firmed t at even the 004 rticle ld ot e s fficiently 
advised SEC of the alleged health risks associated ith Plaintiffs present co plaints: 
Q. ell, [do you] think people that weren't trained in toxicology 
such as yoursel f would have been able to review the medical 
iterat re   ic iterature  isted    t  
a   08     ne    
a e ee  a life altering c ition t at res lte  fr  e er 
spray exposure? 
. I don't see evidence that the nor al ays for industrial hygiene 
officers and personnel to evaluate such kinds of exposures ay 
or ay not have existed at that ti e. I haven't seen it. 
(Aff. Counsel, '110, Exhibit 1,144:21-145:6) 
Based on the testi ony of Plain tifT's o n itnesses,] there can be no genuine dispute that 
SEC had no kno ledge, based on the then-available scientific infor ation, that the har s 
complained of in this litigation would produce from the use of its products (even if lhe 
allegations in Plaintiffs Complaint are otherwise true, which SEC does not concede). As such, 
laintiff cannot eet a funda ental ele ent f her clai s for trict iability and Inadequate 
Warnings. Entry of Summary Judgment in favor of SEC is therefore warranted. 
II I 
3 hile the deposition testimony of Dr. Yost has been provided with this filing, Defendant has 
also taken the deposition of Plaintiffs diagnosing physician, Dr. Karen Pacheco. As that deposition was 
concluded as of the date ofthis filing, the transcript was not immediately available. Nonetheless, Dr. 
Pacheco was similarly unable to identify a basis for Plaintiff to claim that SEC should have known oflhc 
harms alleged by Plaintiff. 
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3 In All Events Plaintiffs Third Cause ofAction Is Preempted
In addition to the foregoing Plaintiffs Third Cause of Action for failure to provide an
adequate warning is preempted by the Federal Hazardous Substances Act FHSA See 15
USC 1261 et seq The FHSA contains an express preemption provision that preempts any
state cause of action that seeks to impose a labeling requirement different From the requirements
found in the FHSA and the regulations promulgated thereunder Leibstein v LaFarge North
America Inc 689FSupp2d 373 380 EDNY2010 The FIiSA and its enabling
regulations provide nationally uniform requirements for adequate cautionary labeling of
packages of hazardous substances which are sold in interstate commerce Richards 1
Home Depot Inc 456 F3d 76 78 2 Cir 2006 If the product complies with the labeling
requirements of the FHSA plaintiffs failure to warn claims are preempted Id
OC Spray is classified as an irritant under the FHSA Nance Aff 67 and Exhibit
B See also 15USC 1261jAccordingly it is a hazardous substance subject to the
labeling requirements of the FHSA Id see also 15USC 1261fAWith respect to the
applicable standards for labeling SECs OC spray products there has been no allegation by
Plaintiff that SEC has failed to comply with the standards promulgated under the FHSA Neitler
has Plaintiff disclosed any expert competent to testify that SECs existing warning labels are
noncompliant with the FHSA
The only expert proffered by Plaintiff to testify to the alleged inadequacies of SECs
product warning labels is Dr James Purswell Aff Counsel 13 and Exhibit L Dr Purswcll
relies exclusively on certain regulations of the Occupational Safety and Health Administration
OSHA specifically 29CFR 191020 Id However the explicit language of the very
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. In ll , l i iffs i d ause  ctio  Is e . 
In addition to the foregoing, laintiffs hird ause f ction for failure to provide an 
adequate arning is pree pted by the Federal azardous Substances ct ("FHS "). See J 5 
.S.c. § 1261, et seq. "The F S  contains an express pree ption provision that 'pree pts any 
state cause of action that seeks to i pose a labeling require ent different fro  the require ents 
found in the F S  and the regulations pro ulgated thereunder. '" eibstein . ge  
A erica Inc., 689 F.Supp.2d 373, 380 (E.D.N.Y. 2010). "The lIS   ts bli  
regulations 'provide nationally unifor  require ents for adequate cautionary labeling of 
packages of hazardous substances which are sold in interstate commerce .... '" i ard.1 1'. 
o e epot, Inc., 456 F.3d 76, 78 (2nd ir. 06). "If t e r ct c lies it  t e la eli  
requirements of the FHSA, plaintiffs failure to warn claims are preempted .... " . 
 Spray is classified as an "irritant" under the F S . (Nance ff. ~~ -7  i it 
B.)  s   .S.C. § 1261(j). cc r i gly, it is a "hazardo s s stance" s ject t  t e 
labeling requirements of the FHSA. Id.; see also 15 U.S.C. § 261 (f)(1 )(A). it  t t  t c 
applicable standards for labeling SEC's OC spray products; there has been no allegation by 
lai tiff t at  as faile  t  c l  it  t e sta ar s r l ate  er t e A. eit:lcr 
has Plaintiff disclosed any expert competent to testify that SEC's existing warning labels are 
nonco pliant ith the FI-IS . 
he only expert proffered by laintiff to testify to the alleged inadequacies f SI~Cs 
product warning labels is Dr. James Purswell. (Aff. Counsel ~11   i it .) r. urs ell 
relies e cl si el   certai  re lati s f t e cc ati al afet  a  ealt  i istrati  
("OS "), specifically 29 .F.R. § 1910.1200. (Id.) o ever, the explicit language of the very 
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regulation relied upon by Dr Purswell renders his entire opinion irrelevant for purposes of this
case
5 This section does not require labeling of the following
chemicals
v Any consumer product or hazardous substance as those
terms are defined in the Consumer Product Safety Act 15USC
2051 et seq and Federal Hazardous Substances Act 15 USC
1261 el seq respectively when subject to a consumer product
safety standard or labeling requirement of those Acts or
regulations issued under those Acts by the Consumer Product
Safety Commission
29CFR 191020 As Plaintiffs deadline to disclose experts in this case has now passed
she will not be able to present any competent or admissible evidence regarding any allcfcd
inadequacies with SECs product warning labels under the FIISA Summary judgment is
warranted
V CONCLUSION
Of the several causes of action asserted by Plaintiff in this litigation she will be unable to
present any evidence sufficient to create a genuine issue of material fact for purposes of
Summary Judgment In addition to already agreeing to dismiss her warranty claims Plaintiff
cannot present evidence that SEC created any express warranty Further Plaintiff cannot
establish through even her own testifying experts that there is any documented scientific
literature that would provide SEC with the requisite notice in order for Strict Liability to attlch
or a duty to warn to arise On these several bases SEC respectfully requests an Order granting
Summary Judgment on all of Plaintiffs Causes ofAction




regulation relied upon by Dr. Purswell renders his entire opinion irrelevant for purposes of this 
c : 
(5) his section does not reqUIre labeling f the follo ing 
c : 
(v) ny consu er product or hazardous substance as those 
ter s re ine  in the  t  ct (15 .S.c. 
2051 et seq.) and Federal azardous Substances ct (15 .S.C. 
1261 et seq.) respectively, when subject to a consumer product 
safety ard  a ing re e t  t ose ,  
regulations issued under those cts by the onsu er Product 
Safety o ission .... 
 .F.R. § 910. 2 0. s l i tiffs line t  is lose erts i  t is s  s  ss d, 
she ill not be able to present any co petent or ad issible evidence regarding any allcged 
inadequacies with SEC's product warning labels under the FlISA.  j e t i  
. 
v.  
f the several causes f action asserted by Plaintiff in this litigation, she ill be unahle to 
present any evidence sufficient to create a genuine issue of material fact for purposes of 
Su ary Judg ent. In addition to already agreeing to dis iss her arranty clai s, laintiff 
cannot present evidence that SEC created any express warranty. rt r, l intiff  
establish through even her o n testifying experts that there is any docu ented, scienti fic 
literature that would provide SEC with the requisite notice in order for Strict Liability to attach 
or a duty to arn to arise. n these several bases, S  respectfully requests an rder grant!ng 
Su ary Judg ent on all of Plaintiffs Causes of Action. 
III 
III 
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CORPORATION a Missouri corporation
Defendant
Defendant Security Equipment Corporation SEC by and through its counsel of
record Greener Burke Shoemaker PA pursuant to Idaho Rules of Civil Procedure Rule 26b
this Courts Order Governing Proceedings and Setting Trial dated June 1 2010 and the
Stipulation for Scheduling and Planning dated May 7 2010 disclose the following retained and
non retained trial expert witnesses
RETAINED EXPERT WITNESSES
I Mark J UtellMD
16 Framingham Lane
Pittsford New York 14534
585 2754861
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P RATI , a issouri corporation, 
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FENDANT'S  
S  
efendant, Security Equip ent orporation ("SE "),   t r  it  l f 
record, reener urke Shoe aker P.A., pursuant to Idaho ules of ivil Procedure ule 26(b), 
t is ourt's r er er i  r cee i s a  etti  rial ate  J e 1,  a  t e 
Stipulation for Scheduling and Planning dated ay 7, 2010, disclose the follo ing retained and 
non-retained trial expert itnesses: 
  ESS  
. r  . t ll, .D. 
16 Fra ingha  Lane 
ittsf r , e  r   
(585) 275-4861 
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A QUALIFICATIONS A copy of Dr UtellsCV is attached hereto as Exhibit A
setting forth his education training professional experience and publications
1 Charges Dr Utell charges 5500 per hour for his time associated with
this litigation
2 Previous Testimony A listing of cases in which Dr Utell has provided
expert testimony in the preceding four years is included with his CV
attached hereto at Exhibit A
B SUBJECT MATTER AND SUBSTANCE OF EXPECTED TESTIMONY Dr
Utell is expected to testify to the pathophysiology of cough vocal cord dysfunction irritant vocal
cord dysfunction esophageal dysmotility gastrointestinal reflux disease GERD obstructive
sleep apnea and the recognized medical causes of these conditions He will testify about various
airway diseases including but not limited to asthma RADS bronchitis bronchiolitis
bronchiectasis rhinitis and sinusitis and their causes and pathophysiology He will discuss the
pathophysiology and recognized medical causes of chronic cough He may discuss
environmental irritants pollutants allergens and other toxic substances collectively
environmental substances and the bodys response to exposure to these environmental
substances
Dr Utell will discuss oleoresin capsaicin OC and capsaicinoids and the acute
temporary reversible adverse health effects which humans may suffer as a result of exposure to
these He may discuss the pathophysiology of the bodys response to exposure to OC and
capsaicinoids He will testify about his reviews of the medical and scientific literature on
OCcapsaicinoids and the associations andor lack of associations between exposure to
OCcapsaicinoids and any health conditions including but not limited to cough chronic cough
vocal cord dysfunction irritant vocal cord dysfunction esophageal dysmotility GERD and
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. :    . tell's  is tt  t   i it  
setting f rt  is e cati , trai i , r fessi al e erie ce a  licati s. 
. harges: r. tell charges $550.00 per hour for his ti e associated ith 
this litigation. 
. r ious ti ny:  listin  f ases i  ic  r. t ll  r i  
expert testi ony in the preceding four years is included ith his , 
    . 
. J       TI NY: r. 
tell is expected to testify to the pathophysiology of cough, vocal cord dysfunction, irritant vocal 
c r  sf cti , es a eal s otilit , astr i testi al refl  isease ("GE "), obstructive 
sleep apnea, and the recognized edical causes of these conditi9ns. He will testify about various 
air ay diseases, including, but not li ited to, asth a, , bronchitis, bronchiolitis, 
bronchiectasis, rhinitis, and sinusitis, and their causes and pathophysiology. e ill discuss the 
pathophysiology and recognized    i  cough.   is ss 
 irrit ts, pollutants, allergens,  t  t i  t nces, (colle ti l  
"environment  "), and the body's response to exposure to these environ ental 
t ces. 
r. tell ill discuss oleoresin capsaicin ("OC")  psaicinoids,  t  cute, 
te porary, reversible adverse health effects hich hu ans ay suffer as a result f exposure to 
these. e ay discuss the pathophysiology of the body's response to exposure to  and 
capsaicinoids. e ill testify about his revie s of the edical and scientific literature on 
/capsaicinoids, and the associations, and/or lack of associations, bet een exposure to 
OC/capsaicinoids and any health conditions, including, but not li ited to, cough, chronic cough, 
vocal cord dysfunction, irritant vocal cord dysfunction, esophageal dysmotility, GERD and 
EFENDANT'S   - age 2 
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obstructive sleep apnea He may testify as to his understanding of the state of the knowledge in
the scientific and medical professions about OCcapsaicinoids the known association between
OCcapsaicinoids exposures and other diseases and the lack of any definitive studies or
publications establishing any association between exposure to OCcapsaicinoids and longterm
chronic adverse health conditions such as those about which Ms Major is complaining in this
lawsuit
Dr Utell may discuss the capsaicum challenge test used in medical research and clinical
practice and the extent to which exposure to capsaicum by patients in those tests may compare
to exposure to OC which Ms Major incurred during her employment with the Idaho Department
of Corrections IDOC Dr Utell may address and characterize the nature and extent of Ms
Majors exposures to OCcapsaicinoids and the relationship between those exposures and her
health conditions
Dr Utell will address specific articles and publications which have been described during
discovery in this case and which relate to issues which are the subject matter of Plaintiffs
complaint Plaintiffs health conditions and these expert disclosures He will address and
respond to opinions conclusions and assumptions made by Plaintiffsexperts and by any health
care providers who have examined treated diagnosed andorcared for Ms Major Dr Utell will
testify about his extensive review of Ms Major medical records about Ms Major numerous
health conditions both before and after she began her employment with IDOC and about the
progression of Ms Majors health conditions over time He will also discuss the reasons for
changes in her health conditions over time He will render opinions as to the causes of Ms
Majorshealth conditions and testify that her exposure to OCcapsaicinoids did not cause or
contribute to her long term chronic health conditions or to aggravation of any preexisting health
conditions
DEFENDANTSEXPERT DISCLOSURES Page 3
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o str ctive slee  a ea. e a  testif  as t  is ersta ing f t e state f t e ledge i  
the scientific and edical professions about /capsaicinoids, the kno n association bet een 
/capsaicinoids exposures and other diseases, and the lack of any definitive studies or 
publications establishing any association bet een exposure to /capsaicinoids and long-ter  
r i  rs  lt  iti s, s  s t se t ic  s. j r is l i i  i  t is 
la i . 
r. tell a  isc ss t e ca saic  c alle ge test se  i  e ical researc  a  cli ical 
practice, and the extent to hich exposure to capsaicu  by patients in those tests ay co pare 
t  e s re t   ic  s. aj r i c rre  ri  er e l e t it  t e I a  e art e t 
  ("IDOC"). r. tell a  a ress a  c aracterize t e at re a  e te t f s. 
ajor's exposures to OC/capsaicinoids and the relationship between those exposures and her 
l  i . 
r. tell ill address specific articles and publications hich have been described during 
discovery in this case, and hich relate to issues hich are the subject atter of Plaintiffs 
co plaint, laintiff s health conditions, and these expert disclosures. e ill address and 
respond to opinions, conclusions, and assu ptions ade by Plaintiff s experts and by any health 
care providers ho have exa ined, treated, diagnosed, and/or cared for s. ajor. r. tell ill 
testify about his extensive revie  of s. ajor's edical records, about s. ajor's nu erous 
health conditions, both before and after she began her e ploy ent ith I , and about the 
progression of s. ajor's health conditions over ti e. He will also discuss the reasons for 
changes in her health conditions over ti e. He will render opinions as to the causes of s. 
ajor's health conditions, and testify that her exposure to /capsaicinoids did not cause, or 
contribute to her long-ter  chronic health conditions or to aggravation of any pre-existing health 
diti s. 
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Dr Utell will testify to the facts and opinions contained in his report a copy of which is
attached to this disclosure as Exhibit B He will give opinion testimony and rebuttal testimony to
that given by Plaintiffsexperts consistent with this disclosure and he will testify to all facts and
opinions to which he has testified or may testify in any deposition given by him in this case
C FACTS AND DATA CONSIDERED Dr Utellstestimony will be based upon
his education training knowledge studies reviewed expertise and experience in the areas of
pulmonary and occupational medicine Those documents considered by Dr Utell in forming his
opinions are detailed in Exhibit C attached hereto
In addition to the case specific documents Dr Utell may use in his review of this case
and the opinions he renders in this case he may also rely upon and review relevant medical and
scientific research andor literature related to any of the subject matters addressed in expert
disclosures or depositions in this case Dr Utell will be provided with the depositions of
Plaintiffsexpert witnesses and other fact witnesses in this case to the extent those have not
previously been provided He will also be provided pertinent documents which Plaintiffs
experts have reviewed andor are relying upon to the extent those have not been previously
provided to him Dr Utell may testify based in part on any literature he has reviewed
concerning relevant information in this case
II Roger O McClellan DVM MMSDSc Honorary
13701 Quaking Aspen PlaceNE
AlbuquerqueNew Mexico 87111
505 2967083
A QUALIFICATIONS A copy ofDr McClellansCV setting forth his education
training professional experience and publications is attached to his report which is attached
hereto as Exhibit D
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r. tell ill testify to the facts and opinions contained in his report, a copy of hich is 
attac e  t  t is iscl s re as i it . e ill i e i i  testi  a  re ttal testi  t  
that given by laintiffs experts, consistent ith this disclosure, and he ill testify to all facts and 
i i s t  ic  e as testifie , r a  testify, i  a  e siti  i e   i  i  t is case. 
.    I : r. tell's testi  ill e ase   
his education, training, kno ledge, studies revie ed, expertise and experience in the areas of 
l r   ti l i i . s  ts si r   r. t ll i  f r i  is 
i i s are etaile  i  i it  attac e  eret . 
In addition to the case-specific docu ents r. tell ay use in his revie  of this case 
 t  i i s  r rs i  t is se,   ls  r l    r i  r l t i l  
scientific research and/or literature related to any of the subject atters addressed in expert 
disclosures or depositions in this case. r. tell ill be provided ith the depositions of 
l intiff s rt itnesses  t r f t itness  i  t is e, t  t  t t t   t 
previously been provided. e ill also be provided pertinent docu ents hich Plaintiff s 
rts  r i e  nd/or r  r l i  , t  t  t t t s   t  r i sl  
provided to hi . r. tell ay testify based, in part, on any literature he has revie ed 
concerning relevant infor ation in this case. 
I. Roger O. cClellan, DV , S, DSc (Honorary) 
13701 Quaking Aspen Place, N.E. 
lbuquerque, e  exico 87111 
(505) 296-7083 
. LIFIC TI S:  copy of r. cClellan's C , setting forth his education, 
trai i , r fessi al e erie ce a  licati s, is attac e  t  is re rt ic  is attac e  
  t . 
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1 Charges Dr McClellan charges 44000per hour for his time associated
with this litigation
2 Previous Testimony A listing of cases in which Dr McClellan has
provided expert testimony in the preceding four years is attached to his
expert report which is attached hereto at Exhibit D
B SUBJECT MATTER AND SUBSTANCE OF EXPECTED TESTIMONY Dr
Roger McClellan is expected to testify generally about OCcapsaicinoids the temporary acute
adverse health effects of exposure to OCcapsaicinoids and the pathophysiology of the bodys
response to OCcapsaicinoids He will discuss his extensive review of the scientific and medical
literature on OCcapsaicinoids the associations and lack of associations between exposure to
OCcapsaicinoids and any health conditions including but not limited to cough chronic cough
vocal cord dysfunction irritant vocal cord dysfunction esophageal dysmotility and
gastroesophageal reflux disease He may testify to his understanding of the state of knowledge in
the scientific community about OCcapsaicinoids the known association between
OCcapsaicinoids exposure and other diseases and the lack of any definitive studies or any
published literature establishing any association between OCcapsaicinoids exposure and long
term chronic health conditions such as those about which Ms Major complains in this lawsuit
Dr McClellan will address the scientific articles and publications that have been
disclosed in discovery in this case and which relate to issues which are the subject of Plaintiffs
complaint Plaintiffs health conditions and these expert disclosures He will address and
respond to opinions conclusions and assumptions made by Plaintiffs experts and any health
care providers who have examined treated diagnosed andorcared for Ms Major
Dr McClellan may testify about the science of toxicology and hazardrisk analysis
including the role of epidemiological studies animal studies controlled human exposure studies
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. r s: r. c lellan r es $4 . 0 r r f r is ti  ss i t  
it  t is litig ti . 
. s ti ny:  is i      r. c le la   
e     t e        
expert report hich is attached hereto at xhibit . 
. J       TI NY: r. 
oger c lellan is expected to testify generally about /capsaicinoids, the te porary, acute 
s  lt  e ts  s re t  /caps i inoids  t  t i l   t  dy's 
res se t  /capsaici i s. e ill isc ss is e te si e re ie  f t e scie tific a  e ical 
literat re  /capsaici i s, t e ass ciati s a  lac  f ass ciati s et ee  e s re to 
/capsaicinoids and any health conditions, including, but not li ited to, cough, chronic cough, 
  dysfunction, ita    dysfunction, esophageal otilit   
gastroesophageal reflux disease. e ay testify to his understanding of the state of kno ledge in 
 i ti  co unity  /capsaicinoids,   i ti  t  
/capsaicinoids e s re a  t er iseases, a  t e lac  f a  efi iti e st ies r a  
published literature establishing any association bet een /capsaicinoids exposure and long 
ter  chronic health conditions such as those about hich s. ajor co plains in this la suit. 
r. c lella  ill a ress t e scie tific articles a  lications t at a e ee  
disclosed in discovery in this case, and hich relate to issues hich are the subject of Plaintiff s 
co plaint, Plaintiff s health conditions, and these expert disclosures. e ill address and 
respond to opinions, conclusions and assu ptions ade by Plaintiffs experts and any health 
care providers ho have exa ined, treated, diagnosed andlor cared for s. ajor. 
Dr. cClellan may testify about the science of toxicology and hazard/risk analysis, 
including the role of epide iological studies, ani al studies, controlled hu an exposure studies 
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and invitro studies in evaluating human health hazardrisks He may testify as to what the
science of epidemiology deems to be sufficient proof to be a causal association between
exposure to environmental and occupational substances and diseases or health effects in humans
and animals He may discuss the differences in the published literature between case reports
animal and invitro studies human studies literature reviews and meta analyses and the weight
to which science gives each Dr McClellan may discuss the science of toxicology
environmental substances and the human bodys response to these He may discuss the
variations in exposures to environmental substances and the extent to and mechanisms by
which environmental substances may become airborne and respirable by humans He may
discuss the doseresponse relationship between environmental substances and adverse health
effects in humans
Dr McClellan may testify about the various types of OC sprays the different properties
between different sprays and the extent if at all to which different OC sprays may be respirable
or cause adverse health conditions He will discuss his review and analysis of Ms Major
OCcapsaicinoids exposure history compare that exposure history to other environmental
substances generally and specifically address the relationship between Ms Major level of
exposure to OCcapsaicinoids and the long term chronic adverse health conditions and
exacerbation of conditions about which Ms Major complains in this lawsuit
Dr McClellan may discuss the capsaicum cough challenge test used in medical and
scientific research and clinical applications the safety of those tests and the manner in which
those tests are administered He may compare the acute exposures to OCcapsaicinoids derived
from those tests with the type of exposure to OCcapsaicinoids received by Ms Major during her
employment at IDOC
DEFENDANTSEXPERT DISCLOSURES Page 6
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a  in-vitro st i s, i  l ting a  lt  azard/risks. e  t    hat e 
scie ce f e i e i lo  ee s t  e s fficient r f to e a ca sal ass ciati n et ee  
exposure to environ ental and occupational substances, and diseases or health effects in hu ans 
 i l . e a  iscuss t  i ferences i  t  lished literat re t e  ase r t , 
i l  in-vitro t i ,  t i , literat r  r ie s  t - l ,  t  i t 
to hich science gives each. r. c lellan ay discuss the science of toxicology, 
iron ental ,    dy's   e.     
variations in exposures to environ ental substances and the extent to, and echanis s by, 
ic  ir t l s st es  e ir r   r s ir l   s.   
discuss the dose/response relationship bet een environ ental substances and adverse health 
fects  . 
r. c lellan ay testify about the various types f  sprays, the different properties 
bet een different sprays, and the extent, if at all, to hich different  sprays ay be respirable 
r  r  lt  iti .  ill i  i  r i   l i   . ajor's 
/capsaicinoids exposure history, co pare that exposure history to other environ ental 
substances, generally, and specifically address the relationship between s. ajor's level of 
exposure to OC/capsaicinoids, and the long-term chronic adverse health conditions and 
r ti  f iti s t i  s. j r l i s i  t is l suit. 
r. c lellan ay discuss the capsaicu  cough challenge test used in edical and 
scientific research and clinical applications, the safety of those tests, and the anner in hich 
those tests are ad inistered. e ay co pare the acute exposures to /capsaicinoids derived 
fro  those tests ith the type of exposure to C/capsaicinoids received by s. ajor during her 
employment at IDOC. 
FENDANT'S   - Page 6 
14542-011 (387404) 
Dr McClellan may comment on the active and non active ingredients in OC pepper spray
products generally and SEC OC pepper spray products specifically He may discuss the
relationship between OC pepper spray active ingredients and potency generally and with respect
to SEC OC products specifically and how potency may be affected by multiple variable factors
Dr McClellan may discuss material safety data sheets MSDS their purpose and function
and the purpose for which the information contained in them can and should be used He may
address the MSDS related to the law enforcement SABRE Red pepper spray products sold by
SEC to IDOC He may also address the warnings on the labels of the pepper spray products sold
by SEC to IDOC and how they may relate to the MSDS for the same products He will also give
the opinion that SECswarning labels on the law enforcement products sold by it to IDOC were
reasonable and adequate in light of the state of knowledge regarding OCcapsaicinoids readily
available and existing within the medical and scientific literature in 2008
Dr McClellan will also testify to the facts and opinions contained in his report a copy of
which is attached to these disclosures as Exhibit D He will give opinion testimony in rebuttal to
that given by Plaintiffsexperts consistent with this disclosure and he will testify to all facts and
opinions to which he has testified or may testify in his deposition given in this case
C FACTS AND DATA CONSIDERED Dr McClellanstestimony will be based
upon his education training knowledge studies reviewed expertise and experience in the areas
of inhalation toxicology aerosol science and human health risk analysis issues Those documents
considered by Dr McClellan in forming his opinions are detailed in Exhibit E attached hereto
In addition to the case specific documents Dr McClellan may use in his review of this
case and the opinions he renders in this case he may also rely upon and review relevant medical
and scientific research andorliterature related to any of the subject matters addressed in expert
disclosures or depositions in this case Dr McClellan will be provided with the depositions of
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r.      cti   - ti  i i  i   r spr y 
t  r ll       t  pecifically.   i  t  
relationship bet een  pepper spray active ingredients and potency generally, and ith respect 
to SE   products specifically, and ho  potency ay be affected by ultiple variable factors. 
r. la     f    ("MS "), their purpose and function, 
and the purpose for hich the infor ation contained in the  can and should be used. e ay 
address the  related to the la  enforce ent  ed pepper spray products sold by 
SE  to I . e ay also address the arnings on the labels of the pepper spray products sold 
by  to I , and ho  they ay relate to the  for the sa e products. e ill also give 
the opinion that EC's arning labels on the la  enforce ent products sold by it to I  ere 
reasonable and adequate in light of the state of kno ledge regarding /capsaicinoids readily 
il l   isti  it i  t  i l  s i tifi  literat r  i  . 
r. c lellan ill ls  t stif  t  t  f ts  i i s t i  i  is r rt,   f 
ic  is attac e  t  t ese isclosures as i it . e ill i e i i  testi  i  re ttal t  
that given by laintiff s experts, consistent ith this disclosure, and he ill testify to all facts and 
opinions to hich he has testified, or ay testify, in his deposition given in this case. 
. FACTS AND DATA CONSIDERED: Dr. cClellan's testi ony will be based 
upon his education, training, kno ledge, studies revie ed, expertise and experience in the areas 
of inhalation toxicology, aerosol science and hu an health risk analysis issues. Those docu ents 
considered by r. c lellan in for ing his opinions are detailed in x i it  attached hereto. 
In addition to the case-specific docu ents r. c lellan ay use in his revie  of this 
case and the opinions he renders in this case, he ay also rely upon and revie  relevant edical 
and scientific research and/or literature related to any of the subject atters addressed in expert 
disclosures or depositions in this case. Dr. cClellan will be provided with the depositions of 
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Plaintiffsexpert witnesses and other fact witnesses in this case to the extent those have not
previously been provided He will also be provided pertinent documents which Plaintiffs
experts have reviewed andor are relying upon to the extent those have not been previously
provided to him Dr McClellan may testify based in part on any literature he has reviewed
concerning relevant information in this case
III Christopher AReillyPhD
Department of Pharmacology and Toxicology
University ofUtah
30 S 2000 E Room 201 Skaggs Hall
Salt Lake City UT 84112
801 5815236
A QUALIFICATIONS A copy of Dr ReillysCV is attached hereto as Exhibit F
setting forth his education training professional experience and publications
1 Charges Dr Reilly charges 25000per hour for his time associated with
this litigation
2 Previous Testimony Dr Reilly has not testified as an expert in any other
lawsuits in the preceding four years
B SUBJECT MATTER AND SUBSTANCE OF EXPECTED TESTIMONY Dr
Christopher Reilly is expected to testify generally about OCcapsaicinoids the temporary acute
adverse health effects of exposure to OC capsaicinoids and the pathophysiology of the bodys
response to OCcapsaicinoids He will discuss his extensive searches and reviews of the
scientific and medical literature on OCcapsaicinoids and the associations and lack of
associations between exposure to OCcapsaicinoids and any health conditions including but not
limited to cough chronic cough vocal cord dysfunction irritant vocal cord dysfunction
esophageal dysmotility and GERD He may testify to his understanding of the state of the
knowledge in the scientific community about OCcapsaicinoids the known association between
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setting forth his education, training, professional experience and publications. 
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. r i s ti ony: r. ill   t t tifie  s  rt i   t r 
l s its i  t  r i  f r rs. 
.       TI NY: r. 
hristopher eilly is expected to testify generally about /capsaicinoids, the te porary, acute, 
adverse health effects of exposure to OC/capsaicinoids and the pathophysiology of the body's 
response to /capsaicinoids. e ill discuss his extensive searches and revie s f the 
i tific  i l literat r   /caps i i i ,  t  oci ti ,  l  f 
associations, between exposure to OC/capsaicinoids and any health conditions, including, but not 
li ited to, cough, chronic cough, vocal cord dysfunction, irritant vocal cord dysfunction, 
esophageal dysmotility, and GERD. He may testify to his understanding of the state of the 
kno ledge in the scientific co unity about /capsaicinoids, the kno n association bet een 
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OCcapsaicinoids exposure and other diseases and the lack of any definitive studies or published
literature establishing any association between OCcapsaicinoids exposure and longterm
chronic adverse health conditions such as those about which Ms Major complains in this
lawsuit
Dr Reilly will address specific articles and publications including his own publications
that have been disclosed in discovery in this case and which address issues which are the subject
of Plaintiffscomplaint Plaintiffshealth conditions and these expert disclosures He will
address and respond to opinions conclusions and assumptions made by Plaintiffsexperts and
any health care providers who have examined treated diagnosed and cared for Ms Major
Dr Reilly may testify about animal studies human studies and invitro studies and what
the science does or does not provide as sufficient proof to show a causal association between
exposure to an irritant pollutant or toxic substance and disease or health effects in humans or
animals He may discuss the differences in the published literature between case reports animal
and invitro studies human studies literature reviews and meta analyses and the weight to
which science gives each of these
Dr Reilly may discuss the science of toxicology environmental pollutants irritants
allergens and toxic substances environmental substances and the bodysresponse to these
He may discuss the variations in exposure to environmental substances and the extent to and
mechanisms by which environmental substances may become airborne and respirable by
humans He may discuss the doseresponse relationship between exposure to environmental
substances and adverse health effects to humans
Dr Reilly may testify about the various types of OC sprays the different properties
between OC sprays and the extent if at all to which different OC sprays may be respirable or
cause adverse health conditions He will discuss his review and analysis of Ms Majors
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la suit. 
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 laintif s l i t, l intif s lt  iti s,    l s.  i  
address and respond to opinions, conclusions and assu ptions ade by laintiff s experts and 
 lt  r  r iders   i ed, tr t , i s   r  f r s. j r. 
r. eilly ay testify about ani al studies, hu an studies, and in-vitro studies, and hat 
the science does or does not provide as sufficient proof to sho  a causal association bet een 
 t   i it t, ll t t,  t i  t   is   lt  t  i    
i l .   i  t  iffere  i  t  lis e  lit r t r  t   r rt , i l 
 i -vitro t i ,  t i s, lit r t r  r i ,  t  l s,  t  i t t  
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r. eilly ay discuss the science of toxicology, environ ental pollutants, irritants, 
ller e   t i  t  ("environment l t "), and the body's response to these. 
e a  isc ss t e ariations i  e s re t  e ir e tal s sta ces a  t e e te t t , a  
echanis s by, hich environ ental substances ay beco e airborne and respirable by 
s.   isc ss t  s /respons  r l ti s i  t  s r  t  ir t l 
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r. eill  a  testif  a t t e ari s t pes f  s rays, t e iffere t r erties 
bet een  sprays, and the extent, if at all, to hich different  sprays ay be respirable or 
cause adverse health conditions. e ill discuss his revie  and analysis of s. ajor's 
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OCcapsaicinoid exposure history compare that history to other environmental substances
generally and specifically address the relationship between Ms Major level of exposure to
OCcapaicinoids and the longterm chronic adverse health conditions and exacerbation of
conditions about which Ms Major complains
Dr Reilly may discuss the capsaicum challenge test used in scientific research and
clinical applications and the extent to which OC exposures from those tests may compare to the
OC exposures Ms Major had during her employment with the IDOC Dr Reilly may comment
on the active and non active ingredients in OC pepper spray products generally and SECs
pepper spray products specifically He may discuss the relationship between OC pepper spray
active ingredients and potency generally and with respect to SEC products specifically and how
potency may be affected by multiple variable factors
Dr Reilly will also discuss his studies and publications comparing the active and non
active ingredients and potencies of various commercial law enforcement pepper sprays including
SECslaw enforcement Sabre Red products He will discuss the variability in potencies among
commercial law enforcement pepper sprays and the reasons for such variations He will discuss
past and present methods for determining and quantifying potencies of OC pepper sprays He
will discuss the potency of SECsSabre Red pepper spray products Dr Reilly will describe his
own intensive research studies and publications on OCcapsaicin the physiological response to
such exposure by humans and animals and the pathophysiology of that response in animals and
humans He will discuss the subject matter addressed in and conclusions derived from those
studies and related studies on these subjects Dr Reilly will testify to the facts and opinions
contained in his report a copy of which is attached to these disclosures as Exhibit G
Additionally Dr Reilly has submitted an affidavit in support of Defendantsmotion for
summary judgment containing additional opinions related to this litigation That affidavit is
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/caps i i i   i t ry,  t t i t  t  t  i t l t  
e erally, a  s ecificall  a ress t e relati s i  et ee  s. ajor's le el f e s re t  
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r. eilly ay discuss the capsaicu  challenge test used in scientific research and 
clinical applications, and the extent to hich  exposures fro  those tests ay co pare to the 
 s r s s. j r  ri  r l t it  t  I . r. ill   t 
 t e acti e a   acti e i re ie ts i   e er s ra  r cts e erally, a  EC's 
pepper spray products specifically. e ay discuss the relationship bet een  pepper spray 
ti  i re ie ts  t  erally,  it  r s t t   r ts s ecifi all ,   
potency ay be affected by ultiple variable factors. 
r. eill  ill als  isc ss is st ies a  licati s c ari  t e acti e a   
active ingredients and potencies of various co ercial la  enforce ent pepper sprays including 
S C's la  enforce ent Sabre ed products. e ill discuss the variability in potencies a ong 
co ercial la  enforce ent pepper sprays, and the reasons for such variations. e ill discuss 
past and present ethods for deter ining and quantifying potencies of OC pepper sprays. He 
ill discuss the potency of SEC's Sabre ed pepper spray products. r. eilly ill describe his 
o n intensive research, studies and publications on C/capsaicin, the physiological response to 
such exposure by hu ans and ani als, and the pathophysiology f that response in ani als and 
s.  ill i  t  j t tt   i ,  l i  ri  , t  
studies, and related studies on these subjects. r. eilly ill testify to the facts and opinions 
contained in his report, a copy of hich is attached to these disclosures as Exhibit . 
dditionally, r. eilly has sub itted an affidavit in support of efendant's otion for 
su ary judg ent containing additional opinions related to this litigation. hat affidavit is 
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incorporated herein by reference Dr Reilly will also give opinion testimony in rebuttal to that
given by Plaintiffsexperts consistent with this disclosure and he will testify to all facts and
opinions to which he has testified or may testify in his deposition given in this case
C FACTS AND DATA CONSIDERED Dr Reillystestimony will be based upon
his education training knowledge studies reviewed expertise and experience in the areas of
lung toxicology Those documents considered by Dr Reilly in forming his opinions are detailed
in Exhibit H attached hereto
In addition to the case specific documents Dr Reilly may use in his review of this case
and the opinions he renders in this case he may also rely upon and review relevant medical and
scientific research andor literature related to any of the subject matters addressed in expert
disclosures or depositions in this case Dr Reilly will be provided with the depositions of
Plaintiffsexpert witnesses and other fact witnesses in this case to the extent those have not
previously been provided He will also be provided pertinent documents which Plaintiffs
experts have reviewed andor are relying upon to the extent those have not been previously
provided to him Dr Reilly may testify based in part on any literature he has reviewed
concerning relevant information in this case
IV Rangemaster Nicholas J Roberts Jr
Unified Police Department of Greater Salt Lake
3365 South 900 West
Salt Lake City UT 84119
801 4670887
A QUALIFICATIONS A copy of Mr Robertscurrent CV is attached hereto as
Exhibit I setting forth his education training professional experience and publications
1 Charges Mr Roberts charges 150 per hour for his time associated with
this litigation
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lung toxicology. Those docu ents considered by r. Reilly in for ing his opinions are detailed 
in xhibit  attached hereto. 
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. ange aster icholas J. oberts, Jr. 
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   est 
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2 Previous Testimony Mr Robertshas testified one time in the preceding
four years That case was Revees vs Churcich case number 02 CV0551K
in Salt Lake County Salt Lake City Utah
B SUBJECT MATTERAND SUBSTANCE OF EXPECTED TESTIMONY
Mr Roberts is an experienced law enforcement officer who has trained both OC Trainers
and law enforcement and correction officers in OC use deployment and safety Mr Roberts will
testify about the benefits risks and safety of OC use by law enforcement and correctional
agencies the differences between consistencies and potencies in various OC pepper spray
products and the risks and benefits associated with pepper spray products of different
consistencies and potencies He will discuss the known and observed adverse health effects of
exposure to OC pepper spray He will discuss the IDOC training procedures education and
safety generally comparing them to industry standards and the specific IDOC trainings given to
Ms Major He will discuss the OC exposures received by Ms Major while working at the IDOC
and during OC trainings He will discuss the relevant literature on use and safety of OC by law
enforcement officers and correctional institutions He is expected to give testimony consistent
with his knowledge training and experience in rebuttal to testimony given by Plaintiffsexperts
and consistent with facts and opinions to which he has testified or may testify in any deposition
given by him in this case
In addition Mr Roberts will give the following opinions
1 OC pepper spray is used by law enforcement officers and correctional institutions
throughout the United States and the world as a non lethal means of subduing and
controlling criminal suspects and inmates without the need for use of more
physical or lethal force Studies and experience have shown that use of OC
pepper spray by law enforcement officers and correctional institutions has
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consistencies and potencies. He will discuss the known and observed adverse health effects of 
exposure to  pepper spray. e ill discuss the I  training procedures, education and 
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s. ajor. e ill discuss the  exposures received by s. ajor hile orking at the I  
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In addition, r. Roberts will give the following opinions: 
.  r r  i    l  f r t ffi r   rr ti l i tit ti  
throughout the nited States and the orld as a non lethal eans of subduing and 
c tr lli  cri i al s s ects a  i ates it t t e ee  f r se f re 
physical or lethal force. tudies and experience have sho n that use of  
pepper spray by la  enforce ent officers and correctional institutions has 
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resulted in marked decreases in injuries among law enforcementcorrectional
officers and criminal suspectsinmates as well as decreases in the number of
reports of excessive use of force by law enforcementcorrectio officers Use of
pepper sprays saves lives
2 Exposure to OC pepper spray may cause people to experience a variety of acute
symptoms including runny noses tearing airway irritation coughing sneezing
pain and skin irritation The extent to which exposed persons may experience any
or all of these symptoms depends on many variables including
a Individual severity to OCcapsaicinoids
b The type of OC pepper spray deployed fog steam or foam
c The level or exposure received direct or indirect or levels I II or III
d The duration of exposure
e Themanner of deployment of spray and
f The potency of pepper sprays active and inactive ingredients
Indirect exposure may cause nothing more than temporary inflammation
3 No matter what symptoms occur with OC pepper spray exposure the adverse
health effects are temporary acute reversible and recoverable usually lasting no
more than a few hours but in no event longer than 3 days There are no known
studies or publications that establish that exposure to OC pepper spray may cause
long term chronic adverse health effects even in the those persons who may have
preexisting health conditions such as asthma respiratory infections GERD or
similar conditions Studies of law enforcement agencies have shown that use of
pepper spray in the manner prescribed in OC trainings is reasonably safe and
effective in controlling criminal inmates and suspects
DEFENDANTSEXPERT DISCLOSURES Page 13
14542011 387404000158
lt  i    i  i j ie   l  nforcement/correctional 
ffi rs,  ri i l s s ts/inmat s, s ll s r s s i  t  r f 
re rts f e cessi e se f f rce  la  enforcement/correction fficers. se f 
   li . 
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health effects are te porary, acute, reversible and recoverable, usually lasting no 
ore than a fe  hours, but in no event longer than 3 days. here are no kno n 
studies or publications that establish that exposure to C pepper spray ay cause 
long ter  chronic adverse health effects, even in the those persons ho ay have 
preexisting health conditions such as asth a, respiratory infections,  or 
si ilar conditions. Studies of la  enforce ent agencies have sho n that use of 
pepper spray in the anner prescribed in C trainings is reasonably safe and 
effective in controlling cri inal in ates and suspects. 
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4 Pepper sprays have different potencies and there has been wide variation in
consistencies and potencies among commercially sold pepper sprays Most
commercially sold law enforcement OC pepper sprays contain between 510
OC depending on whether water or solvent based and between 2 and 133
major capsaicinoids SECs Sabre Red pepper sprays are among the most
consistent in the industry There are other commercially sold law enforcement
OC pepper spray products that are as potent or more potent than SECs 10
OC133major capsaicinoids pepper spray
5 There are safety reasons for use of consistent higher potency pepper spray
products There are risks in using products that have inconsistent or weaker
potencies Some people are not affected by exposure to weaker potencies and
both law enforcement officers and criminal suspectsinmates are at increased risk
of injury if inconsistent or weak potency pepper spray products are ineffective to
subdue or control criminal suspectsinmates Most correctional institutions prefer
both consistency and higher potency in their pepper spray products because
correctional officers do not carry lethal weapons and these more potent products
are more effective in helping to subdue and control inmates while avoiding and
minimizing injuries to correctional officers and inmates Thats why most
correctional facilities use OC pepper spray with higher concentrations of major
capsaicinoids SECs10 OC 133major capsaicinoid products are among the
most consistent and safest on the market
6 It is the industry standard and practice to train law enforcement and correctional
officers in the safe handling and use of OC pepper sprays That training is
generally conducted by certified trainers and generally includes instruction on the
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officers in the safe handling and use of  pepper sprays. t tr i i  i  
generally conducted by certified trainers and generally includes instruction on the 
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risks and the adverse health affects associated with exposure to OC OC training
usually occurs annually and prior to 2009 it was standard practice for officer
trainees to annually receive a minor short duration indirect exposure to OC
pepper spray as part of the training That exposure training is important because
it helps officertrainees overcome their fear and anxieties about OC exposure and
it helps them gain valuable experience on how to act and react to dangerous or
volatile situations while suffering through the effects of OC pepper spray
exposure These officers need to know how to fight and protect themselves in the
event ofexposure to OC
7 I have reviewed the depositions and materials form the IDOC regarding the OC
trainings of Officer Major It is my opinion that those trainings were properly
conducted by certified OC trainers in a reasonable and safe manner consistent
with industry standards and practices It is also my opinion that Officer Major
received proper and adequate instruction in the risks and safety of use of OC and
that the exposures to OC received by her during those trainings were indirect
lowlevel III exposures of short duration in keeping with the standards and
practices in the industry These exposures were not sufficient to cause Ms Major
any long term chronic injury or adverse health conditions
8 Correctional officers are instructed that they must inform OC trainers of any
health conditions that might put them at increased risk in participating in OC
exposure training Ms Major received such instruction from IDOC It was Ms
Majors responsibility to inform her trainers of her existing respiratory illness
before the 308 OC Training and to decline to participate in that training
because of a serious respiratory illness According to IDOC OC trainers Ms
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Major did not inform them of her illness or request that she be excused from the
308 OC training If that is true then Ms Major is responsible for causing any
aggravation to her existing respiratory illness
C SUBSTANCE OF FACTS Mr Robertstestimony will be based upon his
education training knowledge expertise and experience in the areas of law enforcement use of
force specifically as to use of OC sprays training of law enforcement personnel as to the use of
OC sprays and the benefits to law enforcement in using OC spray products Those documents
considered by Mr Roberts in forming his opinions are detailed in Exhibit J attached hereto
In addition to the case specific documents Mr Roberts may use in his review of this case
and the opinions he renders in this case he may also rely upon and review relevant medical and
scientific research andor literature related to any of the subject matters addressed in expert
disclosures or depositions in this case Mr Roberts will be provided with the depositions of
Plaintiffs expert witnesses and other fact witnesses in this case to the extent those have not
previously been provided He will also be provided pertinent documents which Plaintiffs
experts have reviewed andor are relying upon to the extent those have not been previously
provided to him Mr Roberts may testify based in part on any literature he has reviewed
concerning relevant information in this case
NON RETAINED EXPERT WITNESSES
I Robert Nance
Vice President of Operations
Security Equipment Corporation
747 Sun Park Drive
Fenton Missouri 63026
As SECs Vice President of Operations Mr Nance is familiar with most all aspects of
SECs business and with the OC pepper spray industry in theUSA and around the world His
qualifications are more specifically set forth in his affidavit filed in support ofSECs motion for
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disclosures or depositions in this case. r. t  ill  i  it  t  iti   
Plaintiff s expert itnesses and other fact itnesses in this case, to the extent those have not 
previously been provided. e ill also be provided pertinent docu ents hich Plaintiff s 
experts have revie ed and/or are relying upon, to the extent those have not been previously 
provided to him. r. Roberts may testify based, in part, on any literature he has reviewed 
concerning relevant infonnation in this case. 
-   ES  
. r   
Vice President of perations 
Security Equipment Corporation 
  r   
Fenton, issouri 63026 
s SEC's ice President of perations, r. ance is fa iliar ith ost all aspects of 
SEC's business and ith the  pepper spray industry in the .S.A. and around the orld. is 
qualifications are more specifically set forth in his affidavit filed in support of SEC's motion for 
FENDANT'S  I  - age 16 
145 -  ( 404) 
summary judgment That affidavit is incorporated herein by reference Mr Nance may testify as
to the design and manufacture ofSECscivilian and law enforcement OC pepper spray products
He may testify as to manufacturing procedures quality control procedures and testing procedures
utilized by SEC as to its civilian and law enforcement OC spray products He will describe
SECsOC exposure testing on animals Mr Nance may also testify regarding all standards
regulations and requirements applicable to SECs civilian and law enforcement OC spray
products and SECs compliance with those standards regulations and requirements He is
expected to testify to facts and opinions consistent with those set forth in any deposition and
affidavit given and filed by him in this matter and with documents produced by SEC in this
litigation
Mr Nance may testify to the benefits risks and safety of OC use in law enforcement
agencies and correctional institutions the differences in consistencies potencies and
concentrations of OC and capsaicinoids of pepper spray products sold commercially and the
risks and benefits associated with pepper spray products of different consistencies and potencies
He will discuss the effects of exposure to OC pepper sprays He will testify that the state of
knowledge in the pepper spray industry in 2008 was that the adverse health effects of exposure to
OC pepper spray products were acute temporary reversible and recoverable and not chronic or
long term He may discuss the relevant literature in use and safety of OC by law enforcement
agencies and correctional institutions He may discuss the education and training of law
enforcement and correctional officers in OC use deployment and safety He will discuss the
labels and warnings on SECspepper spray products and give the opinion that those labels and
warnings were and are reasonable and adequate
Mr Nance is expected to give testimony consistent with his knowledge training
experience and expertise in rebuttal to testimony given by Plaintiffsexperts as to the
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r  j t. t ffi it i  i r rat  r i   r f r e. r.   t tif  s 
t  t e esi  a  a fact re f EC's ci ilian a  la  e f rce e t  e er s ra  r cts. 
e ay testify as to anufacturing procedures, quality control procedures and testing procedures 
tilize     t  it  i ilia   l  t   t .  ill i  
C's  r  t ti   i l . r.   l  t tif  r r i  ll t r s, 
r l ti s  r ire e ts li l  t  C's i ilia   l  f r t  s r  
r cts, a  EC's c lia ce it  t se sta ar s, re lati s a  re ire e ts.   
e ecte  t  testif  t  facts a  i i s c siste t it  t se set f rt  i  a  e siti  a  
affidavit given and filed by hi  in this atter and ith docu ents produced by SE  in this 
litig ti . 
r. ance ay testify to the benefits, risks and safety f  use in la  enforce ent 
agencies   i tit ti , t  ferences in consistencies, potencies  
concentrations of  and capsaicinoids of pepper spray products sold co ercially, and the 
risks and benefits associated ith pepper spray products of different consistencies and potencies. 
 ill i  t  ff t  f r  t   r r ys.  ill t tif  t t t  t t  f 
kno ledge in the pepper spray industry in 2008 as that the adverse health effects of exposure to 
 pepper spray products ere acute, te porary, reversible and recoverable, and not chronic or 
l  t r .   is ss t  r l t liter t r  i  s   s f t  f   l  f r t 
agencies and correctional institutions. e ay discuss the education and training f la  
enforce ent and correctional officers in  use, deploy ent and safety. e ill discuss the 
l ls  r i s  EC's r s r  r ts  i e t  i i  t t t s  l ls  
arnings ere and are reasonable and adequate. 
r. ance is expected to give testi ony consistent ith his kno ledge, training, 
expenence and expertise in rebuttal to testi ony gIven by Plaintiff s experts as to the 
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regulations standards and requirements applicable to SECs civilian and law enforcement OC
pepper sprays and as to the industry norms and standards of OC and major capsaicinoids in
different civilian and law enforcement OC spray products
II Sergeant Bret Kimmell
Sergeant Kimmell is an experienced correctional officer who has been trained numerous
times as an OC trainer and who has trained other correctional officers at IDOC institutions in
OC use deployment and safety Sergeant Kimmell may testify about the benefits risks and
safety of OC use in correctional institutions the differences in consistencies and potencies in
various OC pepper spray products and the risks and benefits associated with pepper spray
products of different consistencies and potencies He will discuss the known and observed
adverse health effects of exposure to OC pepper spray and give the opinion that these effects are
acute temporary reversible and recoverable and not chronic or long term He will discuss
IDOC training procedures education and safety generally and the specific OC trainings given to
Ms Major He will discuss the OC exposures received by Ms Major while at IDOC and during
OC trainings He may discuss the relevant literature on use and safety of OC by law enforcement
agencies and correctional institutions He is expected to give testimony consistent with his
knowledge training and expertise in rebuttal to testimony given by Plaintiffs experts and
consistent with facts and opinions to which he has testified or may testify in his deposition
given in this case
III Sergeant Daniel Schaffer
Sergeant Schaffer is an experienced correctional officer who has been trained numerous
times as an OC trainer and who has trained other correctional officers at IDOC institutions in
OC use deployment and safety Sergeant Schaffer may testify about the benefits risks and
safety of OC use in correctional institutions the differences in consistencies and potencies in
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re lati s, sta ards a  re ire e ts a lica le t  C's ci ilian a  la  e f rce e t  
pepper sprays and as to the industry norms and standards of OC and major capsaicinoids in 
different civilian and la  enforce ent  spray products. 
. Sergeant Bret i ell 
Sergeant i ell is an experienced correctional officer ho has been trained nu erous 
ti es s   tr i r,   s tr i  t r rr ti l fficers t I  i stit tions i  
 s , l t,  s f t . r t i ll  t stif  t t  efits, ris s  
safety of  use in correctional institutions, the differences in consistencies and potencies in 
arious  r s r  r ts,  t  ris s  fits ss i t  it  r s r  
products of different consistencies and potencies. e ill discuss the kno n and observed 
adverse health effects f exposure to  pepper spray and give the opinion that these effects are 
acute, te porary, reversible and recoverable, and not chronic or long-ter . e ill discuss 
I  training procedures, education and safety generally, and the specific  trainings given to 
s. ajor. e ill discuss the C exposures received by s. ajor hile at I  and during 
C trainings. e ay discuss the relevant literature on use and safety of C by la  enforce ent 
agencies and correctional institutions. e is expected to give testi ony consistent ith his 
kno ledge, training, and expertise in rebuttal to testi ony given by Plaintiffs experts, and 
consistent ith facts and opinions to hich he has testified, or ay testify, in his deposition 
given in this case 
II. Sergeant aniel Schaffer 
Sergeant Schaffer is an experienced correctional officer who has been trained nu erous 
ti es as an  trainer, and ho has trained other correctional officers at I  institutions i  
C use, deploy ent, and safety. Sergeant Schaffer ay testify about the benefits, risks and 
safety of OC use in correctional institutions, the differences in consistencies and potencies in 
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various OC pepper spray products and the risks and benefits associated with pepper spray
products of different consistencies and potencies He will discuss the known and observed
adverse health effects of exposure to OC pepper spray and give the opinion that these effects are
acute temporary reversible and recoverable and not chronic or longterm He will discuss
IDOC training procedures education and safety generally and the specific OC trainings given to
Ms Major He will discuss the OC exposures received by Ms Major while at IDOC and during
OC trainings He may discuss the relevant literature on use and safety of OC by law enforcement
agencies and correctional institutions He is expected to give testimony consistent with his
knowledge training and expertise in rebuttal to testimony given by Plaintiffsexperts and
consistent with facts and opinions to which he has testified or may testify in his deposition
given in this case
IV Sergeant Joshua Overgaard
Sergeant Overgaard is an experienced correctional officer who has been trained
numerous times as an OC trainer and who has trained other correctional officers at IDOC
institutions in OC use deployment and safety Sergeant Overgaard may testify about the
benefits risks and safety of OC use in correctional institutions the differences in consistencies
and potencies in various OC pepper spray products and the risks and benefits associated with
pepper spray products of different consistencies and potencies He will discuss the known and
observed adverse health effects of exposure to OC pepper spray and give the opinion that these
effects are acute temporary reversible and recoverable and not chronic or longterm He will
discuss IDOC training procedures education and safety generally and the specific OC trainings
given toMs Major He will discuss the OC exposures received by Ms Major while at IDOC and
during OC trainings He may discuss the relevant literature on use and safety of OC by law
enforcement agencies and correctional institutions He is expected to give testimony consistent
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arious C pepper s ray r t , a d the risks  be fits as iated ith pepper ra  
products of different consistencies and potencies. He will discuss the known and observed 
adverse health effects of exposure to  pepper spray and give the opinion that these effects are 
acute, te porary, reversible and recoverable, and not chronic or long-ter . e ill discuss 
IDO  training procedures, education and safety generally, and the specific  trainings given to 
s. ajor. e ill discuss the OC exposures received by s. ajor hile at I C and during 
 trainings. e ay discuss the relevant literature on use and safety of  by la  enforce ent 
agencies and correctional institutions. e is expected to give testi ony consistent ith his 
knowledge, training, and expertise in rebuttal to testi ony given by Plaintiff s experts, and 
consistent ith facts and opinions to hich he has testified, or ay testify, in his deposition 
given in this case 
. Sergeant Joshua vergaard 
Sergeant Overgaard is an experienced correctional officer who has been trained 
er s ti es as a   trai er, a   as trai e  t er c rrecti al fficers at I  
institutions in  use, deploy ent, and safety. Sergeant vergaard ay testify about the 
benefits, risks and safety of C use in correctional institutions, the differences in consistencies 
and potencies in various OC pepper spray products, and the risks and benefits associated with 
pepper spray products of different consistencies and potencies. He will discuss the known and 
observed adverse health effects of exposure to  pepper spray and give the opinion that these 
effects are acute, te porary, reversible and recoverable, and not chronic or long-ter . He will 
discuss I  training procedures, education and safety generally, and the specific  trainings 
given to s. ajor. He will discuss the OC exposures received by s. ajor while at IDOC and 
during C trainings. e ay discuss the relevant literature on use and safety of C by la  
enforce ent agencies and correctional institutions. He is expected to give testi ony consistent 
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with his knowledge training and expertise in rebuttal to testimony given by Plaintiffs experts
and consistent with facts and opinions to which he has testified or may testify in his deposition
given in this case
V Sergeant Nicholas Doan
Sergeant Doan is an experienced correctional officer who has been trained numerous
times as an OC trainer and who has trained other correctional officers at IDOC institutions in
OC use deployment and safety Sergeant Doan may testify about the benefits risks and safety
of OC use in correctional institutions the differences in consistencies and potencies in various
OC pepper spray products and the risks and benefits associated with pepper spray products of
different consistencies and potencies He will discuss the known and observed adverse health
effects of exposure to OC pepper spray and give the opinion that these effects are acute
temporary reversible and recoverable and not chronic or longterm He will discuss IDOC
training procedures education and safety generally and the specific OC trainings given to Ms
Major He will discuss the OC exposures received by Ms Major while at IDOC and during OC
trainings He may discuss the relevant literature on use and safety of OC by law enforcement
agencies and correctional institutions He is expected to give testimony consistent with his
knowledge training and expertise in rebuttal to testimony given by Plaintiffs experts and
consistent with facts and opinions to which he has testified or may testify in his deposition
given in this case
VI Healthcare providers
In addition to the experts listed above SEC may also call as a factexpert witnesses in
this case any one or all healthcare providers that at anytime have provided healthcare treatment
diagnosis advice consultation or prognosis to Plaintiff These healthcare providers include but
are not necessarily limited to Steve Asher MD Brent T BurtonMD MPH Joseph J Callanan
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ith his kno ledge, training, and expertise in rebuttal to testi ony given by Plaintiff s experts, 
a  c siste t ith facts a d inions t  ic  e as testifie , r a  testif , i  is e siti n 
given in this case 
. Sergeant Nicholas Doan 
ergeant oan is an experienced correctional officer ho has been trained nu erous 
ti es    tr i r,  ho  traine  t r rr ti l fficers t I  i tit tions i  
C use, deploy ent, and safety. Sergeant oan ay testify about the benefits, risks and safety 
  s  in ti l i tit ti , t  i fere  in ist ies  te ies i  i  
C pepper spray products, and the risks and benefits associated ith pepper spray products of 
iffer t sist ies  t i s. e ill iscuss t    s r  rs  lt  
effects f exposure to  pepper spray and give the opinion that these effects are acute, 
te porary, reversible and recoverable, and not chronic or long-ter . e ill discuss I  
training procedures, education and safety generally, and the specific OC trainings given to s. 
ajor. He will discuss the OC exposures received by s. ajor while at IDOC and during OC 
trainings. He may discuss the relevant literature on use and safety of OC by law enforcement 
agencies and correctional institutions. He is expected to give testimony consistent with his 
kno ledge, training, and expertise in rebuttal to testi ony given by Plaintiffs experts, and 
consistent ith facts and opinions to hich he has testified, or ay testify, in his deposition 
given in this case 
I. ealthcare providers 
In addition to the experts listed above, SE  ay also call, as a fact/expert itnesses in 
this case, anyone or all healthcare providers that at anyti e have provided healthcare, treat ent, 
diagnosis, advice, consultation or prognosis to Plaintiff. These healthcare providers include, but 
are not necessarily li ited to: Steve sher, ; rent T. urton, , PH; Joseph J. allanan, 
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MD at Boise Valley Asthma and Allergy Dan J Hendrickson MD formerly of Northwest
Pulmonary Clinic William Loveland MD at St Lukes Family Health Glenn W Moldenhauer
DC William P Robinson DC Janat EODonnell MD at Northwest Pulmonary Clinic Karen A
Pacheco MD MSPH at National Jewish Heath Matthew B Schwarz MD at Southwest Idaho
Ear Nose and Throat and Mousoomi M Sur MD at St LukesFamily Health
Such healthcare providers may be called to testify to facts and opinions contained in their
medical records regarding Plaintiff and to which they have testified or may give testimony in
any deposition given by them in this case They may also testify to facts and opinions within the
scope of their knowledge expertise and experience as they relate to their care and treatment of
Plaintiff and the subject matters of their expert disclosures in this case
OTHER DISCLOSED EXPERTS
SEC reserves the right to call and elicit expert opinion testimony from any and all experts
disclosed by Plaintiff in her August 5 2010 Expert Witness Disclosure andorin her March 28
2011 Supplemental Expert Witness Disclosure regarding anymatter for which they are qualified
and competent to give testimony including any matter within the scope of their expertise based
on their training education research study andor experience and any matter which is the
subject of their expert disclosures in this case any publications which they have authored
reviewed or relied on and any depositions or trial testimony given by them in this case and in any
other cases in which they have given expert testimony
The testimony of these other disclosed experts may be based on the records and
documents they have reviewed in this case any relevant medical and scientific literature and any
government and industry regulations standards and guidelines related to the subject matters
addressed in their expert disclosures or depositions taken of them in this case
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 at oise alle  sth a a  ller ; an J. e ric s ,  f r erl  f orth est 
Pul onary linic; illia  Loveland,  at St. Luke's Fa ily ealth; lenn . oldenhauer, 
; illia   i s , ; J t . 'Do n ll,  t orth est l r  li i ; ar   
ac ec , , S  at atio al Je ish eat ; atthe  . c arz,  at t est I a  
r, os   r t;  o s i . r,  t t. ke's il  lt . 
c  ealt care r iders a  e calle  t  testif  t  facts a  i i s c tai e  i  t eir 
edical records regarding laintiff and to hich they have testified, or ay give testi ony, in 
any deposition given by the  in this case. They ay also testify to facts and opinions ithin the 
scope f their kno ledge, expertise and experience as they relate to their care and treat ent of 
Plaintiff, and the subject atters of their expert disclosures in this case. 
 S  S 
SE  reserves the right to call and elicit expert opinion testi ony fro  any and all experts 
disclosed by Plaintiff in her ugust 5, 2010 Expert itness isclosure and/or in her arch 28, 
2011 Supple ental Expert itness Disclosure, regarding any atter for which they are qualified 
and co petent to give testi ony, including any atter ithin the scope f their expertise, based 
on their training, education, research, study and/or experience, and any atter hich is the 
subject of their expert disclosures in this case, any publications which they have authored, 
revie ed or relied on and any depositions or trial testi ony given by the  in this case and in any 
other cases in which they have given expert testi ony. 
he testi ony f these other disclosed experts ay be based on the records and 
docu ents they have revie ed in this case, any relevant edical and scientific literature, and any 
government and industry regulations, standards and guidelines related to the subject matters 
addressed in their expert disclosures or depositions taken of the  in this case. 
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CONCLUSION
SEC reserves the right to enlist additional testimony and opinions from the above
designated experts based on information subsequently produced information subsequently
gleaned during other depositions given in this case and through discovery and other opinions
and information subsequently developed by these and other witnesses in this case SEC reserves
the right to disclose additional materials and documents relied on by these experts
SEC reserves the right to amend modify delete from or add to this disclosure by
supplementation as further information is developed through discovery SEC further reserves the
right to withdraw anyone or all of its disclosed experts or to refrain from calling anyone or all of
its disclosed experts or to limit the scope ofany testimony given by its disclosed experts
DATED this 27 day ofApril 2011






 reser es t e ri t t  e list a iti al testi  a  i i s fr  t e a ove-
esi ate  e erts ase   i for atio  s seq entl  r ced, i f r ati  s se entl  
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and infor ation subsequently developed by these and other itnesses in this case.  reserves 
t  ri t t  is lose iti l t ri ls  t  r li    t  rts. 
SE  reserves the right to a end, odify, delete fro  or add to this disclosure by 
supple entation as further infor ation is developed through discovery.  further reserves the 
right to ithdra  anyone or all of its disclosed experts, or to refrain fro  calling anyone or all of 
its disclosed experts, or to li it the scope of any testi ony given by its disclosed experts. 
 t is 7th a  f ril, 1. 
Christopher C. Burke 
tt r e s f r efe a t 
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CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing DefendantsExpert Disclosures
on the following named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED this 27 day of April 2011
AL V
Christopher C Burke
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I hereby certify that I caused to be served the foregoing efendant's Expert isclosures 
n t e follo ing a e  erson(s) n t e ate indicated el , in t e a er indicated el : 
ar in r , . 
Eric B. Swartz, Esq. 
 & , C 
 . r line ri , ite  
. . ox  
oise, Idaho 83707 
E  this 27th day f pril, 2011. 
[ ] ia .S. il 
[X] i   li r  
[ ] ia si ile (208/489-89 ) 
[ ] ia er i t eli er  
Christopher C. Burke 
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Mark J Utell MD
Mark J Utell is Professor of Medicine and Environmental Medicine and Director of the
OccupationalEnvironme t Medicine Divisions at the University of Rochester Medical Center
He is also Associate Chairman of the Department of Environmental Medicine He served as
Director of the Pulmonary and Critical Care Division for 20 years through June 2006 He
received his BA degree from Dartmouth College his MD from Tufts University School of
Medicine in 1972 and upon completion of a fellowship in Pulmonary Medicine joined the
faculty at the University of Rochester in 1977
Dr Utells research and teaching interests have focused primarily on the effects of inhaled
particles fibers and vapors on the respiratory system Most recently his laboratory has focused
on clinical responses to ultrafine particles and mechanisms of response His laboratory has had
an active program examining human responses to oxidant gases including ozone and NO2
efforts have focused on pulmonary inflammatory responses and alterations in lung function in
susceptible groups including asthmatics His current research funding sources include the
Environmental Protection Agency CoDirector of a PM Center on ultrafine particles the
National Institutes of Health NIEHS New York State Energy Research and Development
Authority NYSERDA and the Electric Power Research Institute EPRI Currently he serves as
a consultant to Unifrax Corporation headquartered in Niagara Falls NY and the ConAgra
Corporation in Minneapolis MN Dr Utell has published extensively on the health effects of
inhaled gases particles and fibers in the workplace and environment and has over 100
publications as well as numerous presentations at professional meetings around the world He
has served as the Chairman of Workshops sponsored by the EPA the American Petroleum
Institute the Health Effects Institute and the American Thoracic Society and had significant
experience in developing national meetings
Dr Utell has served on a number of national committees and review panels for federal
public and private agencies He currently serves as Chair Health Effects Institute Research
Committee and has served as Chair of EPAsEnvironmental Health Committee and on the
Executive Committee of the EPA Science Advisory Board He is a former recipient of the
NIEHS Academic Award in Environmental and Occupational Medicine Dr Utell has been a
member of the National Research Councils NRC Committee on Research Priorities for
Airborne Particulate Matter and the Institute of Medicines IOM Committee to Review the
Health Consequences of Service during the Persian Gulf War he is currently a member of the
NRC Board on Environmental Studies and Toxicology BEST and IOM Committee on
Biodefense Analysis and Counter measures He is on the editorial boards of the Journal of
Aerosol Medicine and Environmental Bioindicators having previously served on the editorial
boards of Environmental Health Perspectives Inhalation Toxicology and the Annals of Internal
Medicine
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Mark J Utell MD
Birthplace and Date New York New York
Home Address
Pittsford New York 14534
Business Address Department of Medicine
Pulmonary and Critical Care Unit Box 692
University of Rochester School of Medicine
Rochester New York 146428692
Marital Status Married to Lois Brooks Utell






Dartmouth College Hanover New Hampshire
September 1964June 1968 BA degree cum laude
awarded June 1968
Tufts University School of Medicine Boston Massachusetts
19681972 MD degree awarded June 1972
Straight Medicine St ElizabethsHospital Boston
Massachusetts July 1972June 1973
Internal Medicine St ElizabethsHospital Boston
Massachusetts July 1973June 1975
19751977 Instructor and Fellow in Pulmonary Medicine University of
Rochester School of Medicine Rochester New York
19771982 Assistant Professor of Medicine University of Rochester School of
Medicine Rochester New York
19771989 Director Respiratory and Medical Intensive Care Units Strong
Memorial Hospital Rochester New York
19821986 Associate Professor of Medicine University of Rochester School of
Medicine Rochester New York
19831986 Associate Professor of Toxicology in Biophysics University of
Rochester School of Medicine Rochester New York
19841991 CoDirector Pulmonary and Critical Care Unit University of
Rochester School of Medicine Rochester New York
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Mark J Utell MD
School of Medicine Rochester New York
Professional Appointments contd
19881992 CoDirector Occupational Medicine Program University of
Rochester School of Medicine Rochester New York
1991 2006 Director Pulmonary and Critical Care Unit University of
Rochester School of Medicine Rochester New York
1992 Associate Chairman for Clinical Affairs Director Occupational
and Environmental Medicine Division Department of
Environmental Medicine University of Rochester School of
Medicine Rochester New York
1992 Professor of Medicine and Environmental Medicine University of
Rochester School of Medicine Rochester New York
19981999 Acting Chairman Department of Medicine University of
Rochester School of Medicine Rochester New York
Board Certification
Diplomate of the American Board of Internal Medicine June 1975
Diplomate of the American Board of Internal Medicine Pulmonary Diseases Subspecialty June
1978
Professional Societies
Fellow American Association for the Advancement of Science
Member American Physiological Society
Member American Thoracic Society
Chairman Scientific Assembly on Environmental and Occupational Health 1987
Fellow American College of Chest Physicians
Steering Committee Section Environmental and Occupational Health 19831987
Member New York Trudeau Society President 1986
Fellow American College of Physicians
Member American College of Occupational and Environmental Medicine
National Committees and Service
Consultant Pulmonary Diseases Veterans Administration 1977
Consultant Environmental Protection Agency Air Quality Criteria Document for Particulate
Matter and Sulfur Oxides Research Triangle Park 1980
Consultant American Thoracic Society Committee on Guidelines as to What Constitutes and
Adverse Respiratory Health Effect of Air Pollution 1981 1985
2
000172
c l  edicine, ochester, Ne  ork 
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Associate Chair an for Clinical Affairs, Director, ccupational 
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Mark J. Utell, M.D. 
1992- Professor of Medicine and Environmental Medicine, University of 
t r l f i i , ster,  r  
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iplo ate of the A erican Board of Internal edicine, Pul onary iseases Subspecialty, June 
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, erican racic i t  
hair an, Scientific Asse bly on Environ ental and ccupational ealth (1987) 
, i  lege f t icians 
Steering Co ittee, Section Environ ental and Occupational Health (1983-1987) 
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o lt t, ul onary is , terans Ad inistration (197 - ) 
Consultant, Environmental Protection Agency, "Air Quality Criteria Document for Particulate 
Ma ter and Sulfur xides", Research Triangle Park (1980) 
Cons lt t, A erican Thoracic ociety ittee on "Guidelines as to hat onstitutes nd 
Adverse espiratory Health Effect of Air ollution" (1981-1985) 
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Consultant American Thoracic Society American College of Chest Physicians Committee on
Diagnostic Criteria forAsbestos Related Disease 19821985
Committee American Thoracic Society Update on Health Effects of Air Pollution 1981 1985
Committee American Thoracic Society American Lung Association Air Conservation Materials
19821986
Advisory Committee Department of Energy to Battelle Pacific Northwest Laboratories Richland
for ozone proposals Seattle 1981
Committee Environmental Protection Agency Development of Research Plans for Clinical
Studies of Inhaled Pollutants 1981
Reviewer NIH Site Visit Committee Clinical Research Center at Northwestern University 1982
National Committees and Service contd
Advisory Committee University of North CarolinaEnvironmental Protection Agency Cooperative
Agreement Center for Environmental Health Sciences Chapel Hill 19821992
Outside Reviewer NIH Respiratory and Applied Physiology Study Section 1982
Ad Hoc Reviewer NIH Respiratory and Applied Physiology Study Section 1983
NIEHS Special Study Section Project Site Visit Rancho Los Amigos Hospital Downey CA
1984
Member Scientific Advisory Board Alberta Canada Acid Deposition Research Project 1984
1988
Outside Reviewer Canadian Government Occupational Health and Safety Heritage Grant
Program 1984 1985
Consultant Environmental Protection Agency Research Plans for Nitrogen Dioxide 1984
Member EPA Clean Air Scientific Advisory Committee CASAC Criteria Document for Ozone
19841989
Health Effects Institute Health Research Committee 19851994
Chairman ad hoc NHLBI Cardiovascular and Pulmonary Study Section 1986
Reviewer NIEHS Program Project Site Visit John B Pierce Foundation Yale University 1986
Reviewer NHLBI SCOR Site Visit Tulane University New Orleans 1986
Member National Research Council National Academy of Sciences Commission on Life
Sciences Panel on Pulmonary Toxicology Committee on Biological Markers 19861989
Board of Directors American Lung Association of New York State 19861988
Member Science Advisory Board Environmental Protection Agency 1987
Member Panel on Airborne Particulate Matter in Spacecraft National Aeronautics and Space
Administration NASA Houston Texas 1987
Conference CoChairman Susceptibility to Inhaled Pollutants sponsored by EPA Health Effects
Institute and American Petroleum Institute Williamsburg Virginia 1987
Member Clean Air Science Advisory Committee CASAC Environmental Protection Agency
19881994
Chairman EPA Clean Air Science Advisory Committee CASAC Subcommittee on Acid Aerosols
1988
Member New York State CommissionersPanel on Tuberculosis Syracuse NY 1988
Member RJ Reynolds Corporation Peer Review Panel Criteria and Biological Studies of the
New Cigarette Atlanta Georgia 1988
Chairman EPA Clean Air Science Advisory Committee CASAC Subcommittee on EPA Clinical
Branch Review Chapel Hill NC 1989
Chairman EPA Search Committee Director Human Studies Division Health Effects Research
Laboratory Research Triangle Park NC 1989
Reviewer NIEHS Center Grant Site Visit New York University Institute of Environmental
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Mark J Utell MD
Medicine Tuxedo NY 1989
Member EPA Review Panel NAPAP Direct Health Effects Workshop DurhamNC 1989
Steering Committee Institute for Health Policy Analysis Georgetown University Workshop on
Adverse Effects of Environmental Exposures Washington DC 19891990
Member Ceramic Fiber Advisory Board Carborundum Company Niagara Falls NY 1989
Reviewer NIEHS Center Grant Site Visit Johns Hopkins University School of Hygiene and Public
Health Baltimore MD 1989 1991
CoChairman American Canadian Lung AssociationAmerican Canadian Thoracic Societies
Workshop on Acid Aerosols Santa Fe NM 1990
Reviewer NIEHS Center Grant Site Visit University of Iowa Medical Center Iowa City Iowa
1990
Member NIEHS Environmental Health Sciences Review Study Section Research Triangle Park
NC 19901994
Member DeansCommittee University of North Carolina Center for Environmental Medicine and
Lung Biology Review Chapel Hill NC 1990
Member National Institute of Environmental Health Sciences Fourth Task Force for Research
Planning in Environmental Health Sciences 1991
Member EPANIEHS Workshop Research Needs on Health Effects and Risks of Chronic Ozone
Exposure Crystal City VA 1991
National Committees and Service contd
Member Office of Technology Assessment OTA Workshop Identifying and Controlling
Pulmonary Toxicants Washington DC 1991
Member NASA Environmental Health Sciences Working Group Washington DC 1991 1994
Member Ceramic Fiber Advisory Board CarborundumUnifrax Company Niagara Falls NY
1991
Member ATSDR Workshop Lung and Respiratory Diseases Test Battery Atlanta GA 1992
Member NIEHS Workshop Environmental Asthma Research Triangle Park NC 1992
Member EPANIEHSATSDR Workshop Equity in Environmental Health Research Issues and
Needs Durham NC 1992
Member NIEHS Review of Asthma Technical Proposals Research Triangle Park NC 1992
Member American Thoracic Society Planning Committee 19921994
Member Scientific Advisory Board Center for Indoor Air Research Linthicum MD 19922000
Member EPA Clean Air Scientific Advisory Committee CASAC Criteria Document for SO2
19931994
Member National Academy of Sciences Institute of Medicine Committee to Review the Health
Consequences of Service During the Persian Gulf War 19931996
Member American Thoracic Society Committee on Respirator Protection Guidelines 19931995
Member EPA Clean Air Scientific Advisory Committee CASAC Criteria Document for Ozone
19931995
Member Scientific Advisory Committee for the EPRIDuke Power Company Project Lung Health
and Risk Assessment After Respirable Fiber Exposure 19931996
Member Advisory Committee Colloquium on Particulate Air Pollution Irvine CA 1994
Member
External Advisory Committee Columbia University NIEHS Environmental Health Sciences
Center 1994
Member Siloxane Science Advisory Board Dow Corning Corporation Midland MI
19942000
Consultant EPA Clean Air Scientific Advisory Committee CASAC Criteria Document for
Id
000174
r  . tell, .D. 
dicine, xedo,  (1 9) 
e ber,  evie  anel,  irect ealth ffects orkshop, urham,  (1989) 
t ri  ittee, I tit t  f r lt  li  lysis, r t  i r it  r   
r  ff t  f ir t l osures, shington,  (1 -1 0) 
r, r i  i r i r  rd, r r  pany, i r  lls,  (1 9- ) 
i er, I  t r r t it  isit,  i  i r it  l f i   li  
lth, lti ore,  (1 , 1) 
o- hair an, erican- anadian Lung ssociation/ erican anadian Thoracic ocieties, 
r   i  rosols, t  e,  (1 0) 
i r, I  t r r t it  isit, i r it  f I  i l nter, I  ity, I  
(1 ) 
r, I  vir t l lt  ci c s vi  t y ction, s rc  ri l  ark, 
 (199 -1 4) 
r, ean's itt e,    r lina,      
 i l  i , l ill,  (1 ) 
er, i l i   i l l  i ces, t      
l i  i  i t l lt  i  (1 ) 
r, PAINIEHS r op, r    lt  ff t   i  f r i   
re,  ity,  (1 1) 
    (c nt'd): 
r, ffice of echnology ssess ent (O A), orkshop, Identifying and Controlling 
l r  i t , i t ,  (1 ) 
e ber, ASA, Environ ental ealth Sciences orking roup, ashington,  (1991-1994) 
r, r i  i r i r  r , r r /Unifra  y, i r  lls,  
(19 - ) 
r,  r ,   ir t ry i  t tt r , tl t ,  (1 ) 
e ber, I  orkshop, nviron ental sth a, esearch riangle ark,  (1992) 
r, PAINIEHS/ATSD  , it  i  i t l lth:    
s, r ,  (19 ) 
e ber, NIEHS Review of Asth a Technical Proposals, Research Triangle Park, NC (1992) 
e ber, erican horacic ociety lanning o ittee (1992-1994) 
e ber, Scientific Advisory Board, enter for Indoor Air esearch, Linthicu ,  (1992-2000) 
e ber, EPA lean Air Scientific Advisory o ittee (CASAC), riteria ocu ent for 02 
(199 -19 ) 
r, ti l  f i  - I tit t  f i i , itt  t  i  t  lt  
Consequences of Service During the Persian ulf ar (1993-1996) 
r, ri  r ic i ty itt   ir t r r t tion i li  (199 -19 ) 
r,  l  ir ci tific vis ry itt  (C C), rit ri  c t f r z  
(1993-19 ) 
e ber, cientific dvisory o ittee for the I/Duke o er o pany roject, Lung ealth 
and isk Assess ent After espirable Fiber Exposure (1993-1996) 
e ber, Advisory Co ittee, Colloquiu  on Particulate Air Pollution, Irvine, CA (1994) 
ber 
, xternal dvisory o ittee, olu bia niversity I  nviron ental ealth ciences 
t r (19 - ) 
e ber, Siloxane Science Advisory Board, Dow Corning Corporation, idland, I 
(1994-2000 ) 
Consultant, EPA Clean Air Scientific Advisory Committee (CASAC), Criteria Document for 
4 
Mark J Utell MD
Particulate Matter 19941996
Member American College of Chest Physicians Committee Assessment of Asthma in the
Workplace 19941996
Member American Council on Science and Health Board of Scientific and Policy Advisors
1994
Member US NIEHSMexico National University of Mexico Workshop on Environmental
Health Mexico City Mexico 1995
Member EPA Environmental Health Committee 19952002
Member American Thoracic Society Guidelines as to What Constitutes an Adverse Health Effect
19961998
Member Organizing Committee 2nd Colloquium on Particulate Air Pollution and Health Park
City Utah 1996
Member and Workshop Rapporteur EPA Workshop on Asthma and the Environment RTP NC
1996
Member Workshop Review of the Scientific Evidence in Particulate Matter The Annapolis Center
Annapolis MD 1997
Member EPA Environmental Health Committee Proposed Guidelines for Carcinogen Risk
Assessment Washington DC 1997
Member Institute of Medicine National Academy of Sciences Committee on the Evaluation of
the DOD Comprehensive Clinical Evaluation Program Washington DC 1997
Chair Workshop on Clinical Studies with Particulate Matter American Petroleum Institute
Arlington VA 1997
Consultant Board on Environmental Studies and Toxicology National Research Council
Research Priorities on Particulate Matter 1997
National Committees and Service contd
Member Health Effects Institute Workshop on Designing Studies of Personal Exposure to PM
and Acute Health Effects Chair Working Group on Studies of Acute Health Effects
Washington DC 1997
Member Environmental Protection Agency Workshop on Particulate Matter Research Program
Chair Working Group on Toxicology Durham NC 1997
Member National Research Council Committee on Research Priorities for Airborne Particulate
Matter 1998
Member Executive Committee Science Advisory Board Environmental Protection Agency
19982001
Member National Research Council Subcommittee on Manufactured Vitreous Fibers 1998
2000
Board of Directors Annapolis Center Annapolis MD 19981999
CoChair EPA SABSAP Joint Subcommittee on Data from Human Testing Washington DC
1998
Member Workshop Review of Potential Impact of Climate Change on World Public Health The
Annapolis Center Annapolis MD 1998
Chair Environmental Health Committee Science Advisory Board Environmental Protection
Agency 19982001
Member OSHA Workshop on Environmental Tobacco Smoke Risk Assessment Baltimore MD
1998
Chair EPA Environmental Health Committee Proposed Guideline for Carcinogenic Risk
Assessment Washington DC 1999
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Chair EPA Environmental Health Committee Review of the Health Risk Assessment of 13
Butadiene Washington DC 1999
Chair EPA Science Advisory Board Cancer Risk Assessment Guidelines Review Subcommittee
Application to Children Washington DC 1999
Member Science Advisory Panel New York University Particle Center 1999
Chair Research Committee Health Effects Institute Boston MA 2000
Member EPA Research Strategies Advisory Committee 2000
Chair API and EPA Workshop on Cardiovascular Effects Associated with Air Pollution
Rochester NY 2001
Member Physican Panel Office of Worker Advocacy Department of Energy 20022004
Member Search Committee Director Human Studies Division EPA National Health and
Environmental Effects Research Laboratory 2002
Member and Keynote Speaker NIEHS and EPA Workshop on Role of Environmental Agents in
Cardiovascular Disease Durham NC August 2002
Chair Review of EPA Clinical Studies Division Research Triangle Park NC 2003
Chair External Advisory Committee NIEHS Center Columbia University New York 2003
Chair External Review Committee University of North Carolina Center for Environmental
Medicine Allergy and Lung Biology Chapel Hill NC 2004
Member Institute of Medicine Committee on Biodefense and Countermeasures 2005
Chair External Advisory Committee Clinical Research and Occupational Medicine Division
Environmental and Occupational Health Sciences Robert Wood Johnson Medical School NJ
2004
Member National Institute Environmental Health Sciences Panel in Nanotechnology 2004
Chair Review of EPA Clinical Division Research Triangle Park NC 2005
Keynote Speaker Concepts in Inhalation Toxicology and Pulmonary Drug Development 8th
Annual Lovelace Respiratory Symposium Albuquerque NM 2005
Speaker University of Cincinnati Department of Environmental Health Seminar Clinical studies
with ultrafine particles 2005
Member Institute of Medicine Committee on Biodefense Analysis and Countermeasures 2005
2007
Member DeansCommittee to Review Department of Environmental Health at Harvard School of
Public Health Boston MA 2005
Member National Research Council Board on Environmental Studies and Toxicology BEST
2005
Member World Health Organization Air Quality Guidelines Bonn Germany 2005 2007
Keynote Speaker Nanoparticles Health and Safety Corning Corporation America Health and
Safety Conference Corning NY 2008
National Committees and Service contd
Speaker Chemical Respiratory Allergy RIFM Workshop Physiology and pathology of respiratory
sensitization and airway inflammation Immunological vs irritant responses London 2006
Member EPACDC Symposium on Air Pollution and Health Research Triangle Park 2006
Member EPA Board of Scientific Counselors Human Risk Assessment 20072008
Chair National Research Council Committee to Review the NIOSH Respiratory Disease
Research Program 20062008
Member Institute of Medicine and National Research Council Workshop on Evaluating NIOSH
Programs Lessons Learned and Next Steps Washington DC November 2008
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Awards and Honors
NIH Pulmonary Training Fellowship 19751977
Fellow American College of Chest Physicians 1979
Fellow American College of Physicians 1981
American Cancer Society Research Grant 19791981
National Institute of Environmental Health Sciences Research Grant Award 1981 1994
Health Effects Institute Research Award 19831987
American Physiological Society 1984
Health Effects Institute Health Research Committee 19851994
Member National Institute of Environmental Health Sciences NIEHS Environmental Health
Review Study Section 19901994
National Institute of Environmental Health Sciences Academic Award in Environmental and
Occupational Medicine 19911996
Fellow American Association for the Advancement of Science 1995
Executive Committee Science Advisory Board Environmental Protection Agency 19982001
Environmental Protection Agency Particulate Matter Center Grant Award CoDirector 1999
Health Effects Institute Health Research Committee 2000
Intramural Committees
Strong Memorial Hospital Intensive Care Committee 19771987
Internship Selection Committee Department of Medicine 1981 1988
Development of Environmental and Occupational Medicine Course University of Rochester
School of Medicine 19831984
DeansCommittee on Veterans Administration Affairs 19831985 Toxicology Admissions and
Policy Committee University of Rochester School of Medicine 1986
Human Use of Radioisotopes Committee University of Rochester School of Medicine 1986
Ad Hoc Search Committee Associate Chairman for Clinical Affairs Department of Medicine
19871988
Chairman Search Committee Director of Occupational and Environmental Health in the
University Health Service 1988
Member Search Committee Chair Department of Anesthesiology 19911992
Member Medical Education Council 1992
Member Review Committee Department of Pediatrics and Division of Neonatology 1993
Chair Search Committee Director Division of Allergy Immunology Rheumatology Department
of Medicine 19931994
Member URMFG Advisory Committee 19962001
Member Search Committee Director Critical Care Medicine 1997
Member Review Committee Department of Pediatrics and Division of Neonatology 1997
Member Promotions Committee Department of Medicine 1999
Member Department of Medicine Leadership Committee 2000
Chair Search Committee Director of Liver and Digestive Disorders 2001
Member Medical School Advisory Committee University Promotions 2001 2004
Member Search Committee Senior Associate Dean for Academic Affairs 20022003
Chair Search Committee Director of Neurotoxicology Environmental Medicine 2004
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Greener Burke Shoemaker PA
950 W Bannock Street Suite 900
Boise Idaho 83702
Re Billie Jo Major v Security Equipment Corporation
Dear Mr Burke
At your request I reviewed the medical file and documents in the above referenced
matter Specifically I reviewed the following
k MI
Complaint and Answer
Medical Records National Jewish Hospital DrKaren Pacheco
Medical Records Northwest PulmonaryakIdaho Pulmonary Associates
Medical Records St Lukes Family HealthDr William Loveland
Medical Records Saint Alphonsus Boise Idaho
Medical Report Dr BrentTBurton July 29 2010
Medical Reports Dr Joseph Callanan Boise Valley Asthma and AllergyClinic
1996
Medical Reports Dr Matthew Schwarz Otolaryngology 19962001
Medical Reports Idaho Sleep Disorders Center 20012003
Medical Reports Dr Stephen Asher Neurological Associates
Medical Reports Chiropractic Center
Billie Jo Major Employment History Summary
OC Exposure History Chart
Material Safety Data Sheets for Sabre OC Products
Capsaicin Safety Reports from National Institute of Justice Environmental
Protection Agency University ofNorth Carolina and Police Departments
Product Safety Lab Test Sheets
Deposition Transcript Billie Jo Major workerscompensation case
Deposition Transcript Dr Daniel J Hendrickson March 3 2011
Deposition Transcript Dr William Loveland March 8 2011
Deposition Transcript Dr JanatODonnell March 9 2011
Deposition Transcript Bret RKimmel February 142011 IDOL
601 Elmwood Avenue Box 692 Rochester NY 146428692
585274861 5852731114 fax wwrvurmcrochesteredu
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Department of Medkine 
Pulmonary and Critical Care Medicine Division -RoCHESTER 
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hri t r .  
r r r  r  A. 
 . nnock Str t - it   
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e: ill  J   v. ecurit  i  r t  
Dear r. Burke: 
MEDICl:-lE ofTH1. H1GHEST ORDER 
  st,   t  i l  o   i    f  
tt r. pecifically, I r i  t  f ll ing: 
DOCUMENTS REVIEWED 
•    
• e ical ec r s - ational Je ish ospital (Dr. aren Pacheco) 
• edical ecords -- Northwest Pul onary a/kJa Idaho Pul onary Associates 
• e ical ec r s -- t. uke's a ily ealth (Dr. illia  oveland) 
• edical ecords -  Jpho , is  1da  
•  t -- r. re t . rt  (Jul  , 0) 
• e  e rts -- Dr. Joseph Callanan (Boise Valley Asthma and Allergy Clinic, 
) 
• e ic  ts -- r. atthe  ch arz (Otolaryngology 1996-2001) 
• e ical e rts -- Idaho lee  isorders e ter (2 01-20 ) 
• e ic  e rts - r. t e  s er (Neurological s i t ) 
• e ic  e rts - iropra tic enter 
• illie J  ajor loy e t istory ary 
• C Exposure istory hart 
• aterial Safety ata heets for re  Products 
• apsaicin Safety eports fro  ationa1 Institute of Justice, nviron ental 
Protection Agency, University of North Carolina, and Police Departments 
• Product a ety Lab Test heets 
• Deposition Transcript -- Billie Jo ajor worker's co pensation case 
• Deposition Transcript - Dr. Daniel J. Hendrickson (March 3, 20 ) 
• Deposition Transcript -- Dr. iJliam Loveland (March 8, ) 
• Deposition TlBDScript -- r.Ja at 'Do neD (March 9, ) 
• Deposition Transcript -- Bret R. Kimmel (February 14,20 1 - IDOC) 
601 Elmw od Avenue . Box 692 . Rochester. NY 14642·8692 
585.275.4861 ·585.273.1114 fax· www.urmc.rochest r.edu 
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Deposition Transcript Daniel J Schaffer February 142011 IDOC
Deposition Transcript Sara AnneMare Link February 142011 IDOC
Deposition Transcript Joshua E Overgaard February 142011 IDOC
Deposition Transcript Nicholas Doan February 142011 IDOC
Security Equipment Documents
PlaintiffsExpert Disclosure regarding Dr Gerald Yost
Dr Christopher A ReillysAffidavit April21
Dr Christopher AReilly Final Report
Imaging Studies St LukesRadiology Group February 27 2008
Ms Billie Major began experiencing respiratory symptoms in 1996 She requiredmultiple medical visits for sinus symptoms rhinitis and bronchitis in the late 1990s and
early 2000s In July 2004 she went to work for the Idaho Department of Corrections In
that capacity she was required to receive training with and occasionally use Oleoresin
Capsicum OC spray She reported worsening respiratory symptoms from the OC
exposure while working at the correctional facility She especially noted worseningcough after a training exposure on March 3 2008
VisionofSecruitvtenCorno4 fibre R
18 um
Security Equipment Corporation was the manufacturer and distributor of Sabre Red
Oleoresin Capsicum spray which Ms Majors used from July 2004 to approximatelyMarch 2008
A11Emosure
Ms Major was hired by the Idaho Department of Corrections in July 2004 After herinitial training she began working at the maximum security facility in Boise Her
responsibilities included participation on a response team as well as tier checks feeding
restraining offenders etc In her work capacity she carried pepper spray on her belt She
participated in OC training on July 1382007 and March 3 2008 with a Sabre Red
product There were 2recorded incidents with exposure to SEC Sabre Red products on
January 14 and 31 2008 During the 4 years Ms Major worked at the correctional
facility she estimated that she sprayed pepper spray at 3 or 4 prisoners usually through autility port she did not have any symptoms associated with any ofthese events
CA 9M9zV1 S99 oein dooZL Lt LZ jdv
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• Deposition Transcript -- Danie1 J. Schaffer (February 14,2011 - IDOC) 
• Deposition Transcript -- Sara Anne- are Unit (February ]4,2011 -IDOC) 
• Deposit on Transcript -- Joshua E. Overgaard (February 14,2011 -IDOC) 
• Deposit on Transcript - Nicholas Doan ( bruary 14.201  -IDOC) 
• Security Equipment Documents 
• Plaintiff's Expert Disclosure regarding Dr. Gerald Yost 
• Dr. Christopher A. Reilly's Affidavit ( pril 20, 2(11) 
• Dr. Christopher A. ReiUy's Final Report 
FlLMS REVIEWED 
• I a i  t ies -- St. te's adiology r up -- February 27,2008 
SUMMARY OF RECORDS 
Ms. Billie Major began experiencing respiratory symptoms in 1996. Sbe required 
uJtiple medical visits for sinus sy pto s. rhinitis, and bronchitis in the late 1990s and 
early 2000s. In July 2004, she went to work for the Idaho Department of Corrections. In 
that capacity. she was required to receive training with and occasionalJy use Oleoresin 
Capsicum (OC) spray. She reported worsening respiratory symptOms from the OC 
exposure while working at the correctional facility. She especially noted worsening 
cough ter  training os re  arc  , . 
D agsion f ecuritv EuiPm ot oi]JqraUon Sabre ed Oleomin CapsIcum 
SJray; 
Security Equipment Corporation was the manufacturer and distributor of Sabre Red 
Oleoresin Capsicum spray, which Ms. Majors used from July 2004 to approximately-
March 2008. 
AJle&edEgosore: 
Ms. Major was hired by the Idaho Depa.rtment of Corrections in July 2004. After her 
in tial training. she began working at the maximum security facility in Boise. Her 
responsibilities inc1uded participation on a response team as well as tier checks, feeding, 
restraining offenders, etc. In her work capacity. she carried pepper spray on her belt. She 
participated in OC training on July 13118,1JJ07 and March 3,2008 with a Sabre Red 
product. There were 2-recorded incidents with exposure to SEC Sabre Red products on 
January 14 and 31, 2008. During the 4 years Ms. Major worked at the correctional 
facility, she estimated that she sprayed pepper spray at 3 or 4 prisoners, usually through a 
utility port; she did not have any symptoms associated with any oftbesc events. 
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On March 3 2008 MsMajor was assigned to mandatory training This included walking
into a room that had previously been sprayed with OC spray She was in the room briefly
performing the required actions completed the exercise washed drove home and
changed her clothing She experienced worsening cough that evening and alleged that
she had been using her albuterol inhaler more frequently at the time of the mandatory
training Apparently she did not return to work following the day of mandatory training
Other E
Ms Major has never been a cigarette smoker Her allergist in December 1996 noted that
she does seem to have quite a bit of irritants at work and they were able to clean some
ducts out and apparently cut down on some dust exposure plus irritation Her allergist
stated that he was provided with a long list of chemicals that she was exposed to but that
none of them could be really tested in any way and that they simply needed to be
avoided He further stated that her business was going to be moving to a new location
the new site woWd probably have a better system of ventilation and perhaps at this point
this will take care of her problem
Past Mediml Riltw
Ms Major has an extensive past medical history that includes the following allergic
rhinitis acute sinusitis obstructive sleep apnea chronic bronchitis pneumonia obesity
gastroesophageal reflux disease hypothyroidism hypertension restless leg syndromeherpes labialis depression and affective disorder
MsMajor has a significant respiratory history dating to at least 1996 She had symptoms
of chronic sinusitis persistent rhinitis and mucoid discharge She received multiple
courses of antibiotics for her upper respiratory symptoms in the spring of 1996 In
October 1996 she was evaluated for persistent allergic rhinitis and maintained on
antihistamines and nasal steroids She was evaluated by an allergist in November 1996
and diagnosed with underlying allergy primarily to house dust causing recurrent
symptoms of nasal congestion sinus infections and headaches On formal testing she
was skin test positive to house dust mite She was also begun on an Atrovent nasal
inhaler for her upper respiratory symptoms Over the next couple of years she continued
to require evaluation and treatment for chronic nasal obstruction with multiple
medications including antihistamines decongestants and nasal steroids In January 1999
she underwent a procedure to reduce the size ofher nasal turbinates
In addition to the upper respiratory symptoms Ms Major also experienced frequent
episodes of bronchitis characterized by cough and production of yellow to green mucous
In June and July of 2000 she was treated with antibiotics for an episode of bronchitis In
2001 she was evaluated for sleep disturbance and her review of systems was positive for
nonproductive cough At that time she was diagnosed with obstructive sleep apnea She
continued to have sleep related problems as well as chronic symptoms of rhinosinusitisand bronchitis
trd 900Zt995 Ilsin d00ZL LL LZ add000203
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On Marcb 3, 2008, Ms. Major was assigned to mandatory training. This iocluded walking 
ioto a room that had previously been spraycd with OC spray. She was in the room briefly 
perfonning the Jequired actions, completed the exercise, washed, drove home, and 
changed her clothing. She experienced worsening cougb that evening and alleged that 
she had been usiog her albuterol inhaler more frequently at the time of the maDdatory 
training. Apparently, she did not return to work following the day of mandatory training. 
OtherEagores; 
s. ajor bas never been a cigarette smoker. Her allergist in ece ber 1996 noted that 
"she does see  to have quite a bit of initants at ork and they were able to clean so c 
du t  out and apparentl  cut down on so  dust exposure, plus irritation." Her allergist 
stated that he was provided with a 10Dg list of chemicals that she was exposed to but that 
none of them could be really tested in any way and that they simply needed to be 
avoided. He further stated that her business was going to be moving to a new location; 
the new site would probably have a better system of ventilation and perhaps at tbis point 
 ill t     r blem. 
ut r4caJ Histoa: 
Ms. Major has an extensive past medical history that includes the following: allergic 
rhinitis, acute sinusitis, obstructive sleep apnea, chronic bronchitis, pneumonia. obesity, 
gastroesophageal reflux disease, hypothyroidism. hypertension, restless leg syndrome, 
e  l , i ,   . 
Ms. Major has a significant respiratory history dating to at least 1996. She had symptoms 
of chronic sinusitis, persistent rhinitis. and mucoid discharge. She received multiple 
courses of antibiotics for her upper respiratory symptoms in the spring of 1996. In 
October 1996, she was evaluated for persistent allergic rhinitis and maintained on 
antihistamines aDd nasal steroids. She was evaluated by an alJergist in November 1996 
and diagnosed with underlying allergy primarily to house dust causing recurrent 
symptoms of nasal congestion, sinus infections, and headaches. On fonnal testing. she 
was skin test positive to house dust mile. She was also begun on an Atrovent nasal 
inbaler for her upper respiratory symptoms. Over the next couple of years, she continued 
to require evaluation and treatment for chronic nasal obstruction with multiple 
medications including antihistamines, decongestants, and nasal steroids. In January 1999, 
she underwent a procedure to reduce the sae of her nasal turbinates. 
In addition to the upper respiratory symptoms, Ms. Major also experienced frequent 
episodes of bronchitis characterized by cough and production of yellow to green mucous. 
In June and July of 2000, she was treated with antibiotics for an episode of bronchitis. In 
2001, she was evaluated for sleep disturbance and her review of systems was positive for 
nonproductive cough. At that time, she was diagnosed with obstructive sleep apnea. She 
continued to have sleep related problems as welJ as chronic symptoms of rhinosinusitis 
and bronchitis. 
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In January 2003 Ms Major was diagnosed with pneumonia She reported being under
considerable stress related to work She was suffering from difficulty sleeping and was
using melatonin and Wellbutrin for sleep and her affective disorder In March 2003 she
was again treated for bronchitis In January 2005 she wasseen for 3 weeks of cough and
nasal congestion Herchronic medication included Pepcid for her reflux and Klonopin for
restless leg She complained of shortness of breath and cough and was continued on
inhaled bronchodilators Spirometry performed May 17 2005 was normal In 2006 and
2007 she continued to complain of respiratory symptoms and rhinosinusitis She found
some symptomatic improvement with the inhaled bronchodilators
Following the training episode in March 2008 Ms Major underwent a comprehensive
pulmonary evaluation Over the course of a year she underwent a very extensive workup
with chest xrays chest CT scan GI studies pulmonary function tests methacholine
challenge study and fiberoptic bronchoscopy her studies were all essentially normal
Nodules were noted on a chest Cr scan in February 2008 but they resolved
spontaneously on subsequent studies
In April 2009Ms Major was seen at the National Jewish Hospital in Denver She again
underwent a very extensive workup Her lung function studies were essentially normal
except for an increased residual volume and truncated inspiratory loops A methacholine
challenge test was normal Nasolaryngoscopy performed following the methacholine test
showed vocal cord dysfunction A high resolution Cr scan showed mild bronchial wall
thickening and mild patchy bilateral air trapping consistent with asthma versus chronic
bronchitis A barium swallow with esophagogmmm showed moderately severe esophageal
dysmotility and highgrade spontaneous gastroesophageal reflux to the level of the
clavicle Treatment with protonix elevation of the head of the bed and consultation with
a speech therapist was recommended The possibility of surgery for reflux disease and
obesity were considered Unfortunately when she returned for followup in 2010 she
had gained about another 50 pounds The physician at National Jewish related her cough
reflux and vocal cord dysfunction in part to OC exposure
Based on my review of the medical records and clinical studies it is my opinion that Ms
Major does not have cough or other chronic respiratory symptoms related to oleoresin
capsicum OC exposure She in fact demonstrated the classical medical problems
associated with chronic cough prior to her employment as a corrections officer namely
esophageal reflux disease recurrent bronchitis and allergic rhirmsinusitis These are the
major causes of cough and she required treatment for all of these illnesses prim to 2004
Furthermore given her relatively minor exposure to oleoresin capsicum from her work
with prisoners and during training exercises I find no basis for linking her OC exposure
with her respiratory complaints The exposure issues and toxicity characteristics of OC
9d 90L9z9 i mn d00Z L L L LZ add000204
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CONCLUSIONS 
Based on y revie  of the edical records and clinical studies, it is y opinion that s. 
ajor does not have cough or other chronic respiratory sy pto s related to oleoresin 
capsicu  (OC) exposure. She, in fact, de onstmted the classical edical proble s 
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were reviewed in Dr Reillysreport which I reviewed There is no medical literature
linking shortterm OC exposure with chronic respiratory disease
The safety of OC for human exposure has generally been acknowledged by the US
EPA the National Institute of Justice and other academic review groups A major review
of the safety of Capsaicin in volunteers Chest 2005 128 196202 failed to uncover a
single serious adverse event associated with capsaicin cough challenge testing in humans
One hundred twentyo published studies since 1984 described 4833 subjects4374
adults 459 children undergoing capsairin cough challenge with no serious adverse
events reported Subjects included healthy volunteers as well as patients with asthma
COPD pathologic coughand other respiratory conditions Oleoresin capsicum challenge
test represents a safe tool for studying cough and its track record of safety allows
Institutional Research Boards to approve its use for human clinical and research studies
If it is not oleoresin capsicum that is responsible for her cough what is the etiology
First it is important to again emphasize that Ms Major has multiple medical problems
that preceded her work as a corrections officer She had medical office visits for allergic
rhinosinusitis bronchitis and reflux disease prior to working for the correctional
facilities In fact by 2000 she was already on medications for reflux disease bronchitis
and allergic rhinosinusids and by 2003 she was using inhaled bronchodilators She was
diagnosed at National Jewish Hospital with vocal cord dysfunction which was presumed
due to irritant exposure However the vocal cord dysfunction may well have predated
her exposure to OC Indeed if one reviews the publication from National Jewish on
irritantnduced vocal cord dysfunction Journal of Occupational and Environmental
Medicine 1998 40 13643 it is striking that all of their 11 cases had shortness of
breath and 911 had wheezing these were not prominent features of Ms Majors
complaints Finally she had significant gastroesophageal dysfunction and this is also a
common cause of cough and frequently associated with vocal cord dysfunction It is
much more likely that her worsening gastroesophageal dysfunction was a consequence of
her marked obesity with a progressive increase in weight Undoubtedly the reflux disease
was a major causative and contributing factor in her persistent cough
Following a careful review of the literature it should be noted that exposure to oleoresin
capsicum has not been associated with vocal cord dysfunction gastroesophageal reflux
disease esophageal dysmotility or even chronic cough Although vocal cord dysfunction
has occasionally been linked with irritant inhalation typically high level chemical
exposures were required this was certainly not the case with Ms Major In addition
chemical exposure causing cough typically results in airway hyperreactivity based on a
positive methacholine challenge test Ms Major had negative methacholine tests on 2
occasions an atypical finding for chemical induced cough which virtually eliminated
reactive airways disease as a cause of cough Finally inhalation of respiratory irritants
has rarely been associated with causation or exacerbation of reflux disease Recently
however exposures to high4evels of dust from the World Trade Center disaster have
been reported to worsen esophageal reflux In these cases there was very heavy
sustained particulate matter inhalation a clinical scenario that was not at all similar to
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If it is not oleoresin capsicu  that is responsible for her cough, hat is the etiology? 
First. it js i portant to again e phasize that s. ajor has ultiple edical proble s 
that preceded ber work IS a corrections officer. She had medical otfice visits for aUergic 
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breath and 9/11 had heezing; these ere not pro ineat features of s. ajor's 
co plaiDts. inally. she had significant gastroesophageal dysfunction and this is also a 
co on cause of cough and frequently associated ith vocal cord dysfunction. It is 
much more likely that her worsening gastroesophageal dysfunction was a consequence of 
her arked obesity with a progressive increase in weight. Undoubtedly. the reflux disease 
as I ajor causative and contributing fact r in ber ersiste t cough. 
Follo ing a careful revie  of the literature. it should be noted that exposure to oleoresin 
capsicum has not been associated with vocal cord dysfunction, gastroesophageal reflux 
disease, esophaleaJ dys otility, or even chronic cough. lthough vocal cord dysfunction 
has occasionally been linked with initant inhalation. typically high-level che ical 
exposures ere required; this as certainly not the case with s. ajor. In addition, 
che ical exposure causing cough typically resulls in air ay hyperreactivity based on a 
positive ethacholine cballenge test. s. ajor bad negative ethacholine tests on 2 
occasions, an atypical finding for chemical induced cough which virtually eliminated 
reactive air ays disease as a cause of cough. Finally. inhalation of respiratory irritants 
has rarely been associated with causation or exacerbation of reflux disease. Recently. 
ho e , e posures to high-Jevels of dust fro  the orld rade enler disaster have 
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Ms Major exposure history Thus there is no basis for concluding that her cough was
induced by chemical exposure
In summary Ms Majors findings are consistent with cough resulting from a
multifactorial etiology worsening gastroesophageal retlux underlying allergic rhinitis
chronic bronchitis and perhaps chronic vocal cord dysfunction all contributed to her
disease These medical conditions possibly even the vocal cord dysfunction all predated
her employment with the Idaho Department of Corrections While chronic cough in
selected circumstances is associated with chemical inhalation there is virtually no
evidence in the medical literature that 510 OC concentrations used in the preparations
that Ms Major worked with has resulted in causation or exacerbation of chronic
respiratory disease Based on these observations it is my opinion that her limited
exposure toOC did not contribute to her chronic cough or respiratory symptoms
Please feel free to contact me if you have any question regarding my report or should
require any additional information
Sincerely
k
Mark J Utell MD
Professor ofMedicine and Environmental Medicine
Director Occupational and Environmental
Medicine Division
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s. ajor's exposure history. Thus. there is no basis for concluding that her cough was 
induced by chemical exposure. 
In summary. s. ajor's findings are consistent with cough resulting fro  a 
multifactorial etiology: worsening gastroesophageal reDux. underlying allergic rhinitis, 
chronic bronchitis, and perhaps chronic vocal cord dysfunction aJl contributed to her 
disease. These medical conditions (possibly even the vocal cord dysfunction) all predated 
her employment with the Idaho Department of Corrections. While chronic cough in 
selected circumstances is associated with chemical inhalation. there is virtually no 
evidence in the medical Jiterature that 5-10% OC concentrations used in the preparations 
t t s.   i   r sult  i  sati  r ex cerbati   chr ni  
respiratory disease. Based on these observations, it is y opinion tbat ber li ited 
exposure to OC did not contribute to ber chronic cough or respiratory symptoms. 
Please feel free to contact me if you bave any question regarding my report or should 
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PlaintiffsExpert Disclosures and Supplemental Expert Disclosures with all
attachments thereto
Deposition transcript of Billie Jo Major taken in her workers compensation case
Deposition transcript of Billie Jo Major volumes I and II taken January 5 and 6
2011
Deposition of the Rule30b6designee of Idaho Department ofCorrection Bret
R Kimmel taken February 14 2011
Deposition of Daniel J Schaffer taken February 14 2011
Deposition of Sara AnneMare Link taken February 15 2011
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Summary
I have used my professional expertise in inhalation toxicology aerosol science and risk
assessment to evaluate the Plaintiffsallegation that a few very brief exposures to Pepper Spray
caused her present respiratory condition I have reviewed the depositions of the Plaintiff and her
health care providers medical consultants and other experts I have reviewed the depositions
and expert reports of the Defendant In addition I have conducted an organized review of the
literature searching for published reports on the association between brief exposure to pepper
spray and its active agents Oleoresin Capsicum OC Capsaicinoids and Capsaicin and the
occurrence of respiratory tract effects
I have concluded that there is a welldocumented causal association between brief
exposure to OC and specifically Capsaicin and the occurrence of acute reversible respiratory
effects This causal association linking brief exposures and acute reversible respiratory effects
is consistent with substantial documentation on the physiological and pharmacological
mechanisms of action of OCCapsaicin Moreover the observations of transient reversible
effects are consistent with knowledge of how OCCapsaicin dissolved in a solvent is released
from pressurized delivery devices to maximize exposure of the skin and eyes of target subjects
with small doses delivered to the respiratory tract of the target subjects Moreover minimal
doses are delivered to the respiratory tract of users ofthe pressurized delivery devices as a liquid
stream to maximize delivery to the face of the target subject ie a Level 1 or primary exposure
Only trace quantities of the liquid become aerosolized and are available for potential inhalation
ie a Level 2 or secondary exposure Small Quantities of respirable size droplets containing
OCCapsaicinoids including Capsaicin may be inhaledby the target subject Much smaller
quantities of the respirable size droplets may reach the user of the pressurized delivery device
Training exercises are conducted to acquaint Corrections Officers with the appropriate
procedures to use in restraining uncooperative subjects including the proper use of pressurized
pepper spray devices During the training exercises it is standard practice to expose Trainees to
small quantities of the respirable droplets containing pepper spray so they will experience the
acute reversible respiratory effects of OCCapsaicinoids
Capsaicin has purposefully been administered by mouth breathing during Capsaicin
Cough Challenge Tests performed on thousands of subjects including individuals with pre
existing respiratory disease A published critical review of 122 papers reporting results from
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studies conducted on4374 adults and 459 children concluded Our review has failed to
uncover a single adverse event associated with the use of inhaled Capsaicin in4833 subjects
described in published studies over the past two decades
A thorough review of the literature did not identify any published papers that
demonstrated a causal association between very brief exposures to Capsaicin and the occurrence
of signs and symptoms associated with non reversible pathological changes to the respiratory
tract that would be diagnosed as chronic cough or irritantinduced vocal cord dysfunction In
contrast the published literature and the web site of National Jewish Health identifies a number
of triggers for chronic health conditions of this kind that should appropriately be considered in
any differential etiologybased diagnosis ofthe Plaintiffsmedical condition
In evaluating the Plaintiffsmedical condition a number of diagnoses have been
proposed including chronic cough vocal cord dysfunction irritant vocal cord dysfunction
esophageal dysmotility and gastroesophageal reflux disease In my review of the literature none
of the conditions were identified as being causally associated with brief inhalation exposure to
OCCapsaicinoidsCapsaicin In my professional opinion substantial weight should be given to
this lack of a published causal association for OCCapsaicinoidsCapsaicin when conducting a
differential etiologybased diagnosis ofthe Plaintiffsmedical condition Any alleged
association of the Plaintiffsmedical condition with such exposures should be considered as high
speculative and lacking in scientific foundation
In my professional opinion the absence of published literature on a causal association
between very brief exposures to pepper spray and the active constituent Capsaicin and
induction or aggravation ofchronic respiratory disease such as chronic cough or vocal cord
dysfunction should be given substantial weight when conducting a differential etiologybased
diagnosis evaluation ofthe potential etiology of the Plaintiffscurrent medical condition
Scientific Background and Qualifications
I am an expert in inhalation toxicology aerosol science and human health risk analysis
providing scientific advice to both private and public organizations Inhalation toxicology
sometimes referred to as respiratory toxicology is the field of science concerned with
understanding the characteristics of material in the air how that material may be inhaled and
deposited in the respiratory tract and the nature of the health effects that the inhaled material
may produce Aerosol science is a specialized field of science concerned with the formation of
2
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aerosols relatively stable suspensions of droplets and particles in a gaseous media their
characterization and behavior in the environment Human health risk analysis involves the
integration of different kinds of scientific information including epidemiological investigations
studies with human subjects to specific agents under controlled experimental conditions
laboratory studies with animals exposed under controlled conditions to test agents and
investigations using human or laboratory animal tissues or cells to evaluate human health
hazards and risks under specified conditions of exposure to specific agents or conditions
I received a Doctor of Veterinary Medicine degree from Washington State University in
1960 From 1957 to 1966 I was employed by both private industry and the US Atomic Energy
Commission investigating the toxic effects ofmaterials related to their radiological and chemical
properties In 1966 I joined the Lovelace Foundation for Medical Education and Research in
Albuquerque NM assuming responsibility for a research program on inhaled radioactive
materials and chemicals I provided leadership for that inhalation toxicology program for 22
years during which time it developed into one of the worldsleading organizations concerned
with the health effects of airborne materials From 1988 to 1999 I served as the President and
CEO of the Chemical Industry Institute of Toxicology CIIT in Research Triangle Park NC
Under my leadership CIIT gained an international reputation for the conduct of research on the
mechanisms by which chemicals may cause health effects thereby providing an improved
scientific basis for assessing human health hazards and risks ofexposure to different materials
including airborne materials Since 1999 I have workedparttime as a consultant to public and
private organizations on inhalation toxicology aerosol science and human health risk analysis
matters
I am a Diplomate by examination of the American Board ofToxicology 1980 and
American Board of Veterinary Toxicology 1970 I have been accorded status as a Fellow of
the Academy of Toxicological Sciences Society for Risk Analysis American Association for
Aerosol Research and the American Association for Advancement of Science I was elected in
1990 to the Institute ofMedicine of the National Academy of Science based on my contributions
to improving human health
I have been active in scientific organizations relating to my professional interests
including service as President of the Society of Toxicology Inhalation Toxicology Specialty
Section of the Society of Toxicology and American Association for Aerosol Research I serve
3
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or have served as an Adjunct Faculty member at eight major universities I have served in an
editorial role for a number ofjournals including current service on the Editorial Boards of the
Journal of Risk Analysis and Journal ofRegulatory Toxicology and Pharmacology and as Editor
ofCritical Reviews in Toxicology I have authored or coauthored over 350 publications most
of which are concerned with inhalation toxicology and risk analysis for airborne materials I
have edited or coedited 10 books including Toxicology Toxicology of the Lung and
Concepts in Inhalation Toxicology A list of publications I have authored in the past ten years
is included in my abridged curriculum vitae
I have served on numerous advisory bodies for both public and private organizations
This included service as the Chair of theUSEnvironmental Protection AgencysEPA Clean
Air Scientific Advisory Committee EPAsResearch Strategies Advisory Committee EPAs
Environmental Health Advisory Committee and the National Academy of SciencesNational
Research Council Committee on Toxicology as well as membership on the EPA Science
Advisory Board Executive Committee National Academy ofScienceNational Research Council
Committee on Research Priorities for Airborne Particulate Matter National Institutes ofHealth
National Environmental Health Advisory Committee Department ofEnergy Biological and
Environmental Research Advisory Committee Health Effects Institute Research Committee
Board of Scientific Councilors for the Centers for Disease Control Center for Environmental
Health ResearchAg n y for Toxic Substances and Disease Registry National Aeronautics and
Space AgencysLunar Dust Advisory Committee Institute ofMedicine Committee on
Environmental Justice and Institute ofMedicine Environmental Health Round Table
I have over five decades of experience as a research scientist involved in the planning and
conduct of research the analysis and interpretation of research findings the publication and
presentation of research results and the application of scientific information to issues involving
environmental and occupational health risks from exposure to naturally occurring and manmade
materials In preparing this report I have used my knowledge and experience as a research
scientist information contained in published papers I identified from a review of the literature on
pepper spray and Capsaicin and various health endpoints and my review and analysis of
depositions taken in this case and attachments to the depositions
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Linking Sources and Exposure to Airborne Materials with Health Responses
The sciencebased paradigm traditionally used to evaluate the potential health risks of
inhalation exposure of airborne emissions from various sources is shown in Figure 1 A key
aspect of the paradigm is the linked nature of the multiple steps extending from sources of
airborne material at the left of the figure to health responses at the right of the figure Any
alleged causal association of a disease with a particular source and exposure situation should be
viewed within the context of this sciencebased paradigm
This case is concerned with an alleged causal association between the Plaintiffsexposure
to pepper spray in the course of her employment as a Corrections Officer by the State of Idaho
and her current medical condition
Figure 1 Schematic of ScienceBased Paradigm for Evaluating Link Between Sources of











Sources of Information on Health Responses
Scientists use information from multiple different kinds of studies to develop an overall
understanding of the health responses associated with exposure to particular airborne materials
This includes epidemiological studies controlled human exposure studies laboratory animal
studies and studies with isolated cells McClellan 2010 Ayres et al 2010
Epidemiological studies are designed to study the occurrence of human disease in
populations and how disease may be related to various factors such as diet personal habits
occupation or environmental factors A major advantage of epidemiological studies is that data
are obtained on people In evaluating the results of epidemiological studies it is valuable to use
the sciencebased paradigm shown in Figure 1 The stronger the linkage between a particular
source and the resulting exposure and increased incidence of a particular disease over and above
that observed in the reference population the more likely the relationships is causal In
000216
inking rces  s e  irborne ate ials t   es onses 
 s ience-based r i  tr iti ll  s  t  l t  t  t ti l lt  ris s f 
inhalation e os re f air rne e issi s fr  arious s rces is s  i  i re 1.  e  
aspect f the paradig  is the linked nature f the ultiple steps extending fro  sources f 
airborne aterial, at the left f the figure, to health responses, at the right f the figure. ny 
alleged causal association of a disease ith a particular source and exposure situation should be 
vie ed ithin the context of this science-based paradig . 
his case is concerned ith an alleged causal association bet een the Plaintiffs exposure 
to pepper spray in the course f her e ploy ent as a orrections fficer by the tate f Idaho 
    i . 
igure 1: che atic f cience-Based aradig  for valuating ink et een ources of 
irborne t ials  t ti l lt  pacts 
ces 
 ~ 











cientists use infor ation fro  ultiple different kinds f studies to develop an overall 
understanding of the health responses associated ith exposure to particular airborne aterials. 
This includes epide iological studies, controlled hu an exposure studies, laboratory ani al 
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evaluating a potential causal association it is important to consider the frequency duration and
intensity of exposures and the nature of the alleged health responses including whether they are
acute or chronic manifestations and reversible or irreversible in their nature
Controlled exposure studies may be conducted with human subjects to provide
information linking exposure to a specific agent to human biological responses Obviously such
studies must be conducted under welldefined procedures to assure that the studies are ethical
and the rights of the experimental subjects are appropriately considered Data from controlled
exposure studies conducted in humans are especially valuable because of the direct applicability
of the information to human exposure situations
Laboratory animal studies involving exposure to specific agents may be conducted to
predict human health responses especially if there is an absence of adequate human data In
addition studies may be conducted in laboratory animals to understand the mechanisms by
which an agent may produce disease In such studies the laboratory animals serve as surrogates
for people Laboratory animals have many biological characteristics that are similar to those of
humans However there are significant differences such that no species or strain of laboratory
animal can be considered a perfect human surrogate Scientific judgment must be used in
extrapolating findings in laboratory animals to humans including consideration of the exposure
circumstances frequency duration and intensity in the animal studies and their relevance to
likely human exposures
Studies may be conducted with cells and tissues taken from humans or laboratory animals
and exposed in vitroie outside of the body to specific materials Research using cell
systems may also help understand some aspects of the mechanisms by which an agent may cause
altered responses in an intact person or laboratory animal The relevance of these findings to any
particular human exposure situation involves judgment on two different extrapolations The first
of these is the relevance of the findings in cells to the intact individual whether it is an animal or
human In addition judgment must be exercised in extrapolating from the experimental doses
administered to cells and tissues and the doses likely to be experienced in human exposure
situations
RiskBased Paradigm
Over the last several decades increasing use has been made of a risk paradigm to evaluate
the potential health responses associated with exposure to various agents and to guide the
on
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syste s ay also help understand so e aspects of the echanis s by which an agent ay cause 
altered responses in an intact person or laboratory animal. The relevance of these findings to any 
particular human exposure situation involves judgment on two different extrapolations. The first 
of these is the relevance f the findings in cells to the intact individual, hether it is an ani al or 
hu an. In addition, judg ent ust be exercised in extrapolating fro  the experi ental doses 
ad inistered to cells and tissues and the doses likely to be experienced in hu an exposure 
i ti s. 
-Bas   
ver the last several decades increasing use has been ade of a risk paradig  to evaluate 
the potential health responses associated with exposure to various agents and to guide the 
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management of activities to minimize human health risks McClellan 1999 2010 The risk
assessment process consists of four elements a hazard identification b exposure response
relationship c exposure assessment and d risk characterization
The hazard identification element is directed to determining the hazard characteristics of
the material or source Can exposure to a specific agent produce adverse health effects
Ideally as noted earlier the most relevant information on human health hazards comes from
human studies In the absence of adequate human data it is necessary to use information from
laboratory animal studies or in vitro studies with cells and extrapolate the findings to humans
However as already noted laboratory animal or cellular studies may not necessarily involve the
use of exposure conditions as to frequency duration and intensity of exposure that are
representative of what people are likely to be exposed to in their daily lives The determination
that an agent has hazardous properties does not in and of itself establish that individuals using the
agent or coming into contact with the agent are placed at risk Indeed knowledge of the
hazardous properties of an agent can be used to establish the appropriate use of an agent This is




element represents an attempt to describe in quantitative terms the
characteristics of the relationship between exposure taking into account frequency duration and
intensity ofexposure and increased level of health response above that would be observed in the
absence of exposure What is the nature of the response with brief exposure Are acute
responses reversible and recoverable Do a few brief exposures lead to chronic irreversible
responses Is there a threshold ie some frequency duration and intensity of exposure that
The phrase dose response is used here as it was in the original National Research Council
1983 Report Risk Assessment in the Federal Government Managing the Process The
phrase is sometimes shown as exposureresponse or exposuredose response This is done
since dose refers to the actual quantity of a chemical deposited and retained in the body
Exposure typically refers to the concentration of the chemical in air water or diet Only
occasionally is dose actually measured in toxicological investigations ofpeople or laboratory
animals and very rarely do epidemiological studies involve measurement of dose In addition
most epidemiological studies do not actually evaluate exposure they use ambient air
concentration measurements at a few locations as a surrogate measure of exposure for a
population living in a large geographic area Thus when using such data the appropriate phrase
would be concentration response
7
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anage ent f activities to inimize hu an health risks (McClellan, 1999,2010). he risk 
assess ent process consists of four ele ents; (a) hazard identification, (b) exposure-response 
rel ti i , (c) e posure t  (d) ris  r t ri ti . 
he azar  ide tification ele e t is irected t  eter i i  t e azar  c aracteristics f 
the t rial r s r . a  s r  t   s ifi  t r uce erse lt  ff ts? 
Ideally, as noted earlier, the ost relevant infor ation on hu an health hazards co es fro  
hu an studies. In the absence f adequate hu an data, it is necessary to use infor ation fro  
laboratory animal studies or in vitro studies with cells and extrapolate the findings to humans. 
r,  lre  t , la t  i l  ll l  t i   t saril  i l e t  
use of exposure conditions, as to frequency, duration and intensity of exposure, that are 
representative of hat people are likely to be exposed to in their daily lives. The deter ination 
that an agent has hazardous properties does not in and f itself establish that individuals using the 
agent or coming into contact with the agent are placed at risk. Indeed, knowledge of the 
hazardous properties f an agent can be used to establish the appropriate use f an agent. his is 
the case for products that have incorporated chemicals extracted from plants of the Capsaicin 
fa ily. 
e -r s  ele ent represents an atte pt to describe in quantitative ter s the 
characteristics of the relationship bet een exposure, taking into account frequency, duration and 
intensity of exposure, and increased level of health response above that would be observed in the 
absence of exposure. hat is the nature of the response ith brief exposure? re acute 
responses reversible and recoverable? Do a few brief exposures lead to chronic, irreversible 
responses? Is there a threshold, i.e. so e frequency, duration and intensity of exposure) that 
aThe phrase, dose-response, is used here as it as in the original ational Research Council 
(1983) Report, "Risk ssess ent in the Federal overn ent: anaging the Process." The 
phrase is so eti es shown as "exposure-response" or "exposure-dose-response." This is done 
since dose refers to the actual quantity f a che ical deposited and retained in the body. 
Exposure typically refers to the concentration of the chemical in air, water or diet. Only 
occasionally is dose actually easured in toxicological investigations of people or laboratory 
ani als and very rarely do epide iological studies involve easure ent of dose. In addition, 
most epidemiological studies do not actually evaluate exposure, they use ambient air 
concentration easure ents at a fe  locations as a surrogate easure of exposure for a 
popUlation living in a large geographic area. Thus, when using such data the appropriate phrase 
would be "concentration-response." 
 
must be exceeded before an increased response is observable Does the relationship between
exposure and increased health response increase in a linear monotonic fashion
The exposure assessment element is the step in which specific exposure scenarios are
characterized What are the physical and chemical characteristics of the exposure atmosphere
How do the concentrations of various constituents arising from a particular source vary over
time How does the exposure frequency duration and intensity estimated or measured for an
individual in a given situation relate to the exposures observed in epidemiological controlled
exposure or toxicological studies
The fourth element risk characterization draws together information from the exposure
assessment and exposureresponse elements to provide an overall evaluation ofthe estimated
health risks for a given exposure situation What is the likelihood that specific exposures
considering frequency duration and intensity to agents from a particular source result in an
increased risk of a particular health outcome in an individual
Evaluating Sources and Exposure
In this case the Plaintiff alleges that exposure to pepper spray from commercial products
manufactured by Security Equipment Corporation has caused a change in her health The
Plaintiff also admits that she was exposed to Pepper Spray Products manufactured by other
companies The material I have been provided indicates the Plaintiff may have been exposed to
pepper spray from products likely manufactured by SEC on five occasions possibly on three
times during training sessions and twice when the Plaintiff used OC to control an inmate
Putative Toxic Agent
The Plaintiff has alleged that the putative toxic agent that caused her medical condition
was pepper spray The active agents in pepper spray are capsainoids collectively called
Oleoresin Capsaicum OC extracted from fruits ofmembers of the Capsicum family such as
Chili Peppers The major capsainoid is Capsaicin trans8methylNvanill6noneamide
Capsaicin is a fat soluble odorless pungent tasting offwhite solid with a high melting point
6265C Because it is not water soluble it is necessary to use alcohol and other organic
solvents to solubilize Capsaicin for use in experimental studies or in a spray device
The acute irritant properties of OC and specifically Capsaicin are well known It causes
burning or stinging pain to the skin Eye exposure leads to intense tearing pain conjunctivitis
and blepharospasms If ingested it can cause nausea vomiting abdominal pain and diarrhea
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ust e e ceeded efore a  increase  res se is servable? oes t e relations ip et ee  
exposure and increased health response increase in a linear onotonic fashion? 
he exposure assess ent ele ent is the step in hich specific exposure scenarios are 
characterized. hat are the physical and che ical characteristics of the exposure at osphere? 
o   t e tr ti s f arious titue ts rising fr   rti lar rce r  r 
ti ?  s the os re (frequ , r ti   i t sity) sti ate  r s r  f r  
i i id l in  iven it ti  r late t  the s re  s r e  i  i i l i l, tr lle  
exposure, or toxicological studies? 
he t  t, is  cteri ati n, s  r  r   s re 
assess e t a  e s re-res se ele e ts t  r ide a  erall e al ati  f t e esti ate  
health risks for a given exposure situation. hat is the likelihood that specific exposures, 
considering frequency, duration and intensity, to agents from a particular source result in an 
increased risk of a particular health outco e in an individual? 
l ting ces  e 
I  t is , t  l i tiff ll  t t r  t  r r  fr  r i l r t  
anufactured by Security Equip ent Corporation has caused a change in her health. The 
l i tiff ls  its t t s  as s  t  r r  r ts f t r   t r 
companies. The material I have been provided indicates the Plaintiff may have been exposed to 
pepper spray fro  products likely anufactured by SEC on five occasions, possibly on three 
times during training sessions and twice when the Plaintiff used OC to control an inmate. 
i  i   
The Plaintiff has alleged that the putative toxic agent that caused her edical condition 
was pepper spray. The active agents in pepper spray are capsainoids, collectively called 
leoresin Capsaicu  (OC) extracted fro  fruits of e bers of the Capsicu  fa ily, such as 
Chili Peppers. The ajor capsainoid is Capsaicin (trans-8-methyl-N-vanillyl-6-noneamide). 
Capsaicin is a fat soluble, odorless, pungent tasting, off-white solid with a high melting point 
(62-65°C). ecause it is not ater soluble, it is necessary to use alcohol and other organic 
solvents to solubilize Capsaicin for use in experi ental studies or in a spray device. 
The acute irritant properties of OC and, specifically, Capsaicin, are well known. It causes 
burning or stinging pain to the skin. ye exposure leads to intense tearing, pain, conjunctivitis, 
and blepharospas s. If ingested, it can cause nausea, vo iting, abdo inal pain, and diarrhea. 
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Capsaicin deposited in the airways will cause pain and irritation Themechanisms by which
these acute effects are produced by Capsaicin are increasingly well understood as a result of
investigations by a number of investigators including Drs C A Reilly G S Yost and their
associates A central mechanistic step is that Capsaicin releases Substance P from afferent
neurons activating the neurons and evoking sensations ranging from hotness to burning The
Capsaicin acts in a dose dependent manner
Due to their irritant properties OCCapsaicin containing sprays are widely used as
control agents by Correction Officers and military personnel and by individuals as personal
defense products The intensity of the response to the irritant and the reversible nature of the
effects are key factors in the selection of OC from among a wide array of irritant compounds that
have been considered for use as control agents The material used in spray devices varies in
potency related to the concentration of Capsaicin that has been solubilized in the liquid solvent
placed in pressurized container
Because the mechanisms of action and physiological properties of capsaicin are well
known it is also increasingly being evaluated for medical applications One medical application
germane to this case is the use of Capsaicin in cough testing the socalled Capsaicin Cough
Challenge Test
Source of Exposure
Details ofthe manufacture of commercial devices containing Capsaicin for personnel
control are beyond the scope of this Report However certain aspects of these delivery
devices are highly important to understanding how Capsaicin comes in contact with the target
subjects and may be a source of exposure to Correction Officers using the devices and thus will
be briefly reviewed here
The active agent Capsaicin is dissolved in specific organic solvents and placed with a
pressurized agent in small containers When the pressurized container is triggered the solvent
containing the Capsaicin is released as a jet spray a small portion ofthe spray separates into
aerosol droplets when the jet spray hits the targeted individual or other surfaces The liquid
droplets contain Capsaicin in proportion to the concentration dissolved in the solvent in the
pressurized container The aerosol droplets stick to the body surface such as the skin or eyes and
cause the intended irritant effect The largest droplets will fall to the floor
0
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apsaicin deposited in the air ays ill cause pain and irritation. he echanis s by hich 
these acute effects are produced by apsaicin are increasingly ell understood as a result of 
investigations   nu ber  i ti t r , ind ing . . . ill , . . ost  t i  
associates.  central echanistic step is that apsaicin releases Substance P fro  afferent 
r s ti ating the r ns  ing ti s r i  fro  tness t  r i .  
apsaicin acts in a dose-dependent anner. 
ue t  t ir irrita t r rti s, /Capsaicin t i in  r s r  i l    
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f s  r ts. e i t sit  f t e r s s  t  t e irrita t  t  r rsi l  t re f t  
effects are e  factors i  t e selecti n f  fr  a  a i e arra  f irrita t c s t at 
  si r  f r s  s tr l ts. e t ri l s  i  s r  ices ri s i  
potency related to the concentration of Capsaicin that has been solubilized in the liquid solvent 
placed in pressurized container. 
eca se t e ec a is s f acti  a  si l ical r erties f ca saici  are ell 
kno n, it is also increasingly being evaluated for edical applications. ne edical application 
ger ane to this case is the use of Capsaicin in cough testing, the so-called Capsaicin Cough 
alle e est. 
rce f s re 
etails of the anufacture of co ercial devices containing apsaicin for personnel 
control are beyond the scope of this Report. However, certain aspects of these "delivery 
devices" are highly important to understanding how Capsaicin comes in contact with the target 
subjects and ay be a source of exposure to Correction fficers using the devices and, thus, ill 
be briefly reviewed here. 
The active agent, Capsaicin, is dissolved in specific organic solvents and placed with a 
pressurized agent in small containers. hen the pressurized container is "triggered" the solvent 
containing the Capsaicin is released as ajet spray, a s all portion of the spray separates into 
aerosol droplets when the jet spray hits the targeted individual or other surfaces. The liquid 
droplets contain Capsaicin in proportion to the concentration dissolved in the solvent in the 
pressurized container. The aerosol droplets stick to the body surface such as the skin or eyes and 
cause the intended irritant effect. The largest droplets ill fall to the floor. 
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A small portion of the jet spray is released in the form of small droplets of solvent
containing Capsaicin when the stream of liquid hits a surface DuBay and Rush 1995 have
estimated that only001of the material is aerosolized Airborne particles or droplets are
typically characterized as to their aerodynamic diameter a parameter which relates closely to the
probability that the particles or droplets can be inhaled The aerodynamic diameter is also an
excellent predictor ofwhere the inhaled droplet or particle may deposit in various segments of
the respiratory tract the nose orallaryngeal cavity trachea bronchii and small airways or the
alveolar gas exchange region ofthe respiratory tract DuBay and Rush 1995 sampled air
from a chamber into which First Defense Products had been discharged Using a cascade
impactor they found the mass median aerodynamic diameter of the droplets to be60
micrometers
The largest ofthe inhaled droplets will be deposited in the airways ofthe nose or in the
mouth If the droplets are sufficiently small some portion will be deposited in the trachea the
lower airways the bronchi and bronchioles and the alveoli Small droplets that are inhaled and
do not deposit are exhaled DuBay and Rush 1995 estimated that for the droplet size
distribution they measured 70 of the aerosol would be deposited in the nasopharyngeal region
20 in the tracheobronchial region and 10 in the alveolar region In my opinion these
estimates may be slightly high since some of the smaller droplets will not be deposited but
rather will be exhaled
The OCCapsaicin in the droplets deposited in the respiratory airways produces in
irritation and pain just as do many respiratory tract irritants that may be inhaled as droplets
particles or gases Amajor advantage to the use ofOCCapsaicin in commercial products
intended to aid corrections officers law officers and military personnel in controlling
uncooperative individuals is that OCCapsaicin is delivered in a dissolved form in a jet spray
with only a small portion breaking up into droplets and becoming airborne This is the case
because the OCCapsaicin can only be dissolved in alcohol or other organic solvents and has a
high melting point Thus when the solvent in the droplets evaporates the OCCapsaicin that
remains is an oily liquid In contrast some other irritant agents that have been used or
considered for use as personnel control agents are gases at typical temperatures found in the
human environment Some agents vaporize even if delivered in a liquid quickly converting to
10
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A s all portion of the jet spray is released in the form of s all droplets of solvent 
containing Capsaicin when the stream ofliquid hits a surface. DuBay and Rush (1995) have 
estimated that only 0.001 % of the material is aerosolized. irborne particles or droplets are 
typically characterized as to their aerodyna ic dia eter, a para eter hich relates closely to the 
probability that the particles or droplets can be inhaled. The aerodyna ic dia eter is also an 
excellent predictor of where the inhaled droplet or particle may deposit in various segments of 
the respiratory tract, the nose, oral/laryngeal cavity, trachea, bronchii and small airways or the 
alveolar (gas exchange) region of the respiratory tract. DuBay and Rush (1995) sampled air 
fro   er into ich irst efense r ducts ha  been is r . si   e 
impactor, they found the mass median aerodynamic diameter of the droplets to be 6.0 
icro et . 
The largest of the inhaled droplets will be deposited in the airways ofthe nose or in the 
mouth. If the droplets are sufficiently small, some portion will be deposited in the trachea, the 
lower airways (the bronchi and bronchioles) and the alveoli. Small droplets that are inhaled and 
do not deposit are exhaled. DuBay and Rush (1995) estimated that for the droplet size 
distribution they easured 70% of the aerosol ould be deposited in the nasopharyngeal region. 
20% in the tracheobronchial region and 10% in the alveolar region. In y opinion, these 
esti ates ay be slightly high since so e of the s aller droplets ill not be deposited, but 
 l  l d. 
The ~C/Capsaicin in the droplets deposited in the respiratory airways produces in 
irritation and pain, just as do many respiratory tract irritants that may be inhaled as droplets, 
particles or gases. A major advantage to the use ofOC/Capsaicin in commercial products 
intended to aid corrections officers, la  officers and ilitary personnel in controlling 
uncooperative individuals is that ~C/Capsaicin is delivered in a dissolved for  in ajet spray 
with only a small portion breaking up into droplets and becoming airborne. This is the case 
because the OC/Capsaicin can only be dissolved in alcohol or other organic solvents and has a 
high melting point. Thus, when the solvent in the droplets evaporates the OC/Capsaicin that 
remains is an oily liquid. In contrast, some other irritant agents that have been used or 
considered for use as personnel control agents are gases at typical temperatures found in the 
hu an environ ent. So e agents vaporize, even if delivered in a liquid, quickly converting to 
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the gas phase and disperse in the air which facilitates the agent moving well beyond the intended
target
From this discussion it is apparent that chemical characteristics of the OCCapsaicin
facilitate its use in a specialized delivery device a pressurized container that releases a jet spray
which optimizes the delivery of the agent to the target subject This allows the use of small
volume devices and minimum amounts ofCapsaicin The use of this specialized device in the
intended manner minimizes the potential for the user of the device to be exposed to
OCCapsaicin Exposure of the Corrections Officer only occurs if they inadvertently spray
themselves or are sprayed by someone else or they breathe the very low concentrations of small
droplets that remain suspended in the air and drift back to the user
Two other exposure situations require discussion One exposure situation is associated
with use of the commercial pressurized OC devices by Corrections Officers and other personnel
The second exposure situation occurs when OCCapsaicin is used in the Cough Challenge Test
Correction Officers are routinely trained in the appropriate use of OCCapsaicin delivery
devices As part of the training the trainees briefly enter a closed chamber into which
OCCapsaicin has been released The OCCapsaicin is released in a manner such that some
droplets containing the OCCapsaicin are sufficiently small that some portion of the droplets will
remain suspended in the air Some of these droplets may be inhaled by the Trainee when they
briefly enter and quickly exits the contaminated space thereby experiencing the irritant effects of
the OCCapsaicin The total time the Corrections Officer Trainee has the potential to inhale
OCCapsaicincontaining droplets has been estimated at less than 30 seconds
Capsaicin has been used medically One of these applications is the Capsaicin Cough
Challenge Test used in the evaluation of respiratory tract responses of patients to this well
characterized sensory irritant In this test the provocative agent is Capsaicin and the response is
cough frequency In the Capsaicin Cough Challenge Test patients are exposed to an aerosol of
salt droplets produced by a nebulizer to provide a baseline measurement The nebulizer is a
pressurized system in which the aqueous solution is forced through small jets or openings to
create an aerosol of small droplets The baseline observations are followed by exposure of the
patient to droplets nebulized from solutions with different concentrations of Capsaicin
Sometimes the exposures to Capsaicin are increased in a stepwise manner to higher and higher
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the gas phase and disperse in the air hich facilitates the agent oving ell beyond the intended 
target. 
r  t is is i , it is r t t at i l r t ristics f t e ICapsaicin 
fa ilitate its s  in  s i lized li r  i ,  r ss ri  t i er t at r leas s  jet s r y, 
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intended anner ini izes the potential for the user f the device to be exposed to 
OCICapsaicin. Exposure of the Corrections Officer only occurs if they inadvertently spray 
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droplets that re ain suspended in the air and drift back to the user. 
o other exposure situations require discussion. ne exposure situation is associated 
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 s  s r  sit ti  rs e  ICaps i i  is s  i  t   lle  st. 
Correction fficers are routinely trained in the appropriate use of CICapsaicin delivery 
devices. s part of the training, the trainees briefly enter a closed cha ber into hich 
CICapsaicin has been released. The CICapsaicin is released in a anner such that so e 
droplets containing the OCICapsaicin are sufficiently s all that so e portion of the droplets will 
remain suspended in the air. Some of these droplets may be inhaled by the Trainee when they 
briefly enter and quickly exits the conta inated space, thereby experiencing the irritant effects of 
the ICapsaicin. he total ti e the orrections fficer rainee has the potential to inhale 
OCICapsaicin-containing droplets has been estimated at less than 30 seconds. 
apsaicin has been used edically. ne of these applications is the apsaicin ough 
Challenge Test used in the evaluation of respiratory tract responses of patients to this ell-
c aracterize  se s r  irrita t. I  t is test, t e r cati e a e t is a saici  a  t e res se is 
cough frequency. In the Capsaicin Cough Challenge Test, patients are exposed to an aerosol of 
salt droplets produced by a nebulizer to provide a baseline easure ent. The nebulizer is a 
pressurized system in which the aqueous solution is forced through small jets or openings to 
create an aerosol f s all droplets. he baseline observations are follo ed by exposure f the 
patient to droplets nebulized from solutions with different concentrations of Capsaicin. 
So eti es the exposures to apsaicin are increased in a step-wise anner to higher and higher 
 
concentrations until a concentration produces five coughs In other situations the patients are
exposed in a random manner to the saline droplets and droplets generated from solutions
containing different concentrations of Capsaicin The patient typically wears a nose clip and
thus must breathe the aerosol containing Capsaicin in through a mouth piece This results in a
maximum potential for the droplets to be deposited in the mouth trachea or lower portion of the
respiratory tract The aerodynamic size of the droplets produced by the commercial medical
nebulizers results in maximum deposition in the nasopharynx and conducting airways Mercer et
al 1965 using a Cascade Impactor measured the droplet size for Bennett and DeVilbiss
nebulizers The mass median aerodynamic diameter ranged from 39 to 7 micrometers
Characterization of the Exposure Atmosphere for the Target Subject and the User
As related above the pressurized OCCapsaicin delivery devices are designed to deliver a
stream of liquid to the target subject By analogy think of a water pistol designed to deliver a jet
stream to a subject three to six feet from the user This is very different than the broad spray of
droplets delivered from a pressurized paint can purposefully designed to cover a large surface
area with small paint droplets a short distance from the nozzle
With the OCCapsaicin pressurized delivery device most of the liquid is delivered in a
dense liquid stream to the intended target subject The liquid stream striking the subject will
cause formation of some droplets as observed by DuBay and Rush 1995 Most of the droplets
will be sufficiently large so theywill not remain airborne but will fall to the floor Only a small
portion of the droplets formed will be of an aerodynamic size such that they are inhalable recall
that DuBay and Rush 1995 found that only0001 of the discharged material was
aerosolized A portion of these small droplets may drift back to the user
Dose Delivered to the Respiratory Tract of the Target Subject or the Device User
I have not found any published precise estimates of the dose of Capsaicin delivered to the
respiratory tract of the target subject or user of the OCCapsaicin pressurized devices The best
estimates are those offered by DuBay and Rush 1995 The dose of OCCapsaicin from droplets
inhaled by the target subject would be dependent on the concentration of OCCapsaicin in the
solution the droplet size distribution in the breathing zone of the target subject and the frequency
and depth of breathing of the subject and the duration of their exposure The amount of
respirable material reaching the user would be extremely small
12
000223
c c trations til a tr tion roduces five c . I  t r sit ti , t e tients r  
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ith the ~C/Capsaicin pressurized delivery device, most of the liquid is delivered in a 
dense liquid stream to the intended target subject. The liquid stream striking the subject will 
cause for ation of so e droplets as observed by uBay and Rush (1995). ost of the droplets 
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portion of the droplets for ed will be of an aerodyna ic size such that they are inhalable, recall 
that DuBay and Rush (1995) found that only 0.0001 % of the discharged material was 
aerosolized. A portion of these small droplets may drift back to the user. 
    i     t      
I have not found any published precise esti ates of the dose of Capsaicin delivered to the 
respiratory tract of the target subject or user of the C/Capsaicin pressurized devices. The best 
esti ates are those offered by u ay and ush (1995). he dose f /Capsaicin fro  droplets 
inhaled by the target subject would be dependent on the concentration of ~C/Capsaicin in the 
solution, the droplet size distribution in the breathing zone of the target subject and the frequency 
and depth of breathing of the subject and the duration of their exposure. The a ount of 
respirable material reaching the user would be extremely small. 
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The inhaled dose of Capsaicin for the user of the pressurized delivery device when used
as intended would be very low and will depend on the proximity of the user to the target subject
The dose to a Corrections Officer Trainee in a training exercise will be dependent upon
how long the Trainee is in the exposure room the concentration of inhalable droplets and the
concentration of OCCapsaicin in the droplets I have estimated the inhaled dose of
OCCapsaicin as being approximately equivalent to the doses received bypatients undergoing
the Capsaicin Cough Challenge Test
Responses to Capsaicin Exposure
The acute responses oftarget subject individuals exposed to OCCapsaicin are well
documented The delivery devices are widely used in the United States and they are effective in
helping to subdue uncooperative individuals because ofthe acute reversible irritant effects in the
skin eyes and respiratory tract The effects of brief exposure to the liquid stream of
OCCapsaicin are reversible over a short period of time the duration ofthe effects on the skin
and eyes is dependent upon how quickly the subject eyes and skin are decontaminated
Respiratory tract irritation and coughing quickly subsides when the individuals is no
longer inhaling droplets containing OCCapsaicin The rapid reversibility of the respiratory tract
effects is totally consistent with the substantial body of information available on the mechanisms
of action of Capsaicin as a sensory irritant and the typical brief exposures
A review of the literature on health effects of brief exposures to Capsaicin released from
commercial pressurized OCCapsaicin delivery devices and the possible occurrence ofchronic
effects failed to reveal any papers reporting epidemiological findings from wellconducted
cohort or case control studies that demonstrated a causal association between brief exposure to
OCCapsaicin and signs and symptoms involving the respiratory tract including the nasopharynx
larynx including vocal cords the trachea bronchi and bronchioles or the alveolar region of the
respiratory tract The absence of any positive findings in the literature is not surprising
recognizing the small doses of Capsaicin delivered to the respiratory tract and the fact that
Capsaicin is a potent sensory irritant and exposures are very brief The physiological and
pharmacological changes associated with brief exposures to OCCapsaicin are quickly reversed
and there is no evidence that these responses progress to permanent pathological alterations that
are manifest as chronic disease
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as intended, ould be very lo  and ill depend on the proximity of the user to the target subject. 
he dose to a Co rections ficer Train e in a training exercise ll e depe dent upon 
how long the Trainee is in the exposure room, the concentration of inhalable droplets and the 
concentration of C/Capsaicin in the droplets. I have esti ated the inhaled dose of 
OC/Capsaicin as being approximately equivalent to the doses received by patients undergoing 
the Capsaicin Cough Challenge Test. 
esponses to apsaicin xposure 
The acute responses of target subject individuals exposed to /Capsaicin are ell 
c e te . he eli er  e ices are idely sed in t e ite  tates a  the  are effecti e i  
helping to subdue uncooperative individuals because of the acute, reversible irritant effects in the 
skin, eyes and respiratory tract. The effects of brief exposure to the liquid stream of 
~C/Capsaicin are reversible over a short period of time, the duration of the effects on the skin 
and eyes is dependent upon how quickly the subject's eyes and skin are decontaminated. 
Respiratory tract irritation and coughing quickly subsides when the individuals is no 
longer inhaling droplets containing C/Capsaicin. The rapid reversibility of the respiratory tract 
effects is totally consistent with the substantial body of infor ation available on the echanis s 
of action of Capsaicin as a sensory irritant and the typical brief exposures. 
 revie  of the literature on health effects of brief exposures to apsaicin released fro  
commercial pressurized ~C/Capsaicin delivery devices and the possible occurrence of chronic 
effects failed to reveal any papers reporting epidemiological findings from well-conducted 
rt r s - tr l st i s t t str t   s l ssoci ti  t  ri f s r  t  
~C/Capsaicin and signs and symptoms involving the respiratory tract including the nasopharynx, 
larynx including vocal cords, the trachea, bronchi and bronchioles or the alveolar region of the 
respiratory tract. The absence of any positive findings in the literature is not surprising 
recognizing the small doses of Capsaicin delivered to the respiratory tract, and the fact that 
Capsaicin is a potent sensory irritant and exposures are very brief. The physiological and 
pharmacological changes associated with brief exposures to ~C/Capsaicin are quickly reversed 
and there is no evidence that these responses progress to per anent pathological alterations that 
r  if t as c r i  i ase. 
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The absence of any reported associations between exposure to OCCapsaicin and chronic
disease outcomes is particularly remarkable in view of the widespread usage of pressurized OC
delivery products by numerous law enforcement officers and military personnel all of whom are
regularly trained in the use of the OC products and also use the products in the course of their
employment It is reasonable to expect that if adverse health outcomes were to occur with use of
the OC products reports would have appeared in the literature and ultimately have led to well
conducted epidemiological studies
As described earlier the Capsaicin Cough Challenge Test has been used to evaluate
respiratory function in many patients Dicipinigaitis and Alva 2005 have analyzed 122
published studies that included4374 adults and 459 children who had undergone the Capsaicin
Cough Challenge Test The participants in these studies included healthy volunteers as well as
patients with asthma chronic obstructive pulmonary disease and other diseases Many of the
studies cited involved the performance of not just one but multiple Capsaicin inhalation
challenges on the same subject performed over a period of days to weeks Some studies
involved four cough challenges per subject Recall that the Capsaicin Cough Challenge Test
involves exposing subjects to sufficiently high concentrations of Capsaicin so as to elicit five
coughs Beyond evaluating the published literature Dicipinigaitis and Alva 2005 personally
contacted the authors of 109 studies involving4374 subjects to personally confirm that in fact
no serious adverse events were associated with Capsaicin inhalation an absence of effects based
on the published papers They concluded Our review has failed to uncover a single serious
adverse event associated with the use of inhaled Capsaicin in4833 subjects described in
published studies over the past two decades
Warning Labels and Material Safety Data Sheets for Products Containing Capsaicin
The SEC provides Material Safety Data Sheets MSDS for its products In addition the
products have warning labels The contents of the MSDS and Warning Labels are intended to
provide information to a lay person user on the potential hazardous properties ofthe product
I have examined the MSDSs and Warning Labels for the SEC products that have been
alleged to be a source of exposure of the Plaintiff to Capsaicin In my professional opinion the
contents of the MSDSs and Warning Labels accurately and completely relate in lay language the
acute health responses that may be expected if an individual is exposed to Capsaicin contained in
the product In the absence of any scientific literature describing an association between brief
14
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exposures to Capsaicin and chronic health effects there is no basis for the MSDSs or Warning
Labels describing such potential health effects Indeed to offer such a warning would be highly
speculative and scientifically misleading
Adequate Training Using Capsaicin Delivery Devices
Commercial product such as the SEC products that contain a potentially hazardous agent
such as Capsaicin should only be used by individuals that are well trained in the use of the
products to ensure that they are used as intended Training exercises with pepper spray are
intended to instruct trainees in the proper use of the product The Training Session utilizes
products within inert material and products with the active agent OCCapsaicin The training
exercise with inert materials serves to instruct Trainees on how to deploy the devices and use the
spray stream to hit the target subjects The training exercises with the active agents are intended
to acquaint the Trainees with the acute reversible respiratory effects of exposure to the active
agent OCCapsaicin The training exercises would not be complete if they did not include brief
exposure of the Trainees to Capsaicin at concentrations that elicit acute reversible respiratory
effects
Differential EtiologyBased Diagnosis
It is not the intent of this Report to provide a Differential EtiologyBased Diagnosis for
the Plaintiffscurrent medical condition Weldon 2005 has reviewed the differential diagnosis
of chronic cough and noted the importance of considering postnasal drainage asthma
gastroesophageal disease laryngopharyngeal reflux vocal cord dysfunction occult sinusitis
pertusis andor angiotensinconverting enzyme inhibition A web site for National Jewish Health
entitled Chronic Cough notes that most cases of chronic cough are caused by postnasal drip
asthma and gastroesophageal reflux GERD all manageable conditions account for most
cases of chronic cough A second web page entitled Vocal Cord Dysfunction VCD
Overview notes that the discovery of Vocal Cord Dysfunction VCDParadoxical vocal fold
motion PVFM is relatively new The page notes the role ofNational Jewish Health
Professionals in identifying the condition and providing treatment for the condition A third web
page entitled Vocal Cord Dysfunction VCD Triggers contains the following statement
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the Plaintiff s current edical condition. eldon (2005) has revie ed the differential diagnosis 
of chronic cough and noted the i portance of considering post-nasal drainage, asth a, 
gastroesophageal disease, laryngopharyngeal reflux, vocal cord dysfunction, occult sinusitis, 
ert sis a /or a i te sin-c erti  e z e i i iti .  e  site f r ati al Je is  ealt  
titl  "Chronic gh" t  t t t   i      "post-nas l i , 
asth a and gastroesophageal reflux (GER ) - all anageable conditions -    
cases of chronic cough."  second eb page entitled "Vocal Cord ysfunction (VCD): 
verview" notes that the discovery of ocal Cord ysfunction (VC )/Paradoxical vocal fold 
otion (P F ) is relatively ne . The page notes the role of ational Je ish ealth 
rofessionals in identifying the condition and providing treat ent for the condition.  third eb 
page entitled "Vocal ord ysfunction (V D): Triggers" contains the follo ing state ent: 
 
Possible triggers of vocal cord dysfunction VCD for paradoxical vocal fold motion
PVFM are often similar to asthma triggers However it is important to know that not all
people who experience VCD have asthma
Upper respiratory infections
Exposure to airborne irritants eg pollution chemicals allergens
Postnasal drip
Gastroesophagcal reflux GER or Gastroesophageal reflux disease GERD
Laryngopharyngeal reflux ie silent reflux





Environmental change eg cold air change in temperature or moisture
Heightened emotions
Stress anxiety function
In considering each of these triggers as well as very brief exposure to Capsaicin as a
trigger it is important to consider for each of the airborne agents the frequency duration and
intensity of the exposure to the agent Perkner and colleagues 1998 from National Jewish
Hospital reported on 11 cases of irritantinduced Vocal Cord Dysfunction compared to 33
matched controls The irritants were quite varied and included exposure to a variety of disparate
agents from burning of fiber mesh flooring anhydrous ammonia rosin flux from soldering
aerosolized cleaning solution aerosolized carburetor cleaning solution aerosolized machining
fluid including mineral mist and ethanolamine ceiling tile dust and exposure to smoke and an
organic to combat the smoke odor It is noteworthy that none of the cases involved exposure to
OCCapsaicin and none of the exposures were apparently as brief as the alleged exposures of the
Plaintiff to OCCapsaicin Thus the relevance ofthe observations of Perkner et al 1998 to the
present case is open to question and would be a matter of speculation
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NC Both organizations are internationally recognized for their research on the mechanisms of
action of pollutants and assessing human health risks He has authored over 300 scientific papers
and reports and edited 10 books He frequently speaks on risk assessment and air pollution
issues in the United States and abroad He is a Past President of the Society of Toxicology and
the American Association for Aerosol Research He serves in an editorial role for a number of
journals including continuing service as Editor of Critical Reviews in Toxicology He serves or
has served on the Adjunct Faculty of 8 universities
McClellan has served in an advisory role to numerous public and private organizations
including service on senior advisory committees for 8 federal agencies and on many committees
of the National Academy ofSciencesNational Research Council He is past Chairman of EPAs
Clean Air Scientific Advisory Committee and served on Panels that have reviewed the National
Ambient Air Quality Standards for all of the Criteria Pollutants
McClellanscontributions have been recognized by receipt of a number of honors He
was elected in 1990 to membership in the Institute of Medicine of the National Academy of
Sciences He received the Society of Toxicology Merit Award and Founders Award and the
New Mexico Distinguished Public Service Award In 2005 The Ohio State University awarded
him an Honorary Doctor of Science degree for his contributions to the science under girding
improved air quality In 2008 Washington State University presented him the Regents
Distinguished Alumnus Award the highest recognition the University can bestow on an
alumnus He is a strong advocate of riskbased decision making integrating information from
epidemiological studies clinical investigation laboratory animal bioassays and mechanistic
studies using molecules cells tissues and intact mammals
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Dr McClellansscientific interests center on understanding the effects of airborne
materials on people as a basis for minimizing human health risks He is a strong
proponent of obtaining information from studies at multiple levels of biological
organization from macromolecules to cells to tissues to the intact person or laboratory
animal to populations of people or laboratory animals to predict human health
consequences of exposure to toxic agents His own research has been in inhalation
toxicology with emphasis on diseases occurring at late times after relatively low levels of
exposure to toxicants
EDUCATION
Doctor of Veterinary Medicine with Highest Honors Washington State University
Pullman Washington 1960
Master ofManagement Robert O Anderson Graduate School ofManagement
University ofNew Mexico Albuquerque NM 1980
HONORARY DEGREE
Honorary Doctor of Science The Ohio State University August 28 2005
PROFESSIONAL LICENSURE AND CERTIFICATION
Veterinary Medicine by examination State ofWashington 1960
American Board of Veterinary Toxicology by examination Diplomate 1967
American Board of Toxicology by examination Certificate General Toxicology 1980
Recertification 198590 1995 2000 2005
Academy of Toxicology Sciences by review of credentials Fellow 1992
Recertification 1997 2002 2007
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EXPERIENCE
1999 Advisor Inhalation Toxicology and Human Health Risk Analysis
Dr McClellan currently maintains an active consulting practice advising private
and public organizations on inhalation toxicology and human health risk analysis issues
His primary activities are concerned with understanding the characteristics of airborne
materials as may be encountered in the work place or environment those released from
consumer products or pharmaceuticals designed for inhalation delivery the potential for
these materials to be inhaled by people and the potential health effects of the materials
The ultimate goal is to provide guidance for the control of emission sources and the safe
use of consumer products and pharmaceuticals
1999 President Emeritus Chemical Industry Institute ofToxicology Research
Triangle Park NC
19881999 President and Chief Executive Officer Chemical Industry Institute of
Toxicology Research Triangle Park NC
The Chemical Industry Institute ofToxicology now called Hamner Institutes for
Health Sciences is a not for profit research institute with a mission of developing
through the conduct of research an improved scientific basis for understanding and
assessing the human health risks of exposure to chemicals The research was funded for
many years primarily by 30 major chemical companies This support base was expanded
near the end ofDr McClellansterm through a partnership with the American Chemical
Council which represents 190 leading chemical companies Supplemental funding is
obtained from government agencies trade associations and individual companies The
operating budget for the Institute in 1999 was 19 million
The Institute at the time of Dr McClellans retirement in 1999 had a
multidisciplinary staff of 25 doctoral degreed scientists 100 supporting personnel 25
postdoctoral fellows and 15 coop or pre doctoral students Institute scientists collaborate
extensively with staff at three nearby major research universities two national
government laboratories and neighboring industrial firms During his tenure the
Institute training program was expanded and included nearly 200 undergraduates
graduates and post graduate trainees and fellows All of the Institute research findings
are published in peerreviewed scientific journals In addition Institute scientists are
regular participants in professional organizations and on scientific advisory panels
sponsored by government academic or industrial organizations Under Dr McClellan
leadership the Institute developed an international reputation for its contributions to
reducing the scientific uncertainty in making decisions concerning the human health risks
ofexposure to chemicals
19761988 President and Director Inhalation Toxicology Research Institute
Lovelace Biomedical and Environmental Research Institute a non profit
subsidiary of the Lovelace Foundation Albuquerque New Mexico
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19731976 Vice President and Director of Research Administration and Director
Inhalation Toxicology Research Institute Lovelace Foundation for
Medical Education and Research Albuquerque New Mexico
19661973 Assistant Director ofResearch and Director Fission Product Inhalation
Program Lovelace Foundation for Medical Education and Research
Albuquerque New Mexico
The Inhalation Toxicology Research Institute was a governmentowned
institution operated by the Lovelace Biomedical and Environmental Research Institute
LBERI a non profit corporation for the US Department of Energy The research
operation started as a part of the Lovelace Foundation for Medical Education and
Research the research and educational arm of a clinic hospitalresearch complex Under
Dr McClellan leadership starting in 1966 it grew to achieve an international
recognition for its research on the health effects of airborne radioactive and chemical
toxicants The Institute research was funded primarily by the Department of Energy
with supplemental funding provided by other government agencies and the private sector
In 1988 Dr McClellanslast year as President the Institute had an operating budget of
15 million The Institute in 1988 had a multidisciplinary staffof over 40 doctoral degree
scientists 160 supporting personnel and 10 postdoctoral fellows and students Under Dr
McClellan leadership internship graduate and post graduate programs were initiated
that included nearly 500 participants All of the Institute research findings were
published in the peerreviewed scientific literature and have been widely used in the
setting of standards for airborne toxicants The Institute continues operation today as the
core element of the Lovelace Respiratory Research Institute
19651966 Scientist Medical Research Branch Division ofBiology and Medicine
USAtomic Energy Commission Washington DC
As a term employee Dr McClellan was responsible for providing scientific
oversight for the Commissionsresearch program on internally deposited radioactive
materials The research program funded at a level of 20 million per year in 1966
included research conducted in the multipurpose national laboratories and specialized
single purpose laboratories under longterm contracts and in universities under multiyear
competitively awarded research contracts The research program included investigations
spanning from the study of cells to tissues and organs to laboratory animals to
epidemiological investigations
1965 Senior Scientist Biology Department Pacific Northwest Laboratories
Battelle Memorial Institute Richland Washington leave of absence to
theUSAtomic Energy Commission
19631964 Senior Scientist Biology Laboratory Hanford Laboratories General
Electric Company Richland Washington
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19571964 Biological Scientist to Senior Scientist Biology Laboratory Hanford
Laboratories General Electric Company Richland Washington
McClellans employment with General Electric Company began as a summer
intern in 1957 He joined the fulltime staff in 1960 and advanced to Senior Scientist
before being asked to accept a term assignment in Washington DC As a bench
scientist he conducted research on the toxicity of fission product radionuclides such as
90Sr 131I and 137Cs and transuranic radionuclides such as 239Pu to understand their
metabolism dosimetry and late occurring health effects The principal subjects were
domestic animals with emphasis on the use of miniature pigs to provide a basis for
extrapolation to humans of comparable size Dr McClellan working with the late Dr
Leo K Bustad had responsibility for the conduct of a multigenerational study of the
effects of daily ingestion of 90Sr that extended over 15 years All of the research findings
were reported in the peerreviewed literature and represent important contributions to
understanding the health risks of exposure to fission product radionuclides
19571960 Research Assistant Department of Veterinary Microbiology
Washington State University Pullman Washington
Assisted in the conduct of a broad spectrum of studies ranging from
investigations on the role of enteroviruses in the gastroenteritis pneumonia complex in
calves to the role of vitamin A and D deficiencies in the pathogenesis of moniliasis
infection in chickens
ACADEMIC AFFILIATIONS
2002 present Adjunct Research Professor Department ofEnvironmental
Science Colorado State University
2000 Regents Lecturer University of California at Los Angeles
1994 present Consulting Professor in Community and Family Medicine Duke
University Medical Center Durham NC
1991 2008 Adjunct Professor Department of Toxicology North Carolina
State University Raleigh NC
19892000 Adjunct Professor Curriculum in Toxicology University ofNorth
Carolina Chapel Hill
1988 present Adjunct Professor of Toxicology Integrated Toxicology Program
Duke University Medical Center Durham NC
1986present Clinical Professor College ofPharmacy The University ofNew
Mexico Albuquerque NM
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19801998 Adjunct Professor Department ofVeterinary and Comparative
Anatomy Pharmacology and Physiology and Member Graduate
Faculty of the Program in Veterinary Science College of
Veterinary Medicine Washington State University
19701988 Adjunct Professor Department ofRadiation Sciences School of
Pharmacy University of Arkansas Medical School Little Rock
AR
1971 1988 Clinical Associate Department ofPathology The University of
New Mexico School of Medicine Albuquerque New Mexico
19731983 Adjunct Professor Department of Biology The University of New
Mexico Albuquerque New Mexico
APPOINTMENTS
2007 present Member Board of Scientific and Policy Advisors American
Council on Science and Health
20062008 Scientific Advisory Committee on Alternative Toxicological
Methods National Institute ofEnvironmental Health Sciences
2004 present Lunar Airborne Dust Toxicity Advisory Group National
Aeronautics and Space Administration
20042006 Member Board ofScientific Counselors National Center for
Environmental Health and Agency for Toxic Substances and
Disease Registry Centers for Disease Control and Prevention
2004 present Member Deans Advisory Council College ofVeterinary
Medicine Washington State University Chair 20042006
20032008 Member Steering Committee on Strengthening ScienceBased
Decision Making National Research Council
2003 CoChair Peer Consultation Workshop Proposed Protocol to
Assess Asbestos Related Risk Eastern Research
GroupUSEnvironmental Protection Agency
20022006 Member Committee on Leachable and Extractable Limits for
Inhaled Pharmaceuticals Product Quality Research Institute a
joint Pharmaceutical Industry andUSFood and Drug
Administration Initiative
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20022004 Member Scientific Advisory Committee National Center for
Environmental Health Centers for Disease Control and Prevention
20022008 Member Board ofDirectors Toxicology Excellence in Risk
Assessment Chair Board of Directors 20022004
20022003 Member Community Advisory Committee Intel Corporation
2002 present Distinguished Emeritus Member National Council on Radiation
Protection and Measurements
2001 present Member Board ofVisitors College of Science Washington State
University
2001 present Trustee Washington State University Foundation
20012002 Member Working Committee on Justification ofThresholds for
Leachables in Orally Inhaled and Nasal Drug Products Product
Quality Research Institute
20002006 Member Review Panel for Particulate Matter Clean Air Scientific
Advisory Panel US Environmental Protection Agency
20002008 Member Trustee Advisory Committee Lovelace Respiratory
Research Institute
20002003 Consultant Food Quality Protection Act Science Review Board
USEnvironmental Protection Agency
20002001 Member Committee to Review Protocols for Evaluation of
Fibrous Particles Science Advisory PanelUSEnvironmental
Protection Agency
1999 2004 Member Biological and Environmental Research Advisory
Committee USDepartment ofEnergy
19992004 Member Scientific Advisory Committee Southern California
Particulate Matter Research Center University ofCalifornia
University of Southern California
19992001 Member Nonproliferation Advisory Panel Central Intelligence
Agency
19992001 Member External Advisory Committee for Environmental Science
Initiative Pacific Northwest Laboratory Battelle Memorial
Institute
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19982001 Member Advisory Committee on Alternative Toxicological
Methods Interagency Center for the Evaluation of Alternative
Methods Department ofHealth and Human Services
19982004 Member Committee on Research Priorities for Airborne
Particulate Matter National Research CouncilNationa Academy
of Sciences Prepared Four Reports Research Priorities for
Airborne Particulate Matter
19972000 Member Ad Hoc Committee to Review Proposed Revision of
Cancer Risk Assessment Guidelines Science Advisory Board
USEnvironmental Protection Agency
1997 CoChair Organizing Committee and Chairman Program
Committee Wingspread Conference Creating a Strategy for
Science Based National Policy Addressing Conflicting Views on
the Health Risks of LowLevel Ionizing Radiation
19971999 Member Science Advisory Board Strategic Environmental
Research Program Department ofDefenseepartment of
EnergyUSEnvironmental Protection Agency
19972007 Member External Advisory Committee Center for Rural and
Environmental Health Texas AM University
19962001 Member Diesel Exhaust Health Assessment Document Review
Panel Clean Air Scientific Advisory Committee US
Environmental Protection Agency
19961998 Member Committee on Environmental Justice Institute of
Medicine
19942001 Member Board ofGovernors Research Triangle Institute
Research Triangle Park NC
19942000 Member Advisory Board College ofAgriculture and Life
Sciences North Carolina State University Raleigh NC
1994 1998 Member Committee on Health Risks of Exposure to Radon
Biological Effects of Ionizing Radiation VI National Research
CouncilNationa Academy of Sciences
1994 Member Advisory Committee on Potential Health Hazards of
Manmade Fibers World Health Organization Copenhagen
Denmark
1994 Advisory Member Strategic Planning Advisory Committee for
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r, , ra ce 
7 
1993 present Member Biological Effects of Low Level Exposures BELLE
Advisory Committee
19931996 External Advisory Committee Department ofEnvironmental
Medicine Wayne State University
19921995 Treasurer International Congress of Toxicology VIII Held July 2
6 1995 Seattle WA
19921994 Chair Research Strategies Advisory Committee U S
Environmental Protection Agency
19921995 Member Environmental Economics Advisory Committee U S
Environmental Protection Agency
1992 Member Advisory Committee on Health Hazards ofPlutonium
and Radioiodine World Health Organization Brussels Belgium
1991 1994 Member Committee on Risk Assessment for Hazardous Air
Pollutants National ResearchCouncilNationa Academy of
Sciences Final Report Science and Judgment in Risk
Assessment
19911993 Member Clean Air Act Advisory Committee USEnvironmental
Protection Agency
19901994 Presidential Nominee to the Corporation Visiting Committee for
the Whitaker College ofHealth Sciences and Technology
Massachusetts Institute of Technology Cambridge MA
19901996 Member Board of Directors North Carolina Veterinary Medical
Foundation Inc Raleigh NC Executive Committee 1991 1995
President 1993 1995
19891992 Board ofDirectors North Carolina Association for Biomedical
Research Raleigh NC
1989 Member Strategic Planning Advisory Committee for Monograph
Program International Agency for Research on Cancer Lyon
France
19881997 Member Board ofDirectors Lovelace Anderson Endowment
Foundation Albuquerque NM
19881994 Member Scientific Committee 1 2 on Assessment of Risk for

















e ber, iological ffects of o  evel xposures (BE ) 
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ati , I c., alei h,  (Exec tive ittee, 1-19 ; 
r si t, 3-19 ) 
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adiation Protection Purposes, ational ouncil on adiation 
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19871989 Member Air Toxics Working Group Department of Health and
Environment State ofNew Mexico
19871992 Chairman Clean Air Scientific Advisory Committee US
Environmental Protection Agency
19871992 Member National Advisory Environmental Health Sciences
Council ofthe National Institutes of Health
19871988 Member Scientific Review Panel for Rocky Flats Mixed Waste
Incineration Denver CO
1987 2001 Member Advisory Council for the Center for Risk Management
Resources for the Future Washington DC
1987 Member 3Person Panel to Evaluate Post Chernobyl Radiological
Safety ofUSConsulate Facilities in Kiev Ukraine US
Department of State
1986 Member Review Panel Carcinogenic Effects ofVehicle
Emissions Chair Animal Evidence Sub Panel International
Agency for Research on Cancer
19861987 Member Sister Cities Advisory Board City ofAlbuquerque
Albuquerque NM
19861988 Member Advisory Board Robert O Anderson School of
Management University ofNew Mexico Albuquerque NM
19861988 Member External Advisory Committee Department of
Environmental Medicine University of Cincinnati
19861988 Member External Advisory Committee Institute of
Environmental Medicine New York University
19861988 Member External Scientific Advisory Panel Chemical Industry
Institute ofToxicology
1986 Member Advisory Committee on Health Hazards of Plutonium
and Radioiodine World Health Organization Brussels Belgium
19851987 Member Advisory Committee on Standards and Regulations for
Diesel Powered Equipment in Underground Coal Mines Mine
Safety and Health Administration Department of Labor
19841985 Member Health and Environmental Research Advisory
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e ber, xternal Scientific dvisory Panel, he ical Industry 
Institute f oxicology 
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e ber - dvisory o ittee on Standards and egulations for 
iesel o ered quip ent in nderground oal ines, ine 
Safety and ealth d inistration, epart ent of abor 
e r - lt   ir t l r  is r  
Co ittee to the Secretary of the epart ent of Energy 
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19841985 Chairman Radionuclide Emissions Review Committee Science
Advisory Board USEnvironmental Protection Agency
19831984 Member Board of Directors Lovelace Medical Systems and
Technologies Inc
19821991 Member Board of Directors Toxicology Laboratory
Accreditation Board Treasurer 19841991
1981 1992 Member Health Research Committee The Health Effects
Institute
19801987 Member Dose Assessment Advisory GroupUSDepartment of
Energy
19801987 Member Clean Air Scientific Advisory Committee Panel on
Health Effects of Sulfur Oxide and Particulate Matter US
Environmental Protection Agency
19801983 Member Environmental Health Committee Science Advisory
Board USEnvironmental Protection Agency Chairman 1982
1983
19801987 Ad Hoc Member Board on Environmental Studies and
Toxicology prior to 1986 was Board on Toxicology and
Environmental Health Hazards National Research
CouncilNationa Academy of Sciences
1979 1987 Member Committee on Toxicology National Academy of
SciencesNational Research Council Committee on Toxicology
Chairman 1980 1987
19781979 CoChairman Ad Hoc Committee on Review of Health Effects
Research Program Science Advisory BoardUSEnvironmental
Protection Agency
1978 Chairman Health Effects Panel Environmental Impact of Oil
Shale Technology WorkshopUSEnvironmental Protection
Agency Department ofEnergy and Department of Health
Education and Welfare
19771980 Member Enewetak Atoll Cleanup Advisory Group Advisory to
USDepartment of Energy
19771980 Chairman Subcommittee on Carnivores Committee on Animal
Models for Research on Aging Institute of Laboratory Animal
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   -   ir t l t i   
oxicology (prior to 1986 as oard on oxicology and 
ir e tal ealt  azards), ati al esearc  
ouncillNational ca  f i es 
e ber - o ittee on oxicology, ational cade y of 
cienceslNational esearch ouncil, o ittee on oxicology, 
(Cha r , 0-19 ) 
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 ge  
Chair an - ealth Effects Panel, Environ ental I pact of il 
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cy, rt e t f r   rt e t f alth, 
ti   l ) 
e ber - Enewetak Atoll Cleanup Advisory Group (Advisory to 
.S. rt e t f r y) 
i  - tte   , ttee   
odels for Research on Aging, Institute of Laboratory Animal 
Resources, National Research CouncillNational Acade y of 
i  
0 
19771980 Member Committee on Animal Models for Research on Aging
Institute of Laboratory Animal Resources National Research
CouncilNationa Academy of Sciences
19781980 Chairman Ad Hoc Committee for Annual Review of5 Year
Research Plan Science Advisory BoardUSEnvironmental
Protection Agency
19771978 Chairman Ad Hoc Review Committee on Scientific Criteria for
Environmental Lead Science Advisory BoardUSEnvironmental
Protection Agency Committeesactivities served as template for
Clean Air Scientific Advisory Committee permanent authorization
by 1977 Clean Air Act Amendments
19771989 Member Scientific Committee 457 National Council on
Radiation Protection and Measurements
19761977 Member Ad Hoc Committee on Internal Emitters National
Council on Radiation Protection and Measurements
19761996 MemberBoard of Directors Lovelace Biomedical and
Environmental Research Institute Chair 19881996
19751976 Member Biomedical Advisory Committee on Health Effects for
Reactor Safety StudyUSNuclear Regulatory Commission
19741976 Member Ad Hoc Committee Hot Particles Advisory
Committee on the Biological Effects of Ionizing Radiations
BEIR National Research CouncilNationa Academy of Science
19741990 Member North American Late Effects Group Steering
Committee
19741978 Member National Institutes ofHealth Animal Resources
Advisory Committee
19741980 Member Executive Committee Science Advisory Board US
19811994 Environmental Protection Agency
19731976 Member Advisory Board on Veterinary Specialties American
Veterinary Medical Association
19721977 Member Environmental Radiation Exposure Advisory
Committee USPublic Health Service 19721974 US
Environmental Protection Agency 19741977 Chairman 1974
1977
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by 1977 lean ir ct end ents) 
e be  - ic i tee # , l   
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e  -  c te   "Internal t ",  
      
-Boar   , elace io   
iro e tal esearc  I stitute (C air: -19 ) 
e ber - io edical dvisory o ittee on ealth Effects for 
eactor Safety Study, u.S. uclear egulatory o ission 
e  -   tee - "Hot articles" - is r  
Co ittee on the Biological Effects oflonizing Radiations 
(BEI ) - ational esearch ouncillNational cade y of Science 
e  -  ca   e ts  r  
te  
r - ti l I tit tes  lth, i l r  
dvisory o ittee 
 - ec ti e ittee, cie ce is r  ard, .S. 
Environ ental Protection gency 
e ber - dvisory oard on eterinary Specialties, erican 
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r - ir t l di ti  s r  is r  
itt e, .S. li  lt  r i  (1 2-1974), u.S. 
nviron ental Protection gency (1974-1977) (Chair an 1974-
1977) 
e er - ra s ra i  ec ical r  (Advis r  t  .S. 
epart ent of Energy) 
1  
1971 2001 Member 5 consecutive 6 Year Terms National Council on
Radiation Protection and Measurements Program Committee
Member 19771981 Chairman 1981
19701975 Member Subcommittee on Whole Animal Radiobiology
Pathology Los Alamos Meson Physics Facility LAMPF Los
Alamos National Laboratory
19691979 Chairman Scientific Committee 30 National Council on
Radiation Protection and Measurements
19691973 Member Toxicology Study Section National Institutes of Health
19681971 Consultant National Institute ofEnvironmental Health Sciences
National Institutes ofHealth
19681970 Advisor Laboratory Animal Biology and Medicine Training
Program University of CaliforniaDavis
19671973 Member Joint Space NuclearSystemsBiom dical and
Environmental Research Working Group USAtomic Energy
Commission National Aeronautics and Space Administration
EDITORIAL APPOINTMENTS
20082011 Member Editorial Board Risk Analysis
2003 present Member Editorial Board Dose Response Journal originally
Nonlinearity in Biology ToxicologyMedicine
19992008 Member Editorial Advisory Board UllmansEncyclopedia of
Industrial Chemistry
19982009 Member Editorial Advisory Board The Dictionary of Substances
and their Effects DOSE The Royal Society of Chemistry
1995present Member Editorial Advisory BoardHonorary Advisory Board
Toxicological and Environmental Chemistry
19951997 Member International Advisory Board Comprehensive
Toxicology 12 volumes First Edition
19951998 Executive Editorial Board Research Communications in
Pharmacology and Toxicology
1994 present Editorial Advisory Board Technology A Journal of Science
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e be  - tte   le   & 
Pathology - os la os es  sics ility (LA F), os 
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e ber, oxicology Study Section, ational Institutes of ealth 
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dvisor - Laboratory ni al iology and edicine Training 
Progra , niversity of alifornia-Davis 
e er - J i t ace clear yste slBio edical a  
iron e t l s r  r i  r , .S. t i  r  
iss on - ti l er tics   i istr ti  









er, it ri l r . i  l i  
e ber, ditorial oard, ose- esponse Journal (originally 
Nonlinearity in Biology-Toxicology- edicine) 
e ber, Editorial dvisory Board, ll an's Encyclopedia of 
Industrial he istry 
er,  s  rd,     
and their Effects (DOSE), The Royal Society of Che istry 
e ber, Editorial dvisory oardlHonorary dvisory oard, 
Toxicological and Environ ental he istry 
e ber, International dvisory oard, o prehensive 
Toxicology -  l es (First dition) 
ti  it ri l rd, arc  i ti  i  
Pharmacology and Toxicology 
Editorial Advisory Board Technology: A Journal of Science 
Serving Legislative, Regulatory and Judicial Systems 
1  
19942000 Member Editorial Board Human and Ecological Risk Assessment
19932002 Member Editorial Board Environmental Health Perspectives
1993 present Member Editorial Board Regulatory Toxicology and
Pharmacology
19891999 Member Editorial Advisory Board Modern Methods in
Toxicology
19891999 Editorial Advisor Environmental Business Journal
19891999 Member Editorial Advisory Board Toxicological and
Environmental Chemistry
19871999 Associate Editor Inhalation Toxicology Journal
1987 present Editor Critical Reviews in Toxicology
19861987 Member Editorial Advisory Board Critical Reviews in
Toxicology
19871988 Associate Editor Journal of Fundamental and Applied Toxicology
19841989 Member Editorial Board Journal of Fundamental and Applied
Toxicology
19841996 Member Editorial Board Toxicology and Industrial Health
Journal
1983 1996 Associate Editor Journal of Toxicology and Environmental Health
19801982 Member Editorial Board Journal of Toxicology and
Environmental Health
19761980 Associate Editor Laboratory Animal Science
PROFESSIONAL AFFILIATIONS
Academy of Toxicological Science Elected Fellow 1992
Recertified 1997 2002 2007
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ssociate Editor, Journal of Funda ental and pplied Toxicology 
e ber, Editorial oard, Journal of Funda ental and pplied 
i l  
e ber, ditorial oard, oxicology and Industrial ealth 
r l 
ss iate it r, r l  i l   iro t l lt  
e ber, ditorial oard, Journal of oxicology and 
iron e tal t  
ss iate it r - a r t r  i l i  
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cade y f oxicological cience (Elected ello  - 1992) 
ied - 97, ,  
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American Association for Aerosol Research
Awards Committee Member 20042007
Award Committee Chair 20062007
Board ofDirectors 19821993
Treasurer 19861990
Vice President 1991 1992
President 1992 1993
Fellow 2008
American Association for Cancer Research
American Association for the Advancement ofScience
Fellow 1969
American Board ofToxicology
Certification General Toxicology 1980
Recertified 1985 1990 1995 2000 2005




American Conference ofGovernmental Industrial Hygienists
American Thoracic Society
American Veterinary Medical Association
Gesellschaft fur Aerosolforschung Association for Aerosol Research
Health Physics Society
Program Committee 1970 1973
Chairman1972
Fellow 1997
Institute ofMedicine ofNational Academy ofSciences
Elected to Membership 1990
Chair Section 10 Other Health Professions 19992001
Membership Committee 19972001
International Hormesis Society
International Society of Regulatory Toxicology and Pharmacology
New Mexico Zoological Society Board of Directors 19701972
North Carolina Veterinary Medical Association
Radiation Research Society
Chairman Finance Committee 19791982
SecretaryTreasurer 1982 1984
Management Services Negotiations Committee Chairman 19851986
Society for Experimental Biology and Medicine
Society for Risk Analysis
Fellow 1992
Society ofToxicology
Media Resource Specialist 1998 present
Vice PresidentElect to Past President 1987 1991
Committee on Legislative Assistance 19781980
Program Committee 1980 1983
Committee on Professional Relations and Standards 1982 1983




erica  s i ti   eros l es  
ards itt , r, -2007 
ar  , ir, -2007 
ar   re , -1993 
re r, -1 90 
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 -197  
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erican fere e f r t l I stri l ie ists 
erican horacic Society 
erican eterinary edical ssociation 
esellsc aft f r er s lf rsc  [Association f r er s l esearch] 
lt  si s i t  
 ittee -197  
-197  
ll ,  
I stitute f e icine f ati al ca e  f cie ces 
(Elected t  rs i  - 0) 
air, ti   (Other lt  r f ssions), -20  
e bership o ittee, 1997-2001 
I ter ati al r esis ciet  
International Society of Regulatory Toxicology and Phar acology 
e  exico Zoological Society (Board of irectors 1970-1972) 
rt  r lina t ri r  i l i ti  
adiation esearch ociety 
, a e i , -1982 
Secretary/Treasurer, 1982-1984 
anage ent Services egotiations Co ittee, Chair an, 1985-1986 
Society for Experi ental iology and edicine 
Society for isk nalysis 
ello , 1992 
Society of Toxicology 
edia Resource Specialist, 1998-present 
 -Elec    i nt, -19  
o ittee on egislative ssistance, 1978-1980 
rogra  o ittee, 1980-1983 
ittee  i l l ti   t r s, -19  
ar   licati s, -19 , air a , -198  
i  itt , -1988 
 
Inhalation Specialty Section Vice President to President 19831986
Toxicology Education Foundation President 19901992
Endowment Fund Board ofTrustees Chair 20062009
Ad hoc Committee on Endowment Member 20042006
AWARDS AND HONORS
Founders Award 2009 Society ofToxicology For outstanding leadership and
achievements in understanding the effects of chemicals
Regents Distinguished Alumnus Award 2008 Washington State University For truly
distinguished contributions to Society that have brought distinction to Washington
State University through the recipient personal achievements
Fellow 2008 American Association for Aerosol Research Outstanding contributions to
aerosol science
New Mexico Distinguished Public Service Award 2006 Outstanding national and
international advisory service in the fields of environmental and occupational
health
Honorary Doctor of Science Conferred August 28 2005 The Ohio State University
For invaluable contributions to understanding the effects of environmental
pollutants on human health including nuclear risks
Merit Award 2005 Society of Toxicology Distinguished Career in Toxicology
Hall of Fame 2002ROAnderson Schools ofManagement University of New Mexico
Outstanding contributions to the effective management of multi disciplinary
research organizations
Regents Lecturer 2000 School of Public Health and Department of Chemical
Engineering and Materials Science University ofCalifornia at Los Angeles
Invited lectures in toxicology risk assessment and aerosol science
Distinguished Veterinary Medicine Alumnus Award for Excellence in Research 1999
Washington State University For outstanding contributions to comparative
medicine and understanding the human health risks of airborne materials
Robert Leader Memorial Lecture in Comparative Medicine 1999 Michigan State
University For outstanding contributions to comparative medicine
International Achievement Award 1998 International Society ofRegulatory
Toxicology and Pharmacology Outstanding contributions to improving the
science base for riskbased decision making
International Aerosol Fellow Award 1998 International Aerosol Research Assembly
Outstanding contributions to aerosol science and technology
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Inhalation Specialty Section, ice President to President, 1983-1986 
oxicology ducation Foundation, President, 1990-1992 
ent    ruste , ir, -2009 
d  i tee  nt, r, -2006 
 RDS  : 
rs ard (20 9), i t  f i l  [For tst i  le rs i   
ie e e ts i  t i  t  t   i ls] 
e e ts' istinguished lu nus ar  (2 8), as i t  tate i ersit  [For tr l  
distinguished contributions to Society that have brought distinction to ashington 
t te i e it  t  t  ipient's l i ts] 
ell  (2 8), erica  ss ciati  f r eros l esearc  [Outstan in  c tri tions t  
aerosol science] 
 i  istinguishe  li  r i  ar  (2 6), [Outsta i  ti l  
i ter ti l is r  s r i  i  t  fi l s f ir t l  ti l 
health] 
onorary octor of Science (Conferred ugust 28, 2005), The hio State niversity 
[For invaluable contributions to understanding the effects of environ ental 
pollutants on hu an health including nuclear risks] 
erit Award (2005), Society of Toxicology [Distinguished Career in Toxicology] 
all of Fa e (2002), R.O. nderson Schools of anage ent, niversity of e  exico 
[Outstanding contributions to the effective anage ent of ulti-disciplinary 
research organizations] 
Regents Lecturer (2000), School of Public Health and Depart ent of Che ical 
Engineering and aterials Science, niversity of alifornia at Los ngeles 
[Invited lectures in toxicology, risk assess ent and aerosol science] 
Distinguished Veterinary edicine Alumnus Award for Excellence in Research (1999), 
ashington State University [For outstanding contributions to co parative 
e icine a  ersta i  t e a  ealt  ris s f air r e aterials] 
rt e r ri l t r  i  r ti  i ine (1 9), ic iga  t t  
niversity [For outstanding contributions to co parative edicine] 
I ter ati al c ie e e t ar  (1 98), I ter ati al ciet  f e lat r  
Toxicology and Phar acology [Outstanding contributions to i proving the 
science base for risk-based decision aking] 
International erosol Fello  ard, (1998), International erosol esearch sse bly 
[Outstanding contributions to aerosol science and technology] 
 
Thomas T Mercer Joint Prize 1997 American Association for Aerosol Research and
International Society for Aerosols in Medicine Excellence in the field of
inhalable materials and pharmaceutical aerosols
Fellow 1997 Health Physics Society Outstanding contributions to the field of radiation
protection
Ambassador of Toxicology 1995 Mid Atlantic Chapter of Society of Toxicology
Outstanding contributions to advancement of Toxicology
Fellow 1992 Society for Risk Analysis Outstanding contributions to the science of risk
analysis
Arnold J Lehman Award 1992 Society of Toxicology Recognized for major
contributions to the control of chemical agents including pharmaceuticals
Member 1990 Institute ofMedicine ofNational Academy of Sciences Elected as
active member based on distinguished professional achievement in Veterinary
Medicine and Toxicology
Career Achievement Award 1989 Society of Toxicology Inhalation Specialty Section
Meritorious contributions to the field of inhalation toxicology
Paper of the year 1989 Society ofToxicology Inhalation Specialty Section Coauthor
of best paper in the field of inhalation toxicology during previous year
Frank R Blood Award 1989 Society of Toxicology Coauthor of best paper published
in one of the two official journals of the Society during the previous year
Distinguished Associate Award 1988 Department of Energy In recognition of highly
successful efforts in guiding environmental research for the Department ofEnergy
and its predecessor agencies during the past 22 years
Distinguished Associate Award 1987 Department of Energy For outstanding scientific
vision and research leadership in inhalation toxicology radiation biology and
environmental health sciences
Alumni Achievement Award 1987 Washington State University For leading service in
the field of inhalation toxicology and outstanding contributions to veterinary
medicine
Herbert E Stokinger Award 1985 American Conference ofGovernmental Industrial
Hygienists For outstanding contributions to the field of industrial toxicology
Elda E Anderson Award 1974 Health Physics Society For outstandingcontributions
to the field of radiation protection
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as . erce  t ze (19 7), erican ss a ion     
Inter tio l iety for eros ls i  e icine [Excellence i  t e field f 
inhala le t ri ls  r ti l r sols.] 
ello  (1997), ealth hysics ociety [Outstanding contributions to the field f radiation 
r tecti ] 
bassador of Toxicology (1995), id- tlantic hapter of Society of Toxicology 
[Outstanding contributions to advance ent f oxicology] 
ll  (1 2), i t  f r is  l sis [Outstan in  tri tions t  t  s i  f ris  
l i ] 
rnold J. eh an ard (1992), Society of oxicology [Recognized for ajor 
c tributions t  t e c tr l f c e ical a e ts, i cl i  ar aceuticals] 
e er (19 0), I stitute f e icine f ati al ca e  f cie ces [Electe  as 
active e ber based on distinguished professional achieve ent in eterinary 
edicine and Toxicology] 
areer chieve ent ard (1989), ociety f oxicology Inhalation pecialty ection 
[Meritorious c tri tions t  t e fiel  f i alati  t ic l y] 
Paper ofthe year (1989), Society of Toxicology Inhalation Specialty Section [Co-author 
of best paper in the field of inhalation toxicology during previous year] 
ra  . l  ar  (1 9), ciet  f ic l  [C -a t r f est a er lis e  
i  e f t e t  fficial journals ft e ciet  ri  t e re i s ear] 
istinguished ssociate ard (1988), epart ent of nergy [In recognition of highly 
successful efforts in guiding environ ental research for the epart ent f nergy 
and its predecessor agencies during the past 22 years] 
istinguished ssociate ard (1987), epart ent of Energy [For outstanding scientific 
vision and research leadership in inhalation toxicology, radiation biology and 
environ ental health sciences] 
Alu ni Achieve ent Award (1987), ashington State University [For leading service in 
the field of inhalation toxicology and outstanding contributions to veterinary 
edicine] 
Herbert E. Stokinger Award (1985), American Conference of Governmental Industrial 
ie ists [For tst i  tri ti s t  t  fi l  f i stri l t i ology] 
Elda E. nderson ard (1974), ealth Physics Society [For outstanding contributions 
to the field of radiation protection] 
 
Fellow 1969 American Association for Advancement ofScience for outstanding
contributions to understanding the health effects of ingested and inhaled










Maastricht University The Netherlands
Michigan State University
Munster University Germany
North Carolina State University
Northwestern University



















LISTED IN THE FOLLOWING BIOGRAPHICAL GUIDES
WhosWho in the World
WhosWho in America
WhosWho in Frontier Science and Technology
WhosWho in Science
WhosWho of Intellectuals
WhosWho in Medicine and Healthcare
American Men and Women in Science
WhosWho in Science and Engineering
Biological Directory ofOccupational Health and Safety Specialists
International Whos Who ofIntellectuals
Men of Achievement
AREAS OF INTEREST
Dr McClellansresearch interests center on understanding the effects of toxic
materials on people He is a strong proponent of obtaining information from studies at
multiple levels of biological organization from macromolecules to cells to tissues to the
intact person or laboratory animal to populations of people or laboratory animals to
predict human health consequences of exposure to toxic agents His own research and
that of his immediate colleagues has been in inhalation toxicology with emphasis on
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diseases such as cancer occurring at late times after relatively low levels of exposure to
toxicants These studies have included a wide range of airborne materials including
various radionuclides specific chemicals and complex chemical mixtures such as diesel
exhaust With each of the materials his research has spanned from the conduct of
laboratory investigations to the development of quantitative assessments of risk to people
Dr McClellan has been a leader in developing the field of human health risk
assessment His initial involvement in the field began in the 1960s when he was involved
in developing health risk estimates related to the rise of radionuclide power sources in
space The involvement in assessments for health risks of radiation exposure continued
when he assumed leadership for the Inhalation Toxicology Research Institute program in
1966 This program was concerned initially with fission products such as might be
released in a nuclear power reactor accident and later was expanded to consider
transuranic elements such as plutonium The results of the Institute lifespan studies of
inhaled fission product radionuclides are a primary database for assessing the human
health risks of inhaled beta and gammaemitting radionuclides on the respiratory tract
and other tissues The results of the Institute lifespan studies with inhaled plutonium
238 and 239 particles of different sizes are a primary database for assessing human health
risks of alphaemitting radionuclides on the respiratory tract skeleton and liver In 1971
Dr McClellan was elected to the National Council on Radiation Protection and
Measurements a Congressionally chartered organization concerned with assessing
radiation risks
In the 1970s the mission of the Inhalation Toxicology Research Institute was
broadened to consider airborne chemical toxicants including vehicle emissions and coal
fired power plants He also became increasingly involved in advisory committee
activities many of which had a risk assessment component This included service as a
founding member of the US Environmental Protection AgencysScience Advisory
Board from 1974 to 1994 and 7 years as Chair of the Committee on Toxicology of the
National Research CouncilNationa Academy of Sciences Advisory activities concerned
with assessing human health risks continue to the present time with a special interest in
airborne toxicants
In addition to his direct research interests Dr McClellan has had a long
standing interest in the management of research activities He has been especially
interested in fostering a multidisciplinary team approach to complex scientific problems
He has also had a longstanding interest in fostering collaborations and interactions
among the private industry government and academic sectors of society
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Report Document LF73 1980
53 McClellan RO editor Diesel Exhaust Emissions Toxicology Program Status
Report July 1980 Document LF81 1980
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54 Cuddihy RGFASeilerWCGriffith BR Scott and ROMcClellan Potential
Health and Environmental Effects ofDiesel Light Duty Vehicles Document LF82
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55 Cuddihy RGWCGriffith CR Clark andROMcClellan Potential Health and
Environmental Effects of Light Duty Diesel Vehicles II Document LF89 1981
56 Allsup JRDESeizingerFW CoxALBrooks andROMcClellan Vehicle
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McClellanROInvited Testimony on Fiscal Year 1994 Authorization for the
Environmental Protection Agency Office of Research and Development before the
Subcommittee on Technology Environment and Aviation Committee on Science
Space and TechnologyUSHouse ofRepresentatives Washington DC May 4 1993
2 McClellanROInvited Testimony on Results of an Office of Technology
Assessment Study that Analyzed the Current Federal Research Activities in Support of
Risk Assessment and How Research Results are Used in Updating Risk Assessment
Procedures before the Subcommittee on Technology Environment and Aviation
Committee on Science Space and Technology US House ofRepresentatives
Washington DCNovember 16 1993
McClellanROInvited Testimony on Organizational Management ofEPAsResearch
and Development Committee on Science Space and Technology USHouse of
Representatives Washington DCJune 23 1994
4 McClellanROInvited Testimony on Title III Risk Assessment andCostBenefi
Analysis for New Regulations HR 9 Joint Hearing of Subcommittee on Commerce
Trade and Hazardous Materials and Subcommittee on Health and Environment
Committee on Commerce US House ofRepresentatives Washington DC February
2 1995
5 McClellanRO Invited Testimony Subcommittee on Energy and Environment
House Committee on Science USHouse of Representatives Washington DC
February 16 1995
6 McClellanROInvited Testimony National Ambient Air Quality Standard Setting
Process before hearing of Subcommittee on Health and Environment and Oversight
and Investigations USHouse ofRepresentatives Washington DC November 9
1995
7 McClellanROInvited Testimony on the Occupational Safety and Health
AdministrationsApproach to Updating Permissible Exposure Limits PELs for Air
Contaminants Occupational Safety and Health Administration Francis Perkins
Building Washington DC February 22 1996
8 McClellanROInvited testimony on National Ambient Air Quality Standards for
Ozone and Particulate Matter Subcommittee on Clean Air Wetlands Private Property
and Nuclear Safety US Senate Committee on Environment and Public Works
Washington DC February 5 1997
9 McClellanRO Invited Testimony on the Scientific Basis for Changes in the
Particulate Matter and Ozone Standards Subcommittee on Health and Environment
and Subcommittee on Oversight and Investigations USHouse ofRepresentatives
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Ambient Air Quality Standards for Particulate Matter USSenate Environmental and
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RegulationUSSenate Washington DC July 19 2006
12 McClellan R O Invited Testimony on Revision of the National Ambient Air Quality
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13 McClellan R O Invited Testimony onS742 and Draft Legislation to Ban Asbestos
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Involving Roger OMcClellan as an Expert
20072010
Juan Luis Longoria et al v Forest Oil Corporation et al Case NoC20305D
in the 206 Judicial District Hildalgo County Texas
Engaged by Plaintiffs in 2007
Concepcion and Rosario Acosta Plaintiffs v Shell Western Exploration and Production
Inc Case No CV9900509 in the Fifth Judicial District County ofLea State ofNew
Mexico
Engaged by Defendants 2007 Expert Report Deposition Testimony at Hearing
Case ofVivica Chase Haggins et al Plaintiffs v The Dow Chemical
Company et al Defendants Civil ActionNo 107cv01803BELU S District
Court for District of Maryland Northern Division
Engaged by Defendants 2008 Expert Report
Antenberg et al v Coyote Land Company Inc Case No 060717CA01 First
Judicial Circuit Santa Rosa County State of Florida
Engaged by Defendants 2008 Expert Report
Alonso et al v Louisiana Investment GroupLCet al Case No
2007CA000232J First Judicial Circuit Escambia County State ofFlorida
Engaged by Defendants 2008 Expert Report
Barninger et al v Joiner Fill DirtLCCase No 07233CA First Judicial
District Santa Rosa County Florida
Engaged by Defendants 2008 Expert Report
Larry 1 Newkirk and Ruth A Newkirk Plaintiffs v ConAgra Foods Inc et
al Defendants Case No CV 08 273FVS United States District Court Eastern
District for the State of Washington
Engaged by Defendants 2009 Expert Report
Elaine Khoury and Alex Khoury Plaintiffs v ConAgra Foods Inc et al Defendants
Case No 0816CV31620 United States District Court Circuit Court of Jackson County
Missouri at Independence
Engaged by Defendants 2009 Expert Report
Billie Jo Major Plaintiffv Security Equipment Corporation Defendants Case No CV
PI 1003515 District Court of the Fourth Judicial District of the State of Idaho in and for
the County ofAda
Engaged by Defendants 2010
000293
  
l i   . l ll    r  
-2010 
•  is ri , t I. . t il r ti , t I.  o. - -05-D 
in the 206th Judicial istrict, ildalgo ounty, exas 
a e   lai tiffs i   
• oncepcion and osario costa, Plaintiffs v. Shell estern Exploration and Production, 
I c.,  . -99-0050  i  t  ift  i i l i tri t, t   , t t    
i  
  t ,  [Expe  rt, iti , ti   ri g] 
• ase f i vic a hase aggins, et aI., laintiffs, v. he o  he ical 
o pany, et aI., efendants ivil ction o.1 :07-cv-01803-B L, . S. istrict 
ourt for istrict f aryland, (Northern ivision) 
a e   efe a ts,  [Expert eport] 
• t r , t I. . t   ny, I c.,  . - 7- -Ol. ir t 
Judicial ircuit, Santa osa ounty, State of Florida 
ngaged by efendants, 2008 [Expert eport] 
• l s , t I. . isia  I st t r  .L.c. t I., s  o. 
J, irst J i i l ir it s i  t , t t  f l ri  
ngaged by efendants, 2008. [Expert eport] 
• ar i er, et aI. . J i er ill irt, .L.C., ase . - A, irst J icial 
istri t, t  s  ty, l rida 
Engaged by efendants, 2008. [Expert eport] 
• arry I. e kirk and uth . e kirk, Plaintiffs, v. on gra Foods, Inc., et 
I., t ,  .  - -F , it  t t  i t i t urt, t  
istrict for the tate f ashington 
Engaged by Defendants, 2009 [Expert Report] 
• laine houry and lex houry, Plaintiffs, v. on gra Foods, Inc., et aI., efendants, 
ase o. 0816-C -31620, nited tates istrict ourt, ircuit ourt f Jackson ounty, 
iss ri at I de e e ce 
Engaged by Defendants, 2009 [Expert Report] 
• illie  j r, l i tiff . rit  i t r r ti , f t ,  o. V-
I-I003515, i t i t t t  t  i i l i t i t  t  t t  I aho, i    
the ounty f da. 
a e   efe a ts,  
000294
EXHIBITE 
DOCUMENTSPROVIDED TO DR McCLELLAN























Plaintiffs Expert Disclosures and Supplemental Expert Disclosures with all attachments
thereto
Deposition transcript of Billie Jo Major taken in her workers compensation case
Deposition transcript of Billie Jo Major volumes I and II taken January 5 and 6 2011
Deposition of the Rule 30b6designee of Idaho Department of Correction Bret R
Kimmel taken February 14 2011
Deposition of Daniel J Schaffer taken February 14 2011
Deposition of Sara AnneMare Link taken February 15 2011
Deposition of Joshua E Overgaard taken February 15 2011
Deposition ofNicholas Doan taken February 15 2011
Deposition transcript ofDr Daniel J Hendrickson taken on March 3 2011
Deposition of Dr JanatODonnell taken March 9 2011
Deposition Dr William Loveland taken March 8 2011
Deposition exhibits 01 15 and 18 53
Plaintiffs Responses to DefendantsFirst Set of Interrogatories and Requests for
Production of Documents and Plaintiff s First and Second Supplemental Responses to
same
Plaintiffs Responses to SECsFirst Set of Requests for Admission and Second Set of
Interrogatories and Requests for Production ofDocuments
DefendantsResponses to Plaintiff s first set of discovery requests dated January 26
2011
Page 1 of 2
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U  I   R. c L L  
•  r  docu nts i cluding: 
• SECOOOOOI-9 7; • 000414; 
• OCOOOOOI-2 ; • 00426 
• l y entOOOI-3; • - 7; 
• OOOOI-1 ; • 000442; 
• OOOOI-2 ; • - 9; 
• c co - ; • 00473; 
•  SOOOO 1-  0; • -4 ; 
• OOOl-5; • 489; 
• OOOI-1 ; • 586; 
• OOOOOI-13 ; • 608; 
• orthwest_Polmonary • 617; 
-1 ; • 626; 
• afetyShe tOOOO -4; • -6 ; 
• abreRedOOOO -2; • -6 ; 
• -8 ; • -7 4; 
• 5-11 ; • -7 ; 
• ; • 02; 
• -2 ; • -1 ; 
• -25 ; • 51-105 ;  
• 000260; • 001055-1222. 
• - 7; 
• nt  r; 
• ffs  isclosures    isclosures t   ts 
t ; 
• e siti  tra scri t f illie J  aj r ta e  i  er r ers' c e sati  case; 
• siti  tr s ri t f illie J  j r lu es I  II t  J r    , 1; 
• siti  f t e le 0(b)(6) si nee f Ida  e rt e t f rr cti n, r t . 
i l, t  e ruary , ; 
• siti  f a iel J. ff r t  ruary , ; 
• iti   ra nne-Mare in  t  r r  , ; 
• iti   s a . vergaard ta e  r ary , 1 ; 
• siti  f icholas oa  t  e ruary , ; 
• iti  trans ript f r. a iel . e rickson t  n ar  , ; 
• e sition f r. Ja at 'Do nell ta e  arc  , ; 
• e ition . illiam oveland ta e  arc  ,  II; 
• eposition e ibits 1-15  8-53; 
• Plaintiff's esponses to efendant's First Set ofInterrogatories and equests for 
Production of ocuments and Plaintiffs First and Second Supple ental esponses to 
s ; 
• laintiff's esponses to C's irst et f equests for d ission and econd et f 
Inte rogatories and Requests for ion  oc ; 
• efendant's Responses to Plaintiffs first set of discovery requests dated January 26, 
2 ; 
Page 1 of  
Affidavit of Christopher A Reilly in Support ofDefendantsMotion for Summary
Judgment
Affidavit of Robert Nance in Support of DefendantsMotion for Summary Judgment
OC Exposure summary chart
Article Cough in Hot Pepper Workers by Paul BlancMDMSPHDiane LiuMD
MPHCarlos Juarez MDand Homer A BousheyMDFCwhich was
published in Chest in 1991
Article LongTerm Exposure to inhaled capsaicin Can it induce or worsen asthma by
S Cheikh RouhouHRacil M Zarrouk N Chaouch O Rekhis and A Chabbou
September 6 2008
Report prepared by Sandia National Laboratories entitled Oleoresin Capsicum Toxicology
Evaluation and HazardReview October 1995 and
Article entitled Safety ofCapsaicin Cough Challenge Testing by Peter V Dicpinigaitis
MDFCPand Rakesh V Alva MDwhich was published in Chest in 2005
Page 2 of 2
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• ffidavit of Christopher . eilly in Support of efendant's otion for Summary 
Judgment; 
• ffidavit of obert ance in Support of efendant's otion for Sum ary Judgment; 
•   su ary chart; 
• rticle ough in ot epper orkers by aul lanc, .D., .S.P.H.; iane iu, .D., 
.P.H.; arl s Juarez, .D.; an  er . shey, .D., F.C.C.P. ic  as 
l  i  t i  1991; 
• rti l  - r  s r  t  i l  capsaicin:  it i  r rs  st ?, by 
S. Cheikh Rouhou, .Racil, . Zarro uk, . Chaouch, . Rekhis and . Chabbou, 
pt  , 8; 
• Report prepared by Sandia National Laboratories entitled Oleoresin Capsicum Toxicology 
l ti   r  eview, t ber, 1995;  
• rti l  ntitl  af t  f s i i   ll  esting,  et r . i i i itis, 
.D.,  .C.C.P.;  s  . l , .D. i  s lis  i  st i  005. 
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EXHIBITF 
Christopher A Reilly PhD
1934 S Imperial St
Salt Lake City UT 84105








19941999 PhDToxicology Utah State University Logan UT
1991 1994 BSBiology BiochemistryM lecular Biology emphasis University of Utah Salt Lake
City UT Minor Chemistry
19901991 No Degree Conferred Biology Stockton State College Pomona NJ
Employment
72009current Research Associate Professor Department of Pharmacology and Toxicology
University of Utah Salt Lake City UT Adjunct Associate Anesthesiology
University ofUtah School ofMedicine
7200172009 Research Assistant Professor Department of Pharmacology and Toxicology
University of Utah Salt Lake City UT Adjunct Assistant82008
Anesthesiology University ofUtah School ofMedicine
6199972001 Post Doctoral Fellow Department of Pharmacology and Toxicology University of
Utah Salt Lake City UT Advisors Dennis J Crouch BSMBAand Garold S
Yost PhD
19951999 Research Assistant Department of Chemistry and Biochemistry Utah State
University Logan UT Advisor Steven D Aust PhD
1995 Laboratory Technician Center for Human Toxicology Department of
Pharmacology and Toxicology University ofUtah Salt Lake City UT
1993 ASPET Summer Undereraduate Research Fellow Center for Human Toxicology
Department of Pharmacology and Toxicology University of Utah Salt Lake City
UT
Awards andHonors
Gordon Research Conference Mechanisms of Toxicity Travel Award August 2000
2001 Colgate Palmolive Post Doctoral Fellowship in In Vitro Toxicology Title The Role of the
Capsaicin Receptor VR1 in Human Lung Epithelial Cell Toxicity
ASPET Young Investigator Travel Award April 2002
Manuscript Highlight Toxicological Sciences 891278286
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. 
  ors: 
• Gordon Research Conference "Mechanisms of Toxicity " Travel Award, August, 2000. 
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apsaicin eceptor (YR1) in u an ung pithelial ell oxicity." 
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P450Mediated Dehydrogenation Mechanisms NIHNIGMS GM074249 1012314
864000 total direct costs CoInvestigator
P450 Metabolism ofGlucocorticoids in Lungs ofPediatric Asthmatics NIHNICHD HD060559
1201911200 416220 8 total direct costs CoInvestigator
TRP Channels and Air Pollution NIHNIEHS ES017431 081907311 4000 total
direct costs Principal Investigator
Chemoprevention ofPancreatic Cancer by Capsaicin Sub Contract Metabolism PK Analysis
NIHCI CAl29038 100110 93120 1 32704 total sub contract award Principal
Investigator Utah Sub Contract Srivastava PI
TRPA1 as a Molecular Mediator ofLung Toxicities by Diesel Exhaust Particles DEP Colgate
Palmolive CorporationSOT 44000 total award 31413132 Cassandra E DeeringRice
PhD fellowship recipient Principal InvestigatorSupervisor
Completed
TRPM8 Variant Activation by Novel TRPM8Agonists Dendreon Corporation 0912810
30856 total direct costs Principal Investigator
TRP Channels in Acute Lung Injury and Bronchial Hyper Reactivity University of Utah
Department of Anesthesiology Research Fund 071906301 30869 total direct costs
Principal Investigator
3MethylindoleInduced Lung Injury NIHNHLBI HL013645 31706311013340 2
total award CoInvestigator
P450Mediated Dehydrogenation Mechanisms NIHNIGMS GM074249 016123109
753496total direct costs CoInvestigator
Mechanisms of Vanilloid Capsaicin ReceptorMediated Lung Cell Death NIHNHLBI HL
069813 525000 total direct costs 47033107Principal Investigator
Responses of Lung Cells to Metals in Manufactured Nanoparticles USEPA EPA STAR
RD8317230 75617 total direct costs 101593007CoInvestigator
Analysis of lAD its metabolites and related endogenous hormones by mass spectrometry
United States Anti doping Agency USADA 3120 total direct costs412002313
Principal Investigator
The Role of the Capsaicin Receptor VRI in Human Lung Epithelial Cell Toxicity Colgate
Palmolive CorporationSOT 35000 total award 4013102 Principal
InvestigatorFellowship Recipient
Professional andAcademic Service
Mountain West Society of Toxicology Vice President Elect 20032004 Vice President 2004
2005 President 20052006 Past President 20062007
Society ofToxicology Continuing Education Committee 200811 Chairman 20101011
Society of Toxicology Molecular Biology Specialty Section VPElect 2008 Vice President
2009 President 2010
Gordon Research Conference Mechanisms ofToxicity Poster Session CoChair 2006
Editorial Board Member Journal ofBiochemical and Molecular Toxicology 2007 present
Manuscript Reviews Molecular Pharmacology Journal of Pharmacology and Experimental
Therapeutics Drug Metabolism and Disposition Toxicology and Applied Pharmacology Journal of
Biochemical and Molecular Toxicology Toxicological Sciences Chemical Research in Toxicology
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 ta  -  (Srivasta a I). 
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$30,856 total direct costs. rincipal Investigator. 
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e art e t f est esi l  esearc  d. 7/01/09- 6/30/1 O. $30,869 t tal irect c sts. 
Principal Investigator. 
• "3- t li l -Induce   j ." -  (HL0 645). /17/06- /31/10. $1,334,032 
t t l r . -I ti t r. 
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l li  orporation-S . $35,000  ard. (4/01/01-3/31/02) - rincipal 
Investigator/Fellowship ecipient. 
ofes    rvice: 
• ountain est Society f Toxicology: ice President lect (2003-2004), ice President (2004-
05), r i t (20 - 06), t r i t (2 - 07). 
• Society f oxicology: ontinuing ducation o ittee (2008-2011; hair an 2010-1011) 
• Society f Toxicology: olecular iology pecialty ection, -Elect (2008), ice- resident 
(2009), President (2010) 
• r  esearc  fere ce "Mechanis s f xicity " ster essi  -Chair (2 6) 
• it ri l r  e ber: J r al f i c e ical a  lec lar ic l  (200 - resent). 
• s ri t i s: le lar r cology; J r l f r l   ri t l 
herapeutics; rug etabolis  and isposition; oxicology and pplied har acology, Journal f 
i c e ical a  lec lar ic l gy; ic l ical cie ces; e ical esearc  i  ic l gy; 
Thorax; Journal of Forensic Sciences; Journal of Chro atography  and B, Journal of the Science 
of Food and Agriculture Canadian Journal of Physiology and Pharmacology Neuropeptides
Immunology and Cell Biology Journal of Dermatological Sciences and Molecular Nutrition and
Food Science
Ad Hoc Grant Reviews NSFCDRF CGPRFBRII competition 2008 University of Arizona
Southwest Environmental Health Sciences Center External Reviewer 2008 University of
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Departmental Committee for Research Track Faculty 20032004
University Campus Health and Safety Committee 20082011
Professional Organizations andAffiliations
Mountain West Society of Toxicology 1996Present
American Society ofPharmacology and Experimental Therapeutics 2001Present
Society ofToxicology 1997Present
International Society for the Study ofXenobiotics 2001Present
Faculty of 1000 Medicine Associate Member 2010 present Anesthesiology and Pain
Management Airway and Respiratory Physiology General Pharmacology sections Respiratory
Disorders and Disease Environmental and Occupational Lung Disease section




Post Doctoral Fellow Washington University Dr Evan Kharisch
Karen C Thomas PharmDPhD20052010
Post Doctoral Internship Utah Poison Control Center Dr Barbara Crouch
Post Doctoral
Mark E Johansen PhD20032005
Scientist Jacobs Dugway Team Life Sciences testing Facility Dugway UT
Cassie E DeeringRice PhD2009 present
Graduate Committees
Stacy J Smeal PhDAmy B Cadwallader PhDJason S Biggs PhDHao Sun PhDChad D
Moore PhDDorina Arch PhDJaya Kartha PhDGreg Hadlock PhDRobyn Poerschke
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PHTX 6630 Mechanisms of Toxicity Hepatotoxicity P450 BioactivationReactive Intermediate
Toxicities 2003
PHTX 6600 Methods in Pharmacology Sitedirected Mutagenesis and Molecular Toxicology
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PHTX 7114 Principles ofToxicology Metal Toxicity Pesticide Toxicity Toxic Responses of the
Skin and Ocular and Visual Systems Mechanisms of Renal Toxicology Reactive Intermediates
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PHCEU 7010 Genetic Engineering Recombinant Proteins and Protein Interaction Methods
Macromolecular Binding Interactions Genetic Manipulation of Cells and Organisms and
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Stacy J. S eal, Ph.D., y B. Cad allader, Ph.D., Jason S. Biggs, Ph.D., ao Sun, Ph.D., Chad . 
oore, Ph.D., orina rch, Ph.D., Jaya artha, Ph.D., reg adlock, Ph.D., Robyn Poerschke. 
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Comprehensive Toxicology Volume 9 Chapter 7 2nd Edition Ed McQueen CA Elsevier
Oxford UK
Platform and Invited Presentations
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1 Reilly CA Enhanced DNA Damage by Hydralazine in the Presence of Peroxidase Redox
Mediators 14 Annual Mountain West Chapter of the Society of Toxicology Snowbird UT
1996
2 Reilly CA RedoxMediation as a Model for PeroxidaseDependent DNA Damage by
Hydralazine 36 Annual Society of Toxicology Cincinnati OH 1997
3 ReillyCAOrganSelective Metabolism and Toxicity of Capsaicinoids in Pepper Spray Products
Gordon Research Conference on Mechanisms of Toxicity Plymouth NH 2000 Recipient of a
GRC Travel Award
4 Reilly CA Capsaicinoids Cause Cytotoxicity in Human Airway Epithelial Cells 40 Annual
Society ofToxicology San Francisco CA March 2001
5 Reilly CAVanilloid Receptor Ligands Mediate Cytokine Production and Cytotoxicity in BEAS
2B Cells 19 Annual Mountain West Society of Toxicology Angelfire NM September 2001
6 Reilly CA Vanilloid Receptors Mediate Cytokine Production and Cytotoxicity in BEAS2B
Cells 41 Annual Society of Toxicology Nashville TN March 2002
7 Reilly CAVanilloid Receptors Dictate Cell Death in Airway Epithelial Cells ASPET New
Orleans LA April 2002 Recipient ofa Young Investigator TravelAward
8 Reilly CA Cytochrome P450Mediated Metabolism of Capsaicin Bioactivation or
Detoxification 1 lth North American ISSX Orlando FL October 2002
9 ReillyCAUnique Dehydrogenated Metabolites of Capsaicin Produced by Cytochromes P450
8thEuropean ISSX Dijon France April 2003
10 Buldoc T and Reilly CAMetabolism of Capsaicin by Cytochromes P450 Decreases TRPV1
Mediated Cytotoxicity to Human Bronchiolar Epithelial Cells 21 Annual Mountain West Society
ofToxicology Breckenridge CO September 2003
11 JohansenMEand ReillyCATRPV1 Antagonists Enhance VanilloidInduced Calcium Flux and
Cell Death in Human Bronchial Epithelial Cells FASEB Summer Conference Snowmass Village
CO June 2004
12 Reilly CAChemical and Enzymatic Determinants of P450Dependent Alkyl Dehydrogenation
and Hydroxylation of Capsaicin 15 International Symposium on Microsomes and Drug
Oxidations Mainz Germany July 2004 Short Oral Presentation included
13 Reilly CAMechanisms for the Alkyl Hydroxylation and Dehydrogenation of Capsaicinoids by
P450 7th International ISSX Vancouver BC Canada
14 JohansenME and Reilly CATRPV1 Expression and Activity Determine Sensitivity to Irritants
In Human Lung Epithelial Cells August 2004 47 International ISSX Vancouver BC Canada
15 Johansen ME and Reilly CATRPV1 antagonists enhance vanilloid induced calcium flux and
cell death in human lung epithelial cells 22 Mountain West Society of Toxicology Park City
UT September 2004 PlatformMEJ
16 Sabnis AS and Reilly CA Expression and Characterization of TRPM8 Receptors in the Lung
Epithelium 22 Mountain West Society ofToxicology Park City UT September 2004
17 JohansenMEand ReillyCATRPV1 Antagonists Induce Translocation of Intracellular TRPV 1
to the Plasma Membrane Enhancing VanilloidInduced Toxicities 44 Annual Society of
Toxicology New Orleans LA March 2005 Merck Mechanisms TravelAwardMEJ
18 Sabnis AS and Reilly CA Expression and Characterization of TRPM8 Receptors in the Lung
Epithelium 44 Annual Society of Toxicology New Orleans LA March 2005
19 Thomas KCand Reilly CA Activation of intracellular TRPV 1 induces ER stress response and
cell death 23 Mountain West Society ofToxicology Santa Fe NM September 2005 Platform
KCT
20 Sabnis ASand Reilly CATRPV1 Activation Modulates Cystathionase Expression In Airway
Epithelial Cells 23 Mountain West Society of Toxicology Santa Fe NM September 2005
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21 Sabnis AS and Reilly CA Characterization of TRPM8 receptors in Human Respiratory
Epithelial Cells 45 Society ofToxicology San Diego CA March 2006Travel Award Winner
ASS
22 Reilly CA The Human TRPV 1 Capsaicin Receptor Mediates Endoplasmic Reticulum Stress
Activation and Cell Death in Human Bronchial Epithelial Cells Gordon Research Conference
Mechanisms of Toxicity Colby College ME 2006 Young Investigator Travel Award Winner
CAR
23 Thomas KCand ReillyCA Structure Activity Relationships Between Capsaicinoid Analogues
and TRPV1Mediated Cytotoxicity 24th Mountain West Society of Toxicology Pheonix AZ
September 2006 Platform KCT
24 Thomas KCand Reilly CA Endovanilloids in the Lung Initiate TRPV 1Mediated Acute Lung
Injury 25th Mountain West Society of Toxicology Breckenridge CO September 2007 Platform
KCT
25 Thomas KCand Reilly CA Endovanilloids in the Lung Initiate TRPV1Mediated Acute Lung
Injury 47th Society of Toxicology Seattle WA March 2008 MBSS Travel Award Winner
KCT
26 Thomas KCand ReillyCA Involvement of TRPV1 and ER Stress in Lung Cell Death In Vitro
and Acute Lung Injury In Vivo 26 Mountain West Society of Toxicology Salt Lake City UT
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27 Henion F Reilly CA Glutathione Adducts of Capsaicin Reactive Intermediates of P450
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PlatformFH
28 ThomasKCand ReillyCA Involvement of TRPV1 and ER Stress in Lung Cell Death In Vitro
and Acute Lung Injury In Vivo 48 Society ofToxicology Baltimore MD March 2009
29 Thomas KC and Reilly CA Contributions of TRPV1 the Endoplasmic Reticulum Stress
Response and Endovanilloids in Inflammatory Lung Injury and Lung Cell Death In Vitro 49
Annual Society of Toxicology Salt Lake City UT March 2010
30 Reilly CA TRPV1 Mediates Lung Toxicities of Specific Particulate Materials 49 Annual
Society of Toxicology SaltLake City UT March 2010
31 ReillyCA TRPV1 is a Principal Mediator of Lung Injury by Distinct Environmental PM TRP
2010 2nd International Symposium on TRP Channels and Human Disease Leuven Belgium
September 2010
32 Reilly CA Contributions of TRPVI and TRPM8 to Lung Injury by Coal Fly Ash Society of
Toxicology Washington DC March 2011
33 DearingRice CE and Reilly CA Activation of human TRPA1 by diesel exhaust particles
DEP Association with lung injury Society of Toxicology Washington DC March 2011
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An extensive and comprehensive evaluation of basic scientific and medical literature was performed to
investigate whether a single acute workplace exposure to pepper spray OCcapsaicinoids even or
possibly longerterm low level exposure to OCcapsaicinoids represents a plausible origin for the
chronic respiratory conditions that Ms Billie Jo Major currently suffers from as described in the
Complaint and Demand forJury Trial1 document prepared on February 24 2010 Case number CV PI
1003515 Additionally opinions are offered in response to reports provided by Drs Yost and Purswell
Literature Search Methods
The search was performed using the following search terms listed below using the National Center for
Biotechnology Information NCBI PubMed and PubMed Central databases as well as the general search
engine Googlec m Abstracts and relevant manuscripts were accessed and reviewed for relevance to
the general claims outlined above Additionally pertinent references cited within these manuscripts
were accessed and reviewed when appropriate
Primary Search Terms
Capsaicin Capsaicinoids Oleoresin Capsicum OC Pepper Pepper Spray Chili Pepper Worker Spice
Processing Law Enforcement
Secondary Search Terms and terms
Lung Lung Injury Lung Damage Toxicity Lung Toxicity Lung Disease Asthma Chronic Cough Vocal
Cord Dysfunction Esophageal Dysmotility Reflux GERD GORD Reactive Airway Disease RADS
Respiratory Tract Airway Disease Chronic Disease Acute Toxicity Acute Injury Acute Lung Injury
Chronic Injury Chronic Lung Disease
Major Literature Findings
Oleoresin CapsicumCapsaicinoids
1 Oleoresin Capsicum OC is the viscous concentrated solvent or oil extract of hot peppers
Capsaicinoids capsaicin dihydrocapsaicin nonivamide nordihydrocapsaicin homocapsaicin
homodihydrocapsaicin others are the active components of oleoresin capsicum OC Capsaicin
and Dihydrocapsaicin are the most abundant comprising 6080 of the total analogues in OC
OC capsaicinoids are found in a many products used and consumed by humans including food as
peppers for coloring and flavoring cosmetics dietary supplements as therapeutic agents ie
anti inflammatory agents analgesics anti cancerchemopreventative agents others in nasal
sprays and cough drops and in selfdefense pepper sprayOC sprays
3 Oleoresin capsicum is classified by the United States Food and Drug Administration as Generally
Recognized as Safe GRAS as a food additive and for multiple topical uses The Cosmetic Ingredient
Review panel also classifies capsicum products as safe when formulated not to be irritating
Pharmacological and Toxicological Properties of OCCapsaicinoids
4 The vast majority of OCcapsaicinoid activity in biological systems is attributable to activation of its
receptor TRPV1
5 OCCapsaicinoids are potent acute sensory irritants and pro inflammatory agents that temporarily
elicit sensations of intense pain and burning at sites of exposure with concomitant local
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i  i t  iti  t . illi   j  tl   ,  i  i   
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espiratory ract, ir ay isease, hronic isease, cute oxicity, cute Injury, cute Lung Injury, 
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j r it r t r  i i gs: 
l r i  i /Capsaicin i  
. l r i  i  (O ) is t  i  tr t  l t r il tr t f t rs. 
i i i  (cap i i , i r i i , i i , r i r i i , saicin, 
i r i i , t rs) r  t  ti  t  f l r i  i  (O ). i i  
and ihydrocapsaicin are the ost abundant, co prising ~60-80% of the total analogues in . 
2. /capsaicinoids r  f  i   y r cts s   c s  y s i cl i  f  (as 
rs, f r c l ri ,  fl v ring), c s tics, i t ry s l ts, as t r tic ts (Le., 
ti-i fl t  t , lgeSiCS, ti- r/chemopreventative ts, t ers), i  l 
   ,  i  lf- f  r /O  s. 
. l r i  i  i  l ifi   t  it  t t    r  i i tr ti   r ll  
i   f  (G )   f  iti   f r lti l  t i l .  ti  I r i t 
vi  l ls  cl ssifi s c sic  r cts as s f   f r l t  t t   irrit ti . 
l i l  i l i l ti  f /Capsai i i : 
.  t j rit  f /capsaicinoi  ti it  i  i l i l t  i  ttri t l  t  ti ti  f it  
r t r, l. 
5. /Capsaicinoids are potent acute sensory irritants and pro-infla atory agents that te porarily 
elicit sensations of intense pain and burning at sites of exposure, ith conco itant local 
inflammation and edema via the selective activation of the capsaicin receptor TRPV1 on sensory
neurons and other cells eg skin cells lung epithelial cells etc Activation of TRPV1 on sensory
neurons to produce inflammation is also referred to as neurogenic inflammation
6 Characteristic acute symptoms of exposure for humans include burning of the eyes skin and throat
sneezing dry and involuntary cough shortness of breath runny nose rhinorrhea watery eyes
lacrimation reddening of skin erythema and localized inflammation These symptoms are
transient lasting only a few minutes to hours following removal of individuals from the exposure
source The activation period is also followed by a refractory period where TRPV1 is inactive to
agonists producing a numbing sensation
7 Physiological responses to capsaicinoids are dose related There is a lowdose threshold where
responses are absent or undetectable At higher doses capsaicinoids produce more intense
responses up to a maximum effect where no additional intensification of responses are observed
iethe dose response is non linear The dose response profiles for different responses vary as a
result of multiple factors including TRPV1 expression and other poorly defined individual
differences
8 Both single and repeated high doses of capsaicinoids can be used safely to treat chronic pain
seasonal allergy and headache This is because capsaicinoids desensitize TRPV1 expressing
neurons rendering them resistant to stimulation for extended periods of time when challenged by
capsaicin and other known agonists including pH elevated temperature and select endogenous
pro inflammatory molecules Repeated dose exposures are the basis of using TRPV1 agonists as
therapeutic agents
9 In test animals capsaicinoids are toxic but the dose response relationship for OCcapsaicinoids in
humans is unknown and not easily projected by the animal data due to high species variability
10 Capsaicinoids are extensively metabolized by various drug metabolizing enzymes and exhibit a short
halflife in most tissues Metabolites of capsaicinoids do not activate TRPV1
11 The responses characteristic of exposure to capsaicinoids also occur upon exposure to other TRPV1
agonistsactivating chemicals
12 Other known potent irritants of the respiratory tract including cigarette smoke chlorine gas
hydrogen peroxide isothiocyanates tear gas CS CN others mustard gas components of garlic
onion and many other spices that elicit similar responses to those elicited by capsaicin including
inflammation and cough activate the TRPA1 receptor not TRPV1 Occupational asthma case
reports of severe adverse respiratory effects and death have been reported for most of these TRPA1
agonists CS and CN may be combined with OC in some pepper sprays leading to unique efficacy
and safety profiles
OCCapsaicinoidBased Pepper Sprays
13 Use of OCcapsaicinoid based pepper sprays is widely accepted as a safe and effective method for
temporarily incapacitating non compliant subjects using non physical and non lethal methods by
law enforcement and military personnel worldwide
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/Capsaicinoi -Based r : 
.  f C/capsaicinoid-base  r  i  i ly       t   
te porarily incapacitating non-co pliant subjects using non-physical and non-lethal ethods by 
l  f rce ent  ilit r  r l rl i . 
14 OCbased pepper sprays intended for human use typically contain 510 oleoresin capsicum diluted
in a vehicle which varies from manufacturer This mixture is canned and pressurized 510 OC
based pepper spray products are common and typically contain absolute concentrations of
capsaicinoids in the range of 0217ie0217g100 mL solution depending upon the product
Several commercially available OCbased pepper sprays contain higher or lower percentages of
OC capsaicinoids depending upon product The Sabre Red 10 OC product is 133 major
capsaicinoids and the 5 OC product is067 capsaicinoids which is consistent with other products
available on the market despite manufacturer claims that it is the hottest product available
15 Some pepper sprays are not OC based One example is the 1 Capsaicin II PAVA spray from
Pepperball Technologies This spray while lower in absolute capsaicinoid content than the Sabre
Red 10 OC product is calculated to have a higher Scoville Heat Unitiehotness potency value
3 million SHU
16 OCcapsaicinoid pepper sprays are effective because they rapidly produce acute but temporary and
reversible pain involuntary eye closure and lacrimation tearing nasal irritation and rhinorrhea
runny nose sneezing airway irritation and intense coughing These properties are consistent with
the known pharmacological properties of OCcapsaicinoids described above
17 The effects of pepper sprays generally subside within 30 60 minutes after exposure depending
upon the symptom and extent of decontamination The effects on the respiratory tract and eyes
typically subside first and usually within 5 minutes when the exposed individual is in fresh air Pain
at exposed sites on the skin and erythema are the most persistent with possible reactivation of pain
with exercise andor warming of the skin up to 2448h after depending upon multiple factors such
as bathing
18 OCcapsaicinoids in pepper spray can induce transient laryngospasm which was reported to be
reversible in 45 seconds
19 Since the introduction of OCpepper sprays into law enforcement numerous studies have
demonstrated a reduction in injury to officers and to subjects due to physical altercations with only
isolated cases where OCpepper spray exposure caused significant unanticipated adverse effects
20 Case reports and reviews of literature document several atypical adverse acute responses to
OCpepper spray involving respiratory distress as well as irreversible ocular injury and death
These cases typically involve unusual exposure scenarios products that contain other ingredients
egsolvents that are by themselves acutely toxic poorly defined ingredients individuals with pre
existing injuries or health conditions such as asthma or cardiovascular disease or subjects who were
intoxicated or under the influence of elicit drugs Most OCpepper spray related deaths are
attributed to other factors not a direct toxic effect of the OC or OC components In one commonly
cited case an infant experienced lifethreatening acute respiratory failure following an unusual
direct high dose exposure but fully recovered with medical treatment despite developing an
apparent nosocomial infection during treatment that likely contributed to the severity of the
subject respiratory conditions In non fatal cases involving respiratory distress which represent
the majority of reports subjects recovered fully with no evidence of permanent damage or
exacerbation of a preexisting health condition of any kind
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4. D -b s  p r sprays i t  f r  use ty ic lly c t i  5- 0% ol r si  capsic  il t  
in a vehicle, hich varies fro  anufacturer. his ixture is canned and pressurized. 5-10% DC-
 r r  r t  r    t i ll  c t i  abs l t  conc tr ti  f 
i i i  i  t  r  f .2- .7% (Le., .2- .7 /10   olution), i  u  t  product. 
r l r i ll  il l  D -ba  r r  c t i  i r r l r p rc t  f 
D /ca i i i s, i   product.  r  e  0% D  r t is .3 % j r 
c s ici i s  t  5% D  r ct is .6 % c s ici i s ic  is c sist t it  t r r cts 
il l   t  arket, i  f  l i   i  i   "h st" r  ilable. 
5.  r r  r  t D - sed. D  l  i  t  % i i  II/   f  
ll l ies. i  ray, il  l  i  l t  i i i  t t t  t   
 0% D  r duct, i  l l t  t    i r ill  t it (Le., t ss/pot cy) lue, ~ 
 illi  . 
16. D /capsaicinoid pepper sprays are effective because they rapidly produce acute, but te porary and 
r r i l  in, i l t r   l r   l ri ti  (t ring), l irrit ti   r i rr  
(runn  se), i , ir  irrit ti   i t  ghing.  r rti  r  i t t it  
t   r l i l r rti  f D /capsaicin i  ri  ve. 
17. The effects of pepper sprays generally subside ithin 30-60 inutes after exposure, depending 
upon the sy pto , and extent of deconta ination. The effects on the respiratory tract and eyes 
t i ll  i  fir t  ll  it i   i t   t   i i i l i  i  f  ir. i  
at exposed sites on the skin and erythe a are the ost persistent, ith possible reactivation of pain 
with exercise and/or war ing of the skin up to 24-48h after, depending upon ultiple factors such 
 i g. 
18. D /capsaicinoids in r s r y can i c  tr si t l ry s s , ic  s r rt  t  be 
r r i l  i   . 
. i  t  i tr ti  f D /pepper r  i t  l  f r t r s t i   
de onstrated a reduction in injury to officers and to subjects due to physical altercations, with only 
i l t   re C/pe per r  r   i ifi t ticipated r  ff ts. 
20. ase reports and revie s f literature docu ent several atypical adverse acute responses to 
DC/pepper spray involving respiratory distress, as ell as irreversible ocular injury, and death. 
These cases typically involve unusual exposure scenarios, products that contain "other" ingredients 
(e.g., l ts) t t r   t l  tely t i , rl  fi  i r i ts, i i i l  it  r -
i ti  i j ri s r lth ditions  s t  or r i vascular i , r j t  ho r  
intoxicated or under the influence of elicit drugs. ost DC/pepper spray related deaths are 
attributed to other factors, not a direct toxic effect of the OC or DC components. In one commonly 
cited case, an infant experienced life-threatening acute respiratory failure follo ing an unusual 
direct high dose exposure, but fully recovered with edical treat ent, despite developing an 
r t osoco ial infection ring treatment t t likely tributed to t  rit  f t  
s ject's respiratory con iti s. In on-fatal cases i v lving r s ir t ry istr ss, hich r r s t 
the ajority f re rts, subjects r covered fully ith  vidence f er anent age r 
exacerbation of a pre-existing health condition of any kind. 
21 Inhalation exposure of rats to OC and capsaicinoids in the form of pepper sprays or solutions of pure
capsaicinoids causes acute airway damage at doses of07 mgkg and above Animals cotreated
with methamphetamine and cocaine exhibited enhanced damage due to apparent increased rates
of respiration consistent with literature case reports of OCpepper spray related deaths Airway
injury was rapid observed at 4h was maximal at 24h and reversedrecovered between 48 72h
Irreversible damage was not directly assessed but recovery of animals between 4872h suggested
that irreversible injury was unlikely from a single high dose exposure
22 Health risk analysis of First Defense OC based pepper spray containing021 capsaicinoids in an
ethanol 28 propylene glycol 13 water 59 vehicle demonstrated no adverse effects on
mice or rats 715 days following a 1 minute whole body inhalation exposure to pepper spray aerosol
up to 85 mgL which may be a plausible aerosol concentration in closed environments but
unlikely particularly without constant aerosol generation Discharge of 14 MK4 units as described
above into a 22L chamber only yielded an aerosol concentration of057 mgL 1100 that of the
rodent exposure studies Aerosolization of the sprayed material was 0001 Accounting for
aerosol size an estimated inhalation dose of0006400075 mgkg would be achieved for an
average 70kg subject The authors concluded that this spray posed minimal if any threat to human
health beyond the intended acute effects
23 It has been determined that the Sabre Red 10 OC spray 133 capsaicinoids has a Lethal
Concentration for 50 of the exposed test population LC of 1005 mgL for inhalation exposure
in rats This is a very high dose that is unlikely to be achievable under any normal exposure scenario
for OCpepper sprays Based on data from paragraph 22 and a scaling factor of65 for differences
in capsaicinoid content an inhalation dose of004005 mgkg can be estimated for an average
70kg human exposed to the Sabre red 10 OC product While this estimation is not precise the
calculation provides an estimate that is less than 110 the lowest dose where injury to rat lungs
was observed in OCcapsaicinoid inhalation studies
24 Review of 81 emergency admissions involving OC sprays reported no serious injury or toxicity only
acute responses consisting of corneal abrasions 7 cases redness and respiratory irritation 6
cases were observed
25 Aerosolized capsaicin similar to exposures from pepper sprays is used as a research and clinical tool
for elucidating the origins of chronic cough and diagnosing airway hyper sensitivity conditions
Direct inhalation of capsaicinoids at doses comparable to those predicted for OCpepper spray
exposures are used A comprehensive review of the safety of the capsaicin challenge test
demonstrated that capsaicin inhalation tests are safe for normal subjects and patients with asthma
COPD pathologic chronic cough and other respiratory conditions Transient throat irritation was
the principal adverse effect reported and exposures to capsaicin through cough challenge tests was
not associated with chronic irreversible adverse effects on the respiratory health andor
exacerbation of pre existing health conditions
26 Human inhalation exposures to pepper sprays in a controlled setting indicate no significant adverse
changes in respiratory or cardiovascular function in either an upright or restrained position and no
evidence for longterm adverse effects due to exposure
27 Inhalation of 5 OC aerosol for 60 seconds by humans has been reported without adverse effects
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of respiration, consistent with literature case reports of DC/pepper spray related deaths. Airway 
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i  r r t  -15  f ll i    i t  l -b  i l ti  r  t  r r  r l 
  .5 /L,     l  r l  i  l  ir ents, t 
li ly, rti l rl  it t t t r l r tion. i r  f  -4 its, s ri  
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r l i e,  ti t  i l ti   f . 06 - . 07  /kg l   i  f r  
r   j ct.  t r  l  t t t i  r   i i l if  t r t t   
lth,     ts. 
23. It has been deter ined that the abre ed 10% C spray (1.33% capsaicinoids) has a Lethal 
oncentration for 50% of the exposed test population (LCso) of >100.5 g/L for inhalation exposure 
i  r t . i  i   r  i   t t i  li l  t   i l  r  r l r  ri  
f r /pepper r .   t  fr  r r     li  f t r f .65 f r iff r  
i  i i oid t t,  i l ti   f . 04-0. 05 /kg   ti t  f r  r  
70kg hu an exposed to the Sabre red 10% OC product. hile this esti ation is not precise, the 
calculation provides an esti ate that is less than 1/10th the lowest dose where injury to rat lungs 
 r  i  D /capsaicinoi  i l ti  t i . 
. i  f  r  i i  i l i   r  r rt   ri  i j r  r t i it ; l  
acute responses consisting of corneal abrasions (7 cases), redness, and respiratory irritation (6 
s)  . 
. r liz d i i , i il r t  r  fr  r r , is  s  r r   li i l t l 
for elucidating the origins of chronic cough and diagnosing airway hyper-sensitivity conditions. 
ir t i l ti  f ici oids t  r ble t  t  r i t  f r C/pe per r  
exposures are used. A co prehensive review of the safety of the capsaicin challenge test 
de onstrated that capsaicin inhalation tests are safe for nor al subjects and patients ith asth a, 
, pathologic chronic cough, and other respiratory conditions. ransient throat irritation as 
the principal adverse effect reported and exposures to capsaicin through cough challenge tests was 
t i t  it  ronic/irreversibl  r  ff t   t  r ir t r  lt  d/or 
r ation f - i ti  lt  i i . 
26. u an inhalation exposures to pepper sprays in a controlled setting indicate no significant adverse 
changes in respiratory or cardiovascular function in either an upright or restrained position and no 
i ce f r long-term rse ff t   t  r . 
27. Inhalation of 5%  aerosol for 60 seconds by hu ans has been reported, ithout adverse effects. 
28 Counterforce Technology determined that a dose of 510 aerosol OC is both safe and effective for
its intended uses
OCCapsaicinoids Pepper Sprays and Interactions with Human Diseases
29 Chili pepper processors demonstrate asthmalike symptoms cough and hyper sensitivity to irritants
including capsaicin itself These studies show a relationship between unidentified components of
pepperspepper products and transientreversible changes in human respiratory function While it
was assumed that capsaicinoids contributed to the observed effects there is equal probability that
the responses were attributable to other factors A fungus that grows on peppers MucorStolonifer
causes Paprika Splitters Lung disease Also workers predicted to have the highest levels of daily
exposure to capsaicinoids did not exhibit higher sensitivity relative to other workers Ethnic biases
in samples gender and lifestyle all confounded the results making it impossible to directly correlate
the respiratory data to exposure to OCcapsaicinoids Acute lung injury permanentirreversible
injury or initiation or irreversible exacerbation of a chronic disease eg occupational asthma
chronic cough gastroesophageal reflux or vocal cord dysfunction were not observed in these
studies
30 Processors of other plant materials including garlic onion soy etc also exhibit similar respiratory
changes
31 Oral capsaicinoids can induce functional dyspepsia and exacerbate symptoms of gastroesophageal
reflux Avoidance of chili peppercapsaicinoid ingestion reverses the effects but longterm oral
exposure to capsaicinoids decreased the severity of dyspepsia and gastroesophageal reflux
suggesting a therapeutic use of capsaicinoids for these conditions No effects on respiratory
function were indicated
32 Capsaicinoids can protect the lung from certain types of injury
33 Individuals with preexisting respiratory infection gastroesophageal reflux chronic cough and
asthma are often more sensitive to the short termacute effects of capsaicinoids ie cough in
capsaicin cough challenge tests
34 TRPV1 antagonists as well as capsaicin and other TRPV1 agonists are being explored as treatments
for a number of respiratory gastrointestinal and other disordersdiseases via TRPV1 inhibition
and or longterm TRPV1 desensitization
Dr YostsStatement
35 The assertion that Ms Majors exposure to the Sabre Red 10 OC product lasted 25h in an
unventilated room is not consistent with the exposure scenario described by Ms Major and
colleagues who participated in the training The total doseexposure to OCcapsaicinoids by all
routes appeared minimal
36 The worsening of her health conditions as a result of the exposures to OC is inconsistent with
medical records Ms Major has a welldocumented history of significant and persistent respiratory
problems prior to her employment by the IDC and March 3 2008 Many notable instances occurred
prior to March 3 2008 where OCpepper spray exposure could not be a contributing factor
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r. st's t: 
35. The assertion that s. ajor's exposure to the Sabre Red 10% OC product lasted 2.5h in an 
unventilated roo  is not consistent with the exposure scenario described by s. ajor and 
colleagues who participated in the training. The total dose/exposure to OC/capsaicinoids by all 
t  r  i i l. 
.  r i  f r lt  iti    r lt f t  r  t   i  i i t t ith 
i l r r . . j r   ll- t  i t r  f i ifi t  r i t t r ir t r  
l  i r t  r l t      , .  l   rr d 
prior to arch 3, 2008 here C/pepper spray exposure could not be a contributing factor. 
37 The conclusion that Sabre Red 10 OC product is possibly the most toxic product available on the
market based on the fact that it is among the most potent products is speculative and misleading
The word toxic is not adequately defined Case reports and literature shows that many other
OCpepper sprays may be equally if not more toxic due to the presence of inactive but also toxic
ingredients such as solvents Furthermore if such a direct relationship between potency and
toxicity were true them any OCpepper spray containing equivalent or even more capsaicinoids per
unit volume which are commercially available would exhibit the same or greater toxicity making
the Sabre Red 10 OC product neither uniquely unsafe nor unfit for its intended use as claimed
Reports substantiating the notion that a 10 OC or 133 capsaicinoid pepper sprays is
unreasonably unsafe are lacking
38 Differences in exposure scenario eg degree of spray nebulization direct vs indirect exposure
duration of exposure etc and potential exposure doses to OCcapsaicinoids were not discussed
Variations in any of the criteria above could render a weaker 5 OC or067 major capsaicinoids
spray equally as toxic via the achievement of equivalent doses or a more potent spray less
toxic
39 The conclusion that more TRPV1 expression due to Ms Major preexisting health conditions
combined with a single exposure to OCcapsaicinoids which may or may not have resulted in a
higher dose than prior exposures experienced by Ms Major will lead to disease and or irreversible
exacerbation of preexisting diseases is not supported by the documents provided to me for review
or relevant literature There is no evidence that Ms Major experienced an unusual acute reaction
which would imply a severe acute injury on March 3 2008 and Ms Major did not exhibit new or
excessively intense symptoms beyond those that existed immediately prior to her exposure
Repeated exposures leading to injury which may or may not elicit a longterm consequence is not a
relevant scenario
Dr PurswellsReport
40 Cell Buster OC spray which is not the specific OC product in question was compared to other OC
sprays on the market Pepper sprays containing 10 OC and 133 major capsaicinoids are not
uncommon and OC sprays of equal or greater potency are readily available to consumers and law
enforcement personnel as indicated
41 The Wildfire 18 OC spray rated at3000 SHU is one example of a product that is substantially
more potent than the Sabre Red 10 OC spray While the specific capsaicinoid content is not
provided for the Wildfire spray one can reasonably assume that this product contains equal if not
greater capsaicinoid content than the Sabre Red 10 OC product based on the SHU rating of
3million vs 2 million and the near 2fold higher OC content As such one could conclude that this
product could be more toxic than the Sabre red 10 OC product However the Wildfire label
explicitly states that the product will temporarily stop an attacker for 45 minutes without causing
permanent damage
42 This report also concludes that the Sabre Red 10 OC product should comply with OSHA
regulations and that the current label and MSDS are in violation of such standards As published by
Smith and Stopford in the North Carolina Medical Journal 1999 the Consumer Product Safety
Commission regulates the labeling of OC spray as a hazardous substance under the Federal
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3 illion (vs. 2 illion) and the near 2-fold higher D  content. s such, one could conclude t t this 
product could be ore "toxic" than the abre red 10% D  product. o ever, the ildfire label 
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 age." 
. i  r rt l  l  t t t  r   0% D  r t l  l  it  D  
r l ti s,  t t t  c rr t l l   r  i  vi l ti  f s c  st r s. s lis  y 
ith and topford in t  orth arolina edical Journal (1999), "the onsu er roduct Safety 
o ission regulates the labeling of DC spray as a hazardous substance under the Federal 
Hazardous Substance Act Thus a prominent and conspicuous warning stating the principal hazard
precautionary measures to take when using the product and first aid measures to be used should
appear on the spray The Sabre Red 10 OC spray canister label states that the contents are
dangerous and should be used with care The label provides basic first aid measures to be taken
with specific measures for respiratory ocular and dermal exposures It also instructs individuals to
seek medical attention if the acute symptoms of exposure persist The MSDS accompanying this
product identifies the target organs and also describes the known acute effects of the
OCcapsaicinoids on the specific organ systems including a specific warning that people with
asthma or emphysema ie lung diseases may be at greater risk for the temporary acute effects of
the OC spray The MSDS also describes first aid measures and pertinent acute toxicitysafety data as
discussed above Prior to March 3 2008 there were no conclusive data that should require a SEC to
warn of a specific risk for chronic health effects resulting from useexposure to its OC spray product
43 Information for the OC spray was available to Ms Major and appears to have been presented to her
in training sessions by instructors
Executive Summary
Humans are frequently exposed to OC Capsaicinoids in many ways on a daily basis without
concern OCPepper sprays are an important lawenforcement tool with a long record of both efficacy
and safety despite case reports and comprehensive reviews of pepper spray use and associated injuries
that suggest but do not conclusively show otherwise There are many scientific studies that indicate
potential for concern regarding acute sensitivity to capsaicinoids in OC sprays but no study has
demonstrated any longterm adverse effect involving the respiratory or gastrointestinal systems as
suggested by Ms Major
Through my literature review I could not find any recent or historical ie prior to March 3
2008 report that provides specific and conclusive data that establish a direct causeeffect relationship
between OCpepper spray exposure and the initiation or irreversible exacerbation of chronic diseases
such as those complained of by Ms Major Contrary there are even several examples of beneficial
effects of capsaicinoids on human diseases In my opinion SEC had or has no reason to specifically warn
of possible chronic health effects due to brief exposure to their product because no such data indicate
the possibility Additionally widespread use of OC sprays of similar composition worldwide on a daily
basis provides convincing safety data that support a lack of chronic effect on humans when used
appropriately as directed by manufacturers and professional trainers
I found that OCpepper sprays on the market are variable in composition which may explain
some variations in potency efficacy and adverse events However the Sabre Red 10 OC product is
undoubtedly within the potency range of other pepper spray products on the market and therefore
cannot be deemed uniquely unsafe unreasonably dangerous and defective or unfit for its intended
use due to simply to its documented potencystrength The Sabre Red 10 OC spray is in my expert
and informed opinion a typical 10 OC based pepper spray that is manufactured with extensive quality
control in terms of a potency guarantee on active ingredient content which comparable products
generally do not provide
In conclusion I have found no evidence that conclusively supports the claims that Ms Major
exposure to the Sabre Red 10 OC spray on March 3 2008 was the proximate cause of Ms Major
injuries and current health conditions Given the exposure scenario described and available data I
believe with a reasonable degree of certainty that this single exposure of OC spray neither caused acute
injury nor irreversibly exacerbated Ms Major preexisting health conditions
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and infor ed opinion, a typical 10% D -based pepper spray t t is anufactured ith extensive quality 
control, in ter s of a potency guarantee on active ingredient content, hich co parable products 
nerally  t r i . 
In concluSion, I have found no evidence that concluSively supports the clai s that s. ajor's 
x s r  t  the r  ed 0% D  s ray  rc  ,  s t  "proximat  c s  f s. jor's 
injuries and current health conditions." iven the exposure scenario described and available data, I 
believe ith a reasonable degree of certainty that this single exposure of D  spray neither caused acute 
i j ry r i r rsibly t  . jor's - i ti  lt  iti . 
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If necessary I am willing to discuss the statements and conclusions outlined by this report
Sincerely
jI W
Christopher A Reilly PhD
Research Associate Professor
Department of Pharmacology and Toxicology
University of Utah
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Unified Police Department of Greater Salt Lake
Range Master Firearms Director
3365 South 900 West
Salt Lake City Utah 84119
WK 801 4670887
8 pages total to resume
Highlights of Qualifications
Active law enforcement professional for 32 years
FBINational Academy Graduated Session 192 January 11 to March 271998
Cutting edge expertise in of all areas of training and leadership including FBINational Academy
Member ofFBI National Academy Associates
Certified Firearms Instructor By FLETC FBI NRA Utah POST
Certified armorer by all major weapon manufacturers
Court certified weapons expert
Designed and built first environmentally safe firearms range
Invited to teach at State and Federal levels
Ability to perform as Administrator Prepare and maintain budgets
Provided Professional guidance and leadership to various State and Federal Law Enforcement
Agencies
Experienced with weapons repair and maintenance for 20 years
Good working relationships with other Police and Federal Agencies
Driven Professional with proven record of accomplishments for the Public and Agency
Designed Constructed and implemented extensive training programs
Master Instructor for Colt LLC Sig Sauer Pepper Ball Tec Security Equipment Corp Sabre
Designed Programs forO0 and ECD application
Education
Enrolled Salt Lake Community College July 2003 to finish AA matriculated 48 credits
FBINational Academy Graduate Session 192 January 11 to March 271998
Salt Lake County Supervisor Training Program 1201Irs December 1998
Graduate studies University Virginia through FBINational Academy 14 credits 1998
Continuing Education from Utah Peace Officer Standards and Training Maintaining required
hours for certification of 40 per year 1978 to present
ProvoTechnical College Federal program Fire Fighter Cadet 1 year
Undergraduate studies A Law Enforcement Major Suffolk County Community College New
York 1977 32 credits
Started Firearms training in 1978 to present with Major Manufacturers
Regents Diploma East Islip High School Islip New York State 1976
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Driven Professional with proven record of acco plish ents for the Public and Agency 
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aster Instructor for olt LL , Sig Sauer, Pepper Ball Tec., Security Equip ent orp. (Sabre) 
i  r r  f r .C   li ti  
 
r l  lt  it  ll  ly   fi i   i l t   it  
. B.I ti l  r t  i   ry  t  r  7,1998 
lt  t  r is r r i i  r r  20Hrs. r  
Graduate studies University Virginia through F.B.I. National Academy 14 credits 1998 
Continuing Education from Utah Peace Officer Standards and Training Maintaining required 
r  f r rtific tion f 0 r . 78 t  t. 
r i l ll  / r l r r  / Fire Fighter Cadet 1 year. 
Undergraduate studies, A.A. Law Enforcement Major, Suffolk County Community College, New 
, 977 2 r it  
tarted irear s training in 1978 to present ith ajor anufacturers 
t  i l , st I lip igh l, I li ,  rk t te 6 
Employment History
Unified Police Department of Greater Salt Lake
Director Firearms Unit Range Master0120 0 to present
Sheriffs Office transferred all Law Enforcement to a new formed Police Department
By State Approval Metro type setting
Salt Lake County SheriffsOffice
Director Firearms Unit Range Master 9161998 to present
Promoted to Range Master Level 2 Specialist Lt pay grade
Continue training and certification of 700armed members and train new Jail MCERT 50
member Team
Train and obtain equipment for Public Crowd Control Unit For 2002 Winter Olympics
Designed programs for Pepper Ball O0 and Less Lethal for usage at 2002 Olympics
Continue growth of Range Training Facility with outside agency training
Prepare and Administer with Captain budget and run a Multi Million Dollar Facility
Direct Lead and administer all Range activities
Direct personalized training of all members with firearms and other weapons
Design and institute training to exceed the required legal standards
Perform armorer duties
Perform additional tasks as required
Purchase weapons ammunition parts tools and supplies for Office
Accountable for all weapon transfers and trades for Office use and trade for
cost saving to taxpayers
Responsible for donation of land and continued construction of new range facility
Enhance and develop training programs for outside law enforcement agencies
Train firearm instructors and armorers for outside law enforcement agencies
Finished construction of Ranges 5 6 plus 40 vehicle parking lot
Negotiated upgrade withFATSto new DigitalFATSSupreme system saving
20000
Salt Lake County Sheriffs Office
Range Master 81696 to 91698
National testing for position of Range Master Level 1 Equivalent Specialist Rank of
Sergeant
Ranked number 1 Promoted
Finished major construction of Firearms Training Center with Building and four ranges
Obtained M16 Rifles from Federal Government for Office issue
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cost saving to taxpayers 
esponsible for donation of land and continued construction of ne  range facility 
nhance and develop training progra s for outside la  enforce ent agencies 
r i  fir r  i str ct rs  r r rs f r tsi  l  f rc t ci s 
i i  tr ti  f   &  l   i l  r i  l t 
egotiated upgrade ith F.A.T.S to ne  igital F.A.T.S Supre e syste  saving 
$20,0 0.00 
lt  t  riff's ffi  
 t r, -16-96 t  -16-98 
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i i  j r tr ti  f ir r  r i i  t r it  il i   f r r  
 -16 i l    r t   e. 
Salt Lake County SheriffsOffice
Firearms Unit Supervisor 1993 to 1996
Obtained donation of 40 Acres of land to the Salt Lake County SheriffsOffice
Started construction of new Firearms Training Center
Obtained donation of 20000 dollars to Salt Lake County SheriffsOffice to purchase
FATSTraining simulator
Continued with all previous duties as Instructor and continued training for 700
Designed and implemented Rifle program for Salt Lake County Sheriffs Office
Researched Policy and implementation of Pregnancy Packet for Female Officers on
risks of shooting while pregnant
Coordinated National Sheriffs Assoc Shoot in Salt Lake City with 9 Major Firearms
Manufacturers
InvitedTra n in Israel by IM and Sturm Ruger to train and develop a police carbine
Salt Lake County Sheriffs Office
Corporal Firearms Unit Armorer and Firearms Instructor 19901993
Promoted to Corporal
Designed and implemented Shotgun Rifle and semiauto pistol programs
Developed firearms activity documentation logs
Trained all personnel in pistol shotgun and rifle
Planned and implemented construction of Holladay Sheriffs Firearms Range
Maintain and certify all Office weapons
Train and certify all armed Office personnel
Designed Policy for SheriffsOffice on semiauto pistols
Started sponsoring Nationwide Firearms Training and Armorer schools
Salt Lake County Sheriffs Office
Armorer Firearms Instructor 19891990
Maintain and certify all department weapons to manufacturer specifications
Train and certify all department personnel
Facilitated training for Emergency Response and Recovery Team
Law Enforcement duties as assigned
Built Offices at Range for training
Salt Lake County Sheriffs Office
Deputy Sheriff 19801989
Patrol Deputy
Worked an assigned patrol area answering calls for service by the public
Worked West East and South Patrol
Selective Deployment Unit
Selective highcrime enforcement
Assist with Search and Rescue operations
Perform any duties assigned by the Sheriff
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- i  i -crim   
- i t it  r    r ti  
- Perfor  any duties assigned by the Sheriff 
Metro Jail
Onsite security of inmates during construction phase
Training Division Firearms Unit
Assist on training and Repair of firearms during Office Firearms Training
Riverton City Police Department
Police Officer Riverton City Utah 19781980
Traffic and Patrol Officer
Worked an assigned patrol area answering citizen calls for service and investigation
of crimes
Respond and assist on all medical and fire related details
Emergency Medical Technician
State certified instructor
Firearms Training and repairs of firearms
Attended Smith Wesson Academy
Salt Lake City Fire Department
Firefighter Salt Lake City Utah 19771978
EmergencyMedical Technician
Respond on all medical calls for assistance
Certified IFSTA Firefighter
Respond on all fire related calls for service
Respond on all HazMat incidents requiring immediate response
East Islip New York 1976 to 1977
Graduated East Islip High School with Regents Diploma
Attended Suffolk County Community College 32 credits police Science
Volunteer Ambulance Service New York StateEMT
Honors and Recognition
2007 Awarded Purple Heart Injured while protecting citizen
2002 June 2002 Awarded Olympics Award Citation
2002 May 2002 Awarded Distinguished ServiceMedal
2002 May 2002 Medal and letter of appreciation FromFB1for outstanding
support to theFBI
1998 MayAwarded the SheriffsStar
1996 DeputyEmployee of the Year
In recognition for the development and design of an environmentally safe
rifle and pistol range for the Salt Lake County Sheriffs Office
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 J  002 r d l i  r  it tion 
2002 y  rded i tinguished r i  l 
2 ay 2002 edal and letter f appreciation ro  .B.I f r outstanding 
port to t  .B.I 
998 y arded the eriff's t r 
1996 ty / l  f t e r 
In recognition for the develop ent and design of an environ entally safe 
rifl  and pistol range for the alt Lake ty heriffs ffice 
1994 Team Citation
Recognition for exemplary devotion to duty and for the design creation
and implementation of the semiauto pistol program
Deputy of the Month
1987 For outstanding Professional service while assigned to the West
Patrol Division
1987 For outstanding Professional service while assigned to the West Patrol
Division
1986 For outstanding professional service while assigned to the West Patrol
Division
Professional Certifications
Due to the extensive number of certificates and documentation as to my credentials I have assembled
them in a separate attached binder I have included a date line of training certifications attached to rear
of this resume
Letters of Commendation
2002 Letter of commendation from Salt Lake County District Attorneys Office
2001 Letter of commendation from Taylorsville City for work on the City managers
convention
2000 Letter of commendation and appreciation from Dr David L McCann
2000 Commendation letter from Mrs Lynda Jeppesen Keyes Professional
Speaker Instructor
1998 Commendation Letter from Assistant Director in ChargeFBINational Academy
for teaching
1993 For your commendable instruction provided to police academy cadets with the
Firearms Training System FATS
1992 For your professionalism and excellent training provided at the Ruger Armorer
School
1993 For your dedication and support of the Police Precision Marksmanship Training
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 etter of co endation fro  alt ake ounty istrict ttorneys ffice 
2001 etter f c e ation fr  a l rs ille it  f r r   t e it  a a ers 
convention. 
 ett r f ti   r i ti  fr  r. i  . c  
2000 Commendation letter from rs. Lynda Jeppesen (Keyes Professional 
 I t r) 
1998 Commendation Letter from Assistant Director in Charge F.B.I. National Academy 
f r t i . 
1993 For your co endable instruction provided to police acade y cadets with the 
irear s raining yste  (F ) 
 For your professionalis  and excellent training provided at the uger r orer 
 
 For your dedication and support of the Police Precision arks anship raining 
School sponsored by Federal Cartridge Company
1991 For implementation of the transition program from revolvers to semi automatic
firearms by researching developing and teaching an innovative and complex 24
hour transition course
1991 For your efforts in the development and teaching expertise of the semiauto
transition course
1979 For your professional conduct as a Riverton City Police Officer at the scene of a
serious industrial accident
For you efficient and professional manner exhibited in the handling of an
uncooperative and hostile suspect
Certificates ofRecoenition
2000 20 years service to the Citizens of Salt Lake County as a Salt Lake County
Deputy Sheriff
1999 20 years service to Utah State Employees Association
1995 Professionalism in providing the Automatic Pistol Transition Program to the Salt
Lake County Fire Department
1994 Participation in the Utah Law Enforcement Olympics
1993 Deputy Sheriffs Mutual Aid Association Marksmanship Ribbon Salt Lake
County Sheriffs Office
Certificate ofMerit
1989 For exemplary service to the residents of Salt Lake County for the past ten years
from the Utah Public Employees Association
Letters ofAppreciation
2002 Letter of appreciation and Medal fromFBI Director and Special Agent in charge
Salt Lake City Division
2002 Letter from YWCA battered womensshelter for work on the shop with a Marine
2002 Appreciation letter from Chief James K SchweitzerFBIfor work on a multi
agency training school
1999 Thank you letter for application ofChiefDeputy from SheriffAaron D Kennard
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 eputy Sheriffs utual id ssociation, arks anship ibbon, Salt ake 
t  riffs ffice 
ficate ( r  
 For exe plary service to the residents of Salt Lake ounty for the past ten years 
fro  the tah ublic ployees' ssociation 
te s f Appre iation 
 Letter of appreciation and edal fro  F.B.! irector and Special gent in charge 
lt a e ity i ision 
2002 etter fro   battered o en's shelter for ork on the shop ith a arine. 
 r i ti  letter fr  i f J s . it r .B.! f r r    lti-
cy t i i  s l 
1999 hank you letter for application f hief eputy fro  heriff aron . ennard 
1999 From Mrs Linda Jeppsen Keyes Inc On Murray City Civil Service Commission
letter of appreciation
1999 Thank you letter from Mr Thomas Guinney Salt Lake City Down Town
Alliance Board Member and Health Director
1999 FromFBIAssistant Director in Charge ofFBI National Academy for teaching
to a class in the Behavioral Science Unit
1996 For your dedication and service to Mike Thompson of the Community Advisory
Board during a semi auto pistol transition qualification course
1996 Third District Juvenile Court Letter of appreciation for training to Court Staff
1995 For your efforts and dedication and for the successful qualification of Senator
Orrin Hatch with the semi auto pistol
For your hard work and commitment for the successful qualification of Judge
Michael Zimmerman Chief Justice of the Supreme Court ofUtah with the semi
auto pistol
For outstanding performance and assistance to the Union Pacific Railroad Police
For your professionalism dedication knowledge outstanding skills and
assistance to the Salt Lake City Airport Authority Police
1994 In recognition of fifteen years service to the citizens of Salt Lake County
For your support to the 625th Military Police Company Utah Army National
Guard
1993 For your knowledge and skill in instructing the West Valley City Police SWAT
team with the HKMP5 submachine gun
1993 For your hard work dedication and effort in making the National Sheriffs
Association Shooting Competition so successful Presented Award
For your attention to duty and work with Dr Willard G Smith PhD NCSP of
the Community Advisory Board during the semiauto pistol transition course
For your assistance and hospitality extended to Keith FitzGerald and Tetra Gun
Products during the National Sheriffs Association Convention
For your professional and knowledgeable course of instruction addressing Felony
Arrests from Mark McGillis Allied Advantage
For your specialized firearms instruction for Sheila K McCleve Third Circuit
Court Judge
For your professionalism and dedication to James F Paine Community Advisory
Board during a Firearms Transition Training Course
000327
  rs.  en,  c.   i  i il r  i i , 
  reciation. 
1999   l tt r fr  r. s i  (Salt  it    
lianc      i ctor) 
1999 ro  .B.I ssistant irector in harge of .B.I ational cade y for teaching 
t   l  i  t  i l i  it. 
1996   i ti   ervi  t  i   t  it  i  
oard, during a se i-auto pistol transition qualification course 
 ir  istri t J il  rt tt r f r i ti  f r tr i i  t  rt t ff 
   t   i ti    t  sf l li i ti   t  
  t   -aut   
For your hard ork and co it ent for the successful qualification of Judge 
ic l i r n, i f J sti  f t  r  rt f t  it  t  s i-
t  ist l 
r tsta i  erf r ance a  assista ce t  t e i  acific ailr a  lice 
r r r f i li , i ti , l , t t i  kill ,  
i t  t  t  lt  it  ir t t it  li  
1994 In recognition f fifteen years service to the citizens f alt ake ounty 
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Court Judge 
For your professionalis  and dedication to Ja es F. Paine, o unity dvisory 
oard, during a irear s ransition raining ourse 
For your expertise diligence and ability in dealing with the needs of the Salt
Lake County Sheriffs Office range
For exhibiting the highest standards of law enforcement professionalism in all
areas and for your attention to detail knowledge and courtesy to Sturm Ruger
Company at the National Sheriffs Association Convention
For your assistance in arranging a firing demonstration for Sturm Ruger
Company during the National Sheriffs Association Convention
1992 For your expertise and professional instruction of Judge Timothy R Hanson and
Judge Noel Third Judicial District Court in their qualification of the semi auto
pistol
For your excellent instruction to Craig Ludwig Clerk of the Court Third District
Court in his qualification with the semiauto pistol
For your outstanding extra effort good management and training with regard to
the Sturm Ruger Company armorer school
For your support and security arrangements provided for Mikhail Kalashnikovs
visit to Salt Lake City during the NRA Convention
For your excellent course of instruction and information sharing during the Semi
auto Transition Course from the Salt Lake City Police Department Training Unit
For your organizational expertise exhibited with a Sturm Ruger Company
shooting demonstration for local law enforcement agencies
For your wellorganized Glock Armorers School from Guy Malmborg Lock
Stock and Barrel Gunworks
For your thoroughness in preparation and facilities with regard to supporting law
enforcement use of SIGARMS from the Assistant Director of Training for
SIGARMS
For sponsoring specialized training for the Utah Department of Corrections with a
Glock Armorers School
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 or your outstanding extra effort, good anage ent, and training ith regard to 
t  tur , r &  r r r l 
r r s rt  s rit  rr ts r i  f r i il l shnikov's 
i it t  lt  it  ri  t   ti  
or your excellent course f instruction and infor ation sharing during the e i-
a t  ra siti  rse fr  t e alt a e it  lice e art e t, rai i  it 
For your organizational expertise exhibited ith a Stur , uger & o pany 
ti  t ti   l l la  rce e t ies 
or your ell-organized lock r orers chool fro  uy al borg, ock, 
t   rr l r s 
For your thoroughness in preparation and facilities ith regard to supporting la  
enforcement use ofSIGAR S, from the Assistant Director of Training for 
I  
For sponsoring specialized training for the tah epart ent of Corrections ith a 
loc  r orers l 
1991 For your professionalism devotion to duty and commitment to excellence
in providing an extraordinary firearms course from Captain Gregory R
Dunnavant MD USArmy Special Forces
For your professional and expert assistance to the Weber County Sheriffs
Office during their transition from revolvers to the semiauto pistol
1990 For outstanding training support to the Salt Lake County Sheriffs Office
1990 For your support to theUSCoast Guard unitssmall arms training program
1989 For your assistance and hard work displayed during a Sturm Ruger
Company seminar
1988 For your dedication in making firearms training interesting and proficient
to members of the Salt Lake County Sheriffs Office West Patrol Division
1985 Assistance in establishing shift training subject ofOfficer Survival for the
East Patrol Division Salt Lake County Sheriffs Office
Additional References available upon request
OrrinGHatch Senator
Aaron D Kennard Sheriff
Ray Hintze Assistant Atty General
Randy Horiuchi Councilman
Robert Hughes Attorney




Linda Jeppsen Owner Keyes Inc
United States Senator For Utah 801524 4380
Salt Lake County Sheriffs 8014683900
Utah State Capitol 801 5381948
Salt Lake County Council 801 4692936
Salt Lake City 8013649075
Quantico Virginia 703 7845568
Salt Lake City 801 4919589
Salt Lake City 801 2392412
Exeter NH Sig Arms Academy 603 6792003
Salt Lake City 801 2611777
George Q Nielsen Captain
4683924
Salt Lake County Sheriffs 801
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  (Coun n) 
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ald adsen (A tor y) 
homas inney (Business ) 
e rge s (Direct ) 
Linda Jeppsen (Owner eyes I c.) 
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ITRAINING ~CATION r- DATE 
Saber Instructor I Trainer OC Cert Salt Lake County January 1 ,2009 
Pepper Ball Master Trainer Course San Diego California January 17-20,2009 
National Institute Of Justice TWG working Group Tucson, Arizona December 9-11, 2008 
Smith & Wesson Armorer School M&P Salt Lake County November 14th 2008 
CTS Instructor School Salt Lake County November 10-13 2008 
Taught M-16 Colt Armorer School Sitka Alaska Oct 30 - Nov 1 st 2008 
FBI National Academy Training Seminar Mesquite Nev. Oct. 20-22, 2008 
Taser Administrator School Salt Lake County July 21 ,2008 
Remington Armorer School Pump 308 Salt Lake County July 14th 2008 
FEMA ICS-300 for Expanding Incidents Salt Lake County June 27, 2008 
Colt Armorer Master Trainer West Hartford May 20-21 2009 
National Institute Of Justice TWG Meeting Maryland May 6-9 2009 
Taser Instructor Class Sandy, Utah April 8,9,2008 
Glock Armorer Course Utah State Prison October 3, 2007 
Defense Technology Instructor Salt Lake Cou~ S.O August 20, 2007 
Colt Armorer Certification Salt Lake City, UT August 3, 2007 
F.B.I National Academy Conference Phoenix, AZ July 14-18-2007 
SIMRAD Optronics Night Weapons Sight training seminar Salt Lake City, Utah June 13, 2007 
Concealed Firearm Instructor Certification State of Utah April 23, 2007 
FEMA IS-800 National Response Plan Salt Lake County April 23, 2007 
FEMA IS-700 National Incident Management System Salt Lake County March 19, 2007 
FEMA ICS-200 ICS for Single Resources and Initial Action Incidents Salt Lake County March 16, 2007 
FEMA IS-100 Introduction to the Incident Command System Salt Lake County March 16,2007 
Executive Level Management Education and Training Orlando, FL June 18-21 , 2006 
Pepper ball Master Instructor Certification San Diego, CA January 17, 2006 
Beretta Armorer Salt Lake County October 2005 
TASER Armorer Arizona September 15, 2005 
Advanced Instructor TASER Sandy City PD July 29, 2005 
Armor Holding Instructor Salt Lake County July 11, 2005 
FBI National Academy Conference Orlando, FL July 2005 
National Sheriff's Association Conference Kentucky June 2005 
FBI National Academy Training Seminar Salt Lake City, UT May 2-4, 2005 
Remington Armorer Salt Lake County April 4-6, 2005 
Glock Armorer Sandy, UT March 17, 2005 
Smith & Wesson Armorers Certification-Pistols Spril"lgfield Mass October 28-29, 2004 
Smith & Wesson Armorers Certification-Revolvers Springfield Mass October 25-27,2004 
Simunition Supervisor Training and Safety Course Salt Lake County August24-27,2004 
Springfield Armorer XD Las Vegas, NV February 15,2004 
Beretta Armorer Salt Lake County August 21-23,2003 
Colt Firearms M-16/AR Armorer SaltLake Co,-!nty 
-~- -































































































































































































































































































































































































































































































































































































































































































































































































TRAINING LOCATION DATE I 
DEFTEC I Armor Holding Salt Lake County November 11, 2002 
Saber Instructor OC Cert Salt Lake County September 27, 2002 
Alcohol Tobacco & Firearms Restoration Cert. School SLC I State Of Utah April 4, 2002 
Jaycor Tactical Advanced Instructor School San Diego, CA January 25, 2002 
Glock Armorer Salt Lake County December 17, 2001 
Remington Armorer Salt Lake County December 3, 2001 
Benelli USA Armorer Instructor Salt Lake County August 10, 2001 
Blount Factory School (Ammunition) Idaho Facility August 7,2001 
Beretta Field Armorer School Salt Lake County July 27, 20 1 
FBI Instructor Chemical Agents School Salt Lake County July 16, 2001 
Defense Technology Instructor Provo, UT May 18, 2001 
Tiger Light Instructor Certification Salt Lake County May 9,2001 
Team N.M.P. Less-Lethal I M-26 Taser Salt Lake County April 25, 2001 
Street Survival 2001 The Win seminar Salt Lake City April 12, 2001 
Street Survival Tactical Edge seminar Salt Lake City April 10-11 ,2001 
Jaycor Tactical Instructor Salt Lake County December 2000 
H & K MP5 Operator Salt Lake County September 29,2000 
H & K Armorer Certification Salt Lake County September 22,2000 
Smith & Wesson Armorer SW99 Series Salt Lake County August 31, 2000 
Smith & Wesson Armorer Revolver Salt Lake County August 30,2000 
Smith & Wesson Armorer Auto Pistol Salt Lake County August23,2000 
TASER Instructor Certification Salt Lake County May 20,2000 
Sturm Ruger & Company Armorer Salt Lake County May 11, 2000 
Sig Sauer Range Master Instructor Exeter, NH February 25, 2000 
Street Survival 1999 The Win seminar Las Vegas, NV December 1, 1999 
Street Survival 1999 Caliber Press seminar Las Vegas, NV November 29-30, 1999 
Beretta Armorer Salt Lake County July 21, 1999 
Federal Laboratories Instructor Certification Salt Lake City PD April 16, 1999 
Defense Technology Corp Instructor Certification Salt Lake City PD April 16, 1999 
Glock Advanced Armorer Certification Salt Lake County April 8, 1999 
Sig Arms Armorer Certification Salt Lake County March 31, 1999 
Salt Lake County Supervisor 120 hours Salt Lake County December 6, 1998 
Basic Explosive Entry Salt Lake County December 1, 1998 
20 Years of Service Certificate Salt Lake County November 12,1998 
Salt Lake County Certificate of Commission Salt Lake County September 16,1998 
Colt Manufacturing M-16 Armorer Utah County SO August 12-14, 1998 
Colt Manufacturing Model 0 Armorer Utah County SO August 10-11, 1998 
Sig Sauer Armorer School Salt Lake County June 18-19,1998 
FBI National Academy Session 192 FBI Academy, Quantico VA January 11-March 27, 1998 
FBI Deadly Force Management FBI Academy, Quantico VA January 11-March 27, 1998 







































































































































































































































































































































































































































































































































































































































































































TRAINING LOCATION DATE I 
FBI Chemical Agents In L.E. FBI Academy, Quantico VA January 11-March 27, 1998 
FBI Fitness Challenge Award FBI Academy, Quantico VA January 11-March 27, 1998 
University of Virginia, Criminal Justice FBI Academy, Quantico VA January 11-March 27, 1998 
FBI Instructor Development SLC I University of Utah September 12, 1997 
Glock Pistol Instructor workshop Salt Lake County August 23, 1997 
Glock Armorer Salt Lake County August 20, 1997 
Colt 9 m/m Sub-Machine Gun Salt Lake County July 16-18,1997 
Law Enforcement Advanced Utah County SO June 17-21, 1997 
Federal Cartridge Ballistic School Salt Lake County May 28,1997 
Remington Armorer Salt Lake County January 29-31, 1997 
Beretta Armorer School on 8000 Salt Lake County October 4, 1996 
Smith & Wesson (Pistol Recert) Salt Lake County April 1996 
Federal Cartridge Ballistic School Anoka, MN August 1995 
Ruger Armorer School Salt Lake County July 1995 
L.E.T.C. Advanced Instructor Provo, UT June 1995 i 
Beretta Field School Salt Lake County May 1995 
Beretta Factory School Accokeek, MD April 1995 
Glock Armorer Salt Lake County March 1995 
Sig Sauer Armorer School Salt Lake County March 1995 
Colt Armorer Rifle Salt Lake County March 1995 
Colt Armorer Pistol Salt Lake County March 1995 
Smith & Wesson Sigma Armorer Salt Lake County November 1994 
NRA Weapons Instructor School Salt Lake City, UT August 1994 
I.M.I. School Tel Aviv, Israel August 1994 
Pro Arms Rifle School West Jordan, UT June 1994 
Ruger Armorer Advanced Update Salt Lake County May 1994 
Smith & Wesson Instructor School UT State Prison January 1994 
Smith & Wesson Springfield, MA November 1993 
L.E.T.C. Advanced Instructor Park City, UT June 1993 
ASP Instructor School Salt Lake County February 1993 
Glock Transitional Workshop (offshoots) Salt Lake County December 1992 
Glock Workshop instructor Salt Lake County December 1992 
Instructor Transition (Peregrine Corp) Salt Lake County December 1992 
Glock Armorer Salt Lake County December 1992 
First Line Supervisor school Utah POST September 1992 
Sig Sauer Armorer School Salt Lake County July 1992 
MP5 Instructor and Rifle Basic Course Lake Tahoe, NV June 1992 
Police Precision Marksman Salt Lake City, UT June 1992 
O.F. Mossberg Salt Lake City, UT April 1992 
Colt Factory training Hartford, CT April 1992 

































































































































































































































































































































































































































































































































































































































































TRAINING LOCATION DATE 
Advisor, Police Marksman magazine February 1992 
Ruger Armorers Certificate Salt Lake County January 1992 
Beretta Armorers Certificate Salt Lake County December 1991 
F.L.E.T.C. Firearms Instructor Training Artesia, NM November 1991 
Distinguished Weapons Expert Artesia, NM November 1991 ; 
Federal Cartridge Shotgun Instructor Salt Lake City, UT July 1991 
Certificate of Achievement (Expert Colt 45) Gunsite, Prescott AZ July 1991 
Glock Instructor School Salt Lake County May 1991 
Law Enforcement Olympics Certificate Salt Lake City, UT May 1991 
Colt Armorers Factory Training Hartford, CT March 1991 
S & W Instructor Training Salt Lake County December 1990 
Beretta Armorer training Salt Lake County December 1990 
Beretta Products Orientation Seminar Salt Lake County December 1990 
Remington Factory training llion,NY October 1990 
Ruger Armorer Training Salt Lake City, UT August 1990 
MI Chemical Instructor Salt Lake City, UT April 1990 
Smith & Wesson Springfield, MA January 1990 
Ruger Armorers School Delta, CO June 1989 
Glo k Armorer Certification Salt Lake City, UT March 1989 
Sig Sauer Salt Lake City, UT February 1989 
Advanced Officer Certification Utah POST 1989 
Rifle Marksman/Counter Sniper FBI Phoenix, AZ May 1988 
Officer Survival POST Utah POST January 1988 
Multimedia Instructor SFA Red Cross Salt Lake City, UT December 1987 
Field Training Officer School POST Utah POST April 1987 
Firearms Instructor POST Cedar City, UT September 1985 
Instructor Officer Survival POST Salt Lake County April 1985 
Instructor Development School POST Salt Lake County November 1984 
Instructor Officer Survival POST Salt Lake County April 1984 
Symposium on Violence Weber State College, UT April 1983 
Officer Survival/Advanced Field Tactics UPOAlDancor Ltd. SLC, UT November 1982 
Dangerous Gangs (US Marshals) Salt Lake County July 1982 
Disaster Planning University of Utah June 1982 
Emergency Medical Tech. Instructor State of Utah June 1981 
Disaster Planning University of Utah June 1981 
Emergency Medical Tech. Long Island, NY March 1980 
S & W Armorers School Springfield, MA January 1980 
Captured Officer Survival Public Safety Educators August 1979 
POST Police Academy State of Utah March 1979 
FBI Sex Crimes Seminar Riverton Police Dept, UT 1979 
Utah Ambulance Technician Instructor Utah State Medical Association 1979 
000334
TRAINING LOCATION DATE I 
Firefighter Cadet I Provo Tech. College Utah Technical College, Provo UT December 1977 
Emergency Medical Technician Utah State Medical Association November 1977 
Crash Injury Management US Dept. of Transportation September 1977 
Emergency Medical Technician State of New York March 1976 
000335
EXHIBIT J 
DOCUMENTS PROVIDED TO NICHOLAS ROBERTS






Plaintiff s Expert Disclosures and Supplemental Expert Disclosures as to Dr Yost and JP
Purswell only
Deposition transcripts ofBillie Jo Major volumes I and 11 taken January 5 and 6 2011
Deposition of the Rule30b6designee of Idaho Department ofCorrection Bret R
Kimmel taken February 14 2011
Deposition ofDaniel J Schaffer taken February 14 2011
Deposition ofSara AnneMare Link taken February 15 2011
Deposition of Joshua E Overgaard taken February 15 2011
Deposition ofNicholas Doan taken February 15 2011
Deposition exhibits 1 44
Plaintiff s Responses to DefendantsFirst Set of Interrogatories and Requests for
Production ofDocuments and Plaintiffs first second and third supplemental responses to
same
Plaintiff s Responses to SECsFirst Set of Requests for Admission and Second Set of
Interrogatories and Requests for Production ofDocuments
DefendantsResponses to Plaintiff s First Set of Interrogatories Requests for Production
ofDocuments and Requests for Admission
DefendantsResponses to Plaintiffs Second Set of Interrogatories Requests for
Production ofDocuments and Requests for Admission
DefendantsResponses to Plaintiffs Third Set of Interrogatories and Requests for
Production ofDocuments and
DefendantsResponses to Plaintiffs Fourth Set of Interrogatories and Requests for
Production ofDocuments
Page 1 of 1
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• t   t  i l i : 
• COOOOO 1-29 ; 
• -7 ; 
• -9 ; 
• OO1035-11 ; 
• t  r; 
• laintiffs xpert isclosures and upple ental xpert isclosures as to r. ost and J.P. 
l  l ; 
• siti  tr s ri ts f illie J  j r lu es I  II t  J r    , 1; 
• e siti  f t e le 0(b)(6) esi ee fI  e art e t f rrecti , ret . 
i el, ta e  e r ar  , 1; 
• siti  f i l J. ff r t  r r  , ; 
• iti   ra -Mar  i  t  r r  , ; 
• iti  f J s  . r r  t  r r  , ; 
• e siti  f ic las a  ta e  e r ar  , 11; 
• siti  i its -4 ; 
• l intiff's s ses t  f dant's irst t f I terr at ries  sts f r 
r ti  f ts  l i tiff's first, s   t ir  s l t l r s s s t  
e; 
• Plaintiff's esponses to SEC's First Set of equests for d ission and Second Set of 
I t rr t rie   t  f r r ti   nts; 
• f ndant's ses  l i t     t ,    
f ocu ents and equests for d ission; 
• efendant's esponses to laintiffs econd et ofInterrogatories, equests for 
roduction f ocu ents and equests for d ission; 
• efendant's Responses to Plaintiff's Third Set of Interrogatories and Requests for 
r ti  f nts;  
• efendant's esponses to Plaintiff's Fourth Set ofInterrogatories and equests for 
  ts. 
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CHRIS70PHER D
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRWAtQVRICHClerk
vepUry RAY






Case No CV PI 1003515
NOTICE OF TELEPHONIC STATUS
CONFERENCE UNDERICP16a
16b
A telephonic status conference is hereby set for May 13 2011 at900am
before the Honorable Cheri C Copsey Ada County Courthouse Boise Idaho A
scheduling order underIRCP16bmay be issued following this conference
All parties must appear telephonically at this time in person or by counsel
Counsel must be the handling attorney or be fully familiar with the case and have
authority to bind their client and lawfirm on all matters set forth inIRCP16aand
16b The Court will initiate the conference call unless otherwise specified
Dated this I Q day of May 2011
CHERI C COPSEY
DISTRICT JUDGE
NOTICE OF STATUS CONFERENCE UNDERICP16a 16b Page 1 000337
1«)-
A.LIQ~lij ~ ___ _ 
NAY, 0 20', 
CHRISTOPHER 
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTR~,qsIivE"~H~!;H, Clerk 
DEPUTY 8y 
THE STAT  OF IDAHO, IN AND F  TH  T  OF ADA 
I I  J  AJOR, 
laintiff, Case o. CV PI 10-  
vs. 
I  I  ORP., I   I   
CONFERENCE UNDER LRC.P. 16(a) 
& 16(b) 
f dant. 
 tele ic status conference is hereby set for ay 13, 2011, at 9:00 a.m. 
f r  t  r l  ri . s y,  ty rt ouse, is , I .  
scheduling order under I.RC.P 16(b) ay be issued follo ing this conference. 
All parties ust appear telephonically at this ti e in person or by counsel. 
ounsel ust be the handling attorney, or be fully fa iliar ith the case, and have 
authority to bind their client and lawfirm on all matters set forth in LRC.P 16(a) and 
16(b). The Court will initiate the conference call unless otherwise specified. 
ted t  is j \) y f  . 
I . EY 
I TRICT J  
NOTICE OF STATUS CONFERENCE UNDER I.R.C.P. 16(a) & 16(b) --Page 1--
CERTIFICATE OF MAILING
I hereby certify that on this10 day of May 2011 1 mailed served a true andcorrect copy of the within instrument to
DARWIN OVERSON
JONES SWARTZ PLLC





GREENER BURKE SHOEMAKER PA
950 W BANNOCK ST STE 900
BOISE ID 83702
FAX 3192601
CHRISTOPHER D RI H
Clerk of the District urt
By Joh4Weerby Deputy ourt Clerk
NOTICE OF STATUS CONFERENCE UNDERICP 16a 16b Page 6 000338
It 
CERTIFICATE OF MAILING 
I hereby certify that on this \ 0 day of May 2011, I mailed (served) a true and 
correct copy of the within instrument to: 
DARWIN OVERSON 
JONES & SWARTZ, PLLC 
1673  SHORELINE DR,STE 200 
PO BOX 7808 
BOISE, 10 83707-7808 
FAX: 489-8988 
CHRISTOPHER C. BURKE 
GREENER BURKE & E AKER, P  
9    T,   
B ISE, 10 83702 
FAX: 319-2601 







IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DIST t D O










This matter came before the Court with both parties appearing by and through
counsel
ACCORDINGLY THE FOLLOWING ORDER GOVERNING PROCEEDINGS IS
ORDERED AS FOLLOWS
Each party to the action shall be represented at all pretrial hearings by the
attorney or party who is to conduct the trial or by cocounsel with full knowledge of the
case and with authority to bind the party by stipulation If any attorney has not been
given such authority to bind the party by stipulation the party shall be present or
available at the pretrial conference
1 TRIAL DATE The 11 day Jury Trial of this action shall commence before this
Court on October 17 2011 at900am The Jury will be drawn the afternoon
before trial in chambers You may observe if you wish
NOTICE OF INTENT TO RELY ON PANEL OF JUDGES AS ALTERNATES
Notice is hereby given pursuant toICRP40gthat an alternate judge may be
assigned to preside over the trial of this case The following is a list of potential
alternate judges
Hon Phillip M Becker
Hon GDCarey
Hon Dennis Goff
Hon George R Reinhart III
Hon Ronald Schilling
Hon W H Woodland
Hon R Barry Wood
Hon Kathryn A Sticklen




Hon Daniel C Hurlbutt Jr
Hon Nathan Higer
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p~ oaJ.4( 
Off/if AfAr,  2;;;--:-
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRI1l~'Ff 0 L'!I/ V§Y~NWfA' "",CH C 
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF ADA ~fl!J1/'I1~fie'f' ~91'k 
BILLIE JO MAJOR, 
Plaintiff, Case No. CV PI 10-  
vs.  GOVER I  
I   SETTI  
I  
I  I  ORP., 
efendant. 
This matter came before the Court with both parties appearing by and through 
counsel. 
I L ,  I   I  I  I  
  S: 
Each party to the action shall be represented at all pre-trial hearings by the 
attorney or party who is to conduct the trial or by co-counsel with full knowledge of the 
  it  t rit  t  i  t  rt   ti l ti . If any attorney has not been 
given such authority to bind the party by stipulation, the party shall be present or 
il l  t t  -trial f . 
1) T I L T : The 11 day Jury Trial of this action shall co ence before this 
ourt on ctober 17, 2011, at 9:00 a.m. he Jury ill be dra n the afternoon 
before trial in cha bers. ou ay observe if you ish. 
I   I   LY  L  J   L  
Notice is hereby given, pursuant to I.C.R.P. 40(g) that an alternate judge may be 
aSSigned t  r side over t  tri l f this . The following is a list of potential 
alternate ju : 
. hi lip . Becker 
. .D. arey 
. Dennis off 
H . George R. i , I 
Hon. Ronald Schilling 
Hon. . H. W odland 
Hon. R. Ba ry ood 
Hon. Kathryn A. Sticklen 
All Sitting Fourth District Judges 
. Ja es Judd 
H . Du f cKee 
Ho . Daniel eehl 
Hon. Daniel C. Hurlbutt, Jr. 
Hon. Nathan Higer 
Hon. Linda Copple Trout 
Ho . Peter McDermott 
Ho . Gerald Schroeder 
All Senior Judges 
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Unless a party has previously exercised their right to disqualification without
cause under Rule 40d1each party shall have the right to file one 1 motion for
disqualification without cause as to any alternate judge not later than ten 10 days after
service of this written notice listing the alternate judge
2 PRETRIAL CONFERENCE Counsel for the parties shall appear before this
Court on September 22 2011 at 430 pm for a final pretrial conference
Counsel shall be prepared to discuss settlement possibilities and all items set
forth in Rules 16a through jIRCP Counsel shall file the proposed jury
instructions with the Court at the PreTrial Conference IF A PARTY FAILS TO
APPEAR AT THE PRETRIAL CONFERENCE WITHOUT GOOD CAUSE
SUCH FAILURE SHALL BE SUFFICIENT GROUND FOR ENTRY OF
JUDGMENT AGAINST SUCH PARTY OR DISMISSAL OF THE ACTION OF
SUCH PARTY WITH PREJUDICE WITHOUTFURTHER NOTICE
3 MOTIONS
A Motions to Amend Unless otherwise stipulated all Motions to Amend
including Motions to Amend for Punitive Damages shall be filed 210 days before
trial Any opening brief or response shall be no longer than 25 pages The
moving partys reply shall be no longer than 10 pages See Local Rule 8
B Dispositive Motions Defendant Motion for Summary Judgment shall be
heard on July 14 2011 at 300pm Plaintiffsopposition with attachments or
affidavits shall be filed no later than June 10 2011 Defendant shall file any reply
briefs or affidavits by June 24 2011
Each motion shall be accompanied by a separate brief containing all the
reasons and points and authorities relied upon by the moving party Any
opening brief or response shall be no longer than 25 pages The moving partys
reply shall be no longer than 10 pages See Local Rule 8
NO PARTY SHALL FILE A SEPARATE STATEMENT OF UNDISPUTED
FACTS
All parties shall email all dispositive motion materials to
iweatherbytad webn tat the time the motion or memorandum is filed with
the court Any memoranda shall be emailed in a Word document with any
supporting affidavits or material send in a PDF file
Any party who does not intend to oppose any motion shall immediately notify
opposing counsel and the court by filing a pleading titled NonOpposition to
Motion The moving party shall serve and file with affidavits or other
documentary evidence upon which the moving party intends to rely with the
Motion
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Unless a party has previously exercised their right to disqualification without 
cause under Rule 40(d)(1), each party shall have the right to file one (1) motion for 
disqualification without cause as to any alternate judge not later than ten (10) days after 
service of this written notice listing the alternate judge. 
2) PRE- I  CONFERENCE: Counsel for the parties shall appear before this 
Court on Septe ber 22, 2011, at 4:30 p.m. for a final pre-trial conference. 
Counsel shall be prepared to discuss settle ent possibilities, and all items set 
forth in ules 16(a) throug  0), I,R.C.P. Counsel shall file the proposed jury 
instructions ith the rt at the re- l onference. IF   FAILS TO 
APPEAR AT THE PRE-TRIAL CONFERENCE ITHOUT GOOD CAUSE, 
SUCH F IL   E I I     OF 
J  I     I I L   I  F 
 RTY,  J DICE, I  URT  TICE. 
) TI NS: 
A. ti  t  nd: l  t r i  ti l t d, ll ti  t   
including Motions to Amend for Punitive Damages shall be filed 210 days before 
trial.  i  ri f r r  ll  no longer than 25 pages. The 
vi  rty's r ly s ll   l r t   s.  c l l  . 
B. i iti  ti : Defendant's Motion for Summary Judgment shall be 
heard on July 14, 2011 at 3:00 p.m. Plaintiff's opposition with attachments or 
affidavits shall be filed no later than June 10, 2011. Defendant shall file any reply 
i f   ffi it    .2011. 
Each motion shall be accompanied by a separate brief containing all the 
reasons and points and authorities relied upon by the moving party. Any 
opening brief or response shall be no longer than 25 pages. The moving party's 
reply shall   longer t  0 . e ocal le . 
N  PA TY S ALL FILE A SEPA ATE STATE E T F ISP TE  
F T . 
All arties shall e ail a l dispositive otion aterials to 
jweatherby@adaweb.net at the time the motion or memorandum is filed with 
the court. Any memoranda shall be emailed in a Word document with any 
supporting a fidavits or material send in a PDF fil . 
Any party who does not intend to oppose any motion shall immediately notify 
opposing counsel and the court by filing a pleading titled "Non-Opposition to 
Motion." The moving party shall serve and file with affidavits or other 
documentary evidence upon which the moving party intends to rely with the 
Motion. 
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4 DISCOVERY CUTOFF Unless otherwise stipulated all discovery shall be
initiated 120 days before trial
5 DISCLOSURE OF EXPERTS Unless otherwise stipulated the advancing
partys expert witnesses shall be disclosed 180 days before trial Unless
otherwise stipulated the defending party expert witnesses shall be disclosed by
150 days before Rebuttal experts if any shall be disclosed two weeks after
the defensive experts are disclosed An expert is defined under Rule 702 of the
Idaho Rules of Evidence
6 ATTORNEYS CONFERENCE Plaintiffscounsel shall convene an attorneys
conference two weeks prior to final pretrial conference for the purposes of
exchanging and marking of all exhibits exchanging all witness lists identifying
any foundational objections to exhibits or witnesses stipulating to uncontested
facts exploring all settlement possibilities and preparing a pretrial stipulation
pursuant to Rule 16eIRCPwhich stipulation will be presented to this Court
at the final pretrial conference
7 JURY INSTRUCTIONS Proposed jury instructions must be submitted by the
pretrial conference with copies to opposing counsel However contrary to
IRCP 51 if counsel requests standard Idaho Civil Jury Instructions IDJI
Instructions counsel should only submit a captioned document listing the
requested Instructions by number Counsel need not comply with the
requirements of IRCP 51a1 and submit the actual instructions with
duplicates If counsel requests modified instructions counsel should submit only
one copy of those requested instructions as modified clearly identifying the
source upon which counsel relies for the instruction
8 SANCTIONS Failure to comply with this Order shall subject a party or its
attorney to appropriate sanctions including but not limited to costs and
reasonable attorney fees the dismissal with prejudice of Plaintiffs claim or the
striking of a Defendantsdefenses A party may be excused from strict
compliance with any provisions of this Order only upon motion showing
extraordinary circumstances
9 PRETRIAL MEMORANDA Parties shall submit to the Court no later than five
5 days before the final pretrial conference a pretrial memoranda which will
include the following
a Elements of Plaintiffs case Plaintiff
b Defenses of Defendant case Defendant
C Contested facts
d Contested issues of law
e Evidentiary issues
f Agreed or stipulated facts and
g Memorandum of Points and Authorities on issues of law
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4) DISCOVERY CUT- FF: Unless otherwise stipulated, all discovery shall be 
initiated 120 days before trial. 
5) DISCLOSURE OF EXPERTS: Unless otherwise stipulated, the advancing 
party's expert witnesses shall be disclosed 180 days before trial. Unless 
otherwise stipulated, the defending party expert witnesses shall be disclosed by 
150 days before. Rebuttal experts, if any, shall be disclosed two weeks after 
the d f i  exp rts are disclosed.  expert is defined under Rule 702 of the 
Idaho Rules of Evidence. 
6)  NFERENCE: Plaintiff's counsel shall convene an attorneys 
conference two weeks prior to final pre-trial conference for the purposes of 
exchanging and marking of all exhibits, exchanging all witness lists, identifying 
any foundational objections to exhibits or witnesses, stipulating to uncontested 
facts, exploring all settlement possibilities, and preparing a pre-trial stipulation 
pursuant to Rule 16(e), I.R.C.P., which stipulation will be presented to this Court 
 t  i l -tri  f rence. 
)  I I . Proposed jury instructions must be submitted by the 
r -tri l c f r c  it  c i s t  si  c sel. ver, c tr ry to 
I.R.C.P. 51, if counsel requests standard Idaho Civil Jury Instructions (IDJI) 
instructions, counsel should only sub it a captioned docu ent listing the 
requested i tr ti   r. l  not comply with the 
r ir t  f I.R.C.P. 1 (a)(1)  it t  t l instructions with 
duplicates. If counsel requests modified instructions, counsel should submit only 
one copy of those requested instructions, as modified, clearly identifying the 
r   i   li  f r  ti . 
) I : Failure to comply with this Order shall subject a party or its 
attorney to appropriate sanctions, including, but not li ited to, costs and 
reasonable attorney fees, the dismissal with prejudice of Plaintiff's claim, or the 
striking f  f dant's d f . A party may be excused from strict 
co pliance it  any provisions of this Order only upon motion showing 
extraordinary circu st . 
9) PRE-TRIAL MEMORANDA: Parties shall submit to the Court, no later than five 
(5) days before the final pre-trial conference, a pre-trial e oranda hich will 
include the fo lo i : 
a. Elements of Plaintiff's case (Plaintiff); 
b. Defenses of Defendant's case (Defendant) 
c. Contested facts; 
d. Contested i sues of law; 
e. Evidentiary i sues 
f. Agr ed or stipulated facts; and 
g. Memorandum of Points and Authorities on issues of law. 
ORDER GOVER ING PROC EDINGS AND SETTING TRIAL - Page 3 
10 Exhibits should be premarked prior to opening of court All approved videotape
or audiotape presentations must be cued in advance and all equipment tested
for sound picture etc prior to presenting evidence contained therein The
parties are responsible for reviewing proposed exhibits for redactions to ensure
that objectionable material is not seen by the jury Dry runs are encouraged
before coming to court and before court begins All exhibits are to be handed to
the court officer instead of the witness
11 Counsel should be familiar with the local rules including the page limitations and
argument limitations
IF A PARTY FAILS TO APPEAR AT TRIAL WITHOUT GOOD CAUSE SUCH
FAILURE SHALL BE SUFFICIENT GROUND FOR ENTRY OF JUDGMENT AGAINST
SUCH PARTY OR DISMISSAL OF THE ACTION OF SUCH PARTY WITH
PREJUDICE WITHOUT FURTHER NOTICE
Dated this 13th day of May 2011
CHERI C COPSEY DISTRICT JUDGE
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10) Exhibits should be pre-marked prior to opening of court. All approved videotape 
or audiotape presentations must be cued in advance, and all equipment tested 
for sound, picture, etc. prior to presenting evidence contained therein. The 
parties are responsible for reviewing proposed exhibits for redactions to ensure 
that objectionable material is not seen by the jury. "Dry runs" are encouraged 
before co ing to court, and before court begins. All exhibits are to be handed to 
the court officer, instead of the witnes . 
11) Counsel should be fa iliar with the local rules, including the page limitations and 
argu ent limitations. 
IF A PARTY FAILS TO APPEAR AT TRIAL, WITHOUT GOOD CAUSE, SUCH 
FAIL E S ALL BE S FFI IE T G  F  E T Y F J E T A AI ST 
SUCH PARTY OR IS ISSAL   I  OF  PARTY, ITH 
J DICE, I   TICE. 
t  t i     ay, 011. 
I . EY, I I  J  
ORDER GOVERNING PROCEEDINGS AND SETIING TRIAL· Page 4 
CERTIFICATE OF MAILING
I hereby certify that on this 13th day of May 2011 1 mailed served a true and






GREENER BURKE SHOEMAKER PA
950 W BANNOCK ST STE 900
BOISE ID 83702
CHRISTOPHER D RICH
Clerk of the District rt
X11
A0 41 1UQB
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CERTIFICATE OF MAILING 
I hereby certify that on this 13th day of May, 2011, I mailed (served) a true and 
cor ect copy of the within instru ent to: 
DA I   
JONES & ARTZ, L  
PO BOX 7808 
B ISE, I  83707-7808 
IST P E  C. B KE 
GREENER BURKE & AKER,  
   T,   
B ISE, I  83702 
 .  
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oRieiNaL
FI D
Christopher C Burke ISB 2098
Thomas J Lloyd III ISB 7772
GREENER BURKE SHOEMAKER PA









IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
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I Thomas J Lloyd being first duly sworn upon oath state as follows
1 I am one of the attorneys of record for Defendant Security Equipment Corporation
SEC or Defendant and make this Supplemental Affidavit in support of Defendants
Motions for Summary Judgment based upon personal knowledge
2 At the time of filing SECsMotion for Summary Judgment on April 22 2011 SEC
fi
had just completed the deposition of Dr Karin Pacheco in Denver Colorado and had not
received the transcript from this deposition Though Volume II of the deposition was received
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I, Tho as J. Lloyd, being first duly sworn upon oath, state as follows: 
1. I a  one of the attorneys of record for efendant Security quip ent orporation 
("S "  "Defend "),   t is l t l ffid it i  s rt f f ndant's 
otions for u ary Judg ent, based upon personal kno ledge. 
2. t the ti e of filing SEC's otion for Su ary Judg ent, on pril 22, 2011, SE  
had just co pleted the deposition of r. arin acheco in enver, olorado, and had not 
received the transcript from this deposition. Though Volume II of the deposition was received 
L  I I       FENDANT'S    
JUDG ENT - Page 1 -0  (3 344 .doc) 
on May 7 2011 the transcript for Volume I of this deposition was not received until late in the
afternoon on May 24 2011
3 Attached hereto as Exhibit M are true and correct excerpts from the deposition
transcript for the Deposition ofKarin PachecoMDVolumes I and II which were taken on
April 21 and 22 2011
4 Attached hereto as Exhibit N is a true and correct copy of Exhibit 73 from Dr
Pachecosdeposition Volume I
DATED this 4U day of May 2011
By7TLn
Thomas J Lloyd
SUBSCRIBED AND SWORNTO before me this day of May 2011
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CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Supplemental Affidavit of
Counsel in Support of DefendantsMotion for Summary Judgment to be served on the
following named personson the date indicated below in the manner indicated below
Darwin Overson Esq ViaUSMail
Eric B Swartz Esq X ViaHand Delivery
JONES SWARTZ PLLC Via Facsimile 2084898988
1673 W Shoreline Drive Suite 220 ViaOvernight Delivery
P O Box 7808
Boise Idaho 83707
DATED this day of May 2011
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1 IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT
OF THE STATE OF IDAHO
2 IN AND FOR THE COUNTY OF ADA
3 Case No CVPI1003515
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Q Have you ever actually seen anybody being
sprayed or exposed to pepper spray
A On TV
Q Okay But not in person
A No
Q As part of your medical training did you
actually receive training in health effects of exposure
to pepper sprays
A Im not sure exactly what you mean
Q Well in other words when you went through
your medical training did you have any courses that
specifically addressed the subject of adverse health
effects from exposure to OC
A No no specific courses
Q And Im assuming you periodically go to
medical seminars and conferences
A Yes
Q And over the course of the years youve
probably been to a number of those Have any of those
ever specifically focused on the adverse health effects
of exposure to OC
A No because the exposure is relatively rare in
the general population
Q Prior to having Ms Major as a patient did
you ever do yourself I mean you yourself ever do
Page 21
any independent studies or research on the health
effects of exposure to OC
A No
Q And prior to having Ms Major as a patient
did you ever have occasion to research the medical
literature scientific literature available at the time
on the subject of adverse health effects associated with
OC
A No
Q Prior to having Ms Major as a patient did
you ever have any other patients who had been exposed to
OC who expressed to you they had been exposed to OC
A I believe Idseen a few That was not their
primary complaint
Q Lets talk about that for a minute Do you
remember what the primary complaints of the patients
were who indicated they had that exposure
A No
Q Was OC a factor in any condition that you were
diagnosing or assessing
A What do you mean
Q Well Im assuming you take history from
patients all the time
A Yes
Q And as an occupational medicine specialist
6 Pages 18 to 21
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1 A No 1
2 Q Is there any certification or board 2
3 certification for toxicology per se 3
4 A There is I believe so yes 4
5 Q And you donthave that board certification 5
6 A No 6
7 Q Would you consider yourself to be a specialist 7
8 in toxicology 8
9 A I would consider myself trained in toxicology 9
10 and able to deal with toxicological issues in the 10
11 patients that I evaluate 11
12 Q Do you have any degrees or certifications in 12
13 industrial hygiene 13
14 A Again similarly we are trained in industrial 14
15 hygiene techniques as a part of our training in 15
16 occupational medicine We also now have four industrial 16
17 hygienists on staff with whom we consult regularly 17
18 Q But again you donthave any degrees in 18
19 industrial hygiene 19
20 A I did not do a specific training program in 20
21 industrial hygiene no 21
22 Q Is there a board certification for industrial 22
23 hygiene that youre aware of 23
24 A There is a certification related to being a 24
25 certified industrial hygienist which also involves 25
Page 19
1 about five years of experience in the field and that 1
2 would be considered certification 2
3 Q You donthave that certification 3
4 A No 4
5 Q Letstalk about OC for just a minute I 5
6 assume that youre familiar with that term 6
7 A Yes 7
8 Q What do you understand OC to be 8
9 A It is a derivative of hot peppers 9
10 Q So itsa natural organic ingredient in 10
11 peppers 11
12 A Yes 12
13 Q And its commonly found in pepperbased and 13
14 chillybased food products 14
15 A Yes 15
16 Q Its used for some medical purposes such as 16
17 pain relief 17
18 A Yes 18
19 Q And its also an active ingredient in pepper 19
20 sprays that are used by law enforcement officers and 20
21 officials in the US and throughout the world 21
22 A Yes thatsmy understanding 22
23 Q Have you ever personally been sprayed or 23
24 exposed to pepper spray 24
25 A No 25
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ri  acheco, .D. April 21, 2011 
 1  Page 20 
1 A. No. 1 . Have you ever actually seen anybody being 
2 . I  ther   rtifi ti  or board 2 sprayed or exposed to pepper spray? 
3 rtifi ti  f  t xicology,  e? 3 .  V. 
4 . re is. I li  o, es.  . kay. But not in person? 
5 .   on't h    certification? 5 . o. 
6 A. No. 6 . As part of your edical training, did you 
7 . l   i r r lf t    i li t 7 actually receive training in health effects of exposure 
8 i  icology? 8 t  r sprays? 
9 . I l  i r lf tr i  i  t i l  9 A. I'm not sure exactly what you ean. 
10  l   l i  i l i l i  i  t  10 . ell, i  t r ords,  y  t t r  
11 i   I luate.  y r ic l tr ining, i  y  v  y c rs s t t 
12 .        i   s cific lly r ss  t  s j ct f v rs  lt  ) 
13 i  ygiene? 13 effects fro  exposure to C? 
14 . ain, i il     i  i t i   . ,  i i  r s. 
15 i  t i    rt f r tr i i  i   . And I'm assu ing you periodically go to 
16 ti l i i e.      i      ferences? 
17 i i t   t ff it    lt r larly.  . . 
18 . t in,  on't      Q. And over the course of the years, you've 
19 l iene?  probably been to a number of those. Have any of those 
20 .           ever specifically focused on the adverse health effects 
21 l , o.     C? 
22 .     i i     A. o, because the exposure is relatively rare in 
23  t ou're  f?  the general population. 
24 . r  i   rtifi ti  r l t  t  i    . Prior to having s. ajor as a patient, did 
25 tifi   i t,     y  v r  y rs lf -- I mean you yourself --   
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1 t  rs  i  i  t    t t  y i t st i s r r s rc   t  lt  
2   i red .  ff cts f x s r  t  DC? 
3 .  n't e  ifi ation?  . . 
4 A. No.  . nd prior to having s. ajor as a patient, 
5 . et's t l  t  f r j st  i .   did you ever have occasion to research the edical 
6 e  ou're  ith  ?  lit r t r , i tifi  lit r t re il l  t t  ti  
7 . es.  on the subject of adverse health effects associated with 
8 . at   rstand   e?  D ? 
9 . It i   rivative f t .  . . 
10 . O it's  t ral i  i i  i   . rior to having s. ajor as a patient, did 
11 ers?  you ever have any other patients who had been exposed to 
12 A. Yes.  ~C, who expressed to you they had been exposed to DC? 
13 .  it's l  found i  r-base   13 . I li  I'd   f . t  t t i  
14 ll -based food pr ts?  pri ary co plaint. 
15 A. Yes.  . Let's talk about that for a inute. Do you 
16 . It's sed for so e edical urposes   6 re e ber what the pri ary co plaints of the patients 
17 in r li f? 7 r  h  i icated t y  t t re? 
18 A. Yes.  . . 
19 . And it's also n active i r i t in per 19 . as D  a factor in any condition that you ere 
20 r  that re used y la  enforcement fficers and  diagnosing or assessing? 
21 o ficials in the  and throughout the ld? 21 . hat do you ean? 
22 . Y , t t's y u r t i .  . ell, I'm assu ing you take history fro  
23 . ave you ever personally been sprayed or 23 ti ts all t  ti ? 
24 exposed to pepper s ? 24 . Ye . 
25 A. o. 25 Q. And as an occupational medicine speCialist, 
, ,«<= ,"C, 
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What are the recognized speaking broadly what are
the recognized physiological causes of cough
A Theresa huge number I couldntbegin to be
comprehensive
Q Can we just speak generally Letsfocus it
on this way Is cough generally something that occurs
with airway inflammation
A Cough can occur with airway inflammation
People with asthma cough Cough can be triggered by
again upper airway irritation such as chronic
sinusitis or postnasal drainage Cough can be
triggered by chronic gastroesophageal reflux disease
as well And irritants are a wellrecognized cause of
cough
Q And do all of these conditions Asthma
chronic sinusitis chronic GERD irritants cause some
sort of airway inflammation
A They do although the literature on irritants
is very limited
Q Meaning itsunknown at this point
A Well most irritants I think the general
consensus is that they work through neurologic
mechanisms Some people can have elevated numbers of
receptors indicating they trigger more easily with
exposure to these irritants but irritants dont
Page 25
necessarily cause chronic airways inflammation as their
mechanism of effect What I would say on a broader
level theres a lack of research in this area




Q And any underlying airway disease such as
asthma or bronchitis or pneumonia




Q Rhinitis what is rhinitis Is that runny
nose
A Rhinitis really refers to nasal inflammation
Q Okay So thats inflammation in and of
itself
A Manifest by different symptoms such as runny
nose or nasal obstruction
Q Now the airways are made up of epithelial
cells correct
A Yes
Q And these may become damaged or compromised
with airway inflammation
7 Pages 22 to 25
Page 22
1 thats one of the important things you do You try to 1
2 get into the patients work history correct 2
3 A Yes 3
4 Q What Im getting at is in the patients that 4
5 you had before Ms Major was OC exposure an issue that 5
6 was related to either the symptoms that these patients 6
7 were actually experiencing 7
8 A No 8
9 Q So it would be fair to say then Ms Major 9
10 was the first patient you have had who expressed a 10
11 history of exposure to OC that you haventmade some 11
12 association between that exposure and their health 12
13 condition 13
14 A This is the first patient that Ive seen who 14
15 developed chronic symptoms following OC exposure 15
16 Q Did the other patients whom youve seen 16
17 previously who provided you with any history of OC 17
18 exposure express to you their health reactions to that 18
19 exposure or do you recall 19
20 A Yes to the best of my recollection And most 20
21 of them developed burning eyes burning nose and a 21
22 cough 22
23 Q Okay And it was an acute reaction 23
24 A Yes 24
25 Q Temporary and resolved 25
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1 A They were only exposed on one occasion 1
2 Q Okay But did whatever symptoms they have 2
3 resolve temporarily right 3
4 A After the one yes 4
5 Q What do you understand the physiological 5
6 effects of OC exposure on humans to be 6
7 A When you say physiological effects are you 7
8 asking about the symptom complex 8
9 Q Yeah lets start with that 9
10 A Exposure to oleoresin capsaicin typically 10
11 triggers irritant mucosal symptoms So as I mentioned 11
12 burning red burning eyes burning runny nose throat 12
13 burning and typically it also elicits a cough that can 13
14 be severe 14
15 Q Is it your understanding that the 15
16 adverse health effects of exposure to OC in humans 16
17 are generally deemed to be temporary and reversible 17
18 and not long term 18
19 A In terms of a single exposure yes 19
20 Q What about in terms of multiple single 20
21 exposures 21
22 A Theresno literature on multiple single 22
23 exposures but clearly there are some people who are 23
24 more sensitive to the effects than others 24
25 Q Letstalk about cough for just a second 25
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1 that's o   t  i port t t i   o.  tr  t  1 hat are the recognized -- speaking broadly, hat are 
2 g t i t  t  patient's r  istory, cor ect?  the recognized physiological causes of cough? 
3 A. Yes.  A. here's a huge nu ber. I couldn't begin to be 
4 .  I'm  t is in t  ti t  t t 4 rehensive. 
5  h  b f r  s. ajor,   r   i  t t  . an e just speak generally? Let's focus it 
6  r l t  t  it r t  t  t t t  ti t   on this ay: Is cough generally so ething that occurs 
7  t  xperiencing?  it  ir  inflammation? 
8 . o.  A. Cough can occur with airway infla ation. 
9 . O i    f i  t    s. j   People with asth a cough. Cough can be triggered by, 
10  t        x r   10 ain, r ir  irrit ti    r i  
11   r      aven't    sinusitis or postnasal drainage. Cough can be 
12    r      triggered by chronic gastroesophageal reflux disease 
13 condition?  as ell. nd irritants are a ell-recognized cause f 
14 . i    fi    I've    ough. 
15 l  i  t  f ll i   sure.  . nd do all f these conditions: sth a, 
16 . i  t  t r ti t   ou've   chronic sinusitis, chronic , irritants cause so e 
17 r i l   r i   it   i t r  f   rt f ir  i fl ation? 
 r           .  o, lt  t  lit r t r   irrit t  
19 osure,    call?  is v ry li ited. 
20 . es,      ll ti n.    Q. Meaning it's unknown at this pOint? 
21 f t  l  r i  s, r i  se,    . ll,  i i  -- I think the general 
 h.  consensus is that they ork through neurologic 
23 . .  it   t  ction?  echanis s. So e people can have elevated nu bers of 
24 A. Yes.  receptors, indicating they trigger ore easily with 
25 .   lved?  r  t  t  irrit t , t irrit t  n't 
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1 . ey      i .  necessarily cause chronic air ays infla ation as their 
2 . . t i  r t s    echanis  f ff ct. hat I ould say on a broader 
3 l  t r ril , i ht?  l l, t ere's  l    i  t i  . 
4 . ft r t  , .  . an infla ation be caused by viruses? 
5 . hat o u rstand t  i l ical  . r . 
6 ff t  f  r   ans t  e?  . i l tions? 
7 . en you y "physiological f cts,"  u  . . 
8 i    to  lex?  Q. And any underlying airway disease such as 
9 . , l t's start it  t .  asth a or bronchitis or pneu onia? 
10 . re  l r i  i i  t ica ly  A. Can cause chronic airways inflammation, is 
11 triggers irritant ucosal . o  I , 1 that your question? 
12 r ing -- red r ing ey , rning  , throat 2 . es. 
13 burning, and typically it also elicits a cough that can  . . 
14 be severe.  Q. Rhinitis, what is rhinitis? Is that runny 
15 . Is it your understanding that the  ? 
16 dverse health ffects f xposure to  i  humans  A. Rhinitis really refers to nasal infla ation. 
17 re genera ly ee ed t  e t rary nd r versible  . . o t t's inflammation i   f 
18 and ot long t ?  it lf? , 
19 . In terms f  single ex , y .  A. Manifest by different symptoms such as runny 
20 . hat ut in terms of ultiple single 20 se or nasal . 
21 e res? 21 Q. Now, the airways are made up of epithelial 
22 . T re's no literature on ultiple single 22 c lls, c rr ct? 
23 ex , but clearly there are some people ho re 23 . Y . 
24 ore sensitive t  the effects than ot r . 24 Q. And these may become damaged or compromised 
25 . L t's talk about cough for just a s . 25 with airway infla ation? 
h' .~~' > " 
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A Yes
Q in scientific terms
A Kind of It also talks about the fad that
some people have higher receptor expression who will
have a chronic cough than those who do not
Q Okay Did you review or did you research any
other literature or review any other literature other
than these two articles that were provided to you
A I looked at some yes
Q Do you remember what you looked at
A No
Q Did you retain copies of any of those
articles
A I dontknow
Q Well thatsone of the things that was
included in the deposition notice to bring with you
copies of all medical scientific articles and
publications you have reviewed and relied upon in
connection with your work in this case Have you done
that
A I can look for them for you if you would like
them
Q Well we may want to get them if you actually
have access to them but we can do that at a break




Q Do you remember what the subject matter was
A It related to chemoreception for chronic
cough
Q And was it specific to OC or something else
A I cantrecall I believe some of them were
specific to oleoresin cap capsicum
Q And was there any information that you took
from that research that you can recall right now that
you relied on
A There are receptors for oleoresin capsicum in
the airway Patients with chronic cough have a higher
expression of these receptors than those who do not
Q Anything else
A Thatsthe basic takehome message
Q Do you recall approximately how many other
articles you looked at other than the two that are
referenced in that retention letter
A No
Q If you did not retain copies of those do you
have any notes somewhere that would indicate what
publications you did review
A No
Q Have you ever reviewed any articles or studies
12 Pages 42 to 45
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1 Q Okay Now the National Jewish Health records 1
2 which are contained in the whole gamut of Exhibit 72 do 2
3 they contain all of the notes and memos and labs and 3
4 radiological reports regarding Ms Major care at 4
5 National Jewish that youre aware of 5
6 A They should yes 6
7 Q Okay Any reason to think that they did not 7
8 A No 8
9 Q Okay And to the extent you had handwritten 9
10 notes or memos they would be included in there too 10
11 A Yeah they would be in here 11
12 Q Okay So far as you know are there any 12
13 handwritten notes or memos that you prepared that would 13
14 not be included in Exhibit 72 14
15 A Not to my knowledge no 15
16 Q Okay Now did you personally research any 16
17 medical literature or scientific literature in 17
18 connection with your work workup of Ms Major or work 18
19 on this case 19
20 A Somewhere here I listed some articles that I 20
21 had been provided 21
22 Q I might be able to help you with that If you 22
23 look at your retention letter which I believe was 23
24 Exhibit 69 that actually does list two articles 24
25 doesntit 25
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1 A Yes 1
2 Q And were those articles that were given to you 2
3 by Mr Oversonsoffice 3
4 A I believe so yes 4
5 Q And had you seen were you aware of those 5
6 articles prior to having received them 6
7 A Not these no 7
8 Q And did you review them 8
9 A I believe so yes and they substantiate a 9
10 role for chemoreceptors of capsaicin and the respiratory 10
11 epithelial 11
12 Q And what does that mean 12
13 A Can you be more specific 13
14 Q You said they substantiate a role of 14
15 chemoreceptors of capsaicin in the epithelium What 15
16 does that mean Explain that in laymansterms 16
17 A It means that you have receptors for capsaicin 17
18 in your respiratory epithelium 18
19 Q Is that the main why is that important 19
20 Why is that significant 20
21 A Because it provides a physiologic role for how 21
22 capsaicin can trigger a cough 22
23 Q So what youresaying is essentially that 23
24 tells you why somebody exposed to that would have a 24
25 cough reflex 25
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Q. Okay. Now, the National Jewish Health records 
which are contained in the whole gamut of Exhibit 72, do 
they contain all of the notes and e os and labs and 
radiological reports regarding Ms. Major's care at 
National Je ish that you're aware of? 
A. They should, yes. 
Q. Okay. Any reason to think th t they did not? 
A. No. 
. Okay. And t  the extent y  h  handwrit en 
notes or e os, t  ould be included in ther  too? 
. eah, they ld b  i  here. 
. kay.  f r as  know, r  t r  any 
hand rit en notes or e os t t  r r  t t would 
not be included in Exhibit 72? 
.  t   ledge, o. 
. kay. ow, i   l  r r   
medical literature or scientific literature in 
ti  it  r r  -- r   s.   r  
on this case? 
. r  r  I li t   rti l  t t I 
had been provided. 
. I i t  l  t  l   it  t at. If  
l    i  l tt r, i   li   
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A. Yes. 
Q. -- in scientific terms? 
A. Kind of. It also talks about the fact that 
some people have higher receptor expression who will 
have a chronic cough than those who do not. 
Q. Okay. Did you review or did you research any 
other literature or review any other literature other 
than these two articles that were provided to you? 
A. I looked at some, yes. 
Q. Do you remember what you looked at? 
. o. 
. Did you retain copies of any of those 
articles? 
. I on't know. 
Q. Well, that's one of the things that was 
included in the deposition notice, to bring with you 
copies of all edical, scientific articles, and 
publications you have reviewed and relied upon in 
connection with your work in this case. Have you done 
at? 
A. I can look for them for you if you would like 
. 
Q. Well, we may want to get them if you actually 
have access to the , but e can do that at a break. 




3 by r. verson's office?  Q. Do you remember what the subject matter was? . 
4 
5 
. I li ve , .  A. It related to chemoreception for chronic 
. nd d   -- re  r  f t   c . 




. t t , .  . I c n't r c ll. I elieve s  f the  re 
.  i  you review t ?  specific to oleoresin cap -- capsicum. 
A. I li  s , ye , nd they substa tiate a  Q. And was there any information that you took 
10 role f r oreceptors f i i  and the ir t ry 0 from that research that you can recall right now that 
11 e it li l. 11 you relied on? 
12 . nd what does that ? 12 A. There are receptors for oleoresin capsicum in 
13 
14 
. Can you be ore sp i ? 
. You said they substantiate a role of 
15 chemoreceptors of capsaicin in the epith li . hat 
16 does that m ? Explain that in la n's ter . 
17 A. It eans that you have receptors for capsaicin 
18 in your respiratory epitheliu . 
19 Q. Is that the main -- why is that imp t? 
20 Why is that Signific ? 
21 A. Because it provides a physiologic role for how 
22 capsaicin can trigger a cou . 
23 Q. SO what y u're saying is e sentially that 
24 tells you why somebody exposed to that would have a 
25 cough reflex --
13 the airway. Patients with chronic cough have a higher 
14 expression of these receptors than those who do not. 
Q. Anything else? 15 
16 A. That's the basic take-home message. 
17 Q. Do you recall approximately how many other 
18 articles you looked at other than the two that are 
19 referenced in that retention lett r? 
20 A. No. 
21 Q. If you did not retain copies of those, do you 
2 have any notes somewhere that would indicate what 
23 publications you did review? 
24 A. No. 
25 Q. Have you ever reviewed any articles or studies 
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of law enforcement or correctional officers relating to
occupational exposure to OC
A I don recall I don think so
Q Have you ever found any studies or reviewed
any scientific or medical articles on long term chronic
health effects of prior occupational exposure to OC
after occupational exposure has ceased









































Q But not specific to OC
A No
Q Have you seen any publications on the duration
of time after exposure to OC that adverse health effects
of exposure customarily persist in either humans or
animals
A No I have not
Q Are you aware of any published literature
peer reviewed published literature that indicates that
adverse health effects of OC pepper spray can last
longer than three days
A There was a publication from our group in 1998
looking at irritantassociated vocal cord dysfunction
that lists a number of people who had highdose irritant
exposure that was transient who then developed
longlasting vocal cord dysfunction Although OC is not
Page 47
among the list of exposures it is similar to the ones
listed in that it has irritant properties
Q Hang on just a second here
Deposition Exhibit 73 was marked
Q Let me hand you what Ive had marked as
Exhibit No 73 to your deposition Do you recognize
that document
A Im glad to see that youve read it yes
Q Okay Is that the study that you were just
referencing that National Jewish Health did on irritant
associated vocal cord dysfunction
A Thatscorrect
Q Were you familiar with this study in which
this publication was based
A Yes
Q And I assume that some or all of the authors
are associated with National Jewish Health
A Yes
Q Were you specifically involved in this study
A No I had discussed it but I was not
specifically associated with this study
Q So far as you know is this the first
peerreviewed publication that discussed a condition
referred to as irritant associated vocal cord
dysfunction
Page 48
1 A To my knowledge
2 Q What do you understand the purpose of the
3 study to have been
4 A To describe the clinical entity for other
5 practitioners in the field
6 Q What does that mean describe the clinical
7 entity
8 A Itsto describe a diagnosis that may not have
9 been recognized previously
10 Q How do you understand the study was conducted
11 A It was a retrospective review of medical
12 records for all known outpatients with vocal cord
13 dysfunction
14 Q And would those have been patients that went
15 through the National Jewish Health system
16 A Yes
17 Q Over what period of time
18 A These state between December 1 1992 to
19 June 30 1996
20 Q And by retrospective study I think I
21 understand that but what do you mean by that
22 A It means that they looked at the medical
23 records of patients who had already been evaluated at
24 this medical center
25 Q And they were patients who had a diagnoses of
Page 49
1 vocal cord dysfunction
2 A Yes
3 Q To your knowledge did they actually go back
4 and talk with the patients themselves
5 A I don know
6 Q Were they limited by the information that was
7 contained in the medical records
8 A Since I dontknow if theywere able to go
9 back and talk to the patients I dontknow
10 Q Okay If we turn over to letssee
11 pages page 139 under the heading Results it looks
12 to me like they found about 100 either 184 or 195
13 Im not sure which patients with vocal cord dysfunction
14 that they actually included in their study Is that how
15 you read that
16 A No They first identified 184 patients with a
17 confirmed diagnosis of vocal cord dysfunction
18 Q Okay And if you look over at the end of that
19 section just before demographics it talks about a total
20 of 195 medical records were reviewed Is that different
21 than 184 patients Im just trying to understand what
22 this is telling me
23 A Yes Its a combination of 184 outpatients
24 with vocal cord dysfunction and 11 additional medical
25 records of patients suspected of having irritant vocal
13 Pages 46 to 49
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1  la  enforce e t or corr cti l of icers relating to 1 A. To y knowledge. 
2 ti l exposure to OC? 2 Q. What do you understand the purpose of the 
3 . I don't recall. I on't t i  so. 3 stud  t  have be n? 
4 . a   ever f und any t dies  revie ed  A. o describe the clinical entity for other 
5  scientifi  r i l rti l  o  l -t  c r i   practitioners in the field. 
6  ff t  of  occupational ex  t    . hat d  that ean, " i  t  cli i l 
7 ft r occupational exposure  ceased?  ntity"? 
8 .  ifi ll  t  l i  sicu .  8 A. It's to describe a diagnosis that ay not have 
9 t  i rit ts, es. 9 been recognized previously. 
10 .   ifi  t  C? 10 . o  do you understand the study as conducted? 
11 A. No. 1  . It   r tr ti  revi  f i l 
12 .    y li   t  r ti  12 records for all kno n outpatients ith vocal cord 
13   f        ff t   sfunction. 
14          Q. And would those have been patients that went 
15 animals?  through the National Jewish Health system? 
16 . o,   ot.  . s. 
17 .       lit r t re,  . ver hat period of ti e? 
18 r-r i  li  lit r t r  t t i i t  t t  A. These state between December 1, 1992, to 
19            0, 96. 
20 r   ays?  . And by retrospective study, I think I 
21 .           understand that, but what do you ean by that? I, 
22  t it nt-  l    A. It eans that they looked at the edical 
23 t t li t   r f l    i -do  irrit t  records of patients who had already been evaluated at 
24 r  t       i  i l t r. ~ 25 g-  l  ti n.      Q. And they were patients who had a diagnoses of 
, 
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1  t e  f , it       vocal cord dysfunction? 
2 li ted i  t it s irrita t i .  . . 
3 . ng     .  Q. To your knowledge, did they actually go back 
4 (Deposition ibit  s rked.)  and talk with the patients the selves? t! 
5 . et    at I've  rked   .  n't . 
6 i it .  t  r iti .   r i   Q. ere they li ited by the infor ation that was 
7 that document?  t i  i  th  i l rds? 
8 A. I'm l  to see t t you've r  it, y s.  A. Since I don't know if they were able to go 
9 . . Is t t the t y t t you r  just  back and talk to the patients, I don't kno . 
10 Cing that tional Je ish lt  id n irritant  Q. Okay. If we turn over to, let's see, 
11 associated vocal cord ction?   -- page 139, under the heading Results, it looks 
12 A. hat's correct.  to e like they found about 100 -- either 184 or 195, 
13 . ere you fa iliar with this st  i  hich  I'm not sure which, patients with vocal cord dysfunction 
14 this ublication as d?  that they actually included in their study. Is that how 
15 A. Yes.  you read that? 
16 Q. nd I assume that some r a l of the authors  A. No. They first identified 184 patients with a 
17 are associated with ational Jewish lth? 17 confirmed diagnOSis of vocal cord dysfunction. 
18 A. s. 18 Q. Okay. And if you look over at the end of that 
19 Q. ere you speCifically involved in this st y? 19 section just before demographics, it talks about a total 
20 A. N . I had discu sed it, but I was not 20 of 195 edical records ere revie ed. Is that different 
21 speCifically associated with this stu . 21 than 184 patients? I'm just trying to understand what 
22 Q. SO far as you k , is this the first 22 this is telling . 
23 pe r-reviewed publication that discu sed a condition 23 A. Yes. It's a combination of 184 outpatients 
24 refe red to as i ritant aSSOCiated vocal cord 24 with vocal cord dysfunction and 11 additional edical 
25 dysf ti ? 25 records of patients suspected of having irritant vocal 
"., <,,<,' , "c,~,' <'" 
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adduction of the anterior two thirds of the vocal cords
with the posterior chink that could occur in
inspiration expiration or both And thats how they
describe it
Q Would the signs and symptoms be the same for
the diagnosis of vocal cord dysfunction
A Yes
Q So the main difference between vocal cord
dysfunction and irritant related vocal cord dysfunction
is exposure to respiratory irritants within 24 hours or
symptoms within less than 24 hours
A With exposure to a respiratory irritant yes
Q Now is it your understanding that most or all
the patients who develop symptoms and fit in the
category of irritant vocal cord dysfunction diagnosis
receive a single exposure event
A In this study yes
Q And the irritants which were the subject of
exposures for those patients that had that diagnosis are
contained on Table 4 on page 141 is that right
A Thatscorrect
Q And essentially those irritants were ammonia
flux fumes cleaning chemicals smoke organic solvent





Q And none of those patients reported any
history of exposure to OC is that right
A No
Q No none were reported
A There were none that were included in this
study
Q Can you cite me to any peer reviewed
publications that you were aware of that have associated
specifically OC exposure with vocal cord dysfunction
A No That of course does not invalidate the
association
Q Now on page 142 of that article middle
column second tolast paragraph in the middle column
the last sentence says and I quote Thus chronic
rhinitis may exacerbate vocal cord dysfunction although
this association will require further study
And then at the beginning of that paragraph
it says Although the symptoms of chronic rhinitis are
common in the general population then it goes on to
talk about that Is it your understanding that chronic
rhinitis has been associated with exacerbation of vocal
cord dysfunction
A We already discussed this
14 Pages 50 to 53
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1 cord dysfunction 1
2 Q Okay 2
3 A And so these were added to the total list 3
4 8 were excluded due to coexisting asthma And so 4
5 184 plus 11 gives you 195 5
6 Q Okay So out of the 195 there were 11 total 6
7 that fell into the category of irritant vocal cord 7
8 dysfunction 8
9 A Yes 9
10 Q is that your understanding 10
it A They met the clinical criteria listed in 11
12 Table 1 12
13 Q So lets talk about the clinical criteria 13
14 First of all lets start with vocal cord dysfunction 14
15 Whats the clinical criteria for that 15
16 A Vocal cord dysfunction in this case was 16
17 related to abnormal direct laryngoscopy either in the 17
18 asymptomatic state during symptoms or with a provocative 18
19 study 19
20 Q Okay What is vocal cord dysfunction Tell 20
21 me what that is What does that mean 21
22 A Normal vocal cords function indicates the 22
23 vocal cords normally are relaxed and open during 23
24 breathing in or breathing out and they come together to 24
25 make speech If vocal cords close when the person is 25
Page 51
1 trying to breathe it will impede airflow and that is 1
2 vocal cord dysfunction 2
3 Q And what are the signs and symptoms of vocal 3
4 cord dysfunction 4
5 A They can vary greatly Typically they include 5
6 shortness of breath and as I listhere wheezing 6
7 strider dyspnea shortness of breath cough or throat 7
8 tightness 8
9 Q Okay Anything else that would be included in 9
10 making the diagnoses of vocal cord dysfunction 10
11 A They also excluded other types of vocal cord 11
12 disease such as nodules or trauma 12
13 Q Okay So then we have a new clinical 13
14 diagnosis here of another disease called irritant vocal 14
15 cord dysfunction 15
16 A Irritant associated vocal cord dysfunction 16
17 yes 17
18 Q And what are the clinical criteria for making 18
19 that diagnosis 19
20 A They describe Newly recognized clinical 20
21 entity irritant associated vocal cord dysfunction In 21
22 this instance these are cases of vocal cord dysfunction 22
23 that develop within less than 24 hours of a single 23
24 exposure to a respiratory irritant Each case showed a 24
25 typical laryngoscopy for vocal cord dysfunction 25
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1 cord dysfunction. 1 adduction of the anteri r two-thirds of t  vocal cords 
2 Q. Okay. 2 wit  t  posterior chink t t coul  occur in 
3 A. And s  t  ere ad  t  the t t l list, 3 inspiration, expiration, or both. And that's how they 
4 8 er  ex l   t  i ti  sthma. And so  describe it. 
5 18  l  11 i  you 95. 5 . ould the signs and sy pto s be the sa e for 
6 . kay. o o t f t  95, t  r  11 tot l  the diagnosis of vocal cord dysfunction? 
7 t  fel  i t  t  cat ry f irrit  vocal c r  7 . es. 
8 f ti  --  . O t  ai  difference bet e  vocal c r  
9 A. Yes.  dysfunction and irritant-related vocal cord dysfunction 
10 . -- i  t  y r derstanding? 1  is exposure to respiratory irritants within 24 hours or 
11 .  t t  li i l rit ri  li t  i   sy t s it i  less t n  hours? 
12 Table l. 12 A. With exposure to a respiratory irritant, yes. 
13 . O let's t l  t t  li i l riteria. 13 . OW, is it your understanding that ost or all 
14 ir t f ll, let's t rt it  l r  f tion.  the patients ho develop sy pto s and fit in the 1 
15 What's the clinical criteria for that? 1  category of irritant vocal cord dysfunction diagnosis 
16 . l r  f ti  i  t i  e   receive a single-exposure event? 
17   r al, i   it     A. In this study, yes. 
18      it     . And the irritants which were the subject of 
19 t y.  exposures for those patients that had that diagnosis are 
20 . ay.     function?   contained on Table 4 on page 141; is that right? 
21  t t t i . t  t t an?  . hat's rrect. 
22 . l l  f ti  -- indicates the  Q. And essentially those irritants were ammonia, M 
 l  ly       flux fumes, cleaning chemicals, smoke, organic solvent, 
24 i    i  t,    t r   ceiling tile dust, achining fluids and odors, correct? 
"", 
25  .  l r  l     i   . rs. ~ 
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1 i   ,    ,  t i   . dors, yes? I 
2 l  .  . . ~ 
3 .  hat re t e i    f l  . And none of those patients reported any , 
4 r  f ction?  history of exposure to OC; is that right? 
5 . y  vary . i ll  t ey i l   . . 
6 rt ss f ,   I  , Z ,  Q. No, none were reported? 
7 t , , shortness f r , , r t roat  A. There ere none that ere included in this 
8 ti .  study. 
9 . . t i  else that l  e i cluded i   Q. Can you cite me to any peer-reviewed 
10 ing the i oses f cal cord ction?  li ti  t t  re r  f t t  i t  
11 A. hey also excluded ther types f cal c r   specifically OC exposure with vocal cord dysfunction? 
12 disease c   les or tr .  . . t, f c r , does ot i li t  the 
13 . .  then we ve   linical  i . 
14 diagnosis ere f another disease ll  irritant v l  . , o   42 f t t rti l , i le 
15 cord dy f ti n? 5 column, second-to-Iast paragraph in the middle column, { 
16 A. Irritant associated vocal cord d f , 16 the last sentence says, and I quote, Thus, chronic ~ 
17 y . 17 rhinitis may exacerbate vocal cord dysfunction, although 
18 Q. And hat are the clinical criteria for aking 18 this association will require further study. 
19 that di i ? 19 And then at the beginning of that paragraph, 
r1 20 A. They descri : Newly recognized clinical 20 it says, "Although the sy ptoms of chronic rhinitis are 
21 entity, i ritant associated vocal cord dysfuncti . In 21 common in the general population," then it goes on to 
22 this instance, these are cases of vocal cord dysfunction 22 talk about that. Is it your understanding that chronic 
23 that develop within le s than 24 hours of a single 23 rhinitis has been associated ith exacerbation of vocal 
24 exposure to a respiratory irrita . Each case showed a 24 cord dysfunction? 
25 typical laryngoscopy for vocal cord dysfunctio , 25 A. We already discussed this. 
) 
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Q I kind of got diverted there a minute because
you brought up the article Let me kind of get back on
track a little bit here Can you cite me to any
published literature indicating that adverse health
effects of OC pepper spray exposure are not reversible
once the source of the exposure is removed
A To my knowledge the literature is fairly
limited and so I have not seen a specific publication
relating to that effect
Q You mentioned that you were the director of a
challenge lab I think thats the term you used I may
get that wrong but
A Challenge chamber
Q Challenge chamber yes Im sorry Are you
aware that OC is used in challenge testing in medical
research in clinical application
A It probably is yes
Q Have you yourself ever used OC in challenge
tests in a clinical or research setting
A No
Q And to your knowledge has anybody at National
Jewish used OC in that challenge study when youve been
here
A Not to my knowledge
Q Are you familiar procedurally about how an OC
Page 57
challenge test is run
A I have not run them so no
Q Were you aware that FDA had approved use of
capsaicin for challenge tests such as this
A I would want to know the conditions under
which its been approved for use
Q But do you have any awareness of that one way
or another in the present time
A No
Q Are you aware of any published literature
indicating that the use of OC in challenge tests may
cause any long term chronic irreversible adverse health
effects
A Well presumably the exposure in the challenge
test is a one time exposure
Q Okay
A and presumably the concentration of the
spray and the duration of exposure are limited so as not
to cause any longterm health effects
Q Well presumably and hopefully thats true
but I guess what Im asking Are you aware of any
published literature that indicates that challenge tests
with OC may actually cause long term chronic health
effects
A Again challenge tests are not designed to
15 Pages 54 to 57
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1 Q Okay So the answer would be yes 1
2 A Yes 2
3 Q Were you aware that Ms Major had a long 3
4 history of chronic rhinosinusitis and sinusitis for 4
5 years before she began working at the department of 5
6 correction 6
7 A I did review medical records dating back to 7
8 2001 in which I note that she was seen once in 2002 8
9 twice in 2003 and not at all in 2004 for respiratory 9
10 complaints Four times in 2005 twice in 2006 and then 10
11 four times in 2007 with subsequent escalation in number 11
12 of clinic visits And so on the basis of the medical 12
13 records that I reviewed although she was seen 13
14 intermittently for either sinusitis or bronchitis it 14
15 was not on a chronic basis 15
16 Q So my question really was Were you aware 16
17 that before she began working at the department of 17
18 corrections in July of 2004 did she have a history of 18
19 recurring chronic strike that 19
20 A history of recurring sinusitis and rhinitis 20
21 A Well you really haventdefined what you mean 21
22 by recurring If you mean she had two episodes a 22
23 year then perhaps you could call that recurring 23
24 Thatsnot chronic though Chronic is a need for daily 24
25 medications and chronic symptoms 25
Page 55
1 Q Well 1
2 A So on the basis of the medical records that I 2
3 saw no it does not appear that she had a diagnosis of 3
4 chronic rhinosinusitis requiring daily medication 4
5 Q So your understanding is that she did not 5
6 require daily medications for sinus related issues and 6
7 rhinitis related issues 7
8 A There was none that I saw in the medical 8
9 records 9
10 Q Did you consider chronic rhinitis or sinusitis 10
11 as a possible cause of Ms Major vocal cord 11
12 dysfunction 12
13 A When I asked her about her symptoms under 13
14 review of systems which is designed to elicit symptoms 14
15 that may not have been reported in history of present 15
16 illness she told me that she did not have allergy 16
17 symptoms such as sneezing itchy or stuffy nose or 17
18 itchy or watery eyes She did report episodes of acute 18
19 sinus infection and that she got a runny nose when 19
20 exposed to cold air So it did not appear that chronic 20
21 rhinosinusitis contributed to her cough on the basis of 21
22 that symptom history 22
23 Q So the bottom line is you considered it but 23
24 ruled it out 24
25 A Yes 25
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1 . kay. S  t  ans r oul  be yes? 1 Q. I kind of got diverted there a in t  because 
2 A. Yes. 2 you brought up the article. Let me kind of get back on 
3 . r   a ar  t  s. aj r ha  a lon  3 track a little bit here. Can you cite me to any 
4 hi t r  f chronic r i i iti  and sinusitis f r 4 published literature indicating that adverse health 
5 year  befor  sh   i  at the rt t of 5 effects of  pepper spr y exposure are not reversible 
6 correction?  once the source of the exposure is removed? ~ 
7 . I i  r  i l r r  ti   t   A. To my knowledge, the literature is fairly 
8 2001 in which -- I t  t  sh    once in 002, 8 limited, and so I have not seen a specific publication 
9 t  i  003,   t  i   f  r i  9 relating to that effect. 
10 laints.  ti  i  005, t i  i  006, a  t   . You entioned that you ere the director of a 
11  ti  i     l ti  i    challenge lab, I think that's the term you used. I may 
M 
12 f cli i  i its.    t  i  f t  i l  t t t rong, t --
13    r i ed, lt      A. hallenge cha ber. 
14      chitis, i   . Challenge cha ber, yes. I'm sorry. Are you ~ 15 was not on a chronic basis.  aware that OC is used in challenge testing in edical 
16 . O   l  s: r     r r  i  li i l plication? 
17           . It r ly is, yes. 
18 i  i  l   , i     i    Q. Have you yourself ever used OC in challenge i\ 
19   -- strike that.  tests in a clinical or research setting? 
20     iti   initis?  . o. ~ 21 . l ,   ven't  t    . And to your knowledge, has anybody at National 
22  "re rring."          Jewish used OC in that challenge study when you've been 
23 r,      t i .  ere? Ii 
 at's t  . i      l   A. Not to my knowledge. ~ 
25    .  . re you fa iliar procedurally about ho  an  
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1 . ell--  ll  t t i  r n? 
~ 2 .   the i  f t  i l r r  t t I  A. I have not run the , so no. 3 , , t s  ear t    i nosis   . ere you aware that FDA had approved use of 
4 i  r i osinusitis i  il  ti .  c s ici  f r c ll  t sts s c  s t is? 
~ 5 . SO ur i  i  t   t  . I l  t t    iti   
6  il  i  f r i - l t d i    hich it's been approved for use. 
7 rhinitis-related issues?  Q. But do you have any awareness of that, one way 
8 . r  as none t at I saw i  t  i l  or another, in the present ti e? 
9 records.  . . 
10 . id you sider i  rhinitis r sinusitis  Q. Are you aware of any published literature 
11 as  sible  of . jor's vocal rd  indicating that the use of OC in challenge tests may 
12 f ction?  cause any long-term chronic irreversible adverse health 
13 . hen I asked er bout er sy ptoms nder  cts? 
14 review f s , hich is designed to licit sy ptoms  A. ell, presumably the exposure in the challenge 
15 that ay not have been reported in history of resent 15 test is a one-time exposure --
16 illn , she told e that she id not have allergy 16 . kay. 
17 sy ptoms such as sne i , itchy or stuffy n , or 17 . -- and presumably the concentration of the 
18 itchy or watery ey . he did report episodes f c te 18 spray and the duration of exposure are limited so as not J 
19 sinus inf i , and that she got a runny nose hen 19 to cause any long-term health effects. 
20 exposed to cold ai . o it did not appear that chronic 20 Q. Well, presumably and hopefully that's true, 
21 rhinosinusitis contributed to her cough on the basis of 21 but I guess what I'm asking: Are you aware of any 
22 that symptom histor . 22 published literature that indicates that challenge tests 
23 Q. SO the bo tom line is you considered it, but 23 with OC ay actually cause long-term chronic health 
24 ruled it out? 24 eff ts? 
25 A. Yes. 25 A. Again, challenge tests are not designed to 
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A Right
Q Okay So you were just considering RADS or
irritant induced asthma as a potential cause of this
cough at that point in time
A Yes
Q Okay You also say here that causes of
chronic cough may include bronchiolitis and
bronchiectasis
A Yes
Q Boy thatsa mouthful for me Can you tell
me lets start with bronchiolitis what is that
A Bronchiolitis refers to inflammation of the
smaller bronchioles or branching airways leading down to
the alveoli So it is essentially inflammation of the
smaller airways
Q Okay And what generally causes that
A To simplify bronchiolitis appears to be
either related to hydro irritant exposures can also be
associated either with cigarette smoking or connective
tissue diseases
Q Like Lupus something like that
A Yes
Q Rheumatoid arthritis would that be included
A It can yes




A is scarring of the peripheral airways
Q And what are peripheral airways
A Some of the smaller branching airways leading
down to the alveoli
Q The same airways that would be implicated in
bronchiolitis
A Can be yes
Q And how does that scarring occur What causes
that
A Two of the bigger causes of bronchiectasis
would include chronic respiratory infections such as
tuberculosis various immune disorders such as common
variable hypogammaglobinemia Chronic reflux if the
bronchiectasis is predominantly in the lower lungs
Acute hydro irritant exposures can scar the lungs and
cause this kind of long term sequelae
Q And when you say acute highdose irritant
exposure can you quantify that somehow What do you
mean by high dose
A You know many of these occur related to an
accidental exposure which is never measured But for
example hydrostomia exposure has been reported to cause
bronchiectasis as a long term sequale
22 Pages 82 to 85
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1 A Yes 1
2 Q Now are you aware of any peer reviewed 2
3 publications which support the statement that persons 3
4 with asthma may be more susceptible to cough from OC 4
5 exposure 5
6 A Imnot sure 6
7 Q Now when you say here that OC is a mucosal 7
8 respiratory irritant that may trigger 8
9 bronchoconstriction and cough by that did you mean an 9
10 acute trigger or chronic trigger or did you mean both 10
11 A An acute trigger is what I meant However I 11
12 then go on to say that respiratory irritants can also 12
13 cause an array of more chronic health problems 13
14 Q Are you able to cite me to any peer reviewed 14
15 literature that OC may cause longterm chronic 15
16 bronchoconstriction or cough even in asthma patients 16
17 after the source of the exposure is eliminated 17
18 A Well obviously the paper on irritant 18
19 associated vocal cord dysfunction lays the foundation 19
20 for that kind of an effect As to whether chronic 20
21 oleoresin capsicum exposure has been studied Im not 21
22 aware of any studies 22
23 Q Are you aware of any studies on chronic 23
24 disease resulting from acute exposures acute periodic 24
25 exposures 25
Page 83
1 A What kind of disease 1
2 Q Chronic respiratory disease related to acute 2
3 chronic acute or chronic exposures to OC 3
4 A To my knowledge there are no studies looking 4
5 at chronic exposures But as you know absence of proof 5
6 is not a proof of absence 6
7 Q You talk about respiratory irritants causing 7
8 chronic health problems as you just indicated You say 8
9 including RADS or irritant induced asthma What is 9
10 RADS 10
11 A RADS stands for reactive airways dysfunction it
12 syndrome 12
13 Q What is that 13
14 A It is asthma that is caused by a single 14
15 high dose exposure to a respiratory irritant Since I 15
16 didntknow whether or not she had asthma at the first 16
17 visit it was plausible to try to determine whether or 17
18 not she had developed BADS 18
19 Q Right And thatskind of what Im thinking 19
20 in going through this I mean youre considering 20
21 various things here in your differential diagnoses You 21
22 hadntrun the test yet 22
23 A Right 23
24 Q We later know she didnthave asthma but at 24
25 this point you didntknow that 25
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1 A. Yes. 1 . ight. 
2 . ,  y    a  eer-r i   . Okay. So you were just considering RADS or 
3 l  i   t  st t t t   3 irritant-induced asth a as a potential cause of this 
4 i  t     s  t  c  fr   4 c  t t t poi t i  time? 
5 xposure?  . es. 
6 . I'm t s re.  . kay. Yo  ls  say her  t t caus s of 
7 . ,       is  ucosal  c r ic c  y i cl  bronchiolitis a  
8  i    t i   r nchiectasis? 
9 i i   gh,  t  i      . es. 
10  i   r i  t i   i    oth?  . oy, that's a outhful for e. an you tell 
11 .  t  tri r i  t I nt. ever, I   -- let's start ith bronchiolitis, hat is that? 
12    t    r i    l   . i l  f  t  i fl ti   t e 
13        proble s.  s aller bronchioles or branching airways leading down to 
14 .         r-   the alveoli. So it is essentially infla ation of the 
15 l      -ter    s ll r ir ys. 
16         . kay.  t r lly c s s that? 
17 r   f    i ated?  . o si plify, bronchiolitis appears to be 
18 . l ,       either related to hydro irritant exposures, can also be 
19 i t  l r  f ti  l  t  f ti   associated either ith cigarette s oking or connective 
20 for that kind of an effect. As to whether chronic  ti  i ases. , 
21   re   t i d, 'm   . Like Lupus, so ething like that? 
22    i . 22 . . 
23 . re       i  23 . t i  rt ritis, l  t t  i cluded? 
24 i  lti  r   r s, te i i   . It can, yes. " 
25 osures?  .   i  -- get this right, bronchiectasis? 
    ~ 
1 A. hat kind of disease?  . i t i  --
2 .  i t       . h, okay. 
3 chronic --  r    ?  . -- is scarring of the peripheral air ays. 
4 .   , t re re   l ing  . nd hat are peripheral air ays? 
5 t ic r s. t   ,  f   A. Some of the smaller branching airways leading 
6  t  r of f .  n t  t  l li. 
7 . ou t l  t r ir t r  irrita ts i   Q. The same airways that would be implicated in 
8 ronic lth roble s   j st i .    chiolit s? 
9 i   r it - d . t i   .  , . 
10 RADS?  . nd ho  does that scarring occur? hat causes 
11 .  st nds f r r ctive ir ays ysf ction 11 t t? 
12 s .  A. o of the bigger causes of bronchiectasis 
13 . t i  t t?  l  i cl de iC i t  i f ti    
14 . It is st  that is caused y  i l   t l i , i  i  i r rs  s  
15 high-dose xposure to a r iratory ir it t. ince I  ri l  l i i . r i  r fl  if t  
16 't  ther or t she  th a t the first  bronchiectasis is predo inantly in the lower lungs. 
17 it, it as l i l  to tr  to t r i  hether r  Acute hydro irritant exposures can scar the lungs and 
18 not she ad dev lo  R .   t is ki  f long-term l . 
19 . i t. d t t's kind f hat I'm t i king 9 .  en yo   "acut  i h-dose irrit t 
20 in going through thi . I , y u're sidering  exposure," can you quantify that somehow? hat do you 
21 various things here in your differential di . ou 21 ean by "high dose"? rl ,~
22 h 't run the test y ?  . You k , any f t se r related to  
23 A. i . 23 accidental exposure, which is never measured. But, for 
24 .  later know she di 't have ast , ut at 24 example, hydrostomia exposure has been reported to cause ' 
25 this poi , you di 't know th t? 25 bronchiectasis as a long-term sequale. ~ 
, N~ ,.'- ,.> ,', "' 
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A But I never said that GERD doesntexist
Q I know I know But before you got this
positive test there was evidence of a prior negative
test The mere fact that you have a prior negative test
doesntrule out GERD necessarily does it
A No and she was also on reflux medications
Q Okay So notwithstanding that the prior
negative test its still your opinion that she had
GERD
A Yes
Q now rather than a highgrade severe reflux
condition
A I cantsay that the extent of the GERD was
as bad as it was here She had gained weight in the
interim so you know I cantreally comment on the
severity of her reflux disease before
Q And weight is certainly a contributor
excess weight is a contributor to GERD
A Yes
Q And can aggravate a preexisting GERD correct
A Yes
Q Now we haventaddressed esophageal
dysmotility in any detail other than just a few minutes
ago you kind of told me what you thought it was Are
you aware of any peer reviewed publications associated
Page 117
with esophageal dysmotility with exposure to OC pepper
sprays
A No Probably the best literature that we have
actually came out of the World Trade Center showing that
with this kind of high particulate exposure a fair
enough of the firefighters developed reflux where they
had had none before And so there is some documentation
in the literature that a highdose irritant exposure can
trigger gastroesophageal reflux disease
Q And youre talking about the first responders
who went in to do cleanup you know help with you
know search for any persons who may have been injured
following the collapse of the Trade Centers
A Yes
Q And they continued to do that over a
significant period of time didntthey
A Yes
Q And so the degree of dust exposure they would
have you would characterize as a high exposure
A Well it depends You know in that
literature theres been a nice demonstration of the
dose response in that those who were present at the site
on the day of the World Trade Center collapse had higher
rates of disease than those who came later
Q And did anybody ever do any make any
30 Pages 114 to 117
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1 A Pretty severe reflux meaning reflux came on 1
2 all of a sudden There was a large bolus that went all 2
3 the way up to the clavicles went all all the way up 3
4 the esophagus that came on spontaneously So pretty 4
5 significant reflux 5
6 Q Okay And of course a small hiatal hernia was 6
7 detected here too is that right 7
8 A Yes 8
9 Q So based on these tests you would conclude 9
10 that she did in fact have GERD 10
11 A Yes 11
12 Q Do you know whether Ms Major was on a reflux 12
13 medication at the time of the test 13
14 A Imsure she was She was seen here on the 14
15 30th when she was taking protonic and the test was done 15
16 the next day 16
17 Q Now were you aware that Dr Hendrickson had 17
18 Major undergo an upper GI test in April 2008 18
19 A Yes I see a report from May 1 reporting a 19
20 normal upper GI 20
21 Q Is an upper GI the same as an esophagram or 21
22 are they different 22
23 A I think they are different Theyr not 23
24 performed with a respiratory therapist in attendance 24
25 and it usually involves a single swallow So its much 25
Page 115
1 less extensive than this test 1
2 Q And is it possible to go through either 2
3 esophagram or an upper GI even in a person who 3
4 does later is later found to have GERD possible to 4
5 go through these tests and come up with a negative 5
6 result 6
7 A I dontknow what the statistics would be 7
8 but there are always tests that may be falsepositive 8
9 Q Let me tell you the reason why Im asking 9
10 you this Dr Hendrickson testified in his deposition 10
11 that the test the upper GI test that was run here 11
12 could show up negative 40 percent of the time even in a 12
13 person who has the disease Thatswhy I was asking 13
14 that question Are you aware of any statistics like 14
15 that 15
16 A Yes thatsabsolutely true The upper Im 16
17 sorry The esophagram and barium swallow are useful to 17
18 diagnose reflux because you dontneed to prep the 18
19 patient theyr easily done So if you get it thats 19
20 great But because reflux is intermittent you may miss 20
21 it 21
22 Q Okay And where Im going with this is just 22
23 because there was a prior negative test doesn 23
24 necessarily mean that youve ruled out definitively that 24
25 GERD doesntexist 25
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1 . Pret y r  reflux, i  r flux ca e on 1 A. But I nev r said that GER  doesn't exist. 
2 al  of a sudden. Ther  as a lar  bol s that we t al  2 Q. I know. I know. But before you got this 
3 the  up to th  clavicles, ent all -- all the  up 3 positive test, there was evidence of a prior negative 
4 th  esophagus t  ca  on spontaneously. So r tt  4 test. The ere fact that you have a prior negative test 
5 signific t reflux. 5 doesn't rule out GERD necessarily, does it? 
6 . kay.  of c r    i t  her i   6 . o, nd she was also on r fl x edications. 
7 detect  r  t o; is t  right?  Q. Okay. So notwithstanding that, the prior 
8 A. Yes. 8 negative test, it's still your opinion that she had 
9 . O s d  t  tests,  ld l  9  --
 t t  did, i  fact,  ERD?  . es. 
11 A. Yes.  . -- no  rather than a high-grade severe reflux 
12 .     s. j     r flux  ndition? 
13 edication at the ti e of the test?  . I an't  t t th  t t f th    
14 A. I'm s r  s  s. he s s  r   t   as bad as it was here. She had gained weight in the 
     i  rotoniC,   t t    interi ; so, you know, I can't really co ent on the 
 t   ay.  rit  f r r fl  i  fore. 
17 . ,     r.    . And weight is certainly a contributor --
        l 008?  excess eight is a contributor to ERD? 
19 . es. I   r rt fr    r rti    . . 
 l  I.  Q. And can aggravate a preexisting GERD, correct? 
21 .         ,   . . 
   ifferent?  . Now, we haven't addressed esophageal 
23 .  i    i t. hey're   dys otility in any detail other than just a few inutes 
24  it   i  i t i  nce,  ago you kind of told e what you thought it was. Are 
25   ll     .  t's  25 you aware of any peer-reviewed publications associated 
  Page 117 
1 less extensive than this test.  with esophageal dys otility with exposure to OC pepper 
2 .   it i l  t   t rough   ys? 
3  r  r I  i   r    . . r ly t  st lit r t re t t  v  
4 does later -- i    t   , sible   actually came out of the World Trade Center showing that 
5   t se tests d e p it   tive  with this kind of high-particulate exposure, a fair 
6 result?  enough of the firefighters developed reflux where they 
7 . I 't  at the t tistics l  ,  had had none before. And so there is so e docu entation 
8 t there are l ys tests t t ay  f l - iti .  in the literature that a high-dose irritant exposure can 
9 . et  t ll  t   y I'm king  trigger gastroesophageal reflux disease. 
10 y  thi . . rickson t tified i  his iti  0 Q. And you're talking about the first-responders 
11 that the test -- t e upper I t t that was  r   who went in to do cleanup; you know, help with, you 
12 ld show up gative 40 percent f the ti e even in  2 know, search for any persons who may have been injured 
13 person ho has the dis . t's why I as sking 3 following the collapse of the rade enters? 
14 that . re you re of any statistics like 4 . . 
15 that? 15 . And they continued to do that over a 
16 A. , t t's solutely tr . The per -- I'm 6 significant period of time, didn't they? 
17 s . The esophagram and barium swallow re useful to 7 A. . 
18 diagnose reflux because you d 't need to prep the 8 Q. And so the degree of dust exposure they would 
19 p ti t; t ey're easily do . o if you get it, t t's 19 have, you would characterize as a high exposure? 
20 gr t. But because reflux is inter itte t, you ay iss 20 A. ll, it de . ou k , in that 
21 it. 21 literat r , t re's b  a nic  de onstration of the 
22 Q. Ok . And where I'm going with this is just 22 dose response in that those who were present at the site 
23 because there was a prior negative test d 't 23 on the day of the orld Trade Center collapse had higher 
24 nece sarily mean that y u've ruled out definitively that 24 rates of disease than those who ca e lat . 
25 GERD doesn't exist? 25 Q. And did anybody ever do any -- make any 
1 
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A Yes
Q And let me go down the list of your final
diagnoses here The first one Irritant triggered
vocal cord dysfunction and secondary cough and treatable
to OC exposure What is the basis of that conclusion
A The test results ruling out other exposures
that could have caused it and her personal and medical
history as reflected in her records
Q When you say you ruled out other exposures
that could have caused it how did you do that
A Well for example I considered esophageal
dysmotility but the cough didntseem to be
particularly triggered by that and she had had
dysmotility before this last exposure without the
presence of a chronic cough She didnthave a
history of allergies that would have caused the chronic
cough
If you look at her the totality of her
medical records she really didnthave problems with a
chronic cough before she began working with the Idaho
Department of Corrections
Q Did you do an allergy workup on her
A No I asked her about allergic symptoms and
she reported none
Q And just so Im clear on that when you ask
Page 121
the patient for allergic symptoms what do you do Do
you just say are you allergic to anything is that what
you ask
A No I ask do you have any problems with runny
nose itchy eyes sneezing that occur any particular
time of the year or in relationship to any particular
exposure
Q And she responds no
A Yes
Q Can other environmental irritants cause vocal
cord dysfunction to your knowledge
A What you do you mean by cause Do you mean
cause the onset of or do you mean when encountered in
the environment can cause transient vocal cord
dysfunction
Q Either one
A Well there is literature showing that
irritant exposure can trigger chronic vocal cord
dysfunction that then is triggered by nonspecific
irritants
Q And would that be the study that would that
came out of National Jewish that you and I looked at or
are you referring to something else
A No thatsone example There was recently a
publication on irritant work related work associated
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1 attempt in those reports and studies to identify the 1
2 scope of the dust the chemicals the fumes the 2
3 irritants that would have been included within that 3
4 exposure 4
5 A The dust has been characterized and 5
6 interestingly lavage of some of the firefighters 6
7 lung lavage that was done six months later demonstrated 7
8 dust that showed the same characteristics as the dust 8
9 that was recovered from the site So there is some 9
10 attempt to characterize the exposure 10
11 Q Okay But so far as you know in any of those 11
12 published reports about the relationship between that 12
13 exposure and GERD theresnothing in those publications 13
14 that indicated that OC was part of the dust that was 14
15 involved 15
16 A No 16
17 Q And would you agree that the type of dose and 17
18 exposure that these people reported in these studies 18
19 obtained would be significantly higher than anything 19
20 that Ms Major would have had in terms of her exposure 20
21 to OC 21
22 A But since the two are not comparable I think 22
23 it doesn it doesn matter 23
24 Q Okay But in answer to my question would you 24
25 agree that the doses that each got were different 25
Page 119
1 A Well the dose and the chemicals that each got 1
2 were different 2
3 Q Okay The doses in the Trade Center were much 3
4 higher than those that would have been in the exposure 4
5 that Ms Major had 5
6 A Right But we dontknow if they were more or 6
7 less irritating And certainly with the World Trade 7
8 Center exposure they are not specific receptors in the 8
9 airways for those components the way there is for 9
10 oleoresin capsicum 10
11 Q Now did any of those Trade Center reports 11
12 associate that exposure with chronic cough 12
13 A Yes 13
14 Q And are you aware of any peer reviewed 14
15 publications that have associated OC exposure with 15
16 chronic cough 16
17 MR OVERSON Objection asked and answered 17
18 Q BY MR BURKE You can go ahead and answer 18
19 A As I said theresso few studies that no 19
20 Im not aware of any study 20
21 Q Letsturn to your clinic summary follow up 21
22 report which is 330 through 40 or 4109 I think the 22
23 numbers there are 48 to 51 And this is the report that 23
24 you did with your final diagnoses after youd run all 24
25 these tests that we just talked about is that right 25
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1 tt t in t  r rt   t i  t  i tif  t  1 . es. "' 
2 sc  f t  st, t  che icals, t  f es, t  2 . nd l t  go do  th  list f r fi l 
3 irrit ts t t l  h   i l  it i  t t 3 i s s here.  first ne: Irritant-tri r  
4 xposure?  v c l cor  ysf cti  a  s c ry co   tr t l  
5 .     characterized,  5 t   x osure. h t is t  basis of that conclusion? 
6 i t  l  f   t   -- 6 .  t st results r li  o t t r x s r s 
7 l  l  t    i  t  l  tr t   t t l    i  and r r  an  ic l 
8 dust that sho ed the sa e characteristics as the dust  i t   r fl t  in  r cords. 
9 that as recovered fro  the site. o there is so e  .  y  s y y  rul  o t t r x s r s 
   i   sure. 10 t t l    it,  i    that? 
11 . y.       i      A. ell, for example, I considered esophageal 
12 li  r    l  t    dys otility, but the cough didn't see  to be 
   , t ere's t i  i  t  li ti   rti l l  t i  b  t  and she   
  i i t     t   t    dys otility before this last exposure without the 
15 involved?  r  f  r i  ugh.  idn't   
16 A. No.  i t r  f ll r i  t t l    t  r i  
17 .  l   r  t t t  t  f    . 
18       t  t   If you look at her -- the totality of her 
19    i l  r    edical records, she really didn't have proble s ith a 
  .           chronic cough before she began working with the Idaho 
21 to OC?  epart ent of orrections. ~ 
22 . t     t rable,    . id you do an allergy orkup on her? 
23 it doesn't -- it sn't tter.  A. o. I asked her about allergic sy pto s, and 
24 . y. t i  r t   ti , l     r rt  e. , 
25 r  t t t   t t  t r  iff rent?  . And just so I'm clear on that, when you ask 
    
1 . ll,     i ls t    the patient for allergic sy pto s, hat do you do? o i 
2 were different.  you just say are you allergic to anything, is that hat 
;, 
3 . .   i    t r re    sk? 
4 i r t  t  t t ld   i  t  r   A. No. I ask do you have any proble s ith runny 
5  . j r d?  nose, itchy eyes, sneezing that occur any particular Ii 
6 . i t. t  n't  if t  r  r  r  ti e of the year or in relationship to any particular 
7 l s irri .  rt inly it   rl    re. 
8 t r x s r , t y re t s ecific r c tors i  t   . nd she responds no? 
9 i  f r t s  t  t e  t r  i  f r  . . 
10 i  .  . can other environ ental irritants cause vocal 
11 . , id ny f t  r e enter r orts  cord dysfunction, to your kno ledge? 
12 i t  t at xposure ith r ic c h?  A. hat you do you ean by "cause"? Do you mean 0 
13 A. Yes.   t e t f, r   an en t r  i  
14 . And r   re f any p -r vie ed  t e envir t, c  c s  tr si t v c l c r  
15 lic tions that ave i t   sure ith  dysfunction? 
16 chronic c h?  . ither one. il 
17 . : , asked  .  A. Well, there is literature showing that 
18 . (BY . ) ou n go ad and . 8 irritant exposure can trigger chronic vocal cord 
19 . As I , th re's so few t i s t , n ,  dysfunction that then is triggered by nonspecific 
20 I'm ot a are f any st .  irrit . 
21 . t's turn to your clinic su ary follow-up  Q. And would that be the study that would -- that 
22 r , which is 330 through 4  -- or 41 . I think the  came out of National Jewish that you and I looked at, or 
23 bers there re 48 to 5 . nd this is the report that 23 are you referring to so ething else? 
24 you did ith your final diagnoses after y u'd run all 24 A. No, that's one example. There was recently a 
~ 25 these tests that we just talked a t; is that ri t? 25 publication on irritant ork related -- r  associated 
"< .. ~" 
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exposure could cause or contribute to vocal cord
dysfunction
A Let me rephrase this question to make sure I
understand it
Q Yeah yeah that was a long question I was
kind of trying to set the stage of where Im going
because it kind of causes you to wear two different
hats you as a specialist versus somebody else out there
who doesnthave your expertise
A I would say that one of the benefits of
education is the ability to review facts and studies and
draw conclusions from them that are objective It takes
a long time for physicians or researchers to develop
that capacity and so its unreasonable to expect that
people who are not called on to evaluate information and
make extrapolations from what is known to what is
possible I wouldn expect somebody to be able to do
that
So if I were a layperson in 2008 and all
I saw were advertisements for Mace the understanding
that police officers occasionally used oleoresin
capsicum spray and perhaps selected studies showing
that well if you did a single challenge you didnt
end up with any long term effects that person would
think depending on how you presented the information
Page 141
that this patient was lingering wanting to get some
sort of unfair damages for an exposure that it didn
seem as though it could cause her disease
I think that this patient did have a chronic
intermittent exposure to it I believe based on the
literature that she falls into the category of someone
who is more sensitive either because she starts out with
more receptors or because she just responds more But I
believe in seeing her and especially in seeing her last
fall that she developed a chronic cough that is so
severe that she cantfind employment
The cough and I think I have been fair in
this assessment is multifactorial and I cannot say
that her cough is only due to the capsicum exposure
But her clinical presentation is such that she was able
to work before and she really is not able to work now
Plus to voice myopinion I think its really
tragic in this woman She didntneed very much I
mean all she really needs is adequate speech therapy
treatment for her reflux disease which I think this
physician completely ignored And she probably needs a
lap band procedure to lose weight because now her weight
is such that its making her reflux worse its making
her more depressed Im sure she has horrible sleep
apnea now
36 Pages 138 to 141
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1 any chance 1
2 A I didntlook for it specifically 2
3 Q Okay Well Ive got one here Let me save 3
4 some time and Ill just mark that as the next exhibit 4
5 Deposition Exhibit 75 was marked 5
6 Q Im handing you Exhibit 75 do you recognize 6
7 that as a report from Dr Brent Burton 7
8 A Yes 8
9 Q And is that the report that you reviewed at 9
10 some point in time 10
it A To my knowledge yes 11
12 Q And hes listed here at least on his heading 12
13 as being a medical toxicology and occupational medicine 13
14 specialist is that right 14
15 A Thatswhat it says on the letterhead 15
16 Q Did you ever do any search to see what his 16
17 qualifications were 17
18 A No 18
19 Q I want to ask you about some of the things 19
20 that he said in his report and so Im going to refer 20
21 you to those page numbers that are down at the bottom 21
22 A Okay 22
23 Q And the first area I want to point you to is 23
24 I guess page 21 Now you see there under discussion 24
25 where he says However Ms Major has a clinical course 25
Page 139
1 and objective findings diagnostic of vocal cord 1
2 dysfunction a respiratory condition that is unrelated 2
3 to an alleged exposure to capsaicin 3
4 Do you agree or disagree with that statement 4
5 A I disagree with that statement 5
6 Q And based on what 6
7 A Based on the evaluation that was done here 7
8 and what we know about the triggering of vocal cord 8
9 dysfunction with irritants 9
10 Q So youredrawing on your broader knowledge 10
11 about work that was done on irritants generally and then it
12 extrapolating from that that OC being an irritant could 12
13 lead to the same result 13
14 A Exactly 14
15 Q I want to step back from your role as a 15
16 specialist in this area for just a minute and consider 16
17 probably a layperson who would be a manufacturer of a 17
18 pepper spray product who would typically be looking at 18
19 literature that would come out on a periodic basis to 19
20 see if theresany issues with that product 20
21 Would a person in that position who does not 21
22 have your expertise or hasnthad the benefit of the 22
23 studies of irritant exposure that aren related to OC 23
24 be able to make a determination based upon the 24
25 literature that existed in 2008 or before that OC 25
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1 any chance? 1 x s r  could cause or contrib t  to vocal cord 
2 . I idn't lo  f r it specifically. 2 dysfunction? 
3 . kay. ell, I'v   o  here. L t  save 3 A. Let me rephrase t is questi  to ake sure I 
4 so e ti e,  I'l  j st ark t t as t  next exhibit.   it. 
5 ( i  i    arked.) 5 . eah, yeah, that as a long question. I was 
6 . I'm ha i   x i  75, d  you recogniz   kind of trying to set the stage of where I'm going 
7 t t a   r ort fr  r. Bre t urton? 7 because it kind of causes you to ear t o different 
8 A. Yes.  hats, you as a specialist versus so ebody else out there 
9 .  i  t  t   t   revi  t  who doesn't have your expertise. 
10  i  i  ti e? 10 . I ould say t t on  of t  benefit  f 
11 .   ledge, s. 1  education is the ability to review facts and studies and 
12 .  e's list  r , t l st  is ading, 12 draw conclusions fro  the  that are objective. It takes \ 
13  i    t i   i l  13 a long time for physicians or researchers to develop 
14 cialist; is t t ri ht? 1  that capacity, and so it's unreasonable to expect that , 
15 . hat's t i    t  r ad. 1  l   r  t c ll   t  v l t  i f r ti  an  
16 . i   r   r  t   t i    t l ti    i     i  
17 lifi ti  ere?  possible, I ouldn't expect so ebody to be able to do 
18 A. No.  t at. 
19 .  t       t    So if I were a layperson in 2008 and all 
20   i  i  i  rt,   I'm i     I saw were advertisements for Mace, the understanding 
21     r       tt .  that police officers occasionally used oleoresin 
22 . ay.  capsicum spray and perhaps selected studies showing 
23 .      t     is,  that, ell, if you did a single challenge, you didn't " 
24  ,  . ,     i   end up ith any long-ter  effects, that person ould 
25   , "Ho r, s. r   i i l   think, depending on how you presented the information, 
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1   i i gs i      that this patient was lingering, wanting to get some 
2 ti n,  r ir tory iti  that i  l t   sort of unfair damages for an exposure that it didn't 
3 t   leged r  t  saicin."  see  as though it could cause her disease. 
, 
4   ree r i r  ith t t ent?  I think that this patient did have a chronic 
5 .  i r e it  that t t.  inter ittent exposure to it. I believe, based on the 
6 .    at?  literature, that she falls into the category of so eone 
7 .   the v luation that s e r   ho is ore sensitive either because she starts out ith 
8 nd hat e now about t  triggering f l   ore receptors or because she just responds ore. ut I 
9 ysfunction ith irrit t .  believe in seeing her and especially in seeing her last 
10 . O y u're rawing on ur r er l  1  fall that she developed a chronic cough that is so 
r
i 11 out ork t at was one n irritants r ll  d then 11 severe that she can't find employment. 
12 xtrapolating from that that  being an irritant l  2 The cough -- nd I think I ve  f ir i  
13 lead to the sa e result? 13 this t -- is multifactorial, and I cannot say 
n 14 A. tl . 14 that her cough is only due to the capsicu  exposure. 
15 . I want to step back from your role   15 ut her clinical resentation is s c  that s  s able 
~ 16 specialist in this area for just a inute and consider 16 to work b f r , and s  r ally is not able t  rk n . 
17 probably a layperson ho ould be a facturer f a 17 Plus, to voice my opinion, I think it's really 
18 pepper spray product ho would typically be looking at 8 tragic in this woman. She didn't need very much. I 
19 literature that would come out on a periodic basis to 19 mean, all she really needs is adequate speech therapy 
20 s e if th re's any issues with that prod t. 20 treatment for her reflux disease, which I think this 
21 ould a person in that position who does not 21 physician completely ignored. And she probably needs a 
22 have your expertise or h 't had the benefit of the 22 lap band procedure to lose weight because now her weight I' 
23 studies of irritant exposure that ar 't related to OC 23 is such that it's making her reflux worse, it's making :;', 
24 be able to make a deter i ti , based upon the 24 her more depressed. I'm sure she has horrible sleep 
11 25 literature that existed in 2008 or before, that OC 25 apnea no . 
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1 This is a person who because of state
2 funds and the manufacturer were so anxious to sort
3 of protect their investment in this product that she
4 fell through the cracks in a way that she shouldn
5 have That with not very much money if you think
6 of the money thatsinvolved in us being here she
7 could have been treated and returned to being a
8 functional human being
9 And so you use or I use the kind of butfor
10 argument Yeah she had a lot of stuff going on Yeah
11 she was overweight Yeah she had some reflux
12 beforehand She had intermittent episodes of sinusitis
13 but really if you look hard at her medical history
14 she not seen that frequently for it And she gets
15 this sort of intermittent irritant exposure and she
16 gradually gets worse And if you look at her numbers of
17 clinic visits they gradually get worse
18 This is not a person who didntwant to work
19 And then she gets one particularly high exposure when
20 she probably had a viral respiratory infection and
21 the two things together were what set her off That
22 description of her lungs being on fire to me is
23 very relevant Its a common report that people
24 have when theyr exposed to this high dose irritant
25 exposure and its not something that people would
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1 think to make up
2 And after that she just kind of descends
3 Part of it is that her physician took her out of
4 exposure when probably he shouldn have Mostly
5 because
6 Q I missed that Physician took her out of
7 exposure what do you mean
8 A The physician said she couldntreturn to
9 work
10 Q Oh okay
11 A And so she sort of got stuck in this sick
12 mode and then nobody would allow her to go back to
13 work And then she got depressed and then she ate and
14 then herweight gain and then she had this chronic
15 cough which was horrible I must say Even when she
16 came back you know in the fall of 2010 she gained a
17 hundred pounds you know
18 And it was this woman has not been served
19 by safety nets that she should have and in my
20 estimation is not malingering for some large
21 settlement But she does need some targeted medical
22 care to get her back to being a functional human being
23 able to work
24 Q Okay Well it certainly wasntthe
25 point of my question to say that she was malingering
Page 144
1 I mean Ive seen her in deposition I frankly dont
2 think she malingering so I would agree with you
3 Shes coughing a lot so I cantsay why that is
4 Thatswhat I would leave to you
5 But the point of my question and I think
6 you answered it was you know if you consider all
7 the literature that was out there in 2008 or prior to
8 March of 2008 would a layperson without your
9 qualifications even having reviewed that literature
10 have been able to be on notice that this would have
it caused some long term chronic cough condition in a
12 person like this
13 A Was there enough literature back then to
14 support
15 Q Yeah that would have supported that based
16 upon a laypersonslook at it In other words the
17 layperson didnthave your qualifications your
18 background your experience
19 A Well if youre trying to figure out whether
20 or not you ought to bring this to trial Im not sure I
21 want to answer that but you know probably not
22 Q Okay
23 A But that doesn mean it didn happen It
24 just means that it was hard to put the pieces together
25 And I would also say its one thing that we
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1 especially in the division of occupational medicine do
2 well is that we put the pieces together which is
3 why I didntsay that everything she has is from
4 the OC exposures
5 Q Right I understand that
6 A Its because theres a ton of other stuff
7 thatsfeeding into this that also needs to be
8 addressed
9 Q Okay We were looking at Dr Burtons report
10 and we got kind of sidetracked there And I appreciate
11 that by the way
12 A You know its a quarter till 200
13 Q Yeah
14 A And I have clinic that starts at200
15 Q Okay So maybe we should just adjourn the
16 deposition right now
17 A And pick it up tomorrow
18 Q Pick it up tomorrow I can guarantee you I
19 can finish this before 1100 if you will be here at
20 830
21 A All right
22 Q Is that a promise
23 A Yes
24 Q Okay Why dontwe reconvene at 830
25 MR BURKE Are you still with us there
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A No I didntask her specifically She did
say that she was having to taper off the Neurontin
because she couldntafford it
Q So at least to the extent she was still on
those meds they would still have a tendency to be
aggravating her GERD symptoms
A Yes
Q Is there are there any other medications
in that list or a combination of them together if
not individually that would also maybe contribute to
her GERD symptoms
A Shestaking a lot of ibuprofen That can
certainly cause a gastritis although it wouldn
necessarily worsen her reflux disease
Q Anything else that you see in that that
might be aggravating it other than the Klonopin and
the Neurontin
A No I think it was just those two
Q Okay And I think we already addressed this
point Letssee Down on page 81 under National
Jewish Test Data youre talking there again about the
truncated inspiratory loops consistent with vocal cord
dysfunction Thats what we just talked about wasn
it on the PFT
A Yes
Page 173
Q Okay And back under Physical Examination
the paragraph above it looks like you weighed her
again and now she was up to 317 pounds Is that
right
A Yes
6 Q So she had in fact if were right
7 yesterday that 268 pounds was where she was in April
8 of 2009 She gained a significant number of pounds
9 even since that time
10 A Yes
11 Q And so that too would be continuing to
12 aggravate her GERD symptoms Is that right
13 A Yes
14 Q Letssee I think we mainly discussed this
15 yesterday but I just want to make sure On page 85
16 under Discussion well Ive got to find it here
17 Just a second Okay
18 All right Down near the bottom of the page
19 under Discussion you talk about respiratory irritants
20 have also been reported to trigger gastrointestinal
21 reflux disease This is specifically addressed in the
22 robust literature regarding the World Trade Center
23 first responders
24 Now we discussed this a little bit
25 yesterday And we discussed a little bit about the
Page 174
1 comparison of Ms Major exposure to capsicum with
2 the exposure that these first responders might have
3 had I just want to make sure that Im clear on that
4 You are not equating are you the types of
5 exposures that these first responders had with the
6 type of exposure that Ms Major had in terms of OC at
7 her work
8 A Im using this literature to state that
9 there is now published evidence that exposure to
10 irritants can cause gastroesophageal reflux disease
11 It is something that many people in this field have
12 seen but we lacked the medical literature to
13 substantiate it And so whereas this patient
14 exposures were obviously very different from the World
15 Trade Center it is simply stating that there is
16 medical precedent to make the connection between
17 irritant exposures and gastroesophageal reflux
18 disease
19 Although after that sentence I go on to say
20 that its clear the patients gastroesophageal reflux
21 disease is multifactorial so I dontthink that the
22 capsicum exposure entirely caused her reflux What I
23 am saying is that there is plausible literature to
24 suggest that such exposure aggravated her reflux
25 disease
Page 175
1 Q Just because one type of irritant aggravates
2 GERD does that necessarily mean that all other
3 irritants will also aggravate GERD
4 A It depends And theres not a lot of
5 literature on this
6 Q Okay It would certainly be something that
7 further study might be warranted Would you agree
8 with that
9 A Yes
10 Q And I think I already asked you this
it yesterday but just to be clear Youre not aware of
12 any published literature specifically tying OC
13 exposure to the cause or aggravation of GERD
14 A Theresno specific literature no
15 Q Okay
16 A But as you also know that doesn
17 necessarily rule out an association
18 Q Okay So on your report that wev just
19 been looking at you go on to do an impairment rating
20 Is that correct
21 A Yes
22 Q And this discussion I think begins on page
23 86 and goes thatspretty much on 86 So if you
24 want to add that in front of you there when Im asking
25 you about this But you deemed her to be at maximum
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Vocal cord dysfunction VCD is a poorly understood entity that is
often misdiagnosed as asthma We report eleven cases of VCD in which
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at the authors institution produced 11 cases that met IVCD case
criteria Thirty three control VCD subjects were selected by age matching
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oral cord dysfunction VCD is a
disorder of the larynx in which the
vocal cords adduct inappropriately
during the respiratory cycle Its cause
remains an enigma VCD has been
associated with psychiatric dysfunc
tion female gender and employment
in health care Interestingly there
has been one reported case of VCD
after irritant inhalational exposure
VCD is frequently misdiagnosed as
asthma or can occur concomitantly
with asthma In light of the role of
occupational and environmental irri
tant exposures in the development of
asthma rhinitis and laryngitis we
hypothesized that such exposures
may also induce VCD
We report eleven patients who de
veloped laryngoscopically confirmed
VCD after a single exposure to envi
ronmental or occupational irritant
We conducted a caseontrol study to
assess the differences in demograph
ics clinical signs symptoms spi
rometry psychiatric diagnosis and
occupation of those with irrimt
versus non irritant associated dis
ease This newly recognized entity
which we call irritant VCD IVCD
is found in patients who have had an
occupational or environmental irri
tant exposure followed by the new
rapid onset of respiratory symptoms
due to vocal cord dysfunction alone
Case Reports
Case 1
A 38yearold never smoker s
counting office worker had been
good health until she was exposed
emissions generated when a propa
torch was used to bum fibermesh t
the floorof a construction area 1
workstation was directly adjacent
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by an open door She observed a
plume of steam and dust in the air
next to her workstation After several
minutes of exposure she began to
experience chest burning and nausea
She remained in the area for another
hour during which time she devel
oped shortness of breath wheezing
cough hoarseness neck tightness
headache irritation of her eyes and
mouth lightheadedness and felt like
her nose was on firePulse oxim
etry was normal She was unable to
perform spirometry Despite treat
ment with oral corticosteroids anti
biotics and inhaled bronchodilators
She developed fever rhinorrhea and
a bloody nasal discharge over the
ensuing 24 48 hours Five days af
ter the exposure she was referred to
National Jewish Medical and Re
search Center because of persistent
symptoms At the time of our evalu
ation her examination revealed in
spiratory upper airway sounds on
auscultation of the chest with no
wheezing or stridor Inspiratory trun
cation of the spirometric flow
volume loop was observed Figure
1 Direct laryngoscopy showed in
spiratory and expiratory adduction of
the vocal cords with an inspiratory
posterior chink consistent with
VCD Although her methacholine
challenge test suggested airways hy
perreactivity the test was hindered
by poor reproducibility of spirometry
efforts and distortion of the inspira
Cory limb of flow volume loops Im
ntediately after the methacholine
test a direct laryngoscopy confirmed
both inspiratory and expiratory ad
duction of the vocal cords during a
i lime of symptomatic dyspnea
Case 2
A 44yearold former smoker rail
road inspector had been in good
healthexcept for a history ofallergic
tltinitis until he was exposed to an
hydrous ammonia when the railroad
Car on which he was working devel
oil a leak At the time of exposure
was kneeling to buckle together
airbrake hoses for the train
ed


























Fig 1 A A normal flowvolume loop
B Extrathoracic airflow obstruction with
trunction of the inspiratory loop This is
consistent with symptomatic VCD but may be
seen in other laryngeal diseases FVC forced
vital capacity FIF forced inspiratory flow
at 50 forced vital capacity FEF forced
expiratory flow at 50 forced vital capacity
odor He reported that he immedi
ately developed a cough hoarseness
burning eyes tearing and rhinitis
and described his lungs and stomach
as being on fire He was initially
diagnosed as having possible asthma
and was treated with inhaled bron
chodilators and inhaled corticoste
roids His hoarseness progressed
over several days becoming chronic
He developed dysphagia to liquids
and solids but denied gastroesopha
geal reflux symptoms or persistence
of rhinosinusitis Five months later
his examination at National Jewish
demonstrated no wheezing rales
rhonchi or stridor Flowvolume
curves showed an abnormal inspira
tory flow suggestive of vocal cord
dysfunction or variable extrathoracic
airflow obstruction His methacho
line challenge test result was nega
137
tive Direct laryngoscopy showed
paradoxical adduction of the vocal
cord on inspiration consistent with
VCD
Case 3
A 42 year old former smoker
electronics assembler reported no re
spiratory symptoms until her acci
dental exposure to fumes liberated
by the inappropriate addition of a
large amount of rosin flux to molten
solder Within 20 minutes she noted
the onset symptoms of severe throat
tightness dry cough and dry heaves
Her cough persisted 72 hours after
the exposure leading to her evalua
tion at a local occupational medicine
clinic She was advised to stop sol
dering and was placed on light duty
but she continued to experience
symptoms that led to multiple hospi
talizations for presumed reactive air
ways dysfunction syndrome She
was treated with oral and intravenous
corticosteroids oral and inhaled
bronchodilators and theophylline
and she became severely depressed
Four years after the exposure she
presented to National Jewish for
evaluation At that time her symp
toms included episodic throat tight
ness dyspnea on exertion substernal
chest pain difficulty swallowing sol
ids and liquids and heartburn
Laughing odors perfumes air pol
lution paints exertion and very hot
or cold air triggered respiratory
symptoms She was unable to per
form spirometry consistently Direct
laryngoscopy demonstrated vocal
cord dysfunction with inspiratory
and expiratory vocal cord adduction
In addition she was assessed by
psychiatry as having developed an
undifferentiated somatoform disor
der and panic disorder
Methods
In light of these and similar cases
we conducted a retrospective sys
tematic review ofmedical records at
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.     di-
ately developed a cough, hoarseness, 
burning eyes, tearing, and rhinitis 
and described his lungs and sto ach 
as being "on fire." e as initially 
diagnosed as having possible asth a 
     r n-
  e  rti ste-
roids. His hoarseness progressed 
over several days, becoming chronic. 
e developed dysphagia to liquids 
 l   i  str sopha-
geal reflux sy pto s or persistence 
f r i sinusitis. i e t s later, 
 x i ti  t l  
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r  sho   b r l i pira-
tory flo  suggestive of vocal cord 
dysfunction or variable extrathoracic 
iIfl  struction. i  ethacho-
line challenge test result as nega-
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l ation.   t   y p-
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and expiratory vocal cord adduction. 
 ddition,   sse   
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In light of these and si ilar cases, 
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TABLE 1
Clinical Criteria for Vocal Cord Dysfunction VCD
Irritant VCD
1 Documented absence of preceding vocal cord dysfunction or laryngeal disease
2 Onset of symptoms after a single specific exposure or accident
3 Exposure to an irritating gas smoke fume vapor mist or dust
4 Onset of symptoms within 24 hours after exposure
5 Symptoms of wheezing stridor dyspnea cough or throat tightness
6 Abnormal direct laryngoscopy for vocal cord dysfunction either in the asymp
tomatic state during symptoms or with a provocative study
7 Exclusion of other types of significant vocal cord disease
Non irritant Induced VCD
1 Symptoms of wheezing stridor dyspnea cough or throat tightness
2 Abnormal direct laryngoscopy for vocal cord dysfunction either in the asymp
tomatic state during symptoms or with a provocative study
1 Exclusion of other types of significant vocal cord disease
4 Absence of onset of symptoms after a single specific exposure or accident
Patient Selection
All patients diagnosed at National
Jewish with a primary or secondary
diagnosis of VCD as outpatients
from December I 1992 to June 30
1996 were considered eligible for
this study We generated a list of all
eligible patients by merging a com
puterized medical record list of all
cases having a medical record code
including VCD as a primary or sec
ondary diagnosis with an additional
list of potential IVCD cases main
tained by the occupational medicine
staff All cases of VCD were in
cluded if there was medicalrecord
documentation of a direct laryngos
copy A total of1350 potential cases
were reviewed for eligibility
Diagnostic Criteria
The criteria for diagnosis of both
IVCD and VCD are listed in Table 1
The diagnosis had to be proven la
ryngoscopically and documented in
the procedure report Diagnoses were
based on presence of either vocal
cord adduction during inspiration
with a posterior chink or adduction
during early expiration with a poste
rior chink All eligible case medical
records were reviewed to determine
if they met our criteria for IVCD or
VCD We identified I cases that
met the criteria for IVCD After the
IVCD cases were determined we
selected controls from the remaining
VCD cases the unexposed group
These controls were randomlv cho
sen at a 3 to 1 ratio to IVCD cases
and were matched on age at the time
of diagnosis to within three years
plus or minus the age of the IVCD
case
Exclusion criteria included 1 age
less than 18 years at the time of
0
i
Normal vocal cords at mid inspiration
Vocal cord dysfunction with posterior chinking
Fig 2The appearance of the vocal cords
during A inspiration in a healthy patient and
B during inspiration in a patient with VCD
showing the adduction of the vocal cordswith
the characteristic posterior chink opening
Illustration by Leigh Landskroner
initial presentation 2 diagnosis
made while subject was an inpatient
3 absence of VCD documentation
by laryngoscopy a concurrent or
previous diagnosis of asthma and 5
history of preexisting laryngeal dis
ease
Data Collection
Each IVCD and VCD control sub
jects outpatient chart was reviewed
in its entirety for diagnosis gender
ethnicity race age at diagnosis
symptoms signs pulmonary func
tion test results laryngoscopic find
ings description of any inhalational
exposures time between exposures
and the onset of symptoms and psy
chological assessment
All data were recorded systemati
cally on a standardized collection
form by a single investigator JP
A sample of 25 charts were reviewed
by another investigator KF or
RBto confirm accuracy and com
pleteness of the record review We
recorded each subject occupation
at the time of the exposure We
recorded the number of health care
workers HCW because of past as
sociations of VCD with employment
in health care We defined HCW as
any paid or unpaid person working in
the health care settings who had the
potential for exposure to infectious
materials This included physicians
nurses aides dental workers techni
cians workers in laboratories and
morgues emergency medical ser
vices personnel students and per
sons not directly involved in patient
care but who are potentially at risk
for occupational exposure to infec
tious agents including housekeepers
and clerical staff
Smoking status was recorded as
never former or current in accor
dance with the American Thoracic
Society Guidelines A cigarette
smoker was defined as a person who
has smoked at least 20 packs of
cigarettes or at least I cigarette per
day for at least 1 year A current
cigarette smoker was a person who
was a regular cigarette smoker up to
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and symptom that were specifically
recorded as being present absent or
missing from the chart included
wheezing cough dyspnea stridor
chronic rhinosinusitis chest pain
chest pressurechest tightness gas
iroesophageal reflux dysphagia or
difficulty in swallowing voice
changes throat tightness or choking
sensation We defined chronic rhino
sinusitis as clinician or patient re
ports of recurrent episodes of rhini
tis nasal congestion sinus
congestion posterior nasal drainage
or treatment for sinusitis Voice
changes were based on the patients
report of new onset hoarseness or
ilspy type voice Gastroesophageal
reflux was considered present if the
patient reported symptoms of indi
gestion retrosternal burning water
brash or if there was objective evi
dence of acid reflux such as with a
I1H probe study We recorded the
presence or absence of psychosocial
evaluation and any documented psy
chiatric diagnosis
Pulmonary function test data were
rccorded only if obtained in the pul
monary physiology unit at our insti
tution Spirometry was performed
according to the recommendations of
the American Thoracic Society
rhe following pulmonary function
test results are reported as percent
predicted forced inspiratory flow at
50of forced vital capacity FIF50
forced expiratory flow at 50 of
forced vital capacity FEF forced
expiratory volume exhaled in one
econd FEV forced vital capacity
PVC We calculated the FEF
FIF and FEV1VC Five IVCD
cases underwent methacholine pro
vocative tests These were reviewed
for a 25 drop in the FIF PCas
E
FIF Inspiratory truncation on
Clowvolume loops was listed as
present only if noted in the official
Interpretation of the pulmonary func
ltan studies These interpretations
ore performed by pulmonary phys
logy specialists independent of
r clinical data
Statistical Analysis
We used the chi square test or
Fisher exact test to determine if the
proportion of subjects with a partic
ular feature differed between IVCD
and VCD groups 13 For continuous
variables logistic regression was
used to determine if the distribution
of the continuous variables predicted
whether a patient was IVCD or
VCD14
Because of our 31 matched de
sign we also analyzed the data using
the MantelHaenszel chi square test
for categorical predictors and condi
tional logistic regression for contin
uous predictors The results of the
matched analysis were similar to the
unmatched analysis for all predictors
examined Thus we report results
only for the unmatched analysis
P values of less than 05 were
considered statistically significant
All tests were twoailed
Results
We identified 184 outpatients with
VCD confirmed by laryngoscopy
based on medical records department
diagnosis codes Nine patients met
the diagnostic criteria for IVCD and
118 patients met our criteria for
VCD Table 1 Fiftyseven patients
were excluded for the following rea
sons coexisting asthma n 45
negative laryngoscopy n 7 inpa
tient status n 3 destroyed chart
n 1 and no laryngoscopy per
formed n 0
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An additional 11 medical records
of patients suspected of having
IVCD by the occupational and envi
ronmental medicine group were re
viewed Two additional patients met
our diagnostic criteria for IVCD and
one patient met criteria for the VCD
group Eight patients from this list
were excluded due to coexisting
asthma
Thus a total of 195 medical
records were reviewed yielding I I
cases of IVCD and 119 VCD cases
Demographics
The demographic characteristics
of the subjects are presented in Table
2 We found a statistically significant
difference for ethnicity between
groups IVCD 27 Hispanic VCD
3 Hispanic We observed no sig
nificant statistical differences be
tween the two groups for gender
race or smoking status There was
no statistically significant difference
in the frequency of HCW between
groups IVCD 91 VCD 194
Symptoms at Time of
Presentation
The signs and symptoms of the
IVCD and unexposed VCD groups
are summarized in Table 3 We ob
served a statistically significant dif
ference only for the symptom of
chest discomfort IVCD 100
VCD 57
TABLE 2
Demographic Profile of Patients with IVCD and VCD
IVCD VCO
Characte n 11 n 33 P Val
Age years 4528 451957
Female 8 73 31 94 06
Ethnicity 02
White 8 73 31 97
Hispanic 3 27 1 3
Smoking Status 024
Current 1 9 1 3
Former 545 928
Never 45 2269
Data reported as number followed by percentage in parentheses
n 33 for age and n 32 for smoking status and ethnicity
Values expressed as means tSD
000366
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TABLE 3
VCDAssociated Symptoms
sym IVCD VC P Value
Wheeze
v
911 82 263379 083
Cough 11100 31394 040
Shortness of breath 1100 30391 030
Choking or throat tightness 910 90 22685 068
Chest pain or chest tightness 6 100 17305 04
Stridor 46 67 68 75 073
Gastroesophageal reflux 710 70 19325 055
Voice changes 11100 14688 022
Dysphagia 59 56 3027 011
Rhinosinusitis 811 73 30391 013
Expressed as number of patients reporting symptomnumber of patients for whom the
symptom was adequately recorded percentage in parentheses
Exposures
IVCD exposures and their relation
to onset of symptoms are summa
rized in Table 4 Exposure occurred
at work in 10 of 1l patients in the
IVCD group Two ammonia vapor
exposures occurred including a jan
itor who experienced the sudden on
set of dyspnea and upper airway
irritation after the accidental spilling
of ammonia indoors and the ammo
nia exposure as described in Case 2
Two electronics assemblers were ex
posed to fumes from the inappropri
ate mixing of flux and solder as
described in Case 3 A registered
nurse working in an emergency room
was exposed to an aerosolized clean
ing solution while scrubbing a bed
and noted immediate onset ofwheez
ing and dyspnea A bus driver was
exposed to aerosolized carburetor
cleaning solution while using it to
clean the inside of the bus He devel
oped cough and dyspnea approxi
mately 24 hours later A machine
operator who was exposed to aero
solized machining fluids containing
a mineral oil mist and ethanolamine
developed dyspnea and chest tight
ness two hours after exposure A
delicatessen wrapper experienced the
onset of dyspnea and sore throat 24
hours after exposure to a noxious
odor while cooking Cajun salmon
A PBX operator was exposed to
ceiling file dust when a construction
worker fell through the ceiling above
her workstation She noted the im
mediate onset of cough and hoarse
ness Two study subjects were ex
posed to smoke One involved a
controlled burnoff of a frbermesh
floor covering adhesive by use of a
propane torch Case 1 The second
involved a household exposure to
smoke and to an organic solvent used
to combat the smoke odor She ex
perienced symptoms approximately
24 hours after exposure In several of
the above exposures the exact of
fending agentscould not be deter
mined because of the complex nature
of the irritant the uncontrolled set
ting of the exposure and the limited
data available from the medical
record
There was a variable latency be
tween exposure and onset of IVCD
symptoms ranging from one hour or
less n 7two hours n 1 or up
to 24 hours n 3
Psychosocia Assessment
Psychosocial consultations had
been obtained in 64of IVCD cases
and in 39 of VCD controls P
016 The results of the evaluations
are summarized in Table 5 and dis
play a wide range of psychiatric di
agnoses
Pulmonary Function
Six of nine IVCD subjects who
underwent spirometry at our institu
tion had normal airflow and vital
capacity 66 Interestingly the re
maining three patients were unable
to cooperate with the test procedure
because of the severity of their respi
ratory symptoms and variability in
their flow volume loops The inabil
ity of VCD patients to perform con
sistent spirometry has been noted
recently In the IVCD group the
mean FEV and FEVVC ratio
were normal Eightyfive percent of
unexposed VCD subjects had spi
rometry performed We observed no
statistical difference between the two
groups for any of the spirometric
variables Table 6 We observed
inspiratory loop truncation in 14 of
IVCD cases and in 36 of control
VCDcases as illustrated in Figure 2
Fortyfive percent of our IVCD pa
tients underwent methacholine pro
vocative tests to assess nonspecific
airway hyperreactivity In four of
these five individuals we observed
25 or greater decrease in the FIF
during methacholine challenge
Discussion
This report describes a newly rec
ognized clinical entity irritant
associated vocal cord dysfunction
We report 11 cases of vocal cord
dysfunction developing within less
than 24 hours of a single exposure to
respiratory irritants IVCD was dis
tinguished from non irritant VCD on
the basis of the occupational and
environmental history These IVCD
cases each showed the typical patho
gnomonic laryngoscopic findings of
VCD adduction ofthe anterior two
thirds of the vocal cords with a pos
terior chink This abnormality can
occur in inspiration expiration or in
both phases of the respiratory cycle
Interestingly there was a statisti
cally significant increase in chest
complaints in the IVCD group We
speculate that there may be more
chest discomfort in the IVCD cases
because of the nature of irritant in
halational injury However that re
sult must be interpreted with caution
because of the small number of
cases Notably we observed more
Hispanics with IVCD than with
VCD We speculate that Hispanics
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TABLE 4
Occupation and Characteristics of Exposure in IVCD Group
Exposed Time FromExposure
ID Occupation at Work Type of Exposure to Symptoms Hours
1 Janitor Y Ammonia 1
2 Electronics assembler Y Flux fumes 1
3 Electronics assembler Y Flux fumes 1
4 School bus driver Y Cleaning chemicals 24
5 Deli meatwrapper Y Odors 24
6 Nurse Y Cleaning chemicals 1
7 Farmer N Smoke organic solvent 24
8 Machine operator Y Machining fluid 2
9 Clerical Y Smoke 1
10 PBX operator Y Ceiling file dust 1
11 Railroad inspector Y Ammonia 1
TABLE 5
Results of Psychosocial Evaluation
Concurrent diagnosis of undifferentiated somatoform disorder
tConcurrent diagnosis of depression
One of these patients had a concurrent diagnosis ofdepression
TABLE 6
IVCD VCD
Diagnosis n 7 n 1
0y thymic disorder 1 0
Undifferentiated somatoform disorder 2 0
Phase of frfe problem 2 3
Adjustment disorder 1 1
Major depression 1 7
Panic disorder 1 1 t
Post traumatic stress disorder 0 2
Anxiety disorder 0 1
Pulmonary Function Tests Results
IVCD VCD
Te n 7 n 28 PValue
FEV 82 312 851 125 067
FVC 776t 274 834 114 038
FEF 72 367 716 206 091
FIF 1186 634 995 365 029
FEF 090 45 14 95 052
FEV FVC 082 05 082205 094
Inspiratory truncation of Flow 14 36 028
volume bop
Values are expressed as the mean percent predicted SD
certain work tasks that place them at
greater risk for respiratory irritant
exposure We found no other clini
cal physiologic or demographic fea
tures that discriminate IVCD from
nonirritant etiologies
Because VCD often mimics
ustltma it is essential to consider the
diagnosis of IVCD in symptomatic
patients after irritant exposures in
prder to distinguish it from reactive
airways dysfunction syndrome
RADS and to provide appropriate
treatment14695 Our study design
excluded all patents with coexisting
asthma in order to permit us to ex
amine and describe the single entity
IVCD Notably a large number of
individuals developed both VCD and
asthma Thus future studies should
consider coexisting RADS and
IVCD in patients who fail to respond
141
to conventional asthma therapy Our
study design did not allow us to
estimate the frequency of IVCD in
patients with irritant induced asthma
While little is known about the
pathogenesis of VCD the temporal
association between the onset of
symptoms and irritant exposure in
IVCD suggests a direct inflamma
tory effect on the vocal cords For
example when Bucca performed la
ryngoscopic examination both before
and after histamine challenge she
documented that the drop in inspira
tory flows seen after histamine cor
responded to reddening edema and
paradoxical adduction of the vocal
cords during forced inspiration By
analogy the specific irritants found
in our IVCD cases may cause local
laryngeal inflammation For exam
ple ammonia is a highly water
soluble irritant gas that causes imme
diate irritation of the mucous
membranes of the upper respiratory
tract Smoke inhalation may induce
a variety of symptoms including
hoarseness stridor and wheezing
because of complex mixtures of
toxic gases and particular matter 179
Machining fluids have been impli
cated as respiratory irritants al
though the causative substance is
unknown Solder flux fumes are
known to be respiratory irritants in
man Ceiling the dust may contain
respiratory tract irritants such as fi
brous glass andmineral wool as well
as raise the possibility that high con
centrations of nuisance dust may af
fect the upper airway Cleaning
agents especially if mixed incor
rectly can produce severe respira
tory irritation and have been reported
to cause pulmonary edema as well as
eye and skin irritation
245
Organic
solvents including chemicals in car
buretor cleaners are known to be
toxic and irritating to the respiratory
tract Our retrospective design
and reliance on data from medical
records limits our ability to draw
more detailed inferences about the
mechanism of IVCD Furthermore
laryngeal biopsies were not obtained
from these patients Future studies
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that look prospectively at the upper
airways of irritantexposed patients
are warranted These should include
tissue biopsies to further elucidate
the pathophysiological mechanism
for irritantassociated VCD
The possibility of misclassifica
tion bias exists because patients with
chronic lowlevel irritant exposures
that did not meet our strict definition
of IVCD may have been included in
the non exposed VCD group Con
versely IVCD cases may have been
misciassified as VCD cases because
of inadequate documentation of the
occupational and environmental his
tory
The biological plausibility of ini
tant exposures as a cause of VCD is
further supported by evidence in the
medical literature that irritants cause
other diseases of the upper airways
Occupational laryngitis has been re
ported after exposure to certain
chemicals Negative skinprick tests
and negative immunoglobulin E an
tibodies in these cases imply an irri
tant non immunologic mechanism
Many irritants in the workplace are
known to cause occupational rhinitis
which was also a common finding in
our patients And as described
above the lower airways can become
hyperreactive after irritant expo
sure4529
Early reports suggested that VCD
occurs primarily in females HCW
and patients with psychiatric disor
der4529In our study both the IVCD
and VCD groups consisted predomi
nately of white females possibly be
cause of a bias on the part of physi
cians to look for VCD in women The
frequency of HCW was the same in
our two groups of patients Patients
who underwent formal psych000ccal
evaluations had psychiatric disorders
similar to those previously described in
VCD125930The relationship of
psychiatric disorders to VCD remains
unclear However we know that
chronic respiratory symptoms cancon
tribute to symptoms of depression and
anxiety These patients often have
difficulty adjusting to a new and less
well understood diagnosis We do not
IrritantAssociated Vocal Cord Dysfunction Perkner et al JOEM
know how many of our subjects with
IVCD developed their psychological
problems after their exposures Seiner
et al reported three VCD cases that
initially were associated with environ
mental sensitivities but who had nega
tive blind provocative studies and who
were ultimately diagnosed with con
version disorders 31 Our IVCD pa
tients do not meet the diagnostic crite
ria in DSMlV for conversion
disorders as these patients did not
have a deficit affecting a voluntary
motor function and the deficit may be
explained by the direct irritant effects
of the incriminated agents Our find
ings are consistent with that of New
man and Dubester who reported that
there is little evidence to support the
diagnosis of conversion disorder in
VCD patients Although there may be
a subgroup of patients with major psy
chiatric disturbance others present
without evidence of significant psy
chopathology
Although symptoms of chronic
rhinosinusitis are common 20
40 in the general population the
percentages in both our cases and
controls are much higher than prev
alence rates of previously studied
groups Bucca et al observed ex
trathoracie airway obstruction in
86ofpatients during exacerbations
of chronic sinusitis This phenomena
is reversible with adequate treatment
of the sinusitis Thus chronic rhi
nosinusitis may exacerbate VCD al
though this association will require
further study
The frequency of gastroesopha
geal reflux disease GERD was
much higher in our IVCD and VCD
subjects than the 7 incidence in US
adults An association of GERD
with VCD has not been established
previously The irritative effects of
refluxing gastric contents on the vo
cal cords may play a role in the
pathogenesis of VCD When gastric
contents reflux up the esophagus and
into the larynx a distinct set of
symptoms occur These include
hoarseness a persistent nonproduc
tive cough a sensation of pressure
deep in the throat and a continual
need to clear the throat These
symptoms overlap with those seen in
VCD Laryngeal ulcers may be
found 36 Classic dyspeptic symptoms
are often absent in GERD even
when it is severe enough to cause
laryngeal involvement 37 Further
studies are needed to investigate this
apparent association of GERD and
VCD
We observed no statistically sig
nificant difference in spirometry be
tween the IVCD group and the VCD
controls This was an anticipated
finding since both groups experi
ence the same end organ pathology
ie paradoxical motion of the vocal
cords Although some asthmatic pa
tients can have normal spirometry
between symptomatic episodes nor
mal airflow in a dyspneic and wheez
ing patient should raise the index of
suspicion for VCD masquerading as
asthma 38 The flowvolume loop
may provide additional clues to the
diagnosis of VCD1295although
our data suggest that classic trunca
tion of the inspiratory portion is not
present uniformly Bucca et al previ
ously showed that histamine provoc
ative tests cause a 25 fall in the
midinspiratory flow at 50 vital
capacity PC25 FIF50 reflecting ex
trathoracic obstruction39 Although
our provocative agent was metha
choline and not histamine the major
ity of our VCD subjects who under
went provocation testing showed a
fall in FIF consistent with the
previous findings of Bucca et al
We conclude that when consider
ing the differential diagnosis of a
patient presenting with acute respira
tory complaints after an irritant ex
posure clinicians should now in
clude IVCD on the list of possible
disorders Future prospective studies
should address the frequency with
which RADS and IVCD coexist Di
rect laryngoscopy during symptom
atic periods is the present gold stan
dard for making the correct
diagnosis and must be linked with
careful occupational and environ
mental histories This distinction is
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VCD differs from that of asthma or
RADS VCD patients benefit
from speech therapy to retrain the
voluntary muscles that cause laryn
geal dysfunction Importantly VCD
has not been shown to benefit from
use of inhaled corticosteroids bron
chodilators or oral corticosteroids
Thus misdiagnoses of VCD as
asthma or RADS may lead to un
wanted side effects due to inappro
priate medical interventions
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The parties to the above entitled action by and through their respective counsel of record
hereby stipulate and agree to enlarge the time for disclosing Plaintiffsrebuttal expert witnesses
by seven 7 days Specifically Plaintiff shall have until June 10 2011 to disclose her rebuttal
expert witnesses
DATED this 3 d dam2011
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The parties to the above-entitled action, by and through their respective counsel of record, 
hereby stipulate and agree to enlarge the ti e for disclosing Plaintifrs rebuttal expert witnesses 
by seven (7) days. Specifically, Plaintiff shall have Wltil JWlC 10, 2011, to disclose her rebuttal 
expert itnesses. 
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TO THE CLERK OF THE ABOVE ENTITLED COURT
PLEASE TAKE NOTICE that on the 7th day of June 2011 Plaintiff by and through her
counsel of record Jones Swartz PLLC served Plaintiffs Fourth Supplemental Answers and
Responses to DefendantsFirst Set of Interrogatories and Requests for Production together
with a copy of this Notice of Compliance upon counsel for the Defendant as follows
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P S   I  that on the 7th day of June, 2011, Plaintiff, by and through her 
l  r rd,  & S artz PLLC, served Plaintiff's Fourth Supple ental ns ers and 
esponses to efendant's irst et f Interrogatories a  equests for roduction, together 
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TIME TO DISCLOSE PLAINTIFF
REBUTTAL EXPERT WITNESSES
The Stipulation of the parties having come before this Court and good cause appearing
therefor IT IS HEREBY ORDERED that the time for disclosure of the Plaintiffsrebuttal expert
witnesses is hereby enlarged by seven days 7 days Specifically Plaintiff shall have until
June 10 2011 to disclose her rebuttal expert witnesses
DATED this day of June 2011
eAe
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I HEREBY CERTIFY that on this day ofJune 2011 a true and correct copy of
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Discovery in this matter is ongoing This disclosure is made and based upon the
Plaintiffscurrent understanding of the facts claims and defenses at issue in this litigation It is
anticipated that further discovery investigation and consultation with witnesses and experts may
supply additional facts add meaning to known facts and establish new factual conclusions and
legal contentions all ofwhich may lead to additions to modifications of and variations from the
disclosures set forth herein This disclosure is therefore made without prejudice to Plaintiffs
right to disclose evidence of subsequently discovered facts or opinions thereon Subject to and
PLAINTIFFSDISCLOSURE OF REBUTTAL EXPERT WITNESS TESTIMONY 1
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iscovery in this atter is ongoing. is iscl s re is a e a  ase   t e 
laintiffs rr t rst i  f t  f ts, l i s,  f s s t iss  i  t is liti ti . It is 
anticipated that further discovery, investigation, and consultation with witnesses and experts ay 
supply additional facts, add eaning to known facts, and establish new factual conclusions and 
legal contentions, all of hich ay lead to additions to, odifications of, and variations fro  the 
disclosures set forth herein. This disclosure is therefore ade ithout prejudice to Plaintiffs 
right to disclose evidence of subsequently discovered facts or opinions thereon. Subject to and 
LAINTIF 'S I   BUTTA    STI  - 1 
without waiving the right to supplement the scope of the testimony disclosed herein based upon
information learned or documents acquired through the completion of discovery in this action
Plaintiff makes the following disclosure of rebuttal testimony that may be presented at trial by the
Defendantsexperts
1 Garold S Yost PhD
Professor ofPharmacology and Toxicology
College ofPharmacy
University ofUtah
30 North 1900 East 201
Salt LakeCity Utah 84112
801 5817956
Dr Yost may testify to those matters contained in his affidavit filed on June 10 2011 and
in his deposition He may testify regarding the sensitizing effect some individuals have relating
to OC and other irritants as well as the research that has been done in the scientific community
on the subject He may further discuss those articles cited in his affidavit as well as articles cited
and discussed by other researchers that support his opinions and conclusions He may testify
about any of the research articles cited by any of the Defendantsexperts and explain why that
body of articles does not undermine the expert opinions and conclusions he has expressed in this
case in his report affidavits and deposition He may further explain to the jury how based on the
state of understanding within the scientific community at the time SEC sold its SABRE Red
products to the Idaho Department of Corrections the Defendant either knew or should have
known of the risks associated with their product for individuals with respiratory tract illness He
may testify about Dr Reillysopinions and conclusions contained in Dr Reillysaffidavit expert
report and of Dr Reillystrial testimony He may testify about the opinions conclusions and
alleged basis therefor contained in the expert disclosures and reports of Drs Mark Utell and
Roger McClellan as well as any trial testimony they may offer He may also testify on the
PLAINTIFFSDISCLOSURE OF REBUTTAL EXPERT WITNESS TESTIMONY 2
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I TIF 'S      I  -  
subject of Mr Nancesopinions conclusions trial testimony deposition testimony affidavits
and the discovery responses He may testify regarding any expert opinions and conclusions
offered by the non retained defense experts such as Sergeant Bret Kimmel Sergeant Schaffer
Sergeant Overgaard Sergeant Doan and any of the healthcare providers including Steve Asher
MD MPH Joseph J Callam MD Dan Hendrickson MD William Loveland MD Glenn
Moldenhauer DC William Robinson DC JanatODonnell MD Karin Pacheco MD MSPH




1400 Jackson Street Room G 211
Denver CO 80206
303 3981520
Dr Pacheco may testify to those matters contained in her reports medical records and in
her deposition She may testify regarding the sensitizing effect some individuals have relating to
OC and other irritants as well as the research that has been done in the scientific community on
the subject She may testify about research article IrritantAssociated Vocal Cord Dysfunction
and other similar articles of scientific inquiry She may testy about Irritant Associated Vocal
Cord Dysfunction as an occupational diseaseillness how it is diagnosed treated and caused
She may testify to the understanding of the causes of Irritant Associated Vocal Cord Dysfunction
during the period when the Defendant sold its SABRE Red products to the Idaho Department of
Corrections She may further discuss those articles cited in affidavits ofDr Yost and Dr Reilly
as well as articles cited and discussed by other researchers that support her opinions and
conclusions She may testify about any of the research articles cited by any of the Defendants
experts and explain why that body of articles does not undermine the expert opinions and
PLAINTIFFSDISCLOSURE OF REBUTTAL EXPERT WITNESS TESTIMONY 3
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the subject. he ay testify about research article Irritant- ssociated ocal ord ysfunction, 
and other si ilar articles of scientific inquiry. She ay testy about Irritant ssociated ocal 
ord ysfunction as an occupational disease/illness, ho  it is diagnosed, treated and caused. 
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during the period when the Defendant sold its SABRE Red products to the Idaho Department of 
orrections. She ay further discuss those articles cited in affidavits of r. ost and r. eilly 
as ell as articles cited and discussed by other researchers that support her opinions and 
conclusions. She ay testify about any of the research articles cited by any of the efendant's 
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conclusions she has expressed in this case in her reports affidavits and deposition She may
further explain to the jury how based on the state of understanding within the scientific
community at the time SEC sold its SABRE Red products to the Idaho Department of
Corrections the Defendant either knew or should have known of the risks associated with their
product for individuals with respiratory tract illness She may testify about Dr Reillysopinions
and conclusions contained in Dr Reillysaffidavit expert report and of Dr Reillystrial
testimony She may testify about the opinions conclusions and alleged basis therefor contained
in the expert disclosures and reports of Drs Mark Utell and RogerMcClellan as well as any trial
testimony they may offer She may also testify on the subject of Mr Nancesopinions
conclusions trial testimony deposition testimony affidavits and the discovery responses She
may testify regarding any expert opinions and conclusions offered by the non retained defense
experts such as Sergeant Bret Kimmel Sergeant Schaffer Sergeant Overgaard Sergeant Doan
and any of the healthcare providers including Steve Asher Md MPH Joseph J Callam MD
Dan Hendrickson MD William Loveland MD Glenn Moldenhauer DC William Robinson
DC JanetODonnell MD Karen Pacheco MD MSPH Matthew Schwartz MD Mousoomi
Sur MD in so far as their testimony relates to Dr Pachecosfield of expertise She may testify
to her own clinical experience with patients she has treated for Irritant Associated Vocal Cord
Dysfunction She may also testify on the subject of psychological explanations or lack thereof
for the Plaintiffsmedical condition She may further testify as to the conclusions and findings
ofDr Negron She may also testify regarding the impairment rating she has given the Plaintiff
3 Roberto Negron MD
Sage Health Care
413 N Allumbaugh St Ste 101
Boise ID 83704
208 3231125
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Dr Negron may testify to those matters contained in his reports and in his deposition
including but not limited to the impairment rating he has assigned the Plaintiff and he arrived at
that impairment rating He may testify regarding any psychological explanation or lack thereof
for the Plaintiffsmedical condition
DATED this 4day ofJune 2011
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CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 10 day of June 2011 a true and correct copy of the
foregoing document was served on the following individualsby the method indicated
Christopher C Burke
GREENER BURKE SHOEMAKER PA
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Case No CV PI 1003515
PLAINTIFFSCROSS MOTION FOR
PARTIAL SUMMARY JUDGMENT
Plaintiff Billie Jo Major by and through her counsel of record Jones Swartz PLLC
respectfully moves this Court for an order granting partial summary judgment pursuant to Idaho
Rule of Civil Procedure 56 on the issue of Defendant Security Equipment Corporationsbreach
of the standard of care on the duty to warn by affixing warning labels to the SABRE Red law
enforcement 10 OC Spray that comply with the Hazard Communication Standard 29 CFR
191020 As to this particular issue there are no genuine issues of material fact and
summary judgment is therefore appropriate
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l i tiff illie J  j r,   t r  r s l f r r , J s & S artz PLLC, 
respectfully oves this ourt for an order granting partial su ary judg ent pursuant to Idaho 
Rule of Civil Procedure 56 on the issue of efendant Security Equip ent Corporation's breach 
of the standard of care on the duty to arn by affixing arning labels to the S BRE Red la  
enforce ent 10% C Spray that co ply ith the azard Co unication Standard, 29 CFR 
§ 910. 2 0. s t  this articular i , t ere r   i e i  f t ri l fa t  
s ary judg ent is t erefore r ri t . 
P IFF'S ROSS OTION  P   J E T -  
This Motion is supported by the pleadings depositions and affidavits on file in this case
as well as the Memorandum in Support ofPlaintiff s Motion for Partial Summary Judgment filed
contemporaneously herewith
DATED this 10th day ofJune 2011
CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 10th day of June 2011 a true and correct copy of the
foregoing document was served on the following individualsby the method indicated
Christopher C Burke
GREENER BURKE SHOEMAKER PA
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Plaintiffs opposition to DefendantsMotion for Summary Judgment is twofold First
Defendantspreemption argument is misplaced because the Federal Hazardous Substances Act
does not supply the relevant standards for labeling of industrial products such as the SABRE Red
law enforcement 10 OC Spray at issue in this case
Second a genuine issue of material fact exists as to whether the scientific literature at the
time Defendant sold its SABRE Red products to the Idaho Department of Correction IDOC
should have put the Defendant on notice of the risks its product posed to the respiratory tract
Each party has an expert on this issue and they disagree as to the state of the science at that
PLAINTIFFSOPPOSITION TO DEFENDANTSMOTION FOR SUMMARY JUDGMENT AND
MEMORANDUM IN SUPPORT OF PLAINTIFF CROSS MOTION FOR PARTIAL SUMMARY JUDGMENT 1
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L INTIF 'S    
I    
laintiff s opposition to efendant's otion for Su ary Judg ent is t ofold. First, 
efendant's pree ption argu ent is isplaced because the Federal azardous Substances ct 
does not supply the relevant standards for labeling of industrial products such as the S  ed 
la  enforce ent 10%  Spray at issue in this case. 
Second, a genuine issue of aterial fact exists as to hether the scientific literature at the 
ti e efendant sold its S  ed products to the Idaho epart ent of orrection ("IDO ") 
should have put the efendant on notice of the risks its product posed to the respiratory tract. 
Each party has an expert on this issue and they disagree as to the state of the science at that 
I TIFF'S o osm   FENDANT'S I      
 I    I TIFF'S  I   I    -  
relevant point in time The experts also disagree as to how the relevant literature should be
interpreted As such DefendantsMotion for Summary Judgment should be denied
STATEMENT OFUNDISPUTED FACTS
The Parties
1 Plaintiff Billie Jo Major Ms Major or Plaintiff was at the time of the filing
of this action a resident of Ada County Idaho Ms Major claims that she suffered injuries
following exposure to oleoresin capsicum OC spray also referred to as pepper spray during a
training session she was attending as an employee ofthe IDOC She specifically claims that she
suffers from a long term or chronic respiratory illness such as chronic cough syndrome RADS
vocal cord dysfunction esophageal dysmotility andorgastrointestinal reflux andor a long term
chronic aggravation or exacerbation of an existing health condition as a result of her exposure to
OC spray
2 Defendant Security Equipment Corporation SEC or Defendant is a Missouri
corporation that has in the past conducted business in the state of Idaho SEC is a
manufacturer and retailer of self defense products including a line of pepper sprays or OC
sprays SEC sells its products to law enforcement agencies as well as civilians The SEC
product line which Plaintiff bases her allegations in her Complaint upon is SECs SABRE Red
law enforcement 10 OC spray
1 Def s Statement of Undisputed Facts 1
2 Id
3 Id
4 Defs Statement of Undisputed Facts 2
5 Defs Statement of Undisputed Facts 3
6 Id
7 Defs Statement of Undisputed Facts 14
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 i   e.     s   t  r l t l  l   
interpreted. s such, efendant's otion for Su ary Judg ent should be denied. 
    
 r  
. Plaintiff illie Jo ajor ("Ms. ajor" or "Plaintiff') as, at the ti e of the filing 
 t i  ti ,  i t f  t , ho. 1 s. ajor clai s that she suffered injuries 
ll i   t  l i  i  ("O ") spray, also referred to as pepper spray, during a 
training session she as attending as an e ployee of the I OC.2 She specifically clai s that she 
suffers fro  a long-ter  or chronic respiratory illness, such as chronic cough syndro e, S, 
vocal cord dysfunction, esophageal dysmotility and/or gastrointestinal reflux, and/or a long term 
r i  r ti  r r ti  f  i ti  lt  iti ,   r lt f r r  t  
 ray.3 
. f t rit  i t r r ti  ("S " r "Defenda t")   s ri 
r tion t at , i  t  t, t  i  i  t  t t   ho.4    
anufacturer and retailer of self-defense products, including a line of pepper sprays or  
r . 5  lls its r ducts t  l  f r t ies s ll s i ili ns.6   
product line hich Plaintiff bases her allegations in her o plaint upon is SEC's S E ed 
la  f rce ent 0%  ray.7 
1 ef  t te ent f ndisputed t , ~ l. 
2 Id. 
3 Id. 
4 e  t t e t f ndisputed t , ~ . 
5 efs t te ent of ndisputed t , ~ 3. 
6 Id. 
7 ef  t t e t f ndisputed ts, ~ 4. 
P IFF'S o m N  NDANT'S TION R R  J   
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Plaintiffs Employment With the IDOC
3 Ms Major was employed as a correctional officer for the IDOC from July 2004
through May 2008 During her employment with the IDOL Ms Major worked at two different
correctional facilities the Idaho Maximum Security Institution IMSI and the South Boise
WomensCorrectional Facility Ms Major worked at IMSI from July 2004 to July 2006 and
again from August or September 2007 to May 2008 Ms Major worked at the South Boise
WomensCorrectional Facility from roughly July 2006 through August or September 2007 the
timeframe between her different stints at IMSI
4 While employed with the IDOC Ms Major was required to attend different
training courses which were taught by other IDOC personnel
12
The training courses included
among other training courses annual training regarding the use of OC spray
5 The correctional officers employed by the IDOC typically carried with them a
streambased OC spray
14 Officers also carried OC Spray fogger products at their choice
There are various types of OC spray products manufactured for sale in the United States
including OC sprays which are foams or fogs aerosols streams bombs and powders The
different types of OC sprays have different functions and are used for different purposes
17
6 Level I exposure consists of a subject receiving direct spray exposure generally
8 Defs Statement of Undisputed Facts 15
9 Defs Statement of Undisputed Facts 16
10 Id
11 Id
12 Defs Statement of Undisputed Facts 7
13 Id
14 Defs Statement of Undisputed Facts 10
15 Affidavit of Counsel in Support of Plaintiffs Opposition to DefendantsMotion for Summary Judgment and in
Support of Plaintiffs Cross Motion for Partial Summary Judgment Aff of Pltf s Counsel 9 Ex 7 Schaffer
Dep 3120
16 Defs Statement of Undisputed Facts 16
17 Id
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 i : t  I  i  rit  I stit ti  ("IMSI")  t  t  i  
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i  fro  st r t r  t   008. 10 s. j r r  t t  t  is  
o en's orrectional Facility fro  roughly July 2006 through ugust or Septe ber 2007, the 
e ra  e   ffere  t   SI. II 
. hile e ployed ith the I C, s. ajor as required to attend different 
training courses which were taught by other IDOC personnel. 12 The training courses included, 
a  t er trai ing c rses, a al trai i  re ar i  t e se f  spray.13 
. The correctional officers e ployed by the I  typically carried ith the  a 
strea -based OC spray.14 fficers als  carrie   ra  f er r cts at t eir choice. IS 
There are various types of  spray products anufactured for sale in the nited States 
including  sprays hich are foa s or fogs, aerosols, strea s, bo bs and powders. 16 The 
different types of C sprays have different functions and are used for different purposes. 17 
. Level I exposure consists of a subject receiving direct spray exposure, generally 
8 efs tate ent f ndisputed acts, ~ 5. 
9 efs tate ent f ndisputed acts, ~ 6. 
 . 
II I . 
12 efs State ent of ndisputed Facts, ~ 7. 
 . 
14 efs State ent of ndisputed Facts, ~ . 
IS ffidavit of ounsel in Support of Plaintiff's pposition to efendant's otion for Su ary Judg ent and in 
Support of Plaintiff's ross otion for Partial Su ary Judg ent ("Aff. of ltfs ounsel), ~  .  (Sc  
ep., 31 :3-20). 
16 efs State ent of Undisputed Facts, ~ . 
17 d. 
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under circumstances where an OC stream is sprayed on the subject face The effects of a
Level I exposure are primarily to the eyes and skin 19 The eyes will water and involuntarily swell
shut The skin will be irritated with a severe burning sensation Secondary effects of a Level I
exposure occur to the respiratory system in the form of coughing shortness of breath and mucus
production2 1 Level II exposure consists of a secondary exposure resulting from the subject
handling an object or person that has been sprayed with OC Generally a Level II exposure
involves contact with OC on the skin possibly the eyes and vapor to the respiratory tract
23
Level III exposure consists largely of inhalation of OC vapor and particulate that has been
suspended in the air
24
Factors that determine how much OC is inhaled include the amount of
ventilation in the area where the exposure takes place the amount of OC spray that has been
discharged into the relevant space and the size ofthe space in which the OC has been sprayed
During the course of employment the IDOC correctional officers at IMSI were exposed several
times per week to OC Spray where the exposure could be anywhere from a Level I to a Level
III Of the OC products sold by the Defendant the SABRE Red MK9 Fogger is designed
specifically to cause greater respiratory effects
27
The product is most suited for Level III
exposures
7 Streambased OC products do not have as great an impact of cross contamination
iehigher likelihood of contaminating people outside of the individual you are trying to spray








26 Aff Def Counsel 3 Ex B Kimmel Dep 8917 9014
27 Id
2s Id
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handling an object or person that has been sprayed ith C.22 enerally, a Level II exposure 
i lves c tact it    t e ski , ssi l  t e e es, a  a r t  t e respirat r  tract.  
l III r  i ts l r l  f i l ti  f  r  rti l t  t t   
   i ?4 s  t           
ventilation in the area where the exposure takes place, the a ount of OC spray that has been 
discharged into the relevant space, and the size of the space in hich the C has been sprayed.25 
uring the course of e ploy ent, the I C correctional officers at I SI ere exposed several 
ti es per eek to  Spray here the exposure could be any here fro  a Level I to a Level 
111.26 f the C products sold by the efendant, the S BRE Red -9 Fogger is designed 
ifi ll  t  se re t r r ir t r  ff t ?7 The product is ost suited for Level III 
osures.28 
7. trea -base   r cts  t a e as reat a  i pact f cr ss-c ta i ati  
(i.e., higher likelihood of contaminating people outside of the individual you are trying to spray) 








26 ff. ef. ounsel, ~ 3, x.  (Kimmel ep., 89:17 - 90:14). 
2 I . 
8/d. 
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as fog OC products
29
OC stream products because of the nature of the larger particulates
primarily affect the eyes skin and only secondarily the respiratory tract The SABRE Red
Instructor Training Manual states that the stream has Limited effect on respiratory systemi
By comparison OC fogger products such as Defendant SABRE Red law enforcement 10 OC
Spray MK9 Fogger is designed to primarily inflame and irritate the respiratory tract
32 The
Instructor Training Manual states Microscopic droplets inflame the respiratory tract
DefendantsSABRE Red fogger products such as Cell Buster and the MK9 Fogger are
specifically designed for law enforcement and even more specifically for correctional officers
tactical teams and military
34
There are no warnings in the instructor training manual warning the
instructors against exposing trainees with respiratory illness to OC Spray during trainings
8 During Ms Major employment at IMSI she experienced repeated exposures to
SABRE Red OC Spray
36
During that period the use of OC Spray was significant and at times
was up to several times in a week The facility lacked sufficient ventilation to carry the cross
contamination of OC Spray from those deployments completely out of the work areas
38
During
the period that Ms Major worked at IMSI OC Spray was deployed against inmates on a frequent
basis due to the many conflicts between prisoners that was taking place during that period
9 Ms Major participated in a Level III training with SABRE Red MK9 Fogger in
2007 where the product was sprayed in a hall and the trainees would walk down the hall and turn
29 Id
30 Id
31 Aff of Pltf s Counsel 10 Ex 8 Nance Dep 443 483and Ex E Bates No SEC 353
32 Aff of Pltf s Counsel 10 Ex 8 Nance Dep 506 54206223 642and Ex B
33 Aff ofPltf s Counsel 10Ex 8 Nance Dep 443 483and Ex E Bates No SEC 354
34 Id at Nance Dep 501 22 and Ex B
35 Aff of Pltf s Counsel 110 Ex 8 Nance Dep 443 483and Ex E
36 Id at 691 7123853 15
37
IdAff Pltf s Counsel 11 Ex 9 Link Dep 6014 6215
38 Aff Pltf s Counsel 11 Ex 9 Link Dep 571 5816
39 Id Link Dep 571 5825
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as fog  products?9  strea  t , s   t  t re  t  l  ti l t , 
pri arily affect the eyes, skin, and only secondarily the respiratory tract.30 he S  ed 
Instructor's raining anual states that the strea  has "Limited effect on respiratory system.,,3! 
y co parison,  fogger products such as efendant's  ed la  enforce ent 10%  
pray -9 ogger is designed to pri arily infla e and irritate the respiratory tract.32 he 
Instructor raining anual states "Microscopic droplets infla e the respiratory tract.,,33 
efendant's  ed fogger products, such as ell uster and the -9 ogger, are 
specifically designed for la  enforce ent, and even ore specifically, for correctional officers, 
tactical tea s and ilitary.34 here are no arnings in the instructor training anual arning the 
instructors against exposing trainees ith respiratory illness to  Spray during trainings. 35 
. ring . jor's l t t I I,  ri  r t  r  t  
S  ed  Spray.36 uring that period, the use of  Spray as significant and at ti es 
as up to several ti es in a eek. 37 he facility lacked sufficient ventilation to carry the cross 
conta ination of  Spray fro  those deploy ents co pletely out of the ork areas.38 uring 
the period that s. ajor orked at I I,  pray as deployed against in ates on a frequent 
basis due to the any conflicts bet een prisoners that as taking place during that period.39 
. . j r rti i at  i   l III tr i i  it    -9 r i  
2007 here the product as sprayed in a hall and the trainees ould alk do n the hall and tum 
29/d. 
30/d. 
31 ff. of ltfs ounsel, ~ 10, x. 8 (Nance ep., 44:3 - 8:3  x. ,  .  53). 
32 ff. of ltfs ounsel, ~ 10, x. 8 (Nance ep., 50:6 - 4:20, 2: 3 - 4:2  x. ). 
33 ff. of ltfs ounsel, ~ 0, x.  (Nanc  p., 4:3 - 8:3  x. ,  .  54). 
34 Id. at (Nance Dep., 50:10-22 and Ex. B). 
35 ff. ofPltfs ounsel, ~ 10, Ex. 8 (Nance ep., 44:3 - 8:3  x. ). 
.  9:19 -71:23,85:3 - 5. 
37 Id.; ff. ltf  sel, ~ 11, Ex. 9 (Link Dep., 60:14 - 2:15). 
38 ff. ltf  sel, ~ 11, Ex. 9 (Link Dep., 57:1- 8:16). 
39Id. (Link ep., 57: 17 - 58:25). 
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around and come back during which time particles of the OC fog or cloud hang in the air
microscopic in size and are inhaled by the trainees
10 Ms Major has not been employed nor has she applied for any jobs since her
employment at the IDOC was terminated in May 2008 She has been on disability ever since
her employment ended due to her medical condition
Plaintiffs Use of and Exposure to Product
11 The IDOC purchased law enforcement pepper spray products from SEC during
the timeframe ofDecember 2005 to January 2008 while Plaintiff was employed at the IDOC 43
12 Defendant markets its SABRE Red MK9 Fogger specifically to law enforcement
to be used for crowd control and cell extractions or other situations confronted by law
enforcement and military personnel in which a large amount of cross contamination is required
under the circumstances 44 SABRE Red MK9 Fogger is specifically designed by the Defendant
to have more of an impact on the respiratory tract as compared to its OC Spray that discharges
as a stream
45
Defendant had some understanding of how biologically the OC Spray caused the
irritation and inflammation of the respiratory tract through nerve receptors interacting with
Substance P and had reviewed at least some of the research on the effects of capsicum on the
respiratory tract Mr Nance made the decisions ofwhat studies to have done to test the health
safety of SECsSABRE Red products it conducted eye and skin testing and testing to determine
40 Aff of Pltf s Counsel 7 Ex 5 Doan Dep 229 238252 2715 10 Ex 8 Nance Dep 5122
5224
41 Defs Statement of Undisputed Facts 12
42 Aff of Pltf s Counsel 8 Ex 6 Major Dep 881 25 2415 2443
43 Defs Statement of Undisputed Facts 13
44 Aff ofPltf s Counsel 10 Ex 8 Nance Dep 501 22 and Ex B
45 Id Nance Dep 5122 5420
46 Substance P is the neuropeptide that binds with the capsaicinoid receptor TRVP1 as discussed in Dr Yosts
opinion report It is responsible for pain and inflammation oftissues
47 Id Nance Dep 5122 59171574 1635
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r l t   t  r i l ndition.42 
i t 's s    e   
.  I  r as  l  f r t r s r  r ts fr   ri  
the ti efra e of ece ber 2005 to January 2008 hile Plaintiff as e ployed at the I .43 
. efendant arkets its S BRE Red -9 Fogger specifically to la  enforce ent 
t   s  f r r  tr l  ll tr ti s r t r sit ti ns fr t   l  
f rce e t  ilitar  rs l i  i   large t f r ss- t i ti  is r ir  
r t  ircu stances.44   -9 r is s cifi ll  si   t  f t 
to have "more of an i pact on the respiratory tract" as co pared to its  Spray that discharges 
  .  efendant had so e understanding of ho  biologically the  Spray caused the 
irritation and infla ation of the respiratory tract through nerve receptors interacting ith 
Substance p,46 and had reviewed at least so e of the research on the effects of capsicu  on the 
r ir t r  tr t.47 r.  e          t  lt  
safety of SEC's S E ed products; it conducted eye and skin testing, and testing to deter ine 
 ff.   el, -,r 7, x. 5 (Doan ep., 22:9 - 3:8, 5: 2 - 7:15); -,r 10, x. 8 (Nance ep., 51:22 -
2:24). 
41 efs State ent of ndisputed Facts, -,r . 
42 ff. ofPltfs ounsel, -,r 8, Ex. 6 (Major ep., 88:18-25, 241:25 - 244:23). 
43 efs State ent of ndisputed Facts, -,r . 
44 ff. lt  el, -,r 10, Ex. 8 (Nance ep., 50:10-22 and Ex. ). 
45 Id. (Nance Dep., 51 :22 - 4:20). 
46 Substance P is the neuropeptide that binds ith the capsaicinoid receptor TRVPl as discussed in r. ost's 
i i  r ort. It is r s si l  f r i   i fla atio  f tiss s. 
47 Id. (Nance Dep., 51:22 - 59:17,157:14 - 163:5). 
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the shortterm effects of shortterm inhalation exposure
48
Mr Nance was aware that persons
who suffer respiratory illness such as bronchitis asthma and emphysema would experience
greater effects than other people from exposure to OC Spray
Q BY MR OVERSON Okay Particularly there are concerns
with the safety of OC products when used on individuals with
pulmonary issues generally
MR LLOYD Object to form
Q BY MR OVERSON Respiratory issues
A The effects may be greater
49
The Defendant did not test for either the effects of chronic exposure to OC Spray or to
longterm health effects ofOC Spray
50
13 Mr Nance testified that other manufacturers had been selling OC Spray products
that were 145 20 and maybe even 30 percent capsaicinoids the heat bearing and pain
producing portion of the formula for about ten years and that it was his opinion those
manufacturers were not being responsible because those products are too hot When asked
what would happen if those products are too hot Mr Nance testified Cause could cause some
could possibly cause longterm damage or extremely long recovery periods SEC SABRE
Red products contain133 oleoresin
53
14 On several occasions as part of her job at the IDOC Ms Major deployed her
SABRE Red OC Spray on prisoners she was in the room when SABRE Red OC was deployed
by others and she was exposed to OC during trainings She was part of a response team that
48 Id Nance Dep 214 431113901402
49 Id Nance Dep 441217
50 Id Nance Dep 214 4311567 59171307 137251390 1402and Exs LO
51 Aff of PltFs Counsel 110 Ex 8 NanceDep 6322 643 654
52 Id Nance Dep 641821
53 Id Nance Dep 601 642 and Ex B
54 Aff ofPltf s Counsel 8 Ex 6 Major Dep 7024 8714
PLAINTIFFSOPPOSITION TO DEFENDANTSMOTION FOR SUMMARY JUDGMENT AND
MEMORANDUM IN SUPPORT OF PLAINTIFF CROSS MOTION FOR PARTIAL SUMMARY JUDGMENT 7000390
t  hort-term ff t   hort-tenn i l ti  r .  r.   r  t t r  
 ff r r ir t r  illn ,   r iti , t ,  s  l  ri  
r t r ffe ts t  t r l  fr  r  t   ray: 
. (B  . N) kay. articularly there are concerns 
ith the safety of  products hen used on individuals ith 
pul onary issues, generally? 
. : bject to fonn. 
. (B  . ) espiratory issues. 
. he effects ay be greater.49 
 e e a t                
long-ter  health effects of  Spray. 50 
. r. ance testified that other anufacturers had been selling  pray products 
t at ere .45, .0 a  a e e e  .0 erce t ca saici i s ("the eat eari  a  ai  
producing portion f the fonnula") for about ten years, and that it as his opinion those 
anufacturers ere not being responsible because those products are too hOt.5l   
at l  a e  if t se r cts are t  t, r. a ce testifie  "Cause --    
-- could possibly cause long-tenn da age or extre ely long recovery periods. ,,52   
Red products contain 1.33% oleoresin. 53 
. n several occasions, as part of her job at the I , s. ajor deployed her 
 ed  pray on prisoners, she as in the roo  hen  ed  as deployed 
by others, and she as exposed to  during trainings. 54 She as part of a response tea  that 
48Id. (Nance ep., 21:24 - 43:11,139:10- 140:12). 
49 Id. (Nance Dep., 44:12-17). 
sOld. (Nance ep., 21:24 - 3: 1, 6:7 - 59:17, 130:7 - 137:25, 139:10 - 40:12,  s. -O). 
51 AfT. ofPltf's Counsel, ~ 10, Ex. 8 (Nance ep., 63:6-22, 64:3 - 5:4). 
52Id. (Nance Dep., 64:18-21). 
53 I d. (Nance Dep., 60: 10- 64:2 and Ex. B). 
54 ff. f ltf's ounsel, ~ 8, Ex. 6 (Major Dep., 70:24 - 87:14). 
I TIF 'S o m   ENDANT'S      
    I TIF 'S      ENT-  
used OC fogtype OC grenades as part of cell extractions During her stint at the IDOC in
IMSI Ms Major was exposed to OC Spray approximately 20 or 30 times by being in a room
when another officer deployed OC Spray56 On January 31 2008 she deployed SABRE Red
stream OC Spray on a prisoner and she testified that after deploying the spray she did not go
through a decontamination process because as a matter of practice the prisoners were
decontaminated but the officers were not
March 3 2008SABRE Red MK9Fogger Training
15 On March 3 2008 as part of her employment at the IDOC Ms Major underwent
training on the use of a SABRE Red aerosol product known as the MK9 Fogger which is also
referred to as the Cell Buster when an additional sprayer attachment is included Unlike
DefendantsOC Spray products that shoot a stream the MK9 Fogger produces a fog or mist of
fine particulates that hang in the air in order that they may be inhaled by the target subject59 It is
used for various law enforcement purposes such as crowd control and extracting non compliant
prisoners from an inmate cell The streaming products are designed to spray a stream of OC
that makes contact with the target subject skin and eyes
61
Very little of the OC from the
stream products is in mist or fog form so little ofit gets inhaled 62 By contrast the MK9 Fogger
is specifically designed to distribute the OC spray as microscopic particulate that is easily inhaled
into the pulmonary system SABRE Red OC Grenades create a similar disbursement as the
55 Aff of Pltf s Counsel 8 Ex 6 Major Dep 1599 161 10 Ex 8 601 642 and Ex B
56 Aff of Pltf s Counsel 8 Ex 6 Major Dep 1582 1598
57 Id Major Dep 8417 87191582 1518
58 Aff of Pltf s Counsel 10 Ex 8 Nance Dep 6221 635 7 Ex 5 Doan Dep 267 29153619
3716
59 Id Nance Dep 601 642and Ex B
60 Id
61 Id
62 Aff ofPltfs Counsel 10 Ex 8 Nance Dep 443 483and Ex E Bates Nos SEC 353 358
63 Id
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se   f -type  re a es as art f cell e tractions. 55 ri  er sti t at t e I  i  
I I, s. aj r as e se  t   ra  a r i atel   r  ti es  ei  i  a r  
hen another officer deployed  pray.56 n January 31, 2008, she deployed  ed 
str   r    ris r  s  t stifi  t t, ft r l i  t  s r y, s  i  t  
t r  a ec ta i ation r cess eca se, as a atter f ractice, t e ris ers ere 
inated   ice   ot. 57 
arch ,    K-9   
5.  arc  , , as art f er e l e t at t e I , s. aj r er e t 
training on the use f a  ed aerosol product kno n as the -9 ogger, hich is also 
referred to as the ell uster hen an additional sprayer attach ent is included. 58  
efendant's  pray products that shoot a strea , the -9 ogger produces a fog or ist f 
fine particulates that hang in the air in order that they ay be inhaled by the target subject. 59 It is 
used for various la  enforce ent purposes such as cro d control and extracting non-co pliant 
ris ers fr  a  i ate cell.6o The strea ing products are designed to spray a strea  of C 
that akes contact ith the target subject's skin and eyes.  ery little f the  fro  the 
strea  products is in ist or fog for , so little f it gets inhaled.62 y contrast, the -9 ogger 
is specifically designed to distribute the  spray as icroscopic particulate that is easily inhaled 
into the pul onary system.63    a es   i     
55 ff. f ltfs sel, ~ , .  (Major ep., 59:9 - 61:1 ); ~ 10, Ex. 8 (60:10 - 64:2 and Ex. B). 
56 ff. fpltfs sel, ~ , .  (Major ep., 58:2 - 59:8). 
57Id. (Major ep., 84:17 - 87:19,158:2 -151:8). 
58 ff. f ltfs sel, ~ 10, Ex. 8 (Nance Dep., 62:21 - 63:5); ~ 7, Ex. 5 (Doan Dep., 26:7 - 9:15, 6:19 -
37:16). 
59Id. (Nance ep., 60: 10 - 64:2 and x. ). 
60 ! . 
61 d. 
 ff. l s l, ~ 10, x. 8 (Nance ep., 44:3 - 48:3 and x. E, ates os. S  353 - 358). 
63Id. 
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MK9 Fogger with microscopic particles hanging n the air for a longer period of time than with
the stream OC products
64
16 Part of the March 3 2008 training involved being exposed to the MK9 Fogger
OC Spray
65
After a brief instruction period trainees were taken to a secure area of the prison
facility known as FBlock OC Spray was sprayed with an MK9 Fogger into a prisoner cell
After the IDOC officer conducting the training determined there was sufficient OC particulate in
the air a trainee was sent inside the cell Once inside the trainee would walk around the cell
while being observed and would not be allowed to exit the cell until the trainee answered a
number of questions The purpose of requiring the trainee to answer questions while in the cell
was to ensure that the trainee had inhaled the OC Spray into his or her lungs Once the trainee
exited the cell the trainee was required to engage in physical exertion in the form of doing strikes
and knee kicks against a training bag After performing the strikes on the bag the trainee was
then required to restrain another officer who was simulating an offender After subduing the
simulated offender the trainee was given an opportunity to wash off his or her arms and face at a
sink located near the area where the contaminated cell was positioned At that point the trainee
would get back in line and assist another trainee as that trainee went through the same course
The trainees were required to stay in the area until all the trainees had gone through the
64 Id
65 Aff of Pltf s Counsel 18 Ex 6 Major Dep 1195 13423
66
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-9 er it  icr sc ic articles a i   t e air f r a l er eri  f ti e t a  it  
t  tr   r t . 64 
. art f t e arc  ,  trai i  i lve  ei  e se  t  t e -9 er 
 pray.65 fter a brief instruction period, trainees ere taken to a secure area f the prison 
i    - lock.66     t   -9    s  ell.67 
fter t e I  fficer c cti  t e trai i  eter i e  t ere as s fficie t  artic late i  
 i ,  rainee as    ell.68  ,        
ile ei  ser e  a  l  t e all e  t  e it t e cell til t e trai ee a s ere  a 
nu ber f questions.69 he purpose f requiring the trainee to ans er questions hile in the cell 
as to ensure that the trainee had inhaled the  pray into his or her lungs.7o    
exited the cell, the trainee as required to engage in physical exertion in the for  of doing strikes 
a  ee icks a ai st a trai i  ag.71 fter erf r ing t e stri es  t e a , t e trai ee as 
t e  re ire  t  restrai  a t er fficer  as si lati  a  ffender.72 fter s i  t e 
si lated ffe er, t e trainee as i e  a  rt it  t  as  ff is r er ar s a  face at a 
si  l cate  ear t e area ere t e c ta inated cell as sitioned.73 t t at i t, t e trai ee 
ould get back in line and assist another trainee as that trainee ent through the sa e course. 74 
he trainees ere required to stay in the area until all the trainees had gone through the 
 . 
65 ff. ofPltfs ounsel, ~ 8, Ex. 6 (Major ep., 119:15 - 34:23). 
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training
75
It took approximately twoandahalf to three hours after the exposure training session
began before the trainees left the area Ms Major completed the training
17 During the training the instructor Officer Doan was responsible for spraying the
contents of the MK9 Fogger into the cell Officer Doan testified that before each trainee
entered the cell he would enter and spray the MK9 Fogger at least once or twice in the cell
According to the instructor manual and Mr Nance deployment of the MK9 Fogger should be
no more that two three second bursts or sprays into the cell According to the other instructor
Officer Overgaard after the cellexposure and the physical portion of the training the trainees
were provided access to a sink inside the same area in which they had been training which was
just down a small hall from where the exposure cell was Officer Doan recalled the trainees
were given an opportunity to exit the building for access to fresh air and water but his
recollection is inconsistent with Ms Major and Officer Overgaardsrecollection on whether the
trainees were given access to fresh air by going outside the training area81
18 Prior to the March 3 2008 training Ms Major had been put on light duty due to
having bronchitis
82
Her medical history indicates a history of bronchitis and other pulmonary
conditions 83 Prior to the March 3 2008 training Ms Major suffered episodes during which she
75 Id
76 Id
77 Aff ofPltf s Counsel 7 Ex 5 Doan Dep 2716 29154517 519
78 Id
79 Aff of Pltf s Counsel 10 Ex 8 Nance Dep 443 483 and Ex E Bates Nos SEC 353 358 110 Ex 8
Nance Dep 398 407911 92149815 1012 Note Mr Nance indicated that the products should have a
deployment limit of no more than three one second bursts He indicated the grenades were a sixsecond
deployment
80 Aff of Pltf s Counsel 6 Ex 4 Overgaard Dep Ex 44 9118 98211044 10622
S1 Aff of Pltf s Counsel 8 Ex 6 Major Dep 1195 13423 16 Ex 4 Overgaard Dep 364 452017
Ex 5 Doan Dep 219 24102716 2915
82 Aff of Pltfs Counsel 18 Ex 6 Major Dep 1208 1231
83 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 341 3811 and Ex 72 Bates Nos NJH 48 63 8087
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tr ining.75 It t  approxi atel  t -an -a-halft  t ree rs after t e ex s re trai i  sessio  
began before the trainees left the area. s. ajor co pleted the training. 76 
17. uring the training, the instructor, fficer oan, as responsible for spraying the 
  t  -9   t  ell.77 ff r  t sti  t  f   t  
entered the cell, he ould enter and spray the -9 ogger "at least once or t ice in the cell.,,78 
cc r i  t  t e i structor's a al a  r. a ce e l e t f t e -9 er s l  e 
 r  t t t  t r  s  rsts r s r s i t  t  ll.79 ccording to the other instructor, 
fficer vergaard, after the cell-exposure and the physical portion of the training, the trainees 
ere r i e  access t  a si  i si e t e sa e area i  ic  t e  a  ee  trai i g, ic  as 
just  a s all all fr  ere t e e s re cell as.80 fficer a  recalle  t e trai ees 
r  i   rt it  t  it t  il i  f r ss t  fr s  ir  t r, t is 
rec llecti  is i c siste t it  s. ajor's a  fficer ergaard's rec llecti   et er t e 
trainees ere given access to fresh air by going outside the training area.8! 
. Prior to the arch 3, 2008 training, s. ajor had been put on light duty due to 
ing . 82 er edical history indicates a history of bronchitis and other pul onary 
conditions.83 Prior to the arch 3,2008 training, s. ajor suffered episodes during hich she 
7S I . 
76I . 
77 fT. f ltf  o l, ~ , E . 5 (Doan ., 7:16- 9:15, 5:17 - 1:9). 
8Id. 
79 . of  , ~ 1 , .  (Nance p., 4 :3 - 48:3 and Ex. E, Bates os. SEC 353 - 358); ~ 10, Ex. 8 
(Nance ., 3 :8 - 40:7, 1:1 - 92:14, 8:15 - 101:20) (Note Mr. Nance indicated that the products should have a 
e o e t li it  no ore than three ne-s d b r . e indicated the grenades ere a six-second 
d ent). 
80 Aff. of ltfs ounsel, ~ 6, E . 4 (Overgaard e ., . , 91:18 - 8:21; 4:4 - 106:22). 
81 A T. f f  l, ~ 8, E . 6 (Major e ., 119:15 - 134:23); ~ 6, Ex. 4 (Overgaard Dep., 36:4 - 45:20); ~ 7, 
E .  (Doan ., 2 :9 - 24:10, 7:16 - 9:15). 
82 Aff. of ltfs ounsel, ~ 8, Ex. 6 (Major ep., 120:8 - 123:11). 
83 Aff. ofPltfs o l, ~ 3, E . 1 (Pacheco ., 4: 1 - 38: 11 and Ex. 72, Bates Nos. NJH 48, 63, 80-87). 
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would cough andor have bronchitis The coughing however did not interfere with her ability
to do her job
85
Her coughing at work prior to March 3 2008 was described by a coworker as
I hate to use the word spontaneous but it would come up for a second or two and then and
again Imnot working directly with her for eight hours but you would notice a cough when you
saw her
86
After the March 3 2008 training Ms Major was unable to return to work and has
not worked since Coughing changed from episodic and tolerable to violent and debilitating
Ms Major has never smoked and led a physically active life prior to March 3 2008 Her
coughing is for all practical purposes continuous with very short periods of relief Her chronic
cough interferes with almost every aspect of her life She supports herself with a disability
income from the disability policy she carried through her former employer
92
19 DefendantsSABRE Red MK9 Fogger product label does not provide a warning
that it is an irritant or an inflammatory when inhaled 93 The label does state Caution Severe
Skin and Eye Irritant Contents Under Pressure and See Other Warnings On Back Label
The back label provides no warnings relating to inhalation Shipping boxes received by the
IDOC did not include a label warning that the contents were a pulmonary inflammatory andor
irritant 96 And while Mr Nance testified that if a person is suffering from effects of asthma
84 Id
85 Aff of Def s Counsel 3 Ex B 9016 9116 Aff Pltf s Counsel 11 Ex 9 Link Dep 60513 9 Ex 7
Schaffer Dep 9016 9116
86 Aff Pltfs Counsel 9 Ex 7 Schaffer Dep 9016 9116
87 Aff of Pltf s Counsel 8 Ex 6 Major Dep 881 25 2415 2443
88 Aff of Pltfs Counsel 3 Ex 1 Pacheco Dep 341 3811 and Ex 72 Bates Nos NJH 48 63 8087 8





93 Aff ofPltf s Counsel 10 Ex 8 Nance Dep 904 942 and Exs D and E
94 Id
95 Id
96 Aff of Pltf s Counsel 10 Ex 8 Nance Dep 443 483 and Ex E 9 Ex 7 Schaffer Dep 764 771
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would cough and/or have bronchitis.84 The coughing, however, did not interfere with her ability 
  r b.85 er coughing at ork prior to arch 3, 2008 as described by a co- orker as 
"[I hate to use the ord] 'spontaneous' but it ould co e up for a second or t o and then - and 
again, I'm not working directly with her for eight hours, but you would notice a cough when you 
sa  her.,,86 fter the arch 3,2008 training, s. ajor as unable to return to ork and has 
not worked since.87 Coughing changed fro  episodic and tolerable to violent and debilitating.88 
s. ajor has never s oked and led a physically active life prior to arch 3, 2008.89 Her 
 ,  l   , s   hort   elief. 90  i  
 i t ere  it  l t r  t   life.91 She supports herself ith a disability 
inco e fro  the disability policy she carried through her for er e ployer.  
19. Defendant's SABRE Red K-9 Fogger product label does not provide a warning 
t t it i   i ita t   i la t   i l .     t  "Ca :  
Skin and Eye Irritant," "Contents Under Pressure" and "See Other arnings On Back Label.,,94 
The back label provides no warnings relating to inhalation.95 Shipping boxes received by the 
IDOC did not include a label warning that the contents were a pul onary infla atory and/or 
irritant.96 nd hile r. ance testified that if a person is suffering fro  effects f asth a, 
4/ . 
85 . f'  l, ~ , . , 0:16 - 1:16; ff. Itf's sel, ~ 11, Ex. 9 (Link Dep., 60:5-13), ~ 9, Ex. 7 
(Scha fer p., 0:16 - 91: 6). 
86 ff. Itf's ounsel, ~ 9, x. 7 (Schaffer ep., 90:16 - 91:16). 
81 . o l '  l, ~ 8, Ex. 6 (Major ep., 88:18-25, 241:25 - 244:23). 
88 . f l 's l, ~3, x. 1 (Pacheco ep., 34:1 - 38:11 and Ex. 72, Bates Nos. NJH 48, 63, 80-87), ~8, 





93 . o 's Cou , ~ , E . 8 (Nance ., 90:4 - 94:24 and Exs.  and E). 
94 Id. 
95Id. 
96 f . of 's Couns , ~ , E . 8 (Nance D ., 44:3 - 48:3 and Ex. E), ~ 9, Ex. 7 (Schaffer Dep., 76:4 -77:1). 
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emphysema or bronchitis they recommend that they not be exposed such a warning does not
appear on the shipping labels in the training manual or on the product labels
97
20 Defendant developed a Material Safety and Data Sheet MSDS for each ofits
OC Spray products that identified their product as causing irritation through all routes of entry
and identifying it as a severe skin and eye irritant
98
It identified their product as being a hazard
to the eyes Liquid or vapors may cause redness burning tearing swelling andor pain
And identified the product as being a hazard to the skin Frequent or repeated contact with skin
may cause skin irritation and dermatitis
loo
And a hazard when ingested Ingestion may cause
nausea vomiting andor diarrhea101 The MSDS stated that when inhaled the product may
cause irritation of the respiratory tract
102
Finally the MSDS warned under Medical
Conditions Aggravated that the product may cause more severe temporary effects on those
persons who are asthmatics or suffer from emphysema
103
21 Defendant admitted it completed an MSDS on its law enforcement SABRE Red
OC Spray in compliance with existing law Response to Req for Admission No 18
Defendantslaw enforcement SABRE Red products including its Fogger 920060C do not
include a label that is compliant with OSHA Standards
104
22 Dr Reilly the Defendantsexpert has a business relation with the Defendant
Dr Reilly developed an OC decontamination product that is now marketed by the Defendant
105
97 Aff ofPltfs Counsel 10 Ex 8 Nance Dep 4412 486and Exs B D E 9 Ex 7 Schaffer Dep 764
771






104 Aff ofPltfs Counsel 15 Ex 3 Purswell Aff IM 45 and Ex B
105 Aff ofPltts Counsel 110 Ex 8 Nance Dep 1729 1736
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e physe a, or bronchitis, they "recommend that they not be exposed," such a arning does not 
appear on the shipping labels, in the training anual, or on the product labels.97 
. efendant developed a aterial afety and ata heet ("MSDS")   f  
 pray products that identified their product as causing "irritation through all routes f entry" 
 i ti i  it    i    i it t.  It identified their product as being a hazard 
t  t  s: "Liquid or vapors ay cause redness, burning, tearing, s elling, and/or pain.,,99 
nd identified the product as being a hazard to the skin: "Frequent or repeated contact ith skin 
ay cause skin irritation and der atitis."loo nd a hazard hen ingested: "Ingestion ay cause 
nausea, vo iting, and/or diarrhea." 10 I The S S stated that, hen inhaled, the product "may 
cause irritation of the respiratory tract.,,102 Finally, the S S arned, under "Medical 
onditions ggravated," that the product "may cause ore severe, te porary, effects on those 
persons who are asthmatics or suffer from emphysema.,,103 
. efendant ad itted it co pleted an S S on its la  enforce ent S  ed 
 Spray in co pliance ith existing la . (Response t  .  i i  o. 8) 
efendant's la  enforce ent  ed products, including its ogger (920060-C), do not 
include a label that is co pliant ith S  Standards. l  
. r. eilly, the efendant's expert, has a business relation ith the efendant. 
r. eilly developed an  deconta ination product that is no  arketed by the efendant. 105 
 ff. ltfs sel, ~ 10, Ex. 8 (Nance Dep., 44:12 - 8:6  . ,  & ), ~ 9, x. 7 (Schaffer ep., 6:4-
7:1). 
 ff. ltfs el, ~ 10 x. 8 (Nance ep., 124:25 - 27:21  . ,  .   - 24). 
 . 




104 ff. ofPltfs Counsel, ~ 5, Ex. 3 (Purs ell ff., ~ 4-5 and Ex. B). 
105 Aff. ofPltfs Counsel, ~ 10, Ex. 8 (Nance Dep., 172:9 -173:6). 
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23 Defendantsproduct labels and shipping labels do not comply with the labeling
requirements ofOSHAsHazard Communication Standard 29CFR 191020 106
STATEMENT OF DISPUTED FACTS
24 Defendants Statement of Fact IDOC did not actually issue any of SECs
products to its employees for use until sometime in the late spring or early summer of 2007
Prior to that time IDOC employees were issued and were using pepper spray products from a
competitor manufacturer Defense Technologies
108
Plaintiffs Response Officers at the IDOC Maximum Security prison facility
may have started using SABRE Red products as early as 2003
25 Defendants Statement of Fact The manufacture and sale of OC spray is
regulated by the United States Consumer Product Safety Commission under the Federal
Hazardous Substances Act as a selfpressurized irritant NanceAff 6
Plaintiffs Response The warning label shipping label training and MSDS
standards are those found in OSHAs Hazard Communication Standards 29 CFR
191020
26 DefendantsStatement of Fact The effects of OC sprays exposure to individuals
are acute transient reversible and recoverable within a short period of time typically wearing off
within minutes These effects include mucus production redness of the eyes watery eyes or
crying involuntary closing of the eyes burning sensation of the skin such as a sunburn
106 Aff ofPltf s Counsel 5 Ex 3 Purswell Aff IM 45
107 Aff ofDef s Counsel 7 Ex F 5624 5721
108 Id
109 Aff ofDefs Counsel 3 Ex B Kimmel Dep 18823 1894
110 See Aff of Pltfs Counsel 5 Ex 3 Purswell Aff IM 4 5 and ExB
111 Defs Statement ofUndisputed Facts 118
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. f ant's r t l ls  s i i  la ls  t l  it  t e l li  
re ire ents f HA's a r  i ti  t r ,  .F.R. § 910. 2 0.106 
    
. f ndant's   t:  i  t t ll  i    C's 
products to its e ployees for use until so eti e in the late spring or early su er of 2007. 107 
ri r t  t t ti , I  loyees r  i   ere i  r r  r ts fr   
co petitor anufacturer, efense Technologies. 108 
Fs e: fficers at the I  axi u  ecurity prison facility 
ay have started using  ed products as early as 2003. 109 
. f ndant's   ct: he anufacture and sale f  spray IS 
regulated by the nited tates onsu er roduct afety o ission under the ederal 
azar us sta ces ct as a "self- ress rize  irritant." (Nance ff., ~ .) 
ti Fs ponse: The arning label, shipping label, training and S S 
     SHA's  t  r ,  .F.R. 
§ 910.1200.110 
. efendant's State ent of Fact: The effects of  sprays exposure to individuals 
r  t , tr i nt, r r i l   r r l  it i   rt ri  f ti , t i ll  ri  ff 
ithin inutes. III These effects include ucus production, redness of the eyes, atery eyes or 
crying, involuntary closing of the eyes, burning sensation of the skin (such as a sunburn), 
106 ff. f ltfs ounsel, ~ 5, x. 3 (Purs ell ff., ~ 4-5). 
107 ff. of efs ounsel, ~ 7, x. F, 56:24 - 7:21. 
108/d. 
t09 ff. of efs Counsel, ~ 3, Ex. B (Kim el ep., 188:23 - 89:14). 
ItO See ff. ofPltfs Counsel, ~ 5, Ex. 3 (Purs ell ff., ~ 4-5 and Ex. B). 
III efs tate ent f ndisputed acts, ~ 18. 
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inflammation of the skin sneezing and coughing and can slightly restrict airways
112
OC sprays
are designed and intended to have these acute effects as they are made for self defense and
protection and are used by law enforcement officers to subdue criminal suspects and inmates
without the need to use more lethal forms offorce 13
Plaintiffs Response Individuals may become sensitized to OC by various means
where the mechanism is an increase in TRP calcium channels in the respiratory tract 14 The
effects of OC on such persons will be greater than in people who do not have preexisting
respiratory illness 15 Occupational exposure to DefendantsSABRE Red products can lead to
and in this case did lead to the development or aggravation of respiratory illness such as vocal
cord dysfunction chronic cough and RADs Plaintiffsrespiratory illness prior to March 3
2008 was severally aggravated by the exposure to SABRE Red MK9 Fogger and caused the
injuries she claims in this lawsuit 17 Plaintiffsdamages were caused by exposure to the
DefendantsSABRE Red products
After a lengthy period of medical testing by her local physicians in March 2009
Ms Major was referred to and saw Dr Karin Pacheco at the National Jewish Health and
Department of Medicine Colorado School ofPublic Health and Allergy Immunology University
of Colorado Denver in the Division ofEnvironmental and Occupational Health Sciences where
she is a physician researcher and assistant professor Board certified in internal medicine
112 Id
113 Id
114 Aff ofPltf s Counsel 4 Ex 2 Yost Deppassim Yost Affidavit passim Yost Report
115 Id
116 Aff ofPltfs Counsel 3 Ex 1 Pacheco Dep 1 205and Ex 68341 3811and Ex 72 681 702
4 Ex 2 Yost Deppassim Yost Affidavit passim Yost Report
117 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 1 205and Ex 68 341 3811and Ex 72 681 702
14 Ex 2 Yost Deppassim Yost Affidavit passim Yost Report
118 Aff of Pltfs Counsel 13 Ex 1 Pacheco Dep 1 205and Ex 68 341 3811and Ex 72 681 702
4 Ex 2 Yost Deppassim Yost Affidavit passim Yost Report
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infla ation f the skin, sneezing and coughing, and can slightly restrict air ays. I 12  sprays 
are esi e  a  i te de  t  a e t ese ac te effects as t e  are a e f r self efe se a  
r tecti , a  are se   la  e f rce e t fficers t  s e cri i al s s ects a  i ates 
it  t e  t    let    e. 113 
l i tifrs : I i iduals   iti  t    ri   
r  t  i  is  i reas  i   l i  ls i  t  r ir t r  tr ct. 114  
effects of  on such persons ill be greater than in people ho do not have pre-existing 
i t  ill ss. l S ti l  t  f ndant's   t   l  t , 
 i  t is s  i  l  t , t  l t r r ti  f r s ir t r  illness s  s l 
r  sf cti n, r i  ,  ADs.116 laintiffs r s ir t r  illness ri r t  r  , 
,  r ll  r ate   t  r  t    -9 r   t  
injuries she clai s in this la suit. 1  laintiff's  r    r  t  t  
efendant's  ed products. I 18 
fter  l t  ri  f i l t ti   r l l i i , i  r   
. j r  r f rr  t    r. ri  co, t t  ti l i  lt   
epart ent of edicine, olorado School of Public ealth and llergy I unology, niversity 
f l r , r, i  t  i isi  f ir t l  ti l lt  i s, r  
s  is  si i , r s rc er,  ssist t r f ssor, r  rtifi  i  i t r l i i , 
112 d. 
113Id. 
114 ff. f ltfs sel, ~ , x.  (Yost ep., ssi , st ffi vit, ssi , st eport). 
115 I . 
116 ff. f ltfs ounsel, ~ 3, x. 1 (Pacheco ep., :1- 0:25  x. 8; 4:1 - 8: 1  x. 2; 8:18 -70:2 ), 
~ , x.  (Yost ep., ssi , st ffi it, ssi , st eport). 
117 ff. f ltfs ounsel, ~ 3, x. 1 (Pacheco ep., 1:1 - 0:25  x. ; 4:1 - 8: 1  x. 2; 8:18 -70:2 ), 
~ 4, x. 2 (Yost ep., passi , ost ffidavit, passi , ost eport). 
118 ff. ofPltfs ounsel, ~ 3, Ex. 1 (Pacheco ep., 1:1 - 0:25  . ; 4:1 - 8: 1  x. 2; 8:18 -70:2 ), 
~ 4, Ex. 2 (Yost ep., passi , ost ffidavit, passi , ost eport). 
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allergy and immunology and occupational medicine 19 After extensive testing Dr Pacheco
gave Ms Major a final diagnosis of 1 irritant trigger vocal cord dysfunction and secondary
cough attributable to oleoresin capsicum exposure at the IDOC 2esophageal dysmotility
and reflux aggravated by occupational exposure to oleoresin capsicum weight gain due to lack
of exercise and medications including Klonopin Restoril and Neurontin 3 chronic severe
cough multi factorial and 4 restless leg syndrome In Dr Pachecosdeposition she
testified regarding a study from 1998 that recognized a condition referred to as irritant associated
vocal cord dysfunction
123
In September 2010 Dr Pacheco was retained by Plaintiff s counsel to
provide expert testimony in this case and in a related workerscompensation case
124 Dr
Pacheco discussed scholarly literature relating to irritant vocal cord dysfunction and two other
studies relied upon by Dr Yost explaining that those studies indicate that persons with chronic
cough have higher receptor numbers that are capsaicin receptors in their airways than those
without chronic cough and that an increase in those receptors can be a cause of chronic cough
27 DefendantsStatement of Fact There is no published literature that definitively
states or otherwise establishes within a reasonable degree of scientific probability a conclusive or
causal association between exposure to OC spray and chronic or long term health conditions or
disease
126
Based upon available scientific and medical literature published prior to 2008 a
manufacturer of OC spray products such as SEC could not know or have been put on notice that
exposure to OC spray was a foreseeable cause of any of the chronic medical conditions
119 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 1 205and Ex 68 341 3811 and Ex 72 681 702
120 Id
121 Id
122 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 341 3811and Ex 72 Bates Nos NJH 4863 8087
123 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 473and Ex 73
124 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 2822 and Ex 69
125 Aff ofPltf s Counsel 3 Ex 1 Pacheco Dep 471 641
126 Defs Statement ofUndisputed Facts 19
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allergy and i unology, and occupational edicine.1l9 fter t si e t sti , r.  
a e s. aj r a final ia sis f: (1) irrita t tri er, cal c r  sf cti , a  sec ar  
cough, attributable to oleoresin capsicu  exposure at the I OC; 120 (2) esophageal dys otility 
 r fl , r t   ti l re t  l re i  i , i t i   t  l  
f r is ,  i tions in lu in  l i , storil,  euronti ;121 (3) r ic, s re 
cough, ulti-factorial; and (4) restless leg syndrome. 122 I  r. checo's siti n, s  
t stifie  r r i   st  fr   t t r i   iti  r f rr  t  s irrita t ss i t  
vocal cord dysfunction.  I  t r , r.  s r t i   l i tiff s s l t  
provide expert testi ony in this case and in a related orker's co pensation case. 124 r. 
Pacheco discussed scholarly literature relating to irritant vocal cord dysfunction, and t o other 
st ies relie    r. st, e lai i  t at t se st ies i icate t at ers s it  c r ic 
  i r r t r rs t t r  s i i  r t rs i  t ir ir s t  t s  
ithout chronic cough, and that an increase in those receptors can be a cause f chronic cough. 125 
. f dant's t t t f ct: r  is  lishe  liter t r  t t fi iti l  
st t s r t r ise st lishes it i   r s l  r  f s i tifi  r ilit   l si  r 
causal association between exposure to OC spray and chronic or long ter  health conditions or 
se. 126 ased upon available scientific and edical literature published prior to 2008, a 
anufacturer f  spray products, such as , could not kno  r have been put on notice that 
exposure to OC spray was a foreseeable cause of any of the chronic edical conditions 
119 ff. f ltfs sel, ~ , x.  (Pache  p., :1 - 0:25  x. 8; 4:1 - 8: 1  x. 2; 8:18 -70:20). 
120 [d. 
121 !d. 
122 ff. f ltfs sel, ~ , x.  (Pache  p., 4:1 - 8: 1  x. 2,  .  8, , -87). 
123 ff. f ltfs ounsel, ~ 3, x. 1 (Pacheco ep., 47:3, and x. 73). 
124 ff. of ltfs ounsel, ~ 3, x. 1 (Pacheco ep., 28:2-22 and x. 69). 
125 ff. ofPltfs ounsel, ~ 3, Ex. 1 (Pacheco ep., 47:1- 4:14). 
126 efs State ent of Undisputed Facts, ~ . 
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complained ofby Plaintiff
127
Plaintiffs Response The articles cited in Dr Yostsreport are just a few of
many that support Dr Yostsopinions as expressed in his report in this case 128 Based on his
review of the cited articles and his education training research and knowledge of the scientific
literature in the relevant area it is his expert opinion that the risks to the respiratory tract posed
by exposure to SECsSABRE Red law enforcement 10 OC Spray MK9 Fogger were known
and foreseeable risks at the time SEC sold its product to IDOL
It was known prior to 2008 that people with asthma and chronic cough are more sensitive
to pepper spray than other people with normal respiratory function
129
People with greater
sensitivity to capsaicin would be expected to have increased TRPV1 receptor populations
31
Other important TRP channels exist and several of them particularly TRPA1 are activated by
irritants such as those that exist in cigarette smoke and other environmental sources Thus it
is reasonable to expect the multiple TRP channels act in concert with each other to result in
higher acute respiratory responses to a multitude of respiratory irritants particularly in people
with increased sensitivity to pepper sprays
133
Within a reasonable degree of scientific certainty exposure to the DefendantsSABRE
Red OC Spray product in March 2008 caused Ms Major to suffer acute adverse health responses
and greatly exacerbated her underlying respiratory diseases
34
127 Def s Statement of Undisputed Facts 120
128 Aff ofPltf s Counsel 14 Ex 2 Aff of Yost 6 and Ex B
129 Id
130 The Capsicum receptor
131 Aff of Pltf s Counsel 4 Ex 2 Aff of Yost 6 and Ex B
132 Id
133 id
134 Aff of Pltf s Counsel 14 Ex 2 Aff of Yost 14 and Ex B
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co plained of by Plaintiff. 127 
ffs e: e articles cite  i  r. st's re rt are j st a fe  f 
 t t s rt r. st's i i s s r ss  i  is r rt i  t is case.12     
r i  f t  it  rti les  is cation, tr i i g, r s arch,  l  f t  s i tifi  
literat re i  t e rele a t area, it is is e ert i i  t at t e ris s t  t e res irat r  tract se  
 s re t  EC's   l  f r t 0%  r  (M -9 ger) r   
and foreseeable risks at the ti e SE  sold its product to I C. 
It as  ri r t   t t le it  t   r i   r  r  siti  
t  e er s ra  t a  t er e le it  r al res irat r  f cti n.  e le it  reater 
.. . . . ld b d ' d TRPV 1130 I' 131 se sItI It  t  ca SaICI   e e ecte t  a e Increase rece t r u atlOns. 
ther i portant  channels exist, and several f the , particularly  I, are activated by 
irrita ts, s c  as t se t at e ist i  ci arette s e a  t er e ir e tal sources.132 s, it 
is reasonable to expect the ultiple T P channels act in concert ith each other to result in 
i er ac te res irat r  res ses t  a ltit e f res irat r  irrita ts, artic larl  i  e le 
ith increased sensitivity to pepper sprays. 133 
ithin a reasonable degree of scientific certainty, exposure to the efendant's S BRE 
  r  r t i  r   s  s. j r t  s ff r t  rs  lt  r s s s 
and greatly exacerbated her underlying respiratory diseases. 134 
127 efs tate ent f ndisputed acts, ~ 20. 
128 ff. f ltfs ounsel, ~ 4, x. 2 (Aff. f ost, ~ 6 and x. ). 
129 d. 
130 he apsicu  receptor. 
131 ff. f ltfs ounsel, ~ 4, x. 2 (Aff. f ost, ~ 6 and x. ). 
132 d. 
133 Id. 
134 AfT. ofPltfs Counsel, ~ 4, Ex. 2 (Aff. of ost, ~   . ). 
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ARGUMENT
Summary Judgment Standard
Summary judgment underIRCP56cis proper only when there is no genuine issue of
material fact and the moving party is entitled to judgment as a matter oflaw IRCP56c The
party seeking summary judgment bears the initial burden to show that there is no genuine issue of
material fact and that he or she is entitled to judgment as a matter of law Heath v Honkers
MiniMart Inc 134 Idaho 711 712 App 2000 When assessing a motion for summary
judgment all controverted facts are to be liberally construed in favor of the nonmoving party Id
Furthermore the trial court must draw all reasonable inferences in favor ofthe party resisting the
motion Id When the party moving for summary judgment will not carry the burden of
production or proof at trial the genuine issue of material fact burden may be carried by
establishing the absence of evidence on an element that the nonmoving party will be required to
prove at trial Id Such an absence of evidence may be established either by an affirmative
showing with the moving partysown evidence or by a review of all the nonmoving partys
evidence and the contention that such proof of an element is lacking Id Once such an absence
of evidence has been established the burden then shifts to the party opposing the motion to
show via further depositions discovery responses or affidavits that there is indeed a genuine
issue for trial or to offer a valid justification for the failure to do so underIRCP56f Id
Moot Issues
Plaintiff stipulates to the dismissal of her Third Cause ofAction Express Warranty
Plaintiffs Failure to Warn Claim Is Not Preempted
Defendant argues that Plaintiffs failure to warn claim is preempted by the Federal
Hazardous Substances Act FHSA However Defendantsargument is misplaced since the
PLAINTIFFSOPPOSITION TO DEFENDANTSMOTION FOR SUMMARY JUDGMENT AND
MEMORANDUM IN SUPPORT OF PLAINTIFF CROSS MOTION FOR PARTIAL SUMMARY JUDGMENT 17000400
 
y g e t  
ary j e t er LR.C.P. 6(c) is r er l  e  t ere is  e ine iss e f 
aterial fact a  t e i  art  is e title  t  j e t as a atter fla . LR.C.P. 6(c). e 
party seeking su ary judg ent bears the initial burden to sho  that there is no genuine issue of 
t ri l f t,  t t  r s  is title  t  judg e t s  tt r f l . t  v. nker's 
i i-Mart I c.,  I  ,  (Ap . 00).  ss ssi   ti  f r s r  
ju t, ll tr erte  f t  r  t   li r ll  tr  i  f r f t  i  rty. I . 
rt er re, t e trial c rt st ra  all reas a le i fere ces i  fa r f t e art  resisti  t e 
. ! . e  t e art  i  f r s ar  j e t ill t carr  t e r e  f 
r ti  r r f t tri l, t  i e is  f t ri l f t r    rri   
st lis i  t  s  f i e ce   l t t t t  i  rt  ill  r ir  t  
prove at trial. . Such an absence of evidence ay be established either by an affir ative 
i  it  t  i  rty's  i e e r   r i  f ll t  i  rty's 
i e ce  t  t ti  t t  r f   l t i  l i . I .     
of evidence has been established, the burden then shifts to the party opposing the otion to 
sho , via further depositions, discovery responses or affidavits, that there is indeed a genuine 
issue for trial or to offer a valid justification for the failure to do so under LR.C.P. 56(f). !d. 
 ss es 
Plaintiff stipulates to the dis issal of her Third ause of ction (Express arranty). 
l i ti 's i       e  
efendant argues that Plaintiff's failure to arn clai  is pree pted by the Federal 
   ("F "). o ever, efendant's argu ent is isplaced since the 
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FHSA only governs labeling requirements for household products and the Defendant has failed
to show that its SABRE Red law enforcement 10 OC Spray is a household product See
15USC 1261p The term misbranded hazardous substance means a hazardous substance
intended or packaged in a form suitable for use in the household or by children
16CFR 1261c10i the test shall be whether under any reasonably foreseeable condition
of sale purchase storage or use the article may be found in or about a dwelling Even if law
enforcement officers brought Defendantslaw enforcement grade products into their own homes
from time to time those products still would not fall within the FHSA regulations for labeling of
household goods
The term misbranded hazardous substance does not include
industrial supplies that might be taken into a home by a
serviceman An article labeled as and marketed solely for
industrial use does not become subject to this act because of the
possibility that an industrial worker may take a supply for his own
use
16CFR 1261c0i
To prevail on its preemption argument the Defendant would have to prove that the
product in question fell within the purview of the FHSA regulations that govern labeling of
household goods It is the Defendantsburden to prove its affirmative defense of federal
preemption and since no evidence has been presented that SABRE Red law enforcement 10
OC Spray is a household product summary judgment on this issue is inappropriate See
Bruesewitz v Wyeth LLC 131 SCt 1068 1087 n 2 2011 it is defendant burden to prove
affirmative defense of preemption quoting Brown v Earthboard Sports USA Inc 481 F3d
901 912 6 Cir 2007 and citing Silkwood v KerrMcGee Corp 464 US238 255 1984
Fifth Third Bank v CSX Corp 415 F3d 741 745 7 Cir 2005 Heath v HonkersMiniMart
Inc 134 Idaho 711 712 App 2000 party not carrying burden of proof at trial may establish
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 l  er s la eli  re ire e ts f r se l  r cts a  t e efe a t as faile  
to sho  that its "SABRE ed la  enforce ent 10%  pray" is a household product. See 
 .S.C. § 261(p) ("The ter  ' isbra e  azar s s sta ce' ea s a azar s s sta ce 
... i te e , r ac a e  i  a f r  s itable, f r se i  t e se l  r  c il re , .... "); 
 .F .R. §  (c)( 1 O)(i) ("the test s all e et er er a  reas a l  f reseea le c iti  
f l , r , t r , r  t  rti l    f  i  r t  lli ").  if l  
f rc t fficers r t f ndant's l  f r t r  r ts i t  t ir  s 
fro  ti e to ti e, those products still ould not fall ithin the F S  regulations for labeling of 
se l  s: 
 t r  [misbran  r s s st ] s t i l  
i stri l s lies t t i t  t  i t      
r n. An article labeled as, and arketed solely for, 
industrial use does not beco e subject to this act because of the 
possibility that an industrial orker ay take a supply for his o n 
. 
 .F.R. § 261(c)(10)(i). 
To prevail on its pree ption argu ent, the efendant ould have to prove that the 
product in question fell ithin the purvie  of the F S  regulations that govern labeling of 
household goods. It is the efendant's burden to prove its affir ative defense of federal 
ree ti , a  si ce  e i e ce as ee  rese te  t at  e  la  e f rce e t 0% 
C Spray is a household product, su ary judg ent on this issue is inappropriate.  
ruese itz v. yeth , 131 .Ct. ,  n.  (20 ) (it is efendant's r e  t  r e 
affir ative defense of pree ption) (quoting Brown v. Earthboard Sports USA, Inc., 481 F.3d 
,  (6th ir. 7) a  citi  ilk  v. err- c ee orp.,  .S. ,  (1 4); 
ift  ir  k v.  rp.,  .3d ,  (7th ir. 005)); e t  v. nker's i i-Mart 
Inc., 134 Idaho 711, 712 (App. 2000) (party not carrying burden of proof at trial may establish 
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right to summary judgment by showing absence of proof on element required to be proven at
trial
Defendant has made no attempt to prove that its SABRE Red law enforcement 10 OC
Spray is a household product for purposes of FHSA And such a showing in this case would be
nearly impossible since the product in question is the Defendantslaw enforcement grade
SABRE Red MK9 Fogger a product specifically designed for the law enforcement community
Plaintiff has moved for partial summary judgment on the issue of whether the Defendant
breached the standard of care by failing to include hazard warnings on its labels Defendant
motion for summary judgment should be denied and Plaintiffs motion for partial summary
judgment should be granted
Plaintiff Does Not Need An Expert To Opine About FHSA Labeling Standards
Defendant argues that in order to prevail the Plaintiff needs an expertto opine that
SABRE Red OC Spray label warnings do not comply with FHSA standards However such
testimony is irrelevant in this case Where other plaintiffs have attempted to premise their failure
to warn claims on non household goods by applying FHSA standards they have failed For
instance in Barnes v Litton Industrial Products Inc 555 F2d 1184 118687 4 Cir 1977
the Fourth Circuit Court ofAppeals upheld a summary judgment dismissing the plaintiffsclaims
brought under the FHSA on the grounds that the industrial grade alcohol in question was not
governed by FHSA since it was an industrial supply and not something likely to be used in a
dwelling
135 Id
Since the Defendant admits that the product in question is law enforcement grade it is not
135 It is important to note that the Barnes court reversed the district courtsgrant of summary judgment on the
plaintiffs common law failure to warn claim on the grounds that it was reasonably foreseeable that an end user may
mistakenly believe alcohol designed by the defendant for use in a Bunsenburner could mistakenly be consumed as a
beverage Id at 118889
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ri t t  r  j t  i    r f  l t r ir  t   r  t 
trial). 
t    tt t t   t t it  "S B   l  t 0%  
ray"        A.          
rl  i i l  i  t  t i  ti  i  t  fendant's l  f t  
  -9 er,  r t cifi ll  i  f r t  l  f r t unity. 
l i tiff  e  f r rti l r  j t  t  i   t r t  f t 
             ls. f ndant's 
ti  f r r  j t l   i d,  l i tiff's ti  f r rti l r  
j t s l   r t . 
l i ti  es      e    s 
efe t r s t t, i  r r t  r ail, t  l i tiff s  xpert, to i  t t 
   r  l l r ings  t l  it   t rds. r,  
t ti  i  i l t i  t i  .  t  l i ti fs  tt t  t  is  t i  il  
t  r  l i s  - l    l i   t r s, t   f il d.  
inst , i  rnes v. itt  I stri l r ts, I c.,  .2d , -87 (4th ir. 77), 
t  rt  ir it rt f ppe ls l   s r  jud t is issi  t  l intiffs l i s 
brought under the F S  on the grounds that the industrial grade alcohol in question as not 
governed by F S  since it as an industrial supply and not so ething likely to be used in a 
lli .  I . 
i ce t e efe a t it  t t t e r t i  ti  i  l  f r t r , it i  t 
135 It is i rt t t  te t t t  rnes rt r rs  t e istri t urt's r t f s r  j e t  t  
plaintiffs' co on law failure to warn clai  on the grounds that it was reasonably foreseeable that an end user ay 
ist l  li  l l si e   t  fe dant f r s  i   unse -burner l  ist l   s e  s  
beverage. Id. at 1188-89. 
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a household product for purposes of the FHSA IDOC purchased law enforcement pepper spray
products from SEC during the timeframe of December 2005 to January 2008 while Plaintiff was
employed at IDOC
136
The SEC product line which Plaintiff bases her allegations in her
Complaint upon is SECs SABRE Red law enforcement 10 OC spray
137
Since the
Defendantsproduct is not a household product for FHSA purposes it is not a misbranded
hazardous product under the FHSA and the Plaintiff does not need an expert to opine on the
FHSA labeling standards
The Relevant Labeling Standards in This Case are Those Cited by Plaintiffs Expert
Which are Common Law and the Hazard Communication Standards 29CFR
191020
The labeling requirements for the Defendantslaw enforcement OC Spray products are
dictated by common law and the Hazard Communication Standard 29CFR 191020 set
by the Occupational Safety and Health Administration pursuant to the Occupational Safety and
Health Act 29USCA 653 See Walton v Potlach Corp 116 Idaho 892 89495 1989
holding that in the workplace violations of OSHA regulations may be evidence of negligence
and in certain cases negligence per se Sanchez v Galey 112 Idaho 609 617 1987 OSHA
regulations may be used to establish liability where 1 the statute or regulation must clearly
define the required standard of conduct 2 the statute or regulation must have been intended to
prevent the type of harm the defendantsact or omission caused 3 the plaintiff must be a
member of the class of persons the statute or regulation was designed to protect and 4 the
violation proximately caused the plaintiffs injury see also Martin v American Cyanamid Co
5 F3d 140 14142 6 Cir 1993 upholding citation of defendant by OSHA for violation of
136 Dees Statement ofUndisputed Facts 13
137 Defs Statement ofUndisputed Facts 4 emphasis added
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a household product for purposes of the F SA: "IDO  purchased la  enforce ent pepper spray 
r ts fr   ri  t  ti efra  f ber,  t  uary,  il  l i tiff  
l  t I ."l36 "The SEC product line hich Plaintiff bases her allegations in her 
o plaint upon is SEC's S E ed la  enforce ent 10%  spray."l37 ce  
f ndant's r t i  t  l  r t f r  r s, it i  t  i r  
hazardous product under the F S  and the Plaintiff does not need an expert to opine on the 
F S  labeling standards. 
  i g s  is se  ose te   l i ti 's ert, 
 e  a      t r ,  .F.R. 
§ 910. 2 0 
The labeling require ents for the efendant's la  enforce ent  Spray products are 
dictated by co on la  and the azard o unication Standard, 29 .F.R. § 910. 2 0,  
by the ccupational Safety and ealth d inistration pursuant to the ccupational Safety and 
lt  t,  V.S.C.A. § 653. See alton v. otlach orp., 116 Idaho 892, 894-95 (1989) 
(holding that in the orkplace violations of S  regulations ay be evidence of negligence 
and in certain cases negligence per se); Sanchez v. aley, 112 Idaho 609, 617 (1987) (OS  
regulations ay be used to establish liability here (1) the statute or regulation ust clearly 
define the required standard of conduct; (2) the statute or regulation ust have been intended to 
prevent the type of har  the defendant's act or o ission caused; (3) the plaintiff ust be a 
member of the class of persons the statute or regulation was designed to protect; and (4) the 
violation proxi ately caused the plaintiff s injury); see also artin v. erican yana id o., 
5 .3d 140, 141-42 (6th ir. 1993) (upholding citation of defendant by  for violation of 
136 efs State ent of ndisputed Facts, ~ . 
137 efs State ent of ndisputed Facts, ~ 4 (emphasis added). 
I TIFF'S o m   ENDANT'S I    mDG   
    I TIFF'S    I   mDG  -  
Hazard Communication Standard by finding the standard was designed to protect manufacturers
employees and downstream employers and their employees
Plaintiff has established a failure to warn cause of action by proving the Defendant failed
to comply with OSHA labeling standards OSHAsHazard Communication Standard clearly
requires manufactures to provide appropriate hazard warning for the protection of employees
such as the Plaintiff See 29CFR 191020 Martin v American Cyanamid Co 5 F3d 140
141 42 6t Cir 1993 An appropriate hazard warning requires warning of the effects of
hazardous chemicals on target organs American Cyanamid Co 5 F3d at 141 42
Manufacturers must include such warnings on their shipping and product labels Id
Manufacturers must also provide appropriate hazard warnings by including such information in
a Material Safety Data Sheet and supplying the MSDS to downstream employers Id
Here Dr Purswellsopinion clearly explains how and why the Defendantsproduct label
fails to meet the OSHA requirements
138
Defendant does not have an expert to rebut
Dr Purswells opinions As such the only testimony before this Court relating to whether the
Defendant has breached its duty to comply with the labeling requirements set by OSHA is that of
Dr Purswell
By the Defendantsown admission SEC filled out its MSDS for SABRE Red MK9
Fogger 920060C in accordance with applicable law39 Since its MSDS provides a warning
that the product may cause irritation of the respiratory tract SEC clearly was aware of the
health hazards of its product as they relate to the respiratory tract and chose not to disclose those
hazards on an appropriate product warning label
140
138 Aff of Pltf s Counsel 5 Ex 3 Purswell Aff 4 5 and ExB
139 Aff of Pltf s Counsel 12Ex 10
140 See Aff ofPltf s Counsel 10 Ex 8 Nance Dep 12425 12721and Ex J Bates Nos SEC 22 24
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r  i ti  t r   fi i  t  t r   si  t  r t t anufacturer's 
l e   tr  l r   t ir ployees). 
Plaintiff has established a failure to arn cause of action by proving the efendant failed 
t  l  it   l li  t r s. SHA's azard o unication Standard clearly 
requires anufactures to provide "appropriate hazard arning" for the protection of e ployees 
   laintif .   .F.R. § 1910.1200; artin v. erican yana id o., 5 .3d 140, 
1-42 (6th ir. 93). n "appropriate hazard arning" requires arning f the effects f 
    r ns.   o.,  .3d  -4 . 
anufacturers ust include such arnings on their shipping and product labels. . 
anufacturers ust also provide "appropriate hazard arnings" by including such infor ation in 
a aterial Safety ata Sheet and supplying the S S to do nstrea  e ployers. !d. 
ere, r. urswell's opinion clearly explains ho  and hy the efendant's product label 
ails t  t t   i ts. 138 efendant does not have an expert to rebut 
r. urswell's opinions. s such, the only testi ony before this ourt relating to hether the 
efe a t as reac e  its t  t  c l  ith t e la eli  re ire e ts set   is t at f 
r. urs ell. 
 t e dant's  i i n,  i led t ts S     -9 
er (92006 -C) i  acc r a ce ith a licable law. 139 Since its SDS provides a warning 
that the product "may cause irritation f the respiratory tract",  clearly as a are f the 
health hazards of its product as they relate to the respiratory tract and chose not to disclose those 
hazards on an appropriate product arning label. 140 
138 ff. f lt  l, ~ 5, . 3 (Purs ll ff., mJ 4-5, and Ex. B). 
139 ff. f ltf  s l, ~ , . . 
140 See .  l, ~ 1 , . 8 (Nance p., 24:25 - 27:21, a d . J, ates os.   - 24). 
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For the above stated reasons Defendant motion for summary judgment must be denied
and the Plaintiffscross motion for partial summary judgment must be granted
Plaintiffs Implied Warranty Cause of Action Should Not Be Dismissed
Based on Plaintiff s response to a request for production of documents Defendant argues
that along with the dismissal of her express warranty claim the Court should dismiss Plaintiffs
implied warranty claim However the Court should not dismiss the implied warranty claim since
the Plaintiffs discovery response indicated clearly that the Plaintiff would be dismissing the
warranty claim and the not warranty claims Any confusion that may have arisen from the
response has now been clarified by a supplemental response to the request for production that
clearly states that the referenced intent to dismiss was only in relation to the express warranty
claim 141
Defendant has not been prejudiced by the Plaintiffsdiscovery response It is not
disputed in this case that Ms Major was employed by the IDOC and that SEC sold SABRE Red
law enforcement 10 OC Spray products including the MK9 Fogger to the IDOC during her
employment there
142
It is also not disputed that the Plaintiff used those products while
employed with IDOC for the purpose for which they were intended 143 As such the Plaintiff has
no burden to prove the existence of an express warranty whether it be in writing or otherwise
Her burden is met on her implied warranty claim See Pucket v Oakfabco Inc 132 Idaho 816
824 1999 holding implied warranty between merchant and employer extends to employee and
is governed by UCC with a four year statute of limitations Idaho Code 282314 UCC
141 Aff ofPltf s Counsel 13 and Ex 9
142 Def s Statement of Undisputed Facts 113 Aff of Pltf s Counsel 7 Ex 5 Doan Dep 2614 29154517
5114 6 Ex 4 Overgaard Dep 382 4520
143
Compare Aff of Pltfs Counsel 110 Ex 8 Nance Dep Ex B MK9 Fogger and Cell Buster Literature with
Aff of Pltf s Counsel 17 Ex 5 Doan Dep 2614 29154517 5114 6 Ex 4 Overgaard Dep 382
4520
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l t t . 142 It is also not disputed that the Plaintiff used those products hile 
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 r e  t  r e t e e iste ce f a  e ress arra t  - hether it be in riting or other ise. 
r r  is t  r i lie  rr t  l i .  t v. lif o, I c.,  I  6, 
824 (1999) (holding i plied arranty bet een erchant and e ployer extends to e ployee and 
i  r   V  it   f r e r t t te f li it tions); I   § -2-31  (VC  
141 ff. f ltf's sel, ~ 13 and x. 9. 
142 ef's tate e t f ndisputed acts, ~ 1 ; ff. f ltf's sel, ~ , .  (Doan ep., 6:14 - 9:15, 5:17-
1: 4), ~ , .  (Overgaard p., 8:2 - 5:20). 
143 o pare ff. f ltf's ounsel, ~ 10, x. 8 (Nance ep., x.  (M -9 ogger and ell uster iterature) ith 
ff. f ltf's ounsel, ~7, x.  (Doan ep., 6:14 - 9:15, 5:17 - 1:14), ~6, x.  (Overgaard ep., 8:2-
5:20). 
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Implied Warranty
For the above stated reasons Defendant motion for summary judgment on the
Plaintiffsimplied warranty claim should be denied
Plaintiffs Strict Liability and Failure to Warn Claims Survive Summary Judgment
Because SEC Knew or Should Have Known That Its Law Enforcement Grade SABRE Red
MK9 Fopmer Was or Was Likely To Be Dangerous for the Use for Which it is Supplied
The Hazard Communication Standard 29 CFR 191020brequires chemical
manufacturers or importers to assess the hazards of chemicals which they produce or import
There is no question that the Defendant knew its SABRE Red law enforcement 10 OC Spray
products may cause irritation of the respiratory tract since the MSDS that it developed stated
that fact Similarly Defendant knew its SABRE Red law enforcement 10 OC Spray products
may aggravate at least some respiratory conditions such as asthma and emphysema as that
information was similarly included on the MSDS prepared by the Defendant Defendant also
knew that its product caused inflammation of the respiratory tract when inhaled because it stated
that fact in its training manual used by SEC to certify trainers though with the proviso that the
effects were temporary
Dr Yost explained in his expert report the acute toxicities of capsaicin on skin eyes and
respiratory tract that have been known for years He further explained the chronic toxicities of
capsaicin and how the bodys tissues become sensitized by multiple exposures He explained
that people with chronic cough are up to 30 times more sensitive to capsaicin induced cough
This as he explains is due to the higher expression of Transient Receptor Potential TRP
calcium channels that occurs after repeated exposures Dr Yost has also explained via affidavit
that a person who has been sensitized to capsaicin will be sensitized to other common irritants as
the TRP calcium channels act as receptors for activating the bodys response to inhaled irritants
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that fact in its training anual (used by SEC to certify trainers), though ith the proviso that the 
effects ere te rary. 
r. ost explained in his expert report the acute toxicities f capsaicin on skin, eyes, and 
respiratory tract that have been kno n for years. e further explained the chronic toxicities f 
capsaicin and ho  the body's tissues beco e sensitized by ultiple exposures. e explained 
that people with chronic cough are up to 30 ti es ore sensitive to capsaicin induced cough. 
This, as he explains, is due to the higher expression of Transient Receptor Potential (TRP) 
calci  c a els t at cc rs after re eate  e s res. r. st as als  e lai e , ia affi avit, 
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The scientific articles Dr Yost relies upon includes an array of articles written preMarch
2008 According to Dr Yost the medical complications complained of by Ms Major were risks
known or foreseeably known to SEC and other manufacturers ofOC Spray products Dr Yosts
conclusions are further supported by the testimony and reports of Dr Pacheco The risks
associated with DefendantsSABRE Red products as discussed by Drs Yost and Pacheco are
risks that should have been disclosed on the shipping and product labels
Defendant has submitted the affidavit of Dr Reilly who disagrees with many of
Dr Yostsconclusions Dr Reilly states that there are no definitive studies showing longterm
chronic negative health effects from exposure to OC Spray
144
He also states that none of the
articles cited by Dr Yost definitively state or otherwise establish a conclusive or causal
association between exposure to OC Spray and chronic or longterm health conditions or
disease 145 Dr Reilly expresses his opinion that at the time SEC sold its product to the IDOC
none of the medical conditions complained of by the Plaintiff were known risks or foreseeable
risks known to SEC or any other manufacturer ofOC Spray
146
In short we have a dispute between experts which creates a genuine material issue of fact
for the jury to decide
A reasonable jury could conclude that SEC knew or should have known that its SABRE
Red MK9 Fogger which was specifically designed to cause irritation of the respiratory tract
would cause injury to the respiratory tract According to SECs own literature the microscopic
droplets of the MK9 Fogger are easily inhaled by those in the area 147 In giving direction to its
instructors on how to use the SABRE Red Cell Buster product which is the same as the MK9
144
Reilly Aff IM 710
145 Id at 8
146 Id at 10
147 Aff ofPltfsCounsel 110 Ex 8 Nance Dep Ex E Bates No SEC 355
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Red -9 Fogger, hich as specifically designed to cause irritation of the respiratory tract, 
ould cause injury to the respiratory tract. ccording to SEC's o n literature, the icroscopic 
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Fogger but for the addition of a spray wand SEC limits the Deployment to two trigger
activations of three seconds each 148 If the product does not produce the desired effect after two
attempts resort to the next appropriate level of force The manual indicates that the inmate
should not be left in a cell which has been exposed to SABRE Red 149 The manual also directs
that after the subject has been properly restrained remove the subject from the contaminated
area and immediately examine to ensure that the subject is breathing properly Then ask the
subject if they have any preexisting medical conditions which include Respiratory
Problems
o
The Defendant knew its product posed serious risks to the respiratory system
And to the extent Defendant may not have known the full possible health impacts of its product
such lack of knowledge was deliberate indifference since the scientific literature at the time
clearly delineated the mechanism by which such injury could occur
Defendant may be right that no one has conducted a study of the SABRE Red MK9
Fogger or like product to determine whether longterm chronic illness or aggravation of illness
may be a risk of exposure to such products But the Defendant possessed enough information to
know there was a real possibility based on the state of scientific evidence that capsaicin posed a
serious risk to the respiratory tract Defendant knew that the respiratory exposure involved with
its MK9 Fogger was significantly different than with its other stream spray products Defendant
knew its obligations to test for health safety But Defendant chose not to test for chronic health
effects before putting its MK9 Fogger on the market It cannot now rely on that deliberate
ignorance to avoid liability in this case Defendantsmotion for summary judgment must be
denied
148 Id Nance Dep Ex E Bates No 356
149 Id
150 Id Nance Dep Ex E Bates No 374
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148 [d. (Nance Dep., Ex. E, Bates No. 356). 
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CONCLUSION
For the above stated reasons the DefendantsMotion for Summary Judgment should be
denied and the Plaintiff s cross Motion for Partial Summary Judgment should be granted
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I, GAROLD S. YOST, Ph.D., being first duly sworn upon oath, depo~ and state of ~y 
. ! 
, 
own personal knowledge that, if called upon to testify, I would competendy testifY to the 
following: 
. I a  a professor of Phar acology and Toxicology and an adj*-nct professor! of 
edical Chemistry at the University of Utah, Department of Pharmacology a.Q.d Toxicology~ I 
AFFIDAVIT OF GAROLD S. YOST, PH.D., IN OPPOSITION TO 
DEFENDANT'S I  F  SUM Y JUDGMENT - 1 
hold a Bachelorsof Science in Chemistry a Masters of Science in OrganicCand a
PhDin Organic Chemistry I have been recognized internationally as an authority on toxicology
in the respiratory tract with particular expertise on the cytochrome P450mnedi4ted mecharxisihs
of lung injury Attached hereto as Exhibit A is a true and correct copy ofmy curhriculum vitae
2 I have conducted extensive research into the mechamistris responsible for human
lung disease caused by particulate matter in air pollution In my tab my research team and I have
cloned expressed and characterized multiple irritant receptors that are expressed on humlan
lung epithelial cells and are activated by particulates in polluted air and by capstdcinoids that ire
resent in e spray This work has provided compe evidence for the importance ofP peppr sP Pe g oP
these receptors in human lung disease
3 I have reviewed the discovery materials produced by the parties to the litigation
identified above including the medical records of the Plaintiff and thedpasitians talon
According to the Plaintiffs medical and employment records and according to the depositi n
testimony of her former coworkers the Plaintiff was employed with the Idaho Departmentof
Correction IDOL for a number of years as a prison guard During her employxmemt with the
IDOC the Plaintiff had numerous exposures to OC Spray In March 2008 the Plaintiff visas
exposed during an IDOC training involving one of the Defendants OC Spray Sabre Reed
products that producesa fine aerosol disbursement of the OC material in the air The two ID4bC
employees who conducted the March 2008 training testified in their depositions that the Stc
Sabre Red product that was used was the fog As indicated in SEC vice president Robert Nanlce
the Sabre Zed fog products are specifically designed for increased respiratory tract exposure as
compared to their stream and foam products Increased respiratory tract expooure to eapsaiin
would be expected to produce greater respiratory tract irritation and inflammation
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of hmg injury. Attached hereto as Exhibit A is a true and correct copy of my cmiriculum vitae. : 
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testi ony of her fonner co- orkers, the laintiff as e ployed ith the IdahO Department~ f , ' 
orrection ("IDOC") for a nu ber of years as a prison guard. uring her e ploy ent ith the 
moc, the Plaintiff had numerous exposures to OC Spray. In arch 2008, the Plailltiff ,*as 
exposed during an IDOC training involving one of the Defendant's DC Spray Sabre ~ed 
products that produces a fine aerosol disbursement of the DC material in the air. The two lOOC 
, 
employees who conducted the arch 2008 training testified in their depositions that the SEC 
Sabre Red product that was used was the fog. As indicated in SEC vice presid~t Robert N~e, 
the Sabre Red fog products are specifically designed for increased respiratory tract expos~ as 
compared to their stream and foam products. Increased respiratory tract x~ to eapsaipin 
: : 
would be expected to produce greater respiratory tract irritation and inflammatiop. 
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4 According to the records and other documents I reviewed after the Plaintiff
completed the March 2008 OC Spray training session she was not able to return work due td a
severe chronic cough and other respiratory related disease The records also indicated the
Plaintiff suffered a much milder form of chronic cough prior to the March 200 training andi it
was only after the exposure in that training that her condition worsened to the point that sheYas
no longer able to work whether at IDOC or in other similar employment settings
5 1 have expressed my expert opinions as to the cause of the Plaintiffs acute
adverse health responses to the OC Spray and how it greatly exacerbated her underlyiiag
respiratory diseases Attached hereto as Exhibit B is a true and correct copy of those opinions
6 In reaching my opinions in addition to the records and discovery materiels
already mentioned I relied on a body of scientific research relating to the effects ofcapsaicinoids
on human and animal tissues In assisting the Plaintiff in responding to ono of Deiiendaiits
discovery requests I identified several research articles that support my opinions including 6
following
a M Hayman and P Kate CAPSAICIN A REVIEW OF ITS PHAPMACOLOGYAND
CLINICAL APPLICATTON Current Anesthesia and CriticalCare Vol 19 pp 338043 2008
b K Alawi and J Keeble THE PARADOXICAL ROLE OF TRP1Vl RECEPTOR IN
INFLAMMATION Pharmacology and Therapeutics Vol 125 pp 189195 2010
c CA Reilly DJ Crouch GS Yost and A Fatah DE ERMINATION of
CAPSAIOIN NONIVAMIDE AND DIHYDROCAPSAICIN IN BLOOD ANTI TISSUE BY LIQV D
HRoMAToGRAPHYTANtEMMASS SPECTROMETRY J Anal Toxicol 26 313 3114 2002
d CA Reilly JL Taylor DL LanzaBA Carr DJCrouck and GS Yost
CAPSAICINOIDS CAUSE INFLAMMATION AND EpmMIIAL CELL DEATH THRouoe ACTIVATiomOF
VANILLOID RECEPTORS Tbx Sci 73 170181 2003
e CAReilly andGS Yost STRUCTURAL AND ENZYMATIC PARAMETERS T14AT
DETERMINE ALKYLDERYDROGENATIONIYDROXYLATIO OIL CAPSAICINOIDS By P450 ENZYME
DrugMetab Dispos 33 530536 2005
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I I  PP I I , rre t est esi   ritic l re, l. , . -\34  (2 8). : 
. ..   . le,     V1 T Ri I  
I I , r l   r utics, l. , . -19  (2010)~ 
c. .A eilly, .l. rouch, .S. ost, and .A. Fatah, DE.TER INATION iOF 
PS ICI , I  I E,  I PS I l  I  L  D nSS E B  LIQ~lD 
CHROMATOGRAP y- ANDEM ss SPECI'ROMETRY, J. al. oxicol., , 313-3119 (2 1). 
· , 
. .A. illy, .L. ylor, .L. za, .A. rr, .J. r ~  O.S. ~st, 
    PITJiElJAL  It lHROUOH l lON:  
ttl I REcEPTORS, Tox. Sci., 73,170-181 (2003). : 
. .A. ill  nd O.S. t, I'   Th1 I  !R.A.  nlAr 
ETER I E L L EHYDROOENATIONIHYDROXYLATJON F C PS ICI I S sf 450 B z~s, 
Drug etab. Dispos. 33, 530-536 (2005). 
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i
f CA Reilly ME Jobansen AL Laura J Lee JO Lim and GS Yo4t
CALCIUMDEPNDENT AND INDEPENDENT MECHANISMS OF CAPSAICIN RECEPTOR TRPV1
MEDIATED CYTOKINE PRODUCTION AND CELL DEATH IN HUMANBRONCHIAL EPITHELIAL CELL
J Biochem MOW Toxicol19266752005
g ME Jobansen CA Reilly and GS Yost TRPV1 ANTA RLEVATE
CELL SURFACE POPULATIONS AND RECEPTOR FUNCTION TOEXACERBATE TKPV1MIDATIt
Tm7ac ES IN HUMA LUNG EPITHELIAL CELLS Toxicol Sci 8927962006
h CA Reilly and GS Yost Metabolism OF CAPSAICINOIDSBYP450 ENzymps
A REviEw OF RECENT FINDINGS ON ICEACPION MECHA BIOAdnvATI AND
AEToxiFICATm PROCES DrugMetab Rev 38 685706 2006
i KCThomas AS Sabuis ME Johansen DLLanza PJ MoosGS Yost
andCA Reilly TRPV1 AGom CAUSE ENDOPLASMIC RETICULUM STRESS A CELT DEATH
IN HUMAN LUNG CELLS J Pharmacol Exp Ther 321 830838 2007
j BF Bessac and SE Jordt Breathtaking TRP CHANIV LS TRPA AD
TRP1 INAawAYCHEMOSENSATIONAND REFLEX CONTROL Physiology 23 360370 2008
k DA Gronoberg A Niimi Q Thai Dinh B Cosio Mark I4ew A Fisch4
and KF Chung INCREASED ExPREssm OF TRANSIENT RECEPTOR POTENTIAL VAMLLOIDI JN
AIRwAX NERVES OF CHRONIC COUGH American Journal of Respiratory Md Critical Core
Medicine Vol 1702761280 2004
The articles cited above are just a few ofmy that support my opinions aspres ed in my
report in this case Based on my review of the above cited articles and my education traainithg
research and knowledge of the scientific literature in the relevant area it is my opinion that the
risks to the respiratory tract posed by exposure to SECs SABRE Red law enfocement 10 5C
Spray MK9Fogger were known and foreseeable risks at the time SEC sAd its product to
IDOC
7 It is known now and it was known prior to 2008 that people with asthma 4nd
chronic cough are more sensitive to pepper spray then other people with nprmal respiratory
function People with greater sensitivity to capWcin would be expected to have increaed
TRPV1 receptor populations Other important TRP channels exist and ieveral of th4m
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f. C.A. Reilly, .E. Johansen, D.L. Lanza, J. Lee, J.-O. Li , iand .S. YO$t, 
CAL IUM- EPENDENT ND I EP  E NIS S OF P I I  ECEtro  (TR Vl~­
OlAl D CYro INE P ION  e  E . IN UMAN I  pi I  LL$, 
1. ioche . olec. oxicol. 19,266-275 (2005). . 
~ i 
g. .E. Johansen, C.A. Reilly, and G.S. Yost, TRPV1 ANTAo$NISTS ELEvAtE 
 S F E P P TIONS  c P  F I  T  XACERBATE TRlPV1·~DlATJ!:D 
OXICITIES I  AN NG  , l. i. 9, 278-86 (20 6). : 
h. .A. eilly and O.S. ost, etabolis  OF C PS ICI IOS Y;P450 E ZYMES: 
 VI W   l INGS  R T  ECHANISMS, IO- nvATlON, IiI  
DETOXIFI ATION P OCESSES, rug etab. ev. 38,685-706 (2006). . 
, 
i. .C. , .S. n , .E. , .L. , .J. ~oos, .S. o~t, 
and .A. eilly, P l GONISTS C SE ENDOPLASMIC RETICULU  STRESS AND CELl. E t  
IN  L  CELLS, J. har acol. Exp. Ther. 321,830-838 (2007). . 
j. .F. essac and S.B. Jordt, reathtaking P Ne~: PAI ltro 
RPVl I  IRwAYCHEMOSENSATIO  '  , YSi l , , tlO-370 (2 08).: 
, 
. .A. r e er ,  ii i. . ai i , . sio, r  He , . ischer, 
and .F. hung, INcREASE  EXPRESSION F T SIE T E EPT  P I j NILLOID-l JIN 
J W Y E ES F I  t eric  J r l f es ir t ry arlfl ritic l qre 
edicine, ol. 170, 1276-1280 (2004). j 
he articles cite  a e are just a fe  f any t at support y opinions as Fpressed in y 
report in this case. Based on my review of the above cited articles and my edlIcation. trainiJp,g, 
, 
research and kno ledge f the scientific literature in the relevant area, it is y: opinion that the 
risks to the respiratory tract posed by exposure to SEC's SABRE Red law enfo~ent 10010 <?C , , 
Spray (MK-9 Fogger) were lcnown and foreseeable risks at the time SEC sold its product! to 
! . 
.            t   !Wit  st  dn  
chronic cough are ore sensitive to pepper spray then other people ith n~nnal resp~ry 
ction. eople ith greater sensitivity to capsaicin ould be ~ted to have increa$ed . , , 
TRPV I receptor populations. Other i portant TRP channels exist, and $everal of th~m, 
FID   O L  . ST, H.D., I  POSITI  T  
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particularly TRPA1 are activated by irritants such as those that exist in cigarette smoke abd
other environmental sources Thus it is reasonable to expect the multiple TRIP channels act in
concert with each otba to result in higher acute respiratory responses to a multitude of
respiratory irritants particularly inpeople with increased sensitivity to pepper sprays
8 I have reviewed the Affidavit of Christopher A Reilly phD in Support Of
DefendantsMotion for Summary Judgment and found that there are several major issues
identified in his affidavit that are misleading First the general toque of the affidavit is inisleadiktg
because it makes absolute statements from data that did not warrant conclusions with absolute
certainty Rather many of the conclusions Dr Reilly draws should be basted on a sum of
scientific evidence and judgments of the expert scientists
9 In paragraph 7 Dr Reilly states that within a reasonable degree of scientific
probability a conclusive or causal association between exposure to OC spray or even more
generally capsaicinoids and chronic or long term health conditions or disease do not exist ke
states that all of the scientifically sound and conclusive studies document that the acute advem
health effects from exposure to OCeapsaicinoids in pepper spray are transient reversible Lind
recoverable within a short period of time This is simply not true Certainly tlitre is a degree of
controversy about the chronic effects and whether they can be associated with acute exposures
but to state that all of the studies adhere to this paradigm is not true
10 Characterization of exposures to pepper sprays as transient reversible
recoverable are generally appropriate and supported by literature documentation However thtTe
exist anumber of reports where people have died as a result of acute exposures to pepper sp
Certainly one cannot view death as a transient reversible and recoverable outcome Mortality as
a result of pepper spray exposures was discounted by Dr Reilly when he staUd that the cases
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particularly TRPAl, are activated by irritants, such as those that exist in cigatette smoke, abd 
other environmental sources. Thus, it is .-easonable to expect the IDultiple TRP channels act lin 
, ' 
concert ith ea h other to res lt in ru r a ute res iratory r s nses t '  ultitude ~  
respiratory ittitants, particularly in people with increased sensitivity to pepper sptays. 
. I  re ie ed t e fida it  ist e  . illYt Ph.D;, i  rt ;o  
efendant's otion for SUlllDl3I}' Judg ent and found that there are sevetal ajor issues 
i tified i  is affida~t t at r  isl i . irst, t e r l ton  f t  affi~vit is misleadih  
e a se  es te   ta  id  arra t  t  llilte 
certainty. , any  t   .  ra s l   as~    :of 
scientific evideJ}f;C andjudg ents of the expert scientists. 
. In paragraph 7, 1),:. eilly states that "within a J:eaSonable de~ee of scientific 
probability a conclusive or causal association bet een exposure to DC sprat (or even 6re 
generally capsaicinoids) and chronic or long-term health conditions or disease" do not exist. He 
st tes t t "all f t  i tifi ll  s   l si e t i  wn t t t t  ~ut  rse 
, 
lt  ffe ts fr  r  t  /caps i i ids i  l' r  r  tr i nt, r r i l  ~d 
recoverable within a short period of ti e." This is si ply not true. Certainly t.bere is a degree of 
controversy about the chronic effects and whether they can be associated with 'acute expos~, 
t t  st t  t t ll f t  st i s r  t  t i  r i  is t tr e. 
0. haracterization of exposures to pepper sprays as transient~ reversible $ld 
recoverable are generally appropriate and supported by literature docwnentation. However, there 
exist a nu ber of reports here people have died as a result of acute exposures 'to pepper sprays. 
Certainly one cannot vie  death as a b:ansient, reversible and recoverable outcoi e. ortalitY. as 
a result of pepper sp:r:ay exposures was discounted by Dr. Reilly when he sta~d that the caSes 
FFI IT F A L  S. ST, P D., I  PP Sm  T  
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involve unusual exposure conditions andor individuals with preexisting asthma wxdbr
concomitant physical injury etc The rationale usedby Dr Reilly to discount these reports doles
not support his conclusions Rather because the reported mortality events occurred in
individuals with preexisting lung disease the reports discussed by Dr Reilly actually strongly
support my conclusions espoused in my expert report attached hereto as Exhibit B in which I
discuss the mechanism by which the Plaintiffschroniccough health problems were exacerbatled
by exposures to the Defendantspepper spray products Therefore it is not a scientifically
reasonable argument because several literature reports of death from pepper spray exposures
should not be excluded
11 In paragraph 8 Dr Reilly presents a series of claims relating to the Plaintiffs
discovery responses that are based upon 11 articles Many of those articles were coauthored by
Dr Reilly The conclusions made in paragraph 8 prompted Dr Reilly to state that none of those
articles definitively state or otherwise establish within a reasonable degree of scientific
probability a conclusive or causal association between exposure to OC spray and chronic or long
term health conditions or chronic exacerbation of pre existing health conditions Agalin
Dr Reillysstatement is framed in the absolute and is really not based upon the compilation of
scientific evidence alluded to in the articles To say that none of the articles stage or establish the
association between acute and chronic effects extrapolates to absolute and does not allow one to
take a synthesis ofscientific weight ofevidence presented in the sum ofthese papers When one
takes a synthesis of weight of evidence presented in the aggregate ofthese papersd opine that the
opinions and conclusions I have reached in my report are suppored to a reasonable degree of
scientific certainty
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involve unusual e~posure conditions and/or individuals ith pre-existing· astluna ~r 
conco itant physical injury, etc. The rationale usedby r. Reilly to discount these reports doles 
not support his conclusions. r,   t   h:ts  :ID 
individuals ith pre-existing lung disease, the reports discussed by r. eilly actually stron~ly 
support y conclusions espoused in y expert report attached hereto as Exhibit  in whic~ I 
iscuss      laintiff's -coug     t  
by exposures to the efendant's pepper spray products. r f r , it i  t  i tifi ll  
r s le r t s  s r l liter t r  r rts f eat  fr  r ·s ra  e s tes 
   l ed .. 
. I  ara ra  , r. eill  rese ts a series f clai s relati  t  t e laintifrs 
diSCOvery responses that are based upon 11 articles. any f those articles ert co~authored y 
r. eill . e c cl si s a e i  ara ra   r te  r. eill  t  state t at e f t ese 
articles efi iti el  state r t er ise esta lis  it i  a reas a le e ree f scie tific 
probability a conclusive or causal association bet een exposure to D  spray and chronic or lorig-
tenn ealt  c itions r c r ic e acer ati  f pre-e~isting ealt  c iti s. gWn, 
r. eilly's state e t is fra ed i  t e a s l te a  is reall  t ase   t e c ilati : f 
scie tific e i e ce all e  t  i  t  articles.  sa  t at e f t  articles statF r esta lis  t e 
association bet een acute and chronic effects extrapolates to absolute and does· not allo  one to 
take a synthesis of scientific eight of evidence presented in the swn of these P$pel'S. hen one 
t   t i  f i t f i  r t  i  t  r t  f t  t .l i  t t t  
opinions and conclusions I have reached in y report are suppored to a reasonable degree: of 
scie tific certainty. 
I I   ROLD . T, PH.D., I  op sm   
FENDANT'S   MM   -  
I
12 In paragraph 9 a specific reference is made by Dr Reilly to article No 111 in
Plaintiffs discovery response to Defendants interrogatory No 21 The statement is made that
nothing in that article definitively states or otherwise establishes a causal association between
pepper sprays and chronic conditions Dr Reillysstatement is without merit because the article
provides sound scientific evidence for the direct relationship between chronic cough and
expression of the receptors that respond to capsaicin in a reasonable number of human
volunteers This relationship between receptors and chronic cough precisely identifies a
mechanism whereby the chronic adverse health condition of the Plaintiff is likely to be
dramatically worsened by subsequent exposure to pepper sprays It is noted that the publication
is dated 2004 which is prior to the SEC sold its products to IDOC to which the Plaintiff was
exposed on March 3 2008
13 In paragraph 12 Dr Reilly states that SEC has or had no reasonable basis to
believe that its product was uniquely unsafe and could directly cause irreversible injury as
claimed It was not the contention of the statements by the Plaintiff that the specific pepper splay
was uniquely unsafe Rather the statement was made that the amounts of capsaicin were as high
as any other product on the market Assuming that an adverse effect does occur from exposures
to pepper sprays it is reasonable to assume that the products by SEC that contain the highest
levels of capsaicin and are the same levels as those of other manufacturers would not be Uniquely
unsafe but rather equally as potentially toxic as those produced by other manufacturers
14 in reviewing Dr Reillysaffidavit I see nothing therein that chatiges my original
expert opinion that within a reasonable degree of scientific certainty exposure to the
Subparagraph5kto this affidavit
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. In paragraph 9, a specific reference is made by Dr. Reilly to article No. 111 In 
Plaintiff's discovery response to Defendant's interrogatory No. 21. The statement is made that 
nothing in that article definitively states or othetWise establishes a causal association bet een 
pepper sprays and chronic conditions. Dr. Reilly's statement is without merit bckause the arti~le 
provides sound scientific evidence for the direct relationship between chronic cough and 
expression of the receptors that respond to capsaicin in a reasonable n~ber of humian 
. This relationship bet een receptors and chronic cough preci$ely identifies' a 
echanis  hereby the chronic adverse health condition of the Plaintiff is likely to he 
dra atically orsened by subsequent exposure to pepper sprays. It is noted that the publication 
is dated  hich is prior to the  sold its products to I  to hich the laintiff as 
exposed on arch 3, 2008. 
. In paragraph 12; r. eilly states that SEC has or had no re$onable basis: to 
believe that its product was uniquely unsafe and could directly cause irreversible injury as 
l i d. It  t t  t ti   t  t t t   t  l i tifIt t t  ~if c r ~ 
as uniquely unsafe. Rather, the state ent as ade that the a ounts of capsaicin ere as high 
as a  t er r ct  t e arket. ss i  t at a  a erse effect es cc r fr  e s res 
to pepper sprays, it is reasonable to assume that the products by SEC that contain the highest 
levels of capsaicin and are the same levels as those of other manufacturers would not be uniquely 
unsafe but rather equally as potentially toxic as those produced by other anufacturers. 
. In revie ing r. eilly's affidavit, I see nothing therein that changes y origibal 
expert opinion that, within a reasonable degree of scientific certainty, exposure to the 
I Subparagraph 5(k) to this affidavit. 
AFFIDAVIT OF GAROLD S. YOST, PH.D., IN OPPOSITION TO 
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DefendantsSabre Red OC Spray product in March 2008 caused her to suffer acute adver6e
health responses axed greatly exacerbated her underlying respiratory diseases
FURTHER YOURAFFIANT SAYETH NOT
y
G OL S YOST Ll
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efendant's Sabre Red  Spray product in arch 2008 caused her to suff¢r acute adve~e 
health responses .and greatly exacerbated her underlying respiratory diseases. 
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CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 10th day of June 2011 a true and correct copy of the
foregoing document was served on the following individualsbythe method indicated
Christopher C Burke
GREENER BURKE SHOEMAKER PA
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I  I  that on this 10th day f June, 2011, a true and correct copy f the 
foregoing docu ent was served on the following individual(s) by the ethod indicated: 
ristop er . r e ~. il 
ER E KERP  [ ] x: -260  
 . a  tr t, it   
i , I   
[ ] essenger elivery 
[ ] Email: cb~Ee(g~~efia' 
I I    . T, H.D., I  I I   
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Ic .  
Exhibit A
to Affidavit of Garold S Yost PhD
in Opposition to Defendant
Motion for Summary Judgment
Exhibit A
to Affidavit of Garold S Yost PhD
in Opposition to Defendant
Motion for Summary Judgment
000419
  
 id    . t, h.D. 
i  iti  t  fendant's 
tio    t 
  
 id    . t, h.D. 
i  siti  t  fendant's 






Current Title Professor of Pharmacology and Toxicology
Date ofBirth
Place ofBirth Denver Colorado
Marital Status Married Barbara J Yost










North Newton Kansas 67117
Dates 1969 1971
Degree BSChemistry
3 University of Hawaii
Honolulu Hawaii 96822
Area of Research Organic Chemistry
Director Richard E Moore
Dates 19721974
Degree MSOrganic Chemistry
4 Colorado State University
Fort Collins Colorado 80523







I   
 .  
  
 TA: 
rr t itl : r f r   nn  o l   i l  
  : 
  i t : r, ra  
rital t tus: rri  - r r  J. st 
n: t , awn, , l , r w, ,  
 :  
ndy, tah  
 (8 ) -09  
I : 
I. es t  i  llege 
e t , s   
ates: 1967-1969 
: .A. 
. ethel llege 
orth t , ansas  
: -1  
egree: .S., he istry 
. i it   ii 
lulu,   
re   arch: r i  i tr  
r:  .  
t : -19  
Degree: .S., Organic Che istry 
. lora  tate i ersit  
 l , ra   
rea f esearc : r a ic e istr  
i t r:  . t it  
: -197  






Professor of Pharmacology and Toxicology and Adjunct Professor ofMedicinal Chemistry




Salt Lake City Utah 84112
Phone 801 581 7956 FAX 801 585 3945 Email gyostpharmut hedu
Web Page httpwwwpharmacvutahedupharmtoxfacultyvost
87 present promoted from Associate Professor to Professor on July 1 1992
Past Experience
























University ofCalifornia San Francisco
San Francisco California 94143
Area of Research Pharmaceutical Chemistry








r fess r f ar acol  a  ic l  a  j ct r fess r f e ici al e istr  
rt t fPharmaco)   i l  
   
ll    
   
  ity,   
e: (8 ) 1-7956 X: (801) 585-3945 -mail: gyost@pharm.utah.edu 
 : tt ://www.pharmacv. tah.edu!pharmtoxlfaculty/yost 
/87 - r s t (promote  fr  ss i t  r f ss r t  r f ss r  J l  , 92) 
 r e: 
s  e   t   (te d) 
e    
i t  t t  i r it  
l , i  -6510 
7/87 - 8/87 
ssistant rofessor f har aceutical he istry 
lle e f ar ac  
ashington tate niversity 
ll , i t  -6510 
/81 - 6/87 
 (tenure ck)   
istr  rt t 
o son tate niversity 
n, a land  
ates: /78-6/81 
tdoctoral: 
c l f ar ac  
t.  r ti l i tr  
i ersit  f alif r ia, a  ra cisc  
an , l rnia  
rea of esearch: Phar aceutical he istry 
r r: l .   te lan  
177- 178 
is ting  
rt t  r l  
J s i s i rsit  
lti , a la   
laborated    
: /79- /81 
  
YOST 00010
MEMBERSHIP IN SCIENTIFIC PROFESSIONAL AND SCHOLARLY SOCIETIES
American Chemical Society 1975
Sigma Xi 1979
Rho Chi 1982
American Association ofColleges ofPharmacy 1982
International Society for the Study ofXenobiotics 1982
Society of Toxicology 1984
Phi Kappa Phi Honor Society 1986
MountainWest Society of Toxicology 1987
American Society for Pharmacology and Experimental Therapeutics 1988
PROFESSIONAL RECOGNITION
Best Paper of 1982 Drug Metabolism and Disposition Presented by the American Society for Pharmacology and
Experimental Therapeutics
Recipient of a Research Career Development Award NHLBI NIH 198792
Appointed to National Academy of Sciences Committee on Toxicology 1991 97
Appointed to the Developmental Therapeutics Contracts Review Committee for the National Cancer Institute
199395
Zeneca Traveling Lectureship Award by the Society of Toxicology 2000 This award recognizes excellence in
research and service in toxicology Zeneca provides two awards annually to promote greater collaboration
between European and North American toxicologists and to enable North American toxicologists to
undertake a three to fourweek lecture tour ofFurope
Elected Fellow of the Academy of Toxicological Sciences June 2000 elected to Board of Directors 200407
Colgate Palmolive Traveling Lectureship in Alternative Methods in Toxicology Award presented by the Society
of Toxicology 200 1
Recipient 8 Annual John Doull Toxicology Symposium University ofKansas Sept 23 2004
Appointed to the Environmental Health Sciences Review Committee NIEHS NIH 20022006
Associate Editor DrugMetabolism and Disposition 2002 present
Editorial Boards Toxicology and Applied Pharmacology 1989present Chemical Research in Toxicology
1991 94 199699 2005 08 Journal of Toxicology and Environmental Health 199295 Chemico
Biological Interactions 1992 1998 Drug Metabolism and Disposition 19942002 Toxicological Sciences
2002 present
PROFESSIONAL SERVICE
Registration Chairman 39th American Chemical Society Northwest Regional Meeting 1984
Chairman Symposium on Molecular toxicology 39th American Chemical Society Northwest Regional Meeting
1984
Chairman WashingtonIdaho Border Section of the American Chemical Society 1986
Resolutions Committee Chemistry Section American Association of Colleges ofPharmacy 198586
Chairman and Organizer Symposium titled Mechanisms of Lung Injury by Systemically Administered Chemicals
Annual Society of Toxicology Meeting Atlanta GA February 1989
Councilor Mountain West Society of Toxicology 1989 1991





 I  CIENTIFIC, ROFESSIONAL,  SCHOLARLY OCIETIES: 
erican hemical Society 1975 
i  i 1  
 i  
ri  ss i ti  f ll s f har  1982 
l oci t   t  t  fXenobi  198  
oci t  f i l   
i  i r i t  1  
t i - est i t  f i l   
erican Society for Phar acology and xperi ental herapeutics 1988 
I  OGNITION: 
est Papcr of 1982 - rug etabolis  and isposition. Presented by the erican Society for Phar acology and 
 uti . 
i i t   r  r r l t ar  - I, I  (198 -92). 
i te  t  ati al ca e  f cie ces ittee  ic l  (1991-9 ). 
i te  t  t  l t l r ti  tr ts i  itt  f r t  ti l r I tit t  
(199 -9 ). 
eneca raveling ectureship ard by the Society of oxicology (2000). his a ard "recognizes excellence in 
r r   r ice i  t icology."  r ides t  r s ll  t  r t  r t r lla r ti  
between European and North American toxicologists and to enable North American toxicologists to 
undertake a three- to four-week lecture tour of Europe. 
Elected - ell  f t e ca e  f ic l ical cie ces (June 00); electe  t  ar  f irect rs (200 -0 ). 
olgate-Pal olive Traveling Lectureship in lternative ethods in Toxicology ard - presented by the Society 
  (200 ) 
eci ie t, th nn al J  B icolog  si , i ersit  f a sas, e t. ,  
ppointed t  t e iron e t l lt  iences ie  itt , I , I  (200 -20 ) 
ssociate Editor - r  et lis   is siti  (2002-present) 
ditorial oards - Toxicology and pplied har acology (1989-present), he ical esearch in Toxicology 
(1991-94, ]996-99, 2005-08), Journal of Toxicology and Environmental Health (1992-95), Chemico-
Biological interactions (1992-1998); Drug Metabolism and Disposition (1994-2002), Toxicological Sciences 
(2 02- ent). 
I  I : 
Registration Chair an, 39th merican Che ical Society orthwest Regional eeting (1984) 
Chairman, Symposium on olecular Toxicology, 39th American Chemical Society Northwest Regional eeting 
(19 ) 
Chairman - ashington-Idaho Border Section of the American Chemical Society (1986) 
Resolutions Committee, Chemistry Section, American Association of Colleges of Pharmacy (1985-86) 
Chairman and Organizer, Sy posiu  titled echanis s of Lung Injury by Syste ically Ad inistered Che icals, 
nnual Society f Toxicology eeting, tlanta,  (February 1989). 
Councilor - ountain est Society of Toxicology (1989-1991). 
ecretary/Treasurer - echanisms Section of the ociety of oxicology (1990-92). 
ST 00010 
YOST 00011
Member Education Committee of the Society of Toxicology 199194 Chairman 199294
Member National Academy ofSciencesNational Research Council Committee on Toxicology 1991 97
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Member Advisory Committee for a NIEHS Program Project Grant Univ California Davis April 19 1993
Special Reviewer Toxicology Study Section for NIH June 16 18 1993
Member National Academy ofSciences Subcommittee on Rocket Emission Toxicants 199598
Member Executive Committee Drug Metabolism Division ASPET 199497
Member National Academy of Sciences Subcommittee on Military Smokes and Obscurants 19972000
Vice President Elect Mountain West Society of Toxicology 199596 Vice President 199697 President
199798
Member North American Regional ISSX Committee 199497
Vice President Elect Mechanisms Section of the Society of Toxicology 199798 Vice President 199899
President 19992000
Member Program Committee for Biological Reactive Intermediates IV meeting in Paris July 2000
Member K12 Subcommittee of the Society of Toxicology Education Committee 19971999
Member Review Panel National Institute ofEnvironmental Health Science and US Environmental Protection
Agency RFA for Centers for Children Environmental Health and Disease Prevention Research Research
Triangle Park NC March 23 25 1998
Chair Scientific Affairs Committee International Society for the Study of Xenobiotics 19982001
Member Council International Society for the Study of Xenobiotics 19982001
Chair AACP panel grant review 1999 2000 New Investigators Program for Pharmacy Faculty 1999
Member National Academy of Sciences Subcommittee on Spacecraft Exposure Guidelines 19992009
Member Scientific Advisory Committee 10 North American ISSX Meeting Indianapolis October 2000
Member Scientific Advisory Board and Program Committee 6 International ISSX Meeting Munich Germany
October 2001
Member Organizing Committee 11 North American ISSX Meeting Orlando October 2002
Reviewer University of California Tobacco Related Disease Research Program Cancer Review Committee San
Francisco CA May 45 2000
Chair Biological Sciences AACP grant review 2000 2001 New Investigators Program for Pharmacy Faculty
2000
Member Membership Committee of the Society ofToxicology elected position 2001 2004
Secretary International Society for the Study of Xenobiotics elected position 20022006
Member Organizing Committee 13 North American ISSX Meeting and JSSX Japanese Society Meeting
Maui Hawaii October 2005
Member Review Committee for Site Visit to Johns Hopkins University for NIEHS Center Grant Application
Baltimore MD June 1215 2002
Chair National Academy of Sciences Subcommittee on Spacecraft Exposure Guidelines 20022008
Member NIH Member Conflict Study Section Review Panel Bethesda MD October 7 2002
Member Environmental Health Sciences Review Committee NIEHS NIH 20022006
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 -    cienc slNational      (199 -97). 
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e ber - ational cadc y f ciences ubco ittee on ilitary okes and bscurants (1997-2000). 
- i  e  - t i  st ict  f i l  (199 -96), ice- r si t (19 -9 ), r si t 
(1997-9 ). 
r - rt  ri  i l I  itt  (199 -9 ). 
i - i t l t - echanis s Section of the Society of oxicology (1997-98); ice-President (1998-99); 
 (19 - 00). 
r - r r  ittcc f r i l i l ti  I t r iat s I  ti  i  ris, July, . 
 -  -12 ittee  t  i t   i l  ti  itte  (1 7-199 ). 
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ir - cientific ffairs o ittee, International ociety for the tudy ofXenobiotics (1998-2001). 
e  - ouncil, International Society for the Study of enobiotics (1998-2001). 
ir - P a el ra t re ie , 9-2000 e  I esti at rs r ra  f r ar ac  ac lt  (1 9). 
r - ti l   i  itt   r ft s re i lines (19 - 09). 
e ber - cie tific is r  ittee, 0th rt  erica  I  eeti g, I ia apolis, ct er, 0. 
e ber - Scientific dvisory oard and Progra  o ittee, 6th InternationallSS  eeting, unich, er any, 
, . 
e  - rganizing o ittee, 11 th orth erican ISS  eeting, rlando, ctober, 2002. 
e e  - i rsit  f lif r ia - l t  isease s r  r r , r i  itt ,  
i , , ay -5, . 
 - Biological Sciences CP grant revie , 2000-2001 e  Investigators Progra  for Phar acy Faculty 
(20 0). 
e r - e bership o ittee f the ociety f oxicology - elected position (2001-2004) 
 - I t r ti l i t  f r t  t  f e i tics - l t  siti  (2002-20 ) 
e  - rganizing o ittee, 13th orth erican ISS  eeting and JSS  (Japanese) Society eeting, 
i, i , r,  
e r - evie  o ittee for ite isit to Johns opkins niversity for I  enter rant pplication, 
, O, e -15, . 
ir - ti l ca  f cie ces c ittee  acecraft s re i elines (20 - 08). 
e be  - I  e ber onflict Study Section evie  Panel, ethesda, , ctober 7, 2002 
e r - iron e tal ealt  cie ces e ie  ittee, I , I  (2002-20 ) 
e ber - xecutive o ittee, ivision f he ical oxicology, erican he ical ociety - l t  
siti  (2 04-20 ) 
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Member Program Committee for Biological Reactive Intermediates VII meeting in Tucson AZ Jan 48 2006
Member NIII Special Emphasis Panel for XNDA Member Conflict applications Bethesda MD June 26 2006
Member Expert Panel for Naphthalene State oftheScience Symposium Monterey CA October 912 2006
Member Peer Consultation for Ethylbenzene Panel for the Voluntary Children Chemical Evaluation Program
associated with the US Environmental Protection Agency February 2223 2007
Member Awards Committee of the Society of Toxicology elected position 20072010
MemberNIH Member Conflict Study Section Review Panel Bethesda MD March 13 2007
Member Expert Panel on Styrene for the National Toxicology Program DHHS Report on Carcinogens
Research Triangle Park NC July 21 22 2008
Chair Scientific Liaison Task Force of the Society of Toxicology 20082010
CoChair Symposium on Novel Extrahepatic Cytochrome P450s Functional Roles 9 International ISSX
Meeting Instanbul Turkey September 48 2010
Member NIH Special Emphasis Panel Challenge Grants Panel 19 ZRGI CVRSB 58 R Bethesda MD July
20 2009
Member NIEHS Superfund Basic Research Program P42 Review Meeting RTP NC Oct 2729 2009
Manuscript Reviewer for
Toxicology and Applied Pharmacology
Molecular Pharmacology
Journal ofMedicinal Chemistry
Biomedical and Environmental Mass Spectrometry




Journal of Pharmacology and Experimental Therapeutics
Archives ofBiochemistry andBiophysics
Drug Metabolism andDisposition
Journal ofToxicology andEnvironmental Health
Journal ofOrganic Chemistry













Cross College Coordinating Committee for the Improvement of Instruction 198285
Subcommittee for the Graduate Student Summer Stipend Program 1984





 - r  itt  r i l i l acti  I t i t  II eti  i  son, Z, Ja  4- , 006. 
r - NIH peci l i  l f r  r onfli t ppli ati ns, ethesda, D, Ju  26, 2006. 
e ber - xpert anel for aphthalene tate-of-the- cience Sy posium, onterey, A, ctober 9-12, 2006. 
e ber - Peer onsultation for thylbenzene Panel tor the oluntary hildren's he ical valuation Program; 
associated ith the S Environ ental Protection gency, February 22-23, 2007. 
e ber-  i   t e ci t   xi l  - electe  siti  (2 - 10) 
er- NIH  onfli t t  ecti   anel, t esda, ,  ,2007. 
e ber - rt l  t r  f r t  ti l i l  r ra , S, rt  arcinogens, 
r   ark, , ul  -2 , 08. 
Chair - i ti i  i i     t  ci t   i l  (2 -2 0) 
Co-Chair - i   l tr ti  t r   - ti l l s, th   
ti g, t nbul, y, t  -8,2010. 
e er - I  Special E phasis Panel, Challenge rants Panel 19, ZR  1 C RS-B (58) R, Bethesda, , July 
,2009. 
e ber - IE S Superfund asic esearch Progra  (P42) evie  eeting, TP, , ct 27-29, 2009. 
t  r: 
OXic l   lie  r l  
l   
l  i  y 
i i l  i t l  ct t  
    
f   
i l  tt  
Xenobiotica 
Journal f Phar acology and Experi ental Therapeutics 
rchives  ioche stry  iophysics 
u  t lis   is iti  
l    ron   
 f c e stry 
erican J r l f es ir t ry ell  lec l r i logy 
ty 
ioche s y 
  
Cinogenesis 
T c c  S iences 
J l f i lo ic l i t y 
J  f ics 
t io  ch 
ioorganic  e cinal he istry ette s 
Jo r l f Inorganic ioche istry 
ITTEE : 
niversity-wide: 
ross ollege oordinating o ittee for the Improvement of Instruction (1982-85) 
S co itt e for the raduate t de t Su er tipend Program (19 ) 
Subco ittee on olecular and Cell iology for the rant-in-Aid Progra  (Chairman, 1984-85) 
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Human Subjects Review Board 198687
Mass Spectrometer Advisory Committee with Chemistry Department 198387
Representative Graduate Studies Committee for four Doctors Examinations and Masters Examination 198487
Institutional Animal Care and Use Committee 199497
University Promotion and Tenure Committee 19972000
University Research Committee 20012004 Chair 200304
College ofPharmacy
Recruitment and Admissions Committee for PharmacologyToxicol g program Chairman 198287
Graduate Faculty Executive Committee 198283
Burroughs Wellcome Visiting Professorship Author of Applications 1982 and 1983
Undergraduate Research Awards Chairman 1983
Ad Hoc Committee on Graduate Program 1983
Safety Committee Chairman 1983 84
Pharmaceutics Position Search Committee Chairman 198485
Research Committee 198587
PharmacologyToxicolog Position Search Committee 198687
Research Committee 198791
Teaching Committee for Department of Pharmacology and Toxicology 19881990 19921994
Organizer of Pharmacology and Toxicology Seminar Program 19881992
Pharmacology and Toxicology Faculty Search Committee 198889
Councilor for AACP Research Participation Program for Undergraduate Minorities 19881995
Dean Search Committee 198889
Chairman Pharmacology and Toxicology Faculty Search Committee 199091
Delegate to AACP from College of Pharmacy University of Utah 199192
Scholastic Standards Committee and Advisor for Class of 1994 Pharmacy Students 1991 94 Chair 199394
Graduate Training Committee 1992 1996
Pharmacology and Toxicology Faculty Search Committee 1994
Chairman Graduate Recruitment Committee 19941996
Computer Committee 19972001
Task Force on Faculty Development 1997
Search Committee for Chair of Pharmacology and Toxicology 1998
Curriculum Committee College of Pharmacy 19982001
CoChair Standards for Library Learning Resources Accreditation SelfStudy 199901
Chairman 2001 2008 and Member Learning and Teaching Committee 19972008
Graduate Recruitment Committee Department of Pharmacology and Toxicology 2002 present
Graduate Training Committee Department of Pharmacology and Toxicology 2002 present
Coordinator Academic Affairs College of Pharmacy 20032008
Scholastic Standards Committee College of Pharmacy 2007 present
Assessment Committee College of Pharmacy 2009present
INSTRUCTIONAL ASSIGNMENTS




 Subj  evi  r  (1 - 7) 
 Spectr t r i r  o itt  it  hemistr  part t ( - 7) 
Y  00013 
6 
epresentative, raduate Studies o ittee for four Doctor's Exa inations and aster's Examination (1984-87) 
I stit ti al i al r     (1 - ) 
i r it  r ti  an  r  o itt  (1 -2 0) 
niversity esearch o ittee (2001-2004); hair (2003-04) 
l   ar acy: 
ecruit ent and d issions o ittee for Pharmacologyrroxicology progra  (Chair an, 1982-87) 
r t  facult  ti  itte  (1 -8 ) 
rr s ellc e isiti  r fessorship. t r f licati s (1  a  983) 
 r   (C n, 983) 
  itt   r t  r r  ( 3) 
 t  (Cha r , -8 ) 
r ti s siti  r  ittee (C ir n, -8 ) 
 tte  (198 -8 ) 
harmacologyrr xicology i   tte  (t 98 -8 ) 
  (198  -9 ) 
i  ittee f r rt e t  r l   i l  (1988-1 , -19 ) 
r i r fPhar e l   i l  i r r r  (1988-1 2) 
l   i l  lt   ittee (1988-8 ) 
il r f r  r  rti i ti  r r  f r r ra uate in rities (198 -19 ) 
  ttee (1988-8 ) 
ir , r l   i l  lt  r  itte  (1990-9 ) 
ele ate t   fr  llege f ar ac , i ersit  f ta  (1991-9 ) 
Scholastic Standards o ittee and dvisor for lass of 1994 Phar acy Students (1991-94); hair (1993-94) 
r t  r i ing ittee (1 92- 99 ) 
ar ac l  a  ic lo  ac lt  earc  ittee (19 ) 
ir , raduate r it e t ittee (1994-19 ) 
t  i tee (1997-20 ) 
as  rce  a lty e elop e t (19 ) 
earch o ittee for hair f har acology and oxicology (1998) 
rriculum o itte , llege  a  (1998-200 I) 
- , tandards for ibrar  & earning es urces - Accreditation Self-Study (1999-01) 
hair an (2 01-200 ) and e , ea ing  e ing ittee (1 97-20 ) 
raduate Recruit ent Co ittee, epartment of Phar acology and Toxicology (2002-present) 
Graduate Training Committee, Department of Pharmacology and Toxicology (2002-present) 
oordinator, cade ic ffairs, ollege of Phar acy (2003-2008) 
Scholastic Standards o ittee, College of Phar acy (2007- r s t) 
Assess ent Co ittee, ollege of Phar acy (2009-present) 
INS  AS : 
Course * redit ours Course itle Contact Hours/Quarter r ester 
ashington State niversity 
Y ST 0013 
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Phar 331 3 Organic Med Chemistry 10
Phar 436 3 Chemotherapy 22
Phar 471 4 Chemical Pharmacology 20
Phar 472 5 Pharmacodynamics 9
PT 505 4 Principles of Toxicology 6
PT 506 5 Principles of Pharmacology 5
PT 525 3 Instrumental Techniques in 38
PharmacologyToxicolog
PT 532 2 Drug Metabolism 30
University of Utah
Ph Tx 6610 4 Princ PharmToxico 510 students 18
Ph Tx 6620a 3 Analytical Tox 510 students 4
Ph Tx 6630a 2 Biochemical Tox 510 students 10
Ph Tx 6710 1 Developments Biochem Tox J Club 15
Ph Tx 571 1988 95 5 Pharmacology 60 students 1
Ph Tx 52116 5 Pharmacology 50 students 2
Pharmacol 6030 6040 variable Pharmacology for Med Students 3
Current Courses
Ph Tx 6600 2 Methods in PharmTox 5 10 students 4
PHARM 5113 2 Basics ofPharmaceutical Sciences 4
PHARM 7113 3 Fundamentals ofPharmaceutical Sci 12
Ph Tx 7114 2 Principles of Toxicology 9
Indicates responsibility for administration of course either current or past years Coursemaster for PhTx 572
only for winter quarter of 1988 and 571 for 1989 92
a Taught alternate years
GRADUATE STUDENTS
Name Thesis Title Degree Year
Brent L Finley Characterization and Isolation of PhD 1986
Ethanol Induced UDP
Gl uc uronyltransferase
Michael G Horstman Mechanism ofToxicity and MS 1987
Chemotherapy of the Antineoplastic
Agent Procarbazine
Jeannette Huijzer Bioactivation of3Methylindole and PhD 1987
the Involvement of Cytochrome P450
Monooxygenases






Phar 331* 3 r ani  ed. he istr  10 
Phar 436* 3 he ot erapy 22 
Phar 471 4 hemical Pharmacology 20 
Phar 472 5 har acodyna ics 9 
PIT 505 4 Principles of Toxicology 6 
PIT 506 S ri ci les f h anna co logy 5 
PIT 52S* 3 Instru ental echniques in 38 
harmacology/T xicology 
PIT 532* 2  l   
   
Ph Tx 6610* 4 rine. harm.l oxicol. (S-10 students)  
Ph x 6620  3 nalytical Tox. (5-10 students) 4 
Ph Tx 6630  2 i i l ox. (5-1  tudents)  
Ph Tx 6710* 1  i . x. . l   
Ph Tx 571 * (1988-9 ) S r l  (60 st ents)  
Ph Tx 5211/6211 5 Phar acology (50 students)  
Pharmacol. 6030 &  aria le r col  f r  t ts  
urrent ourses 
Ph Tx 6600 2 t  i  /To  (5-  t ents)  
P  5113 2      
PHAR  7113 3 s fPhar n c uti  i.  
Ph Tx 7114  ri ciples f ic l   
* Indicates responsibility for ad inistration of course, either current or past years. Course aster for PhTx 572 
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Changes in Morphine PhD
Pharmacokinetics After Chronic


















In Vitro Activation ofProcarbazine PhD
to Cytotoxic Species
Metabolism and Mechanism ofToxicity PhD
of3Methylindole in Human and
Goat Tissues
Metabolic Activation of the Pneumotoxin PhD
3Methylindole
Bioactivation of3Methylindole by PhD
Individual Cytochrome P450 Isozymes
Cloning and Sequencing of PhD
Ethanol Induced
UDP Glucuronosyltransferase
Cloning and Characterization of PhD
Pulmonary Cytochrome P450 Genes
Bioactivation and Pneumotoxicity of PhD
Halogenated Hydrocarbons
Cloning ofCytochrome P450 21 a PhD
Catalyst of the Unique Dehydrogenation
of3Methylindole
Characterization ofProtein Targets of PhD
the Pneumotoxin 3Methylindole
Cloning ofEthanol Induced PhD
UDP Glucuronosyltransferase
Protein Targets of 3Methylindole PhD
in Human Lung Cells
Mechanistic Studies of the Cytochrome PhD
P450Dependent Oxygenation and
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 .  hanges in orphine h.D.  
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Treat ent in abbits 
iane S affar I  itr  cti ati  f r car azi e h.D.  
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tt   - in e    
at iss es 
      eu otoxi  h.D.  
- n e 
Janice ioactivation of3- ethylindole by h.D.  
r t - i  I i id l t r   I es 
  loning and equencing f h.D. I st tati  (199 -9 ) 
ol-  
- lucuronosyltransferase 
     h.D. 1995 
a a a t  l r  t r    
  i ti ti   t xi it   h.D.  tati  (1992-9 ) 
alogenated ydrocarbons 
a e a  l i  f t r e  F3,  h.D. 1996 
Catalyst of the Unique Dehydrogenation 
f - et lindole 
J ee aster r t ri ti  f r t i  argets f h.D.  
t e e t in - et lindole 
a c  argas   t a -  h.D. I SI Rotation (1993-94) 
- lucuronos ltransferase 
eanna II ubbard Protein argets of3- ethylindole h.D. 1 Sl Rotation (1995-96) 
in u an Lung Cells 
onsta tine r s echanistic Studies of the ytochro e h.D.  
- t ygenation  





Brian Carr Regulation ofCytochrome P450 CYP2FI PhD 2002
Gene Expression
Chad Borges Intramolecular Deuterium Isotope Effects PhD IRotation 199798
in cDNAExpressed P450 Enzymes
Brian Klein Regulation of Cytochrome P450 CYP4B 1 PhD 2nd Rotation 199899
Gene Expression
Craig Osborne Mutation and Expression of PhD 1Rotation 199899
Cytochrome P450 CYP413 1 2nd Rotation 199900
Jason Biggs Lung Selective Regulation of the PhD 2005
Human CYP3A Genes
Stacy Smeal Metabolism ofCapsaicinoids by PhD 2nd Rotation 2001 02
Human P450 Enzymes
Jaya Kartha Biochemical and Mechanistic PhD 2007
Characterization of Pulmonary Selective
Cytochrome P450 2F 1 and 2173
Ashwini Sabnis Expression and Characterization of PhD 2007
TRPM8 Receptors in the Lung
Epithelium Implications in Asthma
Hao Sun Mechanisms of Cytochrome P450 PhD 2007
Mediated Dehydrogenation
Cassandra DeeringRice Nanoparticle Alteration of PhD 2008
Endothelial Cell Function
Mohammad Shadid DNA Adducts and 3Methylindole PhD 2008
Carcinogenesis
Chad Moore Bioactivation of Raloxifene a new PhD 2009
Hormone Replacement Agent
Kiumars Shahrokh Inactivation ofCYP2B6 and CYP2D6 PhD 2009
by Tamoxifen Reactive Intermediates
Karen Thomas Mechanisms ofCapsaicin PharmDPhD 2010
Dehydrogenation
Fred Henion Structural Characterization ofthe PharmDPhD 2011
Glutathione Adducts of Capsaicin
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h.D. J sl tati  (19 -9 ) 
h.D. nd t ti  (19 -9 ) 
h.D. 51 t ti  (19 -9 ) 
2nd Rotation (1999-00) 
h.D.  















Jessica Roberts Pediatric Asthma PhD 2013
James C Taylor Glucocorticoid Metabolism PhD 2013
GRADUATE STUDENT ANDPOSTDOCTORAL FELLOW RECOGNITION
Brent Finley received a PhRMA Foundation Pre Doctoral Fellowship 1984
Brent Finley won third prize for the Graduate Student Research Award contest for the SOT Mechanisms Section
1986
Janice Thornton Manning received a SOT Graduate Student Fellowship sponsored by Proctor and Gamble for
199192
Janice ThorntonManning received first prize for the best abstract from the Molecular Biology Section of SOT
1991
Gary L Skiles received first prize for the Graduate Student Research Award contest for the SOT Mechanisms
Section 1992
Chris Reilly was awarded the ColgatePalmolive Postdoctoral Fellowship in In Vitro Toxicology through the
Society ofToxicology 2001
Jason S Biggs won the ColgatePalmoliveSOT Award for Student Research Training in Alternative Methods
2001
Jason S Biggs won first prize for the best poster by a graduate student from the North American Meeting of the
International Society for the Study ofXenobiotics Orlando Florida 2002
Ashwini S Sabnis won second prize for student poster presentation at the 2004 Mountain West Society of
Toxicology Regional Chapter Meeting
John M Veranth received the 2004 Project of the Year Award from the Strategic Environmental Research and
Development Program The award was presented by Mr Alex Beehler Assistant Deputy Under Secretary of
Defense for Environmental Safety and Occupational Health of the United States of America
Ashwini S Sabnis was a finalist for the Graduate Student Research Award contest for the SOT Mechanisms
Section 2006
Hao Sun won 3 place in the Graduate Student Research Award contest for the SOT Mechanisms Section 2007
Aaron Rowland won first place award postdoctoral fellows for his abstract by the Molecular Biology Section
Society ofToxicology March 2007
Aaron Rowland won the Colgate Palmolive Post Doctoral Fellowship through the Society of Toxicology April 1
2007 March 31 2008
Aaron Rowland received NRSA Postdoctoral Fellowship from NHLBI July 15 2007 June 30 2010
Kiumars Shahrokh received a Graduate Research Fellow award from the University of Utah Graduate School
200809
Kiumars Shahrokh received 2nd place in the Young Investigator Session in the Division of Chemical Toxicology
American Chemical Society meeting Philadelphia August 18 2008
Mohammad Shadid received 1 prize for the best poster by a graduate student from the North American Meeting
ofthe International Society for the Study of Xenobiotics San Diego October 12 16 2008
Kiumars Shahrokh won the Chemical Computing Group Excellence Award for the Fall 2009 ACS National
Meeting in Washington DC August 16 20 2009
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Jason S. iggs on the olgate-Pal olive-S  ard for Student esearch raining in lternative ethods 
(20 ) 
Jason S. iggs on first prize for the best poster by a graduate student fro  the orth erican eeting of the 
I ter ational ciet  f r t e t  f enobiotics, rla o, l ri a (20 ) 
sh ini . abnis on second prize for student poster presentation at the 2004 ountain est ociety of 
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evelop ent Progra . The a ard as presented by r. lex eehler, ssistant eputy nder Secretary of 
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 (20 ) 
ao un on 3rd place in the raduate tudent esearch ard contest for the  echanis s ection (2007) 
aron Ro land on first place a ard (postdoctoral fello s) for his abstract, by the olecular Biology Section, 
ociety f oxicology (March 2007) 
aron o land on the olgate-Pal olive Post- octoral Fello ship through the Society of Toxicology (April 1, 
 - arch 31, 2008) 
aron o land received S  Postdoctoral Fello ship fro  I (July 15,2007 - June 30, 2010). 
iu ars Shahrokh received a raduate Research Fello  a ard fro  the niversity of tah raduate School 
(2008-0 ) 
Kiu ars Shahrokh received 2nd place in the Young Investigator Session, in the Division of Che ical Toxicology, 
merican he ical ociety eeting, hiladelphia, ugust 18, 2008. 
ohammad Shadid received 1 st prize for the best poster by a graduate student fro  the orth erican eeting 
of the International Society for the Study of enobiotics, San iego, ctober 12-16, 2008. 
iumars Shahrokh on the he ical o puting roup xcellence ard for the Fall 2009 S ational 







James D Adams Jr 1985 87
JohnYan Jaw 198687
David J Kuntz 19871988
Stephen G Gillespie 1987 1988
Jeffrey C Hoyt 19881989
Martin L Appleton 19881995
Ghazi Dannan 1989 92
Bradford Manning 199192
Mark Flood 1992 1994
Joyce Manzella 1992 1994
Rashmi Mehta 1995 1997
Cai Yuan 19951997
Kon Skordos 20022003
Christopher A Reilly 1999 2001 and Res Assoc Prof 2001 present
Jie Wan 2001 2004
John M Veranth Res Asst Prof 2001 present
Mark Johansen 2003 2005
LaHoma Easterwood 20032006
N Shane Cutler Res Asst Prof 2003 2009
Aaron Rowland 20052008
Christopher R Orton 20062009
Takahiro Murai 2008 2010
Cassandra DeeringRice 2009 present
Chad Moore 2009 present
Kiumars Shahrokh 2010 present




Title Submitted to Per Year Period
Stereoselective Drug Pharmaceutical Manufacturers 6500 1821283
Metabolism Association
Alcoholism and Stereo WSU Grant inAid Alcoholism 13952 282183
selective Drug
Metabolism
Stereoselective Drug College of Pharmacy BRSG Funds 3500 482383
Metabolism
Toxicities of the Alkyla WSU American Cancer Society 5131 782683
000430
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Characteristics with Toxicity
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PAPERS POSTERS AND PRESENTATIONS
Invited LecturesSeminars
1 Alcoholism and Drug Metabolism PharmacologyToxicolog Seminar Washington State University April
1983
2 Mechanisms of 3Methylindole Pneumotoxicity University of California San Francisco July 8 1985
3 Recent Findings on the Chemical Nature and Biochemical Mechanisms of the Toxic Agent Involved in 3
Methylindole Induced Acute Lung Injury Natural Toxin Symposium Rocky Mountain Regional Meeting
American Chemical Society Denver Colorado June 812 1986
4 Chemically Induced Pneumotoxicities Animal Investigations and the Human Situation Mountain West
Society of Toxicology Meeting Salt Lake City Utah September 2223 1988
5 3Methylindole Bioactivation and Lung Injury Society of Toxicology Symposium on Mechanisms of Lung
Injury by Systemically Administered Chemicals CoChairmen Garold S Yost and Alan R Buckpitt Atlanta
Georgia February 27 March 3 1989
6 Glutathione Depletion Causes Organ Selective Switch in 3Methylindole Toxicity Battelle Pacific Northwest
Laboratories Richland Washington April 26 1989
7 Glutathione Depletion Causes Organ Selective Switch in 3Methylindole Toxicity Washington State
University Pullman Washington July 28 1989
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I. Alcoholism and Drug Metabolism, PharmacologylToxicology Seminar, Washington State University, April, 
1983. 
. ec a is s  - et l indole toxi it , iver it  f li f mi ,  r i o, l  ,1985. 
3. Recent Findings on the Che ical ature and Bioche ical echanis s of the Toxic gent Involved in 3-
Methylindole Induced Acute Lung Injury, Natural Toxin Symposium, Rocky Mountain Regional Meeting, 
merican e ical , , , e -12, . 
4. he ically Induced Pneu otoxicities; ni al Investigations and the u an Situation, ountain est 
iety f ic lo  e ti , lt ake it , t , t r -23, . 
5. 3-Methylindole Bioactivation and Lung Injury, Society of Toxicology Symposium on Mechanisms of Lung 
Injury by Systemically Administered Chemicals, Co-Chairmen: Garold S. Yost and Alan R. Buckpitt, Atlanta, 
Ge , e ruary 27 - arch , . 
6. lutathione epletion Causes rgan Selective S itch in 3- ethylindole Toxicity Battelle Pacific orthwest 
Laborat ries, Richla , as in t , pril , . 
7. Glutathione epletion Causes rgan Selective S itch in 3- ethylindole Toxicity ashington State 
University, Pullman, ashington July 28, 1989. 
ST 00021 
YOST 00022
8 Mechanisms of Pneumotoxicity and Nephrotoxicity of 3Methylindole University of Connecticut Toxicology
Scholars Colloquium Storrs Connecticut February 1990
9 Pneumotoxicity of Environmental Contaminants Mountain West Society of Toxicology Meeting Tucson
Arizona October 45 1990
10 Biochemical Mechanisms of 3Methylindole Pneumotoxicity Biochemical Interest Group Seminar University
of Utah Salt Lake City Utah February 12 1991
11 Pneumotoxins From Natural Products Continuing Education Course on Natural Toxins Society of Toxicology
Annual Meeting Dallas Texas February 25 1991
12 Chemical and Biochemical Mechanisms of 3Methylindole Pneumotoxicity Program in Molecular and
Environmental Toxicology University of Colorado Boulder Colorado March 13 1991
13 Chemical Bioactivation of 3Methylindole Department of Medicinal Chemistry University of Washington
Seattle Washington April41991
14 Bioactivation of Pulmonary Toxins in Lung Cells Symposium on Contribution of the Respiratory Tract to the
Metabolic Fate of Inhaled Chemicals FASEB Meeting Atlanta Georgia April 14 1991
15 Cytochrome P450 Monooxygenase Based Mechanisms of Lung Toxicity Symposium on The Pulmonary
Cytochrome P450 System American Lung Association and American Thoracic Society Meeting Anaheim
California May 14 1991
16 Mechanisms of 3MethylindoleMediated Pneumotoxicity in Human and Animal Tissues Inhalation
Toxicology Research Institute Albuquerque New Mexico October 9 1991
17 Mechanisms of Bioactivation and Pneumotoxicity of Environmental Chemicals Toxicology Seminar Program
College ofPharmacy University of New Mexico Albuquerque New Mexico October 9 1991
18 Protein and DNA Adducts of Bioactivated 3Methylindole Symposium on Biological Markers Society for
Risk Analysis Meeting Baltimore Maryland December 9 1991
19 Bioactivation of 3Methylindole by cDNAExpressed Cytochrome P450 Enzymes SmithKline Beecham
Pharmaceuticals Swedeland Pennsylvania May 2 1992
20 Role of Cytochrome P450 in the Bioactivation of the Pneumotoxin 3Methylindole Division of Pulmonary and
Critical Care Medicine University of Texas Houston Texas November 17 1993
21 Bioactivation Mechanisms Related to LungSelective Toxicants Symposium on Frontiers in Molecular
Toxicology 1994 North American International Society for the Study of Xenobiotics meeting Raleigh North
Carolina October 25 1994
22 Mechanisms of Cytochrome P450Mediated Formation of Pneumotoxic Electrophiles Fifth International





. i   eu otoxicit   r toxi it   - t li l  i r it  f cti t i l  
l rs ll i , t rrs, nnecticut, ebruary, 0. 
9. Pneu otoxicity of Environ ental Conta inants ountain est Society of Toxicology eeting, Tucson, 
,  -5, 90. 
. i i l i   - t li l  u otoxi it  i i l I t r t r  eminar, i rsit  
f ta , alt a e ity, ta , e r ar  2, 1. 
. t i s r  t r l r ts ti i  ti  rs   t r l i s, i t  f i l  
 ti g, l s, ,  , 91. 
. e ical a  i c e ical ec a is s f - et lin le e t icit  r ra  i  lec lar a  
ir t l i l y, i it   l r do, l r, l r do,  3, . 
. e ical i acti atio  f - et lin le e art e t f e ici al e istry, i ersit  f as i t , 
eattle, ashi gton, ril ,199 . 
14. ioactivation of Pul onary Toxins in Lung ells Sy posiu  on ontribution of the espiratory Tract to the 
etabolic ate fl ale  he icals,   eeting, tlanta, eorgia, pril 14, 1991. 
15. ytochro e -450 onooxygenase ased echanis s f ung oxicity y posiu  on he ul onary 
ytochro e P-450 Syste , erican Lung ssociation and erican Thoracic Society eeting, nahei , 
, a  , . 
16. echanis s of 3- ethylind01e- ediated Pneu otoxicity in u an and ni al Tissues Inhalation 
oxicology esearch Institute, lbuquerque, e  exico, ctober 9, 1991. 
. echa is s f ioacti ation a  e t icit  f iron e tal e icals ic lo  e i ar r ra , 
ollege of Phannacy, niversity of e  exico, lbuquerque, e  exico, ctober 9, 199]. 
18. Protein and  dducts of ioactivated 3- ethylindole Sy posiu  on iological arkers, Society for 
isk nalysis eeting, alti ore, aryland, ece ber 9, 1991. 
19. Bioactivation of 3- ethylindole by cDNA-Expressed Cytochro e P450 Enzy es S ithKline Beecha  
Phannaceuticals, S edeland, Pennsylvania, ay 2, 1992. 
. le f tochro e  i  the ioactivation f t e e t in - et lind le i isio  f l ar  a  
ritical are edicine, niversity of exas, ouston, exas, ove ber 17, 1993. 
21. ioactivation echanisms elated to ung- elective oxicants y posiu  on rontiers in olecular 
Toxicology, 1994 orth erican International Society for the Study of enobiotics eeting, aleigh, orth 
, tober , . 
22. echanis s of Cytochro e P450- ediated Fonnation of Pneu otoxic Electrophiles, Fifth International 
Sy posiu  on iological eactive Inter ediates, unich, ennany, January 4-8, 1995. 
  
YOST 00023
23 Pulmonary Toxicology American Chemical Society short course on Chemical Mechanisms in Toxicology
Atlanta Georgia April 45 1995
24 Molecular Mechanisms of 3Methylindole Induced Lung Toxicity Department of Pharmaceutical Sciences
School of Pharmacy University of Colorado Denver Colorado May 22 1995
25 Mechanisms of 3Methylindole Bioactivation Catalyzed by Pulmonary Cytochrome P450 Enzymes Gordon
Research Conference on Drug Metabolism Holderness New Hampshire July 914 1995
26 Mechanisms of Cytochrome P450Mediated Bioactivation of the Pneumotoxin 3Methylindole Merck
Research Laboratories West Point PA and Rahway NJ October 24 25 1995
273Methylindole Dehydrogenation Mechanisms Protein Targets and Species Selectivity University of
Arizona Tucson Arizona March 34 1997
28 Mechanisms of Formation and Toxicity of Imine and Epoxide Intermediates of the Pneumotoxin 3
Methylindole Department of Medicinal Chemistry and Pharmacognosy University of Illinois at Chicago
Chicago Illinois December 4 1997
29 Multiple Reactive Intermediates of the Pneumotoxin 3Methylindole 7 European ISSX Meeting Budapest
Hungary August 22 1999
30 Molecular Mechanisms of Respiratory Toxicity Associated with Dehydrogenation of Pneumotoxicants by
Cytochrome P450 Enzymes Department of Medicinal Chemistry University of Minnesota Minneapolis
Minnesota December 7 1999
31 Mechanisms of 3MethylindoleMediated Lung Injury Department of Pathology Colorado State University
Ft Collins Colorado May 1 2000
32 Mechanisms of Gene Regulation and Bioactivation of Lung Toxicants by Selective Cytochrome P450
Enzymes l3 International Symposium on Microsomes and Drug Oxidations Stresa Italy July 12 2000
33 Bioactivation of Toxicants by Cytochrome P450Mediated Dehydrogenation Mechanisms 6th International
Symposium on Biological Reactive Intermediates Paris France July 16 2000
34 Lung P450 Enzymes Function Gene Regulation and Dehydrogenation of SubstratesToxicants Pfizer Inc
November1562000
35 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung Zeneca Traveling Lectureship University Rene Descartes Paris France
Nestle Research Center Lausanne Switzerland and GenPharmTox Inc Munich Germany May 2 15
2001
36 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung Zeneca Traveling Lectureship National Institute of Public Health Oslo






3. l r  i l y, ri  i l oci t  sh rt co rs   e i l nis s i  xi ology, 
ta, eorgia, ril -5, 1995. 
4. lec lar ec a is s f - et li le-l ce   xicity, e art ent f ar aceutical ciences, 
c ool  harmacy, i i  f l rado, nver, l rado, y 2, 1995. 
5. ec a is s f - et li le i acti ati  atal ze   l ar  t c r e 450 zy es, r  
    t bolis , ss,  shire, July -1 ,1995. 
.    50-   f  neu oto i  - t yli le,  
r  r t ri s, t i t,   h ay, J, t r -2 ,1995. 
7. 3- in le ti : echanis s, Protein argets, and Species Selectivity, niversity of 
, son, ,  -4, 7. 
. i   ti   i it   i   i  t i t   t  eu t i  -
ethylindole, Department of edicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 
, lin ,  , 7. 
29. ultiple eactive Inter ediates of the Pneu otoxin 3- ethylindole, th European ISS  eeting, udapest, 
r , u s  , . 
30. olecular echanis s of Respiratory Toxicity Associated with Dehydrogenation of Pneu otoxicants by 
Cytochrome P450 Enzymes, Department of edicinal Chemistry, University of innesota, inneapolis, 
in t ,  , . 
31. Mechanisms of 3-Methylindole-Mediated Lung Injury, Department of Pathology, Colorado State University, 
. l , ,  , . 
. echanis s  e e l tion  i ti atio    ica ts  l ti e t r e  
nzy es, 13th International Sy posiu  on icrosomes and rug xidations, Stresa, Italy, July 12,2000. 
33. ioactivation of oxicants by ytochro e P450- ediated ehydrogenation echanis s, 6th International 
si   iological ti e I ter i t s, ris, r , J l  , . 
34. ung P450 nzy es: Function, ene egulation, and ehydrogenation of Substrates/Toxicants, Pfizer, Inc., 
ove ber 5-16, 20 0. 
. e lation f tochro e  e  xpression  echanis s  0- e iated icities  
e toxicants in uman u , eneca ra eling ect res i , iversit  e e escartes, aris, ra ce; 
estle esearch enter, ausanne, S itzerland; and enPhar ox, Inc., unich, er any; ay 2 - 15, 
2001. 
3 . e lation f tochro e  ene pressi   echanis s f - ediated icities f 
Pneu otoxicants in u an ung, eneca raveling ectureship, ational Institute f ublic ealth, slo, 
or ay; straZeneca and Syngenta, lderley Park, ; and niversity of ulu, ulu, Finland; June 29 -
J ly , . 
T  
YOST 00024
37 Dehydrogenation as a Mechanism for Pneumotoxicity 6 International Meeting International Society for the
Study of Xenobiotics Munich Germany October711 2001
38 Human Lung Epithelial Cells Used to Elucidate Mechanisms of P450 Gene Expression and Lung Toxicities
presented through the Colgate Palmolive Traveling Lectureship in Alternative Methods in Toxicology Award
Department of Pharmacology and Toxicology Medical College of Wisconsin Milwaukee Wisconsin August
2 2001
39 Vanilloid Receptors in Human Lung Epithelial Cells Response to Pepper Sprays and Relationship to
Environmental Exacerbation of Pediatric Asthma presented through the ColgatePalmolive Traveling
Lectureship in Alternative Methods in Toxicology Award Department of Pediatrics Medical College of
Wisconsin Milwaukee Wisconsin August 3 2001
40 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung University of Arizona Tucson Arizona January 9 2002
41 Function and Regulation of Human CYP2171 and CYP413 1 in Lung American Society for Pharmacology and
Experimental Therapeutics Meeting New Orleans Louisiana April 20 24 2002
42 Lung P450s Mechanisms of Gene Regulation and Toxicant Bioactivation 14 International Symposium on
Microsomes and Drug Oxidations Sapporo Japan July 22 26 2002
43 Transcriptional Regulation of P450 Genes in Respiratory Tissues 11 North American Meeting International
Society for the Study ofXenobiotics Orlando Florida October 27 31 2002
44 Cytochrome P450Mediated Dehydrogenation vs Oxygenation of Xenobiotics Pathways to Cellular Injury
Purdue Pharmaceuticals Ardsley New York December 17 2002
45 Cytochrome P450Mediated Dehydrogenation vs Oxygenation of Xenobiotics Pathways to Cellular Injury
Merck Research Laboratories Rahway New Jersey and West Point Pennsylvania February 2021 2003
46 Enhanced Cytotoxicity of Capsaicinoids to TRPVIOverexpressing Human Lung Cells Society ofToxicology
Meeting Salt Lake City Utah March 9 13 2003
47 Mechanisms of Respiratory Inflammation from Pepper Sprays Human Effects Risk Characterization of
Non Lethal Weapons National Institute of Justice Oleoresin Capsicum Workshop Aberdeen Proving Ground
MD October 89 2003
48 Bioactivation of Xenobiotics by Dehydrogenation Mechanisms University of Texas Medical School
Galveston TX December 15 2003
49 Mechanisms that Control the Selective Expression of CYP2F1 CYP4B1 and CYP3A5 in Iluman Lung
Society of Toxicology Meeting Baltimore MD March 21 25 2004
50 Respiratory Tissue Selective Metabolism Dependent Toxicity 15 International Symposium on Microsomes





. r ti    is  f r u otoxicity, th I ter ti l ti , I t r ti l i t  f r t  
t  f i ti s, i , r ny, t r -1 I,  I. 
.  un  it li l lls s  t  l idate is  f   r i    i iti , 
presented through the Colgate-Palmolive Traveling Lectureship in Alternative ethods in Toxicology Award, 
epart ent of Phar acology and oxicology, edical ollege of isconsin, il aukee, isconsin, ugust 
, 1. 
. a illoid t rs i  a   it li l lls: s sc t  cr r s  l ti s i  t  
iron e tal acer ati  f e iatric st a, rese te  t r  t e l ate- al li e ra eli  
ectureship in lternative ethods in oxicology ard, epart ent of Pediatrics, edical ollege of 
isconsin, il aukee, isconsin, ugust 3, 200 I. 
40. egulation of ytochro e P450 ene xpression and echanis s of P450- ediated oxicities of 
Pneu otoxicants in u an Lung, niversity of rizona, Tucson, rizona, January 9, 2002. 
. ction a  e lati  f a  P2F I a  P4B  in , erica  ciet  f r ar ac l  a  
eri e tal era e tics eeti , e  rlea s, isia a, ril -2 , 2. 
42. ung P450s: echanis s of ene egulation and oxicant ioactivation, 14th International Sy posiu  on 
icroso es and rug xidations, Sapporo, Japan, July 22-26,2002. 
43. ranscriptional egulation of P450 enes in espiratory issues, 11 th orth erican eeting, International 
Society for the Study of enobiotics, rlando, Florida, ctober 27-31,2002. 
44. ytochro e P450- ediated ehydrogenation vs xygenation of enobiotics - Path ays to ellular Injury, 
Purdue Phar aceuticals, rdsley, e  ork, ece ber 17,2002. 
. t r  0- e iate  r e ti  s ti  f i ti s - t s t  ll l r I j r , 
erck esearch aboratories, ah ay, e  Jersey, and cst Point, Pennsylvania, February 20-21, 2003. 
46. nhanced ytotoxicity of apsaicinoids to PVI- verexpressing u an ung ells, ociety f oxicology 
e ti , lt e it , t , r  -1 ,2003. 
47. echanis s of Respiratory Infla ation fro  Pepper Sprays, u an Effects &  t r  f 
on-Lethal eapons, ational Institute of Justicc leoresin Capsicu  orkshop, berdeen Proving round, 
,  -9, . 
. i ti ti  f i tics  r ti  is s, i rsit  f as i l chool, 
l st n, , r , . 
49. echanis s that ontrol the Selective xpression of Y 2 l, Y 4 l, and Y 3 5 in Hu an ung, 
Society of Toxicology eeting, Balti ore, D, arch 21-25, 2004. 
50. espiratory Tissue Selective etabolis - ependent Toxicity, 15th International Sy posiu  on icroso es 
and Drug Oxidations, ainz, Germany, July 4-9, 2004. 
  
YOST 00025
51 Transcriptional Regulation of LungExpressed P450 Genes Mechanisms and Polymorphisms in Regulatory
Regions Mountain West Society of Toxicology Meeting Park City UT September 910 2004
52 Sequential Oxygenation and Dehydrogenation of Capsaicin Forms Unique Quinoneimines 7 International
Society for the Study of Xenobioties Meeting Vancouver Canada August 29 September 2 2004
53 Lung P450s Mechanisms of Gene Regulation and Toxicant Bioactivation featured speaker John Doull
Toxicology Symposium University of Kansas Kansas City MO September 23 2004
54 Maximal Research Success in a Minimal Funding Climate Speaker for the Winter Retreat with the topic
Strategic Initiatives to Increase Extramural funding to University of New Mexico College of Pharmacy
Albuquerque NM January 14 2005
55 P450Mediated Dehydrogenation Drug Bioactivation and Suicide Inactivation Mechanisms 2005 Rozman
Symposium in the Delaware Valley Drug Metabolism Discussion Group Sheraton bucks County Langhorne
PA June 8 2005
56 Xenobiotic Dehydrogenation Mechanisms Toxic Electrophilic Intermediates and Inactivation of Cytochrome
P450 Enzymes 13 North American ISSX 20 JSSX Joint Meeting Maui Hawaii October 2327 2005
57 Seventh International Symposium on Biological Reactive Intermediates Jan 38 2006 Tucson AZ two
abstracts and chaired a session BRIs and New Reactive Intermediate Chemistry
58 Reactive Intermediates AAPS Conference on Critical Issues in Discovering Quality Clinical Candidates April
24 26 2006 Philadelphia PA
59 Gordon Conference Mechanisms of Toxicity July 23 28 2006 Colby College Waterville ME chaired a
session Chemical Mechanisms of Xenobiotic Bioactivation and Toxicity
60 Session Organizer for Respiratory Drug Metabolizing Enzymes Selective Expression and Toxicology and
speaker CYP2F1 CYP3A45 and CYP4131 Selective Regulation and Bioactivation of Pneumotoxicants
16 International Symposium on Microsomes and Drug Oxidation Budapest Hungary September 37 2006
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This is a brief report intended to summarize my expert opinions about your case of Major v
Security Equipment Corporation and Major v Idaho State Insurance Fund I am a Professor of
Pharmacology and Toxicology at the University of Utah and am an expert in lung diseases
druginduced toxicities and adverse drug reactions I am also an expert in the analysis
chemistry receptor activation and biological effects including toxicities of capsaicinoids You
have asked me to provide opinions about several issues in this case I have formulated three
questions that I understand are salient issues and provided a brief summary of my opinions after
each question
Could occupational exposure to Sabre Red be a causative factor for Billie Majors medical
condition
The medical records and other materials indicate that Ms Major was occupationally
trained at the Idaho Department of Corrections with 5 pepper spray products and was
secondarily exposed to 10 pepper spray products She personally sprayed prisoners
several times about five times in a fouryear period with sprays that presumably
contained 10 oleoresin capsicum OC During this time her medical records indicate
that she had become highly sensitized to the capsaicinoids in OC products and showed
increased frequency and severity of respiratory illness including bronchitis and chronic
cough Her training exposure to Sabre Red a 10 product in an enclosed non
ventilated room for two and a half hours on March 3 2008 certainly caused acute adverse
health responses and greatly exacerbated her underlying respiratory diseases
What are the toxicities of oleoresin capsicum which is the active ingredient in Sabre Red and
other similar OC Spray products
The Material Safety Data Sheet for Sabre Red lists capsaicin dihydrocapsaicin and
nordihydrocapsaicin as the active ingredients of Sabre Red Capsaicin and
dihydrocapsaicin are the two major pungent constituents greater than 80 of the total
capsaicinoids and nordihvdrocapsaicin is a minor constituent less than 5 of OC
products that are derived from extracts of hot peppers
Acute Toxicities acute exposures to OC spray products are highly irritating to all





I I  
f  
r i  1,. r  
 & rt ,  
 . r li  r. 
ite  
i , I   
ear r. verson: 
  
epartment  r col  & Toxicolog  
----" "7", :::C:'()-::::O():-::E-;:R:-:M7,,(::7n-:S:-:~I-:tt-:"<\k:-<.-;:(-'ty-:". C-:'lo-:-h-::-:-84112-$!!20 (801) 581-6287  (Sal) 85"51 1 
l  ,20  
is is a rief re rt i te e  t  s arize  e ert i ions a t r case f j r v. 
curit  i t ti   qj  . I  t t  I  d. I   r f r  
ar ac l  a  ic l  at t e i ersit  f tah, a  a  a  e ert in l  iseases, 
r g-i e  t i iti ,  r  r  r ti s. I a  also an expert in the analysis, 
che istry, receptor activation, and biological effects (including toxicities) f capsaicinoids. ou 
 s   t  r ide i i s t s r l iss s i  t is s . I  f r l t  t re  
ti s t t I r t  r  li t i ,  r ide   ri f r    i ions ft r 
 ti  . 
• :. ould occupational exposure to abre ed be a causative factor for illie ajor's edical 
dition? 
>- e i l r r   t r t ri ls i ic t  t t . j r  ti ll  
tr i  t t  I a  e rt e t f rr ti s it  % r s r  r ts,  s 
secondarily exposed to 10% pepper spray products. She personally sprayed prisoners 
several ti es (about five ti es in a four-year period) ith sprays that presu ably 
c tai e  0% le resi  ca sic  (O ). ri  t is ti e, er e ical rec r s i icate 
that she had beco e highly sensitized to the capsaicinoids in  products, and sho ed 
increased frequency and severity f respiratory illness, including bronchitis and chronic 
. er training exposure to Sabre ed (a 10% product) in an enclosed, non-
ventilated roo  for t o and a half hours on arch 3, 2008 certainly caused acute adverse 
health responses, and greatly exacerbated her underlying respiratory diseases . 
• :. hat are the toxicities of oleoresin capsicu , hich is the active ingredient in Sabre ed and 
other si ilar  pray products? 
>- he t i l t  ata t    lists saicin, i aici ,  
nordihydrocapsaicin as the active ingredients of abre ed. apsaicin and 
ihydrocaps i in r  t  t  j r t stituents (great r t  0% f t  t t l 
capsaicinoids), and nordihydrocapsaicin is a inor constituent (less than 5%)   
r cts t at are eri e  fr  e tracts f t e ers. 
>- cute oxicities: acute exposures to  spray products are highly irritating to all 





erythema itching and pain 2 painful burning and itching of the eyes with tearing and
conjunctivitis 3 respiratory apnea choking and uncontrollable cough that can lead to
severe respiratory depression cardiovascular dysfunction and death Ingestion of large
amounts can lead to nausea vomiting abdominal pain and burning diarrhea These
symptoms reflect the extensive inflammatory responses that are hallmarks of acute
exposures to many different organs and tissues including the skin eyes respiratory tract
and gastrointestinal tract
Chronic Toxicities the biological responses to OC products are caused predominantly by
binding of capsaicinoids to Transient Receptor Potential TRP calcium channels The
population of TRP channels in tissues is regulated by multiple exposures and the number
and activities of TRP channels usually determine the responses to chronic exposures that
lead to sensitization or desensitization from multiple exposures in multiple organ
systems One highly characterized toxicity of capsaicinoids is the exacerbation of
chronic cough and people with this respiratory disease are up to 30 times more sensitive
to capsaicin induced cough The scientific explanation for their heightened response is
that these sensitized people have much higher expression of TRP channels in their airway
nerves
How does the toxicity and strength of Sabre Red compare to other similar OC Spray products
on the market
Sabre Red is advertized by Security Equipment Corporation to contain 10 OC
comprised of 133 major capsaicinoids and the MSDS information reiterates these
values Security Equipment Corporation claims that 133 is the highest concentration
of any defense spray This statement is probably correct and the concentrations of the
major capsaicinoids are probably accurate because the company determines the
concentrations of the major capsaicinoids by HPLC methods that are much more
accurate than other older methods and significantly more accurate predictors of
pungency than the highly subjective Scoville Content commonly used by most vendors
Thus it is reasonable to assume that Sabre Red contains the highest concentrations of the
most potent capsaicinoids and is at least among the most toxic if not the most toxic
defense spray available
I can provide a much more comprehensive explanation for my conclusions and am willing to
provide these opinions in a deposition or testify at trial if you wish
Sincerely
a
Garold S Yost PhD
Professor of Pharmacology and Toxicology
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1 JY PURSWELL Ph11PE CPLbcingfirst duly sworn upon oath depose and state
of niy own personal knowledge that if called upon to testify I would competently testify to the
following
1 I am vice president of Purswell Purswell Ergonomic Salety Consulting 1
consult with manufacturers and attorneys on ergonomic and safety issues I perform hazard
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analysisolproducls formanulaoturers and consult with manufacturers on the development of
warnings and instructions for new and redesigned products In addition I assistmarmfacturers in
product risk assessment development of material safety data sheets and analysis of OSIIA
compliance issues
2 I hold a BS in Chemistry and Biology as a double degree anMSill Industrial
Engineering turd a PhDin Industrial Fuld Systems EngineeringfEluman Factors i am an adjunct
professor in the Engineering Department of Colorado State University Pueblo 1 teach the
graduate ergonomics and senior level safety courses and supervise student research on product
safety and usability issues
3 Attached hereto as Exhibit A is a true and correct copy ofmy curriculum vitae
4 Attacled hereto as Exhibit B is a true and correct copy of the report of my expert
opinions as to whether Defendant SECswarning labels provided with its SABRE Red law
enforcement OC Spray products were OSIIA compliant turd in line with industry standards
In the attached report I explain why SECswarning labels were not compliant and how I came to
that conclusion
5 1 understandfrom reviewing Defendantsmotion for summary judgment that the
position taken by SEC in this case is that the requirements for its warning labels on its SABRE
Rbd law enforcement 10 OC Spray products is governed by the Federal Hazardous Substance
Act That may or may not be tr1ic for other products sold by SEC but the SABRE RedIoggel
product is clearly intended for occupational use thus the requirements Ivor the label olthese law
enforcement gnade products are found in the Occupational Safety and Health Administrations
Hazard Communication Standard Regulation 191020 as that is the express standard in the
industry for labeling of hazardous industrial chemicals While my review of the product
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information and information from SECswebsite suggests that it is highly unlikely that SECs
SABRE Red law enforcement grade 10 OC Spray products would be found in households or
used by children the use of the product by employees in the course of their work renders the
labeling of the product subjcot to the OSHA Hazard Conununication Standard regardless of
whether it 415 also Subject to the FIISA The purpose of SECsSABRE Red lawenbrcment
10 OC Spray products is for use by law enforcement officials in subduing suspected crimilials
crowd control quid inmate compliance Even more specifically the product at issue in this case
which the Plaintiff was exposed to in Match 2008 was a product knas iSABRE Red
Dogger which would have virtually no use in the household and would not be a product used by
children It is also my informed opinion that due to the apparent nature of the product at issue in
this case Ocoupational Safety and Health AdministrationsHazard Communication Standard
Regulation 191020 applies to the product label It is fiirther my opinion that SEC under
OSIIA Hazard Communication Standard Regulation 191020 has die affirmative obligation
to evaluate the potential health hazards of the chemicals in their 10 C spray products and
communicate that information and appropriate protective measures on a warning label for the
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GREENER BURKE SHOEMAKER PA Fax 3192601
950 W Bannock Street Suite 900 Messenger Delivery
Boise ID 83702 Email c 1 erlawcom
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ADDRESS 2035 Mulligan Drive Colorado Springs CO 80920
EMAIL purswella1gmaico JerryPurswellColostatePuebloedu
EDUCATION
PhD Industrial and Systems Engineering Human Factors Option 1997 Virginia Tech
Blacksburg Virginia
MS Industrial Engineering 1989 The University of Oklahoma Norman OK
BS ChemistryBiology double degree 1986 Oklahoma Baptist University Shawnee OK
PROFESSIONAL EXPERIENCE
Vice President 1999 Present
Purswell Purswell Engineering Ergonomics Inc Colorado Springs CO 80920
Consults with manufacturers and attorneys on ergonomics and safety issues Performs hazard
analyses of products for manufacturers Consults with manufacturers on the development of
warnings and instructions for new and redesigned products Consults with employers on the
development and implementation of safe and ergonomically sound work practices
Adjunct Professor 1999 Present
Engineering Department Colorado State UniversityPueblo Pueblo CO 81001
Teaches the graduate ergonomics course and the senior level safety course for the Engineering
department Supervises student research on product safety and usability issues As part of his
involvement with CSUPueblo Dr Purswell has also initiated and supervised several graduate
student ergonomics projects for Pueblo area manufacturing warehousing and retail
establishments
Ergonomics and Safety Consultant 19941999
Purswell Associates Colorado Springs CO 80920
Designed and conducted research concerning user perceptions and comprehension of potential
product hazards Developed experimental protocols and questionnaires performed data
collection data reduction and analysis and wrote reports for clients
Performed hazard analyses of consumer and industrial products applied system safety
principles of hazard abatement including suggested redesign guarding and preparation of
cameraready copies of instructions and onproduct warnings for clients
Researched and interpreted OSHA CPSC and ANSI standards for clients including the
legislative record for OSHA standards Acquired familiarity with OSHA standards applicable to
chemical safety workplacemachine interface issues and constructionmaintenance operations
These include for example the Hazard Communication Standard LockoutTagout Standard
Hearing Conservation Standard Fall Protection Standards etc Performed forensic consulting
for attorneys involved in workplace and product safety litigation including preparation of reports





: .P. ll 
E: - -012  
: - -690  
SS:  lli  ri e, l r  ri ,   
I : j .p rswell@gmail.com , rry. urswell@Colostate- ueblo.edu 
I : 
h.D. I tri l  t  i ri  (Hu a  t r  tion) . ir i i  ch, 
l r , ir i i . 
.S. I t i l i ri  .  i it  f l a, , . 
.S. i tr /Biolog  (doubl  r ) . l  ti t i rsity, ee, . 
 I : 
 i t, - t. 
ll & l ,  & i , c.,  ri s,   
lt  it  f t r r   tt r   r i   f t  i s. rf r  r  
l  f r t  f r f t r r . lt  it  f t r r   t  l t f 
r i   i tr ti  f r   r i  r ts. lt  it  l r   t  
l t  i l t ti  f f   r i ll   r  r ti . 
j t r f r, - r t. 
i ri  rt t, l r  t t  niversity- l , blo,   
Teaches the graduate ergono ics course and the senior level safety course for the ngineering 
depart ent. upervises student research on product safety and usability issues. s part of his 
i v lv t it  U- l , r. rs ll s ls  i iti t   s rvis  s v r l r t  
student ergono ics projects for Pueblo area anufacturing, warehousing and retail 
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Graduate TeachingResearch Assistant 1989 1992
Virginia Tech Blacksburg Virginia 24061
Assisted with Introduction to Industrial Engineering and Probability and Queuing Systems
classes Lectured in the absence of the professor Prepared and graded homework and exams
Documented and analyzed railroad work methods Prepared task descriptions and
ergonomicssafety analyses of work methods Recommended methods improvements and
changes in tool design Authored the project report
Researched finger strength capabilities Designed the data collection equipment Wrote the
software routines to collect and reduce the data Performed statistical analysis of the data
Authored the project report
Industrial Engineer Intern Summer 1989
General Motors Assembly Division Oklahoma City OK 73135
Performed analyses of assembly line ergonomics and safety issues Prepared a safety and
ergonomics training program for plant use
Graduate Teaching Research Assistant 19871989
University of Oklahoma Norman OK 73072
Interfaced a computerized data collection system with analog electrical equipment Taught
ergonomics labs
CERTIFICATIONS LICENCES
Registered Professional Engineer by examination
Board Certified Professional Ergonomist by examination
PROFESSIONAL AFFILIATIONS AND SERVICE
Member Industrial Advisory Board Industrial Engineering Department CSLIPueblo
Program Chair 2004 1 st Annual Spring Symposium of the Rocky Mountain Chapter of the Human
Factors and Ergonomics Society
Member Human Factors and Ergonomics Society Served as a newsletter editor and paper
reviewer for several technical groups Instructor for CPE prep course sponsored by the Rocky
Mountain Chapter of HFES
Secretary 20035 International Society for Occupational Ergonomics and Safety
Senior Member and Director of Professional Registration 2003current for the Institute of Industrial
Engineers Responsible for preparing the Industrial Engineering PElicensure exam administered
by NCEES Served on the 20022003 PAK committee to review and reformulate the Industrial
Engineering PE content areas
Member National Society of Professional Engineers
Member American Industrial Hygiene Association
Associate Member American Council of Government Industrial Hygienists
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HONORS AND AWARDS
Inducted into Alpha Pi Mu the Industrial Engineering Honor Society 1990
Recipient of the Gordon Fellowship from the University of Oklahoma 1986
SHORT COURSESSEMINARS
Psychometric Training presented by the Chauncey Group February 2004
Forklift Truck Operator Instructor Development presented by the Colorado Safety Association
August 2004
Oxyfuel Welding Pikes Peak Community College Fall 2005
Welding Health and Ventilation for Hot Work in Confined Spaces PCIH 2005 102305
SMAW stick welding Pikes Peak Community College Spring 2006
PAPERS AND PRESENTATIONS
Purswell JP 2010 The distribution of pedestrianbacking vehicle accidents by backup alarm status
and vehicle type 3rd International Conference on Applied Human Factors and Ergonomics edited by
Gavriel Salvendy and Waldemar Karwowski
Purswell JP 2009 Crawler Crane Accident Patterns in Proceedings of the 21 st Annual International
Occupational Ergonomics and Safety Conference edited by Robert Marley et al
Brickman D Purswell JP 2009 Tree Chipper Human PerceptionReaction Testing in Proceedings
of the 21 st Annual International Occupational Ergonomics and Safety Conference edited by Robert
Marley et al
Purswell JPand Purswell Jerry L 2005 OSHAsRecent Citation Practices of Ergonomic Hazards
under the General Duty Clause Proceedings of the 18 Annual International Occupational
Ergonomics and Safety Conference edited by Thurmon Lockhart
Peleg L Stern C and Purswell JP 2004 A NIOSH Equation Multi task Calculator in Proceedings of
the 17 Annual International Occupational Ergonomics and Safety Conference edited by Lawrence
JHSchulze
Michael Griffin Pavitree VutraUkra andJP Purswell 2004 An Ergonomic Study of an MMH task in an
Industrial Kitchen in Proceedings of the 17 Annual International Occupational Ergonomics and Safety
Conference edited by Lawrence JH Schulze
Peleg Liran Stem Christopher and Purswell JP 2004 Calculators for NIOSH Lifting Equation The
Single and Multi Task Cases Proceedings of the 1S Annual Spring Symposium of the Rocky
Mountain Chapter of the Human Factors and Ergonomics Society
Purswell JP 2004 Development of an Online Database of Warnings Articles Proceeding of the Spring
Symposium of the Rocky Mountain Chapter of the Human Factors and Ergonomics Society
Gonzalez R and Purswell JP 2003 Usability of the CPSC Website An Update 8th Annual
International Conference on Industrial Engineering Theory Applications Practice Las Vegas
Nevada
Purswell JP2003 Development Of A Searchable Database OfWarnings Articles 8th Annual
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PurswellJP2003 HFE Texts What are ETG Members Teaching From ETG News June 2003
Purswell JP 2001 OSHAsCitation Practices of Ergonomic Hazards under the General Duty Clause
The National Ergonomics Exposition Las Vegas Nevada
Purswell JP 2001 An MS Access Implementation of an OSHA300 Compliant Injury Data Tracking
System Proceedings of the 6 Annual International Conference on Industrial Engineering Theory
Applications and Practice San Francisco CA USA
Lingo M Holland A Shrestha S and Purswell JP 2001 An Ergonomic Evaluation and
Redesign of an Industrial Kitchen Work Station Proceedings of the 6 Annual International
Conference on Industrial Engineering Theory Applications and Practice San Francisco CA
USA
PurswellJP and Purswell Jerry L 2001 OSHAsCitation Practices of Ergonomic Hazards
under the General Duty Clause Proceedings of the Human Factors andErgonomics Society
45tAnnual Meeting 2001 p 1110
PurswellJP Apipat Vithakmontri 2001 A Preliminary Usability Analysis of the CPSC Website
Proceedings of the Human Factors and Ergonomics Society 45 Annual Meeting 2001 p
828
PurswellJPand Purswell Jerry L 2001 The Effectiveness of Audible Backup Alarms as
Indicated by OSHA Accident Investigation Records Advances in Occupational Ergonomics and
Safety pp 444450 IOS Press 2001
Gimlin Dennis Purswell JP Ergonomic Challenges in Modem Endodontic Practices
Advances in Occupational Ergonomics and Safety pp 163170 IOS Press 2001
Purswell JP The OSHA Website Presentation to the Pueblo Safety and Health Promotion
Council October 2000
Purswell JP The OSHA Ergonomics Standard Presentation to the Pueblo Safety and Health
Promotion Council November 2000
Purswell JPMarch 1998 A Review of OSHAsConfined Spaces Advisor 10The Synergist
Purswell JP Factory and Office Ergonomics Invited lecture to Residents of Occupational
Medicine Program at the University Oklahoma Health Sciences February 26 1998
Kasbaum T Purswell JL Purswell JP and KrenekRF1998 Hot Water Burn Hazards
Warning Label Influence on User Temperature Adjustment International Journal of Cognitive
Ergonomics 2 12 145157
Purswell JP 1997 The Effects of Perturbation Frequency Magnitude and Uncertainty During
Static andDynamic Tracking on the Estimated Level of Muscle CoContraction Unpublished
doctoral dissertation Virginia Polytechnic Institute State University Blacksburg Virginia
BowenDJ PurswellJLSchlegel REand Purswell JP1995 Preferred tension
psychophysical lifting limits with and without back belts Advances in Industrial Ergonomics and
Safety VII p 735
Purswell JPand Woldstad JC 1991 Ergonomic evaluation of trackman activities Tech report
submitted to the Association of American Railroads Contract 436182 Blacksburg VA
Virginia Tech Industrial Ergonomics Laboratory
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Purswell JP 1990 Finger force capabilities in keying operations In KHEKroemer ed
Blacksburg VA Virginia Tech Industrial Ergonomics Laboratory Ternary Chorded Keys and
Keyboards Tech Report submitted to the Center for Innovative Technology Grant no 4
42279 Industrial Ergonomics Laboratory VPISU Blacksburg
Purswell JP 1989 Evaluating Alternative Composite Measures for SWAT Ratings Unpublished




rriculu  it  f .P. rs e l 
1/1/2010 
age 5 of 5 
  
Purswell, J.P. (1990). "Finger force capabilities in keying operations." In K.H.E. Kraemer (ed.) 
lacksburg, : irginia Tech, Industrial rgono ics Laboratory. Ternary horded eys and 
eyboards. Tech. eport sub itted to the enter for Innovative Technology (Grant no. 4-
42279), Industrial rgono ics Laboratory, I&SU, lacksburg. 
Purs ell, J.P. (1989). Evaluating Alternative o posite easures for S AT atings. npublished 
ster's t i , i r it  f l , r , . 
L   
Exhibit B
to Affidavit ofJPPurswell PhDPECPE
in Opposition to Defendants
Motion for Summary Judgment
Exhibit B
to Affidavit ofJP PurswellPhDPECPE
in Opposition to Defendants
Motion for Summary Judgment
000471
xhi i   
to ffidavit f J.P. urswell, h.D., .E., PE 
in pposition to efendant's 
otion for Summary Judgment 
it  
to ffidavit of J.P. Purs ell, Ph.D., P.E., CPE 
in pposition to efendant's 















Re Major v SEC
Dear Mr Overson
In response to your request I have reviewed the following materials
related to this matter
1 Complaint
2 SEC Product Labels 1
3 SEC Product Labels 2
4 SEC Product Labels 3
5 SEC Product Line
6 SEC MSDS
7 SEC Suppliers MSDS
8 Product labels from manufacturers other than SEC
9 Expert Report of Dr Pacheco
10 Expert Report of Dr Yost
11 SEC Trainers Certification Manual
12 SEC Training PowerPoint Presentation
13 Defendantsresponses to Plaintiffsrequests for admissions
14 DefendantsResponses to PlaintiffsInterrogatories
15 Depositions with exhibits of the following individuals
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a JOSHUAEOVERGAARD with exhibits 4244
b Nicholas Doan with exhibits 45 and 46
c Robert Nance
d Bret Kimmel with exhibit 2235
e Daniel J Schaffer with exhibit 3641
f SARA ANNE MARIE LINK
Based upon my review of the materials listed above my education research
and experience I have the following opinions related to the matter to a
reasonable of degree of engineering and ergonomics certainty
1 Oleoresin capsicum OC constitutes an irritant to the skin eyes and
respiratory tract of persons exposed to it The material safety data sheet
MSDS for the constituent of the SEC products has only nine sections
and appears to be incomplete However a publicly available MSDS for
oleoresin capsicum from
wwwsciencelabcommsdsphpmsdsld9926319 shows that the OC
product has a HMIS health hazard rating of 3 out of 4 The consequences
of exposure to a health hazard with a rating of 3 are described as major
injury likely unless prompt action is taken and medical treatment is given
2 Because the OC compound is an irritant it constitutes a health hazard
as the term is used in the OSHA Hazard Communication Standard The
standard defines a health hazard as follows
Health hazard means a chemical for which there is statistically
significant evidence based on at least one study conducted in
accordance with established scientific principles that acute or chronic
health effects may occur in exposed employees The term health
hazard includes chemicals which are carcinogens toxic or highly toxic
agents reproductive toxins irritants corrosives sensitizers
hepatotoxins nephrotoxins agents which act on the hematopoietic
system and agents which damage the lungs skin eyes ormucous
membranes Appendix A provides further definitions and explanations
of the scope of health hazards covered and Appendix B describes the
criteria to be used to determine whether or not a chemical is to be
considered hazardous for purposes of the standard
3 The oleoresin capsicum is present in sufficient concentrations 1 in
the various Sabre Red products sold by SEC and in the Cellbuster
formulation in particular to render the CellBuster product a hazardous
industrial chemical according to the definitions in 29 CFR 191020 As
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such SEC had a duty to develop MSDSs and product labels for the Cell
buster formulation that met the requirements of 191020 the OSHA
Hazard Communication Standard for these products Among the
requirements for a product label for a covered chemical or chemical
mixture is that the affected target organs be specified on the product
label The OSHA interpretation entitled The HCSsrequirement for target
organ effects on labels for shipped containers of hazardous chemicals
issued on6291987 explains OSHA reasoning for this requirement The
interpretation includes the following statement The hazard warning must
convey the hazard of the chemical Appendix A of the standard makes it
clear that employees must be apprised of the change in body function and
the signs and symptoms that may occur to signal that change Further
clarification of OSHA position on the need to include complete target
organ information on the product label is provided in the 1994 preamble to
the Final Rule
Hazard warning The 1983 and 1987 final rules included a definition for
hazard warning which states that it means anywords pictures
symbols or combination thereof which convey the hazardsof the
chemical in the containersAppropriate hazard warnings are to be
put on container labels Since the rule covers physical and health
hazards specific information regarding these would be required on a label
to comply and be considered appropriate OSHA provided clarification
regarding the Agencysinterpretations of these requirements in the
preamble to the revised final rule see 52 FR 31864 In the NPRM the
Agency proposed to incorporate these clarifications into the text of the
rule Thus the new definition proposed was that hazard warning means
anywords pictures symbols orcombination thereof appearing on a
label or other appropriate forms of warning which convey the specific
physical and health hazardsincluding target organ effects of the
chemical in the container See the definitions for physical hazard
and health hazard to determine the hazards which must be conveyed
This modification is being adopted in this final rule The Agency
interpretation of the rule in requiring health effects information including
information on target organ effects was challenged and upheld in Martin
v American Cyanamid on No 923321 6th Circuit September 15
1993 In the development of the 1983 final rule the Agency sought to
require on labels that information that it considered to be necessary to
employee protection and which did not appear on many of the labels in
use in industry at that time It appeared to OSHA based on the
information available at that time that labels frequently included
precautionary information but infrequently enumerated the actual hazards
of the chemical In addition the labels often lacked identity information
Thus OSHA chose to require that this limited information the identity and
PURSWELL 000124
000474
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hazards be included on the label while not precluding the addition of
other types of information thought to be appropriate by the chemical
industry The rule also took a performance oriented approach to the
presentation of information allowing various formats to be used as long as
the information required by the HCS was included OSHA did not endorse
or support any particular existing labeling system as being in compliance
with the requirements as drawn In fact it was thought likely that many
existing labels regardless of what system was used would have to be
revised to meet the new requirements
The Sabre Red product label for Cellbuster product does NOT include
any identification of the lungs or respiratory tract as a target organ and is
therefore not in compliance the OSHAsHazard Communication
Standards labeling requirements
4 The failure of SEC to include the lungs or respiratory tract as a target
organs of OC on the CellBuster product label was a violation the Hazard
Communication Standard The omission of this required information on the
product label was a proximate cause of Ms Major injury Had this
information been included on the product label as the Hazard
Communication Standard required the causal relationship between Ms
Majorsexposure to the various OCcontaining Sabre Red products and
her persistent respiratory difficulties would have been apparent to her and
more readily apparent to the IDOC personnel in charge of the training
My curriculum vita is attached which provides a record of my education
experience and research publications My schedule of fees is attached which
lists the charges for services I reserve the right to supplement my report should
new information be made available to me that would affect my opinions
Sincerely
k
JP Purswell PhDPE CPE
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Cheri C Copsey at the Ada County Courthouse in Boise Idaho Plaintiffs Cross Motion
for Partial Summary Judgment
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PLEASE TAKE NOTICE that on Thursday July 14 2011 at300pmor as soon
thereafter as counsel can be heard the undersigned will call for hearing before The Honorable
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CORPORATION a Missouri corporation
Case No CVPI1003515
SEC MOTION TO STRIKE
AFFIDAVIT OF DR YOST FILED IN




Defendant Security Equipment Corporation SEC by and through its counsel of
record Greener Burke Shoemaker PAobjects to and hereby moves this Court to strike the
Affidavit of Garold Yost PhD filed June 10 2011 Yost Affidavit which was filed in
support of PlaintiffsOpposition to DefendantsMotion for Summary Judgment
This Motion to Strike is made on the following grounds
1 The Affidavit directly contradicts deposition testimony and should be stricken
pursuant to the sham affidavit doctrine and
2 The Affidavit does not provide any explanation as to why his testimony has
changed from that testimony given during his deposition on April 19 2011
SEC MOTION TO STRIKE AFFIDAVIT OF DR YOST FILED IN SUPPORT OF OPPOSITION TO
DEFENDANT MOTION FOR SUMMARY JUDGMENT Page 1 14542 011 397809
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Defendant Security Equip ent Corporation ("SEC"), by and through its counsel of 
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support of Plaintiff s pposition to efendant's otion for Su ary Judg ent. 
his otion to Strike is ade on the follo ing grounds: 
. The ffidavit directly contradicts deposition testi ony and should be stricken 
pursuant to the sha  affidavit doctrine; and 
. The ffidavit does not provide any explanation as to hy his testi ony has 
changed from that testimony given during his deposition on April 19, 2011. 
EC'S I      .      I   
FENDANT'S I  F  S  J  - Page 1 -0  (39 9) 
A Memorandum in Support of Defendants Motion to Strike is filed concurrently
herewith
DATED this 24 day of June 2011
GREENER BURKE SHOEMAKER PA
11 T
Christopher C Burke
Thomas J Lloyd III
Attorneys for Defendant
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing SECMOTION TO STRIKE
AFFIDAVIT OF DR YOST FILED IN SUPPORT OF OPPOSITION TO DEFENDANTS
MOTION FOR SUMMARY JUDGMENT on the following named personson the date indicated
below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220
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I Thomas J Lloyd III being first duly sworn upon oath depose and state as follows
1 I am over the age of 18 years and am an attorney with Greener Burke Shoemaker
PA attorneys for Defendant herein I make this affidavit based upon my personal knowledge
2 Attached hereto as Exhibit A is a true and correct copy of PlaintiffsDisclosure
of Expert Witnesses with all exhibits thereto served on August 5 2010
AFFIDAVIT OF THOMAS J LLOYD III IN SUPPORT OF SEC MOTION TO STRIKE AFFIDAVIT OF DR
YOST FILED IN SUPPORT OF OPPOSITION TODEFENDANT MOTION FOR SUMMARY
JUDGMENT Page 1 14542011 397811
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I, Tho as J. Lloyd III, being first duly sworn upon oath, depose and state as follows: 
. I a  over the age of 18 years and a  an attorney ith reener urke Shoe aker 
.A., att r e s f r efe a t erein. I a e t is affi a it ase    ers al le ge. 
. ttached hereto as xhibit  is a true and correct copy of Plaintiffs isclosure 
of Expert itnesses, with all exhibits thereto, served on August 5, 2010. 
I     .   I    EC'S   T I  I I   . 
 I     POSITI  T  FENDANT'S   U  
JUDG ENT - Page 1 14542-  ( 811) 
3 Attached hereto as Exhibit B is a true and correct of PlaintiffsSupplemental
Disclosure of Expert Witnesses served on March 28 2011
4 On Wednesday June 22 20111 participated in a telephone call made by my office
to Esquire the court reporting agency used for the deposition ofDr Garold Yost We spoke
with Ebony Little at Esquire and were notified that Dr Yost has not returned a change sheet or
signature page for his deposition Attached hereto as Exhibit C are copies oftwo emails
received from Ms Little confirming this information
5 Attached hereto as Exhibit D is a true and correct copy of the Read and Sign
Letter dated on May 7 2011 to Eric Swartz with directions for the return of Dr Yosts errata
sheet and signature page for his deposition
6 Although Plaintiff has already included the entire deposition transcript ofDr Yost
as an exhibit to the Affidavit of Counsel in Support of PlaintiffsOpposition to Defendants
Motion for Summary Judgment for the Courts convenience and ease of reference I have
attached hereto as Exhibit E a true and correct copy of the excerpts from the deposition of
Garold S YostMDtaken on April 19 2011 that are pertinent to the instant motion to strike
7 Additionally although Plaintiff s counsel states that the entire transcript ofDr
Yost and exhibits thereto are attached as Exhibit 2 to his affidavit in actuality only two of the 14
exhibits to the deposition of Dr Yost were included Attached hereto as Exhibit F is a true and
correct copy of Exhibit 59 to the deposition of Dr Yost which is the 2004 Article referenced by
Dr Yost in his Affidavit opposing SECsMotion for Summary Judgment
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Further your affiant saith naught
Thomas J Lloyd III
SUBSCRIBED AND SWORN before me this day of June 2011
IOTA k Notary Public for Idaho
Residing at
PUBL1G jZ My commission expires G
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing AFFIDAVIT OF THOMAS J
LLOYD III IN SUPPORT OF SEC MOTION TO STRIKE AFFIDAVIT OF DR YOST FILED
IN SUPPORT OF OPPOSITION TO DEFENDANTSMOTION FOR SUMMARY JUDGMENT
on the following named personson the date indicated below in the manner indicated below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED thisZday of June 2011
Christopher C Bur e
Thomas J Lloyd III
AFFIDAVIT OF THOMAS J LLOYD III IN SUPPORT OF SEC MOTION TO STRIKE AFFIDAVIT OF DR
YOST FILED IN SUPPORT OF OPPOSITION TO DEFENDANTSMOTION FOR SUMMARY
JUDGMENT Page 3 14542
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I hereby certify that I caused to be served the foregoing FFI IT F T S J. 
     EC'S      .   
I    I I   ENDANT'S I     
on the following named person(s) on the date indicated below, in the manner indicated below: 
Darwin Overson, Esq. 
ric . S artz, sq. 
J  & TZ,  
 . r li  ri , it   
. .   
oise, Idaho 83707 
  2-~ day f June, 2011. 
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Christopher C. Bur e 
ho as J. loyd III 
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Darwin Overson ISB 5887
Eric B Swartz ISB 6396
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 200 83702
Post OfficeBox 7808
Boise ID 83707








IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FORTHE COUNTY OF ADA
BILLIE JO MAJOR and individual








Discovery in this matter is ongoing This disclosure is made and based upon the
Plaintiffscurrent understanding of the facts claims and defenses at issue in this litigation It is
anticipated that further discovery investigation and consultation with witnesses and experts may
supply additional facts add meaning to known facts and establish new factual conclusions and
legal contentions all of which may lead to additions to modifications of and variations from the
disclosures set forth herein This disclosure is therefore made without prejudice to Plaintiffs
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eric jonesandswartzlaw.com 
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Greener Burke Shoe aker PA. 
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   I , I        
I IE  J ,  i i i l, 
l intiff, 
vs. 
S I  E IP E T P ATI , 
a issouri corporation, 
nt. 
 .    
LAINTIF 'S  
 S  
LI   
Discovery in this matter is ongoing. his disclosure is ade and based upon the 
laintiff's current understanding f the facts, clai s, and defenses at issue in this litigation. It is 
anticipated that further discovery, investigation, and consultation with witnesses and experts may 
supply additional facts, add meaning to known facts, and establish new factual conclusions and 
legal contentions, all of which may lead to additions to, modifications of, and variations from the 
iscl s res set f rt  erein. is iscl s re is t eref re a e it t rej ice t  lai tiffs 
LAINTIF 'S    -  
right to disclose evidence of subsequently discovered facts or opinions thereon Subject to and
without waiving the right to supplement the scope of the testimony disclosed herein based upon
information learned or documents acquired through the completion of discovery in this action
Plaintiff makes the following disclosure
Garold S Yost PhD
Professor of Pharmacology and Toxicology
College ofPharmacy
University ofUtah
30North 1900 East 201
Salt Lake City Utah 84112
80158 7956
Dr Yost is a Professor ofPharmacology and Toxicology at the University ofUtah and is
an expert in lung diseases druginduced toxicities and adverse drug reactions Dr Yost is also
an expert in the analysis chemistry receptor activation and biological effects including
toxicities of capsaicinoids Dr Yost is expected to testify regarding the human bodysreaction
to capsaicinoids and oleoresin capsicum OC spray which is the subject matter of this case
Dr Yost will testify that Plaintiffsrepeated exposure to OC spray while performing her duties as
a correctional officer caused an acute adverse health response and greatly exacerbated Plaintiffs
underlying respiratory disease Dr Yostsopinions are based upon his review of Plaintiffs
medical records Idaho Department of Corrections records and Sabre Red product information
all of which were produced in discovery by Defendant and Plaintiff Dr Yost has not prepared
any trial exhibits or a written report at this time In the event that any of those items are
prepared they will be produced in accordance with this Court June 1 2010 Scheduling Order
and Rule26a4ofthe Idaho Rules ofCivil Procedure The letterDr Yost has prepared to date
which summarizes his opinions in whole or in part is produced herewith as Exhibit A
PLAINTIFFSEXPERTWITNESS DISCLOSURE 2
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right to disclose evidence of subsequently discovered facts or opinions thereon. Subject to and 
without waiving the right to supplement the scope of the testimony disclosed herein based upon 
infor ation learned or docu ents acquired through the co pletion of discovery in this action, 
Plaintiff  t  f ll i  i cl sure: 
r l  . st, h.D. 
r   har acol  and xi l  
l   r  
i r it  f  
30 orth 1900 ast #201 
al   ity,   
(801)581-7  
Dr. Yost is a Professor of Pharmacology and Toxicology at the University of Utah, and is 
an expert in lung diseases, drug-induced toxicities, and adverse drug reactions. r. ost is also 
an expert in the analysis, chemistry, receptor activation, and biological effects (including 
toxicities) of capsaicinoids. Dr. Yost is expected to testify regarding the hu an body's reaction 
to capsaicinoids and oleoresin capsicu  (OC) spray, hich is the subject atter of this case. 
Dr. Yost will testify that Plaintiffs repeated exposure to OC spray while performing her duties as 
a correctional officer caused an acute adverse health response and greatly exacerbated Plaintiffs 
ing re rat ry . r. ost's opinions are based upon his revie  f laintiffs 
medical records, Idaho Department of Corrections records, and Sabre Red product information, 
all of which were produced in discovery by Defendant and Plaintiff. Dr. Yost has not prepared 
 trial e hibits or a ri ten report at this ti . In the event that any of those items are 
prepared, they will be produced in accordance with this Court's June 1,2010 Scheduling Order 
and Rule 26( a)( 4) of the Idaho Rules of Civil Procedure. The letter Dr. Yost has prepared to date 
which su marizes his opinions in hole or in part is produced here ith as hibit . 
P F'S EXPERT WITNE S DISCLOSURE - 2 
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Dr Yosts qualifications are outlined in his Curriculum Vitae and his profile and
biosketch on the University of Utah College of Pharmacy website and are attached hereto as
Exhibits B and C respectively Dr Yostsagreedupon compensation for analysis of the issues
in this case and to testify is 450 per hour A copy of the signed agreement is attached hereto as
Exhibit D
Plaintiff reserves the right to elicit opinion testimony from any expert non retained
treating medical provider and any other witnesses disclosed in discovery or deposition by the
Plaintiff or Defendant Further Plaintiff reserves the right to supplement or amend this
disclosure and to list rebuttal experts
DATED this 5th day ofAugust 2010
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CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on this 5th day of August 2010 a true and correct copy of the
foregoing document was served on the following individualsby the method indicated
Christopher C Burke
GREENERBURKE SHOEMAKER PA
950W BannockStreet Suite 900
Boise ID 83702






C IFICATE F S ICE 
I EREBY CE IFY that n this Sth day f Augus , 2 , a true and co rect copy of the 
foregoing document was served on the following individual(s) by the method indicated: 
Christopher C. Burke 
ENER BURKE SHOEMAKER   
950 . annock Street, Suite 900 
ois , ID 3702 
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[ ] .S. a l 
[ ] F : 319-2601 
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Department of Pharmacology Toxicology








This is a brief report intended to summarize my expert opinions about your case of Major v
Security Equipment Corporation and Major v Idaho State Insurance Fund I am a Professor of
Pharmacology and Toxicology at the University of Utah and am an expert in lung diseases
drug induced toxicities and adverse drug reactions I am also an expert in the analysis
chemistry receptor activation and biological effects including toxicities of capsaicinoids You
have asked me to provide opinions about several issues in this case I have formulated three
questions that I understand are salient issues and provided a brief summary ofmy opinions after
each question
Could occupational exposure to Sabre Red be a causative factor for Billie Majors medical
condition
The medical records and other materials indicate that Ms Major was occupationally
trained at the Idaho Department of Corrections with 5 pepper spray products and was
secondarily exposed to 10 pepper spray products She personally sprayed prisoners
several times about five times in a fouryear period with sprays that presumably
contained 10 oleoresin capsicum OC During this time her medical records indicate
that she had become highly sensitized to the capsaicinoids in OC products and showed
increased frequency and severity of respiratory illness including bronchitis and chronic
cough Her training exposure to Sabre Red a 10 product in an enclosed non
ventilated room for two and a half hours on March 3 2008 certainly caused acute adverse
health responses and greatly exacerbated her underlying respiratory diseases
What are the toxicities of oleoresin capsicum which is the active ingredient in Sabre Red and
other similar OC Spray products
The Material Safety Data Sheet for Sabre Red lists capsaicin dihydrocapsaicin and
nordihydrocapsaicin as the active ingredients of Sabre Red Capsaicin and
dihydrocapsaicin are the two major pungent constituents greater than 80 of the total
capsaicinoids and nordihydrocapsaicin is a minor constituent less than 5 of OC
products that are derived from extracts of hot peppers
Acute Toxicities acute exposures to OC spray products are highly irritating to all
tissues and acute exposures have been known for many years to cause 1 dermal
000491
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his is a brief report intended to su arize y expert opinions about your case of ajor v. 
Security quip ent orporation a  ajor v. Idaho State Insurance und. I a  a r fess r f 
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r -i  t i iti ,  rs  r  r ti s. I a  also an expert in the analysis, 
che istry, receptor activation, and biological effects (including toxicities) of capsaicinoids. ou 
have asked e to provide opinions about several issues in this case. I have for ulated three 
esti s t at I ersta  are salie t iss es, a  r i e  a rief s ar  f  i i s after 
 ti  . 
• :. ould occupational exposure to Sabre ed be a causative factor for illie ajor's edical 
dition? 
» e e ical rec r s a  t er aterials i icate t at s. aj r as cc ati all  
tr i  t t  I  rt t f rr ti s it  % r s r  r ts,  s 
s ril  s  t  0% r s r  r ts.  rs ll  s r  ris rs 
s r l ti s (abo t fi  ti s i   f r-year ri d) it  s r s t t r s l  
contained 10% oleoresin capsicu  (O ). uring this ti e, her edical records indicate 
t at s e a  ec e i l  se sitize  t  t e ca saici ids i   r cts, a  s e  
i reas  fr   s rit  f r s ir t r  illn ss, i l i  r itis  r i  
cough. er training exposure to Sabre ed (a 10% product) in an enclosed, non-
ventilated roo  for t o and a half hours on arch 3, 2008 certainly caused acute adverse 
ealt  res ses, a  reatl  e acer ate  er erl i  res irat r  iseases . 
• :. hat are the toxicities of oleoresin capsicu , hich is the active ingredient in Sabre Red and 
other si ilar  Spray products? 
» he aterial Safety ata Sheet for Sabre ed lists capsaicin, dihydrocapsaicin. and 
nordihydrocapsaicin as the active ingredients of Sabre ed. Capsaicin and 
ihydrocaps i in r  t  t  j r t stit ts (great r t  0% f t  t t l 
capsaicinoids), and nordibydrocapsaicin is a inor constituent (less than 5%)   
products that are derived fro  extracts of hot peppers. 
» c t  : acute exposures to  spray products are highly irritating to all 
tiss s,  t  s res    f r  rs t  s  ) r l 
erythema itching and pain 2 painful burning and itching of the eyes with tearing and
conjunctivitis 3 respiratory apnea choking and uncontrollable cough that can lead to
severe respiratory depression cardiovascular dysfunction and death Ingestion of large
amounts can lead to nausea vomiting abdominal pain and burning diarrhea These
symptoms reflect the extensive inflammatory responses that are hallmarks of acute
exposures to many different organs and tissues including the skin eyes respiratory tract
and gastrointestinal tract
Chronic Toxicities the biological responses to OC products are caused predominantly by
binding of capsaicinoids to Transient Receptor Potential TRP calcium channels The
population of TRP channels in tissues is regulated by multiple exposures and the number
and activities of TRP channels usually determine the responses to chronic exposures that
lead to sensitization or desensitization from multiple exposures in multiple organ
systems One highly characterized toxicity of capsaicinoids is the exacerbation of
chronic cough and people with this respiratory disease are up to 30times more sensitive
to capsaicin induced cough The scientific explanation for their heightened response is
that these sensitized people have much higher expression of TRP channels in their airway
nerves
How does the toxicity and strength of Sabre Red compare to other similar OC Spray products
on the market
Sabre Red is advertized by Security Equipment Corporation to contain 10 OC
comprised of133 major capsaicinoids and the MSDS information reiterates these
values Security Equipment Corporation claims that 133 is the highest concentration
of any defense spray This statement is probably correct and the concentrations of the
major capsaicinoids are probably accurate because the company determines the
concentrations of the major capsaicinoids by HPLC methods that are much more
accurate than other older methods and significantly more accurate predictors of
pungency than the highly subjective Scoville Content commonly used by most vendors
Thus it is reasonable to assume that Sabre Red contains the highest concentrations of the
most potent capsaicinoids and is at least among the most toxic if not the most toxic
defense spray available
I can provide a much more comprehensive explanation for my conclusions and am willing to
provide these opinions in a deposition or testify at trial ifyou wish
Sincerely
Garold S Yost PhD
Professor of Pharmacology and Toxicology
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Current Title Professor of Pharmacology and Toxicology
Date ofBirth
Place ofBirth Denver Colorado
Marital Status Married Barbara J Yost




Phone 801 944 0908










Area of Research Organic Chemistry
Director Richard E Moore
Dates 19721974
Degree MSOrganic Chemistry
4 Colorado State University
Fort Collins Colorado 80523
Area of Research Organic Chemistry
Director Frank R Stermitz
Dates 19741977
Degree PhD Organic Chemistry
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EXPERIENCE
Present Position
Professor of Pharmacology and Toxicology and Adjunct Professor ofMedicinal Chemistry




Salt Lake City Utah 84112
Phone 801 581 7956 FAX 801 5853945 Email gyosi@pharmutaedu
Web Page http wwwpharmacyutahedunharmtoxfacultyyost
87 present promoted from Associate Professor to Professor on July 1 1992
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Assistant Professor of Pharmaceutical Chemistry
College ofPharmacy
Washington State University
Pullman Washington 99164 6510
81687













Dept of Pharmaceutical Chemistry
University ofCalifornia San Francisco
San Francisco California 94143
Area ofResearch Pharmaceutical Chemistry
Director Paul R Ortiz deMontellano
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MEMBERSHIP IN SCIENTIFIC PROFESSIONAL AND SCHOLARLY SOCIETIES
American Chemical Society 1975
Sigma Xi 1979
RhoChi 1982
American Association ofColleges ofPharmacy 1982
International Society for the Study of Xenobiotics 1982
Society ofToxicology 1984
Phi Kappa Phi Honor Society 1986
MountainWest Society of Toxicology 1987
American Society for Pharmacology and Experimental Therapeutics 1988
PROFESSIONAL RECOGNITION
Best Paper of 1982 Drug Metabolism and Disposition Presented by the American Society for Pharmacology and
Experimental Therapeutics
Recipient of a Research Career Development Award NHLBI NIH 198792
Appointed to National Academy of Sciences Committee on Toxicology 199197
Appointed to the Developmental Therapeutics Contracts Review Committee for the National Cancer Institute
1993 95
Zeneca Traveling Lectureship Award by the Society of Toxicology 2000 This award recognizes excellence in
research and service in toxicology Zeneca provides two awards annually to promote greater collaboration
between European and North American toxicologists and to enable North American toxicologists to
undertake a three to fourweek lecture tour ofEurope
Elected Fellow of the Academy ofToxicological Sciences June 2000 elected to Board ofDirectors 200407
Colgate Palmolive Traveling Lectureship in Alternative Methods in Toxicology Award presented by the Society
of Toxicology 2001
Recipient 8 Annual John Doull Toxicology Symposium University of Kansas Sept 23 2004
Appointed to the Environmental Health Sciences Review Committee NIEHS NIH 20022006
Associate Editor DrugMetabolism andDisposition 2002present
Editorial Boards Toxicology and Applied Pharmacology 1989present Chemical Research in Toxicology
1991 94 199699 200508 Journal of Toxicology and Environmental Health 199295 Chemico
Biological Interactions 19921998 DrugMetabolism and Disposition 19942002 Toxicological Sciences
2002 present
PROFESSIONAL SERVICE
Registration Chairman 39th American Chemical Society Northwest Regional Meeting 1984
Chairman Symposium on Molecular Toxicology 39th American Chemical Society Northwest Regional Meeting
1984
Chairman WashingtonIdaho Border Section of the American Chemical Society 1986
Resolutions Committee Chemistry Section American Association of Colleges of Pharmacy 198586
Chairman and Organizer Symposium titled Mechanisms of Lung Injury by Systemically Administered Chemicals
Annual Society of Toxicology Meeting Atlanta GA February 1989
Councilor Mountain West Society ofToxicology 1989 1991
SecretaryTreasurer Mechanisms Section of the Society of Toxicology 199092
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Member Education Committee of the Society of Toxicology 199194 Chairman 199294
Member National Academy of SciencesNationalResearch Council Committee on Toxicology 199197
Member National Academy of Sciences Subcommittee on Guidelines for Developing Spacecraft Maximum
Allowable Concentrations for Space Station Contaminants 1991 1999
Member Site Visit Team for NIEHS North Carolina State University May 28 1992
Member National Academy of Sciences Subcommittee to Review the USNaval Medical Research Institute
Toxicology Program 199295
Member National Academy of Sciences Subcommittee to Review Toxicity of Alternatives to
Chlorofluorocarbons 199396
Member Developmental Therapeutics Contracts Review Committee for the National Cancer Institute 199395
Member Advisory Committee for a NIEHS Program Project Grant Univ California Davis April 19 1993
Special Reviewer Toxicology Study Section for NIH June 1618 1993
Member National Academy of Sciences Subcommittee on Rocket Emission Toxicants 199598
Member Executive Committee Drug Metabolism Division ASPET 199497
Member National Academy of Sciences Subcommittee on Military Smokes and Obscurants 1997 2000
Vice President Elect Mountain West Society of Toxicology 199596 Vice President 199697 President
199798
Member North American Regional ISSX Committee 199497
Vice President Elect Mechanisms Section of the Society of Toxicology 199798 Vice President 199899
President 1999 2000
Member Program Committee for Biological Reactive Intermediates IV meeting in Paris July 2000
Member K12 Subcommittee ofthe Society of Toxicology Education Committee 19971999
Member Review Panel National Institute of Environmental Health Science andUSEnvironmental Protection
Agency RFA for Centers for Children Environmental Health and Disease Prevention Research Research
Triangle Park NC March 23 25 1998
Chair Scientific Affairs Committee International Society for the Study ofXenobiotics 19982001
Member Council International Society for the Study of Xenobiotics 1998 2001
Chair AACP panel grant review 1999 2000 New Investigators Program for Pharmacy Faculty 1999
Member National Academy of Sciences Subcommittee on Spacecraft Exposure Guidelines 19992009
Member Scientific Advisory Committee 10 North American ISSX Meeting Indianapolis October 2000
Member Scientific Advisory Board and Program Committee 6 International ISSX Meeting Munich Germany
October 2001
Member Organizing Committee 11 North American ISSX Meeting Orlando October 2002
Reviewer University ofCalifornia TobaccoRelated Disease Research Program Cancer Review Committee San
Francisco CA May 45 2000
Chair Biological Sciences AACP grant review 2000 2001 New Investigators Program for Pharmacy Faculty
2000
Member Membership Committee of the Society of Toxicology elected position 2001 2004
Secretary International Society for the Study of Xenobiotics elected position 20022006
Member Organizing Committee 13 North American ISSX Meeting and JSSX Japanese Society Meeting
Maui Hawaii October 2005
Member Review Committee for Site Visit to Johns Hopkins University for NIEHS Center Grant Application
Baltimore MD June1252002
Chair National Academy ofSciences Subcommittee on Spacecraft Exposure Guidelines 2002 2008
Member NIH Member Conflict Study Section Review Panel Bethesda MD October 7 2002
Member Environmental Health Sciences Review Committee NIEHS NIH 20022006




ember - cation o i t e f t e et   ic lo  (1991-9 ), r a  (1992-9 ). 
e ber - ational cade y f ciences INa tiona I es r  il ittee  ic log  (1991-9 ). 
ember - ational cade y of Sciences Subco ittee on uidelines for eveloping Spacecraft axi u  
llowable trations f r ace t ti  ta inants (1 91- 99). 
ember - ite isit ea  for I , orth arolina tate niversity, ay 28, 1992. 
e be  - tio l ca  f iences ittee t  i  t  .S. a al i l r  I tit te's 
Toxicology Program (1992-95). 
e ber - ational ca   e ces i tee  i  i it   lternatives to 
hlorofluorocarbons (1993 -96). 
e ber - evelop ental Therapeutics Contracts Revie  Co ittee for the ational Cancer Institute (1993-95). 
e ber - dvisory o ittee for a I  rogra  roject rant, niv. alifornia, avis (April 19, 1993). 
Special Reviewer - Toxicology Study Section for NIH (June 16-18, 1993). 
e ber - ational cade y of ciences ubco ittee On ocket- ission oxicants (1995-98). 
e ber - xecutive o ittee, rug etabolis  ivision,  (1994-97). 
e ber - ational cade y of Sciences Subco ittee on ilitary S okes and bscurants (1997-2000). 
ice- e   - o tai  est ciet  f ic l  (1995-9 ), ice- resi e t (1996-9 ), resi e t 
(1997-98). 
e ber - orth erican Regional ISS  Co ittee (1994-97). 
ice-   - echanis s ection f the ociety f oxicology (1997-98); ice- resident (1998-99); 
President (1999-2000). 
Member - Program Committee for Biological Reactive Intermediates IV meeting in Paris, July, 2000. 
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gency F  for enters for hildren's nviron ental ealth and isease Prevention esearch, esearch 
Triangle Park, NC, arch 23-25, 1998. 
 - i tific ffairs itt , I t r ti l i t  f r t  t  f i ti s (1 - 01). 
e ber- ouncil, International Society for the Study of enobiotics (1998-2001). 
i  - CP panel grant revie , 1999-2000 e  Investigators Progra  for Phar acy Faculty (1999). 
e ber - ational cade y of ciences ubco ittee on pacecraft xposure uidelines (1999-2009). 
e ber - cie tific is r  ittee, lOth rt  erica  I  eeti g, I ia apolis, ct er, 0. 
 - i tifi  is r  r   r r  itt , th I t r ti l I  ting, ich, r ny, 
October, 2001. 
 - Organizing Committee, 11 th North American ISSX eeting, Orlando, October, 2002. 
i r - niversity of alifornia Tobacco- elated isease esearch Progra , ancer evie  o ittee, San 
Francisco, CA, ay 4-5, 2000. 
i  - Biological Sciences AACP grant review, 2000-2001 New Investigators Program for Pharmacy Faculty 
(2000). 
e ber - embership Committee of the Society of Toxicology - elected position (2001-2004) 
Secretary - International Society for the Study ofXenobiotics - elected position (2002-2006) 
 - Organizing Committee, 13th North American ISSX eeting and JSSX (Japanese) Society eeting, 
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Member Program Committee for Biological Reactive Intermediates VII meeting in Tucson AZ Jan 482006
Member NIH Special Emphasis Panel for XNDAMember Conflict applications Bethesda MD June 26 2006
Member Expert Panel forNaphthalene StateoftheScience Symposium Monterey CA October 912 2006
Member Peer Consultation for Ethylbenzene Panel for the Voluntary Children Chemical Evaluation Program
associated with the US Environmental Protection Agency February 2223 2007
Member Awards Committee of the Society ofToxicology elected position 20072010
Member NIH Member Conflict Study Section Review Panel Bethesda MD March 13 2007
Member Expert Panel on Styrene for the National Toxicology Program DHHS Report on Carcinogens
Research Triangle Park NC July 21 22 2008
Chair Scientific Liaison Task Force of the Society of Toxicology 20082010
CoChair Symposium on Novel Extrahepatic Cytochrome P450s Functional Roles 9 International ISSX
Meeting Instanbul Turkey September 48 2010
Member NIH Special Emphasis Panel Challenge Grants Panel 19 ZRG1 CVRSB 58 R Bethesda MD July
202009
Member NIEHS Superfund Basic Research Program P42 Review Meeting RTP NC Oct 27 29 2009
Manuscript Reviewer for
Toxicology and Applied Pharmacology
Molecular Pharmacology
Journal ofMedicinal Chemistry





Journal ofPharmacology andExperimental Therapeutics
Archives ofBiochemistry and Biophysics
DrugMetabolism andDisposition
Journal ofToxicology and Environmental Health
Journal ofOrganic Chemistry













Cross College Coordinating Committee for the Improvement of Instruction 198285
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Journal f Inorganic Bioche istry 
TE  I : 
niversity-wide: 
ross ollege oordinating o ittee for the I prove ent f Instruction (1982-85) 
c ittee f r t e ra ate t e t er tipe  r ra  (19 ) 
Subco ittee on olecular and Cell Biology for the rant-in-Aid Progra  (Chair an, 1984-85) 
Human Subjects Review Board 198687
Mass Spectrometer Advisory Committee with Chemistry Department 198387
Representative Graduate Studies Committee for four Doctors Examinations and Masters Examination 198487
Institutional Animal Care and Use Committee 199497
University Promotion and Tenure Committee 19972000
University Research Committee 2001 2004 Chair 200304
College ofPharmacy
Recruitment and Admissions Committee for PharmacologyToxicology program Chairman 198287
Graduate Faculty Executive Committee 198283
Burroughs Wellcome Visiting Professorship Author of Applications 1982 and 1983
Undergraduate Research Awards Chairman 1983
Ad Hoc Committee on Graduate Program 1983
Safety Committee Chairman 1983 84
Pharmaceutics Position Search Committee Chairman 1984 85
Research Committee 1985 87
PharmacologyToxicol g Position Search Committee 198687
Research Committee 198791
Teaching Committee for Department of Pharmacology and Toxicology 19881990 19921994
Organizer ofPharmacology and Toxicology Seminar Program 1988 1992
Pharmacology and Toxicology Faculty Search Committee 198889
Councilor for AACP Research Participation Program for Undergraduate Minorities 19881995
Dean Search Committee 1988 89
Chairman Pharmacology and Toxicology Faculty Search Committee 199091
Delegate to AACP from College of Pharmacy University of Utah 199192
Scholastic Standards Committee and Advisor for Class of 1994 Pharmacy Students 199194 Chair 199394
Graduate Training Committee 19921996
Pharmacology and Toxicology Faculty Search Committee 1994
Chairman Graduate Recruitment Committee 19941996
Computer Committee 19972001
Task Force on Faculty Development 1997
Search Committee for Chair of Pharmacology and Toxicology 1998
Curriculum Committee College of Pharmacy 19982001
CoChair Standards for Library Learning Resources Accreditation SelfStudy 199901
Chairman 20012008 and Member Learning and Teaching Committee 19972008
Graduate Recruitment Committee Department ofPharmacology and Toxicology 2002 present
Graduate Training Committee Department of Pharmacology and Toxicology 2002present
Coordinator Academic Affairs College of Pharmacy 20032008
Scholastic Standards Committee College of Pharmacy 2007 present
Assessment Committee College ofPharmacy 2009 present
INSTRUCTIONAL ASSIGNMENTS




u an Subjects evie  oard (1986-87) 
ass tr t r is r  ittee it  istr  rt t (1983-8 ) 
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niversity Pro otion and Tenure o ittee (1997-2000) 
niversity esearch o ittee (2001-2004); hair (2003-04) 
lle  f y: 
r it e t  issi s itte  f r r l /To ic l  r r  (Chair , -8 ) 
ra ate lt  tive ittee (1982-8 ) 
urroughs ellc e isitin  r fess rshi . t r f licati s (1982 a  3) 
ndergraduate r  ards (Chair , ) 
d oc o ittee on raduate Progra  (1983) 
f t  ittee (Chair , -8 ) 
r tics siti  r  itte  (Chair , 4-8 ) 
r  ittee (1985-8 ) 
harmacologyffoxicology osition earch o ittee (1986-87) 
s r  ittee (198 -9 ) 
eaching o ittee for epart ent of Phar acology and oxicology (1988-1990, 1992-1994) 
rganizer f har acology and oxicology e inar rogra  (1988-1992) 
Phar acology and Toxicology Faculty Search Co ittee (1988-89) 
ouncilor for P esearch Participation Progra  for ndergraduate inorities (1988-1995) 
  tte  (1988-8 ) 
ir , r l   i l  lt  r  itt  (199 -9 ) 
elegate to P fro  ollege of Phar acy, niversity of tah (1991-92) 
l sti  t r s ittee  is r f r l ss f  r  t ts (1991-9 ); ir (199 -9 ) 
r t  r i ing ittee (1992-19 ) 
l   icology   te  (19 ) 
air a , ra ate ecr it e t ittee (19 -1 ) 
t r ittee (1997-20 ) 
 rce  lt  l e t (1 ) 
earc  ittee f r air f ar ac l  a  ic lo  (l ) 
urriculu  o ittee, ollege ofPhannacy (1998-2001) 
o- hair, tandards for ibrary & earning esources - Accreditation Self-Study (1999-01) 
Chair an (2001-2008) and e ber, Learning and Teaching Co ittee (1997-2008) 
Graduate Recruitment Committee, Department of Pharmacology and Toxicology (2002-present) 
raduate Training Co ittee, epart ent of Phar acology and Toxicology (2002-present) 
Coordinator, cade ic ffairs, College of Phar acy (2003-2008) 
cholastic tandards o ittee, ollege f har acy (2007-present) 
ssess t itt , lle  f r  (2009- r sent) 
 : 
rs  * it  rs  itle tact o rs/Quarter r e ester 
Washington State University 
7
Phar 331 3 Organic Med Chemistry 10
Phar 436 3 Chemotherapy 22
Phar 471 4 Chemical Pharmacology 20
Phar 472 5 Pharmacodynamics 9
PT 505 4 Principles ofToxicology 6
PT 506 5 Principles ofPharmacology 5
PT 525 3 Instrumental Techniques in 38
PharmacologyToxicol g
PT 532 2 Drug Metabolism 30
University ofUtah
Ph Tx 6610 4 Princ PharmToxicol 510 students 18
Ph Tx 6620a 3 Analytical Tox 510 students 4
PhTx 6630a 2 Biochemical Tox 510 students 10
PhTx 6710 1 Developments Biochem Tox J Club 15
Ph Tx 571 198895 5 Pharmacology 60 students 1
Ph Tx 52116 5 Pharmacology 50 students 2
Pharmacol 6030 6040 variable Pharmacology for Med Students 3
Current Courses
Ph Tx 6600 2 Methods in PharmTox5 10 students 4
PHARM 5113 2 Basics ofPharmaceutical Sciences 4
PHARM 7113 3 Fundamentals ofPharmaceutical Sci 12
Ph Tx 7114 2 Principles ofToxicology 9
Indicates responsibility for administration of course either current or past years Coursemaster for PhTx 572
only for winter quarter of 1988 and 571 for 1989 92
a Taught alternate years
GRADUATESTUDENTS
Name Thesis Title Degree Year
Brent L Finley Characterization and Isolation of PhD 1986
Ethanol Induced UDP
Glucuronyltransferase
Michael G Horstman Mechanism of Toxicity and MS 1987
Chemotherapy of the Antineoplastic
Agent Procarbazine
Jeannette Huijzer Bioactivation of 3Methylindole and PhD 1987
the Involvement of Cytochrome P450
Monooxygenases




Phar 331* 3 r i  d. i tr  1  
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 6   ethods in Phannffox (5- 10 students)  
 5113 2   t  ces  
P 7113     ci.  
71   Principles of Toxicology  
* Indicates responsibility for ad inistration of course, either current or past years. ourse aster for PhTx 572 
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Changes in Morphine PhD 1989
Pharmacokinetics After Chronic
or During Acute Ethanol
Treatment in Rabbits
In Vitro Activation of Procarbazine PhD 1991
to Cytotoxic Species
Metabolism and Mechanism ofToxicity PhD 1991
of 3Methylindole in Human and
Goat Tissues
Metabolic Activation ofthe Pneumotoxin PhD 1992
3Methylindole
Bioactivation of3Methylindole by PhD 1992
Individual Cytochrome P450 Isozymes
Cloning and Sequencing of PhD 1st Rotation 1990 91
EthanolInduced
UDPGlucuronosyltransferase
Cloning and Characterization of PhD 1995
Pulmonary Cytochrome P450 Genes
Bioactivation and Pneumotoxicity of PhD 2nd Rotation 1992 93
Halogenated Hydrocarbons
Cloning ofCytochrome P450 2173 a PhD 1996
Catalyst of the Unique Dehydrogenation
of 3Methylindole
Characterization ofProtein Targets of PhD 1996
the Pneumotoxin 3Methylindole
Cloning ofEthanolInduced PhD 1 Rotation 199394
UDPGlucuronosyltransferase
Protein Targets of3Methylindole PhD I Rotation 199596
in Human Lung Cells
Mechanistic Studies of the Cytochrome PhD 2002
P450Dependent Oxygenation and
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alogenated ydrocarbons 
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t l st f t  i  roge tion 
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the Pneu otoxin 3- ethylindole 
a c ly argas l in  f t anol-I ce  h.D. 151 otation (1993 -94) 
- l  Itransferase 
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Brian Carr Regulation ofCytochrome P450 CYP2F1 PhD 2002
Gene Expression
Chad Borges Intramolecular Deuterium Isotope Effects PhD IRotation 199798
in cDNAExpressed P450 Enzymes
Brian Klein Regulation of Cytochrome P450 CYP413 1 PhD 2 Rotation 199899
Gene Expression
Craig Osborne Mutation and Expression of PhD I Rotation 199899
Cytochrome P450 CYP4B 1 2nd Rotation 199900
Jason Biggs Lung Selective Regulation of the PhD 2005
Human CYP3AGenes
Stacy Smeal Metabolism ofCapsaicinoids by PhD 2nd Rotation 200102
Human P450 Enzymes
Jaya Kartha Biochemical and Mechanistic PhD 2007
Characterization of Pulmonary Selective
Cytochrome P450 2F1 and 2F3
Ashwini Sabnis Expression and Characterization of PhD 2007
TRPM8 Receptors in the Lung
Epithelium Implications in Asthma
Hao Sun Mechanisms ofCytochrome P450 PhD 2007
Mediated Dehydrogenation
Cassandra DeeringRice Nanoparticle Alteration of PhD 2008
Endothelial Cell Function
Mohammad Shadid DNA Adducts and 3Methylindole PhD 2008
Carcinogenesis
Chad Moore Bioactivation ofRaloxifene a new PhD 2009
Hormone Replacement Agent
Kiumars Shahrokh Inactivation ofCYP2B6 and CYP2136 PhD 2009
by Tamoxifen Reactive Intermediates
Karen Thomas Mechanisms ofCapsaicin PharmDh2010
Dehydrogenation
Fred Henion Structural Characterization ofthe PharmDh2011
Glutathione Adducts of Capsaicin
Jessica Weems Lung Cell DNA Damageeathcaused PhD 2010
000502
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 i  
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e drogenation 
Fred enion t ral zation  the harm.D.lPh.D.  
l tat ione dducts f s i i  
Jessica ee s ung ell  amagelDeath ca se  . 10 
m
by 3Methylindole
Jessica Roberts Pediatric Asthma PhD 2013
James C Taylor Glucocorticoid Metabolism PhD 2013
GRADUATE STUDENT ANDPOSTDOCTORAL FELLOW RECOGNITION
Brent Finley received a PhRMA Foundation Pre Doctoral Fellowship 1984
Brent Finley won third prize for the Graduate Student Research Award contest for the SOT Mechanisms Section
1986
Janice Thornton Manning received a SOT Graduate Student Fellowship sponsored by Proctor and Gamble for
1991 92
Janice ThorntonManning received first prize for the best abstract from the Molecular Biology Section of SOT
1991
Gary L Skiles received first prize for the Graduate Student Research Award contest for the SOT Mechanisms
Section 1992
Chris Reilly was awarded the Colgate Palmolive Postdoctoral Fellowship in In Vitro Toxicology through the
Society of Toxicology 2001
Jason S Biggs won the Colgate PalmoliveSOT Award for Student Research Training in Alternative Methods
2001
Jason S Biggs won first prize for the best poster by a graduate student from the North American Meeting of the
International Society for the Study ofXenobiotics Orlando Florida2002
Ashwini S Sabnis won second prize for student poster presentation at the 2004 Mountain West Society of
Toxicology Regional Chapter Meeting
John M Veranth received the 2004 Project of the Year Award from the Strategic Environmental Research and
Development Program The award was presented by Mr Alex Beehler Assistant Deputy Under Secretary of
Defense for Environmental Safety and Occupational Health of the United States of America
Ashwini S Sabnis was a finalist for the Graduate Student Research Award contest for the SOT Mechanisms
Section 2006
Hao Sun won P place in the Graduate Student Research Award contest for the SOT Mechanisms Section 2007
Aaron Rowland won first place award postdoctoral fellows for his abstract by the Molecular Biology Section
Society of Toxicology March 2007
Aaron Rowland won the Colgate Palmolive Post Doctoral Fellowship through the Society of Toxicology April 1
2007 March 31 2008
Aaron Rowland received NRSA Postdoctoral Fellowship from NHLBI July 15 2007 June 30 2010
Kiumars Shahrokh received a Graduate Research Fellow award from the University of Utah Graduate School
200809
Kiumars Shahrokh received 2
d
place in the Young Investigator Session in the Division of Chemical Toxicology
American Chemical Society meeting Philadelphia August 18 2008
Mohammad Shadid received I prize for the best poster by a graduate student from the North American Meeting
ofthe International Society for the Study ofXenobiotics San Diego October 1216 2008
Kiumars Shahrokh won the Chemical Computing Group Excellence Award for the Fall 2009 ACS National
Meeting in Washington DC August16200 9
000503
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Brent Finley received a PhRMA Foundation Pre Doctoral Fellowship (1984). 
Brent Finley won third prize for the Graduate Student Research Award contest for the SOT echanisms Section 
(1986). 
Janice Thornton- anning received a S T raduate Student Fello ship (sponsored by Proctor and a ble for 
91-9 ). 
Ja ice r t - a ing recei e  first rize f r t e est a stract fro  t e lec lar i l  ecti  f  
(1991). 
ary . Skiles received first prize for the raduate Student esearch ard contest for the S  echanis s 
Section (1992). 
hris eilly as a arded the olgate-Pal olive Postdoctoral Fello ship in In itro Toxicology through the 
Society of Toxicology (2001) 
Jason S. iggs on the olgate-Pal olive-SOT ard for Student esearch Training in lternative ethods 
(2001) 
Jason S. Biggs won first prize for the best poster by a graduate student fro  the North A erican eeting of the 
International Society for the Study of enobiotics, rlando, Florida (2002) 
Ashwini S. Sabnis won second prize for student poster presentation at the 2004 ountain est Society of 
Toxicology Regional Chapter eeting 
John . eranth received the 2004 Project of the ear ard fro  the Strategic Environ ental Research and 
Development Program. The award was presented by r. Alex Beehler, Assistant Deputy Under Secretary of 
efense for Environ ental, Safety and ccupational ealth ofthe nited States of erica 
s  . s as  in s      r        
Section (2006) 
Hao Sun won 3rd place in the Graduate Student Research Award contest for the SOT Mechanisms Section (2007) 
Aaron Rowland won first place award (postdoctoral fellows) for his abstract, by the olecular Biology Section, 
Society of Toxicology (March 2007) 
aron o land on the olgate-Pal olive Post- octoral Fello ship through the Society of oxicology (April 1, 
 - arch 31, 2008) 
aron o land received S  Postdoctoral Fello ship fro  L I (July 15,2007 -  , 010). 
iu ars Shahrokh received a raduate esearch Fello  a ard fro  the niversity of tah raduate School 
(2008-09) 
iu ars r  r i e  nd place in the Young Investigator Session, in the Division of Chemical Toxicology, 
American Chemical Society meeting, Philadelphia, August 18,2008. 
oha ad Shadid received 1st prize for the best poster by a graduate student fro  the orth erican eeting 
f the International ociety for the tudy ofXenobiotics, an iego, ctober 12-16,2008. 
iu ars Shahrokh on the Che ical Co puting roup Excellence ard for the Fall 2009 CS ational 






James D Adams Jr 1985 87
JohnYan Jaw 198687
David J Kuntz 1987 1988
Stephen GGillespie 19871988
Jeffrey C Hoyt 19881989
Martin L Appleton 1988 1995
Ghazi Dannan 1989 92
Bradford Manning 199192
Mark Flood 1992 1994
Joyce Manzella 19921994
Rashmi Mehta 1995 1997
Cai Yuan 1995 1997
Kon Skordos 2002 2003
Christopher AReilly 19992001 and Res Assoc Prof 2001present
Jie Wan 2001 2004
John M Veranth Res Asst Prof 2001 present
Mark Johansen 2003 2005
LaHoma Easterwood 2003 2006
N Shane Cutler Res Asst Prof 20032009
Aaron Rowland 20052008
Christopher R Orton 20062009
Takahiro Murai 2008 2010
Cassandra DeeringRice 2009 present
Chad Moore 2009present




Title Submitted to Per Year Period








College ofPharmacy BRSG Funds
13952 282183
3500 482383
Toxicities of the Alkyla WSUAmerican Cancer Society 5131 782683
000504
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Lung Injury no cost extension
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P450Mediated NIGMS RO1 GM0724904 188374 01612310
Dehydrogenation Mechanisms no cost extension
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Characteristics with Toxicity
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PAPERS POSTERS ANDPRESENTATIONS
InvitedLecturesSeminars
1 Alcoholism and Drug Metabolism PharmacologyToxicolog Seminar Washington State University April
1983
2 Mechanisms of3Methylindole Pneumotoxicity University ofCalifornia San Francisco July 8 1985
Recent Findings on the Chemical Nature and Biochemical Mechanisms of the Toxic Agent Involved in 3
Methylindole Induced Acute Lung Injury Natural Toxin Symposium Rocky Mountain Regional Meeting
American Chemical Society Denver Colorado June 8 12 1986
4 Chemically Induced Pneumotoxicities Animal Investigations and the Human Situation Mountain West
Society of Toxicology Meeting Salt Lake City Utah September 2223 1988
5 3Methylindole Bioactivation and Lung Injury Society of Toxicology Symposium on Mechanisms of Lung
Injury by Systemically Administered Chemicals CoChairmen Garold S Yost and Alan R Buckpitt Atlanta
Georgia February 27 March 3 1989
6 Glutathione Depletion Causes Organ Selective Switch in 3Methylindole Toxicity Battelle Pacific Northwest
Laboratories Richland Washington April 26 1989
7 Glutathione Depletion Causes Organ Selective Switch in 3Methylindole Toxicity Washington State
University Pullman Washington July 28 1989
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1. lcoholis  and rug etabolis , PharmacologylToxicology Se inar, ashington State niversity, pril, 
1983. 
2. echanis s of3- ethylindole neu otoxicity, niversity f alifornia, an rancisco, July 8, 1985. 
3. ecent Findings on the he ical ature and ioche ical echanis s of the oxic gent Involved in 3-
ethylindole Induced Acute Lung Injury, Natural Toxin Sy posiu , Rocky ountain Regional eeting, 
erican  i t , , l o, e -1 , . 
. i ll  I ce  otoxi iti s; i l I estigations  t   it ti , t i  est 
Society of Toxicology eeting, Salt Lake City, tah, Septe ber 22-23, 1988. 
5. 3- ethylindole Bioactivation and Lung Injury, Society of Toxicology Sy posiu  on echanis s of Lung 
Injury by Systemically Administered Chemicals, Co-Chairmen: Garold S. Yost and Alan R. Buckpitt, Atlanta, 
e r ia, e r ar   - arch , . 
. lutathione e letion a ses r a  electi e itc  i  - et lindole icit  attelle acific rt est 
a rat ries, ic la d, as i t , ril , . 
7. Glutathione Depletion Causes Organ Selective Switch in 3- ethylindole Toxicity ashington State 
i rsity, ll , a i to  l  , . 
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8 Mechanisms ofPneumotoxicity and Nephrotoxicity of 3Methylindole University ofConnecticut Toxicology
Scholars Colloquium Storrs Connecticut February 1990
9 Pneumotoxicity of Environmental Contaminants Mountain West Society of Toxicology Meeting Tucson
Arizona October 45 1990
10 Biochemical Mechanisms of3Methylindole Pneumotoxicity Biochemical Interest Group Seminar University
ofUtah Salt Lake City Utah February 12 1991
11 Pneumotoxins From Natural Products Continuing Education Course on Natural Toxins Society of Toxicology
Annual Meeting Dallas Texas February 25 1991
12 Chemical and Biochemical Mechanisms of 3Methylindole Pneumotoxicity Program in Molecular and
Environmental Toxicology University ofColorado Boulder Colorado March 13 1991
13 Chemical Bioactivation of 3Methylindole Department of Medicinal Chemistry University of Washington
Seattle Washington April41991
14 Bioactivation of Pulmonary Toxins in bung Cells Symposium on Contribution of the Respiratory Tract to the
Metabolic Fate of Inhaled Chemicals FASEB Meeting Atlanta Georgia April 14 1991
15 Cytochrome P450 Monooxygenase Based Mechanisms of Lung Toxicity Symposium on The Pulmonary
Cytochrome P450 System American Lung Association and American Thoracic Society Meeting Anaheim
California May 14 1991
16 Mechanisms of 3MethylindoleMediated Pneumotoxicity in Human and Animal Tissues Inhalation
Toxicology Research Institute Albuquerque New Mexico October 9 1991
17 Mechanisms of Bioactivation and Pneumotoxicity of Environmental Chemicals Toxicology Seminar Program
College ofPharmacy University of New Mexico Albuquerque New Mexico October 9 1991
18 Protein and DNA Adducts of Bioactivated 3Methylindole Symposium on Biological Markers Society for
Risk Analysis Meeting Baltimore Maryland December 9 1991
19 Bioactivation of 3Methylindole by cDNAExpressed Cytochrome P450 Enzymes SmithKline Beecham
Pharmaceuticals Swedeland Pennsylvania May 2 1992
20 Role ofCytochrome P450 in the Bioactivation ofthe Pneumotoxin 3Methylindole Division ofPulmonary and
Critical Care Medicine University of Texas Houston Texas November 17 1993
21 Bioactivation Mechanisms Related to Lung Selective Toxicants Symposium on Frontiers in Molecular
Toxicology 1994 North American International Society for the Study of Xenobiotics meeting Raleigh North
Carolina October 25 1994
22 Mechanisms of Cytochrome P450Mediated Formation of Pneumotoxic Electrophiles Fifth International
Symposium on Biological Reactive Intermediates Munich Germany January 48 1995
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19. Bioactivation of 3- ethylindole by cDNA-Expressed Cytochro e P450 Enzy es S ithKline Beecha  
har aceuticals, edeland, ennsylvania, ay 2, 1992. 
20. Role of Cytochro e P450 in the Bioactivation of the Pneu otoxin 3- ethylindole ivision of Pul onary and 
ritical are edicine, niversity of exas, ouston, exas, ove ber 17, 1993. 
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oxicology, 1994 orth erican International Society for the Study of enobiotics eeting, aleigh, orth 
l . tober , . 
. echa is s f t c ro e - e iated r tion f t ic l tr il s, ifth I t r ti l 
Sy posiu  on iological eactive Inter ediates. unich, er any, January 4-8, 1995. 
23 Pulmonary Toxicology American Chemical Society short course on Chemical Mechanisms in Toxicology
Atlanta Georgia April 45 1995
24 Molecular Mechanisms of 3Methylindole Induced Lung Toxicity Department of Pharmaceutical Sciences
School of Pharmacy University of Colorado Denver Colorado May 22 1995
25 Mechanisms of 3Methylindole Bioactivation Catalyzed by Pulmonary Cytochrome P450 Enzymes Gordon
Research Conference on Drug Metabolism Holderness New Rampshire July 914 1995
26 Mechanisms of Cytochrome P450Mediated Bioactivation of the Pneumotoxin 3Methylindole Merck
Research Laboratories West Point PA and Rahway NJ October 24 25 1995
273 Methylindole Dehydrogenation Mechanisms Protein Targets and Species Selectivity University of
Arizona Tucson Arizona March 34 1997
28 Mechanisms of Formation and Toxicity of Imine and Epoxide Intermediates of the Pneumotoxin 3
Methylindole Department of Medicinal Chemistry and Pharmacognosy University of Illinois at Chicago
Chicago Illinois December 4 1997
29 Multiple Reactive Intermediates of the Pneumotoxin 3Methylindole 7 European ISSX Meeting Budapest
Hungary August 22 1999
30 Molecular Mechanisms of Respiratory Toxicity Associated with Dehydrogenation of Pneumotoxicants by
Cytochrome P450 Enzymes Department of Medicinal Chemistry University of Minnesota Minneapolis
Minnesota December 7 1999
31 Mechanisms of3MethylindoleMediated Lung Injury Department of Pathology Colorado State University
Ft Collins Colorado May 1 2000
32 Mechanisms of Gene Regulation and Bioactivation of Lung Toxicants by Selective Cytochrome P450
Enzymes 13 International Symposium on Microsomes and Drug Oxidations Stresa Italy July 12 2000
33 Bioactivation of Toxicants by Cytochrome P450Mediated Dehydrogenation Mechanisms 6 International
Symposium on Biological Reactive Intermediates Paris France July 16 2000
34 Lung P450 Enzymes Function Gene Regulation and Dehydrogenation of SubstratesToxicant Pfizer Inc
November 1516 2000
35 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung Zeneca Traveling Lectureship University Rene Descartes Paris France
Nestle Research Center Lausanne Switzerland and GenPharmTox Inc Munich Germany May 2 15
2001
36 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung Zeneca Traveling Lectureship National Institute of Public Health Oslo
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. i acti ati  f ica ts  t c r e 0- e iate  e r e ati  ec a is s, th I ter ati al 
Sy posiu  on Biological Reactive Inter ediates, Paris, France, July 16,2000. 
34. Lung P450 Enzy es: Function, ene Regulation, and ehydrogenation of Substratesrroxicants, Pfizer, Inc., 
ove ber 15-16,2000. 
35. egulation of ytochro e P450 ene Expression and echanis s of P450- ediated Toxicities of 
Pneu otoxicants in u an Lung, Zeneca Traveling Lectureship, niversity ene escartes, Paris, France; 
Nestle Research Center, Lausanne, Switzerland; and GenPharmTox, Inc., unich, Germany; ay 2 - 15, 
. 
36. Regulation of Cytochro e P450 ene Expression and echanis s of P450- ediated Toxicities of 
Pneu otoxicants in u an ung, eneca raveling ectureship, ational Institute of Public ealth, slo, 
r ay; stra e eca a  e ta, l erle  ark, ; a  i ersit  f I , l , i la d; J e  -
July 19,2001. 
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37 Dehydrogenation as a Mechanism for Pneumotoxicity 6 International Meeting International Society for the
Study of Xenobiotics Munich Germany October 711 2001
38 Human Lung Epithelial Cells Used to Elucidate Mechanisms of P450 Gene Expression and Lung Toxicities
presented through the Colgate Palmolive Traveling Lectureship in Alternative Methods in Toxicology Award
Department ofPharmacology and Toxicology Medical College of Wisconsin Milwaukee Wisconsin August
2 2001
39 Vanilloid Receptors in Human Lung Epithelial Cells Response to Pepper Sprays and Relationship to
Environmental Exacerbation of Pediatric Asthma presented through the Colgate Palmolive Traveling
Lectureship in Alternative Methods in Toxicology Award Department of Pediatrics Medical College of
Wisconsin Milwaukee Wisconsin August 3 2001
40 Regulation of Cytochrome P450 Gene Expression and Mechanisms of P450Mediated Toxicities of
Pneumotoxicants in Human Lung University of Arizona Tucson Arizona January 9 2002
41 Function and Regulation of Human CYP2F1 and CYP4B1 in Lung American Society for Pharmacology and
Experimental Therapeutics Meeting New Orleans Louisiana April 2024 2002
42 Lung P450s Mechanisms of Gene Regulation and Toxicant Bioactivation 14 International Symposium on
Microsomes and Drug Oxidations Sapporo Japan July 2226 2002
43 Transcriptional Regulation of P450 Genes in Respiratory Tissues 11 North American Meeting International
Society for the Study ofXenobiotics Orlando Florida October 2731 2002
44 Cytochrome P450Mediated Dehydrogenation vs Oxygenation of Xenobiotics Pathways to Cellular Injury
Purdue Pharmaceuticals Ardsley New York December 17 2002
45 Cytochrome P450Mediated Dehydrogenation vs Oxygenation ofXenobiotics Pathways to Cellular Injury
Merck Research Laboratories Rahway New Jersey and West Point Pennsylvania February 2021 2003
46 Enhanced Cytotoxicity of Capsaicinoids to TRPVI Overexpressing Human Lung Cells Society ofToxicology
Meeting Salt Lake City Utah March 913 2003
47 Mechanisms of Respiratory Inflammation from Pepper Sprays Human Effects Risk Characterization of
NonLethal Weapons National Institute of Justice Oleoresin Capsicum Workshop Aberdeen Proving Ground
MD October892003
48 Bioactivation of Xenobiotics by Dehydrogenation Mechanisms University of Texas Medical School
Galveston TX December 15 2003
49 Mechanisms that Control the Selective Expression of CYP2F1 CYP4B1 and CYP3A5 in Human Lung
Society ofToxicology Meeting Baltimore MD March 21 25 2004
50 Respiratory Tissue Selective Metabolism Dependent Toxicity 15 International Symposium on Microsomes
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. r s ri ti l l ti  fP4  s i  s ir t r  iss s, 1th rt  ri  ti , I t r ti l 
Society for the Study of enobiotics, rlando, Florida, ctober 27-31, 2002. 
44. ytochro e P450- ediated ehydrogenation vs xygenation of enobiotics - Path ays to ellular Injury, 
urdue har aceuticals, rdsley, e  ork, ece ber 17,2002. 
45. ytochro e 450- ediated ehydrogenation vs xygenation f enobiotics - ath ays to ellular Injury, 
r  s r  r t ri s, y,  J rsey,  st int, syl ni , r r  -21, 03. 
46. nhanced ytotoxicity of apsaicinoids to I- verexpressing u an ung ells, ociety f oxicology 
eeting, Salt Lake City, Utah, arch 9-13, 2003. 
47. echanis s f espiratory Infla ation fro  Pepper Sprays, u an ffects &  r   
on-Lethal eapons, ational Institute of Justice leoresin Capsicu  orkshop, berdeen Proving round, 
, ctober 8-9, 2003. 
48. ioactivation of enobiotics by ehydrogenation echanis s, niversity of exas edical School, 
alveston, , ece ber 15, 2003. 
49. echanis s that ontrol the Selective xpression of Y 2 l, Y 4 l, and Y 3 5 in u an ung, 
Society of oxicology eeting, alti ore, , arch 21-25,2004. 
50. Respiratory Tissue Selective Metabolism-Dependent Toxicity, 15th International Symposium on Microsomes 
a  r  i ati s, ai z, er a y, J l  -9, . 
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51 Transcriptional Regulation of Lung Expressed P450 Genes Mechanisms and Polymorphisms in Regulatory
Regions Mountain West Society ofToxicology Meeting Park City UT September 910 2004
52 Sequential Oxygenation and Dehydrogenation of Capsaicin Forms Unique Quinoneimines 7 International
Society for the Study of Xenobiotics Meeting Vancouver Canada August 29 September 2 2004
53 Lung P450s Mechanisms of Gene Regulation and Toxicant Bioactivation featured speaker John Doull
Toxicology Symposium University of Kansas Kansas City MO September 23 2004
54 Maximal Research Success in a Minimal Funding Climate Speaker for the Winter Retreat with the topic
Strategic Initiatives to Increase Extramural funding to University of New Mexico College of Pharmacy
AIbuquerque NM January 14 2005
55 P450Mediated Dehydrogenation Drug Bioactivation and Suicide Inactivation Mechanisms 2005 Rozman
Symposium in the Delaware Valley Drug Metabolism Discussion Group Sheraton bucks County Langhorne
PA June 8 2005
56 Xenobiotic Dehydrogenation Mechanisms Toxic Electrophilic Intermediates and Inactivation of Cytochrome
P450 Enzymes 13 North American ISSX 20 JSSX Joint Meeting Maui Hawaii October 2327 2005
57 Seventh International Symposium on Biological Reactive Intermediates Jan 38 2006 Tucson AZ two
abstracts and chaired a session BRIs and New Reactive Intermediate Chemistry
58 Reactive Intermediates AAPS Conference on Critical Issues in Discovering Quality Clinical Candidates April
2426 2006 Philadelphia PA
59 Gordon Conference Mechanisms of Toxicity July 23 28 2006 Colby College Waterville ME chaired a
session Chemical Mechanisms ofXenobiotic Bioactivation and Toxicity
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Analogues and TRPVIMediated Cytotoxicity 23 Mountain West Society of Toxicology Phoenix AZ
September 2006
129 JM WeemsNSCutler andGSYost 3Methylindole Induced Human Lung Cell DNA Damage and p53
Nuclear Localization 23 Mountain West Society of Toxicology Phoenix AZ September 2006
130 CA Reilly and GS Yost Production of Reactive Electrophilic Metabolites of Capsaicinoids by P450
Enzymes 14 North American ISSX Rio Grande Puerto Rico October 2006
131 NS Cutler M Shadid JM Weems and GS Yost 3Methylindole Induced DNA Damage Leads to
Repair or Apoptosis in Human Bronchial Epithelial Cells Depending on Dosage 24 Mountain West Society
ofToxicology Phoenix AZ September 2007
132 CD Moore and GS Yost Cytochrome P450 3A4Mediated Dehydrogenation of Raloxifene to a Di
quinone Methide 24 Mountain West Society of Toxicology Breckenridge CO September 2007
133 KC Thomas GSYost andCAReilly Endovanilloids in the Lung Initiate TRPVI Mediated Acute Lung
Injury 24th Mountain West Society ofToxicology Breckenridge CO September 2007
134 K Shahrokh TE Cheatham and GS Yost Ab Initio Calculations of the Quinone Methide Species
Formed from the P450Catalyzed Metabolism of Tamoxifen 24th Mountain West Society of Toxicology
Breckenridge CO September 2007
135 JM WeemsNSCutler andGSYost 3MethylindoleInduced DNA Damage in Primary Normal Human
Bronchial Epithelial Cells 24th Mountain West Society of Toxicology Phoenix AZ September 2007
136 CR Orton RM Ward andGSYost Metabolism of Inhaled Glucocorticoids by Cytochrome P450 3A
Enzymes Society ofToxicology March 2008
137 JM Weems and GSYost 3Methylindole Induced DNA Damage in Primary Normal Human Bronchial
Epithelial Cells Society ofToxicology March 2008
138 KCThomas CDeering GS Yost andCAReilly Toxic Endovanilloid Accumulation in the Lung Leads
to TRPV1Mediated ER Stress and Acute Lung Injury Society of Toxicology March 2008
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Epithelial Cells. Society of Toxicology, arch, 2008. 
138. K.C. Thomas, C. Deering, G.S Yost, and C.A. Reilly, Toxic Endovanilloid Accumulation in the Lung Leads 
to TRPVI- ediated ER Stress and Acute Lung Injury. Society of Toxicology, arch, 2008. 
38
139 CD Moore and GSYost Cytochrome P450 3A4 Regiospecific Oxygenation of Raloxifene Evidence for
the Formation of the Diquinone Methide Experimental Biology April 2008
140 K Shahrokh TECheatham III and GSYost the Contribution of Key Enzyme Substrate Interactions to
the Dehydrogenation of Tamoxifen Metabolites and the Role of P450 Conformational Dynamics during
TamoxifenMetabolism American Chemical Society April 2008
141 K ShahrokhTE Cheatham III and GSYost Probing the Influence of Ligand Binding on Cytochrome
P450 Enzyme Remodeling and Dynamics Using Molecular Dynamics Simulation to Give Insight into
Multiple Cytochrome 2134 Structures American Society for Biochemistry and Molecular Biology April
2008
142 K Shahrokh TE Cheatham III and GS Yost A combined theoretical and experimental study of
dehydrogenation selectivity by hepatic P450 enzymes during tamoxifen metabolism American Society for
Pharmacology and Experimental Therapeutics April 2008
143 K Shahrokh TE Cheatham III and GS Yost The P450Catalyzed Dehydrogenation of Tamoxifen
Metabolites 4Hydroxytamoxifen and Metabolite E to Reactive Quinone Methides is Enzyme Specific 17
International Symposium on Microsomes and Drug Oxidations Saratoga Springs NY July 2008
144 Kiumars Shahrokh Thomas E Cheatham III and Garold S Yost The Potential Energy Surface for the
Dehydrogenation of 4Hydroxy tamoxifen and Contribution of P450 Conformational Dynamics to Enzyme
Substrate Interactions durin Tamoxifen Metabolism American Chemical Society August 2008
145 Kiumars Shahrokh Thomas E Cheatham III and Garold S Yost The Contribution of Key Enzyme
Substrate Interactions to the Cytochrome P450 Catalyzed Dehydrogenation of Tamoxifen Metabolites and the
Role ofP450 Conformational Dynamics during Tamoxifen Metabolism American Chemical Society August
2008
146 F HenionGSYost andCAReilly Glutathione Adducts of Capsaicin Reactive Intermediates of P450
Catalysis 25 Mountain West Society of Toxicology Salt Lake City UT October 2008
147 KC Thomas GSYost and CAReilly Involvement of TRPVI and ER Stress in Lung Cell Death In
Vitro and Acute Lung Injury In Vivo 25 Mountain West Society of Toxicology Salt Lake City UT October
2008
148 JM WeemsNS Cutler and GSYost 3MethylindoleMediated DNA Damage and Cytochrome P450
Induction in Primary Normal Human Bronchial Epithelial Cells 25 Mountain West Society of Toxicology
Salt Lake City UT October 2008
149 CR Orton RMWard and GSYost Regulation of Cytochrome P450 3A Gene Expression in Pediatric
Patients and By Glucocorticoids In Vitro International Society for the Study of Xenobiotics October 2008
150 K Shahrokh TECheatham III andGSYost Investigation of Substrate Recognition and the ActiveSite
Stability of Three CYP2B4 Xray Structures Using Molecular Dynamics Simulations International Society for
the Study ofXenobiotics October 2008
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Department ofPharmacology Todcol gy
Garold Yost
Professor of Pharmacology and Toxicology
Title Professor of Pharmacology and Toxicology
Email address gyost@pharnrulahed
Education and Training
BS 1971 Bethel College
r
j
MS 1974 University of Hawaii o
PhD1977 Colorado Stale University Organic Chemistry
ra
Postdoctoral Fellow 197778 University of California San Francisco Pharmaceutical Chemistry
suing Lecturer 197901 Johns Hopkins University Pharmacology
Research Interests
Dr Yost is internationally recognized as an authority on toxicology in the respiratory tract with particular exgxertise on the cytochrome P450mediated mechanisms of lung
Injury Research in the Yost laboratory is largely focused on the elucidation of the chemical biocherrical and cellular mechanisms of toxicity to lung tissues that are
caused by exposure to environmental pollutants There are a number of chemicals that cause selective damage to lung tissues after inhalation or from ingestion followed by
systemic exposure to circulating chemicals One of the major compounds that we have studied is 3methylindore 3MI that is produced in anima and human digestive
systems and is also found in significant quantities in cigarette smoke or several different foods
The toxicity caused by 3MI is specifically targeted to lung tissues and certain cells within the lungs of experimental animals The specificity for lung damage by 3MI is
observed despite the systemic circulation of this toxin to all organs and much of the original work on the etiology of pneumotoxicity of 3MI was done In cattle where the
fermentation or tryptophan produces 3MI Mechanisms for the selective damage to lung tissues include selective bioactivation of 3MI bycytochrome P450 enzymes that are
expressed only in lung cells and poor deloxication of reactive toxic intermediates in lung cells We have pursued both of these hypotheses in our work our observations
have led to the conclusion that both are operative but specific P450mediated bioactivation of 3MI to multiple reactive intermediates Figure 1 is the most important
mechanism for organ selective toxicity of 3Mlto lungs We have used stable isotopes of hydrogen and oxygen to study the specific chemical transforms ions that take place
in the bioactivation and deloxication of 3MI in animal and human lung tissues and specific lung cells 3Methylindole has proven to be a unique probe for the study of
bioiransformation enzymes
Much of the recent work in our lab has centered on the cytochrome P450 genes hat are selectively expressed in lungs or animals and mart We have cloned sequenced
mutated and expressed several new P450 cDNAs These cDNAs have been expressed in E cull expressionssystems to study the slructurelfunction relationships of related
genes within several subfarrilies of P450 genes In addition the cONAs have been expressed in viable human lung cell lines and the mechanisms of bioactivaiion of
toxicants like 3MI and certain halogenated hydrocarbons have been assessed using these transfected cell lines We have also determined the mechanisms responsible for
rung selective expression of four important human P450 genes CYP2F1 CYP3A4 CYP4131 and CYP2S1 The results of this research have established novel pathways
through which human genes are specifically expressed in lung cells throughthe action of novel transcription factors
Additional new studies address the mechanisms of cytochrome P450 enzymes that produce reactive electrophilic intermediates from drugs by dehydrogenation processes
Many of the reactive intermediates alkylate the active sites ofthe enzymes that produced them and they therefore cause a self catalyzed destruction ofthe enzymes This
area of research uses recombinant P450 enzymes and sitedirect d mutants of the enzymes to delemine the mechanism responsible for selective dehydrogenation andor
enzyme inactivation Molecular models of the active sites of P450 enzymes Figure 2 are used to delemrine mechanisms of dehydrogenation
We also have an wdensive research initiative into the mechanisms responsible for human lung disease caused by particulate matter in air pollution We have cloned
expressed and characterized multiple Irritant receptors that are expressed on human lung epithelial cells and are activated by particulates in polluted air and by
capsaicinoids that are present in pepper sprays This work has provided compelling evidence for the importance of these receptors in human lung disease
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Dr. Yost is intemationally recognized as an authonty on loxicology in tile respiratory trad, with particular expertise on Ihe cytochro e P4S().rnediated echanis s of tung 
Injury. Research in the yost laboratory is largely locused on the elucidation ollha cherrical, biochelTical, and cellular mechanisms 01 toxicity to lung tissues that are 
caused by e)q)Osure 10 environmental pollutants. There are a nUrOOsr of cherricals that cause selective damaga to lung tissues after inhalation or from ingestion followed by 
systalTic e>q>Osure to circulating cherriesls. One 01 the major compounds that we have studied is 3-rnelhyUndofe (3MI) that is produced in animal and human digestive 
systems, and is al$O found in significant quantities in cigarette smoke or several differentloods. 
The toxicity caused by 3MI is specificatly targeted to lung tissues and cerlain cells within the lungs 01 experirrental animals. The specificity for lung damage bV 3MI is 
observed despilll the systeme circulatiOll 01 this tOJOn to all organs, and rrocJ1 of the original work on tile etiology of pneumotoxicity of 3MI was done In callie where !he 
lerrrentaUon 01 tryptophan produces 3MI. Mechanisms for lhe selective damage to lung tissues include selective bioadlvation of 3MI by cytochrome P450 enzymes that are 
expressed only in lung cells and poor detollication of reactive, toxic intermediates in lung cells. We have pursued both of these hypotheses in our work; our observations 
ave l  t  the c clusion t t l  r  r tiv , t s cific ()' i t  i ctiv ti  f t 10 IllJlti l  r ctiv  i t r i tes (Figur  ) is t  as! i rt t 
echanis  for organ-selective tOxicity of 3 lto lungs. e have used stable isotopes 01 hydrogen and o~gen to study the specific cherricaltransforrrations that lake place 
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biotransforrration enzyrres. 
Much of the recent work in our lab has centered on the cytochrome P450 genes that are selectively expressed in tungs of animals and man. We have clOned, sequenced, 
IllJlated and expressed several new P450 cDNAs. These cONAs have been expressed in E. coli expressions systems to study the siruclure/1unction relationships of relaled 
genes wilhin several subfamlies of P450 genes. In addition. Ihe cDNAs have been ""Pressed in viable hUlTBn lung cell lines and the rrechanisms 01 bioactivaUon of 
to>icants like 3 I and certain halogenated hydrocarbons have been assessed using these transfeded cell lines. e have also dete ined the echanis s responsible tOI 
lung-selective expression of lour i~rtant human P451) genes, CYP2Fl, CYP3A4. CYP4Bl, and CYP2S1. The results of this research have established novel pathways 
through which human genes are specifICally expressed in lung cells through the action of novel transcription fadors. 
dditional ne  studies address the echanis s of cytochro e 450 enzy es that produce reactive electrophllic Inler ediates fro  drugs by dehydrogenalion processes. 
Many of the reactive intermediates alkyl ate tho active sites of the enzymes that produced tllem, and tlley therefore cause a self·ca\al~d destruction of the enzymes. This 
area of research uses reco binant P450 enzy es and site-direded utants of the enzy es to dele ine the echanisms responsible for selective dehydrogenation andlor 
enzyme inactivation. Molecular models of Ihe active siles of P450 enzyrres (Figure 2) are used to detemina mechanisms of dehydrogenation. 
 l   a  exl i  r r  i ili ti  i t  t  i  respo i l  l r  l  i  caused  rti l t  aH r i  ir pollution. e  loned, 
expressed, and charaderized rnrttiple "imtant receptors" that are expressed on human lung epithelial cells, and are adivated by particulates in polluted air. and by 
capsaicinoids that ere present in pepper sprays. This work has prolJided compelling evidence for Ille importance of these receptors in human lung disease. 
Figure 1. Bioaclivation of the Lung TOxicant, 3-Methylindole to Three Pulative Reactive Interrrediates (shown in boxes). 
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Associate Editor Drug Metabolism and Disposition 2002 present
Chair National Academy of Sciences Subcommittee on Spacecraft Water Exposure Guidelines 2002 present
Member Environmental Health Sciences Review Committee NIEHS NIH 20022006
Secretary International Society for the Study of Xenobictics elected position 20022006
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Selected Publications
JMVeranth NSCutler EGKaserCA Reilly and GS Yost Effects of Cell Type and Culture Media on Intedeukin6 Secretion in Response to Environmental
Particles Tor in Vifro 22 498509 2008
H Sun and GS Yost Metabolic Activation of a Novel 3Substituted Indole Containing TNFoInhibitor Dehydrogenation and Inactivation of CYP3A4 Chem Res
Toxicol 21 37485 2008
JSKartha andGSYost MechanismBased Inactivation of Lung Selective Cytochrome P450 CYP2F Enzymes Drug Metab Dispos36155622006
KTBogen JMBenson GSYostJB Morris ARDahl HJ Clewell 3rdK KrishnanCJ Orriecinsld Naphthalene metabolism in relation to target tissue
anatomy physiology rytoloxicity and tumorigenicmechanismof action Regul Toxlcol Pharmacol 51 S27S36 2008
AS Sabnis M ShadidGSYost and CA Reilly Human Lung epithelial Cells Express a Functional ColdSensing TRPM8 Variant Amer J Resp Cell Molec
Blot 39 466742008
AS Sabnis CA Reilly JMVeranth and GS Yost Increased Transcription ofCytokine Genes in Human Lung Epithelial Cells through Activation of a TRPM8
Variant by Cold Temperatures Amer J PhyslolLung Cell Molee Physiol 295 L194L200 2008
JS Kanha KW S iordos H Sun C Hall LMEasterwood CAReilly EFJohnson and GSYost Single Mutations Change CYP2F3 From a Dehydrogenese of
3Methylindote to an Oxygenase Biochemistry 47975670 2008
GEDeering S Tadjki S Asseni JD Miller GS Yost andJMVeranlh A novel method to detect unlabeled inorganic nanopadicles and subrricren particles in
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H Sun C Moore PMDansette S Kumar JR Halpert and GSYost Dehydrogenation of the Indoline Containing Drug4ChloroN2methyl lindolinyl3
sulfamoylbenzamide Indaparride by CYP3A4 Correlation with in Silico Predictions Drug Mefab Dispos 37 672684 2009
JDAgostino X Zhuo M Shadid DGMorgan X Zhang WGHumphreys YZ ShuGSYost and X Ding The pneumtoloxin 3 methylindole is a substrate as
well as a mechanismbased inactivator of CYP2A13 a human rytochrome P450 enzyme preferentially expressed in the respiratory tract Drug Metab Dispos in press
2009
JMWeemsNS Cutler C MooreWK Nichols D Martin E Makin JGLamb and GSYost 3Methylindole is m utagenic and a possible pulmonary carcinogen
Toxicol Sci in press 2009
BA Carr S Ramakanlh GA Darman and GS Yost Characterization of CYP4B2 Specific Catalyst of Methyl Oxidation of 3Methylindole Mol Pharm 63
1137 1147 2003
SA Carr J Wan RNHines and GS Yost Characterization of the human lung CYP2F1 gene and identification of a novel lung specific binding motif J Biol Chem
278154732003
CA Reilly and GS Yost Structural and Enzymatic Parameters that Determine Alkyl DehydrogenationlHydroxylation of Capsaidnoids by P450 Enzymes Drug Metab
Dispos3353062005
J Wan BA CarrRNHines and GSYost Spl and Sp3 Regulate Basal Transcription of the Human CYP2F1 Gene Drug Metab Dispos 33 124453 2005
K Kassahun K Skordos IMcIntosh D Slaughter GA DossTA Bailfie and GSYost Zafiflukast Metabolism by Cytochrome P450 3A4 Produces an Electrophilic
a0Unsaturated Iminium Species That Results In the Selective MechanisrriBased Inactivation of the Enzyme Chem Res Toxicol 184273 2005
MEJohansen CA Reilly and GSYost TRPV1 Antagonists Elevate Cell Surface Populations and Receptor Function to Exacerbate TRPV1Mediated Toxicities in
Human Lung Epithelial Cells Toxicol Sci 89 278862006
JMVeranth TA Moss JCChow R Labban WKNichols JCWalton JGWatson and GSYost Correlation of In VitroCylokine Responses with the
Chemical Composition of Particulate Matter Samples EnvimnHealth Perspect 114 341349 2006
CAReilly and GSYost Metabolism ofcapsaicinoids by P450 enzymes areview of recent findings on reactionmechanisms bioactivation and detoxification
processes Drug Metab Rev 38 685706 2006
Z YanLMEaslerwood N Maher R Torres N Huebert and GS Yost Metabolism and Bioactivation of 3Methylindole by Human Liver Microsomes Chem Res
Toxicol 20 140148 2007
KCThomas ASSabnis MEJohansen DLLanza PJMoos GSYost and CAReilly TRPV1 Agonists Cause Endoplasr is Reticulum Stress and Cell Death
in Human Lung Cells J Pharmacol Exp Thar 321830838 2007
JS Biggs J Wan NS Culler J Hakkola P Uusirral i H Raunto and GS Yost Transcription Factor Binding to a Putative Double EBox Motif Represses
CYP3A4 Expression in Human Lung Cells Mol Pharmacol inpress 2007
H SunWJ Ehlbardt P KulanthaivelDL Lanza CA Reilly and GS Yost Dehydrogenation of fnddine by Cylochrome P450 Enzymes a Novel Aron alase
Process J Pharmacol Exp Thar 32284351 2007
H Sun and GSYost Metabolic Activation of a Novel 3Substituted IndoleContaining TNFaInhibilor Dehydrogenation and Inactivation of CYP3A4 Chem Res
Toxicol inpress 2008
JSKartha and GS Yost MechanismBased Inactivation of Lung Selective Cytochrome P450 CYP217 Enzymes Drug Metab Dispos in press 2008
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carcinogen through mechanisms of DNA modification 2 to determine the identity and function of the
proteins that are targeted by 3MEIN establish the time and concentration dependency of protein
alkylation events and 3 to correlate and distinguish alkylation events as precursors to 3M1mediated
human lung cell death via apoptotic pathways
Role PI
Completed Research Support
R01 HL6014308 Yost PI 0210120 0063020 9
NIHNHLBI
Cytochrome P450 Gene Regulation in Lung
The major goals of this project are 1 To identify the shared and unique previously uncharacterized
promoter elements of the CYP2F1 CYP2S1 CYP3A5 and CYP481 genes precisely define the core
nucleotides required and correlate the functional activation of the promoter elements by cell and
tissue lung nuclear trans acting factors 2 To identify and characterize the lungspecific factor LSF
and additional members of the LSF family 3 To demonstrate the functional impact of selective gene
expression in lung cells and genetic variants Aim 4 and 4 To identify and validate CYP2F1 and
CYP2S1 genetic variants that contribute to intersubject variation in expression perform similar
analyses on LSF andor other transcription factors regulating the expression of these genes
Role Pl
R01 HL3865018 Williams PI 0915613009
NIHNHLBI
Flavin containing Monooxygenase in Lung
Major goals of Yost subcontract are 1 To provide multiple cell lines that can be used to compare
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VIA EMAIL QNLY gyost@pharmutahedu
Garold S Yost
Professor of Pharmacology and Toxicology
College of Pharmacy
University of Utah
30 North 1900 East 201
Salt Lake City Utah 84112
Re Major v Security Equipment Corporation




This is an agreement between Jones Swartz PLLC and Professor Garold Yost of the
University of Utah Department of Pharmacology Toxicology for Professor Yostrs expert
consultation and expert opinion testimony
Jones Swartz is retaining the expert services of Professor Yost in Billie Major v Security
Equipment Corporation and Billie Major v Idaho State Insurance Fund
More specifically Professor Yost is being retained to
Review materials relating to an OC Spray product manufactured by Security Equipment
Corporation and distributed under the brand name Sabre Red
Review materials relating to the exposure of Billie Major to Sabre Red and her
subsequent medical problems that she and her doctors associate with her having been
exposed to Sabre Red at the Idaho Department of Corrections as part of her employment
there
Provide Jones Swartz his opinion as to whether occupational exposure to Sabre Red
could be a causative factor for Billie Major medical condition
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This is an agreement between Jones &  l     t,  e 
University of Utah, Department of Pharmacology & oXicology, for rofessor ost's expert 
consultation and expert opinion testi ony. 
Jones & Swartz is retaining the expert services of Professor Yost in Billie ajor v. Security 
Equipment Corporation and Billie Major v. Idaho State Insurance Fund. 
More specifically, Professor Yost is being retained to: 
• Revie  aterials relating to an C Spray product anufactured by Security Equip ent 
Corporation and distributed under the brand name Sabre Red; 
• Revie  aterials relating to the exposure of Billie ajor to Sabre Red and her 
subsequent edical proble s that she and her doctors associate with her having been 
exposed to Sabre Red at the Idaho Department of Corrections as part of her employment 
there; 
• Provide Jones & rt  his pi i  as t  t r ccupati l ex s r  to Sabr   
coul   a causativ  f t r f r Billi  ajor's edi l condition; 
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Consult and testify about the toxicity of oleoresin capsicum which is the active
ingredient in Sabre Red and other similar OC Spray products and
U 003
Consult and testify to the comparative toxicity and strength of Sabre Red and other
similar OC Spray products on the market
Professor Yostsfee for services is 300 per hour 4t hr7ma H DrAr r
tcvl eVkIvLr O n d Sa fu modal iAgreed to this 7rday of April 2010 4761VAr eA n dA
Jones Swartz PLLC
B
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Page 2 
G. YOS . U UTAH 
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Attorneys for Plaintiff Billie Jo Major
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF
THE STATE OF IDAHO IN AND FOR THE COUNTY OFADA
BILLIE JO MAJOR and individual
Plaintiff








Discovery in this matter is ongoing This disclosure is made and based upon the
Plaintiffs current understanding of the facts claims and defenses at issue in this litigation It is
anticipated that further discovery investigation and consultation with witnesses and experts may
supply additional facts add meaning to known facts and establish new factual conclusions and
legal contentions all of which may lead to additions to modifications of and variations from the
disclosures set forth herein This disclosure is therefore made without prejudice to Plaintiffs
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isco ery in this atter is i . This disclosure is ade and based upon the 
Plaintiffs current understanding of the facts, clai s, and defenses at issue in this litigation. It is 
anticipated that fUlther discovery, investigation, and consultation with witnesses and experts may 
s ly a itional facts, a  ea ing to no n facts, a  esta lish e  fact al c clusions a  
legal contentions, all of hich ay lead to additions to, odifications of, and variations fro  the 
disclosures set forth herei , This isclosure is therefore ade ithout rejudice to laintiff's 
P I F'S S P ENTAL P  ITNESS DISCLOSURE - 1 
right to disclose evidence of subsequently discovered facts or opinions thereon Subject to and
without waiving the right to supplement the scope of the testimony disclosed herein based upon
information learned or documents acquired through the completion of discovery in this action
Plaintiffmakes the following disclosure
Original Disclosure
Garold S Yost PhD
Professor ofPharmacology and Toxicology
College of Pharmacy
University ofUtah
30North 1900 East 201
Salt Lake City Utah 84112
80158 7956
Dr Yost is a Professor of Pharmacology and Toxicology at the University ofUtah He is
internationally recognized as an authority on toxicology in the respiratory tract with particular
expertise on the cytochrome P450mediated mechanisms of lung injury Research in the Yost
laboratory is largely focused on the elucidation of the chemical biochemical and cellular
mechanisms of toxicity to lung tissues that are caused by exposure to environmental pollutants
There are a number of chemicals that cause selective damage to lung tissues after inhalation or
from ingestion followed by systemic exposure to circulating chemicals He is also an expert in
lung diseases drug induced toxicities and adverse drug reactions His expertise extends also to
the analysis chemistry receptor activation and biological effects including toxicities of
capsaicinoids
Dr Yost is expected to testify regarding the human bodys reaction to and toxicity of
capsaicinoids and oleoresin capsicum OC spray as well as similar compounds Dr Yost will
testify that within a reasonable degree of certainty it was Plaintiffs exposure to DefendantsOC
spray products while performing her duties as a correctional officer with the Idaho Department of
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 2
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from ingestion followed by systemic exposure to circulating chemicals. He is also an expert in 
lung diseases, drug-induced toxicities, and adverse drug reactions. is expertise extends also to 
t  l sis, istry, r t r ti ti n,  i l i l ff ts (includin  t i iti s) f 
capsaicinoids. 
r. ost is expected to testify regarding the hu an body's reaction to, and toxicity of, 
capsaicinoids and oleoresin capsicu  (OC) spray, as well as si ilar co pounds. Dr. Yost will 
testify that ithin a reasonable degree of celiainty it as Plaintiffs exposure to efendant's  
spray products while performing her duties as a correctional officer with the Idaho Department of 
I TIFF'S   ES  S LOSURE-  
Corrections that caused an acute and chronic adverse health response and greatly exacerbated
Plaintiffsunderlying respiratory illness He will testify to how such injury takes place by
explaining the physiological and chemical mechanisms by which the compounds found in the
DefendantsOC Spray products affect the relevant human tissues He will testify about the
research in this area explaining to the jury what is known of these mechanisms and physiological
responses
Dr Yosts opinions are based upon his review of records produced in discovery
including but not limited to Plaintiffs medical records NJHR 1 59 Hendrickson 1 6
Moldenhauer DC 23 St Als 14 other experts reports Idaho Department of Correction
records IDC Records 35120 Sabre Red product information Sabre Red 1 2 Material Safety
Sheet 14 and deposition testimony Billie Major Robert Nance Bret Kimmel Daniel J
Schaffer Joshua Overgaard Nicholas Doan and Sara AnneMarie Link His opinions are also
based on his professional experience education observations and the research of his own and
others including research articles entitled Increased Expression of Transient Receptor Potential
Vanilloid1 in Airway Nerves of Chronic Cough and Breathtaking TRP Channels TRPAI and
TRPVI in AirwayChemosensation and Reflex Controltrai ing
Dr Yost has not prepared any trial exhibits at this time In the event that any of those
items are prepared they will be produced in accordance with this Courts June 1 2010
Scheduling Order and Rule 26a4of the Idaho Rules of Civil Procedure Dr Yosts initial
report outlines his opinions in part and is produced herewith as Exhibit A In the event further
depositions are taken in this matter Dr Yostsopinions may change based on his subsequent
review of such deposition testimony and ifso this disclosure will be supplemented accordingly
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 3
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report outlines his opinions in part and is produced herewith as Exhibit A. In the event further 
depositions are taken in this atter, r. ost's opinions ay change based on his subsequent 
revie  f such deposition testi ony, and if so, this disclosure ill be supple ented accordingly. 
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Exhibits Dr Yost may utilize during trial may include medical records deposition
testimony deposition exhibits photographs monographs research articles material safety data
sheets package inserts and any other document or thing produced by any party or any nonparty
to this matter or which is referred to by any party in discovery or referred to in any document or
answers or response to discovery in this matter Illustrative exhibits demonstrative exhibits and
anatomical models may also be utilized Discovery is ongoing in this matter and additional
information may yet be discovered Plaintiff reserves the right to utilize other presently
unidentified exhibits at trial which will be timely disclosed at a later date
Dr Yostsqualifications are further outlined in his Curriculum Vitae and his profile and
biosketch on the University of Utah College of Pharmacy website which includes a list of his
publications all of which are attached hereto as Exhibits B and C respectively Dr Yosts
agreedupon compensation for analysis of the issues in this case and to testify is 450 per hour
A copy of the signed agreement is attached hereto as Exhibit D
Plaintiff reserves the right to elicit opinion testimony from any expert non retained
treating medical provider and any other witnesses disclosed in discovery or deposition by the
Plaintiff or Defendant Further Plaintiff reserves the right to supplement or amend this




1400 Jackson Street Room G 211
Denver CO 80206
303 3981520
Dr Pacheco is an Assistant Professor of Preventative Medicine and AllergyImmunology
at the University of Colorado Denver where she teaches courses regarding bioaerosols in
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 4
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Exhibits Dr. Yost may utilize during trial may include medical records, deposition 
testimony, depositi  exhibits, photographs, onographs, research articles, aterial safety data 
sheets, package inserts, and any other document or thing produced by any party or any non-party 
to t is atter r ic  is ret erre  t  by any arty i  discover  or referred t  i  any doc e t or 
ans ers or response to discovery in this atter. Illustrative exhibits, demonstrative exhibits and 
anatomical l   l   tili d. iscovery is ongoing in this atter and additional 
i nn ti     i red. Plaintiff reserves the right to utilize other, presently 
i ntifi d, x i it  t t i l i  ill  ti l  i l  at a l t  ate. 
Dr. Yost's qualifications are further outlined in his Curriculum Vitae and his profile and 
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publications, an of hich are attached hereto as Exhibits and C, respectively. r. ost's 
agreed-upon co pensation for analysis of the issues in this case and to testify is $450 per hour. 
       e    t . 
Plaintiff reserves the right to elicit opinion testi ony fro  any expert, non-retained 
treating medical provider, and any other witnesses disclosed in discovery or deposition by the 
l i tiff r efe t. Further, Plaintiff reserves the right to supple ent or a end this 
isclosure a  t  list re  e . 
le e al is : 
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Dr. Pacheco is an Assistant Professor of Preventative edicine and Allergy/Immunology 
at the niversity of Colorado, enver, here she teaches courses regarding bioaerosols in 
PL I 'S SUPP E E TAL EXPERT WITNE S DISCLOSURE -- 4 
occupational medicine and the history of occupational medicine Dr Pacheco is an expert in
environmental and occupational diseases Dr Pacheco is expected to testify to a reasonable
medical certainty that Plaintiffscurrent medical condition has been caused by Plaintiffs
exposure to DefendantsOC spray products while employed by the Idaho Department of
Corrections Dr Pacheco will testify that PIaintiff suffers from irritant triggered vocalcord
dysfunction and chronic cough caused by Plaintiffsexposure to OC spray while performing her
duties as a correctional officer at the Idaho Department of Corrections Dr Pacheco is further
expected to testify that Plaintiff suffers from esophageal dysmotility and reflux exacerbated by
weight gain due to Plaintiffs inability to exercise ever since the occupational injury took place
In addition to her education training and experience Dr Pachecosopinions are based upon
examinations and testing of Plaintiff on March 31 2009 and October 6 2010 her review of
Plaintiffsmedical records and test results Dr Yostsinitial report dated January 13 2011 and
her review and knowledge of the relevant research and medical knowledge
Dr Pacheco has not prepared any trial exhibits at this time but it is anticipated that Dr
Pacheco may use any materials relied upon in the drafting of her Impairment Rating report as
exhibits at trial Additional exhibits Dr Pacheco may utilize during trial may include any of
the medical records deposition testimony deposition exhibits photographs monographs and
material safety data sheets Illustrative exhibits demonstrative exhibits and anatomical models
may also be utilized along with relevant research articles and scholarly publications
Discovery is ongoing in this matter and additional information may yet be discovered
Dr Pacheco has prepared an initial report which summarizes her opinions in whole or in
part and is produced herewith as Exhibit E In Dr Pachecosreport she requests Plaintiff receive
a psychological evaluation which would be factored into Dr Pachecosimpairment rating The
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 5
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In addition to her education, training, and experience, Dr. Pacheco's opinions are based upon 
exa inations and testing of Plaintiff on arch 31, 2009 and ctober 6, 2010; her revie  of 
laintiffs edical records and test results; r. ost's initial report dated January 13,2011, and 
her revie  and kno ledge of the relevant research and edical kno ledge. 
Dr. Pacheco has not prepared any trial exhibits at this ti e but it is anticipated that Dr. 
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exhibits at trial. dditional exhibits r. Pacheco ay utilize during trial ay include any of 
the edical records, deposition testi ony, deposition exhibits, photographs, onographs, and 
aterial safet  ata s eets. Illustrati e e i its, e strati e e i its a  a at ical els 
ay also be utilized, along ith relevant research articles and scholarly publications. 
iscovery is ongoing in this atter and additional infor ation ay yet be discovered. 
Dr. Pacheco has prepared an initial report which su arizes her opinions in whole or in 
rt  is r  r it   i it . I  r. checo's r rt  r t  l i tiffr i e 
a psychological evaluation hich ould be factored into r. Pacheco's i pair ent rating. he 
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psychological evaluation has been performed by Plaintiffsother expert witness Dr Negron and
has been forwarded to Dr Pacheco but Dr Pacheco has not yet had time to prepare a
supplemental report regarding the increase in Plaintiffsimpairment rating Dr Pacheco reserves
the right to revise her opinions to include the information found in Dr Negronspsychological
assessment As discovery is ongoing in this matter additional information may yet be
discovered Dr Pacheco further reserves the right to revise her opinions as new information
becomes available
Dr Pachecosqualifications are outlined in her Curriculum Vitae containing a list of her
scholarly works publications and lectures attached hereto as Exhibit F Dr Pachecosagreed
upon compensation for analysis of the issues in this case and to testify is 480 per hour A copy
ofDr Pachecosfee schedule is attached hereto as Exhibit G A copy ofDr Pachecosretention
letter is attached hereto as Exhibit H Attached hereto as Exhibit 1 is a list of all cases in which
Dr Pacheco has testified going back ten years





Dr BanosBailey is a Bilingual Rehabilitation Counselor Vocational Expert and Life
Care Planner Dr Barros Bailey is the former Chair of the Commission on Rehabilitation
Counseling Certification and also served as the Ethics Committee Chair Dr Barros Bailey is
also one of the founding members of the Inter organizational ONET Task Force Dr Barros
Bailey received her doctorate in Counseling with a cognate in Rehabilitation Counseling from
the University of Idaho Dr BanosBailey serves on the editorial board of several peer review
journals including Journal of Counseling Development Journal of Forensic Vocational
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 6
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r. Pacheco has testified, going back ten years. 
2. at  lT - , , , , C , , 01 ABVE 
I t r t i  ti l r ices 
   
,  -151  
(20 ) -8484 
r. an'os- ailey is a ilingual ehabilitation ounselor, ocational xpelt and ife 
e r. r. arros- ailey is the for er hair f the o ission on ehabilitation 
ounseling ertification and also served as the thics o ittee hair. r. arros- ailey is 
ls  ne f t e fo ing e ers f t e I ter- r iz tional *NET as  r . r. rr s-
ailey received her doctorate in ounseling ith a cognate in ehabilitation ounseling fro  
t e iversity f Ida . r. a ' s- aile  ser es  t e e it rial ard f se eral eer re ie  
journals including J rnal f s ling & evelop ent, Journal of Forensic ocational 
I TIFF'S L P  ITNES  IS LOS RE -  
Analysis and the Journal of Mixed Methods Research Dr BarrosBailey is expected to testify
regarding Plaintiffs earning capacity and life care plan Dr Barros Bailey will testify that due
to Plaintiffs current medical condition caused by the exposure to DefendantsOC spray
products Plaintiff has no probable future earning capacity or residual work life Dr Barros
Bailey will also testify that Plaintiff will need aggressive vocational rehabilitation that could take
years in order to have the chance at a possible future earning capacity In addition to her
education training and experience Dr Barros Bailey opinions are based upon her meeting
with Plaintiffon February 2 2011 her review of Plaintiffs complete set ofmedical records and
bills Bates Nos BSG 15 DHC 1 21 IPA 1 50 MPT 1 26 Moldenhauer 1 196NJH 1 70 NA
1 10 OBGYN 128 OAl6 OSCI 123 SARMC 1 352 SLFH 1 96 SLRMC 1 145 SWEINT
1 20 BSG BILL 1 DHC BILL 12 GSR BILL 1 IPA BILL 16 MOLDENHAUER 127 NJH
BILL 1 4 SAPG BILL 1 SARMC BILL 1 6 SLFH BILL 1 9 SLRMC BILL 13 SWIENT
BILL 1 SLMBS 1 2 SURGEON FEES FOR CASH PAY PATIENTS Dr Yosts initial report
dated January 13 2011 Dr Pachecos initial report dated January 11 2011 PACHECO 17
24 Dr Negrons initial report and Plaintiffs federal tax returns for the years 2003 through
2009 all of which were produced in discovery by Plaintiff with the exception of Dr Pachecos
report Dr Negrons report and the surgeon fees which are produced herewith as Exhibits E L
and J respectively
Dr BarrosBailey has not prepared any trial exhibits at this time but it is anticipated that
Dr Barros Bailey may use any materials relied upon in the drafting of her Earning Capacity
Evaluation and Life Care Plan or such documents themselves as exhibits at trial Additional
exhibits Dr Barros Bailey may utilize during trial may include any of the medical records
deposition testimony deposition exhibits photographs monographs material safety data
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l sis  t  l  i  et  arch. r. nos- il  i  t  t  t ti  
 laintif s  cit     . . nos~Bail   ti    
to Plaintiffs current edical condition caused by the exposure to efendant's  spray 
products, laintiff has no probable future earning capacity or residual ork life. r. Barros~ 
ailey ill also testify that Plaintiff ill need aggressive vocational rehabilitation that could take 
ears i  r er to a e t e c a ce at a ssi le f t re ear i  ca acity.  iti  t   
ati n, tr i i ,  ri e, r. rr s- iley's i i  r    r ti  
it  l i tiff  r r  , ; r r i   l i tiff  l t  t  i l r r   
ills (Bate  .  -5,  -2 , I  -5 ,  -2 , lde r -1 ,  -7 ,  
-10,  -2 , I-6,  -2 ,  -3 ,  -9 ,  -1 ,  
-2 ,  I  ,  I  -2,  I  , I  I  -6,  -2 , J  
 -4,   I,   -6,   -9,   -3,  
I  ,  -2,      IENTS); r. st's i iti l r Olt 
t  r  , ; r. checo's i iti l r rt t  r  ,  (P C E  -
4); r. gron's  rt;  laintiff's      s   
2009; all of which were produced in discovery by Plaintiff with the exception of Dr. Pacheco's 
r rt, r. gron's r rt,  t  r  f  i  r  r  r it   i it  , , 
and J respectively. 
Dr. Barros-Bailey has not prepared any trial exhibits at this time but it is anticipated that 
r. Barros-Bailey ay use any aterials relied upon in the drafting of her Earning Capacity 
l ti   ife r  l , r s  ts t s l s, s i its t tri l. iti l 
exhibits r. arros- ailey ay utilize during trial ay include any f the edical records, 
deposition testi ony, deposition exhibits, photographs, onographs, aterial safety data 
I TIFF'S L   ESS  .. -  
sheets and her reports Illustrative exhibits demonstrative exhibits and anatomical models
may also be utilized along with other scholarly materials Discovery is ongoing in this matter
and additional information may yet be discovered
Dr BarrosBailey has prepared an initial report which summarizes her opinions in whole
or in pant and is produced herewith as Exhibit K Once Dr Pachecosreport has been revised to
include the information found in Dr Negronsreport a copy will be forwarded to Dr Barros
Bailey Dr BarrosBailey reserves the right to revise her opinions to include the information
found in Dr Pachecosrevised impairment rating report As discovery is ongoing in this
matter additional information may yet be discovered Dr Barros Bailey further reserves the
right to revise her opinions as new information becomes available
Included in her report as appendices are copies of Dr BarrosBailey Curriculum Vitae
which includes a list ofall of Dr BarrosBailey publications fee schedule and list of all cases
in which Dr BarrosBailey has testified going back ten years
3 Roberto NegronMD
Sage Health Care
413 N Allumbaugh St Ste 101
Boise ID 83704
208 3231125
Dr Negron is the Clinical Medical Director of Behavioral Health and Chairman of the
Department of Psychiatry at St Alphonsus Regional Medical Center Dr Negron is the Program
director of Adolescent Services at Intermountain Hospital and is the Clinical Medical Director at
Allumbaugh HouseDetoxCenter Dr Negron is expected to testify regarding Plaintiffscurrent
psychiatric state as a result of her current medical condition Dr Negron is expected to testify
that Plaintiffscurrent medical condition has prevented Plaintiff from participating in activities
that previously were her major coping skills Plaintiff has become withdrawn and isolated as a
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ets,  r r rts. Illustr ti e xhibits, strati  i it   t i l l  
 l   z     l rl  terials.   i  i  i   
      red. 
r. arros- ailey has prepared an initial report hich su arizes her opinions in hole 
r i  rt  is r  r it  s i it .  r. acheco's r Olt s  r is  t  
include the infor ation found in r. egron's report, a copy ill be for arded to r. arros-
ailey. r. an'os- ailey reserves the right to revise her opinions to include the infor ation 
f  i  r. checo's r is  i ir t r ti  r rt.       
tter, iti l i f r ti   t  i r d, r. rr - il  fmt r r r  t  
    s     il l . 
I cl e  i  er re Oli as a e ices are c ies f r. arr s- ailey's rric l  itae 
i  i lude   li t  ll  . - iley's li ti s,  l ,  li t  ll  
i  ic  r. arr s- aile  as testified, i  ac  te  ears. 
. rt  r n,  
 lt   
 . lumbaug  t.,   
,   
(2 ) -112  
r. r  is t  li ic l i l irector f i r l lt   ir  f t  
epart ent of Psychiatry at St. lphonsus egional edical enter. r. egron is the Progra  
irect r f dolesce t er ices at I tel tai  s ital a  is t e li ical e ical irect r at 
llu ba  ouseiDetox t r. r. e r  is e ecte  t  testif  re ar i  laintiff's c rre t 
 te      e t  i . . e  s te   ti  
t t l intiffs rr t i l itio  s r t  l i tiff fr  rti i ating i  ti ities 
t t i sl    jor i  ill . l i ti  s  ithdra   i l t    
I TIFF'S  P  ES  S  -  
result and that isolation has caused Plaintiff to become progressively more depressed with
significant suicidal ideation Dr Negron is also expected to testify that if Plaintiffsdepressive
illness goes untreated it could negatively affect the physical recovery from her injuries In
addition to his education training and experience Dr Negronsopinions are based upon his
psychiatric evaluation of Plaintiff on February 4 2011 his review of Plaintiffscomplete set of
medical records Bates Nos BSG 15 DHC 121 IPA 1 50 MPT 126 Moldenhauer 1 196
NJH 170 NA 110 OBGYN 1 28 OA1 6 OSCI 1 23 SARMC 1352 SLFH 1 96 SLRMC I
145 SWEINT 1 20 BSG BILL 1 DHC BILL 1 2 GSR BILL 1 IPA BILL 1 6
MOLDENHAUER 127 NJH BILL 14 SAPG BILL 1 SARMC BILL 16 SLFH BILL 1 9
SLRMC BILL 1 3 SWIENT BILL 1 SLMBS 1 2 SURGEON FEES FOR CASH PAY
PATIENTS Dr Yosts initial report dated January 13 2011 and Dr Pachecos initial report
dated January 11 2011 all ofwhich were produced in discovery by Plaintiff with the exception
of Dr Pachecoswhich is produced herewith as Exhibit E
Dr Negron has not prepared any trial exhibits at this time but it is anticipated that Dr
Negron may use any of the material relied upon in the drafting of his Psychological Evaluation as
exhibits at trial Additional exhibits Dr Negron may utilize during trial may include any of
Plaintiffs medical records deposition testimony deposition exhibits photographs
monographs material safety data sheets and his report Illustrative exhibits demonstrative
exhibits anatomical models and other scholarly materials may also be utilized Discovery is
ongoing in this matter and additional information may yet be discovered
Dr Negronsinitial report is produced herewith as Exhibit L As discovery is ongoing in
this matter additional information may yet be discovered Dr Negron reserves the right to
revise his opinions as new information becomes available
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r s lt  t t is l ti  s s  l i tiff t   r r ssi l  r  r ss  it  
i ific t i i l i ti . r. r  is l  t  t  t tif  t t if laintiff's r i  
illness goes untreated it could negatively affect the physical recovery fro  her injuries.  
addition to his education, training, and experience, r. egron's opinions are based upon his 
   l i tif    , ;    laintiff's    
i l r r  (Bate  .  -5,  -2 , I  I-5 ,  -2 , lde r -1 , 
 -7 ,  -1 ,  -2 , I-6,  -2 ,  -35 ,  -9 ,  1-
,  I-2 ,  I  1,  I  -2,  I  I, I  I  -6, 
 -2 , J  I  -4,  I  I,  I  -6,  I  -9, 
  -3,   ,  -2,      
I NTS); r. st's i itial re rt ate  Ja ar  , ; a  r. acheco's i itial re rt 
t   , ; ll  i    i  i   l i ti  it  t  ti  
f r. acheco's ic  is r ce  ere it  as i it . 
r. egron has not prepared any trial exhibits at this ti e but it is anticipated that r. 
egron ay use any f the aterial relied upon in the drafting f his sychological valuation as 
exhibits at trial. Additional exhibits Dr. Negron ay utilize during trial ay include any of 
laintiff's  r r , iti  t ti ony, siti  i i , t r s, 
onographs, aterial safety data sheets and his report. Illustr ti  i it , tr ti  
e i its, a at ical els a  t er sc larl  aterials a  als  e tilized. isc er  is 
i  i  t is atter a  a iti al i f r ati  a  et e isc ered. 
r. egron's initial report is produced here ith as Exhibit L. s discovery is ongoing in 
this atter, additional infor ation ay yet be discovered, r. egron reserves the right to 
r is  is i ions s  i f r ti  s il l . 
LAINTIFF'S   ITNE S  -  
Dr Negronsqualifications are outlined in his Curriculum Vitae which includes a list of
all of his publications attached hereto as Exhibit M A copy of Dr NegronsRetainer
Agreement is attached hereto as Exhibit N Attached hereto as Exhibit O is a Iist of all cases in
which Dr Negron has testified going back four years
4 Gary R Couillard CPA
131 1 Ave Ste 706
Salt Lake City UT 84103
8018245566
Mr Couillard is a forensic accountant with 38 years of experience providing economic
loss appraisals fraud investigations insurance claims business interruptions lost personal
earnings and benefits life expectancy and work life lost household services personal injury and
wrongful death wrongful termination and discrimination lost commercial profits intellectual
property infringement business and professional practice valuation utility rate and regulations
analysis reasonable compensation tax issues divorce asset analysis arbitration mediation and
structured settlements In this case he has provided analysis opinions and conclusions
pertaining to the economic damages in connection with the injuries sustained by the Plaintiff
which were caused by the Defendantswrongful conduct complained of in this case He has
prepared a report setting forth his opinions and conclusions relating to the economic damages
sustained by the Plaintiff in this case which is attached hereto alongwith Mr Couillardsas
Exhibit R His Curriculum Vitae is attached hereto as Exhibit S His fee schedule is attached
hereto as Exhibit T A list ofarticles Mr Couillard has authored is attached hereto as Exhibit U
Attached hereto as Exhibit V is a list of all cases in which Mr Couillard has testified going back
four years
MrCouillard is expected to testify that the economic loss to the Plaintiff resulting from
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r. egron's qualifications are outlined in his urriculu  itae, hich includes a list of 
all of his publications, attached hereto as Exhibit .   f r. gron's t i r 
gree ent is attached hereto as xhibit . ttached hereto as xhibit 0 is a list of all cases in 
hich r. egron has testified, going back four years. 
. ar  . illar ,  
 5t , .  
alt a e it ,   
(801) 824M 5566 
r. illar  is a f re sic acc ta t ith  ears f e erie ce r i i  ec ic 
loss appraisals, fraud investigations, insurance clai s, business interruptions, lost personal 
eamings and benefits, life expectancy and ork life, lost household services, personal injury and 
rongful death, rongful tel ination and discri ination, lost co ercial profits, intellectual 
r ert  i frin e e t, si ess a  r fessi al ractice al ati , tilit  rate a  re lati s 
analysis, reasonable co pensation tax issues, divorce asset analysis, arbitration, ediation and 
structured settle ents. In this case, he has provided analysis, opinions and conclusions 
pertaining to the econo ic da ages in connection ith the injuries sustained by the Plaintiff 
hich ere caused by the efendant's rongful conduct co plained of in this case. e has 
prepared a report setting forth his opinions and conclusions relating to the econo ic da ages 
sustained by the Plaintiff in this case which is attached hereto along with r. Couillard's as 
t . s  ita      t .      
  t .     r. a      r t   i  u. 
ttac e  eret  as i it  is a list f all cases i  ic  r. illar  as testified, i  ac  
four years. 
r. ouillard is expected to testify that the econo ic loss to the Plaintiff resulting fro  
I TIFF'S L     -  
her injuries in this case ranges from12639 2 to14706 plus medical expenses incurred
through the date of his report In addition to the information in his report Mr Couillard will
testify to the medical expenses incurred to the date of his report are663221 plus the costs of
various prescription medications and interest on all past medical expenses The components of
economic loss to the Plaintiff include past lost earnings future lost earning capacity lost
employment benefits lost household services past medical expenses and a life care plan
including necessary future medical expense and household services He will testify that the
calculations performed in his report that are in partbased on a remaining work life expectancy
for the Plaintiffof 57 years of age based on standard work life tables Hewill further testify that
the standard work life tables for calculating work life expectancy understate the Plaintiffsactual
work life expectancy He will discuss the wealth of recent economic studies that support his
conclusion that the Plaintiff would have worked beyond age 57 and how that impacts the
Plaintiffstotal economic losses beyond that which he has set forth in his report
In addition to his education training and experience Mr Couillardsopinions are
based upon his review ofPlaintiffsfederal tax returns from the years 2003 through 2009
PERSI policies and benefits documents State of Idaho 1 373 functional capacity household
service and economic loss questionnaires a copy of PIaintiffsComplaint Plaintiffs
employment history PlaintiffsSocial Security Summary PlaintiffsSocial Security Statement
Plaintiffsjob responsibilities at SCP and Plaintiffsdisability benefits documents and the
initial expert reports of Dr Pacheco dated January 11 2011 Dr Negron and Dr BarrosBailey
dated March 24 2011 all of which were produced in discovery by Plaintiff with the exception of
Dr Pacheco Dr BarrosBailey reports Dr Negron questionnaires and the PERSI policies and
benefits documents which are produced herewith as Exhibit E I K P and Q respectively
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r i j ri s i  t is s  r s fr  $1,2 3,962 t  $1,4 0,670 l s di l s s i rr  
through the date f his repoli. In addition to the infonnation in his report, r. ouillard ill 
t stif  t  t  i l  i rr  t  t  t   i  r ort r  $66,322.12 l  t  t  f 
various prescription edications and interest on all past edical expenses. he co ponents of 
ec ic l ss t  t e lai tiff i cl e ast l st ear i s, f t re l st ear i  capacity, l st 
e ploy ent benefits, lost household services, past edical expenses, and a life care plan 
including necessary future edical expense and household services. e ill testify that the 
l l ti  rt nne  i  i  r Olt t t r  i  rt    r i i  r  lif  t  
f r t  l i tiff   r  f    t r  r  lif  t l s.  ill f rt r t tif  t t 
t  t   life t les  l l ti   li  t  t t  t  laintif s t l 
r  life e ectancy. e ill isc ss t e ealt  f rece t ec ic st ies t at s rt is 
l i  t t t  l i ti  l    d     t t i t  t  
laintiffs t tal ec ic l sses e  t at ic  e as set f rt  i  is report. 
In addition to his education, training, and experience, r. ouillard's opinions are 
based upon his revie  f laintiffs federal tax returns fro  the years 2003 through 2009 ; 
P SI policies and benefits docu ents (State ofIdaho 1-373); functional capacity, household 
ser ice a  ec ic loss esti aires; a c  f laintiffs lai t; lai tiffs 
e ploy ent histOlY; Plaintiffs Social SecUlity Su ary, Plaintiffs Social Security State ent 
Plaintiffs job responsibilities at S P ; and Plaintiffs disability benefits docu ents; and the 
initial expert reports f r. acheco, dated January 11,2011, r. egron, and r. arrOS-Bailey, 
dated arch 24, 2011; all of hich ere produced in discovery by Plaintiff ith the exception of 
r. Pacheco, r. an·os- ailey's reports, r. egron, questionnaires, and the P SI policies and 
e efits c e ts, ich are roduce  ere ith as i it , L, , , a   res ecti el . 
IFF'S L P  ITNES  ISCLOSURE - 1 
Mr Couillard has prepared his report which mayuse as a trial exhibit along with this
Curriculum Vitae and scholarly articles relating to the issue of the standard tables for work life
expectancy of the Plaintiff being understated Other exhibits that may be used at trial include the
tables for work life expectancy the above listed material that have been provided to him by
Plaintiff as exhibits at trial as well as his report Additional exhibitsMr Couillard may utilize
during trial may include any of Plaintiffsmedical records deposition testimony deposition
exhibits photographs monographs material safety data sheets charts tables and other
materials used to calculate the damages set forth in his report and he may use tables charts
and information in his report as well Illustrative exhibits demonstrative exhibits and models
may also be utilized Discovery is ongoing in this matter and additional information may yet
be discovered that may be used as exhibits
To the extent further investigation discloses additional pertinent information Mr
Couillard reserves the right pursuant to applicable rules to supplement his report Mr Couillard
also reserves that right to revise his report to include additional elements of darnage including
damages based on additional or supplemental information received from other experts in this
case
5 JP Purswell PhD
2035 Mulligan Drive
Colorado Springs CO 80920
719 3300126
Dr Purswell is the Vice President ofPurswell Purswell Engineering Ergonomics
Inc Dr Purswell was the Chair of IE PE exam from 20052009 and he currently serves on the
IE PE Exam committee Dr Purswell also teaches ergonomics and safety engineering at
Colorado State University His Curriculum Vitae which includes a list of his publications is
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r. ouillard has prepared his report hich ay use as a trial exhibit along ith this 
 ita   l  le             
t   t  l i ti  i  t t d. t  i it  t t    t t i l i l  t  
tables for ork life expectancy, the above listed aterial that have been provided to hi  by 
l i tiff  i its t tri l  ll  i  r rt. iti l i it  r. illar   tili  
during trial ay include any f laintiff's edical records, deposition testi ony, deposition 
exhibits, photographs, onographs, aterial safety data sheets, charts, tables and other 
aterials used to calculate the da ages set forth in his report, and he ay use tables, charts 
 r    t  l . lustra ive i its, t t     
ay also be utilized. Discovery is ongoing in this atter and additional infor ation ay yet 
be discovered that ay be used as exhibits. 
To the extent further investigation discloses additional pertinent infor ation, r. 
ouillard reserves the right, pursuant to applicable rules, to supple ent his report. r. ouillard 
also reserves that right to revise his report to include additional ele ents f damage, including 
s s   iti l r s l t l i f r ti  r i  fr  t r rts i  t is 
e. 
. .P. l , h.D. 
 lliga  rive 
l ra o ri s,   
(71 ) -0126 
.      fPurs l  & Purswell, ngineering & rgono ics, 
Inc. r. urs ell as the hair of I   exa  fro  2005-2009 and he cUITently serves on the 
I   a  c ittee. r. rs ell als  teac es er ics a  safet  e i eeri  at 
l r  t te i r it . i  rri l  it , i  i ludes  list  i  li ti s, i  
I TIFF'S     -  
attached hereto as Exhibit W His fee schedule is attached hereto as Exhibit X A list ofcases in
which Dr Purswell has testified is attached hereto as Exhibit Y
Dr Purswell has prepared an initial report of his conclusions and opinions relating to the
adequacy or lack thereof of warnings on the Defendantsproducts labels His initial report is
attached hereto as Exhibit BB Specifically he is expected to testify regarding Defendants
warning label on its Sabre Red OC spray products Mr Purswell is expected to testify that
Defendantswarning labels found on their Sabre Red products are inadequate and do not
properly warn of real and potential dangers their products pose to people suffering from
respiratory impainnent Mr Purswell is also expected to testify that due to the inadequacy of the
warning label found on DefendantsSabre Red products Plaintiff was and the general public
continues to be at risk of suffering from illness due to using DefendantsSabre Red products
because they are not being properly warned on the potential health risks
It is anticipated that Dr Purswell will testify regarding MSDSs in general and SECs
product MSDSs SEC competitor product MSDSs and SECschemical suppliers MSDSs He is
anticipated to testify that based upon the foregoing respiratory inflammation and illness as a
result ofOC exposure were known to or should have been known to SEC and that SEC did not
disclosure ofthe same
In addition to his education training and experience Dr Purswellsopinions are based
upon his review ofMaterial Safety Data Sheets for various Sabre Red Products including
MK9 First Defense HV Stream Sabre 50 CFT Sabre 50 Foam Sabre 50 Sabre Red H2O
Sabre Red Gernade Cell Buster Sabre Red MK9 Fogger Sabre Red CFT and Sabre Red
Cone Dr Purswell also reviewed Material Safety Data Sheets from Defendantssuppliers
for material used in the making of Sabre Red products product and warning labels for the
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at  r t  s i  .  f  sched l  i  tt  r t  s x i it .  li t f c s i  
i  r. t' l   ti   tt  r t  s i i  . 
r. rs ell as re are  an i itial report f is c cl si s and i i s relati  t  t e 
 r l  t r f f r i   t  fendant's r t  l els. i  i iti l r rt i  
tt     . cif l     t  stif  r i  fendant's 
arning label on its Sabre ed  spray products. r. Purs ell is expected to testify that 
f ndant's  l    i      i     
r rl  r  f r l  t ti l r  t ir r t   t  l  uff ri  fr  
r ir t r  i i ent. r. r ll i  l  t  t  t tif  t t  t  t  i  f t  
    f ndant's   t , l i ti  s,    l  
ti s t  , t ris  f s ft ti  fr  ill ss  t  si  f ndant's r   r ts 
          l  s. 
It is a ticipate  t at r. rs ell ill testif  re ar i  s, i  e eral, a  EC's 
t ,  tit  t ,  C's i l li ' .  i  
at  t  t      i g, i t  la   lnes    
  s re   ,    e          
is losure f t  s . 
In addition to his education, training, and experience, r. Purswell's opinions are based 
 is re ie  f aterial afet  ata eets f r arious a re ed r cts i cl i : 
 irst efense  trea , a re .0 , a re .0 a , a re .0, a re e  0, 
re e  em , ll st r, re e  9 r, abre e  ,  re e  
one. r. Purs ell also revie ed; aterial Safety ata Sheets fro  efendant's suppliers 
for aterial used in the aking of Sabre Red products; product and arning labels for the 
P 'S S P E TAL EXPERT ITNESS DISCLOSURE - 13 
various Sabre Red products the promotional literature regarding Defendants Sabre Red
product line and the product and warning labels for various SEC competitor products
Material Safety Data Sheets for various SEC competitors Products SEC training manual and
training presentation Deposition transcripts of Bob Nance and Nicholas Doan Dr Pachecos
initial report dated January 11 2001 Dr Yostsinitial report dated January 13 2011 a copy
of PlaintiffsComplaint and two articles entitled Increased Expression of Transient Receptor
Potential Vanilloid1 in Airway Nerves of Chronic Cow and Brea TRP Channels
TRPA1 and TRPVI in Airway Ch sensation and Reflex Control all ofwhich were produced
in discovery either by Defendant or byPlaintiff with the exception ofDr Pachecosreport
MSDS sheets of competitor products product warnings and labels for competitor products all of
which are being produced herewith as Exhibits E Z and AA
Dr Purswell has not prepared any trial exhibits at this time but it is anticipated that Dr
Purswell may use his report and Curriculum Vitae along with any of the above listed material
that have been provided to him by Plaintiff as exhibits at trial Additional exhibits Dr Purswell
may utilize during trial may include any of Plaintiffsmedical records deposition testimony
deposition exhibits photographs monographs and material safety data sheets Illustrative
exhibits demonstrative exhibits and anatomical models may also be utilized Discovery is
ongoing in this matter and additional information may yet be discovered
To the extent further investigation discloses additional pertinent information Mr
Purswell reserves the right pursuant to applicable rules to supplement his report Mr
Purswell also reserves that right to revise his report to include additional opinions and
conclusions based on additional or supplemental information received from other experts and
medical providers in this case
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 14
000558
i    t , t  ti l lit t  i  t    
product line; and the product and arning labels for various  co petitor products; 
t ri l f t  t  t  f r ri   tit r  r cts;  tr i i  l  
 ntati ;        an; r. acheco's 
i iti l r Oit t  J r  ,2001; r. st's i iti l r ort, t  J r  3, 1;   
 laintif s plaint;  t  rti l  titl   i   i t t r 
tentiaL iLloi -l i  i   f i  ough  reathtaking  els: 
l  l   emo ti  fl  t l ll f i  r  r  
in discovery either by efendant or by Plaintiff ith the exception of r. Pacheco's report, 
 sheets of co petitor products, product arnings and labels for co petitor products, all f 
    r i   its , ,  . 
r. urs ell has not prepared any trial exhibits at this ti e but it is anticipated that r. 
rs ll  s  is r rt  Ul1iculu  it e, l  it   f t   list  t ri l 
t t e  ide  t  i   l i ti   i its t t i l. itio l i it  r. ll 
a  tilize ri  trial a  i cl e a  f laintiff's e ical rec r s, e siti  testi ony, 
deposition exhibits, photographs, onographs, and aterial safety data sheets. lust e 
i its, str ti e i its  t i l ls  ls   tili . is r  is 
ongoing in this atter and additional infor ation ay yet be discovered. 
o the extent further investigation discloses additional pertinent infor ation, r. 
rs ell reser es t e ri t, rs a t t  a lica le r les, t  s le e t is re ort. r. 
Purs ell also reserves that right to revise his report to include additional opinions and 
conclusions based on additional or supple ental infor ation received fro  other experts and 
i l r iders i  t is s . 
I TIFF'S L P  ES   --  
6 Garold S Yost PhD
Professor ofPharmacology and Toxicology
College ofPharmacy
University ofUtah
30 North 1900 East 201
Salt Lake City Utah 84112
80158 7956
Attached hereto as Exhibit CC is a list of all cases in which Dr Yost has testified going
back four years Plaintiff further supplements her disclosure of Dr Yost by stating that Dr Yost
has additionally been provided for his review the deposition transcripts of Joshua Overgaard
Bret R Kimmel Nicholas Doan Daniel J Schaffer Billie Major Vols I iI with errata sheets
Sara AnnMarie Link and the rough transcript from Bob Nances deposition Dr Yosts
publication have previously been disclosed along with his Curriculum Vitae
Dr Yost has not prepared any trial exhibits at this time but it is anticipated that Dr Yost
may use any materials relied upon in the drafting of his initial report as exhibits at trial
Additional exhibits Dr Yost may utilize during trial may include any of Plaintiffs medical
records deposition testimony deposition exhibits photographs monographs and material
safety data sheets Illustrative exhibits demonstrative exhibits and anatomical models may
also be utilized Discovery is ongoing in this matter and additional information may yet be
discovered Dr Yost reserves the right to revise his opinion as additional information becomes
available
In addition to the retained experts identified herein the Plaintiff hereby discloses as
nonretained treating physicians the following medical professionals who may be called upon
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. ar l  . st, h.D. 
r fess r f  nn   l   ic lo  
lle e f annac  
i rsit  f ta  
    #201 
alt a e it , tah  
(80 1)581-7956 
tache    t  s  is    s   r. s   ie   
ac  f r ears. lai tiff f rt er s le ents er iscl s re f r. st  stati  t at r. st 
 iti all ,  r ided f r is r i , t  iti  tr ri t  f  r ard, 
ret . i l, icholas n,  . ff r, llie  .  & I  t   ets, 
ara nn-Marie ink, and the rough transcript fro  ob ance's deposition. r. st's 
licati  a e re i sl  ee  iscl se  al  it  is rric l  itae. 
r. ost has not prepared any trial exhibits at this ti e but it is anticipated that r. ost 
ay use any aterials relied upon in the drafting f his initial report as exhibits at trial. 
itional i its r. st  tilize ri  tri l  i l    l i tiff  i l 
r r s, siti  t sti y, siti  i its, t r s, r s,  t ri l 
safety data sheets. llustrative i it , t ti  i it   t i l l   
also be utilized. iscovery is ongoing in this atter and additional infor ation ay yet be 
discovered. r. ost reserves the right to revise his opinion as additional infonnation beco es 
il ble. 
In addition to the retained experts identified herein, the Plaintiff hereby discloses as 
non-retained treating physicians the follo ing edical professionals ho ay be called upon 
to testif  c siste t it  t eir e ical rec r s a  e siti  testi ony. 
.  'Do ne  
lia   
anny J. endrix 
LAINTIF 'S    ·"  















10 Dr Matthew Schwarz
South West Idaho Ear Nose Throat




Plaintiff also discloses that she may call at trial other medical experts identified in the
previously disclosed medical records to testify consistent with the medical records and
deposition testimony
Plaintiff reserves the right to utilize as exhibits documents that are as yet unknown to
him and any and all materials produced incident to discovery whether produced by a party or
non party any and all pleadings answers and responses to discovery responses to subpoenas
deposition transcripts and deposition exhibits Plaintiff also reserves the right to utilize as
exhibits illustrative and demonstrative materials and anatomical models Plaintiff may utilize
any and all medical records relied upon by the treating physicians and other medical service
providers along with their own records
PLAINTIFFSSUPPLEMENTAL EXPERT WITNESS DISCLOSURE 16
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Plaintiff also discloses that she ay call at trial other edical experts identified in the 
i l  is los  i l  t  t ti  i t t it  t  i l   
i  ti ny. 
l i tiff r s r s t  ri t t  tili  s i its ts t t r  s t  t  
hi , and any and all aterials produced incident to discovery, hether produced by a party or 
- art , a  a  all lea i s, a s ers a  res ses t  isc ery, res ses t  s e as, 
i  ri ,  i  i i . l i tiff ls  r s r s t  ri t t  tiliz  s 
exhibits illustrative and de onstrative aterials, and anato ical odels. Plaintiff ay utilize 
any and all edical records relied upon by the treating physicians and other edical service 
r iders l  ith t ir n r r . 
I TIFF'S  P   IS S  .. ··  
Plaintiff reserves the right to elicit opinion testimony from any person duly qualified
who has been disclosed by Defendants in this action
Plaintiff reserves the right to elicit opinion testimony from any expert non retained
treating medical provider and any other witnesses disclosed in discovery or deposition by the
Plaintiff or Defendants Further Plaintiff reserves the right to supplement or amend this
disclosure and to list rebuttal experts In the event further depositions are taken in this matter
the testimony of non retained medical providers who provided care and treatment to Plaintiff
as a result of the incident at issue in this case may change based on subsequent review of such
deposition testimony and if so this disclosure will be supplemented accordingly
As discovery and Plaintiffstreatment remains ongoing there may be other persons not
identified herein who may fall within the scope of this disclosure that are not yet known If such
persons are identified Plaintiffreserves the right to seasonablydisclose such persons and to call
them as witnesses at the time oftrial
Any of the persons identified above may be called for purposes of rebuttal andor
impeachment Plaintiff also reserves the right to seasonably supplement this list with other
rebuttal andor impeachment witnesses
Plaintiff reserves the right to alter amend or supplement this disclosure as the Idaho
Rules of Civil Procedure and the Court may allow
DATED this 28nd day ofMarch 2011
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TE  this 28nd day of arch, 2011. 
 &   
ERICB. SWARTZ 
L INTIF 'S L   ES  S E -  
CERTIFICATEOF SERVICE
I HEREBY CERTIFY that on this 28nd day of March 2011 a true and correct copy of
the foregoing document was served on the following individualsby the method indicated
Christopher C Burke
GREENERBURKE SHOEMAKER PA
950 W Bannock Street Suite 900
Boise ID 83702
S Mail
r 1 Fax 3192601
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Christina Morrow
From Ebony Little ELittle@esquiresolutionscom
Sent Wednesday June 22 2011 113 AM
To Christina Morrow
Subject ERRATA SHEET FOR GEROLD YOST
Per our conversation this is to confirm non receipt of the errata sheet for deponent Gerald Yost





Firm GREENER BURKE SHOEMAKER PA
Attorney BURKE CHRISTOPHER C ESQ
Scheduled On 04132011 1145AM





Deponent YOST GEROLD PhD
Type DEPOSITION







r Add this to your Outlook schedule 1
Date Tuesday April 19 2011
Time900AM MT
Est Length Hours
Location HOME OF DR YOST
10207 SOUTH 2165 EAST
SANDY UT 84092
View Mao








Date of Corporate Client Claimants







LOCATION IS DRS HOME ATTORNEY WILL BE THERE
WILL NEED NAME AND NUMBER FOR COURT REPORTER
Please review the above information very carefully and notify our office directly with any changes additions or specific
requests you may have regarding this assignment
622011
000564
   
i   
:  ittl  [ELittl esquiresolutions.com] 
t: ay,  ,  1 :31  
: ri ti  rr  
j :      
er r c ersati  t is is t  c fir   recei t f t e errata s eet f r e e t eral  st 
 t e l  tt r. l    t i  f rt r leas  i . 
a  ! 
  
i t # 28372 
fir ation r: 
ir : , , ER, .A. 
tt r : , I  . . 
l  : 4/13/2011 1:45  
t ct: ,  . 
e: 08.350.2174 
: 
il: GRE NERLAW.COM 
i t t il : 
ent: ,  h.D. 
:  
: , I   .  
 
il  ber:  
s  y : I I  
 ket: 
ri l te: 
rt : 
 Type:  BE KLEY/ADMIRAL I S C  
Tracking EMAIL 
: 
i s t : 
-C   - I I  







i l I tr ti : 
  
j t  
 
 
  R'S  -  I    
I         
[      le J 
t : y, il ,  
i e: :00   
t. th:  
tion:   .  
    
,   
t  f 
 
i  p 
r r t  li t 
 
l i t  
 
l  i  t   i f r ti  r  f ll ,  tif   ffi  i tl  it   , iti   ifi  
requests you ay have regarding this assign ent. 
122/ 0 1 
Page 2 of2




An Alexander Gallo Company
5410 NW 33rd Avenue
Suite 100
Fort Lauderdale FL 33309
Telephone 9546221033 x 11033





An Alexander Gallo Company
5410 NW 33rd Avenue
Suite 100
Fort Lauderdale FL 33309
Telephone 9546221033 x 11033
Toll Free 8884 6044
wwwesquiresolutionscom
This message contains confidential information and is intended only for the individual named Ifyou are
not the named addressee you should not disseminate distribute or copy thisemail Please notify the
sender immediately by email if vou have received thisemail bvinistake and delete thisesnail from
your systemEmail transmission cannot be guaranteed to be seeur or error free as information could
be intercepted corrupted lost destroyed arrive late or incomplete or contain viruses The sender
therefore does not accept liability for any errors or omissions in the contents of this message which arise
as a result ofemail transmission If verification is required please request a hardcopy version
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Thank you for your confidence in our services. 
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Esquire Solutions 
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Esquire Solutions 
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  d  
te 0 
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e 0  
This essage contains confidential infot ation and is intended only for the individual na ed. lfyou are 
not the na ed addressee you should not disse inate, distribute or copy this e-mail. Please notify the 
sender i ediately bye- ail if you have received this e-mail by mistake and delete this e-mail fro  
your system. E-mail transmission cannot be guaranteed to be secure or error-free as infonnation could 
be intercepted, cormpted, lost destroyed, arrive late or inco plete, or contain viruses. The sender 
therefore does not accept Iiabilitv for anv errors or o issions in the contents of this essage. hich arise '" 01 .' .. ' .......... 
s  r s lt f -mail tr s ission. Ifverifi ti  is r ir  l s  r st  ard-copy rsi n. 
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Christina Morrow
From Ebony Little ELittle@esquiresolutionscom
Sent Wednesday June 22 2011 1132 AM
To Christina Morrow
Subject ERRATA SHEETS
This is just for you to see what I see We log errata sheets according to the file number O
PgOMPANY3ACKDANIEt
@Q Rename this file
Move this file
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An Alexander Gallo Company
5410 NW 33rd Avenue
Suite 100
Fort Lauderdale FL 33309
Telephone 9546221033 x 11033
Toll Free 888 4864044
wwwesciuiresolutionscom
n187528 Salem Signature Letter 32KB Adobe Acrobat Doc 212
j87528 SALEKLINDA ER 020 130 KB Adobe AcrobatDoc 31
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187666 MAJORBILLIE ER01 358KB Adobe Acrobat Do 31
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madelledward010711 424KB Adobe Acrobat Doc 113
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To ERIC B SWARTZ ESQ
From DIRECTOROF PRODUCTION
RE BILLIE JO MAJOR vs
SECURITY EQUIPMENT et al
File 87666
Depositionof GEROLD YOST PHD
Deposition Date 04192011
Original Transcript Recipient CHRISTOPHERC BURKE ESQ
cc
All counsel present
Your signature is required as acknowledgment that you have read the transcript of your deposition in the
above referenced matter
Please complete the following steps within 30 days ofthe date of this memorandum
Read the enclosed condensed copy of the transcript of your deposition
Make any corrections necessary on the errata sheet only
Sign the bottom of the errata sheet
Sign the certificate
Return only the following to our offices within 30 days of receipt of this memorandum
Original executed certificate
Completed signed errata sheet




Please direct questions regarding this memorandum to Esquire Corporate Solutions Client Support at
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IN THE DISTRICT COURT OF THE FOURTH DISTRICT
OF THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA









GAROLD S YOST MD
Civil No CVPI1003515
April 19 2011 941am
Location 10207 South 2165 East
Sandy Utah
Reporter Sharon Morgan CRR RPR
Notary Public in and for the State of Utah
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IN THE DISTRICT CO R  F THE F RTH ISTRICT 
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otary Public in and for the State of Utah 
a e  
Page 64
A Well the statement was July of last year
I believe thats the date on
Q I have something that might help you
There is something thats called a retention letter
which is Exhibit 55 Its a letter dated April 7
2010 Does that refresh your recollection of about
the time when you may have been first contacted abc
this case
A Yeah it was by phone from Mr Overson
Darwin Overson
Q Is Exhibit 55 a true and accurate copy of
the retention between yourself and Ms Major
attorneys
A Yes
Q Does it accurately describe what they have
asked you to do
A Yes
Q Does it accurately reflect the fees that
you are charging for your services in this case
A Yes
Q And that would be 300 per hour except for
work on evenings and weekends
A Yes
Q And youretrying to charge more there




Q Thank you Do you remember how long pri
to April 7th you first got contacted
A My recollection was that it was several
months It might have been around January or
February of2010
Q And were you asked to do anything
differently than whatsexpressed in that letter
A No
Q Okay Now there is a deposition notice
andIm going to hand it to you thats Exhibit
No 65 Did you ever receive a copy of that
deposition notice
A Yes
Q Okay And as you can see it asks you to
produce certain documents that you may have either
those that you prepared or those that you reviewed in
connection with this case correct
A Correct
Q And you did bring some documents with yoi
today that are responsive to that deposition notice
A Yes
Q What I would like to do is go through and
identify some of those for just a moment And just
17 Pages 62 to 65
Page 62
1 A Sorry Prior to this case did I do 1
2 Q Any independent research ofthe scientific 2
3 and medical literature of the subject Thats what 3
4 Im getting at Did you yourself do that 4
5 A Well yeah Maybe Im not understanding 5
6 the question but we have been working with 6
7 capsaicinoids for 10 years 11 years and I do 7
8 literature all the time especially when we go to 8
9 publish something make sure theresnothing that 9
10 Ive missed 10
11 Q What do you understand either in 11
12 connection with your own experience with exposure 6r12
12
13 what youveread ofwhat the physiological effects 13
14 ofOC exposure on humans to be 14
15 A Well its tissue dependent but in 15
16 general the effects center around the inflammatory 16
17 process pretty much affecting any mucosal tissue 17
18 eyes mouth ears stomach Thatsmostly it 1 18
19 believe And depending upon the specific tissue 19
20 different types of responsiveness certainly tearing 20
21 pain lacrimation tearing same thing from 21
22 eyes reddening of the eyes blood flow changes a 22
23 number of various things In most cases pain 23
24 whether thats eyes mouth skin lungs 24
25 Q Anything else thats associated 25
Page 63
1 symptomwise that youre aware of 1
2 A Usually increase in blood flow Thats 2
3 not necessarily a symptom 3
4 Q Is it your understanding that the adverse 4
5 health effects that exposure to OC and capsaicinoids 5
6 by humans are generally deemed to be temporary 6
7 reversible and not longterm 7
8 A I think thats fair yes 8
9 Q Okay We have been going for a while I 9
10 knowyouresitting there Its probably getting a 10
11 little uncomfortable Why dontwe take a short 11
12 break and come back
13 Eric do you want to stay on the line or 13
14 should we have you call back in a few minutes 14
15 MR SWARTZ Call back 15
16 Recess from 113 am to 1142am 16
17 Q By Mr Burke Back on the record You 17
18 have been retained by Ms Major counsel to act as 18
19 an expert witness on her behalf I guess in two 19
20 cases this one involving Security Equipment 20
21 Corporation and also another one involving a workers 21
22 compensation claim correct 22
23 A Correct 23
24 Q Do you remember about when it was you wer 2 4
25 first contacted by Ms Major attorneys 25
000572
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 the question, but we have been working with 
 capsaicinoids for 10 years, 11 years, and I do 
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 today that are responsive to that deposition notice? 
 . s. 
 . o you re e ber about hen it as you er 24 
25 first contacted by Ms. Major's attorneys?  
. t I l  li  t   i   t r h nd 
identify so e of those for just a o ent. nd just 
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Q Is that what you understand the result of
this study to be
A Yes The issue here was I guess my
misinterpretation of your question was I thought you
were asking about whether or not there was an advert
effect caused by the challenge I mean they are
saying here no serious adverse effects but I thought
that referred to at the time of the test They got
these patients over a long time period but that
doesntmean they followed them for that time period
Now maybe Im misinterpreting that And I think
theres no doubt that the challenge test is
reasonably safe
Q Do you have an understanding of what kind
of doses are given to the patients to elicit the
cough response
A No I dontremember I could find it on
here Im sure
Q Well we dontneed to take the time I
just wondered ifyou remembered
A No I dont
Q All right Do you recall having in your
review of the scientific and medical literature
seeing any peer reviewed publications that
specifically address the association between OC
Page 101
exposure on the one hand and longterm chronic
adverse health effects on the other
A Well thatswhat I was referring to
before that I dont think the studies have been done
or published that definitively well that provide
robust data about that scenario that OC exposure
now Im talking about OC exposure in a chronic
sense multiple cases of exposure
Q Oh multiple exposures
A Yes
Q Thats fine
A And no I dontthink that I havent
seen studies that make that that come to that
conclusion that there are adverse effects because I
dont think people have done the studies
Q Have you ever reviewed any articles or
studies on law enforcement or correction officials
relating to their occupational exposures to OC or
capsaicinoids
A No
Q Have you in your review of peer reviewe
publications seen any articles that focus on the
duration of time after exposure to OC that adverse
health effects are customarily deemed persistent in
humans
26 Pages 98 to 101
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1 field 1
2 A To my knowledge I wouldnthave any ide 2
3 how frequently 3
4 Q Okay Were you aware that the FDA has 4
5 approved the use of capsaicin for this challenge 5
6 test 6
7 A I think so yes 7
8 Q Okay Are you aware of any published 8
9 literature that indicates that the use of this 9
10 capsaicin challenge test in medical research in 10
11 clinical applications with humans causes any sort of 11
12 longterm chronic irreversible adverse health 12
13 effects 13
14 A No 14
15 Q And kind of flipping that over and looking 15
16 at the flip side of it are you actually aware of any 16
17 published literature indicating that the capsaicin 17
18 challenge tests do not cause any long term chronic 18
19 irreversible adverse health effects 19
20 A I dontthink the research has been done 20
21 on that 21
22 Exhibit No 67 marked 22
23 Q ByMr Burke Doctor Im handing you 23
24 whatIve had marked as Exhibit 67 an article that 24
25 was presented in Chest American College of Chest 25
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1 Physicians and it looks like in 2005 Its entitled 1
2 Safety of Capsaicin Cough Challenge Testing Have 2
3 you ever seen that article before 3
4 A Yes I believe I have 4
5 Q So does that refresh your recollection 5
6 that there have been studies on the capsaicin cough 6
7 test 7
8 A I guess Im trying to recall or trying 8
9 to determine if this was chronic exposures because I 9
10 thought thatswhat you asked 10
11 Q No I didn ask about that 11
12 A Oh causes well 12
13 Q I said any adverse health effects Lets 13
14 stop that Do you understand this to be a study 14
15 based upon a review of basically4833 subjects since 15
16 1984 who have gone through the capsaicin cough 16
17 challenge testing 17
18 A Yes 18
19 Q And the conclusion if I just read this 19
20 from the abstract is that A review of 20year 20
21 clinical experience has failed to uncover a single 21
22 serious adverse event associated with capsaicin cough 2 2
23 challenge testing in humans Did I read that 23
24 correctly 24
25 A Right 25
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1 fiel ? 1 
2 A. To my knowledge. I wouldn't have any ide 2 
3 how frequently. 3 
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Q. Is that hat you understand the res t f 
this study to b ? 
A. Yes. The issue here as -- I gue s my 
4 Q. Okay. ere you aware that the F  has 
5 approved the use of capsaicin for this challenge 
6 test? 
4 misinterpretation f our e tion was I thought you ' 
5 were as ing about hether or not there as an a ver e 
6 e fect caused b  the c le . I e , they re 
7 . I think so, yes. 
8 Q. kay. re you a are of any published 
7 sa ing here no serious a erse effects, but I thought 
 that referred to at the ti e of the te . They t 
9 literature that indicates that the use of this  these patients over a long time p , t that 
10 capsaicin challenge test in medical research in 10 d n't ean the  fo lowed the  for that time iod 
11 clinical applications with humans causes any sort of 11 , aybe I'm isinterpreting t t. nd I t ink 
12 long-term chronic, irreversible adverse health  th re's no doubt that the lenge test is 
3 eff ts? 13 reas  s . 
 . .  . o o  e n   t ind 
 Q. And kind of flipping that over and looking   oses re iven t  t e tients t  li it t e 
16 at the flip side of it, are you actually aware of any   re ? 
1 7 published literature indicating that the capsaicin  . , I n't r. I  in  t  
18 challenge tests do not cause any long-term chronic, 18 , I'm . 
 irreversible erse e lth ff ts?  . l ,  n't   ta e  .  
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 Physicians, and it looks like in 2005. It's entitled  
 Safety of Capsaicin Cough Challenge Testing. Have  
 you ever seen that article before?  
 . Yes, I believe I have.  
 Q. SO does that refresh your recollection  
 that there have been studies on the capsaicin cough  
 t st?  
 . I guess I'm trying to recall -- or trying  
 to deter ine if this as chronic exposures, because I  
10 thought that's what you asked.  
 Q. o,ldidn'taskaboutthat.  
 . h, causes -- ll --  
 Q. I said any adverse health effects. Let's  
 stop that. Do you understand this to be a study  
15 based upon a review of basically 4,833 subjects since 15 
 1984 who have gone through the capsaicin cough  
1 7 challenge testing? 1  
 . es.  
19 Q. And the conclusion, ifI just read this  
20 from the abstract, is that "A review of 20-year  
21 clinical experience has failed to uncover a single  
22 serious adverse event associated ith capsaicin cougt 22 
23 challenge testing in humans." Did I read that 2  
2 4 correctly? 2  
  
e      -ter   
 l  f    ther? 
. ell, t at's at I as referri  t  
f ,   on't i  e    m 
 lis  t t fi iti l  -- ell,   
    cenario, t t   -
, I'm tal i  t  s r  i  a c r ic 
se se, lti le cases f e s re. 
. h, l  sures? 
. s. 
. hat's i e. 
. d, , I on't t i  t t -- I haven't 
 t  t   t t -- that co e to that 
cl i  t at t r  ar  adv r  ff cts, b c  I .' 
don't think people have done the studies. 
.    r   arti  or 
t i  o  l  enf r t r corr cti  ffi i l  
r l ti  t  t eir occupational ex  t   or 
capsaicinoids? 
. o. 
.  you, in your revi  ofpe r-r ~ 
publications, seen any articles that focus on the 
durati  of ti  aft r exp sur  t   t t advers  
health eff ts ar  customarily dee ed persistent in 
humans? 25 . Right. 25 
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1 Q How about any written or email 1 1




1 A I would say my general opinion is that 1
2 general conclusion from literature is that they are 2
3 transitory and that would generally mean you know 3
4 more than a minute and probably less than a day or 4
5 two So I think theres substantial evidence that 5
6 the pain irritation lacrimation et cetera that we 6
7 talked about before is not long it doesn persist 7
8 for weeks and months 8
9 Q Okay So its basically your 9
10 understanding that the adverse health effects to 10
11 acute exposures to OC are generally deemed to be 11
12 temporary reversible and recoverable 12
13 A In general I think thatstrue It does 13
14 not mean that they cantexacerbate an underlying 14
15 condition for someone who is highly sensitized and 15
16 thatswhat I opine in my statement But certainly 16
17 in a majority of cases a large majority of cases 17
18 the effects are temporary and reversible yes from 18
19 acute exposure 19
20 Q Now have you prepared or made any notes 20
21 or memos in connection with your work in this case 21
22 A No Just the reports 22
23 Q You have nothing in your computer any 23
24 notes there 24
25 A No 25
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Ms Major do you have anything like that
4 A Well we have several emails almost 4
5 well I think probably all of them have to do with 5
6 obtaining documents depositions reports from the 6
7 sources wev talked about 7
8 Q Did you go through your computer and makc 8
9 a copy of all the electronic communications and 9
10 information you have in connection with this case 10
11 A Did I or 11
12 Q Yes did you 12
13 A No 13
14 Q That of course was one of the items you 14
15 were asked to bring pursuant to the deposition 15
16 notice correct 16
17 A Yes 17
18 Q You haventexactly been close to your 18
19 office for a while right 19
20 A Not for a while 20
21 Q That may be one thing we may want to 21
22 follow up with once you get back to your office and 22
23 have the capacity 23
24 A I can do the mail correspondence 1 24
25 mean I can pull up I think Ive kept them for 25
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probably at least six months and can provide those
from my laptop here
Q Well I dontthink we need to take the
time right now to do it but maybe we can do it on
break or have it followed up and get it later Woulc
that be okay
A Sure
Q Okay Another theresa couple of
other topics that came out in the deposition notice
and one had to do with prior testimony that youve
given in other cases We had that marked as
Deposition Exhibit No 56 Is that an accurate list
of the cases in which youve given testimony
previously
A I was told in the last four years
Q Thats true in the last four years
A Thats correct
Q So youvetestified twice in the last four
years
A Through depositions yes
Q Does either one of those cases involve OC
capsaicinoids or exposure to pepper sprays
A Let me take a quick look No
Q Have you ever given any testimony in any
matter either in deposition or in trial where the
Page 105
subject was exposure to pepper sprays OC or
capsaicinoids
A No I havent
Q Billing statements thatsanother thing
that was requested in the notice of deposition Hav
you brought with you today any of the billing
statements youvesubmitted in connection with yoL
case
A I haventsubmitted it so thats easy
Q I assume youvegot some time invested in
this case is that correct
A Thats correct
Q Can you estimate for me about how many
hours you have into the case to date
A I think I have an estimate of about 1
think it was about 20 hours
Q Okay
A Im pretty sure thatsright
Q And you have not yet sent a bill out is
that right
A No
Q Have you talked with any other persons or
consulted with any other persons in connection wit
your work in this case other than Ms Major
attorneys
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1 A. I would say y general opinion is that --
2 general conclusion from literature is that they are 
3 transitory and that would generally mean, you know 
4 ore than a inute and probably less than a day or 
5 tw . So I think there's s sta tial evidence that 
6 the pain, irritation, lacri ation, et cetera, that we 
7 talked about before is not long -- it do s 't persist 
8 for eeks a d months. 
9 Q. Okay. So it's basically your 
10 understanding that the adverse health effects to 
11 acute exposures to OC are generally deemed to be 
12 temporary, reversible and recoverable? 
 . In general, I think that's true. It does 
14 not ean that they can't exacerbate an underlying 
15 condition for someone who is highly sensitized, and 
16 that's what I opine in my statement. But certainly 
 in a majority of cases, a large majority of cases, 
18 the effects are temporary and reversible, yes, from 
19 acute exposure. 
 Q. Now, have you prepared or made any notes 
21 or memos in connection with your work in this case 
 . No. Just the reports. 
 Q. ou have nothing in your co puter, any 
24 tes t re? 
25 . . 
a e  
 Q. How about any written or e-mail 
 co unications or letters bet een you and counsel f 
 Ms. Major, do you have anything like that? 
4 . ell, e have several e- ails, al ost--
 well, I think probably all of them have to do with 
 obtaining documents, depositions, reports from the 
7 s rces e've t l  t. 
 . Did you go through your computer and makt 
 a copy of all the electronic communications and 
10 information you have in connection with this case? 
11 .   --
 Q. Yes, did you? 
 . o. 
 . That, of course, as one of the ite s you 
15 were asked to bring pursuant to the deposition 
16 notice, correct? 
17 . s. 
1  Q. You haven't exactly been close to your 
19 office for a while, right? 
 . t f r a ile. 
21 Q. That may be one thing we may want to 
22 follow up with once you get back to your office and 
23 have the capacity --
24 . I can do the e-mail correspondence. I 




















































probably at least six onths and can provide those 
from my laptop he . 
Q. , I d 't think e need to take the 
time right now to do it, but aybe we can do it on a 
break or have it fo lowed up a d get it lat . ould·· 
that be o ? 
A. Sure. 
. . nother -- ther 's a uple f 
ther topics that ca e out in the ion n c , 
a d one had to do ith ior tes i ony that ou've 
iven in other . e a  that arked s 
e tion ibit . . Is that  a curate list 
 the s s in hich you've iven te i ony 
previously? 
. I as told  t e last four . 
. at's tr ,  t e a  four . 
. t's t. 
. O ou've t ie  t ice  t e ast  
rs? 
hrough depositions, yes. . 
. oes it er   t ose  i lve  
capsaicinoids or exposure to pepper sprays? 
.     c  . . 
.    en     
tt r,   i    l,   
  
j t  e t   ,   
capsaicinoids? 
. ,  aven't. 
. in  t t ents, at's   
   i     position. v\: 
        i  
t t t  ou've itt  i  ti  it  u 
se? 
. I ven't itt  it,  t at's asy. 
. I  ou've  so  ti  i t  i  
 e;   or ect? 
. hat's or ect. 
.   sti  f r   ho   
hours you have into the case to date? 
. I t i  I h   esti t  f about -- I 
t i k i   ab   hours. 
. kay. 
. I'm pretty sur  that's right. 
.   have not y t sent a bill out; is 
t at right? 
. o. 
. ave you talked with any other persons or 
c sult  it  any ot r pers  i  connecti  with 
your ork i  t is case ot r than s. ajor's 
attorneys? 
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away
Q You agree though just generally law
enforcement officials use pepper spray in order to
try to avoid having to use more lethal forms of
force
A Without having to use other forms yes
Q Okay Are you aware of any studies of law
enforcement use offorce that have shown that after
law enforcement agencies started using pepper spry
that the incidents of physical injuries as a result
offorce diminished over time
A As a result offorce You mean the force
used on a prisoner
Q Yes
A has diminished over time
Q In other words from the interaction
between law enforcement and an inmate or a suspec
that the incidents of injury reports diminished with
the use of OC spray
A Imnot aware of that I think its
possible
Q Now you say here under your Acute
Toxicities paragraph that inhalation Im sorry
that among the responses to OC exposure are leadin
to severe respiratory depression cardiovascular
Page 129
dysfunction and death Do you see that there
A Yes
Q What is the source of that statement
A I dontrecall what I have there are
cases in the literature of people dying from
capsaicin exposure and we documented several of
those in some of our publications So I could go
back and find out where those cases occurred give
you the specific references if you would like but
people have died
Q But isntit also true that studies have
gone back and looked at those death cases and
determined that those cases of death actually
occurred with other issues going on specifically
drug use alcohol use and other underlying physical
force issues that were not related to capsaicin
exposure
A Im aware that there was at least a study
or two that had that the office had the opinions
that other factors could either contribute to or be a
major cause ofmorbidity ormortality in those case
Q Did you do any research that would
indicate that there was that that was not an
accurate conclusion
A Oh no Its possible
33 Pages 126 to 129
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1 whether the exposure was to a stream or a fog or a 1
2 foam product correct 2
3 A Yes Variability yes 3
4 Q And the variability may differ depending 4
5 on whether the product is aerosolized or not 5
6 A Yes 6
7 Q It may be variable depending upon the 7
8 duration of exposure 8
9 A Again that depends on saturation but 9
10 yes 10
11 Q Okay Is that ayes 11
12 A In some cases 12
13 Q All right And you may get the 13
14 variability in adverse response based on where the 14
15 pepper plants are from or when they are grown 15
16 A Its possible 16
17 Q Well your studies showed that didn 17
18 they 18
19 A Yes 19
20 Q In other words extracts from plants in 20
21 Costa Rica may be different from extracts in plants 21
22 from Mexico or USand depending on the season it 22
23 which they were grown 23
24 A Yes The peppers themselves yes 24
25 Q Okay And lastly there may be some 25
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1 variability depending upon the sensitivity of the 1
2 person to the OC 2
3 A Sure 3
4 Q Now wouldntyou agree with me that 4
5 pepper spray products are intended to cause an 5
6 adverse health reaction 6
7 A Yes 7
8 Q I mean thatswhy they are being used by 8
9 law enforcement correction facilities throughout the 9
10 world isntit 10
11 A Thats the purpose 11
12 Q Okay And pepper spray is in essence 12
13 used by those agencies as a nonlethal form of force 13
14 correct 14
15 A Yes 15
16 Q And the idea is that its intended to be 16
17 used by these officers to help subdue criminal 17
18 suspects or inmates or offenders without the need to 18
19 use more severe methods offorce or other lethal 19
20 weapons 20
21 A Well again its situational dependent 21
22 because it isn necessarily more severe It could 22
23 be logistical problems in terms of if yourenot 23
24 close enough to get them with a spray you have to 24
25 hit them with a rubber bullet because youretoo far 1 2 5
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1 Q So would you accept that conclusion as 1
2 being accurate 2
3 A No Iwould accept it as being a 3
4 possibility Theres adifference between proving 4
5 something and postulating something Its possible 5
6 Q When you say theres a difference between 6
7 proving something and postulating something what o7
8 you mean that difference to be What is the 8
9 difference between proving and postulating 9
10 A Well there is no such thing as absolute 10
11 proof in science Ifyourea true scientist then 11
12 nothing is ever absolute So proof to me means a 12
13 weight of evidence argument that the weight of the 13
14 evidence provided is convincing and well 14
15 convincing 15
16 Q And a simple Im sorry 16
17 A Its convincing to me Im only going to 17
18 talk about myselfhere but its convincing to me 18
19 that its true that until proven otherwise thats a 19
20 process that Ill accept as being proof where there 20
21 is no such thing as true proof 21
22 Q A simple case report does not by itself 22
23 make proof does it 23
24 A No 24
25 Q Not even enough to make anything 25
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convincing from a scientific standpoint
2 A It depends on who youretalking to you 2
3 know 3
4 Q Well science doesntrecognize case 4
5 reports individual case reports as being sufficient 5
6 to 6
7 A Not generally 7
8 Q make an association between a toxic 8
9 ingredient and an adverse health effect 9
10 A Its not generally regarded as a 10
11 sufficient weight of evidence from one report no 11
12 Q And usually what you need are case 12
13 controlled studies over a period of time in order to 13
14 draw an association between cause and effect 14
15 A Youregiving me the opposite end of the 15
16 spectrum I would say thats the best type of 16
17 evidence that one can attribute a certain cause to an 17
18 effect But theres certainly accreditations from a 18
19 single report in the literature and a case controlled 19
20 double blinded study where theres robust data enough 2 0
21 to be convincing So anywhere along that line I 21
22 think it depends on where you want to draw your line 22
23 as being what is convincing 23
24 Q Were you able to determine from your 24
25 review of the depositions what specific acute adverse 25
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health response Ms Major had to any exposure to C
while at the Idaho Department ofCorrections
A Well the only source that I could
postulate as being somewhat lending some creden
to the issue of irritation normal kind of things is
what she described in her deposition And of
course thats her opinion so I take it with you
know as it says Shes the complainant here So
other than that I donthave a specific description
Q Well can you tell me what her specific
description was if any of acute response to each
one ofthe training sessions that she went through
A Oh no I dontthink she had it to each
of the training sessions I think she described
particularly after this incident in March a dramatic
change in respiratory problems In terms of each
training session no
Q All right Lets go on to your discussion
here of chronic toxicities Lets get a definition
first ofall What are chronic toxicities
A Generally adverse effects that occur over
extended time period The extended time periods fo
true chronic tend to be weeks months years So on
cantsay acute is one day chronic is two up to
2000 You know its simply a longer time period
Page 133
but in general in the time frame of months or years
Q And by that you mean the adverse health
effects last for a period of months or years
A Or something associated with the exposure
It wouldn necessarily be the same adverse health
effect from the acute toxicity
Q All right You say here that one highly
characterized toxicity of capsaicinoids is the
exacerbation of chronic cough and that people with
respiratory disease are up to 30 times more sensitive
to capsaicininduced cough What is the basis for
that
A That article that I have already
identified
Q The last one we were just talking about
the one from the person from London
A No actually I think it was on the TRP
channel It was 2008
Q Well Imgoing to hand you these back
again the articles Maybe you can tell me which of
that comes from
A I think its Exhibit 59 Ill have to
take a quick look here Yeah its at least in part
from here but I think maybe in part from another
one Let me look Yeah thats part of that
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 e   e  te  in     . o, actually, I think it as on the T P 
 ff ct. t t ere's rt i l  r it tions fr    l.  as 08. 
 i l  r rt i  t  literat r     tr lle   . ell, I'm going to hand you these back 
20 double blinded study here there's robust data enoug~20 again, the articles. aybe you can tell e hich one 
21 to be convincing. So anywhere along that line, I    . 
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25 revie  of the depositions hat specific acute adverse 25 one. Let e look. eah, that's part of that. 



























Q What do you rely upon in here that says
that Im just trying to can you find it
A Cough reflex measured with inhalation of
the pungent ingredient of chili peppers which is
capsaicin is usually augmented in patients with
chronic persistent cough
Q And is there a citation for that
A Yes
Q And what is the citation to
A No 4 whatever that is
Q Can you look up 4 and tell me what that
is
A Sensitivity to the Cough Reflex In
Patients with Chronic Cough European Respiratory
Journal 1992 pages 296 to 300 first author
Chowderly
Q Are you familiar with that article
A No
Q Isntit true that what is being discussed
there is that a patient who may have chronic cough
may have a more acute reaction to OC exposure tha
other persons who do not have chronic cough
A Yes that I think a reasonable
interpretation



























does it that a person with chronic cough who has
been acutely exposed to OC will have an exacerbatio
of that chronic cough longterm
A Yeah but I think theres data in here and
other things that would lead one to believe that that
is the case A significant correlation of the
expression ofTRPV 1 with a capsaicin cough
sensitivity Again its a weight of evidence
Its the numbers Its where they are expressed
Its the TRPV 1 channels It makes sense based upon
mechanistic arguments and whatever else the office
might be basing it on
Q Would you agree that any exacerbation of
chronic cough due to OC exposure will generally
resolve or reverse after a period of time when the
exposure to that source of capsaicin ceases
A Not if theres been anatomical changes
Q And by anatomical changes you mean what
A Remodeling of airway architecture changes
in nerve cell death for instance in one part that
may be taken over by another part There are a lot
of changes that can occur that can cause irreversible
problems
Q Can you cite me to any peerreviewed
publication supporting a conclusion that exacerbatior
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1 of chronic cough due to acute OC exposure will not
2 resolve or be reversible after the source of the OC
3 exposure is eliminate
4 A Well I just showed you I think it does
5 that because of the weight of evidence because of
6 what they are saying how they are saying it happens
7 why it might be attributable to this and
8 scientifically making sense So that theres
9 another one too
10 Q The one yourepointing to being exhibit
11 what
12 A 59 And theres another one thats not in
13 these It has to do with cough capsaicins as well
14 Q Could you cite me to any peerreviewed
15 studies which has specifically associated longterm
16 chronic cough or longterm aggravation of preexistir
17 chronic cough with OC exposure after that exposure
18 gone
19 A I think Ive already answered that
20 question
21 Q You think theres a study out there that
22 does that
23 A Not a study It is a compilation of
24 multiple pieces of evidence both clinical and
25 biochemi althat are consistent with that
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1 conclusion
2 Q Which conclusion
3 A That exposure can cause a longterm effect
4 in a sensitive individual
5 Q And other than Exhibit 59 are you aware
6 of any other publication that would lend credence to
7 that position
8 A Yeah I think theresseveral other ones
9 Imtrying to see if I can see a cross reference to
10 which one of the other papers I was relying on I
11 guess youregoing to have to hand them to me
12 Q Youvegot them all there
13 A Is that all ofthem
14 Q Yes Youvegot them all sitting in front
15 ofyou
16 A Theres something screwy because one frot
17 that review from can I see the other papers that
18 we had
19 Q Youvegot all of them there I handed
20 all of them to you
21 A Well they werentamongst the eight they
22 were amongst the other ones
23 Q Youvegot them over there too I dont
24 have any other documents
25 A Well I do have a couple here Okay
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1 This is Exhibit 66 Well this is the one about the 1
2 capsaicin challenge issue Its not really 2
3 describing here how long the sensitivity is but it 3
4 says that it shows increased sensitivity to capsaicin 4
5 challenges Again thatsa piece of evidence Its 5
6 not by itself convincing 6
7 Q So is it your testimony that just because 7
8 somebody is more sensitive to capsaicin and they have 8
9 a chronic health condition a chronic respiratory 9
10 condition that that respiratory condition will be 10
11 exacerbated chronically longterm 11
12 A I think its possible I wouldn expect 12
13 it to occur in a vast majority of people but I think 13
14 in a sensitized person its quite possible 14
15 Q All right Let me talk about something 15
16 other than possibilities because in the legal 16
17 profession we have to deal in probabilities Okay 17
18 So what Im wondering is are you able to state based 18
19 upon reasonable scientific certainty which I will 19
20 define to you as being from a scientific standpoint 20
21 that a proposition is more probably true than not 21
22 true are you able to say from that standpoint 22
23 whether or not a person who is sensitive to capsaicin 23
24 and has a chronic respiratory condition will get a 24
25 long term exacerbation of that condition because of 25
Page 139
that exposure
2 A Well it depends on what verb you use If 2
3 you say will get or can get I have a different 3
4 answer
4
5 Q Okay How would your answer be different 5
6 A Yes and no It is more likely than not on 6
7 the basis of the literature that Ive seen that the 7
8 cough well the respiratory issues that are in 8
9 play here 9
10 Q Ms Major 10
11 A Ms Major could be exacerbated to a 11
12 chronic respiratory outcome So what Im saying is 12
13 in my opinion it is more probable than not that that 13
14 hypothesis is valid in this case If Im going to 14
15 take somebody with you know who has been sprayed 15
16 on the foot with capsaicin and they get you know 16
17 irritation or something then I may not make that 17
18 same conclusion because I want to see what the 18
19 association is between type of exposure you know 19
20 the type of issues that come about as a result of 20
21 exposure and whether the science bears up as a 21
22 mechanism for that chronic situation developing And 22
23 1 think of all of those things are consistent and 23
24 valid here 24
25 Q So youresaying from a reaso 25
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scientific certainty its more probable than not
that Ms Major underlying respiratory illnesses
were exacerbated causing her to have a chronic
condition
A Yes
Q And you rely upon article 66 and article
59 to support that conclusion
A Yes 66 isnt the one I was specifically
thinking about but it does support it yes
Q Anything else you rely upon any other
reports in the literature
A Well from the Reliance documents coul
I have them back here Do you want this one back
too We did say 61 right Yeah 61 I think is
also supportive
Q How is it supporting
A Because its talking about the
inflammation associated with TRPV 1 exposures an
activation For instance under Summary of the
Effects Pro Inflammatory Effects is listed chronic
persistent cough
Q Is there a citation to that
A Yes Groneberg 2004
Q And have you reviewed that publication
A I dontthink so
Page 141
Q Do you know what its based on
A Well maybe I have seen it Increased
Expression of TRPV 1 Airways Nerves of Chronic Cou
2004 From the title I would say its probably
relevant but Im not sure ifIve seen it I would
have to find it
Q Okay So can you get inflammation with
TRPV 1 exposures that result only in acute adverse
health reactions
A Only in acute
Q Yes
A Probably
Q And just because somebody has inflammation
doesntnecessarily mean youre going to have a
chronic reaction correct
A Thatscorrect
Q As you said most people who have exposure
to OC will resolve their symptoms within a matter of
hours or a day
A Yeah
Q And just because somebody has inflammation
or even if somebody is insensitized and has
inflammation they arentnecessarily going to have a
chronic reaction are they
A No they arentBut thats not my point
36 Pages 138 to 141
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1 This is Exhibit 66. Well, this is the one about the 
2 capsaicin challenge issue. It's not really 
3 describing here how long the sensitivity is, but it 
4 says that it shows increased sensitivity to capsaicin 
5 challenges. Again, that's a piece of evidence. It's 
6 not by itself convincing. 
7 Q. SO is it your testimony that just because 
8 so ebody is ore sensitive to capsaicin and they hay 
9 a chronic health c iti , a chronic res irat r  
10 condition, that that respiratory condition will be 
11 exacerbated chronically long-term? 
12 . I think it's possible. I wouldn't expect 
13 it to occur in a vast majority of people, but I think 
14 in a sensitized person it's quite possible. 
 Q. ll right. Let e talk about so ething 
16 other than possibilities, because in the legal 
17 profession we have to deal in probabilities. Okay? 
18 So hat I'm ondering is are you able to state based 
19 upon reasonable scientific certainty, which I will 
20 define to you as being fro  a scientific standpoint 
21 that a proposition is more probably true than not 
22 true, are you able to say from that standpoint 
23 whether or not a person who is sensitive to capsaicin 
24 and has a chronic respiratory condition will get a 
25 long-term exacerbation of that condition because of 
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1 s ie ific ce , i 's ore probable than not 
2 that s. j r's unde lying res iratory illne ses 
3 were exacerbated causing her to have a chronic 
4 c iti ? 
5 . es. 
6 Q. nd o  re  pon ticle 66 and article 
7 59 to s rt that c cl si ? 
e 8 A. e . 6 is 't the ne I as s i ly 
 thinking a t, but it does s ort i , ye . 
0 . nything lse you re  up , a  ther 
 reports in the liter t re? 
 . l , fro  the iance docu ents -- coul( 
3 I ave the   r ? o ou ant t is ne  
 t ? e did  , ri t? e , , I t i , is 
 also supportive. 
 . o  is t orting? 
 . ecause t's in  t the 
 fla ation ated th P l s res c 
 . r ,     
 ff t , r -I fla t r  ffects i  liste  r i , 
 persistent cough. 
 . Is t ere a citati  t  t at? 
23 . . r r  . 
 .    r ie e  t t li tion? 
 .  n't  . 
  
 .    t it's  n? 
 . ll,  I   it. "Increas  
 xpression of P l ir ays erves of hronic ough 
4 04."  t  titl   l   it's l  
5 l nt, t 'm t  i  've  it.  l  
6    . 
 the basis of the literature that I've seen that the 7 . y.    t i fl ti  it  
 cough -- well, the respiratory issues that are in  l r  t t r lt l  i  t  d r  
9 play here --   actions? 
10 Q. Ms. Major?  . l  i  cute? 
11 . -- Ms. Major could be exacerbated to a  . es. 
12 chronic respiratory outcome. So what I'm saying is  . r bably. 
13 in my opinion it is more probable than not that that  .  j t    i fl ti  
14 hypothesis is valid in this case. IfI'm going to  oesn't cessarily  ou're i     
15 take somebody with -- you know, who has been sprayed 15 r ni  r action, cor ect? 
16 on the foot with capsaicin and they get, you know,  . hat's cor ect. 
17 irritation or so ething, then I ay not ake that  . s  said, st people o ave ex s re 
1  sa e c cl si  eca se I a t t  see at t e  t   il  r sol  t ir sy t  it i   at er of 
19 association is between type of exposure, you know,  r   a day? 
20 the type of issues that come about as a result of  . ah. 
21 exposure and whether the science bears up as a 
22 mechanism for that chronic situation developing. And 
23 I think of all ofthose things are consistent and 
24 alid ere. 
25 Q. SO you're saying from a reasonable 
 . d j t  somebody has infl ation 
22 or ev  i  somebody is i ensiti  and has 
 infl mation, they aren't neces arily going to hav  a 
24 chronic reaction, are they? 
25 . o, they aren't. t that's not y point. 
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claim Thatstheir statement that it contains 133
and that is actually the highest value thatIm aware
of
And so if one assumes that capsaicinoids
causes toxicities then A follows B follows C and it
has to be among the most toxic if not the most
toxic It doesn put any Im not trying to put
any nefarious intentions upon the company Im just
saying that I believe that their product does contain
that and that theyv used a very accurate method
that we developed to determine that and therefore
one would expect more of a response than with a
product that had you know a 10th of that amount
Q You yourself have not done a study of the
various law enforcement OC pepper sprays out there
the market to determine the actual variation between
one and the other as opposed to concentrations of OC
and major capsaicinoids
A What properties of the products
Q In other words you haven done a
comparative study of SEC products with all the other
products on the market to determine whether or not
they had the same or different concentrations of OC
and major capsaicinoids
A Well Chris has that paper that we
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published where the reported amounts and the correc
amounts by our calculations by our determination
were in that paper the concentrations So is that
not a study
Q I guess Im worried about what youre
saying here is basically speculative Let me tell
you whyIm telling you this Can you say
definitively that the Sabre Red product has a higher
concentration of either major capsaicinoids or OC or
both than any other law enforcement product out ther
on the market Can you say that
A No We haventtested all ofthem
Q Okay So in some sense yourespeculating
here as to whether it is the most potent or the most
toxic because you haven tested all of them to
either make that determination isntthat right
A Well thats why the lawful word is in
there among I would say it is highly unlikely that
there is another product that is considerably more
concentrated than this So if one associates
toxicity with capsaicinoids which Im doing thats
the assumption Im making then it is among the mos
toxic if not the most toxic
Its not necessarily the top would I
expect to see the highest and most inflammatory
37 Pages 142 to 145
Page 142
1 My point is it is specifically associated with the 1
2 disease process youretalking about chronic cough 2
3 and TRPV 1 and capsaicins and if the hammer keeps 3
4 hitting you over the head enough times you ought to 4
5 believe them Whether that results in a chronic 5
6 situation or acute is certainly chronic is less 6
7 credible than acute yes 7
8 Q Other than that reference in Exhibit 61 8
9 that you just read me can you cite me to any 9
10 peerreviewed publications that have made an 10
11 association between chronic cough and exposure to OC 11
12 A Yes the ones we have just been talking 12
13 about chronic cough from the 13
14 Q This one 14
15 A No Its this one 59 Its in the 15
16 title 16
17 Im not sure how much longer I can go on 17
18 frankly 18
19 Q Well Im almost done 19
20 A All right Sorry 20
21 Q Do you want to take a break 21
22 A No thats okay 22
23 Q Your report here under the last bullet 23
24 point talks about Sabre Red is advertised by 24
25 Security Equipment Corporation as having 10 percent 25
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1 OC comprised of 133 percent major capsaicinoids 1
2 Then you go on to talk about various things under 2
3 that 3
4 You understand that SEC has used the 4
5 HPLC method of documenting their concentration of 5
6 major capsaicinoids 6
7 A Yes 7
8 Q Many other companies have not though is 8
9 that your understanding 9
10 A Yes 10
11 Q They still use the Scoville method that 11
12 you described earlier 12
13 A Correct 13
14 Q You state here that Itis reasonable to 14
15 assume that Sabre Red contains the highest 15
16 concentrations of the most potent capsaicinoids and 16
17 is at least among the most toxic if not the most 17
18 toxic defense spray available Thatsa pretty 18
19 broad statement What do you base that on 19
20 A Well Im not aware of things that of 20
21 products that contain higher than 10 percent You 21
22 know if theresa self defense weapon that does 22
23 then thats the reason that I say among the most 23
24 toxic because its possible there may be another 24
25 product that Im not aware of But thats their 25
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could be well I think they most certainly at
least some of those at least part of those were
contributory to her sensitivity to respiratory agents
of one sort or another whether thats bacteria or
capsaicinoids or whatever And so would they
contribute to her case now Yes I think so because
they contributed to her sensitivity most likely In
what manner in what relative extent it would be
very difficult to identify for me anyway
Q So Ijust want to be sure Im clear on
this Do you feel qualified to state an opinion
based upon reasonable scientific certainty as to
whether Ms Major OC exposures have caused her
present chronic cough
MR SWARTZ Objection vague as to what
exposures youre referring to
Q ByMr Burke You can go ahead and
answer
A I think theresa reasonable scientific
certainty that exposure to highly concentrated
capsaicinoids found in Sabre Red made her underlyil
sensitivity much worse Do I think she maybe
gotten worse since that occurred I dont know One
would possibly garner that but you know Im not
medically comfortable with saying that theresan
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appreciable difference But I think that there is
there was an appreciable time dependent
concentration dependent information that leads one t
believe that her cough that her physiological
condition got significantly worse and in a short time
period
Q And thatsbased upon the medical records
you reviewed
A Yes
Q Is there anything else that you base that
opinion on
A Well a little bit on her deposition what
she describes as you know her condition before and
after But again I take the source with some
hesitation
Q In your opinion as ofMarch of 2008 was
there anything definitively published in the
peerreviewed scientific and medical literature that
would have put a manufacturer of pepper spray
products such as SEC on notice that exposure to their
products by somebody with the chronic health
conditions ofMs Major would have caused her an
exacerbated response which would have included an
ongoing chronic cough for the subsequent period of
time
39 Pages 150 to 153
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1 to 1
2 Q Yes her exposure to those products 2
3 A I think it is possible yes 3
4 Q Is it also possible that in your opinion 4
5 Ms Major exposure to the First Defense OC products 5
6 exacerbated her underlying respiratory conditions 6
7 A Her response to the First Defense 7
8 products 8
9 Q Yes 9
10 A Forgive me wasntthat what you just 10
11 asked or was that 11
12 Q I think its a little different First I 12
13 asked to chronic health response SecondlyIm 13
14 asking to exacerbation of preexisting condition 14
15 A I see 15
16 Q Same question just a different type of 16
17 response 17
18 A I think its possible 18
19 Q Now do you recall from the testimony of 19
20 Ms Major that she was also exposed to pepper ball 20
21 products during the course of her work at the 21
22 Department ofCorrections 22
23 A I thought she said she was not but I 23
24 wouldnthang my hat on that Thatsa vague 24
25 reference on my part She may have said that I 25
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1 dontrecall 1
2 Q Well lets look at it this way Lets 2
3 assume for a minute that she did have exposure to 3
4 pepper ball products during her work at the 4
5 Department of Corrections Ifthat is in fact 5
6 accurate would that exposure also have contributed 6
7 to any chronic health response or exacerbation of a 7
8 preexisting respiratory disease 8
9 A Its possible yes 9
10 Q Have you as part of your work in this 10
11 case considered any alternative causes of 11
12 Ms Major chronic cough 12
13 A Well to put it in a time context do you 13
14 mean during the time period when she was having 14
15 respiratory problems before and somewhat and 15
16 during her employment 16
17 Q How about right now 17
18 A Oh as ofnow 18
19 Q Yes As it now stands have you 19
20 considered any other alternative causes of her 20
21 present chronic cough condition 21
22 A Well I certainly think that the medical 22
23 history that I read supports a multifactorial 23
24 contribution maybe environmental maybe heredita 24
25 maybe immunological which could be hereditary th t2 5
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1 t ? 
2 . es, her exposure to those products. 
3 A. I think it is possi le, yes. 
4 . Is it also possible that in your opinion 
5 s. ajor's exposure to the First Defense OC pro due 
6 exacerbated her underlying respiratory conditions? 
7 . Her response to the First Defense 
8 products? 
 . e . 
10 . Forgive e, wasn't that what you just 
11 as ed r as that --
 . I thin  i 's a i tle fe t. rst  
13 as e  t  c r ic ealth res se. ec l  I'm 
14 asking to exacerbation of preexisting condition. 
 . I . 
 . Sa e question, just a different type of 
17 response. 
 . I think it's possible. 
 Q. Now, do you recall fro  the testi ony of 
20 s. ajor that she was also exposed to pepper ball 
21 products during the course of her work at the 
22 Department of Corrections? 
 . I thought she said she as not, but I 
24 wouldn't hang y hat on that. That's a vague 
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a e  
 n't r ll.  
 . ell, let's look at it this ay. Let's  
 assu e for a inute that she did have exposure to  
 pepper ball products during her work at the  
 Department of Corrections. If that is, in fact,  
 accurate, ould that exposure also have contributed  
 to any chronic health response or exacerbation of a  
 preexisting respiratory disease?  
 . It's possible, yes.  
 Q. Have you, as part of your work in this  
11 case, considered any alternative causes of  
12 s. ajor's chronic cough?  
 . Well, to put it in a time context, do you  
14 mean during the time period when she was having  
15 respiratory problems before and somewhat --   
16 during her employment?  
 Q. How about right now?  
 . Oh, as of now?  
 Q. Yes. As it now stands, have you  
20 considered any other alternative causes of her  
21 present chronic cough condition?  
 . ell, I certainly think that the edical  
23 history that I read supports a multifactorial 3 
24 contribution, maybe environmental, maybe hereditaf), 2 4 
25 maybe immunological, which could be hereditary, th t25 
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i i  n? 
. l ,      eposition,  
s  scri s s,  , r iti  f r  n  
fter. ut, gain, I t  t  s r  it  s  
esitation. 
. In your opinion, as f arch of2008, as 
there anything definitively published in the 
eer-  ci ntif   edical  t  
ould have put a anufacturer of pepper spray 
r t  su  as   ti  t t r  t  their 
products by so ebody ith the chronic health 
iti  f s. j r l    h r an 
exacer ate  res se ic  ul  have i cl ed an 
i  chr nic coug  for t e subsequent eri  f 
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1 A I dontthink its possible for me to 1
2 place a nefarious intent You know the 2
3 responsibility of whether or not there was sufficient 3
4 evidence there to say you know if you do if you 4
5 expose somebody to this they are going to have 5
6 life altering changes I dont think that existed 6
7 then In the literature today I dontthink it 7
8 exists except through the preponderance of evidence 8
9 and it may very well be that other people dont 9
10 believe that thats the case but I do And so you 10
11 know blame is for thejury to decide 11
12 Q Well do you think people that were 12
13 trained in toxicology such as yourself would have 13
14 been able to review the medical literature and the 14
15 scientific literature that existed on or prior to 15
16 March of2008 and have been able to determine that 16
17 there would have been a lifealtering condition that 17
18 resulted from pepper spray exposure 18
19 A I dontsee evidence that the normal ways 19
20 for industrial hygiene officers and personnel to 20
21 evaluate such kinds of exposures may or may not hav 21
22 existed at that time I haventseen it I mean I 22
23 donthave evidence that would say heres an 23
24 MSVS sheet that says this bad thing is going to 24
25 happen ifyou expose it It does say you know this 25
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1 is an irritant This is an acute thing It is going 1
2 to cause this this and this so you better be aware 2
3 of But Im not aware of anything that the normal 3
4 layperson in the industry would say or would see that 4
5 would necessarily show that 5
6 Conversely maybe there is something in 6
7 the not in the maybe in the product information 7
8 or whatever which I haventseen just the MSVS So 8
9 again I really cant place blame necessarily on 9
10 whomever All I can say is I think theres an 10
11 association between the condition she now has and 11
12 that exposure 12
13 Q And thatsbased upon your many years of 13
14 experience as a toxicologist 14
15 A Yes 15
16 Q Its based on your extrapolation of a 16
17 number of scientific papers and your weighing of the 17
18 evidence is that right 18
19 A Yes 19
20 Q But you cant cite me to one specific 20
21 paper out there that existed prior to March of 2008 21
22 that specifically would have put laypersons without 22
23 your background on notice that exposure to their 23




MR SWARTZ Objection asked and
answered
Q By Mr Burke Okay I think Im almost
done Let me ask you kind of a catchall question
Do you have any other opinions that you have not
expressed in your report or in the deposition here
today as we have been talking through this subject
that you can think of right now
A I thinkwev covered the gamut
Q Okay I am going to stop the deposition
at this point subject to my right to reexamine the
witness based upon articles that we have received
this morning but not yet had a chance to review If
anything should come up from that we reserve the
right to question the witness further
Im assuming we could do this under
circumstances like a telephone deposition that
wouldntrequire everybody to move around But
subject to that I will cease my questions at this
time
MR SWARTZ I have no followup Thank
you
MR BURKE Under the rules of procedure
we have the read and sign procedure and usually w
Page 157
happens is you send the transcript to the witness
The witness looks at it Iftheres any changes
hellmake them on a change sheet and then send thi
back to you Otherwise he can sign it without
changes or he can choose not to sign it I guess
thatsup to Eric about how you want to handle that
Eric
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1 . I d 't think it's possible for e to 1 
2 place a nefarious intent. ou kno , the 2 
3 responsibility of hether or not there as sufficient 3 
4 evidence there to say, you kno , if you do -- if ou 4 
5 expose somebody to this, they are going to have 5 
6 life-altering changes. I don't think that existed  
7 th . In the literature today I d 't thin  it 7 
 exists except through the preponderance of evidence, 8 
 and it may very well be that other people don't  
10 believe that that's the case, but I do. nd so, you  
11 kno , bla e is for the jury to decide.  
12 . ell, do you think people that were 12 
13 trained in toxicology such as yourself ould have 13 
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15 scientific literature that existed on or prior to  
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18 resulted from pepper spray exposure? 18 
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23 don't have evidence that would say, here's an  . 
24 S S sheet that says this bad thing is going to  . : e  t  le   e 
25 happen if you expose it. It does say, you know, this  e      r ,  l  h t 
  
 is an irritant. This is an acute thing. It is going 
 to cause this, this and this, so you better be a are 
 of. ut I'm not a are f anything that the nor al 
 layperson in the industry would say or would see that 
 would necessarily show that. 
 onversely, aybe there is so ething in 
  --    -- aybe in the product infor ation 
 or whatever which I haven't seen, just the SVS. So 
 again, I really can't place blame, necessarily, on 
10 ho ever. ll I can say is I think there's an 
 i ti  t  t  iti      
12 that exposure. 
 Q. And that's based upon your many years of 
14 experience as a toxicologist? 
 . s. 
 Q. It's based on your extrapolation of a 
17 nu ber of scientific papers and your eighing of the 
18 evidence; is that right? 
 . s. 
 . But you can't cite me to one specific 
21 paper out there that existed prior to March of 2008 
22 that specifically would have put laypersons without 
23 your background on notice that exposure to their 
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Increased Expression of Transient Receptor Potential
Vanilloid1 in Airway Nerves of Chronic Cough FDavid A Groneberg Akio Niimi Q Thai Dinh Borla Cosio Mark Hew Axel Fischer and K Fan Chung
Division of Allergy Research Department of Pediatric Pneumology and Immunology Charit Faculty of Medicine HumboldtUniversitat zu awtow ialOtF3dJ
Berlin Berlin Germany and Thoracic Medicine National Heart and Lung Institute Imperial College London United Kingdom
Transient receptor potential vanniloid1 TRPV1mediates the cough
response induced by the pepper extract capsaicin and is expressed
In sensory nerves that innervate the airway wall We determined
the expression of TRPV1 in the airways of patients with chronic
persistent cough of diverse causes and with an enhanced capsaicin
cough responseWe obtainedairway mucosal biopsies by fiberoptic
bronchoscopy in 29 patients with chronic cough and 16 healthy
volunteers without a cough Immunostaining for nerve profiles with
anti protein gene product PGP95antibody showed no increase
in nerve profiles in the airway epithelium of patients with chronic
coughhowever with an anti TRPV1 antibody there was a fivefold
increase of TRPV1 staining nerve profiles p 001 There was
a significant correlation between capsaicin tussive response and
the number of TRPV1positive nerves within the patients with
cough Our findings Indicate thatTRPV1 recepto may contribute
to an enhanced couch reflex and the cough response in chronic
persistent cough of diverse causes
Keywords airway nerves capsaicin cough transient receptor potential
vanniloid1
Chronic cough that persists over many months is a disorder that
is often distressing and debilitating In many patients this may
be associated with asthma or related conditions such as cough
variant asthma and eosinophilic bronchitis gastroesophageal re
flux disease and rhinosinusitis 12 Very often no associated
cause can be determined as specific treatments do not control
the cough 3The cou re x measured with inhalation of
the pungent ingredient of chili peppers campsaicin is usually
augmented in patients with chronic persistent cough 4 Little
is known about the a norms i re a cou receptor itself
in these patients with chronic persistent cough Nerve profiles
in the airway submucosa of patients with chronic persistent cough
are not increased although the number of the neuropeptide
calcitonin gene related peptide CGRPcontaining nerve pro
files were increased 5 It has been hypothesized that cough
sensitization may occur either centrally within the brain stem or
spinal cord afferents or peripherally in cough receptors Cough
itself is mediated by the activation of myelinated AS fibers as
well as possibly unmyelinated C fibers 6
The cloned capsaicin receptor subtype termed transient re
ceptor potential vanniloid1TRPV1is a nonselective ionchan
nel subunit of 838amino acid sequence cloned in 1997 7
Capsaicin and endogenous agonists anandamide eicosanoids
and bradykinin stimulate TRPV189TRPV1 is expressed in
sensory and afferent fibers innervating the airway wall emanating
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from vagal ganglia 10 Activation ofTRPV1 by agonists such
as capsaicin induces Ca21 influx resulting in cough 11 We
postulated that airway nerves of patients with chronicpersistent
cough could express more TRPV1 receptors which could be
the basis for the increased cough reflex and cough symptoms
The aim of this study was therefore to identify whether TRPV1




We investigated 29 consecutive patients referred with chronic cough
through a standard protocol to diagnose and treat the cause of the
cough The mean duration of cough was 67years SD12and the
causes were asthma n 6gastroesophageal reflux n 4rhinosinus
itis n 4bronchiectasis n 1and unexplained n 14We also
enrolled 16 healthy subjects with no history of cough Table 1Patients
and volunteers underwent capsaicin cough challenge and fiberoptic
bronchoscopy The study was approved by the Royal Brompton and
National Heart and Lung Institute Ethics Committee and patients gave
informed consent
Capsaicin Challenge
Coughs were counted for 1 minute after singlebreath inhalation of
09NaCl and capsaicin solutions of increasing concentrations098
500 M Aerosols were generated from a dosimeter attached to a
nebulizer set at a dosing period of 1 minute Increasing concentrations
of capsaicin were inhaled until five or more coughs were counted The
concentration at which this occurs was recorded as the concentration
that causes five or more coughs PC
Fiberoptic Bronchoscopy
Fiberoptic bronchoscopy was performed according to established guide
lines Oxygen 3 Lminute was administered via nasal prongs and
oxygen saturation wasmonitored with a digital oximeter Topical anes
thesia of the upper airways and larynx was obtained using lidocaine
2 Bronchial biopsies were taken from the segmental and subseg
mental carinae in the right lung andwere immediately placed in optimal
cutting temperature embedding media snap frozen in isopentane pre
cooled with liquid nitrogen and stored at 70Cbefore sectioning and
immunostaining
Immunohistochemistry
Immunohistocheistrywas performed on cryostat cut 8msections
obtained from one subsegmental biopsy from each subject Sections
were preincubatedwith 01M phosphate buffer containing Ibovine
serum albumin and 10 normal swine serum for 1 hour to block
nonspecific binding and incubated with polyclonal rabbit antibody
against the pan neuronal marker protein gene product PGP95
1400 Biotrend Cologne Germany To assess epithelial TRPV1
expression alternate sections were incubated with a previously de
scribed polyclonal rabbit antibody against TRPV1 1115000G1axoS
mithKline HarlowUK12Signaling was detected by incubation with
biotinylated goat anti rabbit IgG 1200 Amersham Braunschweig
Germany in combination with a StreptavidinTexas Red conjugate
1150Amersham or with a fluorescein isothiocyanateconjugated goat
anti rabbit IgG1400Cappel OH Fluorescence signaling was ana
lyzed using an epifluorescence microscope and the combination of an
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anti-rabbit-IgG (11400: Cappel. OH). fluorescence signaling was ana-
l  si   illuoresce e i r s   t  i ti  f  
Groneberg Niimi Dinh et ol TRPV1 Expression in Chronic Cough
TABLE 1 CHARACTERISTICS OF NORMAL VOLUNTEERS WITHOUT COUGH AND OF PATIENTS
WITH COUGH
PC
Age Sex FEV Capsakln Smokingt
n yrr MaleFemale Predicted moo Exsmokers
Normal volunteers 16 37 154 97 103713 125 39250 0
Patients with cough 29 50 146 920 97 15 39098250 7
Definition of abbreviation PC concentration of capsaicin causing five coughs or more
Median range
t Participants were current nonsmokers and ex smokers were defined as those that stopped smoking for 3 or more years at
the time of study with less than 5 packyears of smoking
I Mean SD
s p 02
excitation filter with a bandpass of 54610nm and a barrier filter with
a longpass of 590 nm Images of epithelium were captured using an
image system and computerized by SPOT Advanced software SPOT
Insight QE version351Visitron Systems Puchheim Germany The
observers were unaware of the clinical details of the participating sub
jects Images of the epithelium were captured and the area of specific
immunostaining and the total area were measured The PGP95or
TRPV1positive nerve densities were expressed as the percentage of
the epithelial area 5 12 The immunoreactive nerves were distin
guished from any background staining
Data Analysis
For statistical analysis of the immunoreactive percentage of nerve fibers
the Mann Whitney U test was applied as the data were not normally
distributed Pearson rank correlation was used to determine correla
tions A p value of less than05 was taken as significant
RESULTS
Both normal volunteers and patients with cough showed no
evidence of airflow obstruction but the patients with cough
were on average 30fold more sensitive to the tussive effects of
capsaicin Table 1
Staining for PGP95 revealed specific staining of nerve pro
files in the biopsies TRPV1 immunohistochemistry also led to
specific staining of nerve profiles in the subepithelial and epithe
lial layers of the biopsies Occasional staining of a ithehal cells
Iresentand consisted o less than 1 of epithelial cells
t erewtle erenodi erences norm and eatswth
cou h Nerve fiber profiles were measured only in the epithelium
erve fibers immunostained for the general nerve marker
PGP95 and for TRPV1 varied in their density among cases
and between groups The median range total nerve density
PGP95positive fibers was 168 0 to 405 in the patients
and was not significantly different at140 0 to 294 in the
control group Figure 1 in agreement with an earlier study
5However significant differences were found for TRPV1
positive nerve fibers which were higher in cough biopsies with
values of15 0 to39 in the patients versus023 0123
in the control group p 0003 Figure 2 We have also
quantified the expression of TRPV1 in the biopsies as a ratio
of the PGP95 expression measured in the adjacent section for
each subject Thus the TRPV1 to PGP95 ratio was 017 0
065 in normal volunteers and 075096 in the patients with
chronic cough p 0001This indicates a4fold increase in
the staining of epithelial nerves in patients with chronic cough
There were no significant differences in the expression of
PGP95 or of TRPV1 between the patients with unexplained
coughand those in which the cough was associated with a cause
Within the 29 patients with cough the number of TRPV1
positive fibers were inversely correlated to PC r 041
1277
p 05there was no significant correlation between PGP95
expression and PC Figure 3
DISCUSSION
We have shown in a cohort of patients with chronic cough an
increase in the nerve profiles expressing TRPV1 although the
nerve profiles stained with the neuronal marker PGP95were
not increased as compared with healthy volunteers who do not
suffer from chronic cough The area of positive staining with
the anti TRPV1 antibody was 75 of the POP95positive
staining indicating that 75 of the nerve profiles detected in
the epithelium expressed TRPV1 compared with only 17 in
the normal control subjects We found an inverse correlation
between the capsaicin cough responsiveness and the nerve pro
files stained with those expressing TRPV1 within the group of
patients with a cough These results indicate that TRPV1 may
be important in the pathogenesis of chronic cough
The cohort of patients with a chronic cough that we studied
had a wide spectrum of associated causes that included asthma
gastroesophageal reflux and rhinosinusitis but the majority of
these cases had unexplained cough in that noneofthe putative
causes of cough was found to be causing the cough These pa
tients were referred to our cough clinic from a wide area of
southern United Kingdom and have often been seen by other
colleagues and received treatment In nearly half of the patients
48 in this small cohort we could not identify a cause in
contrast to previous series 13All patients with cough had a
sensitive cough response to capsaicin In addition we found that
there was no difference in the expression of either PGP95 or
of TRPV1 between the patients with unexplained cough and
those in whom the cough was associated with a cause
The comparative group of normal control subjects that we
recruited was not equally balanced with the group of patients
with cough in terms ofsex andage The predominance offemales
in the patients with a chronic cough is as one may expect The
influence of sex and age on the degree of expression of PGP95
and TRPV1positive neural fibers in the airway epithelium is
unknown Within the group of normal volunteers and the those
with a cough we found no significant differences between men
and women in terms of the PGP95and TRPV1 expression
and there was no significant correlation between age and the
capsaicin response and TRPV1 expression within the normal
volunteers The lack of relationship between these factors in our
study would suggest that these may not have influenced the
results we found
The phenotypic expression of airway nerves in patients with
chronic cough was changed in that there was a fivefold greater
expression of TRPV1 TRPV1 gene expression is found pre
dominantly in nociceptive like primary afferent neurones whose
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Figure 1 Airway staining for protein gene product
PGP95 lmmunofluorescence staining of airway nerves
in a bronchial biopsy with the pan neuronal marker
PGP95in a normal noncoughing volunteer norm panel
7 and in a patient with cough cough pones 2 Farrel 3
shows no staining with the negative control when the
primary antibody was not added Individual percentages
of bronchial epithelial area staining positive for PGP95
Chronic I Scalthv are shown between patients with a chronic cough and
cough controf healthy control subjects panel 4 The arrowsdenote posi










Figure 2 Airway staining for transient receptor potential vannilold1
TRPV1 ImmUnOflUorescence staining of airway nerves in a bronchia
bi s with an anti TRPV1 antibody in a normal noncoughing volunteer
norm panel t and in a patient with cough cough panel 2 Panel 3
shows no staining with the negative control when the primary antibody
I iealth was not added Individual percentages of bronchial epithelial area stained
controf positive for TRPV1 was significantly greater in patients with chronic cough
than in the control group panel 4 Arrows denote positive neuronal
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Figure 1. Airway staining for protein gene product 
(PGP)-9.5.l rnunofluorescence staining of airway nerves 
in a bronchial biopsy with the an-neuronal r r 
PGP-9.S in a normal oncoughing volunteer (norm; panel 
7) and in ,I patient ith cough (cou ; panel 2). Panel  
shows no staining with the tive control when the 
pri ary antibody as not ad . I dividual percentages 
ut bronchial ithelial rea staining positive f r P-9.5 
are sho n t een patients with a r i   and 
healthy control j t  (panel 4). h  rr  denote -













Figure 1. Airway staining for transient receptor potential vanniloid-l 
( -l). I u ofluor e st i i  of airway nerves in  br i,\! 
~ it   t - H -l ti  in a n r  noncoughing volunteer 
(norm; pOnl?i 7) dnd in a patient with wugh (cough; panel 2). Panel 3 
sho s n  stai i  it  the negativ  contr l when the pri r  anti  
was not added. I i i l perce t  of bronchial epithelial area stained 
positive for TRPV·1 was significantly greater in patients with chronic cough 
than in the contr l gro  ( o l 4). Arrows denote positive r l 
staining. Original magnification x 250. 
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Figure 3 Correlation between PGP95expression percentage of epi
thelial area and the concentration of capsaicin causing five coughs or
more PC response AM upper paned and between TRPV1 expres
sion percentage of epithelial area and the capsaicin PC response
AM lower paned in the 29 patients with chronic cough There was a
significant correlation between TRPV1 expression and thePC response
but not between PGP95expression and the PC response
cell bodies reside in the dorsal root trigeminal and nodose
ganglia Antibodies directed against TRPV1 have revealed the
cellular distribution of TRPV1 in sensory neurones 14 It is
not excluded that there may also be upregulation in airway
ganglia which would not be accessible from the mucosal biopsy
method The cause of the increased number ofTRPV1positive
nerve fibers in patients with chronic cough is unknown Expres
sion of TRPV1 receptors is known to be regulated by growth
factors such as nerve growth factor and glial cell line derived
neurotrophic factor 15 Immunoreactivity to CGRP which is
regulated by nerve growth factor has been reported to be in
creased in epithelial nerves in chronic cough 5 making the role
for nerve growth factor and other growth factors more likely Such
CGRP positive nerve profiles may also be expressing TRPV1
TRPV1 mediates the cough induced b ca saicin as in stud
ies m guinea pigs the ca saicin antagonist ca saze ine m 1 its
caapsaicm to uoe and the endogenous TRPV1figand
anandamide causes cough an a ectinhibited by capsazepine
an resino era oxt w t are both TRPV1 antagonists 11
Although an increase in the number of TRPV1 receptors may
contribute to the enhanced cough reflex to capsaicin other fac
tors may also be involved The activation of AS fibers and C
fibers in the airways of guinea pigs or rats induced by decreasing
pH involvesTRPV1 because protons can increase the TRPV1
ion channel opening 16 Heat activated currents in TRPV1
can be potentiated by relatively small changes in pH 17 and
this would indicate the potential for low pH to augment capsaicin
cough sensitivity in situations such as gastroesophageal reflux
of gastric acid An increase in the content of protons in exhaled
breath condensate of the order of halflog in chronic cough has
been reported 18In addition the reported increase in CGRP
immunoreactive nerves in this condition 5 also indicates the
presence of aneuropeptide that could sensitize visceral afferents
19 Nerve growth factor could also act on mast cells which
we have found to be increased in biopsies from patients with
1279
nonasthmatic cough 20 to release lipoxygenase products that
could activate TRPV1 receptors 21
In summary we found increased expression of TRPV1 in
airway epithelial nerves of patients with chronic cough and a
sinificant correlation of this expression with the ca1 cou
lens ttivityThus TRPV1 expression may be one ofthe determi
nants of the enhanced cough reflex found in patients with chronic
cough TRPV1 antagonists have been described 22 and these
could be effective in the treatmentof chroniccough irrespective
of the type or cause of chronic cough
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record, Greener Burke Shoemaker P.A., pursuant to I.R.C.P. 56(e), submits this emorandum in 
support of its Motion to Strike Portions of the Affidavit of Garold S. Yost, Ph.D. in Opposition 
to efendant's otion for u ary Judg ent ("Motio  t  tri "), il  i  support f 
Plaintiffs Opposition to SEC's Motion for Summary Judgment ("SEC's MSJ"). 
 
In opposition to SEC's MSJ, Plaintiff has filed an affidavit from one of her disclosed 
experts, Garold S. Yost, Ph.D. ("Yost Affidavit"). r pur  of t i  ti  t  trike, SEC 
A U  I  SUPPORT OF SEC'S TI N T  STRI  PORTI S OF T  AFFIDAVI  OF 
GAROLD YOST, Ph.D. - Page 1 14542-  ( 7810) 
seeks only to strike specific opinions rendered and facts asserted by Dr Yost in his affidavit
While SEC does not specifically object to or move to strike the totality of the Yost Affidavit it
reserves the right to do so if necessary at a later time This Motion to Strike is limited to the
issue of whether the scientific knowledge available in March 2008 would have put SEC on
notice that exposure to OC spray could cause the long term adverse health effects of which
Plaintiff complains
Dr YostsAffidavit is approximately eight pages long and contains various opinions and
statements of fact most of which have no bearing on the real issue that Plaintiff must overcome
in order to defeat SECsMSJ The bulk ofDr Yosts Affidavit opinions are focused on whether
SECs OC spray actually caused Plaintiffs alleged longterm chronic injuries These opinions
are not relevant to the issue of whether a duty to warn of unforeseen and unknown risks existed
prior to March 2008 which is the only issue that is the subject of SECs summary judgment
motion It is Dr Yoststestimony regarding the foreseeability of Plaintiffsalleged injuries that
SEC seeks to have stricken from the record based upon the fact that Dr Yosts Affidavit
testimony on this issue directly contradicts his deposition testimony given only two 2 months
ago
FACTUAL BACKGROUND
Plaintiff originally disclosed Dr Yost as an expert witness on August 5 2010 just over
six 6 months in advance of the original deadline for Plaintiffsdisclosure of expert witnesses
See Affidavit of Thomas J Lloyd III filed in Support of Motion to Strike Affidavit of Dr Yost
Lloyd Aff 2 and Exhibit A With that disclosure was an expert report authored by Dr
Yost dated July 28 2010 Id His report detailed his opinions as to three specific questions
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seeks only to strike specific opinions rendered and facts asserted by Dr. Yost in his affidavit. 
hile SE  does not specifically object to or move to strike the totality of the ost ffidavit, it 
reserves the right to do so if necessary at a later ti e. This otion to Strike is limited to the 
issue of hether the scientific knowledge available in arch, 2008 ould have put  on 
notice that exposure to OC spray could cause the long term adverse health effects of which 
Plaintiff complains. 
r. st's ffida it is a r i atel  eight a es l  a  c tai s ari s inions a  
state e ts f fact, ost f ic  a e  eari   the real iss e t at lai tiff st erc e 
 er  efeat C's S . he   . st's ffida t   cus    
SEC's OC spray actually caused Plaintiffs alleged long-term chronic injuries. These opinions 
are not relevant to the issue of hether a duty to arn of unforeseen and unkno n risks existed 
prior to March, 2008, which is the only issue that is the subject of SEC's summary judgment 
otion. It is r. ost's testi ony regarding the foreseeability of Plaintiff s alleged injuries that 
 s s t   stri  fr  t  r rd, s   t  f t t t r. st's ffi it 
testimony on this issue directly contradicts his deposition testimony given only two (2) months 
ago. 
  
Plaintiff originally disclosed Dr. Yost as an expert witness on August 5, 2010, just over 
six (6) months in advance of the original deadline for Plaintiff s disclosure of expert witnesses. 
(See Affidavit of Thomas J. Lloyd III filed in Support of otion to Strike Affidavit of Dr. Yost 
("Lloyd Aff."), ~ 2 an  Exhibit .) it  t at discl s re as an expert report authored by r. 
Yost, dated July 28, 2010. (Id.) His report detailed his opinions as to three specific questions: 
E ORANDU  IN SUPPORT OF SEC'S MOTION TO STRIKE PORTIONS OF THE AFFIDAVIT OF 
GAROLD YOST, Ph.D. - Page 2 14542-011 ( 7810) 
Could occupational exposure to Sabre Red be a causative factor for Billie
Majorsmedical condition
What are the toxicities of oleoresin capsicum which is the active ingredient in
Sabre Red and other similar OC Spray products
How does the toxicity and strength of Sabre Red compare to other similar OC
Spray products on the market
Id Attached to Dr YostsAffidavit is a copy of this very same expert report which has not
been updated or revised Nothing in Dr Yostsreport renders an opinion or makes reference to
any fact regarding the availability of information or literature prior to March 2008 that would
have put SEC on notice of the risk of longterm adverse health effects such as Plaintiff alleges
as a result of exposure to OC spray
SEC took the deposition ofDr Yost in Salt Lake City Utah on April 19 2011 During
that deposition Dr Yost detailed his testimony in this litigation and stated that he did not have
any additional opinions beyond what was covered in the deposition See Lloyd Aff 6 and Ex
E at 156410 SECs counsel questioned Dr Yost extensively as to what information literature
and scientific knowledge was available to SEC at the time it manufactured and sold the OC spray
at issue and whether SEC could have known or foreseen the risk of long term chronic injuries
akin to what Plaintiff alleges in this litigation Dr Yost responded unequivocally and on several
occasions that SEC could not have known or foreseen the risks at that time Id 1536156
On April 22 2011 SEC filed and served its Motion for Summary Judgment and
supporting Memorandum and Affidavit of Counsel SEC moved for summary judgment as to
Plaintiffs claims for strict liability and failure to provide an adequate warning based upon the
fact that the risks of the longterm chronic injuries alleged by Plaintiff were not known or
foreseeable by SEC or anyone else and accordingly Plaintiff s claims fail SEC has no duty to
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• Could occupational exposure to Sabre Red be a causative factor for Billie 
ajor's medical condition? 
• hat are the to icities f oleoresin c , hich is t e e ingre ient in 
a re ed and other si ilar D  ray pr t ? 
•  es the to icit   stre th f a re e  c pare t  t r i ilar  
ray products  t e ar et? 
(ld.) Attached to Dr. Yost's Affidavit is a copy of this very same expert report, which has not 
been updated or revised. othing in r. ost's report renders an opinion or akes reference to 
any fact regarding the availability of information or literature prior to arch, 2008 that would 
have put SE  on notice of the risk of long-term adverse health effects, such as Plaintiff alleges, 
as a result of exposure to OC spray. 
SEC took the deposition of Dr. Yost in Salt Lake City, Utah on April 19, 2011. During 
that deposition, r. ost detailed his testi ony in this litigation and stated that he did not have 
any additional opinions beyond hat as covered in the deposition. (See Lloyd ff. ~ 6 and x. 
at 156:4-10.) SEC's counsel questioned r. ost extensively as to hat infor ation, literature 
 s i tific le  as il l  t   t t  ti  it f t r   s l  t  D  s r  
at issue, and whether SEC could have known or foreseen the risk of long-term chronic injuries 
akin to hat Plaintiff alleges in this litigation. r. ost responded, unequivocally and on several 
occasions, that SEC could not have kno n or foreseen the risks at that ti e. (ld., 153:16-156:1.) 
On April 22, 2011, SEC filed and served its otion for Summary Judgment, and 
supporting Memorandum and Affidavit of Counsel. SEC moved for summary judgment as to 
laintiff s clai s for strict liability and failure to provide an adequate arning based upon the 
fact that the risks of the long-ter  chronic injuries alleged by Plaintiff ere not kno n or 
foreseeable by  (or anyone else) and, accordingly, laintiffs clai s fail.  has no duty to 
 I  S   EC'S I   TRI  TI  F  FI A I   
GAROLD YOST, Ph.D. - Page 3 14542-  ( 810) 
warn against or design around injuries which are not known or foreseeable See generally
SECsMSJ
On June 10 2011 Plaintiff filed her opposition to SECsmotion for summary judgment
including the Yost Affidavit Plaintiff bases her argument that the injuries alleged by Plaintiff
were known and foreseeable to SEC entirely on the Affidavit of Yost Despite having clearly
testified under oath during his deposition that there was no scientific literature available prior to
March 2008 that would put SEC on notice of the risks of Plaintiffs alleged injuries Dr Yost
has now taken a directly contradictory position in his Affidavit
As a result Defendants now move this Court to strike portions the Yost Affidavit as the
Affidavit directly contradicts the prior deposition testimony of Dr Yost and the changed
position is neither based upon any new evidence nor made to clarify or correct earlier testimony
ARGUMENT
A Standard
IRCP56e provides that an affidavit submitted in support of or in opposition to a
motion for summary judgment shall set forth such facts as would be admissible in evidence
IRCP56e Ryan v Beisner 123 Idaho 42 44 844 P2d 24 26 1992 citing Petricevich
v Salmon River Canal Co 92 Idaho 865 452 P2d 362 1969 A court will consider only
that material contained in affidavits or depositions which is based upon personal knowledge and
which would be admissible at trial In ruling on a motion for summary judgment the
admissibility of the evidence presented in support of or in opposition to a motion for summary
judgment is a threshold question to be answered before applying the liberal construction and
reasonable inference standard to determine whether the evidence is sufficient to create a genuine
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warn against or design around injuries which are not known or foreseeable. (See generally, 
SEC's MSJ.) 
n June 1 , , l i ti f filed er opposition to C's otion for ary judg t, 
including the Yost Affidavit. Plaintiff bases her argument that the injuries alleged by Plaintiff 
ere n n a d foreseea le t   e tirely  the ffida it f st. es ite a i  clearl  
testified, under oath, during his deposition that there as no scientific literature available prior to 
arch, 2008 that would put SEC on notice of the risks of Plaintiff s alleged injuries, Dr. Yost 
has now taken a directly contradictory position in his Affidavit. 
s a result, efendants no  ove this ourt to strike portions the ost ffidavit, as the 
ffidavit directly contradicts the prior deposition testi ony of r. ost, and the changed 
position is neither based upon any new evidence nor made to clarify or correct earlier testimony. 
 
. t ndard. 
I.R.C.P. 56(e) provides that an affidavit submitted in support of or in opposition to a 
motion for summary judgment shall " ...      l   i  i  vi ence . 
.. " I.R.C.P. 56(e); Ryan v. Beisner, 123 Idaho 42,44,844 P.2d 24,26 (1992), citing Petricevich 
v. Sal on iver anal o., 92 Idaho 865, 452 .2d 362 (1969) ("[A] court ill consider only 
t t t ri l t i  i  ffi its r positi s i  is sed  rs l l  an  
i  l   d i i l  t t i l"). In ruling on a otion for su ary judg ent, the 
admissibility of the evidence presented in support of or in opposition to a motion for summary 
judgment is a threshold question to be answered before applying the liberal construction and 
r so bl  i f r  stand r  t  deter i  t r t  evi  is suffi i t t  cr at  a genui  
RANDU  I  SUPPORT OF SEC'S TI N T  STRIK  PORTI  OF T  AFFIDA I  OF 
GAROLD YOST, Ph.D. - Page 4 14542- 1 ( 7810) 
issue of fact for trial Hecla Mining Co v StarMorning Mining Co 122 Idaho 778 839 P 2d
1192 1992 Ryan v Beisner 123 Idaho 42 844 P2d 24 1992 Evans v Twin Falls County
118 Idaho 210 796P2d 87 1990 Ifthe admissibility of evidence presented in support of or in
opposition to a motion for summary judgment is raised by one of the parties the Court must
address that issue first Id A courts decision to admit or exclude evidence is reviewed under
the abuse of discretion standard Morris ex rel Morris v Thomson 130 Idaho 138 141 937
P2d 1212 1215 1997
The problem presented by affidavit testimony that contradicts earlier deposition
testimony has been addressed in great detail by Idaho federal and state courts and is generally
known as the sham affidavit rule Essentially the sham affidavit rule precludes a party from
creating an issue of fact to prevent summary judgment by simply submitting an affidavit that
directly contradicts prior deposition testimony by the affiant Without such a rule in place the
utility of summary judgment as a procedure for screening out meritless claims would be lost
Courts have consistently held that parties are not allowed to prevent summary judgment
by filing sham affidavits that directly contradict deposition testimony See egBoise Tower
Associates LLC v Washington Capital Joint Master Trust 2007 WL 1035158 1213 D Idaho
2007 quoting Cleveland v Policy Mgmt Sys Corp 526US 795 806 1999 Courts have
held with virtual unanimity that a party cannot create a genuine issue of fact sufficient to survive
summary judgment simply by contradicting his or her own previous sworn statement by say
filing a later affidavit that flatly contradicts that partys earlier sworn deposition without
explaining the contradiction or attempting to resolve the disparity Van Asdale v Intl Game
Tech 577F3d 989 99899 9th Cir 2009 quoting Kennedy v Allied Mut Ins Co 952F2d
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issue of fact for trial. ecla ining o. v. Star- orning ining o., 122 Idaho 778, 839 P. 2d 
1192 (1992); yan v. eisner, 123 Idaho 42, 844 P.2d 24 (1992); vans v. T in alls ounty, 
118 Idaho 210, 796 P.2d 87 (1990). If the ad issibility of evidence presented in support of or in 
opposition to a otion for su ary judg ent is raised by one of the parties, the Court ust 
e  t at s  fir t. I .  urt's   t  lude e ce  e   
t  s    r .  . i  . ,   , ,  
.2d ,  (1 7). 
he proble  presented by affidavit testi ony that contradicts earlier deposition 
testi ony has been addressed in great detail by Idaho federal and state courts, and is generally 
kno n as the "sha  affidavit rule." ssentially, the sha  affidavit rule precludes a party fro  
creating an issue of fact to prevent su ary judg ent by si ply sub itting an affidavit that 
directly contradicts prior deposition testi ony by the affiant. ithout such a rule in place, the 
utility of su ary judg ent as a procedure for screening out eritless clai s ould be lost. 
ourts have consistently held that parties are not allo ed to prevent su ary judg ent 
by filing "sha " affidavits that directly contradict deposition testi ony. See, e.g., Boise Tower 
ssociates,  v. ashington apital Joint aster rust, 2007  1035158, 12-13 (D. Idaho 
2007) (quoting leveland v. Policy g t. Sys. orp., 526 .S. 795, 806 (1999)) ("[Courts] have 
el  it  irt al a i it  t at a art  ca t create a e i e iss e f fact sufficie t t  survi e 
su ary judg ent si ply by contradicting his or her o n previous s orn state ent (by, say, 
filing a later affidavit that flatly contradicts that party's earlier s orn deposition) ithout 
explaining the contradiction or attempting to resolve the disparity.");  s l  v. I t'l  
Tech., 577 F.3d 989, 998-99 (9th Cir. 2009) (quoting Kennedy v. Allied ut. Ins. Co., 952 F.2d 
 I    EC'S   STRI  TI    I A I   
GAROLD YOST, Ph.D. - Page 5 14542-  ( 10) 
262 266 9thCir1991 Ifaparty who has been examined at length on deposition could raise
an issue of fact simply by submitting an affidavit contradicting his own prior testimony this
would greatly diminish the utility of summary judgment as a procedure for screening out sham
issues of fact see also Matter ofEstate ofKeeven 126 Idaho 290 298 882P2d 457 465 Ct
App 1994 A sham affidavit which directly contradicts prior testimony may be disregarded
on a summary judgment motion Tolmie Farms Inc v J R Simplot Co Inc 124 Idaho
607 862P2d 299 1993 Weagree that the purpose of summary judgment is served by a rule
that prevents a party from creating sham issues by offering contradictory testimony
B Dr Yosts Affidavit Is Not Admissible Because It Directly Contradicts His
Deposition Testimony
Plaintiff is attempting to offer conclusory testimony of Dr Yost that directly contradicts
his deposition testimony given less than two 2 months ago for the simple purpose of
overcoming SECsMSJ The relevant and important contradictions in Dr Yosts affidavit are as
follows
1 Injuries Known and Foreseeable
In his deposition Dr Yost was very clear that he did not believe that there was any
literature or other publication available at any time prior to March 2008 that would have put
SEC on notice that the longterm chronic injuries alleged by Plaintiff could be caused by
exposure to OC products See Lloyd Aff 6 and Ex E at 1536156 At his deposition the
best Dr Yost could say was that he opined there was an association between Plaintiffsalleged
condition and her exposure to OC spray Id 155012 Dr Yostsspecific testimony at his
deposition on April 19 reads in relevant part
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262,266 (9th ir.1991» ("[I]f a party ho has been exa ined at length on deposition could raise 
an issue of fact si ply by sub itting an affidavit contradicting his o n prior testi ony, this 
ould greatly di inish the utility of su ary judg ent as a procedure for screening out sha  
iss es  t."); see ls  tter f st te f eeve ,  Ida  , ,  .2d ,  (Ct. 
App. 1994) ("[A] sham affidavit which directly contradicts prior testimony may be disregarded 
on a su ary judg ent otion .... "); l ie , I . v. R. i l t ., I c.,  I  
,  .2d  (19 ) ("[W]e ree t at t  r s  f s r  j t is s r    r l  
that prevents a party from creating sham issues by offering contradictory testimony ... "). 
. r. st's ffi it s t is i l   I  i e tl  t i ts is 
eposition Testi ony. 
laintiff is atte pting to offer conclusory testi ony of r. ost that directly contradicts 
his deposition testi ony given less than t o (2) onths ago, for the si ple purpose of 
overco ing SEC's SJ. The relevant and i portant contradictions in Dr. Yost's affidavit are as 
: 
. Injuries no n and oreseeable. 
In his deposition, r. ost as very clear that he did not believe that there as any 
literature or other publication available at any ti e prior to arch, 2008 that ould have put 
  tice t at t e l -ter  c r ic i j ries alle e   lai tiff c l  e ca se   
exposure to OC products. (See Lloyd Aff. ~ 6 and x. at 153:16-156:1.) t his deposition, the 
st r. st l  s  s t t  i  t r  s  ssoci ti  t  laintiff s ll  
condition and her exposure to  spray. (Jd., 155:10-12.) r. ost's specific testi ony at his 
deposition on April 19th reads, in relevant part: 
A  I    EC'S I   STRI  ORTI    FIDAVI   
GAROLD YOST, Ph.D. - Page 6 14542-  ( 810) 
Q Is it your understanding that the adverse health affects that
exposure to OC and capcaisinoids by humans are generally deemed to be
temporary reversible and not longterm
A I think thats fair yes
Lloyd Aff 6 and Ex E at 6348
Q All right Do you recall having in your review of the scientific and
medical literature seeing any peerreviewed publications that specifically
address the association between OC exposure on the one hand and long
term chronic adverse health effects on the other
A Well thats what I was referring to before that I dont think the
studies have been done or published that definitively well that provide
robust data about that scenario that OC exposure now Im talking about
OC exposure in a chronic sense multiple cases of exposure
Q Oh multiple exposures
A Yes
Q Thats fine
A And no I dontthink that I haventseen studies that make that
that come to that conclusion that there are adverse effects because I
dontthink people have done the studies
Q Have you in your review of peerreviewed publications seen any
articles that focus on the duration of time after exposure to OC that
adverse health effects are customarily deemed persistent in humans
A I would say my general opinion is that general conclusion from
literature is that they are transitory and that would generally mean you
know more than a minute and probably less than a day or two So I think
theres substantial evidence that the pain irritation lacrimation et
cetera that we talked about before is not long it doesn persist for
weeks and months
Lloyd Aff 6 and Ex E at 10022101 15 and 101211028emphasis added
Q In your opinion as of March of 2008 was there anything definitively
published in the peerreviewed scientific and medical literature that would
have put a manufacturer of pepper spray products such as SEC on notice
that exposure to their products by somebody with the chronic health
conditions of Ms Major would have caused her an exacerbated response
which would have included an ongoing chronic cough for the subsequent
period of time
A I dont think its possible for me to place a nefarious intent You
know the responsibility of whether or not there was sufficient evidence
there to say you know if you do if you expose somebody to this they
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. Is it r ersta i  t at the a erse ealt  affects that 
exposure to OC and capcaisinoids by hu ans are generally dee ed to be 
te porary, reversible and not long-ter ? 
. I think t t's f ir, . 
(Lloyd ff. ~   . t 3:4-8.) 
. ll right. o you recall having in your revie  f the scientific and 
edical literature seeing any peer-revie ed publications that specifically 
ress t e i tion t e   r   t  e   l -
t  ic erse l  ects  t e er? 
. ell, t at's at I as referri  t  ef re, t at I n't t i  t e 
studies have been done or published that definitively -- ll, t t ide 
r st t  t t t ari , t t  s re -- , I'm t l i  t 
C exposure in a chronic sense, ultiple cases of exposure. 
. h, ultiple exposures? 
. . 
. at's . 
. nd, no, I don't think that --  en't  e     
--   t  t t l i  t t t    ff ts,   
on't t i  le   t  st i s. 
[. . .] 
. ave you, in your revie  of peer-revie ed publications, seen any 
ti le  t t s  t  ti   ti  t   t   t t 
adverse health effects are custo arily dee ed persistent in hu ans? 
. I ould say y general opinion is that -- general conclusion fro  
lit t  i  t t t   t it   t t l  r ll  n,  
, re t a  a i te a  r a l  less t a  a a  r t .  I t i  
there's substantial evidence that the pain, irritation, lacrimation, et 
cetera, t t e t lke  t ef re is t l  -- it esn't ersist f r 
  t s. 
(Lloyd ff. ~ 6 and x.  at 100:22-101: 15 and 101 :21-1 02:8 (e phasis added).) 
. In your opinion, as of arch of 2008, as there anything definitively 
published in the peer-reviewed scientific and medical literature that would 
a e t a a fact rer f e er s ra  r cts s c  as   tice 
t at e s re t  t eir r cts  s e  it  t e chr nic ealt  
conditions of s. ajor would have caused her an exacerbated response 
hich ould have included an ongoing chronic cough for the subsequent 
period of ti e? 
. I don't think it's possible for e to place a nefarious intent. You 
know, the responsibility of hether or not there as sufficient evidence 
there to say, you know, if you do -- if  e se s e  t  t is, t e  
 I    EC'S I   STRI  TI    FIDAVIT  
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are going to have life altering changes I dontthink that existed then In
the literature today I dont think it exists except through the
preponderance of evidence and it may very well be that other people
dont believe that thatsthe case but I do And so you know blame is
for the jury to decide
Q Well do you think people that were trained in toxicology such as
yourself would have been able to review the medical literature and the
scientific literature that existed on or prior to March of 2008 and have
been able to determine that there would have been a lifealtering condition
that resulted from pepper spray exposure
A I dont see evidence that the normal ways for industrial hygiene
officers and personnel to evaluate such kinds of exposures may or may
not have existed at that time I haven seen it I mean I donthave
evidence that would say heres an MSVS sheet that says this bad thing is
going to happen if you expose it It does say you know this is an irritant
This is an acute thing It is going to cause this this and this so you better
be aware of ButImnot aware ofanything that the normal layperson in
the industry would say or would see that would necessarily show that
Conversely maybe there is something in the not in the maybe
in the product information or whatever which I haventseen just the
MSVS sic So again I really cant place blame necessarily on
whomever All I can say is I think theres an association between the
condition she now has and that exposure
Q And thats based upon your many years of experience as a
toxicologist
A Yes
Q Its based on your extrapolation of a number of scientific papers
and your weighing of the evidence is that right
A Yes
Q But you cantcite me to one specific paper out there that existed
prior to March of 2008 that specifically would have put laypersons
without your background on notice that exposure to their product could
have caused these longterm health conditions
A No
Lloyd Aff 6 and Ex E at 1536156 emphasis added
Now in his Affidavit Dr Yost completely changes his testimony without any
explanation He does not reference any additional information found or reviewed but relies
instead on the same literature that he was questioned about during his deposition The only
conceivable reason for the change in his testimony then is that Plaintiff needs testimony from
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are going to have life altering changes. I don't think that existed then. In 
the literature today I d 't think it exists except through the 
preponderance of evidence, and it may very well be that other people 
n't believe that t t's the , t I d . nd s , you k , la e is 
for the jury to decide. 
. ell, do you think people that ere trained in toxicology such as 
yourself ould have been able to revie  the edical literature and the 
s ie tific literature that e isted on r prior to arch f    
ee  le to t r ine that t ere ld e e   lif -altering ition 
that resulted fro  pepper spray exposure? 
. I n't  e idence t the  s f  ial ie e 
fficers and ers el t  ev l ate s c  kinds f ex s res y r y 
t ve ste   t t ti .  en't  . I ,  n't  
evidence that ould say, here's an S S sheet that says this bad thing is 
going to happen if you expose it. It does say, you know, this is an irritant. 
This is an acute thing. It is going to cause this, this and this, so you better 
be a are of. ut I'm not a are f anything that the nor al layperson in 
the industry would say or would see that would necessarily show that. 
Conversely, aybe there is so ething in the -- t i  t  -- e 
in the product information or whatever which I haven't seen., just the 
S S (sic). , a ain, I reall  can't lace la e, ecessaril ,  
ver. ll I can say is I think there's an association bet een the 
condition she no  has and that exposure. 
.  t at's       i    
toxicologist? 
. s. 
. It's based on your extrapolation of a nu ber of scientific papers 
and your weighing of the evidence; is that right? 
. s. 
Q. ut you can't cite e to one specific paper out there that existed 
prior to arch of 2008 that specifically would have put laypersons 
ithout your background on notice that exposure to their product could 
have caused these long-ter  health conditions? 
. o. 
(Lloyd Aff. ~ 6 and Ex. Eat 153:16-156:1 (e phasis added).) 
Now, in his Affidavit, Dr. Yost completely changes his testimony without any 
explanation. e does not reference any additional infor ation found or revie ed, but relies 
instead on the sa e literature that he as questioned about during his deposition. T  only 
conceivable reason for the change in his testimony, then, is that Plaintiff needs testi ony fro  
E RANDUM I  SUPPO  OF SEC'S TI  T  STRI  ORTI  OF T  AFFIDA I   
A OL  Y ST, Ph.D. - Page 8 14542- \1 ( 7810) 
Dr Yost establishing a duty to warn in order to overcome SECsMSJ Dr Yosts contradicting
Affidavit gives the following conclusory opinion without further explanation
it is my opinion that the risks to the respiratory tract posed by exposure
to SECs Sabre Red law enforcement 10 OC Spray MK9 Fogger were
known and foreseeable risks at the time SEC sold its product to IDOL
See Yost Aff 6 emphasis added Dr Yosts opinion at the time of his deposition is in direct
and inexplicable conflict with his opinion two months later when he signed his affidavit
Accordingly paragraph 6 of Dr YostsAffidavit should be stricken from the record
2 Studies Regarding Death from Exposure
Another example of Dr Yosts contradictory testimony relates to reported instances of
death following exposure to OC products Dr YostsAffidavit testimony discusses these
reported instances of death as if they would provide notice prior to March 2008 of the risks of
longterm or chronic adverse health effects from exposure to OC products rationalizing that
death is a longterm adverse health effect See Yost Aff 10 His Affidavit specifically states
Characterization of exposures to pepper sprays as transient reversible and
recoverable are generally appropriate and supported by literature
documentation However there exist a number of reports where people
have died as a result of acute exposures to pepper sprays Certainly one
cannot view death as a transient reversible and recoverable outcome
See Yost Aff 10
However these same reports of instances of death following exposure to OC products
were discussed with Dr Yost during his deposition At the time of his deposition Dr Yost
acknowledged that the reports wherein death was reported following exposure to OC products
involved other factors that the scientific literature contained studies of those reports of death
and that the studies concluded that other factors were contributing or major causes of the deaths
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Dr. Yost establishing a duty to warn in order to overcome SEC's SJ. Dr. Yost's contradicting 
Affidavit gives the following conclusory opinion without further explanation: 
... it is y opinion that the risks to the respiratory tract posed by exposure 
to S 's Sabre Red la  enforcement 1 %  Spray (MK-9 Fo r) were 
known and foreseeable risks at the time SEC sold its product to IDOC. 
(See Yost Aff. ~ 6 (emphasis added).) r . ost's opinion at the time of his deposition is in direct 
and inexplicable conflict with his opinion two months later, when he signed his affidavit. 
Accordingly, paragraph 6 of Dr. Yost's Affidavit should be stricken from the record. 
2. Studies Regarding Death fro  Exposure. 
Another example of Dr. Yost's contradictory testimony relates to reported instances of 
death following exposure to OC products. r. st's fida t  ss   
reported instances of death as if they would provide notice prior to March, 2008 of the risks of 
long-term or chronic adverse health effects from exposure to OC products, rationalizing that 
death is a long-term adverse health effect. (See Yost Aff. ~ 0.)  i  pecifi l  t tes: 
haracterization of exposures to pepper sprays as transient, reversible and 
r r l   generally appropriate  rt   literature 
cu entation. ever, t ere e ist a er f re rts ere e le 
a e ie  as a res lt f ac te e s res t  e er sprays. ertai l  o e 
 i  t    tr nsient, r i  an   utcome .... 
(See Yost Aff. ~ 10.) 
o ever, these sa e reports f instances of death follo ing exposure to OC products 
ere discussed ith r. ost during his deposition. t th  ti  of his depositi  r. st 
acknowledged that the reports wherein death was reported following exposure to OC products 
involved other factors, that the scientific literature contained studies of those reports of death, 
and that the studies concluded that other factors ere contributing or ajor causes of the deaths. 
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See Lloyd Aff 6 and Ex E at 12822 131 He admitted in his deposition that the few
reported instances of death had not been definitively linked to the exposure to OC Id
Dr Yostsaffidavit testimony regarding the deaths also contradicts Dr Yostsdeposition
testimony that there was no literature in existence in March 2008 or even at the time of his
deposition which would have put a manufacturer of OC products such as SEC on notice that
exposure to its products could have caused long term or chronic adverse health effects See
Lloyd Aff 6 and Ex E at 1282 1311 and 1536156
Dr Yostsdeposition testimony discussing these reports of death incidents specifically
reads as follows
Q Now you say here under your Acute Toxicities paragraph that
inhalation Im sorry that among the responses to OC exposure are
leading to severe respiratory depression cardiovascular dysfunction and
death Do you see that there
A Yes
Q What is the source of that statement
A I dontrecall what I have there are cases in the literature of
people dying from capsaicin exposure and we documented several of
those in some of our publications So I could go back and find out where
those cases occurred give you the specific references if you would like
but people have died
Q But isnt it also true that studies have gone back and looked at
those death cases and determined that those cases of death actually
occurred with other issues going on specifically drug use alcohol use
and other underlying physical force issues that were not related to
capsaicin exposure
A Im aware that there was at least a study or two that had that
the office had the opinions that other factors could either contribute to
or be a major cause ofmorbidity or mortality in those cases
Q Did you do any research that would indicate that there was that
that was not an accurate conclusion
A Oh no Its possible
Q So would you accept that conclusion as being accurate
A No I would accept it as being a possibility Theres a difference
between proving something and postulating something Its possible
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(See Lloyd Aff. ,-r 6 and E .  at 128:22- 31: 1.) He a itted in his de ition that the fe  
reported instances of death had not been definitively linked to the exposure to Oc. (Id.) 
r. ost's affidavit testi ony regarding the deaths also contradicts r. ost's deposition 
testimony that there was no literature in existence in arch, 2008 (or even at the time of his 
deposition) which would have put a manufacturer of OC products, such as SEC, on notice that 
exposure to its products could have caused long-term or chronic adverse health effects. (Se  
Lloyd Aff. ,-r   .  t 28:22- 31: 1  53: 16- 56: 1.) 
Dr. Yost's deposition testi ony discussing these reports of death incidents specifically 
r   f ll : 
Q. ,  sa  ere er r c te icities ara ra  t at 
 -- I'm sorry, that a ong the responses to OC exposure are 
leading to severe respiratory depression, cardiovascular dysfunction and 
death. Do you see that there? 
. s. 
.       t tement? 
.  n't  t --   --      ter   
people dying fro  capsaicin exposure, and we docu ented several of 
those in some of our publications. So I could go back and find out where 
those cases occurred, give you the specific references, if you ould like, 
but people have died. 
. t i n't it l  t  t t t i      l  t 
t s  t  s s  t r i  t t t s  s s f t  t ll  
occurred with other issues going on, specifically drug use, alcohol use 
and other underlying physical force issues that were not related to 
capsaicin exposure? 
. I'm r  t t t r  s t l st  st  r t  t t  -- t t 
the office had the opinions that other factors could either contribute to 
or be a ajor cause of orbidity or ortality in those cases. 
Q. id you do any research that ould indicate that there as -- t at 
t   t  c t  onclusion? 
. Oh, no. It's possible. 
Q. SO ould you accept that conclusion as being accurate? 
. o, I ould accept it as being a possibility. There's a difference 
between proving something and postulating something. It's possible. 
RANDU  I  SU P   SEC'S I  TO STRI  PORTI  OF THE AFFIDAVI   
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Q When you say theres a difference between proving something and
postulating something what do you mean that difference to be What is
the difference between proving and postulating
A Well there is no such thing as absolute proof in science If youre
a true scientist then nothing is ever absolute So proof to me means a
weight of evidence argument that the weight of the evidence provided is
convincing and well convincing
Q And a simple Im sorry
A Its convincing to me Imonly going to talk about myselfhere but
its convincing to me that its true that until proven otherwise thats a
process that Illaccept as being proof where there is no such thing as true
proof
Q A simple case report does not by itself make proof does it
A No
Q Not even enough to make anything convincing from a scientific
stand point
A It depends on who you are talking to you know
Q Well science doesnt recognize case reports individual case
reports as being sufficient to
A Not generally
Q make an association between toxic ingredient and an adverse
health effect
A Its not generally regarded as a sufficient weight of evidence from
one report no
Lloyd Aff 6 and Ex E at 1282 131 emphasis added To the extent that Dr Yost is
now attempting to definitively link case reports of death following exposure to OC to a chronic
or long term adverse health condition that developed because of exposure to OC that testimony
directly contradicts the prior sworn deposition testimony and ought to be stricken from the
record
3 D A Groneberg 2004 Article
In paragraph 12 of his Affidavit Yost claims that a 2004 article entitled Increased
Expression of Transient Receptor Potential Vanilloid1 in Airway Nerves of Chronic Cough
written by D A Groneberg and others 2004 Article Deposition Exhibit 59 put SEC on
notice of the risks of longterm adverse health effects His affidavit specifically states
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. hen you say there's a difference bet een proving so ething and 
postulating so ething, hat do you ean that difference to be? hat is 
the difference bet een proving and postulating? 
. ll, t ere is   t i   l te r f i  i . If ou're 
a tr e scie tist, then t ing is e er a s l te.  r f t  e ea s a 
weight of evidence argu ent, that the weight of the evidence provided is 
convincing and -- ell, convincing. 
. n   i le -- 'm rr . 
. It's convincing to e. I'm only going to talk about yself here, but 
it's convincing to e that it's true, that until proven other ise, that's a 
process that I'll accept as being proof, here there is no such thing as true 
proof. 
. A simple case report does not by itself make proof, does it? 
. . 
Q. t e e  e  t  a e a t i  c i ci  fr  a scie tific 
stand point? 
. It depends on ho you are talking to, you kno . 
. ll, i e esn't r i   r rt , i i i l s  
reports as being sufficient to -
. ot generally. 
. -- ake an association bet een toxic ingredient and an adverse 
l  f ct? 
. It's not generally regarded as a sufficient weight of evidence from 
one report, no. 
(Lloyd Aff. ~  a  x. at 28:22- 31: 1 (emphasis added).)  t e e te t t at r. st is 
no  atte pting to definitively link case reports of death follo ing exposure to  to a chronic 
or long-ter  adverse health condition that developed because of exposure to ~C, that testi ony 
directly contradicts the prior, sworn deposition testi ony and ought to be stricken fro  the 
cord. 
. . . roneberg 2004 rticle. 
In paragraph 12 of his Affidavit, Yost claims that a 2004 article entitled Increased 
Expression of Transient Receptor Potential Vanilloid-l in Airway Nerves of Chronic Cough, 
written by D. A. Groneberg and others ("2004 Article") (Deposition xhibit 59), put  on 
notice f the risks oflong-ter  adverse health effects. is affidavit specifically states: 
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This relationship between receptors and chronic cough precisely
identified a mechanism whereby the chronic adverse health
condition of the Plaintiff is likely to be dramatically worsened by
subsequent exposure to pepper sprays It is noted that the
publication is dated 2004 which is prior to the sic when SEC
sold its products to IDOC to which the Plaintiff was exposed on
March 3 2008
See Yost Aff 12
However the Deposition Exhibit 59 2004 Article was previously discussed in detail
during Dr Yostsdeposition at which time he had a very different interpretation of its contents
Q Well Im going to hand you these back again the articles
Maybe you can tell me which one that comes from
A I think its Exhibit 59 Ill have to take a quick look here
Yeah its at least in part from here but I think maybe in part
from another one Let me look Yeah thatspart of that
Q What do you rely upon in here that says that Im just trying to
can you find it
A Cough reflex measured with inhalation of the pungent
ingredient of chili peppers which is capsaicin is usually
augmented in patients with chronic persistent cough
Q Isntit true that what is being discussed there is that a
patient who may have chronic cough may have a more
acute reaction to OC exposure than other persons who do
not have chronic cough
A Yes that I think a reasonable interpretation
Lloyd Aff 6 and Ex E at 133913424 emphasis added 7 and Ex F Later in the
deposition Dr Yost was questioned further about the contents of the 2004 Article
Q And have you reviewed that publication
A I dontthink so
Q Do you know what its based on
A Well maybe I have seen it Increased Expression of TRPV 1
Airways Nerves of Chronic Cough 2004 From the title I
would say its probably relevant but Im not sure ifIve seen it
I would have to find it
Q Okay So can you get inflammation with TRPV 1 exposures
that result only in acute adverse health reactions
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is relations ip et ee  rece t rs a  c r ic c  recisel  
i e tified a ec a is  ere  t e c r ic a erse ealt  
c ition f t e lai tiff is likely t  e ra aticall  rse e   
subsequent exposure to pepper sprays. t s  t  
lication is t   ich i  ri r t  t  [si  ] [wh ]  
s l  its roducts t  I  t  ic  t  l i tiff as s   
arc  , . 
(See st ff. ~ 2.) 
, t e iti  i it   ticle  i l  i  i  t il 
ri  r. st's siti , t ich ti e    r  iffer t i t r r t ti  f it  t t : 
. ell, I'm going to hand you these back again, the articles. 
aybe you can tell e hich one that co es fro . 
.   t's  . I'll  t  t   i  l  r . 
ea , it's at least i  art fr  ere, t I t i  a e i  art 
fro  a t er e. et e l . eah, t at's art f t at. 
. hat do you rely upon in here that says that? I'm just trying to 
-- can you find it? 
. "Cough reflex easured ith inhalation f the pungent 
ingredient of chili peppers," hich is capsaicin, "is usually 
aug ented in patients ith chronic, persistent cough." 
[ ... ] 
. Isn't it true t at at is ei  isc sse  t ere is t at a 
patient ho ay have chronic cough ay have a ore 
acute reaction to  exposure than other persons ho do 
not have chronic cough? 
A. es, that's, I think, a reasonable interpretation. 
(Lloyd Aff. ~ 6 and Ex. E at l33:19-l34:24 (emphasis added); ~ 7 and Ex. F.)    
deposition, r. ost as questioned further about the contents f the 2004 rticle: 
.    r i  t t blication? 
.  n't  . 
Q. Do you know what it's based on? 
A. ell, aybe I have seen it. "Increased Expression of TRP 1 
Airways Nerves of Chronic Cough, 2004."  t  titl   
ould say it's probably relevant, but I'm not sure if I've seen it. 
     . 
Q. Okay. So can you get infla ation with TRPV1 exposures 
that result only in acute adverse health reactions? 
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A Only in acute
Q Yes
A Probably
Q And just because somebody has inflammation doesnt
necessarily mean youre going to have a chronic reaction
correct
A Thats correct
Q As you said most people who have exposure to OC will
resolve their symptoms within a matter of hours or a day
A Yeah
Q And just because somebody has inflammation or even if
somebody is insensitized and has inflammation they arent
necessarily going to have a chronic reaction are they
A No they arent But thats not my point My point is it is
specifically associated with the disease process youre talking
about chronic cough and TRPV 1 and capsaicins and if the
hammer keeps hitting you over the head enough times you
ought to believe them Whether that results in a chronic
situation or acute is certainly chronic is less credible than
acute yes
Lloyd Aff 6 and Ex E at 1402 1427emphasis added 7 and Ex F
During his deposition Dr Yost used the 2004 Article to support his causation opinion
that he believes Plaintiff underlying respiratory illnesses were exacerbated by her exposure to
OC spray thereby causing her to suffer a chronic condition Dr Yost did not however use the
2004 Article to support an opinion that in March 2008 SEC should have known and foreseen
the injuries allegedly suffered by Plaintiff as a risk associated with OC spray exposure In fact
as cited above Dr Yostsopinion during his deposition was that the literature did not support
Not only does Dr YostsAffidavit contradict his deposition testimony it also is unsupported
by the 2004 Article itself Despite Plaintiff and Dr Yost both having contended that the 2004 Article is
the very item giving rise the liability alleged neither has presented the Article to the Court The actual
2004 Article Deposition Exhibit 59 relied on by Dr Yost to support his conclusions in paragraph 12 of
his Affidavit is attached to the Lloyd Aff as Exhibit F Nothing in the article specifically states or even
infers that exposure to OC can cause a longterm chronic health condition of the type Ms Major
complains Dr Yost concedes as he must that the article only suggests that persons with preexisting
cough may have a more severe acute reaction to OC exposure than persons without preexisting cough
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. l  in t ? 
. es. 
. Probably. 
. nd just s  so ebody  infla atio  sn't 
necessarily ean you're going to have a chronic reaction, 
ct? 
. at's t. 
. s  sai , st e le ho a e e s re t   ill 
resolve their sy pto s within a atter of hours or a day? 
. e . 
. nd just eca se s e  as i fla ati  r e e  if 
so ebody is insensitized and has infla ation, they aren't 
necessarily going to have a chronic reaction, are they? 
. o, they aren't. But that's not y point.  i t is it is 
specifically associated ith the disease process you're talking 
about, chronic cough, and  1 and capsaicins, and if the 
ha er keeps hitting you over the head enough ti es, you 
t t  lie  t .  t     
situation or acute is certainly --    e  
t , s. 
(Lloyd Aff. ~ 6 and x. at 140:24-142:7 (emphasis added); ~   x. .)l 
uring his deposition, r. ost used the 2004 rticle to support his causation opinion, 
that he believes Plaintiffs underlying respiratory illnesses were exacerbated by her exposure to 
 spray, thereby causing her to suffer a chronic condition. r. ost did not, ho ever, use the 
2004 rticle to support an opinion that, in arch, 2008, SEC should have kno n and foreseen 
the injuries allegedly suffered by Plaintiff as a risk associated with OC spray exposure. In fact, 
as cited above, r. ost's opinion during his deposition as that the literature did not support 
1 Not only does Dr. Yost's Affidavit contradict his deposition testi ony, it also is unsupported 
by the 2004 Article itself. Despite Plaintiff and Dr. Yost both having contended that the 2004 Article is 
the very ite  giving rise the liability alleged, neither has presented the rticle to the ourt. The actual 
2004 Article (Deposition Exhibit 59) relied on by Dr. Yost to support his conclusions in paragraph 12 of 
his Affidavit is attached to the Lloyd Aff. as Exhibit F. Nothing in the article specifically states or even 
infers that exposure to C can cause a long-ter  chronic health condition of the type s. ajor 
complains. Dr. Yost concedes, as he must, that the article only suggests that persons with pre-existing 
cough ay have a ore severe acute reaction to OC exposure than persons without pre-existing cough. 
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that in March 2008 and still did not support that position on April 19 2011 Even insofar as he
relied on the 2004 article to formulate his positions on the causal link between OC and Plaintiffs
alleged chronic injuries Dr Yost was forced to admit that the causal link was less credible
Allowing an affidavit that directly contradicts deposition testimony is contrary to the law
and patently unfair to the moving party on summary judgment SEC has expended many hours
preparing its motion for summary judgment including the time taking the actual deposition SEC
is entitled to rely upon the deposition testimony provided by Yost Plaintiff should not be able to
avoid summary judgment by the submission of an affidavit that is a sham and that should be
stricken as a matter of law
C Dr YostsContradicting Testimony Is a Sham
SEC acknowledges that not every discrepancy between deposition testimony and a
subsequent affidavit constitute an inadmissible sham Courts have found that contradicting
testimony is not a sham where it is the result of an honest discrepancy a mistake or the result
of newly discovered evidence Smythe v Safeco Ins Co ofAmerica 33 Fed Appx 303 9th
Cir 2002 citing from Kennedy v Allied Mut Ins Co 952 F2d 262 9 Cir 1991 However
where the affidavit testimony flatly contradicts earlier testimony the affidavit is a sham and
cannot be used to create an issue of fact Radobenko v Automated Equipment Corp 520 F2d
540 9 Cir 1975 Dr YostsAffidavit does not give any explanation as to why his testimony
has changed so significantly with respect to those issues relevant and necessary for Plaintiff to
overcome SECsMSJ
Dr YostsAffidavit is not based upon any newly discovered information that was
previously unavailable to Plaintiff All of the articles and reports referenced in Dr Yosts
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that in arch, 2008 and still did not support that position on pril 19, 2011. ven insofar as he 
relied  the 2004 rticle to for ulate his positions n t e s l link t ee   a d l intiff's 
alleged chronic injuries, Dr. Yost was forced to ad it that the causal link was "less credible." 
llowing an affidavit that directly contradicts deposition testi ony is contrary to the la  
and patently unfair to the oving party on su ary judg ent. SE  has expended any hours 
preparing its otion for su ary jUdgment including the ti e taking the actual deposition. SEC 
is entitled to rely upon the deposition testimony provided by Yost. Plaintiff should not be able to 
avoid su ary judg ent by the sub ission of an affidavit that is a sha  and that should be 
tri    tt r fl . 
. r. ost's ontradicting esti ony Is a Sha . 
SEC acknowledges that not every discrepancy between deposition testimony and a 
subsequent affidavit constitute an inadmissible sham.     i  
testi ony is not a "sha " where it is "the result of an honest discrepancy, a istake, or the result 
of newly discovered evidence." Smythe v. Safeco Ins. Co. of America, 33 Fed. Appx. 303 (9th 
ir. 2002) citing fro  ennedy v. Allied ut. Ins. o., 952 F.2d 262 (9th ir. 1991). o ever, 
ere t e affi a it testi  flatl  c tra icts earlier testi ony, t e affi a it is a "sha " and 
t   t  r t   i   f ct.  . t t  i ent. orp.,   .2d 
540 (9th Cir. 1975). Dr. Yost's Affidavit does not give any explanation as to why his testi ony 
has changed so significantly with respect to those issues relevant and necessary for Plaintiff to 
erc e EC's J. 
r. ost's i it i  t   ny l  i r  i ti  t t  
previously unavailable to Plaintiff. ll of the articles and reports referenced in r. ost's 
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Affidavit were disclosed by Plaintiff in discovery responses before Dr Yost was deposed were
discussed with Dr Yost during his deposition and were addressed by the Affidavit of
Christopher A Reilly PhDin Support of SECs Motion for Summary Judgment
The Affidavit testimony does not purport to clarify any issues or correct any
misunderstanding from his deposition rather his affidavit plainly contradicts his earlier sworn
testimony Dr Yost answered the same question during his deposition several different times all
with the same result there was not any scientific or medical literature available prior to March
2008 or at the time Dr Yost was deposed in April 2011 that would have enabled SEC or others
to have known or foreseen the risks of injuries such as alleged here by Plaintiff See Lloyd Aff
6 and Ex E at 1536156
As discussed in Tolmie Farms a deponent can correct his or her deposition testimony
pursuant toIRCP30eparticularly if the deponent was confused about a question or as was
the case in Tolmie Farms was not sure of his or her recollection Tolmie Farms 124 Idaho 607
610 That is not the case here Dr Yost was allowed an opportunity to review and make
corrections to his deposition See Lloyd Aff 5 and Ex D However Dr Yost did not timely
submit any edits or corrections to his deposition See Lloyd Aff 4 and Ex C As of June 22
2011 Dr Yost still had not submitted any edits or corrections to his deposition Id Pursuant to
the 30 day requirement outlined in the Court ReportersMay7 2011 letter Dr Yost should have
submitted any changes or corrections to his deposition on or before June 6 2011 Id There
has not been any request by Dr Yost or Plaintiffscounsel for Dr Yost to be given additional
time to make edits or corrections to his deposition Id Accordingly the potential exception
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ffidavit ere disclosed by laintiff in discovery responses before r. ost as deposed, ere 
discussed ith r. ost during his deposition, and ere addressed by the ffidavit of 
hristopher . eilly, Ph.D. in Support of SEC's otion for Su ary Judg ent. 
he ffidavit testi ony does not purport to clarify any issues or correct any 
isunderstanding fro  his deposition; rather, his affidavit plainly contradicts his earlier s orn 
testi ony. r. ost ans ered the sa e question during his deposition several different ti es, all 
ith t e  ult: there as t  i ti ic  i l literat r  ila le i r t  , 
2008 (or at the ti e r. ost as deposed in pril, 2011) that ould have enabled SE  or others 
t  a e  r f resee  t e ris s f i j ries s c  as alle e  ere  laintiff. (See lo d ff. 
~ 6 and x. at 153:16-156:1.) 
s discussed in l ie r s, a deponent can correct his or her deposition testi ony 
pursuant to I.R.C.P. 30( e), particularly if the deponent was confused about a question or as was 
the case in ol ie ar s, as not sure f his or her recollection. ol ie ar s, 124 Idaho 607, 
. t     . r. st  ll   rt it  t  r i    
corrections to his deposition. (See Lloyd Aff. ~ 5 and x. .) o ever, r. ost did not ti ely 
sub it any edits or corrections to his deposition. (See Lloyd ff. ~   x. .) s f J  , 
 r . st still a  t s itte  a  e its r c rrecti s t  is eposition. (I .) rs a t t  
the 30 day requirement outlined in the Court Reporter's ay 7, 2011 letter, Dr. Yost should have 
sub itted any changes or corrections to his deposition on or before June 6, 2011. (Jd.) There 
has not been any request by Dr. Yost or Plaintiff s counsel for Dr. Yost to be given additional 
ti e to ake edits or corrections to his deposition. (Jd.) ccordingly, the potential exception 
 I    EC'S   I  I    I I   
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from contradicting evidence which is allowed under IRCP30e is not applicable in this
instance
CONCLUSION
Dr YostsAffidavit is a prime example of directly contradicting testimony made for the
sole purpose of overcoming a motion for summary judgment As established by the large body
of case law addressing this very issue this simply can not be done If this scenario was allowed
summary judgment as a whole would essentially be rendered pointless Accordingly SEC
respectfully requests that paragraphs 6 10 and 12 of Dr YostsAffidavit be stricken from the
record and the opinions contained therein not be considered in any ruling on SECsMSJ
f
DATED this Zq day of June 2011
GREENER BURKE SHOEMAKER PA
Christopher C Burke
Thomas J Lloyd III
Attorneys for Defendant
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fr  tr i ting idence ic  is ll e  er I.R.C.P. 0(e) is t lica le i  t is 
i t . 
 
r. st's ffida it is  ri  le f ir tl  tr i ti  t sti ,  f r t  
s le rpose f erc i  a ti  f r s ar  j e t. s esta lis e   t e lar e  
f case la  addressing this very issue, this si ply can not be done. If this scenario as allo ed, 
su ary judg ent as a hole ould essentially be rendered pointless. r i l ,  
respectfully requests that paragraphs 6, 10 and 12 f r. ost's ffidavit be stricken fro  the 
r r   t e i io s t i  t r i  t  i r  i   r li   C's . 
  2qr--day of June, 2011. 
   .A. 
~.~ 
rist er . r e 
ho as J. loyd III 
tt r   t 
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Darwin Overson Esq
Eric B Swartz Esq
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CHRISTOPHER D RICH Clark
By JAMIE RANDALL
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation





Defendant Security Equipment Corporation SEC or Defendant by and through its
counsel of record Greener Burke Shoemaker PA pursuant to IRCP56 submits this reply
memorandum in support of its Motion for Summary Judgment
ARGUMENT
1 Plaintiff Should Be Estopped from Resurrecting HerWarranty Claims
By her Opposition Plaintiff is attempting to now after the Courts imposed deadline for
filing Summary Judgment motions resurrect the implied warranty claims that she previously
indicated would be dismissed Rather than bear the consequences of the statements she previously
made Plaintiff argues that SEC ought to have understood that she had omitted an entire word from
her discovery responses she will be dismissing the warranty claim and more
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1. Plaintiff Should e Estopped fro  esurrecting er arranty laim(s). 
y her pposition, Plaintiff is atte pting to no , after the ourt's i posed deadline for 
filing Summary Judgment motions, resurrect the implied warranty claims that she previously 
i i t  l   is issed. t r t  r t  s s f t  st t ts s  r vi sl  
ade, Plaintiff argues that SEC ought to have understood, that she had o itted an entire word fro  
her discovery responses - "she ill be dis issing the [ __ ] rr t  l i  -   
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importantly which word she had omitted express or implied This tactic should not be
condoned
The Idaho Rules of Civil Procedure are designed to ensure the just speedy and
inexpensive administration of justiceIRCP1a The purpose of our discovery rules is to
facilitate fair and expedient pretrial fact gathering It follows therefore that discovery rules are not
intended to encourage or reward those whose conduct is inconsistent with that purpose Edmunds
v Kraner 142 Idaho 867 873 136 P3d 338 344 2006 Along those lines Rule 11 places an
obligation on attorneys and parties signing documents in litigation to certify that the attorney or
party has read the pleading motion or other paper that to the best of the signer knowledge
information and belief after reasonable inquiry it is well grounded in fact Rule 26f further
extends this obligation to discovery documents Here both Plaintiff and her attorney certified her
discovery responses and SEC has relied on those certifications and assurances To permit Plaintiff
to amend her discovery responses after the deadline for filing summary judgment motions and to
therefore resurrect previouslyabandoned claims violates both the letter and the spirit of these Rules
ofCivil Procedure
Moreover well established principles of equity prohibit Plaintiffs intended tactic
This Court adopted the doctrine of judicial estoppel in Loomis v
Church 76 Idaho 87 277P2d 561 1954 In Loomis this Court held
that a litigant who obtains a judgment advantage or consideration
from one party through means of sworn statements is judicially
estopped from adopting inconsistent and contrary allegations or
testimony to obtain a recovery or a right against another party arising
out of the same transaction or subject matter Judicial estoppel
precludes a party from gaining an advantage by taking one position
and then seeking a second advantage by taking an incompatible
position The policies underlying judicial estoppel are general
considerations of the orderly administration of justice and regard for
the dignity of judicial proceedings Judicial estoppel is intended to
prevent a litigant from playing fast and loose with the courts
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Heinze v Bauer 145 Idaho 232 235 178 P3d 597 600 2008 internal citations omitted As
Plaintiff gained the advantage by her previous discovery response of not having SEC make any
substantive argument on summary judgment regarding the implied warranty claim she cannot now
seek a second advantage by resurrecting that claim for trial Further SEC relied upon Plaintiffs
earlier discovery request in formulating the remainder of its discovery and Plaintiff thereby avoided
additional discovery and deposition inquiry regarding the warranty issues Plaintiff should be
judicially estopped from being allowed to ambush SEC at trial with information that was not subject
to the fair and expedient pretrial fact gathering referenced in Edmunds Plaintiffs Third and
Fourth Causes ofAction should therefore be dismissed
2 SEC Is Entitled To Summary Judgment On Plaintiffs Remaining Causes of Action
Plaintiff seeks to divert the Courtsattention away from the real issue raised by SECs
motion by focusing on the causal link between OC exposure and her injuries The question relevant
to this motion for summary judgment is not whether SECsOC spray actually caused Plaintiffs
alleged injuries Rather the relevant question is whether SEC had sufficient notice based on the
then available scientific research to have known that its product could cause the longterm chronic
injury or injuries that Plaintiff has alleged If the answer to this latter question is no then SEC is
entitled to judgment as a matter oflaw on PlaintiffsFirst and Second Causes of Action
Plaintiffs implied warranty claims would be subject to dismissal on summary judgment because
Plaintiff does not have the requisite privity of contract defined in IC 282318 SEC did not sell its
product directly to Plaintiffsemployer but rather to an independent distributor Affidavit of Counsel in
Support of Plaintiffs Opposition to SECs MSJ Aff of Counsel 10 and Ex 8 114417 Plaintiffs
reliance on Puckett v Oakfabco Inc 132 Idaho 816 1999 is therefore misplaced Plaintiff was not as in
Puckett an employee of the entity with whom SEC had a contractual relationship and she therefore lacks
priority to assert any UCC implied warranty claims
2
Notably Plaintiff has not disputed the accuracy of SECsstatement of the law on this issue
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tion  f si   t  s l li  t   s r   r i j ri s.  sti  r l t 
to this otion for su ary judg ent is not hether EC's  spray actually caused laintiffs 
alleged injuries. ather, the relevant question is hether S  had sufficient notice based on the 
then-available scientific research to have kno n that its product could cause the long-term chronic 
injury or injuries that Plaintiff has alleged. If the answer to this latter question is no, then SEC is 
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I Plaintiffs implied warranty claims would be subject to dismissal on summary judgment because 
Plaintiff does not have the requisite privity of contract defined in I.C. § -2-3 .    l   
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Plaintiff does not base her causes of action on the known and obvious acute temporary
reaction that results from exposure to OC spray Rather she specifically claims that she suffers
from a longterm or chronic respiratory illness andor a long term chronic aggravation or
exacerbation of an existing health condition PlaintiffsMemo p 2 To the extent that Plaintiff
has submitted Affidavit testimony andor other evidence attempting to show that OC spray causes
acute respiratory effects and that SEC knew of those acute respiratory effects that evidence is
irrelevant for present purposes In order to survive this motion Plaintiff must be able to present
evidence that prior to March 2008 there was information available creating a causal link between
OC exposure and chronic or longterm adverse health effects In this task Plaintiff has failed to
meet her burden
As more fully explored in SECs concurrentlyfiled Motion to Strike Portions of the
Affidavit of Dr Yost Plaintiff relies on the affidavit testimony of Dr Yost to argue that SEC
should have known that its OC spray could cause the injuries alleged by Plaintiff However Dr
Yoststestimony directly contradicts his prior sworn deposition testimony on the same issue
Q In your opinion as of March of 2008 was there anything
definitively published in the peerreviewed scientific and medical
literature that would have put a manufacturer of pepper spray
products such as SEC on notice that exposure to their products by
somebody with the chronic health conditions of Ms Major would
have caused her an exacerbated response which would have
included an ongoing chronic cough for the subsequent period of
time
A I dontthink its possible for me to place a nefarious intent You
know the responsibility of whether or not there was sufficient
evidence there to say you know if you do if you expose
somebody to this they are going to have life altering changes I
dontthink that existed then In the literature today I dont
think it exists except through the preponderance of evidence
and it may very well be that other people dontbelieve that thats
the case but I do And so you know blame is for the jury to
decide
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Aff of Counsel 4 and Ex 2 1536 1541 emphasis added
In this case blame is not for the jury to decide as Plaintiff cannot meet her requisite legal
burdens While Plaintiff claims there is a dispute between experts on what information was
available to SEC the only real dispute is apparently between Dr Yostsdeposition and his affidavit
testimony Wellsettled law prohibits a party from creating a genuine issue of fact sufficient to
survive summary judgment simply by contradicting his or her own previous sworn statement by
say filing a later affidavit that flatly contradicts that partys earlier sworn deposition without
explaining the contradiction or attempting to resolve the disparity Cleveland v Policy Mgmt Sys
Corp 526US 795 806 119 S Ct 1597 1603 1999
Most indicative of the weaknesses in Plaintiffsargument is that she concedes that
Defendant may be right that no one has conducted a study to determine whether longterm
chronic illness may be a risk of exposure to OC PlaintiffsOpp p 25 Thus Plaintiff
attempts to impose a burden on SEC to divine or simply guess what unknown longterm chronic
effects may arise from exposure to OC based solely on the fact that the product causes known
acute temporary effects to the same part of the body By this theory a drug manufacturer whose
product causes stiff joints ought to warn against paralysis even if no one had ever suffered paralysis
from the product if the drug causes light sensitivity it must warn against total blindness The level
of conjecture that Plaintiff requires to warn against any possibility 1d is not supported by any
Idaho or federal law or common law all of which restrict liability to risks actually known or
reasonably foreseeable As such Plaintiff has failed to come forward with any admissible
evidence to establish that SEC knew or should have k known that its OC products may cause the
3
Importantly Plaintiff did not offer a single source of authority in support of her position on this
issue
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longterm or chronic adverse health effects that she alleges and her claims for strict liability and
failure to provide an adequate warning therefore fail as a matter of law
3 The FHSA Preempts Any State Law Cause Of Action For Inadequate Warning
In moving for Summary Judgment SEC anticipated that Plaintiff would base much of her
defense to the motion on the testimony of Dr Purswell and his claims that SEC has allegedly not
met its obligations under the Occupational Safety and Health Act OSHA Indeed Plaintiff has not
only defended against this motion but has actually filed an untimely cross motion for summary
judgment on that theory Accordingly SEC responds in greater detail to Plaintiffsreliance on
OSHA in its opposition to Plaintiff s cross motion for partial summary judgment Nonetheless as
the preemption provision of the FHSA is dispositive on Plaintiffscause of action for inadequate
warning a brief discussion is also appropriate here
Plaintiff responds to SECscontention that the failure to warn cause of action is preempted
by the Federal Hazardous Substances Act FHSA by relying on the legal conclusion of Dr JP
Purswell regarding the application of the FHSA to SECsOC spray See Affidavit ofJP Purswell
PhDPECPE in Opposition to DefendantsMotion for Summary Judgment Purswell AM
Notwithstanding the fact that Dr Purswell is not qualified to draw this legal conclusion and that
such an effort invades the province of the Court the real problem with Dr Purswellsconclusion is
that it is entirely unsupported by fact or law
Notably Plaintiff has asserted a state law cause of action for failure to warn and not a cause
of action under OSHA See generally Complaint Indeed private citizens do not have a
cause of action for damages based upon a violation of an OSHA standard Helms v Sporicidin
Intl871FSupp 837 839EDNC1994 citing 29USC 653 Johnson v Koppers Co Inc
524FSupp 1182 app dismissed DCOhio 1981 Blessing v United States 447FSupp 1160
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the pree ption provision of the F S  is dispositive on Plaintiff s cause of action for inadequate 
warning, a brief discussion is also appropriate here. 
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by the Federal azardous Substances ct (F S ) - by relying on the legal conclusion of r. J.P. 
Purswell regarding the application of the FHSA to SEC's OC spray. (See Affidavit of J.P. Purswell, 
h.D., .E., , in pposition to efendant's otion for u ary Judg ent ("Purs ell ff.").) 
ot ithstanding the fact that r. Purs ell is not qualified to dra  this legal conclusion, and that 
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that it is entirely unsupported by fact or la . 
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DCPa1978 Otto v Specialties Inc 386FSupp 1240DCMiss1974 As such while a
plaintiff may use alleged OSHA violations as evidence of duty andor breach the underlying
claim must be rooted elsewhere Chilcutt v Ford Motor Co 662FSupp2d967SDOhio 2009
In this case Plaintiff cause of action is undeniably a state statutory or common law cause
of action The question therefore is not whether the FHSA preempts OSHA but whether the
FHSA preempts the underlying state cause of action Cf Helms 871FSupp 837 holding that the
two federal provisions detailing labeling requirements are to be read in conjunction with one
another but determining that the OSHA standard could only be used as evidence of a state law
cause ofaction which was in turn preempted by the remaining federal provision FIFRA see also
Chemical Specialties Mfrs Assn Inc v Allenby 958 F2d 941 945 9 Cir 1992 The
preemption issues arising under FHSA are identical to those arising under FIFRA If the FHSA
applies to SECs Law Enforcement OC spray products then Plaintiffs cause of action for failure to
warn is preempted and must be dismissed Id
To avoid the preemption problem Plaintiff argues and Dr Purswell opines that the FHSA
does not apply to the OC spray products relevant to this litigation because they are clearly intended
for occupational use Purswell Aff 5 Citing to the definitions contained within 15USC
1261p and 16 CFR 15003c0i Plaintiff contends that the FHSA applies only to
household goods and that SECs Law Enforcement branded OC spray is therefore not
encompassed within the purview of the FHSA PlaintiffsOpp p 18
Plaintiffsinterpretation of the scope ofthe FHSA is overly restrictive and inconsistent with
all applicable law She does not cite to any case law in support of her interpretation of the FHSA
but instead relies exclusively on Dr Purswellsconclusions on the intended purpose of the relevant
4 The relevant regulation was erroneously cited by Plaintiff as 16CFR 1261c0iwhich
does not exist
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claim ust be rooted else here. hilcutt v. Ford otor o., 662 F.Supp.2d 967 (S.D. hio 2009). 
In this case, Plaintiff s cause of action is undeniably a state statutory or co on la  cause 
of a . The question, therefore, is not whether the FHSA preempts OSHA, but whether the 
FHSA preempts the underlying state cause of action. Cf Helms, 871 F.Supp. 837 (holding that the 
"two federal provisions detailing labeling requirements are to be read in conjunction with one 
another," but determining that the OSHA standard could only be used as evidence of a state law 
cause of action, hich as in tum pree pted by the re aining federal provision (FIFRA)); see also 
Chemical Specialties Mfrs. Ass 'n, Inc. v. Allenby, 958 F.2d 941, 945 (9th Cir. 1992) ("The 
preemption issues arising under FHSA are identical to those arising under ."). If the F S  
applies to SEC's Law Enforcement OC spray products, then Plaintiffs cause of action for failure to 
warn is preempted and must be dismissed. Id. 
To avoid the preemption problem, Plaintiff argues -  r. l   -    
does not apply to the OC spray products relevant to this litigation because they are "clearly intended 
for occupational use." ( rs ell ff., ~ 5.) Citing to the definitions contained within 15 U.S.C. § 
1261(p) and 16 C.F.R. § 1500.3(c)(10)(i),4 Plaintiff contends that the FHSA applies only to 
"household goods," and that SEC's Law Enforcement branded OC spray is therefore not 
encompassed within the purview of the FHSA. (Plaintiffs Opp., p. 18.) 
Plaintiffs interpretation of the scope of the FHSA is overly restrictive and inconsistent with 
all applicable law. She does not cite to any case law in support of her interpretation of the FHSA, 
but instead relies exclusively on Dr. Purswell's conclusions on the intended purpose of the relevant 
4 The relevant regulation was erroneously cited by Plaintiff as 16 C.F.R. § 1261(c)(10)(i), hi  
d es not exist. 
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OC product line The manufacturer or the distributor intended use however is not the correct
standard for determining whether a product is subject to the federal labeling statutes Canty v
EverLast Supply Co 296 NJ Super 68 77 685 A2d 1365 1370 NJ Super Ct Law Div
1996 Rather as is clear in the regulations the appropriate test is whether under any customary
or reasonably foreseeable condition of purchase storage or use may be brought into or around a
house apartment or other place where people dwell 16CFR 15003ciemphasis
added Courts interpreting the scope of the FHSA have uniformly accepted the somewhat more
expansive definition provided by 16 CFR 15003c
Thus the sewer solvent would not appear to be intended or
packaged in a form suitable for use in the household or by children
under 15USC 1261pBut it would be a substance which under
any customary or reasonably foreseeable condition of purchase
storage or use may be brought into or around a house apartment or
other place where people dwell under 16 CFR 15003cas
demonstrated by its use it this case
The Court finds that the supplementation of the definition of the term
misbranded substance by 16 CFR 15003cis a reasonable
variation authorized by 15 USC 1262bThus the Court holds
that Red Hot Sewer Solvent is subject to regulation under 15USC
1261p As a result Plaintiff s common law claims against ABC
Compounding are preempted and ABC CompoundingsMotion for
Summary Judgment is granted
Santiago v Virgin Islands Housing Authority 2007 WL 4698596 VI Super 2007 See also Cole
v Sunnyside Corp 234 Wis2d 149 2000 industrial lacquer thinner subject to FHSA because it
was reasonably foreseeable that this product could reach an ordinary consumer Wagoner v
Exxon Mobil Corp 2011 WL 2182042EDLa 2011 The key question it bears repeating is
whether under any reasonably foreseeable condition of purchase storage or use the article may be
found in or around a dwelling or related structure emphasis in original
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DC product line. "The anufacturer or the distributor's intended use, however, is not the correct 
st rd for t r i i  het er  r ct is s ject to t e fe r l la ling st tutes." ty v. 
Ever-Last Supply Co., 296 N.J. Super. 68, 77, 685 A.2d 1365, 1370 (N.J. Super. Ct. Law Div. 
1996). ather, as is clear in the regulations, the appropriate test is hether "under any custo ary 
or reasonably foreseeable condition of purchase, storage, or use ay be brought into or around a 
house, apart ent, or other place here people d ell."  .F.R. § 500.3(c)(1 )(i) (emphasis 
added). ourts interpreting the scope f the  have unifor ly accepted the "so e hat ore 
expansive definition ... provided by 16  § 500.3(c)(10)": 
hus, the se er solvent ould not appear to be, "intended, or 
packaged in a form suitable, for use in the household or by children," 
  .S.C. § 261(p). t it l    t  i , "under 
any custo ary or reasonably foreseeable condition of purchase, 
storage, or use ay be brought into or around a house, apart ent, or 
t r lace r  l  ell," r   § 500.3( c)(1 0), s 
de onstrated by its use it this case. 
he ourt finds that the supple entation of the definition of the ter  
"misbrande  s stance"    § 500.3(c)(10) is  "reasona le 
ariation" a t rize    .S.C. § 262(b). ,    
t at e  t e er l e t is s ject t  re lati  er 15 .S.C. § 
1261 (p). s a result, lai tiffs c  la  clai s a ai st  
Compounding arc preempted, and ABC Compounding's otion for 
Su ary Judg ent is granted. 
Santiago v. irgin Islands ousing uthority, 2007  4698596 ( .I. uper. 2007). See also ole 
v. Sunnyside Corp., 234 is.2d 149 (2000) (industrial lacquer thinner subject to FHSA because "it 
as reasonably foreseeable that this product could reach an ordinary consu er."); er v. 
xxon obil orp., 2011  2182042 (E.D.La. 2011) ("The key question, it bears repeating, is 
' hether under any reasonably foreseeable condition of purchase, storage, or use the article ay be 
found in or around a d elling' or related structure." (e phasis in original)). 
L   I    EFENDANT'S I   U  
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For purposes of summary judgment here no reasonable juror can determine that Law
Enforcement OC spray will not under any foreseeable condition of use be brought into or around a
place where people dwell During Plaintiffs deposition now fully introduced into the record by
Plaintiffscounsel she testified to her own experience with a law enforcement officer bringing OC
spray into her own house
Q Have you had any known exposure to OC since March of 08
A Yes
Q Can you tell me about that
A A police officer came to our house because a drunk was there It
was one of Garys girlfriends my roommate I had to do a
statement She was arrested for DUI A statement saying that I
seen sic her leave and how she was acting when she was there
And I asked the I was coughing And I asked the officer if he
had OC on him He said yes And I said thatsthe problem
And I gave him my report and went out of the room I was
coughing pretty bad And he was an Ada County Sheriff I gave
him my report And he actually showed the can to my roommate
I had already left the room And thats when I found out that I
couldnteven be in a room with it
Af of Counsel 8 and Ex 6 163422
It simply cannot be reasonably disputed that law enforcement personnel routinely carry OC
spray canisters on patrol into and around dwellings Even if Plaintiffsuse of the manufacturers
intent standard was correct which the regulations and case law quoted above reject the Rule
30b6deposition of SEC in this case has already revealed that the product is intended specifically
for law enforcement personnel to used in their best judgment and if the need arises in homes
Q Some in fact like the Cell Buster are designed specifically for use
in a correctional facility such as a prison
A Yes
Q Okay That product you market specifically to prisons and jails
A Yeah or tactical teams
Q Yeah I guess
A Like an extraction in a home or office building or something
REPLY MEMORANDUM IN SUPPORT OF DEFENDANTSMOTION FOR SUMMARY
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r rposes   judg e t ,  le juror  t i  t t  
force e t  s r  ill t r  f res l  ition f s   r t i t  r r   
place here people d ell. uring Plaintiff s deposition, no  fully introduced into the record by 
l intif  s l,  t ie  t         ic    
spray into her o n house: 
. ave you had any kno n exposure to  since arch of'08? 
. . 
. an you tell e about that? 
.  lic  ffic r  t  r e,   r  a  t r . It 
as one of ary's girlfriends, y roo ate.      
state e t. e as arreste  f r I.  state e t sa i  t at I 
seen [sic] her leave, and ho  she as acting hen she as there. 
nd    -- I as coughing. nd I asked the officer if he 
   . e said, yes.  I s i , t at's t  r l . 
n  I a e i   re rt, a  e t t f t e r . I as 
coughing pretty bad. nd he as an da ounty heriff. I gave 
i   rt.   t ll   t   t   te. 
I had already left the roo . nd that's hen I found out that I 
ldn't      t  . 
(Aff. of Counsel, ~  a  . ,163:4-2 .) 
It si ply cannot be reasonably disputed that la  enforce ent personnel routinely carry  
spray canisters on patrol into and around "dwellings." Even if Plaintiffs use of the "manufacturer's 
intent" standard as correct, hich the regulations and case la  quoted above reject, the ule 
30(b)( 6) deposition of S  in this case has already revealed that the product is intended specifically 
for la  enforce ent personnel to used, in their best judg ent and if the need arises, in ho es: 
. o e, in fact, like the ell uster are designed specifically for use 
i   rr ti l f cilit     ri on? 
. . 
Q. Okay. That product you arket specifically to prisons and jails? 
. ,  t ti l t s. 
. eah, I guess --
. Like an extraction in a ho e or office building or so ething. 
L      FENDANT'S    
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Aff of Counsel 10 and Ex 8 501 19 emphasis added
In light of the evidence on record in this case SECs Law Enforcement branded OC spray
products fall within the purview of the FHSA and the FHSA provides the exclusive labeling
requirements for those products Any attempt by Plaintiff to impose any different standard on SEC
is preempted by the FHSA Plaintiff has not advanced any argument or evidence to suggest that
SEC has failed to comply with the labeling requirements of the FHSA and no genuine issue of
material fact precludes the entry of summary judgment on PlaintiffsSecond Cause of Action
CONCLUSION
Even if Plaintiff has suffered the longterm chronic injuries she alleges as a result of
exposure to SECsOC products she is nevertheless unable to demonstrate that SEC should have
known or foreseen those injuries prior to March 2008 Accordingly Plaintiff cannot establish any
duty or liability under theories of inadequate warning or strict liability Further Plaintiff cannot
impose any liability for inadequate warnings that is inconsistent with the standards promulgated
under the FHSA as all interpreting case law demonstrates that the OC products fall within the
purview of the FHSA Finally because Plaintiff previously represented that she would not be
pursuing the breach of warranty allegations she should be estopped from now resurrecting any of
those claims Summary judgment is therefore appropriate on the entirety of PlaintiffsComplaint
and SEC respectfully requests entry of the same
DATED this 24 day ofJune 2011 GREENER BURKE SHOEMAKER PA
Christopher C Burke
Thomas J Lloyd III
Attorneys for Defendant
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(Aff. of ounsel, ~   . , 0: 10-19 (emphasis ded).) 
I  light f the e idence  rec r  i  t is case, C's a  f rce e t ra e   s ra  
products fall ithin the purvie  of the F S , and the F S  provides the exclusive labeling 
require ents for those products. ny atte pt by Plaintiff to i pose any different standard on SEC 
is pree pted by the FHSA. Plaintiff has not advanced any argu ent or evidence to suggest that 
  le  t   t  e  ire ents  e ,   e s   
t i l t l  t e t    j e t  l intif s    ti . 
 
e  if l i ti    t  l -ter  i  I June   ll    lt  
s re t  C's  r ts, s  is rt less l  t  strate t t  s l   
kno n or foreseen those injuries prior to arch, 2008. ccordingly, laintiff cannot establish any 
t   li ilit   t ies  i t  i   t i t li ility. t r, l i ti  t 
i pose any liability for inadequate arnings that is inconsistent ith the standards pro ulgated 
er t e , as all i ter reti  case la  e strates t at t e  r cts fall it i  t e 
r ie  f t e A. i all , eca se lai tiff re i sl  re rese te  t at s e l  t e 
pursuing the breach of arranty allegations, she should be estopped fro  no  resurrecting any of 
t s  l i s. r  j e t is t r f r  r ri t   t  tir t  f laintiffs plaint, 
and SEC respectfully requests entry of the same. 
 this 24th day of June, 2011.     .A. 
-rC 'TZfd-= 
hristopher . urke 
Tho as 1. Lloyd III 
tt r e s f r efe a t 
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CHRISTOPHER D RICH Clark
By JAMIE RANDALL
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
CaseNo CVPI 1003515




Defendant Security Equipment Corporation SEC or Defendant by and through its
counsel of record Greener Burke Shoemaker PA pursuant to IRCP 56 submits this
memorandum in opposition to Plaintiff Billie Jo Majors Plaintiff recentlyfiled Cross
Motion for Partial Summary Judgment In addition to this Memorandum SEC relies on the
Affidavits of Christopher Burke Nicholas Roberts and the Second Affidavit of Robert Nance in
Support of Defendants Opposition to Plaintiffs Cross Motion for Summary Judgment and
SECspleadings filed in support of its Motion for Summary Judgment
INTRODUCTION
Following the submission of SECs pending motion for summary judgment this Court
entered an amended Order Governing Proceedings and Setting Trial to establish a briefing and
hearing schedule on that motion sufficiently ahead of the new trial date in this matter The
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Defendant Security Equip ent Corporation ("SEC" or "Defendant"),     
l  r r , re r r  r .A., r t t  I.R.C.P. , it  t i  
e orandu  in opposition to Plaintiff Billie Jo ajor's ("Plaintiff') rece tl -filed r ss-
otion for Partial Summary Judgment.  i    r ndum,     
ffidavits of hristopher urke, icholas oberts, and the Second ffidavit of obert ance, in 
Support of Defendant's Opposition to Plaintiffs Cross- otion for Su ary Judg ent, and 
SEC's pleadings filed in support of its otion for Su ary Judg ent. 
 
Follo ing the sub ission of SEC's pending otion for su ary judg ent, this ourt 
entered an a ended Order Governing Proceedings and Setting Trial, to establish a briefing and 
hearing schedule on that motion sufficiently ahead of the new trial date in this matter.  
 I  PPOSITI  T  LAINTIF 'S - I  F  PARTIA  SUM A Y 
JUDGMENT - Page 1 14542-011 (398511.doc) 
f
deadline for filing motions for summary judgment under the Courts original Order Governing
Proceedings had by that time passed and the Courts new Order did not establish a new deadline
for filing dispositive motions Nonetheless along with her Opposition to SECsmotion Plaintiff
filed the instant Cross Motion for Partial Summary Judgment asserting that Plaintiff is entitled
to judgment as a matter of law on her cause of action alleging that SEC did not properly warn
against certain risks and dangers associated with its products Plaintiff bases her motion on the
standards set forth under the Occupational Safety and Health Act OSHA 29USC 653
For the reasons set forth herein Plaintiff has failed to meet her applicable burden on summary
judgment due largely to the fact that Plaintiffs cause of action is preempted by the Federal
Hazardous Substances Act FHSA and regulations thereunder Summary judgment is
therefore appropriate in favor of SEC
Further even if the FHSA did not preempt Plaintiffs cause of action for inadequate
warnings the rule of law proposed by Plaintiff OSHA nevertheless requires proof that a
manufacturer knew or should have known that its article or product presented the risks
specifically associated with the alleged injuries before any liability will attach Because Plaintiff
has failed to demonstrate that Defendant knew or should have known that its product would
cause the longterm andor chronic injuries alleged by Plaintiff Plaintiff has not met her
applicable burden under Rule 56 of the Idaho Rules of Civil Procedure
Finally even if Plaintiffscause of action is not preempted by the FHSA her apparent
attempt to obtain summary judgment on a theory of negligence per se fails on the merits
Plaintiff is and will be unable to prove all of the elements of a cause of action for negligence per
se and on those additional grounds summary judgment is appropriate in favor of SEC
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deadline for filing motions for su mary judgment under the Court's original Order Governing 
Proceedings had by that time passed, and the Court's new Order did not establish a new deadline 
for filing dispositive motions. Nonetheless, along with her Opposition to SEC's motion, Plaintiff 
filed the instant ross- otion for rtial ar  J t, ss rti  that l i tiff is title  
to judgment as a matter of law on her cause of action alleging that SEC did not properly warn 
against certain risks and dangers associated with its products. Plaintiff bases her motion on the 
standards set forth under the ccupational Safety and ealth ct ("OS "),  .S.C. § 653. 
 the reas ns s t t  h ,   faile  t  eet  icable urden   
judgment due largely to the fact that Plaintiffs cause of action is preempted by the Federal 
azardous ubstances ct ("FHS ") and regulations thereunder.  judg e t i  
therefore appropriate in favor of SEC. 
Further, even if the F S  did not pree pt Plaintiffs cause of action for inadequate 
arnings, the rule of la  proposed by Plaintiff (OS A) nevertheless requires proof that a 
t    l    t t it  ti l   t t  t  i  
specifically associated with the alleged injuries before any liability will attach. Because Plaintiff 
   te           l  
cause the long-term and/or chronic injuries alleged by Plaintiff, Plaintiff has not met her 
applicable burden under Rule 56 of the Idaho Rules of Civil Procedure. 
Finally, even if Plaintiffs cause of action is not pree pted by the FHSA, her apparent 
attempt to obtain summary judgment on a theory of negligence per se fails on the merits. 
Plaintiff is and ill be unable to prove all of the ele ents of a cause of action for negligence per 
se and, on those additional grounds, su ary judg ent is appropriate in favor of SEC. 
 I  OPPOSITI   PLAINTIF 'S - I   PARTIAL SUMMARY 
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For all of these reasons as well as those set forth in SECspending motions for summary
judgment and to strike the Affidavit testimony of Dr Gerald Yost SEC respectfully asks this
Court to enter an Order denying PlaintiffsSummary Judgment motion and granting summary
judgment to SEC on all issues and causes of action in this litigation
STATEMENT OF FACTS
A Plaintiffs Employment at IDOC
1 Plaintiff Billie Jo Major Major was employed as a correctional officer with
the Idaho Department of Corrections IDOC from July 2004 through May 2008 Affidavit of
Christopher Burke in Opposition to Plaintiffs Motion for Summary Judgment Burke Aff
2 Ex AMajor Dep 35216
2 During her employment for the IDOC Major worked at two different correctional
facilities the Idaho Maximum Security Institution IMSI and the South Boise Womens
Correctional Facility SBWCF Burke Af 2 Ex A Major Dep 351725 Major
worked at IMSI from July 2004 to July 2006 and there again from August or September 2007 to
May 2008 Id at 35173612 46612 Major worked at SBWCF from roughly July 2006
through August or September 2007 the time frame between her different positions at IMSI Id
351725 4120427
3 While employed at IDOC Major was required to attend different training courses
which were taught by other IDOC personnel Burke Af 2 3 and 5 Ex A Major Dep
92109317 Ex B Kimmel Dep 905 9213 and Ex D Dep Ex 8 Bates Nos
D00000005658 The training courses included among other training courses annual training
regarding the use of OC Spray Id
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 ll  t  ,  ll  t s  t t  i  C's i  tions   
judg ent and to strike the ffidavit testi ony of r. erald ost, SE  respectfully asks this 
rt t  e ter a  r er e i  laintiff s ar  J e t ti  a  ra ti  s ar  
judg ent to  on all issues and causes of action in this litigation. 
   
. Plaintifrs E ploy ent at I  
. Plaintiff illie Jo ajor ("Major")  l    rr ti l ffi r it  
the Idaho epart ent of orrections ("IDOC") fr  J l   t r   . (Affida it f 
hristopher urke in pposition to laintiffs otion for u ary Judg ent ("Burke ff.") ~ 
, . "A" (Major . 5:2-16).) 
. uring her e ploy ent for the I , ajor orked at t o different correctional 
f iliti s: t  I a  a i u  rit  I stit ti  ("IMSI")   t  s  en's 
Correctional Facility ("SB CF"). (Burke ff. ~ , . "A" (Major e . 5: 17-25).) aj r 
orked at I I fro  July 2004 to July 2006, and there again fro  ugust or epte ber 2007 to 
ay 2008. (Id. at 35:17-36:12; 46:6-12.) ajor orked at S F fro  roughly July 2006 
through ugust or Septe ber 2007, the ti e fra e bet een her different positions at I SI. (Id. 
5: 17-2 ; 1 :20- 2:7.) 
. hile e ployed at I C, ajor as required to attend different training courses 
hich ere taught by other I  personnel. (Burke ff. ~~ 2, 3 and 5, x. "A" ( ajor ep. 
92:10-93:17), Ex. "B" (Kim el ep. 90:5-92:13), and Ex. "D" (Dep. Ex. 8, ates os. 
OC0000056-58).) he training courses included, a ong other training courses, annual training 
regarding the use of OC Spray. (Id.) 
  I   LAINTIF 'S -   I   
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4 IDOC personnel recognize three different levels of OC spray exposure
specifically level 1 level 2 or level 3 Burke Aff 3 Ex B Kimmel Dep 98149911 A
Level 1 exposure occurs when an individual has direct contact with an OC product such as
when someone is sprayed directly in the face Id A Level 2 exposure occurs when an
individual handles a contaminated subject causing the individual to get OC exposure through
contact with the contaminated subject Id A Level 3 exposure occurs when an individual is
generally in an area that has been contaminated typically by walking through a contaminated
area Id
B Plaintiffs Use and Exposure to OC Products
5 IDOC did not actually issue any of SECs OC pepper spray products to its
employees or mandate their use in all IDOC facilities until some time in late spring or summer
of 2007 Burke Aff 1167 Ex F Overgaard Dep 5624 5721 Ex E Schaffer Dep
43214422 Prior to that time IDOC employees were issued and were using pepper spray
products from a competitor manufacturer Defense Technologies Id IMSI has records of
purchases of Defense Technologies pepper spray products in 2004 and 2005 Id at 3 Ex B
Kimmel Dep 71137210 Defense Technologies OC pepper spray products were issued to
and carried by correctional officers at IMSI from at least 2001 through 2005 Id 75237620
Burke Aff 9 ExH Dep Ex 10 Major received her onthejobtraining with Defense
Technologies OC pepper spray and was issued and used Defense Technologies OC pepper spray
during her first sixeight 68 weeks of work at IMSI in 2004 Id at 2 9 ExA Major
Dep 14211442ExHDep Ex 10
6 Major attended IDOC OC training sessions wherein she received minor acute
Level 2 and 3 exposures to OC spray on only five 5 occasions in almost five 5 years namely
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. I OC . ers el rec mze t ree iffere t le els f  s ra  e s re, 
specifically levell, level 2 or level 3. (Burke Aff. ~ , . "B" (Kimmel . 8:14- 9:11).)  
"Levell" exposure occurs hen an individual has direct contact ith an C product, such as 
when so eone is sprayed directly in the face. (Jd.)  "Leve  " s re rs   
in i idual les  ta inated j t, i  t e i i id l t  t   t r  
ta t it  t  t inated s j ct. (Jd.)  "Level " s re rs e   i i idu l is 
generally in an area that has been contaminated, typically by walking through a contaminated 
r . (Jd.) 
. laintiff's se and xposure to  roducts 
. I C did not actually issue any of SEC's C pepper spray products to its 
employees, or mandate their use, in all IDOC facilities, until some time in late spring or summer 
of 2007. (Burke ff. ~~ 6-7, x. "F" (Overgaard ep. 56:24-57:21); x. "E" (Schaffer ep. 
3:21- 4:22).) ri r t  t t ti , I  l e s r  iss   r  si  r s r  
r cts fr  a c etit r a fact rer, efe se ec l ies. (J .) I   f 
purchases of Defense Technologies pepper spray products in 2004 and 2005. (Jd. at ~ , x. "B" 
(Kim el ep. 71:13-72:10).) efense Technologies C pepper spray products ere issued to 
and carried by correctional officers at I I fro  at least 2001 through 2005. (Jd. (75:23- 6:20); 
 f . ~  x. "H" (De . x. 0).) j r r i  r n-the-job tr i i  it  f  
Technologies OC pepper spray and was issued and used Defense Technologies OC pepper spray 
during her first six-eight (6-8) weeks of work at I SI in 2004. (Jd. at ~~ 2, 9, x. "A" ( ajor 
Dep. 142:11-144:12); Ex. "H" (Dep. Ex. 10).) 
. ajor attended I   training sessions herein she received inor acute 
l    s r s t   s r   l  fi  (5) si s i  al st fi  (5) ars: l  
 I  POSITI   LAINTIF 'S -   I  SUM  
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082040214022170713 1807 and 038 Burke Aff T 28 and 10 Ex B
Kimmel Dep 1824195 11925 1218 Ex D Dep Ex 8 Ex J Dep Ex 33 Ex
C Dep Ex 24 Ex BSchaffer Dep 4317442563126612 672681270137223
Ex G Doan Dep 2142214 2392413 27162915 4022411 4517 508Ex F
Overgaard Dep 41174517 7858216 Ex A Major Dep 921010125 10751089
11091128 1129 1194 119525 1232 1340 These exposures generally lasted
only seconds a minute at most Id Major was only exposed to SEC pepper spray at three 3
of these five 5 trainings on021470713 1807 and 038 Id 3 4 and 68 Ex B
Kimmel Dep 119251218 1341385 Ex C Dep Ex 24 Ex E Schaffer Dep
43174425 63126612 6726812 70137223 Ex G Doan Dep 2142214 239
2413 27162915 4022411 4517 508Ex F Overgaard Dep 4117 4517 785
8216 On the other two 2 trainings Major was exposed to OC pepper spray products
manufactured by Defense Technologies Id
7 Major received her first exposure to OC during the August 20 2004 OC training
Burke Aff 2 Ex A Major Dep 931894497623 98251012 She entered a six
foot by eight foot 6x 8 room which had been previously sprayed by her trainer with a white
canister of MK9 fog Id at 98251012 She stayed in the room about 20 seconds until she
started to cough and then walked outside Id She stopped coughing after the training session
ended Id She does not know what brand of OC was sprayed in the room Id She did not
see the writing on the OC canister Id
8 Majors next OC training took place on February 14 2007 Her instructor was
Sgt Brett Kimmel Burke Aff T 2 and 3 Ex B Kimmel Dep 134 1385Ex A
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08/2 /04, 02114/04, 02/2 107, 07/13- 8/07, and 03/0 /08. (Burke . ~~ 2-8 and , . "B" 
(Kimmel Dep. 18:24-19:15; 119:25-121:18; Ex. "D" (Dep. Ex. 8); Ex. "J" (Dep. Ex. 33); Ex. 
"C" (Dep. Ex. 24); Ex. "E" (Schaffer Dep. 43:17-44:25; 63:12-66:12; 67:2-68:12; 70:13-72:23), 
Ex. "G" (Doan ep. 21:24-22:14; 23:9-24:13; 27:16-29:15; 40:22-41:11; 45:17-50:8), Ex. "F" 
(Overgaard ep. 41:17-45:17; 78:5-82:16), Ex. "A" (Major ep. 92:10-101:25; 107:15-108:9; 
10:19- 12:18; 12:19- 19:14; 19:15-25; 23:12- 34:10).) hese e s res e erall  laste  
only seconds, a inute at ost. (Id) ajor as only exposed to  pepper spray at three (3) 
f these five (5) tr i i ,  2/1 /07,07113- 8/07,  3/0 /08. (Id ~~ ,   -8, . "B" 
(Kimmel Dep. 119:25-121:18; 134:14-138:5), Ex. "C" (Dep. Ex. 24), Ex. "E" (Schaffer Dep. 
43:17-44:25; 63:12-66:12; 67:2-68:12; 70:13-72:23), Ex. "G" (Do an ep. 21:24-22:14; 23:9-
4:13; 7:16- 9:15; 0: 2- 1: 1; 5:17- 0:8), . "F" (Overga r  . 1:17- 5:17; 8:5-
82:16).) n the other t o (2) trainings ajor as exposed to  pepper spray products 
anufactured by efense Technologies. (Id) 
. j r r i  r first s r  t   ri  t  st ,   tr i ing. 
(Burke Aff. ~ 2, x. "A" (Major ep. 93:18-94:4; 97:6-23; 98:25-101:12).) he entered a six 
foot by eight foot (6'x 8') roo  hich had been previously sprayed by her trainer ith a hite 
canister of K-9 fog. (Id at 98:25-101:12.) She stayed in the roo  about 20 seconds until she 
started to cough and then walked outside. (Id) She stopped coughing after the training session 
ended. (Id) She does not kno  hat brand of  as sprayed in the room. (Id) She did not 
see the writing on the OC canister. (Id) 
. ajor's next C training took place on February 14, 2007. er instructor as 
Sgt. Brett Kimmel. (Burke Aff. ~~ 2 and 3, Ex. "B" (Kimmel Dep. 134:14-138:5), Ex. "A" 
 I  SI I   LAINTIF 'S - I   PARTI  SUM  
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Major Dep 10751089Major does not recall anything about this training or whether or not
she was exposed to OC Id Ex A Major Dep 10751089
9 Major received OC training from Sgt Dan Schaffer at SBWCF on February 21
2007 Burke Aff 2 and 6 Ex E Schaffer Dep 63126612 Ex A Major Dep
11091128 Major recalls the training It was classroom training She did not get exposed
to OC in that training Id ExA Major Dep 11091128
10 Major received OC training from Sgt Dan Schaffer on July 13 andor 18 2007 at
SBWCF Burke Aff 2 and 6 Ex A Major Dep 11291194 Ex E Schaffer Dep
6726812 70137223 Major received a 15second Level 2 exposure to OC during this
training where she was required to pick up and move an object sprayed with OC pepper spray
Id Ex AMajor Dep 11291194 Major started coughing when the OC was sprayed
on the object but the cough was temporary Id Following her own exposure she watched and
laughed as other correctional officer trainees came out of the building coughing after they
received their exposures to OC Id She does not know the brand name or color of the OC
spray canister that was used in the training Id
11 Major last had OC training at IMSI with Sgts Nick Doan and Joshua Overgaard
on March 3 2008 Burke Aff 2 7 and 8 Ex A Major Dep 119525 1232 1340
Ex G Doan Dep 2392413 27162915 4022 411 4517 508Ex F Overgaard
Dep 41174517 7858216 This was a Level 3 exposure where Major entered a room
which had previously been sprayed with an MK9 OC fog Id Major did not see the canister
ofMK9 OC fog used in this training and doesntknow its color shape size or brand Id Ex
AMajor Dep 13321340
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(Major Dep. 107: 5-108:9).) ajor does not recall anything about this training or whether or not 
she as exposed to ~C. (Id., Ex. "A" (Major ep. 107:5-108:9).) 
9. ajor received OC training fro  Sgt. Dan Schaffer at SB CF on February 21, 
2 . (Burke Aff. ~~ 2 and 6, x. "E" (Schaffer ep. 63:12-66:12), x. "A" (Major ep. 
110:19-112:18).) ajor recalls the training. It as classroo  training. She did not get exposed 
to  i  t at tr i i . (Id., . "A" (Major . 10:19- 12:18).) 
. ajor received OC training from Sgt. Dan Schaffer on July 13 and/or 18, 2007 at 
SB CF. (Burke Aff. ~~   , . "A" (Major . 12:19- 19:14), . "E" (Schaffer . 
67:2-68:12; 70:13-72:23).) ajor received a IS-second Level 2 exposure to OC during this 
training, here she as required to pick up and ove an object sprayed ith  pepper spray. 
(Id., Ex. "A" (Major ep. 112:19-119:14).) ajor started coughing hen the C as sprayed 
on the object, but the cough was temporary. (Id.) Following her own exposure, she watched and 
laughed as other correctional officer trainees ca e out of the building coughing after they 
received their exposures to ~C. (Id.) he does not kno  the brand na e or color of the  
spray canister that was used in the training. (Id.) 
. ajor last had OC training at I SI with Sgts. Nick Doan and Joshua Overgaard 
on arch 3,2008. (Burke ff. ~~ 2,7 and 8, x. "A" (Major ep. 119:15-25; 123:12-134:10), 
x. "G" (Doan ep. 23:9-24:13; 27:16-29:15; 40:22-41:11; 45:17-50:8), x. "F" ( vergaard 
Dep. 41:17-45:17; 78:5-82:16).) i    l  r  r  j r t r   r  
which had previously been sprayed with an MK-9 OC fog. (Id.) Major did not see the canister 
of K-9 OC fog used in this training and doesn't know its color, shape, size or brand. (Id., Ex. 
"A" (Major Dep. 133:12-134:10).) 
 I  SI I   LAINTIF 'S - I   PARTI  SUM  
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12 In June 2007 before providing Major with OC training Sgts Schaffer Doan and
Overgaard received OC instructor training from a representative of SEC and were certified by
SEC as OC instructors Burke Aff 6 7 and 8 Ex E Schaffer Dep 1542419Ex G
Doan Dep 155 1924 Ex F Overgaard Dep 20324 They were instructed by SEC
using the Sabre Instructor Certification Manual SEC Manual Id 6 7 and 11 Ex F
Overgaard Dep 248253ExE Schaffer Dep 751676 Ex JDep Ex 41 Page 7
of the SEC Manual Bates No SEC000338 provides in part
OC oleoresin capcasum red pepper OC produces rapid
physiological affects complete recovery and restricts immunity buildup
because it is an inflammatory agent
Physiological affects
Eyes tear and blink repeatedly
Eyes close
Respiration of OC causes inflammation of the respiratory tract
Inflammation causes coughing gagging and a loss of breath
sensation
Facial areas may also become inflamed and will burn
Swelling may occur around the eyes mouth and nose
The nose will run and produce excessive mucus
Affects may differ with each case Common symptoms include light
headedness uncontrollable shaking of the body weakening legs tightness
of the chest and hearing impairment The affects are all temporary
Ex J Dep Ex 41 SEC000338
13 In providing annual OC training to IDOC correctional officers including Major
the IDOC instructors including Sgts Kimmel Schaffer Overgaard and Doan used a
PowerPoint presentation that was prepared and provided to them by SEC Burke Aff 3 68
and 12 Ex B Kimmel Dep 13271342 16131633ExB Schaffer Dep 7421756
7727820 Ex G Doan Dep 5210 5422 Ex F Overgaard Dep 2542917 668
6723 Ex K Dep Ex 35 The SEC PowerPoint was shown to Major and other
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. I  J e , fore r i in  ajor ith  tr i i , ts. ff r, a   
vergaard received  instructor training fro  a representative of S , and ere certified by 
 s  instr t rs. (Burke ff. ~~ ,   , . "E" (Schaffer . 5:14- 4:19), . "G" 
(Doan ep. 15:5-19:24), x. "F" ( vergaard ep. 20:23-24:2).) hey ere instructed by  
using the Sabre Instructor ertification anual ("SE  anual"). (ld. ~~ ,   , . "F" 
( erga r  . 4:8- 5:3), . "E" (Schaffer . 5:16- 6:7); . "J" (De . . 1).)   
of the  anual (Bates o. 000338) provides in part: 
oc - l e i   - e   . . .  r ces r i  
si l ical ff ts, lete r r ,  r stri ts i it  il -u  
s  it is  i fla at  t. 
hysiological affects 
Eyes tear and blink repeatedly 
es cl se 
espiration f  causes infla ation f the respiratory tract 
Infla ation causes coughing, gagging and a loss of breath 
 
i l r s  ls   i fla   ill r  
S elling ay occur around the eyes, outh and nose 
he nose ill run and produce excessive ucus 
ffects ay differ ith each case. o on sy pto s include light 
ss, tr ll l  s i  f t  y, i  l s, ti tness 
f t e c est a  eari  i air e t. e affects are all te orary. 
(Ex. "1" (Dep. Ex. 41, SEC000338).) 
. In providing annual  training to I  correctional officers, including ajor, 
t e I  i str ctors, i cl i  ts. i el, chaffer, er aar  a  an, se  a 
PowerPoint presentation that was prepared and provided to them by SEC. (Burke Aff. ~~ , -  
a  , x. "B" (Kim el ep. 32:7-134:2; 61:13- 63:3), x. "E" (Sc affer ep. 4:21-75:6; 
77:2-78:20), Ex. "G" (Doan ep. 52:10-54:22), Ex. "F" ( vergaard ep. 25:4-29:17; 66:8-
7:23); x. "K" ( e . x. 5).)   r i    t  j   t r 
 I  POSITI   PLAINTIF 'S -   I  SUM Y 
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correctional officers during their annual OC trainings Id The PowerPoint ExK Dep Ex
35 provides in part
PHYSIOLOGICAL AFFECTS
Eyes tear up and close involuntarily
OC causes inflammation ofthe respiratory tract
Inflammation causes coughing gagging and a loss of breath
sensation
The skin exposed to OC may also become inflamed and will burn
Swelling may occur around the eyes nose and mouth
The nose will run and produce excessive mucus
ExK Dep Ex 35IDCRecords 000053
14 As part of their annual OC training IDOC correctional officers including Major
were administered written tests Burke Aff 3 7 and 1315 Ex B Kimmel Dep 197
211 2132217 Ex FOvergaard Dep 1141153 Dep Ex 28 Ex L Dep Ex 25
ExM Dep Ex 26 ExNDep Ex 28
15 Majorstest results for the 08204 OC training are reflected in Ex L Dep
Ex 25 Burke Aff 3 and 13 Ex B Kimmel Dep 197211 Ex L Dep Ex 25
Question 14 of that test and Majorscorrect answer state
14 What are the 3 distinct physical affects when contaminated with
OC
A Facial burning eye closure respiratory
Id
16 Majorstest results for the 02147 OC training are reflected in Ex M Dep
Ex 26 Burke Aff 3 and 14 Ex B Kimmel Dep197212132ExMDep
Ex 26 Question 12 of that test and Majorscorrect answer state
12 What are the physiological affects of OC
A Redness of the eyes running nose shortness of breath
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re io  ficers in     . (I .)  r oi t, (E . "K" (De . . 
5), r ides i  art: 
 S 
•  t r   l s  i lu t rily 
•  causes infla ation f the respiratory tract 
• I fla ti  s  i , i g   l   r t  
ti  
• e s i  e se  t   a  als  ec e i fla e  a  ill r  
• elli  a  cc r ar  t e e es, se a  t  
•  s  ill   e i  s 
(E . "K" (De . . , I.D.C. ec r s 0053).) 
. s rt f t ir l  tr i i , I  rr ti l ffi rs, i l i  j r, 
ere a i istere  ritte  tests. (Burke ff. ~~ ,  a  -1 , . "B" (Kim el e . 9:17-
21:1; 21:3-22:17), x. "F" (Overgaard ep. 114:1-115:3; ep. x. 28), x. "L" (Dep. x. 25), 
Ex. "M" (Dep. Ex. 26), Ex. "N" (Dep. Ex. 28).) 
. ajor's test res lts f r t e 8/2 104  trai i  are reflecte  i  x. "L" (De . 
Ex. 25). (Burke Aff. ~~ 3 and 13, x. "B" (Kimmel ep. 19:17-21:1; x "L" (Dep. x. 25).) 
uestion 14 of that test, and ajor's correct ans er, state: 
(Id.) 
. at are t e 3 isti ct sical affects e  c ta i ate  it  
C? 
. Facial burning, eye closure, respiratory 
. ajor's test results for the 02114/07  training are reflected in Ex. "M" (Dep. 
Ex. 26). (Burke ff. ~~ 3 and 14, Ex. "B" (Kimmel ep. 19:17-21:121:3-22:17), Ex. "M" (Dep. 
x. 26).) uestion 12 of that test, and ajor's correct ans er, state: 
. hat are the physiological affects of OC? 
. edness of the eyes, running nose, shortness of breath. 
  SI I   LAINTIF 'S -   I   
 - Page 8 145 -  (398511doc) 
Id
17 Majors test results for the 038 OC training are reflected in Ex N Dep
Ex 28 Burke Aff 3 7 and 15 Ex B Kimmel Dep 2112217 Ex FOvergaard
Dep 114 1153ExNDep Ex 28 Question 9 of that test and Majorscorrect answer
state
9 The physiological affects of being sprayed with OC spray are
A Running nose with mucus discharge
B Eyes tear and involuntarily close
C Respiration of OC causes of inflammation of the respiratory tract
D All of the above
The bold ofD indicates Major correct answer Id
18 During the time Major was employed by IDOC IDOC kept and maintained as
part of its business records Material Safety Data Sheets MSDS for the SEC Sabre Red and
Defense Technologies First Defense OC pepper spray products purchased and used by IDOC in
order to identify hazards for health reactivity and fire Burke Aff 3 and 16 Ex B
Kimmel Dep 10151048 ExO Dep Ex 32 A true and accurate copy of the SEC
Sabre Red MSDS is contained within Ex O Dep Ex 32 Bates IDCRecords 0004647
That MSDS provides in part
SECTION 6 HEALTH HAZARDS
Signs and symptoms of exposure Ingredients cause irritation through all routes
of entry Repeated contact may cause dermatitis Ingestion may cause nausea
vomiting andordiarrhea
Medical conditions aggravated by exposure May cause more severe temporary
effects on those persons who are asthmatics or suffer from emphysema
Emergency and first aid procedures Remove victim from contaminated area and
remove contaminated clothing Provide fresh air irrigate with copious amounts
of cool water Obtain medical advice is sic symptoms persist
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(ld.) 
7. ajor's test results for the 03/03/08 OC training are reflected in Ex. "N" (Dep. 
x. 28). (Burke ff. ~~ ,   , x. "B" (Kimmel . 1:1- 2:17), x. "F" (Overga  
. 4:1- 15:3), x. "N" (De . x. 8).) sti   f t t t st,  jor's rr t s r, 
t : 
.  i l i l ffe ts f i  r  it   r  re: 
. i  s  it  s is r  
. es t r  i l t ril  l s  
. espiration f  causes f infla ation f the respiratory tract 
.     
[Th  l  f  i icates jor's rr t swer.] (l .) 
. uring the ti e ajor as e ployed by I , I  kept and aintained as 
part of its business records aterial Safety ata Sheets ("MSDS")       
fe  l ies ir t f   r r  r ts r     I  i  
r er t  i e tif  azar s f r ealth, reacti it  a  fire. (Bur e ff. ~~   , x. "B" 
(Kimmel ep. 101:15-104:18); x. "0" (Dep. x. 32).)  true and accurate copy of the S  
r    is t i  it i  . "0" (De . x. , t s I.D.C. r s -47). 
hat  provides in part: 
  -  S 
i s a  s t s f e s re: I re ie ts ca se irritati  t r  all r tes 
 tr . epeated contact ay cause der atitis. Ingestion ay cause nausea, 
vo iting and/or diarrhea. 
edical conditions aggravated by exposure: ay cause ore severe, te porary 
e ts  t     t ti     a. 
E ergency and first aid procedures: Re ove victi  fro  conta inated area and 
re e c ta inate  cl t i g. r i e fres  air, irrigate it  c i s a ts 
of cool ater. btain edical advice is (sic) sy pto s persist. 
 I  I I   LAINTIF 'S - I   I   
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I Inhalation Provide fresh air
Id
19 The affects of OC pepper spray exposure to individuals are acute transient
reversible and recoverable within a short period of time typically wearing off within minutes
Burke Aff 3 and 68 Ex B Kimmel Dep 36133725 Ex E Schaffer Dep 35
376 Ex I Overgaard Dep 5113564 Ex G Doan Dep 2517266 Affidavit of
Christopher A Reilly PhD in Support of DefendantsMotion for Summary Judgment filed
April 22 2011 Reilly Aff 7 Affidavit of Robert Nance in Support of DefendantsMotion
for Summary Judgment filed April 22 2011 Nance Aff 2 The affects include mucous
production redness of the eyes watery eyes or crying involuntary closing of the eyes burning
sensation of the skin such as a sunburn inflammation of the skin sneezing and coughing and
slightly restricted airways Id Complete recovery from respiratory symptoms occurs within
no longer than thirtysixty 3060 minutes Id Major was aware of the acute affects of OC
exposure having experienced them at least four 4 times in annual OC trainings between 2004
and 2007 prior to her 038 OC training Burke Aff 2 Ex A Major Dep 9210
10125 11291194
20 SECslaw enforcement branded OC products are intended for use by and are
used by police departments the military SWAT teams and security companies in addition to
correctional institutions Second Affidavit of Robert Nance in Support of Defendants
Opposition to PlaintiffsCross Motion for summary Judgment 2 Nance Aff IT 2 5
Those products are also carried stored andor used by law enforcement officers in various
locations including private homes apartment buildings airports parks and other public
locations in addition to correctional facilities 2 Nance Aff 35 Affidavit of Nicholas J
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1. In : de res   
(Jd.) 
. he ffects f  er s r  s re t  i i iduals r  te, tr si nt, 
re rsi le  r era le it i   s rt ri  f ti , t i ll  ri  ff it i  i t s. 
(Burke ff. ~~ 3 and 6-8, x. "B" (Kimmel ep. 36:13-37:25), x. "E" (Schaffer ep. 35:3-
7:6), . "F" (Overgaard . 1: 3- 6:4), . "0" (Doa  O . 5:17- 6: ); fida it  
risto er . ill , h.D. i  rt f f ndant's tio  f r r  J t file  
pril 22, 2011 ("Reilly ff.") ~ 7; ffidavit f obert ance in upport f efendant's otion 
for Su ary Judg ent filed pril 22, 2011 ("Nance ff.") ~ .)  ffe ts i l  s 
r cti , re ness f t e e es, ater  e es r cr i , i l tar  cl si  f t e e es, r i  
ti   t  i  (suc    burn), i la tio   t  i , i   i ,  
slightly restricted air ays. (Id.) Co plete recovery fro  respiratory sy pto s occurs ithin 
no longer than thirty-sixty (30-60) inutes. (Jd.) ajor as a are f the acute affects f  
exposure, having experienced the  at least four (4) ti es in annual  trainings bet een 2004 
and 2007, prior to her 03/03/08 C training. (Burke ff. ~ , . "A" (Major . 2:10-
101 :25; 112:19-119:14).) 
. SEC's la  enforce ent branded C products are intended for use by, and are 
used by, police depart ents, the ilitary, S  tea s and security co panies, in addition to 
 . (Second ffidavit of Robert ance in Support of efendant's 
Opposition to Plaintiffs Cross- otion for summary Judgment ("2nd  ff.") ~~ , .) 
hose products are also carried, stored and/or used by la  enforce ent officers in various 
locations, including private ho es, apart ent buildings, airports, parks and other public 
l ti s, i  iti  t  rr ti l f ciliti s. (2nd  f . ~~ -5; ffid it f i l  J. 
  SITI   L I TIFF'S -   I  U  
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Roberts in Support of Opposition to PlaintiffsCross Motion for Summary Judgment Roberts
Aff T 3 5 It is reasonably foreseeable and likely that SECslaw enforcement branded OC
products including streams fogs foams and aerosol grenades will be brought into carried
stored andor used within homes apartments dormitories and other places where people dwell
2Nance Aff 6 Roberts Aff 6
LEGAL STANDARD
Summary judgment is only appropriate if the pleadings depositions and admissions on
file together with the affidavits if any show there is no genuine issues as to any material fact
and that the moving party is entitled to judgment as a matter of law IRCP56c On a
motion for summary judgment the burden is always upon the moving party to prove the absence
of a genuine issue of material fact Yoakum v Hartford Fire Ins Co 129 Idaho 171 923 P2d
416 1996 citing Petricevich v Salmon River Canal Co 92 Idaho 865 869 452 P2d 362 365
1969 Summary judgment should be granted only if there is no genuine issue of material
fact after the pleadings depositions admissions and affidavits have been construed in a light
most favorable to the opposing party Palmer v Idaho Bank Trust 100 Idaho 642 643 603
P2d 597 600 1979
Similarly the Court is to view all available inferences from the record in the light most
favorable to the non moving party Treasure Valley Bank v Butcher 117 Idaho 974 793 P2d
206 1990 see also Anderson v Liberty Lobby Inc 477 US242 255 1986 The evidence
of the non movant is to be believed and all justifiable inferences are to be drawn in his favor
TW Electric Serv v Pacific Elec ContractorsAssn 809 F2d 626 630631 9th Cir 1987
At the summary judgment stage the non movants version of any disputed issue of fact is
presumed correct If reasonable people could reach different conclusions or draw conflicting
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Roberts in Support of pposition to Plaintiffs ross- otion for Su ary Judg ent ("Roberts 
A .") ~~ 3, 5.) It is reasonably foreseeable and likely that SEC's la  enforce ent branded D  
products, including strea s, fogs, foa s and aerosol grenades, will be brought into, carried, 
stored and/or used ithin ho es, apart ents, dor itories, and other places here people d ell. 
(2nd ance ff. ~ ; oberts ff. ~ .) 
  
Su ary judg ent is only appropriate "if the pleadings, depositions and ad issions on 
file, t gether ith t e affida its, if a , s  t ere is  e i e iss es as t  a  aterial fact 
 t t t  in  rt  i  title  t  judg ent   tt r f l w." I.R.C.P. 6(c). "On  
otion for su ary judg ent, the burden is al ays upon the oving party to prove the absence 
ofa genuine issue of material fact." Yoakum v. Hartford Fire Ins. Co., 129 Idaho 171,923 P.2d 
416 (1996) (citing Petricevich v. Sal on River Canal Co., 92 Idaho 865, 869,452 P.2d 362,365 
(1969)). "[ ]u mary judg ent should be granted only if there is no genuine issue f aterial 
fact after the pleadings, depositions, ad issions and affidavits have been construed in a light 
ost favorable to the opposing party." Pal er v. Idaho Bank & st,   2, ,  
P.2d 597, 600 (1979). 
Si ilarly, the ourt is to vie  all available inferences fro  the record in the light ost 
favorable to the non- oving party. Treasure Valley Bank v. Butcher, 117 Idaho 974, 793 P.2d 
206 (1990); see also Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986) ("The evidence 
ofthe non- ovant is to be believed, and all justifiable inferences are to be dra n in his favor."); 
T  Electric Servo V. Pacific Elec. Contractor's Assn., 809 F .2d 626, 630-631 (9th Cir. 1987) 
("At the su ary judg ent stage, the non- ovant's version of any disputed issue of fact is 
presumed correct."). "If l  l  l   if t l i  r r  nfli ti  
A  I  POSITI   LAINTIF 'S - I  F  PARTIAL U  
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inferences from the evidence the motion for summary judgment must be denied Friel v
Boise City Housing Authority 126 Idaho 484 485 887P2d 29 30 1994 If any genuine issue
of material fact is left unresolved summary judgment is not appropriate McKinley v Fanning
100 Idaho 189 595 P2d 1084 1979
Furthersummary judgment may be rendered for any party not just the moving
party on any or all the causes of action involved under the rule of civil procedure thus allowing
trial courts flexibility in determining the form of relief granted in summary judgment orders
Harwood v Talbert 136 Idaho 672 677 39P3d 612 617 2001 quoting Brummett v Ediger
106 Idaho 724 726 682 P2d 1271 1273 1984
The district court may grant summary judgment to a non moving
party even if the party has not filed its own motion with the court
A motion for summary judgment allows the court to rule on the
issues placed before it as a matter of law the moving party runs
the risk that the court will find against it as in this case
Id Pertinent heresummary judgment dismissal of a claim is appropriate where the plaintiff
fails to submit evidence to establish an essential element of the claim Nelson By Through
Nelson v City ofRupert 128 Idaho 199 202 911 P2d 1111 1114 1996
Because the FHSA preempts Plaintiff cause of action for failure to warn and because in
all events Plaintiffwill be unable to prove each of the elements required to prevail on a claim for
negligence per se SEC is entitled to summary judgment as the non moving party on the issues
raised in PlaintiffsCross Motion for Summary Judgment
ARGUMENT
A Plaintiffs Claim Is Preempted By The Federal Hazardous Substances Act
Both Plaintiff and her designated expert Dr JP Purswell now appear to rely exclusively
on the code and regulations of OSHA to support her second cause of action arguing that SEC
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inferences from the e ide , the tion [for s ary jud t] ust be ied." riel v. 
Boise City Housing Authority, 126 Idaho 484, 485, 887 P.2d 29, 30 (1994). If any genuine issue 
of aterial fact is left unresolved, su ary judgment is not appropriate. c inley v. Fanning, 
100 Idaho 189, 595 P.2d 1084 (1979). 
urther, "'[s]ummary judg ent ay be rendered for any party, not just the oving 
party, on any or all the causes of action involved, under the rule of civil procedure' thus allowing 
trial c rts fle i ilit  i  eter i ing t e for  f relief ra te  in s ar  judg ent r ers." 
arwood v. Talbert, 136 Idaho 672, 677, 39 P.3d 612, 617 (2001) (quoting ru ett v. diger, 
106 Idaho 724, 726, 682 P.2d 1271,1273 (1984». 
he district court ay grant su ary judg ent to a non- oving 
party even if the party has not filed its o n otion ith the court. 
 tion f r r  j e t ll  t  rt t  r l   t  
issues placed before it as a atter of la ; the oving party runs 
t e ris  t at t e c rt ill fi  a ai st it, as i  t is case. 
! . ertinent here, "[s]u mary judg ent dis issal f a clai  is appropriate here the plaintiff 
f il  t  it ide ce t  t li   ti l l t f t  laim." l   &  
Nelson v. City of Rupert, 128 Idaho 199, 202, 911 P .2d 1111, 1114 (1996). 
ecause the F S  pree pts Plaintiff s cause of action for failure to arn, and because in 
all events Plaintiff ill be unable to prove each of the ele ents required to prevail on a clai  for 
negligence per se, SEC is entitled to su ary judg ent as the non- oving party on the issues 
raised in Plaintiffs ross- otion for Su ary Judg ent. 
 
. laintiff's lai  Is ree pted y he ederal azardous ubstances ct. 
Both Plaintiff and her designated expert, Dr. J.P. Purswell, now appear to rely exclusively 
on the code and regulations of S  to support her second cause of action, arguing that S  
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failed to meet the OSHA labeling standards and is therefore liable to Plaintiff for her injuries
See generally PlaintiffsMemorandum The regulation relied upon however expressly
excepts certain articles from its jurisdictional scope
5 This section does not require labeling of the following
chemicals
v Any consumer product or hazardous substance as those terms
are defined in the Consumer Product Safety Act 15USC2051 et
seq and Federal Hazardous Substances Act 15USC 1261 et
seq respectively when subject to a consumer product safety
standard or labeling requirement of those Acts or regulations
issued under those Acts by the Consumer Product Safety
Commission
29 CFR 1910205 emphasis added Similarly the FHSA contains an express
preemption clause
If a hazardous substance or its packaging is subject to a
cautionary labeling requirement under section 2p or 3b 15
USC 1261por 1262bdesigned to protect against a risk of
illness or injury associated with the substance no State may
establish or continue in effect a cautionary labeling requirement
applicable to such substance or packaging and designed to protect
against the same risk of illness or injury unless such cautionary
labeling requirement is identical to the labeling requirement under
2p or3b
15USC 1261 noteb1Aas quoted in Chem Specialties Mfrs AssnInc v Allenby 958
F2d 941 945 9th Cir 1992 Thuswhere a plaintiffsclaim seeks to hold a manufacturer
responsible for failing to provide warning labels which are not identical to those required under
the FHSA that claim is preempted Canty v EverLast Supply Co 296NJSuper 68 84 685
A2d 1365 1374NJSuper Ct Law Div 1996
Accordingly the relevant questions for this inquiry as addressed below are 1 Whether
Plaintiffscause of action is a state law cause of action intended to be preempted by the FHSA
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failed to meet the OS  labeling standards and is therefore liable to Plai tiff for her injuries. 
(See generally Plaintiffs emorandum.) The regulation relied , ho e r, res l  
excepts certain articles from its jurisdictional scope: 
(5) This section does not require labeling of the following 
c : 
[ ... ] 
(v) Any consumer product or hazardous substance as those terms 
re ined in the ons er t t  ct (15 .S.C.  t 
seq.) and Federal azardous Substances ct (15 .S.C. 1261 et 
seq.) respectively, when subject to a consumer product safety 
sta ar  r la eling re ire e t f t ose cts, r re lati s 
ss  der those cts  e s    
i . 
 .F.R. § 1910.1200(5) (emphasis added). i rl , t e    e  
preemption clause: 
[1]f a hazardous substance or its packaging is subject to a 
cautionary labeling requirement under section 2(p) or 3(b) [15 
.S.c. §§ 261(P) r 262(b)] si  t  r t t i st  ris  f 
illness or injury associated with the substance, no State ...  
establish or continue in effect a cautionary labeling require ent 
applicable to such substance or packaging and designed to protect 
against the sa e risk of illness or injury unless such cautionary 
labeling requirement is identical to the labeling requirement under 
2(p) or 3(b). 
 .S.C. § 1261 note (b)(1)(A), as quoted in hern. Specialties frs. ss'n, Inc. v. llenby, 958 
F.2d 941, 945 (9th Cir. 1992). Thus, "[ w ]here a plaintiff s claim seeks to hold a manufacturer 
responsible for failing to provide warning labels which are not identical to those required under 
the F SA, that clai  is preempted." anty v. Ever-Last Supply o., 296 .J.Super. 68, 84, 685 
A.2d 1365, 1374 ( .l Super. Ct. Law Div. 1996). 
Accordingly, the relevant questions for this inquiry, as addressed below, are: 1) hether 
laintiff s ca  f acti  i   st t  l  ca  f cti  i t  to b  r t  by t  SA; 
RA  I  OPPOSITI  TO PLAINTIF 'S CR - I  FOR PARTIAL SUMMA  
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and 2 Whether the FHSA applies to SECs law enforcement branded OC products thereby
triggering the preemption clause of the FHSA
1 Plaintiffs claim is a state law cause of action as OSHA does not provide any
private right of action
Without any significant analysis Plaintiff asserts that she is entitled to judgment as a
matter of law according to OSHA standards but fails to address the underlying question as to
whether she has standing to bring a cause of action on that basis If she cannot assert an
independent cause of action under OSHA then her reliance on the OSHA standards must be
contained within some other state law cause of action which in turn calls into question whether
that state law claim is preempted by the FHSA
Wellestablished case law uniformly holds that private citizens do not have a cause
of action for damages based upon a violation of an OSHA standard Helms v Sporicidin Intl
871 FSupp 837 839EDNC1994 citing 29USC 653 Johnson v Koppers Co Inc
524FSupp 1182 app dismissed DC Ohio 1981 Blessing v United States 447FSupp
1160DCPa1978Otto v Specialties Inc 386FSupp 1240DCMiss1974 See also 35
ALRFed 461 2 The cases are consistent in holding that the Occupational Safety and
Health Act 29USCA 651 et seq does not create a private cause of action for violations of
the Act or the regulations thereunder Indeed Congress did not intend for OSHAbased
actions to be litigated by private actors in federal court Glanton v HarrahsEntmtInc 297
F Appx685 687 9th Cir 2008 As such while a plaintiff may use alleged OSHA violations
as evidence of duty andor breach the underlying claim must be rooted elsewhere Chilcutt v
Ford Motor Co 662FSupp2d967 SDOhio 2009 Importantly hereviolations of the
OSHA standards do not establish a state law cause of action for failure to warn in direct
opposition to an applicable federal law or regulation Helms 871FSupp at 839
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and 2) hether the FHSA applies to SEC's law enforcement branded OC products, thereby 
triggering the preemption clause of the FHSA. 
1. Pl ff's clai  is a state la  cause of , as S  oes not provide  
private right of action. 
ithout any significant analysis, Plaintiff asserts that she is entitled to judg ent as a 
atter of la  according to S  standards, but fails to address the underlying question as to 
hether she has standing to bring a cause f action on that basis. If she cannot assert an 
independent cause of action under OSHA, then her reliance on the OSHA standards must be 
t ine  ithin e t e  tate  ause  , ic   m ls into  et er 
that state law claim is preempted by the FHSA 
ll- t lis e  se la  if r l  l  t t "private itize  ...  t   s  
f acti  f r a a es ase   a i lati  f a   standard." el s v. orici i  I t 'I, 
871 F.Supp. 837, 839 (E.D.N.C. 1994) (citing 29 U.S.C. § 3;  .  o., c., 
524 F.Supp. 1182, app. dismissed, (D.C. Ohio 1981); Blessing v. United States, 447 F.Supp. 
1160 (D.C.Pa.1978); Otto v. Specialties, Inc., 386 F.Supp. 1240 (D.C.Miss.1974)). See also 35 
L.R. .  §  ("Th   r  i t t i  l i  t t t  ti l f t   
Health Act (29 V.S.C.A §§ 651 et seq.) does not create a private cause f action for violations of 
the Act or the regulations thereunder.") ed, "Congress i  t i t  r -ba  
actions to be litigated by private actors in federal court." Glanton v. Harrah's Entm't, Inc., 297 
F. App'x. 685, 687 (9th Cir. 2008). As such, while a plaintiff may use alleged OSHA "violations 
as evidence of duty and/or breach," the underlying clai  ust be rooted elsewhere. hilcutt v. 
ord otor o., 662 .Supp.2d 967 ( .D. hio 2009). I portantly here, "[v]iolations f the 
 stan r   t establi  a st t  l  c  f cti  f r f il r  t  arn i  dir ct 
opposition to" an applicable federal law or regulation. Helms, 871 F.Supp. at 839. 
 I  PPOSITI  T  PLAINTIF 'S - TI  F R PARTIAL SUMMARY 
JU  - Page 14 14542- 1 ( 9851 I. doc) 
None of the cases cited by Plaintiff on page 20 of her Memorandum in support of her
cross motion support the proposition that Plaintiff has a private cause of actionunder OSHA To
the contrary Walton v Potlatch Corp 116 Idaho 892 1989 very clearly states OSHA
regulations may be used as evidence of negligence per se 116 Idaho at 895 emphasis
added Similarly Sanchez v Galey 112 Idaho 609 1987 holds that OSHA standards may only
be used as evidence in a state law action for negligence per se Neither Walton nor Sanchez
recognize any private right of action under OSHA independent of any state law claim
Plaintiffsfinal case Martin v American Cyanamid Co 5 F3d 140 6th Cir 1993
illustrates well Plaintiffs problem with attempting to enforce an OSHA standard independently
from a state law cause of action As described in Helms supra OSHA creates an enforcement
arrangement in which the Department of Labor may bring action against violation of the
statutory provisions 871FSupp at 839 In Martin that was the very scenario Lynn Martin
the Secretary of Labor for the United States had petitioned the Sixth Circuit for review of the
reversal of an OSHA citation by the Occupational Safety and Health Review Commission See
generally 5 F3d 140 There was no private cause of action at issue in Martin rather the case
represents the very mechanism that is contemplated to ensure compliance with OSHA Id
To be viable therefore Plaintiffscause of action must sound in either state statutory or
common law As such the relevant question is whether the FHSA preempts the underlying state
cause of action regardless of Plaintiffs intended reliance on OSHA Cf Helms 871 FSupp
837 holding that the two federal provisions detailing labeling requirements are to be read in
conjunction with one another but determining that the OSHA standard could only be used as
evidence of a state law cause of action which was in turn preempted by the remaining federal
provision FIFRA see also Chemical Specialties Mfrs Assn Inc v Allenby 958 F2d 941
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one of the cases cited by Plaintiff on page 20 of her emorandum in support of her 
cross- otion support the proposition that Plaintiff has a private cause of action under S . To 
the contrary, alton v. Potlatch Corp., 116 Idaho 892 (1989), very clearly states: "OSHA 
regulations may be used as evidence of negligence per se .... "  Idaho at  (emphasis 
added). Similarly, Sanchez v. Galey, 112 Idaho 609 (1987) holds that OSHA standards may only 
e sed as e idence in a state la  action f r e ligence er se. either alton r Sanchez 
recognize any private right of action under OSHA, independent of any state law claim. 
laintiffs final case, artin v. erican yana id o.,  .3d  (6th ir. 93), 
illustrates ell Plaintiffs proble  ith atte pting to enforce an S  standard independently 
   la  se  ti .    , , "OSH  tes   
arrangement in which the Department of Labor may bring action against violation of the 
statutory provisions." 871 F.Supp. at 839. In Martin, that was the very scenario -  rti , 
the Secretary of Labor for the United States, had petitioned the Sixth Circuit for review of the 
reversal of an S  citation by the ccupational Safety and ealth evie  o ission. See 
generally 5 F.3d 140. There as no private cause of action at issue in artin; rather, the case 
represents the very mechanism that is contemplated to ensure compliance with OSHA. Id. 
  i l , t r f r , laintiffs s  f ti  st s  i  it r st t  st t t r  r 
co on la . s such, the relevant question is hether the  pree pts the underlying state 
cause of action, regardless of Plaintiffs intended reliance on SHA. f el s, 871 F.Supp. 
837 (holding that the "two federal provisions detailing labeling require ents are to be read in 
conjunction with one another," but determining that the OSHA standard could only be used as 
e i e ce f a state la  ca se f action, ic  as i  t r  ree ted by t e re ai i  fe eral 
provision (FIFRA»; see also Chemical Specialties Mfrs. Ass 'n, Inc. v. Allenby, 958 F.2d 941, 
 I  PPOSITI   LAINTIF 'S - I   PARTIAL SUMMARY 
J T-Page 15 14542-  ( 1 I. d c) 
945 9 Cir 1992 The preemption issues arising under FHSA are identical to those arising
under FIFRA If the FHSA applies to SECsLaw Enforcement OC spray products then
Plaintiffsstate cause of action for failure to warn is preempted and must be dismissed in the
absence of any allegation argument or evidence that SEC has not complied with the FHSA Id
2 Thewarning labels for SECsOC products are regulated by the FHSA
As addressed in SECs Reply Memorandum on its pending motion for summary
judgment Plaintiffsinterpretation of the regulations governing the FHSA is overly restrictive
and does not accurately portray the scope of that act Citing to the definitions contained within
15USC 1261pand 16CFR 15003iPlaintiff contends that the FHSA applies
only to household goods and that SECslaw enforcement branded OC products are therefore
not governed by the FHSA Plaintiffs Memorandum p 18 However relevant case law has
interpreted the broad language of the FHSA regulations to include even articles that are not
specifically targeted to household use See 16CFR 15003c0i
Preliminarily courts have interpreted the scope of the FHSA to extend beyond the mere
intent of the manufacturer The manufacturer or the distributor intended use is not the
correct standard for determining whether a product is subject to the federal labeling statutes
Canty 685 A2d at 1370 Instead the appropriate test is whether the product under any
customary or reasonablyforeseeable condition of purchase storage or use may be brought into
or around a house apartment or other place where people dwell 16CFR 15003ci
emphasis added Courts interpreting the scope of the FHSA have uniformly accepted the
somewhat more expansive definition provided by 16 CFR 15003c
The relevant regulation was erroneously cited by Plaintiff as 16CFR 1261c0iwhich
does not exist
2 In fact the phrase household goodsdoes not appear anywhere in the relevant regulation
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945 (9th ir. 1992) ("The pree ption issues arising under F S  are identical to those arising 
 ."). If t e  a lies t  C's a  f rce e t  s ra  r cts, t e  
l intif  s t te   ti   il  t   i  t   t  is iss  i  t  
a se ce f a  alle ati , ar e t, r e i e ce t at  as t c lie  it  t e A. l . 
. e ar ing la els f r C's  r cts r  re late   t e . 
s resse  i  C's l  e r   it  i  ti  f r r  
j e t, laintiffs i ter retation f t e re lati s er i  t e  is erl  restricti e 
and does not accurately portray the scope f that act. iting to the definitions contained ithin 
 .S.C. § 261(p) a   .F.R. § 500.3(c)(10)(i),1 lai tiff c te s t at t e  a lies 
only to "household goods," and that EC's la  enforce ent branded  products are therefore 
not governed by the F S . (Plaintiffs e orandu , p. 18.) o ever, relevant case la  has 
interpreted the broad language of the F S  regulations to include even articles that are not 
specifically targeted to household use. See 16 .F.R. § 1500.3(c)(10)(i).2 
Preli inarily, courts have interpreted the scope of the F S  to extend beyond the ere 
   f t r r: "The    i tributor's   [ ... J    
correct standard for deter ining hether a product is subject to the federal labeling statutes." 
anty, 685 .2d at 1370. Instead, the appropriate test is hether the product "under any 
custo ary or reasonably foreseeable condition f purchase, storage, or use ay be brought into 
or around a house, apart ent, or other place here people d ell." 16 .F.R. § 1500.3(c)(10)(i) 
(e phasis added). ourts interpreting the scope of the F S  have unifor ly accepted the 
"so e hat ore expansive definition ... provided by 16 F  § 500.3( c)(1 0)": 
) The relevant regulation as erroneously cited by Plaintiff as 16 .F.R. § 261 (c)(1 O)(i), i  
 t i t. 
2 In fact, the phrase "household good(s)" does not appear any here in the relevant regulation. 
  I   LAINTIF 'S -   I   
 - a e 16 -  ( 1. oc) 
Thus the sewer solvent would not appear to be intended or
packaged in a form suitable for use in the household or by
children under 15 USC 1261pBut it would be a substance
which under any customary or reasonably foreseeable condition
of purchase storage or use may be brought into or around a house
apartment or other place where people dwell under 16 CFR
15003cas demonstrated by its use it this case
The Court finds that the supplementation of the definition of the
term misbranded substance by 16 CFR 15003cis a
reasonable variation authorized by 15USC 1262b Thus
the Court holds that Red Hot Sewer Solvent is subject to regulation
under 15 USC 1261p As a result Plaintiffs common law
claims against ABC Compounding are preempted and ABC
Compounding Motion for Summary Judgment is granted
Santiago v Virgin Islands Housing Authority 2007 WL 4698596 VI Super 2007 See also
Cole v Sunnyside Corp 234 Wis2d 149 2000 industrial lacquer thinner subject to FHSA
because it was reasonably foreseeable that this product could reach an ordinary consumer
Wagoner v Exxon Mobil Corp 2011 WL 2182042EDLa 2011 The key question it bears
repeating is whether under any reasonably foreseeable condition of purchase storage or use the
article may be found in or around a dwelling or related structure emphasis in original
Plaintiff has failed to present any evidence that SECs law enforcement branded OC
products will not under any foreseeable condition of use be brought into or around homes
apartments etc In contrast the evidence presented herewith definitively establishes that SECs
law enforcement branded OC products will be carried into and potentially discharged in houses
or other places where people generally live In addition to the evidence identified in SECsreply
memorandum on its motion for summary judgment SEC has filed concurrently herewith the
Second Affidavit of Robert Nance the Vice President of Operations for SEC and the Affidavit
of Nicholas Roberts the Rangemaster for the Unified Police Department of Greater Salt Lake
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, t e r e   t   , "inten ,  
ac a e  i  a f r  s ita le, f r se i  t e se l  r  
il ren,"   .S.C. § 1261(p). ut it ould be a substance 
i , "under  t r  r r l  forese l  iti  
f r , t r , r    r t i t  r r   , 
apart ent, or other place here people d ell," under 16 F  § 
500.3( c)(1 0), s strate   its s  it t is s . 
e rt finds t at t e s le e tati  f t e efi iti  f t e 
ter  "misbranded s stance"    § 500.3(c)(10)   
"reasonable variation" authorized by 15 .S.C. § 1262(b). hus, 
the ourt holds that ed ot Se er Solvent is subject to regulation 
  .S.C. § 1261(p). s a result, Plaintiffs co on la  
l i s i st  i  r  r t d,   
ounding's ti  f r ar  J e t is ra ted. 
ti  v. ir i  Isl s si  t ority,    (V.1. r. 07).  ls  
le v. ysi e rp.,  is.2d  (20 ) (industrial lac er t i er s ject t   
because "it as reasonably foreseeable that this product could reach an ordinary consu er."); 
agoner v. Exxon obil orp., 2011 L 2182042 (E.D.La. 2011) ("The key question, it bears 
repeating, is ' hether under any reasonably foreseeable condition of purchase, storage, or use the 
article ay be found in or around a d elling' or related structure." (e phasis in original)). 
Plaintiff has failed to present any evidence that SEC's la  enforce ent branded C 
products ill not, under any foreseeable condition f use, be brought into or around ho es, 
apart ents, etc. In contrast, the evidence presented here ith definitively establishes that EC's 
la  enforce ent branded  products ill be carried into, and potentially discharged in, houses 
or other places here people generally live. In addition to the evidence identified in SEC's reply 
e orandu  on its otion for su ary judg ent, SEC has filed concurrently herewith the 
Second ffidavit of obert ance, the ice President of perations for S , and the ffidavit 
of icholas Roberts, the Range aster for the nified Police epart ent of reater Salt Lake. 
  SI I   LAINTIF 'S -   TI   
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Each of these affidavits sets forth the reasonable foreseeability that SECsOC products will be
taken into and around homes and potentially used therein
SECs law enforcement OC products are specifically marketed to more than just
correctional facilities as SEC aims to sell the products to local police departments military
SWAT teams tactical teams and security companies 2 Nance Aff 3 Thus even SEC
expects that its law enforcement branded products will be used in office buildings banks
stores restaurants homes apartments and any other building or location where a criminal or
suspect might be found Id In practice law enforcement personnel do in fact use and carry
law enforcement OC products in all of those locations Roberts Aff 3 In fact some law
enforcement personnel are required to maintain OC on their utility belts at all times the officer
is in uniform Id 5 As a result law enforcement are known to regularly carry OC inside
private homes office buildings apartment buildings and any other building or structure that
any officer enters while on duty Id Both Nance and Roberts have attested that it is
reasonably foreseeable that SECs OC products will be brought into and potentially used in
places where people dwell 2 Nance Aff 6 Roberts Aff 6
In light of the evidence on record in this case SECslaw enforcement branded OC spray
products are within the jurisdiction of the FHSA Thus the FHSA provides the exclusive
labeling requirements for those products Accordingly Plaintiffs state law claim for failure to
warn based on OSHA standards is contrary to the labeling requirements of FHSA and therefore
preempted as a matter of law Summary judgment for SEC not Plaintiff is the proper
disposition of Plaintiff s Second Cause of Action
B Even If Plaintiffs Claim Is Not Preempted It Fails As A Matter Of Law
1 Plaintiff cannot establish each element of a negligence per se claim
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Each of these a fidavits sets forth the reasonable fores i t  that S 's  products i l be 
taken into and around ho es, and potentially used therein. 
SE 's la  enforce ent  products are specifically arketed to ore than just 
correctional fa ilities, as  ai s to s ll the products to "local police de rt ts, ilitar , 
S AT tea s, tactical tea s and security co panies." (2nd Nance Aff. ~ 3.) , e   
expects that its law enforcement branded products will be used "in office buildings, banks, 
stores, restaurants, ho es, apart ents ... a d a  ther ilding r l catio  ere a cri inal r 
suspect might be found." (Jd.) In practice, law enforcement personnel do, in fact, use and carry 
la  enforce ent C products in all of those locations. (Roberts ff. ~ .) In t,  a  
enforcement personnel are required to maintain OC on their utility belts "at all times the officer 
is in uniform." (Jd. ~ 5.) As a result, law enforcement are known to regularly carry OC "inside 
private homes, office buildings, ... a art e t ildings a  a  t er il in  r str ct re t at 
any officer enters [while] on duty." .    ts      
reasonably foreseeable that SEC's OC products will be brought into, and potentially used, in 
places where people dwell. (2nd Nance Aff. ~ ;  ff. ~ .) 
In light of the evidence on record in this case, SEC's law enforcement branded OC spray 
products are within the jurisdiction of the FHSA. ,   e  t  l i  
labeling requirements for those products. Accordingly, Plaintiffs state law claim for failure to 
arn based on S  standards is contrary to the labeling require ents of F SA, and therefore 
preempted as a matter of law. u ar  j e t f r EC, t laintiff, is t e pr er 
disposition of Plaintiff s Second Cause of Action. 
. e  If laintiff's l i  Is t reempted, It ils s  tter f Law. 
. laintif  c  establi  each l  f a gli  r se claim. 
E ORANDU  IN OPPOSITION TO PLAINTIFF'S CROSS- OTION FOR PARTIAL SUM ARY 
JUD ENT - Page 18 14542-011 (398511.doc) 
As set forth above Plaintiff carries the burden of proving each element of her claim in
this case negligence per se in order to prevail on summary judgment Nelson 128 Idaho at
202 It appears that Plaintiff is pursuing liability under a theory of negligence per se based on
SECsalleged failure to comply with OSHA standards Assuming arguendo that Plaintiff is
correct in her proposition that the FHSA does not have any preemptive effect over her failure to
warn claim which SEC disputes she nevertheless is unable to establish the four 4 elements of
a cause of action for negligence per se and summary judgment for SEC is therefore appropriate
under that theory
Citing to Sanchez v Galey 112 Idaho 609 733 P2d 1234 1986 Plaintiff correctly
identifies the necessary elements for negligence per se
First the statute or regulation must clearly define the required
standard of conduct second the statute or regulation must have
been intended to prevent the type of harm defendants act or
omission caused third the plaintiff must be a member of the class
of persons the statute or regulation was designed to protect and
fourth the violation must have been a proximate cause of the
injury
Sanchez 112 Idaho at 617 internal citations omitted For the reasons set forth herein Plaintiff
will be unable to establish the second and fourth necessary elements for negligence per se as a
matter of law
1 OSHA does not intend to prevent unknown or unforeseeable harms
The first issue is whether OSHA was intended to prevent the type of harm to Plaintiff that
SECs alleged act or omission was alleged to have caused To answer this question the focus of
the inquiry must be directed again to the specific injury or injuries claimed by Plaintiff a long
term or chronic respiratory illness andor a long term chronic aggravation or exacerbation of
an existing health condition PlaintiffsMemorandum p 2 Plaintiffs claim does not allege
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As set forth a , Plai tiff carries the burden of proving each element of her claim (in 
this case, negligence per se), in order to prevail on su ary judg ent. Nelson, 128 Idaho at 
202. It appears that Plaintiff is pursuing liability under a theory of negligence per se, based on 
SEC's alleged failure to comply with OSHA standards. ssu ing rgue  t at l i tiff is 
correct in her proposition that the F S  does not have any pree ptive effect over her failure to 
warn claim, which SEC disputes, she nevertheless is unable to establish the four (4) elements of 
a cause of action for negligence per se, and su ary judgment for SE  is therefore appropriate 
under that theory. 
Citing to Sanchez v. Galey, 112 Idaho 609, 733 P.2d 1234 (1986), Plaintiff correctly 
identifies the necessary ele ents for negligence per se: 
First, the statute or regulation ust clearly define the required 
t r  f ct; cond, t  t t t  r r l tio  t  
been intended to prevent the type of har  defendant's act or 
issi  sed; t ir , t  l i tiff st   r f t  l ss 
of persons the statute or regulation was designed to protect; and 
fourth, the violation ust have been a proxi ate cause f the 
InJury. 
Sanchez, 112 Idaho at 617 (internal citations o itted). For the reasons set forth herein, Plaintiff 
  e  t l      r   r      
tt r flaw. 
.  es t i te  t  re e t  r f resee le ar s. 
he first issue is hether  as intended to prevent the type of har  to laintiff that 
SEC's alleged act or omission was alleged to have caused. To answer this question, the focus of 
the inquiry must be directed again to the specific injury or injuries claimed by Plaintiff - "a long-
term or chronic respiratory illness ... andlor a long ter  chronic aggravation or exacerbation of 
an existing health condition." (Plaintiffs e orandum, p. 2.) Plaintiffs clai  does not allege 
A  I  PPOSITI  T  PLAINTIFF'S C SS- TI  F  PARTIAL SUM  
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damages as a result of an acute or temporary reaction to OC Thus the inquiry is whether OSHA
was intended to prevent the type ofharm alleged to have been caused by SECs alleged improper
labeling and failure to warnie longterm or chronic adverse health condition
As argued in the briefing on SECs pending motion for summary judgment and on its
Motion to Strike Portions of the Affidavit of Dr Gerald Yost SEC cannot be held liable for
failing to warn against dangers or risks that were unknown and not reasonably foreseeable at the
time it manufactured its product See generally SECsMSJ In an attempt to sidestep this
fundamental tenet of products liability law a tenet that she did not dispute was applicable to her
state law cause of action Plaintiff relies exclusively on the standards promulgated under
OSHA OSHA does not however provide Plaintiff with safe harbor from the known or
foreseeable standard that she cannot meet Like the common law and the FHSA OSHA only
requires a manufacturer to warn against risks that are known andor foreseeable at the time of
manufacture
On this issue the Court need not look any further than the case law submitted by Plaintiff
in support of her cross motion As evidenced by Sanchez Plaintiff is presented with the same
problem under OSHA as SEC has argued and Plaintiff has not disputed exists under any
common law cause of action for failure to warn A manufacturer cannot be held liable for
injuries that result from unknown or unforeseeable risks The Idaho Supreme Court notes
In order to establish a violation of the OSHA General Duty Clause
which covers unanticipated hazards not covered by specific OSHA
regulations the plaintiff or Secretary of Labor must show a hazard
of which the employer knew or should have known was
causing or likely to cause death or serious bodily injury 29
USCA 654a1
Sanchez 112 Idaho at 618 n 5 emphasis added citing Teal v EI Dupont DeNemours Co
728 F2d 799 804 6t1i Cir 1984 OSHA establishes only a duty of reasonable care to protect
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damages as a result of an acute or temporary reaction to OC. Thus, the inquiry is whether OSHA 
was intended to prevent the type of harm alleged to have been caused by SEC's alleged improper 
labeling and failure to warn (i.e. long-term or chronic adverse health condition). 
As argued in the briefing on SEC's pending motion for summary judgment and on its 
otion to trike rtions f the ffidavit f r. erald ost,  ca not e ld liable for 
failing to warn against dangers or risks that were unknown and not reasonably foreseeable at the 
ti e it anufactured its product. (See generally SEC's SJ.) In an atte pt to side-step this 
funda ental tenet of products liability la  -  te et t at  id t ispute as icable   
te la  ause  on - laintiff relies exclusively on the standards pro ulgated under 
. S  does not, ho ever, provide Plaintiff ith safe harbor fro  the "known or 
eable"   e t et. ike   a    ,   
requires a manufacturer to warn against risks that are known and/or foreseeable at the time of 
f t r . 
n this issue, the Court need not look any further than the case la  sub itted by Plaintiff 
in support of her cross- otion. As evidenced by Sanchez, Plaintiff is presented with the sa e 
problem under OSHA as SEC has argued (and Plaintiff has not disputed) exists under any 
    t   f i   rn:  f t    l   r 
injuries that result from unknown or unforeseeable risks. The Idaho Supreme Court notes: 
I  r r t  t bli   i l ti  f t   r l t  l se, 
ic  c ers a tici ate  azar s t c ere   specific  
regulations, the plaintiff or Secretary of Labor must show a hazard, 
of hich the e ployer kne  or should have known, as 
causing or likely to cause death or serious bodily injury. 9 
.S.C.A. § 654(a)(1). 
Sanchez, 112 Idaho at 618 n. 5 (e phasis added) (citing Teal v. .I upont e e ours o., 
728 F.2d 799, 804 (6th Cir. 1984) (OSHA establishes only a "duty of reasonable care to protect 
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employees from recognized hazards emphasis added See also Engelland v Clean
Harbors Envtl Services Inc 319 Ill App 3d 1059 1068 747NE2d 8 1516 I11 App Ct
2001 Because the accidental emission of chlorine gas at Clean Harbors was not known or
identifiable to WMIL and WM Inc WM Inc and WMIL had no duty under the voluntary
undertaking doctrine or OSHA regulations to warn and train Engelland of this risk
Based on the foregoing even if OSHA is not preempted and therefore does establish the
requirements for labeling SECsOC products Plaintiff will nevertheless be unable to prove that
a warning against longterm or chronic adverse respiratory effects ought to have been included
In other words OSHA was not intended to prevent harms that were at the time of production
unknown and unforeseeable
2 The alleged OSHA violation was not the proximate cause of Plaintiffs injury
Finally no reasonable juror will be able to find that SECs alleged OSHA violation
proximately caused Plaintiffsalleged injuries In Idaho proximate cause is split into two
components
First there is actual cause and second there is true proximate
cause sometimes known as legal cause Munson v State Dept
of Highways 96 Idaho 529 531 531 P2d 1174 1176 1975
Sisters of the Holy Cross 126 Idaho at 103940 n 1 895 P2d at
123233 n 1 Actual cause is the factual question of whether a
particular event produced a particular consequence Sisters of the
Holy Cross 126 Idaho at 103940 n 1 895 P2d at 123233 n 1
True proximate cause focuses upon legal policy in terms of
whether responsibility will be extended to the consequences of
conduct which has occurred
Newberry v Martens 142 Idaho 284 288 127 P3d 187 191 2005 When there are multiple
possible causes of an injury the defendantsconduct or omission amounts to proximate cause if
itwas a substantial factor in bringing about the damage Id Based on the evidence of record
SEC contends that no reasonable juror could determine that SECs alleged conduct in not
MEMORANDUM IN OPPOSITION TO PLAINTIFFSCROSS MOTION FOR PARTIAL SUMMARY
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[ ... ] loyees fr  re ize  r s .... " (emphasis ded».    .  
arbors nvtl. Services, Inc., 319 Ill. pp. 3d 1059, 1068,747 .E.2d 8, 15-16 (Ill. pp. t. 
) ("[B]ecause t e i t l is i  f l ri   t l  ar ors a  t  r 
ide tifiable t  I  a   I c.,  I c. a  I  a   ty, er t e l tar  
undertaking doctrine or S  regulations, to arn and train ngelland of this risk."). 
as   t  f r i g,  if  i  t r t   t r f re  t li  t  
re ire e ts f r la eli  C's  r cts, lai tiff ill e ertheless e a le t  r e t at 
a arning against long-term or chronic adverse respiratory effects ought to have been included. 
In t er r s,  as t i te e  t  re e t ar s t at ere, at t e ti e f r cti , 
  re l . 
. The alleged S  violation as not the proxi ate cause of Plaintiff's injury. 
inally, no reasonable juror ill be able to find that EC's alleged  violation 
proxi ately caused Plaintiffs alleged injuries. In Idaho, "proximate cause" is split into t o 
ts: 
irst there is actual cause, and second there is true proxi ate 
, ti e    "legal use."  . t te, t. 
of ighways, 96 Idaho 529, 531, 531 P.2d 1174, 1176 (1975); 
Sisters of the Holy Cross, 126 Idaho at 1039-40 n. 1, 895 P.2d at 
1232-33 n. 1. ctual cause is the factual question of hether a 
particular event produced a particular consequence. Sisters f the 
oly ross, 126 Idaho at 1039-40 n. 1, 895 P.2d at 1232-33 n. 1. 
True proxi ate cause "focuses upon legal policy in ter s of 
t r r s onsibilit  ill  t  t  t  s s f 
   cur ed." 
e berry v. artens, 142 Idaho 284,288, 127 P.3d 187, 191 (2005). hen there are ultiple 
possible causes f an injury, the defendant's conduct or o ission a ounts to proxi ate cause if 
"it as a substantial factor in bringing about the da age." Id. ased on the evidence of record, 
 contends that no reasonable juror could deter ine that EC's alleged conduct in not 
  SITI   LAINTIF 'S -   I   
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complying with OSHA standards in the labeling of its OC products was a substantial factor
leading to Plaintiffs alleged injuries Therefore this is a legal cause issue which the Court can
decide on summary judgment
The Statement of Facts SOF at the beginning of this memorandum provides an
accounting of Plaintiffs knowledge of and experience with how OC affects the human body
Much of Plaintiffsknowledge and experience was obtained prior to Plaintiff having any
exposure to OC manufactured by SEC SOF 3 5 9 Throughout the course of her
employment with various Idaho correctional institutions Plaintiff received a number of trainings
regarding the use and effects of OC Id As a part of the training Plaintiff was educated on the
use and effects of OC from Idaho Department of Corrections IDOC instructors that had
received direct training from SEC SOF 12 The IDOC instructors that trained Plaintiff used
both a training manual and a PowerPoint presentation provided by SEC each of which identified
the known acute adverse respiratory effects of exposure to OC SOF 41213 As a part of her
training through IDOC Plaintiff was administered written tests on the use and effects of OC and
through those tests Plaintiff was able to correctly identify the known adverse respiratory effects
of exposure to OC SOF 1417 Also as a part of her training Plaintiff was exposed to OC
and witnessed firsthand the respiratory effects of OC exposure SOF 7 10 11 19
Despite having obviously known well the acute adverse respiratory effects of OC
Plaintiff cannot now reasonably argue that her conduct would have changed had the OC
container contained any different label Importantly Plaintiff cannot recall having ever had the
opportunity to review the OC canisters used in any of her training exposures SOF 7 10 11
In short she never saw the labels on SEC canisters from which she alleges OC exposure
Despite having known of and been trained in the adverse respiratory effects of exposure to OC
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JUDGMENT Page 22 14542 011 39851 Ldoc
000637
c l ing ith  sta ar s i  t e la eli  f its  r cts as a s sta tial fact r 
leading to Plaintiffs alleged injuries. herefore, this is a legal cause issue hich the ourt can 
decide on su ary judg ent. 
   ts ("SOF") t t  i i  f t i  r  r i e   
accounting of Plaintiffs kno ledge of and experience ith ho   affects the hu an body. 
uc  f l intiff s le   ri  as t i  ri r t  l i tiff i   
exposure to  anufactured by S . (S  #3,  - .) hroughout the course of her 
l t it  ri s I  rr ti l i stit ti s, l i tiff r i   r f tr i i s 
regarding the use and effects of . (Id.) s a part of the training, Plaintiff as educated on the 
se a  effects f  fr  I a  e art e t f rrections ("IDOC") i t t  t t  
received direct training fro  S . (S F #12.) he I  instructors that trained Plaintiff used 
both a training anual and a Po erPoint presentation provided by SE , each of hich identified 
the kno n acute adverse respiratory effects f exposure to . (S  #12-13.) s a part f her 
training through I , Plaintiff as ad inistered ritten tests on the use and effects of , and 
through those tests Plaintiff as able to correctly identify the kno n adverse respiratory effects 
f e s re t  . (S  #14-1 .) ls  as a art f er trai i g, lai tiff as e se  t   
and itnessed, first-hand, the respiratory effects of  exposure. (S F # , , , 9.) 
espite having obviously kno n ell the acute adverse respiratory effects of C, 
laintiff cannot no  reasonably argue that her conduct ould have changed had the  
container contained any different label. I portantly, Plaintiff cannot recall having ever had the 
rt it  t  re ie  t e  ca isters se  i  a  f er trai i  e sures. (S  #7, , 1.) 
In short, she never sa  the labels on SE  canisters fro  hich she alleges  exposure. 
espite having kno n of and been trained in the adverse respiratory effects of exposure to , 
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and despite having previously experienced the respiratory effects of OC exposure from earlier
trainings using OC pepper spray manufactured by manufacturers other than SEC Plaintiff
nonetheless voluntarily participated in the trainings without regard for the warnings or lack of
warnings on canisters of SEC OC products Thus even if SEC violated the OSHA standards
asserted by Plaintiff which SEC disputes there can be no reasonable argument that such a
violation was the proximate cause of Plaintiffs injuries Clearly it was not SEC is therefore
entitled to entry of summary judgment in its favor on Plaintiffs newlyasserted theory of
negligence per se as a matter of law
CONCLUSION
Plaintiff has asked this Court to enter summary judgment in her favor on a theory of
negligence per se alleging that SEC failed to comply with the labeling requirements of OSHA
As established herein the labeling of SECslaw enforcement branded OC products is governed
by the FHSA not OSHA and Plaintiffsstate law cause of action is therefore preempted by
federal regulation Furthermore Plaintiff cannot prove two of the four essential elements for her
theory of negligence per se For these reasons SEC respectfully requests that the Court deny
Plaintiffs cross motion for summary judgment and instead grant summary judgment to SEC on
the entirety of PlaintiffsComplaint
DATED this 30 day of June 2011 GREENER BURKE SHOEMAKER PA
Christopher C Burke I homas J Lloyd III
Attorneys for Defendant
3 At a minimum based on the evidence of record there is a genuine issue of material fact as to
whether SECs allegedly inadequate warning actually caused or was a substantial factor in Plaintiffs
injuries Given Plaintiffsactual knowledge of adverse respiratory effects of OC exposure and the
conduct of Plaintiff in voluntarily exposing herself to OC products without first examining the label or
otherwise taking precautionary or avoidance measures in light of her preexisting health conditions a jury
would be necessary to determine whether SECsconduct met the substantial factor test
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and despite having previously experienced the respiratory effects of OC exposure from earlier 
trainings using OC pepper spray manufactured by manufacturers other than SEC, Plaintiff 
nonetheless voluntarily participated in the trainings ithout regard for the arnings, or lack of 
warnings, on canisters of SEC OC products. Thus, even if SEC violated the OSHA standards 
asserted by Plaintiff, hich SEC disputes, there can be no reasonable argu ent that such a 
violation was the proximate cause of Plaintiffs injuries. Clearly, it was not. SEC is therefore 
entitled to entry of summary judgment in its favor on Plaintiff s newly-asserted theory of 
negligence per se as a matter of law. 3 
 
l i tiff as s e  t is rt t  t r s r  j e t i  r f r   t r  f 
negligence per se, alleging that SEC failed to comply with the labeling requirements of OSHA. 
As established herein, the labeling of SEC's law enforcement branded OC products is governed 
by the F S , not S A, and Plaintiff s state la  cause of action is therefore pree pted by 
federal regulation. Further ore, Plaintiff cannot prove t o of the four essential ele ents for her 
theory of negligence per se. For these reasons, SEC respectfully requests that the Court deny 
Plaintiff s cross- otion for su ary judg ent, and instead grant su ary judg ent to S  on 
the entirety of Plaintiffs Co plaint. 
DATED this 30th day of June, 2011.   E  .A. 
----rt::-:, . -~-< 
rist er . r e / h  J.  III 
ttorneys for efendant 
3 t a ini u , based on the evidence of record, there is a genuine issue of aterial fact as to 
whether SEC's allegedly-inadequate warning actually caused, or was a substantial factor in, Plaintiffs 
injuries. iven Plaintiffs actual kno ledge of adverse respiratory effects of  exposure, and the 
conduct of Plaintiff in voluntarily exposing herself to C products ithout first examining the label or 
otherwise taking precautionary or avoidance measures in light of her pre-existing health conditions, a jury 
would be necessary to deter ine whether SEC's conduct et the substantial factor test. 
RA  I  OPPOSITI  T  PLAINTIF 'S CR - I  FO  PARTIAL SUMMARY 
JUDGMENT - Page 23 14542- 11 ( 851 1. doc) 
CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing document on the following
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CHRISTOPHER D RICH Clerk
By JAMIE RANDALL
DEPUTY
IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO IN AND FOR THE COUNTY OF ADA




CORPORATION a Missouri corporation
Case No CVPI1003515
AFFIDAVIT OF CHRISTOPHER C
BURKE IN SUPPORT OF OPPOSITION






I Christopher C Burke being first duly sworn upon oath state as follows
1 I am one of the attorneys of record for Defendant Security Equipment Corporation
SEC or Defendant and make this Affidavit in support ofDefendantsMotions for
Summary Judgment based upon personal knowledge
2 Attached hereto as Exhibit A are true and correct excerpts from the transcript of
N
the Deposition of Billie Jo Major Major Vol I which was taken on January 5 2011
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Christopher C. Burke, ISB #2098 
Thomas 1. Lloyd III, ISB #7772 
ER E KER  
 . a  tr t, ite  
oise, Idaho 83702 
Tel: (208) 319-2600 
a : (20 ) -2601 
ttorneys for efendant 
or<' \ A~ :. '!xl ~.~. ___ _ 
   
 . , l  
y I   
 
  IS          
  I , I        
IE  J ,  i i i l, 
Plaintiff, 
v. 
I  I  
CORPORATION, a issouri corporation, 
nt. 
   ) 
)ss. 
County of Ada ) 
 o.: - I-  
   . 
    SI I  
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I, Christopher C. Burke, being first duly sworn upon oath, state as follows: 
. I a  one of the attorneys of record for efendant Security quip ent orporation 
("S "  "Defend "), and ake this Affidavit in support of Defendant's otions for 
Summary Judgment, based upon personal knowledge. 
. tt  r t   i it  r  tr   rr t r t  fr  t  tr scri t f 
the Deposition of Billie Jo ajor ("Major"), l. ,     r  , 1. 
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Attached hereto as Exhibit B are true and correct excerpts from the transcript of
the Rule30b6Deposition of the Idaho Department of Corrections IDOC testimony given
by Bret R Kimmel which was taken on February 14 2011
4 Attached hereto as Exhibit C is a true and correct copy of Deposition Exhibit 24
marked at the Rule30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
5 Attached hereto as Exhibit D is a true and correct copy of Deposition Exhibit 8
marked at the Deposition ofMajor Vol I taken on January 5 2011 bearing Bates Nos
D00000005658
6 Attached hereto as Exhibit E are true and correct excerpts from the transcript of
the Deposition of Daniel J Schaffer which was taken on February 14 2011
7 Attached hereto as Exhibit F are true and correct excerpts from the transcript of
the Deposition of Joshua E Overgaard which was taken on February 15 2011
8 Attached hereto as Exhibit G are true and correct excerpts from the transcript of
the Deposition ofNicholas Doan which was taken on February 15 2011
9 Attached hereto as Exhibit H is a true and correct copy of Deposition Exhibit 10
marked at the Deposition of Major Vol I taken January 5 2011
10 Attached hereto as Exhibit I is a true and correct copy ofDeposition Exhibit 33
marked at the Rule 30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
11 Attached hereto as Exhibit J is a true and correct copy of Deposition Exhibit 41
marked at the Deposition of Daniel Schaffer given February 14 2011
12 Attached hereto as Exhibit K is a true and correct copy of Deposition Exhibit 35
marked at the Rule 30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
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3. Attached hereto as Exhibit B are true and co rect excerpts from the transcript of 
the Rule 30(b)( 6) Deposition of the Idaho Department of Corrections ("IDOC"), testi ony given 
by Bret R. Kimmel, which was taken on February 14,2011. 
4. tached hereto as i it  is a true and rrect copy f e tion ibit 2 , 
arked at the le 30(b)(6) e sition ofI  iven by ret im el n e ruary , . 
. tached hereto  t  is a true d rrect   e tion t  
marked at the Deposition of Major, Vol. I, taken on January 5, 2011, bearing Bates Nos. 
OC0000056-58. 
. tached et   t   true   ts  e t  
the Deposition of Daniel 1. Schaffer, which was taken on February 14,2011. 
7. ttache       e  re t    t  
the Deposition of Joshua E. Overgaard, which was taken on February 15,2011. 
. ttac e          s     
the Deposition of Nicholas Doan, which was taken on February 15,2011. 
.    i i         f siti  i  0, 
arked at the Deposition of ajor, Vol. I, taken January 5, 2011. 
0. tt  t   i i   i   t   r t  f siti  xhi it 33, 
arked at the Rule 30(b)(6) Deposition ofI C given by Bret Ki el on February 14,2011. 
11. tt  r t  s xhi it  i  a tr   corr t c  f positi  xhibit 41, 
marked at the Deposition of Daniel Schaffer given February 14,2011. 
12. tt  hereto as xhibit  is a tr  an  cor ect copy of Deposition Exhibit 35, 
marked at the Rule 30(b)(6) Deposition ofIDOC given by Bret Kimmel on February 14,2011. 
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13 Attached hereto as Exhibit L is a true and correct copy ofDeposition Exhibit 25
marked at the Rule30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
14 Attached hereto as Exhibit M is a true and correct copy of Deposition Exhibit 26
marked at the Rule30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
15 Attached hereto as Exhibit N is a true and correct copy of Deposition Exhibit 28
marked at the Rule30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
16 Attached hereto as Exhibit O is a true and correct copy of Deposition Exhibit 32
marked at the Rule30b6Deposition of IDOC given by Bret Kimmel on February 14 2011
DATED this 28 day of June 2011
By
Christopher C Burke
SUBSCRIBED AND SWORN TO before me this day of June 2011
A U LFN Publicfoqrotary
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1 . tached hereto as ibit  is a true and co rect copy of ep s tion i it 2 , 
marked at the Rule 30(b)(6) Deposition ofIDOC given by Bret Kimmel on February 14,2011. 
. tached hereto s ibit  is  true  co rect c  f e tion it , 
marked at the Rule 30(b)(6) Deposition ofIDOC given by Bret Kimmel on February 14,2011. 
. tached eret   t  s a e  re t   e io  t , 
arked at the ule 30(b)(6) eposition ofI  given by ret immel on ebruary 14,2011. 
. ttached et   i it 0 i   t   rrect   iti  i it , 
arked at the Rule 30(b)(6) eposition ofI C given by Bret i el on February 14,2011. 
DATED this 28th day of June, 2011. 
~ y ____________________ ~---------
 .  
       ?9'/i a  f J e, 1. 
~blicf~z!'-'-~~..!...!.-'~-------
sI m  t ~ /1"":) 
Co ission Expires: V -;;>;;:;>- ~/;)..-
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CERTIFICATE OF SERVICE
I hereby certify that I caused to be served the foregoing Affidavit of Christopher C
Burke in Support of Opposition to Plaintiffs Cross Motion for Summary Judgment to be
served on the following named personson the date indicated below in the manner indicated
below
Darwin Overson Esq
Eric B Swartz Esq
JONES SWARTZ PLLC
1673 W Shoreline Drive Suite 220






DATED this 30 day ofJune 2011
Christopher C Burke
Thomas J Lloyd III
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IFICATE F  
I hereby certify that I caused to be served the foregoing Affidavit of Christopher C. 
Burke in Support of Opposition to Plaintiff's Cross- otion for Summary Judgment to be 
served on the following na ed person(s) on the date indicated belo , in the anner indicated 
b : 
Darwin Overson, Esq. 
Eric B. Swartz, Esq. 
J ES & S RTZ, PLLC 
1673 . Shoreline rive, Suite 220 
. . o   
Boise, Idaho 83707 
DATED this 30th day of June, 2011. 
[ ] ia .S. a  
[X] ia a d eliver  
[ ] ia ile (208/489-8 ) 
[ ] a t  
~-r~ __ 
Christopher C. Burke 
s J. lo  III 
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IN THE DISTRICT COURT OF THE FOURTH J  DISTRICT 
OF THE STATE OF I , IN N  F  THE C  F AD  
BILLIE JO AJO , an in i id l, 
l intif , 
vs. 
SEC RIT  E IP E T C RP R TI , 




I I   I IE  J  
January 5, 2011 
 : 




Q So I would like to kind of break that
down into those three components for just a
moment and get a little bit of information about
each one of them
Letsstart when you first started
working for IMSI What was the time frame that
you worked there before you went to the womens
facility
A Approximately two years
Q Okay So roughly from July of04 to
July of 06 something like that
A Right around there yes
Q Okay And do you recall who your
immediate supervisors or shift commanders were
when you worked there at IMSI the first time
A They changed where depending on what
block I was in or what who was the sergeant
and who was the lieutenant
Q Can you remember any of the names of
any of them
A Yes There was Lieutenant Slenz
Lieutenant Greenland Sergeant Fraser I see
their faces If we had if we had a roster I
could just tell you
Q Okay Well thatsall right If you
Page 37
think of any more as we go along maybe you can
just tell me All right
A All right
Q Now you were hired as a correctional
officer correct
A Yes Sergeant Turner
Q Sergeant Turner Okay
A A lot of them arentthere any more
so
Q Were you assigned any particular tiers
or blocks during the first period of time you
worked for IMSI
A When I was first there I went through
my training I worked all the different blocks
You had to work every block
Q How long was your training
A Five weeks after the seven weeks
offsite training
Q So you had seven weeks offsite Is
that before July of 2004 or is that starting July
of 2004 ending July
A Started in July
Q So you had seven weeks of offsite
training Where did that occur
A At the National Guard one of the
10 Pages 34 to 37
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1 to 2003 did you have any involvement with the 1
2 candles separate and apart from actually 2
3 starting your business 3
4 A I used to purchase them 4
5 Q And when you purchased them what did 5
6 you do with them 6
7 A I burned them when I had company over 7
8 Q And how about since 2004 when you 8
9 terminated your business have you continued to 9
10 use the candles in some way 10
11 A I did When you until I moved to 11
12 Paula Dillonshouse I decided to become a 12
13 roommate instead ofmaintain a place a whole 13
14 house 14
15 Q And so have you used them since then 15
16 A No they are all in storage 16
17 Q Why did you terminate your business 17
18 A Because I worked graveyard shift at the 18
19 prison when I started swing shift and then 19
20 graveyard Swing shift and day shift for a 20
21 few a couple of months 21
22 Q Okay 22
23 A And then I went to maybe I dont 23
24 know three six months I dont know how many 24
25 months I did it at first And then I went to 25
Page 35
1 graveyard So there wasntany time 1
2 Q Well letstalk about your employment 2
3 with the Idaho Department of Corrections which 3
4 Ill probably refer to also as IDOC if thats 4
5 okay with you Its easier to say 5
6 A Yes 6
7 Q It looks like you were employed there 7
8 between July 2004 and sometime in May of 2008 is 8
9 that correct 9
10 A Yes 10
11 Q And as I understand it you were fired 11
12 from IDOC effective 528 of 08 is that correct 12
13 A Yes 13
14 Q But did you work there continuously 14
15 between July of04 and 5 27of08 15
16 A Yes 16
17 Q And you started at Idaho Maximum 17
18 Security Institute IMSI 18
19 A Yes 19
20 Q And at some point you were transferred 20
21 to the South Boise WomensCorrectional Facility 21
22 A Yes 22
23 Q And then you ended up coming back to 23
24 IMSI 24
25 A Yes 25
000646
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1 to 2003, did you have any involvement with the 
2 candles, separate and apart from actually 
starting your business? 3 
A. I used to purchase them. 4 
5 Q. And when you purchased them, what did 
6 you do with them? 
7 
8 
A. I burned them when I had company over. 
Q. And how about since 2004, when you 
9 terminated your business, have you continued to 
lOuse the candles in some ay? 
11 A. I did. When you -- until I moved to 
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Q. So I would like to kind of break that 
down into those thr e components for just a 
moment, and get a little bit of information about 
each one of the . 
Let's start when you first started 
6 working for IMS . hat as the time frame that 
7 you worked there before you went to the wo en's 
8 fa ? 
9 A. Appro i a , two ye . 
10 . Oka . S , rou , from J ly of'04 to 
11 J ly of '06, s t ing like th t? 
12 . Right around ther , yes. 
13 roo ate, instead of maintain a place, a hole 13 . . nd do ou re l ho our 
14 house. 14 i e iate s isors r s ft anders e , 
15 Q. And so have you used them since then?  hen you rked there at I SI the first ti ? 
16 A. No, they are all in storage.  . he  hanged here -- de e ing  hat 
17 Q. Why did you terminate your business?  block I as i ,  hat --  as t e s t, 
18 A. Because I worked graveyard shift at the 18 d  as the lie te t. 
19 prison, when I started swing shift, and then 19 . an u re   f t e a es  
20 graveyard. Swing shift and day shift for a 20   t ? 
21 few -- a couple of months.  . . ere as ieute t l , 
22 Q. Okay.  ie te  l ,  r.   
23 A. And then I went to maybe --  n't 23 t i  .   -- if e had a roster, I 
 kno  -- three, six months. I don't know how many 24  just  . 
 onths I did it at first. nd then I ent to 25 . ay. l , at's l ri ht.   
a e  




Q. Well, let's talk about your employment 
with the Idaho Department of Corrections, which 
I'll probably refer to also as IDOC, if that's 
5 okay with you? It's easier to say. 
6 . es. 
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        l ng, e   
 st t ll . ll i ht? 
 . ll right. 
 . ,   i    ti l 




Q. It looks like you were employed there  
. . r t r er. 
. r t rner. kay. 
between July 2004 and sometime in May of 2008; i5  .   f t  ren't t r  a  ore, 
9 that correct? 
10 . s. 
11 Q. And as I understand it, you were fired 
12 fro  I C effective 5-28 of '08; is that correct? 
1  . es. 
14 Q. But did you work there continuously 
15 between July of'04 and 5-27 of'08? 
16 . s. 
17 Q. And you started at Idaho Maximum 
18 Security Institute, IMSI? 
19 A. Yes. 
20 Q. And at some point, you were transferred 
21 to the South Boise omen's Correctional Facility? 
A. Yes. 22 
23 Q. And then you ended up coming back to 
24 IMSI? 
25 A. Yes. 
 o ... 
 .   assi  ny arti  ti r  
1   l  uri  t  fi t peri  f ti   
12  f r I SI? 
13 .  I  fi t t ere, I nt t r  
14 y training. I r  all t  diff r nt blocks. 
1    t  r  every block. 
16 . o  l  was your training? 
17 . Fi  weeks, aft r the seven weeks 
18 of site training. 
19 Q. SO you had seven weeks of site. Is 
20 that before July of 2004 or is that starting July 
21 of 2004, ending July? 
22 A. Started in July. 
23 Q. SO you had seven weeks of offsite 
24 training. Where did that oc ur? 
25 A. At the National Guard, one of the 
10 ( s 34 to 37) 




1 buildings there It may have been five weeks 1 the training before you actually went on to the
2 six weeks 2 graveyard shift
3 Q Okay 3 A Yeah So we did like bookwork and
4 A And we did a week of training at IMSI 4 then we finally moved into like moves strikes
5 that was pertinent to IMSI and not pretty 5 and learned all that stuff
6 much not the rest 6 Q For prisoner management and control
7 Q Okay And then after you got done with 7 A Yes And how to make sure that we
8 the training you had an additional five weeks on 8 could shoot a gun
9 the various blocks 9 Q Selfdefense type of thing
10 A Yes 10 A Yes
11 Q And after that were you assigned to a 11 Q Okay
12 particular block 12 A And then our last week of training we
13 A When I went finally went to graveyard 13 worked on cell extraction cuffing in cells
14 I was in A Block I believe 14 Worked with how to handle offenders taking therr
15 Q Whats the time frame for the graveyard 15 in and out of cells and single restraint double
16 shift Is that midnight until 700 or800 in 16 restraint full restraints and OC
17 the morning 17 Q Okay And by OC and well be
18 A 103 to630 18 talking a lot about that here today You are
19 Q 103 pm to630am 19 talking about Oleoresin Capsicum
20 A Yes If you worked a 12 hour shift it 20 A Yes
21 was630 You came in at630 or 103 until 21 Q And wellrefer to that as OC Its
22 103 22 a lot easier
23 Q So how long did you work the graveyard 23 A Yes
24 shift in each stint 24 Q Why were you transferred from IMSI to
25 A I think about a year of that 25 the womenscorrectional facility
Page 39 Page 41i
1 Q Does that take us up to July of 06 or 1 A I asked for the transfer
2 did you have a change before July of 06 2 Q And why is that
3 A I do not remember everywhere 3 A I applied so that I could get into
4 Q I understand How about at the 4 training and be have more of a positive
5 graveyard shift Do you know who your shift 5 impact on prisoners The maximum security all
6 supervisor or immediate supervisor was there 6 you did was they were all bad I want to do
7 A Sergeant Schaeffer 7 some good
8 Q Tell me a little bit about your 8 Q So training you are talking about
9 training What did you do 9 training of women prisoners
10 A Im sorry Fraser 10 A For classes to teach them classes
11 Q Okay 11 Q Okay
12 A Sergeant Fraser said you can put up 12 A I actually went to training for
13 with the other people 13 cognitive self change We called it CSC And
14 Q Okay 14 thatswhat I was going to teach prisoners And
15 A Im sorry Can you repeat your last 15 then they decided to come out with the CO
16 question 16 numbers
17 Q Yes Tell me about your training that 17 Q The what
18 you actually went on to the graveyard shift 18 A Correction Officer 3 and they would
19 What did you actually have to go through 19 just do training so
20 A Do you want to know offsite or 20 Q All right So how long were you at the
21 Q Letstalk about offsite first 21 womens facility
22 A Offsite we did a lot of book work to 22 A Sorry
23 learn how to be around prisoners And thats 23 Q No thatsall right Do you want some
24 what I mainly remember 24 more water
25 O How about onsite Im talking about 25 A Yes please
000647
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1 buildings there. It may have been five weeks, 
2 six weeks. 
3 Q. Okay. 
4 A. And we did a week of training at IMSI 
5 that was pertinent to IMSI, and not -- pretty 
6 much, not the rest. 
7 Q. Okay. And then after you got done with 
8 the training, you had an additional five weeks on 
9 the various blocks? 
10 A. e . 
11 Q. And after that, were you assigned to a 
2 particular block? 
 . hen I ent finally ent to graveyard, 
4 I was in A Block, I believe. 
5 Q. hat's the time frame for the graveyard 
6 shift? Is that midnight until 7:00 or 8:00 in 
17 the morning? 
8 . 0:30 t  :30. 
 Q. 10:30 p.m. to 6:30 a.m.? 
20 . es. If you orked a 12-hour shift, it 
21 as 6:30. ou ca e in at 6:30, or 10:30 until 
 0:30. 
 Q. SO how long did you work the graveyard 
 shift in each stint? 
25 . I think about a year of that. 
age  
 Q. Does that take us up to July of '06, or 
 did you have a change before July of '06? 
 A. I do not remember everywhere. 
 Q. I understand. How about at the 
 graveyard shift? Do you know who your shift 
 supervisor or immediate supervisor was there? 
 A. Sergeant Schaeffer. 
 Q. Tell me a little bit about your 
 training. hat did you do? 
 A. I'm sorry. Fraser. 
 Q. Okay. 
 A. Sergeant Fraser said, you can put up 
 with the other people. 
 Q. Okay. 
 A. I'm sorry. Can you repeat your last 
1  question? 
1  Q. Yes. Tell me about your training that 
18 you actually went on to the graveyard shift. 
1  What did you actually have to go through? 
20 A. Do you want to know offsite or --
21 Q. Let's talk about offsite first. 
22 A. Offsite, we did a lot of book work to 
23 learn how to be around prisoners. And that's 
24 what I mainly remember. 
25 Q. o  about onsite? I'm talking about 
Page 4  
1 the training before you act ly went on to the 
2 graveyard s ift. 
3 A. Yea . So we did like bo  r , and 
4 then we fina ly oved into like moves, strike , 
5 and learned a l that st . 
6 Q. For prisoner anagement and c tr l? 
7 A. Yes. nd how to ake sure that e 
8 could shoot a g . 
9 . S l -defense type f th ? 
 . e . 
 . . 
 . nd then r last ee  f tra , e 
 orked n c l , ing in l . 
 orked ith ho  to a le offen , ta ing m k 
5 in a d ut f ,  single r i t, le 
6 re i t, full i ,  . 
 . . nd  "O ,"  e'll e 
 t l ing  lot t that ere t y. ou re 
 in  t e  sicum? 
 . . 
 .  e'll     "Oc." t's 
  lot i r. 
 . s. 
 .  ere  tra sferre  fr  I I t  
  en's orrectiona  cility? 
a e 41 
1 . I as e  f r t e tra sfer. 
2 .   i  t at? 
 . I lie   t t I l  t i t  
 tr i i g,   --     siti  
 i t  ris rs.  xi  security, ll 
6 you did as --  r  l  d.  t   
 s  ood. 
 . O tr ining,  r  t l  b t 
 tr i i  f  ris ners? 
lOA.  l ses, t  t  t  cl sses. 
 . kay. 
 .  ct al  t t  t i  f r 
13 niti  self-change.  call  it c.  
1  that's t I  goi  t  t c  ri ers.  
1  t  t  deci  t  co e out it  t   
16 nu bers. 
t 17 .  what? 
18 . rr ti  f i r 3, and they ul  
1  j st do training, so ... 
20 . ll right. So ho  l ng re you at the 
21 omen's facil ty? 
22 . Sor y. 
23 Q. o, that's all right. Do you want some 
24 or  water? 
25 A. Yes, please. 
11 (  38 to 41) 
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Q That would all bepmcorrect
A Yes
Q All right
A Unless you worked 12 hours then it was
four hours before and four hours after
Q Do you remember any of the coemployees
that you worked with when you worked at the
womensfacility other correctional officers
A At the womensSpackman Haines
Kelm
Q Im sorry I didnt get that
A Kelm Ke1m Forrey she was a
kitchen person Crawell or Crowell There was
another girl there I dontremember her name
She wasn there very long
Q I forgot to ask you that same question
When you were at IMSI during the graveyard
shifts what coemployees did you work with then
A The first time
Q Yes the first time Wellget to the
second time in a second
A Okay When I did my OJTonthejob
training for four or five weeks my field
training officer which was an FTO was Joey





A I dontremember the guy that I worked
with on her days off
Q All right Getting back to the womans
facility then Why did you transfer back to
IMSI
A I didnt get to go into training of
prisoners
Q So what led you to go back then to
IMSI Is that because a position was no longer
open to you at the women facility or you just
preferred to be back at IMSI
A Both
Q Okay
A I decided I liked more security I
also had a conflict with CO Forrey FSO Forrey
she wasnta CO FSO Thats not the reason
Q What was the conflict
A She said that I made some sexual
comments
Q Did you
A Yes everybody did
Q But that got you into some hot water
12 Pages 42 to 45
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1 A year or so 1
2 Q So from roughly July of 06 to July 2
3 of 07 or somewhere in that area 3
4 A August September yes something like 4
5 that 5
6 Q Okay 6
7 A Something like that 7
8 Q Do you remember who your supervisors or 8
9 shift supervisors were at the womensfacility 9
10 A Sergeant Schaeffer oh I wish I 10
11 could remember this guys name He was my direc 11
12 supervisor for a long time I could 12
13 just Shoen Shoen Sergeant Shoen was one 13
14 ofmy direct supervisors 14
15 Q So you were still a corrections officer 15
16 at thewomensfacility 16
17 A Yes 17
18 Q And what were your responsibilities 18
19 there 19
20 A So much easier to just read it The 20
21 same tier checks feeding writing people up 21
22 teaching them how to change their behavior 22
23 making sure they were safe 23
24 Q Did you work on any particular blocks 24
25 or tiers over there 25
Page 43
1 A I worked in what are they called 1 1
2 worked in Building 2 2
3 Q And what was at Building 2 3
4 A Im trying to you have shorttime 4
5 offenders and you have longterm offenders who 5
6 are going through programming Im trying to 6
7 remember what they called the longterm They 7
8 had a name for it where they went through 8
9 classes every day I mean their day is to get 9
10 up eat go to class class class class And 10
11 then at first I worked with the offenders that 11
12 didntdo that They came in and they had jobs 12
13 to do They went to some classes 13
14 And what else did I do Caused a lot 14
15 of problems They had rec time and they watched 15
16 them during the rec times and did checks So 16
17 pretty much you walked around You talked to the 17
18 offenders and talked to ask them how they 18
19 were doing in their classes make sure everyone 19
20 was safe 20
21 Q What shifts did you have when you 21
22 worked at the women facility 22
23 A Swing shift 23
24 Q What was the time period for that 24
25 A 230to 103 125
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a e  
  year or so. 
2 . SO fro , roughly, July of'06 to July 
 f '0 , r e here in that ? 
4 A. August, September, yes, something like 
 t . 
 . kay. 
 . So ething like that. 
 . o you re e ber ho your supervisors or 
 shift supervisors ere at the o en's facility? 
lOA. Sergeant Schaeffer -- oh, I ish I 
11 could re e ber this guy's na e. e as y direc 
 supervisor for a long time. I could 
13 just -- hoen, -h-o-e-n. ergeant hoen as one 
 of my direct supervisors. 
 Q. SO you were still a corrections officer 
 at the o en's facility? 
 . e . 
 . nd hat ere your responsibilities 
 re? 
 A. So much easier to just read it. The 
21 sa e: tier checks, feeding, riting people up, 
 teaching them how to change their behavior, 
 making sure they were safe. 
 Q. Did you work on any particular blocks 
  e s  re? 
e  
1 . hat   e .m.; ct? 
2 . es. 
3 . ll ri t. 
4 . nless ou rke   r , t e  it a  
5  rs re  o  rs r. 
6 . o you re e ber any of the co-e ployees, 
7 that you orked ith hen you orked at the 
8 en's ility,   rs? 
9 . t the omen's? pack an, aines, 
 Irn. 
 . I'm s rry. I i n't et t at? 
12 . Irn, - -I-m. y,    
13 kitchen person; ra ell or ro ell. here as 
   r .  on't e e er  . 
  sn't   . 
 . I f r t t  as   t at sa e estion. 
  e   ere at I I ring t e ra e ar  
18 shifts, hat co-e ployees did you ork ith then? 
 . e irs  e? 
 . es, the first ti e. e'll get to the 
  e   cond. 
 . kay. hen I did y JT, on-the-job 
23 training, for four or five eeks, y field 
 t i i  i r, i    ,   
 rris. t i , l , l , l on. 
~-----------------~-----l--------.... -.-~----~ ... ---"'".-... ~.-... " ... 
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 .    -- hat are they called? 
 orked in uilding 2. 
 . nd hat as at uilding 2? 
 . I'm trying to -- you have short-time 
 offenders, and you have long-ter  offenders, ho 
 are going through programming. I'm trying to 
 remember what they called the long-term. They 





. O-I- - - -o-n. 
. kay. 
  
 .  on't  t   t t   
5 it     ff. 
6 . ll right. etting back to the o an's 
 facility, then. hy did you transfer back to 
 SI? 
 classes every day. I mean, their day is to get  . I didn't get to go into training f 
10 up, eat, go to class, class, class, class. And  ri ers. 
11 then, at first, I orked ith the offenders that  . O t l   t    t  t  
 didn't do that. hey ca e in, and they had jobs  SI?  t t   iti    l r 
13 to do. hey ent to so e classes.   t   t t  en's f cility,   j t 
    i   o?     r f rr  t    t I SI? 
 of problems. They had rec time, and they watched 15 . th. 
16 the  during the rec ti es, and did checks. So  . kay. 
  pretty much you walked around. You talked to the 1 7 . I decided I liked ore security. I 
 offenders, and talked to -- ask the  how they     nfl  i   r  --  or ey, 
 were doing in their classes, ake sure everyone   asn't  O; O. hat's t t  son. 
  afe.  . at as t e conflict? 
 Q. hat shifts did you have when you  .  i  t t I   sex l 
 orked at the o en's facility? 
 . S ing shift. 
 
 
. hat as the ti e period for that? 








. id you? 
. s, v r  did. 
. t t at got  i t  s e t ater? 
 (Pa e   t  45) 
Page 48
officers
A I have mainly worked on when I was
on graveyard I worked with Olevson I dont
remember the guy that I worked with And then it
was different people Ifsomebody was sick or
had vacation different people would come and
workwith me
Q Okay How about on J Block
A There were three ofus AndMcGill
and a woman short I cantremember her name
Q Okay Any others that you remember
A I wish we had a roster here
Q Well I have some documents that Ill
show you in a little while
A Okay
Q Some of those do have names on them
Some of them have been deleted or redacted out
But maybe that will cause you to remember
something back and you can just tell me
A Right Okay
MR BURKE Letsgo to some of those
Exhibit 2 marked
Q BY MR BURKE So Im handing you wl
wev had marked as Exhibit No 2 to your
deposition Have you ever seen this document or
Page 49
one like it before
A Yes
Q And is this a performance evaluation
A Yes
Q So Im assuming this is something that
you periodically got when you were employed by
IDOC
A Yes This was like my exit transfer to
SBWOC
Q Okay So
A This was done a month or two or three
after I transferred
Q All right And in particular it
relates to Lieutenant Greenland Would that have
been a supervisor you had while you were at IMSI
the first time
A Yes I believe I put in I dont
know Did I list him
Q I think you did I just want to make
sure
AndIm assuming that you received
performance evaluations like this periodically
during the whole time that you were at the
Department of Corrections correct
A We were I believe we were supposed
13 Pages 46 to 49
Page 46
1 A Yes because I admitted to it 1
2 Q Her name was Forrey you said 2
3 A Yes uhhuh 3
4 Q Is that Forrey 4
5 A Yes I believe so 5
6 Q So it looks like you went back to IMSI 6
7 starting sometime around August or September of 7
8 2007 is that about right 8
9 A Yeah Yes 9
10 Q And you continued to work at IMSI until 10
11 you were terminated in May of 2008 11
12 A Yes 12
13 Q So where did you work when you came 13
14 back to IMSI 14
15 A I went back to A Block on graveyard 15
16 Q For how long 16
17 A I think the bid was in January and 17
18 then I went to J Block 18
19 Q And were you at J Block for the 19
20 remainder of your time 20
21 A Yes 21
22 Q Okay Who were your supervisors 22
23 andor shift commanders on the A Block graveyard 23
24 shift 24
25 A There are no sup direc 25
Page 47
1 supervisors on graveyard There is Lieutenant 1
2 Greenland and Lieutenant Gerber Sergeant 2
3 Feniger Lieutenant Sterner I believe 3
4 Q Okay How about once you moved over to 4
5 J Block Who were your supervisors there 5
6 A Sergeant Link and she was my direct 6
7 supervisor when I was on graveyard too I had 7
8 to tell her that she was She didntknow 8
9 Q What shift did you have at J Block 9
10 A Swing shift and then she knew she was 10
11 my direct supervisor then 11
12 Q Okay Any other supervisors on J 12
13 Block shift commanders 13
14 A I dontremember The daytime one was 14
15 before my first time Sergeant Overguard was 15
16 a was an A Block supervisor What are we 16
17 talking about in the second time Im sorry 17
18 Q Wer talking about the second time 18
19 Who were the supervisors the second time around 19
20 at IMSI 20
21 A I see their faces A face doesntput 21
22 a name I cantput a name on it here 22
23 Q Thats all right Lets talk about 23
24 coemployees While you worked on the A Block 24











. es, ecause I a itte  t  it. 
. er na e as Forrey, you said? 
A. es, uh-huh. 
Q. Is that F-o-r-r-e-y? 
. es, I elieve s . 
age  
Q. SO it looks like you went back to I SI 
starting so eti e around ugust or epte ber f 
; is t at a t ri t? 
.  e . . 
 . nd you continued to ork at I SI until 
 you ere ter inated in ay of 2008? 
 . e . 
a e  
1 rs? 
 . I a e i ly orked  -- e  I as 
  ,  e  it  l .  n't 
 r er the  that 1 orke  it . nd then it 
5 as iffere t l .   as i , r 
6  ti , iffere t le l  e  
7  ith . 
8 . .  t   l k? 
 . here e t re   .  il , 
   ,  --  n't   . 
 . a .  t ers t at  re e ber? 
 . I is  e   t  . 
 . O ere i   r  e   ca e  . l ,  e e   ' l 
    ttl  il .    I I?  
 . I ent back to  lock on graveyard.  . y. 
 Q. For how long?  . e  s    es  . 
 . I think the bid as in January, and       ,   t. 
ut aybe that ill cause you to re e ber 
so ething back, and you can just tell e. 
 e      . 18 
 . nd ereyouatJBlockforthe  
 re ainder of your ti e?  . i t. . 
 . .  . : et's go to so e f those. 
(Exhi it  rked.)  Q. Okay. ho were your supervisors,  
 and/or shift co anders on the  lock graveyard 23 . (B  . E) So I'm handing you ha 
e've  r   i it .  t  r 
siti .   r  t i  ent, r 
 ift?  
 . There are no supervisor, direct  
-. 
  
 supervisors on graveyard. There is Lieutenant 
 reenland, and Lieutenant erber, Sergeant 
 Feniger, Lieutenant Sterner, I believe. 
 Q. Okay. How about once you moved over to 
 J Block? ho were your supervisors there? 
 A. Sergeant Link, and she was my direct 
 supervisor when I was on graveyard, too. I had 
 t  t ll r t t s  s.  i n't . 
 . hat shift did you have at J Block? 
lOA. S ing shift, and then she kne  she as 
 y direct supervisor, then. 
 Q. kay. ny other supervisors on J 
 Block; shift co anders? 
 A. I don't re e ber. The dayti e one was 
 before my first time Sergeant Overguard was 
  -- was an A Block supervisor. What are we 
17 talking about, in the second ti e? I'm sorry. 
 . e're talking about the second ti e. 
 ho ere the supervisors the second ti e around 
 t SI? 
  
lone  t f re? 
 . . 
3 . nd is this a perfor ance evaluation? 
4 . . 
5 . SO I'm assu ing this is so ething that 
6 u, riodically, t    l  y:, 
 C? 
 A. es. This as like y exit transfer to 
 . 
 . y. --
 .     nth,  ,   
 f   sfer ed. 
 . ll ri ht.  i  articular, it 
    nl nd.    
 been a supervisor you had while you were at I SI . 
  t e? 
  . s, I li  I t i  -- I on't 
 ow. i    im? 
 . I think you did. I just ant to ake 
 ure. 
 . I see their faces.  face doesn't put   I'm ssu i  t t  r cei  
 a na e. I can't put a na e on it here.  perfor ance evaluations like this, periodically, 
 Q. That's all right. Let's talk about  during the whole ti e that you were at the 
 co-e ployees. hile you worked on the A Block, 24 epart ent f orrections; correct? 
25 do you remember any of the co-employees, other 25 .   -- I l    su  
 (Pa s  t  9) 
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to
A Yeah I know In fact Im wearing
bladder protection right now because I cant
control it any more
Q Okay Letschange to OC exposure I
want to talk about your training sessions with
that
MR BURKE Letsmark that
Exhibit 8 marked
Q BY MR BURKE All right Let me ha
you what Ive had marked as Exhibit 8 to your
deposition This is a document that apparently
came from the Idaho Department of Corrections
Its titled Training Transcript And it
appears to relate to you
Have you ever seen this document
before
A Yes
Q Okay And I know its consisting of
three pages Does it appear to list all the
various training classes that you had while you
were employed by IDOC
A Yes
Q Okay
A I think almost everything is on there
Page 93
Q At least at this point you cant think
of anything that you had as far as training
goes while you were at IDOC thats not listed
here
A Yes
Q Okay And so this covers training
sessions beginning in July 30 2004 and going
all the way to your last one which was March 3rd
of 2008 is that right
A 411 its not in date order Here
youvegot on page 3 411 319 Oh those are
2007 Oh there we go
Q I think its in chronological order
A Okay
Q So basically you are going from July
30 2004 through March 3 of 2008
A Yes
Q All right I want to focus on the ones
that may relate to OC Letsstart with the
first one which is on the first page about
halfway down It says Oleoresin Capsicum OC
82004 And then under that it says
Pepperball Systems82004 Do you recall that
particular training
A Yes I dontremember Kevin Nation
24 Pages 90 to 93
Page 90
1 A Yeah that was one of the reasons 1
2 Q And there were others too a number of 2
3 other reasons including inappropriate use of a 3
4 computer Thats another reason correct 4
5 A Yes I was on MySpace 5
6 Q Okay And there was also some charges 6
7 that had to do with improper sexual 7
8 communications or viewing sexually explicit 8
9 material on the computer 9
10 A I asked to see that and they never 10
11 showed me any And I think it was when I was on 11
12 MySpace when I clicked on these pictures and 12
13 stuff 13
14 Q But that was on the chart though 14
15 wasntit 15
16 A Yeah 16
17 Q So why do you think the Department 17
18 terminated you if it wasn appropriate in 18
19 terms of the charges that they were making 19
20 against you 20
21 A Because several other officers were 21
22 doing the same things and they were never let 22
23 go
23
24 Q So why do you think you were let go 24
25 A When I smiled on camera they didnt 25
Page 91
1 like that at all They didnt know how to defend 1
2 that in a court of action is what they had told 2
3 to me verbally 3
4 Q Have you had any employment since May 4
5 of2008 5
6 A No 6
7 Q Have you applied for any jobs since 7
8 then 8
9 A No 9
10 Q And why not 10
11 A We haventcome up with a job that I 11
12 could do yet 12
13 Q And by that you mean what 13
14 A Walking talking everything makes me 14
15 cough so and I need to be able to use the 15
16 rest room you know as needed And I am on 16
17 Norco 10325s to help suppress the cough And 17
18 people dontwant you working for them when you 18
19 are on narcotics 19
20 Q Okay 20
21 A Thatsa big one And I dontknow of 21
22 anyone that would hire me Would you hire me 22
23 Q You haventapplied 23
24 A Should I do that 24








Page 90 Page 92 
A. Yeah, that was one of the reasons. 1 to. 
2 Q. And there were others, too, a number of A. Yea , I kn . In fa , I'm wearing 
other reasons, including inappropriate use of a 3 bladder protection right no , because I c 't 
computer. That's another reason; correct? 4 control it any more. 
A. Yes, I was on MySpace. 5 Q. Oka . Let's change to OC e s . I 
Q. Okay. And there was also some charges 6 ant to talk about your training sessions ith 
7 that had to do with improper sexual 7 th . 
8 co unications, or viewing sexually explicit 8 . B : L t's ark that. 
9 material on the co puter? 9 (Exhibit 8 d.) 
10 A. I asked to see that, and they never 10 . (BY . ) l rig . et e and 
11 showed me any. And I think it was when I was on 11 you hat I've had arked as it  to your 
12 MySpace, when I clicked on these pictures and 12 iti . his is a docu ent t t, r ntl , 
 st f .  a e from the Idaho epart ent f rre . 
4 Q. But that was on the chart, though;  It's titled "Training script." nd it 
5 n't it?  e s to relate to y . 
6 . e .  a e ou er  t is c ent 
7 Q. SO why do you think the Department  f re? 
18 terminated you, if it wasn't appropriate, in  . . 
19 ter s of the charges that they ere aking  . . nd I  it's sisting f 
 against you?  t ree . oes it r t  list ll t e 
21 . ecause r l t er fficers r   a ious  as     le  
 doing the same things, and they were never let  r  loye   I ? 
 go.  . . 
 Q. SO why do you think you were let go?  . y. 
25 . hen I s iled on ca era, they didn't  . J      . 
,~-~,~-~--'"~~---~"'"-""~"-~-~"'~-,~~'"'-+~"-~-'-
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1 like that at all. They didn't kno  ho  to defend 
 t at i  a c rt f acti  is at t e  a  t l  
 to me verbally. 
 Q. Have you had any employment since May 
 f2008? 
 . o. 
7 Q. Have you applied for any jobs since 
8 then? 
 . . 
 Q. And why not? 
 A. e haven't co e up with ajob that I 
12 could do yet. 
13 Q. And by that, you mean, what? 
14 A. Walking, talking, everything makes me 
15 cough, so -- and I need to be able to use the 
 rest room, you know, as needed. And I am on 
17 Norco 10/325s to help suppress the cough. And 
18 people don't want you working for them when you 
 are on narcotics. 
 Q. Okay. 
 A. That's a big one. And I don't know of 
2  anyone that would hire me. Would you hire me? 
23 Q. You haven't applied. 
24 A. Should I do that? 



























.    s i t,  n't  
f t i  t t  , s f r s tr i i  
s, il   r  t I , t at's t list  
re? 
. s. 
. .  s  t i   t i i  
si  i i  i  l  , 04,  i  
ll t   t  r l st e, i  s r  r  
 08; i  t i ht? 
. -1 , it's t i  t  r er.  
ou've t   3, -1 ,3- . h, t s  ar  
07. h, t r   o. 
. I t i  it's i  chronologi al order. 
. kay. 
. SO, basically, y  ar  going fr  July 
0, 2  t r  rch 3 f 2008? 
. s. 
. l  ri ht. I ant t  f s o  t  o s 
t at ay rel te to C. Let's start ith the 
fi t ne, i  is on t  first page, about 
half  down. It says, Ol or si  apsicu  O  
8/20/04. And then under that it says, 
" rbalJ Syst  8/20/ 4." o you recall that 
particul r training? 
A. es. I don't re e ber Kevin Nation, 
24 (  90 t  93) 
Page 96
A I thought it was The week preceding
that was one of this classroom So that day was
only OC training
Q So what does that mean OC training
Tell me about that then What occurred
A They walked us through OC procedures
And then OC and how to use deploy the OC
And thats how thats when we started learning
about foam stream which we used and fog
Q Okay
A So first we went through the paper part
of it and learned about it and then we went
into
Q By paper part do you mean like you
were given brochures or something like that or
manuals
A Yeah much like an exhibit that this is
a
Q Like a handout
A Yes a manual
Q So would that be in a classroom
setting then
A Yes
Q And was that usually at the beginning
of the training
Page 971
A This was the very last day of our
training
Q And so how long did the paperwork part
of the training occur
A That was early in the morning so
Q All right So after you got done with
the paperwork then what happened
A Then we went and they sprayed it My
very first time thats what this is They
sprayed a room with OC About half the well
if you took that line right there indicating to
the line right there indicating and came right
across in a room that big And they sprayed a
bunch of OC in there Mark 9s
Q Let me stop you there so we can get
that down Thatsnot going to come out on the
record Can you give me approximate dimensions
of the room so many feet by so many feet
A Is that about a six a six by eight
room
Q Okay And were you present when the OC
was sprayed in the room
A No
Q And how many people went through the
training at that time
25 Pages 94 to 97
Page 94
1 s pecifically but yeah 1
2 Q Okay Was that your first training 2
3 with respect to OC 3
4 A Yes that was Yeah 4
5 Q Was that during your training session 5
6 inside or outside the facility 6
7 A Inside 7
8 Q Okay 8
9 A That was that last week of training 9
10 inside the facility 1 0
11 Q It does mention here Sergeant Kevin 1 1
12 Nation Do you have any recollection of who that 1 2
13 was 1 3
14 A We had so many instructors I dont 1 4
15 remember him 1 5
16 Q So you dont remember him at all 1 6
17 A No 1 7
18 Q Okay So you cant say whether he was 1 8
19 the instructor or not 1 9
20 A No I cant 20
21 Q Okay Regardless do you remember who 2 1
22 the instructor was for that specific training 22
23 p rogram 2 3
24 A No we had so many instructors They 2 4
25 came in different days 2 5
Page 95
1 Q Okay 1
2 A I dontthink they 2
3 Q Now I want to talk about two different 3
4 components here This talks about OC and its 4
5 got under the hours it says three hours And 5
6 then under that it says pepperball systems two 6
7 hours Were those trainings conducted on the 7
8 s ame day is that your recollection 8
9 A Yes 9
10 Q Do you know who did the pepperball 1 0
11 training Was that the same person who trained 1 1
12 the other stuff 1 2
13 A Yeah there were there were several 1 3
14 s ergeants and stuff there that helped out all 1 4
15 through the day 1 5
16 Q Do you remember who any of them were ol 1 16
17 that particular training 1 7
18 A No 1 8
19 Q So tell me about what you do recall 1 9
20 a bout the training that day Letskind of take 2 0
21 me through the process I mean was it first of 2 1
22 a ll just by way of example was any of it 2 2
23 c lassroom training 2 3
24 A Yes it was 2 4
125 Q How much of the time was classroom 1
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Page 94 Page 96 
1 specifically, but, yeah. 1 A. I thought it was. The eek preceding 
2 Q. Okay. as that your first training 2 that was one of this classr . So that day was 
3 with respect to OC? 3 only C trai . 
4 A. Yes, that was. Yeah. 4 . SO what does that mea , "~C training"? 
5 Q. Was that during your training session 5 Te l me about tha , the . hat oc d? 
6 inside or outside the facility? 6 A. They walked us through OC proced re . 
7 A. Inside. 7 And then OC -- and ho  to us , deploy the ~ . 
8 Q. Okay. 8 nd th t's ho  -- t t's hen e started learning 
9 A. That was that last week of training 9 about foam stre , hich e us , and fo . 
10 inside the facility. 10 . . 
11 Q. It does ention here Sergeant evin 11 . So first e ent throug  the paper part 
12 Nation. Do you have any recollection of who that 12 f i , a d learned a ut it,  t e  e ent 
 was?  into--
4 . e had so any instructors. I don't  . y "paper rt," o  ean like ou 
5 re e ber hi .  ere ive  r r s, r s t ing like t t, r 
6 . SO you don't re e ber hi  at all?  ls? 
1 7 . .  7 . , ch ike  t that is s 
8 Q. Okay. So you can't say whether he was  --
 the ins  r t?  . ike a a out? 
0 A. No, I can't. 20 . ,  l. 
 Q. Okay. Regardless, do you remember who 21 . O   e    
22 the instructor was for that specific training  tti , t ? 
 program?  . s. 
 A. No, we had so many instructors. They  .    ll     
 ca e in different days.  f t  tr i ing? 
I-------------~ ________ __+-~----"--.. ~-,~"'--".-"'W""'-""-."~",".",,',,"' •• , "",,'" 
Page 95 
1 Q. Okay. 
 A. I don't think they --
 Q. Now, I want to talk about two different 
 components here. This talks about OC, and it's 
 got under the hours, it says three hours. And 
 then under that, it says, pepperball systems two 
7 hours. ere those trainings conducted on the 
8 same day; is that your recollection? 
 . es. 
 Q. Do you know who did the pepperball 
11 training? Was that the same person who trained 
 the other stuff? 
13 A. Yeah, there were -- t  r  sever l 
 sergeants, and stuff there that helped out all 
15 through the day. 
 Q. Do you remember who any of them were 0 
1 7 that particular training? 
 . o. 
 Q. SO tell me about what you do recall 
 about the training that day. Let's kind of take 
 me through the process. I mean, was it, first of 
2  all, just by way of example, was any of it 
 classroom training? 
24 A. Yes, it was. 
25 Q. How much of the time was classroom? 
  
 .         
 i i . 
 .       r   
 f t  tr i i  ccur? 
5 .   rl    rning, o ... 
 .  t.       
 t  erwork, t  t ppened? 
 .   t,   spr  it.  
 r  first ti e, that's t t is is. y 
 spr   r  it  ~C. t lf t  -- well, 
 if  t  t t li  ri t t r  (in i ting) t  
 t  li  ri t t r  (in i ating), a  c  ri t 
. 1  acr  i  a r  t t big.  t y spr  a 
  of  i  there, r  9s. 
1  . t  stop y  t ere, so  c  get 
16 t t down. hat's not goi  to co  o t o  t  
1 7 record. a  y  gi e e approxi ate di ensi s 
18 f t  r om; so any f et y so any feet? ' 
19 . I  t t about a six -- a si  by eight 
20 room. 
21 Q. kay. A d were you present en the OC 
22 w s spray d in the room? 
23 A. No. 
24 Q.  ho  any peopl  went through the 
25 traini g at that time? 
25 (  94 t  97) 
Page 100
Q How many people did
A Eight or ten of us And we stayed in
there until we started coughing so that we
would we had to know the effects of OC that
it had on us So when we started coughing we
walked outside out of the room outside And we
were handed paper towels to wipe off our face
Q So how long were you in the room during
that training
A 20 seconds
Q And did you start coughing within that
20 seconds
A Yes
Q Did other people start coughing too
A Some people in a matter of seconds
yes
Q Okay And so at that point you were
taken outside correct
A Yes
Q Handed the towel Did you continue to
cough when you were outside
A Yes everybody did I believe
Q For about how long
A I do not remember
Q At some point in time though did you
Page 101
stop coughing after that training session
A Yes
Q Do you remember how long it took for
that to happen
A No
Q Did you have a chance to observe close
up the canister of OC that was actually deployed
in that room
A I only seen the one white one
Q Okay Did you read any of the writing
on the canister
A No
Q And how do you know what name brand
canister was
A That I didntI just know it was a
Mark 9
Q Okay
A But I knew we used five percent at that
time
Q How do you know that
A Because thatswhat we were trained in
our little manuals they gave us on training
Q The manuals told you it was five
percent
A Yes
26 Pages 98 to 101
Page 98
1 A I believe there were about ten of us 1
2 Some people were doing a refresher course and 2
3 there were only three new employees 3
4 Q Do you remember who any of the 4
5 coemployees were who went through the training 5
6 A I cantthink of their names offhand 6
7 Bunn she was a new hire when I was 7
8 Q Who 8
9 A Bunn Bunn 9
10 Q Is that a last name 10
11 A Yes We always went by last names 11
12 Q Okay So she went through the training 12
13 at the same time then 13
14 A Yes there were three of us that went 14
15 to maximum security I cantremember the guys 15
16 name 16
17 Q Okay So somebody had previously 17
18 deployed OC in that particular room correct 18
19 A Yes And it was dripping from the 19
20 ceiling 20
21 Q What color was the OC Could you see a 21
22 color on it 22
23 A It was a color but I dontrecall the 23
24 color 24
25 Q Okay Did you actually see the 25
Page 99
1 canister that deployed it 1
2 A It was a one ofthe canisters was a 2
3 Mark 9 that I seen 3
4 Q And what color was the canister 4
5 A White 5
6 Q You talk about a spray an aerosol a 6
7 gel a 7
8 A Fog 8
9 Q A fog yeah What component was this 9
10 Mark 9 on the wall that you observed 10
11 A We only used the spray delivery systems 11
12 as far as I knew The fog you have to be too 12
13 close The foam they can wipe off and throw 13
14 back at you so we used stream 14
15 Q So I take it you did not see whoever 15
16 deployed the Mark 9 into this particular room do 16
17 it 17
18 A When we were walking into the corridor 18
19 the hallway I didnt I dontremember the 19
20 personsname but I did see him using a Mark 9 20
21 Q In that room or somewhere else 21
22 A Spraying it into that room 22
23 Q Okay So what happened then What 23
24 did you do in the room 24
25 A We walked into the room 25
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1 
2 
A. I believe there ere a out ten f . 1 . o  any e le i ? 
Some people were doing a refresher course, and 2 . ight or ten of u . nd e stayed in 
3 there were only three new e ployees. 3 there until e started c , s  that e 
4 Q. Do you re e ber who any of the 4 o ld -- e had to kno  the fects , that 
5 co-employees were who went through the training? 5 it had n u . o hen e ted co , e 
6 . I c n't think  their na es fha . 6 alked o ts , ut f the ro , . n  e 
7 Bu , she as a e  hire hen I as. 
8 Q. ho? 
9 . u , -u-n-n. 
 Q. Is that a last na e? 
1 A. Yes. e always went by last names. 
 Q. Okay. So she went through the training 
 at the sa e ti e, then? 
 . es, there ere three f us t t e t 
 to i u  s rit . I n't re e er the y's 
 . 
 Q. kay. So so ebody had previously 
18 deployed OC in that particular roo ; correct? 
 . es. nd it as dripping fro  the 
 ceiling. 
 Q. hat color was the OC? Could you see a 
 lor  it? 
 . It as a color, but I don't recall the 
 l r. 
 Q. Okay. Did you actually see the 
  
 canister that deployed it? 
 . t   --   e s   
 r   t t I . 
 Q. And what color was the canister? 
 . it . 
 Q. You talk about a spray, an aerosol, a 
 gel, a--
 A. Fog. 
 Q. A fog, yeah. What component was this 
10 ark 9 on the all that you observed? 
 A. e only used the spray delivery syste s 
 as far as I knew. The fog, you have to be too 
 close. The foa , they can wipe off and throw 
 back at you, so we used stream. 
 Q. SO I take it, you did not see whoever 
 deployed the ark 9 into this particular room do 
 it? 
 . hen e ere alking into the corridor, 
19 the hallway, I didn't --  on't r r t  
 person's name, but I did see him using a Mark 9. 
 Q. In that room, or somewhere else? 
 A. Spraying it into that room. 
 Q. Okay. So what happened, then? What 
 did you do in the room? 
 .  l  i t  t  . 
7 ere handed aper to els to ipe f  fa . 
8 . O how long ere you in the  ring 
9 that training? 
.  s .  
 .    start ing ithin that 
12  nds? 
13 . . 
 .  ther le t i , t ? 
 . e le   e   , 
 . 
 . y. nd s  t t t i t,  ere 
18 a en i ; rr ct? 
19 . . 
20 . a e  e t l.     
 cough hen you ere outside? 
 . ,  i ,  li . 
 .  t  l g? 
 .    er. 
 . t  i t i  ti , t gh, i   
  
 t  i  ft r t t tr i i  ssion? 
 . . 
3 .   r r  l  it t  f r 
4 t t t  pen? 
5 . o. 
6 . i      t   l  
III 78   i      t l   
  om? 
 . I l  s  t   it  ne. 
 . ay. i   r   f t  riti  
   anister?' 
 . . 
 .      t  r  the f 
 i  as? 
 . at,  idn't.       
 r  . 
 . kay. 
 .  I    fi    t 
1  ti e. 
 .     that? 
 .  that's    t i  i  
 r littl  ls t y v  s o  tr ining. 
 . he anuals told you it as five 
 percent? 
 . s. 
 (P  9  t  101) 
Page 108
lasted for about three hours while you were at
IMSI in February of2006
A We probably did I know I had one not
very long after I trained at the womensSo I
know I had overlap there where we only did it
once ayear
Q Okay But right now you dont have a
specific recall of this particular training
A No
Q All right Lets move on There is
one above it that says OC Training Policy 307
Use of Instructor Julio Vega and the date on
that is82306 And it says one hour
So let me start out by saying do you
recall that training
A Yes it was like a refresher course
Q Okay And were you at the womens
prison at that time
A Yes thats where Vega was
Q And who was Vega
A He was an officer who was working his
way up the ranks
Q And he didnt have a rank of sergeant
or lieutenant or anything like that
A No
Page 109
Q And was that just classroom training
A Yes
Q So you didntactually get exposure to
OC in that training
A No we just went over the document
Q Now the document there in question is
that Policy 307
A Yes the use of it
Q And what is Policy 307
A The use ofOC
Q And as far as you know was it an
official policy of IDOC
A Yes because it was the policy for 307
Q Do you know when that policy was first
adopted
A No
Q Was it about the time it was adopted
or was it in place already before that
A I believe it was in place before that
Q Is Policy 307 the master document that
relates to the use and deployment of OC
A I believe it is
Q Were you provided with a copy of Policy
307
A Yes during the training
28 Pages 106 to 109
Page 106
1 Q But it actually doesnthave OC in it 1
2 does it 2
3 A No its a green can Was a green can 3
4 Q So on this particular training you 4
5 were exposed to OC in the small room correct 5
6 A Yes 6
7 Q And you dont know whether OC was 7
8 contained in the pepperballs 8
9 A No I dont 9
10 Q But you are fairly confident and 10
11 certain that OC was not contained in the 11
12 canisters which you trained with 12
13 A Right the inert no 13
14 Q The inert Okay 14
15 All right Letsgo to the next one on 15
16 this list And it looks like its on page 2 16
17 And these are actually a little bit reversed I 17
18 think There is two dates here One is21406 18
19 which I think would be the next one in line Let 19
20 me refer you to that particular one 20
21 A Okay Could I take a break 21
22 Q Well why dont we do this Its about 22
23 five minutes until noon Why dontwe just take 23
24 our lunch break at this time 24
25 A Okay 25
Page 107
1 MR BURKE Maybe try to be back here 1
2 about 100 2
3 A lunch recess was had 3
4 MR BURKE Back on the record 4
5 Q BY MR BURKE We were talking about 5
6 Exhibit No 8 the training schedule And I want 6
7 to continue going through that 7
8 The next training that Im concerned 8
9 with is the one thats dated February 14 of 9
10 2006 And it just says Oleoresin Capsicum It 10
11 has a date of21406and it has three hours by 11
12 it with instructor Bret Kimmel 12
13 Do you have a specific recall of that 13
14 training session 14
15 A I donteven remember when Kimmel 15
16 trained us So you know sorry about that 16
17 Q Do you know who Kimmel is 17
18 A Yes I know who he is 18
19 Q And do you recall him doing training on 19
20 you at all 20
21 A I only recall him doing one 21
22 Q Now in February of 2006 you were 22
23 still at IMSI correct 23
24 A Yes 2
125 Q Do you remember having a training that 125
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a e 06 
 . ut it actually doesn't have  in it; 
2 does it? 
3 . o, it's a green can. as a green can. 
4 . SO on this particular training, you 
 ere exposed to C in the s all roo ; correct? 
 . . 
 . nd you don't kno  hether  as 
 contained in the pepperballs? 
 . o, I don't. 
0 . ut you are fairly confident and 
1 ertain t at  as t tained i  t  
 canisters, hich you trained ith? 
 . Right, the inert, no. 
 . he inert. a . 
 All right. Let's go to the next one on 
 this list.  it l s like it's  a e . 
  nd these are actually a little bit reversed, I 
 t i . ere is t  t s r .  is 11 /06, 
 ich  t ink    t ne  .  
 e refer you to that particular one. 
 . kay. ould I take a break? 
 Q. ell, why don't we do this. It's about 
 five inutes until noon. hy don't e just take 
  c    s . 
e 8 
1 laste  for t ree urs hile ou ere  
 I SI in ary 06? 
 . e r l  i . I n  I a  e t 
 er  long fter I traine  t t e en's.  I 
 n  I a  erlap t ere r  e ly i  it 
 ce  r. 
7 . y. t rig t ,  n't   
8 i i  re ll  t is ticular t i i g? 
9 . . 
 . l t. t's e . ere is 
  e i , t  , "oc  l   
 se" fI str t r J li  ,  t e t   
 t at is /23/06.  it says, e r. 
  le      yi ,   
 recall t at trai i g? 
 . ,   ike  res  . 
 . ay. nd ere  at t e en's 
 prison at that ti e? 
 . , at's e ega s. 
 .    a? 
 .    icer     
    . 
 . nd he didn't have a rank f sergeant, 
  lie t t,  t i  like t at? 
 . .  . kay. 
f-------~-------------__l_-------------------,~-,-"-
    ' 
 R. BURKE: aybe try to be back here 1 . nd as that just classroo  training? 
 t :00.  . s. 
 (A lunch recess was had.)  . O  idn't t ll  t  t  
 . :    r .   in that training? 
 . (B  . ) e ere talking about  . o, e just ent over the docu ent. 
 xhibit o.8, the training schedule. nd I ant 6 . , t  t t  i  stion, i  
 to continue going through that.  t t li  07? 
 The next training that I'm concerned  . s,    . 
 ith is the one that's dated, February 14 of  .  t is li  07? 
10 2006. nd it just says, leoresin Capsicum. It lOA.    . 
11 has a date of 2114/06, and it has three hours by  .  s f r s  ow, s it  
 it, ith instructor ret i el.  official policy ofI OC? 
 Do you have a specific recall of that  . s, s  it s t  li  f r 07. 
14 training session?  . o you kno  hen that policy as first I' 
 . I n't  r r  i l  adopted? 
16 trained us. So, you kno , sorry about that.  . o. 
 . o you kno  ho i el is?  . s it t t  ti  it s opted, 
 . es, I   e is.  r as it i  lace already ef re t at? 
 . And do you recall hi  doing training on  . I elie e it as i  lace ef re t at. 
 you at all?  . Is olicy 307 the aster docu ent that 
 A. I only recall him doing one.      n  epl t f C? 
 Q. Now, in February of 2006, you were  . I l   is. 
 still at I SI; correct?  . ere you provided ith a copy of Policy 
 . s. 4 07? 
25 Q. o you re e ber having a training that 25 . es, uri  t e training. 
 (Pages 106 t  109) 
10 Q Is this the same policy wer talking 10 would deploy it against another person
11 about before Policy 307 11 A Yes
12 A Yes 12 Q So as far as you know actual OC was
13 Q So I take it you were not 13 not included in the inert spray
14 specifically exposed to OC during that training 14 A Exactly
15 A Yes 15 Q Okay And you had some classroom
16 Q Now I also note that at the same date 16 training on that day also
17 you see the next item is Annual Training Use of 17 A Yes
18 Force2107and it also says one hour for 18 Q All right And then on 720 it looks
19 that Was that a training that was done in 19 like it actually was over a period of time 718
20 conjunction with your OC refresher 20 to 720 But as you indicated they would take
21 A The way Sergeant Schaeffer did the 21 some people at a few people at a time and go
22 training at the womensprison because there was 22 over that is that how they do it
23 a lower training You read the policy and you 23 A Yes
24 answered his questions 24 Q And Sergeant Schaeffer was the one in
125 Q So what did the annual training use of 125 charge of that training
29 Pages 110 to 113
Page 110 Page 112
1 Q And what did you do with it 1 force what was that training about the same
2 A Left it on the table 2 d ay
3 Q Is that what everybody did orjust 3 A It was just a policy We read and
4 you personally did that 4 a nswer the questions
5 A Yes we did because all of the 5 Q Okay And what types of force were
6 policies were available in the units 6 i ncluded in the instruction that day
7 Q And the unit is what you call the 7 A The use of force as restraining and
8 control room for the block ofthe tier 8 a ll the different uses of force that we have
9 A Yes 9 reactive planned and reactive verbal Its
10 Q So if I wanted to find a copy of Policy 1 0 been awhile
11 307 today I could go to one of the block units 1 1 Q Physical restraints too
12 and pick one up 1 2 A I thinkso
13 A If it was in there yes 1 3 Q Did use of force training include OC
14 Q Thatswhere its supposed to be 1 4 deployment
15 A Yes 1 5 A No
16 Q Is there a particular place where they 1 6 Q So at least on2107you didnthave
17 kept those policies 1 7 a ny direct exposure to OC is that right
18 A A cabinet 1 8 A Exactly
19 Q Okay Letsgo to the next one in 1 9 Q Okay So the next one we have appears
20 s equence which is on the last page And this is 2 0 to be down the same page 7 13 of 07 It says
21 2 107 21 Oleoresin Capsicum and it says Instructor Dan
22 A Yes 2 2 S chaeffer and it says two hours Do you recall
23 Q You were at the womens facility at 2 3 that specific instruction
24 that time correct 2 4 A That one was we went through the
25 A Yes 2 5 paperwork and we did the delivery system And
Page 111 Page 113
1 Q And you see there where it says 1 then on 720 because you are going to ask me
2 Annual Training OC Refresher 2 about that one During 718 and 720 different
3 A Yes 3 ones of us depending on which shift you worked
4 Q And the instructor is Dan Schaeffer 4 did the actual OC training
5 A Yes 5 Q Okay Let me see if I can summarize
6 Q Do you recall that training 6 then So on 713 was there any actual
7 A Yes we read the policy We answered 7 deployment of OC in that training
8 questions on the computer and submitted it to 8 A Just inert
9 h im 9 Q And you were showing physically how you
000654
    
 . nd hat did you do ith it?  ,  as   ut, e  
, 
 . e t t  e .  day? 
 . s t at hat  ,  just  . It as just  li . e r   
 you, personally, did that?  ans er the questions. 
 . e , e i , ecause ll  t e  . .  t t pes  f rce r  
 policies ere available in the units. I  i lude  i  t  i tr ti  t t y? 
 . n  e t is  ou    . e se f f r   r training,  
    t e   the r?    fere t     e , 
 . .  r cti , l   r cti , r l. It's 
 . O if I t  t  fin     li    ile. , 
 307 today, I could go to one f the block units  . Physical restraints, too? 
 and pick one up?  .   . 
 . f t a   , .  . id use of force training include  
 . hat's here it's supposed to be?  l ent? 
 . .  . . 
 . Is there a particular place here they  . O t le t  /21 07,  i n't  
 kept those policies?  any direct exposure to ~C; is that right? 
 .  i t.  . ctly. 
 . kay. Let's go to the next one in  . ay.  t e e t e e a e a ears 
 sequence, hich is on the last page. nd this is 20 t  e  t e sa e a e, -13 f '0 . It sa s 
 /21/0 .  e  i ,   ,   
 . .  aef er,  t   .   l  
 .  r  t t  en's f ilit  t 23 that specific instruction? 
 t t ti ; rr ct?  .    -- e ent through the 
 . . 25 a er rk, a  e i  t e eli er  s ste .  
    
 .   s  t r , ere it s s,  t   -2 , s   r  i  t  s   
 "Annual Training C Refresher"?  t t t . ri  -18  -2 , iffere t 
 . .  s f s, i   i  s ift  r , 
 .  t  i str t r is a  aeffer?  i  t  t l  tr i i g. 
 . .  . ay. et e see ifl ca  s arize, 
 . o you recall that training?  t .   -1 , s t r   t l 
 . es, e rea  t e lic . e a s ere   deploy ent of OC in that training? 
 questions on the co puter, and sub itted it to  .  rt. 
 i .  . nd you ere sho ing physically ho  you 
 . Is this the sa e policy e're talking  ould deploy it against another person? 
11 about before, Policy 3O??  . s. 
 . .  . O s f r s  ow, t l  s 
 . SO I take it, you ere not,  t i l  i  t  i rt spray? 
 specifically, exposed to C during that training?  . actly. 
 . s.  . ay.   a  s e classr  
 . o , I also note that at the sa e date,  training on that day, also? 
17 you see the next item is "Annual Training Use of  . . 
18 orce, /21/07," and it also says, one hour for  . ll right. nd then on 7-20, it looks 
19 that. as that a training that was done in 19 like it actually as over a period of ti e, 7-18 
 conjunction with your OC refresher?  t  -2 . t   i i t d, t  l  t  
 A. The way Sergeant Schaeffer did the  so e people at a fe  people at a ti e, and go 
22 training at the women's prison, because there was  over that; is that ho  they do it? 
 a lo er training. ou read the policy, and you  . s. 
 ans ered his questions.  .  er ea t c aeffer as t e e i  
25 . SO hat did the annual training use f 25 charge of that training? 
 (Pages   13) 
Page 116
that training
A I believe around eight of us
Q Do you remember any of the other
persons who were in that training with you
A Spackman
Q And Kelm
A Yes those are the two I mainly worked
with Thatswhy I remember their names
Q Did you go into the building
individually or in groups
A Individually
Q Okay Once you came out with the box
what happened
A We put the box down and then some of
us carried it back in
Q Did you ever do that
A I dontrecall if I did that or not
Q Did everybody use the same box
A Yes
Q So the same box got sprayed with OC a
lot of times
A Yes
Q At least eight
A Yes





1 A Yes 1
2 Q And it says here it took two hours 2
3 What was involved in that two hours 3
4 A We were at the womensfacility and 4
5 there was a little building out back So he 5
6 sprayed a bunch of OC in there 6
7 Q How big was the building Can you give 7
8 me relative dimensions in feet 8
9 A Three by five 9
10 Q Like a shack 10
11 A Yeah Well it was a shack 11
12 Q So probably you couldntget a lot of 12
13 people in that building 13
14 A The way we did the training was we 14
15 stand at the door and shout commands as we 15
16 walked to the back of the building and we 16
17 sprayed a box with OC Sorry We sprayed the 17
18 box with OC holstered our OC and carried the 18
19 box back out the door 19
20 Q Okay So let me see ifIve got this 20
21 straight So is this a room that had OC sprayed 21
22 on the walls before you went in or did this just 22
23 happen that you went into the room and you 23





A No it had OC sprayed in there into the building spraying the box bringing the
2 previously 2 box out then what did you do
3 Q Previously 3 A I stood there with everyone else and
4 A Then when it came our turn we sprayed 4 laughed and watched the other people go in and
5 it as we walked in shouting commands and 5 cough and come back
6 sprayed the box Holstered our OC picked up the 6 Q So basically you waited for everybody
7 box and carried it back out of the room out 7 to finish the drill
8 of the shack 8 A Yes
9 Q So the room already had some OC sprayed 9 Q And once everybody finished the drill
10 on the walls before you went in 10 then what happened
11 A Everywhere in there yeah 11 A We were done
12 Q Okay So you went in you unholstered 12 Q Did you do any sort of decontamination
13 your specific OC Sprayed it on the box picked 13 A No
14 up the box walked out of the room with the box 14 Q The OC that you deployed was that the
15 A Yes 15 personal OC that you were issued and carried with
16 Q How long did that take 16 you at the time
17 A Maybe a minute 17 A No
18 Q Okay Or less 18 Q or was it issued specifically for
19 A One to two minutes yeah 19 that particular training
20 Q One to two minutes A We used whatever he handed us for that
A But I dontknow what position I was in 21 training
22 line But every time we went in there we 22 Q Okay Do you remember what it was that
23 sprayed it Everybody who went in sprayed it 23 he handed you
24 so 24 A No
25 Q Okay How many people were involved in 2 5 Q Do you know did it in fact have OC
30 Pages 114 to 117
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age  
. e .  
2 . nd it says here, it took t o hours. 
 hat as involved in t at t o ? 
4 . e ere at the o en's facility, and 
 there as a little building out back. So he 
 sprayed a bunch of OC in there. 
 . o  big as the building? an you give 





A. Three by five. 
. Like a shack? 
. eah. ell, it as a shack. 
Q. SO, probably, you couldn't get a lot of 
 people in that building? 
 . The ay e did the training as, e 
 stand at the door, and shout co ands as e 
 alked to the back of the building, and e 
 sprayed a box with OC. Sorry. e sprayed the 
 box ith , holstered our ~C, and carried the 
     r. 
 Q. Okay. So let me see if I've got this 
 straight. So is this a room that had OC sprayed 
 on the walls before you went in, or did this just 
 happen that you went into the room, and you 
a e 6 
1 t t tr i i g? 
2 .  lie e  i t f . 
 . o  e e er   t e ther 
4 ersons ho ere in t at tr i ing ith u? 
5 . . 
 .  Irn? 
 . , t s  e t e t   i l  e  
8 it . at's  I  t i  . 
9 . id   i t  t e ilding 
 individually or in groups? 
. I i i ll .  
 . kay. nce you ca e out ith the box, 
 hat happened? 
 . e t t   ,  t    






.     at? 
.  n't       t. 
. id everybody use the sa e box? 
. . 
. SO the sa e box got sprayed ith  a 




 deployed your own OC, and then brought the box  
. t least eight? 
. . 
 ut? 
 A. No, it had OC sprayed in there, 
 previously. 
 . Previously? 
  
 . Then hen it ca e our tum, e sprayed 
 it as e alked in, shouting co ands, and 
 sprayed the box. Holstered our OC, picked up the 
 box, and carried it back out of the roo  -- t 
   ck. 
 Q. SO the room already had some OC sprayed 
lOon the walls before you went in? 
 . Every here in there, yeah. 
 Q. Okay. So you went in, you un-holstered 
 your specific OC. Sprayed it on the box, picked 
 up the box, walked out of the room with the box? 






. o  long did that take? 
. aybe a inute. 
Q. Okay. Or less? 
. ne to t o inutes, yeah. 
. ne to t o inutes? 
 . ut I don't kno  hat position I as in 
 line. But every time we went in there, we 
 sprayed it. Everybody who went in, sprayed it, 
 . kay. nce)'()tl got done ith going 
  
 into the building, spraying the box, bringing the 
 ut,     o?  
 .      l e,  
 laughed, and atched the other people go in, and 
5 cough, and co e back. 
 . SO, basically, you aited for everybody 
  s   rill? 
 . s. 
 . nd once everybody finished the drill, 




.   ne. 
. id you do any sort f decontamination? 
. o. 
 .     ployed,   t  
15 personal  that you ere issued and carried ith . 
16 you at the ti e --
. o.  
 . -- r  it i sued, pecifically, f r 
 t t rti l r tr ining? 
 .       f  t 
 trai ing. 
 . kay.   r er t it s t t 
 he handed you? 
 so...  . o. 
 Q. Okay. How many people were involved in 25 .  y  ow, di  it, i  fact, have  
 (Pa   t  117) 
Page 120
Q Okay
A And it was CO Doan at the time It
wasntSergeant Doan
Q Okay Any other management personnel
there
A I think they were going through it I
dontknow
Q All right Now you had previously
been on light duty is that correct
A Yes
Q And that was because you had had
bronchitis and coughing for about two to three
months
A I had been coughing for a long time
but I had bronchitis and a sinus infection But
thats when I believe they found nodules on my
lungs
Q But you were also coughing in
conjunction with all that correct
A Yes
Q And who was it that put you on light
duty
A That had to be approved by the Deputy
Warden And that was just me working in the
control room only
Page 121
Q Okay Let me make sure that I
understand the light duty issue Is that
something that you received a recommendation




A Naomi Sir Dr Loveland was not
available
Q Sir is another doctor in Dr Lovelands
office
A Yes
Q And did she write you a prescription
or some sort of a note that says go on light
duty
A Yes
Q And do you still have a copy of that
note by any chance
A No I gave it to the prison
Q Who did you give it to do you
remember
A Deputy Warden Im sure
Q Who was that
A We had two of them I cantrecall his
name at this minute
31 Pages 118 to 121
Page 118
1 in it to your knowledge 1
2 A Yes 2
3 Q But you dontknow what brand name it 3
4 was 4
5 A No 5
6 Q Do you remember the color of the OC 6
7 that came out ofit 7
8 A No 8
9 Q Do you remember whether it was a spray 9
10 a foam an aerosol a fog 10
11 A They are all sprays 11
12 Q Okay 12
13 A Because we only used spray 13
14 Q Okay Do you remember what color the 14
15 canister was 15
16 A No I know that we swapped over to 10 16
17 percent at the womensprison too but I dont 17
18 know when 18
19 Q Do you have any specific knowledge as 19
20 to what concentration of OC or major capsaicin 20
21 were of the OC that you deployed on that day 21
22 A No Wev only ever used five and ten 22
23 percent 23
24 Q Okay So you dontknow whether this 24
25 was five percent or ten percent 25
Page 119
1 A It could have been both I dontknow 1
2 Q Now when you went into the room and 2
3 you deployed the OC during this training did you 3
4 start coughing 4
5 A Yes we all did 5
6 Q And when you came out of the room did 6
7 you continue to cough 7
8 A Yes 8
9 Q Do you remember for about how long 9
10 A No 10
11 Q Was it temporary 11
12 A Yes 12
13 Q At some point in time it ceased 13
14 A Yes 14
15 Q All right Letsmove to the training 15
16 of March 3rd of 2008 As I understand it you 16
17 did attend that training correct 17
18 A Yes 18
19 Q And it indicates here that the 19
20 instructor was Nick Doan is that accurate 20
21 A He was the one at the door 21
22 Q Who else was there who participated in 22
23 that training from the management standpoint 23
24 A Sergeant Overguard Sergeant Overguard 24
25 was the training sergeant 125
000656
e  
 in it, to your kno ledge? 
 . . 
 . ut  n't kno  hat brand a e it 
 ? 
5 . . 
 Q. Do you re e ber the color of the OC 
 that a e t  i ? 
 . . 
 . o  re e r et r it as  s r , 
lO  foa , an aerosol, a fog? 
 A. They are all sprays. 
 . kay. 
 . ecause e l  se  s ray. 
 . kay. o you re e ber hat color the 
 ster s? 
 . o. I kno  that e s apped over to 10 
 percent at the o en's prison, too, but I don't 
  . 
 Q. o you have any specific kno ledge as 
 to what concentration of OC or ajor capsaicin 
 ere f t e  t at  e l e   t at ay? 
 . . e've ly r s  fi   t  
 percent. 
 . kay. So you don't kno  hether this 
25 was five percent or ten percent? 
Page 119 
 .     .  n't . 
 . , e   e t i t  t e r , a  
 you deployed the C during this training, did you 
 start coughing? 
 . es, e all i . 
 . nd hen you ca e out of the roo , did 
 you continue to cough? 
 . . 
 Q. Do you remember for about how long? 
 . . 
 . as it te porary? 
 . . 
 Q. At some point in time, it ceased? 
 . . 
 Q. All right. Let's move to the training 
 of arch 3rd of2008. s I understand it, you 
  did attend that training; correct? 
 . . 
 . nd it indicates here that the 
 i str ct r as ic  an; is t at accurate? 
 .       r. 
 Q. ho else was there who participated in 
 that training from the management standpoint? 
 A. Sergeant Overguard; Sergeant Overguard 
  as the training sergeant. 
age  
1 . . 
2 . nd it as  oan  e ti . t 
3 n't e t . 
 . . n  ther t s el 
 t r ? 
6 . I t i  t e  ere ing t rough it. I 
7 n't . 
 . ll ri t. ,  a  re i sl  
   ig t ty; s  ct? 
 . e . 
 . n  t at as eca se  a  a  
 r itis  i  f r t t  t  t ree 
'  t s? 
 . I   ing f r  l  ti , 
    is   s ti .  
 at's e   e e  o  les   
 l s. 
 . t  r  l  i  i  
 c j cti  it  all t at; c rrect? 
 . s. 
 .   as it t at t   li t 
 uty? 
 . at a  t  e a r e   t e e t  
 r n.  t t s just  r i  i  t  
 c tr l r  l . 
 . y.       
     .   
  
 s et i  t at  recei e  a rec e ati  fron 
 a ealt  care ractiti er t at    li t 
 duty? 
 . . 
 . ho? 
 .  ir. r.    
 vailable. 
 . ir i  t r t r i  r. land's 
 f ice? 
 . . 
 . nd did she rite you a prescription, 
 r s  s rt f  t  t t says,   li t 
 duty? 
 . s. 
 .    still    f t t 
 te  a  c ance? 
 . o, I a e it t  t e ris n. 
 . ho did you give it to; do you 
 ember? 
 . eputy arden, I'm sure. 
 . ho as that? 
 .    f t .  can't r cal  hi  
25  t t i  i ute. 
 (Pa   t  121) 
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Page 122 Page 124
1 Q Okay And once you gave it to this 1 sitting and watched And then we went into
2 person did you have any discussion with the 2 where we did the OC actually
3 person about light duty 3 Q Okay So at first you had a
4 A Yes and I was allowed to be on light 4 classroom and then you had cell extraction Was
5 duty as long as they could understand on the 5 cell extraction part of the classroom or
6 radio 6 separate from the classroom
7 Q And this is the Deputy Warden who told 7 A It was part of the classroom
8 you that 8 Q And the third thing you did was the
9 A Yes 9 actual OC
10 Q So what became of that light duty Was 10 A Yes
11 some order in a written form issued by IDOC 11 Q What did that involve
12 that allowed you to go on light duty or how did 12 A There could have been more in between
13 it come about 13 there I dontremember it
14 A The warden communicated it to the 14 Q Okay
15 sergeant lieutenant 15 A These were the main things The OC we
16 Q And to which sergeant and which 16 went into that first room that I described with
17 lieutenant 17 my first day of OC training And we worked in
18 A Whichever one was on from my shift 18 partners So we walked down the hall about 20
19 Q Do you know who that was 19 30 steps maybe more And we went into the room
20 A At that point no I didntmake it 20 which was saturated with OC And there was a mat
21 through my light duty I on Friday I 21 on the floor a rug three by three
22 called Friday before the Monday of the 3rd 22 Q Three by three feet
23 because I was off for the weekend I called 23 A Yeah Not inches feet We had to
24 Lieutenant I mean Sergeant Overguard and 24 walk around that four times And we walked up to
25 told him I was on ligh duty with bronchitis and 25 the door CO Doan asked us three question that
Page 123 Page 125
1 a sinus infection And did I need to come to the 1 we had to answer correctly before we would get
2 training or could I reschedule And he told me 2 let out of there
3 I had to come to the training So I showed up 3 Then we would go down we came out of
4 there on Monday for training and I was using my 4 that room And my partner picked me up and we
5 inhalers all day 5 walked down and across the hallway into the
6 Q Are these inhalers that were prescribed 6 other hall And did three shoulder strikes
7 by Dr Loveland or Dr Sir 7 three knee kicks on pads People are holding
8 A Yes Albuterol and I was on I know 8 pads Went down had a can of OC that we were
9 I was on steroids steroid antibiotics regular 9 not to deploy We just pretended Yelled
10 antibiotics and so I coughed all through 10 commands get down on the ground Get down on
11 training 11 the ground Handcuffed a person And then we
12 Q So give me a summary ofwhat happened 12 were done Then we went right back through it
13 in the training Then Im going to go back and 13 with our partner
14 get specifics So just step by step what did 14 Q Okay
15 you do In other words classroom deployment I 15 A I do not know where I was in line And
16 mean tell me exactly what you did 16 then OC just it fills the whole corridor
17 A We did classroom training Then we did 17 Q Okay How many people went through
18 cell extraction And I was put in charge of 18 this training
19 telling the commands And I told him that I had 19 A I believe 12 to 14
20 problems talking Sergeant Overguard that I had 20 Q And was this at IMSI
21 problems talking And he said well do it 21 A Yes
22 anyway So I tried to talk them through it the 22 Q And who was your partner
23 cell extraction coughing and stuff And then 23 A A woman
24 Sergeant Link showed the proper way to do it 24 Q Do you remember her name
25 without coughing And I went back to where I wa 2 5 A No
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a e 2 e  
1 . kay. nd once you gave it to this 1 itti , a  t . nd t  e t into 
2 person, did you have any discussion ith the  here e id the oe, t al y. 
3 person about light duty?  . .   ir t,    
4 . s,  I as llo e  t  e  light  a , a     l . as 
5 duty as long as they could understand on the  ll tr tion art f t  lassr , r 
6 r i . 6 rate fr  t  l room? 
7 . nd this is the eputy arden ho told 7 . It as rt f t e la r . 
 you that?  . nd t e t ir  t in   i  as the 
 . . 9 l e? 
 . SO hat beca e of that light duty? as  . es. 
11 so e order, in a ritten for , issued by looe  . t id t t i l e? 
12 that allo ed you to go on light duty, or ho  did  .  ld e  re   
 it e ut?  .  n't  . 
 . e arden icated t    . y. I: 
 sergeant, lieutenant.  . hes     .  oe,  !: 
 .  t  ic  s r t  i   t i t  t t first r  t t I s ri  ith 
 7 lie nt? 1 7 y first day of oe training. nd e orked in 
 . hichever one as on fro  y shift.  rt r .   l e   t  ll t , 
 . o you kno  ho that as?  30 steps, aybe ore. nd e ent into the roo , 
 . t that point, no. I didn't ake it      oe.      
21 through my light duty. I -- on Friday --    t  fl r,  r , t r   t r . 
 called Friday before the onday of the 3rd, 1  . r   t r  f et? 
      e .  l   . . t , t.    
 ieute a  -- I ean, Sergeant verguard, and  l  r  t t f r ti s.   l   t  
25 told hi  1 was on light duty with bronchitis and  t e o r.  O a  as e  s t ree uestions t at 
.~-~--~-------------r----------------------------~----------1 
    
   .          e  t  s r rr tl  f re e l  t 
 training, or could I reschedule? nd he told e     re. 
 I had to co e to the training. So I sho ed up 3 Then e ould go do n --     
 there on onday for training, and I as using y 4 that roo . nd y partner picked e up, and e 
 inhalers all day. 5 l  n,   t  ll  i t  t  
 . re these inhalers that ere prescribed   l .     tri s, 
 by Dr. Loveland or Dr. Sir?  three knee kicks on pads. People are holding 
 A. Yes, Albuterol, and I was on --    pads. ent down, had a can of e that we were 
 I was on steroids, steroid antibiotics, regular  not to deploy. e just pretended. Yelled 
 antibiotics, and so I coughed all through  co ands, get do n on the ground. et do n on . 
11 training.  t e r d. a c ffe  a ers n.  t e  e 
 Q. SO give e a su ary of what happened 12 were done. Then we went right back through it 
 in the training. Then I'm going to go back and  it  r artner. 
 get specifics. So just step by step, what did  . kay. 
 you do? In other ords, classroo  deploy ent, I  .      I   l .  
 ean, tell e exactly hat you did.  t  oe j st -- i     rri or. 
 . e did classroo  training. hen e did  . kay. o  any people ent through 
 cell extraction. nd I as put in charge f  this training? 
 telling the co ands. nd I told hi  that I had  .  li ve,   4. 
 problems talking; Sergeant Overguard, that I had  . nd as this at I Sl? 
 problems talking. And he said, well, do it  . s. 
 anyway. So I tried to talk them through it, the  . nd ho as your partner? 
 cell extraction, coughing and stuff. nd then  .  an. 
 Sergeant Link showed the proper way to do it  . o you re e ber her name? 
 without coughing. And I went back to where I was 25 . o. 
 (Pa   t  125) 
Page 128
A Yes So to the left of the
Q What kind of training was done in the
hallway
A Im getting down here indicating
So we walked up here indicating And this is
where we had OC indicating I guess I should
put these over here indicating These are cell
doors on the other side indicating
Q Can you label them as such please
A Witness complying




A So thatswhere they sprayed the OC in
It had a regular door on it with no utility port
like I drew here earlier
Q All right
A So we walked in and there was 11
draw the room bigger And there was this little
carpet here that we walked around four times
And then we came to the door and Doan asked us
three questions and we were locked in there
Q You say we Did you go in that door
with your partner
Page 129
A No by myself You went in
individually Doan asked you three personal
questions then you answered them You met with
your partner here indicating
Q In the hallway
A Right Then you walked down the
hallway You are coughing Everybody is
coughing And then you cross the corridor and
you come to this person indicating This is an
important room here indicating janitor closet
sink Okay We walked through this
indicating down that hallway to get through
the corridor down to the hallway down to the
first person Do three strikes up here
indicating to the shoulder area
Q Is that your partner you are doing the
strikes with
A No there is two people And your
partner is just walking with you
Q And they are in the hallway corridor
A Yes they are in there close to the
wall holding pads
Q Okay
A So you do the three shoulder strikes
And you are walking You do the three knee
33 Pages 126 to 129
Page 126
1 Q Do you remember any other people who 1
2 were there at the training at the same time 2
3 A No Sergeant Link she was there 3
4 Q Okay 4
5 A I dontknow if she did the OC part or 5
6 not 6
7 Q So how much time well lets back 7
8 up This training log indicates that the OC 8
9 training took place for three hours Does that 9
10 sound about right 10
11 A Yes 11
12 Q And how much of that time was the 12
13 classroom and the cell extraction 13
14 A We did cell extraction and then we did 14
15 the OC So it was about cell extraction 15
16 was 16
17 Q And the classroom combined 17
18 A That was at least an hour but that was 18
19 not the three hours 19
20 Q I know What Im trying to say is 20
21 A Yeah 21
22 Q how much time was the OC training 22
23 specific I mean where you actually got exposed 23
24 A About two andahalfhours 24
25 Q Okay So letstake that a step at a 25
Page 127
1 time The first thing I want you to do is draw 1
2 me another picture And let me tell you what I 2
3 want on there I want the big picture So you 3
4 can see the cells You can see the halls the 4
5 classrooms the room that you had to go into with 5
6 the OC And then I think you said there was 6
7 another room that you went to where you did the 7
8 kicking and the pretend deployment of OC 8
9 A The hallway 9
10 Q Okay So I want to see where all of 10
11 that is in this drawing 11
12 A Witness drawing This is F Block 12
13 Q F Block Okay 13
14 A F Block is where training is done I 14
15 call this the corridor because I dontknow what 15
16 else to call it Hallway so I can like F 16
17 Blockwhere we came in and did training in this 17
18 classroom indicating 18
19 Q And youvelabeled classroom correct 19
20 A Correct And I put four direction 20
21 arrows So when it came time to do the training 21
22 in the hallways we had lined up here 22
23 indicating 23
24 Q And you are drawing little dash marks 24
25 to show where you would line up 25
000658
Page 126 
1 Q. Do you remember any other people who 
2 were there, at the training, at the same time? 
3 A. No. Sergeant Link, she was there. 
4 Q. Okay. 
5 . I don't know if she did the C part or 
6 n t. 
7 Q. SO how much time -- ll, let's ba  
8 up. This training log indicates that the OC 
9 training took place for three hours. Does that 
10 sound about right? 
11 . e . 
12 Q. And how much of that time was the 
 classroo  and the ll e tr ti ? 
 . e did cell e tr ti , a  the  e id 
 the .  it as t --  e tra io  
 as--
I 7 Q. And the classroom combined? 
 . That as at least an hour, but that as 
 ot the three . 
 Q. I know. What I'm trying to say is --
 . ea . 
 Q. -- how uch ti e was the OC training, 
 specific, I mean, where you actually got exposed? 
 .  - -a-ha  . 
 Q. Okay. So let's take that a step at a 
Page 127 
 ti e. The first thing I want you to do is draw 
 me another picture. And let me tell you what I 
 want on there. I want the big picture. So you 
   t  ll .    t  ll , t  
 classroo s, the roo  that you had to go into ith 
 the OC. And then I think you said, there was 
 another roo  that you went to where you did the 
 kicking, and the pretend deployment of OC. 
 A. The hallway. 
 Q. Okay. So I want to see where all of 
11 that is, in this drawing. 
 . ( itness drawing.) This is F Block. 
 Q. F Block. Okay. 
 A. F Block is where training is done. I 
 call this the corridor, because I don't know what 
 else to call it. Hallway, so I can --   
1 7 Block, where we ca e in, and did training in this 
 classroom (indicating). 
 Q. And you've labeled classroom; correct? 
 A. Correct. And I put four direction 
21 arrows. So hen it ca e ti e to do the training 
 in the hallways, we had lined up here 
 (indicating). 
 Q. And you are drawing little dash marks 
25 to show where you would line up? 
Page 128 
. Yes. So to the left of the --1 
2 
3 




. I'm getting -- do n here (indica ). 
 we alked up here (indica g). And this is 
6 here e ad C (indic ti g). I gue s I s ld 
7 put these over here (indicating). hese are cell 
8 doors n the other ide (indic i g). 
9 
10 
. an you la  the  as s , ple ? 
. (Witness c l i g.) 
11 . nd o  do ou label the r  here t e 
  ? 
 
 
. "OC r m." 
. . 
 .  t t's he  the  a ed t e  . 
 t a   re lar r  it ith  lity rt, 
1 7 like I re  ere earlier. 
 . ll ri t. 
 .  e alked ,  t e  as -- I'll 
    r.  ere  t is ttle 
  ere  e a e    . 
       r,  a    , 
 ree ti ,  e  e   r . 
 . ou y, "w ."       
  ith your partner? 
  
 . ,  elf.   , 
 al y.      
 ti ,    .  t  
4 r rt r r  (in i ting). 
5 .   l ay? 
 . i ht. e   al e   t e 
 l ay.   oughing.  i  
 c ghing.  t e   cr ss t e c rri or, a  
    t   (ind ting).  i  a  
 i portant roo  here (indicating), janitor closet, 
 sink. kay. e alked through this 
1  (in icating),  t at all a  t  et t r  
1  t  or idor,    al ay,  t  t  
 first erson.  t ree stri es  ere 
1  (in ating), t  t  shoul  rea. 
1  . Is t at r art er  are oi  t e 
1  stri  ith? 
1  . o, t r  i  t  eople.  y r 
1  partner is just alking ith you. 
2  .  t  ar  i  t  hall y cor idor? 
 . es, t  ar  i  t ere, cl e t  t  
22 all, holdi g pads. 
23 . kay. 
24 . So you do the thr  shoul er strikes. 
25  you are walking. Y  do t  thr e knee 
33 (  12  t  129) 
Page 130
1 strikes And then you come over here 1
2 indicating and you get your can of OC from 2
3 another person 3
4 And the other person is 4
5 standing this isntexact You walk up and 5
6 this person is standing here indicating And 6
7 you yell commands at them Get down on the 7
8 ground Get down on the ground The actual 8
9 person gets down on the ground and you cuff 9
10 them You hand your OC there is there was 10
11 another person standing right here indicating 11
12 Q Now the OC that you were handed that 12
13 you used in the cuffing process As I understand 13
14 it you did not deploy that is that right 14
15 A Exactly And handed it back to them 15
16 and cuffed them Then we were done Then we 16
17 came back and got in line and waited to go with 17
18 our partners So we walked back down here 18
19 indicating And our partner went in the room 19
20 and did the same thing And we walked with them 20
21 to make sure 21
22 Q Okay So all that took about 22
23 two andahalf hours for everybody to complete 23
24 that 24
25 A Yes This is our decontamination if 25
Page 131
1 you want to call it that 1
2 Q Well thats what I was going to ask 2
3 you Was there any decontamination 3
4 A After we were done cuffing the person 4
5 and were done We could walk over here to this 5
6 janitor closet to the sink and we could wash our 6
7 face and hands if we wanted to 7
8 Q Did you do that 8
9 A Yes 9
10 Q Did everybody else do that 10
11 A Yes if you wanted to Thats when you 11
12 went back in line 12
13 Q So after your partner went through that 13
14 process do you remember if you went first or 14
15 your partner went first 15
16 A I went first 16
17 Q So after you got done and you went 17
18 back to the closet and washed your face and 18
19 hands and got back in line then your partner 19
20 went through that process Did you go back and 20
21 decontaminate again 21
22 A No 22
23 Q Let me backup a little bit Im 23
24 assuming that after you got done with going in 24
25 the room with the OC you answered three 25
Page 132
questions and got out of the room
A And we walked out
Q And did you correctly answer the
questions the first three times they were asked
A Yes and he didntask them fast
either Make sure you are breathing it in
Q All right
A Oh CO Doan had a respirator on
Q He was wearing a respirator
A Yes Thatswhy he got to ask all the
questions
Q Okay So Im assuming you are coughing
out and into the hallway correct
A Im coughing the whole day
Q You were coughing even before you went
in there
A Yes
Q Was your cough any different before you
went in there than when you came out of there
lets say an hour or two later
A Well yeah it was worse
Q It was worse
A Yes And it didn get any better
Q Okay And it hasn got any better to
this day isnt that right
Page 133
A Not really I take my Codeine and
that helps the cough a little bit It gets me to
where I can be in this room with you But I
wasnttaking Codeine then for the cough
MR BURKE All right Lets have this
marked so we can have a record ofthat
Exhibit 9 marked
Q BY MR BURKE So Exhibit 9 is a copy
of the drawing you just made for me is that
right
A Yes
Q Okay Were you present when somebody
sprayed the walls of the room with OC
A They sprayed inside every time before
one of us went in
Q Okay And who did that Was that
Officer Doan
A Yes I believe so
Q And did you see the canister that he
was using to spray
A No
Q when he went through the process
A I dontremember it
Q So Im assuming you dontremember its
color size or shape
34 Pages 130 to 133
000659
  e  
 strikes. nd then you co e over here 1 questions, and got out of the roo ? 
 (indicating), and you get your can f  fro  2 .  e l e  t. 
 another person. 3 . nd did you correctly ans er the 
 nd the other person is  questions the first three ti es they ere asked? 
 standing -- this isn't exact. ou alk up, and 5 . ,   i n't  t  t 
 this person is standing here (indicating). nd 6 either. ake sure you are breathing it in. 
 you yell co ands at the . et do n on the 7 .  t. 
 . t    .   8 . ,      . 
 person gets do n on the ground, and you cuff 9 . e as earing a respirator? 
10 the . ou hand your  -- e is --  as 10 . es. hat's hy he got to ask all the 
11 another person standing right here (indicating).  questions. 
 . o , the  that you ere handed, that 12 . y.  'm     
 you used in the cuffing process. s I understand 13     ll y; rrect? 
 it, you did not deploy that; is that right? 14 . I'm coughing the hole day. 
 . actl .  a e  it ac  t  t e   .        
   . e  e  e. e     re? 
  ca e ac  a  t i  li e, a  aite  t   it    . s. 
 r rt rs.   alke    r  18 . s r   iffere t f r   
 (indicating). nd our partner ent in the roo   t i  t  t    e t  t r , 
  i  t e e t i .  e l e  it  t   l t's ,    t  l t r? 
 t   .  . ell, h, it  . 
 . kay. So all that took about  . It as orse? 
23 t o-and-a-half hours for everybody to co plete 23 . es. nd it didn't get any better. 
 t t?  . y.  it sn't t  tt  t  
 . . i  i   t i ti , i   this day; isn't that right? 
~--------------------------------~-----+------~. 
  
 you want to call it that. 
 . ell, that's hat I as going to ask 
 you. as there any deconta ination? 
 . fter e ere done cuffing the person, 
   e. e d     s 
 ja it  l s t t  t  i k,  e l    
       . 
 . id you do that? 
 . . 
 Q. Did everybody else do that? 
 . es, if you anted to. That's hen you 
    . 
 Q. SO after your partner went through that 
 process, do you re e ber if you ent first, or 
 your partner went first? 
 .   t. 
 . SO after you got done, and you ent 
 back to the closet and ashed your face and 
 hands, and got back in line, then your partner 
 went through that process. Did you go back and 
21 decontaminate again? 
 . . 
 . Let e back up a little bit. I'm 
 assu ing that after you got done ith going in 
 the roo  ith the , you ans ered three 
  
 .  al y.    i ,  
 that helps the cough a little bit. It gets e to 
3  I   i  t i   it  u. t I 
4 asn't taking odeine then for the cough. 
5 . :  t. et's   
6   e      t. 
 (Exhibit  rked.) 
 . (B  . )  i it  i    
 of the drawing you just made for me; is that 
 right? 
 . . 
 . y.   t   
   s    i  C? 
 . They sprayed inside, every ti e, before 
     . 
 . ay.   i  t at?  t t 
   an? 
 . s,  l  o. 
 .  i   see t e ca ister t at e 
  as si  t  s ra  --
 . o. 
 . -- e  e e t t r  t e r cess? 
 .  on't r it. 
 . O I'm ssuming,  on't r r its 
 c l r, size, r s ape? 
 (Pa es  t  33) 
Page 134 Page 136
1 A No 1 Q On any of your other trainings
2 Q Do you remember the color of the OC 2 A No
3 material that was in the room 3 Q withOC
4 A No 4 A No
5 Q Did you see the name brand on the OC 5 Q Okay I want to continue here with OC
6 canister that was sprayed in connection with your 6 a little bit and talk about the canisters that
7 entry into the room 7 you were issued I just want to understand the
8 A I dontrecall it My recollection 8 procedure there
9 was cough cough cough Letsget this done 9 Im assuming that thatssomething that
10 with 10 was a regular part of your equipment as a
11 Q Now you have alleged in your 11 correctional officer at IMSI and at the women
12 complaint that what was sprayed in connection 12 facility
13 with that training when you went into that room 13 A Yes
14 was Sabre Red correct 14 Q And is it something that you carried
15 A Yes 15 with you all the time
16 Q How do you know that 16 A Yes
17 A We didntuse anything else but Sabre 17 Q And was it always holstered like you
18 Red at the time 18 indicated on your person
19 Q So thatsjust 19 A Yes
20 A To my knowledge 20 Q You attach it to a belt
21 Q So thatsjust an assumption you are 21 A You have a holder in your belt
22 making then 22 Q So part of the belt that you wear
23 A Yep Yes 23 A Specifically for it yes
24 Q Now youve also alleged in your 24 Q And is it for the small size that you
25 complaint that the concentration or the 25 indicated the fourinch size
35 Pages 134 to 137
Page 135 Page 137
1 percentage of the concentration of OC that was 1 A Mark 4
2 sprayed in this particular that was sprayed 2 Q Okay Mark 4
3 for this particular training session was ten 3 A MK4
4 percent is that right 4 Q MK4 Okay Now how do you obtain
5 A Yes 5 these Do you go to a storeroom Where do they
6 Q Now how do you know that 6 come from
7 A Right this minute I dontremember 7 A You walk through the door in the block
8 Q You didnt know at the time In other 8 and they had a cabinet And everybody has what
9 words you didnt see it on the canister itself 9 they call a chit Its got your name and picture
10 correct 10 on it And your chit goes into the canister
11 A I dontremember that part 11 container and you take the canister and put it
12 Q And you cant recall today how it is 12 on
13 that you determined that the spray that was 13 Q So the chit is actually on the
14 placed in that room you cant recall the day the 14 canister
15 spray that was used in that room how you 15 A The chit is in the plastic container
16 determined that it was 10 percent 16 that the canister sits in
17 A I determined it because thats all we 17 Q Okay
18 ever used after they implemented it 18 A So they can account that one officer
19 Q Again so its an assumption it was 10 19 has one OC There were four and there were
20 percent is that correct 20 usually two to three of us that had to carry it
21 A Yes I dontthink it goes any higher 21 Q Okay So is this something that you do
22 Q Were you offered any sort of eye 22 on a daily basis When you show up to work you
23 protection or mask protection at any time during 23 go to this cabinet and you pick up your OC
24 that training 24 container
25 A No 25 A Yes
000660
e 34 e l  
1 . .  .  a  f r ther trainings --
2 . o you re e ber the color of the   . . 
3 ate ial that as in the ?  . -- with ? 
4 . .  . . 
5 . id you see the na e brand on the   . kay. I ant to continue here ith  
6 canister that as sprayed in connection ith your  a little it, a  tal  a t t e ca isters t at 
 entry into the roo ?   ere iss . I just t to rsta d t  
 . I n't r ll it. y re llection  procedure there. 
 was, cough, cough, cough. Let's get this done  I'm i  t t t at's t i  t t 
 .  as a regular part f your equip ent as a 
 . o , you have alleged in your   ic   S    e en's 
 co plaint, that hat as sprayed in connection  cility? 
 ith that training hen you ent into that roo   . es. 
 as re d; ct?  . n  i  it t i  t t  rri  
 . e .  ith you all the ti e? 
 Q. How do you know that?  . . 
 . e didn't use anything else, but Sabre  .   it l  l t r d, like  
    .  i i t ,   r on? 
 Q. SO that's just --  . . 
 A. To my knowledge.  .  tt  it t   lt? 
 Q. SO that's just an assumption you are  .    l r i  r lt. 
 aking, then?  . O rt  t  lt t t  ar? 
 . ep. es.  . Specifically for it, yes. 
 Q. Now, you've also alleged in your  .  i  it f r t  ll i  t t  
 complaint that the concentration, or the  ,  -inc  ize? 
--~~--~~--~~----- ~,=.,~ 
   l3  
 percentage of the concentration, of OC that was  .  . 
 sprayed in this particular -- that as sprayed  . y. r  ? 
 for this particular training session was ten  . -4. 
, 
 percent; is that right?  . -4. kay. o , ho  do you obtain 
 . .  these? o you go to a storeroom? here do they 
 Q. Now, how do you know that?   ? 
 A. Right this minute, I don't remember.  . ou alk through the door in the block, 
 Q. You didn't know at the time? In other  and they had a cabinet. nd everybody has hat 
 words, you didn't see it on the canister, itself;  they calI a chit. It's got your na e and picture 
 rr ct?   it.  r c it es i t  t e ca ister 
 A. I don't re e ber that part.  c tai er, a   ta e t e ca ister a  t it 
 Q. And you can't recall today, how it is  n. 
 that you determined that the spray that was  . O t e c it is act all   t e 
 placed in that room, you can't recall the day the  nister? 
 spray that was used in that room, how you  . he chit is in the plastic container 
 deter ined that it was 10 percent?  t   i   i . 
 . I deter ined it, because that's all e  . kay. 
 ever used after they i ple ented it.  . o they can account that one officer 
 . gain, so it's an assu ption it as 10    .   ur,  t r   
 percent; is that correct?  ually, t  t  t r    t t  t  rr  it. 
 . es, I don't think it goes any higher.  . kay. So is this so ething that you do 
 . ere you offered any sort of eye  on a daily basis? hen you sho  up to ork, you 
 protection or mask protection at any time during  go to this cabinet, and you pick up your OC 
 that training?  ntainer? 
 . o.  . s. 
" 
 (Pa s  t  137) 
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Page 142 Page 144
1 sheets And if the instructor noted exposure on 1 Q BY MR BURKE Meaning What doe
2 the objectives like we had it would have been 2 that mean data input issue
3 If not it wouldn have been entered 3 A You would have to ask Sergeant Schaffer
4 Q If you look at this it looks like the 4 this afternoon
5 time period involved in this training was one 5 Q We will But does that suggest that
6 hour Would that suggest to you anything about 6 maybe they both occurred the same day they jus
7 whether or not OC exposure was actually involve 7 had different dates on them or something
8 A That would suggest that it was more of 8 A Or it was a double input
9 a policy review 9 Q But regardless did these take place at
10 Q And would that be consistent with 10 the womensfacility
11 Policy 307 being in the title 11 A Yes
12 A Yes 12 Q And can youtell by both of the
13 Q So would it be more likely than not 13 documents that are in front of you whether either
14 that OC was not used on this occasion 14 one of them may have involved exposure to OC
15 A If it was only an hour I would guess 15 A It doesn state
16 that it was not that there was no exposure 16 Q And do you have any specific knowledge
17 Q Lets go to the next one in order 17 one way or another whether it did or did not
18 which I believe is the one for February 21st of 18 A No
19 2007 Were you familiar with that particular 19 Q And do you have any specific knowledge
20 training 20 about what type of training went on in that
21 A No 21 particular training session
22 Q Now it says there the instructor is 22 A No
23 Dan Schaffer is that correct 23 Q Do you know where they actually did the
24 A Yes thatswhat the document says 24 training at the womensprison
25 Q And do you know whether this training 25 A I dont
Page 143 Page 145
1 took place at IMSI or at the womensprison 1 Q All right The last one I have is
2 A I believe its South Boise Women 2 dated 3 of08 And that looks like its a
3 Q Exhibit No 8 indicates that this was a 3 SABRE OC aerosol projector certification
4 one hour class In looking at that and also at 4 instructor Sergeant Nick Doan It looks like
5 Exhibit No 33 is there anything about those 5 that was a threehour class And that was at the
6 documents that would indicate that there was 6 IMSI wasntit
7 actual OC exposure during that training 7 A Yes
8 A Nothing in the training record 8 Q Do you have specific recall or
9 Q And would the time of one hour suggest 9 familiarity with that session
10 that there probably was not 10 A No
11 A I would assume so 11 Q Where were you working at that point in
12 Q All right letsgo to the next one in 12 time
13 order It actually looks like theres two right 13 A I was at Idaho State Correctional
14 there in short proximity One is 713 of07 14 Institution the medium custody facility
15 Sergeant Dan Schaffer and then the next one is 15 Q So I take it you were not involved in
16 718 of07 Do you have a specific knowledge or 16 this series of instruction on OC in March of
17 recollection about either one of those trainings 17 2008
18 MR LOOMIS Chris for the record 18 A No
19 ours says 713 of07 and then720 of 07 19 Q At least at IMSI
20 THE WITNESS Indicating 20 A Correct
21 MR LOOMIS Im sorry my fault 21 Q All right
22 THE WITNESS I dontHonestly Im 22 Exhibit 34 marked
23 looking at these and I would hazard a guess that 23 Q BY MR BURKE Im going to hand yo
24 it was probably a data input issue that both of 24 another document here Its been marked as





















































sheets. And if the instructor noted e posure on 1 
the objectives like we had, it would have been. 2 
If n t, it l 't have been e t r . 3 
. If you look at this, it looks like the  
time period involved in this training was one 5 
hour . ould that suggest to you anything about  
whether or not  e posure was a t ll  involvec? 7 
. hat ould s ggest that it as re f 8 
a policy revie . 9 
. nd ould that be consistent ith 0 
"Policy 307" being in the title?  
. e .  
. SO, ould it be ore likely than not  
that  as n t used n this sion?  
. If it as only an hour, I ould guess  
that it as not, that there as no exposure.  
. Let's go to the next one in order,  
hich I elie e is the ne f r e r ar   st f  
2007. ere you familiar with that particular  
training?  
. .  
Q. Now, it says there the instructor is  
an chaffer; is that correct?  
. es, that's hat the docu ent says.  
Q. And do you know whether this training  
  
took place at I SI or at the wo en's prison?  
.  e e t's  ise men's.  
Q. Exhibit o.8 indicates that this was a  
one-hour class. In looking at that and also at  
xhibit o. 33, is there anything about those  
   icate     
actual OC exposure during that training?  
A. Nothing in the training record.  
Q. And would the time of one hour suggest  
that there probably was not?  
.  l  e .  
Q. All right, let's go to the next one in  
order. It actually looks like there's t o right  
there in short proximity. One is 7113 of'07,  
Sergeant Dan Schaffer, and then the next one is  
7118 of '07. Do you have a specific knowledge 0 16 
recollection about either one of those trainings? 1  
. L MIS: hris, for the record, 1  
ours says 7/13 of'07 and then 7120 of'07.  
T E IT ESS: (Indicating).  
R. L MIS: I'm sorry, y fault. 2  
THE ITNESS: I don't. Honestly, I'm 22 
looking at these and I would hazard a guess that 23 
it was probably a data input issue that both of 24 
t  r   it i  a ek. 2  
Page 144 
. (BY . ) e i ? hat oe 
that e , "data input issue"? 
. ou o ld a e to ask ea t fer 
this a t . 
. e ill. ut oes that s ggest that 
aybe the  th ccurred the sa e a , the  jus 
had i ferent tes on the   ething? 
. r it as  le in . 
. t re e , d these ta e lace t 
the en's f ility? 
. . 
. n    tell  th f the 
ts  re in ront  ou t e  t er 
ne f t e  a   in olved s re t  ? 
. It sn't . 
. n   ou e  ifi  no ledge. 
ne ay r t er t er it i  r i  t? 
. o. 
. n   ou a e a  s ecific le e 
a t at t e f training e t  i  t at 
c lar tra ning ssion? 
. . 
.    ere t e  act all  i  t e 
training at t e en's rison? 
. I on't. 
  
. ll ri t. e last e I a e is 
 /3  '0 .   s  t's  
  aerosol projector certification, 
instructor ergeant ick oan. It looks like 
t t   t r -ho r l s.  t t  t t  
I; sn't t? 
. s. 
. o you have specific recall or 
fa iliarity ith that session? 
. o. 
.    i  t t t i t i  
ti e? 
.   t  t t  ti l 
I tit ti n, t  i  t  f cility. 
. SO, I take it you ere not involved in 
 r  f i tr t    i   f 
008? 
. o. 
. t l t t I SI? 
. rrect. 
. ll ri ht. 
(E i it  arked.) 
. (  . RKE) I'm going to hand yo 
anot er c nt here. It's been ark  as 
xhi it o. 34.  fr nkly, I t i  t is is 





IN THE DISTRICT COURT OF THE FOURTH JUDICIAL DISTRICT
OF THE STATE OF IDAHO IN AND FOR THE COUNTY OF ADA







THE RULE 30b6DEPOSITION OF
IDAHO DEPARTMENT OF CORRECTION
TESTIMONY OF BRET R KIMMEL
TAKEN FEBRUARY 14 2011
REPORTED BY
SHERI FOOTE CSR No 90 RPR CRR
Notary Public
000663
IN THE DISTRICT COURT OF THE F RT  J I I L DISTRICT 
F THE S TE F ID , IN AND F  THE CO  OF ADA 
BILLIE J  AJ , an in i i l, 
l intiff, 
vs. 
SE IT  E IP E T P TI , 
a iss ri r r ti , 
nt. 
ase . V-PI- 515 
  0(b) (6)   
I    I  
I    . I  
  ,  
 ; 
SHERI FOOTE, CSR o. 90, RPR, CRR 
Notary Public 
age 1 
6 Pages 18 to 21
Page 18 Page 20
1 We have this would have probably been it looks 1 A Yes
2 like 2008s refresher for use of force And this 2 Q Is it your understanding this is
3 was the written exam that was given to staff to 3 something that she filled out
4 test their understanding of the policy 4 A Yes it appears to be
5 Q And theresa date on this of 3 of 5 Q And is this a true and accurate copy of
6 08 is that right 6 a document that appears in the Department of
7 A Yes 7 Corrections files
8 Q And it says Instructor Correction 8 A Yes
9 Officer Higgins Who is that 9 Exhibit 26 marked
10 A That would be Tim Higgins Jr 10 Q BY MR BURKE Let me hand you Exhibi
11 Q And what was his responsibility in 11 No 26 Do you recognize that
12 2008 do you know 12 A Yes
13 A Hesbeen a use of force instructor for 13 Q And what is it
14 the department for obviously since then 14 A It is an exam from 214 of 06 another
15 Q Would it be your understanding that 15 OC test Its basically a knowledge test of
16 this is a document that was actually filled out 16 understanding
17 by Officer Major 17 Q Does Exhibit No 26 then relate to
18 A It appears to be 18 Billie Jo Major
19 Q And that would be a true and accurate 19 A Yes
20 copy of a document that appears in the records of 20 Q And is it so far as you know a true and
21 the IDOC 21 accurate copy of a document that appears in the
22 A Yes 22 Department of Correctionsfiles
23 Exhibit 24 marked 23 A Yes
24 Q BY MR BURKE Heresanother one th 24 Q And this is a document that would have
25 Ive had marked as Exhibit N 24 Do you 25 been filled out by her
Page 19 Page 21
1 recognize that 1 A Yes
2 A Yes 2 Exhibit 27 marked
3 Q And what is it 3 Q BY MR BURKE Im going to hand you
4 A Its her first aid certificate and then 4 Exhibit No 27 Do you recognize that
5 the next page is a training record from our 5 A Yes this is a SCBA self contained
6 training excuse me our training database for 6 breathing apparatus written exam
7 an OC course in 046 it looks like 07 7 Q What is an SCBA
8 yeah through 08 8 A Selfcontained breathing apparatus
9 Q And these all relate to Billie Jo 9 Q Does this have anything to do with OC
10 Major 10 A No
11 A Yes 11 Q But it does relate to Officer Major
12 Q And are these true and accurate copies 12 A Yes
13 of documents that appear in the Department of 13 Q Is this a true and accurate copy of a
14 Correctionsfiles for her 14 document prepared kept and maintained by the
15 A Yes 15 Department ofCorrections
16 Exhibit 25 marked 16 A Yes
17 Q BY MR BURKE Heresanother one 17 Exhibit 28 marked
18 here I have Exhibit No 25 Do you recognize 18 Q BY MR BURKE Exhibit No 28 do yo
19 that 19 recognize that
20 A Yes that a written exam to test the 20 A Yes
21 student understanding of OC aerosol 21 Q What is it
22 Q And is this particular exam one that 22 A Its an OC SABRE aerosol projector
23 relates to Billie Jo Major 23 exam
24 A Yes 24 MR LOOMIS Chris you donthave





















































We have -- this would have probably been it look~ 1 
like 20 's refresher for use of force. And this 2 
was the written exam that was given to staff to 3 
test their understanding ofthe policy. 4 
Q. And there's a date on this of 3/3 of 5 
'08; is that right? 6 
A. Yes. 7 
Q. And it says: "Instructor: Correction 8 
Officer Higgins." Who is that? 9 
A. That would be Tim Higgins, Jr. 10 
Q. And what was his responsibility in 11 
2008; do you know? 2 
A. H 's been a use of force instructor for 13 
the department for -- obviously since then. 14 
Q. ould it be your understanding that 5 
this is a docu ent that as actually filled out 16 
by Officer Major? 1 7 
A. It appears to be.  
Q. And that would be a true and accurate  
copy of a document that appears in the records of 20 
the IDOC?  
. es.  
(Exhibit 24 marked.)  
Q. (BY MR. BURKE) Here's another one tha 24 
I've a  ar e  as i it o. .    
a e  
recognize that?  
. s.  
Q. And what is it?  
. It's er first ai  certificate a  t e   
the next page is a training record from our  
training -- excuse e, our training database for 6 
an OC course in '04, '06, it looks like '07,  
yeah, through '08.  
Q. And these all relate to Billie Jo  
Major?  
. es.  
Q. And are these true and accurate copies 12 
of docu ents that appear in the Depart ent of 13 
Correction's files for her? 14 
. es. 15 
(Exhibit 25 marked.) 16 
Q. (BY R. BURKE) Here's another one 17 
here. I have Exhibit No. 25. Do you recognize 18 
ili~ 19 
A. Yes, that's a written exam to test the 20 
student's understanding of OC aerosol. 21 
Q. And is this particular exam one that 22 
relates to Billie Jo Major? 23 
A. Yes. 24 
Q. And the date on it is 8/20 of'04? 25 
Page 20 
A. Yes. 
Q. Is it your understanding this is 
so ething that she filled ou ? 
A. Yes, it a pears to be. 
Q. And is this a true and accurate copy of 
a document that appears in the epartment of 
Cor ti n's file ? 
A. Yes. 
(Exhibit 26 d.) 
Q. (BY . B ) et e hand you Exhibi , 
. 2 . Do you re ize t t? 
A. Yes. 
. nd hat is i ? 
. It is an exa  fro  /14 f '06, another 
 te . t's   kno ledge test  
. 
. oes hibit . 2  t  relate t  
llie J  j r? 
. e . 
. nd  t       tr e  
rate  f   t rs   
e rt e t f rrection's fil s? 
. s. 
.         




(Exhi it  arked.) 
. (B  . KE) 'm     
 . .   r  at? 
. s,    BA, elf-  
t i    xam. 
.  i  an CBA? 
. elf- t i  r athi  pparatus. 
.  t  hav  anyt i  t  d  it  C? 
. o. 
.  it d  rel t  t  ff  ajor? 
. s. 
. Is t i  a true an  cc  copy of a 
docu t prepared, kept, and aint i  by t  
epart ent of orrections? 
. es. 
( i it 28 arked.) 
Q. (  R. BURKE) Exhibit o. 28, do yo 
recognize that? 
. Yes. 
Q. hat is it? 
A. It's an O  SABRE aerosol projector 
exam. 
MR. LOOMIS: Chris, you don't have 
copies of--
6 (  18 to 21) 
Page 221 Page 24
1 MR BURKE Im sorry Im trying to do 1 A No
2 too many things at one time 2 Q Do you know why it is that OC is used
3 Q BY MR BURKE And does it relate to 3 by the Department ofCorrections
4 Billie Major 4 A Staff safety
5 A Yes 5 Q And describe why it is that a staff
6 Q And the date on it is 3of08 6 safety issue
7 A Yes 7 A Primarily staff safety where it comes
8 Q And it looks like the instructor 8 down to law enforcement and corrections both is
9 signature was Correction Officer Doan is that 9 instead of having to ifyou have two
10 right 10 individuals fighting we have a sworn duty to
11 A Yes 11 break them up to prevent injury to the inmates
12 Q And does this appear to be a test that 12 And to do that without you either have to put
13 was taken by Billie Jo Major 13 hands on or get in the middle of the fight which
14 A Yes 14 puts staff at risk and injury to the inmates
15 Q Is it a true and accurate copy of a 15 With the use of OC you can use the OC
16 document in the Correction Department files 16 as a deterrent to break up the fight and reduce
17 A Yes 17 the need for physical intervention and that
18 Q Thank you I think these are all the 18 also which reduces the risk of staff being
19 same You know rather than do this piecemeal I 19 injured and also the further injury to the
20 think Im just going to mark all of these as one 20 inmate
21 Discussion held off the record 21 Q How does IDOC characterize or classify
22 Exhibit 31 marked 22 OC What is it
23 MR LOOMIS And Exhibit No 31 23 A OC is a natural irritant It affects
24 includes all of the individual packet 24 the mucous membranes of the body or excusem
25 MR BURKE Yes 25 i an inflammatory Excuse me CS is an
Page 23 Page 25
1 MR LOOMIS All right 1 irritant OC is an inflammatory it inflames the
2 Q BY MR BURKE All right Sergeant 2 mucous membranes of the body and produces mucu
3 Kimmel Im handing you what wev marked as 3 production watery eyes gives you an involuntary
4 Deposition Exhibit No 31 Its a compilation of 4 closure of the eyes produces kind of a dry cough
5 a number of documents that were provided to us 5 just from the inflammation
6 today Do they appear to all be related to 6 Q Is it characterized as a defensive
7 Officer Major 7 product or a defensive weapon
8 A Reviewing documents They appear to 8 A Yes in the State of Idaho its
9 be 9 considered a defensive aerosol
10 Q And so far as you know are they true 10 Q Are you familiar with a defensive
11 and accurate copies of documents which appear i ll product with the initials CN
12 the Department ofCorrection business files 12 A Yes
13 A Yes 13 Q And what is that
14 Q All right why dontwe talk generally 14 A CN was a gas produced right around
15 about OC for just a moment And wellstart ve 15 World War I Its not in any use in the
16 generally and we will go from there 16 Department of Correction
17 First of all does IDOC presently use 17 Q Has it ever been used since you were
18 OC products 18 there
19 A Yes 19 A Not since 1998 no
20 Q And do you have any idea about when in 20 Q Is that commonly known as tear gas or
21 time IDOC first started using OC 21 mace
22 A OC was in use in the department when 1 122 A No CS is not commonly known as tear
23 started in98 So previous to that 23 gas or mace
24 Q But you dont know when prior to that 24 Q So is there a difference between CN
25 thev started 25 and CS another product




























MR. BU : I'm sorr , I'm trying to do \  
too many things at one time. 2 
Q. (BY . B E) And does it relate to' 3 
Billie Major? 4 
A. Yes. 5 
Q. And the date on it is 3/3 of'08? 6 
A. Yes. 7 
Q. And it looks like the instructor's 8 
signature was Correction Officer Doan; is that 9 
right? 0 
. e . 1 
Q. And does this appear to be a test that 2 
was taken by Billie Jo ajor? 13 
. e . 4 
Q. Is it a true and accurate copy of a 5 
cu ent in the rrection e art ent files? 6 
. e .  
Q. Thank you. I think these are all the  
same. You know, rather than do this piecemeal, I 19 
think I'm just going to mark all of these as one.  
(Discussion held off the record.)  
(Exhibit 31 marked.)  
. : nd i it .   
Page 24 
. N . 
. Do you know why it is that  is used 
by the Department of Corre ? 
. Staff s . 
. nd des ibe hy it is t t's a st f 
safety issue. 
. Pri a ly s f s t  here it co es 
do n to la  force ent a d corrections both is 
instead  ing to -- if you ave t o 
individuals fig , e a e  s rn t  t  
reak the   t  revent i jur  to t e in at . 
nd to  t  ithout -- ou either ave t   
ands  r et in t  iddle  fi t, hich 
uts  t is   injur  t  t e in at . 
it   se f ,  a  se   
s  re t  reak  the ig   re ce 
the need for physical intervention and that 
ls  --   t e     
injured and also the further injury to the 
i t . 
.      i  
? ha  s t? 
.  is a at ral irrita t. It affects 
includes all of the individual packet?   s ra es    -- r e c se 1m, 
. : s. i  it's  i fl t ry.  ,  is  


























a e 23 
. L IS: ll right. 1 
Q. (BY R. BURKE) All right, Sergeant  
Kimmel, I'm handing you what we've marked as  
Deposition Exhibit No. 31. It's a compilation of 4 
a number of documents that were provided to us  
today. Do they appear to all be related to  
Officer Major?  
A. (Reviewing documents.) They appear to  
e. I  
Q. And so far as you know, are they true  
and accurate copies of documents which appear i n11 
the Department of Correction's business files? 1  
. es. 1  
Q. All right, why don't we talk generally 1  
about OC for just a moment. And we'll start veT) 1  
generally and we will go from there. 1  
First of all, does IDOC presently use 17 
OC products? 1  
. s. 19 
Q. And do you have any idea about when in 20 
time IDOC first started using OC? 21 
A. OC was in use in the department when I 22 
started in '98. So, previous to that. 23 
Q. But you don't know when prior to that 24 
they started? 25 
  
t t.    tory,  la   
us       m 
production, atery eyes, gives you an involuntary 
l   t  ,  i      
j t  t  i l tion. 
. I  it t ri    i  
r t r  f i  apon? 
. s,   t t  f I  t's 
  f i  rosol. 
. r   f ili r it   f si  
r t it  t  i iti l  "C "? 
. s. 
.   i  that? 
.  s a  r  ri t r  
rl  r I. It's t i   s  i  t  
rt t f rrection. 
. s it ever b  ed si  y  r  
t ere? 
. t since 1998, no. 
. I  t t co l  k o  as tear g  or 
ace? 
. No,  is not co onl  kno  as tear 
g s or ace. 
Q. SO, is t ere a diff r ce between CN 
and S, another product? 
7 (P  2  t  25) 
10 Pages 34 to 37
Page 34 Page 36
1 So if you get it across the brow it will 1 quicker but it still affects the eyes
2 actually start to run into the eye 2 Stream because of the nature of larger
3 The foam sticks You can kind of in 3 particulates its primary effect is the eyes and
4 laymansterms you could kind of think of it 4 then a secondary is the respiratory
5 like the difference between the stream of a 5 Foam is primarily the eyes and very
6 squirt gun you know a nice water that runs down 6 little respiratory just because of the nature
7 with gravity and foam would be more like silly 7 because the particulates are bigger
8 string wherever it hits its just going to kind 8 Q Okay
9 ofstick there and not move 9 A And thatswhat prevents the cross
10 Q So ifwe put it in the order of cross 10 contamination is the big heavy particulates
11 contamination would aerosol and fog have more fll staying where you put them and not evaporating
12 a cross contamination than a stream 12 and becoming available to the respiratory system
13 A Well theyr all aerosols 13 Q So based on your experience what are
14 Q Okay thats true 14 generally the effects on humans from exposure t
15 A The fog would be the highest cross 15 OC
16 contamination stream and then foam lowest 16 A Youllget temporary again temporary
17 cross contamination 17 mucus production Most people their eyes have i
18 Q Okay thatswhat I was getting to 18 an involuntary closure You get redness of the
19 Ive got to get the terminology right 19 eyes You get kind of again kind of a sunburn
20 A Thats like really big for our as 20 feeling to the exposed skin You know when it
21 far as terminology as far as report writing and 21 affects the respiratory youllget coughing A
22 everything else So its something that we 22 lot of the coughing generally comes from
23 drum just as much as the use is the proper 23 honestly the mucus production and the
24 documentation 24 inflammation of the mucous membrane Becaus
25 MR OVERSON Im sorr you said the 25 then you startgetting the mucus productio kind
Page 35 Page 37
1 fog was the highest what 1 of like a cold when it comes down
2 THE WITNESS Cross contamination 2 And then most people it goes away
3 Q BYMR BURKE Cross contamination 3 You get once youreexposed to clean air you
4 Meaning that you have a higher likelihood of 4 get 10 to 15 minutes at worst of good respiratory
5 contaminating people outside of the person youre 5 recovery And then after youvewashed off
6 trying to 6 everything youregenerally back to normal
7 A Correct 7 within an hour to two hours
8 Q address 8 Q When is the longest time that you think
9 A Yeah if you were my target with fog 9 you have experienced the effects of OC after
10 he would just because of the air and the 10 initial exposure
11 nature of the particulates he would be affected 11 A Me personally
12 Q Right And then the stream there 12 Q Yes
13 would be less cross contamination 13 A Respiratorily 5 to 10 minutes max
14 A Correct 14 Once I actually decontaminated as far as washin
15 Q than the fog And the foam less 15 it off within 30 minutes I was back to normal
16 even still 16 you know with proper decontamination
17 A Yes 17 Q And based upon your observations of the
18 Q Okay thatswhat I was wondering All 18 use of OC at IDOC with others is that consistent
19 right letstalk about the effect of exposure to 19 with the pattern that youve seen with others in
20 OC on humans Does that vary depending upon 20 terms of their experience in the effects of OC
21 which ones of these types of products that youre 21 A Yes I think probably the longest Ive
22 using or is it pretty much the same 22 ever seen anybody go was an hour without you
23 A The spray pattern really doesntvary 23 know until I guess what I would consider
24 the effects The fog because of the finer 24 100 percent recovery That was honestly that




























So, if you get it across the brow, it will 1 
actually start to run into the e e. 2 
The foa  s . ou can kind of -- in 3 
layman's terms, you could kind of think of it  
like the di ference betw en the strea  of a 5 
squirt gun, you know, a nice water that runs down 6 
with gravity; and foa  would be ore like silly 7 
string, wherever it hits it's just going to kind 8 
o  stick there a  not .  
Q. SO, if we put it in the order of cross-  
conta ination, would aerosol and fog have ore ( f.L 1 
a cross-c ta ination than  s ?  
. ell, they're all aerosols.  
Q. Okay, that's true.  
. e fo  ould e t e ighest cr ss-  
t i ti , str ,  t e  foa  lo est  
ross- i ti .  7 
. kay, that's hat I as getting to.  
I've got to get the ter inology right.  
. at's like reall  ig f r r --   
far as ter inology, as far as report writing and  
everything else. So, it's something that we  
dru , just as uch as the use is the proper  
t .  




























fog was the highest what? 1 
 I : r ss- t i ti .  
Q. (BY MR. BURKE) Cross-contamination 3 
eaning that you have a higher likelihood of 4 
conta inating people outside of the person you'r 5 
~~~- 6 
. rr t.  
Q. -- address?  
A. Yeah, if you were my target with fog,  
 l  -- just because of the air and the  
nature of the particulates, he would be affected.  
Q. Right. And then the stream, there  
l    -  --  
. rrect.  
Q. -- than the fog. And the foa  less  
 till?  
. s.  
Q. Okay, that's what I was wondering. All  
right, let's talk about the effect of exposure to  
 on hu ans. oes that vary depending upon  
which ones of these types of products that you're 21 
using or is it pretty much the same?  
A. The spray pattern really doesn't vary  
the effects. The fog, because of the finer  
particulates, generally affects the respiratory  
Page 36 
q ic , ut it still a fects the e e . 
Stre , because  the nature f larger 
particulates, its primary effect is the eyes and 
then a s  is the re . 
oa  is i ily the es a  very 
little respiratory just because f the nature 
because the articulates are ig er. 
. . 
. n  t t's hat revents the cross-
ion is the ,  a ticulates 
s ng here o  t the   ot ing 
and beco ing available to the respiratory syste  
. SO, based on your experience, hat are 
generally the effects on hu ans fro  exposure t( 
? 
. ou'll  rary, i ,  
ucus r ti . ost l , t ir es e ; 
 involuntar  l re.  t r es  f t  
e es.  et ind f, a ain, i  f a s r  
feeling t  t e e se  s i .  , he  it 
affects t e respiratory, u'll et c i g.  
l t f t e c i  e erall  c es fr , 
estly, t e c s r cti  a  t e 
infla ation   s .  
t e   start ettin  t e c s r duction i  
  
       . 
 t  t l , it  ay. 
ou t --  ou're  t  l  ir,  
t  t   i te  t r t f  r pir t r  
r ry.  t  ft r ou've  ff 
erything, ou're r ll   t  r l 
it i   r t  t  rs. 
. e  is t e l est ti e t at  t i  
 a e e erie ce  t e effects f  after 
initial exposure? 
. e ersonally? 
. . 
. espiratorily,  t   i tes ax. 
ce I act all  ec ta i ate  as far as as i ! 
it off, ithin 30 inutes I as back to nor al, 
you know, ith proper decontamination. 
. nd based upon your observations of the 
 f   I   t rs, i  t t sistent 
it  t  tt r  t t ou've se  it  t  i  
t r s f t ir ex ri  i  t  eff ts of C? 
. s. I t i  r l  t  l  I've 
v r seen ny  g   a   i out,  
now, ntil I ss t I l  co si r 
 ercent recovery. at as -- onestly, t at 
 an i te. 
 (Pa s  t  37) 
Page 701 Page 72
1 approval of the shift commander 1 IMSI
2 Q Now is PepperBall still a product 2 A Yes
3 thats purchased and used at IDOC 3 Q And does it appear that they are
4 A We still have the ability to use it 4 purchases of Defense Technology products
5 but we haventpurchased any product thatIm 5 A Yes
6 aware of in a couple of years just because of the 6 Q And would that refresh your
7 fact that it hasn been 7 recollection as to whether Defense Technology
8 Q Deployed 8 products were being purchased by IMSI at least
9 A anecessity Yes 9 this time period in 2005
10 Q Do you recall whether PepperBall was 10 A Yes
11 deployed at IMSI at any time between 2004 and 11 Q And there are a number of different
12 2008 12 types of products on here correct
13 A Yes 13 A Yes
14 Q Do you know about how many times 14 Q Can you explain to me what some of the
15 A I dontknow how many times 15 are For instance whats this CSOC MK9
16 Q Can you recall any specific instances 16 aerosol blend What is that
17 where it was deployed 17 A That was a CSOC MK9 aerosol blend
18 A One in particular we had segregation 18 Those were purchased for test and evaluation
19 inmates We had a lock mechanism problem and we 19 Q Okay
20 had about 16 segregation cells open And so the 20 A So CSOC blend gives a mixed effect
21 shift commander authorized PepperBall to go down 21 Theresabout 11 to 15 percent of the population
22 in the institution to basically protect the staff 22 that isnt completely affected by OC depending
23 and keep the inmates in case they tried to get 23 on studies national studies And by blending it
24 out of their cells while the staff resecured the 24 with the CS you get a greater effect rate You
25 cells 25 reduce that 11 percent generally down into the
19 Pages 70 to 73
Page 71 Page 73
1 Q Can you remember any other instances 1 single digits
2 where its been deployed 2 Q All right
3 A We had an inmate fight with weapons in 3 A Those were purchased We had those for
4 A block at one point where it was used where it 4 test and evaluation 12 gauge stingers those
5 was deployed to stop the fight 5 are a specialty impact munition The same with
6 Q Any others 6 the wood batons
7 A Some inmates with weapons in 7 Q Do they have anything to do with OC
8 segregation rec cages were 8 A No
9 Q Any others 9 Q And heresStingball with OC Whats
10 A Not off the top ofmy head 10 that
11 Q Im going to hand you another exhibit 11 A Stingball theyr a hand thrown
12 Exhibit 30 marked 12 munition Theyr used for mob and crowd
13 Q BY MR BURKE Exhibit No 30 to you 13 control basically a tactical situation where you
14 deposition do you recognize that as some 14 need to affect multiple people as a diversion
15 purchase orders invoices relating to OC 15 And they have rubber pellets that come out and
16 purchases 16 then they have the powdered OC within them
17 A Yes 17 Q And a flameless OC expulsion grenade
18 Q And again its got your name up there 18 what is that
19 at the top of at least the first page is that 19 A That is a CO2 charged hand thrown
20 right 20 munition thatsused again with the powdered O
21 A Yes 21 that we spoke about earlier
22 Q And these appear to be dated in 2005 22 Q Is that different then from the OCCS
23 correct 23 aerosol grenade
24 A Yes 24 A Yes





















































approval of the shift commander. 1 
Q. No , is Pepper all still a product 2 
that's purchased and used at m ? 3 
. e still have the ability to use it, 4 
but we haven't purchased any product that I'm 5 
aware of in a couple of years just because of the 6 
fact that it h 't been -- 7 
Q. Deployed? 8 
A. -- a necessity. Yes. 9 
Q. Do you recall whether PepperBall was 0 
deployed at IMSI at any time between 2004 and  
2 ? 2 
. e .  
Q. Do you know about how many times?  
. I don't kno  ho  any ti es.  
Q. Can you recall any specific instances  
where it was deployed?  7 
. ne in particular, e had segregation  
in ates. e had a lock echanis  proble  and e 19 
had about 16 segregation cells open. And so, the  
shift co ander authorized PepperBall to go down  
in the institution to basically protect the staff  
and keep the inmates, in case they tried to get  
t f t ir lls il  t e st ff res re  t   
.  
a e  
Q. Can you remember any other instances  
where it's been deployed?  
A. e had an inmate fight with weapons in  
A block at one point where it was used, where it  
was deployed to stop the fight.  
Q. Any others? 6 
. So e in ates ith eapons in I  
segregation rec cages were --  
Q. Any others?  
. ot off the top of y head.  
Q. I'm going to hand you another exhibit.  
(Exhibit 30 marked.)  
Q. (BY MR. BURKE) Exhibit No. 30 to you 13 
deposition, do you recognize that as some  
purchase orders, invoices relating to OC  
purchases? 1  
. s. 17 
Q. And again, it's got your name up there 18 
at the top of at least the first page; is that 19 
right? 20 
. es. 21 
Q. And these appear to be dated in 2005; 22 
correct? 23 
. es. 24 
Q. ould these have been purchases for the 25 
Page 72 
I I? 
. e . 
Q. And does it appear that they are 
purchases of efense Technology pro t ? 
. es. 
. nd would that refresh our 
rec lection as to hether efense e og  
products ere being rchased by I SI t least i h 
this time period i  5? 
. es. 
. nd there   ber f iffere t 
types f products n h ; c ct? 
. es. 
. an o  l i  t  e hat s e f t en .. 
? r inst , at's t is S/OC -9 
r l l ? hat is t t? 
. at as  /OC -9 r l l . 
hose ere rchased  test  ti . 
. . 
. , /OC  e   e  f ct. 
ere's t  t   r t f t e l ti  
that isn't l t l  ffecte   , i  
 i s,  t i s.     
it  t e   t  r t r ff t r t .  
r ce t t  r t r ll   i t  t  
  
i l  i it . 
. ll ri t. 
.   d.    f r 
t t  val ati n. -gaug  ti rs, t  
are a specialty i pact unition. The sa e ith 
  t s. 
.  t e  a e anyt i  t   it  oC'! 
. o. 
.  ere's "Stin ll it  C." hat's 
at? 
. ti gball, they're  -t r  
unition. hey're se  f r  an  cr  
ontrol, sicall   t cti l sit ti  r   
  aff t ulti     i rsion. 
 t   r r l  t t co   an  
then they have the po dered  ithin them. 
. nd a "flameless  expulsion grenade,' 
t i  that? 
. t i  a 0  char  and-t r  
uniti n that's used again it  t  po r  OC 
that e spoke about earlier. 
. I  that different, then, fr  th  /  
aerosol grenade? 
. es. 
Q. nd how is it different? 
19 (P  7  t  73) 
20 Pages 74 to 77
Page 74 Page 76
1 A The OCCS aerosol grenade again is 1 going to show you a color version This is
2 aerosol Its mixed so you have small droplets 2 Deposition Exhibit No 10 and here is a color
3 come out in kind of a fog That was another one 3 version of it Do you recognize that
4 that was purchased for test and evaluation to see 4 A Yes
5 if we had an area that we could use 5 Q Is that a First Defense product a MK4
6 Q And the red smoke grenade the last 6 product that was for some time period used by
7 one on that list what does that relate to 7 IDOC
8 A That is used for marking landing zones 8 A Yes
9 in case ofa medical evac 9 Q Can you tell me approximately the time
10 Q That has nothing to do with OC 10 frame over which it was used
11 A No 11 A Like I said it was used when lets
12 Q These products that are indicated on 12 see at least 2001 to when we dedicated all of
13 this purchase order and the attached invoice to 13 our OC to SEC which was like I said 04
14 your knowledge were any of those deployed betwee 14 05ish
15 2005 and 2008 15 Q Is this a version of OC that was issued
16 A The flameless expulsion grenades they 16 routinely to correction officers
17 were used we did have an incident in that time 17 A Yes
18 period at IMSI where OC expulsion grenades were 18 Q And they would carry it around on a
19 used 19 holster or a belt
20 Q Any of the others that you recall 20 A Yes
21 A Not that I recall Well the drag 21 MR OVERSON Can I see a copy
22 stabilized 12 gauge but thats not an OC 22 MR BURKE Im sorry here handing
23 product 23 Q BY MR BURKE Did IDOC purchase an
24 Q Its not Okay All right thanks 24 ASP products over the time that youvebeen
25 Do you know whether there are any Defense 25 working there
Page 75 Page 77
1 Technology products that are currently being use J 1 A ASP
2 at IDOC 2 Q ASP Have you ever heard of that
3 A Yes 3 A No sir
4 Q Which ones are 4 Q How about have you ever heard of CTS
5 A Currently we still use the 12 gauge 5 products They come in levels 1 2 3
6 drag stabilized We still use 12 gauge stinger 6 A No
7 rounds The tactical team has wood batons 7 Q Have you ever heard of Aerko
8 stingballs flameless expulsions 8 Aerko
9 Q So any of these OC related products 9 A No
10 then that you just mentioned The stingballs 10 Q How about Zarc International products
11 A I believe the stingballs and the OC 11 like CapStun or Vexor
12 expulsions are still available to the tactical 12 A No
13 team 13 Q How about Fox Labs Mean Green
14 Q And theyr still in use at IDOC 14 A No
15 A Yeah We haven used them in 15 Q UDAP products such as Jogger Fogger
16 again theyr there for a contingency of a 16 ClipOn Commander
17 largescale incident 17 A No
18 Q Have any of those been used in the 18 Q Reliapon products such as American
19 period 2004 to 2008 19 Defense red white and blue
20 A The only one like I said was I 20 A No I never heard of them
21 remember an incident at IMSI in recreation wher 21 Q Have you heard of Counter Assault
22 they used the flameless OC expulsion 22 products OC10 Pepper Blitz
23 Q Im going to hand you a copy of another 2 3 A No
24 deposition exhibit that we have previously 24 Q CQB Supply levels 1 through 3
25 marked This one is in black and white Im 2 5 A No
000668
e    
 . he /CS r l renade i  is  i  t  s    lor rsi . is is 
 r l. It's ixe  so you e s ll roplets  e iti  ibit .   r  is  l r 
 e t i  in  f  f . at as t r e  ersion  i . o  ize t? 
 that as purchased for test and evaluation to see  . es. 
5 if e had  rea at e c ld .  . Is   rs  efense ,  -4 
 Q. And the "red smoke grenade," the last  product that as for so e ti e period used by 
 one on that list, hat does that relate to?  O ? 
8 . hat is used for arking landing zones  . e . 
9 in case  a  .  . a   t ll e i t l  t e ti e 
0 . hat has nothing to do ith ?  ra e  i  it  d? 
 . .  . ike  i ,  as s  e  -- let's 
 Q. These products that are indicated on  , t      ate    
 this purchase order and the attached invoice, to     , ic  ,   i , '0 , 
 your kno ledge ere any of those deployed bet eer 14 '0 i . 
   8?  . s t is  i    t t  is  
 .  fla eless lsion r s, t   r ti l  t  rr ti  ffi rs? 
 ere s  -- e    i   t e  . . 
 period at I SI here  expulsion grenades ere  .  t  l  rr  it r    
 .  lster   elt? 
 Q. Any of the others that you recall?  . . 
 . t t at I recall. ell, t e ra   . :  I s   py? 
 stabilized l2-gauge, but that's not an C  . : I'm s rry, r  (ha ing.) I 
 product.  . (B  . KE) i  I  r as   
 Q. It's not? kay. ll right, thanks.  S  r ts r t  ti  t t ou've  




























echnology products that are currently being use~ 1 
~I C?  
. .  
. hich ones are?  
. urrently e still use the 12-gauge  
drag stabilized. e still use 12-gauge stinger 6 
r s.  t ti l t  s  t s,  
stingballs, fla eless expulsions.  
Q. SO, any of these OC related products,  
then, that you just mentioned? The stingballs?  
. I believe the stingballs and the   
expulsions are still available to the tactical  
.  
. nd they're still in use at IO C? !  
. h.  aven't    --  
again, they're there for a contingency of a  
large-scale incident.   
. Have any of those been used in the  
period 2004 to 2008?  
. he only one, like I said, as I  
   t I  r ti    
they used the flame less OC expulsion.  
Q. I'm going to hand you a copy of another 3 
deposition exhibit that we have previously  
rked.     l   hite. 'm  
  
. P? 
. .      at? 
. , ir. 
. o  about have you ever heard of S 
products? hey co e in levels , , . 
. o. It 
. ave you ever heard f erko, 
- - -k-o? 
. . 
. o  about arc International products 
like ap-Stun or exor? 
. o. 
.  t  bs,  reen? 
. . 
.  r ts s  s J r ger, 
lip-On o ander? 
. o. 
. eliapon products such as erican 
f se, r d, ite, an  lue? 
. o, I r r  f t em. 
.   r  f t r ss lt 
products OC-I 0, Pepper Blitz? 
. o. 
.  Supply, levels 1 through 3? 
. o. 
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24 Pages 90 to 93
Page 90 Page 92
1 taking away that unexpected I know what to 1 felt that realistically its not a necessary
2 expect I know I can deal with it I know Im 2 component now
3 going home at the end of the day so that you 3 You know again I mean personally
4 take a component of that out 4 Ivebeen exposed hundreds of times in various
5 Q Are there certifications for completion 5 levels whether it be on thejob or in training
6 of the training by correctional officers for the 6 and it just its not a necessary component to
7 end use training 7 the refresher as long as you can articulate what
8 A For the user training 8 it felt like from your initial exposure
9 Q Yeah for the OC 9 Q Do you remember approximately at what
10 A We require your initial training at 10 point in time the philosophy changed from an
11 academy theresa classroom portion that covers 11 annual exposure to that wasn necessary on an
12 like I said why We go through the history why 12 annual basis
13 wer using it staff safety when its 13 A Probably 07 08
14 appropriate you know when you use it when it 14 Q Now the people who make the decision
15 appropriate And then we talk about the how we 15 then as to whether or not to have a refresher
16 talk about deployment considerations We cover 16 course follow the OC exposure or not who are
17 decontamination Again we cover those 17 those people again
18 psychological and the physiological effects that 18 A It would be we have an emergency
19 wev talked about today 19 coordinator at central office that is kind of I
20 We spend as much time in 20 guess the governing body or the hewould have
21 decontamination as we do in deployment 21 oversight over the use of force committee And
22 considerations honestly because thatsa huge 22 then that use of force committee would make a
23 component Not liability wise honestly an 23 recommendation for review to the training bureau
24 ethics wise for the staff is understanding that 24 And then the department chiefs at the time would
25 thatsimpoto get people decontaminate 25 have listened to those recommendations and
Page 91 Page 93
1 once the need for force is over And then we 1 decided made the final decision
2 cover documentation and proper terminology of the 2 Q Who is on the use of force committee
3 use of force and decontamination process 3 A Various people It changes again
4 Q And then when you do the refresher 4 annually
5 courses on an annual basis are correctional 5 Q Have you ever been on it
6 officers then sometimes exposed to OC during 6 A No not for the department
7 those courses 7 Q Do you know who was on it from the tin
8 A In some refreshers Like I said in 8 period 2004 to 2008
9 previous years we would do an annual exposure o 9 A I dont not off the top of my head
10 a level 3 which is an area contamination The 10 Q Who trains the correctional officers in
11 tactical team I believe does an annual exposure 11 end use ofOC
12 which is again but thatsa specialized 12 A The instructors
13 component 13 Q And the instructors are other
14 Q Who makes the decision on an annual 14 correctional officers who have advanced training
15 basis as to whether or not to expose correctional 15 A Yeah officers sergeants somebody
16 officers on their refresher course to OC 16 that works for the department Within probation
17 A The training bureau at central office 17 and parole its other parole officers or
18 Q So some years they may opt for 18 supervisors
19 exposure and other years not 19 Q And you yourself have been an
20 A Oh to the best ofmy knowledge we 20 instructor is that correct
21 used like I said we used to go by the one 21 A Yes
22 standard Kind of the whole industry standard 22 Q And did you go through instructor
23 shifted so we as a department shifted with that 23 training
24 standard And it was just one of those 24 A Yes





















































taking away that unexpected. "I know what to 1 
expect. I know I can deal with it. I know I'm 2 
going home at the end of the day," so that you 3 
take a component of that out. 4 
Q. Are there certifications for completion 5 
of the training by correctional officers for the 6 
end use training? 7 
A. For the user training? 8 
Q. Yeah, for the Oc. 9 
A. We require -- your initial training at 0 
academy, there's a classroom portion that covers, 11 
like I said, why. e go through the history, why 12 
we're using it, staff safety, when it's 13 
appropriate, you know, when you use it, when it' 14 
appropriate. And then we talk about the how, we 15 
talk about deployment considerations. e cover 16 
decontamination. Again, we cover those  7 
psychological and the physiological effects that 18 
e've talked about today.  
e spend as much time in 20 
deconta ination as e do in deploy ent  
considerations honestly, because that's a huge  
component. Not liability wise, honestly an  
ethics ise for the staff is understanding that 24 
that's important to get people decontaminated 25 
  
 t   f r f r  is r.  t    
cover docu entation and proper ter inology of th~ 2 
use of force and decontamination process.  
Q. And then when you do the refresher  
courses on an annual basis, are correctional  
officers then so eti es exposed to  during  
those courses?  
. In so e refreshers. Like I said, in  
previous years we would do an annual exposure 0  
a level 3, which is an area contamination. The  
tactical tea  I believe does an annual exposure,  
which is, again, but that's a specialized  
component.  
Q. Who makes the decision on an annual 1  
basis as to whether or not to expose correctional 15 
officers on their refresher course to C? 16 
A. The training bureau at central office. 1 7 
Q. SO, some years they may opt for 18 
exposure and other years not? 19 
A. Oh, to the best of my knowledge, we 20 
use  -- like I said, we used to go by the one 21 
standard. Kind of the whole industry standard 22 
shifted, so we as a department shifted with that 23 
standard. And it was just one of those -- 24 
honestly, the standard shifted because it was 25 
felt that realistica ly it's not a nece sary 
component no . 
Page 92 
You kn , ag , I mea , personally 
I've b en exposed hundreds of times in various 
levels, whether it be on the job or in trainin , 
and it just -- i 's not a necessary co ponent to 
the refresher as long as you can articulate hat 
it felt like fro  your initial e p s . 
. o you re e ber a r i ately at hat 
point in time the philosophy a ged fro  an 
annual exposure to that a 't necessary on an 
annual b is? 
.  '0 , '0 . 
. , the e ple ho ake e , 
th , s t  hether r t  a e  refresher 
urse fo lo  the  s re r , ho  
se pe ple in? 
. It ould be -- e e  e  
c r inator at ce tral ffice t at is i  f, I 
e , t e r i   r t e -- he would have 
ersi t r t  s  f forc  itt .  
t en    rc  i tee ld a e  
    e  e  
    s  e i e  
 listene  t  t s  r ti s  
_ '~m_' ,~'""_, 
  
,    cision. 
.  i   t    f r  mittee? 11 
. s l .   i  
nually. 
.      t? 
. o, t  t  part ent. 
.       it  t  tim 
period 2004 to 2008? 
. I on't,  f  t     ad. 
.  t  t  rr cti l f  i  
en  use of C? 
.  i tructors. 
.  t  i t t  r  t  
corr cti l f    adv  t ~ 
. ah, ffi rs, sergeants, so ebody 
t t  f r t  department. it i  probation 
and parol  it's other parol  offi  or 
supervisors. 
. d y  yourself hav  been an 
instructor; is that cor ect? 
. es. 
Q. d did y  go through i structor 
training? 
A. Yes. 
Q. Okay, tell me about that. 
24 (  90 to 93) 
Page 100
Q And level 1 would be the most severe
exposure correct because youregetting it
directly into your eyes
A Yes youregetting it directly youre
getting in theory ifyourenot one of the
1 I percent people youregetting the full
effect youregetting the eye contact and youre
getting the respiratory effect
Q And a level 3 exposure would be a
lesser exposure
A Yes
Q Because youreexposed in an area but
not directly to your person
A Correct
Q So if I understand you correctly most
correctional officers who were not themselves
instructors or part of the tactical team would
only get a level 3 exposure in their training if
they got any at all
A Correct
Q To your knowledge were the OC
trainings that took place at the womens facility
any different than the trainings that took place
at IMSI
A I dontknow Ive never taught any of
Page 1011
the courses for South Boise Womens
Q Do you know who has
A I know Sergeant Schaffer is one of
their instructors
Q And wellhave the opportunity to talk
with him so I guess we can ask him that
question
Okay lets shift gears here and talk
about Billie Jo Major
A Can we grab a break before
MR BURKE Yes we can Its a good
place to do that
Recess held
Exhibit 32 marked
Q BY MR BURKE Theresone other
document I guess I wanted to show you before w
get into Billie Jo Major specifically Exhibit
No 32 And this actually consists of a number
ofdocuments Its Bates numbered at the bottom
IDC Records 000046 and it goes to 47 and all of
the way through 51 And these are records that
we got from the IDOC Do you recognize those
copies ofmaterial safety data sheets for various
OC types of products
A Yes
26 Pages 98 to 101
Page 98
1 forehead Ive been exposed and then you did 1
2 a task oriented you know with strikes 2
3 basically defense type tasks all of the way to 3
4 controlling a subject with respiratory where you 4
5 had to kind of run get your respiratory up after 5
6 exposure to a level 3 which is area exposure to 6
7 handling contaminated subjects which is a 7
8 level 2 where youregetting OC all over you and 8
9 you kind of have the vapor coming off And thet 9
10 like I said every I cantthink of a time 10
11 when Ive taught a class that I haventbeen 11
12 exposed Generally I go through with the 12
13 students 13
14 Q What I wanted to do is get a 14
15 clarification on you mentioned the levels 1 2 15
16 and 3 What do those exposures relate to How 16
17 are they different 17
18 A Level 1 again is direct contact of the 18
19 OC product on you contaminating the eyes 19
20 respiratory system 20
21 A level 2 is yourehandling a 21
22 contaminated subject So another object has 22
23 been contaminated and then you have to handle i 2 3
24 closely So youregetting the OC product kind 24
25 of youregetting it on your skin secondary 25
Page 99
1 and then youregetting the vapor coming off the 1
2 subject as far as the respiratory effect 2
3 Level 3 is yourein an area thats 3
4 been contaminated generally with the fogger style 4
5 and then you either go youreeither you 5
6 walk through get contaminated and then you hav 6
7 to perform and then you decontaminate 7
8 Some of those like currently with our 8
9 academy we require a level 3 and then you do 9
10 again another defensive task oriented test to 10
11 make yourself work through it and 11
12 Q And I dont know if this is possible to 12
13 generalize but in trainings that youvebeen 13
14 involved with where you are training or 14
15 witnessing training by others of correctional 15
16 officer end users in OC and when the decision is 16
17 made to have the officers exposed to OC do they 17
18 always have the same level of exposure or does 18
19 that differ from training to training 19
20 A No line staff the average 20
21 correctional officer since Ive been with the 21
22 department has always received only a level 3 22
23 which is an area contamination And then 23
24 tactical team members receive a level 1 24
25 Instructors all receive level 1 25
000670
Page 98 Page 100 
1 forehead. I've been exposed -- and then you did 1 . And level 1 ould be the most severe 
2 a task oriented, you kno , with strikes, 2 e pos , corre t, because y u're getting it 
3 basically defense type tasks all of the way to 3 directly into your e ? 
4 controlling a subject with respiratory where you 4 . e , y u're ge ting it r tl , y u're 
5 had to kind of run, get your respiratory up after 5 getting -- in the , if y u're ot ne of the 
6 exposure to a level 3, which is area exposure, to 6 11 percent people, you're getting the full 
7 handling contaminated subjects, which is a 7 e fe t, y u're getting the e tact and y u're . 
8 level 2 here you're getting OC all over you and 8 getting the respiratory effect. 
9 you kind of have the vapor coming off. And ther 9 . nd a level 3 posure o ld be a 
10 like I said, every -- I c 't think of a time  le ser e r ? 
11 when I've taught a class that I haven't been  . e . 
 exposed. Generally I go through with the  . ecause ou're posed in a  , t 
3 s .  t irectl  to r ers n? 
 Q. hat I wanted to do is get a  . t. 
 clarification on, you entioned the levels 1,2,  . O, fl derstand o  tl , st 
 a  . hat  those e posures relate t ?   rre tional fficers  ere t t s l es 
 7 are they different?  7 instructors  t  the c  e   
8 . Level 1 again is direct contact of the  ly t  le l  s re i  t ir tr i ing if 
 OC product on you contaminating the eyes,  they got any at all? 
 respiratory system.  . t. 
  le el  is ou're a li  a  .   e ,    
 conta inated subject. So, another object has  trainings t at t  lace at t e en's facilit  
 been conta inated and then you have to handle i 23  fer    ings   ace 
 closely. So, you're getting the OC product kind   I? 
 f -- you're getting it on your skin secondary  .  n't . 've     



























and then you're getting the vapor coming off the  
subject as far as the respiratory effect.  
Level 3 is you're in an area that's  
been contaminated generally with the fogger style  
and then you either go -- you're either -- you  
walk through, get contaminated, and then you hav  
to perform and then you decontaminate.  
So e of those, like currently ith our  
academy, we require a level 3 and then you do,  
again, another defensive task oriented test to  
make yourself work through it and --  
Q. And I don't know if this is possible to  
generalize, but in trainings that you've been  
involved with where you are training or  
witnessing training by others of correctional  
fficer e  sers i   a  e  t e ecisi  is  
made to have the officers exposed to ~C, do they 1 7 
always have the same level of exposure or does  
that differ from training to training?  
A. No, line staff, the average  
correctional officer since I've been ith the  
department has always received only a level 3, 2 
i  is an ar  contamination.  t  23 
tactical t a  e bers receiv  a l v l 1. 24 
I tr t  al  r cei  level 1. 25 
  
t  s   t  is  omen's. 
. o you kno  ho has? 
.   r t ff  i    
 t tors. 
. nd e'll have the opportunity to talk 
 i ,       i   
stion. 
kay, l t's hift r  r   t l  
t illi  10 jor. 
.      fore? 
. KE: s,  an. t's   
l  t   t at. 
(Rece  eld.) 
(E i it  arked.) 
. (  . RKE) here's  ot r 
t I  I t  t  ho   bef r  e 
g t i t  illi  10 j r specifically, Exhibit 
o. 2.  t i  actually c i t  f a r 
of docu ents. It's t  nu r  at t  ott  
I  c r  0  and it g  t  4  and al  0 f 
t e a  t r  1.  t ese are recor s that 
e g t fr  the I OC.  you recog ize those a 
copies of aterial safety data sheets for various 
 t s of products? 
. es. 
26 (P  9  t  101) 
27 Pages 102 to 105
Page 102 Page 104
1 Q And the first couple of pages relate to 1 health hazards exposure contamination ofthe
2 SABRE Red is that right 2 eyes fire risk And then reactivity which is
3 A Yes 3 how it would if you mixed it with other
4 Q And it looks like the last four relate 4 things what would it do
5 to various First Defense products 5 Q Like water or use of tasers or
6 A Yes 6 something like that
7 Q One being a MK4 and one being a MK9 7 A You dont generally MSDS sheets
8 for First Defense 8 under OSHA dontgenerally the taser would b
9 A Yes 9 under the flammability portion Reactivity woul
10 Q And it looks like the SABRE Red just 10 be more how it would react with water how it
11 says SABRE Red These would be documents thal 11 would react with general fire extinguishing
12 were kept and maintained in the regular course of 12 components things like that
13 business by IDOC 13 TheresMSDS sheets kept on most
14 A Yes 14 products or some form of database to look those
15 Q Does IDOC keep material safety data 15 up We also use the emergency response guide
16 sheets on all of the OC products that it 16 which is used which you can look up pretty
17 purchases 17 much any chemical in use anywhere and it tells
18 A Yes to the best ofmy knowledge 18 you the same information
19 Q And they would be on file somewhere 19 Q All right letsmove on to Billie Jo
20 A They would be kept with the current 20 Major Wellstart with some general backgroun
21 product 21 questions Were you personally acquainted with
22 Q The current product meaning what 22 her
23 A Where we store the current product 23 A She worked on the shift I worked
24 like the armory or the storage facility 24 Q At what period of time
25 Q G i 25 A Whil I was at IMSI
Page 103 Page 105
1 A would have a copy You would have a 1 Q Was that the swing shift or the day
2 copy with that storage area 2 shift do you recall
3 Q So wherever the canisters or whatever 3 A I believe she was on swing shift for
4 are stored thats where you would have the 4 part of that I canttell you the exact dates
5 A Yeah the primary storage area When 5 Q NowIll just represent to you that
6 theyr out in duty use it would be in a central 6 Major was employed by IDOC between July of 200
7 location so if there were an issue and you needed 7 and May of 2008 My understanding is that she
8 to know some information people could go get it 8 worked for IMSI from 2004 to about July of 2006
9 Q For instance would there be one of 9 and then she went over to the womens facility
10 these for PepperBall products too somewhere 10 from July of 2006 to about September of 2007
11 A Yes there should be 11 And then she came back to IMSI from September of
12 Q And once IDOC changes from one brand cf12 2007 until she was terminated in terms of her
13 product to another what does it do with the old 13 employment in May of 2008
14 material safety data sheets Does it keep them 14 Do you remember which of those two time
15 around or dispose of them do you know 15 periods at IMSI you may have worked with her
16 A I dontknow 16 whether it was the first one or the second one
17 Q Whats the reason that IDOC keeps the 17 A It would have been the first one That
18 material safety data sheets on hand 18 second time period I was working at ISCI
19 A Material safety data sheets are for any 19 Q So did you have any supervisory
20 type of chemical They just give you they 20 control or responsibility over her at the time
21 give you the three primary hazards are health 21 that you worked with her on the same shift
22 reactivity and fire for any chemical Material 22 A I had supervisory responsibility over
23 safety data sheets give you the risks for all 23 the whole shift as far as for that eighthour
24 three of those areas and then mitigations or 24 period managing incidents inmate management





















































. nd the first couple of pages relate to 1 
S BRE ; is that ri t? 2 
. e .  
. nd it looks like the last four relate 4 
to various First efense products? 5 
. e .  
Q. ne being a -4 and one being a -9 7 
for irst e? 8 
. e .  
Q. And it looks like the SABRE Red just  
says "SABRE Red." These would be documents tha 11 
were kept and aintained in the regular course of  
business by m C?  
. e .  
Q. oes moc keep aterial safety data  
sheets on all of the OC products that it  
purchases?  7 
A. Yes, to the best of my knowledge.  
. nd they ould be on file so e here?  
. hey ould be kept ith the current  
product.  
Q. "The current product" meaning what?  
A. here we store the current product,  
like the armory or the storage facility --  
. ot it.  
age 103 
. -- ould have a copy. ou ould have a  
copy with that storage area.  
. SO, herever the canisters or hatever  
are stored, that's here you ould have the -- 4 
. eah, the pri ary storage area. hen 5 
they're out in duty use, it would be in a central 6 
location so ifthere were an issue and you needed  
to know some information, people could go get it.  
Q. For instance, would there be one of  
these for PepperBall products too somewhere?  
. es, there should be.  
. nd once I  changes fro  one brand c0  
product to another, what does it do with the old  
aterial safety data sheets? oes it keep the   
around or dispose of the ; do you know?  
. I on't ow.  
Q. hat's the reason that IDOC keeps the  
aterial safety data sheets on hand?  
A. aterial safety data sheets are for any  
type of chemical. They just give you -- they  
give you -- the three pri ary hazards are health,  
reactivity, and fire for any chemical. aterial  
safety data sheets give you the risks for all  
three ofthose areas and then itigations or  
treat ent, whether it be, you know, exposure to  
age 4 
health ha , e posure -- conta ination of the 
e e , fire ris . nd then r ti i , hich is 
ho  it l  -- if ou ixed it ith other 
thin , hat o ld it d ? 
. Like ater r se t rs r 
s et ing like t t? 
. ou n't ll  -- S S sheets 
under S  n't r ll  -- the taser ould b 
under the la ilit  ti . ti it  l 
be ore  t d  ith r,  t 
ould rea t ith l ire tinguishing 
co ponents, things like that. 
re's  ts   st 
roducts  e or   tabase t   t ose 
. e s  s  the  es nse , 
c   se  -- c  u    t  
c   ical i   here  it t lls 
 t   infor ti . 
. ll ri t, l t's e  t  illie J  
aj r. e'll start ith s e e eral ac r ( 
sti s. ere  rs ll  i t  it  
r? 
.  rked  e i   . 
. t hat period of ti e? 
. hile    I. 
  
.     i     
ift;   r call? 
. I li     i  ift f r 
rt f t t. I n't t ll  t  t t s. 
. , I'll j t r r t t   t t 
j   l    t  l   ~ 
   8.  r t i  i  t t  
e   I     l  20  
 t   t  t  t  en's cilit  
 l    t  t t  f2007. 
 t     t   f  t  f 
 til      f r 
l t i    08. 
  r r i  f t  t  ti  
ri  t I I    r  it  er, 
 i    f t   t  secon  ne? 
. I  ul   n t  fi t ne. t 
s  ti  eri d I s r i  t I CI. 
. SO, di   a e a  supervis r  
c tr l r responsibility o er her at t e ti e 
t t   i  r o  t  sa  shift? 
. I had supervisory responsibility over 
t  l  shift as f r as for t t eight-h r 
period anaging incidents, in ate anagement, 
t i s li e t at. s far as irect personnel 
27 (Pa  1   105) 
31 Pages 118 to 121
Page 118 Page 120
1 topics At some point in time we may need to 1 No 33 and Exhibit No 8 together do they look
2 talk to somebody who does if none of these other 2 like they are parts of a training transcript that
3 witnesses do 3 relate specifically to Billie Jo Major
4 MR LOOMIS Thats fine And for the 4 A Yes
5 record when I received your original subpoena 1 5 Q And I dontknow why theyr in
6 did contact HR Ill call it our central office 6 different forms We just got them from IDOC in
7 and basically requested Ms Major personnel 7 these different forms But so far as you can
8 file So just for the record I received what 8 tell though looking at them a training
9 they told me they had on her and I then responde 1 9 transcript is what
10 to your subpoena And so again theresa little 10 A A training transcript is just a
11 bit of a question mark as to you know 11 generally its a chronological record of classes
12 presumably it sounds like her institutional file 12 youve taken during your employment The
13 got merged with the HR file And again I 13 difference in format is this is just the
14 responded to your subpoena so 14 course
15 Are you doing okay on food 15 Q This being what
16 THE WITNESS Oh yeahIm good 16 A Exhibit No 8 is just the course
17 MR BURKE Do you want to take a brea 17 listing with dates of completion
18 now spend a few minutes 18 Q And Exhibit No 33
19 THE WITNESS Im good 19 A And Exhibit No 33 has the training
20 MR OVERSON Sure 20 objective and course description
21 MR BURKE Okay why dontwe take a 21 Q Okay
22 short break 22 A expanded Thatsthe only thats
23 Luncheon recess taken 23 the difference
24 Q BY MR BURKE When we broke for 24 Q But the courses on them should be the
25 lunch we were talking aboutOfficer Major and 25 same shouldn they
Page 119 Page 121
1 some of your knowledge about her employment 1 A They should be yes
2 performance and background Before we finish 2 Q And so it would be fair to say that
3 that part of it I just wanted to ask you this 3 either with one or both of these exhibits 8 and
4 In terms of your interaction with Officer Major 4 33 we would have a complete list of all of the
5 did you ever notice that she had any unusual or 5 trainings that Correctional Officer Major went
6 excessive amount of coughing going on 6 through while she was employed by IDOC
7 A Not that I remember 7 A Should be yes
8 Q Do you recall anybody ever having 8 Q And specifically I think Exhibit No 8
9 teased her about coughing 9 seems to be a little more up to date I think it
10 A I dontremember nothing or anything 10 goes through to the last date which is308
11 about that It doesn ring a bell 11 is that correct
12 Exhibit 33 marked 12 A Yes
13 Q BY MR BURKE All right I am going 13 Q And we know from speaking with her
14 to show you actually two documents Lets take 14 that was the last date she actually was present
15 them one at a time here One ofthem has been 15 on thejob at IDOC So would Exhibit No 8
16 already marked as an exhibit its Exhibit No 8 16 appear to be a complete list of all of her
17 And thenIve got one that may be related It 17 trainings
18 looks like its about the same thing its just 18 A Yes
19 kind of formatted differently and its Exhibit 19 Q And that would include among that list
20 No 33 Did I give you more than one there 20 some ofher OC trainings is that correct
21 A No 21 A Correct
22 MR OVERSON Is that this one 22 Q So what Id like to do is go through
23 MR BURKE Oh I already gave it to 23 some of these and just see about your knowledge
24 you Thats why 24 and recollection about them And yourewelcom





















































topics. t so e point in ti e e ay need to  
tal  t    es if e  t ese t   
itne ses .  
. : t's .   e  
r r , e  I rec ived our ri inal s a,  
i  ta t , I'll ll it r tr l ffi ,  
and basically requested s. ajor's personnel  
fil . , just f r the r r , I r i  hat  
t  told  t    r  I t  r s  i  
to your subpoena. nd so again, there's a little  
bit of a question ark as to, you kno ,  
presu ably it sounds like her institutional file  
got erged ith the  file. nd again, I  
res ded t  r s , s  --  
re  i  a  n f d?  
 I : , , I'm .  
R. B R E: o you ant to take a brea 17 
, s   fe  i t s?  
 I : I'm good.  
. : r .  
. : ay,  n't e ta e a  
 .  
(Luncheon recess taken.)  
. (BY . ) hen e broke for  
lunch, e ere talking about fficer ajor and  
  
so e f your kno ledge about her e ploy ent  
perfor ance and background. efore e finish  
that part of it, I just wanted to ask you this:  
In terms of your interaction with Officer ajor,  
did you ever notice that she had any unusual or  
excessive a ount f coughing going on?  
.    r.  
. o you recall anybody ever having  
teased her about coughing?  
. I don't re e ber nothing -- or anything  
about that. It doesn't ring a bell.  
(Exhibit 33 arked.)  
. (B  . ) ll right, I a  going 13 
to sho  you actually t o docu ents. Let's take  
    e r . e f     
already arked as an exhibit, it's xhibit o.8.  
nd then I've got one that ay be related. It   
looks like it's about the sa e thing, it's just  
kind of for atted differently, and it's Exhibit  
No. 33. Did I give you ore than one there?  
. o.  
. :    e?  
R. BURKE: Oh, I already gave it to  
you. That's hy.  
Q. (BY MR. BURKE) So, looking at Exhibi 25 
 0 
.  a  i it .  t et er,  t e  l  
like t  re rts f  tr i ing tr s ri t t at 
relate s ifi ll  t  illie 10 jor? 
. s. 
. n   n't   ey're in 
ffere t . e ust      
t ese iffere t f r s. t s  far as  ca  
t ll, t h, l i  t t ,  tr i in  
transcript is hat? 
.  training transcript is just a --
generally it's a chronological record of classes 
you've taken during your e ploy ent. The 
ifference i  f r t is t is is j t t  
rse --
. "This" i  t? 
. t .  s us   rse 
listin  it  t s f l ti . 
.  i it . ? 
. nd xhibit o. 33 has the training 
jecti e a  c rse escri ti  --
. y. 
. -- expanded. That's the only -- t at's 
e fe . 
. ut the courses  the  should be the 
sa e; shouldn't they? 
  
.  l  , . 
.  ,        
       i i ,   
33, e ould have a co plete list f all f the 
trai ings t at rrecti al fficer aj r e t 
t r  ile s e as e l e   I ? 
. hould be, yes. 
. nd specifically, I think xhibit o.8 
see s to be a little ore up to date. I think it 
goes through to the last date, hich is 3/3/08; 
  rrect? 
. s. 
.     i  it  r, 
that as the last date she actually as present 
 t  j  t I . , l  i it .8 
appear to be a co plete list of all of her 
trainings? 
. . 
.  t t l  i l   t t list 
s  f r  tr i i s; is t t rrect? 
. rr ct. 
. SO, hat I'd like to do is go through 
so e ofthese and just see about your kno ledge 
and recollection about the . nd you're elco ( 
to look at both of those exhibits as you need to 
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Page 130 Page 132
1 effects 1 exposure you would receive on the job
2 Q They would be part of that 11 percent 2 Q Back in August of 2004 do you have a
3 that doesn get affected 3 specific recall as you sit here today of which
4 A Yeah they would be part of that 4 brand of OC aerosol was used for that particula
5 11 percent 5 training
6 Q And how about in the hallway What wa 6 A I dont
7 the size of the hallway that you would have them 7 Q During that training period of a week
8 walk through 8 or two what was your responsibility during that
9 A The hallway was approximately 20 feet 9 week Were you doing instruction yourself
10 long 10 A Yeah at some point I would have been
11 Q And how wide 11 instructing
12 A Oh 4 feet 12 Q And I assume that all of the
13 Q And was the hallway closed off at all 13 instructors follow pretty much the same protoc
14 ends exits and entrances 14 for the instruction and the training
15 A No it had a door at each end and the 15 A Yes sir We all use a consistent
16 hallway would be exposed and you would walk 16 PowerPoint a consistent the same test is use
17 through similar like just walk through at a 17 across the board The training protocol is the
18 pace The pace was led by an instructor and then 18 same
19 an instructor behind as a safety officer 19 At that time Sergeant Braseth was the
20 Q Okay 20 training sergeant So kind of his job was
21 A And then again like I said you would 21 with multiple instructors his job was to
22 walk out we would walk through the 22 facilitate those periods of training and make
23 contaminated area into the fresh outdoors air 23 sure the course curriculum was consistent day t
24 Q And was it a fog that was used in each 24 day
25 one ofthese trainings 25 Q And the tests youretalking about were
Page 131 Page 133
1 A Yes 1 written tests like some thatwev seen here
2 Q And how much of a fog do you use One 2 today
3 application Two applications How does it 3 A Yes like the exhibits you gave me
4 work 4 earlier
5 A When we were in the cell it was 5 Q Right And all of the officers would
6 generally about a one to twosecond burst up in 6 have to do the written test as well as the field
7 the air to get it churning through the to get 7 work too
8 it you know moving through the circulation of 8 A Correct
9 the room When it was the hallway it was a 9 Q You mentioned the PowerPoint Who
10 larger area so generally it was about two to 10 created the PowerPoint
11 three one second bursts the length of the hall 11 A Themanufacturers We used Defense
12 Q So you kept doing that two or three 12 Technologys We used Defense Technology
13 seconds all of the way down the hall 13 PowerPoint And then when we went to SABRE
14 A Well it would be done it would be 14 SABRE supplied us with their product PowerPoin
15 done and then the group would start through the 15 and thats what was used
16 hallway So the area was exposed and then you 16 Q Did IDOC modify those PowerPoints by
17 walked into an exposed area Which the reason 17 adding any of their own stuff as part of the work
18 that was much more consistent with the 18 on them
19 environment that you would face at work Becaus 19 A The only thing that was ever added to
20 generally as a responding staff or even in an 20 it was where it applies in our individual use of
21 area youregoing to expose an area with the 21 force policy Because all of the manufacturers
22 inmate in it and then youregoing to have to 22 they just basically they have a slide that says
23 enter that area to restrain them and control 23 Apply this to your use of force policy Follow
24 them So it was much more consistent with the 24 your policy And we would add a slide of




















































 l  
t . 1 
.  l   rt ft t  r t 2 
that doesn't get affected? 3 
. , t  l   rt f t t  
 r nt.  
.   t i  t  ll ay? t   
t e size f t e all a  t at  l  a e t e   
l  t r ugh?  
. e all a  as a r i atel   feet  
l .  
. nd ho  ide?  
. ,  t.  
. nd as the hall ay closed ff at all 13 
, ts  ces?  
. , it a  a r at eac  e  a  t e  
ll a  l   s    l  l   
t r  si il r, like j st l  t r  t   
.   s l    i str t r  t   
an instructor behind as a safety officer.  
. kay.  
. nd then again, like I said, you ould  
  -- e ould alk through the  
t inated ea  e   ir.  
. nd as it a fog that as used in each  
one of these trainings?  
  
. . 
. nd ho  uch f a fog do you use? ne 
application? o applications? o  does it 
rk? 
.    i  t  ll, it  
generally about a one- to t o-second burst up in 
t  ir t  t it r i  t r  t  -- to get 
it, you kno , oving through the circulation of 
the roo . hen it as the hall ay, it as a 
larger area, so generally it as about t o to 
three one-second bursts the length of the hall. 
. SO, you kept doing that t o or three 
seconds all ofthe ay do n the hall? 











done and then the group ould start through the 
hall ay. So, the area as exposed and then you 
alked into an exposed area. hich the reason --  
t t    i t t it  t   




generally as a responding staff or even in an  
area, you're going to expose an area ith the  
in ate in it and then you're going to have to  
         
t . , it as  r  sist t it  t   
act al r ing e ir e t a  t e t e f 25 
 l  
exposure you ould receive on the job. 
. ac  i  st f 4,   a e a 
s ifi  r ll s  sit r  t  f i  
ra  f  aer s l as se  f r t at artic la 
tr ining? 
.  on't. 
. uring that training period f a eek 
r t , at as r res onsibilit  ri  t a 
eek? ere  i  i str ction rself? 
. eah, at s e i t I l  a e ee  
i str cti g. 
. nd I assu e that all f the 
i str ctors f ll  rett  c  t e sa e r t co 
for the instruction and the training? 
. s, sir.  ll s   sist t 
r oi t,  i t t --     d 
across the board. The training protocol is the 
e. 
t that ti e ergeant raseth as the 
trai i  ser eant. , i  f is j  as --
ith ultiple instructors, his job as to 
facilitate those periods of training and ake 
s re t e c rse c rric lu  as c siste t a  t( 
. 
.  t e tests ou're tal i  a t ere 
 l  
t      e've   
today? 
. es, like the exhibits you gave e 
rli r. 
. ight. nd all of the officers ould 
    tte    ll    
 ? 
. rrect. 
. ou entioned the Po erPoint. ho 
  erPoint? 
.  t r . e   
echnology's. e used efense echnology's 
r oi t.  t    t t  E, 
S E supplied us ith their product Po erPoin 
 at's   . 
. id 100  odify those Po erPoints by 
adding any of their o n stuff as part of the ork 
 t m? 
. e l  t i  t at as e er a e  t  
it as here it applies in our individual use f 
force policy. ecause all f the anufacturers, 
they just basically, they have a slide that says: 
"Apply this to your use of force policy. Follo  
your policy." nd e ould add a slide of--
. at t at is? 
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1 A Yes just a direct quote right out of 1 it states that they were exposed
2 our policy of where it would apply 2 Q Do you recall how that exposure was
3 Q Do you recall for this August of 2004 3 handled
4 training whether you used a SABRE Red training 4 A That exposure I believe we used the
5 PowerPoint or a First Defense PowerPoint 5 hallway 06 would have been
6 A I dontrecall 6 Q And would that still have been at the
7 Q Do you specifically recall Officer 7 F block at IMSI
8 Major going through that training 8 A Yes
9 A Not specifically 9 Q So you had the group walk through the
10 Q So I take it you cant tell how she 10 hallway after it had been
11 reacted to exposure to OC in that particular 11 A Contaminated
12 training 12 Q contaminated with aerosol OC
13 A No 13 A Yes
14 Q Lets go on to the next one in order 14 Q Do you specifically remember which
15 here by date And if I am correct it looks 15 brand of OC was used in the 06 training
16 like and it may be a little out of order here 16 A That was SABRE
17 but it looks like its February 14 of 2006 17 Q And do you know how many bursts ofO
18 A Yes 18 were actually employed as part of that training
19 Q And that refers to an oleoresin 19 A I dontremember exactly
20 capsicum training in which you are the named 20 Q Would it have been two to three
21 instructor is that correct 21 A Two to three
22 A Yes 22 Q And this says again that it looks
23 Q Does that suggest to you that you were 23 like its a threehour class is that right
24 actually the instructor of Officer Major as part 24 A Yes
25 of this particular training 25 Q What percentage of that three hours
Page 135 Page 137
1 A Yes 1 would have been devoted to the actual exposure o
2 Q And again would that be part of an 2 OC
3 annual refresher course 3 A Well the demonstrate proper technique
4 A It appears to be yes Yes because 4 and exposure would consist of an hour to an hour
5 its combined later with specialty impact 5 and a halfofthe course
6 munitions and the stun baton and the use of force 6 Q But part of that is demonstrating the
7 annual refresher that all were the same date 7 proper technique correct
8 Q So do you have a specific recall of 8 A Correct
9 that particular group of trainings that went on 9 Q And when youredoing that youre
10 in February of 2006 10 using inert OC
11 A In general 11 A Yes
12 Q Tell me what you generally recall about 12 Q So that doesn have the active
13 them What do they consist of 13 ingredient in it is that right
14 A What they consist of again was the 14 A Correct
15 lecture portion We would start the day with the 15 Q And what yourejust doing is teaching
16 use of force annual review where we talk about 16 them the manner in which to deploy it so it gets
17 levels of force proper documentation what types 17 into the eye and nose area is that right
18 of force our own our use offorce continuum 18 A Correct
19 for our department at the time And then we 19 Q And as opposed to that practice where
20 would go in and do the subject specific such as 20 youreteaching them deployment and the part
21 OC and specialty impact munitions and stun bato 21 where theyr actually exposed how much of the
22 Q And on this particular one in February 22 time is invested in each
23 of06 was there any specific exposure of the 23 A Approximately 30 minutes to the
24 trainees to OC 24 demonstration and then an hour to the exposure



























e    
. es, just a direct quote right out of 1 it states that they ere exposed. 
our policy f here it ould apply. 2 .      re  
. o  recall f r t is ugust f  3 dled? 
training ether  se  a RE e  trai in  4 . hat e s re, I elie e e se  t e 
 r  rst efense rPoint?  l . '0  ld  . 
.  n't r ll.  . n    ti      
. o you specifically recall fficer   l  t I? 
ajor going through that training? 8 . . 
. t s ecificall .  . O,        
Q. SO, I take it you can't tell how she  a   t   --
reacted to exposure to C in that particular  . t i t d. 
trai i g?  . -- nated th  ? 
. .  . s. 
. et's   t  t e e t e i  r er  .   s ecificall  re e er ic  
ere  t . nd if I  rr ct, it l s     a     '06 i i g? 
like --  it    little t f r r r ,  .   . 
t it l s li e it's r r   f 06?   .       rsts f ( 
. .  r  t ll  l e   rt f t t tr ining? 
. nd that refers to an oleoresin  . I don't re e ber exactly. 
ca sicu  trai i  i  ic   are t e a e   .  t     ree? 
t r; s  rrect?  .   . 
. .  .   , i ,   s 
Q. oes that suggest to you that you ere  li e it's  t ree-hour l ss; is t t ri ht? 
actually the instructor of Officer ajor as part  . s. 
f t is rti lar tr ining?  . t r t  f t t t r  rs 


























age 135   
. .  
.  a ain, l  t at e art f a   
 res  r e?  
. It appears to be, yes. es, because  
it's co bined later ith specialty i pact  
tions           
 res   l     t .  
. SO, do you have a specific recall f  
that particular group of trainings that went on  
in February of2006?  
. In general.  
. ell e hat you generally recall about  
the . hat do they consist of?  
. hat they consist of again as the  
lecture portion. e ould start the day ith the  
          
levels of force, proper docu entation, hat types 17 
f f r , r  --   f  t   
for our depart ent at the ti e. nd then e  
ould go in and do the subject specific, such as  
C and specialty i pact unitions and stun baton. 21 
Q. And on this particular one in February  
of '06, as there any specific exposure ofthe  
  C?  
A. Yes. It's in the course description,  
l  a e ee  e te  t  t e act al e s re 0 
C? 
. ell, the de onstrate proper technique 
and exposure ould consist f an hour to an hour 
  l  f  r e. 
. t art f t at is e strati  t e 
proper technique; correct? 
. rr ct. 
. nd hen you're doing that, you're 
using inert C? 
. . 
. SO, that doesn't have the active 
ingredient in it; is that right? 
. rr ct. 
. nd hat you're just doing is teaching 
the  the anner in hich to deploy it so it gets 
i t  t     rea; i  t t i ht? 
. rrect. 
.    t  t t r ti  r  
ou're t i  t  l t  t  rt 
r  t ey're ctuall  sed,   f t  
    ach? 
. pproxi ately 30 inutes to the 
de onstration and then an hour to the exposure. 
    -- that's, you kno , the 
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Page 138 Page 140
1 exposure itself takes a couple ofminutes And 1 Being February Im assuming it was probably a
2 then we always take about 30 to 40 minutes at the 2 little chilly
3 end of the class to make sure everybody is 3 We have an outdoor fenced area so its
4 cleared out and kind of a safety barrier before 4 secured away from any inmate population They
5 we actually send them home 5 can spend as much time as they want out there
6 Q And you go through the decontamination 6 We provide clean paper towels for anybody if the
7 process too correct 7 want to you know again if any of the vapor
8 A Yes 8 got on them and they want to dab off And then
9 Q But the actual exposure time is fairly 9 we have in F block theres actually numerous
10 minimal isntit 10 water sources that people are encouraged to use
11 A Yeah it would be the length you 11 and wipe off
12 know it would be 12 We also at that time we had been
13 Q Minutes 13 using making sure encouraging people to bring
14 A Yeah what it would take you to walk 14 like outer clothing so that they would put on
15 20 feet at a normal walk 15 like a sweatshirt or something that you could
16 Q Minutes at the most 16 take off that if any vapor hit you would take
17 A Id say a minute at the most 17 off and remove after the training so you didnt
18 Q And do you have any specific recall 18 have to wear it around all of the way home
19 about how Officer Major reacted to her exposure 19 Q And did the correctional officers
20 to OC in that particular training 20 usually do that
21 A I dontremember anything out of the 21 A Most of them yes
22 ordinary that I 22 Q Do you recall anything specific about
23 Q And if it had been something out of the 23 Major in that regard
24 ordinary is that something that you would have 24 A No nothing stands out
25 noted in writing somewhere o made som note in 12 5 Q And it lo like the next one io
Page 139 Page 141
1 file somewhere 1 we have here is a training that took place on
2 A Yes if we had any the only like 2 August 23rd of 2006 It says OC training
3 I told you earlier the only out of the ordinary 3 policy 307 use And then it looks like the
4 reactions I ever remember we documented in 4 instructor was Officer Julio Vega Do you know
5 departmental accident reports 5 who Julio Vega is
6 Q And those are the ones involving the 6 A Yes
7 mascara 7 Q Is this a training that occurred at
8 A Yes 8 IMSI or did it occur at the womens prison
9 Q And the makeup 9 A I believe it was at the women because
10 A Yes 10 to the best ofmy knowledge Vega has never bee
11 Q And so does the fact well let me 11 assigned to IMSI
12 put it this way If there isnt any specific 12 Q And actually I think thatsconsistent
13 notation any documentation about an adverse 13 with the time frame that Major was actually there
14 reaction by Officer Major to this particular 14 at the womensprison I think it was after July
15 training does that suggest to you that there was 15 of 2006 So do you have any particular
16 no extraordinary issue with that anything out of 16 familiarity about this training
17 the ordinary 17 A No
18 A I would assume since there is no 18 Q Can you tell by the records in front of
19 documentation that there wasntanything broug t19 you Exhibit No 33 and Exhibit No 8 whether o
20 to our attention or noted for that day 20 not that training involved OC exposure
21 Q Do you remember the decontamination 21 A It doesn state
22 process that was involved with that particular 22 Q If there had been OC exposure would it
23 training session 23 state
24 A The decontamination was they walk 24 A Honestly it depends on the data entry




























exposure itself takes a couple of minutes. And 1 
then we always take about 30 to 40 minutes at the 2 
end of the cla s to ake sure e erybody is 3 
cleared out and kind of a safety barrier before 4 
we actually send them ho e. 5 
. nd you go through the deconta ination 6 
process too; correct? 7 
. e . 8 
. But the actual exposure time is fairly 9 
ini al; isn't it? 0 
. eah, it ould be the length -- you  
kno , it ould be -- 2 
Q. Minutes? 3 
. ea , hat it ould ta e you to alk 4 
2  e  at  nor al .  
Q. inutes at the ost?  
A. I'd say a inute at the ost. 1 7 
Q. nd do you have any specific recall  
about how Officer ajor reacted to her exposure  
to OC in that particular training?  0 
. I don't re e ber anything out f the  
ordinary that I --  
Q. And ifit had been something out ofthe  
ordinary, is that something that you would have  




























file so e here?  
A. Yes, if we had any -- the only -- ike  
I told you earlier, the only out of the ordinary  
        
departmental accident reports.  
Q. And those are the ones involving the  
~~M~  
. es.  
Q. And the makeup?  
. s.  
Q. And so, does the fact -- ell, l t   
put it this way: If there isn't any specific  
notation, any documentation about an adverse  
reaction by Officer Major to this particular  
training, does that suggest to you that there was  
no extraordinary issue with that, anything out of 16 
the ordinary? 1  
. I l  ssu  si  t r  i  n  1  
docu entation, that there asn't anything broug~tl9 
to our attention or noted for that day. 20 
Q. Do you remember the decontamination 21 
process that was involved with that particular 22 
training session? 23 
. he decontamination as they alk -- 24 
like I said, they would walk into nice fresh air. 25 
Page 140 
Being Fe , I'm ass ing it as proba ly a I) 
li tle c . 
e have an outdoor fenced are , so it's 
s red a a  fro  any inmate p . he  
can spend s uch time as they ant out the . 
e provide clean paper to els for a body ift e 
a t to -- you k , a ai , if a  of the vapor 
got on the  and they ant to dab . nd  
e h , in  lock th re's  nu erous 
ater s urces t at people are e couraged to use 
a  ipe ff. 
e s  t that ti e, e ad een 
us , ing s , ng e ple t   
like ter lothing s  t t  ld t  
ike  rt   t o   
ta e f t  if   ,  o ld ta e 
f   ter    ou n't 
  ea  t     a  . 
. nd did the correctional officers 
  t t? 
.   , . 
.   r ll t i  ifi  t 
ajor in that regard? 
. , t i  t s t. 
.  it looks li  t  ext  in rder 
  
e   i   t i i  t t t  l   
ugust r  f2006. It ys: fl  i i g/ 
li   se."  t  it l  li  t  
i t t   ic  li  .    
 l   ? 
. . 
.  t i   t i i  t t  t 
   i     en's rison? 
.  l  i     omen's  
t  t  t f  l ge,   r r 
i  t  I. 
.  ctually, I t i  that's i t t 
I' 
  t  f  t t j   ctual y t r  . 
t t  en's rison. I t i  it s ft r Jul  
f 06. So,    ny rti l r 
f ili rit  t t i  training? 
. o. 
. a   tell by t e rec r s i  fr t of 
ou, x i it o. 33 and xhi it .8, et er or 
not t t tr i i  i v l   exposure? 
. It oesn't state. 
. If th r     exposure, ould it 
state? 
A. onestly, it depends o  the data entry 
because this data is entered off the traini g 






























1 sort ofan odor to it 1 things you mentioned is as they went through the
2 A Yeah it smells like after its 2 training procedure you recommended to all of
3 deployed some of the aerosols have kind of a in 3 them that they bring an outer layer of clothing
4 the fogger have a light citrusy well it has 4 that they could have exposed and then remove
5 to do with the carrier component It actually 5 A Correct
6 adds a little bit of a citrus component 6 Q But what happens to correctional
7 Q Like a scent to it 7 officers say during the course of the day and
8 A Yeah a slight scent 8 they get exposed to OC as part of somebody
9 Q Like when you go to the car wash and 9 deployment with an inmate How do they
10 somebody gives you a scent that sort of thing 10 decontaminate with respect to their clothing
11 A Yeah kind of 11 A As far as their clothing
12 Q Okay 12 Q Yes
13 A As far as in general it smells like 13 A Theyr given the opportunity if they
14 it smells like peppers You know ifyou were to 14 have clothing at the locker room to go change
15 take and sniff a big can of cayenne it would be 15 wash up We have showers available for staff
16 a similar scent because thatswhat its based 16 We have uniform issue rooms Ive had staff com
17 out of 17 up and you know their shirt is saturated or has
18 Q So if theresbeen a contamination 18 a decent amount and welljust go get them
19 letssay an aerosol thatsin a cell or in an 19 another uniform shirt of some sort At some
20 area before its cleaned up or decontaminated 20 point sometimes when you dont have that
21 can you smell it in there 21 available for some people we let them go home
22 A Before its 22 and
23 Q Yeah before its decontaminated 23 Q And change
24 A Yes 24 A And change I mean I personally have
25 Q And once its been cleaned up is the 25 had to do two of those Ive been contaminated
Page 159 Page 161
1
2
Q And I think youvealready talked about 3
this a little bit but in terms of clothing once 4
an inmate has been contaminated one of the 5
procedural options is to exchange the clothing 6
is that right 7
A Thatsnot an option its required 8
Q Its required 9
A Yes any time youregoing to well 10
any time you use force on an inmate youregoing 11
to remove all of their clothing as part of 12
one as part of the decontamination and two as 13
part of the search procedure before theyr 14
placed in a decontaminated cell because you dont 15
know they could leave a weapon whatever else o 16
the 17
Q What becomes of the clothing that has 18
been decontaminated 19
A Its taken to the laundry and washed 20
Q And theyr given new clothing before 21
theyr put back in their cell 22
A Correct 23
Q And in terms of correctional officers 24
in terms of their clothing I think one of the 25
to the point on duty that I had to go up and take
a full shower and put a completely clean uniform
on or contamination was just going to continue
for the rest ofthe shift
Q Do you ever recall Officer Major
complaining about any contamination to OC
A I dontrecall
Q Do you ever recall her complaining
about the coughing effects ofOC exposure
A I dontrecall
Exhibit 35 marked
Q BY MR BURKE Let me hand you wh
Ive had marked as Exhibit No 35 again some
documents that we received from IDOC And yc
had mentioned a PowerPoint and I was just
wondering ifyou recognized Exhibit No 35
A Yes it looks similar to if not the
PowerPoint that was used during that period for
the
Q For OC training
A For OC training
Q Would this be part of refresher
trainings
A It would have been part of refresher
and initial trainings





















































sort of an odor to it? 1 
A. Yea , it s ells like -- after i 's 2 
deployed, so e of the aerosols have kind of a, in 3 
the fogger, have a light citrusy -- well, it has 
to do with the carrier component. It actually 
adds a little bit of a citrus co ponent. 
Q. Like a scent to it? 
A. Yeah, a slight scent. 
Q. Like when you go to the car wash and 
so ebody gives you a scent, that sort of thing? 
A. Yeah, kind of. 
Q. Okay. 
A. As far as in general, it smells like --
4 
 
it smells like peppers. You know, if you were to 14 
take and sniff a big can of cayenne, it would be  
 si ilar t ecause t t's hat it's ase  
t f. 
Q. SO, ifthere's been a contamination, 
let's sayan aerosol that's in a cell or in an 
area, before it's cleaned up or deconta inated, 
can you smell it in there? 
.  it's --
Q. Yeah, before it's decontaminated? 
. . 
Q. And once it's been cleaned up, is the 








s ell usually gone at that point?  
. .  
Q. And I think you've already talked about I  
this a little bit, but in ter s of clothing, once I  
 i ate   t i t ,   t  I  
procedural options is to exchange the clothing; II  
is that right?  
A. That's not an option, it's required.  
Q. It's required?  
A. Yes, any time you're going to -- ell,  
any time you use force on an inmate, you're going 11 
to re ove all of their clothing as part of -- 1  
one, as part of the decontamination; and two, as 1  
part of the search procedure before they're 14 
placed in a decontaminated cell because you don't, 15 
know, they could leave a weapon, whatever else oh16 
t  -- 1  
Q. What becomes of the clothing that has 1  
been decontaminated? 19 
A. It's taken to the laundry and washed. 20 
Q. And they're given new clothing before 21 
they're put back in their cell? 22 
. Correct. 23 
Q. And in terms of correctional officers 24 
in ter s f their clothing, I think one of the 25 
Page 160 
things you mentioned is as they ent through the 
training proce r , you recommended to all of 
them that they bring an outer layer of clothing 
that they could have exposed and then re ? 
A. rr t. 
. But hat happens to c rre tional 
o ficers say during the course f the a  a d 
they et e posed to  as part f body's 
de loy e t ith an i t ? o  do the  
deconta inate ith respect to their c i g? 
. s far s t r c ? 
. e . 
. ey're ive  t  rt ity if t e  
a e lothing t t e locker r  t   , 
a  . e  e s a e  t f . 
e  ifor  issue r s. I've  st ff  
p , o  ,   s ate  r s 
 t t,  e'll   t t e  
t e  for  rt  e .  e 
i t s eti es e   n't a e t at 
   ,  e     
a  --
.  nge? 
.  . I n, I rs ll   
     . 've  ate  
  
t  t  i t  t  t t I  t     t  
 f ll r  t  l t l  l  if r  
 r t i ti   j st i  t  ti  
     hift. 
.    l  c  j  
l i i  t  t i ti  t  C? 
. I on't cal . 
.   r r ll r l i i  
   f    x osure? 
. I on't r call. 
(E i it  arked.) 
. (B  . RKE) et e a  y u a ; 
've    x i i  o. 35, i  so  
cu ents t t  r cei   I C.  o 
had t   o r oi t  I   
deri g if  r c i  xhi it o. 5? 
. s, it l  si il r to, i  not t  
o er oi t t at s used duri  t t eri  for 
the --
. For  training? 
. r O  training. 
. ould this be part of refresher 
trainings? 
. It l  have been part of refr sher 
and i it l trainings. 
4  (  15  t  161) 
42 Pages 162 to 165
Page 162 Page 164
1 Q Do you know what time frame this may 1 A Yes
2 have been used 2 Q Tell me about that
3 A Oh I dont I dont know exact time 3 A Their rep used to contact me when 1 was
4 frames when a specific PowerPoint was used 4 at IMSI and then also a couple of times since
5 Q But looking at it does it appear to 5 Ive been at ISCI just in regards to the
6 contain the same basic information that the 6 products things like that Ive received a
7 PowerPoints that you were involved with had 7 couple theyv given us a couple of products
8 during the time you trained 8 to test and evaluate as far as like one was
9 A Yes 9 the OCCS blend their product and thats
10 Q As I recall your testimony were these 10 when like the invoice you showed me earlier
11 PowerPoints then put together by one of the 11 with the OCCS from Defense Technology
12 manufacturers 12 Q Yes
13 A Yes 13 A We tested and evaluated it as far as
14 Q Can you tell by looking at it which 14 the SEC product as opposed to the Defense
15 manufacturer may have performed this one 15 Technologysyou know compared them side by
16 A This looks like SECs 16 side by exposing each other
17 Q And you can tell that because the use 17 Q How did that comparison go
18 of SABRE is in there on occasion 18 A I personally because I personally
19 A Yes and the background format 19 took was exposed to both of them a level 1
20 Defense Technology uses a difference slide 20 And the Defense Technology to me was not as
21 background 21 effective as the SEC product
22 Q And is this the training PowerPoint 22 Q And effective to you means what
23 that would have been used to train end users as 23 A Getting the desired effects getting
24 opposed to trainers 24 compliant you know to the point that youre
25 A This is lets see Yes It has 25 going to be compliant with you know affecting
Page 163 Page 165
1 some of the instructor information in it but a 1 the respiratory affecting the eyes Quite
2 lot of that was left in and yeah this was the 2 honestly what it comes down to is youregoing
3 end user PowerPoint 3 to gain compliance because youre taking away
4 Q Now Illrepresent to you that Officer 4 that personsability to fight you You know
5 Major was fired from her job at the Department c f 5 without being able to see whatsgoing on and
6 Transportation pursuant to a disciplinary 6 breathe what you consider effectively yourenot
7 proceeding 7 going to it takes the fight out of you so
8 MR LOOMIS Department of 8 Q And if you have a product thatsless
9 Transportation 9 effective does that impact the safety of the
10 Q BY MR BURKE Im sorry Departme 10 inmate and the officer both
11 of Corrections sorry as part of a disciplinary 11 A Absolutely If it makes you if its
12 proceeding in May of 2008 Were you aware of 12 less effective then it means you have a greater
13 that 13 percentage of chance that youre going to have to
14 A No not until today 14 go use physical control which increases the
15 Q So I take it you had no information of 15 potential danger to the inmate Because theres
16 the factors that led to that termination 16 more potential of physical harm or of hurting
17 A No 17 them long term with physical force And less
18 Q Have you had any communication with 18 physical you have a greater potential of
19 Officer Major since March of 2008 19 physical injury to the staffbecause of the same
20 A No 20 thing One you have to enter an area you dont
21 Q Have you had any observations of her 21 want to be in thats controlled by them Two
22 since March of2008 122 you have to use physical control and you increase
23 A No 23 the potential for injury from joint injury to
24 Q Have you yourself had any direct 24 muscular injury to just slipping and falling
25 communications with SEC representatives 25 to
000677
Page 162 Page 164 
1 Q. Do you know what time frame this may 1 A. Yes. 
2 have been us ? 2 Q. Te l me about th . 
3 A. Oh, I don't. I don't know exact time 3 . Their rep used to contact me when 1 as 
4 frames when a specific PowerPoint was used. 4 at I SI and then also a couple of times since 
5 Q. But looking at it, does it appear to 5 I've been at ISCI just in regards to the 
6 contain the sa e basic information that the 6 prod ts, things like that. I've received a 
7 Po erPoints that you ere involved with had 7 couple -- t ey've given us a couple of products 
8 during the time you trained? 8 to test and evaluate as far as --like one was 
9 A. e . 9 the C/CS ble , their pro , a d t t's 
10 Q. As I recall your testimony, were these 10 hen -- like the invoice ou s ed e e  ier 
11 Po erPoints then put together by one ofthe 11 ith the C/CS fro  efense e logy --
12 t r ?  . e . 
 . es.  . e tested a  e aluated it as far as 
4 Q. Can you tell by looking at it which 4 the  t s pposed to the efens  
5 manufacturer may have performed this one?  hnology's,  , are  t  e  
6 . is looks like C's. 16 side  i   t r. 
7 Q. And you can tell that because the use  . o  i  t t arison ? 
8 f "SA " is in there n sion?  . I al , a se   
 A. Yes, and the background format.  , as osed    ,   . 
 efense Technology uses a difference slide  n   efense hnology's      
 background.  ffe tive  t e  r t. 
 Q. And is this the training PowerPoint  .  "e fe i e"   s t? 
 t t l     t  tr i   r    . tti  t  ire  ff t , tti  
 opposed to trainers?  co pliant, you kno , to the point that you're 
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age 163 
so e of the instructor infor ation in it, but a  
l t f t t s l ft i   -- yeah, this as the  
  rPoint.  
. o , I'll represent to you that fficer  
Major was fired from her job at the Department (f 5 
Transportation pursuant to a disciplinary  
proceeding.  
MR. LOOMIS: Department of  
Transportation?  
Q. (BY MR. BURKE) I'm sorry, Departmen  
of Corrections, sorry, as part of a disciplinary 1  
proceeding in May of2008. Were you aware of 12 
t at? 1  
A. No, not until today. 1  
Q. SO, I take it you had no information of 1  
t  f t  t t l  t  t t t r ination? 16 
. o. 17 
Q. Have you had any communication with 18 
Officer Major since March of 2008? 19 
. o. 20 
Q. Have you had any observations of her 21 
since arc  of 20087 22 
A. No. 23 
Q. Have you yourself had any direct 24 
communications with SEC representatives? 25 
  
 ir tory,   s.  
stly,       ou're  
t  i  lia   ou're t i   
t t erson's bilit  t  i t u.  w, 
 i  bl    hat's i    
    ff ctively, ou're t 
going to -- it t s t  fi t t f u, s  -- .. 
.  if    r t that's l  
ff ctive,  t t i t t  f t  f t  
i   t  f  oth? 
. olutely. I  it   -- if it's 
l s ef ective, t n i    h v   t r 
r t  of c  t t ou're goi  to hav  to 
  i l control, i  i  t  
potential dan er t  t e i ate. eca se there's 
r  tenti l of si l har  or of hurti  
t  l  ter  i  physical force.  less 
hysical -- you hav  a gr ater potential f 
physical inj ry to the staf  b c  of the same 
thing. ne, y  have to enter an ar  you don't 
want to be in that's control d by them. Two, 
you have to use physical control and you incr as 
the potential for injury fro  joint injury to 
muscular injury to j st slipping and falling 
to --
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Idaho Department of Correction Page 1
Class Summary 02172009
No 55917
inasictifnOC Type Emergency Preparedness
Start 08200 4 End 08200 4 Hours 30
Instructor KEVIN D NATION
History and use of OCDescribe Delive s stems Levels of contaminationDemonstrate
proper techniqueOperate a MK4 c
Student Name Number Hours Score Pass
kux 3
DEBORAH DAWN MCCLELLAN 3686 30 0 Pass
JIM DIXON 6800 30 0 Pass
MICHAEL R BOYD 7557 30 0 Pass
MICHELLE L NICK 4354 30 0 Pass
SARA M BUNN 7619 30 0 Pass




Idaho epart ent of rrection 
lass Summary 
Pa : 1 
02117/2009 
~glfi6i~~lgu1W~~8~i;' 
St rt: 08120/2004 E : 08/20/2004 
Ty : r cy Preparedne s 
Hour : 3.0 
I tr t r: KEVIN D NATION 
istory and use of O - escribe D~~~; ~~m. ' s-. L ~ s of cont i ti - onstrate 
proper technique-Operate a -4~l_t 
t t a e u ber rs r  ss 
  L LLAN  .0 0.0 ss 
I  I   .0 0.0 Pass 
I L  Y   .0 0.0 ass 
I LLE  I   .0 .0 ss 
RA    .0 .0 ass 
 IFER  .0 .0 ass 
t l ts:  
Idaho Department of Correction Page 1
Class Summary 02172009
No 57898
009041lti Type Emergency Preparedness
Start 02142006 End 021142006 Hours 30
Instructor BRET R KIMMEL
Explain where OC can be used in the use of force continuum Explain the different dilivery
systems Demonstrate proper tecnique for deploying OC ands
Student Name Number Hours Score Pass
AMY D BAYONA 8292 30 0 Pass
A
CODY BRIAN LARSEN 5095 30 0 Pass
GABRIEL NEAL BROMLEY 8185 30 0 Pass
JEFFREY S LOUGH 5471 30 0 Pass
JENNIFER A WEBB 5487 30 0 Pass
MAURICIO A STEFFEN 5340 30 0 Pass
MICHAEL S HALE 7659 30 0 Pass
PAUL EVAN SHAY 3548 30 0 Pass
STEVEN LEROY TAYLOR 6170 30 0 Pass
STEVEN R DUELL 1577 30 0 Pass
TIMOTHY J RICHARDSON 5486 30 0 Pass




Idaho Department of Correction 






Start: 02114/2006 End: 0 1 4/2006 
Type: Emergency Preparedne s 
Hours: 3.0 
Instructor: BRET R KIMMEL 
Explain where OC can be used in the use of force continuum. Explain the different dilivery 
syste s. Demonstrate proper tecnique for deploying OC n~ 
Student Na e Number Hours Score Pass 
A Y D BAYONA 8292 3.0 0.0 Pass 
~:~.W~;'~~~~1~~~'~~~f(*l2~~:~~~~~~XS~;:*i;t~~~~a~~;[~~,~:~~ I 
CODY BRIAN LARSEN 95 . ..... 3.0 0.0  
I  L MLEY 5 3.0 .0 ss 
J   71 3.0 0.0 Pass 
JE IFE  A EBB  3.0 0.0 ass 
RICIO    .0 0.0 ss 
I    .0 .0  
PA L EVA  S AY  .0 0.0 ass 
    .0 .0 ss 
  LL  .0 .0  
I   I   .0 .0  
T DD R AH NEY  .0 .0  
 t :  
Idaho Department of Correction Page 1
Class Summary 021712009
No 58880
AW i 096EW erofFore Type Risk Control
Start 0823006 end 0823006 Hours 10
Instructor JULIO VEGA
OC Aerosol TrainingReview Policy 307 Use of Force
Student Name Number Hours Score Pass
y
BRIAN L CROWL 8514 18
CATHRAN LEEANN KELM 8495 10 0 Pass
DON MORGAN TENNISON 8274 10 0 Pass
KRISTIAN L FORREY 8257 10 0 Pass
MARIE ELAINE HADE 7053 10 0 Pass
RACHAEL ALENA NUTTALL 7721 10 0 Pass
ROBYN M SMYTHE 8605 10 0 Pass
ROY J GRAY 4075 10 0 Pass
SUSAN PHARIS 3692 10 0 Pass
TAMARA LYNN HOY 5647 10 0 Pass
TERESA LORRAINE GUANCHE 3985 10 0 Pass




Idaho Department of Correction 
Cla s Summary 
"-«"if.~q~eM~~gl~iM~~~~t~9{.~i,~ 
Start: 08/23/2006"~rid: 08/2 /2006 
Type: Risk Control 
Hour : 1.0 
Instructor: JULIO VEGA 
OC Aerosol Training/Review Policy 307 Use of Force 
Student Name Number ours Score Pa s 
~~~~~~i~t~t0tt55~:4ii~~i;l\~~;~1,~~~~t:~;.t1'~"'~;i~~~\;:;:.\';i~ii;;~:X~\~~£~~t~§;i ! 
AT A  LEEANN KEL  8495 .0 0.0 ass 
N AN T IS N 8274 .0 0.0 ass 
I TIA    8257 .0 0.0  
IE L I   7053 .0 0.0 Pass 
A AEL ALE A Un ALL 7721 .0 0.0 ass 
ROBYN M SMYTHE  .0 .0 ss 
 J   .0 .0  
SUSAN PHARIS  .0 .0 ss 
    .0 .0  
 I  HE  .0 .0  
ZETA J STETLE   .0 .0  
 :  
Page: 1 
02117/2009 
Idaho Department of Correction Page 1
Class Summary 02172009
No 60354
11 i Type Emergency Preparedness
Start 0221007 End 0221007 Hours 10
Instructor DAN JAY SCHAFFER
annual training




CARL T HAYNES 7278 10 0 Pass
CATHRAN LEEANN KELM 8495 10 0 Pass
CHRISTINA MAE PROCTOR 5789 10 0 Pass
DANIEL S COLE 1404 10 0 Pass
DON W PEEBLES 3922 10 0 Pass
JACOB M BEASON 8865 10 0 Pass
KARLA J KESLER 9050 10 0 Pass
KATHLEEN LEE BREEN 6502 10 0 Pass
KRISTIAN L FORREY 8257 10 0 Pass
LOIS RUTH FITZLOFF 7667 10 0 Pass
MARY K CALDWELL 1319 10 0 Pass
MIRIAM CLAIRE ANDERSON 7880 10 0 Pass
MONICA R FORD 1676 10 0 Pass
RACHAEL ALENA NUTTALL 7721 10 0 Pass
RICHARD D WEYERTS 3708 10 0 Pass
ROBERT A FOGG 5550 10 0 Pass
ROBIN L LUM 6618 10 0 Pass
ROBIN P SPACKMAN 8768 10 0 Pass
RODNEYWSCHLIENZ 2861 10 0 Pass
SANDRA LEE HERDT 8552 10 0 Pass
SEDENA L ALLEN 9110 10 0 Pass
SHARRON LINETTE PENCE 8203 10 0 Pass
SHERRI L JENKINS 4565 10 0 Pass
SHIRLEY J JACKSON 8421 10 0 Pass
SUSAN PHARIS 3692 10 0 Pass
TAMARA LYNN HOY 5647 10 0 Pass





Idaho rt t f rrection 
l  u ary 




t : 02121/2007 : 02121/2007 
T : ergency r ess 
Ho r : 1.0 
Instr t r:  J Y AFFER 
annual training 
tudent Name ber ours Score Pass 
L   
\~~~~~0~!~,~,.~j0~~:~~~~;~~~~~~rt~,~~~t~~I~"~tf,~~:·\[:;::" ii ~:;~.f;,.::;<~:~~.~tl1~i~~;:~(~~;:~l:t}·,:::)::p§$,S·l 
""""" :0'· .0 ss 
 L ANN   .0 0.0 Pass 
I I   T R  .0 0.0 Pass 
I L   04 1.0 0.0 ass 
   3922 1.0 0.0 ass 
   8865 .0 .0  
    .0 .0 ss 
    .0 0.0 ass 
  Y  .0 .0  
    .0 .0  
    .0 .0  
 I    .0 .0  
    .0 .0  
  I   .0 .0  
 0   .0 .0  
    .0 .0  
I  L   .0 .0  
    .0 .0 ss 
  l   .0 .0 ss 
    .0 .0  
    .0 .0  
 l TI    .0 0.0 ass 
  I   .0 .0 ss 
    .0 .0  
 I   .0 .0  
    .0 .0  
    .0 .0  
 t ents:  
Idaho Department of Correction
Class Summary
No 60952
es1t apsicum Type Risk Control
Start 071312007 End 07132007 Hours 20
Instructor DAN JAY SCHAFFER
Effects of OC Delivery system advantages and disadvantages Factors affecting proper
level of force Decontamination procedures Warning signs which require EMS
Student Name Number Hours Score Pass
ALLISON J NIELSEN 8699 20 0 Pass
7
RIAN P BOWLIN 1236 20 0 Pass
CARL T HAYNES 7278 20 0 Pass
CATHRAN LEEANN KELM 8495 20 0 Pass
DANIEL S COLE 1404 20 0 Pass
DIANE CARTER 9450 20 0 Pass
DON W PEEBLES 3922 20 0 Pass
JAMES A MELIN 7176 20 0 Pass
JANET BRYANTGROVES 9322 20 0 Pass
KARLA J KESLER 9050 20 0 Pass
KATHLEEN LEE BREEN 6502 20 0 Pass
MARGARET L FUNK 1715 20 0 Pass
MARY K CALDWELL 1319 20 0 Pass
MICHAEL WILLARD SHOEN 3537 20 0 Pass
PAMELA MARIE MURRAY 4003 20 0 Pass
RACHAEL ALENA NUTTALL 7721 20 0 Pass
ROBIN L LUM 6618 20 0 Pass
ROBIN P SPACKMAN 8768 20 0 Pass
ROBYN M SMYTHE 8605 20 0 Pass
ROSALIND A LUSK 2277 20 0 Pass
SCOTTWILLIAM MURRAY 2509 20 0 Pass
SEDENA L ALLEN 9110 20 0 Pass
SHARRON LINETTE PENCE 8203 20 0 Pass
SHERRI L JENKINS 4565 20 0 Pass
SHIRLEY J JACKSON 8421 20 0 Pass
SUSAN PHARIS 3692 20 0 Pass
TAMARA LYNN HOY 5647 20 0 Pass
THOMAS E POPERSZKY 8703 20 0 Pass
TODD DAVID JACKSON 4149 20 0 Pass






Idaho epart ent of o rection 
lass Summary 
_~'i'ri~~~~i~&~~{~" , 
St rt: 07 13/2 07 
In tr : DAN JAY SCHAFFER 
E : 07/13/2007 
T : isk ontrol 
: 2.0 
Effects of C; Delivery syste -advantages and disadvantages; Factors affecting proper 
level of force; Decontamination procedures; arning signs which require E S 
t t a e Number ours Score  
I  J I  8699 2.0 0.0 Pass 
~'t.'~,,*l>$0~gfiif~~~~~;;:W~:;~;i~~S;:'~?il~:~t;';~!J~~)j~:L;:t.;j~~~X!~:!!:' 
L  7278 .0 0.0 ass 
 L EANN   2.0 0.0 ss 
I L  L   2.0 .0  
I    .0 .0  
  L   .0 .0  
  I  6 .0 .0  
 -   .0 .0  
    .0 .0  
    .0 .0  
    .0 .0  
A Y K AL ELL  .0 .0  
I  I    .0 .0  
 I    .0 .0  
L L  LL  .0 .0  
I     .0 0.0 ass 
I     .0 0.0 ass 
    .0 .0  
LI   L   .0 .0  
 I I    .0 0.0  
    .0 .0  
 I    .0 .0  
I  I   .0 .0  
    .0 .0  
S SA  P A IS  .0 .0  
    .0 .0  
   87  .0 0.0  
 I  J   .0 0.0  
Valerie c urray 7  .0 0.0  
 t dents: 31 
Pa : 1 
02117/2009 
Idaho Department of Correction Page 1
Class Summary 02172009
No 60659
1r r scd bsert Type Risk Contro
Start 07182007 End 07200 7 Hours 20
Instructor DAN JAY SCHAFFER
Effects produced by OC Delivery system advantages and disadvantages Factors
affecting proper level of force Decontamination procedures Warning signs which require
EMS
Student Name Number Hours Score Pass
ALLISON J NIELSEN 8699 20 0 Pass
x rA radsFr Sz tyH1 rzf4r
BRIAN P BOWLIN 1236 20 0 Pass
CARL T HAYNES 7278 20 0 Pass
CATHRAN LEEANN KELM 8495 20 0 Pass
DANIEL S COLE 1404 20 0 Pass
DIANE CARTER 9450 20 0 Pass
JAMES A MELIN 7176 20 0 Pass
KARLA J KESLER 9050 20 0 Pass
KATHLEEN LEE BREEN 6502 20 0 Pass
MARGARET L FUNK 1715 20 0 Pass
MARY K CALDWELL 1319 20 0 Pass
MICHAEL WILLARD SHOEN 3537 20 0 Pass
PAMELA MARIE MURRAY 4003 20 0 Pass
RACHAEL ALENA NUTTALL 7721 20 0 Pass
ROBIN L LUM 6618 20 0 Pass
ROBIN P SPACKMAN 8768 20 0 Pass
ROBYN M SMYTHE 8605 20 0 Pass
ROSALIND A LUSK 2277 20 0 Pass
SCOTT WILLIAM MURRAY 2509 20 0 Pass
SEDENA L ALLEN 9110 20 0 Pass
SHARRON LINETTE PENCE 8203 20 0 Pass
SHERRI L JENKINS 4565 20 0 Pass
SHIRLEY J JACKSON 8421 20 0 Pass
TAMARA LYNN HOY 5647 20 0 Pass
THOMAS E POPERSZKY 8703 20 0 Pass




Idaho Department of orrection 
lass Summary 
N : 60659 
~~~~p$.R~~~~~~~ff 
St rt: 07/18/2007 En : 07/20/2007 
Instru t : DAN JAY SCHAFFER 
Typ : isk Contr l 
Hours: 2.0 
Effects produced by OC; Delivery syste , advantages and disadvantages; Factors 
affecting proper level of force; Decontamination procedures; arning signs which require 
E S 
tudent Name u ber ours core ass 
LLISON J I  8699 2.0 .0 ass 
~_~;'[~~~~I~~;{~J.gi3f{~;;~;r~~l?i~~;j~}iII~;~~~~~\~tlfW~Ji.~}~} 
B IAN  B LI  36 .0 0.0 ass 
L T   2.0 0.0 ass 
T  ANN   2.0 0.0 ass 
I   LE  .0 .0 ass 
I  TE   .0 .0 ass 
  I   .0 .0  
  L   .0 .0  
    .0 .0 ss 
T    .0 0.0 Pass 
    .0 0.0 ass 
I L I    .0 .0  
L  I    .0 0.0 Pass 
  n   .0 0.0 ass 
I     .0 0.0 ass 
I     .0 .0  
    .0 0.0 ass 
I     2.0 .0  
scon I I    .0 .0  
    .0 0.0 ass 
 l n    .0 0.0 ass 
I L J I   .0 .0  
I     .0 .0  
    .0 .0  
    .0 .0  
T  AVI  JA KS   .0 .0  
t l tudents:  
Pag : 1 
02117/2009 
Idaho Department of Correction Page 1
Class Summary 02172009
No 61737
Class Sabre OC Aerosol Projector Certification Type Risk Control
Start 032008 End 032008 Hours 30
Instructor NICHOLAS P DOAN
ReviewSabre OC Aerosol power point physiological psychological effects of OC
understand level of force when using OC proper deployment methods What Hydraulic
needle effect is minim recommended distance for deployming MK4 MK9 projectors
Proper decontamination procedures Practial applic of deploying inert OC
series of tasks demonstrated by contaminated officer
Student Name Number Hours Score Pass
wwoFA
CARL S SMITH 7009 30 0 Pass
DONALD KEITH RAST 8205 30 0 Pass
JOLANTA ELIZABETH THOMAS 9664 30 0 Pass
LARISSA MICHAELLA PFEIFER 7984 30 0 Pass
RANDY R MARTINEZ SR 9181 30 0 Pass
RONALD DUANE PIXLER 9638 30 0 Pass
SARA ANNMARIE LINK 6286 30 0 Pass
STERLING A MATHIS 4328 30 0 Pass
STEVEN LEROY TAYLOR 6170 30 0 Pass




Idaho epart ent of rrection 
lass u ary 
N : 61737 
Class: Sabre OC Aerosol Projector Certification 
Start: 03/03/2008 E : 03/03/2008 
Ty : isk ontrol 
ours: 3.0 
I tr t r: NI H LAS P A  
Review Sabre OC Aerosol power point; physiological & psychological e fects f ; 
understand level of force when using ; proper deploy ent ethods; hat ydraulic 
edle ff ct is & ini  r  distance for deployming K-4 & -9, p ~Ie ; 
Proper deconta ination procedures; Practial applic of deploying inert oc;.,IU 
•••••• k series of tasks onstrated by conta inated ffi r 
t   er rs c r  ass 
~~\J£l.~;t:~i~I"t;;f:l.1'\.1*';"'ii,;g~,)Ic\i(~"':i'it~11t~hi'~~'Nif:~i;;;~;{SiJ~19~~:i£~\';;;~\(\;ii~J?AM: t 
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No Class Start End Hours Score
56195 Administration 6A 073020 4 073020 4 10 0
56191 AssesmentCas Planning 073020 4 073020 4 10 0
56220 Auto Pistol Qualification 08122004 08122004 20 0
56206 Body Searches 0822004 08212004 40 0
56213 CPR 081020 4 081020 4 30 0
56211 Cell Searches 0892004 0892004 40 0
56182 Con Games 0726004 072612004 50 0
56192 Core programsEvalu tion 073020 4 073020 4 10 0
56214 Correctional Health Care 081012004 081020 4 20 0
56202 Disciplinary Offence Report Wr 072004 072004 40 0
56204 Emergency Preparedness 0729004 0729004 80 0
56203 Ethics in Corrections 0728004 0728004 20 0
56200 Final exam 08132004 08132004 15 0
56215 Firearm Safety 081020 4 081020 4 20 0
56216 Firearms Task Testing 08112004 08112004 80 0
56217 Firearms Task Testing 081122004 081122004 20 0
56212 First Aid 081012004 081020 4 30 0
66199 Graduation and Rehersal 08132004 08132004 35 0
56184 Intorduction to TrainingF cil 072612004 0726004 25 0
56185 Intorduction to TrainingF cil 0726004 0726004 10 0
56183 Introduction to Criminal Justi 0726004 0726004 30 0
56168 Legal Issues 071282004 0728004 40 0
47829 ORIENTATION TOURS OTHERS 081612004 08192004 320 0
55917 Oleoresin CapsicumOC 08200 4 08200 4 30 0
Instructor Sgt Kevin Nation
55916 Pepperball Systems 081202004 08200 4 20 0
55745 Principles of Subject Control 12062004 12062004 80 0
56207 Principles of SubjectControl 08412004 0842004 80 0
56209 Principles of Subject Control 0832004 08312004 80 0
56210 Property 0892004 0892004 40 0
56187 Public Records 072812004 0728004 20 0
56186 Report Writing 0728004 0728004 20 0
56208 Restraints 0822004 0822004 40 0
56218 Rifle Qualification 08122004 08122004 20 0
56201 Security Principles and Concep 072004 072004 50 0
56181 Sexual HarassmentRespectfulW 0712004 0712004 10 0
56219 Shotgun Qualification 08122004 08122004 20 0
56190 Social learning theory 071302004 073020 4 10 0
55918 Specialty Impact Munitions 08202004 08200 4 30 0
56193 Stress and Wellness 073020 4 073020 4 40 0
55797 Stun Master Stun Baton User 08200 4 08200 4 15 0
56196 SuicideAwarenessinterv tion 0852004 0852004 20 0
56189 Transition Process 073020 4 073020 4 10 0
56205 Use of Force 081022004 0822004 30 0







I  t t f ti  Page: 1 
r i i  r ri t 06/15/2010 
 
I I  J   ire: 7/19/2004 
 -  sepa~atjon: 5128/~OO.8 . 
7621 
No Class t rt  ours Scor  
 i i t ti  0"& . . 7/30/2004 7/3012004 1.0 0.0 
 s esmentiCase  7/3012004 713012004 1.0 0.0 
 t  i t l lifi ti  8/12/  8/121 004 .0 0.0 
. ~'r):'  O   8/ 21 004 8/021200  .0 0.0 
56213  8/10/2004 8/1012004 .0 .0 
 ll r  8/ 912004 8/ 9/2004 .0 .0 
56182 on a es 7/26/2004 7/2612 04 .Q .0 
  rogr msJEvaluation 7/30/2004 7/30/2004 .0 .0 
56214 orrectional ealth are 8/ 0/200  8/1012004 .0 .0 
 i Ci li  f ce· t  7127/2004 7/27/2004 .0 .0 
  ss 7/2912004 7/29/2004 .0 .0 
56203 t ics i  rr cti s 7/28/2004 7/2812004 .0 .0 
56200 Final exa  8/1312004 811312004 .5 .0 
 ir r  f t  8/1012004 8/1012004 .0 .0 
 i   i  8/11/2004 8/1112004 .0 .0 
 Rr nn   ti 9 8/1212004 811212004 .0 .0 
~21  Ar t i  8/ 0/200  8/~0/2004 .0 .0 
56199 raduation and ehersal. 8/1312004 8/13/2004 .5 .0 
6  t r ction  rainlng/Facil 712612 0  J 712612004 .5 .0 
 t r ction  rainlng/Facit 712612004 712612004 .0 .0 
 I tr ti  t  ri i l tl 7/2612004 7/2612004 .0 .0 
: .:.. ~. a1.8 " l  7/281 004 7/2812004 .0 .0 
47829 I T TI  - T  ~ T  8/ 6/2 04 8/1912004 2.0 .0 
 l i  i -O  8/20/2004 8/20/2004 .0 .0 
I str ct r: t. vi  ti  
 r all t  8120/ 0 4 8/20/2004 .0 .0 
 i i l  f j t tr l 2/ 6/ 004 . 2/ 6/ 004 .0 .0 
()  ri i l s f  tr l 810412 04 810412004 .0 .0 
 rinciples f j t trol 8103/2004 8/03/2 04 .0 .0 
 r erty 8/09/2004 8/09/2004 .0 .0 
 lic r s 7128/2 04 7/2812004 .0 .0 
 ort riti  7128/2004 7/2812004 .0 .0 
8 str ints 8/ 212004 8/ 21 004 .0 .0 
218 ifle lification 8/1212004 8/1212004 .0 .0 
6201 rity ri ciples  cep 7127/2004 7/2712004 .0 .0 
1 x al aras ment/Respectful  7/17/2004 7/1712004 .0 0.0 
9 t  O  811212004 8/1212004 .0 .0 
190 i l learning t ry 7/30/20 4 7/30/2004 .0 .0 
918 i lt  I pact itions 8120/200  8/20/2004 .0 .0 
 tress  lln ss 7/3012004 7/30/2004 .0 .0 
.<),  tun M~st  tun t  (Us ) 8/20/2004 8/20/2004 .5 .0 
6 uicide Awareness/Intervention 8/ 512004 8/05/2004 .0 .0 
9 Transition rocess 7/30/2004 7/3012004 .0 .0 
56205 se of r  8/ 212004 8/ 212004 3.0 0.0 
56197 erbal Judo ay 1 8/05/2 04 08/05/2 04 8.0 0.0 
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7621 Academy
No Class Start End Hours Score
56198 Verba Judo Day 2 0862004 081062004 80 0
56194 Week One Exam 073020 4 073020 4 05 0
Total Hours for 2004 1825
57846 Attempted escape drill 112005 112112005 15 0
55909 Bloodbom Pathogens 03152005 03152005 10 0
57352 Code Blue Drill 101192 05 101192 05 05 0
57845 Code blue drill duress system 10260 5 10260 5 05 0
57847 Fire drill in Gblock 11412005 1142005 09 0
57666 Gender identity Disorder 12082005 12082005 10 0
56495 ICESEmergency Preparedness 04192005 04192005 80 0
57818 Policy 201 Respectful workple 12082005 12082005 10 0
56649 Radio Mandown Procedures 021912005 021192005 10 0
55914 Rape Elimination Act 03152005 03152005 20 0
57245 Response Team training 0322005 032212005 05 0
57813 Suicide Prevention 12082005 1210812005 20 0
57814 Suicide Prevention 1210812005 12082005 20 0
56650 Use of Institutional IMSI Vehl 0232005 0232005 05 0
55911 Verbal Judo Refresher 03152005 031512005 40 0
57855 Wardensmeeting on policy 220 10270 5 10270 5 10 0
Total Hours for 2005 274
58452 CPR RECERTIFICATION 0523006 0523006 30 0
59555 Cognitive Self Change 12062006 12062006 80 0
59558 Cognitive Self Change 12062006 12062006 80 0
59588 Cognitive Self Change 12082006 12082006 80 0
59562 Fire Drill 1229006 1229006 07 0
58771 IMSI WEAPONS QUALIFICATIONS 0627006 0627000 20 0
58880 OC TrainingPolicy 307 Use of 0823006 0823006 10 0
Instructor Officer Julio Vega
57898 Oleoresin Capsicum OC 02142006 0211412006 30 0
Instructor Sgt Bret Kimmel
59278 Policy3070211 USE OF FO 1102006 110112006 30 0
59561 Policy Test 324 1152006 1152006 20 0
58443 Prison Rape Elimination Act 0523006 0523006 15 0
57899 Specialty Impact Munitions 021412006 02142006 30 0
58444 Staff Sexual Misconduct 0523006 051232006 15 0
57900 Stun Baton Qualification 02142006 02142006 20 0
59508 SuicidePreventlonSuicideRis 1211212006 12212006 10 0
58052 UA Procedures 02282006 0228006 05 0
57897 Useof Force Annual review 02142006 02142006 10 0
57816 Wardens Briefing 0152006 0152006 10 0
Total Hours for 2006 502
60352 1st Ald CPR 0126007 0126007 30 0
61267 Annual CPR Training 12052007 12052007 20 0
000689
I  rt t f rr cti  Page: 2 
r i ing, r ri t 06/1512010 
,; ,,'  
ILLI  J  J  ire: 7(19/2004 
 -  r tion: 512812006 
 e y: 
No lass t rt  r  r  
     8/ 6/2004 8/ 612004 .0 .0 
 k  x  7/30/2004 7/30/2004 .5 .0 
t l r  f r 4: 82.5 
 tt t   ill 1/21/2005 1121/200  .5 .0 
   3/1512005 3/15/2005 .0 .0 
57352 ode lue rill 0/19/2005 0/19/2005 .5 .0 
  l  ill  t  0/26/2005 0/26/2005 .5 .0 
 ir  rill i  -bloc  1/ 4/2005 1/1412005 .9 .0 
  I   2108/ 005 2108/ 005 .0 .0 
 I - r  r r  4119/2005 4/1912005 .0 .0 
6 lf  - tf l la 2108/2005 21 81 005 .0 .0 
56649 i   r r  21 9/ 0  2/1912005 .0 .0 
  i ti n  3/1512005 3/1512005 .0 .0 
:C:    i i  3/221 005 3/2212 05 .5 .0 
57813 ici  r v ti  2/ 81 005 /  .0 .0 
57814 uicide revention /  210812005 .0 .0 I 
   ti l   2/ 3/ 005 21 312005 .5 .0 
 r l  fr r 3/15/2005 3/ 512 0  .0 .0 
 rden's ti   li   0/27/2005 0127/2005 .0 .0 
   : 7.4 
  · I I I  5123/2006 5123/2006 .0 .0 
 iti  l   2106/ 006 2106/2006 .0 .0 
 i  lf  210612006 2106/2006 .0 .0 
 i  lf  210812006 210812006 .0 .0 
 ir  rill 212912006 2129/2006 .7 .0 
n  I I  I I I  6/27/2006 6127120 0 .0 .0 
  i i g/Policy   f 8123/2006 8123/2006 .0 .0 
:  li   
 l r in i  (O ) 211412006  .0 .0 
Instructor: Sgt. Bret Ki el 
 li  07. 2.01.001    1101/2006 /01/2 06 .0 .0 
 li  t 4 1/15/2006 1/1512006 .0 .0 
(!.; 
 rison  li i ti  t 5123/2006 5/23/2006 .5 .0 
 i lty t iti s 2114/2 06 211412006 .0 .0 
44 taff l i t OS/2312006 5/231 006 .5 .0 
0 t  t  lification 2114/2006 2114/2006 .0 .0 
8 l kl  revention/Suicide l  {  1 12 06 .0 .0 
58052 .A. rocedures 2128/200  212812006 .5 .0 
7  f - l i  2114/2006 2/1412006 .0 .0 
6 ardens riefing 1/ 5/2006 1/ 512006 .0 .0 
t l  f r : 0.2 
 st Id I  1/26/2007 112612007 .0 .0 
7 l  tr i i  2105/2007 210512007 .0 .0 
OC 005  






No Class Start End
61056 Annual Firearms Qualification 04112007 04112007
60834 Annual TCM Training 0512007 05112007
60355 AnnualTraining Arrest Techn 03192007 03192007
60354 Annual Training OC Refresher 021212007 0221007
Instructor Sgt Dan Shaffer
60353 AnnualTraining Use of Force 0221007 0221007
61062 Annual Training FY07 Verbal Ju 0529007 0529007
60356 Annual Training FY07 Arrest T 031192007 03192007
61271 Arrest Techniques Mandatory A 12062007 12062007
59676 CPR 1st Aid at SBWCC 0126007 0126007
61269 DIG Offender Management 12062007 12062007
60347 Emergency Fire Drill 0362007 0310612007
61141 Emergency Preparedness 08112007 0812007
60845 FY07 Annual FirearmsQualifica 04112007 04112007
61266 ICES Annual Training 121052007 12052007
60952 Oleoresin Capsicum 0711312007 07132007
Instructor Sgt Dan Schaffer
60659 Oleoresin Capsicum Refresher 07182007 072012007
Instructor Sgt Dan Schaffer
60357 PREA 0322007 0322007
59804 Policy 607260111 Therapeut 0212007 0212007
61270 Respectful WorkplaceSexual Ha 12062007 120612007
61127 SBWCC FY07 Annual Training IC 0812007 0812007
61265 SCBA 12052007 12052007
61268 Suicide Risk Management 12062007 12062007
60217 Suicide Risk Management 0322007 032212007
Total Hours for 2007 548
61734 Basic Planned Action 032008 032008
61737 Sabre OC Aerosol Projector Car 032008 0310312008
Instructor Sgt Nick Doan
61735 Use of Force 032008 0310320 8
Total Hours for 2008 80






























I  rt t f rr ti  age: 3 
r i i  r scri t 06115/2010 
 
I I    : 7/19/2004 
I SI ~ SE ITY Separation: 05/28/2008 
 : 
 l  t rt    
   lifi ti  4/1112007 4111/2007 .0 .0 
60834 nnual  raining 5/ 1/2007 5/0112 07 .0 0.0 
  i i  ~   3/1912007 3/19/2007 2.5 .0 
.:.  l r ining· D  fr r 212 / 007 212112007 1.0 .0 
Instructor: gt. an haffer 
3  i i  -    2/21/ 007 02/2112007 1.0 .0 
2 l r i i   r l  5/2912007 512912007 4.0 0.0 
6  l!1i g:  t  3119/2007 3/1912007 .5 .0 
1'271   l -MandatOfY  210612007 2/ 612007 .0 .0 
 ;     1/26/2007 112612007 3.0 .0 
 I  ff r t 2106/ 007 2106/ 007 .0 .0 
  i  ill 3/06/2007 /  .6 .0 
 r  r r  8/01/2 07 8/ 112007 3.0 .0 
    li ie  4/11/2007 4/11/2007 .0 .0 
 . I  al r i i  210512007 210612007 .0 .0 
 l r si  i  / /2  7/13/2007 .0 0.0 
I t t r: t.  ff  
 l r i  i  fr r 7/18/2007 7/20/2 07 .0 .0 
I tr tor: t.  ff r 
  312212007 312212007 .0 .0 
59804 'Policy 607.26.01.011 Therapeut 2101/2007 2101/ 007 .0 0.0 
i. I 70· s ctf l rk l c /Sexu l e 2106/ 007 2/061 07 1.0 .0 
   l r ining: I  8/ 1/2007 8/ 1/2007 .0 .0 
  2/ 51 007 2105/ 007 .0 .0 
 i i  i  t 2106/2007 2106/ 007 1.0 .0 
7 i i  i  t Q3/2212007 3/2212 07 .0 .0 
   7: 4.8 
 i    3/ 3/2008 3/ 3/2008 .0 .0 
 r   r l r j t r er 310312008 /  .0 .0 
I tr t r: t. i   
  f  3/ 3/2008 3/ 3/2008 .0 .0 
   8: .0 
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5 Pages 14 to 17
Page 14 Page 16
1 believe 1 Q Well Imay be able to help you with
2 Q But you think they started earlier at 2 that
3 IMSI 3 A Okay
4 A I think so yes 4 Q Lets see if I can dig something out
5 Q Do you know when that was 5 here
6 A I have no idea 6 A They forgot the R at the end ofmy
7 Q So at some point at IMSI in 2007 the 7 name
8 First Defense products were taken off the shelf 8 MR BURKE All right lets mark that
9 and the SABRE Red products were put on the shelf 9 Exhibits 36 and 37 marked
10 A I dontknow if they were taken off the 10 Q BY MR BURKE Now Sergeant let me
11 shelf AndIm just going off I believe they 11 hand you what wev marked as Exhibit Nos 36 an
12 were replenishing it When something got used 12 37 to your deposition and ask you if you
13 they would order I dont think they just threw 13 recognize those
14 everything away and then ordered more 14 A I do
15 Q Good point Good point And so lets 15 Q And what are they
16 follow up with that a little bit So as that 16 A One is 36 would be the certificate
17 transition occurred it would have been a gradual 17 of my completion of the course
18 transition such that you used up the product that 18 Q Which course is that
19 you had already purchased but then you replaced 19 A The SABRE Red Law Enforcement Aeroso
20 it with a different brand of product 20 Projectors Instructor Course
21 A Yes And again like I said I left 21 Q That would have been the training
22 Max at that time so Im just going off I hate 22 course for the trainers that occurred by SEC
23 to use the word hearsay but what I was being 23 A Yeah
24 told from people I knew at IMSI 24 Q And it looks like the date of that is
25 Q Now when you went through the Defense 25 June 12 2007
Page 15 Page 17
1 Technology training did somebody from the 1 A Thatscorrect
2 manufacturer come and perform that training for 2 Q Would that be the date that you
3 you 3 completed the course
4 A Yes It was in Garden City I believe 4 A Yes
5 at the police station down there in Garden City 5 Q And then Exhibit No 37 those two
6 Q Okay 6 pages were they part of the materials involved
7 A It was a fiveday training I went to 7 with that same training
8 just the OC part of the training 8 A From what I recall yes because that
9 Q How long did the OC training last 9 looks like my signature and everything
10 A Eight hours 10 Q And ifyou look at the bottom of the
11 Q And at the end of that time did you 11 second page theresa little Bates number down
12 become certified 12 at the bottom that says SEC 000934
13 A Yes 13 A Yes
14 Q And at some point in time then you 14 Q That page is filled out in your
15 went through the training for SABRE Red is that 15 handwriting
16 correct 16 A Thats correct
17 A Yes 17 Q And your signature
18 Q And do you remember when that happene 18 A Yes
19 A Its either July or August of 07 19 Q And both of these pages then would have
20 Q And was that training conducted by 20 been something that would have been handed ou
21 somebody from SEC 21 and the second page is just something that you
22 A Yes 22 filled out at the time of this SABRE Train the
23 Q Do you remember who the trainer was 23 Trainer training
24 A I dontI have my certificate but I 24 A Thats correct





















































b ie . 1 
. ut you think they started earlier at 2 
I I? 3 
. I think so, yes.  
. o you kno  hen that as?  
. I   id .  
. SO, at so e point at I SI in 2007 the 7 
First efense products ere taken off the shelf 8 
and the S E ed products ere put on the shelf) 9 
. I don't kno  if they ere taken off the  
shelf. nd I'm just going off -- I believe they  
ere replenishing it. hen so ething got used,  
they would order. I don't think they just threw  
everything a ay and then ordered ore. 14 
. ood point. ood point. nd so, let's  
follow up with that a little bit. So, as that  
transition occurred, it ould have been a gradual   
transition such that you used up the product that  
you had already purchased, but then you replaced  
it ith a different brand of product?  
. es. nd again, like I said, I left '  
ax at that ti e, so I'm just going off --    
to use the ord "hearsay," but hat I as being   
told fro  people I knew at I SI.  
. o , hen you ent through the efense  
  
Technology training, did somebody from the  
anufacturer co e and perfor  that training for  
you?  
. es. It as in arden ity, I believe  
at the police station do n there in arden ity.  
. kay,  
. It as a five-day training. I ent to  
just the C part of the training.  
. o  long did the OC training last?  
A. Eight hours.  
. And at the end of that ti e did you  
 rtifi d?  
. s.  
. nd at so e point in ti e, then, you  
went through the training for SABRE Red; is that 15 
rrect?  
. .  
Q. And do you remember when that happenec?l8 
A. It's either July or August of'07.  
. nd as that training conducted by  
somebody from SEC?  
. s.  
. o you re e ber who the trainer was? 
A. I don't. I have y certificate, but I 




a e  
. ll, I  e l  to l   ith 
that. 
. . 
. t's  f!   ng  
. 
. he  f r t t e "R" t t e  f  
. 
. : ll ri t, l t's r  t t. 
(Exhibits    rked.) 
. (BY . ) , r nt, let  
 ou t e've r ed  i it .   i 
 t  r iti    ou if  
r i  t s . 
. I . 
.  t r  t ey? 
. ne is --    e icate 
  l ti   t  . 
. ich s  i  t at? 
.     rce  cros  
j t rs t t  . 
. t l    t  tr i i  
s    s  re   C? 
. . 
.  it l  like t e t  f t t i  
J  , n 
. hat's r ct. 
. l  t t  t  t  t t  
co pleted the course? 
. . 
 7 
.  t  i  o. ,   
pages, ere they part f the aterials involved 
it  t t  tr ining? 
. r  t I r call, s,  t t 
l s li   i t r   ryt i . 
. nd if you look at the botto  of the 
second page, there's a little ates nu ber do n 
t t  tt  t t   0934. 
. s. 
. t  i  fill  t i   
handwriting? 
. hat's rr ct. 
.  r si ature? 
. s. 
.  t  f t s  s t  l   
ee  s et i  t at l  a e ee  a e   , 
and t e second a e is j st so ething that  
le  t  t  ti  f t i   "Tr  t  
Trainer" training? 
. hat's rrect. 
.  it l  ha e ee  t e sa e e 
5 (Pa   t  7) 
6 Pages 18 to 21
Page 18 Page 20
1 that would have occurred on or about June 12 1 believe because that would be kind of mean to
2 2010 2 take it after the OC contamination So I think
3 A 2007 3 we took a test prior to going out to the obstacle
4 Q Im sorry 2007 thatsright 4 course
5 A Thats correct 5 Q All right
6 Q Oh I was reading the bottom So the 6 A And then we ran the obstacle course and
7 expiration date would be the date that the 7 we had a decontamination in which we worked wit
8 certification would expire is that your 8 our partner who got sprayed We partnered up
9 understanding 9 one got sprayed one helped with the
10 A Thatscorrect 10 decontamination And then when the other one wa
11 Q And is that the certification that you 11 ready they switched roles and responsibilities
12 indicated recently expired 12 Q Now you mentioned a level 1
13 A Yes 13 contamination Wev had some discussion about
14 Q And you haventrecertified since that 14 levels of contamination before but just so I
15 time 15 understand where yourecoming from what is a
16 A No 16 level 1 contamination
17 Q Do you recall that particular training 17 A It would be a direct contamination in
18 session with the SEC people 18 which we were sprayed across the eyes by the
19 A Yes 19 instructor I believe is the one who did it
20 Q Can you tell me how long did the 20 Q And that would be the most significant
21 training last 21 contamination is a level 1
22 A It was about eight hours 22 A Yes
23 Q And what occurred during the training 23 Q And then theresalso a level 2 and a
24 A We had a presentation of I think 24 level 3 is that right
25 basically PowerPoint fo most of th morning an 25 A Thats correct
Page 19 Page 21
1 reviewed the slides I believe it was the same 1 Q And those are lesser levels of
2 slide show that they gave to us at the end of the 2 contamination
3 completion of the course We went outside later 3 A Thats correct
4 in the day we had a practical course in which we 4 Q How would you describe a level 2 What
5 got a level 1 contamination and we had to run 5 is that
6 through an obstacle course 6 A Level 2 in my mind is when you go to a
7 Q After the contamination 7 room which had been sprayed by OC and either
8 A Yes It was outside It was at POST 8 remove an object or a person from that area fro
9 in Meridian Idaho It was hot that day 9 that contaminated area
10 Q Were you the only agency involved in 10 Q And a level 3 is where yourejust in
11 the training or were there other agencies too 11 an area thatsbeen sprayed by a fog
12 A I want to say I dontknow the 12 A Yeah a fog stream yourejust kind of
13 answer to that question but I believe we were 13 in that area but not necessarily not
14 the only agency involved because I believe we 14 necessarily maybe working specifically in the
15 sponsored the training but I could be wrong on 15 area itself
16 that part 16 Q And was contamination as part of this
17 Q Was that at POST in Meridian 17 training class required of all trainers who go
18 A Yes 18 through the program
19 Q All right I cut you off and you were 19 A Did everybody go through the same
20 telling me about the training You talked about 20 Q Yes
21 the level 1 contamination the obstacle course 21 A Yes
22 and then what 22 Q And what do you understand the reason
23 A We got level 1 contamination 1 23 to be for requiring some sort of contamination
24 believe before we went out there I believe we 24 during that eighthour class




























that would have occu red on or about June 1 , 
2 O? 
A. 20 ? 
Q. I'm sorry, 2007, that's right. 
A. Th t's corre t. 
Q. Oh, I was reading the bottom. So, the 
expiration date would be the date that the 
certification ould expire; is that your 
understanding? 
. t's corr t. 
Q. And is that the certification that you 
indicated recently expired? 
. e . 



















Q. Do you recall that particular training 7 
session ith the S  people? 18 
. .  
Q. Can you tell me, how long did the 20 
training last?  
A. It was about eight hours.  
Q. And what occurred during the training?  
A. e had a presentation of I think  
Page 2  
be ie , because that would be kind f ean to 
take it after the OC conta i ti . So, I think 
we took a test prior to g ing out to the obstacle 
cours . 
. All rig t. 
. nd then e ran the obstacle course  
e had a de ta ination in hich e orked it' 
our art er ho t s r . e partnered , 
one got s r , ne lpe  ith the 
ec ta i ati . n  then he  the other one a 
r , the  itche  les a d r i iliti . 
. , ou e tioned a le el  
. e've a  e iscussion t 
levels   io  ,  just s  I 
dersta  here u're ing r , hat s  
level I i ation? 
. It  e  rect ion in 
ich e  e  ss t e es  t  
, I e  s    id . 
.  t at ld    c  
t ,    I? 
. . 
.   ere's       
l l ; is t t ri ht? 




























revie ed the slides. I believe it as the sa e  
slide show that they gave to us at the end of the  
completion of the course. e went outside later  
in the day, we had a practical course in which we  
got a level 1 conta ination and we had to run  
through an obstacle course.  
Q. After the contamination?  
. es. It as tsi e. It as at   
in eridian, Idaho. It was hot that day.  
Q. ere you the only agency involved in  
the training or were there other agencies too?  
A. I want to say --  on't    
answer to that question, but I believe we were  
the only agency involved because I believe we  
sponsored the training, but I could be wrong on  
that part.  
Q. as that at POST in Meridian?  
. s.  
Q. All right, I cut you off and you were 1  
telling me about the training. You talked about 2  
the level 1 contamination, the obstacle course,  
and then hat? 22 
A. e got level I contamination. I 23 
believe -- bef r   t out t r  I believe we 24 
took a ritten test, before e ent out there I 25 
.     s  
t ination? 
. at's rr ct. 
  
.    r   el ?  
i  t at? 
.            
    r     i  
  j t     t t r a, n 
t  r a. 
. nd a level 3 is here you're just in 
an area that's been sprayed by a fog? 
. ah, a f  tr am, ou're j t  f 
i  t r  t ot ssaril  -- not 
cessaril   r i  specifi all  i  t  
ar  i elf. 
.   conta i ati   rt of t i  
tr i i  cl  r q i  f all tr i r   go 
t r  t  rogram? 
. i  everybody g  t r  t  same? 
. s. 
. s. 
. nd hat do you understand the reason 
to be for requiring so e sort of contamination 
during that eight-hour class? 
A. I beli  it's done for the si pl  fact 
6 (  1  t  21) 
Page 24
young and had a little fear and anxiety back
then so if they said I was only going to get one
eye burned I was okay with that
Q How did you compare the training the
First Defense training for the trainers versus
the SABRE training for the trainers
A I thought the training aspect from the
instructors was equal in the fact that you get
both qualified well knowledgeable people
presenting the class You know a lot of big
words in those classes you know youvegot to
learn them but I thought they did a good job
But I thought both sides tried to sell
their product a little bit more and you know 1
thought it was odd because we already decided
buy each product But then again when I went
Def Tech it was multiple agencies it wasn
just the Department ofCorrection But I thougl
it was really good knowledgeable training
Q So while youwere at the womens
facility and I believe you said you started
there in July of 06 is that right
A Thats correct
Q For a period of time at the womens
facility was the only brand of product of OC th
Page 22
1 that the instructor gets a better knowledge of 1
2 the product they get a better understanding to 2
3 be able to instruct to the student what to expect 3
4 when they do spray somebody 4
5 Q And do you think thatsa good thing or 5
6 a bad thing 6
7 A I lean more to good 7
8 Q Im sure you didnt like being sprayed 8
9 but 9
10 A No when we switched from Def Tech it 10
11 was like two months later and I was like 11
12 Really I just got sprayed We have to do it 12
13 again 13
14 Q So your training for Def Tech was 14
15 pretty close in time to the one you had with 15
16 SABRE 16
17 A Yeah about six months 17
18 Q And why do you think its a good thing 18
19 its a benefit 19
20 A I believe it shows I mean theres 20
21 the personal training theory that it shows the 21
22 staff that they can overcome a lot more than the 2 2
23 believe they can But I believe it just gives 23
24 them that responsibility that one theyr going 24
25 to have to deal with either a secondhand 25
7 Pages 22 to 25
Page 23 Page 25
1 contamination or a thirdhand contamination from 1 you used the Defense Technology products
2 it that they can survive working through it 2 A Yes When I came there in 06 they
3 Q So basically it gives them some 3 already had some OC spray there I want to say
4 experience that they can draw on in the future 4 its Def Tech but I just don know that answer
5 A Yes 5 what it was when I got there but we got rid of
6 Q And it kind of relieves some of the 6 that
7 anxiety of the unknown because theyr already 7 Q Over what period of time did you get
8 exposed to it at least once 8 rid of it
9 A Yeah because you see it a lot in the 9 A I would say relatively quick because I
10 academies before they go theresreally a lot of 10 believe it was ready to expire but I just don
11 anxiety and fear kind of going through their 11 remember what the product was here when I first
12 minds and stuff 12 arrived
13 Q Now when you went through the First 13 Q And what product did you replace it
14 Defense as a trainer and you got your training 14 with
15 certificate there did you also get exposed to 15 A With a Def Tech
16 First Defense products during that training 16 Q And was that a MK4 or a MK9 or what
17 A Yes I go ahead 17 A We pretty much only used MK4sbecaus
18 Q And do you remember what type of 18 sinceIve been there in 06 wev never had a
19 exposure you had there 19 reason to use OC except for training We just
20 A It was a level I by definition but 20 never had a use of force thatsever been used
21 there they asked you to put one hand over one ey 21 But to answer your question it was the MK4
22 and they sprayed the other eye 22 Q Just so Im clear on that while you
23 Q Any reason why you understood that was 23 have been at the womens facility there has never
24 the case 24 been a deployment ofOC on an inmate





















































that the instructor gets a better knowledge of 1 
the product, they get a better understanding to I 2 
be able to instruct to the student what to expect' 3 
when they do spray somebody. 4 
Q. And do you think that's a good thing or 5 
a bad thing? 6 
A. I lean more to good. 7 
. I'm sure you didn't like being sprayed, 8 
but -- 9 
. o, hen e s itched fro  efTech it 10 
as like t o onths later a d I as like, 1 
"Really? I just got sprayed. e have to do it 12 
again?"  
Q. SO, your training for DefTech was  
pretty close in time to the one you had with  
?  
A. Yeah, about six onths.  7 
. nd hy do you think it's a good thing, 18 
i 's  efit?  
. I elieve it s s -- I ea , t ere's  
the personal training theory, that it shows the  
staff that they can overco e a lot ore than the 22 
believe they can. But I believe it just gives  
the  that responsibility that one, they're going  
t   t  l ith it r  s   
Page 23 
   rdha     
it, that they can survive working through it.  
Q. SO, basically it gives them some  
experience that they can draw on in the future?  
. .  
Q. And it kind of relieves so e of the  
anxiety of the unknown because they're already  
exposed to it at least once?  
A. Yeah, because you see it a lot in the  
academies before they go, there's really a lot of  
anxiety and fear kind of going through their  
i   tuff.  
Q. Now, when you went through the First  
Defense as a trainer and you got your training  
certificate there, did you also get exposed to  
First Defense products during that training? 16 
A. Yes. I -- go ahead. 1 7 
Q. And do you remember what type of 18 
exposure you had there? 19 
A. It was a level 1 by definition, but  
there they asked you to put one hand over one ey ~ 21 
and they sprayed the other eye. 22 
Q. Any reason why you understood that was 23 
the case? 24 
. I have no idea. ou know, again, I as 25 
Page 24 
young and had a li tle fear and a iety back 
the , so if they said I as only going to get one 
eye burne , I as okay ith th . 
. ow did you co pare the trainin , the 
First Defense training for the trainers versus 
the S RE training for the tra rs? 
. I thought the training as e t from the 
instructors as e l in the fact that you et 
both q ie , e l no ledgeable e ple 
pres ing the cla . ou , a lot f ig 
ords in those class , ou k , u've got to 
learn th , but I thought t  id  od jo . 
ut I thought t  ides trie  t  ll 
their product  little it ore ,  , I 
tho t it as  a se e lready e ided t( 
bu   r t. t then i , hen I e t t 
e , t as tiple , it n't 
just t e e t e t  ti . t  t ht r 
it as reall  , ledgea le trai i . 
. O, le  e e   en's 
f ilit  --   ieve     
t re i  J l  f '0 ; is t t ri t? 
. at's t. 
. r a eri  f ti e at t e en's 
t          at 
  
     r ucts? 
. .      '0 ,  
already had so e  spray there. I ant to say 
t's  ,    on't   er, 
      r ,      
t t. 
.   ri  fti     
  t? 
.  l  s  l ti l  i   I 
l  it  r   xpir , t I j t on't 
r  t  r t   n I fi t 
r ived. 
.   r t i    it 
ith? 
.  a fTech. 
.   t t a -  r  -  or hat? 
.  r tt  uc  onl  used - 's bec  
si  I've  t r  i  '  e've nev r had a 
r s  t  u   except for training.  j st 
v r  a  f f r  that's ev r b  sed. 
But to ans er your question, it as the - . 
. Just so I'm cl r o  that, hil  you 
have been at th  women's facility there has never 
been a deploy ent of  on an inmate? 
. That's correct. 
7 (P  22 t  25) 
10 Pages 34 to 37
Page 34 Page 36
1 week too 1 the stream
2 Q Let me talk a little bit about your 2 A Yeah
3 experience We already know that youvebeen 3 Q And again based upon your experience
4 exposed to OC through your trainer training 4 of your own exposures and your observations of
5 A Yes 5 others being exposed how long do the effects of
6 Q Did you also get exposed to OC during 6 the spray generally seem to last
7 your training of end users 7 A You know I think if applied correctly
8 A I did when I went to the Correctional 8 again I think youllprobably see some relief
9 Emergency Response Team at the academy We di 9 probably in the 10 to 15 minute period you know
10 get a level 1 exposure I want to say that 10 proper decontamination But probably anywhere
11 was I want to say its DefTech This was 11 from a half hour to a full one hour before
12 2000 so 12 complete recovery It kind of varies For
13 Q Okay 13 myselfwhen I got my level 1 exposures to SABRI
14 A I want to say it was DefTech 14 Red it probably was about 30 minutes before 1
15 Q So how many times do you think youve 15 quit swearing you know
16 been exposed to OC 16 Q So would 30 minutes then be the
17 A Oh thats easy four times Oh you 17 longest that youveever experienced the effects
18 mean like level 1 exposure 18 or would it be longer than that
19 Q No not just level 1 any exposures 19 A Typically 30 minutes is the most I
20 A At Max quite a bit I would say 10 20 mean theres still some discomfort there but
21 15 They might be like level type 3 exposures 21 Id actually say its nothing you cantdeal
22 where you just walk by a contaminated area 22 with Id say 30 minutes is probably about
23 Every once in a while a couple of level 2s and 23 15 or 20 to 30 minutes youreprobably
24 1 know five level 1s 24 starting to get back to comfortable
25 Q And youveobserved others who have 25 Q Has there ever been a time ofexposure
Page 35 Page 37
1 been exposed correct 1 when you have not completely recovered
2 A Yes 2 A No
3 Q Now based upon your experience in 3 Q Have you ever observed anybody who has
4 having been exposed yourself and your 4 gone through an exposure who has not completel
5 observations of others who have been exposed how 5 recovered
6 would you describe the effects on humans of 6 A Have I seen it No
7 exposure to OC 7 Q Other than Billie Jo Major who is the
8 A If done correctly and applied 8 Plaintiff in this case are you aware of any
9 correctly its highly effective 9 complaints by anybody reporting that OC exposur
10 Q What are the human responses 10 effects have lasted longer than three days
11 A Crying swearing compliance 11 A NoIve probably never even heard of
12 Q Physiologically what happens to them 12 one day Three no
13 I mean based upon your observations 13 Q Have you ever heard of any inmate ever
14 A They pull themselves back They stop 14 complaining of exposure to OC effects lasting
15 fighting They typically will have a little bit 15 longer than three days
16 ofpain discomfort 16 A No
17 Q Where is the pain and discomfort Tell 17 Q Have you ever known a correctional
18 me about that 18 officer other than Billie Jo Major to have filed
19 A Wherever theyr sprayed Typically a 19 a Workers Compensation claim as a result of
20 good spray would be in the facial area in which 20 exposure to OC
21 the eyes will voluntarily close the nose will 21 A No
22 start running 22 Q PepperBall products are you familiar
23 Q Any coughing involved 23 with those
24 A Sometimes especially with the fogger 24 A A little bit



























e    
e  t . 1 t e t m? 
. et e tal  a little it a t r 2 . . 
e erie ce. e alrea   that ou've ee   . nd i ,  n  ience 
exposed to  through your trainer training.  f your o n exposures and your observations f 
. .  others being exposed, ho  long do the effects of 
. id u als  et e se  t   ri   t e s ra  e erall  see  t  last? 
r trai i  f e  sers?  . o  ,   f e  t  
.   e    t  the ional  a ai , I t in  u'll r a l  see s e relief 
Emergency Response Team at the academy. e di~  y      te ri d,   
get a level  exposure. I ant to say that   t i ati n. t  ere 
a  -- I ant to say it's ef ech. his as  fr   lf r t   f ll e r f r  
2000, so --  co plete recovery. It kind f varies. or 
. kay.  l  e       s res   ~ 
. I ant t  sa  it as ef ec .  , t   t  nutes e I 
. O,  a  ti es   t i  ou've   ari g,  . 
been exposed to OC?  . O,   , n,   
. h, that's easy, four ti es. h, you  longest that you've ever experienced the effects 
ea  like le el  e s re?  r ld it e l er t a  t at? 
. o, not just levell, any exposures.  . ypically 30 inutes is the ost. I 
. t ax quite a bit. I ould say 10,  , ere's   s t r ,  
15. hey ight be like level type 3 exposures  'd ll   t's   n't  
here you just alk by a conta inated area.  it . 'd   i tes i  bl , t 
very once in a hile a couple of level 2's, and   -- or 20 to 30 inutes you're probably 
I  ive evell's.  starting to get back to co fortable. 
































. o , based upon your experience in  
having been exposed yourself and your  
observations f others ho have been exposed, ho  5 
ould you describe the effects on hu ans f  
exposure to ?  
. If done correctly and applied  
correctly, it's highly effective.  
. hat are the hu an responses?  
. rying, s earing, co pliance.  
. Physiologically, hat happens to the ,  
I ean, based upon your observations?  
. They pull the selves back. They stop  
fighting. They typically ill have a little bit  
of pain, disco fort.  
. here is the pain and discomfort? Tell  
  t.  
. herever they're sprayed. Typically a  
good spray ould be in the facial area in hich  
the eyes will voluntarily close, the nose will  
start running.  
Q. Any coughing involved?  
. So eti es, especially ith the fogger.  
. ore likely ith the fogger than ith  
  
    l l  overed? 
. o. 
. ave you ever observed anybody ho has 
gone through an exposure ho has not co pletely 
red? 
.    it? . 
. t r t  illie 10 j r,  i  t  
l i tiff i  t i  e, r   r    
co plaints by anybody reporting that  exposur~ 
effects have lasted longer than three days? 
. o, I've probably never even heard of 
one day. Three, no. 
.         
co plaining f exposure to  effects lasting 
longer than three days? 
. o. 
.   r   rr ti l 
fficer t r t  illi  10 j r t   fil  
 r rs' s ti  l i  s  r s lt f 
s r  t  C? 
. o. 
. epperBall products, are you fa iliar 
 se? 
.  e it. 
.    tr i i  i  epperBall? 
 (Pa    7) 
12 Pages 42 to 45
Page 42 Page 44
1 of steps behind them 1 Q Defense Technology okay Im sorry
2 Q So they would both be in the room at 2 And then how about in 07 do you remember
3 the same time though 3 A I dontknow if we had annual training
4 A Yes 4 before we switched over but I know in 07 at
5 Q They would just be at different 5 some point that year we did use SABRE products
6 spacing 6 Q And so it just depends on what you had
7 A And a safety officer was behind them in 7 available at the time of the 07 training
8 case they both got a little some of that anxiety 8 A Well like I guess it was June so we
9 and fear 9 switched over somewhere in that summer month i
10 Q And so did the person who sprayed the 10 which we ordered some And then I know I did a
11 bucket or whatever the object was then have a 11 training
12 canister of spray 12 Q And wer going to get to your training
13 A Yes 13 record here in a minute
14 Q And was it usually a canister of MK4 14 A All right
15 A It was always MK4 We dont wev 15 Q Im just trying to help you out here
16 ordered one MK9 canister and we typically 16 make it a little easier
17 exchange that with Max because it sits there at 17 A It seems like 07 is so far back now
18 IMSI and it gets close to expiring So within a 18 Q So you believe that the switchover to
19 year of expiring we just trade with Max because 19 SABRE products at the womens facility occurred
20 it just its there in case something happens 20 sometime around Juneof07
21 big but typically we never use MK9s 21 A Yeah its more probably the summer
22 Q So during that training procedure 22 months
23 then with the level 2 was the type of OC that 23 Q Okay summer months And did the
24 was deployed to the object a stream a spray or 24 training also include decontamination
25 a foam 25 A Yes
Page 43 Page 45
1 A It was all ofthe above We would 1 Q And how was decontamination handled
2 use 2 with the trainees
3 Q Let me strike that That was kind of 3 A What we did was we had a water hose out
4 confusing because by spray what I really mean 4 there if they needed it We had paper towels if
5 to say was a stream 5 they needed it And we assigned a buddy to help
6 A Yeah 6 them if they got a contamination which they had
7 Q A stream a fog or a gel 7 to wander around Because its a parking lot
8 A Yeah we would never use the foam for 8 there and its not its a very open facility
9 training 9 very open facility to just people would be
10 Q Okay 10 around so we wanted to make sure staff safety
11 A We would never use that 11 was up there
12 Q Okay 12 Q How long was the actual contamination
13 A But it would be the stream or the cone 13 In other words once a person walked into that
14 You know one group would have a stream one 14 room and got contaminated and came out how lon
15 group would have the fog just so they can see 15 would that take
16 the difference in the training aspect 16 A I think if they werentshowing off
17 Q And so for the period of time that you 17 less than 30 seconds
18 did training lets see you started there in 18 Q Okay
19 06 correct 19 A Probably more like 10 to 15
20 A Yes 20 Q And again except for the two people
21 Q In 06 what brand ofOC did you use 21 you indicated earlier none of these people would
22 for the training in 06 22 have had a direct level 1 contamination
23 A I want to say its Def Tech 23 A No
24 Q Step Tech 24 Q All right Can you explain to me how





















































of steps behind the . 1 
. SO, they ould both be in the room at  
the sa e ti e, though?  
. e . 4 
Q. They would just be at different 5 
spacing? 6 
A. And a safety officer was behind the  in  
case they both got a little, so e of that anxiety  
 fe r.  
Q. nd so, did the person who sprayed the 10 
bucket or whatever the object was then have a  
canister of spray?  
. e .  
.  as it s ll   ister f -4?  
A. It as always -4. e don't -- e've  
ordered one -9 canister and we typically  
exchange that ith ax because it sits there at 1 7 
I SI and it gets close to expiring. So, ithin a 18 
year of expiring, we just trade with ax becaus 19 
it just -- it's there in case something happens  
big, but typically e never use K-9's.  
. SO, during that training procedure,  
t e , ith t e le el , as t e t e f  t at  
was deployed to the object a strea , a spray, or 24 
 m?  
e  
. efense l , , I'm rr . 
nd then  t in '0 ;   ber? 
. I n't  f e ad a al tra in  
efore e tche  , t  no   '07 t 
s e  t ear e id se  r  .. 
. nd , t just s n    
la le  the ti e   '0  t i g? 
. l , like   t as ,  e 
s itched er e here i  t t r t  i ~ 
ic  e r re  . nd then I  I i   
trai in  --
. nd e're       
re r  re i   i t . 
.  t. 
. 'm  n    u  r , 
a e t  ittle i r. 
. It s s like '0  is s  far  . 
. O,  e   e tc er  
    en's i  e  
ti  r   f ' on 
. eah, it's ore probably the su er 
. 
. ay, s er t s.  i  t e 








. et e stri e t at. at as i  f  
c f si  eca se  "spray" at I reall  ea   
to say was a "stream."  
. h.  
Q. A stream, a fog, or a gel?  
. eah, e ould never use the foa  for  
training.  
Q. Okay.  
. e l    t.  
Q. Okay.  
.      t    .  
You know, one group would have a stream, one  
group would have the fog, just so they can see  
the difference in the training aspect.  
. nd so, for the period of ti e that you  
did training -- let's see, you started there in  
'06; correct?  
. .  
Q. In '06, what brand of OC did you use  
for the training in '06?  
A. I want to say it's Def Tech.  
Q. Step Tech?  
. f ech.  
  
. nd ho  as deconta ination handled 
it  t  tr i ees? 
.   i         
t ere if t e  ee e  it. e a  a er t els if 
t   it.   ssi    t  l  
the  if they got a conta ination hich they had 
to ander around. ecause it's a parking lot 
t r   it's t -- it's a very open facility, 
very open facility to -- just people ould be 
around, so e anted to ake sure staff safety 
as up there. 
. o  long as the actual contamination? 
In other ords, once a person alked into that 
roo  and got conta inated and ca e out, ho  Ion 
  ke? 
. I think if they eren't sho ing off, 
 t   econds. 
. kay. 
. Probably ore like 10 to 15. 
. nd again, except for the t o people 
 i icate  earlier, e f t ese e le l  
   i t l l  contamination? 
. o. 
. ll right. an you explain to e ho  
your level 3 conta ination procedure ent for 
 (Pa e   t  5) 
Page 621 Page 641
1 Q Then theresanother one here of823 1 you see that
2 of 06 with Officer Julio Vega 2 A Yes
3 A Yes 3 Q Do you recall whether that particular
4 Q Its right next to the last one And 4 training involved exposure to OC
5 it says OC TrainingPolicy 307 use Did yoL 5 A It did It had a level 3 exposure
6 have any familiarity with that particular 6 Q So tell me what happened as best you
7 training 7 can recall in that level 3 exposure on that
8 A No I think after let me think 8 particular training
9 about this for a second Yes a little bit as a 9 A Thatsthe one we discussed earlier
10 student 10 about just going next to the tool shed spraying
11 Q Okay 11 a projectile at an object outside the tool shed
12 A Because I believe after this training 12 in an open air environment Staff sprayed a
13 we had because thatstraining she received at 13 bucket box whatever Them and their partner
14 South Boise Im pretty sure 14 went and picked it up and moved it about 10 to
15 Q That was the women facility right 15 15 feet and then they switched roles
16 A Yeah I was a student not an 16 Q And this was all in the open air
17 instructor 17 A Yeah
18 Q You see here that this training 18 Q Not an enclosed space
19 occurred for about one hour 19 A Not an enclosed space
20 A Yeah 20 Q And did they spray either a stream or a
21 Q Do you recall whether that training 21 foam or
22 actually involved exposure to OC or was it mor 22 A I think for that one they had the
23 classroom instruction 23 option of all three Because we had some product
24 A It was classroom instruction We 24 that was ready to expire with Def Tech and so
25 didnt Im pretty sure Julio Vega used the 25 made sure to get rid of it
17 Pages 62 to 65
Page 63 Page 65
1 same training because what we did was we kind o Q So were these Defense Technology
2 broke it up an hour here this day of the week 2 brands that were used in this training
3 so we didnthave to really bring people on their 3 A Thatscorrect Because I would have
4 day off and time off to come for an hour 4 just gone I want to say September of 06 through
5 training So we kind of spread it out through 5 the Def Tech or October of06 through the
6 the week And so I believe Julio Vega did the 6 DefTech
7 same training at all of those times and there was 7 Q And how long did the actual exposure in
8 no exposure at all 8 that outside environment last
9 Q Lets go to the next one which I think 9 A 10 15 seconds at the most
10 might be one of yours actually 10 Q And were the correctional officers who
11 A Yes 11 went through the training afforded a
12 Q So the one I want to focus on right 12 decontamination procedure at that point
13 now is the one of the 21 st of February of2007 13 A Yes
14 A Okay 14 Q And what did the decontamination
15 Q Is that a training that you were an 15 consist of
16 instructor on 16 A I believe it just boy Im going
17 A Yes 17 from memory here I believe it was just simply
18 Q And so Im assuming then that you 18 wet paper towels
19 were an instructor or actually did the training 19 Q And I believe we discussed this before
20 for Billie Jo Major on that day 20 but did most of your trainees actually get any
21 A Yes 21 effects of the OC exposure out there in the open
22 Q And did that instruction then occur 22 air
23 at the womens facility 23 A No nobody I can remember
24 A Thats correct 24 Q Do you know whether Officer Major



























Page 62 Page 64 I: 
Q. Then there's another one here of 8/23 1 you see th t? 
of '06 with Officer Julio Vega. 2 . es. 
A. e . 3 Q. Do you reca l hether that particular 
Q. It's right next to the last one. And 4 training involved exposure to O ? 
it says: "OC Training/Policy 307 use." Did YOt 5 A. It d . It had a level 3 e pos . 
have any familiarity with that particular 6 Q. SO, tell e hat happened s best you 
training? 7 can reca l in that level  exposure n that 
. . I think after -- let e think 8 particular trai in . 
about this for a second. es, a little bit as a 9 . at's the one e discussed earlier 
st t.  about just ing ne t to the to l s , s a ing 
Q. Okay.   je tile at an ject tside t e t l e  
A. Because I believe after this training 12 in an open ir i t. t f s ra e  a 
e a  -- because that's training she received at l  t, , t r. e   their t  
South Boise, I'm pretty sure. 14 e t a d c e  t  d ed it ut   
Q. That was the women's facility; right?  5   t e   itche  . 
. eah. I as a student, not an  . nd s as  i  the  ir? 
i t r.   . e . 
Q. You see here that this training 18 . t  l s  ce? 
rred f r t ne r.  .   se  . 
. e .  . nd i  t  s r  ither  str  r  
Q. Do you recall whether that training  o   --
actually involved exposure to OC or was it mon 22 .  n        
lassr  i str cti n?    l  . s  e   ( 
. It as lassr  i str ti .   t at s r  t  ir  it  f ch,  s  ~~ 




























sa e training because what we did was we kind 0 1 
broke it up an hour here, this day of the week, I  
so we didn't have to really bring people on their  
day off and time off to come for an hour  
training. So, we kind of spread it out through  
the eek. nd so, I believe Julio ega did the  
same training at all of those times and there was  
no exposure at all.  
Q. Let's go to the next one, which I think  
might be one of yours actually?  
. .  
Q. SO, the one I want to focus on right 1  
no  is the one ofthe 21st of February of2007. 1  
A. Okay.  
Q. Is that a training that you were an 1  
i str t r n? 1  
. s. 17 
Q. And so, I'm assuming, then, that you 18 
were an instructor or actually did the training 19 
for Billie Jo ajor on that day? 20 
. s. 21 
Q. And did that instruction, then, occur 22 
at the women's facility? 23 
. hat's correct. 24 
Q. And that one says there "one hour." Do 2 5 
  
. o, r  t s  fe s  l  
      i ing? 
. at's ct.   l   
j st  I t t  s  t r f '  t r  
  ch,    '    
f ech. 
.   l  i   t l  i  
t t t i  i t l st? 
. 0,  sec   t  ost. 
.  ere t e c rrecti al fficers  
ent through the training afforded a 
c nt i ti   at t t oint? 
. s. 
.   i   econta i ti  
consist f? 
. I li  it j t -- oy, I'm goi  
fr  r  here. I li  it s j t si pl  
t paper towels. 
.  I elie e e isc sse  t is before, 
but di  t f y r tr i  actually t any 
effects of the  ex s re o t t ere i  t e ope  
air? 
. o, nobody I can re ember. 
Q. o you know hether Officer ajor 
exhibit  any of the sy pt  ofOC exposure or 
17 (Pa  62 t  65) 
12 Q So there really would have been only 12 the other one Brian Bowlin Im not sure ifhe
13 one course there 13 had transferred over yet Really really really
14 A Yeah only one Im not really 14 close to that time
15 sometimes it pops up where people because 15 Q And are Spackman Bowlin and Haynes
16 sometimes people will pop up twice in the same 16 still employed by IDOC
17 training Im not really sure why 17 A Yes all three of them are still at the
18 Q Do you recall that particular training 18 womens facility too
19 during that week 19 Q So approximately how long was the
20 A Yes I believe thats when we did our 20 exposure by the trainees to OC during this July
21 first training with the SABRE Red 21 of2007 training
22 Q And tell me about that training What 22 A Id say about 15 seconds
23 was done then 23 Q And what was sprayed on the object
24 A We had the classroom portion in which 24 Was it a stream Was it a fog
25 we viewed the PowerPoint had the written test 125 A It was a fog and a stream Again some
18 Pages 66 to 69
Page 66
P age 68
1 that particular training 1 that was supplied by the instructor did the
2 A Not at that training or any other 2 level 1 exposure with the inerts inside the
3 training 3 classroom And thatswhen we went outside to
4 Q Do you recall whether Officer Major 4 o ur greenhouse and did a level 2 exposure in
5 e xhibited anything out of the ordinary in terms 5 which we went into the greenhouse as a team One
6 o f her reaction to that training that would be 6 s prayed gave oral commands The other kind of
7 different than what you observed on a daily basis 7 as a backup officersafety officer They both
8 with her 8 went in picked up the object removed it while
9 A No not verbally or physically 9 g iving verbal commands and placed it outside
10 Q Did she have any complaints about the 10 And they were afforded the option for
11 e xposure in that particular training 1 1 decontamination and we had a water hose and pape
12 A Not that training no 12 towels at that time
13 Q Do you remember anybody else who wen 13 Q And do you remember how many officers
14 through that particular training with her 14 went through the same training at the same time
15 A Yes 15 as Major
16 Q Who 16 A I dontTypically what we did is we
17 A Robin Spackman Rich Weyerts 1 7 kind of broke it up one in the morning and one
18 Q How do you spell his last name 18 in the evening And so probably I want to say
19 A Weyerts 1 9 s ix to eight people each training
20 Q Do you remember anybody else 2 0 Q Do you remember any of the people who
21 A Not that I can remember 2 1 went through with Major at that time in July of
22 Q Are either one of them still with the 22 2007
23 facility 23 A Again that would be Robin Spackman
24 A Yes theyr still both there 24 and the only reason I say that is because they
25 Q At the womenspris 2 5 both worked primarily the same days off and first
Page 67 P age 69
1 A Thats correct 1 s hift graveyard This is 07 Thatsthe only
2 Q Okay letsmove down the list here 2 ones I can think of right now
3 W ev got two of them and Sergeant Kimmel 3 Q Okay
4 s uggested I ask you this One is dated 713 of 4 A Scratch that I had Carl or Brian
5 07 and the other is dated 718 of07 Theyr 5 Bowlin and Carl Haynes I believe they were
6 both for two hours Were these different courses 6 there
7 or the same course or what was going on there d 7 Q Brian Bowlin
8 you know 8 A Bowl in and Carl Haynes
9 A It should be the same course For some 1 9 Q Hay nes
10 reason its been entered twice in what we call s 10 A Yes sir I know one of them was there





















































Page 66 1 
that particular trai i ? 1;11 
A. Not at that training or any other 2 
training. 3 
Q. Do you recall whether Officer ajor 4 
exhibited anything out of the ordinary in terms 5 
of her reaction to that training that would be 6 
different than what you observed on a daily basis 7 
ith h r? 8 
A. No, not verbally or physically. 9 
Q. id she have any co plaints about the 10 
exposure in that particular training? III 
A. Not that training, no. 112 
Q. Do you re e ber anybody else who wenf 13 
through that particular training with her? I 4 
. es. 1  
Q. ho?  
A. Robin Spackman, Rich eyerts.  
Q. How do you spell his last name?  
A.  -e-y-e-r-t-s.  
Q. Do you remember anybody else? 20 
. t that I a  re .  
Q. Are either one of them still with the  
facility?  
A. Yes, they're still both there. !  
Q. At the women's prison?  
  
. at's rr ct.  
Q. Okay, let's move down the list here. 2 
e've got two of them and Sergeant Kimmel  
suggested I ask you this. One is dated 7/13 of  
'07 and the other is dated 7/18 of '07. hey're  
t   t  rs.  t  i e t   
or the sa e course or hat as going on there; d)  
you know?  
. It l   t   r e. r  I  
r s  it's  t r  t i  i  t  cal1 I  
T AS, Training Administrative System.  
Q. SO, there really would have been only  
e c rse t ere?  
A. eah, only one. I'm not real\y --  
sometimes it pops up where people --   
sometimes people wil\ pop up twice in the same 16 
training. I'm not real\y sure why. 17 
Q. Do you recall that particular training 18 
during that week? 19 
A. Yes, I believe that's when we did our 20 
first training with the SABRE Red. 21 
Q. And tell me about that training. What 22 
as done then? 23 
A. e had the classroom portion in which 24 
we viewed the PowerPoint, had the written test 25 
Page 68 
that was supplied by the instruct , did the 
level 1 exposure with the inerts inside the 
class . nd th t's hen we ent outside to 
our greenhouse and did a level 2 e posure in 
which e went into the ree house as a te . ne 
s , a e oral co a . The other ind f 
as a backup officer/safety o fice . he  both 
ent i , picked up the t, re oved it hile 
giving verbal co , a d placed it o t . 
nd they ere forded the  for 
de ta ination  e ha   ater se  ape 
to els  that ti . 
. n   ou er  a  ficers 
e t through the s e training t the e ti e 
s j r? 
. I n't.  hat   s e 
kind  r ke it ,  in t e ing   
 e .  , r a y  a t   
i  t  i t le  tr i i . 
.      t e le  
e t t  ith j  t t t ti e i  l   
7? 
. i ,      --
          
  ri    s    
  
ift, yard.   '0 . at's   
      . 
. ay. 
. r t  t t. I  rl -- or Brian 
li   arl a es, I elie e t e  ere 
r . 
.  wlin? 
. - - -l-i-n,   ynes. 
. - - - -e-s? 
. s, ir.     t   t r  
r ure, i   li   rl ynes. d 
t  t  e, i  owlin, I'm t  if  
   et. eally, r ally, r al  
l  t  t t ti e. 
.  ar  Spackman, li  an   
still e ployed by I OC? 
. es, al  t  f t  ar  stil  at t  
omen's f cility t o. 
. O, approxi ately h  l  s t  
exp sur  by t  tr i  t   duri  t i  July 
of  training? 
. I'd say about 1  seconds. 
.  what as sprayed on the object? 
 it a stream?  it a fog? 
A. It was a fog and a stream. Again, some : 
18 (P  6  t  69) 
19 Pages 70 to 73
Page 70 Page 72
1 groups some teams would have fog and some 1 trainees have to go through the decontamination
2 teams would have stream 2 procedure where they actually took advantage of
3 Q Was it the same object that was used 3 it In other words if there was a hose did
4 over and over again 4 they have to use the hose If there was a wet
5 A Yes 5 paper towel did they have to use it or was it
6 Q Was the object decontaminated in 6 their option to use it whether they wanted to or
7 between tests 7 not
8 A No 8 A It was their option
9 Q So basically once one team went in and 9 Q And I dontknow if you recall this
10 sprayed the object it was put back and then 10 but do you recall whether Officer Major actually
11 another team would go in and spray it again 11 used any of the decontamination procedures wit
12 A Yes 12 this training
13 Q And its your recall that that was the 13 A I dontremember She could have
14 first time that an OC SABRE Red spray was usec 14 Typically them and their partner got together
15 during the training 15 and whether they used paper towels most
16 A Yes Because if I went to the 16 everybody used paper towels but I dontknow if
17 instructor course in June then we just followed 17 everybody used the hose
18 up with the institutional training the next 18 Q Were they wet paper towels or dry paper
19 month 19 towels or both
20 Q Now do you recall whether Officer 20 A They were on a roll So they would
21 Major had any complaints about the effects of OC 21 wet them if they needed them wet Or if they
22 based on this training 22 wanted them dry they would use them dry
23 A I dontwant to quote her but she said 23 Q Was there any change of clothing or
24 she an IMSI person and they use OC for 24 anything like that as a result of that
25 breakfast they put it o their food because 25 decon proced
Page 71 Page 73
1 she a Max person So she had no complaints 1 A Specifically for Billie Major it was
2 no issues It is just something you always 2 at the end of her shift So again it was an
3 smelled when you were at IMSI 3 option Because when we put the training
4 Q So basically she said At IMSI we had 4 announcement out it was Hey ifyouvegot to
5 this for breakfast so this is a minor thing 5 go to work that day bring a change of clothes if
6 A Yeah This is minor Its an 6 you want If you want to run around in OC
7 inconvenience for you guys not her 7 thats your choice too But it was the end of
8 Q So to be more specific did she 8 her shift so she had the opportunity to change
9 actually complain of any exposure to OC 9 clothes if she wanted to Whether she did or
10 A No 10 not I dontknow
11 Q during this training 11 Q But they were at least given notice
12 A No 12 beforehand that if they wanted to bring a change
13 Q At any time did she complain 13 of clothes they should do that
14 A No never once did I have a complaint 14 A Yes And some people coming off shift
15 from Officer Major about OC 15 did change And again I just don know if
16 Q Did you observe that she experienced 16 Officer or Billie Major did that or not
17 any effects of the OC exposure during this 17 Q The last one we have on the list is
18 training in July of 2007 18 March 3 of 2008 This is a training that
19 A No 19 occurred at IMSI Did you have any involveme
20 Q Was she coughing any more than her 20 with that whatsoever
21 usual coughing pattern as a result of that 21 A No I didnt
22 particular training 22 Q Have you received any information about
23 A No 23 what happened in that training as far as
24 Q When we talk about the decontamination 24 Billie Jo Major goes



























    
s -- s e tea s ld    e 1 trainees  t   t  t  t i ti  
tea s  a e . 2 r ce re r  t  t ll  t  ta e f 
. as it the e ject t t  s  3 i ?   s,  e a   ,  
over and over again?  they have to use the hose? If there as a et 
. . 5 paper to el, did they have to use it or as it 
. as t  je t ta inated i  6 t ir tion t   it, t r t  a te  t  r 
ee  ts? 7 ot? 
. . 8 . It  t ir ti . 
. O, i lly   t   i    .   on't    ll t i , 
sprayed the object, it as put back and then  but do you recall hether fficer ajor actually 
another team would go in and spray it again?  used any f the deconta ination procedures itt 
. . 12 this training? 
.  t's r    as  13 .  n't er.  ld e. 
first ti e that an   ed spray as usee 14        
ri  t e trai ing?   -- t er    ls,  
. . s  f         l ,   on't   
instructor course in June, then e just follo ed  everybody used the hose. 
up ith the institutional training the next 18 .     s    
t .  s  oth? 
. o , do you recall hether fficer  . hey ere on a roll. o, they ould 
ajor had any co plaints about the effects f 01 21  t   t   t  t.   t  
based on this training?  anted the  dry, they ould use the  dry. 
. I don't ant to quote her, but she said  . as there any change of clothing or 
she's an I SI person and they use  for  anything like that as a result of that 



























a e  
she's a ax person. So, she had no complaints,  
no issues. It is just something you always  
s elled hen you ere at I I.  
. O, basically she said, "At I I e had  
t is f r rea fast, s  t is is a i r t i "?  
. ea , "This is i r. It's a   
inconvenience for you guys," not her.  
. SO, to be ore specific, did she  
actually complain of any exposure to OC --  
. .  
. -- during this training?  
. .  
Q. At any time did she complain?  
. o, never once did I have a co plaint  
from Officer Major about Oc.  
. id you observe that she experienced  
any effects of the OC exposure during this   
training in July of 20077  
. o.  
. as she coughing any ore than her  
usual coughing pattern as a result of that  
particular training?  
. o.  
. hen e talk about the decontaminatiOl 24 
as a result of this training, did all of the  
  
. cifi ll   illie j r, it  
at the end of her shift. So, again, it as an 
option. Because when we put the training 
a ce e t t, it as, "He , if ou've t t  
 t  r  t t y, ri   e f l thes if 
you ant. If you ant to run around in ~C, 
that's r choice too." t it as the end f 
her shift, so she had the opportunity to change 
t es    .     
t,  on't . 
. ut they ere at least given notice 
ef re a  t at if t e  a te  t  ri  a c a e 
f clothes they should do that? 
. es. nd so e people co ing ff shift 
did change. nd again, I j st don't kno  if 
ic  -- or illie ajor did that or not. 
.          
r    8. i  i   tr i i  t t 
rr  t I I. i     i l e n 
 t atsoever? 
. o,  idn't. 
. a e  recei e  a  i f r ati  abo t 
hat happened in that training as far as 
illie Jo ajor goes? 
. I  t, t I -- I'm going off 
 (Page    3) 
20 Pages 74 to 77
Page 74 Page 76
1 memory here but I believe that happened at South 1 A It might be on the disk they offered to
2 Boise 2 us and I believe it could have been given to us
3 Q This training on 3of08 3 at the instructor course
4 A Yes I believe it happened at the 4 Q And this would have been the instructor
5 womenscenter I dont 5 course for the instructor training that was
6 Q Ill represent to you that she actually 6 offered by SEC
7 transferred back out ofthe womenscenter at 7 A Thats correct
8 some point in time and if the records are 8 Q And looking now at Exhibit No 41 and
9 correct it was probably around September of 9 comparing that to Exhibit No what is it
10 2007 So from September of 2007 until you 10 A 35
11 know March 3 of 2008 she actually was employe 11 Q 35 does that refresh your
12 at IMSI 12 recollection as to whether one or both of those
13 A Okay Then no I have no knowledge 13 were involved in the instructor training as
14 about that 14 opposed to end user training
15 Q Ifthis training did occur at IMSI you 15 A You mean did we receive this training
16 were not involved in it is that right 16 Q Yes In other words where did you
17 A Thatscorrect 17 receive these or where were they used
18 Q So you wouldnthave personal 18 A We received it in our training in June
19 knowledge of that 19 of 2007
20 A No 20 Q So were both of them involved in the
21 Q Theres a large exhibit over there I 21 same instruction for the instructors in June of
22 think its Exhibit No 35 22 2007
23 MR LOOMIS Is that the PowerPoint 23 A I would like to say yes on this one
24 MRBURKE Yes the PowerPoint 24 Im pretty sure Because Ive seen this before
25 THE WITNESS Revdocume 25 and Im guessing thats the only place I can
Page 75 Page 77
1 Q BY MR BURKE Do you recognize that 1 remember getting it from
2 A Yes I do 2 Q And heres where Im going with this
3 Q What do you understand it to be 3 ultimately In terms of the training that you
4 A Without going through every slide it 4 performed on other correctional officers did you
5 looks like the PowerPoint that was given to us at 5 do a PowerPoint in connection with that training
6 the instructor course in 2007 6 A Yes
7 Q Im actually going to show you another 7 Q And was that similar to or different
8 one too In addition to the PowerPoint did you 8 from what is Exhibit No 35
9 have any handouts that were given during the 9 A The first training no this was
10 instructor course in 2007 10 exactly what we used We used the PowerPoint
11 A You mean for I believe we were given 11 slide by slide the first time in which we
12 the presentation what the instructor was 12 incorporated the changeover to SABRE Red
13 presenting to us a handout I know we were 13 Q And after that did you do a different
14 given a written test at the end that we could 14 PowerPoint presentation
15 take back to our agency and use 15 A We narrowed it down a little bit yes
16 Q I want to show you another document 16 Q Okay thatsfine So Billie Jo Major
17 Im going to have this marked too 17 went through the first PowerPoint presentation
18 Exhibit 41 marked 18 that you had after you became an instructor
19 Q BY MR BURKE This one is actually 19 certified by SEC correct
20 called SABRE Instructor Certification Manual 20 A Yes
21 Have you ever seen this before 21 Q And would she have actually been shown
22 A I believe so I think so I think 22 the PowerPoint that would have been Exhibit
23 I at least most ofthis material I have 23 No 35
24 Q And where do you think you saw this 24 A Yes



























e    
e ory here, but I believe that happened at South 1 . It i t   t e is  t  ere  t  
is . 2 s   ie e t       
. is tra ing  /3 f'08? 3 t the instr t r r . 
. es, I believe it happened at the  . nd t is l   e  t e instructor 
en's r. I n't --  course for the instructor training that as 
. I'll represent to you that she actually 6 fered  C? 
tra s erre   ut  e en's    . at's rr ct. 
so e point in ti e and if the records are 8 .  n    t .   
correct, it was probably around Septe ber of  c arin  t at t  i it . -- t i  it? 
. , fr  t r f  til,   . . 
, arc   f  s e act all  as e l e  . -- ,   e   
 I.     ether e    s  
. a . e  , I a e  led e  ere e   e    
t t .  s  t   s r tr i i g? 
. If t is tr i i  id r t I I,   .       ining? 
r  t i l e  i  it; is t at ri ht?  . s. I  t r r s, r  i   
. at's ct.  r i  t es  r r  r  t  ed? 
. SO, you ouldn't have personal  . e  t      
ledge f t at?   7. 
. .  . O, ere t  f t e  i l e  i  t e 
. ere's a lar e e i it er t ere, I   o        
 t's t . .  07  
. : s  e rPoint?  . I l  like t  sa  es  t is e, 
. : ,  r oi t.  I'm rett  s re. eca se I've see  t is ef re 
 I : (Reviewing ocument.)  a  I'm essi  t at's t e l  lace I ca  



























. (B  . )   rec ize t at? 1 
. es, I do.  
. hat do you understand it to be?  
. it t ing t r  e er  sli e, it  
l s like t e er i t t at as i e  t  s at  
  rse  .  
. I'm act all  i  t  s   a t er  
one too. In addition to the o er oint, did you  
have any handouts that ere given during the  
 s   07?  
.    -- I believe e ere given 
the presentation, hat the instructor as 
presenting to us, a handout. I kno  e ere 
given a ritten test at the end that e could 
take back to our agency and use. 
. I ant to sho  you another docu ent. 
I'm going to have this arked too. 
(Exhibit 41 arked.) 










l  "S BR   rti  nual."   
ave you ever seen this before? 
.   .  i  o.   
 --      t ri   ve. 
. nd here do you think you sa  this 







   . 
.  re's  'm    
ulti ately. In ter s f the training that you 
perfor ed on other correctional officers, did you 
  t   t    
. s. 
.   t t i il  t   i t 
 t  i  . 5? 
. he first training, no, this as 
exactly hat e used. e used the o erPoint, 
slide by slide the first ti e in hich e 
incorporated the changeover to  ed. 
.  t  t t i     i e t 
Po erPoint presentation? 
. e narro ed it do n a little bit, yes. 
. kay, that's fine. So, illie Jo ajor 
ent through the first Po erPoint presentation 
that you had after you beca e an instructor 
certified by SEC; correct? 
. s. 
.  l  s   t ll   s o n 




 (Pages   7) 
21 Pages 78 to 81
Page 78 Page 80
1 A Im sure it was presented on the 1 Q Have you had any other communication
2 projector and was given to the students as a 2 with her since then
3 handout too 3 A No
4 Q Now when you instructed correctional 4 Q Have you had any observations of her
5 officers in February of 2007 using the Defense 5 since then
6 Technologysmethod did you also do a PowerPoi it 6 A No
7 for them at that time 7 Q Have you had any communications with
8 A Yes 8 any representatives of Security Equipment
9 Q And was that one that was prepared by 9 Corporation SEC
10 Defense Technology 10 A Since then
11 A Yes 11 Q Or at anytime
12 Q I take it then that after you 12 A No I mean I get amails
13 presented the PowerPoint for the SEC the SAB 13 occasionally but from the company
14 to the correctional officers you did not use 14 Q Is that because you were on their list
15 Exhibit No 41 with the correctional officers you 15 of people who were
16 instructed did you 16 A Instructors
17 A Thats correct 17 Q instructors and also who were
18 Q That was only something that you 18 involved with purchasing
19 received as part of your own training 19 A Yes
20 A Yes 20 Q Were you ever involved with purchasin
21 Q Okay I thinkIve got it Im almost 21 SEC products
22 finished here Let me look 22 A Yes
23 Are you personally aware of any 23 Q And that would have been for a period
24 incidents where Major deployed OC outside of the 24 of time after the summer of 2007
25 training rea 25 A Yes
Page 79 Page 81
1 A No Like I said nobody at South Boise 1 Q Okay
2 has deployed it even accidentally 2 A And again like I said typically we
3 Q We have some records of OC deployment 3 order it and it gets close to expiring and then
4 by Officer Major at IMSI Would you have had ai y4 welltrade out with another institution and then
5 knowledge or familiarity with those 5 wellorder some new ones
6 A No 6 MR BURKE All right I have no
7 Q Have you had any communications with 7 further questions Thank you Unfortunately
8 Officer Major since March of 2008 8 hesprobably going to have a few followups
9 A Is that when she left the department 9 but
10 Q Well that was the last day she was 10 EXAMINATION
11 physically there on the site She actually got 11 QUESTIONS BY MR OVERSON
12 terminated effective May of2008 12 Q All of the training that you conducted
13 A No but she did request me as a friend 13 with the SABRE Red it was outside
14 on Facebook 14 A Well the classroom portion was inside
15 Q Did you respond 15 but the exposure was outside Well let me
16 A I did not I have not done anything 16 rephrase that The level 2 was always in the
17 else 17 greenhouse and level 3 was a one time training
18 Q So its a recent request for a friend 18 which was outside
19 A Whenever you sent your email to me for 19 Q And let me see You have been asked
20 this like in the next day or two of this I get 20 some questions about these memorandums Exhib 1
21 a request for Facebook So its just sitting 21 Nos 38 and 39 and 40 And you testified about
22 there in the cyber world 22 some level of knowledge Were you able to locat
23 Q And you have not yet responded to that 23 those
24 request 24 A Yes



























a e 8 
. I'm sure it as presented on the 1 
projector and as given to the students as a 2 
handout t . 3 
Q. Now, when you instructed correctional 4 
officers in February of2007 using the efense 5 
Technology's ethod, did you also do a Po erPoi 1t 6 
for the  at that ti ?  
. e .  
Q. And was that one that was prepared by  
efense Technology?  
. e .  
. I take it, then, that after you  
presented the Po erPoint for the SE , the S RI ,13 
to the correctional officers, you did not use  
Exhibit o. 41 ith the correctional officers you  
instructed; did you?  
. at's .   
. at as l  s et ing t at   
received as part of your own training?  
. e .  
Q. Okay, I think I've got it. I'm almost  
inishe  . t e l .  
Are you personally aware of any   
incidents where ajor deployed OC outside ofth{ 24 
training realm?  
I-~---,-~~,--," 
e  
 . . ike I sai ,  at t  ise  
 has deployed it even accidentally.  
 Q. e have some records ofOC deployment  
 by Officer ajor at I SI. ould you have had a y4 
 knowledge or familiarity with those?  
 . .  
 Q. Have you had any communications with  
 Officer Major since March of2008?  
 . Is that hen she left the department?  
 . ell, that as the last day she as  
 physically there on the site. She actually got  
 ter inated effective ay of 2008.  
 . o, but she did request e as a friend  
  ook.  
 . id you respond?  
 . I did not. I have not done anything  
 lse. 1  
 Q. SO, it's a recent request for a friend?  
 A. Whenever you sent your e-mail to me for  
 this, like in the next day or t o of this, I get 20 
 a request for Facebook. So, it's just sitting 21 
 there in the cyber world. 2  
 Q. And you have not yet responded to that 23 
 request? 24 
 . o. 25 
Page 0 
. ave ou had  other co ication 
with her since then? 
. . 
. ave ou had  obser ations of er 
since t n? 
. o. 
. ave ou had  cations ith; 
a  re res ives f ty ip ent 
r rati , ? 
. ince t ? 
. r t  ti . 
. . I ,   e-mails 
i al , t ro  the . 
. Is that e a se  ere  t r ist 
f e le ho ere --
. Inst t . 
. -- instr t rs  l   re 
involved ith purchasing? 
. es. 
. ere  r i l e  it  i ~ 
SE  products? 
. . 
.  t t l      i  
 e     7? 
. . 
_m~m" __ ' ____ ,_"""",,, "'"'''''''' 
 1 
. ay. 
.  a ain, li e I sai , t icall  e 
order it and it gets close to expiring and then 
e'll t  t it  t  i tit ti   t  
e'll    s. 
. :  i ht,    
further questions. hank you. nfortunately, 
he's probably going to have a fe  follo -ups, 
ut --
  I  
  . N: 
.  f  tr i i     
   d, it  tside? 
. ell, t  l r  rti   i ide, 
but the exposure as outside. ell, let e 
 t at.  l l   l  i  t  
  l v l    -ti  t i i  
  outside. 
.  l t  ee.  hav   sk  
so  sti  t t  emorandums, i  t 
s.  nd   40.  y  t stifi  about 
s  l l f o ledge. r   bl  t  l t 
those? 
. s. 
. I j t t to ki  f get a sense f 
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6 Pages 18 to 21
Page 18 Page 20
1 A Yes 1 Q So you had a direct application of OC
2 Q So basically what youresaying is all 2 to your face
3 of the trainees had to sign those waivers 3 A Yes
4 A Thats correct 4 Q And in that particular class did they
5 Q So once you went through the classroom 5 use Defense Technology products
6 training Im assuming you got to some of the 6 A Yes
7 videos and the CDROMs the PowerPoints that 7 Q What like an MK4
8 sort of thing 8 A A MK4
9 A Yes 9 Q Was it a stream or a fog or a foam
10 Q And then what happened What happene 110 What was it
11 in the rest of that particular training 11 A It was a stream and it was X2
12 A Im not following you 12 Q X2
13 Q Besides the classroom training did 13 A Brand yes
14 they give you direct instruction on manner of 14 Q And tell me about the decontamination
15 deployment Is that one thing they did 15 instruction that occurred in the class
16 A Yes they did 16 A Apply copious amounts of cool running
17 Q Did you actually get exposed to OC 17 water not stagnant water Use dry paper towels
18 A Yes we did 18 that are clean And you would only use one once
19 Q Did they go through decontamination 19 and then throw it away They say the
20 procedures 20 manufacturer recommends at least I believe abou
21 A Yes 21 ten minutes of cool running water and then after
22 Q So all of that was done 22 that then just time
23 A Yes 23 Q When was the next time you had
24 Q So tell me about that Tell me about 24 instructor training
25 that part othe course 25 A A month later in June of 2007
Page 19 Page 21
1 A Okay We were basically explained on 1 Q And that was the SABRE training
2 how how they contaminate a class safety 2 A Thatscorrect
3 procedures recommendations of us when we 3 Q And where did that take place
4 instruct people and perform this Then they 4 A At Meridian POST here in Idaho
5 would physically demonstrate it without so an 5 Q And that was conducted by a
6 instructor without actually being contaminated 6 representative from SEC Security Equipment
7 would pretend like he got sprayed And then he 7 Corporation
8 would go through the series of tasks that we 8 A Thats correct
9 would have to do like straight punches and kicks 9 Q And tell me about that instruction
10 to pads and then apply restraints so 10 What was that like
11 After that that procedure well he 11 A It was very similar to Defense
12 would also explain that we would partner up and 12 TechnologysThere was PowerPoints and it
13 person would kind of be their guide to make sure 13 was you know there was some differences but
14 that their safety is looked after during this 14 mainly it was the same Virtually the same
15 situation Then they would once they apply 15 contamination levels decontamination procedure
16 restraints then they would guide them over to 16 There was a lesson plan with the information
17 the running water station and help them 17 we received a booklet and a CDROMwith the
18 decontaminate So they would offer them like 18 PowerPoints and videos and also some I believe
19 dry paper towels and fresh running water and just 19 tests
20 talk to them make sure that theyr calm and 20 Q A test that you would have to take
21 that they are breathing 21 A Well yeah a written test and then
22 Q And so tell me about the exposure 22 basically a I dontreally know how to
23 What kind of a level of exposure did you have in 23 describe it but like their own the companies
24 that particular class 24 what they would do for any kind of tests and





















































. Yes. 1 
. SO, basically what you're saying is all 2 
f the trainees had to sign those ai ers? 3 
. T t's corre t. 4 
Q. SO, once you went through the classroom 5 
training, I'm assu ing you got to so e of the 6 
ideos and the -RO s, the P i t , that 7 
sort f thing? 8 
. e . 9 
. nd then hat happened? hat happene ~  
in the rest of that particular training?  
. I'm not following you.  
. esides the classroo  training, did  
they give you direct instruction on anner of  
deployment? Is that one thing they did?  
. es, they did.  
Q. Did you actually get exposed to OC?  
. , e i .  
Q. Did they go through deconta ination  
procedures?  
. .  
Q. SO, all of that was done?  
. .  
. SO, tell e about that. Tell e about  
that part of the course.  
  
. kay. e ere basically explained on  
how, how they contaminate a class, safety  
procedures, recommendations of us when we  
instruct people and perform this. Then they  
would physically demonstrate it without -- o,   
instructor ithout actually being conta inated  
would pretend like he got sprayed. And then he  
ould go through the series of tasks that e  
would have to do, like straight punches and kicks  
to pads, and then apply restraints, so -- 1  
fter that, that procedure -- ell,  I  
ould also explain that e ould partner up and ~  
person would kind of be their guide to make sure  
that their safety is looked after during this  
situation. Then they ould -- once they apply  
restraints, then they ould guide the  over to  
the running water station and help them 1 7 
deconta inate. So, they ould offer the  like 1  
dry paper towels and fresh running water and just 19 
talk to the , ake sure that they're cal  and   
that they are breathing.  
Q. And so, tell me about the exposure.  
hat kind of a level of exposure did you have in 23 
that particular class? 24 
. e ell. 25 
Page 20 
Q. SO, you had a irect a ication of  
to your fa ? 
. e . 
. nd in that pa ticular clas , id the  
use efense e ology's r ts? 
. e . 
. t, like  -4? 
. -4. 
. as it  trea  r  fog r a fo ? 
hat as ? 
. It as a strea  a  it as . 
. ? 
. ra , s. 
. nd t ll e t t e t i ation 
i str ti  t t rre  i  t  l ss. 
. p l  ious ts f l r i  
r,  t t r. s    els 
t at r  l .   l  l  s   ( 
   t y.   -- t  I 
f t r r r ends t l t I lie  ll~ 
ten inutes  l      
t t, t e  just ti . 
. e  as t  t ti    
i str t r tr i ing? 
.      2007. 
  
.  t t  t   t ining? 
. at's c rrect. 
.  r  i  t t t  l ce? 
.      ho. 
.       
representative fro  , ecurity quip ent 
rporation? 
. at's rrect. 
.  t ll  t t t i struction. 
t   ? 
. It  r  i il r t  f  
echnol gy'S. ere as er i ts a  it 
 --  ow, t r  s s  iff r s, t 
ai l  it s t  sa e. irt ll  t  s  
t i t  l vels, cont i ti  r dures 
       ti  --
  a l  an  a -R   t  
o er oi ts an  i e s a  als  s e I belie e 
tests. 
.  t  t t  l   t  take? 
. ell, ah, a ri  t t an  t  
basically a --  on't r ally  ho  t  
scri  it, but li  their n, t  co panies, 
hat they ould do for any kind of tests and 
valuations. I don't -- I i  I l  descri  
6 (  1  t  1) 
7 Pages 22 to 25
Page 22 Page 24
1 it 1 midway down the page
2 Q Some sort of feedback on the test 2 A Yes
3 result 3 Q Im looking for another document here
4 A Yeah its just like people who do a 4 So just bear with me
5 scientific study on it I guess you would say 5 A Do you mind if I grab some more
6 Q Okay 6 MR LOOMIS Ill get it for you Ill
7 A Thatsthe best I can describe it 7 just fill it up
8 Q All right So did you have a level 1 8 Q BY MR BURKE There is a group of
9 contamination there 9 exhibits here and I want you to find Exhibit
10 A Yes 10 No 41 Its probably the last one on the
11 Q So you received a direct application 11 bottom the big one there
12 of the product to your face area 12 A Okay
13 A Yes 13 Q Do you have that there in front of you
14 Q And then you went through the 14 A Yes
15 decontamination process 15 Q Now I will represent that this is a
16 A Yes 16 revised version August of 2008 but its
17 Q What product brand was used in that 17 entitled SABRE Instructor Certification Manual
18 particular training 18 Just thumbing through that does this look
19 A It was SEC 19 familiar to you
20 Q SABRE Red 20 A Yes it does
21 A SABRE Red to the best of my knowledge 21 Q And would this have been or a version
22 yes 22 of this have been something that you would have
23 Q Okay 23 received during the course work that you took
24 A And if it wasn SABRE Red it would 24 with the SEC representative in June of2007
25 have been a SABRE 25 A Yes and I still have my copy of it
Page 23 Page 25
1 Q Product 1 too
2 A a SABRE product yes 2 Q So you still have that at home
3 Exhibits 42 and 43 marked 3 A Yes
4 Q BY MR BURKE Sergeant let me hand 4 Q And theresone other that I wanted to
5 you what Ive had marked as Deposition Exhibit 5 ask you about if I can figure out what that
6 Nos 42 and 43 and ask if you recognize those 6 number is Something tells me it might be 35 an
7 A I do 7 it is Exhibit No 35 in that package
8 Q And are these documents that were 8 A Reviewing document
9 generated in connection with your training at the 9 Q Have you ever seen this before It
10 POST academy by representatives of SEC in the O l0 looks like a PowerPoint
11 trainers certification course 11 A This looks familiar yes
12 A Yes they are 12 Q Is this something that you have seen in
13 Q And Exhibit No 42 would be a copy of 13 connection with your training as an instructor or
14 your training certificate that you obtained as a 14 is it something that you have used as an
15 result ofthe completion of that course 15 instructor in your training of others
16 A Yes 16 A Both
17 Q And Exhibit No 43 would be documents 17 Q Both Okay And when do you recall
18 that were provided to you during the course of 18 that you first received this as part of your
19 the instruction 19 training as an instructor
20 A Yes 20 A During my certification is when we
21 Q And the first page of Exhibit No 43 21 received that
22 the handwritten part is that something that you 22 Q So that would have been in June of
23 filled out 23 2007
24 A Yes 24 A Thats correct






















































Q. Some sort of feedback on the test 2 
re lt? 3 
A. Yeah, it's just like people who do a 4 
scientific study on it, I guess you would say. 5 
. kay. 6 
A. T t's the best I can describe i . 7 
Q. All right. So, did you have a level 1 8 
ion th ? 9 
. e .  
Q. SO, you received a direct application  
of the product to your face area?  
. .  
. nd then you ent through the  
deconta ination process?  
. es.  
Q. hat product brand was used in that  
particular training?  
. t as .  
yes. 
Q. SABRE Red?  
.  ed t  t e est f  ledge  
 
Q. Okay. 
. nd if it asn't  ed, it ould 





. Product?  
. -- a SABRE product, yes.  
(Exhibits 42 and 43 marked.)  
. (B  . ) ergeant, let e hand  
you what I've had marked as Deposition Exhibit  
os. 42 and 43 and ask if you recognize those.  
.  .  
Q. And are these documents that were  
generated in connection with your training at the  
POST academy by representatives of SEC in the 01 ~ 1 0 
tr i rs rtifi ti  rse?  
A. Yes, they are.  
. nd Exhibit o. 42 ould be a copy of  
your training certificate that you obtained as a  
result of the completion of that course?  
. .  
. nd xhibit o. 43 ould be docu ents 1   
that were provided to you during the course of  
t  truction?  
. .  
Q. And the first page of Exhibit No. 43,  
the handwritten part, is that something that you  
fi  ut?  
. .  
Q. And it has your signature there about  
Page  
idway  the p ? 
A. es. 
. I'm looking for a ther c e t h . 
, just bear ith . 
. o you ind if I grab s e ore --
. : I' l et it for . I'll 
just fill it . 
. (BY . ) here is  roup  
ts ere  I a t u t  ind it 
. . t's proba ly the last e n  
, the ig one th . 
. a . 
. o  a e t at there in fr t f u? 
. . 
. ,   e   s is  
re ise  ersi , st f2008, t it's 
tled "SABRE s  ication ual.' 
J st t in  t r  t t, s t is l  
fa iliar t  u? 
. ,  . 
.   is e e     
 t is   t i  t t  l   
   rse     
 t e  e    07? 
. ,   ti       
. 
. O,  till  t t t e? 
. s. 
  
.  t ere's  t r t t I t  t  
s   t if I  fi r  t t t t 
 . t  s       
 , i  .   t ge. 
. (Revie in  cument.) 
. ave you ever seen this before? It 
l  e  erPoint. 
.   f iliar, s. 
. Is t is s t i  t t   s  i  
ti  it  r tr i i  s  i str t r r 
i   so et i  t      
i    i  f thers? 
. oth. 
. oth? kay. nd hen do you recall 
that you first received this as part f your 
tr i i  a   i structor? 
. uring y certification is hen e 
r i  that. 
. O, t t l  v   i  Ju  f 
007? 
. hat's cor ect. 
.  y u ul  have recei e  t is 
 (Pa  2  t  25) 
8 Pages 26 to 29
Page 26 Page 28
1 through SEC 1 that changed the PowerPoints and reduced them t
2 A Yes 2 make them end user and Idaho Department of
3 Q And then later when you instructed 3 Correction
4 others in OC at IMSI then you made use of this 4 Q Specific
5 same PowerPoint 5 A specific yeah would be Sergeant
6 A Yes 6 Doan Nick Doan Kimmel Bret Kimmel and the
7 Q Did you make any modifications to it 7 myself
8 A Yes we did 8 Q All right And you think this page is
9 Q And do you remember what kind of 9 one of the ones that you changed
10 modifications you made to it 10 A Yeah I believe so
11 A Yes we eliminated or reduced some of 11 Q Did that go on to the next page too or
12 the information to make it an end user course 12 is that
13 rather than the instructor course to slim down 13 A Yes
14 the time And we also added some of our 14 Q Any others And did it continue on to
15 departmentsuse of force policy and procedures 15 the third page after that
16 in there as well 16 A No I believe this was from the actual
17 Q Just thumbing through this particular 17 company
18 version can you tell by looking at it what 18 Q So at least Bates Nos 69 and 70 would
19 portions of it you may have added 19 have been ones that you changed
20 A Its not all here 20 A Yes
21 Q And it may not be This came to us 21 Q Okay Any others
22 from the Department of Corrections 22 A 74
23 A Oh really 23 Q All right
24 Q So I dont know what version it is and 24 A 75
25 I was wondering if you migh be able to help us 25 Q Okay
Page 27 Page 29
1 with that 1 A 76
2 A Reviewing document Im not sure who 2 Q All right
3 made this one to be exact So I do have copies 3 A 77 78 81 I believe Im not
4 of all of the ones that I used as well So if 4 100 percent positive 82 yeah I know for
5 you need those 5 positive 82 83 84 85 1 also have theCDRO
6 Q Okay 6 still that has the original PowerPoint I believe
7 A So youreasking me whats the 7 on there from the company that we received and
8 difference between what the company made and wh 8 then like I said the modifications that I made
9 we 9 Q Would they be on the CDROM too
10 Q Yes I mean if theres anything you 10 A No theyr on my drive So I have
11 can tell by looking at it And let me show you 11 them available to you if you need them
12 theres little numbers that appear on the side 12 Q All right Thank you
13 here that say IDC Records and it would be 13 A You bet
14 000052 or some other number So you can refer 14 Q So the pages that you gave me were the
15 to a page that way if you find anything in there 15 ones that you believe most likely were changed
16 A Okay Reviewing document Im not 16 from the original SEC is that correct
17 100 percent positive but 000069 17 A To the best ofmy knowledge yes
18 Q 69 Okay For Training and then 18 Q All right Youvegiven me two of the
19 During Actual Use of Force 19 training courses that you had as an instructor of
20 A Yeah So I believe that I made this 20 OC When was the third one
21 one s21 A It would have been 2009
22 Q Okay 22 Q And where did that occur
23 A So at the time throughout this process 23 A It would be at the Meridian POST as
24 when we used SABRE Security Equipment 24 well as we used the IDOC range for the practical




1 through SEC? 
2 A. Yes. 
3 . And then later when you instructed 
4 others in C at I I, then you ade use of this 
5 sa e P oint? 
6 . Yes. 
7 Q. Did you make any modifications to it? 
8 . es, e did. 
9 . And do you re e ber hat kind of 
10 odifications you ade to it? 
11 A. Yes, we eliminated or reduced some of 
12 the information to ake it an end user course 
13 rather than the instructor c rs , t  s i  n 
 the ti . nd e also ded e  r 
 department's use of force policy and procedures 
 in there as ell. 
 Q. Just thumbing through this particular 
 version, can you tell by looking at it what 
 portions of it you may have added? 
 . t's t  . 
 Q. And it may not be. This came to us 
 from the Department of Corrections. 
 A. Oh, really? 
 Q. SO, I don't know what version it is and 
 I was wondering if you might be able to help us 
  
1 t  t. 
 A. (Reviewing document.) I'm not sure who 
 made this one, to be exact. So, I do have copies 
 of all of the ones that I used as ell. So, if 
 you need those --
 Q. Okay. 
7 A. So, you're asking me what's the 
 difference bet een hat the co pany ade and h2 
  --
 Q. Yes. I mean, if there's anything you 
 can tell by looking at it. And let me show you, 
12 there's little numbers that appear on the side 
 here that say "IDC Records" and it would be 
14 000052 or so e other nu ber. So, you can refer 
15 to a page that way if you find anything in there. 
16 A. Okay. (Reviewing document.) I'm not 
17 100 percent positive, but 000069. 
18 Q. 69? kay. "For Training" and then 
19 "During Actual Use of Force"? 
20 A. Yeah. So, I believe that I ade this 
2  ne. 
22 Q. Okay. 
23 A. So, at the time throughout this process 
24 n  used A  -- Security Equipment 




















































that changed the P erP ints a d reduced the  tc 
ake the  e d user and Idaho epartment of 
orrection --
Q. S ifi ? 
A. -- s , ye , ould be Sergeant 
o , ick o , i l, ret im , a  the 
s lf. 
. l rig . nd you think this page is 
one of e ones that you d? 
. e , I ie e . 
. id that o  to the e t age too r 
is that --
. es. 
. n  t ers? n  i  it c tinue  t  
t e rd e ter t t? 
. ,  ieve is a  r    
. 
. O, t east ates .     
a e e   t at  d? 
. . 
. y.  rs? 
. . 





.  t. 
. , 8. ,  l , 'm t 
  siti . , h,   r 
siti  . , , . I ls   t  D-ROt-. 
till t t  t  ri i l r i t I li  
 t r  fr  t   t t  r i   
   aid, t  i  t r e. 
. l  t e  e  t e -R  t o? 
. , they're   rive. o, I a e 
the  available to you if you need the . 
. ll right. hank you. 
.  et. 
. O, t   t t     t  
 t t  eli  t li l   c  
fr  t e ori i al EC; is t at correct? 
. o the best of y kno ledge, yes. 
. l  ri ht. ou've i   t  f t  
trai i   t at y   as a  i str ct r of 
c. en s t  t ir  one? 
. I  ul  hav  been 2009. 
.  r  di  t at oc ur? 
. It ould b  at the ri i   as 
ell as e used the I  range for the practical 
Q. nd who put on that presentation? 
8 (P  2  t  29) 
Page 381 Page 40
1 youreusing 1 monitoring them
2 Q And what kind of contamination 2 Q And about how long would it take them
3 exposure then was used in the 2007 instructions 3 to walk through that exposed area
4 that you did 4 A Two seconds three seconds maximum I
5 A We would use area contamination 5 would say
6 Q Which would be a level 3 contamination 6 Q And that would be the length of time of
7 A Yes 7 their exposure
8 Q And describe where that would take 8 A Yes
9 place and how it would take place 9 Q And then would you go through some so
10 A Sure Its down a secured tier 10 of a decontamination process at that time
11 Q And that was in the F block 11 A We offered water from a sink and dry
12 A Yes And its a rough estimation of 12 paper towels
13 that of the size of that tier would be 30 to 13 Q And you had them outside too or
14 40 feet long by maybe 10 to 12 feet wide 14 outside of the hallway
15 Q And that would just be like a hallway 15 A Thewater
16 A Yes 16 Q No where was the decontamination done
17 Q In the tier 17 A What we would do is have them just go
18 A Yes 18 outside The way that this structure is made up
19 Q And did the hallway have exits and 19 is when they would go out into this area it has
20 entrances 20 a chainlink fence around it
21 A Yes 21 Q Is it an outside environment
22 Q And did you just have the trainees walk 22 A Yes an outside environment And then
23 through the hallway 23 there would be dry paper towels out that way
24 A Yes We closed the doors 24 Then this is where we found the error in that
25 Q Okay 25 trai is that we woul have to gothrough that
Page 39 Page 41
1 A But did not secure them with a lock 1 contaminated area again
2 Wedhave somebody spray in there 2 Q To get back
3 Q Spray with what 3 A Yeah
4 A With a MK9 canister 4 Q Oops
5 Q And would that be a fog 5 A Where the sink was with water
6 A A fog 6 Q So did they actually have to go
7 Q And how much spray was actually put in 7 through it twice then the contaminated area
8 there 8 A Yes
9 A Id say about equivalent to a 9 Q How did you decontaminate them at the
10 three second spray 10 other end
11 Q Three bursts three second bursts 11 A There would be still dry paper towels
12 A Yes 12 and then thatswhere the sink would be But w
13 Q And was that done once or more than 13 would have them stay outside out there for like
14 once throughout the training process in a 14 10 minutes or so while we were airing out that
15 particular training course 15 tier We would have fans as well trying to get
16 A Just once 16 as much out as we could
17 Q And then would you have the trainees 17 Q So that was in 2008 How did your
18 then walk from one end to the other 18 process change in or in 2007 How did the
19 A Yes So they would start in the 19 process change in 2008
20 they would start from one area from one end an 12 0 A We used an actual specific cell on that
21 they would hold on to each other just with their 21 tier
22 hands on their shoulders their eyes closed head 22 Q Okay tell me about how that that
23 down and then walk through to therewas 23 was on the F block
24 another theres an exit point to fresh air 24 A Yes
25 outside An instructor would be out there 25 Q Which tier was it




























you're using. 1 
Q. And what kind of contamination 2 
exposure, then, was used in the 2007 instructions 3 
that you did? 4 
A. We would use area conta ination. 5 
Q. Which would be a level 3 contamination? 6 
A. Yes. 7 
Q. And describe where that would take 8 
place and how it would take place. 9 
. S re. It's do n a secured tier. 10 
Q. And that was in the F block? 11 
A. Yes. And it's, a rough estimation of 12 
that, of the size ofthat tier would be 30 to 13 
40 feet long by aybe 10 to 12 feet wide. 14 
Q. And that would just be like a hallway? 15 
. es.  
Q. In the tier?  7 
. e . 18 
Q. And did the hallway have exits and  
t s?  
. es.  
Q. And did you just have the trainees walk  
through the hallway?  
. . e losed t e r .  




























. t i  t r  t e  ith  l . 1 
e'd have so ebody spray in there.  
Q. Spray with what?  
.   -9 i t r. 4 
Q. And would that be a fog? 5 
A. A fog. 6 
Q. And how much spray was actually put in  
ili~?  
A. I'd say about equivalent to a  
three-second spray. 1  
Q. Three bursts, three second bursts?  
. s. 1  
Q. And was that done once or more than 1  
once throughout the training process in a 1  
particular training course? 1  
. Just nce. 1  
Q. And then would you have the trainees 1  
t  al  fr   en  t  t  other? 1  
. es. So, they ould start in the -- 19 
they would start from one area, from one end, an 20 
they would hold on to each other just with their 2  
hands on their shoulders, their eyes closed, head 22 
down, and then walk through to -- there s 23 
another -- there's an exit point to fresh air 24 
outside. An instruct r would b  out there 25 
Page 40 
monitoring the . 
Q. And about how long would it take them 
to walk through that exposed are ? 
A. Two s , thr e seconds aximum I 
would s . 
. And that would be the length of time f 
their exposure? 
. es. 
. nd then ould you go through so e sor , 
f a dec ta ination process at that ti ? 
. e o fered ater fro  a sink and  
paper to els. 
. nd ou had the  tside t , or 
outside of the h l y? 
. he ater? 
. , here as the t i tion one) 
. hat e ld  is  the  just  
. e  that is t re is a e  
is hen t e    t i t  s , it  
  ink ence d i . 
. Is it  t i e ir ent? 
. ,  s de t. n  en 
ere    er els t  y. 
e  t is is ere e f  t e err r i  t at 
raining s  e ould ave   hroug   
  ain. 




.  t  i   it  t r. 
. O, i  t  t ll   t   
t r  it t i e, t n, t  t i t  rea? 
. s. 
.  i   co t   at t  
t  nd? 
.  l   stil  r  r t l  
an  t  t at's r  t  si  ul  be. t  
oul   t  st  outsi  t t  f r li  
1   or so hil    iri  out t t 
tier.  ul  hav  f  as wel  tr  t  get 
as  out as  could. 
. SO, t at s i  2008.  did y ur 
process change in -- or i  2007.  di  t  
process change in 2008? 
.  used an actual specific cel  on that 
tier. 
Q. kay, tell  about ho  that -- that 
was on t  F block? 
A. es. 
Q. Which tier was it? 
11 (  38 t  41) 
12 Pages 42 to 45
Page 42 Page 44
1 A Its lets say if yourefacing the 1 the hall
2 building it would be the lefthand tier 2 Q And what would happen there
3 Q So tell me about what you did 3 A Then the people would be holding strike r
4 A We would have instructors would have 4 pads and then they would they would do a series
5 gas masks and they would go in one at a time 5 of strikes or kicks that theyv been trained in
6 Q And do what 6 Q Okay
7 A Its a level 3 exposure 7 A And then they would apply restraints on
8 Q Okay 8 an individual at the very end of the tier
9 A So we would use a MK9 canister 9 Q And then what
10 Q And that was also a fog 10 A Then once thats done their partner
11 A A fog 11 would start talking to them and guide them to the
12 Q And how much would you apply 12 decontamination station where there was a sink
13 A One to two second bursts 13 with running water and a hose and then dry pape
14 Q And what was the size of this cell 14 towels
15 A Its a standard size cell So Id say 15 Q And then go through the decontamination
16 10 by 12 to the best ofmy knowledge 16 procedure at that time
17 Q And it had just one exit and entrance 17 A Thats correct
18 right 18 Q And at that point would they then turn
19 A Correct 19 around and have their partner go through that
20 Q And was that shut off 20 process while they stayed outside
21 A It was at the end of the hallway So 21 A Yes once we knew that they were
22 right next to it is an open door where the 22 they were okay to go then they would switch
23 instructor thats why we had we used 23 Q And the partner would go through it
24 protective masks So if we saw any safety 24 A Yes
25 anything that had like we had to get them out 25 Q So when their partner went into the
Page 43 Page 45
1 of there we could enter safely take them out 1 cell the partner would go in alone
2 into the fresh air outside 2 A Thatscorrect
3 Q So tell me procedurally then what 3 Q And then come out and at some point
4 you had them do what you had the trainees do 4 down the hall meet up with the first person that
5 A Sure They would go inside that cell 5 went through
6 we would close it talk with them through the 6 A Yes And typically we would have
7 door 7 another instructor in there in the opposite
8 Q Just one at a time they would 8 hallway who was familiar with our arrest
9 A Just one at a time yes We would have 9 techniques
10 mats on the ground to make sure they didnt slip 10 Q Okay
11 Q Okay 11 A So they would make sure that theyr
12 A So they would go in That instructor 12 doing it in a safe and appropriate manner And
13 would talk to them They would be exposed to it 13 they were educated as well to look for any safety
14 anywhere from five to ten seconds 14 precautions that would be effects from OC
15 Q Okay 15 Q Do you recall what brand of MK9 you
16 A Then they would come out of the cell 16 used as a fog in 2008
17 and they would have to go up into a high guard 17 A SEC SABRE Red
18 Q And do a what 18 Q And do you recall what kind of brand of
19 A A high guard Thats like how to 19 fog you used in 2007
20 protect yourself put your hands up and yell 20 A SEC SABRE Red
21 Back what we would do with an offender 21 Q Now prior to having trainees go
22 Q Okay 22 through the instruction and in particular the
23 A Then they would walk on some mats 23 exposure to the level 3 OC contamination did yo
24 across that tier where they would be met by their 24 have them sign anything to indicate that they
25 nartner who would euide them to the tier across 25 understood any risks or issues that might be
000709
  
 . It's -- t's s  f u're a  t e 
 building, it ould be the left-hand tier. 
 . O, t   t at  . 
 . e  e -- i tr t rs l  e 
 gas masks and they would go in one at a time. 
 . nd do hat? 
 . It's a level 3 exposure. 
 . kay. 
 . , e l  se  -9 i t r. 
 . nd t t as ls   f g? 
 .  fog. 
 . nd ho  uch ould you apply? 
 .  t    . 
 . nd at as t e   t is l ? 
 . It's a standard size cell. o, I'd say 
 10 by 12 to the best f y kno ledge. 
 . nd it had just one exit and entrance; 
 right? 
 . rr ct. 
 . n  as t at s t ff? 
 . It s t t e  f t e ll . , 
 ri t t t  it is   r r  t  
  -- that's hy e had, e used 
 protective asks. So, if e sa  any safety, 
 anything that had -- li e   t  t t  t 
  
 f t ere, e c l  e ter safely, ta e t e  t 
   re   i e. 
 . O, t ll  r durally, t n, t 
 you had the  do, hat you had the trainees do. 
 A. Sure. They would go inside that cell, 
 e ld cl se it, tal  it  t e  t r  t e 
 r. 
 . J st e at a ti e t e  uld? 
 . J st e at a ti e, es. e l  a e 
 mats on the ground to make sure they didn't slip. 
 Q. Okay. 
 . , t e  l   i . at i str ct r 
 would talk to the . They would be exposed to it 
 a ere fr  fi e t  te  sec s. 
 Q. Okay. 
 . hen they ould co e out f the cell 
 and they would have to go up into a high guard -
 . nd do a hat? 
 .  high guard. hat's like ho  to 
 protect yourself, put your hands up and yell 
 "Back," hat e ould do ith an offender. 
 . kay. 
 . Then they ould alk on so e ats 
 across that tier where they would be met by their 




















































the l . 
. nd hat ould happen there? 
. e  t e e le l  e l ing stri e 
pads and then they ould, they ould do a series < 
 t ikes  ic s t at t ey've  t ine  i . 
. . 
.  t  t  l  l  t i ts  
 i i id l t t     t  ti r. 
.  t  t? 
.   t at's , t ir rt r 
ould start talking to the  and guide the  to th~ 
i    e    
ith       e   e 
t l . 
.      nation' 
   e? 
. at's ct. 
.  t t t i t l  t  t  t  
ar d a  a e t eir art er  t r  t at 
r cess ile t e  sta e  tsi e? 
. es, ce e e  t at t e  ere--
they ere okay to go, then they ould s itch. 
. nd the partner ould go through it? 
. . 
. O, e  t eir art er e t i t  t e 
  
cell, t e art er l   i  al ne? 
. at's rr t. 
.  t e  c e t a  at s e i t 
do n the hal1 eet up ith the first person that 
ent through? 
. es.  t ical1  e l  a e 
another instructor in there in the opposite 
hall ay ho as fa iliar ith our arrest 
tec i es. 
. kay. 
. o, they ould ake sure that they're 
doing it in a safe and appropriate anner. nd 
t e  ere e cate  as el1 t  l  f r a  safet  
reca ti s t at l  e effects fr  . 
. o you recal1 hat brand of -9 you 
used as a fog in 2008? 
.   d. 
. nd do you recall hat kind of brand of 
fog you used in 2007? 
.   d. 
. , ri r t  vi  tr i s  
t r  t  i str ti   i  rti l r t  
exposure to the level 3 OC contamination, did yOl 
have the  sign anything to indicate that they 
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14 Pages 50 to 53
Page 50 Page 52
1 want to know about before you sent them througl 1 A Coughing if it affects my respiratory
2 the procedure 2 Q Does it always affect the respiratory
3 A Definitely 3 A Not necessarily no It depends on
4 Q And why would you want to know that 4 what spray pattern is used
5 A Well I mean wer not experts in 5 Q In that regard there are different
6 stating that OC being exposed to the OC will 6 forms of OC One would be a stream correct
7 cause any damage but to be on the safe side 7 A Yes
8 its just better that they dontgo through it 8 Q One would be a fog
9 Q Well you would not want to exacerbate 9 A Yes
10 it 10 Q And one would be a foam
11 A Exactly 11 A Yes
12 Q or make it worse correct 12 Q How do the different spray types affect
13 A Exactly 13 the likelihood of getting a respiratory impact
14 Q That would be one of the reasons that 14 A Okay your fog very likely because
15 you would want to know about it 15 thats what its intended for
16 A Yes 16 Q What about the stream
17 Q And if somebody asked to be excused 17 A The stream can
18 because they did have some sort of a respiratory 18 Q But less likely than a fog
19 illness that was in an acute phase you would 19 A Less likely but itsstill very
20 honor that 20 possible
21 A Yes and we would me personally as 21 Q And would that depend upon whether it
22 an instructor on the training sheet I would 22 was a direct level 1 exposure versus an indirect
23 document that in the Comments section 23 exposure
24 Q Okay you can put that back together as 24 A And whether it comes out in a full
25 part ofExhibit No 31 25 stream pattern Because if it comes out in
Page 51 Page 53
1 A Sure Im not sure why these are 1 spurts then it could affect start to almost
2 stapled to that 2 become a fog itself
3 Q I dontknow either Thats the way we 3 Q And how about a foam
4 got them 4 A Virtually none Its designed to
5 A Okay Do you guys did you guys get 5 whatever it comes in contact with it causes the
6 access to her training file 6 heat and for your eyes to close so
7 MR LOOMIS It was produced 7 Q But probably very little respiratory
8 Q BY MR BURKE Yeah and wer goina 8 effect
9 to go over that in a minute 9 A If you swallow it it could cause I
10 MR LOOMIS Josh are you okay 10 would imagine its just like swallowing hot
11 MR BURKE Do you need a break 11 sauce
12 Discussion held off the record 12 Q So we were talking about the various
13 Q BY MR BURKE I want to talk about 13 effects on humans the sunburn feeling the mucus
14 the effects of OC as you have experienced and 14 excess the salivation the eyes tearing up and
15 observed it through your trainings that youve 15 closing and coughing if it gets to a respiratory
16 taken and trainings that youve given Based 16 exposure Anything else
17 upon that experience and those observations wh tl7 A Sneezing
18 are the general effects that you have observed 18 Q Anything else
19 and felt from exposure to OC 19 A Some people Ive seen them kind of
20 A An intense sunburn feeling rhinorrhea 20 gag
21 Q And that means what 21 Q Anything else
22 A It means excessive mucus running from 22 A Thats all I can think of right now
23 your nose Salivation eyes tear up and then 23 Q All right So based upon your actual
24 they involuntarily close So blepharospasm 24 experiences with exposure and observations of



























  age 2 
ant to kno  about before you sent the  throug 1 . oughing if it affects y respiratory. 
the procedure? 2 . oes it a s e  the ir tory? 
. efi itel . 3 . ot ssaril , . t epends  
Q. And why would you want to know that?  hat s ra  attern is se . 
. ell, I ean, e're not experts in  . In that regard, there are different 
stating that OC -- being exposed to the  ill  or s  .  d e  ; rr ct? 
cause any damage, but to be on the safe side,  . e . 
it's just better that they don't go through it.  . ne ould be a fog? 
Q. ell, you would not want to exacerbate  . e . 
it --  . nd e o ld e  ? 
A. Exactly.  . . 
. --  a e  s ; ct?  . o  do the different spray types affect 
. actl . 13 t e likelihood f etting a res irat r  i act? 
. hat ld e e f t e reas s t at  . ay, r f , er  likely eca se 
u ld a t t   a t it?  t at's t it's i t  f r. 
. e .  .  t  t am? 
. nd if so ebody asked to be excused  .   . 
because they did have so e sort of a respiratory  . t less likely t  a f ? 
illness that as in an acute phase, you ould  . ess likely, but it's still very 
 at?  possible. 
. ,  e  -- e personally as  .  d    t er  
an instructor, on the training sheet I would  as  ire t l l  e s s  i ir t 
t t t i  t  "Co ts" ti .  exposure? 
Q. Okay, you can put that back together as  . nd t er       




























. re. I'm t s re  t ese are  
stapled to that.  
Q. I don't know either. That's the way we  
got them.  
A. Okay. Do you guys, did you guys get  
access to her training file?  
. L IS: It as produced.  
Q. (BY R. BURKE) Yeah, and we're going 8 
to go over that in a minute.  
. IS: Josh, are you okay?  
R. BURKE: Do you need a break?  
(Discussion held off the record.)  
. (B  . ) I ant to talk about  
the effects of  as you have experienced and  
observed it through your trainings that you've  
taken and trainings that you've given. Based  
upon that experience and those observations, wh 11 7 
are the general effects that you have observed  
and felt fro  exposure to C?  
. n intense sunburn feeling, rhinorrhea.  
. nd that eans hat?  
. It eans excessive ucus running fro   
your nose. Salivation, eyes tear up and then  
they involuntarily close. So, blepharospasm.  
Q. Anything else?  
  
spurts, then it could affect -- t t t  l t 
   it lf. 
.   t  ? 
. l  . t's   --
     , i    
      ,  --
. t r l  r  littl  r pir t r  
ff ct? 
.   ll  it, it l   --  
ould i agine it's just like s allo ing hot 
e. 
. SO, e ere talking about the various 
  s,  sun r  eling,  m 
s, t  alivation, t   t ri    
l i ,  i  i  it t  t   r ir t r  
exposure. nything else? 
. Sneezing. 
. t i  else? 
. e eople, I've see  t e  i  f 
ag. 
. t i  else? 
. hat's all I can think f right now. 
. ll right. So, based upon your actual 
experiences ith exposure and observations of 
t rs    x sed, t ar  t  
 (Pa    53) 
15 Pages 54 to 57
Page 54 Page 56
1 typical ranges of time over which the effects of 1 Q All right So after an hour thats
2 OC exposure seem to last with people who have 2 usually the only residual and that usually goes
3 been exposed 3 away in 24 to 48 hours
4 A It could be anywhere from youre 4 A Yes from my experience
5 talking about from a level I exposure 5 Q Other than Billie Jo Major who is the
6 Q Any exposure And you can 6 subject of this lawsuit are you aware of any
7 differentiate as you wish 7 correctional officer ever having complained of
8 A Sure A level 3 exposure Ive seen 8 experiencing the effects of OC exposure for a
9 recovery times from immediately once they 9 period longer than three days
10 received fresh air to up to 30 minutes 10 A No
11 Q Okay 11 Q Have you ever heard of any inmate
12 A For a full recovery 12 complaining of the effects of OC exposure lasting
13 Q Okay 13 for longer than three days
14 A A level 1 exposure can be Ive seen 14 A No
15 anywhere from 10 minutes up to an hour 15 Q Are you aware of any correctional
16 Q What is the longest time you have ever 16 officer other than Officer Major who has filed or
17 experienced the effects of OC following exposure 17 asserted a Workers Compensation claim as a
18 a level I or otherwise 18 result of exposure to OC
19 A Well actually so youresaying 19 A No
20 lets back up on your previous question 20 Q Im going to have to look this up
21 Q Okay 21 What was the time period that you worked at 1MS
22 A SoIm talking about a recovery to 22 You started when again
23 where youreable to see and your eyes arent 23 A October of2004
24 closed or anything You still have that sunburn 24 Q So when you started working at IMSI
25 feeling 25 what brand of OC was being dispensed to
Page 55 Page 57
1 Q Okay 1 correctional officers at that time
2 A You can have it up to 24 48 hours 2 A To the best ofmy knowledge Defense
3 Q Okay 3 Technologys
4 A It gradually decreases the intensity 4 Q And was that a MK4 version of that
5 of that sunburn feeling 5 A MK4 and
6 Q And that would be like a sunburn on 6 Q MK9
7 your skin somewhere 7 A MK9 was available
8 A Yes 8 Q At some point in time did IMSI andor
9 Q So where the OC would contact the 9 the Department of Corrections change the brand c
10 skin that would be the feeling that you would 10 OC that they were using
11 have 11 A At some point yes they did
12 A Yes 12 Q Do you remember approximately when the
13 Q How about the symptoms of sneezing 13 was
14 coughing tearing how long would those typicall 14 A I believe it was shortly before we were
15 last 15 instructed
16 A Once theyr decontaminated they have 16 Q Shortly before you were instructed in
17 taken dry paper towels wiped it off and then 17 the instructor training by Security Equipment
18 used water then coughing virtually is over with 18 Corporation
19 there because theres no more sediments 19 A By Security Equipment Corporation yes
20 irritating the throat Sneezing can happen up to 20 Q So shortly before June of2007
21 an hour I would say 21 A To the best ofmy knowledge yes
22 Q All right 22 Q Okay
23 A But generally after that hour the only 23 A It could be it could be anywhere
24 experience thatIve seen people have is the 24 from six months maybe to a year prior to this





















































typical ranges of time over hich the effects of  
OC exposure see  to last with people ho have 2 
been exposed? 3 
A. It could be any here fro  -- you're 4 
talking about from a level 1 exposure? 5 
Q. Any exposure. And you can 6 
differentiate as you ish. 7 
. ure.  level 3 exposure, I've seen 8 
recovery times from immediately once they  
received fresh air to up to 30 inutes.  
Q. Okay.  
. For a full recovery. 12 
. kay. 13 
.  level 1 exposure can be -- 've  14 
anywhere from 10 minutes up to an hour.  
Q. hat is the longest time you have ever  
experienced the effects of OC following exposure 1 7 
 le  1  r i e? 18 
. ell, actually, so you're saying --  
let's back up on your previous question.  
Q. Okay.  
. So, I'm talking about a recovery to  
where you're able to see and your eyes aren't  
closed or anything. ou still have that sunburn  
feeling.  
a e  
Q. Okay.  
A. You can have it up to 24, 48 hours.  
Q. Okay.  
A. It gradually decreases, the intensity  
of that sunburn feeling.  
. nd that ould be like a sunburn on I  
your skin somewhere?  
. s.  
Q. SO, where the OC would contact the  
skin, that ould be the feeling that you ould  
ave?  
. s.  
Q. How about the symptoms of sneezing,  
coughing, tearing, how long would those typicallv14 
last?  
A. nce they're deconta inated, they have  
taken dry paper towels, wiped it off, and then 1  
used water, then coughing virtually is over with 1  
t   ere's   i  19 
irritating the throat. Sneezing can happen up to  
an hour I would say.  
Q. All right.  
A. But generally after that hour the only  
experience that I've seen people have is the 24 
sunburn feeling still there. 25 
Page 56 
. ll ri t. S , after an hour t at's 
usua ly the ly re  and that us ally oes 
a ay in 24 to 8 r ? 
. e , ro  y e . 
. ther than illie  aj r, ho is the 
s je t  t is la it, e ou are  a  
c rrectional ficer ever ing c plained  
e e iencing the fects   osure fo   
period longer than three days? 
. . 
. ave  er e    in ate 
laining f the fects  osure la ti  
for l  t a  t re  s? 
. o. 
. re      
ficer  t an ice  a r   ile   
  '     
   t  ? 
. o. 
. 'm i  t   t  l  t is . 
hat a   i e        ? 
 t rt   ain? 
.  f2004. 
. ,   t rt  r in  t I I, 
        
  
c rrecti al fficers at t at ti e? 
.      e   
Technology'S. 
.   t t  -4 i   t at? 
. -4  --
. -9? 
. -9  vail ble. 
.   i     I /o  
t  rt t f rr ti s  t  r  0 
C that they ere using? .. 
. t so e oint, es, t e  id. 
.   re e er a r i atel  e  th(l~ 
as? 
.  l  i   ortl  f   r  
i structed. 
. hortl  f r   r  i str t  i  
  t i i   ecurit  i nt 
orporation? 
.  ecurit  qui nt r oration, s. 
. O, hortl  bef  J  f 007  
.  t  b st f  l ge, s. 
. kay. 
. It coul  be -- it ul   any r  
fr  six t s a e t  a year ri r t  t is. 
. O, at so e oi t i  ti e y u switc e  
1  (P  5   7) 
Page 661 Page 681
1 maybe even a couple of incidents I cant 1 or 12 different points on it and they initial
2 Q You cantreally speak to that 2 those what happens to those sheets
3 A I cantspeak to that 3 A They should be filed along with their
4 MR LOOMIS Chris can we take just 4 training in their training file along with their
5 one second 5 written tests that they do
6 Recess held 6 Q All right Id like to switch gears
7 MR BURKE Back on the record 7 here for a moment
8 Q BY MR BURKE When you yourself hav 8 A Sure
9 instructed others in OC training have you used 9 Q and talk about Billie Jo Major
10 PowerPoint materials to do that 10 A Okay
11 A Yes 11 Q Were you personally acquainted with
12 Q And would those be consistent with the 12 from your work at IMSI
13 ones we looked through earlier today where you 13 A Not personally
14 showed me pages that you had replaced or changed 14 Q Did you know who she was
15 A Yes 15 A Yes I guess youresaying personally
16 Q Do you provide handouts at the same 16 on a personal level or professional level
17 time when you do that 17 Q Professional level
18 A Yes 18 A Professional yes To my knowledge
19 Q What kind of handouts do you provide 19 she spent most of her time on graves
20 A The actual the PowerPoint slides and 20 Q Graveyards you mean
21 then that provides themselves an opportunity to 21 A Yeah excuse me
22 write themselves little notes and they get to 22 Q Youretalking about the graveyard
23 keep those if they wish to 23 shift
24 Q So they would have for instance I 24 A Yeah the graveyard shift
25 think it was Exhibit No 35 that we looked at I 25 Q And how did you interact with her in
18 Pages 66 to 69
Page 67 Page 69
1 could be wrong on that Do you have that there 1 your work
2 somewhere Is that Exhibit No 35 2 A Well I cantbe positive or not but I
3 A Yes 3 believe that when I was the A block sergeant for
4 Q So they would be handed out somethin 4 that stint that she was she was in that unit
5 like Exhibit No 35 5 I believe so
6 A Similar There would just be the 6 Q Okay
7 actual the slide is reduced in size 7 A So as an employee I haventhad too
8 Q Okay 8 many negative runins with her but Ive hardly
9 A Probably Id say 21 by 3 9 had any positive either So she was just kind
10 Q So they would have multiple slides on 10 ofmiddle of the road I guess youdsay from m
11 one page 11 experiences with her
12 A So there would be three slides on each 12 Q And as a trainer did you have occasion
13 page with lines on the righthand side 13 to train her or participate in trainings where
14 Q And thats what they would be handed 14 she went through OC training
15 out 15 A Yes
16 A Yes 16 Q And did you train her in other aspects
17 Q And every trainee gets those 17 of the profession too in addition to OC
18 A With the classroom portion yes And 18 A Yes Im an instructor in a handful of
19 those are the ones Ive experienced is actual 19 classes that we
2 0 classroom where we sit down and me as an 20 Q What other kinds of classes did you
21 instructor we talk about the slides any 21 instruct
22 information and then answer any questions the 22 A Well I do arrest techniques or
23 students may have 23 defensive tactics Itsthe handson handson
24 Q And when the trainee signs the little 24 stuff that you apply pressure points strikes




























a be e e  a c le f i ci e ts. I can't --  
.  can't reall  s ea  t  t at?  
. I n't s  t  t t.  
. I : ris, ca  e ta e just  
 s cond?  
(Recess held.)  
. :   t  r rd.  
. (B  . ) hen you yourselfhav  
i str cte  t ers i   trai i , a e  se   
r i t t ri l  t   t t?  
. .  
.  l  t s   iste t it  t   
ones e looked through earlier today here you  
sho ed e pages that you had replaced or changed 14 
. .  
.   r i e a ts at t e sa e  
ti e hen you do that?   
. .  
. hat kind of handouts do you provide?  
.  t l, t  i t li ,   
then that provides the selves an opportunity to  
rite the selves little notes and they get to  
keep those if they ish to.  
. SO, they ould have -- f r i t e, I  
   t .     t.   
  
  fere    t    
,  s   eets? 
.    le    i  
training in their training file, along ith their 
ritte  t sts t t t  o. 
Q. All right. I'd like to switch gears 
    --
. re. 
. -- and talk about illie 10 ajor. ' 
. y. 
. r   rs ll  i t  it  he 
fr  r r  at I I? 
. t rsonally. 
. id you kno  ho she as? 
. s. I ss ou're s i  rs ll  
on a personal level or professional level? 
. r f i l l el. 
. r f i al, .   l e, 
s e s e t st f er ti e  ra es. 
. ra e ar s,  ean? 
. ea , e c se e. 
. ou're tal i  a t t e ra e ar  
hift? 
. eah, the graveyard shift. 
~-----------~~,-,-----,------+---,----



























c l  e r   t at.   a e t at t ere  
here?   t . 5?  
. .  
. O, they ould be handed out so ethin§  
like i it . 5?  
. i i r. e ld just   6 
 --   s   .  
. kay.  
. Probably I'd say 2-112 by 3.  
. SO, they ould have ultiple slides on  
one page?  
. ,     ides    
page with lines on the right-hand side.  
. nd that's hat they ould be handed  
t?  
. .  
.  r  trainee t  t e?  
. it  t e lassr  rti , s.   
t s  r  t  es I've rie ce  is t l  
 ere e        
instructor, e talk about the slides, any  
i f r ti ,  t  s r  sti s t   
students ay have.  
. nd hen the trainee signs the little  
sheets that we discussed earlier that had the 10 25 
a e 69 
r rk? 
. ell, I can't be positive or not, but I 
believe that hen I as the  block sergeant for , 
     --     it, 
 e e . 
. y. 
. , s  l , I ven't  t  
any negative run-in's ith her, but I've hardly 
had any positive either. So, she as just kind 
of iddle of the road, I guess you'd say, fro  ) 
experiences ith her. 
. nd as a trainer, did you have occasion 
to train her or participate in trainings here 
she ent through  training? 
. . 
. nd did you train her in other aspects 
f t  r fe i  t o, i  iti  t  ? 
. , 'm       
   --
. at t er in s f classes i   
truct? 
. ell, I do arrest techniques or 
i  t ti s. t's t  -o , -o  
stuff that you apply pressure points, strikes, 
kicks, apply restraints, that kind of thing. 
 (Pages   9) 
21 Pages 78 to 81
Page 78 Page 80
1 in Boise in February and in July of 2007 Did 1 particular class that Officer Major participated
2 you have any involvement in those either as a 2 in
3 participant or as an instructor 3 A Correct
4 A No 4 Q Did sometimes the two of you instruct a
5 Q And then the one that Im most 5 class together
6 interested in is the last one here which is the 6 A Yes
7 SABRERed OC Aerosol Projector Certification 7 Q Do you recall specifically whether you
8 that occurred on3of2008 8 were involved in the instruction of Officer Majo
9 A Okay 9 on or around March 3 of2008
10 Q Did you have involvement in that 10 A Im sure its possible Im sure its
11 A Possibly Possibly If not the actual 11 possible yeah And if we were to look up the
12 instruction then the coordination of the 12 description of the class
13 training And that would have been the 13 Q Yes and its on one of those the
14 PowerPoint that I made or any kind of alterations 14 description of the class which I think is
15 to the companysPowerPoint then I would have 15 Exhibit No 33 And you can see the description
16 done it 16 ofthe class there
17 Q And this particular one indicates that 17 A Reviewing document
18 the instructor is Sergeant Nick Doan Do you 18 Q Well maybe you cantMaybe its not
19 know who that is 19 on this one Yeah unfortunately 1 dontthink
20 A Yes 20 this one goes all of the way to that particular
21 Q And he actually went through the SABRE 21 class Would there be a record somewhere of the
22 training course at the same time you did didnt 22 classes that you have actually instructed and the
23 he 23 dates that you instructed them
24 A Yes 24 A Yes
25 Q And he has been an instructor at IMSI 25 Q And for instance ifyou and Sergeant
Page 79 Page 81
1 for at least some period of time since then 1 Doan had instructed a class together would it
2 A Yes 2 necessarily show both of you as being the
3 Q Ifwe look at the whole time period 3 instructors or sometimes it would
4 over which instruction is given to all of the 4 A Most likely yes
5 officers at IMSI in other words that two week 5 Q only show one ofyou
6 period thatwer talking about does one 6 A Usually you know during this time
7 instructor do all of the instructions during that 7 when I had other instructors to help me out and
8 time period or do you trade off 8 relieve me I could have them do the PowerPoint
9 A No we dont we do trade off So 9 the classroom and the written test while I was in
10 around this time I would most likely have 10 my office catching up on other work fulfilling
11 instructed other courses 11 my other duties
12 Q And in that regard did you and Officer 12 Q Are you able to tell me from your
13 Doan coordinate your instruction so that the 13 recollection what happened in this training of
14 instruction that was being given was consistent 14 March 3 of2008
15 A The exact same 15 A No nothing strikes strikes anything
16 Q So the idea is that all officers would 16 Q But you previously here today described
17 get the same instruction regardless ofwhich 17 the training process that you went through in
18 instructor gave the instruction 18 2008 is that correct
19 A Correct we try to as much as possible 19 A Im sorry What
20 Obviously everybody has their own style 20 Q Previously today in the deposition you
21 Q So in this time frame around March 3 21 previously described the training instruction
22 of 2008 you would have been giving instruction o722 that you gave to officers in 2008 correct
23 the same type of class 23 A Yes Yes
24 A Yes 24 Q Where you described the level 3
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A. No, nothing strikes, strikes anything. 
Q. But you previously here today described 
the training process that you ent through in 
;   ct? 
. I'm sorry? hat? 
. reviously today in the deposition you 
previously described the training instruction 
that you gave to officers in 2008; correct? 
. . . 
Q. here you described the level 3 
t i ti  i  t  ll. 
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1 A Yes 1 coughing and asked you whether or not they shou
2 Q And that would have been the 2 be excused from training such as this what woulc
3 instruction that took place around March of 2008 3 your response have been
4 A Im positive 4 A Id say if its something thats
5 Q And the location would have been the 5 correlated to like I mean if it could cause
6 same that you indicated 6 further damage or extend her time at light duty
7 A Exactly 7 then no Iwouldntexpect her to go through it
8 Q And all correctional officers including 8 so
9 Officer Major would have gone through that 9 Q But as you sit here today you dont
10 process as youvealready earlier described it 10 have any recall of having had a discussion
11 A Yes 11 similar to this with Officer Major
12 Q And so if Officer Major went through 12 A I mean I dont no nothing strikes
13 that instruction on March 3 of 2008 that would 13 Q And I want to make sure that I have
14 have been the instruction that she would have 14 your testimony accurately on this point because
15 received 15 its kind of important
16 A Yes 16 A Okay
17 Q Now do you recall having had a 17 Q Is it just that you dontrecall having
18 communication with Officer Major about whether or 18 had this conversation or you do recall and you
19 not she should undergo that instruction on that 19 didnthave it
20 day 20 A I I just don recall it at all
21 A No I dontNothing strikes 21 so
22 Q She has testified in her deposition 22 Q Okay
23 that she actually did communicate with you and 23 A I mean its possible that it could
24 that she advised you that she was on light duty 24 have happened sure But I mean if it was to
25 work 25 the poin where it was a safety issue then or
Page 83 Page 85
1 A Okay 1 a safety concern I believe I would recall the
2 Q by order ofphysician and that she 2 situation so
3 was currently experiencing some sort of an acute 3 Q And you dontrecall it
4 respiratory condition that had related coughing 4 A I dontrecall it
5 A Okay 5 Q Does it seem consistent with your past
6 Q And she asked you whether or not she 6 procedures that if someone was on lightduty wor
7 should go through the procedure the training 7 with an acute respiratory problem that involved
8 A Okay 8 coughing that you would tell them that they had
9 Q And you advised her Yes Do you 9 to go through the OC training
10 have any recollection of that at all 10 A Typically what would happen if they
11 A No No I mean if it was something 11 were on light duty for acute respiratory I would
12 to the point where if there was a concern I 12 think that I would be notified so
13 wouldn tell them to go through a course 13 Q And if somebody did notify you would
14 Q You would not tell them to go through a 14 you require them to go through the training
15 course 15 A No No So I mean if no if
16 A Yeah I wouldntrecommend them going 16 there was I would think that she would have
17 through it And then I would also think that 17 notified like her immediate supervisor or the
18 I mean Iwould like to see the training safety 18 shift commander or something and then a
19 waiver form and see what she put on there 19 discussion would occur and say Hey this is the
20 Q We donthave it unfortunately at 20 problem Or if there was a legitimate concern
21 least we haventbeen able to find it so far 21 there she would have brought paperwork or if
22 If hypothetically someone had come to 22 there was a legitimate concern she would have
23 you and you were advised that they were on 23 said NoIm not doing it
24 lightduty work pursuant to doctors orders and 24 And thats fine I mean I would just
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.  l  t tell t e  to go through a  
rse?  
. eah, I ouldn't reco end the  going  
through it. nd then I ould also think that --   
I ean, I ould like to see the training safety  
aiver for  and see hat she put on there.  
. e don't have it unfortunately, at  
 e ven't  e  in    r.  
If hypothetically so eone had co e to  
you and you were advised that they were on  
light-duty ork pursuant to doctor's orders and  
that they had a respiratory issue that involved  
  
a safety concern, I believe I ould recall the 
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. nd you don't recall it? 
.  on't l  . 
. es it see  c siste t it  r ast 
procedures that if so eone as on light-duty or .. 
it  a  ac te res irat r  r le  t at i l e  
coughing, that you ould tell the  that they had 
to go through the OC training? 
. ypically hat ould happen, if they 
ere on light duty for acute respiratory, I ould 
     ti ,  --
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you require the  to go through the training? 
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note it do n that this participant such and such 
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1 have handled the classroom portion of the
Page 114
Q So you could have participated in both
Page 116
1 Q If you could find in that pile Exhibit 1 Q Okay
2 No28 2 A But if they were left behind most
3 A Sure 3 of I mean I haven I dontrecall any
4
6
MR LOOMIS What is 28 4 time where they hadntbut typically we would
5
have any medical issues
THE WITNESS Its right here 5 file them We would file them in their training
6 Q BY MR OVERSON Its a set of 6 file
7 documents and I think it might have been with th 7 Q In their training file
8 other 8 A Yes
9 A Ive got it right here 9 Q Wev received others from different
10 Q Youve got it 10 trainings but not for this particular training
11 A Yes 11 Any idea why that might be
12 Q And hold up what youvegot in your 12 A I dont
13 hand
17
13 Q Have you ever done a training where you
14 A Sure Witness complied 14 didnthave them sign that form
15 Q Do you recognize that document 15 A Its possible Im sure
16 A Yes its our written test on SABRE OC 16 Q Okay
17 Q And its the test that was given and 17 A its been overlooked
18 completed by Billie Jo Major 18 Q Im sorry I kind of asked this
19 A It looks like it yes 19 question but I didntask it quite as pointedly
20 Q And she scored 100 20 as I probably should have Looking at Exhibit
21 A It looks like it yes 21 No 28 does that suggest to you then that you
22 Q And it says Instructor Signature 22 did the exposure portion of the training
23 CODoan 23 A It doesn suggest that no
24 A Correct 24 Q It doesn
25 Q Does that indicate to you that Doan may 25 A N
Page 115 Page 117
1
2 instruction 2 halves of the training
3 A Most likely yes 3 A I could have yeah
4 Q This email we talked earlier about 4 Q The form that we were just talking
5 You talked about a form that the student would 5 about where they sign off you know attesting
sign saying that they were attesting they didnt 6 that they donthave any medical issues what
7 7 kind of medical issues are you asking them to
8 A Mmhmm 8 advise you of
9 Q Thats a Yes 9 A Anything that they feel would be
10 A Yes 10 related that could be a safety issue
11 Q Would that have been something that 11 Q Such as
12 would have been included in the test or would 12 A Well like OC would be if they have
13 have been something done later 13 an allergic reaction to peppers any medical
14 A No at the beginning of the course we 14 conditions that have to do with you know the
15 have them sign it and then at the end of the 15 airway system
16 course typically what we would do is have them 16 Q Some people are allergic to OC spray
leave their written tests graded and then the 17 A Very minute
18 safety waiver form as they leave 18 Q A small portion
19 Q And you would make sure that as those 19 A A small portion of the population
20 tests were picked up and waiver forms were picke 2 0 Q What happens with them if you know
21 up that both of those were left behind for each 21 A I dontknow to be exact so
22 student 22 allergic reaction typical allergic reaction
23 A Id say its possible that we didnt 23 Q Have you seen that before
24 collect 100 percent of them before they go out 24 A I have not seen that
2S the door 125 Q Do you tell them in your instruction
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1 weapon on somebody that was role playing as an 1 attended that with you
2 offender with a weapon 2 A Yes
3 Q Then did you go through a decontaminatio 1 3 Q Was Sergeant Overgaard one of those
4 procedure 4 A Yes
5 A Yes we did 5 Q Any others
6 Q And describe that for me please 6 A The ones that I can remember was
7 A Decontamination after the series of 7 Sergeant Sidwell Sergeant White Officer Earl
8 events was over was we would go to a hose where 8 and those are the only ones that I can recall
9 we would apply copious amounts of cool running 9 Q So describe that training for me
10 water to our face 10 A That training also had various other
11 Q Where did that SABRE Red training take 11 components to it It had OC less lethal impact
12 place 12 munitions sound sight distractionary devices
13 A It happened at the Meridian POST 13 and chemical munitions
14 Academy 14 Q Letstalk about just the OC portion of
15 Q And how long did that training take 15 it What happened there
16 A It was one day 16 A OC it was similar to all of the other
17 Q And at the end of that day you received 17 types of training I believe it actually used a
18 your certification 18 Def Tech type PowerPoint where it went over
19 A I dontrecall if we received the 19 proper deployment psychological and physical
20 certification that day or if it was mailed to us 20 effects and also they had an exposure component
21 afterwards 21 to it at the very end
22 Q Is Exhibit No 45 the actual 22 Q What was the exposure like there
23 certification 23 A The exposure was 1 wasnt1
24 A Yes it is 24 didntreceive an exposure
25 Q Then you mentioned a third train 2 Q And why was that
Page 19 Page 21
1 that you had as an instructor ofOC When was 1 A At that training it was given a choice
2 that 2 if where ifyou had already received an
3 A I cantrecall the exact date 3 exposure before then you could opt whether or
4 Q Do you remember the year 4 not to be exposed again or not
5 A I believe it was last year in 2009 5 Q And you opted out
6 or sorry 6 A Correct
7 Q 2010 7 Q Do you see some benefit or advantage of
8 A I believe it was 2010 yes 8 instructors going through a training program such
9 Q Where did that take place 9 as this for OC and actually receiving exposure
10 A That took place at the Meridian POST 10 A Yes
11 Academy as well 11 Q And what benefits do you think that
12 Q And who presented that training 12 serves
13 A TheNational Tactical Officers 13 A The benefit is it gives credibility
14 Association 14 While instructing we expose officers to it And
15 Q And what is that association 15 so having said that we have experienced it and
16 A That association is a group of 16 we know the effects and how it affects others as
17 individuals that compile information and put on 17 well as ourselves it also enables us to show
18 training classes for different various law 18 other officers that you can work through it and
19 enforcement agencies to try to spread knowledge 19 that yes there is pain but you can still
20 and equipment techniques and that type of thing 20 function
21 Q Is either association associated with 21 Q Do you remember which OC products wer
22 any particular manufacturers of OC products 22 used in that training
23 A Not that I believe I dontknow 23 A I dontrecall
24 Q In that particular training were there 24 Q Now since you received your first
25 others from the Department of Corrections who 2 5 training with Defense Technology in 2007 have
6 Pages 18 to 21
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1 you on occasion instructed other correctional 1 Q And you were the one who had to ask the
2 officers in OC training 2 questions
3 A Yes 3 A Correct
4 Q And have you done that on an annual 4 Q And then once the correctional officer
5 basis 5 trainee left the cell then they would go on to a
6 A Yes 6 different part of the facility and you would work
7 Q Since 2007 7 with the next trainee
8 A Yes 8 A Correct
9 Q While you were at IMSI and you did OC 9 Q And did you work with Sergeant
10 training did you actually do the training the 10 Overgaard in that 2008 training
11 annual trainings for the years 2007 and 2008 11 A I did
12 A I believe I was an assistant 12 Q Did you also work with him in 2007
13 Q In both of those trainings 13 A I did
14 A Yes 14 Q Approximately how many staff
15 Q And were the protocols and procedures 15 correctional officers do you think you have
16 that you followed in those trainings similar for 16 trained since you started doing these trainings
17 each of those years 17 for OC in 2007
18 A Yes 18 A Probably over 500
19 Q Were there any variations that you can 19 Q And while you worked at IMSI did you
20 think of 20 also have experience where you were exposed to O
21 A The only variation I can think of was 21 outside of the training context
22 the exposure component 22 A Yes
23 Q I think Ive heard this before but Id 23 Q Either deploying it yourself or being
24 like to get your explanation ofwhat you recall 24 in the vicinity when it had been deployed
25 the diffebeing 25 A Yes
Page 23 Page 25
1 A I believe the first time the exposure 1 Q Can you give me some idea about the
2 component would be that we would fill a hallwaX 2 frequency of which you may have been exposed t
3 with OC and have particulates in the air and then 3 OC at IMSI outside of the training context
4 we would line all of the officers up at one door j 4 A Myself it wasn a high percentage of
5 and have them walk slowly to another door and 5 exposure
6 then return afterwards 6 Q Can you break it down to once a week
7 Q And that was the first one in 2007 7 Once a month Twice a month I mean is there
8 A Correct 8 any range that you can give me that might be
9 Q And then how was it different in terms 9 credible
10 of exposure in 2008 10 A Well on graveyards I was probably
11 A I believe in 2008 we would take an 11 exposed maybe once a month
12 individual officer in to a cell expose that 12 Q Can you tell me approximately how many
13 officer to particulates make them walk around 13 times you have actually deployed OC with respec
14 the cell and then proceed to ask them questions 14 to an inmate or an inmate situation outside of a
15 Q And then after they left the cell did 15 training session
16 they then have to do some exercises like some 16 A Once
17 knee kicks and that sort of thing 17 Q All right Based upon your personal
18 A Not that I recall 18 experience in being exposed to OC as well as you
19 Q You dontrecall that 19 observations of others who have gone through the
20 A Witness shaking head 20 training programs on OC what do you perceive a
21 Q As you went through the 2008 OC 21 being the effects ofOC upon humans
22 training process as an instructor was it part of 22 A The effects ofOC can range from
23 your responsibility to be the person at the door 23 inflammation of the skin a burning sensation
24 of the cell that was contaminated with OC 24 such as a really bad sunburn Youllhave





















































you on occasion instructed other correctional 1 
officers in OC trai i ? 2 
. e . 3 
. nd have you done that on an annual 4 
ba i ?  
. es.  
. ince 2 7 I ~ 
. es. ' 
Q. hile you were at I SI and you did OC 9 
training, did you actually do the training, the  
annual trainings, for the years 2007 and 2008? 11 
. I elieve I as a  a t.  
. In th f t ose trai i s?  
. e .  
. nd ere the protocols and procedures  
that you followed in those trainings si ilar for  
each of those years?  7 
. . I  
. ere t ere a  ariations t at  can  
t in  f?  
. he only variation I can think f as 21 
the exposure component.  
Q. I think I've heard this before, but I'd  
like to get your explanation of what you recall 24 
the difference being. 25 
  
. I believe the first ti e the exposure  
component would be that we would fill a hallwa' 2 
with OC and have particulates in the air and thenl 3 
we would line all of the officers up at one door I 4 
a  a e t e  al  sl l  t  a t er r a  I'  
  .  
. nd that as the first one in 2007?  
. rr ct.  
Q. And then how was it different in terms  
of exposure in 2008?  
. I li  i    l  t    
individual officer in to a cell, expose that  
officer to particulates, make them walk around  
the cell, and then proceed to ask the  questions. 14 
Q. And then after they left the cell, did  
they then have to do some exercises like some  
knee kicks and that sort of thing?   
.  t  call.  
Q . You don't recall that?  
A. (Witness shaking head.)  
Q. As you went through the 2008 OC  
training process as an instructor, was it part of  
your responsibility to be the person at the door 3 
f t  cell t t  t i t  it  C?  
. s.  
Page 24 
Q. And o  ere the ne ho had to as  the 
qu ? 
A. orrect. 
. nd then nce the re ti l fficer 
trainee left the ll, then the  ould go n to  
i ferent part f t  fa ilit  a  ou ould or  
ith the next trainee? 
. orrect. 
. nd d ou r  ith ea t 
ergaard in t t 8 tr i i ? 
. I d . 
. id   ork ith  i  77 
. I i . 
. pproximately    
 ficers   t ink ou e 
ne   o   ing t ese tra ings 
f r  in 77 
.   . 
.  il   r e  t I I, i   
ls  a e rie ce ere  er  s  t  C 
tside    t xt? 
. . 
. ther  t    
i  t  icinity  it  e  l yed? I; 
. . 
  
.   i  e  i  t t  
fre   ic       t 
 t  t i   t  t i i  ntext? 
. elf, it sn't  i  ta e  
ure. 
.    it  t    ek? 
  nth?   onth? T an,   
any range that you can give e that ight be 
dible? 
. ell,  r r  I  r l  
exposed aybe once a onth. 
.   t ll  pproxi t l    
ti e    ct all  l   it  r  
t   i    i  i ti  t i  f a 
tr i i  session? 
. ce. 
. ll ri ht. ase   r ers al 
e erie ce i  ei  ex se  t   as ell as  
r ti  f     t r  t  i 
training progra s on C, hat do you perceive a~ 
i  t  eff t  f  up  u ans? 
.  eff t  f  c  r  f  
i fl ti  f t  skin, a r i  sensation 
suc  as a really ba  sunburn. ou'll have 
lacri ation, hich is your tear ducts ill start 
7 (P   t  25) 
8 Pages 26 to 29
Page 26 Page 28
1 running Youllalso have whatscalled 1 Q And was that a fog or a stream
2 rhinorrhea where your mucous membranes will start 2 A A fog
3 going and so mucus will start Depending on the 3 Q And do you recall how many times you
4 type of exposure that you receive it could have 4 sprayed the fog before you allowed somebod to
5 it could cause sneezing coughing It will 5 in
6 restrict your airway slightly 6 A Each time I would spray at least once
7 Q Now we have heard over the course of 7 or twice in the cell
8 the last couple of days that there are various 8 Q And so let me get that straight
9 types of OC products For instance there are 9 Before each individual went into the cell you
10 streams there are foams and there are fogs or 10 resprayed the cell
11 cones Are you familiar with each ofthose 11 A Depending on how many particulates wer
12 types 12 in the air in that cell yes I would either add
13 A Yes 13 more or not
14 Q And when you said depending upon the 14 Q Can you see that If the particulates
15 type you might get some sneezing or coughing 15 are in the air can you see it
16 which types are you talking about that would be 16 A You cantreally see the particulates
17 most likely to cause that reaction 17 due to the size
18 A Most likely it would be a fog or a 18 Q So how do you when you said you
19 cone 19 could see it I guess I misunderstood what you
20 Q A fog and a cone are the same thing 20 were talking about
21 arentthey 21 A You can tell just from the reaction of
22 A Yes 22 the officer previous and then just by smelling
23 Q And is that because the particles of 23 myself
24 the fog or the cone kind of hang in the air like 24 Q And so ifyou thought it needed more
25 a mist 25 then you would spray it again
Page 27 Page 29
1 A Correct 1 A Correct
2 Q Now do you recall when you did the 2 Q Did you necessarily have to spray it
3 training in 2007 which is the one involving 3 before each individual officer walked in
4 the hallway right 4 A No
5 A Yes 5 Q Sometimes you could go more than one
6 Q Do you recall what brand of OC you used 6 time
7 for that training 7 A Yes
8 A SABRE Red 8 Q It just depends on whether you still
9 Q And do you recall whether that was a 9 had the reaction you were hoping for
10 stream or a fog orwhat 10 A Correct
11 A It was a fog 11 Q And if somebody went in and didnt
12 Q And do you recall how much of the OC 12 really feel enough of the effects then there
13 was actually deployed in the hallway before 13 probably wasntenough in there is that what
14 officers were marched through it 14 youresaying
15 A I do not know 15 A Correct
16 Q And then in 2008 when you did the cell 16 Q Now based again upon your experience
17 type exposure was the OC then deployed inside 17 from your own exposures and your observations of
18 the cell alone 18 others who have been exposed about how long doe s
19 A Correct 19 it customarily take before the effects of the OC
20 Q And who did that exposure Who 20 exposure wear off
21 deployed it 21 A About half an hour
22 A I did 22 Q Have you ever heard anybody complain of
23 Q And do you recall what you used for the 23 having the effects of OC exposure last for
24 deployment 24 greater than three days





















































running. You'll also have what's called 1 
rhinorrhea where your mucous membranes ill st r 2 
going and so ucus will start. epending on the 3 
type of exposure that you receive it could have, 4 
it could cause sneezing, coughing. It will 5 
restrict your airway slightly.  
. , we have heard over the course of 7 
the last couple of days that there are various  
types of C products. For instance, there are  
streams, there are foams, and there are fogs or  
cones. Are you fa iliar with each of those  
types?  
. e .  
. nd he  ou said e e i  on t e  
type you ight get so e sneezing or coughing,  
which types are you talking about that would be  
most likely to cause that reaction?  7 
A. ost likely it would be a fog or a  
.  
.  fog and a cone are the sa e thing;  
aren't they?  
. .  
. nd is that because the particles of  
the fog or the cone kind of hang in the air like  
 ist?  
  
. rrect.  
. o , do you recall hen you did the  
training in 2007 -- which is the one involving  
the hallway; right?  
. .  
Q. Do you recall what brand of OC you used 6 
for that training?  
.  .  
Q. And do you recall whether that was a  
stream or a fog or what?  
. It as a fog.  
Q. And do you recall how much of the OC 12 
was actually deployed in the hallway before  
officers were marched through it? 1  
. I  t ow.  
Q. And then in 2008 when you did the cell  
type exposure, was the OC then deployed inside 17 
t e cell alone?  
. orrect.  
Q. And who did that exposure? Who 0 
deployed it?  
. I id. 2 
Q. And do you recall what you used for the 2  
deployment?  
.  S   - . 5 
. nd was that a fog r a s ? 
A.  f . 
age 28 
. nd o ou re l  a  times ou 
s rayed the fog before o  llo ed s y to 0 
i ? 
. a  ti e I ould ra  t east once 
or twice i  the cell. 
. nd s , let e  that s . 
efore e  individual e t into the c ll, ou 
res ra e  the l ? 
. e ing  o   particulates rt: •. 
in the ir in that ll, ,  l  it e   
re r t. 
. an  e t t? f the rticulates 
re i  t  ,   e ? 
. o  n't l  e t e iculates 
e t  t e . 
. O,    --     
ld  ,    s  t  
ere in  . 
. ou   just r     
t e fficer re i s a  t e  j st  s elli  
yself. 
.  so, if  t t it ee e  re, 
t en  l  s ra  it again? 
 9 
. ct. 
. i   saril   t   it 
  i i i l ic  l  i ? 
. o. 
. ti   l    t   
e? 
. . 
. It just depends on hether you still 
 t  r ti   r  i  f r? 
. rrect. 
.  if s e  e t i  a  idn't 
r ll  f l  f t  ff ts, t  t r  
r l  sn't  i  t re; is t t t 
ou're saying? 
. or ect. 
. w, s  gai   r ri  
fro  your own exposures and your observations of 
t rs    x sed, bo t  l   s 
i  sto aril  t  f  t  f  f t   .. 
e s re ear off? 
. t half an hour. 
. ave you ever heard anybody co plain of 
vi  t  eff t  f  ex r  l t f r 
greater than three days? 
. o. 
8 (Pa  2  t  29) 
11 Pages 38 to 41
Page 38 Page 40
1 that he performed of Officer Major while he was 1 about or are you thinking about something
2 at the womensprison And its your 2 different
3 recollection that he actually worked with you for 3 A Ive only taught once with Sergeant
4 this particular training on March 3rd of2008 4 Schaffer at South Boise Women
5 A Correct 5 Q What Im telling you is this training
6 Q Do you remember about how many officer 3 6 that Major went through did not occur at South
7 went through the training on that particular day 7 Boise Womensit occurred at IMSI
8 along with Officer Major 8 A Okay
9 A I cantrecall an exact number 9 Q And so thatswhy Im a little bit
10 Q Wev heard testimony that the number 10 confused Are you positive as you sit here toda
11 ofofficers who went through those trainings you 11 that the training of March 3rd of 2008 actually
12 know varied somewhere between 7 or 8 up to 15 12 took place at the womensfacility or did it take
13 per each session Does that sound about right 13 place at IMSI
14 A That sounds about right 14 A I do not recall exactly
15 Q And you couldntdo them all in the 15 Q Regardless of where it took place do
16 same day obviously Theresjust too many of 16 you recall the actual training where Officer
17 them 17 Major was involved
18 A Correct 18 A Not in 2008 no
19 Q So your time period over which you did 19 Q Do you recall any training where
20 these trainings could last a couple ofweeks 20 Officer Major was involved
21 A For OC no 21 A No
22 Q How long would they usually last 22 Q In 2008 you did do a training at IMSI
23 A For a facility such as the women 23 is that right
24 its a smaller facility 24 A Correct
25 Q I mean just at IMSI Werejust 25 Q And that was the one that you described
Page 39 Page 41
1 talking about 1 for me where the exposure was inside a cell as
2 A Yes a couple of weeks 2 opposed to the hallway
3 Q A couple ofweeks for IMSI 3 A Correct
4 A Yes 4 Q And that was conducted with Officer
5 Q Now this training that occurred on 5 Overgaard
6 March 3rd of 2008 was that at IMSI 6 A Sergeant Overgaard
7 A No 7 Q Sergeant Overgaard Do you know what
8 Q Are you sure about that 8 time of the year that training took place
9 A To the best ofmy recollection it was 9 A I cantrecall
10 held at SBWCC South Boise WomensCorrection 110 Q Could it have been in March of 2008
11 Center 11 A It could have
12 Q Now we know that Officer Major was 12 Q Do you recall having had any discussion
13 employed at IMSI on that date March 3rd of 2008 13 with Officer Major about the fact that she was
14 and had been since September of 2007 And so I 14 placed on light duty by her doctorsorders
15 guess Im kind of curious of why there would have 15 because she was experiencing an acute upper
16 been a training over at the womens facility of 16 respiratory system illness that also involved
17 maximum security correctional officers 17 coughing and the discussion continued as to
18 A I dontrecall Officer Major at the 18 whether or not it would be appropriate for her to
19 South Boise WomensCorrectional training 19 go through the OC training in 2008
20 Q I want to make surewer talking about 20 A I dontrecall having any conversation
21 the same thing Im talking about the training 21 with Officer Major about it
22 of March 3rd of 2008 the very last one thats on 22 Q As part of the training process when
23 here 23 you are the instructor and youretraining an OC
24 A Okay 24 class do you go over some procedures in advanc





















































that he perfor ed of fficer ajor hile he as 1 
 t e n's s . nd i 's  2 
 that e l  orked t     
this artic lar training  arc  r  f 08?  
. ct.  
. o you re e ber about ho  any officer~ 6 
ent through the training on that particular day 7 
along ith fficer ajor? 8 
.  n't    r.  
. e've heard testi ony that the nu ber  
of officers ho ent through those trainings, you 11 
kno , varied so e here bet een 7 or 8 up to 15 12 
per each session. oes that sound about right? 13 
. at s s a t ri t.  
. nd you couldn't do the  all in the  
sa e day obviously. here's just too any of  
.  
. ct.  
. SO, your ti e period over hich you did  
t s  tr i i s l  last  le f ks?  
. r , .  
. o  long ould they usually last?  
. For a facility such as the o en's,  
it's a s aller facility.  
. I ean just at I SI. e're just  
talking about --
A. Yes, a couple of weeks. 
Q.  couple of eeks for I SI? 






. , t is trai i  t at cc rre    
arc  r  f , as t at at I I?  
. .  
Q. Are you sure about that?  
A. To the best of y recollection, it was  
held at , outh oise o en's orrectiom 110 
.  
. o , e kno  that fficer ajor as  
e l e  at I I  t at ate, arc  r  f2008,  
and had been since Septe ber of2007. And so, I  
guess I'm kind of curious of why there would have 15 
been a training over at the o en's facility f  
axi u  security correctional officers.   
. I don't recall fficer ajor at the  
outh oise o en's orrectional training.  
. I ant to ake sure e're talking about  
the sa e thing. I'm talking about the training  
of arch 3rd of2008, the very last one that's on  
r .  
A. Okay.  
Q. Is that the one you've been talking 25 
  
t    t i i  t t i  
iff r nt? 
. 've    t  t 
f    ise en's. 
. hat I'm telling you is this training 
that ajor ent through did not occur at South 
ise omen's, t   I. 
. . 
Ii 
. nd so, that's hy I'm a little bit 
d. re  iti e   it  t a 
that the training f arch 3rd f 2008 actually 
took place at the o en's facility or did it t ke, 
lace at I I? 
.    l  ctl . 
. e ar less f ere it t  lace,  
 recall t e act al trai i  ere fficer 
ajor as involved? 
.   , . 
.   ll  t i i   
ice  j   i l d? 
. . 
. In 2008 you did do a training at I SI; 
i  t t i t? 
. ct. 
.  t t  t e  t t  ribed, 
  
f r e r  t  s r  s i si   ll s 
s  t  t  ll ay? 
. t. 
.  t t s t  it  ffi r 
r aard? 
. r t r ard. 
. er ea t ergaard?    at. 
ti e of the year that training took place? 
.  an't al . 
. l  it   i  r  f2008? 
.   . 
Q. Do you recall having had any discussion 
it  ffic r j r t t  f t t t s  s 
placed on light duty by her doctor's orders 
eca se s e as e erie ci  a  ac te er 
respiratory syste  illness that also involved 
coughing, and the discussion continued as to 
hether or not it ould be appropriate for her to 
go through the OC training in 2008? 
.  on't l    r ti  
ith fficer ajor about it. 
. s part of the training process hen 
you are the instructor and you're training an C 
class, do you go over so e procedures in advanc ~ 
f exposure to  herein you discuss ith the 
 (Page    1) 
12 Pages 42 to 45
Page 42 Page 44
1 trainees whether they have any conditions or 1 Q Has there ever been a circumstance
2 circumstances that might make it appropriate that 2 where somebody has indicated to you that for
3 they not go through the training 3 whatever illness or allergy considerations that
4 A Yes 4 were going on at the time they did not feel like
5 Q And do you usually have them fill out a 5 they should go through the exposure on a
6 form and make some initials on it 6 particular date
7 A Usually Its a waiver yes 7 A Not that I can recall
8 Q Im going to show you a copy of a 8 Q And ifsomeone had come to you and said
9 waiver thats unfortunately not for this 9 hypothetically that Im on light duty work
10 particular training its for a different one 10 Ive got a bronchial illness Ive been coughing
11 but to see if it was like the one in question 11 and wonder whether or not it would be appropriat
12 MR BURKE And does somebody have a 12 to go through the training how would you
13 recall ofwhat number that is 13 respond
14 MR LOOMIS I think its part ofthe 14 A We would not allow them to go through
15 packet in 31 1 believe Maybe Imwrong on 15 the training due to being on light duty and under
16 that 16 doctors orders
17 MR BURKE I think youreright 1 17 Q So ifyou actually knew that somebody
18 think its the last page 18 was on light duty and under doctorsorders you
19 MR LOOMIS Thats right thats 19 would not allow them to go through the training
20 right Here you go handing 20 A Correct
21 Q BY MR BURKE Werehanding you th 21 Q And they wouldn be penalized or
22 last two pages of Exhibit No 31 Do you 22 disciplined for not going through the training at
23 recognize that form 23 that time would they
24 A Yes 24 A No
25 Q And is that the kind of form that yo 25 Q Do you see any benefit in having staff
Page 43 Page 45
1 were talking about that you would have trainees 1 correctional officers go through OC training on
2 review and fill out and initial before they got 2 an annual basis where they actually receive the
3 exposed to OC 3 exposure to OC
4 A Yes 4 A Yes
5 Q Does it appear to be identical to the 5 Q And are the benefits similar to those
6 form that you would have used in 2007 and 2008 6 you previously described for you going through i
7 A Similar yes 7 as an instructor
8 Q And as part of your process do you go 8 A Yes
9 over each one of those 10 items or do you just 9 Q And it would be beneficial for them to
10 ask them to review them and initial them 10 have the experience of that exposure in terms of
11 A We ask them to review it and then 11 dealing with fears and anxiety about it in case
12 initial it 12 they were ever exposed to it in the future
13 Q Item No 9 it talks about you know 13 A Yes
14 whether anyone has honestly and without 14 Q And it wouldhelp them manage that if
15 malicious intent reported any present past or 15 they had exposure in connection with an inmate
16 current personal injury or illness which may 16 A Yes
17 prohibit participating in this course 17 Q When you conducted the training for OC
18 Is that something that you discuss with 18 at IMSI in 2008 with Sergeant Overgaard and yo
19 them at the time of the training 19 went through the cell exposure process
20 A Yes 20 approximately how much time was spent by the
21 Q And what do you understand the purpose 21 trainees inside the actual cell before they were
22 of that to be 22 released from the cell
23 A For liability reasons if they have any 23 A 30 seconds to a minute
24 preexisting conditions such as an allergy to 24 Q And during that time you were standing
25 neoners 125 outside the door is that right
000722
Page 42 
1 trainees hether they have any conditions or 
2 circumstances that ight ake it appropriate that 
3 they not go through the training? 
4 . es. 
5 Q. And do you usually have them fill out a 
6 for  and ake s e initials on i ? 
7 . Usually. It's a aiver, yes. 
8 . I'm going to sho  you a copy of a 
9 ai er t at's fortunatel  t for t is 
 particular training, it's for a different one, 
 but to see if it was like the one in question. 
2 . : nd does s e dy a e  
3 re l  hat ber that i ? 
4 . I : I think it's part f the 
 packet in 31, I believe. Maybe I'm wrong on 
 t t. 
 R. BURKE: I think you're right. I 
 think it's the last page. 
 . I : hat's right, that's 
 right. Here you go (handing.) 
 Q. (BY R. BURKE) e're handing you thl 
 last two pages of Exhibit No. 31. Do you 
 recognize that form? 
 . . 
 Q. And is that the kind of for  that you 
age 43 
 ere talking about that you ould have trainees 
 revie  and fill out and initial before they got 
 exposed to OC? 
 . s. 
 . oes it appear to be identical to the 
 for  that you ould have used in 2007 and 2008 
 A. Similar, yes. 
 Q. And as part of your process, do you go 
 over each one of those 10 ite s or do you just 
 as  t e  t  re ie  t e  a  i itial t em? 
 .         
  t. 
 Q. Item No.9, it talks about, you know, 
 whether anyone has "honestly and without 
 malicious intent reported any present, past, or 
 current personal injury or illness which may 
 prohibit participating in this course." 
 Is that something that you discuss with 
 the  at the ti e f the training? 
 . s. 
 Q. And what do you understand the purpose 
 f t t t  e? 
 A. For liability reasons, if they have any 





















































. as there ever been a circumstance 
here s e ody has indicated to you that for 
hatever i lness r a lergy c siderations that 
ere going n at the ti e the  id not fe l like 
they should go through the exposure on a 
ticular te? 
.  that I a  r ll. 
. nd if s eone ad co e to ou  s id 
 t , "I'm n light-dut  . 
I've ot a  i lnes . I've ee   
d onder et e   t it ould e a riat 
to go through the training," ho  ould you I;, 
r s nd? 
. e ld t lo  t e  to o t r  
the n      light t   er 
tor's r rs. 
. O,   l  e    
as  light t  a  er ctor's r ers,  
o ld        i ing? 
. t. 
.   l n't e   
ine       ing  
that ti e; ould they? 
. . 
. o you see any benefit in having staff 
"""""'~-~ 
 5 
 icers      
     t l    
s re t  ? 
. . 
.  are t e e efits si ilar t  t se 
 r i sl  s ri  f r  i  t r  i 
  tructor? 
. s. 
.  it l   fi i l f r t  t  
a e t e e erie ce f t at e s re i  ter s f 
eali  it  fears a  a xiet  a t it i  case 
t e  ere e er e se  t  it i  t e f ture? 
. s. 
. nd it ould 'help the  anage that if 
t   ex r  i  ti  it   i ate? 
. s. 
. hen you conducted the training for  
at I I i   i  r  r    ~ 
t t r  t  ll r  r s, 
approxi t l    ti   spent by t  
tr i  i i  t  act al cel  f  t  r  
r l  fr  t  cell? 
.  seconds t  a inute. 
. nd during that ti e you ere standing 
o t i  t  oor; i  t at right? 
12 (Pa  4  t  5) 
13 Pages 46 to 49
Page 46 Page 48
1 A Correct 1 A They would go get decontaminated
2 Q And what did you do in connection with 2 Q How would they get there
3 their involvement in the interior ofthe cell 3 A They had partners and usually the
4 A I observed their reaction and then 1 4 partner would help them lead them down the
5 proceeded to ask them a series of questions 5 hallway to get decontaminated
6 Q And what kind of questions did you ask 6 Q And ifyou had a group letsjust say
7 them 7 for example 10 people each one of those would b
8 A Basic questions such as What is your 8 paired up with a partner is that right
9 name What is your employee number Do you have 9 A Correct
10 any pets Pet names 10 Q So you had five groups of partners
11 Q And whats the purpose of that 11 A Correct
12 A To be able to show them that they can 12 Q Would you run partner A and partner B
13 work through the physiological effects of OC and 13 through the cell consecutively or would you run a
14 still function 14 whole group of partners through once and then thi
15 Q Was the door closed when they were 15 second group of partners through the second time
16 inside 16 A The latter
17 A Yes 17 Q So there wouldn be backtoback
18 Q Did the door have a window or 18 exposure of one partner and then the next
19 observation port so you could look inside 19 partner
20 A Yes 20 A Correct
21 Q Were you personally wearing a mask 21 Q What kind of decontamination was used
22 A Yes 22 for the officers who went through that training
23 Q And the reason for that is what 23 in 2008
24 A Due to the amount of exposures and the 24 A Copious amounts of cool running water
25 amount of OC that I was introducing to the cell 25 and paper towels
Page 47 Page 49
1 for the number of people to be able to actively 1 Q And where was the water obtained
2 be able to speak myself I wore the mask 2 A The water was obtained by a hose I
3 Q And you had to go in and out of the 3 believe
4 cell repeatedly during the course of the 4 Q Where was the hose
5 training 5 A The hose was outside Either that or
6 A Correct 6 they went to the bathroom where the sink was
7 Q And you were the one that did the 7 Q Was there a janitorscloset in the
8 deployment of the OC 8 vicinity
9 A Correct 9 A There was a janitors closet
10 Q Did they have to perform anything 10 Q Did that have a sink
11 inside the cell other than just answer your 11 A I believe it had a floor sink yes
12 questions 12 Q Was that used in connection with the
13 A They had to walk around the cell twice 13 decontamination
14 Q Were there any mats on the floor 14 A I cantrecall
15 A There were rubber mats 15 Q Do you remember any of the officers wh
16 Q Did they have to walk around those 16 you actually trained in 2008 Well
17 mats 17 theoretically you would have trained all of them
18 A Either around or on 18 right
19 Q And do they have to walk around the 19 A Correct
20 mats twice before they could actually respond t 20 Q And Im not going to sit here and have
21 questions or were they responding to questions 21 you tell me who every one of them are I dont
22 during the whole time they were walking 22 think that would be reasonable
23 A Both 23 Did you have occasion then to observe
24 Q And once you let them out of the cell 24 the exposure reaction by those trainees in 2008





















































. Corre . 1 
. And what did you do in connection ith 2 
their involvement in the interior f the c l ? 3 
. I observed their rea tion a  then I 4 
proceeded to ask them a series of questions. 5 
Q. And what kind of questions did you ask 6 
ili~? 7 
. Basic questions such as, "What is your 8 
na e? hat is your e ployee nu ber? o you have  
any pets?" Pet na e .  
Q. nd hat's the purpose ofthat?  
.  be a le t  s  the  that they ca   
work through the physiological effects of OC and  
s l fu .  
Q. as the door closed when they were  
i i e?  
. .  
. id the door have a indo  or  
observation port so you could look inside?  
. .  
Q. ere you personally wearing a ask?  
. .  
Q. And the reason for that is what?  
. ue to the a ount of exposures and the  
a ount of  that I as introducing to the cell  
a e  
for the nu ber of people, to be able to actively  
be able to speak myself, I wore the mask.  
Q. nd you had to go in and out of the  
cell repeatedly during the course of the  
training?  
. t.  
. nd you ere the one that did the  
deployment of the OC?  
. rr ct.  
Q. Did they have to perform anything  
inside the cell other than just ans er your  
questions?  
A. They had to walk around the cell twice.  
Q. ere there any mats on the floor?  
.    ts.  
Q. Did they have to walk around those  
ats?  
. i r r   n.  
Q. And do they have to walk around the  
ats twice before they could actually respond tc 20 
questions, or were they responding to questions 21 
during the whole time they were walking?  
. th. 23 
Q. And once you let them out of the cell, 24 
what happened to them next? 25 
Page 4  
A. They ould go et de t i t . 
Q. How ould they get th ? 
A. hey had partners d s y the 
partner ould help the , lead the  n the 
hallway to et de ta inate . 
. nd if you ad  , l t's just say 
for le  l , h one f those o ld  
paired up ith  r; is that r t? 
. rr t. 
. SO, ou had ive roups f rs? 
. t. 
. ould  ru  t e    t   
t rough t e ll ti l   l     " 
hole r   rtners t rough ce  t e  t € . 
s d roup  t ers r    ti  
.  l tt r. 
. O,  l n't e -to-bac  
e s re f e art er a  t e  t e e t 
t er? 
. orrect. 
. t ind  t i tion   
 t e ficers  t t  t t t i i  
 8? 
. i s ts  l i  t  
  t l . 
 9 
.      t i ed? 
.       e,  
li e. 
.    se? 
.    tside. it r t t r 
t e  e t t  t e at r  ere t e si  as. 
.  t   j nitor's l t i  t  
vicinity? 
.    j nitor's l et. 
. i  t t   ink? 
.  li  it   fl  ink, s. 
.  t t  i  ti  it  t  
contamination? 
.  an't recall. 
. o you re e ber any of the officers hc 
you actually trained in 2008? ell, 
t reti ll   l   tr i  all f t em; 
right? 
. orrect. 
.  I'm t goi  t  sit   hav  
y  t ll   v r  o  of t  are. I don't 
t i k t t ould  r asonable. 
id you have occasion, then, to observe 
the exposure reaction by those trainees in 2008 
as t y t t r  t  cell and l ft t  cell? 
1  (Pa  4  t  9) 
14 Pages 50 to 53
Page 50 Page 52
1 A Can you explain the question again 1 A I dontrecall whether or not for OC or
2 Q Did you observe their reaction to the 2 for use of force or chemical munitions
3 OC how it affected them 3 Q It could have been one or the other of
4 A Yes 4 those three
5 Q And what observations did you make 5 A Correct I cotaught with Sergeant
6 about that 6 Overgaard and we switched off
7 A Coughing crying sneezing a lot of 7 Q But were there occasions in 2008 where
8 mucus 8 you may have taken a classroom instruction on OC
9 Q Did you observe anybody react in a 9 A Yes
10 manner that was extraordinary in other words 10 Q How did you instruct In other words
11 out of what you normally see and expect with al 111 what material did you provide If there was a
12 of the other trainees that go through the 12 DVDor a PowerPoint involved tell me about that
13 program 13 A There was a SABRE Red PowerPoint that
14 A I can remember one 14 we use to instruct
15 Q And was that in 2008 15 Q And this is one that you received
16 A Yes 16 during your SABRE Red instructor training
17 Q What do you remember about that 17 A Correct
18 A The officer began to panic and started 18 Q And I have heard from Sergeant
19 to get deep breath and hyperventilate 19 Overgaard that that was actually modified from
20 Q And that was not Officer Major was it 20 the version that you received from SEC during
21 A No 21 that training is that right
22 Q And did you intervene and take 22 A Yes
23 precautionary action at that time 23 Q And did you and Sergeant Overgaard work
24 A Yes I did 24 on that modification together
25 Q What did you do 25 A Hedidmostotwy
Page 51 Page 53
1 A I removed them from the cell 1 Q But it wasmodified
2 Q And what did you do after that 2 A Yes
3 A I removed them from the cell began to 3 Q I want to show you another exhibit if
4 talk to them tried to get them to relax and 4 I can figure out which one that is I think it
5 start breathing and then they went to get 5 might be 35 Lets try that It is 35
6 decontaminated 6 MR LOOMIS Does that have a yellow
7 Q And is that the first time that officer 7 sticker on it
8 had been through that program 8 MR BURKE Yes its this thing right
9 A No 9 here
10 Q Is that the only instance that you 10 MR LOOMIS Okay handing
11 recall in 2008 of anybody having an extraordinary 11 Q BYMR BURKE Idlike you to thumb
12 reaction that was different than you would expect 12 through that briefly just so you know whats in
13 from all of the others that went through 13 it
14 A Yes 14 A Witness complied
15 Q Do you recall anybody complaining of 15 Q Does that look like a copy of the
16 feeling the effects of the exposure in that 16 PowerPoint that you would have presented to
17 particular training that lasted more than lets 17 trainees in OC training in either 2007 or 2008
18 say an hour 18 A Yes
19 A No 19 Q And does it appear to have some of the
20 Q Do you recall anybody exhibiting 20 modifications that you andor Sergeant Overgaar
21 coughing symptoms that lasted more than an hour 12 1 made to the SABRE PowerPoint
22 A No 22 A Yes
23 Q Now in the 2008 training did you also 23 Q Ive already asked him to go through
24 participate in the classroom part of the training 24 those but you did note those in there




























. an you explain the question again? 1 
.   e     2 
,  t e te  ? 3 
. . 4 
.  t r ti s i    5 
 t? 6 
. hi g, i , zi ,  l t  7 
us. 8 
. i   r e  r t i   9 
r t t  tr r i ry, i  t r r s,  
out of what you normally see and expect with alII 
f the other trainees that go through the 12 
ram? 13 
.    . 14 
.  as t t i  8?  
. .  
. hat do you re e ber about that? 17 
. e icer  t  i   t t  18 
t  t  r t   r til t .  
. nd that as not fficer ajor; as it? 20 
. .  
.  i   i tervene  t   
precautionary action at that ti e?  
. es, I i .  
 2 
.  n't l        
     i l iti . 
.          
t  t ree? 
. orrect. I co-taught ith Sergeant 
vergaard and e s itched off. 
. t  t  i  i    
you ay have taken a classroo  instruction on  
. . 
. o  did you instruct? In other ords, 
t t ri l i   r vide? If t r  s  
    l , l    t. 
.      i   
  t  i truct. 
.  t is is e t at  recei e  
ri  r  e  i structor's training? 
. rr ct. 
. nd I have heard fro  ergeant 
vergaard that that as actually odified fro  
the version that you received fro  S  during 
that training; is that right? 
. . 
. nd did you and Sergeant vergaard ork 
on that odification together? 



























.  ed  r   l . 
.  at i    after t at? 
  
. I re e  t e  fr  t e cell, e a  t  
tal  t  t e , trie  t  et t e  t  rela  a  
start reat i g, a  t e  t e  e t t  et 
t i ted. 
.  is t at t e first ti e t at fficer 











. Is that the only instance that you  
recall in 2008 f anybody having an extraordinary  
reaction that as different than you ould expect 12 
fr  all ft e t ers t at e t t r gh?  
. .  
. o you recall anybody co plaining of  
feeling the effects of the exposure in that  
particular training that lasted ore than, let's   
say, an hour?  
. .  
. o you recall anybody exhibiting  
coughing sy pto s that lasted ore than an hour 21 
. .  
Q. Now, in the 2008 training did you also  
participate in the classroo  part f the training  
ur C?  
. t it as dified? 
. . 
  
. I a t t  s   a t er e hibit, if 
I ca  fig re t ic  e t at is. I t i  it 
i t  . et's tr  t t. It i  . 
. IS: es t t   ll  
  t? 
. : es, it's t is t i  ri t 
. 
. IS: kay (handing.) 
. (B  . E) I'd li e  t  t  
t r  t at riefl  j st s    at's i  
. 
. (Witness co plied.) 
. oes that look like a copy of the 
Po erPoint that you ould have presented to 
trainees in  training in either 2007 or 2008? 
. . 
. nd does it appear to have so e of the 
odifications that you and/or ergeant Overgaar~ 
    erPoint? 
. s. 
. I've already asked hi  to go through 
those, but you did note those in there? 
. . 
 (Pages 50  ) 
15 Pages 54 to 57
Page 54 Page 56
1 Q Do you have any recollection of having 1 before you put the exposed inmate back into the
2 observed Officer Majorsreaction to exposure to 2 same environment
3 OC at any time 3 A Yes
4 A I have no recollection 4 Q And if exposure occurred out in a
5 Q Did you ever have any discussion with 5 larger area like a cell or a foyer or something
6 her about her reaction to OC 6 like that would an effort be made to try to
7 A No 7 clean up that area too
8 Q Having trained about 500 different 8 A Yes
9 officers over the course of the years that youve 9 Q That would have been standard protocol
10 been training on OC is it sometimes hard to 10 at IMSI
11 remember who goes through training at any given 11 A Yes
12 particular point in time 12 Q As part of the training of correctional
13 A Yes 13 officer staff in OC did you advise them in
14 Q And your memory today is probably not 14 advance to bring extra clothing or overclothing
15 as good as it was back in 2008 of those issues 15 that they could shed and not have with them if
16 is that right 16 they went through the training
17 A Correct 17 A Ifpossible
18 Q Are you personally aware of any 18 Q And did correctional officers tend to
19 incidents wherein Officer Major actually deployec 19 do that
20 OC 20 A Some did some didntdue to when
21 A No 21 sometimes their training was right after shift
22 Q outside of a training context 22 Its just a matter of whether or not they
23 A No 23 prepared
24 Q Have you heard of any incidents 24 Q And if an officer did have some
25 A I haventheard of any incidents 25 exposure that got on thei clothing werethey
Page 55 Page 57
1 Q While you were at IMSI could you give 1 afforded an opportunity to change their clothing
2 me an estimate ofwhat frequency some range of 2 A Ifthey brought clothing
3 frequency that OC would be deployed at the 3 Q And what if they didn
4 facility You know once a week Twice a week 4 A Then we would make sure before they
5 Once amonth 5 left the training that they were okay to be able
6 A While I was there maybe once a week 6 to drive home or we would keep them there until
7 Q And was it part of the protocol for 7 we were satisfied as instructors that they were
8 decontamination where an inmate OC deployment 8 capable to go on about their day
9 incident occurred to attempt to clean up the area 9 Q Now when an inmate gets exposed to OC
10 where the contamination occurred to does part of the decontamination process call for
11 A Yes 11 the removal of their clothing and washing that
12 Q In other words if it occurred in a 12 clothing
13 cell then some effort would be made to wash do 13 A Yes
14 the cell 14 Q And that would occur with every inmate
15 A Yes 15 deployment
16 Q And that was usually done by janitor 16 A Yes
17 inmates 17 Q Do inmates also are they required to
18 A Correct 18 have showers in connection with the deployment f
19 Q And is it your understanding they would 19 OC
20 typically use soap and water to do that 20 A Its not required
21 A Yes 21 Q But its an option
22 Q And the idea was to get as much as 22 A It is an option later
23 possible of the OC out of the environment 23 Q Later meaning what
24 A Correct 24 A The process for decontamination of an





















































.     l    1 
 ic  ajor's t    t  2 
   e? 3 
. I have no recollection. 4 
. i      i i  it  5 
her about her reaction to C? 6 
. o. 7 
.     fere t 8 
icers        ou've  
   ~C,       
    i    i   
a    e? 12 
. es. 13 
.        14 
      i     s;  
  ht?  
. rr ct. 1 7 
.   ll     18 
i ide ts i  ice  j  t all  l   
 -- 20 
. o.  
. -- t ide   t i i  text?  
. . 23 
.      i i nts?  
.  n't    i i t .  
  
. ile  r  t I I, l   i e  
  ti ate  t r cy,     
re  t t  l   l  t t   
ility?  ,   ek? ic    4 
nce a onth?  
. ile   t re, e   k. 6 
.   it rt  t  r t l f r  
deconta ination here an in ate  deploy ent 8 
incide t rr  t  tt t t  l   t  r   
   r d? 10 
. s.  
.  t  , if it  i    
l ,         w~  
t  l ?  
. .  
.  t t s s ll    j it r  
s?  
. rr ct.  
. nd is it r ersta i  t e  l   
typically use soap and ater to do that?   
. e .  
. nd the idea as to get as uch as  
possible of the  out of the environ ent?  
. rr t.  
. nd  t ically i  t at if  c l   
  
before you put the exposed in ate back into the 
 nvir n ent? 
. s. 
.     t i   
larger area like a cell or a foyer or so ething 
like that, ould an effort be ade to try to 
clea   t at area t o? 
. . 
. at l  a e ee  sta ar  r t c l 
 SI? 
. s. 
. s part f the training f correctional 
officer staff in ~C, did you advise the  in 
advance to bring extra clothing or overclothing 
          
they ent through the training? 
. If ssible. 
.  i  c rrecti al fficers te  t  
 t at? 
. e i , s e idn't, e t  e  --
s eti es t eir trai i  as ri t after shift. 
It's j st a atter f et er r t t e  
prepared. 
. nd if an officer did have so e 
exposure that got on their clothing, ere they 
a e 57 
ff r   rt it  t   t ir l thing? 
. If they brought clothing. 
. nd hat if they didn't? 
. hen e ould ake sure before they 
left the training that they ere okay to be able 
to drive ho e or e ould keep the  there until 
e ere satisfied as instructors that they ere 
capable to go on about their day. 
. o , hen an in ate gets exposed to  
does part of the deconta ination process call for 
the re oval of their clothing and ashing that 
clothing? 
. . 
. nd that ould occur ith every in ate 
deploy ent? 
. . 
.  i ates als , are t e  re ire  t  
a e s ers i  c ecti  it  t e e l e t f 
? 
. It's not required. 
. ut it's an option? 
. It is an option later. 
. "Later" eaning hat? 
. The process for deconta ination of an 
in ate is after exposure e ould deconta inate • 
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IDCRecords 000039 03172010
Idaho Department of Correction Page 2
Training Transcript 03112008
Student
BILLIE JO MAJOR Hire 07192004
IMSI SECURITY Separation
7621 Academy
No Class Start End Hours Score
describe the nomenclature of each IDOC weapon Identify firearm cleaning and
maintenance Participate in a qualification course with each of the 3 IDOC weapons
56216 Firearms Task Testing 08112004 08112004 80 0
Identify legal aspects for carrying and using an IDOC firearmIdentify the 3 main firearms
used by IDOC Identify the types of ammunition used in each type of weapon identify and
describe the nomenclature of each IDOC weapon Identify firearm cleaning and
maintenance Participate in a qualification course with each of the 3 IDOCweapons
56217 Firearms Task Testing 08122004 08122004 20 0
Identify legal aspects for carving and using an IDOC firearmIdentify the 3 main firearms
used by IDOCIdentify the types of ammunition used in each type of weapon Identify and
describe the nomenclature of each IDOC weapon identify firearm cleaning and
maintenanceParticipate in a qualification course with each of the 3 IDOC weapons
56212 First Aid 081020 4 081020 4 30 0
Basic First aid
56199 Graduation and Rehersal 08132004 08132004 35 0
Graduation and Rehersal
56184 Intorduction to TrainingFacil 0726004 0726004 25 0
Identify training and training facility needs and rules associated with attending
classes DirectorLeaderwelcome and comments
56185 intorduction to TrainingF cil 0726004 0726004 10 0
Identify the two components of our mission statement Define control and risk
reduction Identify the core of risk reduction Identify the components of our vision
statementUnderstand the relationship between the stated values and the mission and
vision
56183 Introduction to Criminal Justi 0726004 0726004 30 0
Identify how one proceeds through the Criminal Justice SystemDefine FelonyDefine the
difference between probation vs parole system Define recidivismDefine the sentencing
options Identify the significance of a Gold Sea
56188 Legal Issues 0728004 072812004 40 0
Define liability and vicarious liability Define to types of vilations offenders can sue
forDefine the types of damages offenders can be awarded Define the constitutional
amendments as they pertain to offender lawsuits
47829 ORIENTATION TOURS OTHERS 08162004 08192004 320 0
tileorsin Capscurr7C3C 08200 4 0812012004 30 0
History and use of OCDescribe Delivery systems Levels of contamination Demonstrate Z
proper techniqueOperate a MK4Be exposed to OC
55916 Pepperball Systems 08200 4 08200 4 20
TacticsargetingTraining
0
Introduction System ComponentsSystem Operations
IssuesTestCertification a55745 Principles of Subject Control 12062004 12062004 80 0
No training objectives listed X
56207 Principles of Subject Control 0842004 0842004 80 0
Identify and demonstrate all aspects of use of force and force related equiptment
56209 Principles of Subject Control 0832004 0832004 80 0
Identify and demonstrate all aspects of use of force and force related equiptment
IDCRecords 000039 03172010
000729
I.D.C. r  0039 3/17/2010 
I  rt ent f ti  
i i  i t 
:  
03/11/2008 
ILUE  J R 
I I - ITY 
 
t t 
ir : 7/19/2004 
ti : 
: 
 lass   ours core 
describe the no~enclature of each I  eapon-Identify firear  cleaning and 
aintenance- articipate in a qualification course ith each of the 3 I  eapons. 
 irear s ask esting 8/11/2004 8/11/2004 .0 .0 
I tif  l l t  f r rr i   sing  I  fir r -I tif  t   i  fir r  
used by ID C-Identify the types of a unition used in each type of weapon-Identify and 
describe the no enclature of each I  eapon-Identify firear  cleaning and 
i t c - rtici te in  lific ti  c rs  it  c  f t   I  s. 
 ir r s sk sting 08/12/2004 08/1212004 2.0 0.0 
Identify legal aspects for carrying and using an I  firear -Identify the 3 ain firear s 
  I -I tif  t  t  f iti   i   t e f -I tify  
ri e t  l t r  f  I  n-I tif  fir r  l i   
i t ance- rtici t  i   lific ti  c rs  it  c  f t   I  s. 
 t i  8/10/2004 8/10/2004 3.0 0.0 
i  t  
   l. 8/13/2004 8/13/2004 .5 .0 
i    
 Intorduction to Training/Faci! 7/26/2004 7/26/2004 .5 .0 
Identify training and training facility needs and rules associated ith attending 
- /Le r-   ts. 
 Intorduction to Training/Faci! 7/26/2004 7/26/2004 .0 0.0 
Identify the two co ponents of our ission state ent-Define control and risk 
reduction-Identify the core of risk reduction-Identify the co ponents of our vision 
t t ent- . t  t  l ti i  t  t  t t  l   t  i i   
i n. 
 tion   i 7/2612004 7/26/2004 .0 
Identify how one proceeds through the Cri inal Justice Syste -Define Felony-Define the 
difference between probation vs. parole syste -Define recidivis -Define the sentencing 
options-Identify the significance of a Old eal. 
.0 
 Legal Issues 7/28/2004 7/28/2004 .0 .0 
Define liability and vicarious liability-Define te types of vilations offenders can sue 
for-Define the types of da ages offenders can be awarded-Define the constitutional 
a end ents, as they pertain to offender la suits. 
 I I  -  -  8/16/2004 8/19/2004 2.0 0.0 
(~~jjf;;;;~::'~~~(E!$ittq~p~i99.1,1f9q(ii ~'9~t~!M2,P~~,::;PW~9/~W?~,';;.>. 3.0 0.0 
History and use of OC-Describe Delivery syste s-Levels of conta ination-De onstrate 
proper technique- perate a K-4-Be exposed to . 
 Pepperball Syste s 8/20/2004 812012004 .0 0.0 
Introduction-Syste  Co ponents-Syste  perations- acticsIT argetin - r i i  
I sues- est/Certificatio . 
 Principles of Subject Control 2106/ 004 121 6/ 004 8.0 0.0 
o training objectives listed. 
 Principles of Subject Control 8/ 4/2004 08/ 4/2004 8.0 0.0 
Identify and de onstrate all aspects of use of force and force related equiptment. 
 Principles of Subject Control 8103/2004 081 3/2004 8.0 0.0 
Identify and de onstrate all aspects of use of force, and force related equipt ent. 
.D.C.   3/17/2010 
IDCRecords 000040 03172010
Idaho Department of Correction Page 4
Training Transcript 03112008
Student
BILLIE JO MAJOR Hire 071912004
IMSI SECURITY Separation
7621 Academy
No Class Start End Hours Score
providedDescricbe first respinder action Identigy watch procedures Recognize steps in
theafter action process
56189 Transition Process 073020 4 073020 4 10
Define the goal of the structured reentry process Define the purpose of the structured
reentry process Define the two phases of the process Define the three steps to the reentr
process
56205 lJseof 08Q7200408102120Q4 30
Explain the differences between and when authorized Reactive use of force Planced use
of force Lethal force less lethal Corporal punishment Explain what types of force are
prohibited Explain the defferent types of restraints and when to use and not to use
them Expalin ones obligation to the public on and off duty in or out of uniform
56197 Verba Judo Day 1 0852004 0852004 80
Identify the 3 great arts Identify and understand the 4 appeals Identify each step in
LEAPSIdentify the 3 step elements of essence of controlDemonstrate the 5 step hard
style
56198 Verba Judo Day 2 0862004 0862004 80
Identify the 3 great artsIdentify and understand the 4 appeals Identify each step in
LEAPSIdentify the 3 step elements of essenceof controlDemonstrate the 5 step hard
style
56194 Week One Exam 073020 4 073020 4 05
Exam on material covered in Week One of academy
Total Hours for 2004 1815
57846 Attempted escape drill 112005 112005 15
The exercise was to evaluate the programmed response from the ASC central control
and staff
55909 Bloodbom Pathogens 03152005 03152005 10
Awareness
57352 Code Blue Drill 101192 05 10920 5 05
Establish and train in officer duress protocols
57845 Code blue drill duress system 10260 5 10260 5 05
Evaluation ofASCs ability to assume command Response officers ability to assume
ASC position Staff ability to secure their areas and the response time
57847 Fire drill in Gblock 1142005 1142005 09
To evaluate the programmed response from staff by securing their units without
prompting Notifying control not responding limiting radio traffic and knowing the
evacuation routes
57666 Gender Identity Disorder 12082005 12082005 10
Review policy 4010635 and define GID Establish guidelines for dealing with GID
inmates
56495 ICESEmergency Preparedness 04192005 04192005 80
Define the history of the Idaho Correctional Emergency System Define the rational of the
Idaho Correctional Emergency System Define the principles involved in the Idaho
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BILLIE JO MAJOR Hire 07192004
IMSI SECURITY Separation
7621 Academy
No Class Start End Hours Score
58771 IMSIWEAPONS QUALIFICATIONS 0627006 0627000 20 0
YEARLY IMSI WEAPONS QUALIFICATIONS FOR THE RIFLE SHOTGUN AND
PISTOL
5880FxOCTrarnVVIPPolicy 307 Use of 0823006cr08230 6i 10 0
OC Aerosol TrainingReview Policy 307 Use of Force
57858 Oleoresin Capsicum tOC p2141200ki 0214L2006 30 0
Explain where OC can be used in the use of force continuum Explain the different dilivery
systems Demonstrate proper tecnique for deploying OC and be exposed
59278 P06y307 02 01 001 USEP 3 0
Reviewed policy and took a test and handed it into Schaffer
59561 Policy Test 324 1152006 1152006 20 0
Monthly policy test on Retained Jurisdiction
58443 Prison Rape Elimination Act 0523006 0523006 15 0
Review policy 325 Define PREA identify 5 areas of concern 2 characteristics of potentia
sexual assault victims and 3 ways that staff can help prevent sexual assault
57899 Specialty Impact Munitions 02142006 02142006 30 0
Define specialty impact munitions and the psychological and physiological effects Identify
impact zones and the effects on Demonstrate functional knowledge of multiple shot
delivery system and deploy Define the Use of Force continuum and the appropriate level
for SIMS
58444 Staff Sexual Misconduct 0523006 0523006 15 0
Review policies 218 219 and policy 11602101 Identify prohibited behaviors as
stated in policy 219 Identify indicators of an imappropriate staffinmate sexual
relationship Strategies to prevent staff sexual misconduct
57900 Stun Baton Qualification 02142006 02142006 20 0
Review FM 1002 30703 and understand the proper deployment of the stun baton
Practice a proper shock and recieve a shock from the stun baton
59508 Suicide PreventionSuicide Ris 122006 122006 10 0
1 Definition of suicide 2 Risk factors 3 Indicators for suicidal risk 4 Over view of Polic
3155 Role of offender companions 6 Role of security during watch close observatio
status 7 Role of staff in event of suicide attempt
58052 UAProcedures 0228006 0228006 05 0
Power point training on proper UA procedures with a final test
5797 Usentforge Annual review 021x42006 02142Q06 10
0
Review Use of force policy 3070211and define the levels of force proper
documentation and authorization of force
57816 Wardens Briefing 0152006 0152006 10 0
Institutional expectations and Introduction
Total Hours for 2006 502
60352 1st Aid CPR 0126007 0126007 30 0
re cert
61267 Annual CPR Training 12052007 12052007 20 0
Review 60 Medic First Aid video Demonstrate proper technique for applying medic FA
IDCRecords 000041 03172010
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I.D.C.   
I  rt t f rr ti  





ILLIE   
I I - ITY 
7  
ire: 7/19/2004 
r ti : 
: 
 l ss t nd rs r  
 I   I I TI NS 6/27/2006 6/27/2000 2.0 0.0 
 I I S I I I    I , ,  
I TOl. 
ti~!l,~gfi;~~t8,!i?fJj ... ~tti.l®ZB(iil6YZ3bl;;G~(!ififP g~~~£?';2gp.~:§~{9~f?'9,,~qQ,Q~ 1.0 0.0 
 r s l r i i /Review licy  se f rc  
@'t$9 't;Y<()I~~fesrn('(Japsicii'mlQCY~? pg(;;1:4l?:Q9&"/;.'.O~t~/2906! 3.0 0.0 
Explain where DC can be used in the use of force ~ntinuum, Explain the different dilivery 
systems. Demonstrate proper lecnique for deployin9 OC and be exposed, 
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Reviewed policy and tooki3 test and handed it into Scheffer .' .. , 
 licy st  1/15/2006 1/1512006 2.0 0.0 
onthly policy test on Retained Jurisdiction 
 Prison ape Eli ination Act 5/23/2006 OS/23/2006 .5 .0 
Review policy 325. Define PREA. Identify 5 areas of concern, 2 characteristics of potentia 
sexual assault victims, and 3 ways that staff can help prevent sexual assault. 
 Specialty Impact Munitions 211412006 2114/ 006 3.0 0.0 
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delivery syste  and deploy. Define the Use of Force continuu  and the appropriate level 
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Review policies 218, 219, and policy 116.02.01.001. Identify prohibited behaviors as 
stated in policy 219, Identify indicators of an imappropriale staff/inmate sexual 
r l ti s i . tr t ies t  r v t st ff s x l isc duct. 
    2/14/ 006 2114/ 006 2.0 0.0 
Review FM 10-02-307-03 and understand the proper deployment of the stun baton. 
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  /S i  i  2112/ 006 211212006 1.0 0.0 
1) Definition of suicide. 2) Risk factors. 3) Indicators for suicidal risk. 4) ver view of Polic 
315. 5) Role of offender co panions. 6) Role of security during watch & l  r ti  
status. 7) ole of staff in event of suicide atte pt. 
 A  2128/ 006 2128/ 006 .5 0.0 
Power point training on proper UA procedures with a final test. 
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Review Use of force policy- 307.02.01.001 and define the levels of force, proper 
docu entation, and authorization of force. 
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No Class Start End Hours Score
CPR
61056 Annual Firearms Qualification 041112007 04112007 30 0
Annual Qualification on handgun
60834 Annual TCM Training 0512007 05112007 20 0
Q A on SOP Proper way to apply TCM How staff can be a part of TCM
60355 Annual Training Arrest Techn 031912007 03192007 25 0
Annual Training
0354 Annul I Traimr g OCrR0the X21212007022007 10 0
annual training
60353 Annual Training Use of Force 0221007 0221007 10 0
Annual Refresher
61062 Annual Training FY07 Verbal Ju 051292007 052912007 40 0
annual refresher training
60356 Annual Training FY07 ArrestT 03192007 03192007 25 0
Annrual refresher training
61271 Arrest Techniques Mandatory A 12062007 12062007 40 0
Clothed Body Searchees Application and removal of wrist restraints waist restraints
ankle restraints Overview of sendreceiving inmates from Rear SAllyport Escorting
restrained offenders
59676 CPR 1st Aid at SBWCC 0126007 0126007 30 0
Training to be Certified
61269 DIG Offender Management 12062007 12062007 10 0
Explain reason behind IDOC programs and the long term affects of programming Review
policy4010635 define gender identify disorder establish guidelines for dealing with
GID offenders
60347 Emergency Fire Drill 0362007 03612007 08 0
Evacuation Procedures resetting of fire alarm Count Procedures
61141 Emergency Preparedness 0812007 0812007 30 0
Bomb threats avoiding emergencies written test Q and A
60845 FY07 Annual Firearms Qualifica 04112007 041112007 30 0
Annual qualification
61266 ICES Annual Training 12052007 12052007 20 0
ICES rationale principleongoing training history Table top scenarios
60952 Oleoresin Gapsicum 07132007071132007 20 0
Effects of OC Delivery systemadvantages and disadvantages Factors ecting proper
level of force Decontamination procedures Warning signs which require EMS
613659 laresinlCaptiGpmRefrestit 0718J20077l207
20 0
Effects produced by OC Delivery system advantages and disadvantages Factors
affecting proper level of force Decontamination procedures Warning signs which require
EMS
60357 PREA 0322007 0322007 20 0
Prohibited behaviors as stated in Policy 219 Attitudes and behaviors that demonstrate
professional distancing Indicators of staff inmate sexual relationship Employee reporting
obligations Petential outcomes of engaging in sexual miscnoduct Ways staff can become
IDCRecords 000042 03172010
000732
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Annual qualification 
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Lesslethal products have vastly improved over the past decade and become more and more
relied upon by the law enforcement community Law enforcement officers are faced with a
significant challenge in that they must provide and enforce safety while at the same time
having to control aggressive uncooperative and sometimes dangerous subjects Obligated to
using the least amount of force necessary to control a subject Less lethal products have
become a key ingredient in the force options available to law enforcement officers
Since their introduction less lethal products have significantly improved in performance and
safety applications In spite of their enhancements all products have their limitations and
drawbacks which is why training plays a key role in maintaining safety Through this course
you will learn the following
Effects produced by Oleoresin CapsicumOC
Effects produced by different formulations
Delivery systems advantages disadvantages
Proper use of Oleoresin Capsicum
Use of force continuum Presented as a guideline
Factors affecting the proper level of force
Decontamination procedures
Warning signs which require EMS
In addition to becoming knowledgeable in the above areas each instructor will be
contaminated with OC during the training program The advantages of personal
contamination are twofold
I Prior contamination will better permit an officer to protect oneself and ones
firearm if the officer becomes contaminated while attempting to control a subject
2 Personal contamination allows the officer to relate to and have empathy for the
subject after contamination occurs This will likely cause the officer to take the
required steps necessary to properly decontaminate a contaminated subject
Furthermore our legal system will be more likely to value the testimony of an
officer who has been contaminated previously than with one who has not
Many significant advancements have been made in the equipment available to help protect
law enforcement officers However it should be noted that no device or physical maneuver is
guaranteed effective and safe 100 of the time Proper training is imperative to reduce
injuries and promote safety This program has been designed to offer additional safety to
officers through familiarization of products and acceptable procedures Mastering the
objectives and components of the following training program will greatly reduce the potential






Less-lethal products have vastly improved over the past decade and become more and more 
relied upon by the law enforcement community. Law enforc~ment officers are faced with a 
significant challenge in that they must provide and enforce safety while at the same time 
having to control aggressive, uncooperative and sometimes dangerous subjects. Obligated to 
using the least amount of force necessary to control a subject, Less-lethal products have 
become a key ingredient in the force options available to law enforcement officers. 
Since their introduction, less-lethal products have sig ificantly improved in performance a d 
safety applications. In spite of their enhancements, all products have their limitations and 
drawbacks, which is why training plays a key role in maintaining safety. Through this course, 
you will learn the following: 
» Effects produced by Oleoresin Capsicum-OC . 
» Effects produced by different formulations 
» elivery syste s' advantages & disadvantages 
» Proper use of Oleoresin Capsicum 
» se f force c tinuum ( rese ted as a i eline,) 
» Factors affecting the proper level offorce 
» Decontamination procedures 
» Warning signs which require EMS 
In addition to becoming knowledgeable in the above areas, each instructor will be 
conta inated with OC during the training progra .     
t i ti  r  t f l : 
1. ri r c ta i ati  ill etter er it a  fficer t  r tect eself a  es 
i  i t  f i   t i t  il  tt ti  t  t l  ubj ct. 
. ers al c ta i ati  all s t e fficer t  relate t  a  a e e at  f r t e 
subject after contamination occurs. This will likely cause the officer to take the 
required steps necessary to properly decontaminate a contaminated subject. 
Further ore, our legal syste  will be ore likely to value the testi ony of an 
officer ho has been conta inated previously than ith one ho has not. 
Many significant advancements have been made in the equipment available to help protect 
law enforce ent officers. However, it should be noted that no device or physical aneuver is 
guaranteed effective and safe 100% of the time. Proper training is imperative to reduce 
injuries and promote safety. This program has been designed to offer additional safety to 
officers through familiarization of products and acceptable procedures. astering the 
objectives and components of the following training program will greatly reduce the potential 





The following requirements must be demonstrated to become a certified instructor Security
Equipment Corporation will not issue a certificate unlessuntil these requirements are met
Each Instructor must demonstrate understanding of the principles of this
training course A written test will be administered and a passing grade of 80
or better must be attained
Exercises will be conducted using inert spray You must take part in these
exercises and demonstrate proficiency with the product
Each Instructor is required to be contaminated with a SABRE product See 1
and 2 above Re certification with SABRE does not require another
contamination
Each Instructor must demonstrate proper decontamination techniques You will
be required to help with the decontamination of fellow instructors This will be
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Quantitative Analysis of Capsaicinoids Article
IACP Pepper Spray InCustody Death
Hogtying Article
Positional Asphyxia Sudden Death Article
InCustody Deaths and Positional Asphyxiation
The Effectiveness and Safety ofPepper Spray NIJ Study
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Force Options Letter Sgt Richard Gentry
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TaserTest Cases
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Maintenance of Visual Acuity After Exposure to OC Spray following LASIK
Journal ofRefractive Surgery Volume 18 2002
Tenn v Garner
Humboldt County OC Case
Graham v Connor
Spray Today Gone Tomorrow By John Willis and Jeff Quail
Force Science Lowest Risk of Injury from Use of Force
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Oleoresin Capsicum OC a mixture of the oil and resin within red peppers OC is the
active ingredient within red peppers
Capsaicinoids a component found within OC responsible for making pepper sprays
pungent or hot They are the heat bearing and pain producing components within OC spray
The higher the major capsaicinoids the stronger the spray will be Capsaicinoids are the
most accurate measure of OC pungency and level of incapacitation
Capsaicin Capsaicinoids consist of seven compounds and capsaicin makes up the largest
percentage of the capsaicinoids Other important capsaicinoids are Dihydrocapsaicin and
Norodihydrocapsaicin but capsaicin is considered to be the most important and the main
active ingredient within OC
Scoville Heat Units SHUs a measurement used to determine the pungency of OC
Initially SHUs were determined through a taste test procedure which has now been replaced
by a more accurate method of measurement called the High Performance Liquid
Chromatography HPLC test The HPLC test measures the capsaicinoids within red peppers
and a simple calculation allows SHUs to be determined more accurately The drawback of
SHUs is that it indicates the strength of OC before it is diluted by the propellant and
carrier SHUs are not an accurate measure as to the strength of the entire spray
Propellant a liquid or gas which pushes the active ingredients out of the canister towards
the target
Carrier the inactive ingredients within defense sprays responsible for creating an even
disbursement of OC throughout the formulation The carrier affects the flammability and
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r t r  (H ) t st.   t st s r s t  s i i i s it i  r  rs, 
and a si ple calculation allo s S s to be deter ined ore accurately. he dra back of 
U's is t t it i icates t e stre t  f  ef re it is il te   t e r ella t a  
carrier. HU's are not an accurate easure as to the strength of the entire spray. 
 - a liq id r as, ic  s es t e acti e i re ie ts t f t e ca ister t ar s 
 t. 
rrier - t e i acti e i re ie ts it i  efe se s ra s res si le f r creati  a  e e  
is rs e t   t r t t  f r l tion.  rri r ff t  t  fl ilit   





OC Oleoresin Capsicum Red Pepper
OC sprays have become very popular because they do not rely upon pain inducement to
incapacitate Using an inflammatory agent instead of an irritant OC sprays are more effective
on subjects under the influence of alcohol andor drugs OC produces rapid physiological
effects a complete recovery and restricts immunity build up because it is an inflammatory
agent
Physiological Effects
Eyes tear and blink repeatedly
Eyes close
Respiration of OC causes inflammation of the respiratory tract
Inflammation causes coughing gagging a loss ofbreathe sensation
Facial areas may also become inflamed and will burn
Swelling may occur around the eyes mouth and nose
The nose will run and produce excessive mucous
The effects may differ with each case Common symptoms include light
headedness uncontrollable shaking of the body weakening legs tightness of
the chest and hearing impairment The effects are all temporary
Psychological Effects
The restriction of normal breathing causes many of the victims to panic which
results many times in hyperventilation and anxiety attacks Allergic reactions
are highly unlikely
Tear Gas CN CS
Tear Gas either CN or CS produces very similar effects to those of OC Tear gas irritation
relies on nerves in mucous membrane skin being affected Reactions produced by tear gas
may vary significantly from one individual to the next These reactions are affected by ones
emotional state motivation goal orientation physical activity ambient temperature and
humidity
CN OmegaChloracetphenone Tear Gas Mace
CN is a Lachrymator which causes profuse tearing of the eyes and mild burning and itching
of the facial area CN works poorly on those under the influence of alcohol andordrugs and
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OC sprays have beco e very popular because they do not rely upon pain induce ent to 
incapacitate. sing an infla atory agent instead of an irritant,  sprays are ore effective 
on subjects under the influence of alcohol and/or drugs. OC produces rapid physiological 
effects, a co plete recovery, and restricts i unity build up because it is an infla atory 
agent. 
Physiological Effects 
es tear  li  r t l  
es l s  
Respiration ofOC causes inflammation of the respiratory tract. 
Infla ation causes coughing, gagging &    re t e ati . 
i l r s  ls  e i fla e   ill r . 
S elling ay occur around the eyes, outh and nose. 
The nose will run and produce excessive ucous. 
he effects ay differ ith each case. o on sy pto s include light-
headedness, uncontrollable shaking f the body, eakening legs, tightness f 
the chest and hearing i pair ent. The effects are all te porary. 
s c l ical ffects 
he restriction of nor al breathing causes any of the victi s to panic, hich 
results any ti es in hyperventilation and anxiety attacks. Allergic reactions 
are highly unlikely. 
  -  &  
Tear Gas, either CN or CS, produces very similar effects to those of OC. Tear gas irritation 
relies  er es i  c s e ra e ski  ei  affected. eacti s r ce   tear as 
may vary significantly from one individual to the next. These reactions are affected by one's 
emotional state, motivation (goal orientation), physical activity, ambient temperature and 
hu idity. 
 - O ega-Chloracetphenone -   -  
C  is a Lachry ator, hich causes profuse tearing of the eyes and ild burning and itching 
of the facial area.  orks poorly on those under the influence of alcohol and! or drugs, and 





Military Tear Gas Super Tear Gas
CS is an irritantwhich is designed to affect the respiratory system CS will affect the eyes and
skin causing tearing and a burning sensation CS will also cause the sinus cavity to empty
CS became very popular after the US Army switched from CN to CS in 1959 The Army
switched to CS because of the following reasons
1 CS takes effect quicker
2 CS produces a more intense effect
3 CS is more potent but less toxic than CN tear gas
CS causes an intense burning of the eyes nose and skin It causes the eyes to close and
tightness in the chest and throat in extreme contaminations CS causes a more intense pain
and a greater effect on the respiratory tract than does CN See Edgewood Arsenal Report in
the Appendix for Additional Information
CNOC CSOC
The combination of an inflammatory OC and an IrritantLachrymator CS or CN causes the
effects of the spray to become more intense The combination produces a synergistic effect
which means the result is stronger than if the agents were used individually The CSOC
mixture is more effective than CNOC
The advantage to the OCCS mixture is that the CS affects the respiratory system causing the
subject to lose their breath with movement while the OC affects the eyes
f
CNOC does not work as well because CN is a Lachrymator The eyes produce a profuse flow
of tears in a contamination of CN This effect would aid the subject in decontamination and
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CS is an irritant which is designed to affect the respiratory syste . CS ill affect the eyes and 
skin causing tearing and a burning sensation. CS will also cause the sinus cavity to empty. 
CS became very popular after the S i y s itched from C  to CS in 1959. The rmy 
s itched to S because of the follo ing reasons: 
1. S takes effect quicker. 
2.  roduces a r  intense ff t. 
.  is ore p t t, t less t ic than  tear . 
 auses an intense rning f t e , ose d i . It causes t e  to lose  
tightness in the chest and throat (in extre e conta inations). S causes a ore intense pain 
a  a reater effect  the res irat r  tract than oes . (See e  rse al e rt i  
the Appendix for Ad<;litional Information). 
+OC & S+OC 
The co bination of an infla atory (O ) and an Irritant/Lachrymator (CS or ) causes the 
effects f the spray to beco e ore intense. he co bination produces a synergistic effect 
ich eans t e r s lt is str r t  if t e ts. ere s  i i i ll . e +OC 
xture  re  t a  +O . 
The advantage to the OC/CS ixture is that the CS affects the respiratory syste  causing the 
subject to lose their breath with movement while the OC affects the eyes. 
/O  es t r  as ell eca se  is a ac r at r. e e es r ce a r fuse fl  
 t rs i   t i ti   eN. is t l  i  t  j t i  t i ti   






It is a common misconception that aerosol projector pungency can be measured or compared
by OC Concentration For example some believe that products measuring 10 OC are
automatically stronger than those which measure less than 10 The truth is that OC
percentages measure only the amount of Oleoresin contained within the formulation OC
percentages do not address the pungency of the OC only the amount In order to determine
the pungency of aerosol projectors one must also consider the Scoville Heat Units Scoville
Content and Major Capsaicinoids
SCOVILLE HEAT UNITS SHUs
The Scoville Organic Test was developed by Wilbur Scoville in 1912 His method required a
committee of members to taste test peppers in order to determine a pepperspungency Due
to the subjectiveness of Scoville taste test SHUsare not considered to be the most accurate
measure of OC pungency Most defense sprays available today measure between 5000 to
2000 SHUs It is important to realize SHUs measure the pungency of the OC used
before it is diluted by the inactive ingredients which include the carrier and propellant SHUs
in and ofthemselves are not an accurate measure of aerosol projector pungency
SCOVILLE CONTENT
The Scoville Content of OC sprays measures the actual pungency of the entire formulation
Thus the Scoville Content measures the liquid which is propelled out of the aerosol projector
canister Because this measurement takes into account the OC carrier and propellant it is a
much more accurate measurement than either the OC concentration or SHUs To determine
the Scoville Content of a product multiply the SHUs by the OC Concentration ex
2000 x 010 2000 ex 253Million SHU formulation 53000 x 02
1060 0
MAJOR CAPSAICINOIDS
Major Capsaicinoids are the components within red pepper which make them pungent Thus
the most modern and accurate way to determine the pungency of an OC spray is to determine
its level of majorr capsaiciniods In fact Scovillestest was replaced by the more accurate
High Performance Liquid Chromatography HPLC which measures the major capsaicinoids
within OC sprays Security Equipment Corporation the Environmental Protection Agency
EPA and Health Canada recognize the American Organization of Analytical Chemists
Method 99503 as the latest most accurate method to determine the major capsaicionoid level
of OC products To accurately compare the heat level of OC sprays compare the major
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It is a common misconception that aerosol projector pungency can be measured or compared 
by  oncentration. For exa ple, so e believe that products easuring 10%  are 
auto atically stronger than those hich easure less than 10%. he truth is that  
percentages easure only the a ount of Oleoresin contained within the for ulation. OC 
percentages do not address the pungency of the C, only the a ount. In order to deter ine 
the pungency f aer s l r ject rs, e st als  c sider t e c ille eat its, c ille 
Content and ajor Capsaicinoids. 
I E  ITS (S U's) 
The Scoville Organic Test was developed by ilbur Scoville in 1912. His method required a 
co ittee of e bers to taste test peppers in order to deter ine a pepper's pungency. Due 
to the subjectiveness of Scoville's taste test, SHU's are not considered to be the most accurate 
measure of OC pungency. ost defense sprays available today measure between 500,000 to 
2,000,000 SHUs. It is important to realize SHUs measure the pungency of the OC used 
before it is diluted by the inactive ingredients, which include the carner and propellant. SHUs 
in and of the selves are not an accurate easure of aerosol projector pungency. 
E  
e c ille te t f  s ra s eas res t e act al e c  f t e e tire f r lati n. 
Thus the Scoville ontent easures the liquid, hich is propelled out of the aerosol projector 
ca ister. eca se t is eas re e t ta es i t  acc t t e , carrier a  r ellant, it is a 
.     i      .   
the Scoville ontent of a product, ultiply the S s by the  oncentration. (e . 
2,000,000 x 0.10 = 200,000) (ex. 2% 5.3 illion S  for ulation - ,3 0,000  .  = 
106,000) 
J   
ajor Capsaicinoids are the co ponents within red pepper which ake the  pungent. Thus, 
t  t m  r t   t  t r i  t      r  i  t  t r i  
its level of major capsaiciniods. In fact, Scoville's test was replaced by the more accurate 
High Performance Liquid Chromatography (HPLC) which measures the major capsaicinoids 
within OC sprays. Security Equipment Corporation, the Environmental Protection Agency 
(EP ) and ealth anada recognize the erican rganization of nalytical he ists' 
 95.03   l t st, t acc    r   aj  saici   
of OC products. To accurately co pare the heat level of OC sprays, co pare the ajor 




TAKING SAFETY ONE STEP FURTHER
l
INHOUSE HPLC LABORATORY
SABRE Law Enforcement Aerosol Projectors containing Oleoresin Capsicum OC as their
active ingredient use only food grade red pepper Because OC is grown naturally there can
be a wide inconsistency in the pungency of the peppers with each harvest For example if the
harvest received significant precipitation and grew in soil rich with nutrients the OC will
likely be more potent than normal Likewise if the harvest did not receive adequate
precipitation and the soil lacked nutrients the OC within that harvest will be less potent
The University of Utah recently conducted extensive testing on Oleoresin Capsicum Aerosol
Projectors A summary of their findings is published in the Journal of Forensic Sciences May
2001 in the article titled Quantitative Analysis of Capsaicinoids in Fresh Peppers Oleoresin
Capsicum and Pepper Spray Products see appendix Here are some important facts
covered within the article
Capsaicinoids are the active and pain producing components of the hot pepper
Capsaicinoid variability was observed from different product lots from the same
manufacturers
Variability explains why pepper sprays have been shown to be only 70 effective in
discouraging attacks by aggressive individuals
SHU values were sometimes overstated by a factor of 100 times
Variability could alter potency and ultimately jeopardize the safety and health
ofusers and assailants
Manufacturers of oleoresin capsicum and self defense weaponry employ few ifany
analytical measures to determine the concentration of active ingredients in the product
and to ensure consistent chemical composition
Recognizing this Security Equipment Corporation has an inhouse laboratory dedicated to
performing High Performance Liquid Chromatography HPLC analysis on all raw OC
material received from our suppliers Security Equipment Corporation does not assume the
raw OC shipped to us is consistent with our pungency requirements Instead we perform
HPLC analysis on every batch of OC we receive from our suppliers From the results of the
HPLC analysis our chemists determine what adjustments need to be made to the quantity of
active ingredient used in order to consistently provide the stated pungency level for each of
our OC formulations In addition to testing of the raw OC our chemists also perform HPLC
analysis on the final formulation to ensure specifications are met As a result of our in house
HPLC technology SABRE provides the most consistent level of pungency possible







ING   P E  
IN-HOUSE P C ABOR TO  
S BRE a  Enforcement Aerosol Projectors containing leoresin a ic  (O )  their 
active ingredient use only food grade red pepper. Because OC is grown naturally, there can 
be a wide inconsistency in the pungency of the peppers with each harvest. For example, if the 
harvest received significant precipitation and gre  in soil rich ith nutrients, the  ill 
likely be more potent than normal. ike is , if the arvest id  receive ate 
precipitation and the soil lacked nutrients, the OC within that harvest will be less potent. 
The University of Utah recently conducted extensive testing on Oleoresin Capsicu  Aerosol 
Projectors. A summary of their findings is published in the Journal of Forensic Sciences, May 
200 I in the article titled, "Quantitative nalysis of apsaicinoids in resh eppers, leoresin 
Capsicu  and Pepper Spray Products" (see appendix).  re e t  a ts 
ere  it  t e : 
• "Capsaicinoids are the active and pain producing co ponents ofthe hot pepper." 
• "Capsaicinoid variability was observed fro  different product lots fro  the sa e 
facturers." 
• "Variability explains why pepper sprays have been shown to be only 70% effective in 
discouraging attacks by aggressive individuals." 
• "SH  values ere so eti es overstated by a factor of>  ti es." 
• "Variability could alter potency and ulti ately jeopardize the safety and health 
 s  sailants." 
• "Manufacturers of oleoresin capsicu  and self-defense eaponry e ploy fe , if any, 
analytical measures to determine the concentration of active ingredients in the product 
and to ensure consistent che ical co position." 
Recognizing this, Security Equipment Corporation has an in-house laboratory dedicated to 
performing High Performance Liquid Chromatography (HPLC) analysis on all raw OC 
material received from our suppliers. Security Equipment Corporation does not assume the 
raw OC shipped to us is consistent with our pungency requirements. Instead, we perform 
HPLC analysis on every batch of OC we receive from our suppliers. From the results of the 
PLC analysis, our che ists deter ine hat adjust ents need to be ade to the quantity of 
active ingredient used in order to consistently provide the stated pungency level for each of 
our OC formulations. In addition to testing of the raw ~C, our chemists also perform HPLC 
analysis on the final formulation to ensure specifications are met. As a result of our in-house 
HPLC technology, SABRE provides the most consistent level of pungency possible 
increasing officer safety and product effectiveness allowing agencies to utilize SABRE to 
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The sample identified above was run for Capsaicin content according to the protocol of the
AOAC Procedure 99503
The sample was found to contain the following133 010 Total Capsaicinoids on a
wtwt basis









This is an example of independent HPLC Testing performing on SABRE Red The
marketing claim for this product is 10 OC2000SHUs 2000 Scoville Content
133Major Capsaicinoids In this example the lab has chosen to measure the SHUsof the
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The sa ple identified above as run for apsaicin content according to the protocol of the 
  95.03. 
The sa ple as found to contain the follo ing-l.33 +/- .010% t l i i i    
t.lw . i . 
he I  Percentage of each capsaicin old found in the sa ple is as follo s: 
 % 
ordihydrocapsaicin (N ) .33 
a saici  (C) 5.02 
ihydrocapsaicin (D ) 8.65 
The Scovllle eat Units (SHU) based on this assay calculates to 199,500. 
Submitted By: 
// .~ 
""'fa· e..- .  
arlin ensinger 
 
(This is an "exa ple of independent PLC Testing perfonning on S BRE Red. The 
arketing clai  for this product is 10% I 2,000,000 SHU's I 200,000 Scoville ontent I 
1.33% ajor Capsaicinoids. In this example, the lab has chosen to measure the SHU's of the 
e tire f nnulation, ic  e call t e scoville c ntent. s  ca  see i  t e a e sa ple, 
( 
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SHUs and Major Capsaicinolds
Report of Analysis
Date 324002





























Total SHU In formulation
1000
19955783
Percentage of Major Capsaicinoids 133
AOAC Method 99503
This Is an example of SECs In house HPLC Testing preformed on SABRE Red The marketing claim is
10 OC 2000 SHUs 2000 Scoville Content 133 Major Capsaicinoids Again SECslab
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(This Is an example of SEC's In-house HPLC Testing preformed on SABRE Red. The marketing claim is 
10% OC 12,000,000 SHU's 1200,000 Scoville Content 11.33% ajor Capsaicinolds. Again, SEC's lab 
r  t  HU's f t  tir  f r ulation, t t  HU's of t  r  ,  i  this sa ple our 




Why is it necessary to meet pungency specifications with each canister produced
Scenario 1 Spray exceeds pungency specifications
If the spray exceeds specifications not only will the decontamination period increase but
the potential also exists of causing permanent injury to those exposed to the spray
Scenario II Spray falls short ofpungency specifications
If the spray falls short of pungency specifications the spray may fail to assist the officer
while controlling and restraining the subject The inability of the spray to affect the subject
could result in injury to the officer Furthermore the officer would likely have to escalate
to a higher level of force increasing the likelihood of injury to the subject as well
Scenario III Spray used in field differs from spray used during training
During training exercises officers become familiar with the effects of the aerosol projector
used by their agency Expectations are developed from their training experience These
expectations affect their decision as to whether or not they should use their spray to control
a given subject depending upon the scenario at hand If the spray used in the field does not
meet similar pungency specifications as the spray used during training the effects of the
spray may take the officer by surprise which could lead to serious injury
SABRE USERSWILL NEVER HAVE OC FAILURES
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ce ari   - r  s  s cifi ti s . 
.  t  r   cifi ti , t l  ill t  t i ti  ri  i r e, t 
the potential also exists f causing per anent injury to those exposed to the spray. 
Scenario II -  ll  t   cifi ti . 
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ri  III - pray used in field differs fro  spray used during training. 
ri  trai i  e ercises, fficers ec e fa iliar it  t e effects f t e aer s l r ject r 
used by their agency. Expectations are developed fro  their training experience. These 
expectations affect their decision as to hether or not they should use their spray to control 
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t si il r  s ifications s t  s r  s  ri  tr i ing, t  ff ts f t  
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Since a governing body does not regulate the aerosol projector spray industry guidelines
involving the standards for measuring oleoresin content in formulations do not exist There
are two methods widely used to measure the capsaicin content They are ASTA Method 213
and AOAC method 99503 Both methods are very similar and an example of each is
demonstrated below The AOAC developed its method in 1996 The ASTA was in the
process of updating their Method 211 but instead decided to adopt AOAC This in effect
brought uniformity to the capsaicin assay procedure in the spice industry
Since Security Equipment Corporation is the only aerosol projector manufacturer that has
invested in HPLC technology we can provide our customers with a consistent level ofMajor
Capsaicinoids identified on our label This allows Security Equipment Corporation the
capability to carry more product lines and offer a wider variety of products because we do not
have to send samples of each batch of formulation to outside labs We can mix and fill
formulations in the same day where other manufacturers must wait weeks or skip this process
entirely
Comparison of AOAC and ASTA Methods for the Analysis of Maior
Capsaicinoids in OLEORESIN CAPSICUM Raw Material
The following chart represents samples of raw oleoresin capsicum that were tested via HPLC
analysis by both the AOAC method and the ASTA method The total capsaicin varies slightly
for the 10 OC @ 5000 SHU 1000 SHU and2000 SHU raw Oleoresin
Capsicum The Major Capsaicinoid percentage is also calculated below The Capsaicinoid
percentage also varies
Product Maior Capsaicinoids AOACMethod ASTA Method
05MMSHU Nordihydrocapsaicin N 16806 16810
10 OC @5000 Capsaicin C 299084 297306
Dihydrocapsaicin D 185811 184008
Total NCD 5017 498124
Capsaicionoid 33 31
10MM SHU Nordihydrocapsaicin N 49641 49623
10OC 01000 Capsaicin C 6879 2 68389
Dihydrocapsaicin D 429647 427093









i   i    t l t  t  l j t   i try, i lines 
i l i  t  st r s f r s ri  l r si  t t i  f r l ti s  t ist. r  
are t o ethods idely used to easure the capsaicin content. They are ST  ethod 21.3 
   95.03. oth ethods are very si ilar and an exa ple f each is 
de onstrated belo . The C developed its ethod in 1996. The ST  as in the 
process f updating their ethod 21.1 but instead decided to adopt . his in effect 
r t if r it  t  t e ca saici  assa  r ce re i  t e s ice i stry. 
i ce ec rit  i e t r ration is t e l  aer s l r ject r a fact rer t at as 
i este  i   t l gy,   r i  r t rs it   i t t l l  j r 
a saici ids i e tifie   r la el. is all s ec rit  i e t r rati  t e 
bilit  t  rr  r  r t li es  ffer  i r riet  f r cts, s    t 
have to send sa ples of each batch of for ulation to outside labs. e can ix and fill 
for ulations in the sa e day here other anufacturers ust ait eeks or skip this process 
entirely. 
is   q    s   s s  j  
oids   I   t rial: 
The follo ing chart represents sa ples of ra  oleoresin capsicu  that ere tested via PLC 
analysis by both the  ethod and the   ethod. he total capsaicin varies slightly 
f r t e 0%   0 ,0 0 , ,0 0,000  a  ,0 0,000  ra  le resi  
Capsicu . The ajor Capsaicinoid percentage is also calculated belo . The Capsaicinoid 
percentage also varies. 
t ajor apsaicinoids t   
.5  r i droca s i i  (N): 6,806 6,810 
0%   0 ,0 0 Capsaicin (C): 9 ,084 97,306 
ihydrocapsaicin (D): 185,811 84,008 
t l (N+C+D): 501,701 98,124 
apsaicionoid % .33% .31% 
.0  ordihydrocapsaicin (N): 49,641 49,623 
0%  @ ,0 0, 00 apsaicin (C): 687,982 83,893 
Dihydrocapsaicin CD): 429,647 427,093 
Total (N+C+D): ,1 7,270 ,1 0,609 
apsaicionoid % .78% .73% 
 
 
20MM SHU NordihydrocapsaicinN 62934










Because the AOAC ASTA Methods vary slightly one must determine the methods used
when comparing the Major Capsaicinoids different products
Why does Security Equipment Corporation useAOCMethod 99503
The AOAC is the analytical method provider for the Federal Government Federal Agencies






The bottom section on the front panel of every SABRE canister contains the above white box
This information is listed to increase officer safety and reduce agency liability by accurately
identifying most important features of a given canister Security Equipment Corporation uses
the superior Thermal Transfer TT system to list the above information which lends to long
term legibility The TT system uses a thermal transfer ribbon which burns the resin into the
canisterslabel Traditional systems which transfer ink directly onto the label tend to rub off
easily with minimalwear and tear while the TT system holds up for a considerably longer
period Each label contains the following information
DeliveEy System Identifies the spray pattern stream cone or foam
Expiration Date Identifies when the canister is no longer warranted by Security
Equipment Corporation When the expiration date is reached the canister must be
taken out of service and returned to the quartermaster for proper disposal Security
Equipment Corporation believes it is more beneficial to list the Expiration Date than
the Manufacture Date because the Manufacture Date does not identify when the
manufacturerswarranty expires
Batch Identifies the exact formulation mix within a given canister This number
matches up to a HPLC laboratory report which identifies the exact major capsaicinoid
content within a given canister
l






2.0  ordihydrocapsaicin (N): 2,934 62,951 
10%  @ 2,0 0, 00 a saicin (C): ,3 8,480 ,3 0,643 
ihydrocapsaicin (D): 3 ,777 729,415 
Total (N+C+D): ,1 5,192 2,1 3,009 
s i i id % .41 1.31 
ecause the O C & S  ethods vary slightly, one ust detennine the ethods used 
when co paring the ajor Capsaicinoids different products. 
hy oes rity ip e t r r tion se .O.A.C. ethod 95.03? 
he C is the analytical ethod provider for the ederal ovenunent. ederal gencies 
such as F , EP , E , T, , Coast uard, Border Patrol, and J lean to ards the 
 . 
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 tt  s ti   t  fr t l f r   ist r t i s t   it  x. 
This infonnation is listed to increase officer safety and reduce agency liability by accurately 
identifying ost i portant features f a given canister. ecurity quip ent orporation uses 
the superior Thennal Transfer (TT) system to list the above infonnation which lends to long 
tenn legibility. he  syste  uses a thennal transfer ribbon hich burns the resin into the 
canister's labe1. ra iti al s ste s ic  tra sfer i  irectl  t  t e la el te  t  r  ff 
easily with minimal wear and tear while the IT system holds up for a considerably longer 
period. Each label contains the follo ing infonnation: 
eliver  ste  - Identifies the spray pattern: strea , cone or foa  
Expiration Date - Identifies hen the canister is no longer arranted by ecurity 
Equip ent Corporation. hen the expiration date is reached, the canister ust be 
taken out of service and returned to the quartennaster for proper disposal. Security 
Equip ent orporation believes it is ore beneficial to list the Expiration ate than 
    t     t i ntif   t  
anufacturer's arra t  expires. 
 # - Identifies the exact fonnulation ix ithin a given canister. This nu ber 
atches up to a P  laboratory report hich identifies the exact ajor capsaicinoid 
c te t it i  a i e  canister. 










LevelI SABRE DEFENSE SABRE50
Level 11 SABRE506 SABRE CSO
Level III SABRERED SABRE ADVANCED
The higher the level the greater the incapacitating effect and the less likely the officer will
have to escalate to a higher level of force Furthermore use of force reduction will also
reduce injuries The lower the level the quicker the decontamination period will be
Level I Options
Level I sprays provide the entry level or lowest effective incapacitating level with the
advantage of the shortest decontamination period
SABRE DEFENSE@ 5100 Series
Our entry level formulation consists of 10 OC
measured at 33 major capsaicinoids
SABRE5 5500 Series
Containing5 OC measured at 37 major
capsaicinoids SABRE 5 provides a slightly
higher pungency than does SABRE Defense
Level II Options
Level II sprays are approximately twice as potent as level I sprays providing the medium level
of incapacitation without a significant increase to the decontamination period
SABRE CS 5400 Series
SABRE CS contains 15 CS Military Tear
Gas As reported in their Edgewood Arsenal
Publication the US Department of Defense found
CS to take effect quicker and be significantly more
potent than CN Tear Gas
SABRE50 5600 Series
5 OC measured at 67 major capsaicinoids
SABRE 50 is the midpoint between SABRE




I I  
Leve  I: 
Level II: 
Leve  I : 
 TIONS 
S BRE D SE® & S BRE 5.5® 
S BRE 5.0® & BRE ® 
S BRE R D® & S BRE  ED® 
he higher the level, the greater the incapacitating effect and the less likely the officer ill 
have to escalate to a higher level offorce. Furthermore, use offorce reduction will also 
reduce injuries. The lower the level, the quicker the decontamination period will be. 
evel I ptions: 
evel I sprays provide the entry level or lowest effective incapacitating level ith the 
advantage of the shortest decontamination period. 
SABRE DEFENSE® (5100 - eries) 
Our entry level formulation consists of 10% oe 
measured at .33% major capsaicinoids. 
SABRE 5.5® (5500 - Series) 
( Containing 5.5% oe measured at .37% major 
\ capsaicinoids, SABRE 5.5® provides a slightly 
higher pungency than does SABRE Defense®. 
Level n Options: 
Level II sprays are approximately twice as potent as level I sprays providing the medium level 
of incapacitation without a significant increase to the decontamination period. 
SABRE CS® (5400 - eries) 
 es® c tai s .5%  "Military" ear 
as. As reported in their Edgewood Arsenal 
Publication, the S epart ent of efense found 
CS to take effect quicker and be significantly more 
potent than eN Tear Gas. 
SABRE 5.0® (5600 - Series) 
5% oe measured at .67% major capsaicinoids, 
SABRE 5.0® is the, midpoint between SABRE 





Level III sprays provide maximum incapacitation requiring a longer decontamination period
SABRE RED 5200 Series
With 10 Oleoresin Capsicum measuring 133
major capsaicinoids SABRE REDe supplies
unsurpassed single ingredient stopping power
SABRE ADVANCED 5300 Series
The Advanced Formulation combines the
inflammatory benefits of OC with the irritant
advantages of CS to produce a more intense effect
than any single ingredient defense spray
SEC AEROSOL PROJECTOR OC COMPARISON CHART
Oleoresin Scoville Capsaicinoid
Product Capsicum SHUs Content Content
SABRE RED 10 2000 2000 133
SABRE 50 5 000 1000 67
SABRE5 5 1000 55000 37
SABRE DEFENSE 10 5000 50000 33
SABRE ADVANCED 25OC 2000 50000 33
Includes 15CS tear gas
The Major Capsaicinoid Content is the best heat producing indicator of Oleoresin Capsicum defense sprays





Level III Options: 
Level III sprays provide maximum incapacitation requiring a longer decontamination period. 
S BRE R D® (S200 - Series) 
ith 1 % Oleoresin Capsicu  eas ring 1.33% 
major capsaicinoids, S BRE ® supplies 
unsurpassed single ingredient stopping power. 
  ED® (53 0 - S ri ) 
The dvance  or ulation. ines the 
inflammatory benefits of C ith the irritant 
advantages of CS to produce a more intense effect 
than any single ingredient defense spray. 
  .PR J     
i  ill  i  
r ct Capsicu  s t t t t 
S EREDI8 0% ,0 0, 00 0 ,0 0 1.33% 
 S.ot % 2,0 0,000 0 ,0 0 .67% 
S.59 .5% ,000,000 5,0 0 .37% 
 ENSEe 0% 0 ,0 0 0,0 0 .33% 
  CED® .5%  ,000,000 0,0 0 .33% 
(Includes \.5% CS tear gas) 
The Major Capsaicinoid Content is the best heat producing indicator of Oleoresin Capsicum defense sprays. 







The propellant is responsible forpushing the liquid out of the canister
DPS Series
The SABRE Dual Propellant System DPS Series of defense sprays combine
pharmaceutical grade Dymel 134aPwhich is the safest and most advanced
propellant available worldwide with nitrogen gas Dymel meets the most stringent
requirements of health officials throughout the world because it is manufactured in full
compliance with the US Food Drug Administrations current Good Manufacturing
Practices cGMP DuPont began manufacturing Dymel primarily for oral sprays and
nasal inhalers Dymel is nonflammable and nonozone depleting
Because the SABRE DPS Series uses Dymel as part of its dual propellant the DPS
provides the following advantages
1 SABRE canisters contain up to two 2 times more active ingredient in
the exact same size cans as its competitors
MK3 Stream 201 second bursts
MK4Stream 351 second bursts
2 SABRE DPS products always fire a consistent distance because Dymel
maintains its original operating pressure from first to last shot As a result
the very last shot out of each SABRE canister is just as strong and forceful
and shoots just as far as the very first shot out of the can
The DPS Series includes nitrogen because nitrogen provides the following advantages
1 Nitrogen allows the stream delivery to reach up to 12 feet
2 Nitrogen increases the velocity of the spray pattern
H2O Series
The SABRE H2O Series uses nitrogen exclusively as the propellant By using only
nitrogen as the propellant the H2O Series provides the following advantages
1 Nitrogen allows the stream delivery to reach twelve 12 to fifteen 15 feet
or three 3 to four 4 meters
2 Nitrogen increases the velocity of the spray pattern
3 Nitrogen allows the H2O Series to fire effectively when exposed to zero







 r ll t i  r i l  f r i  t  li i  t  t  nister. 
PS Series 
he S  ual Propellant Syste  (DPS) Series of defense sprays co bine 
ti  e, l 34 alP ,        
ll t il l  rl i , it  it  s. l t  t  t tri t 
  l  f  t  t  rl       ll 
     & rug d inistrations "current ood, anufacturing 
Practices" (c P). uPont began anufacturing y el pri arily for oral sprays and 
asal i alers. el is fla a le a  -ozo e epleting. 
Because the S BRE PS Series uses y el as part of its dual propellant, the PS 
provides the follo ing advantages: 
.  s     (2)      
       tit r . 
-3 Strea  = -1  s 
-4 t  = -1  sts 
. E  r ts l s fir   sist t ist  s  l 
i t ins its ri inal r ti  r r  fr  fir t t  l t hot.   r sult, 
the very last shot out of each SABRE canister is just as strong and forceful, 
 s ts j st s f r s t  r  first s t t f t  . 
he  eries includes nitrogen because nitrogen provides the follo ing advantages: 
1. Nitrogen allows the stream delivery to reach up to 12 feet. 
2. Nitrogen increases the velocity of the spray pattern. 
0 ies 
The SABRE H20 Series uses nitrogen exclusively as the propellant. By using only 
nitrogen as the propellant, the 20 Series provides the following advantages: 
1. Nitrogen allows the stream delivery to reach twelve (12) to fifteen (15) feet 
r three (3)   (4) . 
. itroge  increases t e el city f t e s ra  atter . 
3. Nitrogen allows the 20 Series to fire effectively when exposed to zero 





The carrier is responsible for diluting the active ingredients and producing a liquid substance
The ideal carrier will allow for a homogenous solution which prevents the canister from
requiring shaking before it is used Additionally good effective carriers allow the product to
take effect immediately
Whether you chose the SABRE DPS or H2O Series both products contain ingredients which
mix completely to provide a homogenous solution As result SABRE products do not require
shaking before each usage
Like most manufacturers SEC views the percentage of its inactive ingredients and its carriers
as a trade secret as defined in Hazard Communications Act 29 CFR 191020 Para l 1 end
Appendix D to CFR 191020 and does not disclose this information Though formulations
can be patented the process requires complete disclosure of the entire formulation and
unfortunately formulations can be very closely copied without violation of existing patents
Countless hours of research development and laboratory testing have resulted in the creation
of the SABRE Aerosol Projectors and this commitment to offering the industries best
products continues today SEC is not willing to share these trade secrets with our
competitors
Although SEC does not disclose all ingredients we do confirm SABRE products do not
contain any chlorinated solvents which are linked to cancer These solvents include
Methylene Chloride Tetrachloroethylene and Trichloroethylene See Appendix for Material
Safety Data Sheets MSDS on the three 3 chlorinated solvents These ingredients increase
the likelihood of injuries agency liability and negative public relations for your agency It is
strongly recommended that you take a close look at the aerosol projector MSDS and
question themanufacturer regarding the usage of any chlorinated solvents before choosing the
aerosol projector for your agency
FLAMMABILITY CAUTION
CAUTION Most manufacturers claim their aerosol projectors are nonflammable and some
may even provide independent laboratory testing to serve as further evidence Be advised that
the EPA Flame Extension Test measures flammability by firing the aerosol projector through
a flame Unfortunately these results arenot relevant for agencies using Electronic
Immobilization Devices NONFLAMMABLE DOES NOT EQUAL EID
COMPATIBILITY
The use of EID brings to light a new set of circumstances Unlike the Flame Extension Test
with EID the concern relates to a spark coming into contact with the liquid from the aerosol
projector which has already reached the skin and clothing of the subject If the spark from an
EID reaches the area covered by the flammable aerosol projector injuries will occur The
bestway to prevent this problem from occurring is via usage of aerosol projectors which state
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The carrier is responsible for diluting the active ingredients and producing a liquid substance. 
he ideal carrier ill allo  for a ho ogenous solution, hich prevents the canister fro  
requiring shaking before it is used. dditionally, good, effective carriers allo  the product to 
take effect ~mediately. 
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CAUTION: ost manufacturers claim their aerosol projectors are nonflammable, and some 
may even provide independent laboratory testing to serve as further evidence. Be advised that 
the P  Fla e xtension est easures fla ability by firing the aerosol projector through 
a fla e. Unfortunately, these results are not relevant for agencies using Electronic 
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PATIBILITY! 
The use ofEID brings to light a new set of circu stances. Unlike the Fla e Extension Test, 
ith EI  the concern relates to a spark co ing into contact ith the liquid fro  the aerosol 
projector which has already reached the skin and clothing of the subject. If the spark from an 
EID reaches the area covered by the flammable aerosol projector, injuries will occur. The 
best way to prevent this problem from occurring is via usage of aerosol projectors which state 




Agencies should not assume that an aerosol projector is EID Compatible because a
manufacturer or an independent laboratory claims that it is nonflammable Instead they
should be absolutely certain of a productsflammability and EID compatibility status by
employing their own practical testing procedures IT IS IMPERATIVE THAT AGENCIES
TEST THEIR AEROSOL PROJECTORS IN CONJUNCTION WITH THEIR EID BEFORE
ISSUING BOTH TO THEIR PUBLIC SAFETY OFFICERS
EID COMPATIBILITY
Why the need for EID Compatibility
The demand for compatible aerosol projectors exists among agencies using electronic
immobilization devices EID Though the SABRED DPS series has successfully passed the
EPA Flame Extension Test Security Equipment Corporation SEC does not recommend
agencies use the SABRE DPS Stream formulations in conjunction with EIDs For additional
information on DPS compatibility please contact Robert NanceVP of Operations at 800
325 9568 or mance@sabresabreredcom
The methods of flammability testing which have been completed on SABRED Law
Enforcement aerosol projectors include
16 CFR 150045Flame Extension tests
Spraying a burning rag with the SABREa aerosol projector to determine flammability
Using a high voltage stun gun on a tshirt which has been saturated with the SABRE
aerosol projector
M26 Taser WorstCase Scenario
M26 Taser Timed Post Exposure Test
Both the H2O DPS Series of SABRED aerosol projectors pass the EPA Flame Extension
Test The SABREH2O Series extinguishes the burning rag and does not ignite the saturated
t shirt when shocked with a stun gun The SABREa DPS Series does not extinguish the
burning rag it does not extend the flame and will not ignite the saturated tshirt when
shocked with a stun gun not the M26 Taser
M26 TASER Compatibility Test Scenario
Security Equipment Corporation contacted Steve Tuttle Director ofGovernment Law
Enforcement Affairs for TASER International Mr Tuttle identified the testing process
required to most accurately determine the compatibility ofM26 TASER@ and the SABRE@
Law Enforcement Aerosol Projector The purpose of the test was to identify the worstcase
scenario when using a SABRE Aerosol Projector and the M26 TASER@ device The worst
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SABRE EID Compatible Products
SABRE offers an EID compatible solution in stream foam cone
All H2O Stream Delivery MK2 MK3 MK35 MK4 MK6 MK9MK46
All H2O Stream Crossfire Technology Products MK3 MK4
All H2O Foam Delivery MK2 MK3 MK35MK4 MK9
All DPS Cone Delivery MK2 MK3 MK35MK4
All DPS Heavy Foggers MK9
SABRE Non EID Compatible Products
All DPS Stream Delivery MK2 MK3 MK35MK4 MK6
Beginning August 1 2003 Security Equipment Corporation began marking the EID
Compatibility status on all SABRE canisters Agencies with SABRE canisters which were
purchased prior to 8103 and do not mention EID compatibility should disregard the above
lists and do the following
1 Contact Robert Nance at 800 3259568VPof Operations
2 Perform the M26 Taser test documented above with their OC
SECURITY EQUIPMENT CORPORATION STRONGLY RECOMMENDS AGENCIES
USING BOTH AEROSOL PROJECTORS AND ELECTRONIC IMMOBILIZATION
DEVICES CONDUCT THEIR OWN WELL DOCUMENTED COMPATIBILITY TESTING




C FI I L 
SABRE I  atible Pr ducts 
SABRE o fers an EID co patible solution in stream. foa  & cone. 
All 20 Stream Delivery (MK-2, K-3, -3.S, K-4, K-6, K-9, K-46) 
A l 20 tream Crossfire Technology Products (MK-3 & K-4) 
All 20 Foam elivery (MK-2, -3, -3.S, K-4, K-9) 
All  ne elivery (MK-2, -3, -3.S, K-4) 
All DPS Heavy Foggers (MK-9) 
  I  ti le r ts 
ll S tream liv ry (MK-2, -3, -3.5, -4, -6) 
Beginning August 1st, 2003, Security Equipment Corporation began marking the ElD 
Compatibility status on all SABRE canisters. Agencies with SABRE canisters which were 
purchased prior to 8/1/03 arid do not mention EID compatibility should disregard the above 
lists and do the follo ing: 
1). Contact Robert Nance at 800-325-9568 (V.P. of Operations) 
2). Perfor  the 26 Taser® test docu ented above with their OC. 
SECURITY EQUIP ENT CORPORATION STRONGLY RECO ENDS AGENCIES 
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SPRAY PATTERNS DELIVERY SYSTEM





4 Heavy Fogger MK9
5 High Volume StreamerMK9 MK46
Each of the above spray patternsprovides the officer advantages and disadvantages Officers
should train periodically with inert units to master their proficiency of the delivery system





Range of up to 12 feet H20 15 feet or 3 to 4 meters
Good visualization process of acquisition area
Disadvantage
Limited effect on the respiratory system
Contact with eyes is imperative for an immediate affect
Spray from ear to ear across the eyes If possible use a Z like pattern
spraying across the eyes down the nose and across the mouth This is a
suggestion IFPOSSIBLE Do you want it removed I think its fine
At five 5 feet or 15 meters the stream delivery has a diameter of four 4
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 ERNS - E   
he S  a  nforce ent aerosol projectors utilize all five, defense spray delivery 
s ste s: 
.  
2. one /Fog 
.  
4. eavy Fogger (M -9) 
5. igh olu e trea er (MK-9 & -4 ) 
ach of the above spray patterns provides the officer advantages and disadvantages. fficers 
s l  train ri i ll  it  i ert its t  st r t ir r fi ie  f t  li r  s st  
used by their agency. 
 
dvantages 
~   i ti . 
~   -ba . 
~ a e f  t  12 feet (H2O =  t)     . 
~ ood visualization process of acquisition area. 
isadvantage 
~ Li ited effect on the respiratory system. 
~ ontact ith eyes is i perative for an i ediate affect. 
Spray fro  ear to ear across the eyes. If possible, use a. Z like pattern 
spraying across the eyes down the nose and across the mouth. is i   
suggestion, IF P SSIBLE. o you aut it re oved? I think it's fine. 
At five (5) feet or 1.5 meters, the stream delivery has a diameter of four (4) 







Requires less accuracy making it easier to contact subject
Microscopic droplets inflame the respiratory tract
Effects occur instantly through penetration of microscopic
droplets
Disadvantages
Areas surrounding target may be contaminated
Individuals surrounding target may be contaminated
Down wind contamination is increased
Does not fire as far as the stream spray pattern
Lowest visualization process of all patterns
Aim for the center of the face and spray while moving canister up and
down The Cone Fog delivery fires approximately ten 10 feet or three 3
meters with increased distance if the wind is at your back
At five 5 feet or 15meters the cone fog delivery has a diameter of twelve





a ta es 
> equires less accuracy aking it easier to contact subject. 
> icros i  r l t  i fla  t  r ir t r  tr t. 
> fe ts  t      
droplets. . 
is a ta  
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>     d. 
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i  for the center of the face and spray hile oving canister up and 
do n. he one / og delivery fires approxi ately ten (10) feet or three (3) 
eters it  i crease  ista ce if t e in  is at r ack. 
t fi  (5) f t r .5 t rs, t  e / f  li r  s  i t r f t l  






j Gel substances trap the heat of OC on the skin
Wiping foam from skinpushes the OC into the skin
Reduces contamination ofunwanted areas individuals
Ideal for indoor usage
Provides the greatest visualization process of all patterns
Disadvantages
Effects may be delayed especially in cold weather
Subject can throw foam back at the officer
Aim for the center of the face and move canister in a circular motion The
Foam delivery fires approximately six 6 to eight 8 feet or two 2 to two
and a half25meters
At five 5 feet or 15 meters the foam delivery has a diameter of eight 8
inches twenty 20 centimeters
HEAVY FOGGER MK9 Crowd Management Unit
Advantages
Covers a wide area
Fires up to twenty five 25 feet eight 8 meters or further
with wind at your back
Excellent for crowd management
Microscopic droplets are easily inhaled by those in the area
Disadvantage
Increases contamination ofunwanted areas individuals
Aim towards the face of the closest subject and move from side to side
At fifteen 15 feet or45meters the heavy fogger delivery has a diameter of






~ l t  t  t  t    t  i . 
~ i i  f  fr  s i  s s t   i t  t  skin. 
~      & l . 
~    . 
~ r i es t e reatest is alizati  r cess f all atter s. 
isadvantages 
~ ffects ay be delayed, especially in cold eather. 
~ Subject can thro  foa  back at the officer. 
    f         ti .  
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and a half (2.5) eters. 
t fi e (5) feet r .5 eters, t e f a  eli er  as a ia eter f ei t (8) 
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  - -9 ro d anage ent nit 
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~    . 
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ith ind at your back. 
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~ creas      & i i i l . 
i  to ards the face of the closest subject and ove fro  side to side. 
t fifteen (15) feet or 4.5 eters the heavy fogger delivery has a dia eter of 




HIGH VOLUME STREAMER MK9 Crowd Management Unit
Advantages
Excellent for crowd management
Fires up to thirty 30 feet nine 9 meters
Disadvantage
Does not cover wide areas as well as the Heavy Fog Blast
Aim towards the upper torso or head of the subject and move from side to
side
At fifteen 15 feet or 45 meters the highvolume streamer delivery has a
diameter of fifteen 15 inches thirtyeight 38 centimeters
CELL BUSTERS
Cell Busters reduces the need to make Hard Entries during the cell extraction process Cell
Busters consists of an 185oz MK9 canister with hose and wand attachment and deliveries a
heavy fog of SABRE REDS Thewand can be maneuvered underneath cell doors through
vents the food slot or other openings which lead into the cell The heavy fog delivery will
reach the top portion of the rear wall of the cell when being deployed from the floor
underneath the cell door
Set Up
You must attach the hose to the housing assembly of Cell Bustersbefore deployment Insert
hose into the extraction assembly located at the canistersnozzle Pull in opposite directions
to ensure hose is securely attached If after pulling away from assembly the hose comes lose
push the hose further into the assembly to ensure it locks into place Once this is done pull
again in opposite directions to ensure hose is securely attached
Deploy
Slide wand under the cell door and mattress if possible Remove safety pin and press yellow
trigger with thumb for three 3 continuous seconds Move wand side to side while
deploying This will help prevent the inmate from grabbing the wand After deploying for
three 3 seconds immediately remove wand from cell and wait for product to take affect
If the product does not produce the desired affect within a few minutes repeat the above
process If after two 2 attempts the desired affect is not achieved secure Cell Busters in its
storage locker and then resort to the next appropriate level of force The inmate should not be
left in a cell which has been exposed to SABRE RED
Secure
Since Cell Busters delivers a heavy fog of SABRE RED into the cell the product will
produce the desired affect with most contaminations In order to increase officer safety Cell
Busters should be secured in its storage locker before entering the cell Although safety
devices have been built into Cell Busters to prevent puncture wounds reduce injuries by t
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IDG  O U E E  - -9 ro d anage ent t 
dvantages 
~ Exce lent for crowd a . 
~ Fires up to thirty (30) feet / nine (9) eters. 
isadvantage 
~ oes not cover ide reas s ell  the ea  Fog la . 
i  towards the upper torso or head of the subject and ove fro  side to 
. 
t fifteen (15) feet or 4.5 eters the high volume strea er delivery has a 
ia eter f fiftee  (15) inches / thirty-eight (3 ) ce ti eters. 
 ® 
ell ster®re uces the eed t  a e "Hard tries" ring t e cell e traction r cess. ell 
t r® sists   8.5 OZ, -9 i t r ith s    tt t  liveries  
heavy fog of S  ®. he and can be aneuvered underneath cell doors, through 
e ts, t e f  sl t r t er e ings ich lea  i t  t e cell. e ea  f  eli er  ill 
reach the top portion of the rear all of the cell hen being deployed fro  the floor 
r t  t e ll r. 
Set p 
ou ust attach the hose to the housing asse bly of ell uster® before deploy ent. Insert 
se i t  t  tr ti  ss l  l cate  t t e nister's l . ll i  site ir ti s 
to ensure hose is securely attached. If after pulling a ay fro  asse bly the hose co es lose, 
push the hose further into the asse bly to ensure it locks into place. nce this is done, pull 
again in opposite directions to ensure hose is securely attached. 
Deploy 
Slide wand under the cell door and mattress, if possible. Remove safety pin and press yellow 
trigger ith thu b for three (3) continuous seconds. ove and side to side hile 
deploying. This will help prevent the inmate from grabbing the wand. After deploying for 
three (3) seconds, i ediately re ove wand fro  cell and wait for product to take affect. 
If the product does not produce the desired affect within a few minutes, repeat the above 
process. If after two (2) attempts the desired affect is not achieved, secure Cell Buster® in its 
storage locker and then resort to the next appropriate level of force. The in ate should not be 
left in a cell hich has been exposed to S E ED. 
 
Since Cell Buster® delivers a heavy fog of SABRE RED into the cell, the product will 
produce the desired affect with ost contaminations. In order to increase officer safety, Cell 
uster® should be secured in its storage locker before entering the cell. lthough safety 
devices have been built into Cell Buster® to prevent puncture wounds, reduce injuries by ( 




Securing the product before making the entry will also prevent it from being used on
correction officers
In unique circumstances you may not be able to secure Cell Buster before making your
entry In these situations do not use the wand Removewand from hose and leave it in the
secured storage locker Remove by pulling the compression fitting toward the wand and pull
the hose out
Reattach wand by pushing hose into the compression fitting at end of wand Listen for snap
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Securing the product before aking the entry ill also prevent it fro  being used on 
rr ti  ffi r . 
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secured storage locker. e ove by pulling the co pression fitting to ard the and and pull 
 s  t. 
eattach and by pushing hose into the co pression fitting at end of and. isten for snap 






These grenades are designed for control and disbursement of crowds or securing and
denying an area They are also a very effective tool for Cell Extractions They are designed to
be hand held or thrown into an area The grenade will spin or roll when delivered onto a hard
surface providing full coverage of the area They are non flammable and may be delivered
into carpeted areas as well The contents will aerosolize and remain airborne for a long period
of time The locking actuator provides for continuous discharge of the canister contents
MK3 Payload of this munition is 2 ounces 56 grams 60 ml and empties in
approximately 6 seconds It has an approximate coverage area of 10000 cubic feet 283 cubic
meters in 60 seconds time will be shorter for smaller rooms
MK5 Payload of this munition is 5 ounces 140 grams 150 ml and empties in
approximately 14 seconds It has an approximate coverage area of 22000 cubic feet 623
cubic meters in 60 seconds time will be shorter for smaller rooms
Advantages Helps to disperse large crowds Useful for securing or denying areas Can be
hand held or delivered into the area
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denying an area. They are also a very effective tool for Cell Extractions. They are designed to 
b~ hand held or thrown into an area. he grenade ill spin or roll hen delivered onto a hard 
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into carpeted areas as ell. The contents ill aerosolize and re ain airborne for a long period 
of ti e. he locking actuator provides for continuous discharge of the canister contents. 
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a r i ately  sec s. It as a  a r imate c era e area f 0, 0 c ic feet /  c ic 
eters in 60 seconds (time ill be shorter for s aller roo s). 
-5 - Payload of this unition is 5 ounces/ 140 gra s/ 150 l, and e pties in 
approxi ately 14 seconds. It has an approxi ate coverage area of 22,000 cubic feet / 623 
i  t r  i   s (time ill  rt r f r ller r s). 
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WARNING NEVER UNSCEW THE FIRING MECHANISM OF A CHARGED UNIT
THESE UNITS ARE UNDERHIGH PRESURE
The SABRE MK 46 Crowd Management unit is designed to gain control or disperse crowds
Practical scenarios for deployments of the MK46 include protests large entertainment
venues and correctional facilities mess halls yards
Fill Refill Instructions
EYE PROTECTION AND RUBBER GLOVES REQUIRED
PRESSURIZE WITH NITROGEN ONLY
WARNING THE DISPENSER MAY RUPTURE IF OVER PRESSURIZED DO NOT
ATTEMPT PRESSURIZATION WITHOUT A REGULATED CHARGING SOURCE DO
NOTUSE LOCKING TYPE INFLATION CHUCKS
1 Invert canister and depress valve lever to release all remaining pressure
2 Making sure the dispenser has no pressure remaining Then unscrew the valve head
from the bottle and carefully empty any remaining formulation Dispose of remaining
formulation according to local regulations
3 Place funnel into neck of bottle and carefully pour the premeasured contents into
canister NOTE Do not put live formulation in a unit marked for Inert
000762
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he S  -46 ro d anage ent unit is designed to gain control or disperse cro ds. 
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fro  the bottle and carefully e pty any re aining for ulation. ispose of re aining 
for ulation according to local regulations. 
3. lace funnel into neck f bottle and carefully pour the pre- easured contents into 







4 Replace O ring on the valve and place valve back onto canister and hand tighten
NOTE If filling new hardware for the first time valve will already be equipped with
ORing
5 Remove the protective cap from the Schrader Valve
6 Before beginning pressurization verify that the inflation chuck does not lock down on
the stem
7 Turn on nitrogen gas c lender and adjust the regulator to approximately 250 PSI
Maw X
S Prepare the canister for pressurization by inverting the canister
9 Engage the air chuck and begin pressurizing Disengage the air chuck when the
needle on the gauge is in the green
WARNING NEVER EXCEED 300 PSI WHILE PRESSURIZING IF YOU HEARA
HISSINGNOISE STOP PRESSURIZATION WHILE PRESSURIZING IF THE GUAGE





4. l  -ri  on the l  an  l  valv  back ont  canist r and h  ti hten. 
( E: If filling ne  hard are for the first ti e; valve ill already be equipped ith 
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. a e t e air c c  a  e i  ressurizi . ise a e t e air c c  e  t e 
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j 10 If the canister is accidentally over pressurized depress the valve lever while holding
the canister in an inverted position to relieve the excess pressure
11 Replace the protective cap on the Schrader Valve
Transport
The SABRE MK 46 should be carried via its secure canister holstershoulder strap The
shoulder strap allows easy transport of the MK46 and one hand deployment
Deploy
Remove safety pin behind trigger Pull trigger to fire at subject face and upper body in Y2 to
one 1 second bursts Stop firing by releasing pressure from the trigger
Do not discharge at distances of less than twelve 12 feet four 4 meters Deploying from
at distances of less than twelve 12 feet four 4meters may cause soft body tissue injuries
Avoid discharge into headwinds or shield face to prevent blow back exposure
Monitor
Periodically monitor the MK46 to ensure the pressure gauge is within the green area
If used and not completely emptied the unit can be stored according to manufacturer
recommendation and can be used until the expiration date of the OC
If you are refilling the canister you must clearer attach the date of filling and the expiration
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10. If the canister is accidentally over pressurized, depress the valve lever while holding 
the canister in an inverted position to relieve the excess pressure. 
. e lace t e r tective cap  t e c ra er al e. 
ra s rt 
he E -46 ld  e  ia ts   /shoulder . e 
l e  trap llo s e s  t t  t  K-46  e  l nt. 
eploy 
e ve s f t  i  e ind tri r. ll trigger t  fir  t s bject's f   r  i  Y2 t  
one (1) second bursts. Stop firing by releasing pressure fro  the trigger. 
 t ischarge at istances fless t a  t elve (1 ) feet / f r (4) eters. e l i  fr  
t ista ces f less t  t l  (1 ) f t / f r (4) eters   ft  tissue i j ri . 
void discharge into head inds or shield face to prevent blo  back exposure. 
 
eri icall  it r t e -46 t  e s re t e ress re a e is it i  t e ree  area. 
l     e          
r ti     s  til t  ir ti  t  f t  ~C. 
If you are reftlling the canister, you ust clearly attach the date of filling and the expiration 
date of the refill product in a visible location. 
l e art: 
rig!;l6r Solely Pin 
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